PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kawai, T; Akira, S				Kawai, Taro; Akira, Shizuo			The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors	NATURE IMMUNOLOGY			English	Review							PLASMACYTOID DENDRITIC CELLS; NF-KAPPA-B; SYSTEMIC-LUPUS-ERYTHEMATOSUS; INDEPENDENT ANTIVIRAL RESPONSE; AICARDI-GOUTIERES-SYNDROME; I INTERFERON; CRYSTAL-STRUCTURE; ANTIMICROBIAL PEPTIDE; SIGNAL-TRANSDUCTION; NEGATIVE REGULATOR		[Kawai, Taro; Akira, Shizuo] Osaka Univ, Host Def Lab, World Premier Int Immunol Frontier Res Ctr, Osaka, Japan; [Kawai, Taro; Akira, Shizuo] Osaka Univ, Dept Host Def, Microbial Dis Res Inst, Osaka, Japan	Osaka University; Osaka University	Akira, S (corresponding author), Osaka Univ, Host Def Lab, World Premier Int Immunol Frontier Res Ctr, Osaka, Japan.	sakira@biken.osaka-u.ac.jp	Akira, Shizuo/C-3134-2009	Kawai, Taro/0000-0001-7510-4662	NIAID NIH HHS [P01 AI070167] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI070167] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akashi-Takamura S, 2008, CURR OPIN IMMUNOL, V20, P420, DOI 10.1016/j.coi.2008.07.001; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; An HZ, 2008, NAT IMMUNOL, V9, P542, DOI 10.1038/ni.1604; Asagiri M, 2008, SCIENCE, V319, P624, DOI 10.1126/science.1150110; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; Carrick DM, 2004, ARTHRITIS RES THER, V6, P248, DOI 10.1186/ar1441; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Chang M, 2009, NAT IMMUNOL, V10, P1089, DOI 10.1038/ni.1777; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Coban C, 2010, CELL HOST MICROBE, V7, P50, DOI 10.1016/j.chom.2009.12.003; Croker BA, 2008, P NATL ACAD SCI USA, V105, P15028, DOI 10.1073/pnas.0806619105; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Ermolaeva MA, 2008, NAT IMMUNOL, V9, P1037, DOI 10.1038/ni.1638; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Fairhurst AM, 2008, EUR J IMMUNOL, V38, P1971, DOI 10.1002/eji.200838138; FERNANDESALNEMR.T, 2010, NAT IMMUNOL     0328, DOI DOI 10.1038/NI1859; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Goodridge Helen S., 2008, V183, P87; Guillot L, 2002, J IMMUNOL, V168, P5989, DOI 10.4049/jimmunol.168.12.5989; Haas T, 2008, IMMUNITY, V28, P315, DOI 10.1016/j.immuni.2008.01.013; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; HACKER H, 2006, SCI STKE, V357, pRE13, DOI DOI 10.1126/STKE.3572006RE13; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Jung A, 2008, J VIROL, V82, P196, DOI 10.1128/JVI.01640-07; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Kawagoe T, 2009, NAT IMMUNOL, V10, P965, DOI 10.1038/ni.1771; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Kiyokawa T, 2008, INT IMMUNOL, V20, P1407, DOI 10.1093/intimm/dxn098; Koyama S, 2007, J IMMUNOL, V179, P4711, DOI 10.4049/jimmunol.179.7.4711; Kumar H, 2008, J IMMUNOL, V180, P683, DOI 10.4049/jimmunol.180.2.683; Kuwata H, 2006, IMMUNITY, V24, P41, DOI 10.1016/j.immuni.2005.11.004; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lee PY, 2008, J EXP MED, V205, P2995, DOI 10.1084/jem.20080462; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; Marshak-Rothstein A, 2007, ANNU REV IMMUNOL, V25, P419, DOI 10.1146/annurev.immunol.22.012703.104514; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Matsumoto F, 2008, BIOCHEM BIOPH RES CO, V367, P693, DOI 10.1016/j.bbrc.2007.12.130; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Okabe Y, 2009, NATURE, V460, P520, DOI 10.1038/nature08138; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Palsson-McDermott EM, 2009, NAT IMMUNOL, V10, P579, DOI 10.1038/ni.1727; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Peter ME, 2009, J IMMUNOL, V182, P7690, DOI 10.4049/jimmunol.0900819; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Pobezinskaya YL, 2008, NAT IMMUNOL, V9, P1047, DOI 10.1038/ni.1639; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Rowe DC, 2006, P NATL ACAD SCI USA, V103, P6299, DOI 10.1073/pnas.0510041103; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Sepulveda FE, 2009, IMMUNITY, V31, P737, DOI 10.1016/j.immuni.2009.09.013; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Shi M, 2008, NAT IMMUNOL, V9, P369, DOI 10.1038/ni1577; Shinohara ML, 2006, NAT IMMUNOL, V7, P498, DOI 10.1038/ni1327; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takahashi K, 2007, J EXP MED, V204, P2963, DOI 10.1084/jem.20071132; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Tanimura N, 2008, BIOCHEM BIOPH RES CO, V368, P94, DOI 10.1016/j.bbrc.2008.01.061; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; Tsujimura H, 2004, J IMMUNOL, V172, P6820, DOI 10.4049/jimmunol.172.11.6820; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6; Vollmer J, 2005, J EXP MED, V202, P1575, DOI 10.1084/jem.20051696; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; YANG H, 2009, BIOCHIM BIOPHYS ACTA, V1799, P149; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599	136	5811	6198	41	1343	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2010	11	5					373	384		10.1038/ni.1863	http://dx.doi.org/10.1038/ni.1863			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	585TN	20404851				2022-12-18	WOS:000276852200006
J	Fontenot, JD; Gavin, MA; Rudensky, AY				Fontenot, JD; Gavin, MA; Rudensky, AY			Foxp3 programs the development and function of CD4(+)CD25(+) regulatory T cells	NATURE IMMUNOLOGY			English	Article							SCURFY MOUSE MUTANT; INTESTINAL INFLAMMATION; POSITIVE SELECTION; SF MOUSE; MICE; IL-2; AUTOIMMUNITY; HOMEOSTASIS; ENTEROPATHY; TOLERANCE	CD4(+)CD25(+) regulatory T cells are essential for the active suppression of autoimmunity. Here we report that the forkhead transcription factor Foxp3 is specifically expressed in CD4(+)CD25(+) regulatory T cells and is required for their development. The lethal autoimmune syndrome observed in Foxp3-mutant scurfy mice and Foxp3-null mice results from a CD4(+)CD25(+) regulatory T cell deficiency and not from a cell-intrinsic defect of CD4(+)CD25(-) T cells. CD4(+)CD25(+) regulatory T cells rescue disease development and preferentially expand when transferred into neonatal Foxp3-deficient mice. Furthermore, ectopic expression of Foxp3 confers suppressor function on peripheral CD4(+)CD25(-) T cells. Thus, Foxp3 is a critical regulator of CD4(+)CD25(+) regulatory T cell development and function.	Univ Washington, Dept Immunol, Howard Hughes Med Inst, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Rudensky, AY (corresponding author), Univ Washington, Dept Immunol, Howard Hughes Med Inst, Box 357370, Seattle, WA 98195 USA.							Almeida ARM, 2002, J IMMUNOL, V169, P4850, DOI 10.4049/jimmunol.169.9.4850; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Barton GM, 1999, SCIENCE, V283, P67, DOI 10.1126/science.283.5398.67; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; BLAIR PJ, 1994, J IMMUNOL, V153, P3764; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Clark LB, 1999, J IMMUNOL, V162, P2546; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; Grubin CE, 1997, IMMUNITY, V7, P197, DOI 10.1016/S1074-7613(00)80523-3; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kanangat S, 1996, EUR J IMMUNOL, V26, P161, DOI 10.1002/eji.1830260125; LYON MF, 1990, P NATL ACAD SCI USA, V87, P2433, DOI 10.1073/pnas.87.7.2433; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Murakami M, 2002, P NATL ACAD SCI USA, V99, P8832, DOI 10.1073/pnas.132254399; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Tommasini A, 2002, CLIN EXP IMMUNOL, V130, P127, DOI 10.1046/j.1365-2249.2002.01940.x; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707	26	5715	6230	21	382	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2003	4	4					330	336		10.1038/ni904	http://dx.doi.org/10.1038/ni904			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	663CG	12612578				2022-12-18	WOS:000181987700011
J	Akira, S; Takeda, K; Kaisho, T				Akira, S; Takeda, K; Kaisho, T			Toll-like receptors: critical proteins linking innate and acquired immunity	NATURE IMMUNOLOGY			English	Review							CELL WALL COMPONENTS; BACTERIAL CPG-DNA; NF-KAPPA-B; CUTTING EDGE; DENDRITIC CELLS; PATTERN-RECOGNITION; DIFFERENTIAL EXPRESSION; ACTIVATION; LIPOPOLYSACCHARIDE; TLR4	Recognition of pathogens is mediated by a set of germline-encoded receptors that are referred to as pattern-recognition receptors (PRRs). These receptors recognize conserved molecular patterns (pathogen-associated molecular patterns), which are shared by large groups of microorganisms. Toll-like receptors (TLRs) function as the PRRs in mammals and play an essential role in the recognition of microbial components. The TLRs may also recognize endogenous ligands induced during the inflammatory response. Similar cytoplasmic domains allow TLRs to use the same signaling molecules used by the interleukin I receptors (IL-I Rs): these include MyD88, IL-IR-associated protein kinase and tumor necrosis factor receptor-activated factor 6. However, evidence is accumulating that the signaling pathways associated with each TLR are not identical and may, therefore, result in different biological responses.	Osaka Univ, Dept Host Def, Microbial Dis Res Inst, Osaka 5650871, Japan; Japan Sci & Technol Corp, SORST, Tokyo, Japan	Osaka University; Japan Science & Technology Agency (JST)	Akira, S (corresponding author), Osaka Univ, Dept Host Def, Microbial Dis Res Inst, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp	Takeda, Kiyoshi/C-9331-2009; Li, Chia Cheng/D-9906-2015; Kaisho, Tsuneyasu/B-4130-2012					Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Anderson KV, 2000, CURR OPIN IMMUNOL, V12, P13, DOI 10.1016/S0952-7915(99)00045-X; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bauer M, 2001, J IMMUNOL, V166, P5000, DOI 10.4049/jimmunol.166.8.5000; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; BUAER S, 2001, IN PRESS P NATL ACAD; CHANG TH, 2001, BIOCHIM BIOPHYS ACTA, V1518, P157; Chu WM, 1999, IMMUNITY, V11, P721, DOI 10.1016/S1074-7613(00)80146-6; Chu WM, 2000, CELL, V103, P909, DOI 10.1016/S0092-8674(00)00194-X; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; Du X, 2000, EUR CYTOKINE NETW, V11, P362; Eaves-Pyles T, 2001, J IMMUNOL, V166, P1248, DOI 10.4049/jimmunol.166.2.1248; Faure E, 2000, J BIOL CHEM, V275, P11058, DOI 10.1074/jbc.275.15.11058; Flo TH, 2000, J IMMUNOL, V164, P2064, DOI 10.4049/jimmunol.164.4.2064; Frantz S, 2001, J BIOL CHEM, V276, P5197, DOI 10.1074/jbc.M009160200; Hacker H, 2000, J EXP MED, V192, P595, DOI 10.1084/jem.192.4.595; Hacker H, 1999, EMBO J, V18, P6973, DOI 10.1093/emboj/18.24.6973; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Heine H, 1999, J IMMUNOL, V162, P6971; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kadowaki N, 2001, J IMMUNOL, V166, P2291, DOI 10.4049/jimmunol.166.4.2291; Kaisho T, 2001, TRENDS IMMUNOL, V22, P78, DOI 10.1016/S1471-4906(00)01811-1; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawasaki K, 2000, J BIOL CHEM, V275, P2251, DOI 10.1074/jbc.275.4.2251; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Kodaira Y, 2000, J IMMUNOL, V165, P1599, DOI 10.4049/jimmunol.165.3.1599; Krieg AM, 2000, IMMUNOL TODAY, V21, P521, DOI 10.1016/S0167-5699(00)01719-9; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Liu YJ, 2001, NAT IMMUNOL, V2, P585, DOI 10.1038/89726; MARCO AS, 2001, J IMMUNOL, V167, P416; Matzinger P, 1998, SEMIN IMMUNOL, V10, P399, DOI 10.1006/smim.1998.0143; Means TK, 1999, J IMMUNOL, V163, P3920; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Opitz B, 2001, J BIOL CHEM, V276, P22041, DOI 10.1074/jbc.M010481200; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Poltorak A, 2000, P NATL ACAD SCI USA, V97, P2163, DOI 10.1073/pnas.040565397; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pulendran B, 2001, TRENDS IMMUNOL, V22, P41, DOI 10.1016/S1471-4906(00)01794-4; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Rudolph D, 2000, GENE DEV, V14, P854; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Seki E, 2001, J IMMUNOL, V166, P2651, DOI 10.4049/jimmunol.166.4.2651; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Sousa CRE, 1999, CURR OPIN IMMUNOL, V11, P392, DOI 10.1016/S0952-7915(99)80066-1; Steiner TS, 2000, J CLIN INVEST, V105, P1769, DOI 10.1172/JCI8892; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Takeuchi O, 1999, GENE, V231, P59, DOI 10.1016/S0378-1119(99)00098-0; Takeuchi O, 2000, J IMMUNOL, V164, P554, DOI 10.4049/jimmunol.164.2.554; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Takeuchi O, 2000, INT IMMUNOL, V12, P113, DOI 10.1093/intimm/12.1.113; Termeer CC, 2000, J IMMUNOL, V165, P1863, DOI 10.4049/jimmunol.165.4.1863; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; Tokunaga T, 1999, JPN J INFECT DIS, V52, P1; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Visintin A, 2001, J IMMUNOL, V166, P249, DOI 10.4049/jimmunol.166.1.249; Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354; WHITHAM S, 1994, CELL, V78, P1101, DOI 10.1016/0092-8674(94)90283-6; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Yoshimura A, 1999, J IMMUNOL, V163, P1	83	3640	3994	19	541	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2001	2	8					675	680		10.1038/90609	http://dx.doi.org/10.1038/90609			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	459BN	11477402				2022-12-18	WOS:000170230100008
J	Harrington, LE; Hatton, RD; Mangan, PR; Turner, H; Murphy, TL; Murphy, KM; Weaver, CT				Harrington, LE; Hatton, RD; Mangan, PR; Turner, H; Murphy, TL; Murphy, KM; Weaver, CT			Interleukin 17-producing CD4(+) effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages	NATURE IMMUNOLOGY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IFN-GAMMA PRODUCTION; INTERFERON-GAMMA; TH1 DEVELOPMENT; TRANSCRIPTION FACTOR; TARGETED DISRUPTION; DENDRITIC CELLS; MICE; BET; CYTOKINE	CD4(+) T cells producing interleukin 17 (IL-17) are associated with autoimmunity, although the precise mechanisms that control their development are undefined. Here we present data that challenge the idea of a shared developmental pathway with T helper type 1 (T(H)1) or T(H)2 lineages and instead favor the idea of a distinct effector lineage we call 'T-H-17'. The development of T-H-17 cells from naive precursor cells was potently inhibited by interferon-gamma (IFN-gamma) and IL-4, whereas committed T-H-17 cells were resistant to suppression by T(H)1 or T(H)2 cytokines. In the absence of IFN-gamma and IL-4, IL-23 induced naive precursor cells to differentiate into T-H-17 cells independently of the transcription factors STAT1, T-bet, STAT4 and STAT6. These findings provide a basis for understanding how inhibition of IFN-gamma signaling enhances development of pathogenic T-H-17 effector cells that can exacerbate autoimmunity.	Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol & Immunol, St Louis, MO 63110 USA	University of Alabama System; University of Alabama Birmingham; Howard Hughes Medical Institute; Washington University (WUSTL)	Weaver, CT (corresponding author), Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA.	weaver@path.uab.edu		Weaver, Casey/0000-0002-2180-1793; Hatton, Robin/0000-0002-4797-9899	NIAID NIH HHS [T32 AI007051, AI035783, AI057956] Funding Source: Medline; NIDDK NIH HHS [DK64400] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035783, R01AI057956, R21AI035783, T32AI007051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064400] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Berenson LS, 2004, IMMUNOL REV, V202, P157, DOI 10.1111/j.0105-2896.2004.00208.x; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Bettelli E, 2005, J EXP MED, V201, P169, DOI 10.1084/jem.20042279; BOTTOMLY K, 1988, IMMUNOL TODAY, V9, P268, DOI 10.1016/0167-5699(88)91308-4; Chitnis T, 2001, J CLIN INVEST, V108, P739, DOI 10.1172/JCI200112563; Cho JY, 2003, INT IMMUNOL, V15, P1149, DOI 10.1093/intimm/dxg113; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Ferber IA, 1996, J IMMUNOL, V156, P5; Ghilardi N, 2004, J IMMUNOL, V172, P2827, DOI 10.4049/jimmunol.172.5.2827; Gran B, 2002, J IMMUNOL, V169, P7104, DOI 10.4049/jimmunol.169.12.7104; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; Hibbert L, 2003, J INTERF CYTOK RES, V23, P513, DOI 10.1089/10799900360708632; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Kubo T, 2004, J IMMUNOL, V173, P7249, DOI 10.4049/jimmunol.173.12.7249; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Lovett-Racke AE, 2004, IMMUNITY, V21, P719, DOI 10.1016/j.immuni.2004.09.010; Lucas S, 2003, P NATL ACAD SCI USA, V100, P15047, DOI 10.1073/pnas.2536517100; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Ota N, 2004, NAT IMMUNOL, V5, P208, DOI 10.1038/ni1032; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Robinson DS, 2002, IMMUNITY, V16, P755, DOI 10.1016/S1074-7613(02)00331-X; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; Smits HH, 2004, EUR J IMMUNOL, V34, P1371, DOI 10.1002/eji.200324815; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Willenborg DO, 1996, J IMMUNOL, V157, P3223; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	51	3465	3864	3	244	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2005	6	11					1123	1132		10.1038/ni1254	http://dx.doi.org/10.1038/ni1254			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	977WD	16200070				2022-12-18	WOS:000232833300013
J	Dunn, GP; Bruce, AT; Ikeda, H; Old, LJ; Schreiber, RD				Dunn, GP; Bruce, AT; Ikeda, H; Old, LJ; Schreiber, RD			Cancer immunoediting: from immunosurveillance to tumor escape	NATURE IMMUNOLOGY			English	Review							ORGAN ALLOGRAFT RECIPIENTS; IFN-GAMMA; NUDE-MICE; T-CELLS; INFILTRATING LYMPHOCYTES; PROGNOSTIC-SIGNIFICANCE; IMMUNOCOMPETENT MICE; INTERFERON-GAMMA; INDUCED SARCOMAS; NKG2D RECEPTOR	The concept that the immune system can recognize and destroy nascent transformed cells was originally embodied in the cancer immunosurveillance hypothesis of Burnet and Thomas. This hypothesis was abandoned shortly afterwards because of the absence of strong experimental evidence supporting the concept. New data, however, clearly show the existence of cancer immunosurveillance and also indicate that it may function as a component of a more general process of cancer immunoediting. This process is responsible for both eliminating tumors and sculpting the immunogenic phenotypes of tumors that eventually form in immunocompetent hosts. In this review, we will summarize the historical and experimental basis of cancer immunoediting and discuss its dual roles in promoting host protection against cancer and facilitating tumor escape from immune destruction.	Washington Univ, Sch Med, Dept Pathol & Immunol, Ctr Immunol, St Louis, MO 63110 USA; Mem Sloan Kettering Canc Ctr, Ludwig Inst Canc Res, New York Branch, New York, NY 10021 USA	Washington University (WUSTL); Ludwig Institute for Cancer Research; Memorial Sloan Kettering Cancer Center	Schreiber, RD (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, Ctr Immunol, 660 S Euclid Ave, St Louis, MO 63110 USA.	schreiber@immunology.wustl.edu	Schreiber, Robert/Q-7550-2019; Schreiber, Robert D/A-1276-2013	Schreiber, Robert D/0000-0001-6311-0432; Schreiber, Robert/0000-0003-1590-2341	NATIONAL CANCER INSTITUTE [R37CA043059, R01CA043059, P01CA076464] Funding Source: NIH RePORTER; NCI NIH HHS [CA76464, CA43059] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BANCROFT GJ, 1991, IMMUNOL REV, V124, P5, DOI 10.1111/j.1600-065X.1991.tb00613.x; BIRKELAND SA, 1995, INT J CANCER, V60, P183, DOI 10.1002/ijc.2910600209; Boshoff C, 2002, NAT REV CANCER, V2, P373, DOI 10.1038/nrc797; Bromberg JF, 1996, P NATL ACAD SCI USA, V93, P7673, DOI 10.1073/pnas.93.15.7673; BURNET FM, 1970, PROG EXP TUMOR RES, V13, P1; BURNET M, 1964, BRIT MED BULL, V20, P154, DOI 10.1093/oxfordjournals.bmb.a070310; BURNET M, 1957, BMJ-BRIT MED J, V1, P841, DOI 10.1136/bmj.1.5023.841; BURSTEIN NA, 1971, NATURE, V231, P450, DOI 10.1038/231450a0; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; CLARK WH, 1989, JNCI-J NATL CANCER I, V81, P1893, DOI 10.1093/jnci/81.24.1893; Clemente CG, 1996, CANCER, V77, P1303, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Coughlin CM, 1998, IMMUNITY, V9, P25, DOI 10.1016/S1074-7613(00)80585-3; DELIGDISCH L, 1982, AM J OBSTET GYNECOL, V144, P885, DOI 10.1016/0002-9378(82)90178-8; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; DIGHE AS, 1994, IMMUNITY, V1, P447, DOI 10.1016/1074-7613(94)90087-6; EATHERSTONE C, 1999, CURR BIOL, V9, pR759; Ehrrlich P., 1909, NED TIJDSCHR GENEES, V5, P273; Engel AM, 1996, APMIS, V104, P629, DOI 10.1111/j.1699-0463.1996.tb04923.x; Engel AM, 1997, SCAND J IMMUNOL, V45, P463, DOI 10.1046/j.1365-3083.1997.d01-419.x; EPSTEIN NA, 1976, CANCER, V37, P2455, DOI 10.1002/1097-0142(197605)37:5<2455::AID-CNCR2820370539>3.0.CO;2-V; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; FLANAGAN SP, 1966, GENET RES, V8, P295, DOI 10.1017/S0016672300010168; GATTI RA, 1971, CANCER-AM CANCER SOC, V28, P89, DOI 10.1002/1097-0142(197107)28:1<89::AID-CNCR2820280117>3.0.CO;2-Q; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; GRANT GA, 1965, NATURE, V205, P1124, DOI 10.1038/2051124a0; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; HEIDELBERGER C, 1975, ANNU REV BIOCHEM, V44, P79, DOI 10.1146/annurev.bi.44.070175.000455; Herberman R B, 1978, Adv Cancer Res, V27, P305; Hoover RN, 1977, ORIGINS HUMAN CANCER, P369; HUNIG T, 1983, IMMUNOL TODAY, V4, P84, DOI 10.1016/0167-5699(83)90125-1; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; IKEHARA S, 1984, P NATL ACAD SCI-BIOL, V81, P886, DOI 10.1073/pnas.81.3.886; JASS JR, 1986, J CLIN PATHOL, V39, P585, DOI 10.1136/jcp.39.6.585; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; KAPLAN HS, 1971, BRIT J CANCER, V25, P620, DOI 10.1038/bjc.1971.78; KLEIN G, 1966, ANNU REV MICROBIOL, V20, P223, DOI 10.1146/annurev.mi.20.100166.001255; Klein G, 1973, Harvey Lect, P71; KOURI RE, 1977, ORIGINS HUMAN CANCER, P811; Kumar A, 1997, SCIENCE, V278, P1630, DOI 10.1126/science.278.5343.1630; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; LIAO F, 1995, J EXP MED, V182, P1301, DOI 10.1084/jem.182.5.1301; Lipponen P. K., 1993, European Journal of Cancer, V29A, P69, DOI 10.1016/0959-8049(93)90579-5; LUSTER AD, 1993, J EXP MED, V178, P1057, DOI 10.1084/jem.178.3.1057; LUSTER AD, 1987, J EXP MED, V166, P1084, DOI 10.1084/jem.166.4.1084; MALECKAR JR, 1987, J IMMUNOL, V138, P3873; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Mihm MC, 1996, LAB INVEST, V74, P43; NACOPOULOU L, 1981, CANCER-AM CANCER SOC, V47, P930, DOI 10.1002/1097-0142(19810301)47:5<930::AID-CNCR2820470519>3.0.CO;2-1; Naito Y, 1998, CANCER RES, V58, P3491; NISHIZUKA Y, 1965, NATURE, V205, P1236, DOI 10.1038/2051236b0; Noguchi Y, 1996, P NATL ACAD SCI USA, V93, P11798, DOI 10.1073/pnas.93.21.11798; OLD LJ, 1964, ANNU REV MED, V15, P167, DOI 10.1146/annurev.me.15.020164.001123; OUTZEN HC, 1975, J RETICULOENDOTH SOC, V17, P1; PALMA L, 1978, J NEUROSURG, V49, P854, DOI 10.3171/jns.1978.49.6.0854; PANTELOURIS EM, 1968, NATURE, V217, P370, DOI 10.1038/217370a0; Pardoll DM, 2002, NAT REV IMMUNOL, V2, P227, DOI 10.1038/nri774; Penn I, 1999, TRANSPLANT P, V31, P1260, DOI 10.1016/S0041-1345(98)01987-3; Penn I, 1996, TRANSPLANTATION, V61, P274, DOI 10.1097/00007890-199601270-00019; Penn I, 1995, TRANSPLANTATION, V60, P1485, DOI 10.1097/00007890-199560120-00020; Penn I, 1970, MALIGNANT TUMORS ORG; Pham SM, 1995, ANN THORAC SURG, V60, P1623, DOI 10.1016/0003-4975(95)00120-4; Piccioli D, 2002, J EXP MED, V195, P335, DOI 10.1084/jem.20010934; PREHN RT, 1971, J RETICULOENDOTH SOC, V10, P1; Qin ZH, 2000, IMMUNITY, V12, P677, DOI 10.1016/S1074-7613(00)80218-6; RILKE F, 1991, INT J CANCER, V49, P44, DOI 10.1002/ijc.2910490109; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; RYGAARD J, 1974, TRANSPLANTATION, V17, P135; RYGAARD J, 1974, ACTA PATH MICRO IM B, VB 82, P99; SANFORD BH, 1973, J IMMUNOL, V110, P1437; SCHULER W, 1986, CELL, V46, P963, DOI 10.1016/0092-8674(86)90695-1; Sgadari C, 1996, BLOOD, V87, P3877, DOI 10.1182/blood.V87.9.3877.bloodjournal8793877; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; SHEIL AGR, 1986, WORLD J SURG, V10, P389; SHELL AGR, 2001, KIDNEY TRANSPLANTATI, P558; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SIlverstein AM., 1989, HIST IMMUNOLOGY; Smyth MJ, 2000, J EXP MED, V191, P661, DOI 10.1084/jem.191.4.661; Smyth MJ, 2001, INT IMMUNOL, V13, P459, DOI 10.1093/intimm/13.4.459; Smyth MJ, 2001, NAT IMMUNOL, V2, P293, DOI 10.1038/86297; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; Street SEA, 2001, BLOOD, V97, P192, DOI 10.1182/blood.V97.1.192; Street SEA, 2002, J EXP MED, V196, P129, DOI 10.1084/jem.20020063; Stutman O, 1975, Adv Cancer Res, V22, P261; STUTMAN O, 1979, J NATL CANCER I, V62, P353; STUTMAN O, 1974, SCIENCE, V183, P534, DOI 10.1126/science.183.4124.534; STUTMAN O, 1973, P INT WORKSH NUD MIC, V1, P257; Stutman O., 1978, NUDE MOUSE EXPT CLIN, P411; Svane IM, 1996, EUR J IMMUNOL, V26, P1844, DOI 10.1002/eji.1830260827; Takeda K, 2002, J EXP MED, V195, P161, DOI 10.1084/jem.20011171; THOMAS L, 1982, YALE J BIOL MED, V55, P329; Thomas L, 1959, CELLULAR HUMORAL ASP, P529; TRAININ N, 1967, INT J CANCER, V2, P326, DOI 10.1002/ijc.2910020407; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.iy.13.040195.001343; URBAN JL, 1982, J EXP MED, V156, P1025, DOI 10.1084/jem.156.4.1025; UYTTENHOVE C, 1980, J EXP MED, V152, P1175, DOI 10.1084/jem.152.5.1175; vandenBroek MF, 1996, J EXP MED, V184, P1781, DOI 10.1084/jem.184.5.1781; Yokoyama WM, 2000, NAT IMMUNOL, V1, P95, DOI 10.1038/77878	101	3293	3494	26	530	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2002	3	11					991	998		10.1038/ni1102-991	http://dx.doi.org/10.1038/ni1102-991			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612KE	12407406				2022-12-18	WOS:000179073000003
J	Park, H; Li, ZX; Yang, XO; Chang, SH; Nurieva, R; Wang, YH; Wang, Y; Hood, L; Zhu, Z; Tian, Q; Dong, C				Park, H; Li, ZX; Yang, XO; Chang, SH; Nurieva, R; Wang, YH; Wang, Y; Hood, L; Zhu, Z; Tian, Q; Dong, C			A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17	NATURE IMMUNOLOGY			English	Article							AUTOIMMUNE INFLAMMATION; IL-17-DEFICIENT MICE; FAMILY-MEMBERS; C-MAF; IMMUNE; ACTIVATION; RESPONSES; RECEPTOR; IL-17; EXPRESSION	Interleukin 17 (IL-17) has been linked to autoimmune diseases, although its regulation and function have remained unclear. Here we have evaluated in vitro and in vivo the requirements for the differentiation of naive CD4 T cells into effector T helper cells that produce IL-17. This process required the costimulatory molecules CD28 and ICOS but was independent of the cytokines and transcription factors required for T helper type 1 or type 2 differentiation. Furthermore, both IL-4 and interferon-gamma negatively regulated T helper cell production of IL-17 in the effector phase. In vivo, antibody to IL-17 inhibited chemokine expression in the brain during experimental autoimmune encephalomyelitis, whereas overexpression of IL-17 in lung epithelium caused chemokine production and leukocyte infiltration. Thus, IL-17 expression characterizes a unique T helper lineage that regulates tissue inflammation.	Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Inst Syst Biol, Seattle, WA 98103 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD 21224 USA	University of Texas System; UTMD Anderson Cancer Center; University of Washington; University of Washington Seattle; Institute for Systems Biology (ISB); Johns Hopkins University	Dong, C (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	cdong@mdanderson.org	Chang, Seon Hee/AAQ-9521-2020; Yang, Xuexian/Y-2472-2019; dong, chen/B-3181-2009	Chang, Seon Hee/0000-0002-9389-508X; Yang, Xuexian/0000-0001-6816-7024; dong, chen/0000-0002-0084-9130	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050746, R01AI050761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050772] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI050746, R01 AI050761] Funding Source: Medline; NIAMS NIH HHS [R01 AR050772] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1; Beeh KM, 2003, RESP MED, V97, P634, DOI 10.1053/rmed.2003.1493; Bush KA, 2002, ARTHRITIS RHEUM-US, V46, P802, DOI 10.1002/art.10173; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dong C, 2003, J AUTOIMMUN, V21, P255, DOI 10.1016/S0896-8411(03)00119-7; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Glimcher LH, 2000, GENE DEV, V14, P1693; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Huang DR, 2001, J EXP MED, V193, P713, DOI 10.1084/jem.193.6.713; Ideker T, 2000, J COMPUT BIOL, V7, P805, DOI 10.1089/10665270050514945; Infante-Duarte C, 2000, J IMMUNOL, V165, P6107, DOI 10.4049/jimmunol.165.11.6107; Kim JI, 1999, IMMUNITY, V10, P745, DOI 10.1016/S1074-7613(00)80073-4; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Linden A, 2001, INT ARCH ALLERGY IMM, V126, P179, DOI 10.1159/000049511; Moseley TA, 2003, CYTOKINE GROWTH F R, V14, P155, DOI 10.1016/S1359-6101(03)00002-9; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Prasad DVR, 2003, IMMUNITY, V18, P863, DOI 10.1016/S1074-7613(03)00147-X; Ransohoff RM, 2002, J INFECT DIS, V186, pS152, DOI 10.1086/344266; Robinson DS, 2002, IMMUNITY, V16, P755, DOI 10.1016/S1074-7613(02)00331-X; Ruddy MJ, 2004, J BIOL CHEM, V279, P2559, DOI 10.1074/jbc.M308809200; Schwandner R, 2000, J EXP MED, V191, P1233, DOI 10.1084/jem.191.7.1233; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Sun MY, 2002, J IMMUNOL, V168, P6294, DOI 10.4049/jimmunol.168.12.6294; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Vignola AM, 1998, AM J RESP CRIT CARE, V158, P1945, DOI 10.1164/ajrccm.158.6.9803014; Yang JF, 1999, EUR J IMMUNOL, V29, P548, DOI 10.1002/(SICI)1521-4141(199902)29:02<548::AID-IMMU548>3.0.CO;2-Z; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; YOO ZB, 1995, J IMMUNOL, V155, P5483; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	38	3149	3564	10	226	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2005	6	11					1133	1141		10.1038/ni1261	http://dx.doi.org/10.1038/ni1261			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	977WD	16200068	Green Accepted			2022-12-18	WOS:000232833300014
J	Iwasaki, A; Medzhitov, R				Iwasaki, A; Medzhitov, R			Toll-like receptor control of the adaptive immune responses	NATURE IMMUNOLOGY			English	Review							CD8-ALPHA(+) DENDRITIC CELLS; INDUCE DIFFERENT CLASSES; SINGLE-STRANDED RNA; T-HELPER TYPE-1; CUTTING EDGE; LANGERHANS CELLS; LYMPH-NODES; CPG-DNA; ANTIVIRAL RESPONSES; INNATE RESISTANCE	Recognition of microbial infection and initiation of host defense responses is controlled by multiple mechanisms. Toll-like receptors (TLRs) have recently emerged as a key component of the innate immune system that detect microbial infection and trigger antimicrobial host defense responses. TLRs activate multiple steps in the inflammatory reactions that help to eliminate the invading pathogens and coordinate systemic defenses. In addition, TLRs control multiple dendritic cell functions and activate signals that are critically involved in the initiation of adaptive immune responses. Recent studies have provided important clues about the mechanisms of TLR-mediated control of adaptive immunity orchestrated by dendritic cell populations in distinct anatomical locations.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute	Iwasaki, A (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 333 Cedar St, New Haven, CT 06520 USA.	akiko.iwasaki@yale.edu; ruslan.medzhitov@yale.edu	Li, Chia Cheng/D-9906-2015; Iwasaki, Akiko/Z-1591-2019	Iwasaki, Akiko/0000-0002-7824-9856	NIAID NIH HHS [AI46688, AI05502, AI054359] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046688, R01AI054359, R37AI046688] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; Akbari O, 2001, NAT IMMUNOL, V2, P725, DOI 10.1038/90667; Akbari O, 2003, INT ARCH ALLERGY IMM, V130, P108, DOI 10.1159/000069012; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Alpan O, 2001, Curr Allergy Asthma Rep, V1, P572, DOI 10.1007/s11882-001-0067-6; Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510; Anjuere F, 1999, BLOOD, V93, P590, DOI 10.1182/blood.V93.2.590.402k11_590_598; Ashkar AA, 2003, J VIROL, V77, P8948, DOI 10.1128/JVI.77.16.8948-8956.2003; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Boonstra A, 2003, J EXP MED, V197, P101, DOI 10.1084/jem.20021908; Bourgeois C, 2002, EUR J IMMUNOL, V32, P2199, DOI 10.1002/1521-4141(200208)32:8<2199::AID-IMMU2199>3.0.CO;2-L; Brawand P, 2002, J IMMUNOL, V169, P6711, DOI 10.4049/jimmunol.169.12.6711; Cella M, 2000, NAT IMMUNOL, V1, P305, DOI 10.1038/79747; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Dahl ME, 2004, NAT IMMUNOL, V5, P337, DOI 10.1038/ni1041; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Doxsee CL, 2003, J IMMUNOL, V171, P1156, DOI 10.4049/jimmunol.171.3.1156; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Fan J, 2003, NAT MED, V9, P315, DOI 10.1038/nm832; Filippi C, 2003, J EXP MED, V198, P201, DOI 10.1084/jem.20021893; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Geissmann F, 2002, J EXP MED, V196, P417, DOI 10.1084/jem.20020018; Gilliet M, 2002, J EXP MED, V195, P953, DOI 10.1084/jem.20020045; Gilliet M, 2002, HUM IMMUNOL, V63, P1149, DOI 10.1016/S0198-8859(02)00753-X; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2003, J IMMUNOL, V170, P3059, DOI 10.4049/jimmunol.170.6.3059; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; Hertz CJ, 2003, J IMMUNOL, V171, P6820, DOI 10.4049/jimmunol.171.12.6820; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Honda K, 2003, P NATL ACAD SCI USA, V100, P10872, DOI 10.1073/pnas.1934678100; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Hoshino K, 2002, INT IMMUNOL, V14, P1225, DOI 10.1093/intimm/dxf089; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; ITANO AA, IN PRESS IMMUNITY; Ito T, 2002, J EXP MED, V195, P1507, DOI 10.1084/jem.20020207; Iwasaki A, 2001, J IMMUNOL, V166, P4884, DOI 10.4049/jimmunol.166.8.4884; Janeway CA, 1998, SEMIN IMMUNOL, V10, P349, DOI 10.1006/smim.1998.0142; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Jarrossay D, 2001, EUR J IMMUNOL, V31, P3388, DOI 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kagnoff MF, 1997, J CLIN INVEST, V100, P6, DOI 10.1172/JCI119522; Kaisho T, 2002, INT IMMUNOL, V14, P695, DOI 10.1093/intimm/dxf039; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Krug A, 2001, EUR J IMMUNOL, V31, P3026, DOI 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H; Lambrecht BN, 2003, NAT REV IMMUNOL, V3, P994, DOI 10.1038/nri1249; Laudanna C, 2002, IMMUNOL REV, V186, P37, DOI 10.1034/j.1600-065X.2002.18604.x; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Legge KL, 2003, IMMUNITY, V18, P265, DOI 10.1016/S1074-7613(03)00023-2; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; Mantovani A, 1999, IMMUNOL TODAY, V20, P254, DOI 10.1016/S0167-5699(99)01469-3; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Martin P, 2002, BLOOD, V100, P383, DOI 10.1182/blood.V100.2.383; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; McCurdy JD, 2003, J IMMUNOL, V170, P1625, DOI 10.4049/jimmunol.170.4.1625; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; Nagase H, 2003, J IMMUNOL, V171, P3977, DOI 10.4049/jimmunol.171.8.3977; Neufert C, 2001, J IMMUNOL, V167, P1542, DOI 10.4049/jimmunol.167.3.1542; Nguyen KB, 2002, SCIENCE, V297, P2063, DOI 10.1126/science.1074900; Palliser D, 2004, J IMMUNOL, V172, P3415, DOI 10.4049/jimmunol.172.6.3415; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Pulendran B, 2001, J IMMUNOL, V167, P5067, DOI 10.4049/jimmunol.167.9.5067; Randolph GJ, 2002, J EXP MED, V196, P413, DOI 10.1084/jem.20021240; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Redecke V, 2004, J IMMUNOL, V172, P2739, DOI 10.4049/jimmunol.172.5.2739; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; Rogge L, 1998, J IMMUNOL, V161, P6567; Rui LX, 2003, NAT IMMUNOL, V4, P594, DOI 10.1038/ni924; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Sareneva T, 1998, J IMMUNOL, V160, P6032; Schilling JD, 2003, P NATL ACAD SCI USA, V100, P4203, DOI 10.1073/pnas.0736473100; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Smith CM, 2003, J IMMUNOL, V170, P4437, DOI 10.4049/jimmunol.170.9.4437; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Supajatura V, 2002, J CLIN INVEST, V109, P1351, DOI 10.1172/JCI200214704; Supajatura V, 2001, J IMMUNOL, V167, P2250, DOI 10.4049/jimmunol.167.4.2250; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Taniguchi T, 2002, CURR OPIN IMMUNOL, V14, P111, DOI 10.1016/S0952-7915(01)00305-3; Tough DF, 1999, IMMUNOL REV, V170, P39, DOI 10.1111/j.1600-065X.1999.tb01327.x; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; Valladeau J, 2002, J IMMUNOL, V168, P782, DOI 10.4049/jimmunol.168.2.782; Visintin A, 2001, J IMMUNOL, V166, P249, DOI 10.4049/jimmunol.166.1.249; Yang YP, 2004, NAT IMMUNOL, V5, P508, DOI 10.1038/ni1059; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109	117	3095	3279	8	421	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2004	5	10					987	995		10.1038/ni1112	http://dx.doi.org/10.1038/ni1112			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	857YO	15454922				2022-12-18	WOS:000224156600005
J	Yoneyama, M; Kikuchi, M; Natsukawa, T; Shinobu, N; Imaizumi, T; Miyagishi, M; Taira, K; Akira, S; Fujita, T				Yoneyama, M; Kikuchi, M; Natsukawa, T; Shinobu, N; Imaizumi, T; Miyagishi, M; Taira, K; Akira, S; Fujita, T			The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses	NATURE IMMUNOLOGY			English	Article							INTERFERON REGULATORY FACTOR-3; NF-KAPPA-B; CREB-BINDING PROTEIN/P300; IFN-BETA; GENE-EXPRESSION; TRANSCRIPTION FACTORS; SIGNALING PATHWAY; CRYSTAL-STRUCTURE; VIRUS-INFECTION; BACTERIAL-DNA	Intracellular double-stranded RNA (dsRNA) is a chief sign of replication for many viruses. Host mechanisms detect the dsRNA and initiate antiviral responses. In this report, we identify retinoic acid inducible gene I (RIG-I), which encodes a DExD/H box RNA helicase that contains a caspase recruitment domain, as an essential regulator for dsRNA-induced signaling, as assessed by functional screening and assays. A helicase domain with intact ATPase activity was responsible for the dsRNA-mediated signaling. The caspase recruitment domain transmitted 'downstream' signals, resulting in the activation of transcription factors NF-kappaB and IRF-3. Subsequent gene activation by these factors induced antiviral functions, including type I interferon production. Thus, RIG-I is key in the detection and subsequent eradication of the replicating viral genomes.	Tokyo Metropolitan Org Med Res, Tokyo Metropolitan Inst Med Sci, Dept Tumor Cell Biol, Bunkyo Ku, Tokyo 1138613, Japan; Hirosaki Univ, Sch Med, Dept Vasc Biol, Hirosaki, Aomori 0368562, Japan; Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Osaka 5650871, Japan	Tokyo Metropolitan Institute of Medical Science; Hirosaki University; University of Tokyo; Osaka University	Fujita, T (corresponding author), Tokyo Metropolitan Org Med Res, Tokyo Metropolitan Inst Med Sci, Dept Tumor Cell Biol, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138613, Japan.	fujita@rinshoken.or.jp	Yoneyama, Mitsutoshi/D-8244-2017; Miyagishi, Makoto/L-8174-2016; Akira, Shizuo/C-3134-2009	Yoneyama, Mitsutoshi/0000-0001-9512-0408; Miyagishi, Makoto/0000-0001-7654-3616; 				Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bouchier-Hayes L, 2002, EMBO REP, V3, P616, DOI 10.1093/embo-reports/kvf139; De Maeyer E, 1998, Int Rev Immunol, V17, P53, DOI 10.3109/08830189809084487; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; DU W, 1992, P NATL ACAD SCI USA, V89, P2150, DOI 10.1073/pnas.89.6.2150; Farrar JD, 2000, IMMUNOL TODAY, V21, P484, DOI 10.1016/S0167-5699(00)01710-2; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; FUJITA T, 1989, NUCLEIC ACIDS RES, V17, P3335, DOI 10.1093/nar/17.9.3335; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; HOEE K, 2003, NATURE, V424, P743; Hoshino K, 2002, INT IMMUNOL, V14, P1225, DOI 10.1093/intimm/dxf089; Hoshino K, 1999, J IMMUNOL, V162, P3749; Imaizumi T, 2002, BIOCHEM BIOPH RES CO, V292, P274, DOI 10.1006/bbrc.2002.6650; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Iwamura T, 2001, BIOCHEM BIOPH RES CO, V282, P515, DOI 10.1006/bbrc.2001.4606; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; Kovacsovics M, 2002, CURR BIOL, V12, P838, DOI 10.1016/S0960-9822(02)00842-4; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LENARDO MJ, 1989, CELL, V57, P287, DOI 10.1016/0092-8674(89)90966-5; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Miyagishi M, 2003, OLIGONUCLEOTIDES, V13, P325, DOI 10.1089/154545703322617005; Mori M, 2004, J BIOL CHEM, V279, P9698, DOI 10.1074/jbc.M310616200; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qin BY, 2003, NAT STRUCT BIOL, V10, P913, DOI 10.1038/nsb1002; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 1998, FEBS LETT, V425, P112, DOI 10.1016/S0014-5793(98)00210-5; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Sing A, 2000, INFECT IMMUN, V68, P1600, DOI 10.1128/IAI.68.3.1600-1607.2000; Smith EJ, 2001, J BIOL CHEM, V276, P8951, DOI 10.1074/jbc.M008717200; Suhara W, 2002, J BIOL CHEM, V277, P22304, DOI 10.1074/jbc.M200192200; Sun Y.W., 1997, THESIS SHANGHAI 2 ME; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Takahasi K, 2003, NAT STRUCT BIOL, V10, P922, DOI 10.1038/nsb1001; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Tijsterman M, 2002, ANNU REV GENET, V36, P489, DOI 10.1146/annurev.genet.36.043002.091619; VISVANATHAN KV, 1989, EMBO J, V8, P1129, DOI 10.1002/j.1460-2075.1989.tb03483.x; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WATANABE N, 1991, NUCLEIC ACIDS RES, V19, P4421, DOI 10.1093/nar/19.16.4421; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Weaver BK, 1998, MOL CELL BIOL, V18, P1359, DOI 10.1128/MCB.18.3.1359; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoneyama M, 1996, J BIOCHEM-TOKYO, V120, P160; Zhang XX, 2000, MICROB PATHOGENESIS, V28, P267, DOI 10.1006/mpat.1999.0349	56	2948	3140	1	273	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2004	5	7					730	737		10.1038/ni1087	http://dx.doi.org/10.1038/ni1087			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	833IO	15208624				2022-12-18	WOS:000222331200026
J	Biswas, SK; Mantovani, A				Biswas, Subhra K.; Mantovani, Alberto			Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm	NATURE IMMUNOLOGY			English	Review							TUMOR-ASSOCIATED MACROPHAGES; REGULATORY T-CELLS; HUMAN DECIDUAL MACROPHAGES; ALTERNATIVE ACTIVATION; DIFFERENTIAL REGULATION; IMMUNE SURVEILLANCE; SUPPRESSOR-CELLS; M2 MACROPHAGES; POOR-PROGNOSIS; KAPPA-B	Plasticity is a hallmark of cells of the myelomonocytic lineage. In response to innate recognition or signals from lymphocyte subsets, mononuclear phagocytes undergo adaptive responses. Shaping of monocyte-macrophage function is an essential component of resistance to pathogens, tissue damage and repair. The orchestration of myelomonocytic cell function is a key element that links inflammation and cancer and provides a paradigm for macrophage plasticity and function. A better understanding of the molecular basis of myelomonocytic cell plasticity will open new vistas in immunopathology and therapeutic intervention.	[Biswas, Subhra K.] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore; [Mantovani, Alberto] Inst Ricovero & Cura Carattere, Ist Clin Humanitas, Rozzano, Italy; [Mantovani, Alberto] Univ Milan, Dept Translat Med, I-20122 Milan, Italy	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); IRCCS Humanitas Research Hospital; University of Milan	Biswas, SK (corresponding author), Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore.	subhra_biswas@immunol.a-star.edu.sg; alberto.mantovani@humanitasresearch.it	Mantovani, Alberto/HCI-7449-2022	Mantovani, Alberto/0000-0001-5578-236X	Biomedical Research Council, Agency for Science, Technology Research; European Commission; Italian Association for Cancer Research	Biomedical Research Council, Agency for Science, Technology Research(Agency for Science Technology & Research (A*STAR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	Supported by Biomedical Research Council, Agency for Science, Technology & Research (S.K.B.), the European Commission (A.M.) and the Italian Association for Cancer Research (A.M.).	Andreu P, 2010, CANCER CELL, V17, P121, DOI 10.1016/j.ccr.2009.12.019; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Biswas SK, 2006, BLOOD, V107, P2112, DOI 10.1182/blood-2005-01-0428; Biswas SK, 2008, J IMMUNOL, V180, P2011, DOI 10.4049/jimmunol.180.4.2011; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Bowdish DME, 2007, MICROBES INFECT, V9, P1680, DOI 10.1016/j.micinf.2007.09.002; Butti E, 2008, GENE THER, V15, P504, DOI 10.1038/gt.2008.10; Cassatella MA, 2009, IMMUNITY, V31, P698, DOI 10.1016/j.immuni.2009.10.003; Chan G, 2008, J IMMUNOL, V181, P698, DOI 10.4049/jimmunol.181.1.698; Charles KA, 2009, J CLIN INVEST, V119, P3011, DOI 10.1172/JCI39065; Chiaramonte MG, 2003, J EXP MED, V197, P687, DOI 10.1084/jem.20020903; Clear AJ, 2010, BLOOD, V115, P5053, DOI 10.1182/blood-2009-11-253260; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; DE SANTA F, 2007, CELL, V130, P1083; DE VISSER KE, 2005, CANCER CELL, V7, P411; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Duluc D, 2009, INT J CANCER, V125, P367, DOI 10.1002/ijc.24401; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gary-Gouy H, 2002, BLOOD, V100, P4537, DOI 10.1182/blood-2002-05-1525; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gleissner CA, 2010, J IMMUNOL, V184, P4810, DOI 10.4049/jimmunol.0901368; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Guiducci C, 2005, CANCER RES, V65, P3437, DOI 10.1158/0008-5472.CAN-04-4262; Gustafsson C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002078; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Hagemann T, 2006, J IMMUNOL, V176, P5023, DOI 10.4049/jimmunol.176.8.5023; Hazlett LD, 2010, INVEST OPHTH VIS SCI, V51, P1524, DOI 10.1167/iovs.09-3983; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Jeannin P, 2005, IMMUNITY, V22, P551, DOI 10.1016/j.immuni.2005.03.008; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Junttila IS, 2008, J EXP MED, V205, P2595, DOI 10.1084/jem.20080452; Kadl A, 2010, CIRC RES, V107, P737, DOI 10.1161/CIRCRESAHA.109.215715; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Kuang DM, 2009, J EXP MED, V206, P1327, DOI 10.1084/jem.20082173; Kurowska-Stolarska M, 2009, J IMMUNOL, V183, P6469, DOI 10.4049/jimmunol.0901575; Leidi M, 2009, J IMMUNOL, V182, P4415, DOI 10.4049/jimmunol.0713732; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Li CL, 2009, P NATL ACAD SCI USA, V106, P5767, DOI 10.1073/pnas.0901173106; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Liu XX, 2010, APPL MATH SER B, V25, P1, DOI 10.1007/s11766-010-2106-3; Loges S, 2010, BLOOD, V115, P2264, DOI 10.1182/blood-2009-06-228684; Loke P'ng, 2002, BMC Immunol, V3, P7, DOI 10.1186/1471-2172-3-7; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Luo YP, 2006, J CLIN INVEST, V116, P2132, DOI 10.1172/JCI27648; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2008, EUR J IMMUNOL, V38, P3269, DOI 10.1002/eji.200838918; Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Moretta A, 2008, IMMUNOL REV, V224, P58, DOI 10.1111/j.1600-065X.2008.00651.x; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ostrand-Rosenberg S, 2008, CURR OPIN GENET DEV, V18, P11, DOI 10.1016/j.gde.2007.12.007; PARKES H, 1988, BRIT J CANCER, V58, P715, DOI 10.1038/bjc.1988.296; Pesce J, 2006, J CLIN INVEST, V116, P2044, DOI 10.1172/JCI27727; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; PRICE AE, 2010, P NATL ACAD SCI US; Pucci F, 2009, BLOOD, V114, P901, DOI 10.1182/blood-2009-01-200931; Puig-Kroger A, 2009, CANCER RES, V69, P9395, DOI 10.1158/0008-5472.CAN-09-2050; Rae F, 2007, DEV BIOL, V308, P232, DOI 10.1016/j.ydbio.2007.05.027; Raes G, 2005, J LEUKOCYTE BIOL, V77, P321, DOI 10.1189/jlb.0304212; Recalcati S, 2010, EUR J IMMUNOL, V40, P824, DOI 10.1002/eji.200939889; Reimann M, 2010, CANCER CELL, V17, P262, DOI 10.1016/j.ccr.2009.12.043; Roca H, 2009, J BIOL CHEM, V284, P34342, DOI 10.1074/jbc.M109.042671; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Saccani A, 2006, CANCER RES, V66, P11432, DOI 10.1158/0008-5472.CAN-06-1867; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Said EA, 2010, NAT MED, V16, P452, DOI 10.1038/nm.2106; SATOH T, NAT IMMUNOL IN PRESS; Savage NDL, 2008, J IMMUNOL, V181, P2220, DOI 10.4049/jimmunol.181.3.2220; Schmidt T, 2010, NATURE, V465, P697, DOI 10.1038/465697a; Shahrara S, 2009, J IMMUNOL, V182, P3884, DOI 10.4049/jimmunol.0802246; Shaul ME, 2010, DIABETES, V59, P1171, DOI 10.2337/db09-1402; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Sierra JR, 2008, J EXP MED, V205, P1673, DOI 10.1084/jem.20072602; Sinha P, 2005, CANCER RES, V65, P11743, DOI 10.1158/0008-5472.CAN-05-0045; Sironi M, 2006, J LEUKOCYTE BIOL, V80, P342, DOI 10.1189/jlb.1005586; Solinas G, 2010, J IMMUNOL, V185, P642, DOI 10.4049/jimmunol.1000413; Song LP, 2009, J CLIN INVEST, V119, P1524, DOI 10.1172/JCI37869; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Stout RD, 2009, J LEUKOCYTE BIOL, V86, P1105, DOI 10.1189/jlb.0209073; Sutterwala FS, 1998, J EXP MED, V188, P217, DOI 10.1084/jem.188.1.217; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; Torroella-Kouri M, 2009, CANCER RES, V69, P4800, DOI 10.1158/0008-5472.CAN-08-3427; Vacca P, 2010, P NATL ACAD SCI USA, V107, P11918, DOI 10.1073/pnas.1001749107; Van den Bossche J, 2009, BLOOD, V114, P4664, DOI 10.1182/blood-2009-05-221598; Varol C, 2010, NAT REV IMMUNOL, V10, P415, DOI 10.1038/nri2778; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Wang L, 2010, IMMUNITY, V32, P518, DOI 10.1016/j.immuni.2010.03.014; Wang YC, 2010, CANCER RES, V70, P4840, DOI 10.1158/0008-5472.CAN-10-0269; Welch JS, 2002, J BIOL CHEM, V277, P42821, DOI 10.1074/jbc.M205873200; Willment JA, 2003, J IMMUNOL, V171, P4569, DOI 10.4049/jimmunol.171.9.4569; Wong SC, 2010, EUR J IMMUNOL, V40, P2296, DOI 10.1002/eji.200940288; Zhang JP, 2009, J HEPATOL, V50, P980, DOI 10.1016/j.jhep.2008.12.033; Zhang Y, 2009, J IMMUNOL, V182, P554, DOI 10.4049/jimmunol.182.1.554	113	2434	2538	13	433	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2010	11	10					889	896		10.1038/ni.1937	http://dx.doi.org/10.1038/ni.1937			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	651KP	20856220				2022-12-18	WOS:000281926900007
J	Bogdan, C				Bogdan, C			Nitric oxide and the immune response	NATURE IMMUNOLOGY			English	Review							NECROSIS-FACTOR-ALPHA; NADPH PHAGOCYTE OXIDASE; SYNTHASE MESSENGER-RNA; NATURAL-KILLER-CELLS; CD4(+) T-CELLS; REACTIVE NITROGEN; NO SYNTHASE; MYCOBACTERIUM-TUBERCULOSIS; TRYPANOSOMA-CRUZI; INTERFERON-GAMMA	During the past two decades, nitric oxide (NO) has been recognized as one of the most versatile players in the immune system. It is involved in the pathogenesis and control of infectious diseases, tumors, autoimmune processes and chronic degenerative diseases. Because of its variety of reaction partners (DNA, proteins, low-molecular weight thiols, prosthetic groups, reactive oxygen intermediates), its widespread production (by three different NO synthases (NOS) and the fact that its activity is strongly influenced by its concentration, NO continues to surprise and perplex immunologists. Today, there is no simple, uniform picture of the function of NO in the immune system. Protective and toxic effects of NO are frequently seen in parallel. Its striking inter- and intracellular signaling capacity makes it extremely difficult to predict the effect of NOS inhibitors and NO donors, which still hampers therapeutic applications.	Univ Erlangen Nurnberg, Inst Clin Microbiol Immunol & Hyg, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Bogdan, C (corresponding author), Univ Erlangen Nurnberg, Inst Clin Microbiol Immunol & Hyg, Wasserturmstr 3-5, D-91054 Erlangen, Germany.	christian.bogdan@mikrobio.med.uni-erlangen.de		Bogdan, Christian/0000-0002-2300-0631				Adams LB, 2000, INFECT IMMUN, V68, P5462, DOI 10.1128/IAI.68.9.5462-5465.2000; Adamson DC, 1996, SCIENCE, V274, P1917, DOI 10.1126/science.274.5294.1917; Aiello S, 2000, J IMMUNOL, V164, P4649, DOI 10.4049/jimmunol.164.9.4649; Akaike T, 2000, FASEB J, V14, P1447, DOI 10.1096/fj.14.10.1447; Allione A, 1999, J IMMUNOL, V163, P4182; Andonegui G, 1999, J IMMUNOL, V162, P2922; Angulo I, 2000, BLOOD, V95, P212; Banerjee R, 2000, INFECT IMMUN, V68, P4361, DOI 10.1128/IAI.68.7.4361-4362.2000; Banick PD, 1997, J CELL PHYSIOL, V172, P12, DOI 10.1002/(SICI)1097-4652(199707)172:1<12::AID-JCP2>3.0.CO;2-G; Bartholdy C, 1999, J GEN VIROL, V80, P2997, DOI 10.1099/0022-1317-80-11-2997; Bauer H, 1997, IMMUNOLOGY, V90, P205, DOI 10.1046/j.1365-2567.1997.00161.x; Bauer PM, 2001, J BIOL CHEM, V276, P34458, DOI 10.1074/jbc.M105219200; Berendji D, 1999, MOL MED, V5, P721, DOI 10.1007/BF03402096; Blank C, 1996, EUR J IMMUNOL, V26, P792, DOI 10.1002/eji.1830260410; Bobe P, 1999, BLOOD, V94, P1028, DOI 10.1182/blood.V94.3.1028.415k24_1028_1037; Bodnar KA, 2001, INFECT IMMUN, V69, P800, DOI 10.1128/IAI.69.2.800-809.2001; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7; Bogdan C, 1998, J EXP MED, V187, P1361, DOI 10.1084/jem.187.9.1361; Bogdan C, 2000, HANDB EXP PHARMACOL, V143, P443; Bogdan C, 2001, TRENDS CELL BIOL, V11, P66, DOI 10.1016/S0962-8924(00)01900-0; Brito C, 1999, J IMMUNOL, V162, P3356; Brown CR, 1999, J INFECT DIS, V179, P1573, DOI 10.1086/314774; Brune B, 1999, CELL DEATH DIFFER, V6, P969, DOI 10.1038/sj.cdd.4400582; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; Bucci M, 2000, NAT MED, V6, P1362, DOI 10.1038/82176; Burnett TG, 2000, J IMMUNOL, V164, P5245, DOI 10.4049/jimmunol.164.10.5245; Cao S, 2001, J BIOL CHEM, V276, P14249, DOI 10.1074/jbc.M006258200; Carpenter L, 2001, J BIOL CHEM, V276, P5368, DOI 10.1074/jbc.M010036200; Cauwels A, 2000, IMMUNITY, V13, P223, DOI 10.1016/S1074-7613(00)00022-4; Chakravortty D, 2001, J IMMUNOL, V166, P2011, DOI 10.4049/jimmunol.166.3.2011; Chan ED, 2001, INFECT IMMUN, V69, P2001, DOI 10.1128/IAI.69.4.2001-2010.2001; Chandrasekar B, 2000, CLIN EXP IMMUNOL, V121, P112, DOI 10.1046/j.1365-2249.2000.01258.x; Chang CI, 1998, AM J PHYSIOL-HEART C, V274, pH342, DOI 10.1152/ajpheart.1998.274.1.H342; Cherayil BJ, 2000, INFECT IMMUN, V68, P5567, DOI 10.1128/IAI.68.10.5567-5574.2000; Cherla RP, 2001, J IMMUNOL, V166, P3067, DOI 10.4049/jimmunol.166.5.3067; Chiwakata CB, 2000, INFECT IMMUN, V68, P394, DOI 10.1128/IAI.68.1.394-399.2000; Cifone MG, 1999, BLOOD, V93, P3876, DOI 10.1182/blood.V93.11.3876.411k25_3876_3884; Closs EI, 2000, MOL PHARMACOL, V57, P68; Coccia EM, 2000, INT IMMUNOL, V12, P977, DOI 10.1093/intimm/12.7.977; Connelly L, 2001, J IMMUNOL, V166, P3873, DOI 10.4049/jimmunol.166.6.3873; Cooper AM, 2000, INFECT IMMUN, V68, P6879, DOI 10.1128/IAI.68.12.6879-6882.2000; Cruz MT, 1998, BIOCHEM BIOPH RES CO, V248, P98, DOI 10.1006/bbrc.1998.8865; Cruz MT, 2001, NITRIC OXIDE-BIOL CH, V5, P53, DOI 10.1006/niox.2000.0320; Dalton DK, 2000, J EXP MED, V192, P117, DOI 10.1084/jem.192.1.117; Degroote M.A., 2002, NITRIC OXIDE INFECT, V12, P231, DOI [10.1007/0-306-46816-6_12, DOI 10.1007/0-306-46816-6_12]; Diefenbach A, 1999, SCIENCE, V284, P951, DOI 10.1126/science.284.5416.951; DiNapoli MR, 1996, J EXP MED, V183, P1323, DOI 10.1084/jem.183.4.1323; Dlaska M, 1999, J IMMUNOL, V162, P6171; Eckmann L, 2000, J IMMUNOL, V164, P1478, DOI 10.4049/jimmunol.164.3.1478; Efron D T, 2000, Curr Opin Clin Nutr Metab Care, V3, P197, DOI 10.1097/00075197-200005000-00006; EHRT S, 2001, IN PRESS J EXP MED; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; FEHSEL K, 1995, J IMMUNOL, V155, P2858; Felley-Bosco E, 2000, P NATL ACAD SCI USA, V97, P14334, DOI 10.1073/pnas.250406797; Flam BR, 2001, NITRIC OXIDE-BIOL CH, V5, P187, DOI 10.1006/niox.2001.0340; Fligger J, 1999, IMMUNOBIOLOGY, V200, P169, DOI 10.1016/S0171-2985(99)80068-0; Flodstrom M, 2001, VIROLOGY, V281, P205, DOI 10.1006/viro.2000.0801; Forstermann U, 1998, FASEB J, V12, P773; Freire-de-Lima CG, 2000, NATURE, V403, P199, DOI 10.1038/35003208; Fritsche G, 2001, J INFECT DIS, V183, P1388, DOI 10.1086/319860; FRUCHT DM, 2001, IN PRESS TRENDS IMMU; Furuke K, 1999, J IMMUNOL, V163, P1473; Ganster RW, 2001, P NATL ACAD SCI USA, V98, P8638, DOI 10.1073/pnas.151239498; Gao JJ, 1999, J IMMUNOL, V163, P4095; Gaston B., 2002, NITRIC OXIDE INFECT, P37, DOI [10.1007/0-306-46816-6_3, DOI 10.1007/0-306-46816-6_3]; Gilkeson GS, 1997, J EXP MED, V186, P365, DOI 10.1084/jem.186.3.365; Gobert AP, 2000, INFECT IMMUN, V68, P4653, DOI 10.1128/IAI.68.8.4653-4657.2000; Gotoh T, 1999, J CELL BIOL, V144, P427, DOI 10.1083/jcb.144.3.427; Grisham MB, 1998, FREE RADICAL BIO MED, V25, P404, DOI 10.1016/S0891-5849(98)00094-X; Guidotti LG, 2000, J EXP MED, V191, P1247, DOI 10.1084/jem.191.7.1247; HALL LR, 1995, J IMMUNOL, V155, P3501; HATTORI Y, 1994, J BIOL CHEM, V269, P9405; Henson SE, 1999, J IMMUNOL, V163, P1845; Hertz CJ, 1999, CELL IMMUNOL, V192, P24, DOI 10.1006/cimm.1998.1429; Hesse M, 2000, AM J PATHOL, V157, P945, DOI 10.1016/S0002-9440(10)64607-X; Hickey MJ, 1997, FASEB J, V11, P955, DOI 10.1096/fasebj.11.12.9337148; Huang H, 1999, J MOL CELL CARDIOL, V31, P75, DOI 10.1006/jmcc.1998.0848; Hung K, 1998, J EXP MED, V188, P2357, DOI 10.1084/jem.188.12.2357; Iniesta V, 2001, J EXP MED, V193, P777, DOI 10.1084/jem.193.6.777; Iwase K, 2000, J BIOL CHEM, V275, P11929, DOI 10.1074/jbc.275.16.11929; Jimenez JL, 2001, J VIROL, V75, P4655, DOI 10.1128/JVI.75.10.4655-4663.2001; Jin YX, 2001, INFECT IMMUN, V69, P1093, DOI 10.1128/IAI.69.2.1093-1100.2001; Kahn DA, 2001, J EXP MED, V193, P1261, DOI 10.1084/jem.193.11.1261; Karaghiosoff M, 2000, IMMUNITY, V13, P549, DOI 10.1016/S1074-7613(00)00054-6; Khanolkar-Young S, 1998, CLIN EXP IMMUNOL, V113, P438; Kleinert H, 1998, BRIT J PHARMACOL, V125, P193, DOI 10.1038/sj.bjp.0702039; Kolb H, 1998, IMMUNOL TODAY, V19, P556, DOI 10.1016/S0167-5699(98)01366-8; Kristof AS, 2001, J BIOL CHEM, V276, P8445, DOI 10.1074/jbc.M009563200; Kroncke KD, 1998, CLIN EXP IMMUNOL, V113, P147; Kuthejlova M, 2001, INFECT IMMUN, V69, P575, DOI 10.1128/IAI.69.1.575-578.2001; Kwak JY, 2000, CELL IMMUNOL, V203, P84, DOI 10.1006/cimm.2000.1682; Lee C, 2000, J BIOL CHEM, V275, P38965, DOI 10.1074/jbc.M006341200; Lee PC, 1999, CLIN EXP PHARMACOL P, V26, P1013, DOI 10.1046/j.1440-1681.1999.03183.x; Lefer DJ, 1999, AM J PHYSIOL-HEART C, V276, pH1943, DOI 10.1152/ajpheart.1999.276.6.H1943; Leitch GJ, 1999, INFECT IMMUN, V67, P5885, DOI 10.1128/IAI.67.11.5885-5891.1999; Li JR, 1999, J BIOL CHEM, V274, P17325, DOI 10.1074/jbc.274.24.17325; Lu LN, 1996, J IMMUNOL, V157, P3577; Luckhart S, 1998, P NATL ACAD SCI USA, V95, P5700, DOI 10.1073/pnas.95.10.5700; Mach F, 1999, J CLIN INVEST, V104, P1041, DOI 10.1172/JCI6993; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; MacPherson JC, 2001, J IMMUNOL, V166, P5763, DOI 10.4049/jimmunol.166.9.5763; Maneerat Y, 2000, HISTOPATHOLOGY, V37, P269, DOI 10.1046/j.1365-2559.2000.00989.x; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; Marshall HE, 2000, FASEB J, V14, P1889, DOI 10.1096/fj.00.011rev; Martins GA, 2001, IMMUNOLOGY, V103, P122, DOI 10.1046/j.1365-2567.2001.01216.x; Mastroeni P, 2000, J EXP MED, V192, P237, DOI 10.1084/jem.192.2.237; McCartney-Francis NL, 2001, J IMMUNOL, V166, P2734, DOI 10.4049/jimmunol.166.4.2734; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; Miles PR, 1998, AM J PHYSIOL-LUNG C, V274, pL360, DOI 10.1152/ajplung.1998.274.3.L360; Millar AE, 1999, INFECT IMMUN, V67, P3334, DOI 10.1128/IAI.67.7.3334-3338.1999; Morales-Ruiz M, 2001, J BIOL CHEM, V276, P19672, DOI 10.1074/jbc.M009993200; Mori N, 1999, BLOOD, V94, P2862, DOI 10.1182/blood.V94.8.2862.420k24_2862_2870; Moulian N, 2001, BLOOD, V97, P3521, DOI 10.1182/blood.V97.11.3521; Munder M, 1999, J IMMUNOL, V163, P3771; Murray HW, 1999, J EXP MED, V189, P741, DOI 10.1084/jem.189.4.741; Musial A, 2001, J BIOL CHEM, V276, P24268, DOI 10.1074/jbc.M100725200; Nabeshima S, 1999, INFECT IMMUN, V67, P3221, DOI 10.1128/IAI.67.7.3221-3226.1999; Nagasaki A, 1996, J BIOL CHEM, V271, P2658, DOI 10.1074/jbc.271.5.2658; Nathan C, 1997, J CLIN INVEST, V100, P2417, DOI 10.1172/JCI119782; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nicholson B, 2001, J BIOL CHEM, V276, P15881, DOI 10.1074/jbc.M010030200; Niedbala W, 1999, EUR J IMMUNOL, V29, P2498, DOI 10.1002/(SICI)1521-4141(199908)29:08<2498::AID-IMMU2498>3.0.CO;2-M; Noda S, 2001, J IMMUNOL, V166, P3533, DOI 10.4049/jimmunol.166.5.3533; Noguchi S, 2000, J BIOL CHEM, V275, P2376, DOI 10.1074/jbc.275.4.2376; NUSSLER AK, 1994, J BIOL CHEM, V269, P1257; Nuszkowski A, 2001, J BIOL CHEM, V276, P14212, DOI 10.1074/jbc.M007659200; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; OLDS GR, 1980, J EXP MED, V151, P1557, DOI 10.1084/jem.151.6.1557; Paul-Clark MJ, 2001, J IMMUNOL, V166, P1169, DOI 10.4049/jimmunol.166.2.1169; Pellacani A, 2001, J BIOL CHEM, V276, P1653, DOI 10.1074/jbc.M008170200; Perkins DJ, 1999, INFECT IMMUN, V67, P4977, DOI 10.1128/IAI.67.9.4977-4981.1999; Pervin S, 2001, P NATL ACAD SCI USA, V98, P3583, DOI 10.1073/pnas.041603998; Pfeiffer S, 2001, J BIOL CHEM, V276, P34051, DOI 10.1074/jbc.M100585200; Pfeilschifter J, 2001, PFLUG ARCH EUR J PHY, V442, P479, DOI 10.1007/s004240100586; Piacenza L, 2001, P NATL ACAD SCI USA, V98, P7301, DOI 10.1073/pnas.121520398; Pritchard KA, 2001, J BIOL CHEM, V276, P17621, DOI 10.1074/jbc.C100084200; Qureshi AA, 1996, J INVEST DERMATOL, V107, P815, DOI 10.1111/1523-1747.ep12330572; Rai RM, 1998, P NATL ACAD SCI USA, V95, P13829, DOI 10.1073/pnas.95.23.13829; Ratovitski EA, 1999, J BIOL CHEM, V274, P30250, DOI 10.1074/jbc.274.42.30250; Reiling N, 1996, EUR J IMMUNOL, V26, P511, DOI 10.1002/eji.1830260302; RIBEIRO JMC, 1993, SCIENCE, V260, P539, DOI 10.1126/science.8386393; Rodriguez-Pascual F, 2000, J BIOL CHEM, V275, P26040, DOI 10.1074/jbc.M910460199; Roman V, 1997, IMMUNOLOGY, V91, P643, DOI 10.1046/j.1365-2567.1997.d01-2263.x; Ross R, 1998, INT IMMUNOL, V10, P61, DOI 10.1093/intimm/10.1.61; Rutschman R, 2001, J IMMUNOL, V166, P2173, DOI 10.4049/jimmunol.166.4.2173; Saeftel M, 2001, INFECT IMMUN, V69, P2252, DOI 10.1128/IAI.69.4.2252-2259.2001; Salvucci O, 1998, BLOOD, V92, P2093, DOI 10.1182/blood.V92.6.2093.418k31_2093_2102; Sato E, 2000, J BIOL CHEM, V275, P10826, DOI 10.1074/jbc.275.15.10826; Scanga CA, 2000, J EXP MED, V192, P347, DOI 10.1084/jem.192.3.347; Schindler H, 2001, INT IMMUNOPHARMACOL, V1, P1443, DOI 10.1016/S1567-5769(01)00089-3; Sciorati C, 1997, J BIOL CHEM, V272, P23211, DOI 10.1074/jbc.272.37.23211; Seydel KB, 2000, INFECT IMMUN, V68, P400, DOI 10.1128/IAI.68.1.400-402.2000; Shi FD, 2001, J IMMUNOL, V167, P3000, DOI 10.4049/jimmunol.167.5.3000; Shoda LKM, 2001, INFECT IMMUN, V69, P2162, DOI 10.1128/IAI.69.4.2162-2171.2001; Smith AL, 2000, INFECT IMMUN, V68, P6273, DOI 10.1128/IAI.68.11.6273-6280.2000; SPLECKER M, 1998, J LEUKOCYTE BIOL, V63, P732; St John G, 2001, P NATL ACAD SCI USA, V98, P9901; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; Tai XG, 1997, J IMMUNOL, V158, P4696; Tarrant TK, 1999, J EXP MED, V189, P219, DOI 10.1084/jem.189.2.219; TAYLORROBINSON AW, 1994, EUR J IMMUNOL, V24, P980, DOI 10.1002/eji.1830240430; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; Thuring H, 1995, EUR J IMMUNOL, V25, P3229, DOI 10.1002/eji.1830251205; Tochio H, 1998, NAT STRUCT BIOL, V5, P965, DOI 10.1038/2940; Trifilieff A, 2000, J IMMUNOL, V165, P1526, DOI 10.4049/jimmunol.165.3.1526; Trimmer BA, 2001, SCIENCE, V292, P2486, DOI 10.1126/science.1059833; Uma S, 2001, J BIOL CHEM, V276, P14875, DOI 10.1074/jbc.M011476200; Umansky V, 1998, EUR J IMMUNOL, V28, P2276, DOI 10.1002/(SICI)1521-4141(199808)28:08<2276::AID-IMMU2276>3.0.CO;2-H; van der Heyde HC, 2000, J IMMUNOL, V165, P3317, DOI 10.4049/jimmunol.165.6.3317; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; Vodovotz Y, 1999, CANCER RES, V59, P2142; Vos IHC, 2000, EUR J PHARMACOL, V391, P31, DOI 10.1016/S0014-2999(00)00021-2; Wang SB, 1999, J BIOL CHEM, V274, P33190, DOI 10.1074/jbc.274.47.33190; Weinberg JB, 1998, MOL MED, V4, P557, DOI 10.1007/BF03401758; Weiss G, 1998, J INFECT DIS, V177, P1064, DOI 10.1086/515229; WERNERFELMAYER G, 2001, IN PRESS CURR DRUG M; Wilhelm P, 2001, J IMMUNOL, V166, P4012, DOI 10.4049/jimmunol.166.6.4012; Williams KE, 1998, ENERG EXPLOR EXPLOIT, V16, P1; Winkler F, 2001, J INFECT DIS, V183, P1749, DOI 10.1086/320730; Wu GF, 2000, J VIROL, V74, P7683, DOI 10.1128/JVI.74.16.7683-7686.2000; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Xie KP, 1996, J LEUKOCYTE BIOL, V59, P797, DOI 10.1002/jlb.59.6.797; Xu WM, 2000, NAT CELL BIOL, V2, P339, DOI 10.1038/35014028; ZAMORA R, 2001, UNPUB DNA MICROARRAY; ZARGOZA C, J IMMUNOL, V163, P5497; Zhang ZL, 2000, J BIOL CHEM, V275, P15839, DOI 10.1074/jbc.M000604200; Zhao HX, 1998, BLOOD, V92, P1031	189	2404	2485	10	265	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2001	2	10					907	916		10.1038/ni1001-907	http://dx.doi.org/10.1038/ni1001-907			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	478TM	11577346				2022-12-18	WOS:000171361500009
J	Vivier, E; Tomasello, E; Baratin, M; Walzer, T; Ugolini, S				Vivier, Eric; Tomasello, Elena; Baratin, Myriam; Walzer, Thierry; Ugolini, Sophie			Functions of natural killer cells	NATURE IMMUNOLOGY			English	Review							MHC-CLASS-I; CD4(+) T-CELLS; HUMAN NK CELLS; DENDRITIC CELLS; INHIBITORY RECEPTORS; INNATE IMMUNITY; SELF-TOLERANCE; LYMPH-NODES; IFN-GAMMA; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS	Natural killer (NK) cells are effector lymphocytes of the innate immune system that control several types of tumors and microbial infections by limiting their spread and subsequent tissue damage. Recent research highlights the fact that NK cells are also regulatory cells engaged in reciprocal interactions with dendritic cells, macrophages, T cells and endothelial cells. NK cells can thus limit or exacerbate immune responses. Although NK cells might appear to be redundant in several conditions of immune challenge in humans, NK cell manipulation seems to hold promise in efforts to improve hematopoietic and solid organ transplantation, promote antitumor immunotherapy and control inflammatory and autoimmune disorders.	[Vivier, Eric; Tomasello, Elena; Baratin, Myriam; Walzer, Thierry; Ugolini, Sophie] Univ Mediterranee, Ctr Immunol Marseille Luminy, Case 906, INSERM U631, F-13288 Marseille, France; [Tomasello, Elena; Baratin, Myriam; Walzer, Thierry; Ugolini, Sophie] Univ Mediterranee, CNRS, UMR 6102, Case 906, F-13288 Marseille, France; [Vivier, Eric] AP HP, Hop Concept, F-13385 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Vivier, E (corresponding author), Univ Mediterranee, Ctr Immunol Marseille Luminy, Case 906, INSERM U631, Campus Luminy, F-13288 Marseille, France.	vivier@ciml.univ-mrs.fr	Trinchieri, Giorgio/F-9369-2015; Walzer, Thierry/L-9418-2014; Ritz, Jerome/C-7929-2009; Vivier, Eric/F-8939-2010	Trinchieri, Giorgio/0000-0001-5892-7464; Walzer, Thierry/0000-0002-0857-8179; Ritz, Jerome/0000-0001-5526-4669; Vivier, Eric/0000-0001-7022-8287; Tomasello, Elena/0000-0002-6839-5219; Ugolini, Sophie/0000-0003-4041-0103				Alter G, 2007, J EXP MED, V204, P3027, DOI 10.1084/jem.20070695; Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Badgwell B, 2002, SURGERY, V132, P205, DOI 10.1067/msy.2002.125311; Bignon JD, 2005, CURR OPIN IMMUNOL, V17, P553, DOI 10.1016/j.coi.2005.07.014; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Bolovan-Fritts CA, 2008, BLOOD, V111, P175, DOI 10.1182/blood-2007-08-107730; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Buentke E, 2002, J INVEST DERMATOL, V119, P850, DOI 10.1046/j.1523-1747.2002.00132.x; Carr WH, 2007, J IMMUNOL, V178, P647, DOI 10.4049/jimmunol.178.2.647; Cerwenka A, 2001, P NATL ACAD SCI USA, V98, P11521, DOI 10.1073/pnas.201238598; Chen SH, 2005, J EXP MED, V202, P1679, DOI 10.1084/jem.20051473; Chen YY, 2007, HEPATOLOGY, V46, P706, DOI 10.1002/hep.21872; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Croy BA, 2006, IMMUNOL REV, V214, P161; Crozat K, 2007, J EXP MED, V204, P853, DOI 10.1084/jem.20062447; Dalod M, 2002, J EXP MED, V195, P517, DOI 10.1084/jem.20011672; de Matos CT, 2007, IMMUNOLOGY, V122, P291, DOI 10.1111/j.1365-2567.2007.02638.x; Degli-Esposti MA, 2005, NAT REV IMMUNOL, V5, P112, DOI 10.1038/nri1549; Desrosiers MP, 2005, NAT GENET, V37, P593, DOI 10.1038/ng1564; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Dunn C, 2007, J EXP MED, V204, P667, DOI 10.1084/jem.20061287; Fairweather D, 2001, J AUTOIMMUN, V16, P175, DOI 10.1006/jaut.2000.0492; Fehniger TA, 2003, BLOOD, V101, P3052, DOI 10.1182/blood-2002-09-2876; Fehniger TA, 2007, IMMUNITY, V26, P798, DOI 10.1016/j.immuni.2007.04.010; Ferlazzo G, 2004, J IMMUNOL, V172, P1333, DOI 10.4049/jimmunol.172.3.1333; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Fischer A, 2007, IMMUNITY, V27, P835, DOI 10.1016/j.immuni.2007.11.012; Flodstrom M, 2002, NAT IMMUNOL, V3, P373, DOI 10.1038/ni771; Freud AG, 2006, IMMUNOL REV, V214, P56, DOI 10.1111/j.1600-065X.2006.00451.x; Gerosa F, 2005, J IMMUNOL, V174, P727, DOI 10.4049/jimmunol.174.2.727; Ghiringhelli F, 2005, J EXP MED, V202, P1075, DOI 10.1084/jem.20051511; Gregoire C, 2007, IMMUNOL REV, V220, P169, DOI 10.1111/j.1600-065X.2007.00563.x; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Hart OM, 2005, J IMMUNOL, V175, P1636, DOI 10.4049/jimmunol.175.3.1636; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Hayakawa Y, 2004, J IMMUNOL, V172, P123, DOI 10.4049/jimmunol.172.1.123; Imai K, 2000, LANCET, V356, P1795, DOI 10.1016/S0140-6736(00)03231-1; Jamieson AM, 2004, J IMMUNOL, V172, P864, DOI 10.4049/jimmunol.172.2.864; Janka GE, 2007, BLOOD REV, V21, P245, DOI 10.1016/j.blre.2007.05.001; Johansson MH, 1997, J EXP MED, V186, P353, DOI 10.1084/jem.186.3.353; Johansson S, 2005, TRENDS IMMUNOL, V26, P613, DOI 10.1016/j.it.2005.08.008; Jordan MB, 2004, BLOOD, V104, P735, DOI 10.1182/blood-2003-10-3413; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Katchar K, 2005, EUR RESPIR J, V26, P77, DOI 10.1183/09031936.05.00030805; Kelly JM, 2002, NAT IMMUNOL, V3, P83, DOI 10.1038/ni746; Kerr AR, 2005, MICROBES INFECT, V7, P845, DOI 10.1016/j.micinf.2005.02.011; Kim CH, 1999, CELL IMMUNOL, V193, P226, DOI 10.1006/cimm.1999.1483; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kim S, 2000, P NATL ACAD SCI USA, V97, P2731, DOI 10.1073/pnas.050588297; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Koh CY, 2001, BLOOD, V97, P3132, DOI 10.1182/blood.V97.10.3132; Korbel DS, 2004, INT J PARASITOL, V34, P1517, DOI 10.1016/j.ijpara.2004.10.006; Kumar V, 2005, NAT REV IMMUNOL, V5, P363, DOI 10.1038/nri1603; Lambiase A, 2007, MOL VIS, V13, P1562; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Laouar Y, 2005, NAT IMMUNOL, V6, P600, DOI 10.1038/ni1197; Lee SH, 2007, TRENDS IMMUNOL, V28, P252, DOI 10.1016/j.it.2007.04.001; Ljunggren HG, 2007, NAT REV IMMUNOL, V7, P329, DOI 10.1038/nri2073; Long EO, 2007, IMMUNITY, V26, P385, DOI 10.1016/j.immuni.2007.04.001; Lu LR, 2007, IMMUNITY, V26, P593, DOI 10.1016/j.immuni.2007.03.017; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Mavilio D, 2005, P NATL ACAD SCI USA, V102, P2886, DOI 10.1073/pnas.0409872102; McKenna DH, 2007, TRANSFUSION, V47, P520, DOI 10.1111/j.1537-2995.2006.01145.x; Miller JS, 2005, BLOOD, V105, P3051, DOI 10.1182/blood-2004-07-2974; Moffett A, 2007, PLACENTA, V28, pS51, DOI 10.1016/j.placenta.2006.11.008; Morandi B, 2006, EUR J IMMUNOL, V36, P2394, DOI 10.1002/eji.200636290; Moretta L, 2006, IMMUNOL REV, V214, P219, DOI 10.1111/j.1600-065X.2006.00450.x; Nedvetzki S, 2007, BLOOD, V109, P3776, DOI 10.1182/blood-2006-10-052977; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Orange JS, 2006, CURR OPIN ALLERGY CL, V6, P399, DOI 10.1097/ACI.0b013e3280106b65; Ottaviani C, 2006, EUR J IMMUNOL, V36, P118, DOI 10.1002/eji.200535243; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Parolini S, 2007, BLOOD, V109, P3625, DOI 10.1182/blood-2006-08-038844; PAYA CV, 1989, J IMMUNOL, V143, P95; Piccioli D, 2002, J EXP MED, V195, P335, DOI 10.1084/jem.20010934; Poirot L, 2004, P NATL ACAD SCI USA, V101, P8102, DOI 10.1073/pnas.0402065101; Raulet DH, 2006, NAT REV IMMUNOL, V6, P520, DOI 10.1038/nri1863; Raulet DH, 2004, NAT IMMUNOL, V5, P996, DOI 10.1038/ni1114; Rieben R, 2005, TRENDS IMMUNOL, V26, P2, DOI 10.1016/j.it.2004.11.011; Robbins SH, 2007, PLOS PATHOG, V3, P1152, DOI 10.1371/journal.ppat.0030123; Roetynck S, 2006, IMMUNOL REV, V214, P251, DOI 10.1111/j.1600-065X.2006.00446.x; Ruggeri L, 2006, IMMUNOL REV, V214, P202, DOI 10.1111/j.1600-065X.2006.00455.x; Scalzo AA, 2007, IMMUNOL CELL BIOL, V85, P46, DOI 10.1038/sj.icb.7100013; Shanker A, 2007, J IMMUNOL, V179, P6651, DOI 10.4049/jimmunol.179.10.6651; Sivori S, 2004, P NATL ACAD SCI USA, V101, P10116, DOI 10.1073/pnas.0403744101; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Smyth MJ, 2006, J IMMUNOL, V176, P1582, DOI 10.4049/jimmunol.176.3.1582; Smyth MJ, 2005, J EXP MED, V202, P583, DOI 10.1084/jem.20050994; Stewart CA, 2007, IMMUNE SYSTEM RECOGN, P37; Street SEA, 2004, J EXP MED, V199, P879, DOI 10.1084/jem.20031981; TAGLIABUE A, 1982, J EXP MED, V155, P1785, DOI 10.1084/jem.155.6.1785; TAKEDA K, 1993, J EXP MED, V177, P155, DOI 10.1084/jem.177.1.155; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; van Dommelen SLH, 2006, IMMUNITY, V25, P835, DOI 10.1016/j.immuni.2006.09.010; Vidal SM, 2006, CURR TOP MICROBIOL, V298, P183; Vieillard V, 2005, P NATL ACAD SCI USA, V102, P10981, DOI 10.1073/pnas.0504315102; Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478; Voigt S, 2007, IMMUNITY, V26, P617, DOI 10.1016/j.immuni.2007.03.013; Walzer T, 2005, BLOOD, V106, P2252, DOI 10.1182/blood-2005-03-1154; Walzer T, 2007, NAT IMMUNOL, V8, P1337, DOI 10.1038/ni1523; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Wu HJ, 2007, J EXP MED, V204, P1911, DOI 10.1084/jem.20070285; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055; Yoneda O, 2000, J IMMUNOL, V164, P4055, DOI 10.4049/jimmunol.164.8.4055; Yu G, 2006, J EXP MED, V203, P1851, DOI 10.1084/jem.20060603; Yu J, 2007, J IMMUNOL, V179, P5977, DOI 10.4049/jimmunol.179.9.5977; Zhang Y, 2007, IMMUNOLOGY, V121, P258, DOI 10.1111/j.1365-2567.2007.02573.x	109	2342	2428	11	356	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2008	9	5					503	510		10.1038/ni1582	http://dx.doi.org/10.1038/ni1582			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	290WM	18425107				2022-12-18	WOS:000255153500012
J	Ricklin, D; Hajishengallis, G; Yang, K; Lambris, JD				Ricklin, Daniel; Hajishengallis, George; Yang, Kun; Lambris, John D.			Complement: a key system for immune surveillance and homeostasis	NATURE IMMUNOLOGY			English	Review							FACTOR-H POLYMORPHISM; C-REACTIVE PROTEIN; CD4(+) T-CELLS; APOPTOTIC CELLS; DENDRITIC CELLS; PORPHYROMONAS-GINGIVALIS; MACULAR DEGENERATION; CLASSICAL PATHWAY; IL-12 PRODUCTION; IN-VIVO	Nearly a century after the significance of the human complement system was recognized, we have come to realize that its functions extend far beyond the elimination of microbes. Complement acts as a rapid and efficient immune surveillance system that has distinct effects on healthy and altered host cells and foreign intruders. By eliminating cellular debris and infectious microbes, orchestrating immune responses and sending 'danger' signals, complement contributes substantially to homeostasis, but it can also take action against healthy cells if not properly controlled. This review describes our updated view of the function, structure and dynamics of the complement network, highlights its interconnection with immunity at large and with other endogenous pathways, and illustrates its multiple roles in homeostasis and disease.	[Ricklin, Daniel; Yang, Kun; Lambris, John D.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40292 USA	University of Pennsylvania; University of Louisville	Lambris, JD (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	lambris@mail.med.upenn.edu	Mohammed, Imran/J-8271-2012; Hajishengallis, George N./K-1117-2019; Lambris, John/Q-5633-2018; Ricklin, Daniel/F-5104-2011	Mohammed, Imran/0000-0002-8412-0768; Hajishengallis, George N./0000-0001-7392-8852; Lambris, John/0000-0002-9370-5776; Ricklin, Daniel/0000-0001-6140-0233; Yang, Kun/0000-0002-1060-8082	US Public Health Service [CA112162, AI68730, AI30040, AI72106, EB3968, GM62134, DE015254, DE018292]; NATIONAL CANCER INSTITUTE [R01CA112162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI068730, R01AI030040, R01AI072106, N01AI030040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE018292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062134] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The scope of research into complement over the past decade makes it impossible to cover every important aspect; we have had to focus on certain areas, and we acknowledge the research that we could not mention specifically. We thank D. McClellan for editorial assistance and A. Tenner for comments. Supported by US Public Health Service grants CA112162, AI68730, AI30040, AI72106, EB3968, GM62134 (to J.D.L.), and DE015254 and DE018292 (to G.H.).	Addis-Lieser E, 2005, J IMMUNOL, V175, P1894, DOI 10.4049/jimmunol.175.3.1894; Alexander JJ, 2008, J NEUROCHEM, V107, P1169, DOI 10.1111/j.1471-4159.2008.05668.x; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Atkinson JP, 2006, J CLIN INVEST, V116, P1215, DOI 10.1172/JCI28622; Bamberg CE, 2010, J BIOL CHEM, V285, P7633, DOI 10.1074/jbc.M109.092106; Bergmann S, 2007, THROMB HAEMOSTASIS, V98, P512, DOI 10.1160/TH07-02-0117; Bexborn F, 2008, MOL IMMUNOL, V45, P2370, DOI 10.1016/j.molimm.2007.11.003; Botto M, 2009, MOL IMMUNOL, V46, P2774, DOI 10.1016/j.molimm.2009.04.029; Boyajyan A, 2010, NEUROCHEM RES, V35, P894, DOI 10.1007/s11064-010-0126-2; Braun MC, 2000, J IMMUNOL, V164, P3009, DOI 10.4049/jimmunol.164.6.3009; Campagne MV, 2007, CELL MICROBIOL, V9, P2095, DOI 10.1111/j.1462-5822.2007.00981.x; CARMONAFONTAINE C, 2009, 6 INT C INN IMM, V44, P36; Carr TR, 2008, SOC SCI COMPUT REV, V26, P128, DOI 10.1177/0734282907301625; Chai L, 2010, J PERIODONTAL RES, V45, P301, DOI 10.1111/j.1600-0765.2009.01234.x; Chang M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000107; Chen CB, 2004, J BIOL CHEM, V279, P26058, DOI 10.1074/jbc.M401318200; Chen NJ, 2007, NATURE, V446, P203, DOI 10.1038/nature05559; Cole DS, 2003, CLIN SCI, V104, P455, DOI 10.1042/CS20020362; Cole DS, 2006, MOL IMMUNOL, V43, P1953, DOI 10.1016/j.molimm.2005.11.015; Croix DA, 1996, J EXP MED, V183, P1857, DOI 10.1084/jem.183.4.1857; Da Costa XJ, 1999, P NATL ACAD SCI USA, V96, P12708, DOI 10.1073/pnas.96.22.12708; de Pablo P, 2009, NAT REV RHEUMATOL, V5, P218, DOI 10.1038/nrrheum.2009.28; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Diepenhorst GMP, 2009, ANN SURG, V249, P889, DOI 10.1097/SLA.0b013e3181a38f45; Dobo J, 2009, J IMMUNOL, V183, P1207, DOI 10.4049/jimmunol.0901141; Drouin SM, 2002, J IMMUNOL, V169, P5926, DOI 10.4049/jimmunol.169.10.5926; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fang CY, 2009, BLOOD, V114, P1005, DOI 10.1182/blood-2009-01-198283; FEARON DT, 1975, J EXP MED, V142, P856, DOI 10.1084/jem.142.4.856; Finkelman FD, 2010, J IMMUNOL, V184, P1663, DOI 10.4049/jimmunol.0902185; Fischer MB, 1998, SCIENCE, V280, P582, DOI 10.1126/science.280.5363.582; Fischer WH, 1997, J IMMUNOL, V159, P4279; Fischetti F, 2007, ARTHRITIS RHEUM-US, V56, P1187, DOI 10.1002/art.22492; Flierman R, 2007, IMMUNOBIOLOGY, V212, P363, DOI 10.1016/j.imbio.2006.11.005; Fonseca MI, 2009, J IMMUNOL, V183, P1375, DOI 10.4049/jimmunol.0901005; Gaboriaud C, 2004, TRENDS IMMUNOL, V25, P368, DOI 10.1016/j.it.2004.04.008; Gehrs KM, 2010, ARCH OPHTHALMOL-CHIC, V128, P349, DOI 10.1001/archophthalmol.2010.18; Gershov D, 2000, J EXP MED, V192, P1353, DOI 10.1084/jem.192.9.1353; GHEBREHIWET B, 1981, J EXP MED, V153, P665, DOI 10.1084/jem.153.3.665; Goriely S, 2008, NAT REV IMMUNOL, V8, P81, DOI 10.1038/nri2225; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Gullstrand B, 2009, CLIN EXP IMMUNOL, V156, P303, DOI 10.1111/j.1365-2249.2009.03896.x; Guo RF, 2004, SHOCK, V21, P1, DOI 10.1097/01.shk.0000105502.75189.5e; GUSTAVSSON S, 1995, J IMMUNOL, V154, P6524; Haas KM, 2002, IMMUNITY, V17, P713, DOI 10.1016/S1074-7613(02)00483-1; Haas PJ, 2007, IMMUNOL RES, V37, P161, DOI 10.1007/BF02697367; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hajishengallis G, 2007, J IMMUNOL, V179, P2359, DOI 10.4049/jimmunol.179.4.2359; Hajishengallis G, 2010, TRENDS IMMUNOL, V31, P154, DOI 10.1016/j.it.2010.01.002; Harboe M, 2008, J CELL MOL MED, V12, P1074, DOI 10.1111/j.1582-4934.2008.00350.x; Harokopakis E, 2006, J IMMUNOL, V176, P7645, DOI 10.4049/jimmunol.176.12.7645; Hashimoto M, 2010, J EXP MED, V207, P1135, DOI 10.1084/jem.20092301; Hawlisch H, 2005, IMMUNITY, V22, P415, DOI 10.1016/j.immuni.2005.02.006; He JQ, 2008, MOL IMMUNOL, V45, P4041, DOI 10.1016/j.molimm.2008.07.011; Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039; Hillebrandt S, 2005, NAT GENET, V37, P835, DOI 10.1038/ng1599; Holers VM, 2008, IMMUNOL REV, V223, P300, DOI 10.1111/j.1600-065X.2008.00641.x; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Inal JM, 2005, J IMMUNOL, V174, P356, DOI 10.4049/jimmunol.174.1.356; Ingram G, 2009, CLIN EXP IMMUNOL, V155, P128, DOI 10.1111/j.1365-2249.2008.03830.x; Ip WKE, 2008, J EXP MED, V205, P169, DOI 10.1084/jem.20071164; Jalili A, 2010, EXP HEMATOL, V38, P321, DOI 10.1016/j.exphem.2010.02.002; Kaczorowski DJ, 2010, J LEUKOCYTE BIOL, V88, P609, DOI 10.1189/jlb.0809588; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kagan JC, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3120pe15; Karp CL, 1996, SCIENCE, V273, P228, DOI 10.1126/science.273.5272.228; Kaya Z, 2001, NAT IMMUNOL, V2, P739, DOI 10.1038/90686; Kim DD, 2006, CLIN IMMUNOL, V118, P127, DOI 10.1016/j.clim.2005.10.014; Kim SJ, 2004, IMMUNITY, V21, P643, DOI 10.1016/j.immuni.2004.09.009; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; Kohl J, 2006, J CLIN INVEST, V116, P783, DOI 10.1172/JCI26582; Kopf M, 2002, NAT MED, V8, P373, DOI 10.1038/nm0402-373; Kourtzelis I, 2010, BLOOD, V116, P631, DOI 10.1182/blood-2010-01-264051; Krarup A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000623; Krauss JL, 2010, PERIODONTOL 2000, V52, P141, DOI 10.1111/j.1600-0757.2009.00324.x; Krych-Goldberg M, 2001, IMMUNOL REV, V180, P112, DOI 10.1034/j.1600-065X.2001.1800110.x; Kumar V, 2006, J CLIN INVEST, V116, P512, DOI 10.1172/JCI25536; la Sala A, 2005, J IMMUNOL, V175, P2994, DOI 10.4049/jimmunol.175.5.2994; Lachmann PJ, 2009, SCAND J IMMUNOL, V69, P471, DOI 10.1111/j.1365-3083.2009.02258.x; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Lappegard KT, 2009, P NATL ACAD SCI USA, V106, P15861, DOI 10.1073/pnas.0903613106; Le Friec G, 2009, ARCH IMMUNOL THER EX, V57, P393, DOI 10.1007/s00005-009-0047-4; Li K, 2008, BLOOD, V112, P5084, DOI 10.1182/blood-2008-05-156646; Lillis AP, 2008, J IMMUNOL, V181, P364, DOI 10.4049/jimmunol.181.1.364; Liu JB, 2008, J IMMUNOL, V180, P5882, DOI 10.4049/jimmunol.180.9.5882; Loeffler DA, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-29; Longhi MP, 2006, TRENDS IMMUNOL, V27, P102, DOI 10.1016/j.it.2005.12.008; Lowell CA, 2006, IMMUNITY, V24, P243, DOI 10.1016/j.immuni.2006.03.002; Lutz HU, 2006, MOL IMMUNOL, V43, P2, DOI 10.1016/j.molimm.2005.06.020; MacLaren R, 2008, ADV EXP MED BIOL, V632, P1, DOI 10.1007/978-0-387-78952-1_1; Manderson AP, 2004, ANNU REV IMMUNOL, V22, P431, DOI 10.1146/annurev.immunol.22.012703.104549; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655; Markiewski MM, 2007, AM J PATHOL, V171, P715, DOI 10.2353/ajpath.2007.070166; Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006; Markiewski MM, 2009, J IMMUNOL, V182, P5412, DOI 10.4049/jimmunol.0804179; Markiewski MM, 2009, TRENDS IMMUNOL, V30, P286, DOI 10.1016/j.it.2009.04.002; Markiewski MM, 2008, J CELL MOL MED, V12, P2245, DOI 10.1111/j.1582-4934.2008.00504.x; Markiewski MM, 2006, MOL IMMUNOL, V43, P45, DOI 10.1016/j.molimm.2005.06.019; Marsh JE, 2001, TRANSPLANTATION, V72, P1310, DOI 10.1097/00007890-200110150-00022; Marth T, 1997, J EXP MED, V185, P1987, DOI 10.1084/jem.185.11.1987; Mayilyan KR, 2008, DRUG NEWS PERSPECT, V21, P200, DOI 10.1358/dnp.2008.21.4.1213349; McCoy JM, 2002, J CLIN INVEST, V110, P651, DOI 10.1172/JCI200215528; Mevorach D, 1998, J EXP MED, V188, P2313, DOI 10.1084/jem.188.12.2313; Morelli AE, 2003, BLOOD, V101, P611, DOI 10.1182/blood-2002-06-1769; MULLEREBERHARD HJ, 1985, J INVEST DERMATOL, V85, pS47; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Muscari A, 2007, DIABETES CARE, V30, P2362, DOI 10.2337/dc07-0637; Nakayama Y, 2009, J IMMUNOL, V183, P2921, DOI 10.4049/jimmunol.0801191; NICHOLSONWELLER A, 1993, IMMUNOL RES, V12, P244, DOI 10.1007/BF02918256; Niculescu F, 2001, IMMUNOL RES, V24, P191, DOI 10.1385/IR:24:2:191; Nilsson B, 2010, TRENDS IMMUNOL, V31, P32, DOI 10.1016/j.it.2009.09.005; Noris M, 2009, NEW ENGL J MED, V361, P1676, DOI 10.1056/NEJMra0902814; Norsworthy PJ, 2004, J IMMUNOL, V172, P3406, DOI 10.4049/jimmunol.172.6.3406; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Ohinata K, 2008, ADV EXP MED BIOL, V632, P35, DOI 10.1007/978-0-387-78952-1_3; Okroj M, 2007, ANN MED, V39, P517, DOI 10.1080/07853890701477546; Oliva C, 2009, P NATL ACAD SCI USA, V106, P13957, DOI 10.1073/pnas.0902392106; Ottonello L, 1999, J IMMUNOL, V162, P6510; Pangburn MK, 2008, VACCINE, V26, pI15, DOI 10.1016/j.vaccine.2008.11.023; PANGBURN MK, 1981, J EXP MED, V154, P856, DOI 10.1084/jem.154.3.856; Peng Q, 2009, J IMMUNOL, V183, P6058, DOI 10.4049/jimmunol.0804186; Pettigrew HD, 2009, ANN NY ACAD SCI, V1173, P108, DOI 10.1111/j.1749-6632.2009.04633.x; Price JD, 2005, J IMMUNOL, V175, P677, DOI 10.4049/jimmunol.175.2.677; Raisz Lawrence G., 2001, American Journal of Medicine, V110, p43S; RAISZ LG, 1974, SCIENCE, V185, P789, DOI 10.1126/science.185.4153.789; Ratajczak MZ, 2006, EXP HEMATOL, V34, P986, DOI 10.1016/j.exphem.2006.03.015; Rawal N, 2008, J BIOL CHEM, V283, P7853, DOI 10.1074/jbc.M707591200; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Ritis K, 2006, J IMMUNOL, V177, P4794, DOI 10.4049/jimmunol.177.7.4794; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Rooijakkers SHM, 2009, NAT IMMUNOL, V10, P721, DOI 10.1038/ni.1756; Roozendaal R, 2007, IMMUNOL REV, V219, P157, DOI 10.1111/j.1600-065X.2007.00556.x; Sacks SH, 2010, EUR J IMMUNOL, V40, P668, DOI 10.1002/eji.201040355; SAHU A, 1994, BIOCHEM J, V302, P429, DOI 10.1042/bj3020429; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Schafer DP, 2010, BIOCHEM SOC T, V38, P476, DOI 10.1042/BST0380476; Scola AM, 2007, J BIOL CHEM, V282, P3664, DOI 10.1074/jbc.M609178200; Selander B, 2006, J CLIN INVEST, V116, P1425, DOI 10.1172/JCI25982; Shinjyo N, 2009, STEM CELLS, V27, P2824, DOI 10.1002/stem.225; Shushakova N, 2002, J CLIN INVEST, V110, P1823, DOI 10.1172/JCI200216577; SILASIMANSAT R, 2010, BLOOD           0513, DOI DOI 10.1182/BLOOD-2010-02-269746; Skerka C, 2009, MOL IMMUNOL, V46, P2801, DOI 10.1016/j.molimm.2009.05.018; Spitzer D, 2007, J IMMUNOL, V179, P2600, DOI 10.4049/jimmunol.179.4.2600; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001; Sunyer JO, 1998, IMMUNOL TODAY, V19, P519; Tarr J, 2005, CRIT REV IMMUNOL, V25, P305, DOI 10.1615/CritRevImmunol.v25.i4.40; Thornton BP, 1996, CLIN EXP IMMUNOL, V104, P531, DOI 10.1046/j.1365-2249.1996.57761.x; Trouw LA, 2008, MOL IMMUNOL, V45, P1199, DOI 10.1016/j.molimm.2007.09.008; Tsonis PA, 2006, ADV EXP MED BIOL, V586, P63; Vaknin-Dembinsky A, 2008, J NEUROIMMUNOL, V195, P140, DOI 10.1016/j.jneuroim.2008.01.002; Verbovetski I, 2002, J EXP MED, V196, P1553, DOI 10.1084/jem.20020263; Waggoner SN, 2005, J IMMUNOL, V175, P4706, DOI 10.4049/jimmunol.175.7.4706; Wagner C, 2006, MOL IMMUNOL, V43, P643, DOI 10.1016/j.molimm.2005.04.006; Wagner E, 2010, NAT REV DRUG DISCOV, V9, P43, DOI 10.1038/nrd3011; Wallis R, 2010, IMMUNOBIOLOGY, V215, P1, DOI 10.1016/j.imbio.2009.08.006; Wang M, 2007, J IMMUNOL, V179, P2349, DOI 10.4049/jimmunol.179.4.2349; Wang M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000697; Ward PA, 2004, NAT REV IMMUNOL, V4, P133, DOI 10.1038/nri1269; Ward PA, 2009, J MOL MED, V87, P375, DOI 10.1007/s00109-009-0442-7; Warren OJ, 2009, J CARDIOTHOR VASC AN, V23, P223, DOI 10.1053/j.jvca.2008.08.007; Weaver DJ, 2010, EUR J IMMUNOL, V40, P710, DOI 10.1002/eji.200939333; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Williams AS, 2004, ARTHRITIS RHEUM-US, V50, P3035, DOI 10.1002/art.20478; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755; Zarewych DM, 1996, J IMMUNOL, V156, P430; Zhang XH, 2007, BLOOD, V110, P228, DOI 10.1182/blood-2006-12-063636; Zhang X, 2010, EXPERT REV CLIN IMMU, V6, P269, DOI 10.1586/ECI.09.84; Zhang X, 2009, J IMMUNOL, V182, P5123, DOI 10.4049/jimmunol.0804276; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	176	2337	2438	8	398	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2010	11	9					785	797		10.1038/ni.1923	http://dx.doi.org/10.1038/ni.1923			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	641HN	20720586	Green Accepted			2022-12-18	WOS:000281115500006
J	Wherry, EJ				Wherry, E. John			T cell exhaustion	NATURE IMMUNOLOGY			English	Review							CHRONIC VIRAL-INFECTION; VIRUS-SPECIFIC CD4(+); GROWTH-FACTOR-BETA; HEPATITIS-C; PD-1 EXPRESSION; UP-REGULATION; PROGRAMMED DEATH-1; IMMUNE-RESPONSES; DENDRITIC CELLS; CD8	T cell exhaustion is a state of T cell dysfunction that arises during many chronic infections and cancer. It is defined by poor effector function, sustained expression of inhibitory receptors and a transcriptional state distinct from that of functional effector or memory T cells. Exhaustion prevents optimal control of infection and tumors. Recently, a clearer picture of the functional and phenotypic profile of exhausted T cells has emerged and T cell exhaustion has been defined in many experimental and clinical settings. Although the pathways involved remain to be fully defined, advances in the molecular delineation of T cell exhaustion are clarifying the underlying causes of this state of differentiation and also suggest promising therapeutic opportunities.	Univ Penn, Sch Med, Dept Microbiol, Inst Immunol, Philadelphia, PA 19104 USA	University of Pennsylvania	Wherry, EJ (corresponding author), Univ Penn, Sch Med, Dept Microbiol, Inst Immunol, Philadelphia, PA 19104 USA.	wherry@mail.med.upenn.edu	Wherry, John/ABI-1280-2020		US National Institutes of Health [AI071309, AI083022, AI082630, HHSN226200500030]; Commonwealth of Pennsylvania; Ellison Medical Foundation; Dana Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082630, U19AI083022, R01AI071309] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania; Ellison Medical Foundation(Lawrence Ellison Foundation); Dana Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	I thank the members of my laboratory and N. Haining for discussions. Supported by the US National Institutes of Health (AI071309, AI083022, AI082630, HHSN226200500030), the Commonwealth of Pennsylvania, the Ellison Medical Foundation and the Dana Foundation.	Agnellini P, 2007, P NATL ACAD SCI USA, V104, P4565, DOI 10.1073/pnas.0610335104; Akbar AN, 2011, NAT REV IMMUNOL, V11, P289, DOI 10.1038/nri2959; Alatrakchi N, 2007, J VIROL, V81, P5882, DOI 10.1128/JVI.02202-06; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Bikoff EK, 2009, CURR OPIN GENET DEV, V19, P379, DOI 10.1016/j.gde.2009.05.005; Blackburn SD, 2007, TRENDS MICROBIOL, V15, P143, DOI 10.1016/j.tim.2007.02.006; Blackburn SD, 2010, J VIROL, V84, P2078, DOI 10.1128/JVI.01579-09; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Blattman JN, 2003, NAT MED, V9, P540, DOI 10.1038/nm866; Blattman JN, 2009, J VIROL, V83, P4386, DOI 10.1128/JVI.02524-08; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Brooks DG, 2008, J EXP MED, V205, P533, DOI 10.1084/jem.20071948; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Brooks DG, 2008, P NATL ACAD SCI USA, V105, P20428, DOI 10.1073/pnas.0811139106; Brooks DG, 2005, J VIROL, V79, P10514, DOI 10.1128/JVI.79.16.10514-10527.2005; Bucks CM, 2009, J IMMUNOL, V182, P6697, DOI 10.4049/jimmunol.0800997; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Chevalier MF, 2011, J VIROL, V85, P733, DOI 10.1128/JVI.02030-10; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Crawford A, 2009, CURR OPIN IMMUNOL, V21, P179, DOI 10.1016/j.coi.2009.01.010; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Freeman GJ, 2006, J EXP MED, V203, P2223, DOI 10.1084/jem.20061800; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Fuller MJ, 2003, J IMMUNOL, V170, P477, DOI 10.4049/jimmunol.170.1.477; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Garba ML, 2002, J IMMUNOL, V168, P2247, DOI 10.4049/jimmunol.168.5.2247; Grosso JF, 2009, J IMMUNOL, V182, P6659, DOI 10.4049/jimmunol.0804211; Ha SJ, 2008, J EXP MED, V205, P543, DOI 10.1084/jem.20071949; Haining WN, 2010, IMMUNITY, V32, P152, DOI 10.1016/j.immuni.2010.02.001; Hertoghs KML, 2010, J CLIN INVEST, V120, P4077, DOI 10.1172/JCI42758; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Joosten SA, 2007, P NATL ACAD SCI USA, V104, P8029, DOI 10.1073/pnas.0702257104; Joshi NS, 2008, J IMMUNOL, V180, P1309, DOI 10.4049/jimmunol.180.3.1309; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; KAO C, NAT IMMUNOL IN PRESS; Kasprowicz V, 2010, J VIROL, V84, P1656, DOI 10.1128/JVI.01499-09; Kassu A, 2010, J IMMUNOL, V185, P3007, DOI 10.4049/jimmunol.1000156; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Lauer GM, 2006, CLIN INFECT DIS, V42, P953, DOI 10.1086/500944; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Leone A, 2009, CURR HIV RES, V7, P83, DOI 10.2174/157016209787048519; Lichterfeld M, 2008, BLOOD, V112, P3679, DOI 10.1182/blood-2008-01-135442; Liu BS, 2009, J LEUKOCYTE BIOL, V85, P205, DOI 10.1189/jlb.0408241; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; Matsuzaki J, 2010, P NATL ACAD SCI USA, V107, P7875, DOI 10.1073/pnas.1003345107; Matter M, 2006, J EXP MED, V203, P2145, DOI 10.1084/jem.20060651; Mehta DS, 2005, P NATL ACAD SCI USA, V102, P2016, DOI 10.1073/pnas.0409512102; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Migueles SA, 2009, J VIROL, V83, P11876, DOI 10.1128/JVI.01153-09; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Miller NE, 2005, J VIROL, V79, P9419, DOI 10.1128/JVI.79.15.9419-9429.2005; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; Mueller SN, 2007, P NATL ACAD SCI USA, V104, P15430, DOI 10.1073/pnas.0702579104; Nakamoto N, 2008, GASTROENTEROLOGY, V134, P1927, DOI 10.1053/j.gastro.2008.02.033; Nakamoto N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000313; NANJAPPA SG, 2011, BLOOD           0323, DOI DOI 10.1182/BLOOD-2010-12-323154; Oestreich KJ, 2008, J IMMUNOL, V181, P4832, DOI 10.4049/jimmunol.181.7.4832; Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598; Oxenius A, 1998, IMMUNITY, V9, P449, DOI 10.1016/S1074-7613(00)80628-7; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Pellegrini M, 2011, CELL, V144, P601, DOI 10.1016/j.cell.2011.01.011; Pentcheva-Hoang T, 2004, IMMUNITY, V21, P401, DOI 10.1016/j.immuni.2004.06.017; Petrovas C, 2007, BLOOD, V110, P928, DOI 10.1182/blood-2007-01-069112; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Punkosdy GA, 2011, P NATL ACAD SCI USA, V108, P3677, DOI 10.1073/pnas.1100213108; Quigley M, 2010, NAT MED, V16, P1147, DOI 10.1038/nm.2232; Reignat S, 2002, J EXP MED, V195, P1089, DOI 10.1084/jem.20011723; Rifa'i M, 2004, J EXP MED, V200, P1123, DOI 10.1084/jem.20040395; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Said EA, 2010, NAT MED, V16, P452, DOI 10.1038/nm.2106; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Schacker T, 2008, AIDS, V22, pS13, DOI 10.1097/01.aids.0000327511.76126.b5; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Sevilla N, 2003, CURR TOP MICROBIOL, V276, P125; Shin H, 2007, CURR OPIN IMMUNOL, V19, P408, DOI 10.1016/j.coi.2007.06.004; Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Streeck H, 2008, PLOS MED, V5, P790, DOI 10.1371/journal.pmed.0050100; Tinoco R, 2009, IMMUNITY, V31, P145, DOI 10.1016/j.immuni.2009.06.015; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Trimble LA, 2000, BLOOD, V96, P1021, DOI 10.1182/blood.V96.3.1021.015k37_1021_1029; Urbani S, 2006, HEPATOLOGY, V44, P126, DOI 10.1002/hep.21242; van Leeuwen EMM, 2006, IMMUNOL REV, V211, P225, DOI 10.1111/j.0105-2896.2006.00379.x; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Vezys V, 2006, J EXP MED, V203, P2263, DOI 10.1084/jem.20060995; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Williams KL, 2001, EUR J IMMUNOL, V31, P1620, DOI 10.1002/1521-4141(200105)31:5<1620::AID-IMMU1620>3.0.CO;2-3; Williams LD, 2011, J VIROL, V85, P2316, DOI 10.1128/JVI.01476-10; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Wirth TC, 2010, IMMUNITY, V33, P128, DOI 10.1016/j.immuni.2010.06.014; Workman CJ, 2004, J IMMUNOL, V172, P5450, DOI 10.4049/jimmunol.172.9.5450; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Yue FY, 2010, J IMMUNOL, V185, P498, DOI 10.4049/jimmunol.0903915; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zeng M, 2011, J CLIN INVEST, V121, P998, DOI 10.1172/JCI45157; Zhou SH, 2002, J VIROL, V76, P829, DOI 10.1128/JVI.76.2.829-840.2002	116	2319	2459	22	462	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2011	12	6					492	499		10.1038/ni.2035	http://dx.doi.org/10.1038/ni.2035			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	765LI	21739672				2022-12-18	WOS:000290707100007
J	Karin, M; Lin, A				Karin, M; Lin, A			NF-kappa B at the crossroads of life and death	NATURE IMMUNOLOGY			English	Review							TUMOR-NECROSIS-FACTOR; IKK-BETA SUBUNIT; TNF RECEPTOR 1; TRANSCRIPTION FACTOR; INDUCED APOPTOSIS; STRUCTURAL BASIS; MICE LACKING; FACTOR-ALPHA; CELL-DEATH; BCL-X(L) EXPRESSION	The choice between life and death is one of the major events in regulation of the immune system. T cells that specifically recognize viral or bacterial antigens are selected to survive and proliferate in response to infection, whereas those that are self-reactive are eliminated via apoptosis. Even the survival of alloreactive T cells requires their proper costimulation and, when infection subsides, the activated T cells are eliminated. A major regulator of such life or death decisions is the transcription factor NF-kappaB. However, NF-kappaB cannot function alone. A variety of mechanisms exist to modulate its activity and thereby affect the ultimate outcome of a cell's fate.	Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA	University of California System; University of California San Diego; University of Chicago	Karin, M (corresponding author), Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu						Alcamo E, 2001, J IMMUNOL, V167, P1592, DOI 10.4049/jimmunol.167.3.1592; Arch RH, 2000, BIOCHEM BIOPH RES CO, V272, P936, DOI 10.1006/bbrc.2000.2873; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Attar RM, 1997, SEMIN CANCER BIOL, V8, P93, DOI 10.1006/scbi.1997.0060; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Barkett M, 1997, J BIOL CHEM, V272, P29419, DOI 10.1074/jbc.272.47.29419; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bentires-Alj M, 2001, ONCOGENE, V20, P2805, DOI 10.1038/sj.onc.1204343; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Clem RJ, 1998, P NATL ACAD SCI USA, V95, P554, DOI 10.1073/pnas.95.2.554; Clem RJ, 2001, J BIOL CHEM, V276, P7602, DOI 10.1074/jbc.M010259200; Conte D, 2001, P NATL ACAD SCI USA, V98, P5049, DOI 10.1073/pnas.081547998; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Dechend R, 1999, ONCOGENE, V18, P3316, DOI 10.1038/sj.onc.1202717; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; DEVERAUX QL, 1998, EMBO J, V17, P2215, DOI DOI 10.1093/EMBOJ/17.8.2215; Doi TS, 1999, P NATL ACAD SCI USA, V96, P2994, DOI 10.1073/pnas.96.6.2994; Duckett CS, 1997, GENE DEV, V11, P2810, DOI 10.1101/gad.11.21.2810; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; FORNACE AJ, 1992, ANN NY ACAD SCI, V663, P139, DOI 10.1111/j.1749-6632.1992.tb38657.x; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Freire-de-Lima CG, 2000, NATURE, V403, P199, DOI 10.1038/35003208; Fujita N, 1998, ONCOGENE, V17, P1295, DOI 10.1038/sj.onc.1202065; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Grossmann M, 2000, EMBO J, V19, P6351, DOI 10.1093/emboj/19.23.6351; Grumont RJ, 1999, GENE DEV, V13, P400, DOI 10.1101/gad.13.4.400; Hamasaki A, 1998, J EXP MED, V188, P1985, DOI 10.1084/jem.188.11.1985; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Hong SY, 2000, J BIOL CHEM, V275, P18022, DOI 10.1074/jbc.M001202200; Horwitz BH, 1997, IMMUNITY, V6, P765, DOI 10.1016/S1074-7613(00)80451-3; Huang YH, 2001, CELL, V104, P781, DOI 10.1016/S0092-8674(01)00273-2; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Javelaud D, 2001, ONCOGENE, V20, P4365, DOI 10.1038/sj.onc.1204570; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kasof GM, 2001, ONCOGENE, V20, P7965, DOI 10.1038/sj.onc.1204985; Khoshnan A, 2000, J IMMUNOL, V165, P1743, DOI 10.4049/jimmunol.165.4.1743; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; Lavon I, 2000, NAT MED, V6, P573, DOI 10.1038/75057; Lee C, 1996, FOLD DES, V1, P1, DOI 10.1016/S1359-0278(96)00006-5; Lee SY, 1997, IMMUNITY, V7, P703, DOI 10.1016/S1074-7613(00)80390-8; Lenczowski JM, 1997, MOL CELL BIOL, V17, P170, DOI 10.1128/MCB.17.1.170; Leo E, 2001, J BIOL CHEM, V276, P8087, DOI 10.1074/jbc.M009450200; Levkau B, 1999, NAT CELL BIOL, V1, P227, DOI 10.1038/12050; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; LIN EY, 1993, J IMMUNOL, V151, P1979; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; Medzhitov R, 2001, NAT IMMUNOL, V2, P15, DOI 10.1038/83121; Mills SD, 1997, P NATL ACAD SCI USA, V94, P12638, DOI 10.1073/pnas.94.23.12638; Mitchell TC, 2001, NAT IMMUNOL, V2, P397, DOI 10.1038/87692; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Natoli G, 1997, SCIENCE, V275, P200, DOI 10.1126/science.275.5297.200; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594; Ravi R, 2001, NAT CELL BIOL, V3, P409, DOI 10.1038/35070096; Reuther JY, 1999, J BIOL CHEM, V274, P20664, DOI 10.1074/jbc.274.29.20664; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(01)00274-4; Rosenfeld ME, 2000, AM J PATHOL, V156, P997, DOI 10.1016/S0002-9440(10)64967-X; Schafer H, 1999, BIOCHEM BIOPH RES CO, V262, P139, DOI 10.1006/bbrc.1999.1131; Schwenzer R, 1999, J BIOL CHEM, V274, P19368, DOI 10.1074/jbc.274.27.19368; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Senftleben U, 2001, IMMUNITY, V14, P217, DOI 10.1016/S1074-7613(01)00104-2; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Shu HB, 1997, IMMUNITY, V6, P751, DOI 10.1016/S1074-7613(00)80450-1; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; Sizemore N, 1999, MOL CELL BIOL, V19, P4798; Solan NJ, 2002, J BIOL CHEM, V277, P1405, DOI 10.1074/jbc.M109619200; Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Tang GL, 2001, MOL CELL, V8, P1005, DOI 10.1016/S1097-2765(01)00380-X; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Tsukahara T, 1999, J VIROL, V73, P7981, DOI 10.1128/JVI.73.10.7981-7987.1999; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Wang CY, 1999, MOL CELL BIOL, V19, P5923; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wu MX, 1998, SCIENCE, V281, P998, DOI 10.1126/science.281.5379.998; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Zheng Y, 2001, J IMMUNOL, V166, P4949, DOI 10.4049/jimmunol.166.8.4949; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; ZONG WX, 1999, GENES DEV, V13	98	2313	2423	2	120	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2002	3	3					221	227		10.1038/ni0302-221	http://dx.doi.org/10.1038/ni0302-221			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	525LV	11875461				2022-12-18	WOS:000174074000009
J	Gajewski, TF; Schreiber, H; Fu, YX				Gajewski, Thomas F.; Schreiber, Hans; Fu, Yang-Xin			Innate and adaptive immune cells in the tumor microenvironment	NATURE IMMUNOLOGY			English	Review							PLASMACYTOID DENDRITIC CELLS; FIBROBLAST ACTIVATION PROTEIN; CD8(+) T-CELLS; PHASE-II TRIAL; HOMEOSTATIC PROLIFERATION; ANTITUMOR IMMUNITY; ANTICANCER CHEMOTHERAPY; SELECTIVE-INHIBITION; METASTATIC MELANOMA; DENILEUKIN DIFTITOX	Most tumor cells express antigens that can mediate recognition by host CD8(+) T cells. Cancers that are detected clinically must have evaded antitumor immune responses to grow progressively. Recent work has suggested two broad categories of tumor escape based on cellular and molecular characteristics of the tumor microenvironment. One major subset shows a T cell-inflamed phenotype consisting of infiltrating T cells, a broad chemokine profile and a type I interferon signature indicative of innate immune activation. These tumors appear to resist immune attack through the dominant inhibitory effects of immune system-suppressive pathways. The other major phenotype lacks this T cell-inflamed phenotype and appears to resist immune attack through immune system exclusion or ignorance. These two major phenotypes of tumor microenvironment may require distinct immunotherapeutic interventions for maximal therapeutic effect.	[Gajewski, Thomas F.; Schreiber, Hans; Fu, Yang-Xin] Univ Chicago, Chicago, IL 60637 USA	University of Chicago	Gajewski, TF (corresponding author), Univ Chicago, Chicago, IL 60637 USA.	tgajewsk@medicine.bsd.uchicago.edu	Ren, Zhenhua/R-3751-2018	Ren, Zhenhua/0000-0002-2560-5618; fu, yang-xin/0000-0001-8441-6617	NCI NIH HHS [R01 CA127475, R01 CA118153, R01 CA161005] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA161005, R01CA127475, R01CA118153] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahrens S, 2012, IMMUNITY, V36, P635, DOI 10.1016/j.immuni.2012.03.008; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Appay V, 2006, J IMMUNOL, V177, P1670, DOI 10.4049/jimmunol.177.3.1670; Attia P, 2005, J IMMUNOTHER, V28, P582, DOI 10.1097/01.cji.0000175468.19742.10; Azimi F, 2012, J CLIN ONCOL, V30, P2678, DOI 10.1200/JCO.2011.37.8539; Balachandran VP, 2011, NAT MED, V17, P1094, DOI 10.1038/nm.2438; Barber A, 2009, J IMMUNOL, V183, P6939, DOI 10.4049/jimmunol.0902000; Barber GN, 2011, IMMUNOL REV, V243, P99, DOI 10.1111/j.1600-065X.2011.01051.x; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; BOON T, 1995, IMMUNOL TODAY, V16, P334, DOI 10.1016/0167-5699(95)80149-9; Bos R, 2012, ONCOIMMUNOLOGY, V1, P1239, DOI 10.4161/onci.21285; BOUSSIOTIS VA, 1994, SCIENCE, V266, P1039, DOI 10.1126/science.7973657; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brichard VG, 2007, VACCINE, V25, pB61, DOI 10.1016/j.vaccine.2007.06.038; Brose MS, 2002, CANCER RES, V62, P6997; Brown IE, 2006, J IMMUNOL, V177, P4521, DOI 10.4049/jimmunol.177.7.4521; Buckanovich RJ, 2008, NAT MED, V14, P28, DOI 10.1038/nm1699; Bui JD, 2007, CURR OPIN IMMUNOL, V19, P203, DOI 10.1016/j.coi.2007.02.001; Burdelya L, 2005, J IMMUNOL, V174, P3925, DOI 10.4049/jimmunol.174.7.3925; Burnette Byron, 2012, Front Oncol, V2, P143, DOI 10.3389/fonc.2012.00143; Burnette BC, 2011, CANCER RES, V71, P2488, DOI 10.1158/0008-5472.CAN-10-2820; CHEN LP, 1992, CELL, V71, P1093, DOI 10.1016/S0092-8674(05)80059-5; Chen W, 2008, J IMMUNOL, V181, P5396, DOI 10.4049/jimmunol.181.8.5396; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Daniel D, 2003, J EXP MED, V197, P1017, DOI 10.1084/jem.20021047; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; Delahaye NF, 2011, NAT MED, V17, P700, DOI 10.1038/nm.2366; Delmas V, 2007, GENE DEV, V21, P2923, DOI 10.1101/gad.450107; Demoulin S, 2013, J LEUKOCYTE BIOL, V93, P343, DOI 10.1189/jlb.0812397; Dengel LT, 2010, J IMMUNOTHER, V33, P965, DOI 10.1097/CJI.0b013e3181fb045d; Di Carlo E, 2013, MOL THER, V21, P1034, DOI 10.1038/mt.2013.38; Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158; Dunn GP, 2005, NAT IMMUNOL, V6, P722, DOI 10.1038/ni1213; Edosada CY, 2006, J BIOL CHEM, V281, P7437, DOI 10.1074/jbc.M511112200; Engels B, 2013, CANCER CELL, V23, P516, DOI 10.1016/j.ccr.2013.03.018; Fine JH, 2010, CANCER RES, V70, P7102, DOI 10.1158/0008-5472.CAN-10-1316; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Frederick DT, 2013, CLIN CANCER RES, V19, P1225, DOI 10.1158/1078-0432.CCR-12-1630; Fuertes MB, 2013, TRENDS IMMUNOL, V34, P67, DOI 10.1016/j.it.2012.10.004; Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159; Gajewski TF, 2007, CLIN CANCER RES, V13, P5256, DOI 10.1158/1078-0432.CCR-07-0892; Gajewski TF, 2012, CANCER IMMUNOL IMMUN, V61, P1343, DOI 10.1007/s00262-012-1305-6; Gajewski TF, 2010, CANCER J, V16, P399, DOI 10.1097/PPO.0b013e3181eacbd8; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Galon J, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-205; Gattinoni L, 2005, J EXP MED, V202, P907, DOI 10.1084/jem.20050732; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Hamid O, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-204; Harlin H, 2006, CANCER IMMUNOL IMMUN, V55, P1185, DOI 10.1007/s00262-005-0118-2; Harlin H, 2009, CANCER RES, V69, P3077, DOI 10.1158/0008-5472.CAN-08-2281; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Ji RR, 2012, CANCER IMMUNOL IMMUN, V61, P1019, DOI 10.1007/s00262-011-1172-6; Jinushi M, 2006, P NATL ACAD SCI USA, V103, P9190, DOI 10.1073/pnas.0603503103; Johnson LA, 2006, J EXP MED, V203, P2763, DOI 10.1084/jem.20051759; Jung H, 2012, J EXP MED, V209, P2409, DOI 10.1084/jem.20120565; Kabelitz D, 2004, J IMMUNOL, V173, P6767, DOI 10.4049/jimmunol.173.11.6767; Kim-Schulze S, 2009, MOL THER, V17, P380, DOI 10.1038/mt.2008.249; Kline J, 2008, CLIN CANCER RES, V14, P3156, DOI 10.1158/1078-0432.CCR-07-4696; Kobayashi H, 2011, CANCER IMMUNOL IMMUN, V60, P1075, DOI 10.1007/s00262-011-1021-7; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Kreike B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1771; Kunz M, 1999, J PATHOL, V189, P552, DOI 10.1002/(SICI)1096-9896(199912)189:4<552::AID-PATH469>3.0.CO;2-I; Larue L, 2006, FRONT BIOSCI-LANDMRK, V11, P733, DOI 10.2741/1831; Liang H, 2013, J IMMUNOL, V190, P5874, DOI 10.4049/jimmunol.1202612; Liu CW, 2008, J CLIN INVEST, V118, P1165, DOI 10.1172/JCI33583; Liu RB, 2012, CANCER RES, V72, P1964, DOI 10.1158/0008-5472.CAN-11-3208; Liu XD, 2010, BLOOD, V115, P3520, DOI 10.1182/blood-2009-09-246124; Lou YY, 2007, J IMMUNOL, V178, P1534, DOI 10.4049/jimmunol.178.3.1534; Ma Y, 2013, IMMUNITY, V38, P729, DOI 10.1016/j.immuni.2013.03.003; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Marcu-Malina V, 2011, BLOOD, V118, P50, DOI 10.1182/blood-2010-12-325993; Martinet L, 2012, ONCOIMMUNOLOGY, V1, P829, DOI 10.4161/onci.20492; Massi D, 2006, MODERN PATHOL, V19, P246, DOI 10.1038/modpathol.3800526; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Mattarollo SR, 2007, CANCER IMMUNOL IMMUN, V56, P1285, DOI 10.1007/s00262-007-0279-2; Messina JL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00765; Messina Jane L, 2008, Cancer Control, V15, P196; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Mishra R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000924; Mlecnik B, 2011, J CLIN ONCOL, V29, P610, DOI 10.1200/JCO.2010.30.5425; MONACH PA, 1995, IMMUNITY, V2, P45, DOI 10.1016/1074-7613(95)90078-0; Moreno M, 2008, J IMMUNOL, V181, P2446, DOI 10.4049/jimmunol.181.4.2446; Mortarini R, 2005, CANCER RES, V65, P3428, DOI 10.1158/0008-5472.CAN-04-3239; Mortarini R, 2003, CANCER RES, V63, P2535; Mukai S, 1999, CELL IMMUNOL, V192, P122, DOI 10.1006/cimm.1998.1439; Nagaraj S, 2007, NAT MED, V13, P828, DOI 10.1038/nm1609; Narra K, 2007, CANCER BIOL THER, V6, P1691, DOI 10.4161/cbt.6.11.4874; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Niu G, 2002, ONCOGENE, V21, P7001, DOI 10.1038/sj.onc.1205859; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Paget C, 2012, J IMMUNOL, V188, P3928, DOI 10.4049/jimmunol.1103582; Peng G, 2007, IMMUNITY, V27, P334, DOI 10.1016/j.immuni.2007.05.020; Petrella TM, 2012, J CLIN ONCOL, V30, P3396, DOI 10.1200/JCO.2011.40.0655; Poulin LF, 2012, BLOOD, V119, P6052, DOI 10.1182/blood-2012-01-406967; Pufnock JS, 2009, J IMMUNOL, V182, P5498, DOI 10.4049/jimmunol.0801284; Quatromoni JG, 2012, AM J TRANSL RES, V4, P376; Rakhra K, 2010, CANCER CELL, V18, P485, DOI 10.1016/j.ccr.2010.10.002; Rasku MA, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-12; Rech AJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003330; Richter J, 2013, BLOOD, V121, P423, DOI 10.1182/blood-2012-06-435503; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Rodriguez PC, 2003, J IMMUNOL, V171, P1232, DOI 10.4049/jimmunol.171.3.1232; Rosenberg SA, 2009, CURR OPIN IMMUNOL, V21, P233, DOI 10.1016/j.coi.2009.03.002; Rusakiewicz S, 2013, CANCER RES, V73, P3499, DOI 10.1158/0008-5472.CAN-13-0371; Russell JP, 2003, ONCOGENE, V22, P4569, DOI 10.1038/sj.onc.1206759; Salmon H, 2012, J CLIN INVEST, V122, P899, DOI 10.1172/JCI45817; Sancho D, 2008, J CLIN INVEST, V118, P2098, DOI 10.1172/JCI34584; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Shields JD, 2010, SCIENCE, V328, P749, DOI 10.1126/science.1185837; Shimizu K, 2013, CANCER RES, V73, P62, DOI 10.1158/0008-5472.CAN-12-0759; SINGH S, 1992, J EXP MED, V175, P139, DOI 10.1084/jem.175.1.139; Sisirak V, 2012, CANCER RES, V72, P5188, DOI 10.1158/0008-5472.CAN-11-3468; Smyth MJ, 2005, J EXP MED, V202, P583, DOI 10.1084/jem.20050994; Sportes C, 2010, CLIN CANCER RES, V16, P727, DOI 10.1158/1078-0432.CCR-09-1303; Spranger S., SCI TRANSL IN PRESS; Strasly M, 2001, J IMMUNOL, V166, P3890, DOI 10.4049/jimmunol.166.6.3890; Sullivan RJ, 2009, J CLIN ONCOL, V27; Swann JB, 2009, BLOOD, V113, P6382, DOI 10.1182/blood-2009-01-198564; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Telang S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-515; Terabe M, 2000, NAT IMMUNOL, V1, P515, DOI 10.1038/82771; TOPALIAN SL, 1992, J IMMUNOTHER, V12, P203, DOI 10.1097/00002371-199210000-00013; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Uccellini L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-170; Ugurel S, 2008, CANCER IMMUNOL IMMUN, V57, P685, DOI 10.1007/s00262-007-0407-z; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Watkins SK, 2011, J CLIN INVEST, V121, P1361, DOI 10.1172/JCI44325; Wei S, 2005, CANCER RES, V65, P5020, DOI 10.1158/0008-5472.CAN-04-4043; Wen YA, 2010, CANCER SCI, V101, P2325, DOI 10.1111/j.1349-7006.2010.01695.x; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yu P, 2004, NAT IMMUNOL, V5, P141, DOI 10.1038/ni1029; Yu P, 2007, J IMMUNOL, V179, P1960, DOI 10.4049/jimmunol.179.3.1960; Zelenay S, 2012, J CLIN INVEST, V122, P1615, DOI 10.1172/JCI60644; Zeng J, 2013, INT J RADIAT ONCOL, V86, P343, DOI 10.1016/j.ijrobp.2012.12.025; Zhang B, 2008, CANCER RES, V68, P1563, DOI 10.1158/0008-5472.CAN-07-5324; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zhang T, 2005, BLOOD, V106, P1544, DOI 10.1182/blood-2004-11-4365; Zheng Y, 2013, MOL IMMUNOL, V55, P283, DOI 10.1016/j.molimm.2013.03.006; Zhou XP, 2000, AM J PATHOL, V157, P1123, DOI 10.1016/S0002-9440(10)64627-5	147	2247	2332	46	629	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2013	14	10					1014	1022		10.1038/ni.2703	http://dx.doi.org/10.1038/ni.2703			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	220LH	24048123	Green Accepted			2022-12-18	WOS:000324584700006
J	Khattri, R; Cox, T; Yasayko, SA; Ramsdell, F				Khattri, R; Cox, T; Yasayko, SA; Ramsdell, F			An essential role for Scurfin in CD4(+)CD25(+) T regulatory cells	NATURE IMMUNOLOGY			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; SF MOUSE; LYMPHORETICULAR DISEASE; CTLA-4-DEFICIENT MICE; RECEPTOR; MUTANT; RESPONSIVENESS; AUTOIMMUNITY; ENTEROPATHY; DISRUPTION	The molecular properties that characterize CD4(+)CD25(+) regulatory T cells (T-R cells) remain elusive. Absence of the transcription factor Scurfin (also known as forkhead box P3 and encoded by Foxp3) causes a rapidly fatal lymphoproliferative disease, similar to that seen in mice lacking cytolytic T lymphocyte-associated antigen 4 (CTLA-4). Here we show that Foxp3 is highly expressed by T-R cells and is associated with T-R cell activity and phenotype. Scurfin-deficient mice lack T-R cells, whereas mice that overexpress Foxp3 possess more T-R cells. In Foxp3-overexpressing mice, both CD4(+)CD25(-) and CD4(-)CD8(+) T cells show suppressive activity and CD4(+)CD25(-) cells express glucocorticoid-induced tumor-necrosis factor receptor-related (GITR) protein. The forced expression of Foxp3 also delays disease in CTLA-4(-/-) mice, indicating that the Scurfin and CTLA-4 pathways may intersect and providing further insight into the T-R cell lineage.	Celltech R&D Inc, Bothell, WA 98021 USA		Ramsdell, F (corresponding author), Celltech R&D Inc, 220th St SE, Bothell, WA 98021 USA.							Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bensinger SJ, 2001, J EXP MED, V194, P427, DOI 10.1084/jem.194.4.427; BLAIR PJ, 1994, J IMMUNOL, V153, P3764; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chambers CA, 1997, P NATL ACAD SCI USA, V94, P9296, DOI 10.1073/pnas.94.17.9296; Chambers CA, 2002, BLOOD, V99, P4509, DOI 10.1182/blood.V99.12.4509; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Clark LB, 1999, J IMMUNOL, V162, P2546; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; GODFREY VL, 1994, AM J PATHOL, V145, P281; GODFREY VL, 1991, P NATL ACAD SCI USA, V88, P5528, DOI 10.1073/pnas.88.13.5528; GODFREY VL, 1991, AM J PATHOL, V138, P1379; Hong NA, 1997, MOL CELL BIOL, V17, P2151, DOI 10.1128/MCB.17.4.2151; Itoh M, 1999, J IMMUNOL, V162, P5317; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kanangat S, 1996, EUR J IMMUNOL, V26, P161, DOI 10.1002/eji.1830260125; Khattri R, 2001, J IMMUNOL, V167, P6312, DOI 10.4049/jimmunol.167.11.6312; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; LYON MF, 1990, P NATL ACAD SCI USA, V87, P2433, DOI 10.1073/pnas.87.7.2433; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Piccirillo CA, 2002, J EXP MED, V196, P237, DOI 10.1084/jem.20020590; Roncarolo MG, 2000, CURR OPIN IMMUNOL, V12, P676, DOI 10.1016/S0952-7915(00)00162-X; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707	33	2208	2381	2	51	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2003	4	4					337	342		10.1038/ni909	http://dx.doi.org/10.1038/ni909			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	663CG	12612581				2022-12-18	WOS:000181987700012
J	Sakaguchi, S				Sakaguchi, S			Naturally arising Foxp3-expressing CD25(+) CD4(+) regulatory T cells in immunological tolerance to self and non-self	NATURE IMMUNOLOGY			English	Review							INDUCED TNF RECEPTOR; IN-VIVO EXPANSION; CUTTING EDGE; TGF-BETA; INTERLEUKIN-2-RECEPTOR ALPHA; IMMUNE DYSREGULATION; AUTOIMMUNE-DISEASE; ANTIGEN-4 BLOCKADE; TUMOR REJECTION; DENDRITIC CELLS	Naturally arising CD25(+)CD4(+) regulatory T cells actively maintain immunological self-tolerance. Deficiency in or dysfunction of these cells can be a cause of autoimmune disease. A reduction in their number or function can also elicit tumor immunity, whereas their antigen-specific population expansion can establish transplantation tolerance. They are therefore a good target for designing ways to induce or abrogate immunological tolerance to self and non-self antigens.	Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan	Kyoto University	Sakaguchi, S (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan.	shimon@frontier.kyoto-u.ac.jp	Eckhardt, Erik/G-1567-2010; Sakaguchi, Shimon/C-9535-2009					Almeida ARM, 2002, J IMMUNOL, V169, P4850, DOI 10.4049/jimmunol.169.9.4850; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Bachmann MF, 1999, J IMMUNOL, V163, P1128; Baecher-Allan C, 2004, J EXP MED, V200, P273, DOI 10.1084/jem.20040812; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.immunol.12.1.337; Bour-Jordan H, 2004, J CLIN INVEST, V114, P979, DOI 10.1172/JCI200420483; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Chastagner P, 1996, EUR J IMMUNOL, V26, P201, DOI 10.1002/eji.1830260131; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Coutinho A, 2001, IMMUNOL REV, V182, P89, DOI 10.1034/j.1600-065X.2001.1820107.x; Danke NA, 2004, J IMMUNOL, V172, P5967, DOI 10.4049/jimmunol.172.10.5967; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Encinas JA, 1999, NAT GENET, V21, P158, DOI 10.1038/5941; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Fehervari Z, 2004, INT IMMUNOL, V16, P1769, DOI 10.1093/intimm/dxh178; Fisson S, 2003, J EXP MED, V198, P737, DOI 10.1084/jem.20030686; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Furtado GC, 2002, J EXP MED, V196, P851, DOI 10.1084/jem.20020190; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; GINSBERGFELLNER F, 1985, REV INFECT DIS, V7, pS170; Godfrey WR, 2004, BLOOD, V104, P453, DOI 10.1182/blood-2004-01-0151; Golgher D, 2002, EUR J IMMUNOL, V32, P3267, DOI 10.1002/1521-4141(200211)32:11<3267::AID-IMMU3267>3.0.CO;2-1; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hoffmann P, 2004, BLOOD, V104, P895, DOI 10.1182/blood-2004-01-0086; Horak I, 1995, IMMUNOL REV, V148, P35, DOI 10.1111/j.1600-065X.1995.tb00092.x; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Huber S, 2004, J IMMUNOL, V173, P6526, DOI 10.4049/jimmunol.173.11.6526; Itoh M, 1999, J IMMUNOL, V162, P5317; Ji HB, 2004, J IMMUNOL, V172, P5823, DOI 10.4049/jimmunol.172.10.5823; Kanamaru F, 2004, J IMMUNOL, V172, P7306, DOI 10.4049/jimmunol.172.12.7306; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Klebb G, 1996, CLIN IMMUNOL IMMUNOP, V81, P282, DOI 10.1006/clin.1996.0190; Klein L, 2003, P NATL ACAD SCI USA, V100, P8886, DOI 10.1073/pnas.1533365100; KRAMER S, 1995, J EXP MED, V182, P1769, DOI 10.1084/jem.182.6.1769; Kumanogoh A, 2001, J IMMUNOL, V166, P353, DOI 10.4049/jimmunol.166.1.353; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Manzotti CN, 2002, EUR J IMMUNOL, V32, P2888, DOI 10.1002/1521-4141(2002010)32:10<2888::AID-IMMU2888>3.0.CO;2-F; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; McHugh RS, 2002, J IMMUNOL, V168, P5979, DOI 10.4049/jimmunol.168.12.5979; MCKEEVER U, 1990, P NATL ACAD SCI USA, V87, P7618, DOI 10.1073/pnas.87.19.7618; Munn DH, 2004, J IMMUNOL, V172, P4100, DOI 10.4049/jimmunol.172.7.4100; Murakami M, 2002, P NATL ACAD SCI USA, V99, P8832, DOI 10.1073/pnas.132254399; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Nelson BH, 1998, ADV IMMUNOL, V70, P1, DOI 10.1016/S0065-2776(08)60386-7; Nishikawa H, 2003, P NATL ACAD SCI USA, V100, P10902, DOI 10.1073/pnas.1834479100; Nishimura E, 2004, INT IMMUNOL, V16, P1189, DOI 10.1093/intimm/dxh122; Onizuka S, 1999, CANCER RES, V59, P3128; Pasare C, 2004, IMMUNITY, V21, P733, DOI 10.1016/j.immuni.2004.10.006; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Paust S, 2004, P NATL ACAD SCI USA, V101, P10398, DOI 10.1073/pnas.0403342101; Peng YF, 2004, P NATL ACAD SCI USA, V101, P4572, DOI 10.1073/pnas.0400810101; Phan GQ, 2003, P NATL ACAD SCI USA, V100, P8372, DOI 10.1073/pnas.1533209100; Podolin PL, 2000, CYTOKINE, V12, P477, DOI 10.1006/cyto.1999.0609; POWRIE F, 1990, J EXP MED, V172, P1701, DOI 10.1084/jem.172.6.1701; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Reddy J, 2004, P NATL ACAD SCI USA, V101, P15434, DOI 10.1073/pnas.0404444101; Ronchetti S, 2002, BLOOD, V100, P350, DOI 10.1182/blood-2001-12-0276; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SAKAGUCHI S, 1985, J EXP MED, V161, P72, DOI 10.1084/jem.161.1.72; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Serra P, 2003, IMMUNITY, V19, P877, DOI 10.1016/S1074-7613(03)00327-3; SETOGUCHI R, IN PRESS J EXP MED; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Shimizu J, 1999, J IMMUNOL, V163, P5211; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Singh B, 2001, IMMUNOL REV, V182, P190, DOI 10.1034/j.1600-065X.2001.1820115.x; Stephens GL, 2004, J IMMUNOL, V173, P5008, DOI 10.4049/jimmunol.173.8.5008; Stephens LA, 2000, J IMMUNOL, V165, P3105, DOI 10.4049/jimmunol.165.6.3105; Sullivan KE, 2002, CLIN DIAGN LAB IMMUN, V9, P1129, DOI 10.1128/CDLI.9.5.1129-1131.2002; Suri-Payer E, 1998, J IMMUNOL, V160, P1212; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Taguchi O, 1996, EUR J IMMUNOL, V26, P1608, DOI 10.1002/eji.1830260730; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Tang QZ, 2004, EUR J IMMUNOL, V34, P2996, DOI 10.1002/eji.200425143; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; Tarbell KV, 2004, J EXP MED, V199, P1467, DOI 10.1084/jem.20040180; Thompson C, 2004, CURR OPIN PHARMACOL, V4, P408, DOI 10.1016/j.coph.2004.05.001; Thornton AM, 2004, J IMMUNOL, V172, P6519, DOI 10.4049/jimmunol.172.11.6519; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Tommasini A, 2002, CLIN EXP IMMUNOL, V130, P127, DOI 10.1046/j.1365-2249.2002.01940.x; Tone M, 2003, P NATL ACAD SCI USA, V100, P15059, DOI 10.1073/pnas.2334901100; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Waldmann H, 2004, SEMIN IMMUNOL, V16, P119, DOI 10.1016/j.smim.2003.12.007; Walker LSK, 2003, J EXP MED, V198, P249, DOI 10.1084/jem.20030315; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Wolf M, 2001, EUR J IMMUNOL, V31, P1637, DOI 10.1002/1521-4141(200106)31:6<1637::AID-IMMU1637>3.0.CO;2-T; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165; Yamazaki S, 2003, J EXP MED, V198, P235, DOI 10.1084/jem.20030422; Zheng Y, 2004, J IMMUNOL, V172, P2778, DOI 10.4049/jimmunol.172.5.2778	107	2101	2282	2	154	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2005	6	4					345	352		10.1038/ni1178	http://dx.doi.org/10.1038/ni1178			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	909KY	15785760				2022-12-18	WOS:000227860000005
J	Hornung, V; Bauernfeind, F; Halle, A; Samstad, EO; Kono, H; Rock, KL; Fitzgerald, KA; Latz, E				Hornung, Veit; Bauernfeind, Franz; Halle, Annett; Samstad, Eivind O.; Kono, Hajime; Rock, Kenneth L.; Fitzgerald, Katherine A.; Latz, Eicke			Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization	NATURE IMMUNOLOGY			English	Article							LEUCINE METHYL-ESTER; TOLL-LIKE RECEPTORS; CATHEPSIN-B; INTERLEUKIN-1-BETA RELEASE; APAF-1 APOPTOSOME; INTRACELLULAR K+; CELL-DEATH; URIC-ACID; CASPASE-1; MACROPHAGES	Inhalation of silica crystals causes inflammation in the alveolar space. Prolonged exposure to silica can lead to the development of silicosis, an irreversible, fibrotic pulmonary disease. The mechanisms by which silica and other crystals activate immune cells are not well understood. Here we demonstrate that silica and aluminum salt crystals activated inflammasomes formed by the cytoplasmic receptor NALP3. NALP3 activation required phagocytosis of crystals, and this uptake subsequently led to lysosomal damage and rupture. 'Sterile' lysosomal damage (without crystals) also induced NALP3 activation, and inhibition of either phagosomal acidification or cathepsin B activity impaired NALP3 activation. Our results indicate that the NALP3 inflammasome senses lysosomal damage as an endogenous 'danger' signal.	[Hornung, Veit; Halle, Annett; Samstad, Eivind O.; Fitzgerald, Katherine A.; Latz, Eicke] Univ Massachusetts, Sch Med, Dept Immunol & Infect Dis, Worcester, MA 01605 USA; [Bauernfeind, Franz] Univ Munich, Dept Internal Med, Div Clin Pharmacol, D-80336 Munich, Germany; [Samstad, Eivind O.; Latz, Eicke] Norwegian Univ Sci & Technol, Inst Canc Res & Mol Med, N-7489 Trondheim, Norway; [Kono, Hajime; Rock, Kenneth L.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Munich; Norwegian University of Science & Technology (NTNU); University of Massachusetts System; University of Massachusetts Worcester	Latz, E (corresponding author), Univ Massachusetts, Sch Med, Dept Immunol & Infect Dis, Worcester, MA 01605 USA.	eicke.latz@umassmed.edu	Bauernfeind, Franz-Georg/ABF-1148-2020; Braga, Tarcio T/E-4827-2014; Latz, Eicke/H-3951-2014; Fitzgerald, Katherine/ABE-6317-2020; Hornung, Veit/C-3565-2012	Braga, Tarcio T/0000-0002-2989-1076; Latz, Eicke/0000-0003-1488-5666; Hornung, Veit/0000-0002-4150-194X; Fitzgerald, Kate/0000-0003-3175-609X; Kono, Hajime/0000-0002-4578-8677	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043543, R01AI083713, R01AI065483, R01AI067497] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI065483, R01 AI-067497, R01 AI043543-01A1, R01 AI-065483, R01 AI043543, R01 AI083713, R01 AI083713-02, R01 AI067497, R01 AI065483-01, R01 AI067497-03] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Asagiri M, 2008, SCIENCE, V319, P624, DOI 10.1126/science.1150110; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; BUTTLE DJ, 1992, ARCH BIOCHEM BIOPHYS, V299, P377, DOI 10.1016/0003-9861(92)90290-D; Cain K, 2002, BIOCHIMIE, V84, P203, DOI 10.1016/S0300-9084(02)01376-7; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; DOSTERT C, 2008, SCIENCE, V230, P647; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Fubini B, 2003, FREE RADICAL BIO MED, V34, P1507, DOI 10.1016/S0891-5849(03)00149-7; Fujisawa A, 2007, BLOOD, V109, P2903, DOI 10.1182/blood-2006-07-033597; Hentze H, 2003, CELL DEATH DIFFER, V10, P956, DOI 10.1038/sj.cdd.4401264; Huaux F, 2007, CURR OPIN ALLERGY CL, V7, P168, DOI 10.1097/ACI.0b013e32802bf8a5; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Karki P, 2007, CELL DEATH DIFFER, V14, P2068, DOI 10.1038/sj.cdd.4402221; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Li HF, 2007, J IMMUNOL, V178, P5271, DOI 10.4049/jimmunol.178.8.5271; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Marina-Garcia N, 2008, J IMMUNOL, V180, P4050, DOI 10.4049/jimmunol.180.6.4050; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mossman BT, 1998, AM J RESP CRIT CARE, V157, P1666, DOI 10.1164/ajrccm.157.5.9707141; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Pelegrin P, 2007, J BIOL CHEM, V282, P2386, DOI 10.1074/jbc.M610351200; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; ROBERSON SM, 1988, CELL IMMUNOL, V116, P341, DOI 10.1016/0008-8749(88)90236-5; Schiltz C, 2002, ARTHRITIS RHEUM, V46, P1643, DOI 10.1002/art.10326; Severa M, 2006, J BIOL CHEM, V281, P26188, DOI 10.1074/jbc.M604516200; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; THIELE DL, 1985, P NATL ACAD SCI USA, V82, P2468, DOI 10.1073/pnas.82.8.2468; THIELE DL, 1990, P NATL ACAD SCI USA, V87, P83, DOI 10.1073/pnas.87.1.83; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009	40	2063	2145	5	297	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2008	9	8					847	856		10.1038/ni.1631	http://dx.doi.org/10.1038/ni.1631			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	328EN	18604214	Green Accepted			2022-12-18	WOS:000257780700007
J	Latchman, Y; Wood, CR; Chernova, T; Chaudhary, D; Borde, M; Chernova, I; Iwai, Y; Long, AJ; Brown, JA; Nunes, R; Greenfield, EA; Bourque, K; Boussiotis, VA; Carter, LL; Carreno, BM; Malenkovich, N; Nishimura, H; Okazaki, T; Honjo, T; Sharpe, AH; Freeman, GJ				Latchman, Y; Wood, CR; Chernova, T; Chaudhary, D; Borde, M; Chernova, I; Iwai, Y; Long, AJ; Brown, JA; Nunes, R; Greenfield, EA; Bourque, K; Boussiotis, VA; Carter, LL; Carreno, BM; Malenkovich, N; Nishimura, H; Okazaki, T; Honjo, T; Sharpe, AH; Freeman, GJ			PD-L2 is a second ligand for PD-I and inhibits T cell activation	NATURE IMMUNOLOGY			English	Article							INTERFERON-GAMMA; PD-1-DEFICIENT MICE; B7 FAMILY; CTLA-4; EXPRESSION; CD4(+); MEMBER; LEADS; LYMPHOPROLIFERATION; DIFFERENTIATION	Programmed death I (PD-1)-deficient mice develop a variety of autoimmune-like diseases, which suggests that this immunoinhibitory receptor plays an important role in tolerance. We identify here PD-1 ligand 2 (PD-L2) as a second ligand for PD-1 and compare the function and expression of PD-L1 and PD-L2. Engagement of PD-1 by PD-L2 dramatically inhibits T cell receptor (TCR)-mediated proliferation and cytokine production by CD4(+) T cells,At low antigen concentrations, PD-L2-PD-1 interactions inhibit strong B7-CD28 signals, In contrast, at high antigen concentrations, PD-L2-PD-1 interactions reduce cytokine production but do not inhibit T cell proliferation. PD-L-PD-1 interactions lead to cell cycle arrest in G(0)/G(1) but do not increase cell death. In addition, ligation of PD-1 + TCR leads to rapid phosphorylation of SHP-2, as compared to TCR ligation alone, PD-L expression was up-regulated on antigen-presenting cells by interferon gamma treatment and was also present on some normal tissues and tumor cell lines,Taken together, these studies show overlapping functions of PD-L1 and PD-L2 and indicate a key role for the PD-L-PD-1 pathway in regulating T cell responses.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med,Dept Adult Oncol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Div Immunol Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Wyeth Ayerst Res, Genet Inst, Cambridge, MA 02140 USA; Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Pfizer; Kyoto University	Freeman, GJ (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med,Dept Adult Oncol, 44 Binney St, Boston, MA 02115 USA.		Honjo, Tasuku/N-4470-2016; Nunes, Raquel/AAE-1543-2020; Freeman, Gordon/AAC-5380-2019	Freeman, Gordon/0000-0002-7210-5616; Okazaki, Taku/0000-0003-4790-1925; Chernova, Irene/0000-0003-3346-0559	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040614, R37AI038310, R01AI139671, R01AI038310, P01AI039671] Funding Source: NIH RePORTER; NIAID NIH HHS [AI40614, AI39671, AI38310] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Badovinac VP, 2000, SCIENCE, V290, P1354, DOI 10.1126/science.290.5495.1354; Chambers CA, 1997, IMMUNITY, V7, P885, DOI 10.1016/S1074-7613(00)80406-9; Chu CQ, 2000, J EXP MED, V192, P123, DOI 10.1084/jem.192.1.123; Chuang E, 1999, J IMMUNOL, V162, P1270; Dong HD, 1999, NAT MED, V5, P1365; DUNCAN AR, 1988, NATURE, V332, P563, DOI 10.1038/332563a0; FREEDMAN AS, 1991, CELL IMMUNOL, V137, P429, DOI 10.1016/0008-8749(91)90091-O; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Konieczny BT, 1998, J IMMUNOL, V160, P2059; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; McAdam AJ, 2000, J IMMUNOL, V165, P5035, DOI 10.4049/jimmunol.165.9.5035; McAdam AJ, 1998, IMMUNOL REV, V165, P231; MORGAN A, 1995, IMMUNOLOGY, V86, P319; Nishimura H, 1998, INT IMMUNOL, V10, P1563, DOI 10.1093/intimm/10.10.1563; Nishimura H, 2000, J EXP MED, V191, P891, DOI 10.1084/jem.191.5.891; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; OKAZAKI T, 2001, UNPUB J EXP MED; Thompson CB, 1997, IMMUNITY, V7, P445, DOI 10.1016/S1074-7613(00)80366-0; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Walunas TL, 1996, J EXP MED, V183, P2541, DOI 10.1084/jem.183.6.2541; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985	24	2013	2390	8	221	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2001	2	3					261	268		10.1038/85330	http://dx.doi.org/10.1038/85330			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	409YT	11224527				2022-12-18	WOS:000167413800020
J	Fitzgerald, KA; McWhirter, SM; Faia, KL; Rowe, DC; Latz, E; Golenbock, DT; Coyle, AJ; Liao, SM; Maniatis, T				Fitzgerald, KA; McWhirter, SM; Faia, KL; Rowe, DC; Latz, E; Golenbock, DT; Coyle, AJ; Liao, SM; Maniatis, T			IKK epsilon and TBK1 are essential components of the IRF3 signaling pathway	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; DOUBLE-STRANDED-RNA; INTERFERON REGULATORY FACTOR-3; TOLL-LIKE RECEPTOR-3; VIRUS-INFECTION; TRANSCRIPTION FACTORS; GENE-EXPRESSION; KINASE COMPLEX; ACTIVATION; PHOSPHORYLATION	The transcription factors interferon regulatory factor 3 (IRF3) and NF-kappaB are required for the expression of many genes involved in the innate immune response. Viral infection, or the binding of double-stranded RNA to Toll-like receptor 3, results in the coordinate activation of IRF3 and NF-kappaB. Activation of IRF3 requires signal-dependent phosphorylation, but little is known about the signaling pathway or kinases involved. Here we report that the noncanonical lkappaB kinase homologs, IkappaB kinase-epsilon, (IKKepsilon) and TANK-binding kinase-I (TBK1), which were previously implicated in NF-kappaB activation, are also essential components of the IRF3 signaling pathway. Thus, IKKKepsilon and TBKI have a pivotal role in coordinating the activation of IRF3 and NF-kappaB in the innate immune response.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Univ Massachusetts, Div Infect Dis & Immunol, Worcester, MA 01605 USA; Millennium Pharmaceut Inc, Dept Inflammat, Cambridge, MA 02139 USA	Harvard University; University of Massachusetts System; University of Massachusetts Worcester; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Maniatis, T (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.		Latz, Eicke/H-3951-2014; Fitzgerald, Katherine/ABE-6317-2020	Latz, Eicke/0000-0003-1488-5666; Fitzgerald, Kate/0000-0003-3175-609X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054060] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI20642] Funding Source: Medline; NIGMS NIH HHS [R01 GM54060] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Barnes B, 2002, J INTERF CYTOK RES, V22, P59, DOI 10.1089/107999002753452665; Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Chariot A, 2002, J BIOL CHEM, V277, P37029, DOI 10.1074/jbc.M205069200; Chu WM, 1999, IMMUNITY, V11, P721, DOI 10.1016/S1074-7613(00)80146-6; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Genin P, 2000, J IMMUNOL, V164, P5352, DOI 10.4049/jimmunol.164.10.5352; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hiscott J, 1999, J INTERF CYTOK RES, V19, P1, DOI 10.1089/107999099314360; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Imler JL, 2003, NAT IMMUNOL, V4, P105, DOI 10.1038/ni0203-105; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; JORDANOV MS, 2001, MOL CELL BIOL, V21, P61; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Maniatis T, 1986, Harvey Lect, V82, P71; Matsumoto M, 2002, BIOCHEM BIOPH RES CO, V293, P1364, DOI 10.1016/S0006-291X(02)00380-7; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Peters RT, 2000, MOL CELL, V5, P513, DOI 10.1016/S1097-2765(00)80445-1; Peters RT, 2001, BBA-REV CANCER, V1471, pM57, DOI 10.1016/S0304-419X(00)00024-X; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Servant MJ, 2003, J BIOL CHEM, V278, P9441, DOI 10.1074/jbc.M209851200; Servant MJ, 2002, BIOCHEM PHARMACOL, V64, P985, DOI 10.1016/S0006-2952(02)01165-6; Servant MJ, 2001, J BIOL CHEM, V276, P355, DOI 10.1074/jbc.M007790200; Shimada T, 1999, INT IMMUNOL, V11, P1357, DOI 10.1093/intimm/11.8.1357; Smith EJ, 2001, J BIOL CHEM, V276, P8951, DOI 10.1074/jbc.M008717200; tenOever BR, 2002, J VIROL, V76, P3659, DOI 10.1128/JVI.76.8.3659-3669.2002; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yang HM, 2002, EUR J BIOCHEM, V269, P6142, DOI 10.1046/j.1432-1033.2002.03330.x; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoneyama M, 2002, J INTERF CYTOK RES, V22, P73, DOI 10.1089/107999002753452674	45	1987	2078	3	145	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2003	4	5					491	496		10.1038/ni921	http://dx.doi.org/10.1038/ni921			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	674YN	12692549				2022-12-18	WOS:000182665400018
J	Nakahira, K; Haspel, JA; Rathinam, VAK; Lee, SJ; Dolinay, T; Lam, HC; Englert, JA; Rabinovitch, M; Cernadas, M; Kim, HP; Fitzgerald, KA; Ryter, SW; Choi, AMK				Nakahira, Kiichi; Haspel, Jeffrey Adam; Rathinam, Vijay A. K.; Lee, Seon-Jin; Dolinay, Tamas; Lam, Hilaire C.; Englert, Joshua A.; Rabinovitch, Marlene; Cernadas, Manuela; Kim, Hong Pyo; Fitzgerald, Katherine A.; Ryter, Stefan W.; Choi, Augustine M. K.			Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome	NATURE IMMUNOLOGY			English	Article							AIM2 INFLAMMASOME; OXIDATIVE STRESS; HOST-DEFENSE; ACTIVATION; IL-1-BETA; SEPSIS; MECHANISMS; EXPRESSION; SECRETION; PATHWAYS	Autophagy, a cellular process for organelle and protein turnover, regulates innate immune responses. Here we demonstrate that depletion of the autophagic proteins LC3B and beclin 1 enhanced the activation of caspase-1 and secretion of interleukin 1 (IL-1 beta) and IL-18. Depletion of autophagic proteins promoted the accumulation of dysfunctional mitochondria and cytosolic translocation of mitochondrial DNA (mtDNA) in response to lipopolysaccharide (LPS) and ATP in macrophages. Release of mtDNA into the cytosol depended on the NALP3 inflammasome and mitochondrial reactive oxygen species (ROS). Cytosolic mtDNA contributed to the secretion of IL-1 beta and IL-18 in response to LPS and ATP. LC3B-deficient mice produced more caspase-1-dependent cytokines in two sepsis models and were susceptible to LPS-induced mortality. Our study suggests that autophagic proteins regulate NALP3-dependent inflammation by preserving mitochondrial integrity.	[Nakahira, Kiichi; Haspel, Jeffrey Adam; Lee, Seon-Jin; Dolinay, Tamas; Lam, Hilaire C.; Englert, Joshua A.; Cernadas, Manuela; Kim, Hong Pyo; Ryter, Stefan W.; Choi, Augustine M. K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Haspel, Jeffrey Adam] VA Boston Healthcare Syst, Pulm & Crit Care Med Sect, Boston, MA USA; [Rathinam, Vijay A. K.; Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA USA; [Rabinovitch, Marlene] Stanford Univ, Sch Med, Wall Ctr Pulm Vasc Dis, Stanford, CA 94305 USA; [Kim, Hong Pyo] Univ Ulsan, Coll Nat Sci, Sch Biol Sci, Ulsan 680749, South Korea	Harvard University; Brigham & Women's Hospital; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; University of Massachusetts System; University of Massachusetts Worcester; Stanford University; University of Ulsan	Choi, AMK (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA.	amchoi@rics.bwh.harvard.edu	Haspel, J./K-3563-2019; Dolinay, Tamas/ABG-1399-2020; Fitzgerald, Katherine/ABE-6317-2020; Lee, Seon-Jin/AAJ-8258-2020; Rathinam, Vijay/ABE-7544-2020	Rathinam, Vijay/0000-0002-8009-3977; Lee, Seon-Jin/0000-0001-7214-7536; Fitzgerald, Kate/0000-0003-3175-609X; Englert, Joshua/0000-0002-1257-2239	National Institutes of Health [HL079904-12, HL08554, HL060234-10, HL097005, AI083713, AI067497]; New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases (National Institute of Allergy and Infectious Diseases of the National Institutes of Health) [AI057159]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085547, R01HL055330, R01HL079904, R01HL060234, R03HL097005, F35HL008554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083713, U54AI057159, R01AI067497, R56AI067497, R37AI067497] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases (National Institute of Allergy and Infectious Diseases of the National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Levine (University of Texas Southwestern Medical Center) for Becn1<SUP>+/</SUP>-mice; and E. Ifedigbo for technical assistance. Supported by National Institutes of Health (HL079904-12, HL08554, HL060234-10 and HL097005 to A. M. K. C., and AI083713 and AI067497 to K. A. F.) and the New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases (National Institute of Allergy and Infectious Diseases of the National Institutes of Health; AI057159 to V.A.K.R).	Adinolfi E, 2005, MOL BIOL CELL, V16, P3260, DOI 10.1091/mbc.E04-11-1025; Aoki H, 2008, AUTOPHAGY, V4, P467, DOI 10.4161/auto.5668; Cann GM, 2008, DEV DYNAM, V237, P187, DOI 10.1002/dvdy.21392; Chandel NS, 1999, FEBS LETT, V454, P173, DOI 10.1016/S0014-5793(99)00783-8; Chen ZH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003316; Chung SW, 2008, J CLIN INVEST, V118, P239, DOI 10.1172/JCI32730; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; d'Avila JC, 2008, CRIT CARE MED, V36, P1925, DOI 10.1097/CCM.0b013e3181760c4b; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eaton JS, 2007, J CLIN INVEST, V117, P2723, DOI 10.1172/JCI31604; Fahy RJ, 2008, AM J RESP CRIT CARE, V177, P983, DOI 10.1164/rccm.200703-418OC; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Fredriksson K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003686; Garcia-Marcos M, 2005, FEBS LETT, V579, P5407, DOI 10.1016/j.febslet.2005.08.074; Hashiguchi K, 2009, METHODS MOL BIOL, V554, P383, DOI 10.1007/978-1-59745-521-3_23; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Jiang JF, 2009, RADIAT RES, V172, P706, DOI 10.1667/RR1729.1; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Juliana C, 2010, J BIOL CHEM, V285, P9792, DOI 10.1074/jbc.M109.082305; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Meissner F, 2008, NAT IMMUNOL, V9, P866, DOI 10.1038/ni.1633; Mortensen M, 2010, P NATL ACAD SCI USA, V107, P832, DOI 10.1073/pnas.0913170107; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Stutz A, 2009, J CLIN INVEST, V119, P3502, DOI 10.1172/JCI40599; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Trnka J, 2009, FREE RADICAL RES, V43, P4, DOI 10.1080/10715760802582183; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Virgin HW, 2009, NAT IMMUNOL, V10, P461, DOI 10.1038/ni.1726; Wang XM, 2009, J IMMUNOL, V182, P3809, DOI 10.4049/jimmunol.0712437; Watanabe E, 2009, LAB INVEST, V89, P549, DOI 10.1038/labinvest.2009.8; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	48	1981	2044	12	412	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2011	12	3					222	U57		10.1038/ni.1980	http://dx.doi.org/10.1038/ni.1980			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	721KZ	21151103	Green Accepted			2022-12-18	WOS:000287354400009
J	Kawai, T; Takahashi, K; Sato, S; Coban, C; Kumar, H; Kato, H; Ishii, KJ; Takeuchi, O; Akira, S				Kawai, T; Takahashi, K; Sato, S; Coban, C; Kumar, H; Kato, H; Ishii, KJ; Takeuchi, O; Akira, S			IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; DOUBLE-STRANDED-RNA; DOMAIN-CONTAINING ADAPTER; IFN-REGULATORY FACTOR-3; TANK-BINDING KINASE-1; TOLL-LIKE RECEPTORS; ANTIVIRAL RESPONSE; SIGNALING PATHWAY; ALPHA INDUCTION; VIRAL-INFECTION	Type I interferons are central mediators for antiviral responses. Using high-throughput functional screening of interferon inducers, we have identified here a molecule we call interferon-beta promoter stimulator 1 (IPS-1). Overexpression of IPS-1 induced type I interferon and interferon-inducible genes through activation of IRF3, IRF7 and NF-kappa B transcription factors. TBK1 and IKKi protein kinases were required for the IPS-1-mediated interferon induction. IPS-1 contained an N-terminal CARD-like structure that mediated interaction with the CARD of RIG-I and Mda5, which are cytoplasmic RNA helicases that sense viral infection. 'Knockdown' of IPS-1 by small interfering RNA blocked interferon induction by virus infection. Thus, IPS-1 is an adaptor involved in RIG-I-and Mda5-mediated antiviral immune responses.	Osaka Univ, Dept Host Def, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; Osaka Univ, Microbial Dis Res Inst, Combined Program Microbiol & Immunol, 21st Century COE, Suita, Osaka 5650871, Japan; Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sakyo Ku, Kyoto 6068507, Japan	Osaka University; Osaka University; Kyoto University		sakira@biken.osaka-u.ac.jp	Kumar, Himanshu/J-4494-2012; COBAN, Cevayir/P-1928-2019; Akira, Shizuo/C-3134-2009; Coban, Cevayir/B-2129-2012; Kumar, Himanshu/A-8070-2010; Takeuchi, Osamu/D-6007-2011; Takeuchi, Osamu/AAG-9359-2019; Ishii, Ken J/B-1685-2012	Kumar, Himanshu/0000-0001-5246-2694; COBAN, Cevayir/0000-0002-4467-7799; Takeuchi, Osamu/0000-0002-1260-6232; Ishii, Ken J/0000-0002-6728-3872; Kawai, Taro/0000-0001-7510-4662; Sato, Shintaro/0000-0001-5156-3354				Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Balachandran S, 2004, NATURE, V432, P401, DOI 10.1038/nature03124; Breiman A, 2005, J VIROL, V79, P3969, DOI 10.1128/JVI.79.7.3969-3978.2005; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hemmi H, 2003, J IMMUNOL, V170, P3059, DOI 10.4049/jimmunol.170.6.3059; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Hoshino K, 2002, INT IMMUNOL, V14, P1225, DOI 10.1093/intimm/dxf089; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jayakar HR, 2002, J VIROL, V76, P8011, DOI 10.1128/JVI.76.16.8011-8018.2002; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kovacsovics M, 2002, CURR BIOL, V12, P838, DOI 10.1016/S0960-9822(02)00842-4; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Nomura F, 2000, GENES CELLS, V5, P191; O'Connell RM, 2005, J IMMUNOL, V174, P1602, DOI 10.4049/jimmunol.174.3.1602; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Pomerantz JL, 2002, EMBO J, V21, P5184, DOI 10.1093/emboj/cdf505; Sasai M, 2005, J IMMUNOL, V174, P27, DOI 10.4049/jimmunol.174.1.27; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Stockinger S, 2004, J IMMUNOL, V173, P7416, DOI 10.4049/jimmunol.173.12.7416; Sugiyama T, 2005, J IMMUNOL, V174, P2273, DOI 10.4049/jimmunol.174.4.2273; SUMPTER R, 2005, J VIROL, V79, P2689, DOI DOI 10.1128/JVI.79.5.2689-2699.2005; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	38	1928	2042	5	217	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2005	6	10					981	988		10.1038/ni1243	http://dx.doi.org/10.1038/ni1243			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	966NR	16127453				2022-12-18	WOS:000232027200016
J	Rescigno, M; Urbano, M; Valzasina, B; Francolini, M; Rotta, G; Bonasio, R; Granucci, F; Kraehenbuhl, JP; Ricciardi-Castagnoli, P				Rescigno, M; Urbano, M; Valzasina, B; Francolini, M; Rotta, G; Bonasio, R; Granucci, F; Kraehenbuhl, JP; Ricciardi-Castagnoli, P			Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria	NATURE IMMUNOLOGY			English	Article							PEYERS PATCH; SALMONELLA-TYPHIMURIUM; RECRUITMENT; MATURATION; MOLECULES	Penetration of the gut mucosa by pathogens expressing invasion genes is believed to occur mainly through specialized epithelial cells, called M cells, that are located in Peyer's patches. However, Salmonella typhimurium that are deficient in invasion genes encoded by Salmonella pathogenicity island I (SPII) are still able to reach the spleen after oral administration. This suggests the existence of an alternative route for bacterial invasion, one that is independent of M cells. We report here a new mechanism for bacterial uptake in the mucosa tissues that is mediated by dendritic cells (DCs). DCs open the tight junctions between epithelial cells, send dendrites outside the epithelium and directly sample bacteria. In addition, because DCs express tight-junction proteins such as occludin, claudin I and zonula occludens I,the integrity of the epithelial barrier is preserved.	Univ Milano Bicocca, Dept Biosci & Biotechnol, Milan, Italy; CNR, Cellular & Mol Pharmacol Ctr, I-20133 Milan, Italy; Univ Lausanne, Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland	University of Milano-Bicocca; Consiglio Nazionale delle Ricerche (CNR); Swiss Institute Experimental Cancer Research; University of Lausanne	Ricciardi-Castagnoli, P (corresponding author), Univ Milano Bicocca, Dept Biosci & Biotechnol, Milan, Italy.	paola.castagnoli@unimib.it	Castagnoli, Paola/E-8288-2010; GRANUCCI, Francesca/K-6150-2019; Bonasio, Roberto/P-1356-2014; Eckhardt, Erik/G-1567-2010; Rescigno, Maria/J-9704-2012	Bonasio, Roberto/0000-0002-0767-0889; Rescigno, Maria/0000-0002-6464-509X; granucci, francesca/0000-0002-7046-4914; Rotta, Gianluca/0000-0002-5613-9453; FRANCOLINI, MAURA/0000-0002-3126-1575				Austyn JM, 1996, J EXP MED, V183, P1287, DOI 10.1084/jem.183.4.1287; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BROWN A, 1987, J INFECT DIS, V155, P86, DOI 10.1093/infdis/155.1.86; Del Maschio A, 1999, J EXP MED, V190, P1351, DOI 10.1084/jem.190.9.1351; Dieu-Nosjean MC, 2000, J EXP MED, V192, P705, DOI 10.1084/jem.192.5.705; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Gasperi C, 1999, J LEUKOCYTE BIOL, V66, P263, DOI 10.1002/jlb.66.2.263; Hopkins SA, 2000, CELL MICROBIOL, V2, P59; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Huber D, 2000, J BIOL CHEM, V275, P5773, DOI 10.1074/jbc.275.8.5773; INMAN LR, 1983, J CLIN INVEST, V71, P1, DOI 10.1172/JCI110737; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Kelsall BL, 1996, J EXP MED, V183, P237, DOI 10.1084/jem.183.1.237; Kerneis S, 1997, SCIENCE, V277, P949, DOI 10.1126/science.277.5328.949; KOHBATA S, 1986, MICROBIOL IMMUNOL, V30, P1225, DOI 10.1111/j.1348-0421.1986.tb03055.x; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Madara J L, 1990, Monogr Pathol, P306; Maric I, 1996, J IMMUNOL, V156, P1408; Monack DM, 2000, J EXP MED, V192, P249, DOI 10.1084/jem.192.2.249; Mowat AM, 1997, IMMUNOL REV, V156, P145, DOI 10.1111/j.1600-065X.1997.tb00966.x; Neutra MR, 1996, ANNU REV IMMUNOL, V14, P275, DOI 10.1146/annurev.immunol.14.1.275; POZZI G, 1990, RES MICROBIOL, V141, P659, DOI 10.1016/0923-2508(90)90060-4; Rajasekaran AK, 1996, J CELL BIOL, V132, P451, DOI 10.1083/jcb.132.3.451; Rescigno M, 1998, P NATL ACAD SCI USA, V95, P5229, DOI 10.1073/pnas.95.9.5229; Rescigno M, 1999, IMMUNOL TODAY, V20, P200, DOI 10.1016/S0167-5699(98)01427-3; RESCIGNO M, 1999, DENDRITIC CELLS BIOL, P403; Ruedl C, 1997, EUR J IMMUNOL, V27, P1325, DOI 10.1002/eji.1830270605; Tsukita S, 1999, CURR OPIN CELL BIOL, V11, P628, DOI 10.1016/S0955-0674(99)00016-2; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; WASSEF JS, 1989, INFECT IMMUN, V57, P858, DOI 10.1128/IAI.57.3.858-863.1989; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Wong V, 1997, J CELL BIOL, V136, P399, DOI 10.1083/jcb.136.2.399	34	1849	1928	3	152	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2001	2	4					361	367		10.1038/86373	http://dx.doi.org/10.1038/86373			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	420AZ	11276208				2022-12-18	WOS:000167982900018
J	Hemmi, H; Kaisho, T; Takeuchi, O; Sato, S; Sanjo, H; Hoshino, K; Horiuchi, T; Tomizawa, H; Takeda, K; Akira, S				Hemmi, H; Kaisho, T; Takeuchi, O; Sato, S; Sanjo, H; Hoshino, K; Horiuchi, T; Tomizawa, H; Takeda, K; Akira, S			Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway	NATURE IMMUNOLOGY			English	Article							TOLL-LIKE RECEPTORS; BACTERIAL CPG-DNA; PATTERN-RECOGNITION; CUTTING EDGE; HOST-DEFENSE; INNATE; IMIQUIMOD; VIRUS; INTERFERON; LIPOPROTEINS	The imidazoquinoline compounds imiquimod and R-848 are low-molecular-weight immune response modifiers that can induce the synthesis of interferon-alpha and other cytokines in a variety of cell types. These compounds have potent anti-viral and anti-tumor properties; however, the mechanisms by which they exert their anti-viral activities remain unclear. Here we show that the imidazoquinolines activate immune cells via the Toll-like receptor 7 (TLR7)-MyD88-dependent signaling pathway. In response to the imidazoquinolines, neither MyD88- nor TLR7-deficient mice showed any inflammatory cytokine production by macrophages, proliferation of splenocytes or maturation of dendritic cells. Imidazoquinoline-induced signaling events were also abolished in both MyD88- and TLR7-deficient mice.	Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, Solut Oriented Res Sci & Technol, Suita, Osaka 5650871, Japan; Japan Energy Corp, Pharmaceut & Biotechnol Lab, Toda, Saitama 3358502, Japan	Osaka University; Japan Science & Technology Agency (JST); Japan Energy Corporation	Akira, S (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Host Def, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp	Hoshino, Katsuaki/AAE-2830-2022; Kaisho, Tsuneyasu/B-4130-2012; Takeuchi, Osamu/D-6007-2011; Akira, Shizuo/C-3134-2009; Takeuchi, Osamu/AAG-9359-2019; Takeda, Kiyoshi/C-9331-2009; Hoshino, Katsuaki/L-9162-2014	Hoshino, Katsuaki/0000-0003-0493-4815; Takeuchi, Osamu/0000-0002-1260-6232; Hoshino, Katsuaki/0000-0003-0493-4815; Sato, Shintaro/0000-0001-5156-3354				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Bernstein DI, 2001, J INFECT DIS, V183, P844, DOI 10.1086/319262; Bishop GA, 2000, J IMMUNOL, V165, P5552, DOI 10.4049/jimmunol.165.10.5552; Bishop GA, 2001, CELL IMMUNOL, V208, P9, DOI 10.1006/cimm.2001.1769; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; CHEN M, 1988, ANTIMICROB AGENTS CH, V32, P678, DOI 10.1128/AAC.32.5.678; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Chuang TH, 2000, EUR CYTOKINE NETW, V11, P372; Du X, 2000, EUR CYTOKINE NETW, V11, P362; Hacker H, 2000, J EXP MED, V192, P595, DOI 10.1084/jem.192.4.595; HARRISON CJ, 1994, ANTIMICROB AGENTS CH, V38, P2059, DOI 10.1128/AAC.38.9.2059; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoshino K, 1999, J IMMUNOL, V162, P3749; Imler JL, 2000, CURR OPIN MICROBIOL, V3, P16, DOI 10.1016/S1369-5274(99)00045-4; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krieg AM, 2001, TRENDS MICROBIOL, V9, P249, DOI 10.1016/S0966-842X(01)02039-X; Krug A, 2001, EUR J IMMUNOL, V31, P3026, DOI 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Liu YJ, 2001, NAT IMMUNOL, V2, P585, DOI 10.1038/89726; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; MEGYERI K, 1995, MOL CELL BIOL, V15, P2207; Miller RL, 1999, INT J IMMUNOPHARMACO, V21, P1, DOI 10.1016/S0192-0561(98)00068-X; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Schnare M, 2000, CURR BIOL, V10, P1139, DOI 10.1016/S0960-9822(00)00700-4; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Stephenson J, 2001, JAMA-J AM MED ASSOC, V285, P2182, DOI 10.1001/jama.285.17.2182; Takeuchi O, 2000, J IMMUNOL, V164, P554, DOI 10.4049/jimmunol.164.2.554; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; TESTERMAN TL, 1995, J LEUKOCYTE BIOL, V58, P365, DOI 10.1002/jlb.58.3.365; Tomai MA, 2000, CELL IMMUNOL, V203, P55, DOI 10.1006/cimm.2000.1673; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Vasilakos JP, 2000, CELL IMMUNOL, V204, P64, DOI 10.1006/cimm.2000.1689; Verthelyi D, 2001, J IMMUNOL, V166, P2372, DOI 10.4049/jimmunol.166.4.2372; von Krogh G, 2000, SEX TRANSM INFECT, V76, P162, DOI 10.1136/sti.76.3.162; Wagner H, 1999, ADV IMMUNOL, V73, P329, DOI 10.1016/S0065-2776(08)60790-7; WEEKS CE, 1994, J INTERFERON RES, V14, P81, DOI 10.1089/jir.1994.14.81; YAMAMOTO T, 1994, JPN J CANCER RES, V85, P775, DOI 10.1111/j.1349-7006.1994.tb02947.x; Yoshimura A, 1999, J IMMUNOL, V163, P1	49	1843	2100	7	181	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2002	3	2					196	200		10.1038/ni758	http://dx.doi.org/10.1038/ni758			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	516PJ	11812998				2022-12-18	WOS:000173562400021
J	Zhou, RB; Tardivel, A; Thorens, B; Choi, I; Tschopp, J				Zhou, Rongbin; Tardivel, Aubry; Thorens, Bernard; Choi, Inpyo; Tschopp, Juerg			Thioredoxin-interacting protein links oxidative stress to inflammasome activation	NATURE IMMUNOLOGY			English	Article							NALP3 INFLAMMASOME; MURAMYL DIPEPTIDE; GLUCOSE; TXNIP; IDENTIFICATION; CRYSTALS; CANCER; VDUP1	The NLRP3 inflammasome has a major role in regulating innate immunity. Deregulated inflammasome activity is associated with several inflammatory diseases, yet little is known about the signaling pathways that lead to its activation. Here we show that NLRP3 interacted with thioredoxin (TRX)-interacting protein (TXNIP), a protein linked to insulin resistance. Inflammasome activators such as uric acid crystals induced the dissociation of TXNIP from thioredoxin in a reactive oxygen species (ROS)-sensitive manner and allowed it to bind NLRP3. TXNIP deficiency impaired activation of the NLRP3 inflammasome and subsequent secretion of interleukin 1 beta (IL-1 beta). Akin to Txnip(-/-) mice, Nlrp3(-/-) mice showed improved glucose tolerance and insulin sensitivity. The participation of TXNIP in the NLRP3 inflammasome activation may provide a mechanistic link to the observed involvement of IL-1 beta in the pathogenesis of type 2 diabetes.	[Zhou, Rongbin; Tardivel, Aubry; Tschopp, Juerg] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Thorens, Bernard] Univ Lausanne, Ctr Integrat Genom, CH-1066 Epalinges, Switzerland; [Choi, Inpyo] Korea Res Inst Biosci & Biotechnol, Taejon, South Korea	University of Lausanne; University of Lausanne; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Tschopp, J (corresponding author), Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland.	jurg.tschopp@unil.ch	Zhou, Rongbin/B-1430-2013		Swiss National Science Foundation, MUGEN; Swiss National Center of Competence in Research for Molecular Oncology	Swiss National Science Foundation, MUGEN(Swiss National Science Foundation (SNSF)); Swiss National Center of Competence in Research for Molecular Oncology	We thank P. Vandenabeele (Ghent University) for antibody to mouse caspase-1 (p20); V. Dixit (Genentech) for Ipaf<SUP>-/-</SUP> mice; R. V. Bruggen (Free University Amsterdam) for S. typhimurium; R. Solari (Glaxo) for antibody to mouse IL-1 beta; M. Joffraud for technical help; and K. Schroder, C. Dostert and O. Gross for reading the manuscript. Supported by the Swiss National Science Foundation, MUGEN and the Swiss National Center of Competence in Research for Molecular Oncology (A. T.).	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Chen JQ, 2008, FASEB J, V22, P3581, DOI 10.1096/fj.08-111690; Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; Dasu MR, 2007, AM J PHYSIOL-ENDOC M, V293, pE337, DOI 10.1152/ajpendo.00718.2006; Didierlaurent A, 2006, MOL CELL BIOL, V26, P735, DOI 10.1128/MCB.26.3.735-742.2006; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Dostert C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006510; Franchi L, 2007, EUR J IMMUNOL, V37, P3030, DOI 10.1002/eji.200737532; Gokulakrishnan K, 2009, MOL CELL BIOCHEM, V324, P173, DOI 10.1007/s11010-008-9996-x; GOTOH M, 1987, TRANSPLANTATION, V43, P725, DOI 10.1097/00007890-198705000-00024; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hattersley AT, 2005, DIABETES, V54, P2503, DOI 10.2337/diabetes.54.9.2503; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hui STY, 2008, P NATL ACAD SCI USA, V105, P3921, DOI 10.1073/pnas.0800293105; Kaimul AM, 2007, FREE RADICAL BIO MED, V43, P861, DOI 10.1016/j.freeradbiomed.2007.05.032; Kim SY, 2007, CELL MOL IMMUNOL, V4, P345; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lee KN, 2005, IMMUNITY, V22, P195, DOI 10.1016/j.immuni.2004.12.012; Maedler K, 2004, DIABETES, V53, P1706, DOI 10.2337/diabetes.53.7.1706; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Marina-Garcia N, 2008, J IMMUNOL, V180, P4050, DOI 10.4049/jimmunol.180.6.4050; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Oka S, 2009, ENDOCRINOLOGY, V150, P1225, DOI 10.1210/en.2008-0646; Papin S, 2007, CELL DEATH DIFFER, V14, P1457, DOI 10.1038/sj.cdd.4402142; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Son A, 2008, EUR J IMMUNOL, V38, P1358, DOI 10.1002/eji.200737939; Suh SW, 2008, ANN NEUROL, V64, P654, DOI 10.1002/ana.21511; Turturro F, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-96; van Greevenbroek MMJ, 2007, DIABETIC MED, V24, P498, DOI 10.1111/j.1464-5491.2007.02109.x	38	1749	1855	4	279	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2010	11	2					136	U51		10.1038/ni.1831	http://dx.doi.org/10.1038/ni.1831			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	545KF	20023662				2022-12-18	WOS:000273730200010
J	Serhan, CN; Savill, J				Serhan, CN; Savill, J			Resolution of inflammation: The beginning programs the end	NATURE IMMUNOLOGY			English	Review							MONOCYTE-DERIVED MACROPHAGES; POLYUNSATURATED FATTY-ACIDS; KAPPA-B ACTIVATION; APOPTOTIC CELLS; LIPOXIN A(4); ANTIINFLAMMATORY PROPERTIES; STABLE ANALOGS; IN-VIVO; NONPHLOGISTIC PHAGOCYTOSIS; MYOCARDIAL-INFARCTION	Acute inflammation normally resolves by mechanisms that have remained somewhat elusive. Emerging evidence now suggests that an active, coordinated program of resolution initiates in the first few hours after an inflammatory response begins. After entering tissues, granulocytes promote the switch of arachidonic acid-derived prostaglandins and leukotrienes to lipoxins, which initiate the termination sequence. Neutrophil recruitment thus ceases and programmed death by apoptosis is engaged. These events coincide with the biosynthesis, from omega-3 polyunsaturated fatty acids, of resolvins and protectins, which critically shorten the period of neutrophil infiltration by initiating apoptosis. Consequently, apoptotic neutrophils undergo phagocytosis by macrophages, leading to neutrophil clearance and release of anti-inflammatory and reparative cytokines such as transforming growth factor-beta 1. The anti-inflammatory program ends with the departure of macrophages through the lymphatics. Understanding these and further details of the mechanism required for inflammation resolution may underpin the development of drugs that can resolve inflammatory processes in directed and controlled ways.	Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Ctr Expt Therapeut & Reperfus Injury, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Edinburgh, Queens Med Res Inst, Med Res Council Ctr Inflammat Res, Edinburgh EH16 4TJ, Midlothian, Scotland	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Edinburgh	Serhan, CN (corresponding author), Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Ctr Expt Therapeut & Reperfus Injury, Boston, MA 02115 USA.	cnserhan@zeus.bwh.harvard.edu			NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE016191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038765, R29GM038765, R37GM038765] Funding Source: NIH RePORTER; NIDCR NIH HHS [P50-DE016191] Funding Source: Medline; NIGMS NIH HHS [GM38765] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Bellingan GJ, 1996, J IMMUNOL, V157, P2577; Bose Jens, 2004, J Biol, V3, P15, DOI 10.1186/jbiol10; Brown SB, 1999, J IMMUNOL, V162, P480; Burr GO, 1929, J BIOL CHEM, V82, P345; Byrne A, 2002, J IMMUNOL, V168, P1968, DOI 10.4049/jimmunol.168.4.1968; CAPDEVILA JH, 1990, METHOD ENZYMOL, V187, P385; Chiang N, 1999, J CLIN INVEST, V104, P309, DOI 10.1172/JCI7016; CLARIA J, 1995, P NATL ACAD SCI USA, V92, P9475, DOI 10.1073/pnas.92.21.9475; COLGAN SP, 1993, J CLIN INVEST, V92, P75, DOI 10.1172/JCI116601; Devitt A, 2004, J CELL BIOL, V167, P1161, DOI 10.1083/jcb.200410057; Duffield JS, 2001, AM J PATHOL, V159, P1397, DOI 10.1016/S0002-9440(10)62526-6; Erwig LP, 1998, J IMMUNOL, V161, P1983; Erwig LP, 2000, AM J PATHOL, V156, P295, DOI 10.1016/S0002-9440(10)64730-X; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fiorucci S, 2004, P NATL ACAD SCI USA, V101, P15736, DOI 10.1073/pnas.0404722101; Fukunaga K, 2005, J IMMUNOL, V174, P5033, DOI 10.4049/jimmunol.174.8.5033; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gallin J.I., 1999, INFLAMMATION BASIC P; Giles KM, 2001, J IMMUNOL, V167, P976, DOI 10.4049/jimmunol.167.2.976; GILMOUR JS, IN PRESS J IMMUNOL; Gilroy DW, 2005, CURR OPIN PHARMACOL, V5, P405, DOI 10.1016/j.coph.2005.02.006; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Godson C, 2000, J IMMUNOL, V164, P1663, DOI 10.4049/jimmunol.164.4.1663; Golpon HA, 2004, FASEB J, V18, P1716, DOI 10.1096/fj.04-1853fje; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Hughes J, 2005, CURR OPIN NEPHROL HY, V14, P389, DOI 10.1097/01.mnh.0000172728.82993.4e; HURLEY JV, 1983, ACUTE INFLAMMATION, P109; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; JONSSON H, 2005, NAT MED; Karp CL, 2004, NAT IMMUNOL, V5, P388, DOI 10.1038/ni1056; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; LEE A, 1993, J LEUKOCYTE BIOL, V54, P283, DOI 10.1002/jlb.54.4.283; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Liu YQ, 1999, J IMMUNOL, V162, P3639; Lucas M, 2003, J IMMUNOL, V171, P2610, DOI 10.4049/jimmunol.171.5.2610; Maddox JE, 1996, J EXP MED, V183, P137, DOI 10.1084/jem.183.1.137; Maderna P, 2005, J IMMUNOL, V174, P3727, DOI 10.4049/jimmunol.174.6.3727; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Marchioli R, 2002, CIRCULATION, V105, P1897, DOI 10.1161/01.CIR.0000014682.14181.F2; Meagher LC, 1996, J IMMUNOL, V156, P4422; Metchnikoff E., 1893, LECT COMP PATHOLOGY; Mitchell S, 2002, J AM SOC NEPHROL, V13, P2497, DOI 10.1097/01.ASN.0000032417.73640.72; Morse D., 1976, MED HIST, V20, P461; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; NEWMAN SL, 1982, J EXP MED, V156, P430, DOI 10.1084/jem.156.2.430; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Pouliot M, 2002, J IMMUNOL, V169, P5279, DOI 10.4049/jimmunol.169.9.5279; Ren Y, 2001, J IMMUNOL, V166, P4743, DOI 10.4049/jimmunol.166.7.4743; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Savill J, 1997, J LEUKOCYTE BIOL, V61, P375, DOI 10.1002/jlb.61.4.375; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Savill J, 2001, KIDNEY INT, V60, P1203, DOI 10.1046/j.1523-1755.2001.0600031203.x; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; Schottelius AJ, 2002, J IMMUNOL, V169, P7063, DOI 10.4049/jimmunol.169.12.7063; SERHAN CN, 1995, BIOCHEMISTRY-US, V34, P14609, DOI 10.1021/bi00044a041; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Stuart LM, 2005, J IMMUNOL, V174, P3220, DOI 10.4049/jimmunol.174.6.3220; Takano T, 1998, J CLIN INVEST, V101, P819, DOI 10.1172/JCI1578; Taylor PR, 2000, J EXP MED, V192, P359, DOI 10.1084/jem.192.3.359; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Wallace JL, 2003, TRENDS PHARMACOL SCI, V24, P323, DOI 10.1016/S0165-6147(03)00166-4; Ward C, 2002, J IMMUNOL, V168, P6232, DOI 10.4049/jimmunol.168.12.6232; Ward C, 1999, J BIOL CHEM, V274, P4309, DOI 10.1074/jbc.274.7.4309; WILLIAMS TJ, 1977, NATURE, V270, P530, DOI 10.1038/270530a0	76	1671	1747	7	264	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2005	6	12					1191	1197		10.1038/ni1276	http://dx.doi.org/10.1038/ni1276			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	985IX	16369558				2022-12-18	WOS:000233371900004
J	Halle, A; Hornung, V; Petzold, GC; Stewart, CR; Monks, BG; Reinheckel, T; Fitzgerald, KA; Latz, E; Moore, KJ; Golenbock, DT				Halle, Annett; Hornung, Veit; Petzold, Gabor C.; Stewart, Cameron R.; Monks, Brian G.; Reinheckel, Thomas; Fitzgerald, Katherine A.; Latz, Eicke; Moore, Kathryn J.; Golenbock, Douglas T.			The NALP3 inflammasome is involved in the innate immune response to amyloid-beta	NATURE IMMUNOLOGY			English	Article							NITRIC-OXIDE SYNTHASE; ALZHEIMERS-DISEASE; CATHEPSIN-B; MOUSE MODEL; MICROGLIA; RECEPTOR; ACTIVATION; EXPRESSION; INTERLEUKIN-1-BETA; CASPASE-1	The fibrillar peptide amyloid-beta (A beta) has a chief function in the pathogenesis of Alzheimer's disease. Interleukin 1 beta (IL-1 beta) is a key cytokine in the inflammatory response to A beta. Insoluble materials such as crystals activate the inflammasome formed by the cytoplasmic receptor NALP3, which results in the release of IL-1 beta. Here we identify the NALP3 inflammasome as a sensor of A beta in a process involving the phagocytosis of A beta and subsequent lysosomal damage and release of cathepsin B. Furthermore, the IL-1 beta pathway was essential for the microglial synthesis of proinflammatory and neurotoxic factors, and the inflammasome, caspase-1 and IL-1 beta were critical for the recruitment of microglia to exogenous A beta in the brain. Our findings suggest that activation of the NALP3 inflammasome is important for inflammation and tissue damage in Alzheimer's disease.	[Halle, Annett; Hornung, Veit; Monks, Brian G.; Fitzgerald, Katherine A.; Latz, Eicke; Golenbock, Douglas T.] Univ Massachusetts, Sch Med, Dept Immunol & Infect Dis, Worcester, MA 01605 USA; [Petzold, Gabor C.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Petzold, Gabor C.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Stewart, Cameron R.; Moore, Kathryn J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Lipid Metab Unit, Boston, MA 02114 USA; [Reinheckel, Thomas] Univ Freiburg, Inst Mol Med & Cell Res, D-79104 Freiburg, Germany	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard University; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Freiburg	Golenbock, DT (corresponding author), Univ Massachusetts, Sch Med, Dept Immunol & Infect Dis, Worcester, MA 01605 USA.	douglas.golenbock@umassmed.edu	Moore, Kathryn/ABE-6416-2020; Hornung, Veit/C-3565-2012; Reinheckel, Thomas/AAL-9761-2021; Monks, Brian/B-8362-2015; Latz, Eicke/H-3951-2014; Fitzgerald, Katherine/ABE-6317-2020; Stewart, Cameron R/E-6823-2011	Moore, Kathryn/0000-0003-2505-2547; Hornung, Veit/0000-0002-4150-194X; Reinheckel, Thomas/0000-0001-9866-9105; Monks, Brian/0000-0003-4008-3093; Latz, Eicke/0000-0003-1488-5666; Stewart, Cameron/0000-0002-3395-7859; Fitzgerald, Kate/0000-0003-3175-609X	NIAID NIH HHS [AI065483, R01 AI065483] Funding Source: Medline; NIA NIH HHS [R01 AG020255-06A1, R01 AG020255, AG20255] Funding Source: Medline; NIGMS NIH HHS [GM54060, R01 GM054060, R37 GM054060] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054060, R01GM054060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020255] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Akama KT, 2000, J BIOL CHEM, V275, P7918, DOI 10.1074/jbc.275.11.7918; Amstad PA, 2001, BIOTECHNIQUES, V31, P608, DOI 10.2144/01313pf01; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; BlumDegen D, 1995, NEUROSCI LETT, V202, P17, DOI 10.1016/0304-3940(95)12192-7; Boraschi D, 2006, VITAM HORM, V74, P229, DOI 10.1016/S0083-6729(06)74009-2; BUTTLE DJ, 1992, ARCH BIOCHEM BIOPHYS, V299, P377, DOI 10.1016/0003-9861(92)90290-D; Cataldo AM, 1997, J NEUROSCI, V17, P6142; Combs CK, 2001, J NEUROSCI, V21, P1179; Dinarello CA, 2007, IMMUNITY, V26, P383, DOI 10.1016/j.immuni.2007.04.005; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; El Khoury JB, 2003, J EXP MED, V197, P1657, DOI 10.1084/jem.20021546; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; FRACKOWIAK J, 1992, ACTA NEUROPATHOL, V84, P225; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; Hook VYH, 2008, J BIOL CHEM, V283, P7745, DOI 10.1074/jbc.M708362200; Ishii KJ, 2005, J CLIN IMMUNOL, V25, P511, DOI 10.1007/s10875-005-7829-1; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006; Lehnardt S, 2006, J IMMUNOL, V177, P583, DOI 10.4049/jimmunol.177.1.583; Li M, 2004, J NEUROCHEM, V91, P623, DOI 10.1111/j.1471-4159.2004.02765.x; Liu Y, 2005, BRAIN, V128, P1778, DOI 10.1093/brain/awh531; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Moore KJ, 2002, J BIOL CHEM, V277, P47373, DOI 10.1074/jbc.M208788200; Mueller-Steiner S, 2006, NEURON, V51, P703, DOI 10.1016/j.neuron.2006.07.027; Qi YP, 1997, J NEUROSCI, V17, P1217; Richard KL, 2008, J NEUROSCI, V28, P5784, DOI 10.1523/JNEUROSCI.1146-08.2008; ROBERSON SM, 1988, CELL IMMUNOL, V116, P341, DOI 10.1016/0008-8749(88)90236-5; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Severa M, 2006, J BIOL CHEM, V281, P26188, DOI 10.1074/jbc.M604516200; Shaftel SS, 2007, J CLIN INVEST, V117, P1595, DOI 10.1172/JCI31450; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Tahara K, 2006, BRAIN, V129, P3006, DOI 10.1093/brain/awl249; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Weiner HL, 2006, NAT REV IMMUNOL, V6, P404, DOI 10.1038/nri1843; Weldon DT, 1998, J NEUROSCI, V18, P2161; Xie Z, 2002, J NEUROSCI, V22, P3484; Yang AJ, 1998, J NEUROSCI RES, V52, P691, DOI 10.1002/(SICI)1097-4547(19980615)52:6<691::AID-JNR8>3.0.CO;2-3	47	1660	1765	5	234	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2008	9	8					857	865		10.1038/ni.1636	http://dx.doi.org/10.1038/ni.1636			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	328EN	18604209	Green Accepted			2022-12-18	WOS:000257780700008
J	Zhou, LA; Ivanov, II; Spolski, R; Min, R; Shenderov, K; Egawa, T; Levy, DE; Leonard, WJ; Littman, DR				Zhou, Liang; Ivanov, Ivaylo I.; Spolski, Rosanne; Min, Roy; Shenderov, Kevin; Egawa, Takeshi; Levy, David E.; Leonard, Warren J.; Littman, Dan R.			IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways	NATURE IMMUNOLOGY			English	Article							INFLAMMATORY-BOWEL-DISEASE; REGULATORY T-CELLS; ROR-GAMMA-T; AUTOIMMUNE INFLAMMATION; TRANSCRIPTION FACTOR; HELPER-CELLS; T-H-17 CELLS; TH2 CELLS; RESPONSES; CYTOKINE	T helper cells that produce interleukin 17 (IL-17; 'T-H-17 cells') are a distinct subset of proinflammatory cells whose in vivo function requires IL-23 but whose in vitro differentiation requires only IL-6 and transforming growth factor-beta (TGF-beta). We demonstrate here that IL-6 induced expression of IL-21 that amplified an autocrine loop to induce more IL-21 and IL-23 receptor in naive CD4(+) T cells. Both IL-21 and IL-23, along with TGF-beta, induced IL-17 expression independently of IL-6. The effects of IL-6 and IL-21 depended on STAT3, a transcription factor required for the differentiation of T-H-17 cells in vivo. IL-21 and IL-23 induced the orphan nuclear receptor ROR gamma t, which in synergy with STAT3 promoted IL-17 expression. IL-6 therefore orchestrates a series of 'downstream' cytokine-dependent signaling pathways that, in concert with TGF-beta, amplify ROR gamma t-dependent differentiation of TH-17 cells.	NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA; NHLBI, Lab Mol Immunol, Bethesda, MD 20892 USA; NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	New York University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Howard Hughes Medical Institute; New York University; New York University; New York University	Littman, DR (corresponding author), NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA.	littman@saturn.med.nyu.edu	Levy, David/AAG-6202-2019; Levy, David/GPS-4945-2022; Leonard, Warren/AAA-1397-2022	Levy, David/0000-0002-7320-7788; Shenderov, Kevin/0000-0002-5255-6815	Intramural NIH HHS Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL005401, Z01HL005402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Belkaid Y, 2003, EXPERT OPIN BIOL TH, V3, P875, DOI 10.1517/14712598.3.6.875; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Colgan J, 2006, NAT IMMUNOL, V7, P899, DOI 10.1038/ni0906-899; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Ghilardi N, 2004, J IMMUNOL, V172, P2827, DOI 10.4049/jimmunol.172.5.2827; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Kikly K, 2006, CURR OPIN IMMUNOL, V18, P670, DOI 10.1016/j.coi.2006.09.008; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lee CK, 2002, IMMUNITY, V17, P63, DOI 10.1016/S1074-7613(02)00336-9; Leonard WJ, 2005, NAT REV IMMUNOL, V5, P688, DOI 10.1038/nri1688; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Mehta DS, 2004, IMMUNOL REV, V202, P84, DOI 10.1111/j.0105-2896.2004.00201.x; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Peluso I, 2007, J IMMUNOL, V178, P732, DOI 10.4049/jimmunol.178.2.732; Pesce J, 2006, J CLIN INVEST, V116, P2044, DOI 10.1172/JCI27727; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Witowski J, 2004, CELL MOL LIFE SCI, V61, P567, DOI 10.1007/s00018-003-3228-z; Wu Z, 2005, MOL CELL BIOL, V25, P9741, DOI 10.1128/MCB.25.22.9741-9752.2005; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143; Zeng R, 2007, BLOOD, V109, P4135, DOI 10.1182/blood-2006-10-054973; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou L, 2004, MOL CELL BIOL, V24, P2385, DOI 10.1128/MCB.24.6.2385-2396.2004	50	1585	1685	3	95	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2007	8	9					967	974		10.1038/ni1488	http://dx.doi.org/10.1038/ni1488			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	202QN	17581537				2022-12-18	WOS:000248918200020
J	Soumelis, V; Reche, PA; Kanzler, H; Yuan, W; Edward, G; Homey, B; Gilliet, M; Ho, S; Antonenko, S; Lauerma, A; Smith, K; Gorman, D; Zurawski, S; Abrams, J; Menon, S; McClanahan, T; de Waal-Malefyt, R; Bazan, F; Kastelein, RA; Liu, YJ				Soumelis, V; Reche, PA; Kanzler, H; Yuan, W; Edward, G; Homey, B; Gilliet, M; Ho, S; Antonenko, S; Lauerma, A; Smith, K; Gorman, D; Zurawski, S; Abrams, J; Menon, S; McClanahan, T; de Waal-Malefyt, R; Bazan, F; Kastelein, RA; Liu, YJ			Human epithelial cells trigger dendritic cell-mediated allergic inflammation by producing TSLP	NATURE IMMUNOLOGY			English	Article							THYMIC STROMAL LYMPHOPOIETIN; T-HELPER-CELL; MHC CLASS-II; MOLECULAR-CLONING; INTERLEUKIN-10; RECEPTOR; EXPRESSION; CHEMOKINE; RESPONSES; ANTIGEN	Whether epithelial cells play a role in triggering the immune cascade leading to T helper 2 (T(H)2)-type allergic inflammation is not known. We show here that human thymic stromal lymphopoietin (TSLP) potently activated CD11c(+) dendritic cells (DCs) and induced production of the T(H)2-attracting chemokines TARC (thymus and activation-regulated chemokine; also known as CCL17) and MDC (macrophage-derived chemokine; CCL22). TSLP-activated DCs primed naive T-H cells to produce the proallergic cytokines interleukin 4 (IL-4), IL-5, IL-13 and tumor necrosis factor-alpha, while down-regulating IL-10 and interferon-gamma. TSLP was highly expressed by epithelial cells, especially keratinocytes from patients with atopic dermatitis. TSLP expression was associated with Langerhans cell migration and activation in situ. These findings shed new light on the function of human TSLP and the role played by epithelial cells and DCs in initiating allergic inflammation.	DNAX Res Inst Molec & Cellular Biol Inc, Palo Alto, CA 94304 USA; Univ Dusseldorf, Dept Dermatol, D-40225 Dusseldorf, Germany; Univ Helsinki Hosp, Dept Dermatol, Helsinki, Finland	Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Heinrich Heine University Dusseldorf; University of Helsinki; Helsinki University Central Hospital	Liu, YJ (corresponding author), DNAX Res Inst Molec & Cellular Biol Inc, 901 Calif Ave, Palo Alto, CA 94304 USA.	yong-jun.liu@dnax.org	Reche, Pedro A/B-1881-2013; Bazan, J. Fernando/B-4562-2010; Lauerma, Antti/J-8180-2016	Reche, Pedro A/0000-0003-3966-5838; de Waal Malefyt, Rene/0000-0002-2663-383X				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Akbari O, 2001, NAT IMMUNOL, V2, P725, DOI 10.1038/90667; Andrew DP, 2001, J IMMUNOL, V166, P103, DOI 10.4049/jimmunol.166.1.103; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Borish L, 1996, J ALLERGY CLIN IMMUN, V97, P1288, DOI 10.1016/S0091-6749(96)70197-5; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; de Saint-Vis B, 1998, IMMUNITY, V9, P325, DOI 10.1016/S1074-7613(00)80615-9; Hammad H, 2001, BLOOD, V98, P1135, DOI 10.1182/blood.V98.4.1135; Holgate ST, 2000, BMJ-BRIT MED J, V320, P231, DOI 10.1136/bmj.320.7229.231; Holt PG, 1997, ADV EXP MED BIOL, V417, P301; HOLT PG, 1993, CLIN EXP ALLERGY, V23, P4, DOI 10.1111/j.1365-2222.1993.tb02476.x; Homey B, 1999, CURR OPIN IMMUNOL, V11, P626, DOI 10.1016/S0952-7915(99)00028-X; Homey B, 2002, NAT MED, V8, P157, DOI 10.1038/nm0202-157; Imai T, 1999, INT IMMUNOL, V11, P81, DOI 10.1093/intimm/11.1.81; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Koch F, 1996, J EXP MED, V184, P741, DOI 10.1084/jem.184.2.741; Lambrecht BN, 2000, J CLIN INVEST, V106, P551, DOI 10.1172/JCI8107; Levin SD, 1999, J IMMUNOL, V162, P677; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; McWilliam AS, 1996, J EXP MED, V184, P2429, DOI 10.1084/jem.184.6.2429; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Novak N, 1999, ALLERGY, V54, P792, DOI 10.1034/j.1398-9995.1999.00101.x; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Pandey A, 2000, NAT IMMUNOL, V1, P59, DOI 10.1038/76923; Park LS, 2000, J EXP MED, V192, P659, DOI 10.1084/jem.192.5.659; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Ray RJ, 1996, EUR J IMMUNOL, V26, P10, DOI 10.1002/eji.1830260103; Reche PA, 2001, J IMMUNOL, V167, P336, DOI 10.4049/jimmunol.167.1.336; Renauld JC, 2001, J CLIN PATHOL, V54, P577, DOI 10.1136/jcp.54.8.577; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; Robinson DS, 1996, AM J RESP CELL MOL, V14, P113, DOI 10.1165/ajrcmb.14.2.8630259; ROMAGNANI S, 2002, CURR OPIN ALLERGY CL, V1, P73; SEMPER AE, 1999, DENDRITIC CELLS BIOL, P435; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Sims JE, 2000, J EXP MED, V192, P671, DOI 10.1084/jem.192.5.671; STINGL G, 1991, IMMUNOLOGICAL PHARM, P1; Tonozuka Y, 2001, CYTOGENET CELL GENET, V93, P23, DOI 10.1159/000056941; TunonDeLara JM, 1996, CLIN EXP ALLERGY, V26, P648, DOI 10.1046/j.1365-2222.1996.1095481.x; Vestergaard C, 2000, J INVEST DERMATOL, V115, P640, DOI 10.1046/j.1523-1747.2000.00115.x; ZUANYAMORIM C, 1995, J CLIN INVEST, V95, P2644, DOI 10.1172/JCI117966	43	1543	1627	9	103	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2002	3	7					673	680		10.1038/ni805	http://dx.doi.org/10.1038/ni805			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	566RH	12055625	Green Accepted			2022-12-18	WOS:000176441700018
J	Wilson, NJ; Boniface, K; Chan, JR; McKenzie, BS; Blumenschein, WM; Mattson, JD; Basham, B; Smith, K; Chen, T; Morel, F; Lecron, JC; Kastelein, RA; Cua, DJ; McClanahan, TK; Bowman, EP; Malefyt, RD				Wilson, Nicholas J.; Boniface, Katia; Chan, Jason R.; McKenzie, Brent S.; Blumenschein, Wendy M.; Mattson, Jeanine D.; Basham, Beth; Smith, Kathleen; Chen, Taiying; Morel, Franck; Lecron, Jean-Claude; Kastelein, Robert A.; Cua, Daniel J.; McClanahan, Terrill K.; Bowman, Edward P.; Malefyt, Rene de Waal			Development, cytokine profile and function of human interleukin 17-producing helper T cells	NATURE IMMUNOLOGY			English	Article							AUTOIMMUNE INFLAMMATION; ANTIMICROBIAL PEPTIDES; HUMAN KERATINOCYTES; BETA-DEFENSINS; HOST-DEFENSE; IL-23; EXPRESSION; PSORIASIS; DISTINCT; DIFFERENTIATION	T-H-17 cells are a distinct lineage of proinflammatory T helper cells that are essential for autoimmune disease. In mice, commitment to the T-H-17 lineage is dependent on transforming growth factor-beta and interleukin 6 (IL-6). Here we demonstrate that IL-23 and IL-1 beta induced the development of human T-H-17 cells expressing IL-17A, IL-17F, IL-22, IL-26, interferon-gamma, the chemokine CCL20 and transcription factor ROR gamma t. In situ, T-H-17 cells were identified by expression of the IL-23 receptor and the memory T cell marker CD45RO. Psoriatic skin lesions contained IL-23-producing dendritic cells and were enriched in the cytokines produced by human T-H-17 cells that promote the production of antimicrobial peptides in human keratinocytes. Our data collectively indicate that human and mouse T-H-17 cells require distinct factors during differentiation and that human T-H-17 cells may regulate innate immunity in epithelial cells.	Schering Plough Biopharma, Dept Discovery Res, Palo Alto, CA 94304 USA; Schering Plough Biopharma, Dept Expt Pathol & Pharmacol, Palo Alto, CA 94304 USA; Ctr Hosp Univ Poitiers, EA 3806, Lab Cytokines & Inflammat, F-86022 Poitiers, France	Merck & Company; Merck & Company; CHU Poitiers; Universite de Poitiers	Malefyt, RD (corresponding author), Schering Plough Biopharma, Dept Discovery Res, Palo Alto, CA 94304 USA.	rene.de.waal.malefyt@spcorp.com	Boniface, Katia/N-5577-2016; Morel, Franck/AAI-4274-2021	Boniface, Katia/0000-0003-4428-1222; Morel, Franck/0000-0003-3812-9304; de Waal Malefyt, Rene/0000-0002-2663-383X; LECRON, Jean-Claude/0000-0003-3990-5213				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Gurney AL, 2004, INT IMMUNOPHARMACOL, V4, P669, DOI 10.1016/j.intimp.2004.01.016; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Harder J, 2005, J LEUKOCYTE BIOL, V77, P476, DOI 10.1189/jlb.0704409; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hoover DM, 2002, J BIOL CHEM, V277, P37647, DOI 10.1074/jbc.M203907200; Hor S, 2004, J BIOL CHEM, V279, P33343, DOI 10.1074/jbc.M405000200; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Kleinschek MA, 2006, J IMMUNOL, V176, P1098, DOI 10.4049/jimmunol.176.2.1098; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Liao F, 1999, J IMMUNOL, V162, P186; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nagalakshmi ML, 2004, INT IMMUNOPHARMACOL, V4, P577, DOI 10.1016/j.intimp.2004.01.007; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Sheikh F, 2004, J IMMUNOL, V172, P2006, DOI 10.4049/jimmunol.172.4.2006; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Teunissen MBM, 1998, J INVEST DERMATOL, V111, P645, DOI 10.1046/j.1523-1747.1998.00347.x; Vanbervliet A, 2002, EUR J IMMUNOL, V32, P231, DOI 10.1002/1521-4141(200201)32:1<231::AID-IMMU231>3.0.CO;2-8; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wiekowski MT, 2001, J IMMUNOL, V166, P7563, DOI 10.4049/jimmunol.166.12.7563; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; YSSEL H, 2001, CURRENT PROTOCOLS IM, P7; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	50	1536	1654	1	133	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2007	8	9					950	957		10.1038/ni1497	http://dx.doi.org/10.1038/ni1497			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	202QN	17676044				2022-12-18	WOS:000248918200018
J	Hansson, GK; Hermansson, A				Hansson, Goran K.; Hermansson, Andreas			The immune system in atherosclerosis	NATURE IMMUNOLOGY			English	Review							LOW-DENSITY-LIPOPROTEIN; REGULATORY T-CELLS; ALDEHYDE-MODIFIED PEPTIDE; RHEUMATOID-ARTHRITIS; APOLIPOPROTEIN B-100; INTERFERON-GAMMA; OXIDIZED LDL; AGGRAVATE ATHEROSCLEROSIS; ENHANCES ATHEROSCLEROSIS; REDUCED ATHEROSCLEROSIS	Cardiovascular disease, a leading cause of mortality worldwide, is caused mainly by atherosclerosis, a chronic inflammatory disease of blood vessels. Lesions of atherosclerosis contain macrophages, T cells and other cells of the immune response, together with cholesterol that infiltrates from the blood. Targeted deletion of genes encoding costimulatory factors and proinflammatory cytokines results in less disease in mouse models, whereas interference with regulatory immunity accelerates it. Innate as well as adaptive immune responses have been identified in atherosclerosis, with components of cholesterol-carrying low-density lipoprotein triggering inflammation, T cell activation and antibody production during the course of disease. Studies are now under way to develop new therapies based on these concepts of the involvement of the immune system in atherosclerosis.	[Hansson, Goran K.; Hermansson, Andreas] Karolinska Inst, Karolinska Univ Hosp Solna, Ctr Mol Med, Dept Med, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Hansson, GK (corresponding author), Karolinska Inst, Karolinska Univ Hosp Solna, Ctr Mol Med, Dept Med, Stockholm, Sweden.	goran.hansson@ki.se	Hansson, Goran K/B-7423-2012	Hansson, Goran/0000-0003-4148-5190	Swedish Research Council; Foundation for Strategic Research; VINNOVA; Swedish Heart-Lung Foundation; Leducq Foundation; European Union	Swedish Research Council(Swedish Research CouncilEuropean Commission); Foundation for Strategic Research; VINNOVA(Vinnova); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Leducq Foundation(Leducq Foundation); European Union(European Commission)	We thank J. Andersson and A.-K. Robertson for critical reading of the manuscript. Supported by the Swedish Research Council, Foundation for Strategic Research, VINNOVA, the Swedish Heart-Lung Foundation, the Leducq Foundation and the European Union (AtheroRemo project).	Afek A, 2000, J AUTOIMMUN, V14, P115, DOI 10.1006/jaut.1999.0351; Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Ait-Oufella H, 2010, J EXP MED, V207, P1579, DOI 10.1084/jem.20100155; Ameli S, 1996, ARTERIOSCL THROM VAS, V16, P1074, DOI 10.1161/01.ATV.16.8.1074; Andersson J, 2010, CLIN IMMUNOL, V134, P33, DOI 10.1016/j.clim.2009.07.002; Back M, 2005, P NATL ACAD SCI USA, V102, P17501, DOI 10.1073/pnas.0505845102; Binder CJ, 2004, J CLIN INVEST, V114, P427, DOI 10.1172/jci200420479; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; Bjorkbacka H, 2004, NAT MED, V10, P416, DOI 10.1038/nm1008; Bochkov VN, 2002, BLOOD, V99, P199, DOI 10.1182/blood.V99.1.199; Buono C, 2005, P NATL ACAD SCI USA, V102, P1596, DOI 10.1073/pnas.0409015102; Buono C, 2003, ARTERIOSCL THROM VAS, V23, P454, DOI 10.1161/01.ATV.0000059419.11002.6E; Caligiuri G, 2002, J CLIN INVEST, V109, P745, DOI 10.1172/JCI200207272; Caligiuri G, 2007, J AM COLL CARDIOL, V50, P540, DOI 10.1016/j.jacc.2006.11.054; Curtiss LK, 2009, J LIPID RES, V50, pS340, DOI 10.1194/jlr.R800056-JLR200; Dahlof Bjorn, 2010, Am J Cardiol, V105, p3A, DOI 10.1016/j.amjcard.2009.10.007; Davenport P, 2003, AM J PATHOL, V163, P1117, DOI 10.1016/S0002-9440(10)63471-2; de Boer OJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000779; de Boer OJ, 2010, J PATHOL, V220, P499, DOI 10.1002/path.2667; Dixon WG, 2007, ARTHRITIS RHEUM, V56, P2905, DOI 10.1002/art.22809; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Dwyer JH, 2004, NEW ENGL J MED, V350, P29, DOI 10.1056/NEJMoa025079; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; Edfeldt K, 2006, ARTERIOSCL THROM VAS, V26, P1551, DOI 10.1161/01.ATV.0000223901.08459.57; Eid RE, 2009, CIRCULATION, V119, P1424, DOI 10.1161/CIRCULATIONAHA.108.827618; Elhage R, 2003, CARDIOVASC RES, V59, P234, DOI 10.1016/S0008-6363(03)00343-2; Erbel C, 2009, J IMMUNOL, V183, P8167, DOI 10.4049/jimmunol.0901126; Fredrikson GN, 2003, ARTERIOSCL THROM VAS, V23, P872, DOI 10.1161/01.ATV.0000067935.02679.B0; Fredrikson GN, 2007, STROKE, V38, P1495, DOI 10.1161/STROKEAHA.106.474577; Frostegard J, 1999, ATHEROSCLEROSIS, V145, P33, DOI 10.1016/S0021-9150(99)00011-8; Gabriel SE, 2008, AM J MED, V121, P9, DOI 10.1016/j.amjmed.2008.06.011; Gargalovic PS, 2006, ARTERIOSCL THROM VAS, V26, P2490, DOI 10.1161/01.ATV.0000242903.41158.a1; Gharavi NM, 2007, J BIOL CHEM, V282, P31460, DOI 10.1074/jbc.M704267200; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Gotsman I, 2007, J CLIN INVEST, V117, P2974, DOI 10.1172/JCI31344; Grabner R, 2009, J EXP MED, V206, P233, DOI 10.1084/jem.20080752; Greaves DR, 2009, J LIPID RES, V50, pS282, DOI 10.1194/jlr.R800066-JLR200; Gupta S, 1997, J CLIN INVEST, V99, P2752, DOI 10.1172/JCI119465; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Hansson GK, 2010, SCIENCE, V328, P1641, DOI 10.1126/science.1191663; Harats D, 2002, J AM COLL CARDIOL, V40, P1333, DOI 10.1016/S0735-1097(02)02135-6; Hauer AD, 2005, CIRCULATION, V112, P1054, DOI 10.1161/CIRCULATIONAHA.104.533463; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; Heller EA, 2005, CIRCULATION, V112, P578, DOI 10.1161/CIRCULATIONAHA.105.545616; Hermansson A., CIRCULATION IN PRESS; Hermansson A, 2010, J EXP MED, V207, P1081, DOI 10.1084/jem.20092243; Hjerpe C, 2010, ATHEROSCLEROSIS, V209, P436, DOI 10.1016/j.atherosclerosis.2009.10.003; Holmqvist ME, 2009, ARTHRITIS RHEUM, V60, P2861, DOI 10.1002/art.24855; Huang W, 2010, ARTERIOSCL THROM VAS, V30, P1542, DOI 10.1161/ATVBAHA.109.191189; Huber SA, 2001, CIRCULATION, V103, P2610; Hui YQ, 2010, CIRCULATION, V121, P2654, DOI 10.1161/CIRCULATIONAHA.109.910687; Hulthe J, 1998, ARTERIOSCL THROM VAS, V18, P1203, DOI 10.1161/01.ATV.18.8.1203; Jury EC, 2006, J IMMUNOL, V177, P7416, DOI 10.4049/jimmunol.177.10.7416; King VL, 2007, AM J PATHOL, V171, P2040, DOI 10.2353/ajpath.2007.060857; King VL, 2002, ARTERIOSCL THROM VAS, V22, P456, DOI 10.1161/hq0302.104905; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Klareskog L, 2004, LANCET, V363, P2011, DOI 10.1016/S0140-6736(04)16485-4; Klingenberg R, 2010, ARTERIOSCL THROM VAS, V30, P946, DOI 10.1161/ATVBAHA.109.202671; Kovanen PT, 2007, IMMUNOL REV, V217, P105, DOI 10.1111/j.1600-065X.2007.00515.x; Kyaw T, 2010, J IMMUNOL, V185, P4410, DOI 10.4049/jimmunol.1000033; Lee TS, 1999, ARTERIOSCL THROM VAS, V19, P734, DOI 10.1161/01.ATV.19.3.734; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Liuzzo G, 2000, CIRCULATION, V101, P2883, DOI 10.1161/01.CIR.101.25.2883; Lloyd-Jones DM, 2010, CIRCULATION, V121, P1768, DOI 10.1161/CIRCULATIONAHA.109.849166; Ludewig B, 2000, P NATL ACAD SCI USA, V97, P12752, DOI 10.1073/pnas.220427097; Lundberg AM, 2010, CLIN IMMUNOL, V134, P5, DOI 10.1016/j.clim.2009.07.016; Mach F, 1998, NATURE, V394, P200, DOI 10.1038/28204; Major AS, 2002, ARTERIOSCL THROM VAS, V22, P1892, DOI 10.1161/01.ATV.0000039169.47943.EE; Maron R, 2002, CIRCULATION, V106, P1708, DOI 10.1161/01.CIR.0000029750.99462.30; Mehrabian M, 2002, CIRC RES, V91, P120, DOI 10.1161/01.RES.0000028008.99774.7F; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Miller AM, 2008, J EXP MED, V205, P339, DOI 10.1084/jem.20071868; Miller YI, 2003, J BIOL CHEM, V278, P1561, DOI 10.1074/jbc.M209634200; Mor A, 2007, ARTERIOSCL THROM VAS, V27, P893, DOI 10.1161/01.ATV.0000259365.31469.89; Muller-Ehmsen J, 2004, EXPERT OPIN THER TAR, V8, P203, DOI 10.1517/14728222.8.3.203; Mullick AE, 2005, J CLIN INVEST, V115, P3149, DOI 10.1172/JCI25482; Nicoletti A, 1999, EUR J IMMUNOL, V29, P512, DOI 10.1002/(SICI)1521-4141(199902)29:02<512::AID-IMMU512>3.0.CO;2-Y; Niessner A, 2006, CIRCULATION, V114, P2482, DOI 10.1161/CIRCULATIONAHA.106.642801; Niessner A, 2010, CLIN IMMUNOL, V134, P25, DOI 10.1016/j.clim.2009.05.006; Nilsson J, 2005, ARTERIOSCL THROM VAS, V25, P18, DOI 10.1161/01.ATV.0000149142.42590.a2; Olofsson PS, 2008, CIRCULATION, V117, P1292, DOI 10.1161/CIRCULATIONAHA.107.699173; PALINSKI W, 1995, P NATL ACAD SCI USA, V92, P821, DOI 10.1073/pnas.92.3.821; Paulsson G, 2000, ARTERIOSCL THROM VAS, V20, P10, DOI 10.1161/01.ATV.20.1.10; Qiu H, 2006, P NATL ACAD SCI USA, V103, P8161, DOI 10.1073/pnas.0602414103; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Reardon CA, 2001, ARTERIOSCL THROM VAS, V21, P1011, DOI 10.1161/01.ATV.21.6.1011; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Samuelsson B, 2007, PHARMACOL REV, V59, P207, DOI 10.1124/pr.59.3.1; Sasaki N, 2009, CIRCULATION, V120, P1996, DOI 10.1161/CIRCULATIONAHA.109.863431; Schiopu A, 2004, CIRCULATION, V110, P2047, DOI 10.1161/01.CIR.0000143162.56057.B5; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Seimon TA, 2010, CELL METAB, V12, P467, DOI 10.1016/j.cmet.2010.09.010; Sjogren P, 2008, EUR HEART J, V29, P2218, DOI 10.1093/eurheartj/ehn336; Skalen K, 2002, NATURE, V417, P750, DOI 10.1038/nature00804; Smith E, 2010, CIRCULATION, V121, P1746, DOI 10.1161/CIRCULATIONAHA.109.924886; SMITH JD, 1995, P NATL ACAD SCI USA, V92, P8264, DOI 10.1073/pnas.92.18.8264; Spanbroek R, 2003, P NATL ACAD SCI USA, V100, P1238, DOI 10.1073/pnas.242716099; Steinberg D, 2009, J LIPID RES, V50, pS376, DOI 10.1194/jlr.R800087-JLR200; STEMME S, 1995, P NATL ACAD SCI USA, V92, P3893, DOI 10.1073/pnas.92.9.3893; Swanberg M, 2005, NAT GENET, V37, P486, DOI 10.1038/ng1544; Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890; Taleb S, 2009, J EXP MED, V206, P2067, DOI 10.1084/jem.20090545; Tall AR, 2008, J INTERN MED, V263, P256, DOI 10.1111/j.1365-2796.2007.01898.x; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tornvall P, 2003, ATHEROSCLEROSIS, V167, P347, DOI 10.1016/S0021-9150(03)00021-2; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; Tsimikas S, 2007, J LIPID RES, V48, P425, DOI 10.1194/jlr.M600361-JLR200; van Es T, 2009, BIOCHEM BIOPH RES CO, V388, P261, DOI 10.1016/j.bbrc.2009.07.152; Veillard NR, 2004, ARTERIOSCL THROM VAS, V24, P2339, DOI 10.1161/01.ATV.0000146532.98235.e6; Vliegen I, 2005, ATHEROSCLEROSIS, V181, P39, DOI 10.1016/j.atherosclerosis.2004.12.035; Wang XS, 2005, NAT GENET, V37, P365, DOI 10.1038/ng1524; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Whitman SC, 2000, AM J PATHOL, V157, P1819, DOI 10.1016/S0002-9440(10)64820-1; Whitman SC, 2002, J INTERF CYTOK RES, V22, P661, DOI 10.1089/10799900260100141; Whitman SC, 2002, CIRC RES, V90, pE34, DOI 10.1161/hh0202.105292; Wick G, 2004, ANNU REV IMMUNOL, V22, P361, DOI 10.1146/annurev.immunol.22.012703.104644; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158; Yvan-Charvet L, 2010, CIRC RES, V106, P1861, DOI 10.1161/CIRCRESAHA.110.217281; Zernecke A, 2008, ARTERIOSCL THROM VAS, V28, P1897, DOI 10.1161/ATVBAHA.107.161174; Zhou XH, 2000, CIRCULATION, V102, P2919; Zhou XH, 2006, ARTERIOSCL THROM VAS, V26, P864, DOI 10.1161/01.ATV.0000206122.61591.ff; Zink A, 2009, ANN RHEUM DIS, V68, P1240, DOI 10.1136/ard.2008.091926	125	1501	1580	7	349	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2011	12	3					204	212		10.1038/ni.2001	http://dx.doi.org/10.1038/ni.2001			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	721KZ	21321594				2022-12-18	WOS:000287354400007
J	Acosta-Rodriguez, EV; Napolitani, G; Lanzavecchia, A; Sallusto, F				Acosta-Rodriguez, Eva V.; Napolitani, Giorgio; Lanzavecchia, Antonio; Sallusto, Federica			Interleukins 1 beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells	NATURE IMMUNOLOGY			English	Article							COLONY-STIMULATING FACTOR; IL-1 RECEPTOR ANTAGONIST; AUTOIMMUNE ENCEPHALOMYELITIS; DENDRITIC CELLS; RHEUMATOID-ARTHRITIS; LANGERHANS CELLS; LYMPH-NODES; IN-VIVO; CYTOKINE; INFLAMMATION	Interleukin 17 (IL-17)-producing CD4(+) helper T cells (T-H-17 cells) have been linked to host defense and autoimmune diseases. In mice, the differentiation of T-H-17 cells requires transforming growth factor-beta and IL-6 and the transcription factor ROR gamma t. We report here that for human naive CD4+ T cells, ROR gamma t expression and T-H-17 polarization were induced by IL-1 beta and enhanced by IL-6 but were suppressed by transforming growth factor-beta and IL-12. Monocytes and conventional dendritic cells, but not monocyte-derived dendritic cells activated by microbial stimuli, efficiently induced T-H-17 priming, and this function correlated with antigen-presenting cell production of IL-1b and IL-6 but not IL-12. Our results identify cytokines, antigen-presenting cells and microbial products that promote the polarization of human T-H-17 cells and emphasize an important difference in the requirements for the differentiation of T-H-17 cells in humans and mice.	Inst Res Biomed, CH-6500 Bellinzona, Switzerland	Universita della Svizzera Italiana	Acosta-Rodriguez, EV (corresponding author), Inst Res Biomed, CH-6500 Bellinzona, Switzerland.	eva.acosta@irb.unisi.ch; federica.sallusto@irb.unisi.ch		Acosta Rodriguez, Eva/0000-0001-5871-2391	NIAID NIH HHS [U19 AI057266-01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057266] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Chabaud M, 1998, J IMMUNOL, V161, P409; Cho ML, 2006, J IMMUNOL, V176, P5652, DOI 10.4049/jimmunol.176.9.5652; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Geissmann F, 1998, J EXP MED, V187, P961, DOI 10.1084/jem.187.6.961; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Hoeve MA, 2006, EUR J IMMUNOL, V36, P661, DOI 10.1002/eji.200535239; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Janatpour MJ, 2001, J EXP MED, V194, P1375, DOI 10.1084/jem.194.9.1375; Koenders MI, 2005, ARTHRITIS RHEUM-US, V52, P3239, DOI 10.1002/art.21342; Krutzik SR, 2005, NAT MED, V11, P653, DOI 10.1038/nm1246; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Mathur AN, 2006, BLOOD, V108, P1595, DOI 10.1182/blood-2006-04-015016; McInnes IB, 2005, NAT CLIN PRACT RHEUM, V1, P31, DOI 10.1038/ncprheum0020; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nakae S, 2003, P NATL ACAD SCI USA, V100, P5986, DOI 10.1073/pnas.1035999100; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Santini SM, 2000, J EXP MED, V191, P1777, DOI 10.1084/jem.191.10.1777; Sousa CRE, 2004, CURR OPIN IMMUNOL, V16, P21, DOI 10.1016/j.coi.2003.11.007; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; THORNBERRY NA, 1994, BIOCHEMISTRY-US, V33, P3934, DOI 10.1021/bi00179a020; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zhang Z, 2006, INFLAMM BOWEL DIS, V12, P382, DOI 10.1097/01.MIB.0000218764.06959.91; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	43	1427	1526	1	82	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2007	8	9					942	949		10.1038/ni1496	http://dx.doi.org/10.1038/ni1496			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	202QN	17676045				2022-12-18	WOS:000248918200017
J	Kotenko, SV; Gallagher, G; Baurin, VV; Lewis-Antes, A; Shen, ML; Shah, NK; Langer, JA; Sheikh, F; Dickensheets, H; Donnelly, RP				Kotenko, SV; Gallagher, G; Baurin, VV; Lewis-Antes, A; Shen, ML; Shah, NK; Langer, JA; Sheikh, F; Dickensheets, H; Donnelly, RP			IFN-lambda s mediate antiviral protection through a distinct class II cytokine receptor complex	NATURE IMMUNOLOGY			English	Article							INTERFERON-GAMMA RECEPTOR; INTRACELLULAR DOMAIN; SIGNAL-TRANSDUCTION; INTERLEUKIN-10; IDENTIFICATION; ALPHA; CHAIN; BETA; ACTIVATION; EXPRESSION	We report here the identification of a ligand-receptor system that, upon engagement, leads to the establishment of an antiviral state. Three closely positioned genes on human chromosome 19 encode distinct but paralogous proteins, which we designate interferon-lambda1 (IFN-lambda1), IFN-lambda2 and IFN-lambda3 (tentatively designated as IL-29, IL- 28A and IL-28B, respectively, by HUGO). The expression of IFN-lambda mRNAs was inducible by viral infection in several cell lines. We identified a distinct receptor complex that is utilized by all three IFN-lambda proteins for signaling and is composed of two subunits, a receptor designated CRF2-12 (also designated as IFN-lambdaR1) and a second subunit, CRF2-4 (also known as IL-10R2). Both receptor chains are constitutively expressed on a wide variety of human cell lines and tissues and signal through the Jak-STAT (Janus kinases-signal transducers and activators of transcription) pathway. This receptor-ligand system may contribute to antiviral or other defenses by a mechanism similar to, but independent of, type I IFNs.	Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA; Univ Med & Dent New Jersey, New Jersey Dent Sch, Dept Oral Biol, Newark, NJ 07103 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Microbiol Mol Genet & Immunol, Piscataway, NJ 08854 USA; US FDA, Ctr Biol Evaluat & Res, Div Therapeut Prot, Bethesda, MD 20892 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; US Food & Drug Administration (FDA)	Kotenko, SV (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA.	kotenkse@umdnj.edu; gallaggr@umdnj.edu	Donnelly, Raymond P./AFT-8600-2022; Gallagher, Grant/AAL-7952-2020	Donnelly, Raymond P./0000-0002-0695-5276; Langer, Jerome/0000-0002-4617-3260	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051139] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI051139, R01 AI51139] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Angel J, 1999, J INTERF CYTOK RES, V19, P655, DOI 10.1089/107999099313802; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; Biron CA, 2001, IMMUNITY, V14, P661, DOI 10.1016/S1074-7613(01)00154-6; Blumberg H, 2001, CELL, V104, P9, DOI 10.1016/S0092-8674(01)00187-8; CONKLIN DC, 2002, Patent No. 6329175; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Domanski Paul, 1996, Cytokine and Growth Factor Reviews, V7, P143, DOI 10.1016/1359-6101(96)00017-2; Dumoutier L, 2002, EUR CYTOKINE NETW, V13, P5; Familletti P C, 1981, Methods Enzymol, V78, P387; Fickenscher H, 2002, TRENDS IMMUNOL, V23, P89, DOI 10.1016/S1471-4906(01)02149-4; Gallagher G, 2000, GENES IMMUN, V1, P442, DOI 10.1038/sj.gene.6363714; Goldman LA, 1996, BIOTECHNIQUES, V21, P1013; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; Knappe A, 2000, J VIROL, V74, P3881, DOI 10.1128/JVI.74.8.3881-3887.2000; Kotenko SV, 1996, J BIOL CHEM, V271, P17174, DOI 10.1074/jbc.271.29.17174; KOTENKO SV, 1995, J BIOL CHEM, V270, P20915, DOI 10.1074/jbc.270.36.20915; Kotenko SV, 1999, P NATL ACAD SCI USA, V96, P5007, DOI 10.1073/pnas.96.9.5007; Kotenko SV, 2002, CYTOKINE GROWTH F R, V13, P223, DOI 10.1016/S1359-6101(02)00012-6; Kotenko SV, 2000, ONCOGENE, V19, P2557, DOI 10.1038/sj.onc.1203524; Kotenko SV, 2000, P NATL ACAD SCI USA, V97, P1695, DOI 10.1073/pnas.97.4.1695; Kotenko SV, 1997, EMBO J, V16, P5894, DOI 10.1093/emboj/16.19.5894; Kotenko SV, 2001, J IMMUNOL, V166, P7096, DOI 10.4049/jimmunol.166.12.7096; Kotenko SV, 2001, J BIOL CHEM, V276, P2725, DOI 10.1074/jbc.M007837200; LaFleur DW, 2001, J BIOL CHEM, V276, P39765, DOI 10.1074/jbc.M102502200; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Levy DE, 2002, J EXP MED, V195, pF15, DOI 10.1084/jem.20020075; Levy DE, 2001, CYTOKINE GROWTH F R, V12, P143, DOI 10.1016/S1359-6101(00)00027-7; LI BL, 1989, P NATL ACAD SCI USA, V86, P558, DOI 10.1073/pnas.86.2.558; Lu BF, 1998, P NATL ACAD SCI USA, V95, P8233, DOI 10.1073/pnas.95.14.8233; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nadeau OW, 1999, J BIOL CHEM, V274, P4045, DOI 10.1074/jbc.274.7.4045; Pestka S, 1999, PROTEIN EXPRES PURIF, V17, P203, DOI 10.1006/prep.1999.1118; Pestka Sidney, 1997, Seminars in Oncology, V24, P4; Prejean C, 2000, SEMIN CANCER BIOL, V10, P83, DOI 10.1006/scbi.2000.0311; REICH N, 1987, P NATL ACAD SCI USA, V84, P6394, DOI 10.1073/pnas.84.18.6394; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; SOH J, 1993, P NATL ACAD SCI USA, V90, P8737, DOI 10.1073/pnas.90.18.8737; STEINHOFF U, 1995, J VIROL, V69, P2153, DOI 10.1128/JVI.69.4.2153-2158.1995; Tian ZG, 2000, J IMMUNOL, V165, P3959, DOI 10.4049/jimmunol.165.7.3959; Wagner TC, 2002, J BIOL CHEM, V277, P1493, DOI 10.1074/jbc.M108928200; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Yu SH, 2000, HEPATOLOGY, V32, P1089, DOI 10.1053/jhep.2000.19287	44	1417	1613	0	78	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2003	4	1					69	77		10.1038/ni875	http://dx.doi.org/10.1038/ni875			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	629MG	12483210				2022-12-18	WOS:000180053000017
J	Wherry, EJ; Teichgraber, V; Becker, TC; Masopust, D; Kaech, SM; Antia, R; von Andrian, UH; Ahmed, R				Wherry, EJ; Teichgraber, V; Becker, TC; Masopust, D; Kaech, SM; Antia, R; von Andrian, UH; Ahmed, R			Lineage relationship and protective immunity of memory CD8 T cell subsets	NATURE IMMUNOLOGY			English	Article							IN-VIVO; EFFECTOR FUNCTION; CUTTING EDGE; HOMEOSTATIC PROLIFERATION; DENDRITIC CELLS; DEFICIENT MICE; LYMPH-NODES; L-SELECTIN; ANTIGEN; NAIVE	Memory CD8 T cells can be divided into two subsets, central (T-CM) and effector (T-EM), but their lineage relationships and their ability to persist and confer protective immunity are not well understood. Our results show that T-CM have a greater capacity than T-EM to persist in vivo and are more efficient in mediating protective immunity because of their increased proliferative potential. We also demonstrate that, following antigen clearance, T-EM convert to T-CM and that the duration of this differentiation is programmed within the first week after immunization. We propose that T-CM and T-EM do not necessarily represent distinct subsets, but are part of a continuum in a linear naive effector --> T-EM --> T-CM differentiation pathway.	Emory Univ, Dept Biol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Emory University; Emory University; Emory University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Ahmed, R (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.		masopust, david/B-5027-2008; von Andrian, Ulrich H/A-5775-2008; Wherry, John/ABI-1280-2020		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI030048, R01AI030048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER; NIAID NIH HHS [AI44644, AI30048] Funding Source: Medline; NIGMS NIH HHS [T32 GM008169] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; BRADLEY LM, 1994, J EXP MED, V180, P2401, DOI 10.1084/jem.180.6.2401; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Campbell JJ, 2001, J IMMUNOL, V166, P877, DOI 10.4049/jimmunol.166.2.877; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Harrington LE, 2000, J EXP MED, V191, P1241, DOI 10.1084/jem.191.7.1241; Harrington LE, 2002, J VIROL, V76, P3329, DOI 10.1128/JVI.76.7.3329-3337.2002; Hislop AD, 2001, J IMMUNOL, V167, P2019, DOI 10.4049/jimmunol.167.4.2019; Iezzi G, 2001, J EXP MED, V193, P987, DOI 10.1084/jem.193.8.987; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kieper WC, 2002, J EXP MED, V195, P1533, DOI 10.1084/jem.20020067; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; Laouar Y, 2000, IMMUNITY, V13, P291, DOI 10.1016/S1074-7613(00)00029-7; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; Lauvau G, 2001, SCIENCE, V294, P1735, DOI 10.1126/science.1064571; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI200113296; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; Mueller SN, 2002, J EXP MED, V195, P651, DOI 10.1084/jem.20012023; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Norbury CC, 2002, NAT IMMUNOL, V3, P265, DOI 10.1038/ni762; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; Ostler T, 2001, EUR J IMMUNOL, V31, P2574, DOI 10.1002/1521-4141(200109)31:9<2574::AID-IMMU2574>3.0.CO;2-V; RAZVI ES, 1995, J IMMUNOL, V154, P620; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sallusto F, 2001, J CLIN INVEST, V108, P805, DOI 10.1172/JCI14005; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Schluns KS, 2002, J IMMUNOL, V168, P4827, DOI 10.4049/jimmunol.168.10.4827; Sprent J, 2001, CURR OPIN IMMUNOL, V13, P248, DOI 10.1016/S0952-7915(00)00211-9; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Tomiyama H, 2002, J IMMUNOL, V168, P5538, DOI 10.4049/jimmunol.168.11.5538; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; Tussey L, 2000, EUR J IMMUNOL, V30, P1823, DOI 10.1002/1521-4141(200007)30:7<1823::AID-IMMU1823>3.0.CO;2-6; Unsoeld H, 2002, J IMMUNOL, V169, P638, DOI 10.4049/jimmunol.169.2.638; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Wills MR, 2002, J IMMUNOL, V168, P5455, DOI 10.4049/jimmunol.168.11.5455; Wong P, 2001, J IMMUNOL, V166, P5864, DOI 10.4049/jimmunol.166.10.5864; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	56	1413	1473	7	92	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2003	4	3					225	234		10.1038/ni889	http://dx.doi.org/10.1038/ni889			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	649HH	12563257	Bronze			2022-12-18	WOS:000181201000010
J	Blackburn, SD; Shin, H; Haining, WN; Zou, T; Workman, CJ; Polley, A; Betts, MR; Freeman, GJ; Vignali, DAA; Wherry, EJ				Blackburn, Shawn D.; Shin, Haina; Haining, W. Nicholas; Zou, Tao; Workman, Creg J.; Polley, Antonio; Betts, Michael R.; Freeman, Gordon J.; Vignali, Dario A. A.; Wherry, E. John			Coregulation of CD8(+) T cell exhaustion by multiple inhibitory receptors during chronic viral infection	NATURE IMMUNOLOGY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; PD-1 EXPRESSION; UP-REGULATION; CUTTING EDGE; MEMORY; ACTIVATION; ANTIGEN; EFFECTOR; LAG-3; RESPONSES	T cell exhaustion often occurs during chronic infection and prevents optimal viral control. The molecular pathways involved in T cell exhaustion remain poorly understood. Here we show that exhausted CD8(+) T cells are subject to complex layers of negative regulation resulting from the coexpression of multiple inhibitory receptors. Exhausted CD8(+) T cells expressed up to seven inhibitory receptors. Coexpression of multiple distinct inhibitory receptors was associated with greater T cell exhaustion and more severe infection. Regulation of T cell exhaustion by various inhibitory pathways was nonredundant, as blockade of the T cell inhibitory receptors PD-1 and LAG-3 simultaneously and synergistically improved T cell responses and diminished viral load in vivo. Thus, CD8(+) T cell responses during chronic viral infections are regulated by complex patterns of coexpressed inhibitory receptors.	[Blackburn, Shawn D.; Shin, Haina; Zou, Tao; Polley, Antonio; Wherry, E. John] Wistar Inst Anat & Biol, Program Immunol, Philadelphia, PA 19104 USA; [Blackburn, Shawn D.; Shin, Haina; Zou, Tao; Polley, Antonio; Wherry, E. John] Wistar Inst Anat & Biol, Wistar Vaccine Ctr, Philadelphia, PA 19104 USA; [Haining, W. Nicholas] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Freeman, Gordon J.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Betts, Michael R.] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; [Workman, Creg J.; Vignali, Dario A. A.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	The Wistar Institute; The Wistar Institute; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; University of Pennsylvania; St Jude Children's Research Hospital	Wherry, EJ (corresponding author), Wistar Inst Anat & Biol, Program Immunol, Philadelphia, PA 19104 USA.	jwherry@wistar.org	Wherry, John/ABI-1280-2020; Freeman, Gordon/AAC-5380-2019	Freeman, Gordon/0000-0002-7210-5616; Shin, Haina/0000-0002-1014-1451	National Institute of Allergy and Infectious Diseases [AI071309, HHSN26620050030C]; Bill and Melinda Gates Foundation Grand Challenge in Global Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071309] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation Grand Challenge in Global Health(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Long, V. Kumar and S. Reiner for comments and suggestions, and B. Laidlaw for critically reading the manuscript. Supported by the National Institute of Allergy and Infectious Diseases (AI071309 to E. J. W and HHSN26620050030C to E. J. W. and G. J. F.) and the Bill and Melinda Gates Foundation Grand Challenge in Global Health ( G. J. F. and E. J. W.).	AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; BAIXERAS E, 1992, J EXP MED, V176, P327, DOI 10.1084/jem.176.2.327; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Boettler T, 2006, J VIROL, V80, P3532, DOI 10.1128/JVI.80.7.3532-3540.2006; Boni C, 2007, J VIROL, V81, P4215, DOI 10.1128/JVI.02844-06; Brooks DG, 2008, J EXP MED, V205, P533, DOI 10.1084/jem.20071948; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Byun HJ, 2007, CELL BIOL INT, V31, P257, DOI 10.1016/j.cellbi.2006.11.002; Cai GF, 2008, NAT IMMUNOL, V9, P176, DOI 10.1038/ni1554; Chlewicki LK, 2008, J IMMUNOL, V180, P8159, DOI 10.4049/jimmunol.180.12.8159; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Freeman GJ, 2006, J EXP MED, V203, P2223, DOI 10.1084/jem.20061800; Fuller MJ, 2005, J IMMUNOL, V174, P5926, DOI 10.4049/jimmunol.174.10.5926; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Grosso JF, 2007, J CLIN INVEST, V117, P3383, DOI 10.1172/JCI31184; Ha SJ, 2008, J EXP MED, V205, P543, DOI 10.1084/jem.20071949; Hannier S, 1998, J IMMUNOL, V161, P4058; Hermans IF, 2004, J IMMUNOL METHODS, V285, P25, DOI 10.1016/j.jim.2003.10.017; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Katz HR, 1996, P NATL ACAD SCI USA, V93, P10809, DOI 10.1073/pnas.93.20.10809; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Kostense S, 2001, EUR J IMMUNOL, V31, P677, DOI 10.1002/1521-4141(200103)31:3<677::AID-IMMU677>3.0.CO;2-M; Kotturi MF, 2007, J VIROL, V81, P4928, DOI 10.1128/JVI.02632-06; Kumar V, 2005, NAT REV IMMUNOL, V5, P363, DOI 10.1038/nri1603; Laouar A, 2007, J IMMUNOL, V178, P652, DOI 10.4049/jimmunol.178.2.652; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; McNerney ME, 2005, MOL IMMUNOL, V42, P489, DOI 10.1016/j.molimm.2004.07.032; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Radziewicz H, 2007, J VIROL, V81, P2545, DOI 10.1128/JVI.02021-06; Rojo S, 1997, J IMMUNOL, V158, P9; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Shin H, 2007, CURR OPIN IMMUNOL, V19, P408, DOI 10.1016/j.coi.2007.06.004; Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937; Streeck H, 2008, PLOS MED, V5, P790, DOI 10.1371/journal.pmed.0050100; Takai T, 2005, IMMUNOLOGY, V115, P433, DOI 10.1111/j.1365-2567.2005.02177.x; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Triebel F, 2003, TRENDS IMMUNOL, V24, P619, DOI 10.1016/j.it.2003.10.001; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Wherry EJ, 2005, J VIROL, V79, P8960, DOI 10.1128/JVI.79.14.8960-8968.2005; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Workman CJ, 2005, J IMMUNOL, V174, P688, DOI 10.4049/jimmunol.174.2.688; Workman CJ, 2004, J IMMUNOL, V172, P5450, DOI 10.4049/jimmunol.172.9.5450; Workman CJ, 2003, EUR J IMMUNOL, V33, P970, DOI 10.1002/eji.200323382; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zhang JY, 2007, BLOOD, V109, P4671, DOI 10.1182/blood-2006-09-044826	56	1400	1484	6	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2009	10	1					29	37		10.1038/ni.1679	http://dx.doi.org/10.1038/ni.1679			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	385BV	19043418	Green Accepted			2022-12-18	WOS:000261788800009
J	Kaech, SM; Tan, JT; Wherry, EJ; Konieczny, BT; Surh, CD; Ahmed, R				Kaech, SM; Tan, JT; Wherry, EJ; Konieczny, BT; Surh, CD; Ahmed, R			Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells	NATURE IMMUNOLOGY			English	Article							HOMEOSTATIC PROLIFERATION; IL-7 RECEPTOR; CUTTING EDGE; VIRAL-INFECTIONS; NAIVE; SURVIVAL; DIFFERENTIATION; APOPTOSIS; ACTIVATION; PHENOTYPE	A major unanswered question is what distinguishes the majority of activated CD8 T cells that die after an acute viral infection from the small fraction (5-10%) that survive to become long-lived memory cells. In this study we show that increased expression of the interleukin 7 receptor alpha-chain (IL-7Ralpha) identifies the effector CD8 T cells that will differentiate into memory cells. IL-7R(hi) effector cells contained increased amounts of antiapoptotic molecules, and adoptive transfer of IL-7R(hi) and IL-7R(lo) effector cells showed that IL-7R(hi) cells preferentially gave rise to memory cells that could persist and confer protective immunity. Thus, selective expression of IL-7R identifies memory cell precursors, and this marker may be useful in predicting the number of memory T cells generated after infection or immunization.	Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Emory University; Emory University; Scripps Research Institute	Ahmed, R (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, 1510 Clifton Rd, Atlanta, GA 30322 USA.	ra@microbio.emory.edu	Wherry, John/ABI-1280-2020					AHMED R, 1987, J VIROL, V61, P3920, DOI 10.1128/JVI.61.12.3920-3929.1987; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Badovinac VP, 2000, SCIENCE, V290, P1354, DOI 10.1126/science.290.5495.1354; Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; Boothby M, 2001, CRIT REV IMMUNOL, V21, P487; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; FOXWELL BMJ, 1992, INT IMMUNOL, V4, P277, DOI 10.1093/intimm/4.2.277; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Grayson JM, 2000, J IMMUNOL, V164, P3950, DOI 10.4049/jimmunol.164.8.3950; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Harrington LE, 2000, J EXP MED, V191, P1241, DOI 10.1084/jem.191.7.1241; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kieper WC, 2002, J EXP MED, V195, P1533, DOI 10.1084/jem.20020067; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Maraskovsky E, 1996, J IMMUNOL, V157, P5315; Murali-Krishna K, 2000, J IMMUNOL, V165, P1733, DOI 10.4049/jimmunol.165.4.1733; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Opferman JT, 2001, INT IMMUNOL, V13, P411, DOI 10.1093/intimm/13.4.411; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Petschner F, 1998, EUR J IMMUNOL, V28, P560, DOI 10.1002/(SICI)1521-4141(199802)28:02<560::AID-IMMU560>3.0.CO;2-Q; Plas DR, 2002, NAT IMMUNOL, V3, P515, DOI 10.1038/ni0602-515; Prlic M, 2002, J EXP MED, V195, pF49, DOI 10.1084/jem.20020767; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Rathmell JC, 2002, CELL, V109, pS97, DOI 10.1016/S0092-8674(02)00704-3; RAZVI ES, 1995, AM J PATHOL, V147, P79; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Schluns KS, 2002, J IMMUNOL, V168, P4827, DOI 10.4049/jimmunol.168.10.4827; SUDO T, 1993, P NATL ACAD SCI USA, V90, P9125, DOI 10.1073/pnas.90.19.9125; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; van Leeuwen EM, 2002, J IMMUNOL, V169, P5838, DOI 10.4049/jimmunol.169.10.5838; Van Parijs L, 1998, SCIENCE, V280, P243; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Vella A, 1997, J EXP MED, V186, P325, DOI 10.1084/jem.186.2.325; Voehringer D, 2001, J IMMUNOL, V167, P4838, DOI 10.4049/jimmunol.167.9.4838; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wang XTZ, 2003, IMMUNITY, V18, P631, DOI 10.1016/S1074-7613(03)00116-X; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Whitmire JK, 2000, PHILOS T R SOC B, V355, P373, DOI 10.1098/rstb.2000.0577; Xue HH, 2002, P NATL ACAD SCI USA, V99, P13759, DOI 10.1073/pnas.212214999	48	1397	1428	2	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2003	4	12					1191	1198		10.1038/ni1009	http://dx.doi.org/10.1038/ni1009			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	746VZ	14625547				2022-12-18	WOS:000186769500012
J	Acosta-Rodriguez, EV; Rivino, L; Geginat, J; Jarrossay, D; Gattorno, M; Lanzavecchia, A; Sallusto, F; Napolitani, G				Acosta-Rodriguez, Eva V.; Rivino, Laura; Geginat, Jens; Jarrossay, David; Gattorno, Marco; Lanzavecchia, Antonio; Sallusto, Federica; Napolitani, Giorgio			Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells	NATURE IMMUNOLOGY			English	Article							CHEMOKINE RECEPTOR EXPRESSION; HUMAN AIRWAY EPITHELIUM; MYCOBACTERIUM-TUBERCULOSIS; UP-REGULATION; CUTTING EDGE; IL-17; CYTOKINE; INFLAMMATION; EFFECTOR; IL-23	Interleukin 17 (IL-17)-producing T helper cells (TH-17 cells) have been characterized in mice as a distinct subset of effector cells, but their identity and properties in humans remain elusive. We report here that expression of CCR6 and CCR4 together identified human memory CD4+T cells selectively producing IL-17 and expressing mRNA encoding the human ortholog of mouse ROR gamma t, a transcription factor, whereas CCR6 and CXCR3 identified T(H)1 cells producing interferon-c and T helper cells producing both interferon-c and IL-17. Memory T cells specific for Candida albicans were present mainly in the CCR6+ CCR4+ TH-17 subset, whereas memory T cells specific for Mycobacterium tuberculosis were present in CCR6+ CXCR3+ T helper type 1 subset. The elicitation of IL-17 responses correlated with the capacity of C. albicans hyphae to stimulate antigen-presenting cells for the priming of TH-17 responses in vitro and for the production of IL-23 but not IL-12. Our results demonstrate that human TH-17 cells have distinct migratory capacity and antigenic specificities and establish a link between microbial products, T helper cell differentiation and homing in response to fungal antigens.	Inst Res Biomed, CH-6500 Bellinzona, Switzerland; Ist Giannina Gaslini, I-16148 Genoa, Italy	Universita della Svizzera Italiana; University of Genoa; IRCCS Istituto Giannina Gaslini	Sallusto, F (corresponding author), Inst Res Biomed, CH-6500 Bellinzona, Switzerland.	sallusto@irb.unisi.ch; giorgio.napolitani@irb.unisi.ch	Geginat, Jens/AAA-5818-2019; Gattorno, Marco/AAL-2974-2020	Geginat, Jens/0000-0003-4813-0384; Gattorno, Marco/0000-0003-0704-1916; Rivino, Laura/0000-0001-6213-9794; Acosta Rodriguez, Eva/0000-0001-5871-2391	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057266] Funding Source: NIH RePORTER; NIAID NIH HHS [U19 AI057266-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Campbell JJ, 1999, NATURE, V400, P776, DOI 10.1038/23495; Cook DN, 2000, IMMUNITY, V12, P495, DOI 10.1016/S1074-7613(00)80201-0; Cruz A, 2006, J IMMUNOL, V177, P1416, DOI 10.4049/jimmunol.177.3.1416; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; DELPRETE GF, 1991, J CLIN INVEST, V88, P346, DOI 10.1172/JCI115300; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Geginat J, 2001, J EXP MED, V194, P1711, DOI 10.1084/jem.194.12.1711; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hohl TM, 2006, CURR OPIN IMMUNOL, V18, P465, DOI 10.1016/j.coi.2006.05.003; Homey B, 2000, J IMMUNOL, V164, P6621, DOI 10.4049/jimmunol.164.12.6621; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kao CY, 2005, J IMMUNOL, V175, P6676, DOI 10.4049/jimmunol.175.10.6676; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Keller M, 2005, J IMMUNOL, V175, P7678, DOI 10.4049/jimmunol.175.11.7678; Khader SA, 2005, J IMMUNOL, V175, P788, DOI 10.4049/jimmunol.175.2.788; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kikly K, 2006, CURR OPIN IMMUNOL, V18, P670, DOI 10.1016/j.coi.2006.09.008; Kohler RE, 2003, J IMMUNOL, V170, P6298, DOI 10.4049/jimmunol.170.12.6298; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Kwon JH, 2002, GUT, V51, P818, DOI 10.1136/gut.51.6.818; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Liao F, 1999, J IMMUNOL, V162, P186; Lukacs NW, 2001, J EXP MED, V194, P551, DOI 10.1084/jem.194.4.551; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nakae S, 2003, P NATL ACAD SCI USA, V100, P5986, DOI 10.1073/pnas.1035999100; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Rivino L, 2004, J EXP MED, V200, P725, DOI 10.1084/jem.20040774; Romagnani S, 2002, MOL IMMUNOL, V38, P881, DOI 10.1016/S0161-5890(02)00013-5; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Ruth JH, 2003, LAB INVEST, V83, P579, DOI 10.1097/01.LAB.0000062854.30195.52; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Schaerli P, 2004, J IMMUNOL, V173, P2151, DOI 10.4049/jimmunol.173.3.2151; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Wakugawa M, 2001, J INVEST DERMATOL, V117, P188, DOI 10.1046/j.0022-202x.2001.01430.x; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519	52	1371	1435	4	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2007	8	6					639	646		10.1038/ni1467	http://dx.doi.org/10.1038/ni1467			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	170YY	17486092				2022-12-18	WOS:000246703300018
J	Kawai, T; Akira, S				Kawai, T; Akira, S			Innate immune recognition of viral infection	NATURE IMMUNOLOGY			English	Review							NF-KAPPA-B; TOLL-LIKE RECEPTOR-3; PLASMACYTOID DENDRITIC CELLS; DOUBLE-STRANDED-RNA; HEPATITIS-C VIRUS; DOMAIN-CONTAINING ADAPTER; INTERFERON-ALPHA INDUCTION; IFN-REGULATORY FACTOR-3; TANK-BINDING KINASE-1; INDUCIBLE GENE-I	Induction of the antiviral innate immune response depends on recognition of viral components by host pattern-recognition receptors. Members of the Toll-like receptor family have emerged as key sensors that recognize viral components such as nucleic acids. Toll-like receptor signaling results in the production of type I interferon and inflammatory cytokines and leads to dendritic cell maturation and establishment of antiviral immunity. Cells also express cytoplasmic RNA helicases that function as alternative pattern-recognition receptors through recognition of double-stranded RNA produced during virus replication. These two classes of pattern-recognition receptor molecules are expressed in different intracellular compartments and induce type I interferon responses via distinct signaling pathways.	Japan Sci & Technol Agcy, Suita, Osaka 5650871, Japan; Osaka Univ, Res Inst Microbial Dis, Dept Host Def, Suita, Osaka 5650871, Japan	Japan Science & Technology Agency (JST); Osaka University	Akira, S (corresponding author), Japan Sci & Technol Agcy, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp		Kawai, Taro/0000-0001-7510-4662				Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Balachandran S, 2004, NATURE, V432, P401, DOI 10.1038/nature03124; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Boule MW, 2004, J EXP MED, V199, P1631, DOI 10.1084/jem.20031942; Coccia EM, 2004, EUR J IMMUNOL, V34, P796, DOI 10.1002/eji.200324610; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Dai JH, 2004, J IMMUNOL, V173, P1535, DOI 10.4049/jimmunol.173.3.1535; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Edelmann KH, 2004, VIROLOGY, V322, P231, DOI 10.1016/j.virol.2004.01.033; Ferreon JC, 2005, J BIOL CHEM, V280, P20483, DOI 10.1074/jbc.M500422200; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Gohda J, 2004, J IMMUNOL, V173, P2913, DOI 10.4049/jimmunol.173.5.2913; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hemmi H, 2003, J IMMUNOL, V170, P3059, DOI 10.4049/jimmunol.170.6.3059; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Hornung V, 2004, J IMMUNOL, V173, P5935, DOI 10.4049/jimmunol.173.10.5935; Hoshino K, 2002, INT IMMUNOL, V14, P1225, DOI 10.1093/intimm/dxf089; Hur GM, 2003, GENE DEV, V17, P873, DOI 10.1101/gad.1062403; ISHII KJ, IN PRESS NAT IMMUNOL; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jin G, 2004, P NATL ACAD SCI USA, V101, P2028, DOI 10.1073/pnas.0307314101; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kim T, 1999, J BIOL CHEM, V274, P30686, DOI 10.1074/jbc.274.43.30686; Kovacsovics M, 2002, CURR BIOL, V12, P838, DOI 10.1016/S0960-9822(02)00842-4; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Lopez CB, 2004, J IMMUNOL, V173, P6882, DOI 10.4049/jimmunol.173.11.6882; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Sen GC, 2005, NAT IMMUNOL, V6, P1074, DOI 10.1038/ni1105-1074; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Takaoka A, 2003, CANCER SCI, V94, P405, DOI 10.1111/j.1349-7006.2003.tb01455.x; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146; Yu YX, 2005, IMMUNITY, V22, P59, DOI 10.1016/j.immuni.2004.11.011	89	1364	1446	2	339	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2006	7	2					131	137		10.1038/ni1303	http://dx.doi.org/10.1038/ni1303			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	005DB	16424890				2022-12-18	WOS:000234801700013
J	Zhu, C; Anderson, AC; Schubart, A; Xiong, HB; Imitola, J; Khoury, SJ; Zheng, XX; Strom, TB; Kuchroo, VK				Zhu, C; Anderson, AC; Schubart, A; Xiong, HB; Imitola, J; Khoury, SJ; Zheng, XX; Strom, TB; Kuchroo, VK			The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity	NATURE IMMUNOLOGY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FUNCTIONAL DIVERSITY; CELL APOPTOSIS; BINDING LECTIN; TOLERANCE; LYMPHOCYTES; RESPONSES; GENE; IDENTIFICATION; ACTIVATION	Tim-3 is a T helper type 1 (T(H)1)-specific cell surface molecule that seems to regulate T(H)1 responses and the induction of peripheral tolerance. However, the identity of the Tim-3 ligand and the mechanism by which this ligand inhibits the function of effector T(H)1 cells remain unknown. Here we show that galectin-9 is the Tim-3 ligand. Galectin-9-induced intracellular calcium flux, aggregation and death of T(H)1 cells were Tim-3-dependent in vitro, and administration of galectin-9 in vivo resulted in selective loss of interferon-c-producing cells and suppression of T(H)1 autoimmunity. These data suggest that the Tim-3-galectin-9 pathway may have evolved to ensure effective termination of effector T(H)1 cells.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Sci, Boston, MA 02114 USA; CUNY Mt Sinai Sch Med, Ctr Immunol, New York, NY 10029 USA; Harvard Univ, Sch Med, Beth Israel & Deaconess Hosp, Div Immunol & Transplant Res Ctr, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Kuchroo, VK (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Sci, Boston, MA 02114 USA.	vkuchroo@rics.bwh.harvard.edu	Anderson, Ana C/ABD-6829-2021; Strom, Terry B./E-9268-2010	Anderson, Ana C/0000-0002-0877-2932; Strom, Terry B./0000-0002-7570-0736; khoury, samia/0000-0003-3198-6063; Schubart, Anna/0000-0003-4253-0600				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Chae SC, 2004, IMMUNOL LETT, V95, P91, DOI 10.1016/j.imlet.2004.06.008; Ferber IA, 1996, J IMMUNOL, V156, P5; Hernandez JD, 2002, GLYCOBIOLOGY, V12, p127R, DOI 10.1093/glycob/cwf081; Hirofumi A, 2002, J IMMUNOL, V169, P5912, DOI 10.4049/jimmunol.169.10.5912; Imaizumi T, 2002, J LEUKOCYTE BIOL, V72, P486; Kamradt T, 2001, NEW ENGL J MED, V344, P655, DOI 10.1056/NEJM200103013440907; Kashio Y, 2003, J IMMUNOL, V170, P3631, DOI 10.4049/jimmunol.170.7.3631; Khademi M, 2004, J IMMUNOL, V172, P7169, DOI 10.4049/jimmunol.172.11.7169; LAM M, 1994, P NATL ACAD SCI USA, V91, P6569, DOI 10.1073/pnas.91.14.6569; Matsumoto R, 1998, J BIOL CHEM, V273, P16976, DOI 10.1074/jbc.273.27.16976; Matsushita N, 2000, J BIOL CHEM, V275, P8355, DOI 10.1074/jbc.275.12.8355; McIntire JJ, 2001, NAT IMMUNOL, V2, P1109, DOI 10.1038/ni739; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; ODA Y, 1993, J BIOL CHEM, V268, P5929; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; PENDER MP, 1992, J AUTOIMMUN, V5, P401, DOI 10.1016/0896-8411(92)90001-7; Rabinovich G, 1999, J EXP MED, V190, P385, DOI 10.1084/jem.190.3.385; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; ROMAGNANI S, 1994, ANNU REV IMMUNOL, V12, P227, DOI 10.1146/annurev.iy.12.040194.001303; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Salama AD, 2003, J EXP MED, V198, P71, DOI 10.1084/jem.20022119; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; SHER A, 1992, ANNU REV IMMUNOL, V10, P385, DOI 10.1146/annurev.iy.10.040192.002125; STREET NE, 1991, FASEB J, V5, P171, DOI 10.1096/fasebj.5.2.1825981; Sturm A, 2004, J IMMUNOL, V173, P3825, DOI 10.4049/jimmunol.173.6.3825; Vercammen D, 1998, J EXP MED, V188, P919, DOI 10.1084/jem.188.5.919; Wada J, 1997, J CLIN INVEST, V99, P2452, DOI 10.1172/JCI119429; Wada J, 1997, J BIOL CHEM, V272, P6078, DOI 10.1074/jbc.272.9.6078; Weiner HL, 2001, MICROBES INFECT, V3, P947, DOI 10.1016/S1286-4579(01)01456-3; Yoshida H, 2001, NEUROREPORT, V12, P3755, DOI 10.1097/00001756-200112040-00030	32	1351	1485	5	91	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2005	6	12					1245	1252		10.1038/ni1271	http://dx.doi.org/10.1038/ni1271			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	985IX	16286920				2022-12-18	WOS:000233371900013
J	Fontenot, JD; Rasmussen, JP; Gavin, MA; Rudensky, AY				Fontenot, JD; Rasmussen, JP; Gavin, MA; Rudensky, AY			A function for interleukin 2 in Foxp3-expressing regulatory T cells	NATURE IMMUNOLOGY			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; LETHAL AUTOIMMUNITY; SUPPRESSOR FUNCTION; CUTTING EDGE; IL-2; HOMEOSTASIS; MICE; DISEASE; MAINTENANCE; ACTIVATION	Regulatory T cells (T-reg cells) expressing the forkhead family transcription factor Foxp3 are critical mediators of dominant immune tolerance to self. Most Treg cells constitutively express the high-affinity interleukin 2 (IL-2) receptor alpha-chain (CD25); however, the precise function of IL-2 in T-reg cell biology has remained controversial. To directly assess the effect of IL-2 signaling on Treg cell development and function, we analyzed mice containing the Foxp3(gfp) knock-in allele that were genetically deficient in either IL-2 (Il2(-/-)) or CD25 (Il2ra(-/-)). We found that IL-2 signaling was dispensable for the induction of Foxp3 expression in thymocytes from these mice, which indicated that IL-2 signaling does not have a nonredundant function in the development of Treg cells. Unexpectedly, Il2(-/-) and Il2ra(-/-) Treg cells were fully able to suppress T cell proliferation in vitro. In contrast, Foxp3 was not expressed in thymocytes or peripheral T cells from Il2rg(-/-) mice. Gene expression analysis showed that IL-2 signaling was required for maintenance of the expression of genes involved in the regulation of cell growth and metabolism. Thus, IL-2 signaling seems to be critically required for maintaining the homeostasis and competitive fitness of Treg cells in vivo.	Univ Washington, Dept Immunol, Howard Hughes Med Inst, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Fontenot, JD (corresponding author), Rockefeller Univ, Lab Lymphocyte Signaling, 1230 York Ave, New York, NY 10021 USA.	jfontenot@rockefeller.edu; aruden@u.washington.edu			NIAID NIH HHS [R01AI034206] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034206] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Almeida ARM, 2005, SEMIN IMMUNOL, V17, P239, DOI 10.1016/j.smim.2005.02.002; Almeida ARM, 2002, J IMMUNOL, V169, P4850, DOI 10.4049/jimmunol.169.9.4850; Antov A, 2003, J IMMUNOL, V171, P3435, DOI 10.4049/jimmunol.171.7.3435; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Bayer AL, 2005, J EXP MED, V201, P769, DOI 10.1084/jem.20041179; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Brusko TM, 2005, J IMMUNOL, V174, P5181, DOI 10.4049/jimmunol.174.9.5181; Chan CWY, 2003, J IMMUNOL, V170, P4036, DOI 10.4049/jimmunol.170.8.4036; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; de Lafaille MAC, 2004, J IMMUNOL, V173, P7259, DOI 10.4049/jimmunol.173.12.7259; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Furtado GC, 2002, J EXP MED, V196, P851, DOI 10.1084/jem.20020190; Gentleman R, 2004, COMPSTAT 2004: PROCEEDINGS IN COMPUTATIONAL STATISTICS, P171; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GODFREY VL, 1991, AM J PATHOL, V138, P1379; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Grossman WJ, 2004, IMMUNITY, V21, P589, DOI 10.1016/j.immuni.2004.09.002; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Malek TR, 2000, J IMMUNOL, V164, P2905, DOI 10.4049/jimmunol.164.6.2905; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Nelson BH, 2004, J IMMUNOL, V172, P3983, DOI 10.4049/jimmunol.172.7.3983; Paust S, 2004, P NATL ACAD SCI USA, V101, P10398, DOI 10.1073/pnas.0403342101; Piccirillo CA, 2002, J EXP MED, V196, P237, DOI 10.1084/jem.20020590; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Snow JW, 2003, J IMMUNOL, V171, P5042, DOI 10.4049/jimmunol.171.10.5042; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Thornton AM, 2004, J IMMUNOL, V172, P6519, DOI 10.4049/jimmunol.172.11.6519; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; WU Z, 2004, 1 HOPK U DEP BIOST	40	1350	1414	1	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2005	6	11					1142	1151		10.1038/ni1263	http://dx.doi.org/10.1038/ni1263			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	977WD	16227984				2022-12-18	WOS:000232833300015
J	Shimizu, J; Yamazaki, S; Takahashi, T; Ishida, Y; Sakaguchi, S				Shimizu, J; Yamazaki, S; Takahashi, T; Ishida, Y; Sakaguchi, S			Stimulation of CD25+CD4+regulatory T cells through GITR breaks immunological self-tolerance	NATURE IMMUNOLOGY			English	Article							AUTOIMMUNE-DISEASE; REGULATORY CELLS; TUMOR-IMMUNITY; INDUCTION; LIGAND; SUPERFAMILIES; MECHANISMS; CTLA-4; OX-40	CD25(+)CD4(+) regulatory T cells in normal animals are engaged in the maintenance of immunological self-tolerance. We show here that glucocorticoid-induced tumor necrosis factor receptor family-related gene (GITR, also known as TNFRSF18)-a member of the tumor necrosis factor-nerve growth factor (TNF-NGF) receptor gene superfamily-is predominantly expressed on CD25(+)CD4(+) T cells and on CD25(+)CD4(+)CD8(-) thymocytes in normal naive mice. We found that stimulation of GITR abrogated CD25(+)CD4(+) T cell-mediated suppression. In addition, removal of GITR-expressing T cells or administration of a monoclonal antibody to GITR produced organ-specific autoimmune disease in otherwise normal mice. Thus, GITR plays a key role in dominant immunological self-tolerance maintained by CD25(+)CD4(+) regulatory T cells and could be a suitable molecular target for preventing or treating autoimmune disease.	Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan; Tokyo Metropolitan Inst Gerontol, Dept Immunopathol, Tokyo 1730015, Japan; Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan	Kyoto University; Tokyo Metropolitan Institute of Gerontology; Nara Institute of Science & Technology	Sakaguchi, S (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan.	shimon@frontier.kyoto-u.ac.jp	Sakaguchi, Shimon/C-9535-2009	Shimizu, Jun/0000-0002-6461-4648				Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Bansal-Pakala P, 2001, NAT MED, V7, P907, DOI 10.1038/90942; Bluestone JA, 1997, J IMMUNOL, V158, P1989; Gurney AL, 1999, CURR BIOL, V9, P215, DOI 10.1016/S0960-9822(99)80093-1; HALL BM, 1990, J EXP MED, V171, P141, DOI 10.1084/jem.171.1.141; Hara M, 2001, J IMMUNOL, V166, P3789, DOI 10.4049/jimmunol.166.6.3789; Hendriks J, 2000, NAT IMMUNOL, V1, P433, DOI 10.1038/80877; Itoh M, 1999, J IMMUNOL, V162, P5317; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kubota H, 2000, J BIOL CHEM, V275, P28641, DOI 10.1074/jbc.M005009200; Kumanogoh A, 2001, J IMMUNOL, V166, P353, DOI 10.4049/jimmunol.166.1.353; Kuniyasu Y, 2000, INT IMMUNOL, V12, P1145, DOI 10.1093/intimm/12.8.1145; Kwon B, 1999, CURR OPIN IMMUNOL, V11, P340, DOI 10.1016/S0952-7915(99)80054-5; Kwon BS, 1999, J BIOL CHEM, V274, P6056, DOI 10.1074/jbc.274.10.6056; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Nocentini G, 1997, P NATL ACAD SCI USA, V94, P6216, DOI 10.1073/pnas.94.12.6216; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; SAKAGUCHI S, 1985, J EXP MED, V161, P72, DOI 10.1084/jem.161.1.72; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Sakaguchi S, 2000, Rev Immunogenet, V2, P147; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Shimizu J, 1999, J IMMUNOL, V163, P5211; Sotomayor EM, 1999, NAT MED, V5, P780, DOI 10.1038/10503; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; Suri-Payer E, 1998, J IMMUNOL, V160, P1212; TAKABE Y, 1988, MOL CELL BIOL, V8, P466; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Taylor PA, 2001, J EXP MED, V193, P1311, DOI 10.1084/jem.193.11.1311; Thompson CB, 1997, IMMUNITY, V7, P445, DOI 10.1016/S1074-7613(00)80366-0; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Toh BH, 1997, NEW ENGL J MED, V337, P1441, DOI 10.1056/NEJM199711133372007; Watts TH, 1999, CURR OPIN IMMUNOL, V11, P286, DOI 10.1016/S0952-7915(99)80046-6; Weinberg AD, 1998, SEMIN IMMUNOL, V10, P471, DOI 10.1006/smim.1998.0146; Weinberg AD, 2000, J IMMUNOL, V164, P2160, DOI 10.4049/jimmunol.164.4.2160	43	1346	1505	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2002	3	2					135	142		10.1038/ni759	http://dx.doi.org/10.1038/ni759			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	516PJ	11812990				2022-12-18	WOS:000173562400013
J	Hunter, CA; Jones, SA				Hunter, Christopher A.; Jones, Simon A.			IL-6 as a keystone cytokine in health and disease	NATURE IMMUNOLOGY			English	Review							SOLUBLE INTERLEUKIN-6 RECEPTOR; C-REACTIVE PROTEIN; T-HELPER-CELLS; STIMULATORY FACTOR-II; IN-VIVO; RHEUMATOID-ARTHRITIS; SIGNAL TRANSDUCER; TRANSGENIC MICE; DENDRITIC CELLS; INFLAMMATORY ARTHRITIS	Interleukin 6 (IL-6) has a broad effect on cells of the immune system and those not of the immune system and often displays hormone-like characteristics that affect homeostatic processes. IL-6 has context-dependent pro-and anti-inflammatory properties and is now regarded as a prominent target for clinical intervention. However, the signaling cassette that controls the activity of IL-6 is complicated, and distinct intervention strategies can inhibit this pathway. Clinical experience with antagonists of IL-6 has raised new questions about how and when to block this cytokine to improve disease outcome and patient wellbeing. Here we discuss the effect of IL-6 on innate and adaptive immunity and the possible advantages of various antagonists of IL-6 and consider how the immunobiology of IL-6 may inform clinical decisions.	[Hunter, Christopher A.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Jones, Simon A.] Cardiff Univ, Sch Med, Cardiff Inst Infect & Immun, Cardiff CF10 3AX, S Glam, Wales	University of Pennsylvania; Cardiff University	Hunter, CA (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA.	chunter@vet.upenn.edu; jonessa@cardiff.ac.uk	Jones, Simon Arnett/Q-7017-2018	Jones, Simon Arnett/0000-0001-7297-9711	Arthritis Research UK [20770, 19796] Funding Source: Medline; Versus Arthritis [19796, 20770] Funding Source: Medline	Arthritis Research UK(Versus Arthritis); Versus Arthritis(Versus Arthritis)		Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Alonzi T, 1998, J EXP MED, V187, P461, DOI 10.1084/jem.187.4.461; ANDUS T, 1987, FEBS LETT, V221, P18, DOI 10.1016/0014-5793(87)80344-7; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Atsumi T, 2002, J EXP MED, V196, P979, DOI 10.1084/jem.20020619; Baran P, 2013, J BIOL CHEM, V288, P14756, DOI 10.1074/jbc.M113.466169; Barkhausen T, 2011, CRIT CARE MED, V39, P1407, DOI 10.1097/CCM.0b013e318211ff56; Barr TA, 2012, J EXP MED, V209, P1001, DOI 10.1084/jem.20111675; Barr TA, 2010, J IMMUNOL, V185, P2783, DOI 10.4049/jimmunol.1001431; BEAMAN MH, 1994, J IMMUNOL, V153, P4583; Bethin KE, 2000, P NATL ACAD SCI USA, V97, P9317, DOI 10.1073/pnas.97.16.9317; Bleier JI, 2004, J IMMUNOL, V172, P7408, DOI 10.4049/jimmunol.172.12.7408; Briso EM, 2008, J IMMUNOL, V180, P7102, DOI 10.4049/jimmunol.180.11.7102; Brown S, 2001, CURR BIOL, V11, P1700, DOI 10.1016/S0960-9822(01)00524-3; Campbell IL, 2014, J NEUROSCI, V34, P2503, DOI 10.1523/JNEUROSCI.2830-13.2014; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chatterjee M, 2002, SCIENCE, V298, P1432, DOI 10.1126/science.1074883; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chen Q, 2004, IMMUNITY, V20, P59, DOI 10.1016/S1074-7613(03)00358-3; Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763; Chou DB, 2012, J LEUKOCYTE BIOL, V92, P123, DOI 10.1189/jlb.1011527; Choy EH, 2013, NAT REV RHEUMATOL, V9, P154, DOI 10.1038/nrrheum.2013.8; Crabe S, 2009, J IMMUNOL, V183, P7692, DOI 10.4049/jimmunol.0901464; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Curnow SJ, 2004, J IMMUNOL, V173, P5290, DOI 10.4049/jimmunol.173.8.5290; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Diamant M, 1997, FEBS LETT, V412, P379, DOI 10.1016/S0014-5793(97)00750-3; DICOSMO BF, 1994, J CLIN INVEST, V94, P2028, DOI 10.1172/JCI117556; Dienz O, 2012, MUCOSAL IMMUNOL, V5, P258, DOI 10.1038/mi.2012.2; Dienz O, 2009, J EXP MED, V206, P69, DOI 10.1084/jem.20081571; Dileepan T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002252; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Esteve E, 2006, CLIN ENDOCRINOL, V65, P88, DOI 10.1111/j.1365-2265.2006.02553.x; Eugster HP, 1998, EUR J IMMUNOL, V28, P2178, DOI 10.1002/(SICI)1521-4141(199807)28:07<2178::AID-IMMU2178>3.0.CO;2-D; Fielding CA, 2005, J IMMUNOL, V175, P4024, DOI 10.4049/jimmunol.175.6.4024; Fielding CA, 2014, IMMUNITY, V40, P40, DOI 10.1016/j.immuni.2013.10.022; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Fraunberger P, 2006, SHOCK, V26, P10, DOI 10.1097/01.shk.0000215319.06866.bd; Freeman AF, 2010, DIS MARKERS, V29, P123, DOI [10.1155/2010/580197, 10.3233/DMA-2010-0734]; Fujimoto M, 2011, J IMMUNOL, V186, P32, DOI 10.4049/jimmunol.0903314; Garbers C, 2014, BBA-MOL BASIS DIS, V1842, P1485, DOI 10.1016/j.bbadis.2014.05.018; Garbers C, 2013, J BIOL CHEM, V288, P4346, DOI 10.1074/jbc.M112.432955; Garbers C, 2011, J BIOL CHEM, V286, P42959, DOI 10.1074/jbc.M111.295758; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; Gealy C, 2005, J VIROL, V79, P472, DOI 10.1128/JVI.79.1.472-485.2005; GEARING DP, 1991, CELL, V66, P9, DOI 10.1016/0092-8674(91)90131-H; Genovese MC, 2014, ANN RHEUM DIS, V73, P1607, DOI 10.1136/annrheumdis-2013-204760; Greenhill CJ, 2011, J IMMUNOL, V186, P1199, DOI 10.4049/jimmunol.1002971; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Harker JA, 2011, SCIENCE, V334, P825, DOI 10.1126/science.1208421; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hegde S, 2004, FASEB J, V18, P1439, DOI 10.1096/fj.03-0969fje; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; Hodes GE, 2014, P NATL ACAD SCI USA, V111, P16136, DOI 10.1073/pnas.1415191111; Hoge J, 2013, J IMMUNOL, V190, P703, DOI 10.4049/jimmunol.1201044; Hombria JCG, 2005, DEV BIOL, V288, P420, DOI 10.1016/j.ydbio.2005.09.040; HONDA M, 1992, J IMMUNOL, V148, P2175; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Hurst SM, 2001, IMMUNITY, V14, P705, DOI 10.1016/S1074-7613(01)00151-0; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Jenkins BJ, 2004, MOL CELL BIOL, V24, P1453, DOI 10.1128/MCB.24.4.1453-1463.2004; Jenkins BJ, 2007, BLOOD, V109, P2380, DOI 10.1182/blood-2006-08-040352; Jones GW, 2013, ANN RHEUM DIS, V72, P1738, DOI 10.1136/annrheumdis-2013-203771; Jones GW, 2015, ATHEROSCLEROSIS, V238, P321, DOI 10.1016/j.atherosclerosis.2014.12.037; Jones GW, 2010, J IMMUNOL, V184, P2130, DOI 10.4049/jimmunol.0901528; Jones KD, 1999, BLOOD, V94, P2871; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Jones SA, 2001, FASEB J, V15, P43, DOI 10.1096/fj.99-1003rev; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Kingsolver MB, 2012, P NATL ACAD SCI USA, V109, P18639, DOI 10.1073/pnas.1216736109; Klein B, 1992, Curr Top Microbiol Immunol, V182, P237; KLIMPEL GR, 1980, J IMMUNOL, V125, P1243; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Korn T, 2008, P NATL ACAD SCI USA, V105, P18460, DOI 10.1073/pnas.0809850105; Kraakman MJ, 2015, CELL METAB, V21, P403, DOI 10.1016/j.cmet.2015.02.006; Lally F, 2005, ARTHRITIS RHEUM-US, V52, P3460, DOI 10.1002/art.21394; Lattanzio G, 1997, AM J PATHOL, V151, P689; Lauder SN, 2013, EUR J IMMUNOL, V43, P2613, DOI 10.1002/eji.201243018; Li N, 2011, CANCER CELL, V19, P429, DOI 10.1016/j.ccr.2011.03.018; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; Lin M, 2006, BIOCHEM J, V398, P577, DOI 10.1042/BJ20060544; Lissilaa R, 2010, J IMMUNOL, V185, P5512, DOI 10.4049/jimmunol.1002015; Liu FL, 1997, BLOOD, V90, P2583, DOI 10.1182/blood.V90.7.2583.2583_2583_2590; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Longhi MP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000006; LU ZY, 1992, EUR J IMMUNOL, V22, P2819, DOI 10.1002/eji.1830221110; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; Marin V, 2001, J IMMUNOL, V167, P3435, DOI 10.4049/jimmunol.167.6.3435; Marin V, 2002, EUR J IMMUNOL, V32, P2965, DOI 10.1002/1521-4141(2002010)32:10<2965::AID-IMMU2965>3.0.CO;2-V; Masuda K, 2013, P NATL ACAD SCI USA, V110, P9409, DOI 10.1073/pnas.1307419110; Matsumiya T, 2001, EXP CELL RES, V269, P35, DOI 10.1006/excr.2001.5300; Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865; McFarland-Mancini MM, 2010, J IMMUNOL, V184, P7219, DOI 10.4049/jimmunol.0901929; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; McLoughlin RM, 2003, J CLIN INVEST, V112, P598, DOI 10.1172/JCI200317129; McLoughlin RM, 2004, J IMMUNOL, V172, P5676, DOI 10.4049/jimmunol.172.9.5676; Modur V, 1997, J CLIN INVEST, V100, P2752, DOI 10.1172/JCI119821; Moore PS, 1996, SCIENCE, V274, P1739, DOI 10.1126/science.274.5293.1739; Mroczko B, 2010, J CLIN LAB ANAL, V24, P256, DOI 10.1002/jcla.20395; Muller-Newen G, 1998, J IMMUNOL, V161, P6347; Nagabhushanam V, 2003, J IMMUNOL, V171, P4750, DOI 10.4049/jimmunol.171.9.4750; NARAZAKI M, 1993, BLOOD, V82, P1120, DOI 10.1182/blood.V82.4.1120.bloodjournal8241120; Navarini AA, 2011, J ALLERGY CLIN IMMUN, V128, P1128, DOI 10.1016/j.jaci.2011.09.009; Neveu WA, 2009, J IMMUNOL, V183, P1732, DOI 10.4049/jimmunol.0802923; Nishimoto N, 2000, BLOOD, V95, P56, DOI 10.1182/blood.V95.1.56; NOVICK D, 1989, J EXP MED, V170, P1409, DOI 10.1084/jem.170.4.1409; Nowell MA, 2009, J IMMUNOL, V182, P613, DOI 10.4049/jimmunol.182.1.613; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; O'Connor RA, 2012, EUR J IMMUNOL, V42, P1174, DOI 10.1002/eji.201142216; Ohshima S, 1998, P NATL ACAD SCI USA, V95, P8222, DOI 10.1073/pnas.95.14.8222; Panichi V, 2004, NEPHROL DIAL TRANSPL, V19, P1154, DOI 10.1093/ndt/gfh052; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Peters M, 1996, J EXP MED, V183, P1399, DOI 10.1084/jem.183.4.1399; Pitzalis C, 2014, NAT REV IMMUNOL, V14, P447, DOI 10.1038/nri3700; Puel A, 2008, J IMMUNOL, V180, P647, DOI 10.4049/jimmunol.180.1.647; Rebouissou S, 2009, NATURE, V457, P200, DOI 10.1038/nature07475; Richards HB, 1998, J EXP MED, V188, P985, DOI 10.1084/jem.188.5.985; Richards PJ, 2006, ARTHRITIS RHEUM-US, V54, P1662, DOI 10.1002/art.21818; Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461; Rohleder N, 2012, ANN NY ACAD SCI, V1261, P88, DOI 10.1111/j.1749-6632.2012.06634.x; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Rose-John S, 2012, INT J BIOL SCI, V8, P1237, DOI 10.7150/ijbs.4989; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Rosser EC, 2014, NAT MED, V20, P1334, DOI 10.1038/nm.3680; Sarwar N, 2014, MOL CELL NEUROSCI, V59, P37; Sarwar N, 2012, LANCET, V379, P1205, DOI 10.1016/S0140-6736(11)61931-4; SATO K, 1993, CANCER RES, V53, P851; Schett G, 2013, NAT MED, V19, P822, DOI 10.1038/nm.3260; SCHOBITZ B, 1995, FASEB J, V9, P659, DOI 10.1096/fasebj.9.8.7768358; Schroers A, 2005, PROTEIN SCI, V14, P783, DOI 10.1110/ps.041117105; Schuster B, 2003, J BIOL CHEM, V278, P9528, DOI 10.1074/jbc.M210044200; Screpanti I, 1996, J EXP MED, V184, P1561, DOI 10.1084/jem.184.4.1561; SHARKEY AM, 1995, BIOL REPROD, V53, P974, DOI 10.1095/biolreprod53.4.974; Sharma MD, 2013, IMMUNITY, V38, P998, DOI 10.1016/j.immuni.2013.01.013; Sharma S, 2011, P NATL ACAD SCI USA, V108, P19001, DOI 10.1073/pnas.1107087108; Shaw S, 2014, MABS-AUSTIN, V6, P773, DOI 10.4161/mabs.28612; Silver JS, 2011, J IMMUNOL, V187, P350, DOI 10.4049/jimmunol.1004144; Skiniotis G, 2005, NAT STRUCT MOL BIOL, V12, P545, DOI 10.1038/nsmb941; Smith KA, 2014, EUR J IMMUNOL, V44, P150, DOI 10.1002/eji.201343746; Smith KA, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00456; Sommer J, 2014, INT J MOL MED, V34, P651, DOI 10.3892/ijmm.2014.1825; Song YX, 2007, METABOLISM, V56, P925, DOI 10.1016/j.metabol.2007.02.006; Spehlmann ME, 2013, J IMMUNOL, V191, P837, DOI 10.4049/jimmunol.1201716; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Steiner MK, 2009, CIRC RES, V104, P236, DOI 10.1161/CIRCRESAHA.108.182014; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Stumhofer JS, 2010, NAT IMMUNOL, V11, P1119, DOI 10.1038/ni.1957; SUEMATSU S, 1989, P NATL ACAD SCI USA, V86, P7547, DOI 10.1073/pnas.86.19.7547; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; TAGA T, 1987, J EXP MED, V166, P967, DOI 10.1084/jem.166.4.967; Tanaka M, 2000, J CLIN INVEST, V106, P137, DOI 10.1172/JCI7479; Tanaka Y, 2014, ANN RHEUM DIS, V73, P1595, DOI 10.1136/annrheumdis-2013-205002; Taniguchi K, 2015, NATURE, V519, P57, DOI 10.1038/nature14228; TILG H, 1994, BLOOD, V83, P113; vanderPoll T, 1997, J INFECT DIS, V176, P439, DOI 10.1086/514062; Varghese JN, 2002, P NATL ACAD SCI USA, V99, P15959, DOI 10.1073/pnas.232432399; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; WAAGE A, 1989, J EXP MED, V169, P333, DOI 10.1084/jem.169.1.333; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; WOLOSKI BMRNJ, 1985, P NATL ACAD SCI USA, V82, P1443, DOI 10.1073/pnas.82.5.1443; Woodcock KJ, 2015, IMMUNITY, V42, P133, DOI 10.1016/j.immuni.2014.12.023; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; YAMASAKI K, 1988, SCIENCE, V241, P825, DOI 10.1126/science.3136546; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; YASUKAWA K, 1987, EMBO J, V6, P2939, DOI 10.1002/j.1460-2075.1987.tb02598.x; Yoshida K, 1996, P NATL ACAD SCI USA, V93, P407, DOI 10.1073/pnas.93.1.407; YOSHIZAKI K, 1984, J IMMUNOL, V132, P2948; YOSHIZAKI K, 1989, BLOOD, V74, P1360; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zhou YW, 1998, MICROBIOL IMMUNOL, V42, P109, DOI 10.1111/j.1348-0421.1998.tb02258.x	182	1323	1395	21	300	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2015	16	5					448	457		10.1038/ni.3153	http://dx.doi.org/10.1038/ni.3153			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5BN	25898198				2022-12-18	WOS:000353305200006
J	Gautier, EL; Shay, T; Miller, J; Greter, M; Jakubzick, C; Ivanov, S; Helft, J; Chow, A; Elpek, KG; Gordonov, S; Mazloom, AR; Ma'ayan, A; Chua, WJ; Hansen, TH; Turley, SJ; Merad, M; Randolph, GJ				Gautier, Emmanuel L.; Shay, Tal; Miller, Jennifer; Greter, Melanie; Jakubzick, Claudia; Ivanov, Stoyan; Helft, Julie; Chow, Andrew; Elpek, Kutlu G.; Gordonov, Simon; Mazloom, Amin R.; Ma'ayan, Avi; Chua, Wei-Jen; Hansen, Ted H.; Turley, Shannon J.; Merad, Miriam; Randolph, Gwendalyn J.		Immunological Genome Consortium	Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELL; STEADY-STATE; BONE-MARROW; IN-VIVO; DIFFERENTIATION; HETEROGENEITY; PROGENITORS; HOMEOSTASIS; ACTIVATION; REVEALS	We assessed gene expression in tissue macrophages from various mouse organs. The diversity in gene expression among different populations of macrophages was considerable. Only a few hundred mRNA transcripts were selectively expressed by macrophages rather than dendritic cells, and many of these were not present in all macrophages. Nonetheless, well-characterized surface markers, including MerTK and Fc gamma R1 (CD64), along with a cluster of previously unidentified transcripts, were distinctly and universally associated with mature tissue macrophages. TCEF3, C/EBP-alpha, Bach1 and CREG-1 were among the transcriptional regulators predicted to regulate these core macrophage-associated genes. The mRNA encoding other transcription factors, such as Gata6, was associated with single macrophage populations. We further identified how these transcripts and the proteins they encode facilitated distinguishing macrophages from dendritic cells.	[Gautier, Emmanuel L.; Jakubzick, Claudia; Randolph, Gwendalyn J.] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Gautier, Emmanuel L.; Miller, Jennifer; Greter, Melanie; Jakubzick, Claudia; Helft, Julie; Chow, Andrew; Merad, Miriam; Randolph, Gwendalyn J.] Mt Sinai Sch Med, Inst Immunol, New York, NY USA; [Gautier, Emmanuel L.; Ivanov, Stoyan; Chua, Wei-Jen; Hansen, Ted H.; Randolph, Gwendalyn J.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Miller, Jennifer; Greter, Melanie; Helft, Julie; Chow, Andrew; Merad, Miriam] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Miller, Jennifer; Greter, Melanie; Helft, Julie; Chow, Andrew; Merad, Miriam] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA; [Shay, Tal] Broad Inst, Cambridge, MA USA; [Elpek, Kutlu G.; Turley, Shannon J.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA; [Elpek, Kutlu G.; Turley, Shannon J.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Gordonov, Simon; Mazloom, Amin R.; Ma'ayan, Avi] Mt Sinai Sch Med, Dept Pharmacol, New York, NY USA; [Gordonov, Simon; Mazloom, Amin R.; Ma'ayan, Avi] Mt Sinai Sch Med, Syst Therapeut & Syst Biol Ctr New York, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Washington University (WUSTL); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Randolph, GJ (corresponding author), Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA.	grandolph@path.wustl.edu	Gautier, Emmanuel L./E-2259-2017; Ma'ayan, Avi/AAG-3131-2019; Helft, Julie/ABE-6179-2020; Gazit, Roi/J-3352-2017; Heng, Tracy/AAR-5712-2021; Shay, Tal/J-4028-2016; Heng, Tracy/B-9847-2015	Gautier, Emmanuel L./0000-0003-2976-7566; Ma'ayan, Avi/0000-0002-6904-1017; Helft, Julie/0000-0002-2733-1972; Heng, Tracy/0000-0003-4147-8986; Shay, Tal/0000-0003-0755-1350; Heng, Tracy/0000-0003-4147-8986; Fletcher, Anne/0000-0003-1534-1142; Chow, Andrew/0000-0003-1151-2450; Yankelevich, Wei-Jen/0000-0002-5234-7845; kang, joonsoo/0000-0001-8419-7995; Gazit, Roi/0000-0002-0548-2147; Kim, Charles/0000-0001-6474-8227; Tata, Nageswara Rao/0000-0002-9928-5944; Ivanov, Stoyan/0000-0002-0527-2297; Malhotra, Deepali/0000-0002-8215-7639; Greter, Melanie/0000-0002-7220-5369	National Institute of Allergy and Infectious Diseases of the US National Institutes of Health [R24 AI072073]; US National Institutes of Health [R01AI049653, R01AI061741, P50GM071558-03, R01DK08854, 5T32DA007135-27]; American Heart Association [10POST4160140]; NATIONAL CANCER INSTITUTE [R01CA154947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061741, R24AI072073, R01AI049653, R01AI046553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558, R01GM098316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007135] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank our colleagues of the ImmGen Project consortium; V. Jojic, J. Ericson, S. Davis and C. Benoist for contributions; eBioscience and Affymetrix for material support of the ImmGen Project; and M. Colonna (Washington University School of Medicine) for monoclonal antibodies (including anti-Siglec-H) and other reagents. Supported by the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health (R24 AI072073 to fund the ImmGen Project, spearheaded by C. Benoist), the US National Institutes of Health (R01AI049653 and R01AI061741 to G.J.R.; P50GM071558-03 and R01DK08854 to A.M.; and5T32DA007135-27 to ARM.) and the American Heart Association (10POST4160140 to E.L.G.).	Aziz A, 2009, SCIENCE, V326, P867, DOI 10.1126/science.1176056; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Chua WJ, 2011, J IMMUNOL, V186, P4744, DOI 10.4049/jimmunol.1003254; Desch AN, 2011, J EXP MED, V208, P1789, DOI 10.1084/jem.20110538; ELSTAD MR, 1989, J BIOL CHEM, V264, P8467; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Ginhoux F, 2007, J EXP MED, V204, P3133, DOI 10.1084/jem.20071733; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hama M, 2012, ARTHRITIS RHEUM-US, V64, P1518, DOI 10.1002/art.33497; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Hashimoto D, 2011, J EXP MED, V208, P1069, DOI 10.1084/jem.20101709; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hume DA, 2008, MUCOSAL IMMUNOL, V1, P432, DOI 10.1038/mi.2008.36; Kim HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011439; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Moolmuang B, 2011, CELL CYCLE, V10, P518, DOI 10.4161/cc.10.3.14756; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Sacher M, 2005, P NATL ACAD SCI USA, V102, P18326, DOI 10.1073/pnas.0505071102; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; Takahashi K., 2001, J CLIN EXP HEMATOP, V41, P1, DOI DOI 10.3960/JSLRT.41.1; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Veal E, 1998, MOL CELL BIOL, V18, P5032, DOI 10.1128/MCB.18.9.5032; Veal E, 2000, ONCOGENE, V19, P2120, DOI 10.1038/sj.onc.1203529	34	1318	1340	4	134	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2012	13	11					1118	1128		10.1038/ni.2419	http://dx.doi.org/10.1038/ni.2419			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	024EO	23023392	Green Published, Green Submitted, Green Accepted			2022-12-18	WOS:000310091700015
J	Jordan, MS; Boesteanu, A; Reed, AJ; Petrone, AL; Holenbeck, AE; Lerman, MA; Naji, A; Caton, AJ				Jordan, MS; Boesteanu, A; Reed, AJ; Petrone, AL; Holenbeck, AE; Lerman, MA; Naji, A; Caton, AJ			Thymic selection of CD4(+)CD25(+) regulatory T cells induced by an agonist self-peptide	NATURE IMMUNOLOGY			English	Article							DIFFERENTIAL AVIDITY MODEL; POSITIVE SELECTION; TRANSGENIC MICE; INFLUENZA HEMAGGLUTININ; AUTOIMMUNE-DISEASE; NEGATIVE SELECTION; RECEPTOR; EXPRESSION; COMPLEX; RECOGNITION	Despite accumulating evidence that regulatory T cells play a crucial role in preventing autoimmunity, the processes underlying their generation during immune repertoire formation are unknown. We show here that interactions with a single self-peptide can induce thymocytes that bear an autoreactive T cell receptor (TCR) to undergo selection to become CD4(+)CD25(+) regulatory T cells. Selection of CD4(+)CD25(+) thymocytes appears to require a TCR with high affinity for a self peptide because thymocytes that bear TCRs with low affinity do not undergo selection into this pathway. Our findings indicate that specificity for self-peptides directs the selection of CD4(+)CD25(+) regulatory thymocytes by a process that is distinct from positive selection and deletion.	Wistar Inst, Philadelphia, PA 19104 USA; Univ Penn, Dept Surg, Philadelphia, PA 19104 USA	The Wistar Institute; University of Pennsylvania	Caton, AJ (corresponding author), Wistar Inst, Philadelphia, PA 19104 USA.		Lerman, Melissa/AGG-2451-2022	Lerman, Melissa/0000-0003-1378-5292	NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY007131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024541, R56AI024541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007442] Funding Source: NIH RePORTER; NCI NIH HHS [CA10815] Funding Source: Medline; NEI NIH HHS [5T32EY07131] Funding Source: Medline; NIAID NIH HHS [AI24541] Funding Source: Medline; NIAMS NIH HHS [5T32AR07442] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; BEVAN MJ, 1994, SCIENCE, V264, P796, DOI 10.1126/science.8171333; BRANDLE D, 1994, EUR J IMMUNOL, V24, P145, DOI 10.1002/eji.1830240122; Caton AJ, 1996, J EXP MED, V183, P13, DOI 10.1084/jem.183.1.13; CERASOLI DM, 1995, INT IMMUNOL, V7, P935, DOI 10.1093/intimm/7.6.935; CERASOLI DM, 1995, J EXP MED, V182, P1327, DOI 10.1084/jem.182.5.1327; DUTZ JP, 1995, J IMMUNOL, V154, P2588; Girao C, 1997, J IMMUNOL, V159, P4205; HABERMAN AM, 1990, J IMMUNOL, V145, P3087; Hogquist KA, 1997, IMMUNITY, V6, P389, DOI 10.1016/S1074-7613(00)80282-4; HOGQUIST KA, 1995, IMMUNITY, V3, P79, DOI 10.1016/1074-7613(95)90160-4; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Itoh M, 1999, J IMMUNOL, V162, P5317; JAMESON SC, 1994, NATURE, V369, P750, DOI 10.1038/369750a0; Jordan MS, 2000, EUR J IMMUNOL, V30, P136, DOI 10.1002/1521-4141(200001)30:1<136::AID-IMMU136>3.3.CO;2-S; KIRBERG J, 1994, J EXP MED, V180, P25, DOI 10.1084/jem.180.1.25; KOUSKOFF V, 1993, J IMMUNOL METHODS, V166, P287, DOI 10.1016/0022-1759(93)90370-M; KOUSKOFF V, 1995, J IMMUNOL METHODS, V180, P273, DOI 10.1016/0022-1759(95)00002-R; Laufer TM, 1996, NATURE, V383, P81, DOI 10.1038/383081a0; Merkenschlager M, 1997, J EXP MED, V186, P1149, DOI 10.1084/jem.186.7.1149; MODIGLIANI Y, 1995, P NATL ACAD SCI USA, V92, P7555, DOI 10.1073/pnas.92.16.7555; Nakano N, 1997, SCIENCE, V275, P678, DOI 10.1126/science.275.5300.678; PAWLOWSKI T, 1993, NATURE, V364, P642, DOI 10.1038/364642a0; Riley MP, 2000, J IMMUNOL, V165, P4870, DOI 10.4049/jimmunol.165.9.4870; SCHONRICH G, 1992, EUR J IMMUNOL, V22, P1687, DOI 10.1002/eji.1830220704; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; Seddon B, 1999, J EXP MED, V189, P877, DOI 10.1084/jem.189.5.877; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Shih FF, 1997, INT IMMUNOL, V9, P249, DOI 10.1093/intimm/9.2.249; SPAIN LM, 1992, J EXP MED, V176, P213, DOI 10.1084/jem.176.1.213; Suri-Payer E, 1998, J IMMUNOL, V160, P1212; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; WEBER S, 1992, NATURE, V356, P793, DOI 10.1038/356793a0; Williams CB, 1999, J EXP MED, V189, P1531, DOI 10.1084/jem.189.10.1531	38	1313	1378	0	30	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2001	2	4					301	306		10.1038/86302	http://dx.doi.org/10.1038/86302			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	420AZ	11276200				2022-12-18	WOS:000167982900010
J	Schluns, KS; Kieper, WC; Jameson, SC; Lefrancois, L				Schluns, KS; Kieper, WC; Jameson, SC; Lefrancois, L			Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo	NATURE IMMUNOLOGY			English	Article							CYTOKINE GENE-EXPRESSION; RECEPTOR-DEFICIENT MICE; MHC CLASS-I; DENDRITIC CELLS; IRRADIATED MICE; LYMPHOCYTES-T; GAMMA-CHAIN; SURVIVAL; PROLIFERATION; IL-7	The naive and memory T lymphocyte pools are maintained through poorly understood homeostatic mechanisms that may include signaling via cytokine receptors. We show that interleukin-7 (IL-7) plays multiple roles in regulating homeostasis of CD8(+) T cells. We found that IL-7 was required for homeostatic expansion of naive CD8(+) and CD4(+) T cells in lymphopenic hosts and for CD8(+) T cell survival in normal hosts. In contrast, IL-7 was not necessary for growth of CD8(+)T cells in response to a virus infection but was critical for generating T cell memory. Up-regulation of Bcl-2 in the absence of IL-7 signaling was impaired after activation in vivo. Homeostatic proliferation of memory cells was also partially dependent on IL-7. These results point to IL-7 as a pivotal cytokine in T cell homeostasis.	Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT 06030 USA; Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA	University of Connecticut; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Lefrancois, L (corresponding author), Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT 06030 USA.	llefranc@neuron.uchc.edu	Jameson, Stephen C/D-9892-2013; Schluns, Kimberly/R-5635-2019	Jameson, Stephen C/0000-0001-9137-1146; 	NIAID NIH HHS [AI38903, AI-07313, AI35917] Funding Source: Medline; NIAMS NIH HHS [AR-07582] Funding Source: Medline; NIDDK NIH HHS [DK45260] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038903, R37AI038903, R01AI035917, R29AI038903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045260] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Ariel A, 1997, EUR J IMMUNOL, V27, P2562, DOI 10.1002/eji.1830271015; BELL EB, 1987, J IMMUNOL, V139, P1379; Bender J, 1999, J EXP MED, V190, P367, DOI 10.1084/jem.190.3.367; Berzins SP, 1998, J EXP MED, V187, P1839, DOI 10.1084/jem.187.11.1839; Boursalian TE, 1999, J IMMUNOL, V162, P3795; Brocker T, 1997, J EXP MED, V186, P1223, DOI 10.1084/jem.186.8.1223; Bruno L, 1996, EUR J IMMUNOL, V26, P3179, DOI 10.1002/eji.1830261251; BRUNO L, 1995, IMMUNITY, V2, P37, DOI 10.1016/1074-7613(95)90077-2; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; FUNK PE, 1995, BLOOD, V86, P2661; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; GRABSTEIN KH, 1990, J IMMUNOL, V144, P3015; Grayson JM, 2000, J IMMUNOL, V164, P3950, DOI 10.4049/jimmunol.164.8.3950; Gudmundsdottir H, 1999, J IMMUNOL, V162, P5212; HARRISON DE, 1972, BRIT J HAEMATOL, V22, P155, DOI 10.1111/j.1365-2141.1972.tb08797.x; Hassan J, 1998, EUR J IMMUNOL, V28, P3057, DOI 10.1002/(SICI)1521-4141(199810)28:10<3057::AID-IMMU3057>3.3.CO;2-Q; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hong JH, 1999, INT J RADIAT BIOL, V75, P1421, DOI 10.1080/095530099139287; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kieper WC, 1999, P NATL ACAD SCI USA, V96, P13306, DOI 10.1073/pnas.96.23.13306; Kim K, 1998, J IMMUNOL, V160, P5735; Kim SK, 1999, J IMMUNOL, V163, P4125; Kim SK, 1998, P NATL ACAD SCI USA, V95, P10814, DOI 10.1073/pnas.95.18.10814; KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076; Kroncke R, 1996, EUR J IMMUNOL, V26, P2541, DOI 10.1002/eji.1830261040; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Lantz O, 2000, NAT IMMUNOL, V1, P54, DOI 10.1038/76917; Levin SD, 1999, J IMMUNOL, V162, P677; LIMANNI A, 1995, BLOOD, V85, P2377, DOI 10.1182/blood.V85.9.2377.bloodjournal8592377; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Maraskovsky E, 1996, J IMMUNOL, V157, P5315; Marrack P, 2000, NAT IMMUNOL, V1, P107, DOI 10.1038/77778; MOORE NC, 1993, EUR J IMMUNOL, V23, P922, DOI 10.1002/eji.1830230424; Moore TA, 1996, J IMMUNOL, V157, P2366; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Nesic D, 1998, J IMMUNOL, V160, P3705; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; Pandey A, 2000, NAT IMMUNOL, V1, P59, DOI 10.1038/76923; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; PETERSON VM, 1994, J IMMUNOL, V153, P2321; ROCHA B, 1989, EUR J IMMUNOL, V19, P905, DOI 10.1002/eji.1830190518; SARMIENTO M, 1980, J IMMUNOL, V125, P2665; Schober SL, 1999, J IMMUNOL, V163, P3662; SHEN FW, 1981, MONOCLONAL ANTIBODIE, P25; Sorg RV, 1998, IMMUNOBIOLOGY, V198, P514, DOI 10.1016/S0171-2985(98)80075-2; SUDO T, 1993, P NATL ACAD SCI USA, V90, P9125, DOI 10.1073/pnas.90.19.9125; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; TAKEISHI T, 1996, IMMUNITY, V5, P217; TANCHOT C, 1995, EUR J IMMUNOL, V25, P2127, DOI 10.1002/eji.1830250802; Tanchot C, 1997, Semin Immunol, V9, P331, DOI 10.1006/smim.1997.0090; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Vella A, 1997, J EXP MED, V186, P325, DOI 10.1084/jem.186.2.325; vonFreedenJeffry U, 1997, IMMUNITY, V7, P147, DOI 10.1016/S1074-7613(00)80517-8; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; WATANABE M, 1995, J CLIN INVEST, V95, P2945, DOI 10.1172/JCI118002; WILES MV, 1992, EUR J IMMUNOL, V22, P1037, DOI 10.1002/eji.1830220424; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6	60	1268	1317	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2000	1	5					426	432		10.1038/80868	http://dx.doi.org/10.1038/80868			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	369PL	11062503				2022-12-18	WOS:000165076100016
J	Kim, JM; Rasmussen, JP; Rudensky, AY				Kim, Jeong M.; Rasmussen, Jeffrey P.; Rudensky, Alexander Y.			Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR FOXP3; IN-VIVO; DENDRITIC CELLS; ANTIGEN; TOLERANCE; SELF; RESPONSES; THYMUS; MOUSE; PROLIFERATION	Mice lacking the transcription factor Foxp3 (Foxp3(-)) lack regulatory T (T-reg) cells and develop fatal autoimmune pathology. In Foxp3(-) mice, many activated effector T cells express self-reactive T cell receptors that are expressed in T-reg cells in wild-type mice. Thus, in wild-type mice, most self-reactive thymocytes escaping negative selection are diverted into the T-reg lineage, and whether T-reg cells are critical in self-tolerance in wild-type mice remains unknown. Here, acute in vivo ablation of T-reg cells demonstrated a vital function for T-reg cells in neonatal and adult mice. We suggest that self-reactive T cells are continuously suppressed by T-reg cells and that when suppression is relieved, self-reactive T cells become activated and facilitate accelerated maturation of dendritic cells.	Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Rudensky, AY (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	aruden@u.washington.edu		Rasmussen, Jeffrey/0000-0001-6997-3773				Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; BOGUE M, 1992, P NATL ACAD SCI USA, V89, P11011, DOI 10.1073/pnas.89.22.11011; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Cederbom L, 2000, EUR J IMMUNOL, V30, P1538, DOI 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Foussat A, 2003, J IMMUNOL, V171, P5018, DOI 10.4049/jimmunol.171.10.5018; Gavin MA, 1995, IMMUNITY, V3, P793, DOI 10.1016/1074-7613(95)90068-3; Grossman WJ, 2004, IMMUNITY, V21, P589, DOI 10.1016/j.immuni.2004.09.002; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Houot R, 2006, J IMMUNOL, V176, P5293, DOI 10.4049/jimmunol.176.9.5293; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Jonuleit H, 2002, J EXP MED, V196, P255, DOI 10.1084/jem.20020394; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; Kawahata K, 2002, J IMMUNOL, V168, P4399, DOI 10.4049/jimmunol.168.9.4399; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim JM, 2006, IMMUNOL REV, V212, P86, DOI 10.1111/j.0105-2896.2006.00426.x; Min BK, 2003, IMMUNITY, V18, P131, DOI 10.1016/S1074-7613(02)00508-3; Misra N, 2004, J IMMUNOL, V172, P4676, DOI 10.4049/jimmunol.172.8.4676; NISHIZUK.Y, 1969, SCIENCE, V166, P753, DOI 10.1126/science.166.3906.753; Ramsdell F, 2003, IMMUNITY, V19, P165, DOI 10.1016/S1074-7613(03)00207-3; RUSSELL WL, 1959, P NATL ACAD SCI USA, V45, P18, DOI 10.1073/pnas.45.1.18; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SHEWACH EM, 2000, ANNU REV IMMUNOL, V18, P423; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Thorstenson KM, 2001, J IMMUNOL, V167, P188, DOI 10.4049/jimmunol.167.1.188; Veldhoen M, 2006, J IMMUNOL, V176, P6202, DOI 10.4049/jimmunol.176.10.6202; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Waldmann H, 2001, IMMUNITY, V14, P399, DOI 10.1016/S1074-7613(01)00120-0; Walker LSK, 2003, J EXP MED, V198, P249, DOI 10.1084/jem.20030315; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707	42	1266	1310	1	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2007	8	2					191	197		10.1038/ni1428	http://dx.doi.org/10.1038/ni1428			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	127PA	17136045				2022-12-18	WOS:000243597600017
J	Colonna, M; Trinchieri, G; Liu, YJ				Colonna, M; Trinchieri, G; Liu, YJ			Plasmacytoid dendritic cells in immunity	NATURE IMMUNOLOGY			English	Review							INTERFERON-PRODUCING CELLS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; IFN-ALPHA PRODUCTION; REGULATORY T-CELLS; INFLAMED LYMPH-NODES; SINGLE-STRANDED RNA; TOLL-LIKE RECEPTORS; CUTTING EDGE; IN-VIVO; VIRUS TYPE-1	Human and mouse plasmacytoid dendritic cells have been shown to correspond to a specialized cell population that produces large amounts of type I interferons in response to viruses, the so-called natural interferon-producing cells. As a result, intensive investigation is now focused on the potential functions of plasmacytoid dendritic cells in both innate and adaptive immunity. Here we review recent progress on the characterization of plasmacytoid dendritic cell origin, development, migration and function in immunity and tolerance, as well as their effect on human diseases.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; Schering Plough Corp, Lab Immunol Res, F-69571 Dardilly, France; Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA	Washington University (WUSTL); Merck & Company; Schering Plough Corporation; University of Texas System; UTMD Anderson Cancer Center	Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	mcolonna@pathology.wustl.edu	Trinchieri, Giorgio/F-9369-2015	Trinchieri, Giorgio/0000-0001-5892-7464; Colonna, Marco/0000-0001-5222-4987				ABB J, 1983, CLIN EXP IMMUNOL, V52, P179; Agnello D, 2003, J CLIN IMMUNOL, V23, P147, DOI 10.1023/A:1023381027062; Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Arpinati M, 2000, BLOOD, V95, P2484, DOI 10.1182/blood.V95.8.2484; Asselin-Paturel C, 2003, J IMMUNOL, V171, P6466, DOI 10.4049/jimmunol.171.12.6466; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BANDYOPADHYAY S, 1986, J EXP MED, V164, P180, DOI 10.1084/jem.164.1.180; BARCHET W, IN PRESS EUR J IMMUN; Bave U, 2003, J IMMUNOL, V171, P3296, DOI 10.4049/jimmunol.171.6.3296; Bell D, 1999, J EXP MED, V190, P1417, DOI 10.1084/jem.190.10.1417; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Bilsborough J, 2003, IMMUNOLOGY, V108, P481, DOI 10.1046/j.1365-2567.2003.01606.x; Bjorck P, 2001, BLOOD, V98, P3520, DOI 10.1182/blood.V98.13.3520; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Blasius A, 2004, BLOOD, V103, P4201, DOI 10.1182/blood-2003-09-3108; Blom B, 2000, J EXP MED, V192, P1785, DOI 10.1084/jem.192.12.1785; Boonstra A, 2003, J EXP MED, V197, P101, DOI 10.1084/jem.20021908; Brawand P, 2002, J IMMUNOL, V169, P6711, DOI 10.4049/jimmunol.169.12.6711; Cederblad B, 1998, J AUTOIMMUN, V11, P465, DOI 10.1006/jaut.1998.0215; Cella M, 2000, NAT IMMUNOL, V1, P305, DOI 10.1038/79747; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Cella M, 1999, J EXP MED, V189, P821, DOI 10.1084/jem.189.5.821; Chaperot L, 2004, EUR J IMMUNOL, V34, P418, DOI 10.1002/eji.200324531; Chaux P, 1997, ADV EXP MED BIOL, V417, P525; CHEHIMI J, 1989, IMMUNOLOGY, V68, P486; Chehimi J, 2002, J IMMUNOL, V168, P4796, DOI 10.4049/jimmunol.168.9.4796; Chen W, 2004, BLOOD, V103, P2547, DOI 10.1182/blood-2003-09-3058; Coccia EM, 2004, EUR J IMMUNOL, V34, P796, DOI 10.1002/eji.200324610; Comeau MR, 2002, J IMMUNOL, V169, P75, DOI 10.4049/jimmunol.169.1.75; Corcoran L, 2003, J IMMUNOL, V170, P4926, DOI 10.4049/jimmunol.170.10.4926; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; Dai JH, 2004, J IMMUNOL, V173, P1535, DOI 10.4049/jimmunol.173.3.1535; Dalod M, 2003, J EXP MED, V197, P885, DOI 10.1084/jem.20021522; Dalod M, 2002, J EXP MED, V195, P517, DOI 10.1084/jem.20011672; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; del Hoyo GM, 2002, NATURE, V415, P1043, DOI 10.1038/4151043a; Dhodapkar MV, 2002, BLOOD, V100, P174, DOI 10.1182/blood.V100.1.174; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dzionek A, 2002, HUM IMMUNOL, V63, P1133, DOI 10.1016/S0198-8859(02)00752-8; Dzionek A, 2001, J EXP MED, V194, P1823, DOI 10.1084/jem.194.12.1823; Facchetti F, 2003, VIRCHOWS ARCH, V443, P703, DOI 10.1007/s00428-003-0918-8; Fallarino F, 2004, J IMMUNOL, V173, P3748, DOI 10.4049/jimmunol.173.6.3748; Farkas L, 2001, AM J PATHOL, V159, P237, DOI 10.1016/S0002-9440(10)61689-6; FELDMAN M, 1990, J INTERFERON RES, V10, P435, DOI 10.1089/jir.1990.10.435; Feldman S, 2001, CLIN IMMUNOL, V101, P201, DOI 10.1006/clim.2001.5111; Fiebiger E, 2001, J EXP MED, V193, P881, DOI 10.1084/jem.193.8.881; Fong L, 2002, J VIROL, V76, P11033, DOI 10.1128/JVI.76.21.11033-11041.2002; Fonteneau JF, 2003, BLOOD, V101, P3520, DOI 10.1182/blood-2002-10-3063; Gerosa F, 1996, J EXP MED, V183, P2559, DOI 10.1084/jem.183.6.2559; Gilliet M, 2002, J EXP MED, V195, P953, DOI 10.1084/jem.20020045; Gilliet M, 2002, J EXP MED, V195, P695, DOI 10.1084/jem.20011603; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101; Iezzi G, 2001, J EXP MED, V193, P987, DOI 10.1084/jem.193.8.987; Ito T, 2004, J IMMUNOL, V172, P4253, DOI 10.4049/jimmunol.172.7.4253; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Izaguirre A, 2003, J LEUKOCYTE BIOL, V74, P1125, DOI 10.1189/jlb.0603255; Jahnsen FL, 2000, J IMMUNOL, V165, P4062, DOI 10.4049/jimmunol.165.7.4062; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Krug A, 2003, J EXP MED, V197, P899, DOI 10.1084/jem.20021091; Krug A, 2002, J IMMUNOL, V169, P6079, DOI 10.4049/jimmunol.169.11.6079; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Krug A, 2001, EUR J IMMUNOL, V31, P3026, DOI 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H; Kuwana M, 2002, HUM IMMUNOL, V63, P1156, DOI 10.1016/S0198-8859(02)00754-1; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; LeibundGut-Landmann S, 2004, NAT IMMUNOL, V5, P899, DOI 10.1038/ni1109; LENNERT KARL, 1958, ACTA HAEMATOL, V19, P99; Levings MK, 2001, J IMMUNOL, V166, P5530, DOI 10.4049/jimmunol.166.9.5530; Liu YJ, 2001, NAT IMMUNOL, V2, P585, DOI 10.1038/89726; LOPEZ C, 1983, J INFECT DIS, V148, P962, DOI 10.1093/infdis/148.6.962; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Mahnke K, 2003, BLOOD, V101, P4862, DOI 10.1182/blood-2002-10-3229; Martin P, 2002, BLOOD, V100, P383, DOI 10.1182/blood.V100.2.383; Megjugorac NJ, 2004, J LEUKOCYTE BIOL, V75, P504, DOI 10.1189/jlb.0603291; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Moseman EA, 2004, J IMMUNOL, V173, P4433, DOI 10.4049/jimmunol.173.7.4433; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; O'Keeffe M, 2002, J EXP MED, V196, P1307, DOI 10.1084/jem.20021031; ODOHERTY U, 1994, IMMUNOLOGY, V82, P487; Palamara F, 2004, J IMMUNOL, V173, P3051, DOI 10.4049/jimmunol.173.5.3051; Palucka AK, 2003, BLOOD, V102, P3302, DOI 10.1182/blood-2003-02-0384; Penna G, 2002, J IMMUNOL, V169, P6673, DOI 10.4049/jimmunol.169.12.6673; Penna G, 2001, J IMMUNOL, V167, P1862, DOI 10.4049/jimmunol.167.4.1862; PERUSSIA B, 1985, Natural Immunity and Cell Growth Regulation, V4, P120; Poeck H, 2004, BLOOD, V103, P3058, DOI 10.1182/blood-2003-08-2972; PREBLE OT, 1982, SCIENCE, V216, P429, DOI 10.1126/science.6176024; Pulendran B, 2000, J IMMUNOL, V165, P566, DOI 10.4049/jimmunol.165.1.566; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; Rissoan MC, 2002, BLOOD, V100, P3295, DOI 10.1182/blood-2002-02-0638; RONNBLOM L, 1983, EUR J IMMUNOL, V13, P471, DOI 10.1002/eji.1830130608; RONNBLOM LE, 1990, J INTERN MED, V227, P207; Salio M, 2004, J EXP MED, V199, P567, DOI 10.1084/jem.20031059; Santini SM, 2000, J EXP MED, V191, P1777, DOI 10.1084/jem.191.10.1777; Schlecht G, 2004, BLOOD, V104, P1808, DOI 10.1182/blood-2004-02-0426; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Soumelis V, 2001, BLOOD, V98, P906, DOI 10.1182/blood.V98.4.906; Spits H, 2000, J EXP MED, V192, P1775, DOI 10.1084/jem.192.12.1775; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tamura T, 2002, J INTERF CYTOK RES, V22, P145, DOI 10.1089/107999002753452755; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; TRINCHIERI G, 1978, J EXP MED, V147, P1299, DOI 10.1084/jem.147.5.1299; Vallin H, 1999, J IMMUNOL, V163, P6306; Vanbervliet B, 2003, J EXP MED, V198, P823, DOI 10.1084/jem.20020437; Vermi W, 2003, J PATHOL, V200, P255, DOI 10.1002/path.1344; Vicari AP, 2002, J EXP MED, V196, P541, DOI 10.1084/jem.20020732; Weijer K, 2002, BLOOD, V99, P2752, DOI 10.1182/blood.V99.8.2752; Yoneyama H, 2004, INT IMMUNOL, V16, P915, DOI 10.1093/intimm/dxh093; Zou WP, 2001, NAT MED, V7, P1339, DOI 10.1038/nm1201-1339; Zuniga EI, 2004, NAT IMMUNOL, V5, P1227, DOI 10.1038/ni1136	123	1247	1300	2	101	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2004	5	12					1219	1226		10.1038/ni1141	http://dx.doi.org/10.1038/ni1141			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	874MC	15549123				2022-12-18	WOS:000225353500010
J	Holler, N; Zaru, R; Micheau, O; Thome, M; Attinger, A; Valitutti, S; Bodmer, JL; Schneider, P; Seed, B; Tschopp, J				Holler, N; Zaru, R; Micheau, O; Thome, M; Attinger, A; Valitutti, S; Bodmer, JL; Schneider, P; Seed, B; Tschopp, J			Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule	NATURE IMMUNOLOGY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; T-CELLS; APOPTOSIS; ACTIVATION; PROTEIN; DOMAIN; LYMPHOCYTES; INHIBITION; INITIATION	Cell death is achieved by two fundamentally different mechanisms: apoptosis and necrosis,Apoptosis is dependent on caspase activation, whereas the caspase-independent necrotic signaling pathway remains largely uncharacterized. We show here that Pas kills activated primary T cells efficiently in the absence of active caspases, which results in necrotic morphological changes and late mitochondrial damage but no cytochrome c release,This Pas ligand-induced caspase-independent death is absent in T cells that are deficient in either Fas-associated death domain (FADD) or receptor-interacting protein (RIP), RIP is also required for necrotic death induced by tumor necrosis factor (INF) and TNF-related apoptosis-inducing ligand (TRAIL), In contrast to its role in nuclear factor kappaB activation, RIP requires its own kinase activity for death signaling. Thus, pas, TRAIL and TNF receptors can initiate cell death by two alternative pathways, one relying on caspase-8 and the other dependent on the kinase RIP.	Univ Lausanne, Inst Biochem, BIL Biomed Res Ctr, CH-1066 Epalinges, Switzerland; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	University of Lausanne; Harvard University; Massachusetts General Hospital	Tschopp, J (corresponding author), Univ Lausanne, Inst Biochem, BIL Biomed Res Ctr, Chemin des Boveresses, CH-1066 Epalinges, Switzerland.		Valitutti, Salvatore/M-2999-2014; Thome, Margot/F-8167-2011; micheau, olivier/C-3574-2011	Valitutti, Salvatore/0000-0002-6432-4421; Thome, Margot/0000-0002-5656-2139; micheau, olivier/0000-0001-8499-7984; Schneider, Pascal/0000-0003-0677-9409; Zaru, Rossana/0000-0002-3358-4423				Baker B, 1997, SCIENCE, V276, P726, DOI 10.1126/science.276.5313.726; Berndt C, 1998, P NATL ACAD SCI USA, V95, P12556, DOI 10.1073/pnas.95.21.12556; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; BOONE E, 2000, IN PRESS J BIOL CHEM; Drenou B, 1999, J IMMUNOL, V163, P4115; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Grimm S, 1996, P NATL ACAD SCI USA, V93, P10923, DOI 10.1073/pnas.93.20.10923; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Juo P, 1999, CELL GROWTH DIFFER, V10, P797; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Kawahara A, 1998, J CELL BIOL, V143, P1353, DOI 10.1083/jcb.143.5.1353; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Khwaja A, 1999, J BIOL CHEM, V274, P36817, DOI 10.1074/jbc.274.51.36817; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Kitanaka C, 1999, CELL DEATH DIFFER, V6, P508, DOI 10.1038/sj.cdd.4400526; KLAS C, 1993, INT IMMUNOL, V5, P625, DOI 10.1093/intimm/5.6.625; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Lewis J, 2000, J BIOL CHEM, V275, P10519, DOI 10.1074/jbc.275.14.10519; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Luschen S, 2000, J BIOL CHEM, V275, P24670, DOI 10.1074/jbc.M003280200; Pimentel-Muinos FX, 1999, IMMUNITY, V11, P783, DOI 10.1016/S1074-7613(00)80152-1; Scaffidi C, 1999, CURR OPIN IMMUNOL, V11, P277, DOI 10.1016/S0952-7915(99)80045-4; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; Smith KGC, 1996, EMBO J, V15, P5167, DOI 10.1002/j.1460-2075.1996.tb00901.x; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Vercammen D, 1998, J EXP MED, V188, P919, DOI 10.1084/jem.188.5.919; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Walsh CM, 1998, IMMUNITY, V8, P439, DOI 10.1016/S1074-7613(00)80549-X; WATANABE FR, 1992, NATURE, V356, P314; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1	37	1239	1307	5	84	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2000	1	6					489	495		10.1038/82732	http://dx.doi.org/10.1038/82732			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	380VR	11101870				2022-12-18	WOS:000165724600012
J	Kurt-Jones, EA; Popova, L; Kwinn, L; Haynes, LM; Jones, LP; Tripp, RA; Walsh, EE; Freeman, MW; Golenbock, DT; Anderson, LJ; Finberg, RW				Kurt-Jones, EA; Popova, L; Kwinn, L; Haynes, LM; Jones, LP; Tripp, RA; Walsh, EE; Freeman, MW; Golenbock, DT; Anderson, LJ; Finberg, RW			Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus	NATURE IMMUNOLOGY			English	Article							TOLL-LIKE RECEPTOR-2; CELL WALL COMPONENTS; CUTTING EDGE; DROSOPHILA TOLL; HOST-DEFENSE; LIPOPOLYSACCHARIDE; MICE; ACTIVATION; GENE; LPS	The innate immune system contributes to the earliest phase of the host defense against foreign organisms and has both soluble and cellular pattern recognition receptors for microbial products. Two important members of this receptor group, CD14 and the Toll-like receptor (TLR) pattern recognition receptors, are essential for the innate immune response to components of Gramnegative and Cram-positive bacteria, mycobacteria, spirochetes and yeast. We now find that these receptors function in an antiviral response as well,The innate immune response to the fusion protein of an important respiratory pathogen of humans, respiratory syncytial virus (RSV), was mediated by TLR4 and CD14. RSV persisted longer in the lungs of infected TLR l-deficient mice compared to normal mice,Thus, a common receptor activation pathway can initiate innate immune responses to both bacterial and viral pathogens.	Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA; Dana Farber Canc Inst, Dept Adult Oncol, Program Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Massachusetts Gen Hosp, Boston, MA 02115 USA; Univ Rochester, Sch Med & Dent, Rochester, NY USA; Boston Univ, Sch Med, Maxwell Finland Lab Infect Dis, Boston, MA 02118 USA	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Centers for Disease Control & Prevention - USA; Harvard University; Massachusetts General Hospital; University of Rochester; Boston University	Kurt-Jones, EA (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA.	evelyn.kurt-jones@umassmed.edu	Finberg, Robert W/E-3323-2010; Tripp, Ralph/F-5218-2011	Tripp, Ralph/0000-0002-2924-9956	NIAID NIH HHS [R01AI31628, R01AI38515, R01AI39576] Funding Source: Medline; NIDDK NIH HHS [R01DK50305] Funding Source: Medline; NIGMS NIH HHS [R01GM54060] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039576, R01AI031628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054060] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; ALWAN WH, 1994, J EXP MED, V179, P81, DOI 10.1084/jem.179.1.81; ANDERSON LJ, 1995, J INFECT DIS, V171, P1, DOI 10.1093/infdis/171.1.1; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; CAVAILLON JM, 1986, MOL IMMUNOL, V23, P965, DOI 10.1016/0161-5890(86)90127-6; Chaudhary PM, 1998, BLOOD, V91, P4020, DOI 10.1182/blood.V91.11.4020.411a44_4020_4027; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; GRAHAM BS, 1988, J MED VIROL, V26, P153, DOI 10.1002/jmv.1890260207; GRAHAM BS, 1993, J IMMUNOL, V151, P2032; HALL CB, 1986, NEW ENGL J MED, V315, P77, DOI 10.1056/NEJM198607103150201; HAYNES LM, 2000, UNPUB J IMMUNOL; HEILMAN CA, 1990, J INFECT DIS, V161, P402, DOI 10.1093/infdis/161.3.402; Heine H, 1999, J IMMUNOL, V162, P6971; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Means TK, 1999, J IMMUNOL, V163, P3920; Means TK, 1999, J IMMUNOL, V163, P6748; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Meister M, 1997, BIOESSAYS, V19, P1019, DOI 10.1002/bies.950191112; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; PRINCE GA, 1986, J VIROL, V57, P721, DOI 10.1128/JVI.57.3.721-728.1986; PUGIN J, 1994, IMMUNITY, V1, P509, DOI 10.1016/1074-7613(94)90093-0; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Savedra R, 1996, J IMMUNOL, V157, P2549; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Solomon KR, 1998, J CLIN INVEST, V102, P2019, DOI 10.1172/JCI4317; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tripp RA, 2000, J IMMUNOL, V164, P5913, DOI 10.4049/jimmunol.164.11.5913; ULEVITCH RJ, 1993, ADV IMMUNOL, V53, P267, DOI 10.1016/S0065-2776(08)60502-7; WALSH EE, 1985, J GEN VIROL, V66, P409, DOI 10.1099/0022-1317-66-3-409; Waris ME, 1997, J VIROL, V71, P6935, DOI 10.1128/JVI.71.9.6935-6939.1997; Williams MJ, 1997, EMBO J, V16, P6120, DOI 10.1093/emboj/16.20.6120; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Yoshimura A, 1999, J IMMUNOL, V163, P1	41	1232	1307	2	104	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2000	1	5					398	401		10.1038/80833	http://dx.doi.org/10.1038/80833			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	369PL	11062499				2022-12-18	WOS:000165076100012
J	Franchi, L; Eigenbrod, T; Munoz-Planillo, R; Nunez, G				Franchi, Luigi; Eigenbrod, Tatjana; Munoz-Planillo, Raul; Nunez, Gabriel			The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis	NATURE IMMUNOLOGY			English	Review							NF-KAPPA-B; NOD-LIKE RECEPTORS; MUCKLE-WELLS-SYNDROME; CASPASE-1 ACTIVATION; NALP3 INFLAMMASOME; HOST-DEFENSE; LISTERIA-MONOCYTOGENES; MURAMYL DIPEPTIDE; P2X(7) RECEPTOR; INNATE IMMUNITY	The inflammasome is a multiprotein complex that mediates the activation of caspase-1, which promotes secretion of the proinflammatory cytokines interleukin 1 beta (IL-1 beta) and IL-18, as well as 'pyroptosis', a form of cell death induced by bacterial pathogens. Members of the Nod-like receptor family, including NLRP1, NLRP3 and NLRC4, and the adaptor ASC are critical components of the inflammasome that link microbial and endogenous 'danger' signals to caspase-1 activation. Several diseases are associated with dysregulated activation of caspase-1 and secretion of IL-1 beta. Thus, understanding inflammasome pathways may provide insight into disease pathogenesis that might identify potential targets for therapeutic intervention.	[Nunez, Gabriel] Univ Michigan, Sch Med, Ctr Comprehens Canc, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Nunez, G (corresponding author), Univ Michigan, Sch Med, Ctr Comprehens Canc, Dept Pathol, Ann Arbor, MI 48109 USA.	bclx@umich.edu	Nuñez, Gabriel/A-7160-2014		National Institutes of Health; Arthritis Foundation; Jung-Stiftung fur Wissenschaft und Forschung; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063331, R01AI064748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; Jung-Stiftung fur Wissenschaft und Forschung; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We apologize to our colleagues whose work was not cited here because of space limitations. Supported by the National Institutes of Health, the Arthritis Foundation (L.F.) and the Jung-Stiftung fur Wissenschaft und Forschung (T. E.).	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; AM A, 2006, J BIOL CHEM, V281, P35217; Arenillas I, 2008, TERRA NOVA, V20, P38, DOI 10.1111/j.1365-3121.2007.00784.x; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Bruey JM, 2004, J BIOL CHEM, V279, P51897, DOI 10.1074/jbc.M406741200; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Cervantes J, 2008, CELL MICROBIOL, V10, P41, DOI 10.1111/j.1462-5822.2007.01012.x; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Dowds TA, 2003, BIOCHEM BIOPH RES CO, V302, P575, DOI 10.1016/S0006-291X(03)00221-3; Dowds TA, 2004, J BIOL CHEM, V279, P21924, DOI 10.1074/jbc.M401178200; Eigenbrod T, 2008, J IMMUNOL, V181, P8194, DOI 10.4049/jimmunol.181.12.8194; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; FERNANDESALNEMR.T, 2009, NATURE          0121, DOI DOI 10.1038/NATURE07710; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549; Franchi L, 2008, CELL MICROBIOL, V10, P1, DOI 10.1111/j.1462-5822.2007.01059.x; Franchi L, 2007, EUR J IMMUNOL, V37, P3030, DOI 10.1002/eji.200737532; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Franchi L, 2006, J IMMUNOL, V177, P3507, DOI 10.4049/jimmunol.177.6.3507; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Gattorno M, 2007, ARTHRITIS RHEUM, V56, P3138, DOI 10.1002/art.22842; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Grenier JM, 2002, FEBS LETT, V530, P73, DOI 10.1016/S0014-5793(02)03416-6; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hawkins PN, 2004, ARTHRITIS RHEUM-US, V50, P607, DOI 10.1002/art.20033; Hawkins PN, 2003, NEW ENGL J MED, V348, P2583, DOI 10.1056/NEJM200306193482523; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; HORNUNG V, 2009, NATURE          0121, DOI DOI 10.1038/NATURE07725; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Inohara N, 2001, ONCOGENE, V20, P6473, DOI 10.1038/sj.onc.1204787; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Ishii KJ, 2007, J CLIN IMMUNOL, V27, P363, DOI 10.1007/s10875-007-9087-x; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Kahlenberg JM, 2005, J IMMUNOL, V175, P7611, DOI 10.4049/jimmunol.175.11.7611; Kang TJ, 2008, EUR J IMMUNOL, V38, P1574, DOI 10.1002/eji.200838141; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kim YG, 2008, IMMUNITY, V28, P246, DOI 10.1016/j.immuni.2007.12.012; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Lamkanfi M, 2007, J LEUKOCYTE BIOL, V82, P220, DOI 10.1189/jlb.1206756; Lamkanfi M, 2007, J IMMUNOL, V178, P8022, DOI 10.4049/jimmunol.178.12.8022; Lamkanfi M, 2008, MOL CELL PROTEOMICS, V7, P2350, DOI 10.1074/mcp.M800132-MCP200; Leppla SH, 1999, J APPL MICROBIOL, V87, P284, DOI 10.1046/j.1365-2672.1999.00890.x; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; Lindblad EB, 2004, IMMUNOL CELL BIOL, V82, P497, DOI 10.1111/j.0818-9641.2004.01286.x; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Marina-Garcia N, 2008, J IMMUNOL, V180, P4050, DOI 10.4049/jimmunol.180.6.4050; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Masumoto J, 2006, J EXP MED, V203, P203, DOI 10.1084/jem.20051229; Masumoto J, 2003, BIOCHEM BIOPH RES CO, V303, P69, DOI 10.1016/S0006-291X(03)00309-7; McDonald C, 2005, J BIOL CHEM, V280, P20177, DOI 10.1074/jbc.R500001200; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Ozoren N, 2006, J IMMUNOL, V176, P4337, DOI 10.4049/jimmunol.176.7.4337; Pan QL, 2007, J LEUKOCYTE BIOL, V82, P177, DOI 10.1189/jlb.1006627; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Shaw MH, 2008, CURR OPIN IMMUNOL, V20, P377, DOI 10.1016/j.coi.2008.06.001; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; So A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2143; Sokolovska A, 2007, VACCINE, V25, P4575, DOI 10.1016/j.vaccine.2007.03.045; Sun YH, 2007, J BIOL CHEM, V282, P33897, DOI 10.1074/jbc.C700181200; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Suzuki T, 2007, PLOS PATHOG, V3, P1082, DOI 10.1371/journal.ppat.0030111; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Walev I, 2000, J IMMUNOL, V164, P5120, DOI 10.4049/jimmunol.164.10.5120; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Warren SE, 2008, J IMMUNOL, V180, P7558, DOI 10.4049/jimmunol.180.11.7558; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009; Ye ZM, 2008, CURR OPIN IMMUNOL, V20, P3, DOI 10.1016/j.coi.2008.01.003; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305	100	1225	1297	5	268	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2009	10	3					241	247		10.1038/ni.1703	http://dx.doi.org/10.1038/ni.1703			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	408SY	19221555	Green Accepted			2022-12-18	WOS:000263456500007
J	Wen, HT; Gris, D; Lei, Y; Jha, S; Zhang, L; Huang, MTH; Brickey, WJ; Ting, JPY				Wen, Haitao; Gris, Denis; Lei, Yu; Jha, Sushmita; Zhang, Lu; Huang, Max Tze-Han; Brickey, Willie June; Ting, Jenny P-Y			Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling	NATURE IMMUNOLOGY			English	Article							INNATE IMMUNITY; PROTEIN-KINASE; DIABETES-MELLITUS; ADIPOSE-TISSUE; TNF-ALPHA; RESISTANCE; AUTOPHAGY; EXPRESSION; IL-1-BETA; RECEPTORS	High-fat diet (HFD) and inflammation are key contributors to insulin resistance and type 2 diabetes (T2D). Interleukin (IL)-1 beta plays a role in insulin resistance, yet how IL-1 beta is induced by the fatty acids in an HFD, and how this alters insulin signaling, is unclear. We show that the saturated fatty acid palmitate, but not unsaturated oleate, induces the activation of the NLRP3-ASC inflammasome, causing caspase-1, IL-1 beta and IL-18 production. This pathway involves mitochondrial reactive oxygen species and the AMP-activated protein kinase and unc-51-like kinase-1 (ULK1) autophagy signaling cascade. Inflammasome activation in hematopoietic cells impairs insulin signaling in several target tissues to reduce glucose tolerance and insulin sensitivity. Furthermore, IL-1 beta affects insulin sensitivity through tumor necrosis factor-independent and dependent pathways. These findings provide insights into the association of inflammation, diet and T2D.	[Wen, Haitao; Gris, Denis; Lei, Yu; Jha, Sushmita; Zhang, Lu; Huang, Max Tze-Han; Brickey, Willie June; Ting, Jenny P-Y] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA; [Wen, Haitao; Gris, Denis; Ting, Jenny P-Y] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Lei, Yu; Zhang, Lu; Huang, Max Tze-Han] Univ N Carolina, Dept Oral Biol, Chapel Hill, NC USA; [Ting, Jenny P-Y] Univ N Carolina, Ctr Translat Immunol, Chapel Hill, NC USA; [Ting, Jenny P-Y] Univ N Carolina, Inflammatory Dis Inst, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Ting, JPY (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.	jenny_ting@med.unc.edu	Wen, Haitao/AAJ-7621-2020; Gris, Denis/ABE-5229-2021; Gris, Denis/AGA-1192-2022; Jha, Sushmita/I-8867-2019; Ariel, Pablo/AGJ-4118-2022; Lei, Yu Leo/ABF-1293-2020; Zhang, Lu/P-6929-2015	Gris, Denis/0000-0003-1215-2434; Gris, Denis/0000-0003-1215-2434; Jha, Sushmita/0000-0003-2336-5064; Lei, Yu Leo/0000-0002-9868-9824; 	US National Institutes of Health [R37-AI029564-17, CA-156330-01]; American Heart Association Mid-Atlantic Affiliate; Cancer Research Institute; NATIONAL CANCER INSTITUTE [R01CA156330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI029564] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Mid-Atlantic Affiliate(American Heart Association); Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank V. Dixit (Genentech), R. Flavell (Yale University), B. Koller (University of North Carolina at Chapel Hill) and D. Chaplin (University of Alabama at Birmingham) for gene-deletion mice; H. Shi (Wake Forest University) and D. Carling (Imperial College) for AMPK constructs; K. Hua from the University of North Carolina Nutrition Obesity Research Center for metabolic studies; V. Madden from the University of North Carolina Microscopy Services Laboratory for TEM analysis; L. Li and S. Wang for technical support; R. Coleman and M. Su for critique of the manuscript; and G. Hotamisligil, L. Makowski and J. Suttles for discussions. Supported by the US National Institutes of Health (R37-AI029564-17 and CA-156330-01 to J.P.-Y.T.) and American Heart Association Mid-Atlantic Affiliate and the Cancer Research Institute (H. W.).	Ahren B, 2009, NAT REV DRUG DISCOV, V8, P369, DOI 10.1038/nrd2782; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Boden G, 2002, CURR OPIN CLIN NUTR, V5, P545, DOI 10.1097/00075197-200209000-00014; Brookheart RT, 2009, CELL METAB, V10, P9, DOI 10.1016/j.cmet.2009.03.011; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Lagathu C, 2006, DIABETOLOGIA, V49, P2162, DOI 10.1007/s00125-006-0335-z; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Mandrup-Poulsen T, 2010, NAT REV ENDOCRINOL, V6, P158, DOI 10.1038/nrendo.2009.271; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Roden M, 2006, NAT CLIN PRACT ENDOC, V2, P335, DOI 10.1038/ncpendmet0190; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shornick LP, 1996, J EXP MED, V183, P1427, DOI 10.1084/jem.183.4.1427; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Ting JPY, 2010, SCIENCE, V327, P286, DOI 10.1126/science.1184004; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wang SX, 2010, CIRC RES, V106, P1117, DOI 10.1161/CIRCRESAHA.109.212530; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Yang ZG, 2010, J BIOL CHEM, V285, P19051, DOI 10.1074/jbc.M110.123620; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	50	1217	1261	8	181	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2011	12	5					408	U61		10.1038/ni.2022	http://dx.doi.org/10.1038/ni.2022			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	752CT	21478880	Green Accepted, Green Submitted			2022-12-18	WOS:000289666600011
J	Oeckinghaus, A; Hayden, MS; Ghosh, S				Oeckinghaus, Andrea; Hayden, Matthew S.; Ghosh, Sankar			Crosstalk in NF-kappa B signaling pathways	NATURE IMMUNOLOGY			English	Review							INDUCED GENE-EXPRESSION; INSULIN-RECEPTOR SUBSTRATE-1; TRAF-INTERACTING PROTEIN; INNATE IMMUNE-RESPONSES; NECROSIS-FACTOR-ALPHA; NECROTIC CELL-DEATH; TOLL-LIKE RECEPTORS; IKK-ALPHA; TRANSCRIPTION FACTORS; NF-KAPPA-B1 P105	NF-kappa B transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. A variety of stimuli coalesce on NF-kappa B activation, which can in turn mediate varied transcriptional programs. Consequently, NF-kappa B-dependent transcription is not only tightly controlled by positive and negative regulatory mechanisms but also closely coordinated with other signaling pathways. This intricate crosstalk is crucial to shaping the diverse biological functions of NF-kappa B into cell type- and context-specific responses.	[Oeckinghaus, Andrea; Hayden, Matthew S.; Ghosh, Sankar] Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10027 USA	Columbia University	Ghosh, S (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10027 USA.	sg2715@columbia.edu	Oeckinghaus, Andrea/AAW-9933-2020; Hayden, Matthew/C-1263-2008	Hayden, Matthew/0000-0003-1670-6430; Ghosh, Sankar/0000-0002-3227-0588	US National Institutes of Health [R37-AI33443]; American Heart Association	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	Supported by the US National Institutes of Health (R37-AI33443) and the American Heart Association (A.O.).	Agarwal A, 2005, ONCOGENE, V24, P1021, DOI 10.1038/sj.onc.1208296; Albanese C, 2003, MOL BIOL CELL, V14, P585, DOI 10.1091/mbc.02-06-0101; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Anest V, 2004, J BIOL CHEM, V279, P31183, DOI 10.1074/jbc.M404380200; Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Balkhi MY, 2010, CELL SIGNAL, V22, P117, DOI 10.1016/j.cellsig.2009.09.021; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Beinke S, 2004, MOL CELL BIOL, V24, P9658, DOI 10.1128/MCB.24.21.9658-9667.2004; Beinke S, 2003, MOL CELL BIOL, V23, P4739, DOI 10.1128/MCB.23.14.4739-4752.2003; Benedict CA, 2002, NAT IMMUNOL, V3, P1013, DOI 10.1038/ni1102-1013; Bettermann K, 2010, CANCER CELL, V17, P481, DOI 10.1016/j.ccr.2010.03.021; Biton S, 2011, CELL, V145, P92, DOI 10.1016/j.cell.2011.02.023; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Bohuslav J, 2004, J BIOL CHEM, V279, P26115, DOI 10.1074/jbc.M313509200; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Bracken CP, 2005, J BIOL CHEM, V280, P14240, DOI 10.1074/jbc.M409987200; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Bryce PJ, 2006, INT IMMUNOL, V18, P101, DOI 10.1093/intimm/dxh354; Carayol N, 2006, CELL SIGNAL, V18, P1941, DOI 10.1016/j.cellsig.2006.02.014; Chapuis N, 2010, BLOOD, V116, P4240, DOI 10.1182/blood-2009-12-260711; Chariot A, 2009, TRENDS CELL BIOL, V19, P404, DOI 10.1016/j.tcb.2009.05.006; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Cheng CS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001501; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Chung JY, 2002, J CELL SCI, V115, P679; CLARK K, 2011, BIOCHEM J, V27, P93; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Comer FI, 2000, J BIOL CHEM, V275, P29179, DOI 10.1074/jbc.R000010200; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Descargues P, 2008, P NATL ACAD SCI USA, V105, P2487, DOI 10.1073/pnas.0712044105; Ea CK, 2009, P NATL ACAD SCI USA, V106, P18972, DOI 10.1073/pnas.0910439106; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Ferrier R, 1999, ONCOGENE, V18, P995, DOI 10.1038/sj.onc.1202374; Frelin C, 2008, CELL DEATH DIFFER, V15, P152, DOI 10.1038/sj.cdd.4402240; Fujioka S, 2004, MOL CELL BIOL, V24, P7806, DOI 10.1128/MCB.24.17.7806-7819.2004; Fujita F, 2003, MOL CELL BIOL, V23, P7780, DOI 10.1128/MCB.23.21.7780-7793.2003; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Gerondakis S, 1999, ONCOGENE, V18, P6888, DOI 10.1038/sj.onc.1203236; Ghosh S, 2006, CANCER CELL, V10, P215, DOI 10.1016/j.ccr.2006.08.007; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Guo ZH, 1998, CELL, V94, P537, DOI 10.1016/S0092-8674(00)81594-9; Habib AA, 2001, J BIOL CHEM, V276, P8865, DOI 10.1074/jbc.M008458200; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Haller D, 2002, J BIOL CHEM, V277, P38168, DOI 10.1074/jbc.M205737200; Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; He JY, 2006, MOL ENDOCRINOL, V20, P114, DOI 10.1210/me.2005-0107; Hepp G, 2005, J BIOL CHEM, V280, P6610, DOI 10.1074/jbc.M412126200; Heyninck K, 1999, FEBS LETT, V442, P147, DOI 10.1016/S0014-5793(98)01645-7; HINZ M, 2007, SCI STKE, pPE19; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Hu YL, 2001, NATURE, V410, P710, DOI 10.1038/35070605; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Jones SJ, 1999, J IMMUNOL, V162, P1042; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kawagoe T, 2009, NAT IMMUNOL, V10, P965, DOI 10.1038/ni.1771; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kawauchi K, 2009, P NATL ACAD SCI USA, V106, P3431, DOI 10.1073/pnas.0813210106; Keshet Y, 2010, METHODS MOL BIOL, V661, P3, DOI 10.1007/978-1-60761-795-2_1; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Knox PG, 2011, J CELL BIOL, V192, P391, DOI 10.1083/jcb.201003087; Koga K, 2009, IMMUNITY, V30, P372, DOI 10.1016/j.immuni.2008.12.021; Kopp E, 1999, GENE DEV, V13, P2059, DOI 10.1101/gad.13.16.2059; Krappmann D, 2004, MOL CELL BIOL, V24, P6488, DOI 10.1128/MCB.24.14.6488-6500.2004; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Kwak YT, 2011, MOL CANCER RES, V9, P341, DOI 10.1158/1541-7786.MCR-10-0248; Kwak YT, 2005, J BIOL CHEM, V280, P33945, DOI 10.1074/jbc.M506206200; Lamberti C, 2001, J BIOL CHEM, V276, P42276, DOI 10.1074/jbc.M104227200; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Lang V, 2004, MOL CELL BIOL, V24, P5235, DOI 10.1128/MCB.24.12.5235-5248.2004; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Lee SH, 2004, P NATL ACAD SCI USA, V101, P17416, DOI 10.1073/pnas.0408061101; Lee SY, 1997, J EXP MED, V185, P1275, DOI 10.1084/jem.185.7.1275; Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6; Levkau B, 1999, NAT CELL BIOL, V1, P227, DOI 10.1038/12050; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Li S, 2009, MOL CELL, V33, P30, DOI 10.1016/j.molcel.2008.11.023; Li Y, 2008, J BIOL CHEM, V283, P26771, DOI 10.1074/jbc.M802800200; Li ZQ, 2003, BIOCHEM BIOPH RES CO, V309, P980, DOI 10.1016/j.bbrc.2003.08.104; Liang JA, 2010, J EXP MED, V207, P2959, DOI 10.1084/jem.20092641; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Lieberson R, 2001, J EXP MED, V194, P89, DOI 10.1084/jem.194.1.89; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Liu BG, 2008, CANCER CELL, V14, P212, DOI 10.1016/j.ccr.2008.07.017; Liu ZG, 2005, CELL RES, V15, P24, DOI 10.1038/sj.cr.7290259; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Lu T, 2010, P NATL ACAD SCI USA, V107, P46, DOI 10.1073/pnas.0912493107; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Matsuzawa A, 2008, SCIENCE, V321, P663, DOI 10.1126/science.1157340; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Meylan E, 2005, TRENDS BIOCHEM SCI, V30, P151, DOI 10.1016/j.tibs.2005.01.003; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Moquin D, 2010, TRENDS BIOCHEM SCI, V35, P434, DOI 10.1016/j.tibs.2010.03.001; Nakamori Y, 2006, J CELL BIOL, V173, P665, DOI 10.1083/jcb.200601065; Nomura F, 2000, GENES CELLS, V5, P191; O'Donnell MA, 2007, CURR BIOL, V17, P418, DOI 10.1016/j.cub.2007.01.027; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Ohazama A, 2004, DEV CELL, V6, P219, DOI 10.1016/S1534-5807(04)00024-3; Oshima S, 2009, NATURE, V457, P906, DOI 10.1038/nature07575; Osipo C, 2008, LAB INVEST, V88, P11, DOI 10.1038/labinvest.3700700; Ozes ON, 1999, NATURE, V401, P82; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Papa S, 2004, J CELL SCI, V117, P5197, DOI 10.1242/jcs.01483; Papoutsopoulou S, 2006, NAT IMMUNOL, V7, P606, DOI 10.1038/ni1334; Park KJ, 2005, MOL CELL, V18, P71, DOI 10.1016/j.molcel.2005.03.006; Park S, 2009, CANCER RES, V69, P4107, DOI 10.1158/0008-5472.CAN-09-0474; Pasparakis M, 2006, CELL DEATH DIFFER, V13, P861, DOI 10.1038/sj.cdd.4401870; Perkins ND, 1997, INT J BIOCHEM CELL B, V29, P1433, DOI 10.1016/S1357-2725(97)00088-5; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Polgar J, 2003, J BIOL CHEM, V278, P44369, DOI 10.1074/jbc.M307864200; Ramnarain DB, 2008, CELL DEATH DIFFER, V15, P344, DOI 10.1038/sj.cdd.4402268; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Ravi R, 1998, CANCER RES, V58, P4531; Reuther JY, 1999, J BIOL CHEM, V274, P20664, DOI 10.1074/jbc.274.29.20664; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Rocha S, 2005, EMBO J, V24, P1157, DOI 10.1038/sj.emboj.7600608; Rothe M, 1996, P NATL ACAD SCI USA, V93, P8241, DOI 10.1073/pnas.93.16.8241; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; SANCEAU J, 1995, J BIOL CHEM, V270, P27920, DOI 10.1074/jbc.270.46.27920; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Schomer-Miller B, 2006, J BIOL CHEM, V281, P15268, DOI 10.1074/jbc.M513793200; Schwabe RF, 2002, AM J PHYSIOL-GASTR L, V283, pG204, DOI 10.1152/ajpgi.00016.2002; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Shen RR, 2011, ONCOGENE, V30, P631, DOI 10.1038/onc.2010.493; Sil AK, 2004, NATURE, V428, P660, DOI 10.1038/nature02421; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Song LL, 2008, ONCOGENE, V27, P5833, DOI 10.1038/onc.2008.190; Song L, 2010, BBA-MOL CELL RES, V1803, P323, DOI 10.1016/j.bbamcr.2010.01.006; STEIN B, 1993, MOL CELL BIOL, V13, P7191, DOI 10.1128/MCB.13.11.7191; STEIN B, 1993, EMBO J, V12, P3879, DOI 10.1002/j.1460-2075.1993.tb06066.x; Suzuki K, 2008, CELL, V134, P485, DOI 10.1016/j.cell.2008.05.050; Tada K, 2001, J BIOL CHEM, V276, P36530, DOI 10.1074/jbc.M104837200; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Tang GL, 2001, MOL CELL, V8, P1005, DOI 10.1016/S1097-2765(01)00380-X; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tergaonkar V, 2002, CANCER CELL, V1, P493, DOI 10.1016/S1535-6108(02)00068-5; Thomas GS, 2009, CANCER RES, V69, P3665, DOI 10.1158/0008-5472.CAN-08-4867; Tilg H, 2008, MOL MED, V14, P222, DOI 10.2119/2007-00119.Tilg; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Vandenabeele P, 2008, TRENDS BIOCHEM SCI, V33, P352, DOI 10.1016/j.tibs.2008.05.007; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Verstrepen L, 2009, BIOCHEM PHARMACOL, V78, P105, DOI 10.1016/j.bcp.2009.02.009; Vilimas T, 2007, NAT MED, V13, P70, DOI 10.1038/nm1524; Vogel RO, 2007, GENE DEV, V21, P615, DOI 10.1101/gad.408407; Wajant H, 2001, CELL SIGNAL, V13, P389, DOI 10.1016/S0898-6568(01)00160-7; Wang D, 2000, J BIOL CHEM, V275, P32592, DOI 10.1074/jbc.M001358200; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wang RP, 2008, MOL IMMUNOL, V45, P1926, DOI 10.1016/j.molimm.2007.10.034; Wang TY, 2001, J IMMUNOL, V167, P6924, DOI 10.4049/jimmunol.167.12.6924; Waterfield M, 2004, MOL CELL BIOL, V24, P6040, DOI 10.1128/MCB.24.13.6040-6048.2004; Waterfield MR, 2003, MOL CELL, V11, P685, DOI 10.1016/S1097-2765(03)00070-4; Webster GA, 1999, MOL CELL BIOL, V19, P3485; Wei L, 2006, J BIOL CHEM, V281, P11678, DOI 10.1074/jbc.M513286200; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Wietek C, 2003, J BIOL CHEM, V278, P50923, DOI 10.1074/jbc.M308135200; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Wu RC, 2002, MOL CELL BIOL, V22, P3549, DOI 10.1128/MCB.22.10.3549-3561.2002; Xia CL, 1997, INT J BIOCHEM CELL B, V29, P1525, DOI 10.1016/S1357-2725(97)00083-6; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yang XD, 2009, EMBO J, V28, P1055, DOI 10.1038/emboj.2009.55; Yaspelkis BB, 2009, AM J PHYSIOL-REG I, V296, pR1709, DOI 10.1152/ajpregu.00117.2009; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zhang LQ, 2011, MOL BIOL CELL, V22, P128, DOI 10.1091/mbc.E10-06-0556; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X; Zhu F, 2007, MOL CELL, V27, P214, DOI 10.1016/j.molcel.2007.05.042	186	1215	1282	9	263	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2011	12	8					695	708		10.1038/ni.2065	http://dx.doi.org/10.1038/ni.2065			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	794BT	21772278				2022-12-18	WOS:000292870700005
J	Aluvihare, VR; Kallikourdis, M; Betz, AG				Aluvihare, VR; Kallikourdis, M; Betz, AG			Regulatory T cells mediate maternal tolerance to the fetus	NATURE IMMUNOLOGY			English	Article							TRYPTOPHAN CATABOLISM; PREGNANCY; SUPPRESSION; HOMEOSTASIS; PREVENTION; IMMUNOLOGY; MECHANISMS; SELECTION; REJECTION; DEPLETION	Pregnancy constitutes a major challenge to the maternal immune system, as it has to tolerate the persistence of paternal alloantigen. Although localized mechanisms contribute to fetal evasion from immune attack, maternal alloreactive lymphocytes persist. We demonstrate here an alloantigen-independent, systemic expansion of the maternal CD25(+) T cell pool during pregnancy and show that this population contains dominant regulatory T cell activity. In addition to their function in suppressing autoimmune responses, maternal regulatory T cells suppressed an aggressive allogeneic response directed against the fetus. Their absence led to a failure of gestation due to immunological rejection of the fetus.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Addenbrookes NHS Trust, Dept Med, Cambridge CB2 2YH, England	MRC Laboratory Molecular Biology; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital	Aluvihare, VR (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	vra1000@cus.cam.ac.uk; betz@mrc-lmb.cam.ac.uk	Kallikourdis, Marinos/AAA-5593-2019; Betz, Alexander/GQQ-2221-2022	Kallikourdis, Marinos/0000-0001-9318-3368; 	Medical Research Council [MC_U105184296] Funding Source: Medline; MRC [MC_U105184296] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Annacker O, 2001, IMMUNOL REV, V182, P5, DOI 10.1034/j.1600-065X.2001.1820101.x; Annunziato F, 2002, J EXP MED, V196, P379, DOI 10.1084/jem.20020110; Aseffa A, 2002, J IMMUNOL, V169, P3232, DOI 10.4049/jimmunol.169.6.3232; Barthlott T, 2003, J EXP MED, V197, P451, DOI 10.1084/jem.20021387; Beagley KW, 2003, FEMS IMMUNOL MED MIC, V38, P13, DOI 10.1016/S0928-8244(03)00202-5; Bystry RS, 2001, NAT IMMUNOL, V2, P1126, DOI 10.1038/ni735; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Golgher D, 2002, EUR J IMMUNOL, V32, P3267, DOI 10.1002/1521-4141(200211)32:11<3267::AID-IMMU3267>3.0.CO;2-1; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; HETHERINGTON CM, 1977, J IMMUNOGENET, V4, P271; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; James E, 2003, BLOOD, V102, P388, DOI 10.1182/blood-2002-10-3170; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Jiang SP, 1998, J IMMUNOL, V160, P3086; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Makrigiannakis A, 2001, NAT IMMUNOL, V2, P1018, DOI 10.1038/ni719; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; MATTSSON R, 1991, CLIN EXP IMMUNOL, V85, P41, DOI 10.1111/j.1365-2249.1991.tb05679.x; Mellor AL, 2001, NAT IMMUNOL, V2, P64, DOI 10.1038/83183; Mellor AL, 2000, ANNU REV IMMUNOL, V18, P367, DOI 10.1146/annurev.immunol.18.1.367; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Pearson H, 2002, NATURE, V420, P265, DOI 10.1038/420265a; Read S, 2001, CURR OPIN IMMUNOL, V13, P644, DOI 10.1016/S0952-7915(01)00273-4; RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P11520, DOI 10.1073/pnas.94.21.11520; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; TAFURI A, 1995, SCIENCE, V270, P630, DOI 10.1126/science.270.5236.630; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Thellin O, 2000, CURR OPIN IMMUNOL, V12, P731, DOI 10.1016/S0952-7915(00)00170-9; Xu CG, 2000, SCIENCE, V287, P498, DOI 10.1126/science.287.5452.498	33	1215	1298	2	109	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2004	5	3					266	271		10.1038/ni1037	http://dx.doi.org/10.1038/ni1037			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	779ZV	14758358				2022-12-18	WOS:000189344600009
J	Bettelli, E; Oukka, M; Kuchroo, VK				Bettelli, Estelle; Oukka, Mohamed; Kuchroo, Vijay K.			T-H-17 cells in the circle of immunity and autoimmunity	NATURE IMMUNOLOGY			English	Article							REGULATORY T-CELLS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR-BETA; IFN-GAMMA; IL-17 PRODUCTION; TGF-BETA; INTERLEUKIN-17 FAMILY; TRANSCRIPTION FACTOR; RECEPTOR ANTAGONIST	CD4(+) effector T cells have been categorized into two subsets: T helper type 1 ( T(H)1) and T(H)2. Another subset of T cells that produce interleukin 17 ( IL-17; 'T-H-17 cells') has been identified that is highly proinflammatory and induces severe autoimmunity. Whereas IL-23 serves to expand previously differentiated T-H-17 cell populations, IL-6 and transforming growth factor-beta ( TGF-beta) induce the differentiation of T-H-17 cells from naive precursors. These data suggest a dichotomy between CD4(+) regulatory T cells positive for the transcription factor Foxp3 and T-H-17 cells: TGF-beta induces Foxp3 and generates induced regulatory T cells, whereas IL-6 inhibits TGF-beta-driven Foxp3 expression and together with TGF-beta induces TH-17 cells. Emerging data regarding T-H-17 cells suggest a very important function for this T cell subset in immunity and disease.	Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Ctr Neurol Dis, Brigham & Womens Hosp, Sch Med, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Bettelli, E (corresponding author), Brigham & Womens Hosp, Ctr Neurol Dis, 75 Francis St, Boston, MA 02115 USA.	vkuchroo@rics.bwh.harvard.edu						Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1; AKIMZHANOV AM, 2007, J BIOL CHEM     0111; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Bettelli E, 2005, J EXP MED, V201, P169, DOI 10.1084/jem.20042279; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bush KA, 2002, ARTHRITIS RHEUM-US, V46, P802, DOI 10.1002/art.10173; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen Y, 2006, J CLIN INVEST, V116, P1317, DOI 10.1172/JCI25308; Chitnis T, 2001, J CLIN INVEST, V108, P739, DOI 10.1172/JCI200112563; Chung YS, 2006, CELL RES, V16, P902, DOI 10.1038/sj.cr.7310106; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dzhagalov I, 2004, CELL MOL IMMUNOL, V1, P401; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Faria Ana M. C., 2006, Inflammation & Allergy Drug Targets, V5, P179; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hashimoto T, 2005, INT ARCH ALLERGY IMM, V137, P51, DOI 10.1159/000085432; Hofstetter HH, 2005, CELL IMMUNOL, V237, P123, DOI 10.1016/j.cellimm.2005.11.002; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jones LS, 1997, J IMMUNOL, V158, P5997; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; KHOURY SJ, 1992, J EXP MED, V176, P1355, DOI 10.1084/jem.176.5.1355; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; KORN T, IN PRESS NAT MED; Krakowski M, 1996, EUR J IMMUNOL, V26, P1641, DOI 10.1002/eji.1830260735; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Linden A, 2000, EUR RESPIR J, V15, P973, DOI 10.1034/j.1399-3003.2000.15e28.x; Liu XKK, 2005, MOL CELLS, V20, P339; Lohr J, 2006, J EXP MED, V203, P2785, DOI 10.1084/jem.20061341; Lovett-Racke AE, 2004, IMMUNITY, V21, P719, DOI 10.1016/j.immuni.2004.09.010; Maini RN, 2006, ARTHRITIS RHEUM-US, V54, P2817, DOI 10.1002/art.22033; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mathur AN, 2006, BLOOD, V108, P1595, DOI 10.1182/blood-2006-04-015016; Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206; MERRILL JE, 1992, P NATL ACAD SCI USA, V89, P574, DOI 10.1073/pnas.89.2.574; Moseley TA, 2003, CYTOKINE GROWTH F R, V14, P155, DOI 10.1016/S1359-6101(03)00002-9; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nakae S, 2003, P NATL ACAD SCI USA, V100, P5986, DOI 10.1073/pnas.1035999100; PANITCH HS, 1992, DRUGS, V44, P946, DOI 10.2165/00003495-199244060-00004; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Peng YF, 2004, P NATL ACAD SCI USA, V101, P4572, DOI 10.1073/pnas.0400810101; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; POWRIE F, 1993, IMMUNOL TODAY, V14, P270, DOI 10.1016/0167-5699(93)90044-L; Rangachari M, 2006, J EXP MED, V203, P2009, DOI 10.1084/jem.20052222; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Segal BM, 1998, J EXP MED, V187, P537, DOI 10.1084/jem.187.4.537; Shevach EM, 2006, IMMUNITY, V25, P195, DOI 10.1016/j.immuni.2006.08.003; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tran EH, 2000, J IMMUNOL, V164, P2759, DOI 10.4049/jimmunol.164.5.2759; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wan YSY, 2006, IMMUNOL REV, V212, P114, DOI 10.1111/j.0105-2896.2006.00407.x; Willenborg DO, 1999, J IMMUNOL, V163, P5278; Willenborg DO, 1996, J IMMUNOL, V157, P3223; Wolk K, 2006, CYTOKINE GROWTH F R, V17, P367, DOI 10.1016/j.cytogfr.2006.09.001; Wong CK, 2000, LUPUS, V9, P589, DOI 10.1191/096120300678828703; Woo P, 2005, ARTHRITIS RES THER, V7, pR1281, DOI 10.1186/ar1826; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	73	1208	1320	2	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2007	8	4					345	350		10.1038/ni0407-345	http://dx.doi.org/10.1038/ni0407-345			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	148LK	17375096				2022-12-18	WOS:000245075900009
J	Fillatreau, S; Sweenie, CH; McGeachy, MJ; Gray, D; Anderton, SM				Fillatreau, S; Sweenie, CH; McGeachy, MJ; Gray, D; Anderton, SM			B cells regulate autoimmunity by provision of IL-10	NATURE IMMUNOLOGY			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; ENCEPHALITOGENIC T-CELLS; CENTRAL-NERVOUS-SYSTEM; INTERLEUKIN-10-DEFICIENT MICE; TARGETING AUTOANTIGEN; TRANSGENIC MICE; DEFICIENT MICE; BASIC-PROTEIN; B-1 CELLS	To assess the importance of B cell control of T cell differentiation, we analyzed the course of the T helper type 1 (T(H)1)-driven disease experimental autoimmune encephalomyelitis in mice with an altered B cell compartment. We found that recovery was dependent on the presence of autoantigen-reactive B cells. B cells from recovered mice produced interleukin 10 (IL-10) in response to autoantigen. With a bone marrow chimeric system, we generated mice in which IL-10 deficiency was restricted to B cells but not T cells. In the absence of IL-10 production by B cells, the proinflammatory type 1 immune response persisted and mice did not recover. These data show that B cell-derived IL-10 plays a key role in controlling autoimmunity.	Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland	University of Edinburgh	Anderton, SM (corresponding author), Univ Edinburgh, Inst Cell Anim & Populat Biol, Kings Bldg W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.		Gray, David/L-8295-2013	Gray, David/0000-0003-3785-4934; Fillatreau, Simon/0000-0002-7730-9917				Beech JT, 1997, J IMMUNOL METHODS, V205, P163, DOI 10.1016/S0022-1759(97)00072-0; Bettelli E, 1998, J IMMUNOL, V161, P3299; Cannella B, 1996, J NEUROSCI RES, V45, P735, DOI 10.1002/(SICI)1097-4547(19960915)45:6<735::AID-JNR10>3.0.CO;2-V; Chan O, 1998, J IMMUNOL, V160, P51; Colgan SP, 1999, P NATL ACAD SCI USA, V96, P13938, DOI 10.1073/pnas.96.24.13938; Croxford JL, 2001, J IMMUNOL, V166, P4124, DOI 10.4049/jimmunol.166.6.4124; Cua DJ, 1999, J EXP MED, V189, P1005, DOI 10.1084/jem.189.6.1005; Cumberbatch M, 1997, IMMUNOLOGY, V92, P388, DOI 10.1046/j.1365-2567.1997.00360.x; D'Amico G, 2000, NAT IMMUNOL, V1, P387, DOI 10.1038/80819; DAY MJ, 1992, J EXP MED, V175, P655, DOI 10.1084/jem.175.3.655; Fulcher DA, 1996, J EXP MED, V183, P2313, DOI 10.1084/jem.183.5.2313; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Harris DP, 2000, NAT IMMUNOL, V1, P475, DOI 10.1038/82717; Herzenberg LA, 2000, IMMUNOL REV, V175, P9, DOI 10.1111/j.1600-065X.2000.imr017520.x; Iglesias A, 2001, GLIA, V36, P220, DOI 10.1002/glia.1111; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; KENNEDY MK, 1992, J IMMUNOL, V149, P2496; KHOURY SJ, 1992, J EXP MED, V176, P1355, DOI 10.1084/jem.176.5.1355; KITAMURA D, 1992, NATURE, V356, P154, DOI 10.1038/356154a0; KUCHROO VK, 1993, J IMMUNOL, V151, P4371; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lyons JA, 1999, EUR J IMMUNOL, V29, P3432, DOI 10.1002/(SICI)1521-4141(199911)29:11<3432::AID-IMMU3432>3.0.CO;2-2; Macaulay AE, 1997, J IMMUNOL, V158, P4171; Maldonado-Lopez R, 2001, J IMMUNOL, V167, P4345, DOI 10.4049/jimmunol.167.8.4345; MARTIN R, 1995, CRIT REV CL LAB SCI, V32, P121, DOI 10.3109/10408369509084683; Mathisen PM, 1997, J EXP MED, V186, P159, DOI 10.1084/jem.186.1.159; Mauri C, 2000, NAT MED, V6, P673, DOI 10.1038/76251; MENDEL I, 1995, EUR J IMMUNOL, V25, P1951, DOI 10.1002/eji.1830250723; Miller JFAP, 1996, CURR OPIN IMMUNOL, V8, P815, DOI 10.1016/S0952-7915(96)80010-0; Mizoguchi A, 2002, IMMUNITY, V16, P219, DOI 10.1016/S1074-7613(02)00274-1; Moulin V, 2000, J EXP MED, V192, P475, DOI 10.1084/jem.192.4.475; MYERS KJ, 1992, J NEUROIMMUNOL, V41, P1, DOI 10.1016/0165-5728(92)90188-Q; OGARRA A, 1992, EUR J IMMUNOL, V22, P711, DOI 10.1002/eji.1830220314; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; Rothstein M, 2001, FR FORUM, V26, P1, DOI 10.1353/frf.2001.0010; Samoilova EB, 1998, CELL IMMUNOL, V188, P118, DOI 10.1006/cimm.1998.1365; SAOUDI A, 1995, J EXP MED, V182, P335, DOI 10.1084/jem.182.2.335; Segal BM, 1998, J EXP MED, V187, P537, DOI 10.1084/jem.187.4.537; Singh AK, 2001, J EXP MED, V194, P1801, DOI 10.1084/jem.194.12.1801; Skok J, 1999, J IMMUNOL, V163, P4284; Stockinger B, 1996, J EXP MED, V183, P891, DOI 10.1084/jem.183.3.891; Whitmore AC, 1996, INT IMMUNOL, V8, P533, DOI 10.1093/intimm/8.4.533; Wolf SD, 1996, J EXP MED, V184, P2271, DOI 10.1084/jem.184.6.2271; Xiao BG, 1998, J NEUROIMMUNOL, V84, P230, DOI 10.1016/S0165-5728(97)00264-6; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6	45	1198	1257	2	42	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2002	3	10					944	950		10.1038/ni833	http://dx.doi.org/10.1038/ni833			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	597VU	12244307				2022-12-18	WOS:000178242100015
J	Sheppard, P; Kindsvogel, W; Xu, WF; Henderson, K; Schlutsmeyer, S; Whitmore, TE; Kuestner, R; Garrigues, U; Birks, C; Roraback, J; Ostrander, C; Dong, D; Shin, J; Presnell, S; Fox, B; Haldeman, B; Cooper, E; Taft, D; Gilbert, T; Grant, FJ; Tackett, M; Krivan, W; McKnight, G; Clegg, C; Foster, D; Klucher, KM				Sheppard, P; Kindsvogel, W; Xu, WF; Henderson, K; Schlutsmeyer, S; Whitmore, TE; Kuestner, R; Garrigues, U; Birks, C; Roraback, J; Ostrander, C; Dong, D; Shin, J; Presnell, S; Fox, B; Haldeman, B; Cooper, E; Taft, D; Gilbert, T; Grant, FJ; Tackett, M; Krivan, W; McKnight, G; Clegg, C; Foster, D; Klucher, KM			IL-28, IL-29 and their class II cytokine receptor IL-28R	NATURE IMMUNOLOGY			English	Article							INTERLEUKIN-10 RECEPTOR; FUNCTIONAL-CHARACTERIZATION; MOLECULAR-CLONING; INTERFERON-ALPHA; INDUCIBLE FACTOR; CELLS; IDENTIFICATION; EXPRESSION; IL-10; COMPLEX	Cytokines play a critical role in modulating the innate and adaptive immune systems. Here, we have identified from the human genomic sequence a family of three cytokines, designated interleukin 28A (IL-28A), IL-28B and IL-29, that are distantly related to type I interferons (IFNs) and the IL- 10 family. We found that like type I IFNs, IL- 28 and IL- 29 were induced by viral infection and showed antiviral activity. However, IL- 28 and IL- 29 interacted with a heterodimeric class II cytokine receptor that consisted of IL-10 receptor beta (IL-10Rbeta) and an orphan class II receptor chain, designated IL-28Ralpha. This newly described cytokine family may serve as an alternative to type I IFNs in providing immunity to viral infection.	Zymogenet Inc, Seattle, WA 98102 USA	Zymogenet Inc.	Klucher, KM (corresponding author), Zymogenet Inc, 1201 Eastlake Ave E, Seattle, WA 98102 USA.			Fox, Brian/0000-0001-6620-3853				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BERG K, 1990, APMIS, V98, P156, DOI 10.1111/j.1699-0463.1990.tb01016.x; Biron CA, 1998, SEMIN IMMUNOL, V10, P383, DOI 10.1006/smim.1998.0138; Blumberg H, 2001, CELL, V104, P9, DOI 10.1016/S0092-8674(01)00187-8; Buelens C, 2002, BLOOD, V99, P993, DOI 10.1182/blood.V99.3.993; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; DE WMR, 1991, J EXP MED, V174, P1209; Dondi E, 2001, J BIOL CHEM, V276, P47004, DOI 10.1074/jbc.M104316200; Dumoutier L, 2000, P NATL ACAD SCI USA, V97, P10144, DOI 10.1073/pnas.170291697; Dusheiko G., 1997, HEPATOLOGY S1, V26, p112S; Familletti P C, 1981, Methods Enzymol, V78, P387; FELLOUS M, 1982, P NATL ACAD SCI-BIOL, V79, P3082, DOI 10.1073/pnas.79.10.3082; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; GUTTERMAN JU, 1994, P NATL ACAD SCI USA, V91, P1198, DOI 10.1073/pnas.91.4.1198; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Kotenko SV, 2002, CYTOKINE GROWTH F R, V13, P223, DOI 10.1016/S1359-6101(02)00012-6; Kotenko SV, 1997, EMBO J, V16, P5894, DOI 10.1093/emboj/16.19.5894; Kotenko SV, 2001, J BIOL CHEM, V276, P2725, DOI 10.1074/jbc.M007837200; LaFleur DW, 2001, J BIOL CHEM, V276, P39765, DOI 10.1074/jbc.M102502200; LIU Y, 1994, J IMMUNOL, V152, P1821; Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; NOVICK D, 1994, CELL, V77, P391, DOI 10.1016/0092-8674(94)90154-6; Oritani K, 2000, NAT MED, V6, P659, DOI 10.1038/76233; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.bi.56.070187.003455; Radhakrishnan R, 1996, STRUCTURE, V4, P1453, DOI 10.1016/S0969-2126(96)00152-9; RAJ NBK, 1983, P NATL ACAD SCI-BIOL, V80, P3923, DOI 10.1073/pnas.80.13.3923; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; UZE G, 1990, CELL, V60, P225, DOI 10.1016/0092-8674(90)90738-Z; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; WeberNordt RM, 1996, J BIOL CHEM, V271, P27954, DOI 10.1074/jbc.271.44.27954; Xie MH, 2000, J BIOL CHEM, V275, P31335, DOI 10.1074/jbc.M005304200; Xu WF, 2001, P NATL ACAD SCI USA, V98, P9511, DOI 10.1073/pnas.171303198; ZDANOV A, 1995, STRUCTURE, V3, P591, DOI 10.1016/S0969-2126(01)00193-9	35	1196	1390	2	61	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2003	4	1					63	68		10.1038/ni873	http://dx.doi.org/10.1038/ni873			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	629MG	12469119				2022-12-18	WOS:000180053000016
J	Davies, LC; Jenkins, SJ; Allen, JE; Taylor, PR				Davies, Luke C.; Jenkins, Stephen J.; Allen, Judith E.; Taylor, Philip R.			Tissue-resident macrophages	NATURE IMMUNOLOGY			English	Review							MARGINAL METALLOPHILIC MACROPHAGES; LANGERHANS CELLS; DENDRITIC CELL; APOPTOTIC CELLS; ALTERNATIVE ACTIVATION; PERITONEAL-MACROPHAGES; ALVEOLAR MACROPHAGES; ZONE MACROPHAGES; MYELOID CELLS; PPAR-GAMMA	Tissue-resident macrophages are a heterogeneous population of immune cells that fulfill tissue-specific and niche-specific functions. These range from dedicated homeostatic functions, such as clearance of cellular debris and iron processing, to central roles in tissue immune surveillance, response to infection and the resolution of inflammation. Recent studies highlight marked heterogeneity in the origins of tissue macrophages that arise from hematopoietic versus self-renewing embryo-derived populations. We discuss the tissue niche-specific factors that dictate cell phenotype, the definition of which will allow new strategies to promote the restoration of tissue homeostasis. Understanding the mechanisms that dictate tissue macrophage heterogeneity should explain why simplified models of macrophage activation do not explain the extent of heterogeneity seen in vivo.	[Davies, Luke C.; Taylor, Philip R.] Cardiff Univ, Sch Med, Cardiff Inst Infect & Immun, Cardiff CF10 3AX, S Glam, Wales; [Jenkins, Stephen J.] Univ Edinburgh, Queens Med Res Inst, Med Res Council Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Allen, Judith E.] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland; [Allen, Judith E.] Univ Edinburgh, Inst Immunol & Infect Res, Sch Biol Sci, Edinburgh, Midlothian, Scotland	Cardiff University; University of Edinburgh; University of Edinburgh; University of Edinburgh	Taylor, PR (corresponding author), Cardiff Univ, Sch Med, Cardiff Inst Infect & Immun, Cardiff CF10 3AX, S Glam, Wales.	taylorpr@cf.ac.uk	Allen, Judith E/C-9198-2011	Allen, Judith E/0000-0002-3829-066X; Taylor, Philip/0000-0003-0163-1421; Jenkins, Stephen/0000-0002-0233-5424; Davies, Luke/0000-0001-7767-4060	Medical Research Council (MRC) [G0601617/1, MR/J002151/1, MR/K02003X/1]; Wellcome Trust [097824/Z/11]; MRC; Cardiff University; University of Edinburgh;  [MR/K01207X/1]; MRC [MR/K01207X/1, G0600818, MR/J002151/1, G0601617, MR/K02003X/1] Funding Source: UKRI; Medical Research Council [984199, G0600818, G0601617, MR/K02003X/1, MR/J002151/1, MR/K01207X/1] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cardiff University; University of Edinburgh; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by funding from the Medical Research Council (MRC), including Senior Fellowship and Project grants to P. R. T. (G0601617/1, MR/J002151/1 and MR/K02003X/1) and a Programme grant to J.E.A. (MR/K01207X/1). P. R. T. is additionally supported through a Wellcome Trust Institutional Strategic Support Fund (097824/Z/11). L. C. D. is an MRC-funded PhD student and holds a Cardiff University 125 for 125 Scholarship. S.J.J. is funded by a University of Edinburgh Chancellor's Fellowship.	A-Gonzalez N, 2013, NAT IMMUNOL, V14, P831, DOI 10.1038/ni.2622; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Ajuebor MN, 1999, J IMMUNOL, V162, P1685; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Allen JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002003; Antoniades CG, 2012, HEPATOLOGY, V56, P735, DOI 10.1002/hep.25657; Aschoff L., 1924, ERG INN MED KINDERHK, V26, P1, DOI [DOI 10.1007/978-3-642-90639-8_1, 10.1007/978-3-642-90639-8_1]; Backer R, 2010, P NATL ACAD SCI USA, V107, P216, DOI 10.1073/pnas.0909541107; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; BARTH MW, 1995, J LEUKOCYTE BIOL, V57, P361, DOI 10.1002/jlb.57.3.361; Bedoret D, 2009, J CLIN INVEST, V119, P3723, DOI 10.1172/JCI39717; Bellingan GJ, 2002, J EXP MED, V196, P1515, DOI 10.1084/jem.20011794; Cailhier JF, 2005, J IMMUNOL, V174, P2336, DOI 10.4049/jimmunol.174.4.2336; Cailhier JFO, 2006, AM J RESP CRIT CARE, V173, P540, DOI 10.1164/rccm.200504-538OC; Cao CZ, 2005, BLOOD, V106, P3234, DOI 10.1182/blood-2005-03-1288; Capotondo A, 2012, P NATL ACAD SCI USA, V109, P15018, DOI 10.1073/pnas.1205858109; Carey B, 2010, CLIN IMMUNOL, V135, P223, DOI 10.1016/j.clim.2010.02.017; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; Chihara T, 2010, CELL DEATH DIFFER, V17, P1917, DOI 10.1038/cdd.2010.60; Chorro L, 2010, TRENDS IMMUNOL, V31, P438, DOI 10.1016/j.it.2010.09.003; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; Chow A, 2013, NAT MED, V19, P429, DOI 10.1038/nm.3057; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; CZERNIELEWSKI JM, 1987, J INVEST DERMATOL, V88, P17, DOI 10.1111/1523-1747.ep12464659; Daems W.T., 1971, RETICULOENDOTHELIAL, V15, P19; Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877; Davies LC, 2011, EUR J IMMUNOL, V41, P2155, DOI 10.1002/eji.201141817; den Haan JMM, 2012, J INNATE IMMUN, V4, P437, DOI 10.1159/000335216; Dioszeghy V, 2008, J IMMUNOL, V181, P6514, DOI 10.4049/jimmunol.181.9.6514; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Dupasquier M, 2006, J LEUKOCYTE BIOL, V80, P838, DOI 10.1189/jlb.1005564; ELOMAA O, 1995, CELL, V80, P603, DOI 10.1016/0092-8674(95)90514-6; Eloranta ML, 1999, SCAND J IMMUNOL, V49, P391; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; Fainaru O, 2004, EMBO J, V23, P969, DOI 10.1038/sj.emboj.7600085; Ganz T, 2012, J INNATE IMMUN, V4, P446, DOI 10.1159/000336423; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gautier EL, 2012, J IMMUNOL, V189, P2614, DOI 10.4049/jimmunol.1200495; Geijtenbeek TBH, 2002, BLOOD, V100, P2908, DOI 10.1182/blood-2002-04-1044; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Henson PM, 2006, TRENDS IMMUNOL, V27, P244, DOI 10.1016/j.it.2006.03.005; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Honke N, 2012, NAT IMMUNOL, V13, P51, DOI 10.1038/ni.2169; Hume DA, 2012, BLOOD, V119, P1810, DOI 10.1182/blood-2011-09-379214; Hvidberg V, 2005, BLOOD, V106, P2572, DOI 10.1182/blood-2005-03-1185; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Isbel NM, 2001, NEPHROL DIAL TRANSPL, V16, P1638, DOI 10.1093/ndt/16.8.1638; Jakubzick C, 2006, J IMMUNOL, V176, P3578, DOI 10.4049/jimmunol.176.6.3578; Janssen WJ, 2011, AM J RESP CRIT CARE, V184, P547, DOI 10.1164/rccm.201011-1891OC; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kang YS, 2004, P NATL ACAD SCI USA, V101, P215, DOI 10.1073/pnas.0307124101; Kanitakis J, 2004, NEW ENGL J MED, V351, P2661, DOI 10.1056/NEJM200412163512523; Karlsson MCI, 2003, J EXP MED, V198, P333, DOI 10.1084/jem.20030684; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Khan TN, 2013, J IMMUNOL, V190, P1433, DOI 10.4049/jimmunol.1200824; Kirby AC, 2009, J IMMUNOL, V183, P1983, DOI 10.4049/jimmunol.0901089; Klaas M, 2012, J IMMUNOL, V189, P2414, DOI 10.4049/jimmunol.1200776; Klein I, 2007, BLOOD, V110, P4077, DOI 10.1182/blood-2007-02-073841; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Kolaczkowska E, 2007, IMMUNOL LETT, V113, P99, DOI 10.1016/j.imlet.2007.07.017; Kolaczkowska E, 2009, ARCH IMMUNOL THER EX, V57, P459, DOI 10.1007/s00005-009-0053-6; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Landsman L, 2007, J IMMUNOL, V178, P2000, DOI 10.4049/jimmunol.178.4.2000; Lanoue A, 2004, J EXP MED, V200, P1383, DOI 10.1084/jem.20040795; Lauder SN, 2011, THORAX, V66, P368, DOI 10.1136/thx.2010.150318; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Lichanska AM, 2000, EXP HEMATOL, V28, P601, DOI 10.1016/S0301-472X(00)00157-0; Liddiard K, 2011, EUR J IMMUNOL, V41, P2503, DOI 10.1002/eji.201141743; Liu HL, 2012, BBA-PROTEINS PROTEOM, V1824, P938, DOI 10.1016/j.bbapap.2012.04.012; London A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00034; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Manderson AP, 2004, ANNU REV IMMUNOL, V22, P431, DOI 10.1146/annurev.immunol.22.012703.104549; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Maus UA, 2002, AM J PHYSIOL-LUNG C, V282, pL1245, DOI 10.1152/ajplung.00453.2001; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; MELNICOFF MJ, 1988, J LEUKOCYTE BIOL, V44, P367, DOI 10.1002/jlb.44.5.367; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455; Metchnikoff E, 1892, LECONS PATHOLOGIE CO; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Murphy J, 2008, AM J RESP CELL MOL, V38, P380, DOI 10.1165/rcmb.2007-0224RC; Nagata S, 2007, IMMUNOL REV, V220, P237, DOI 10.1111/j.1600-065X.2007.00571.x; Naito M, 1996, J LEUKOCYTE BIOL, V59, P133, DOI 10.1002/jlb.59.2.133; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; PARWARESCH MR, 1984, CELL TISSUE KINET, V17, P25, DOI 10.1111/j.1365-2184.1984.tb00565.x; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Quinn JMW, 1999, BONE, V25, P1, DOI 10.1016/S8756-3282(99)00094-0; Rosas M, 2008, J IMMUNOL, V181, P3549, DOI 10.4049/jimmunol.181.5.3549; Rosas M, 2010, J LEUKOCYTE BIOL, V88, P169, DOI 10.1189/jlb.0809548; Ryan GR, 2001, BLOOD, V98, P74, DOI 10.1182/blood.V98.1.74; Sabin F. R., 1925, Contributions to Embryology, V16, P125; Sadahira Y, 1999, PATHOL INT, V49, P841, DOI 10.1046/j.1440-1827.1999.00954.x; Satoh T, 2013, NATURE, V495, P524, DOI 10.1038/nature11930; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; SAWYER RT, 1982, LAB INVEST, V46, P165; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Seitz HM, 2007, J IMMUNOL, V178, P5635, DOI 10.4049/jimmunol.178.9.5635; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Takahashi K., 2000, J CLIN EXP HEM, V41, P1; Taylor PR, 2005, EUR J IMMUNOL, V35, P2163, DOI 10.1002/eji.200425785; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Uderhardt S, 2012, IMMUNITY, V36, P834, DOI 10.1016/j.immuni.2012.03.010; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; VANFURTH R, 1972, B WORLD HEALTH ORGAN, V46, P845; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Yang NS, 1998, KIDNEY INT, V54, P143, DOI 10.1046/j.1523-1755.1998.00978.x; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Yoshida H, 2005, NATURE, V437, P754, DOI 10.1038/nature03964; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146; Zigmond E, 2013, TRENDS IMMUNOL, V34, P162, DOI 10.1016/j.it.2013.02.001	134	1181	1211	16	294	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2013	14	10					986	995		10.1038/ni.2705	http://dx.doi.org/10.1038/ni.2705			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	220LH	24048120	Green Accepted			2022-12-18	WOS:000324584700003
J	McGeachy, MJ; Bak-Jensen, KS; Chen, Y; Tato, CM; Blumenschein, W; McClanahan, T; Cua, DJ				McGeachy, Mandy J.; Bak-Jensen, Kristian S.; Chen, Yi; Tato, Cristina M.; Blumenschein, Wendy; McClanahan, Terrill; Cua, Daniel J.			TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell-mediated pathology	NATURE IMMUNOLOGY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; TRANSFORMING GROWTH-FACTOR-BETA-1; CHRONIC INFLAMMATION; MULTIPLE-SCLEROSIS; IMMUNE PATHOLOGY; TRANSGENIC MICE; CUTTING EDGE; HELPER-CELLS	Studies have shown that transforming growth factor-beta (TGF-beta) and interleukin 6 (IL-6) are required for the lineage commitment of pathogenic IL-17- producing T helper cells ( T(H)- 17 cells). Unexpectedly, here we found that stimulation of myelin-reactive T cells with TGF-beta plus IL-6 completely abrogated their pathogenic function despite upregulation of IL-17 production. Cells stimulated with TGF-beta plus IL- 6 were present in the spleen as well as the central nervous system, but they failed to upregulate the proinflammatory chemokines crucial for central nervous system inflammation. In addition, these cells produced IL- 10, which has potent anti-inflammatory activities. In contrast, stimulation with IL- 23 promoted expression of IL- 17 and proinflammatory chemokines but not IL-10. Hence, TGF-beta and IL- 6 'drive' initial lineage commitment but also 'restrain' the pathogenic potential of TH- 17 cells. Our findings suggest that full acquisition of pathogenic function by effector T(H)- 17 cells is mediated by IL- 23 rather than by TGF-beta and IL-6.	Schering Plough Biopharma, Palo Alto, CA 94304 USA	Merck & Company	Cua, DJ (corresponding author), Schering Plough Biopharma, Palo Alto, CA 94304 USA.	daniel.cua@dnax.org		Tato, Cristina M./0000-0002-0614-756X				Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; Baecher-Allan C, 2004, J EXP MED, V200, P273, DOI 10.1084/jem.20040812; Bailey SL, 2007, NAT IMMUNOL, V8, P172, DOI 10.1038/ni1430; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 1998, J IMMUNOL, V161, P3299; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; Chen YH, 1998, J NEUROIMMUNOL, V82, P149, DOI 10.1016/S0165-5728(97)00193-8; Columba-Cabezas S, 2002, J NEUROIMMUNOL, V130, P10, DOI 10.1016/S0165-5728(02)00170-4; Cua DJ, 2006, NAT IMMUNOL, V7, P557, DOI 10.1038/ni0606-557; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Cua DJ, 1999, J EXP MED, V189, P1005, DOI 10.1084/jem.189.6.1005; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; GODISKA R, 1995, J NEUROIMMUNOL, V58, P167, DOI 10.1016/0165-5728(95)00008-P; Huang DR, 2001, J EXP MED, V193, P713, DOI 10.1084/jem.193.6.713; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Karpus WJ, 1998, J IMMUNOL, V161, P2667; Kent SC, 1997, ANN NY ACAD SCI, V815, P412, DOI 10.1111/j.1749-6632.1997.tb52092.x; Kleinschek MA, 2007, J EXP MED, V204, P161, DOI 10.1084/jem.20061738; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI200213605; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; KURUVILLA AP, 1991, P NATL ACAD SCI USA, V88, P2918, DOI 10.1073/pnas.88.7.2918; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; LEIBUNDGUTLANDM.S, 2007, NAT IMMUNOL; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; RACKE MK, 1991, J IMMUNOL, V146, P3012; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Vanderlugt CJ, 1996, CURR OPIN IMMUNOL, V8, P831, DOI 10.1016/S0952-7915(96)80012-4; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Willenborg DO, 1996, J IMMUNOL, V157, P3223; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	51	1156	1222	4	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2007	8	12					1390	1397		10.1038/ni1539	http://dx.doi.org/10.1038/ni1539			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	235XG	17994024				2022-12-18	WOS:000251267000020
J	Serbina, NV; Pamer, EG				Serbina, NV; Pamer, EG			Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2	NATURE IMMUNOLOGY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CHEMOATTRACTANT PROTEIN-1; DENDRITIC CELLS; HOST-DEFENSE; MICE LACKING; LISTERIA-MONOCYTOGENES; WHIM-SYNDROME; ATHEROSCLEROSIS; RECRUITMENT; ADHESION	Monocytes recruited to tissues mediate defense against microbes or contribute to inflammatory diseases. Regulation of the number of circulating monocytes thus has implications for disease pathogenesis. However, the mechanisms controlling monocyte emigration from the bone marrow niche where they are generated remain undefined. We demonstrate here that the chemokine receptor CCR2 was required for emigration of Ly6C(hi) monocytes from bone marrow. Ccr2(-/-) mice had fewer circulating Ly6Chi monocytes and, after infection with Listeria monocytogenes, accumulated activated monocytes in bone marrow. In blood, Ccr2(-/-) monocytes could traffic to sites of infection, demonstrating that CCR2 is not required for migration from the circulation into tissues. Thus, CCR2-mediated signals in bone marrow determine the frequency of Ly6Chi monocytes in the circulation.	Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Sect, Program Immunol,Sloan Kettering Inst, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Serbina, NV (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Sect, Program Immunol,Sloan Kettering Inst, New York, NY 10021 USA.	serbinan@mskcc.org						Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Bruno L, 2001, EUR J IMMUNOL, V31, P3403, DOI 10.1002/1521-4141(200111)31:11<3403::AID-IMMU3403>3.0.CO;2-T; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Cyster JG, 2003, IMMUNOL REV, V195, P5, DOI 10.1034/j.1600-065X.2003.00075.x; Deo R, 2004, J AM COLL CARDIOL, V44, P1812, DOI 10.1016/j.jacc.2004.07.047; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; FLEMING TJ, 1993, J IMMUNOL, V151, P2399; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gorlin RJ, 2000, AM J MED GENET, V91, P368, DOI 10.1002/(SICI)1096-8628(20000424)91:5<368::AID-AJMG10>3.0.CO;2-9; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Held KS, 2004, VIROLOGY, V329, P251, DOI 10.1016/j.virol.2004.09.006; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; Hidalgo A, 2001, EXP HEMATOL, V29, P345, DOI 10.1016/S0301-472X(00)00668-8; Hokeness KL, 2005, J IMMUNOL, V174, P1549, DOI 10.4049/jimmunol.174.3.1549; Huo YQ, 2001, J CLIN INVEST, V108, P1307, DOI 10.1172/JCI200112877; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Lagasse E, 1996, J IMMUNOL METHODS, V197, P139, DOI 10.1016/0022-1759(96)00138-X; Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4; Legler DF, 1998, J EXP MED, V187, P655, DOI 10.1084/jem.187.4.655; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Luther SA, 2001, NAT IMMUNOL, V2, P102, DOI 10.1038/84205; Muraille E, 2005, EUR J IMMUNOL, V35, P1463, DOI 10.1002/eji.200526024; Nagaoka H, 2000, J EXP MED, V191, P2113, DOI 10.1084/jem.191.12.2113; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; Palladino MA, 2003, NAT REV DRUG DISCOV, V2, P736, DOI 10.1038/nrd1175; Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296; Peters W, 2001, P NATL ACAD SCI USA, V98, P7958, DOI 10.1073/pnas.131207398; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Robben PM, 2005, J EXP MED, V201, P1761, DOI 10.1084/jem.20050054; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Ross GD, 2000, CRIT REV IMMUNOL, V20, P197; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Sato N, 2000, J EXP MED, V192, P205, DOI 10.1084/jem.192.2.205; Serbina NV, 2003, IMMUNITY, V19, P891, DOI 10.1016/S1074-7613(03)00330-3; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shen HM, 2001, J IMMUNOL, V166, P5027, DOI 10.4049/jimmunol.166.8.5027; Takahashi K, 2003, J BIOL CHEM, V278, P46654, DOI 10.1074/jbc.M309895200; Taylor PR, 2003, EUR J IMMUNOL, V33, P2090, DOI 10.1002/eji.200324003; Ueda Y, 2004, J EXP MED, V199, P47, DOI 10.1084/jem.20031104; Vallance P, 2002, NAT REV DRUG DISCOV, V1, P939, DOI 10.1038/nrd960; YOSHIMURA T, 1989, J EXP MED, V169, P1449, DOI 10.1084/jem.169.4.1449	50	1142	1166	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2006	7	3					311	317		10.1038/ni1309	http://dx.doi.org/10.1038/ni1309			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	012SR	16462739				2022-12-18	WOS:000235360400016
J	Lanier, LL				Lanier, Lewis L.			Up on the tightrope: natural killer cell activation and inhibition	NATURE IMMUNOLOGY			English	Review							LINKED LYMPHOPROLIFERATIVE DISEASE; HUMAN NK CELLS; RECEPTOR 2B4 CD244; CD8(+) T-CELLS; CUTTING EDGE; SIGNAL-TRANSDUCTION; TYROSINE PHOSPHORYLATION; 2B4-MEDIATED ACTIVATION; CYTOTOXIC LYMPHOCYTES; SURFACE-MOLECULE	Natural killer (NK) cells circulate through the blood, lymphatics and tissues, on patrol for the presence of transformed or pathogen-infected cells. As almost all NK cell receptors bind to host-encoded ligands, signals are constantly being transmitted into NK cells, whether they interact with normal or abnormal cells. The sophisticated repertoire of activating and inhibitory receptors that has evolved to regulate NK cell activity ensures that NK cells protect hosts against pathogens, yet prevents deleterious NK cell-driven autoimmune responses. Here I highlight recent advances in our understanding of the structural properties and signaling pathways of the inhibitory and activating NK cell receptors, with a particular focus on the ITAM-dependent activating receptors, the NKG2D-DAP10 receptor complexes and the CD244 receptor system.	Univ Calif San Francisco, Canc Res Inst, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Lanier, LL (corresponding author), Univ Calif San Francisco, Canc Res Inst, Dept Microbiol & Immunol, Box 0128, San Francisco, CA 94143 USA.	lewis.lanier@ucsf.edu	Lanier, Lewis L/E-2139-2014	Lanier, Lewis L/0000-0003-1308-3952	NATIONAL CANCER INSTITUTE [R01CA095137, U01CA105379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI066897, P01AI064520, R01AI068129] Funding Source: NIH RePORTER; NCI NIH HHS [U01 CA105379, CA105379, R01 CA095137-05, CA095137, R01 CA095137] Funding Source: Medline; NIAID NIH HHS [AI068129, P01 AI064520-040002, AI066897, P01 AI064520, R01 AI068129, R01 AI068129-08, AI64520, R37 AI066897, R37 AI066897-08] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alvarez-Arias DA, 2007, J IMMUNOL, V179, P5281, DOI 10.4049/jimmunol.179.8.5281; Andre P, 2004, EUR J IMMUNOL, V34, P961, DOI 10.1002/eji.200324705; Aoukaty A, 2005, J IMMUNOL, V174, P4551, DOI 10.4049/jimmunol.174.8.4551; Aoukaty A, 2002, J BIOL CHEM, V277, P13331, DOI 10.1074/jbc.M112029200; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bhat R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000326; Billadeau DD, 2003, NAT IMMUNOL, V4, P557, DOI 10.1038/ni929; Billadeau DD, 1998, J EXP MED, V188, P549, DOI 10.1084/jem.188.3.549; Bloch-Queyrat C, 2005, J EXP MED, V202, P181, DOI 10.1084/jem.20050449; Bottino C, 2000, EUR J IMMUNOL, V30, P3718; Bottino C, 2001, J EXP MED, V194, P235, DOI 10.1084/jem.194.3.235; Bouchon A, 2001, J IMMUNOL, V167, P5517, DOI 10.4049/jimmunol.167.10.5517; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Calpe S, 2006, IMMUNOGENETICS, V58, P15, DOI 10.1007/s00251-005-0056-3; Cella M, 2004, J EXP MED, V200, P817, DOI 10.1084/jem.20031847; Chen RY, 2006, MOL CELL BIOL, V26, P5559, DOI 10.1128/MCB.00357-06; Chen RY, 2004, MOL CELL BIOL, V24, P5144, DOI 10.1128/MCB.24.12.5144-5156.2004; Chiesa S, 2006, BLOOD, V107, P2364, DOI 10.1182/blood-2005-08-3504; Chuang SS, 2001, J IMMUNOL, V167, P6210, DOI 10.4049/jimmunol.167.11.6210; Clarkson NG, 2007, J BIOL CHEM, V282, P25385, DOI 10.1074/jbc.M704483200; Colucci F, 2002, NAT IMMUNOL, V3, P288, DOI 10.1038/ni764; Diefenbach A, 2002, NAT IMMUNOL, V3, P1142, DOI 10.1038/ni858; Ehrlich LIR, 2005, J IMMUNOL, V174, P1922, DOI 10.4049/jimmunol.174.4.1922; Eissmann P, 2005, BLOOD, V105, P4722, DOI 10.1182/blood-2004-09-3796; Feng JW, 2005, IMMUNITY, V22, P427, DOI 10.1016/j.immuni.2005.02.005; Galandrini R, 2002, BLOOD, V100, P4581, DOI 10.1182/blood-2002-04-1058; GARNIWAGNER BA, 1993, J IMMUNOL, V151, P60; Garrity D, 2005, P NATL ACAD SCI USA, V102, P7641, DOI 10.1073/pnas.0502439102; Gilfillan S, 2002, NAT IMMUNOL, V3, P1150, DOI 10.1038/ni857; Giurisato E, 2007, MOL CELL BIOL, V27, P8583, DOI 10.1128/MCB.01477-07; Graham DB, 2006, J IMMUNOL, V177, P2349, DOI 10.4049/jimmunol.177.4.2349; Hesslein DGT, 2006, P NATL ACAD SCI USA, V103, P7012, DOI 10.1073/pnas.0601851103; Horng T, 2007, NAT IMMUNOL, V8, P1345, DOI 10.1038/ni1524; HOUCHINS JP, 1991, J EXP MED, V173, P1017, DOI 10.1084/jem.173.4.1017; Huntington ND, 2005, J EXP MED, V201, P1421, DOI 10.1084/jem.20042294; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Klem J, 2002, J IMMUNOL, V169, P55, DOI 10.4049/jimmunol.169.1.55; Kubin M, 2001, EUR J IMMUNOL, V31, P1428, DOI 10.1002/1521-4141(200105)31:5<1428::AID-IMMU1428>3.0.CO;2-4; LANIER LL, 1991, J IMMUNOL, V146, P1571; LANIER LL, 1989, NATURE, V342, P803, DOI 10.1038/342803a0; Lee KM, 2006, BLOOD, V107, P3181, DOI 10.1182/blood-2005-01-0185; Lee KM, 2004, J EXP MED, V199, P1245, DOI 10.1084/jem.20031989; Ma CS, 2007, ANNU REV IMMUNOL, V25, P337, DOI 10.1146/annurev.immunol.25.022106.141651; Mason LH, 2006, J IMMUNOL, V176, P6615, DOI 10.4049/jimmunol.176.11.6615; MATHEW PA, 1993, J IMMUNOL, V151, P5328; McVicar DW, 1998, J BIOL CHEM, V273, P32934, DOI 10.1074/jbc.273.49.32934; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Nakajima H, 2000, EUR J IMMUNOL, V30, P3309, DOI 10.1002/1521-4141(200011)30:11<3309::AID-IMMU3309>3.0.CO;2-3; Paolini R, 2001, P NATL ACAD SCI USA, V98, P9611, DOI 10.1073/pnas.161298098; Parolini S, 2000, J EXP MED, V192, P337, DOI 10.1084/jem.192.3.337; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Roncagalli R, 2005, NAT IMMUNOL, V6, P1002, DOI 10.1038/ni1242; Rosen DB, 2004, J IMMUNOL, V173, P2470, DOI 10.4049/jimmunol.173.4.2470; Saborit-Villarroya IN, 2005, J IMMUNOL, V175, P4226, DOI 10.4049/jimmunol.175.7.4226; Schatzle JD, 1999, P NATL ACAD SCI USA, V96, P3870, DOI 10.1073/pnas.96.7.3870; Stebbins CC, 2003, MOL CELL BIOL, V23, P6291, DOI 10.1128/MCB.23.17.6291-6299.2003; Sutherland CL, 2002, J IMMUNOL, V168, P671, DOI 10.4049/jimmunol.168.2.671; Tangye SG, 2000, MOL IMMUNOL, V37, P493, DOI 10.1016/S0161-5890(00)00076-6; Tangye SG, 2000, J IMMUNOL, V165, P2932, DOI 10.4049/jimmunol.165.6.2932; Tangye SG, 1999, J IMMUNOL, V162, P6981; Taniguchi RT, 2007, BLOOD, V110, P2020, DOI 10.1182/blood-2007-02-076927; Tassi I, 2005, J IMMUNOL, V175, P749, DOI 10.4049/jimmunol.175.2.749; Tessmer MS, 2007, INT IMMUNOL, V19, P391, DOI 10.1093/intimm/dxm004; TING AT, 1992, J EXP MED, V176, P1751, DOI 10.1084/jem.176.6.1751; Upshaw JL, 2006, NAT IMMUNOL, V7, P524, DOI 10.1038/ni1325; Vaidya SV, 2005, J IMMUNOL, V174, P800, DOI 10.4049/jimmunol.174.2.800; VALIANTE NM, 1993, J EXP MED, V178, P1397, DOI 10.1084/jem.178.4.1397; Veillette A, 2007, IMMUNITY, V27, P698, DOI 10.1016/j.immuni.2007.11.005; Veillette A, 2006, IMMUNOL REV, V214, P22, DOI 10.1111/j.1600-065X.2006.00453.x; Verneris MR, 2004, BLOOD, V103, P3065, DOI 10.1182/blood-2003-06-2125; Wahle JA, 2007, J IMMUNOL, V179, P8009, DOI 10.4049/jimmunol.179.12.8009; Wahle JA, 2006, J IMMUNOL, V176, P7165, DOI 10.4049/jimmunol.176.12.7165; Watzl C, 2000, J IMMUNOL, V165, P3545, DOI 10.4049/jimmunol.165.7.3545; Watzl C, 2003, J EXP MED, V197, P77, DOI 10.1084/jem.20020427; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Wu J, 2000, J EXP MED, V192, P1059, DOI 10.1084/jem.192.7.1059; Zompi S, 2003, NAT IMMUNOL, V4, P565, DOI 10.1038/ni930	78	1132	1177	3	94	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2008	9	5					495	502		10.1038/ni1581	http://dx.doi.org/10.1038/ni1581			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	290WM	18425106	Green Accepted			2022-12-18	WOS:000255153500011
J	Gerard, C; Rollins, BJ				Gerard, C; Rollins, BJ			Chemokines and disease	NATURE IMMUNOLOGY			English	Review							MONOCYTE CHEMOATTRACTANT PROTEIN-1; MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA; CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; COLLAGEN-INDUCED ARTHRITIS; RECEPTOR 5 POLYMORPHISM; CELL LUNG-CANCER; MULTIPLE-SCLEROSIS; T-CELLS; RHEUMATOID-ARTHRITIS	We examine here several diseases that are associated with inappropriate activation of the chemokine network. Detailed comment has been restricted to pathological states for which there are compelling data either from clinical observations or animal models. These include cardiovascular disease, allergic inflammatory disease, transplantation, neuroinflammation, cancer and HIV-associated disease. Discussion focuses on therapeutic directions in which the rapidly evolving chemokine field appears to be headed.	Harvard Univ, Childrens Hosp, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Dana Farber Canc Inst, Sch Med, Dept Adult Oncol, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Gerard, C (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Dept Pediat, Boston, MA 02115 USA.	gerard_c@gonzo.tch.harvard.edu; barrett_rollins@dfci.harvard.edu						Abi-Younes S, 2000, CIRC RES, V86, P131, DOI 10.1161/01.RES.86.2.131; AlMughales J, 1996, CLIN EXP IMMUNOL, V106, P230, DOI 10.1046/j.1365-2249.1996.d01-836.x; Arenberg DA, 1996, J CLIN INVEST, V97, P2792, DOI 10.1172/JCI118734; Balashov KE, 1999, P NATL ACAD SCI USA, V96, P6873, DOI 10.1073/pnas.96.12.6873; Barcellos LF, 2000, IMMUNOGENETICS, V51, P281, DOI 10.1007/s002510050621; BAROUDY BM, 2000, INFECT ABSTR, pS17; BASHFORD EF, 1905, SCI REPORTS INVESTIG; BELPERIO JA, 2000, J IMMUNOL, V461, P72; Bennetts BH, 1997, HUM IMMUNOL, V58, P52, DOI 10.1016/S0198-8859(97)00207-3; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Blanpain C, 2000, BLOOD, V96, P1638, DOI 10.1182/blood.V96.5.1638.h8001638_1638_1645; Boisvert WA, 2000, IMMUNOL RES, V21, P129, DOI 10.1385/IR:21:2-3:129; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; BOTTAZZI B, 1985, INT J CANCER, V36, P167, DOI 10.1002/ijc.2910360207; BOTTAZZI B, 1992, J IMMUNOL, V148, P1280; BOTTAZZI B, 1983, SCIENCE, V220, P210, DOI 10.1126/science.6828888; Buckley CD, 2000, J IMMUNOL, V165, P3423, DOI 10.4049/jimmunol.165.6.3423; Bush E, 2000, HYPERTENSION, V36, P360, DOI 10.1161/01.HYP.36.3.360; Butterfield RJ, 2000, AM J PATHOL, V157, P637, DOI 10.1016/S0002-9440(10)64574-9; Carrel A, 1922, J EXP MED, V36, P385, DOI 10.1084/jem.36.4.385; Cella M, 2000, NAT IMMUNOL, V1, P305, DOI 10.1038/79747; D'Ambrosio D, 1998, J IMMUNOL, V161, P5111; Dabbagh K, 2000, J IMMUNOL, V165, P3418, DOI 10.4049/jimmunol.165.6.3418; Dawson TC, 1999, ATHEROSCLEROSIS, V143, P205; De Benedetti F, 1999, J RHEUMATOL, V26, P425; Dilloo D, 1996, NAT MED, V2, P1090, DOI 10.1038/nm1096-1090; Egashira K, 2000, FASEB J, V14, P1974, DOI 10.1096/fj.00-0141com; Elsner J, 1997, EUR J IMMUNOL, V27, P2892, DOI 10.1002/eji.1830271122; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Fushimi T, 2000, J CLIN INVEST, V105, P1383, DOI 10.1172/JCI7548; Gao W, 2000, J CLIN INVEST, V105, P35, DOI 10.1172/JCI8126; Garred P, 1998, J RHEUMATOL, V25, P1462; Glabinski AR, 1995, BRAIN BEHAV IMMUN, V9, P315, DOI 10.1006/brbi.1995.1030; GODISKA R, 1995, J NEUROIMMUNOL, V58, P167, DOI 10.1016/0165-5728(95)00008-P; Gomez-Reino JJ, 1999, ARTHRITIS RHEUM-US, V42, P989, DOI 10.1002/1529-0131(199905)42:5<989::AID-ANR18>3.0.CO;2-U; Gong JH, 1997, J EXP MED, V186, P131, DOI 10.1084/jem.186.1.131; Gonzalo JA, 1998, J EXP MED, V188, P157, DOI 10.1084/jem.188.1.157; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Haley KJ, 2000, CIRCULATION, V102, P2185; Hancock WW, 2000, CURR OPIN IMMUNOL, V12, P511, DOI 10.1016/S0952-7915(00)00130-8; Hancock WW, 2000, J EXP MED, V192, P1515, DOI 10.1084/jem.192.10.1515; Haque NS, 2000, CIRCULATION, V102, P786, DOI 10.1161/01.CIR.102.7.786; Iarlori C, 2000, J NEUROIMMUNOL, V107, P100, DOI 10.1016/S0165-5728(00)00261-7; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Jordan NJ, 1999, J CLIN INVEST, V104, P1061, DOI 10.1172/JCI6685; Kapoor A, 2000, TRANSPLANT P, V32, P793, DOI 10.1016/S0041-1345(00)00985-4; KARPUS WJ, 1995, J IMMUNOL, V155, P5003; Karpus WJ, 1997, J LEUKOCYTE BIOL, V62, P681, DOI 10.1002/jlb.62.5.681; Katoh S, 2000, J ALLERGY CLIN IMMUN, V106, P730, DOI 10.1067/mai.2000.109827; Kleine-Lowinski K, 1999, INT J CANCER, V82, P6, DOI 10.1002/(SICI)1097-0215(19990702)82:1<6::AID-IJC2>3.0.CO;2-3; Kol A, 1999, AM HEART J, V138, pS450, DOI 10.1016/S0002-8703(99)70273-5; Kondo T, 2000, TRANSPLANTATION, V69, P969; Konig A, 2000, VIRCHOWS ARCH, V436, P449, DOI 10.1007/s004280050472; KPOO RA, 2000, TRANSPLANTATION, V69, P1147; Lamkhioued B, 2000, AM J RESP CRIT CARE, V162, P723, DOI 10.1164/ajrccm.162.2.9901080; LANING J, 1994, J IMMUNOL, V153, P4625; Leek RD, 1996, CANCER RES, V56, P4625; Lloyd CM, 2000, J EXP MED, V191, P265, DOI 10.1084/jem.191.2.265; LUSTER AD, 1993, J EXP MED, V178, P1057, DOI 10.1084/jem.178.3.1057; Mach F, 1999, J CLIN INVEST, V104, P1041, DOI 10.1172/JCI6993; MANOME Y, 1995, CANCER IMMUNOL IMMUN, V41, P227; McManus C, 1998, J NEUROIMMUNOL, V86, P20, DOI 10.1016/S0165-5728(98)00002-2; Melter M, 1999, Pediatr Transplant, V3, P10, DOI 10.1034/j.1399-3046.1999.00023.x; MIYAGISHI R, 1995, J NEUROL SCI, V129, P223, DOI 10.1016/0022-510X(95)00004-L; Molestina RE, 1998, INFECT IMMUN, V66, P1370, DOI 10.1128/IAI.66.4.1370-1376.1998; Mule JJ, 1996, HUM GENE THER, V7, P1545, DOI 10.1089/hum.1996.7.13-1545; Murdoch C, 1999, IMMUNOLOGY, V98, P36; Nanki T, 2000, ARTHRITIS RES, V2, P415, DOI 10.1186/ar120; Negus RPM, 1997, AM J PATHOL, V150, P1723; NELKEN NA, 1991, J CLIN INVEST, V88, P1121, DOI 10.1172/JCI115411; Ogata H, 1997, J PATHOL, V182, P106; Ortego M, 1999, ATHEROSCLEROSIS, V147, P253, DOI 10.1016/S0021-9150(99)00193-8; Oyamada H, 1999, INT ARCH ALLERGY IMM, V120, P45, DOI 10.1159/000053593; Palacios E, 1998, CURR BIOL, V8, P943, DOI 10.1016/S0960-9822(07)00378-8; Petrek M, 2000, AM J RESP CRIT CARE, V162, P1000; PlaterZyberk C, 1997, IMMUNOL LETT, V57, P117, DOI 10.1016/S0165-2478(97)00075-8; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; RANSOHOFF RM, 1993, FASEB J, V7, P592, DOI 10.1096/fasebj.7.6.8472896; Ransohoff RM, 1997, METHOD ENZYMOL, V287, P319; RICHMOND A, 1988, EMBO J, V7, P2025, DOI 10.1002/j.1460-2075.1988.tb03042.x; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; ROLLINS BJ, 1991, MOL CELL BIOL, V11, P3125, DOI 10.1128/MCB.11.6.3125; Romano M, 2000, LAB INVEST, V80, P1095, DOI 10.1038/labinvest.3780115; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rottman JB, 2000, EUR J IMMUNOL, V30, P2372, DOI 10.1002/1521-4141(2000)30:8<2372::AID-IMMU2372>3.0.CO;2-D; RUSSELL BRG, 1908, SCIENTIFIC REP IMPER, V3, P341; Schecter AD, 1997, J BIOL CHEM, V272, P28568, DOI 10.1074/jbc.272.45.28568; Sekiya T, 2000, J IMMUNOL, V165, P2205, DOI 10.4049/jimmunol.165.4.2205; Shimizu K, 2000, J IMMUNOL, V165, P3506, DOI 10.4049/jimmunol.165.6.3506; Simpson J, 2000, J NEUROIMMUNOL, V108, P192, DOI 10.1016/S0165-5728(00)00274-5; SMITH DR, 1994, J EXP MED, V179, P1409, DOI 10.1084/jem.179.5.1409; Sorensen TL, 1999, J CLIN INVEST, V103, P807, DOI 10.1172/JCI5150; Streblow DN, 1999, CELL, V99, P511, DOI 10.1016/S0092-8674(00)81539-1; STRIETER RM, 1995, J BIOL CHEM, V270, P27348, DOI 10.1074/jbc.270.45.27348; Takamori H, 2000, PANCREAS, V21, P52, DOI 10.1097/00006676-200007000-00051; Taylor PC, 2000, ARTHRITIS RHEUM-US, V43, P38, DOI 10.1002/1529-0131(200001)43:1<38::AID-ANR6>3.0.CO;2-L; Tellides G, 2000, NATURE, V403, P207, DOI 10.1038/35003221; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Tran EH, 2000, EUR J IMMUNOL, V30, P1410, DOI 10.1002/(SICI)1521-4141(200005)30:5<1410::AID-IMMU1410>3.0.CO;2-L; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Tuttle DL, 1998, J VIROL, V72, P4962, DOI 10.1128/JVI.72.6.4962-4969.1998; Ueno T, 2000, CLIN CANCER RES, V6, P3282; Vicari AP, 2000, J IMMUNOL, V165, P1992, DOI 10.4049/jimmunol.165.4.1992; VIRCHOW R, 1863, KRANKHAFTEN GESCHWUL, P1862; WALTER S, 1991, INT J CANCER, V49, P431, DOI 10.1002/ijc.2910490321; Wang JY, 1996, J INTERF CYTOK RES, V16, P53, DOI 10.1089/jir.1996.16.53; Watarai Y, 2000, J IMMUNOL, V164, P6027, DOI 10.4049/jimmunol.164.11.6027; Wedderburn LR, 2000, ARTHRITIS RHEUM-US, V43, P765, DOI 10.1002/1529-0131(200004)43:4<765::AID-ANR7>3.0.CO;2-B; Wilcox J N, 1994, J Atheroscler Thromb, V1 Suppl 1, pS10; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Ying S, 1999, J IMMUNOL, V163, P6321; YLAHERTTUALA S, 1991, P NATL ACAD SCI USA, V88, P5252, DOI 10.1073/pnas.88.12.5252; Yun JJ, 2000, TRANSPLANTATION, V69, P2515, DOI 10.1097/00007890-200006270-00009; Zhou XH, 1998, J CLIN INVEST, V101, P1717, DOI 10.1172/JCI1216; Zingoni A, 1998, J IMMUNOL, V161, P547	118	1131	1253	1	86	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2001	2	2					108	115		10.1038/84209	http://dx.doi.org/10.1038/84209			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	398WD	11175802				2022-12-18	WOS:000166778700005
J	Unterholzner, L; Keating, SE; Baran, M; Horan, KA; Jensen, SB; Sharma, S; Sirois, CM; Jin, TC; Latz, E; Xiao, TS; Fitzgerald, KA; Paludan, SR; Bowie, AG				Unterholzner, Leonie; Keating, Sinead E.; Baran, Marcin; Horan, Kristy A.; Jensen, Soren B.; Sharma, Shruti; Sirois, Cherilyn M.; Jin, Tengchuan; Latz, Eicke; Xiao, T. Sam; Fitzgerald, Katherine A.; Paludan, Soren R.; Bowie, Andrew G.			IFI16 is an innate immune sensor for intracellular DNA	NATURE IMMUNOLOGY			English	Article							CYTOSOLIC DNA; I INTERFERONS; IFN-BETA; RECOGNITION; RNA; PROTEIN; INFLAMMASOME; ACTIVATION; VIRUS; INDUCTION	The detection of intracellular microbial DNA is critical to appropriate innate immune responses; however, knowledge of how such DNA is sensed is limited. Here we identify IFI16, a PYHIN protein, as an intracellular DNA sensor that mediates the induction of interferon-beta (IFN-beta). IFI16 directly associated with IFN-beta-inducing viral DNA motifs. STING, a critical mediator of IFN-beta responses to DNA, was recruited to IFI16 after DNA stimulation. Lowering the expression of IFI16 or its mouse ortholog p204 by RNA-mediated interference inhibited gene induction and activation of the transcription factors IRF3 and NF-kappa B induced by DNA and herpes simplex virus type 1 (HSV-1). IFI16 (p204) is the first PYHIN protein to our knowledge shown to be involved in IFN-beta induction. Thus, the PYHIN proteins IFI16 and AIM2 form a new family of innate DNA sensors we call 'AIM2-like receptors' (ALRs).	[Unterholzner, Leonie; Keating, Sinead E.; Baran, Marcin; Bowie, Andrew G.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland; [Horan, Kristy A.; Jensen, Soren B.; Paludan, Soren R.] Aarhus Univ, Dept Med Microbiol & Immunol, Aarhus, Denmark; [Jensen, Soren B.; Sharma, Shruti; Sirois, Cherilyn M.; Latz, Eicke; Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA USA; [Jin, Tengchuan; Xiao, T. Sam] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Latz, Eicke] Univ Bonn, Inst Clin Chem & Pharmacol, D-5300 Bonn, Germany	Trinity College Dublin; Aarhus University; University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Bonn	Bowie, AG (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland.	agbowie@tcd.ie	Latz, Eicke/H-3951-2014; Jin, Tengchuan/B-5883-2014; Xiao, Tsan Sam/A-8590-2010; Xiao, Tsan/I-7616-2013; Unterholzner, Leonie/ABG-4199-2020; Fitzgerald, Katherine/ABE-6317-2020	Latz, Eicke/0000-0003-1488-5666; Jin, Tengchuan/0000-0002-1395-188X; Xiao, Tsan Sam/0000-0001-9688-475X; Xiao, Tsan/0000-0001-9688-475X; Unterholzner, Leonie/0000-0001-9824-692X; Fitzgerald, Kate/0000-0003-3175-609X; Bowie, Andrew/0000-0001-5316-4373; Sirois, Cherilyn M./0000-0002-5472-4288	Science Foundation Ireland [07/IN1/B934]; Irish Health Research Board; Danish Medical Research Council [09-072636]; Lundbeck Foundation [R17-A1528, R34-A3855]; US National Institutes of Health [AI083713, AI067497]; Faculty of Health Sciences, Aarhus; Lundbeck Foundation [R34-2009-3855, R17-2007-1526] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083713, R37AI067497, R56AI067497, R01AI067497, ZIAAI000960] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Health Research Board; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Faculty of Health Sciences, Aarhus; Lundbeck Foundation(Lundbeckfonden); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Liu (New York University) for antibody to p204; S. Akira (Osaka University) for Myd88<SUP>-/-</SUP>, Ticam1<SUP>-/-</SUP> and Zbp1<SUP>-/-</SUP> mice; T. Taniguchi (University of Tokyo) for Irf3<SUP>-/-</SUP> mice; M. Kelliher (University of Massachusetts Medical School) for Tnfrsf1a<SUP>-/-</SUP> mice; T. Mak (University of Toronto) for Tbk1<SUP>-/-</SUP> Tnfrsf1a<SUP>-/-</SUP> mice; G. Barber (University of Miami) for Tmem173<SUP>-/-</SUP> femurs; D. Golenbock (University of Massachusetts Medical School) for immortalized BMDMs lacking MyD88 or TRIF; I. Julkunen (National Public Health Institute, Finland) for Sendai virus; and S. Corr (Trinity College Dublin) for Listeria monocytogenes DNA. Supported by Science Foundation Ireland (07/IN1/B934 to L.U., S.E.K., M.B. and A.G.B.), the Irish Health Research Board (S.E.K. and A.G.B.), the Danish Medical Research Council (09-072636 to S.R.P.), the Lundbeck Foundation (R17-A1528 to S.R.P. and R34-A3855 to K.A.H.), the US National Institutes of Health (AI083713 and AI067497 to K.A.F.; Division of Intramural Research, National Institute of Allergy and Infectious Diseases to T.S.X.) and the Faculty of Health Sciences, Aarhus (S.B.J.).	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Choubey D, 2008, IMMUNOL LETT, V119, P32, DOI 10.1016/j.imlet.2008.06.001; Cristea IM, 2010, J VIROL, V84, P7803, DOI 10.1128/JVI.00139-10; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Johnston JB, 2005, IMMUNITY, V23, P587, DOI 10.1016/j.immuni.2005.10.003; Kimkong I, 2009, LUPUS, V18, P1066, DOI 10.1177/0961203309106699; Lippmann J, 2008, CELL MICROBIOL, V10, P2579, DOI 10.1111/j.1462-5822.2008.01232.x; Liu CJ, 1999, EMBO J, V18, P2845, DOI 10.1093/emboj/18.10.2845; Liu T, 2003, PROTEIN SCI, V12, P1872, DOI 10.1110/ps.0359603; Luan Y, 2008, CYTOKINE GROWTH F R, V19, P357, DOI 10.1016/j.cytogfr.2008.11.002; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; MASSUNG RF, 1995, VIROLOGY, V211, P350, DOI 10.1006/viro.1995.1416; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mondini M, 2007, ANN NY ACAD SCI, V1110, P47, DOI 10.1196/annals.1423.006; Monroe KM, 2010, CELL MICROBIOL, V12, P881, DOI 10.1111/j.1462-5822.2010.01478.x; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Prantner D, 2010, J IMMUNOL, V184, P2551, DOI 10.4049/jimmunol.0903704; Rahman MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000635; Rasmussen SB, 2007, J VIROL, V81, P13315, DOI 10.1128/JVI.01167-07; ROBERSON SM, 1988, CELL IMMUNOL, V116, P341, DOI 10.1016/0008-8749(88)90236-5; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Roberts ZJ, 2007, J EXP MED, V204, P1559, DOI 10.1084/jem.20061845; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Yan HY, 2008, BBA-PROTEINS PROTEOM, V1784, P1087, DOI 10.1016/j.bbapap.2008.04.004; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	42	1117	1164	1	163	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2010	11	11					997	U42		10.1038/ni.1932	http://dx.doi.org/10.1038/ni.1932			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	666PI	20890285	Green Submitted, Green Accepted, Bronze			2022-12-18	WOS:000283127800009
J	Schnare, M; Barton, GM; Holt, AC; Takeda, K; Akira, S; Medzhitov, R				Schnare, M; Barton, GM; Holt, AC; Takeda, K; Akira, S; Medzhitov, R			Toll-like receptors control activation of adaptive immune responses	NATURE IMMUNOLOGY			English	Article							INNATE IMMUNITY; MYD88; IL-1; MICE; PATHWAY; PROTEIN; ABSENCE; T1/ST2; TLR4; IRAK	Mechanisms that control the activation of antigen-specific immune responses in vivo are poorly understood. It has been suggested that the initiation of adaptive immune responses is controlled by innate immune recognition. Mammalian Toll-like receptors play an essential role in innate immunity by recognizing conserved pathogen-associated molecular patterns and initiating the activation of NF-kappaB and other signaling pathways through the adapter protein, MyD88. Here we show that MyD88-deficient mice have a profound defect in the activation of antigen-specific T helper type 1 (T(H)1) but not T(H)2 immune responses. These results suggest that distinct pathways of the innate immune system control activation of the two effector arms of adaptive immunity.	Yale Univ, Sch Med, Immunol Sect, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA; Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan	Yale University; Howard Hughes Medical Institute; Osaka University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Immunol Sect, New Haven, CT 06520 USA.	ruslan@yale.edu	Takeda, Kiyoshi/C-9331-2009; Eckhardt, Erik/G-1567-2010; Akira, Shizuo/C-3134-2009	Barton, Gregory/0000-0002-3793-0100	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044220] Funding Source: NIH RePORTER; NIAID NIH HHS [AI44220-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Erb KJ, 1999, IMMUNOL TODAY, V20, P317, DOI 10.1016/S0167-5699(99)01475-9; Fantuzzi G, 1999, J CLIN IMMUNOL, V19, P1, DOI 10.1023/A:1020506300324; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; Hoshino K, 1999, J EXP MED, V190, P1541, DOI 10.1084/jem.190.10.1541; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Means TK, 1999, J IMMUNOL, V163, P3920; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Satoskar AR, 1998, EUR J IMMUNOL, V28, P2066, DOI 10.1002/(SICI)1521-4141(199807)28:07<2066::AID-IMMU2066>3.0.CO;2-X; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1	23	1090	1157	1	64	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2001	2	10					947	950		10.1038/ni712	http://dx.doi.org/10.1038/ni712			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	478TM	11547333				2022-12-18	WOS:000171361500014
J	Heng, TSP; Painter, MW				Heng, Tracy S. P.; Painter, Michio W.		Immunological Genome Project	The Immunological Genome Project: networks of gene expression in immune cells	NATURE IMMUNOLOGY			English	Editorial Material							DATABASE		[Heng, Tracy S. P.; Painter, Michio W.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Sect Immunol & Immunogenet,Joslin Diabet Ctr, Boston, MA 02215 USA; [Heng, Tracy S. P.; Painter, Michio W.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Heng, TSP (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Sect Immunol & Immunogenet,Joslin Diabet Ctr, Boston, MA 02215 USA.		Gray, Daniel HD/A-3293-2013; Heng, Tracy/AAR-5712-2021; Heng, Tracy/B-9847-2015	Gray, Daniel HD/0000-0002-8457-8242; Heng, Tracy/0000-0003-4147-8986; Heng, Tracy/0000-0003-4147-8986; kang, joonsoo/0000-0001-8419-7995	NIAID NIH HHS [R24AI072073] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI072073] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; Bammler T, 2005, NAT METHODS, V2, P351, DOI 10.1038/nmeth0605-477a; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Ebert BL, 2004, BLOOD, V104, P923, DOI 10.1182/blood-2004-01-0274; Edwards AD, 2003, J IMMUNOL, V171, P47, DOI 10.4049/jimmunol.171.1.47; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Hijikata A, 2007, BIOINFORMATICS, V23, P2934, DOI 10.1093/bioinformatics/btm430; Hoffmann R, 2003, J IMMUNOL, V170, P1339, DOI 10.4049/jimmunol.170.3.1339; Hyatt G, 2006, NAT IMMUNOL, V7, P686, DOI 10.1038/ni0706-686; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252; Matos M, 2004, DIABETES, V53, P2310, DOI 10.2337/diabetes.53.9.2310; Mick VE, 2004, J IMMUNOL, V173, P5434, DOI 10.4049/jimmunol.173.9.5434; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Splendiani A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S1-S21; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101	18	1070	1080	2	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2008	9	10					1091	1094		10.1038/ni1008-1091	http://dx.doi.org/10.1038/ni1008-1091			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	349XC	18800157				2022-12-18	WOS:000259315600003
J	Latz, E; Schoenemeyer, A; Visintin, A; Fitzgerald, KA; Monks, BG; Knetter, CF; Lien, E; Nilsen, NJ; Espevik, T; Golenbock, DT				Latz, E; Schoenemeyer, A; Visintin, A; Fitzgerald, KA; Monks, BG; Knetter, CF; Lien, E; Nilsen, NJ; Espevik, T; Golenbock, DT			TLR9 signals after translocating from the ER to CpG DNA in the lysosome	NATURE IMMUNOLOGY			English	Article							TOLL-LIKE RECEPTORS; DEOXYRIBONUCLEIC-ACID FRACTION; MYCOBACTERIUM-BOVIS BCG; BACTERIAL-DNA; IMMUNOSTIMULATORY ACTIVITY; ENDOPLASMIC-RETICULUM; MEDIATED PHAGOCYTOSIS; CROSS-PRESENTATION; CELL ACTIVATION; DENDRITIC CELLS	Microbial DNA sequences containing unmethylated CpG dinucleotides activate Toll-like receptor 9 (TLR9). We have found that TLR9 is localized to the endoplasmic reticulum (ER) of dendritic cells (DCs) and macrophages. Because there is no precedent for immune receptor signaling in the ER, we investigated how TLR9 is activated. We show that CpG DNA binds directly to TLR9 in ligand-binding studies. CpG DNA moves into early endosomes and is subsequently transported to a tubular lysosomal compartment. Concurrent with the movement of CpG DNA in cells, TLR9 redistributes from the ER to CpG DNA-containing structures, which also accumulate MyD88. Our data indicate a previously unknown mechanism of cellular activation involving the recruitment of TLR9 from the ER to sites of CpG DNA uptake, where signal transduction is initiated.	Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; Norwegian Univ Sci & Technol, Inst Canc Res & Mol Med, N-7489 Trondheim, Norway	University of Massachusetts System; University of Massachusetts Worcester; Norwegian University of Science & Technology (NTNU)	Golenbock, DT (corresponding author), Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, 364 Plantat St,Lazare Res Bldg 308, Worcester, MA 01605 USA.	douglas.golenbock@umassmed.edu	Fitzgerald, Katherine/ABE-6317-2020; Latz, Eicke/H-3951-2014; Monks, Brian/B-8362-2015; Nilsen, Nadra/G-5592-2017	Latz, Eicke/0000-0003-1488-5666; Monks, Brian/0000-0003-4008-3093; Nilsen, Nadra/0000-0003-0407-1060; Fitzgerald, Kate/0000-0003-3175-609X				Agrawal S, 2002, TRENDS MOL MED, V8, P114, DOI 10.1016/S1471-4914(01)02264-X; Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Desjardins M, 2003, NAT REV IMMUNOL, V3, P280, DOI 10.1038/nri1053; Flo TH, 2002, J BIOL CHEM, V277, P35489, DOI 10.1074/jbc.M201366200; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Gursel I, 2001, J IMMUNOL, V167, P3324, DOI 10.4049/jimmunol.167.6.3324; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Johnson S, 2001, TRENDS CELL BIOL, V11, P122, DOI 10.1016/S0962-8924(01)01926-2; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Manzel L, 1999, ANTISENSE NUCLEIC A, V9, P459, DOI 10.1089/oli.1.1999.9.459; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Okazaki Y, 2000, J BIOL CHEM, V275, P35751, DOI 10.1074/jbc.M007476200; Stenmark H, 2002, FEBS LETT, V513, P77, DOI 10.1016/S0014-5793(01)03308-7; Takeshita F, 2001, J IMMUNOL, V167, P3555, DOI 10.4049/jimmunol.167.7.3555; Tauszig S, 2000, P NATL ACAD SCI USA, V97, P10520, DOI 10.1073/pnas.180130797; TOKUNAGA T, 1984, J NATL CANCER I, V72, P955; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; YAMAMOTO S, 1988, JPN J CANCER RES, V79, P866, DOI 10.1111/j.1349-7006.1988.tb00049.x; YAMAMOTO T, 1994, MICROBIOL IMMUNOL, V38, P831, DOI 10.1111/j.1348-0421.1994.tb01867.x; Yi AK, 1998, J IMMUNOL, V160, P4755	36	1070	1145	13	103	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2004	5	2					190	198		10.1038/ni1028	http://dx.doi.org/10.1038/ni1028			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	768DB	14716310				2022-12-18	WOS:000188512000015
J	Monticelli, LA; Sonnenberg, GF; Abt, MC; Alenghat, T; Ziegler, CGK; Doering, TA; Angelosanto, JM; Laidlaw, BJ; Yang, CY; Sathaliyawala, T; Kubota, M; Turner, D; Diamond, JM; Goldrath, AW; Farber, DL; Collman, RG; Wherry, EJ; Artis, D				Monticelli, Laurel A.; Sonnenberg, Gregory F.; Abt, Michael C.; Alenghat, Theresa; Ziegler, Carly G. K.; Doering, Travis A.; Angelosanto, Jill M.; Laidlaw, Brian J.; Yang, Cliff Y.; Sathaliyawala, Taheri; Kubota, Masaru; Turner, Damian; Diamond, Joshua M.; Goldrath, Ananda W.; Farber, Donna L.; Collman, Ronald G.; Wherry, E. John; Artis, David			Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; HUMAN MAST-CELLS; GENE-EXPRESSION; AMPHIREGULIN; IMMUNITY; AIRWAY; DIFFERENTIATION; MECHANISMS; EFFECTORS; CYTOKINES	Innate lymphoid cells (ILCs), a heterogeneous cell population, are critical in orchestrating immunity and inflammation in the intestine, but whether ILCs influence immune responses or tissue homeostasis at other mucosal sites remains poorly characterized. Here we identify a population of lung-resident ILCs in mice and humans that expressed the alloantigen Thy-1 (CD90), interleukin 2 (IL-2) receptor alpha-chain (CD25), IL-7 receptor alpha-chain (CD127) and the IL-33 receptor subunit T1-ST2. Notably, mouse ILCs accumulated in the lung after infection with influenza virus, and depletion of ILCs resulted in loss of airway epithelial integrity, diminished lung function and impaired airway remodeling. These defects were restored by administration of the lung ILC product amphiregulin. Collectively, our results demonstrate a critical role for lung ILCs in restoring airway epithelial integrity and tissue homeostasis after infection with influenza virus.	[Monticelli, Laurel A.; Sonnenberg, Gregory F.; Abt, Michael C.; Alenghat, Theresa; Ziegler, Carly G. K.; Doering, Travis A.; Angelosanto, Jill M.; Laidlaw, Brian J.; Wherry, E. John; Artis, David] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Monticelli, Laurel A.; Sonnenberg, Gregory F.; Abt, Michael C.; Alenghat, Theresa; Ziegler, Carly G. K.; Doering, Travis A.; Angelosanto, Jill M.; Laidlaw, Brian J.; Wherry, E. John; Artis, David] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Monticelli, Laurel A.; Sonnenberg, Gregory F.; Abt, Michael C.; Alenghat, Theresa; Artis, David] Univ Penn, Dept Pathobiol, Sch Vet Med, Philadelphia, PA 19104 USA; [Yang, Cliff Y.; Goldrath, Ananda W.] Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; [Sathaliyawala, Taheri; Kubota, Masaru; Turner, Damian; Farber, Donna L.] Columbia Univ, Med Ctr, Dept Surg, New York, NY USA; [Sathaliyawala, Taheri; Kubota, Masaru; Turner, Damian; Farber, Donna L.] Columbia Univ, Med Ctr, Columbia Ctr Translat Immunol, New York, NY USA; [Diamond, Joshua M.; Collman, Ronald G.] Univ Penn, Dept Med, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of California System; University of California San Diego; Columbia University; Columbia University; University of Pennsylvania	Wherry, EJ (corresponding author), Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	wherry@mail.med.upenn.edu; dartis@mail.med.upenn.edu	Wherry, John/ABI-1280-2020	Collman, Ronald/0000-0002-0508-3701; Farber, Donna/0000-0001-8236-9183; Artis, David/0000-0002-1753-4100; Abt, Michael/0000-0002-7351-2061; Ziegler, Carly/0000-0002-8279-7150	US National Institutes of Health [U19AI083022, AI071309, HHSN266200500030C, HL098957, AI061570, AI074878, AI087990, AI095608, AI091759, AI095466, U01AI095608, T32AI007532, T32AI05528]; Burroughs Wellcome Fund; National Institute of Diabetes and Digestive and Kidney Diseases Center for the Molecular Studies in Digestive and Liver Diseases Molecular Pathology and Imaging Core [DK50306]; University of Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL098957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071309, U01AI095608, U19AI083022, R01AI067545, R21AI087990, R01AI074878, T32AI007532, R01AI072117, R01AI061570, R01AI091759, R01AI095466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK093784, P30DK050306] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institute of Diabetes and Digestive and Kidney Diseases Center for the Molecular Studies in Digestive and Liver Diseases Molecular Pathology and Imaging Core; University of Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank all members of the Artis and Wherry laboratories; M. Siracusa, S. Saenz, L. Osborne, E. Tait Wojno, M. Noti, M. Nair and A. Crawford for discussions and critical reading of the manuscript; D. Kobuley and D. Hill for care of the germ-free mouse facility; Yadav and A. Fitzgerald for assistance with the human BAL samples; and L. Fouser, S. Olland, R. Zollner, K. Lam and A. Root (Pfizer) for the preparation of anti-IL-22. Supported by US National Institutes of Health (U19AI083022, AI071309 and HHSN266200500030C to E.J.W.; HL098957 to R.G.C. for human pulmonary BAL studies; AI061570, AI074878, AI087990, AI095608, AI091759, AI095466 and U01AI095608 to D.A.; T32AI007532 to L.A.M. and G.F.S.; and T32AI05528 to M.C.A.), the Burroughs Wellcome Fund (D.A.), the National Institute of Diabetes and Digestive and Kidney Diseases Center for the Molecular Studies in Digestive and Liver Diseases Molecular Pathology and Imaging Core (DK50306) and the University of Pennsylvania (D.A.).	Altemeier WA, 2005, J IMMUNOL, V175, P3369, DOI 10.4049/jimmunol.175.5.3369; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Bradley JS, 2009, BIOFACTORS, V35, P258, DOI 10.1002/biof.41; Broide DH, 2008, J ALLERGY CLIN IMMUN, V121, P560, DOI 10.1016/j.jaci.2008.01.031; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cannarile MA, 2006, NAT IMMUNOL, V7, P1317, DOI 10.1038/ni1403; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Crellin NK, 2010, IMMUNITY, V33, P752, DOI 10.1016/j.immuni.2010.10.012; Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; DAHUANG W, 2009, CURRENT PROTOCOLS BI, P1; Decman V, 2010, J IMMUNOL, V184, P5151, DOI 10.4049/jimmunol.0902063; Doherty T, 2007, CURR OPIN IMMUNOL, V19, P676, DOI 10.1016/j.coi.2007.07.017; Dolinay T, 2006, PHYSIOL GENOMICS, V26, P68, DOI 10.1152/physiolgenomics.00110.2005; Enomoto Y, 2009, J ALLERGY CLIN IMMUN, V124, P913, DOI 10.1016/j.jaci.2009.08.044; Fukumoto J, 2010, AM J PHYSIOL-LUNG C, V298, pL131, DOI 10.1152/ajplung.90576.2008; Guo HL, 2010, J VIROL, V84, P7750, DOI 10.1128/JVI.00187-10; Hughes T, 2010, IMMUNITY, V32, P803, DOI 10.1016/j.immuni.2010.06.007; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kohlmeier JE, 2009, ANNU REV IMMUNOL, V27, P61, DOI 10.1146/annurev.immunol.021908.132625; Le Goffic R, 2011, AM J RESP CELL MOL, V45, P1125, DOI 10.1165/rcmb.2010-0516OC; Monticelli LA, 2009, P NATL ACAD SCI USA, V106, P19461, DOI 10.1073/pnas.0908249106; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Okumura S, 2005, J ALLERGY CLIN IMMUN, V115, P272, DOI 10.1016/j.jaci.2004.10.004; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Rankin L, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/281569; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; Saenz SA, 2010, TRENDS IMMUNOL, V31, P407, DOI 10.1016/j.it.2010.09.001; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Satoh-Takayama N, 2010, J EXP MED, V207, P273, DOI 10.1084/jem.20092029; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Sonnenberg GF, 2010, ADV IMMUNOL, V107, P1, DOI [10.1016/S0065-2776(10)07008-2, 10.1016/B978-0-12-381300-8.00001-0]; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Wang SW, 2005, J ALLERGY CLIN IMMUN, V115, P287, DOI 10.1016/j.jaci.2004.11.037; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812	47	1065	1103	3	146	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2011	12	11					1045	U47		10.1038/ni.2131	http://dx.doi.org/10.1038/ni.2131			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	841GG	21946417	Bronze, Green Accepted			2022-12-18	WOS:000296500100009
J	Petit, I; Szyper-Kravitz, M; Nagler, A; Lahav, M; Peled, A; Habler, L; Ponomaryov, T; Taichman, RS; Arenzana-Seisdedos, F; Fujii, N; Sandbank, J; Zipori, D; Lapidot, T				Petit, I; Szyper-Kravitz, M; Nagler, A; Lahav, M; Peled, A; Habler, L; Ponomaryov, T; Taichman, RS; Arenzana-Seisdedos, F; Fujii, N; Sandbank, J; Zipori, D; Lapidot, T			G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4	NATURE IMMUNOLOGY			English	Article							COLONY-STIMULATING FACTOR; HEMATOPOIETIC PROGENITOR CELLS; CHEMOKINE RECEPTOR CXCR4; CD4(+) T-LYMPHOCYTES; PERIPHERAL-BLOOD; CD34(+) CELLS; FACTOR-I; SULFATED POLYSACCHARIDES; PLASMA-LEVELS; EXPRESSION	Granulocyte colony-stimulating factor (G-CSF)-induced hematopoietic stem cell mobilization is widely used for clinical transplantation; however, the mechanism is poorly understood. We report here that G-CSF induced a reduction of the chemokine stromal cell-derived factor 1 (SDF-1) and an increase in its receptor CXCR4 in the bone marrow (BM), whereas their protein expression in the blood was less affected. The gradual decrease of BM SDF-1, due mostly to its degradation by neutrophil elastase, correlated with stem cell mobilization. Elastase inhibition reduced both activities. Human and murine stem cell mobilization was inhibited by neutralizing CXCR4 or SDF-1 antibodies, demonstrating SDF-1-CXCR4 signaling in cell egress. We suggest that manipulation of SDF-1-CXCR4 interactions may be a means with which to control the navigation of progenitors between the BM and blood to improve the outcome of clinical stem cell transplantation.	Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; Meir Med Ctr, Kefar Sava, Israel; Sheba Med Ctr, Tel Hashomer, Israel; Hadassah Univ Hosp, IL-91120 Jerusalem, Israel; Assaf Harofeh Med Ctr, IL-70300 Zerifin, Israel; Univ Michigan, Sch Dent, Ann Arbor, MI 48109 USA; Inst Pasteur, Unite Immunol Virale, Paris, France; Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto, Japan	Weizmann Institute of Science; Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Hebrew University of Jerusalem; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; University of Michigan System; University of Michigan; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Kyoto University	Lapidot, T (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	Tsvee.Lapidot@weizmann.ac.il	Petit, isabelle/AAF-5620-2020; Arenzana-Seisdedos, Fernando/E-5835-2016; Lapidot, Tsvee/A-1812-2010	Petit, isabelle/0000-0002-9782-0683; Taichman, Russell S./0000-0002-7890-0020				Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Benboubker L, 2001, BRIT J HAEMATOL, V113, P247, DOI 10.1046/j.1365-2141.2001.02717.x; Broxmeyer HE, 1999, BLOOD, V94, p650A; BROXMEYER HE, 2001, BLOOD, V98, P810; Cashman J, 2002, BLOOD, V99, P792, DOI 10.1182/blood.V99.3.792; Champagne B, 1998, J IMMUNOL, V161, P6398; Cinamon G, 2001, NAT IMMUNOL, V2, P515, DOI 10.1038/88710; Coulomb-L'Hermine A, 1999, P NATL ACAD SCI USA, V96, P8585, DOI 10.1073/pnas.96.15.8585; Dale DC, 2000, BLOOD, V96, P2317, DOI 10.1182/blood.V96.7.2317.h8002317_2317_2322; Delgado MB, 2001, EUR J IMMUNOL, V31, P699, DOI 10.1002/1521-4141(200103)31:3<699::AID-IMMU699>3.0.CO;2-6; Derdeyn CA, 1999, AIDS RES HUM RETROV, V15, P1063, DOI 10.1089/088922299310359; Dutt P, 1998, J IMMUNOL, V161, P3652; Frenette PS, 2000, BLOOD, V96, P2460, DOI 10.1182/blood.V96.7.2460.h8002460_2460_2468; Gazitt Y, 2000, STEM CELLS, V18, P390, DOI 10.1634/stemcells.18-6-390; Gazitt Y, 2001, STEM CELLS, V19, P37, DOI 10.1634/stemcells.19-1-37; Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hendrix CW, 2000, ANTIMICROB AGENTS CH, V44, P1667, DOI 10.1128/AAC.44.6.1667-1673.2000; Janowska-Wieczorek A, 2000, EXP HEMATOL, V28, P1274, DOI 10.1016/S0301-472X(00)00532-4; Janowska-Wieczorek A, 1999, BLOOD, V93, P3379, DOI 10.1182/blood.V93.10.3379.410k09_3379_3390; Jinquan T, 2000, IMMUNOLOGY, V99, P402, DOI 10.1046/j.1365-2567.2000.00954.x; Kawabata T, 1999, P NATL ACAD SCI USA, V96, P5663, DOI 10.1073/pnas.96.10.5663; Kim CH, 1998, BLOOD, V91, P100, DOI 10.1182/blood.V91.1.100.100_100_110; Kollet O, 2001, BLOOD, V97, P3283, DOI 10.1182/blood.V97.10.3283; Lambeir AM, 2001, J BIOL CHEM, V276, P29839, DOI 10.1074/jbc.M103106200; Lataillade JJ, 2000, BLOOD, V95, P756, DOI 10.1182/blood.V95.3.756; LATERVEER L, 1995, BLOOD, V85, P2269, DOI 10.1182/blood.V85.8.2269.bloodjournal8582269; Levesque JP, 2001, BLOOD, V98, P1289, DOI 10.1182/blood.V98.5.1289; Levesque JP, 2001, BLOOD, V98, p831A; Liles WC, 2001, BLOOD, V98, p737A; Lin TJ, 2000, J IMMUNOL, V165, P211, DOI 10.4049/jimmunol.165.1.211; Link DC, 2000, SEMIN HEMATOL, V37, P25, DOI 10.1016/S0037-1963(00)90086-6; Liu FL, 1997, BLOOD, V90, P2522, DOI 10.1182/blood.V90.7.2522.2522_2522_2528; Ma Q, 1999, IMMUNITY, V10, P463, DOI 10.1016/S1074-7613(00)80046-1; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Mohle R, 1993, J Hematother, V2, P483, DOI 10.1089/scd.1.1993.2.483; Moore MAS, 2001, ANN NY ACAD SCI, V938, P36; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Papayannopoulou T, 1998, BLOOD, V91, P2231, DOI 10.1182/blood.V91.7.2231.2231_2231_2239; Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Pelletier AJ, 2000, BLOOD, V96, P2682; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Poznansky MC, 2000, NAT MED, V6, P543, DOI 10.1038/75022; Proost P, 1998, FEBS LETT, V432, P73, DOI 10.1016/S0014-5793(98)00830-8; Pruijt JFM, 1999, P NATL ACAD SCI USA, V96, P10863, DOI 10.1073/pnas.96.19.10863; ROBERTS AW, 1995, BLOOD, V86, P1600, DOI 10.1182/blood.V86.4.1600.bloodjournal8641600; Shen HM, 2001, J IMMUNOL, V166, P5027, DOI 10.4049/jimmunol.166.8.5027; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Sweeney EA, 2002, BLOOD, V99, P44, DOI 10.1182/blood.V99.1.44; Sweeney EA, 2000, P NATL ACAD SCI USA, V97, P6544, DOI 10.1073/pnas.97.12.6544; Tamamura H, 2001, BIOORG MED CHEM LETT, V11, P1897, DOI 10.1016/S0960-894X(01)00323-7; To LB, 1997, BLOOD, V89, P2233, DOI 10.1182/blood.V89.7.2233; Uchida N, 1997, BLOOD, V89, P465, DOI 10.1182/blood.V89.2.465; Vaday GG, 2000, J LEUKOCYTE BIOL, V67, P149, DOI 10.1002/jlb.67.2.149; Valenzuela-Fernandez A, 2002, J BIOL CHEM, V277, P15677, DOI 10.1074/jbc.M111388200; van der Loo JCM, 1998, BLOOD, V92, P2556, DOI 10.1182/blood.V92.7.2556.2556_2556_2570; Voermans C, 2001, BLOOD, V97, P799, DOI 10.1182/blood.V97.3.799; Wang JB, 1998, J LEUKOCYTE BIOL, V64, P642, DOI 10.1002/jlb.64.5.642; Watanabe T, 1999, BLOOD, V93, P1157, DOI 10.1182/blood.V93.4.1157.404k13_1157_1163; ZIPORI D, 1985, BLOOD, V66, P447; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	64	1060	1140	1	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2002	3	7					687	694		10.1038/ni813	http://dx.doi.org/10.1038/ni813			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	566RH	12068293				2022-12-18	WOS:000176441700020
J	Sharpe, AH; Wherry, EJ; Ahmed, R; Freeman, GJ				Sharpe, Arlene H.; Wherry, E. John; Ahmed, Rafi; Freeman, Gordon J.			The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection	NATURE IMMUNOLOGY			English	Review							T-CELL-ACTIVATION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; HELICOBACTER-PYLORI INFECTION; RESPIRATORY SYNCYTIAL VIRUS; DEATH-1 PD-1 PATHWAY; DENDRITIC CELLS; RHEUMATOID-ARTHRITIS; VIRAL-INFECTION; B7 FAMILY; DISEASE PROGRESSION	The programmed cell death 1 (PD-1) surface receptor binds to two ligands, PD-L1 and PD-L2. Studies have shown that PD-1-PD-L interactions control the induction and maintenance of peripheral T cell tolerance and indicate a previously unknown function for PD-L1 on nonhematopoietic cells in protecting tissues from autoimmune attack. PD-1 and its ligands have also been exploited by a variety of microorganisms to attenuate antimicrobial immunity and facilitate chronic infection. Here we examine the functions of PD-1 and its ligands in regulating antimicrobial and self-reactive T cell responses and discuss the therapeutic potential of manipulating this pathway.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Wistar Inst Anat & Biol, Program Immunol, Philadelphia, PA 19104 USA; Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; Harvard Univ, Sch Med, Dept Med,Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; The Wistar Institute; Emory University; Emory University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Sharpe, AH (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	arlene_sharpe@hms.harvard.edu	Freeman, Gordon/AAC-5380-2019; Wherry, John/ABI-1280-2020	Freeman, Gordon/0000-0002-7210-5616; 				Anderson KM, 2006, J IMMUNOL, V176, P5306, DOI 10.4049/jimmunol.176.9.5306; Ansari MJI, 2003, J EXP MED, V198, P63, DOI 10.1084/jem.20022125; Augello A, 2005, EUR J IMMUNOL, V35, P1482, DOI 10.1002/eji.200425405; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2005, P NATL ACAD SCI USA, V102, P4512, DOI 10.1073/pnas.0408773102; Blank C, 2003, J IMMUNOL, V171, P4574, DOI 10.4049/jimmunol.171.9.4574; Blocki FA, 2006, FASEB J, V20, P2408, DOI 10.1096/fj.06-6171fje; Boettler T, 2006, J VIROL, V80, P3532, DOI 10.1128/JVI.80.7.3532-3540.2006; Brown JA, 2003, J IMMUNOL, V170, P1257, DOI 10.4049/jimmunol.170.3.1257; Chang J, 2002, NAT MED, V8, P54, DOI 10.1038/nm0102-54; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Cohen N, 2004, J DENT RES, V83, P429, DOI 10.1177/154405910408300515; Daniel-Ribeiro CT, 2000, ACTA TROP, V76, P205, DOI 10.1016/S0001-706X(00)00099-1; Das S, 2006, J IMMUNOL, V176, P3000, DOI 10.4049/jimmunol.176.5.3000; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Dong HD, 2004, IMMUNITY, V20, P327, DOI 10.1016/S1074-7613(04)00050-0; Dong HD, 2003, J CLIN INVEST, V111, P363, DOI 10.1172/JCI200316015; Dong HD, 1999, NAT MED, V5, P1365; Eppihimer MJ, 2002, MICROCIRCULATION, V9, P133, DOI 10.1038/sj/mn/7800123; Ferreiros-Vidal I, 2004, ARTHRITIS RHEUM-US, V50, P2590, DOI 10.1002/art.20436; Fife BT, 2006, J EXP MED, V203, P2737, DOI 10.1084/jem.20061577; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Guleria I, 2005, J EXP MED, V202, P231, DOI 10.1084/jem.20050019; Hirata S, 2005, J IMMUNOL, V174, P1888, DOI 10.4049/jimmunol.174.4.1888; Holets LM, 2006, BIOL REPROD, V74, P352, DOI 10.1095/biolreprod.105.046581; Hori J, 2006, J IMMUNOL, V177, P5928, DOI 10.4049/jimmunol.177.9.5928; Huber SA, 2006, AUTOIMMUNITY, V39, P55, DOI 10.1080/08916930500484906; Isogawa M, 2005, IMMUNITY, V23, P53, DOI 10.1016/j.immuni.2005.05.005; Iwai YH, 2003, J EXP MED, V198, P39, DOI 10.1084/jem.20022235; James ES, 2005, GENES IMMUN, V6, P430, DOI 10.1038/sj.gene.6364223; Johansson M, 2005, ARTHRITIS RHEUM-US, V52, P1665, DOI 10.1002/art.21058; Jun H, 2005, FEBS LETT, V579, P6259, DOI 10.1016/j.febslet.2005.09.098; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; KAMRADT T, 1993, J RHEUMATOL, V20, P904; Kaufmann SHE, 2006, IMMUNITY, V24, P351, DOI 10.1016/j.immuni.2006.04.003; Keir ME, 2005, J IMMUNOL, V175, P7372, DOI 10.4049/jimmunol.175.11.7372; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; Kirchberger S, 2005, J IMMUNOL, V175, P1145, DOI 10.4049/jimmunol.175.2.1145; Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241; Koga N, 2004, ARTERIOSCL THROM VAS, V24, P2057, DOI 10.1161/01.ATV.0000145015.23656.e4; Kong EKP, 2005, ARTHRITIS RHEUM-US, V52, P1058, DOI 10.1002/art.20966; Kroner A, 2005, ANN NEUROL, V58, P50, DOI 10.1002/ana.20514; Kuipers H, 2006, EUR J IMMUNOL, V36, P2472, DOI 10.1002/eji.200635978; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Latchman YE, 2004, P NATL ACAD SCI USA, V101, P10691, DOI 10.1073/pnas.0307252101; Lee SH, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2071; Liang SC, 2006, EUR J IMMUNOL, V36, P58, DOI 10.1002/eji.200535458; Liang SC, 2003, EUR J IMMUNOL, V33, P2706, DOI 10.1002/eji.200324228; Lin SC, 2004, ARTHRITIS RHEUM-US, V50, P770, DOI 10.1002/art.20040; Loomis WP, 2006, J IMMUNOL, V177, P4021, DOI 10.4049/jimmunol.177.6.4021; Meng QL, 2006, INVEST OPHTH VIS SCI, V47, P4444, DOI 10.1167/iovs.06-0201; Muhlbauer M, 2006, J HEPATOL, V45, P520, DOI 10.1016/j.jhep.2006.05.007; Nakae S, 2006, J IMMUNOL, V176, P2238, DOI 10.4049/jimmunol.176.4.2238; Nielsen C, 2004, LUPUS, V13, P510, DOI 10.1191/0961203303lu1052oa; Nielsen C, 2003, TISSUE ANTIGENS, V62, P492, DOI 10.1046/j.1399-0039.2003.00136.x; Nishimura H, 2000, J EXP MED, V191, P891, DOI 10.1084/jem.191.5.891; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Okazaki T, 2006, TRENDS IMMUNOL, V27, P195, DOI 10.1016/j.it.2006.02.001; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Probst HC, 2005, NAT IMMUNOL, V6, P280, DOI 10.1038/ni1165; Prokunina L, 2004, ARTHRITIS RHEUM-US, V50, P1770, DOI 10.1002/art.20280; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; Rodig N, 2003, EUR J IMMUNOL, V33, P3117, DOI 10.1002/eji.200324270; Sabapatha A, 2006, AM J REPROD IMMUNOL, V56, P345, DOI 10.1111/j.1600-0897.2006.00435.x; Salama AD, 2003, J EXP MED, V198, P71, DOI 10.1084/jem.20022119; Sawada S, 2005, AUTOIMMUN REV, V4, P106, DOI 10.1016/j.autrev.2004.08.034; Schreiner B, 2004, J NEUROIMMUNOL, V155, P172, DOI 10.1016/j.jneuroim.2004.06.013; Selenko-Gebauer N, 2003, J IMMUNOL, V170, P3637, DOI 10.4049/jimmunol.170.7.3637; Sigal LH, 1997, ANNU REV IMMUNOL, V15, P63, DOI 10.1146/annurev.immunol.15.1.63; Smith P, 2004, J IMMUNOL, V173, P1240, DOI 10.4049/jimmunol.173.2.1240; Stanciu LA, 2006, J INFECT DIS, V193, P404, DOI 10.1086/499275; Stromberg E, 2003, FEMS IMMUNOL MED MIC, V36, P159, DOI 10.1016/S0928-8244(03)00026-9; Terrazas LI, 2005, INT J PARASITOL, V35, P1349, DOI 10.1016/j.ijpara.2005.06.003; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; Van Keulen VP, 2006, CLIN EXP IMMUNOL, V143, P314, DOI 10.1111/j.1365-2249.2005.02992.x; Wang J, 2005, P NATL ACAD SCI USA, V102, P11823, DOI 10.1073/pnas.0505497102; Wang SC, 2006, J CLIN IMMUNOL, V26, P506, DOI 10.1007/s10875-006-9048-9; Watson MP, 2006, INVEST OPHTH VIS SCI, V47, P3417, DOI 10.1167/iovs.05-1597; Wherry EJ, 2005, J VIROL, V79, P8960, DOI 10.1128/JVI.79.14.8960-8968.2005; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Zaccone P, 2006, PARASITE IMMUNOL, V28, P515, DOI 10.1111/j.1365-3024.2006.00879.x; Zhang Y, 2006, P NATL ACAD SCI USA, V103, P11695, DOI 10.1073/pnas.0601347103; Zhu B, 2006, J IMMUNOL, V176, P3480, DOI 10.4049/jimmunol.176.6.3480	90	1059	1200	3	147	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2007	8	3					239	245		10.1038/ni1443	http://dx.doi.org/10.1038/ni1443			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	137EF	17304234				2022-12-18	WOS:000244275100009
J	Tian, J; Avalos, AM; Mao, SY; Chen, B; Senthil, K; Wu, H; Parroche, P; Drabic, S; Golenbock, D; Sirois, C; Hua, J; An, LL; Audoly, L; La Rosa, G; Bierhaus, A; Naworth, P; Marshak-Rothstein, A; Crow, MK; Fitzgerald, KA; Latz, E; Kiener, PA; Coyle, AJ				Tian, Jane; Avalos, Ana Maria; Mao, Su-Yau; Chen, Bo; Senthil, Kannaki; Wu, Herren; Parroche, Peggy; Drabic, Stacey; Golenbock, Douglas; Sirois, Cherilyn; Hua, Jing; An, Ling Ling; Audoly, Laurent; La Rosa, Greg; Bierhaus, Angelika; Naworth, Peter; Marshak-Rothstein, Ann; Crow, Mary K.; Fitzgerald, Katherine A.; Latz, Eicke; Kiener, Peter A.; Coyle, Anthony J.			Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE	NATURE IMMUNOLOGY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PLASMACYTOID DENDRITIC CELLS; GLYCATION END-PRODUCTS; MOBILITY GROUP BOX-1; CHROMATIN PROTEIN HMGB1; ALPHA-PRODUCING CELLS; IFN-ALPHA; B-CELLS; TOLL-LIKE-RECEPTOR-9 ACTIVATION; I INTERFERON	Increased concentrations of DNA-containing immune complexes in the serum are associated with systemic autoimmune diseases such as lupus. Stimulation of Toll-like receptor 9 (TLR9) by DNA is important in the activation of plasmacytoid dendritic cells and B cells. Here we show that HMGB1, a nuclear DNA-binding protein released from necrotic cells, was an essential component of DNA-containing immune complexes that stimulated cytokine production through a TLR9-MyD88 pathway involving the multivalent receptor RAGE. Moreover, binding of HMGB1 to class A CpG oligodeoxynucleotides considerably augmented cytokine production by means of TLR9 and RAGE. Our data demonstrate a mechanism by which HMGB1 and RAGE activate plasmacytoid dendritic cells and B cells in response to DNA and contribute to autoimmune pathogenesis.	Medimmune Inc, Dept Res, Inflammat & Autoimmune Grp, Gaithersburg, MD 20878 USA; Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA; Hosp Special Surg, Rheumatol Res & Autoimmun & Inflammat Program, New York, NY 10021 USA; Crit Therapeut, Lexington, MA 02421 USA; Univ Heidelberg, Dept Med, D-69115 Heidelberg, Germany	AstraZeneca; Medimmune; Boston University; University of Massachusetts System; University of Massachusetts Worcester; Northwell Health; Ruprecht Karls University Heidelberg	Coyle, AJ (corresponding author), Medimmune Inc, Dept Res, Inflammat & Autoimmune Grp, Gaithersburg, MD 20878 USA.	coylea@medimmune.com	Latz, Eicke/H-3951-2014; Crow, Mary/R-8480-2019; Fitzgerald, Katherine/ABE-6317-2020	Latz, Eicke/0000-0003-1488-5666; Sirois, Cherilyn M./0000-0002-5472-4288; Fitzgerald, Kate/0000-0003-3175-609X	NIAID NIH HHS [AI0677497-01] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; Andersson U, 2004, J INTERN MED, V255, P344, DOI 10.1111/j.1365-2796.2003.01303.x; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Asselin-Paturel C, 2005, J EXP MED, V202, P461, DOI 10.1084/jem.20051395; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; Crow Mary K, 2005, Curr Rheumatol Rep, V7, P463, DOI 10.1007/s11926-005-0053-4; Degryse B, 2001, J CELL BIOL, V152, P1197, DOI 10.1083/jcb.152.6.1197; Denny MF, 2006, J IMMUNOL, V176, P2095, DOI 10.4049/jimmunol.176.4.2095; Dumitriu IE, 2005, EUR J IMMUNOL, V35, P2184, DOI 10.1002/eji.200526066; Dumitriu IE, 2005, J IMMUNOL, V174, P7506, DOI 10.4049/jimmunol.174.12.7506; Ehlers M, 2006, J EXP MED, V203, P553, DOI 10.1084/jem.20052438; Fiuza C, 2003, BLOOD, V101, P2652, DOI 10.1182/blood-2002-05-1300; Goodnow CC, 2006, SCIENCE, V312, P1606, DOI 10.1126/science.1129797; Gottenberg JE, 2006, P NATL ACAD SCI USA, V103, P2770, DOI 10.1073/pnas.0510837103; Guiducci C, 2006, J EXP MED, V203, P1999, DOI 10.1084/jem.20060401; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hua J, 2006, ARTHRITIS RHEUM-US, V54, P1906, DOI 10.1002/art.21890; Ishihara K, 2003, FEBS LETT, V550, P107, DOI 10.1016/S0014-5793(03)00846-9; Ishii KJ, 2006, TRENDS IMMUNOL, V27, P525, DOI 10.1016/j.it.2006.09.002; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Kirou KA, 2005, ARTHRITIS RHEUM-US, V52, P1491, DOI 10.1002/art.21031; Kokkola R, 2005, SCAND J IMMUNOL, V61, P1, DOI 10.1111/j.0300-9475.2005.01534.x; Kokkola R, 2002, ARTHRITIS RHEUM, V46, P2598, DOI 10.1002/art.10540; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Lakowicz JR, 2000, PHOTOCHEM PHOTOBIOL, V72, P421, DOI 10.1562/0031-8655(2000)072<0421:OSRIP>2.0.CO;2; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Li JH, 2004, J IMMUNOL METHODS, V289, P211, DOI 10.1016/j.jim.2004.04.019; Lovgren T, 2004, ARTHRITIS RHEUM-US, V50, P1861, DOI 10.1002/art.20254; Magnusson M, 2001, SCAND J IMMUNOL, V54, P543, DOI 10.1046/j.1365-3083.2001.01018.x; Marshak-Rothstein A, 2004, J ENDOTOXIN RES, V10, P247, DOI 10.1179/096805104225005850; Means TK, 2005, ANN NY ACAD SCI, V1062, P242, DOI 10.1196/annals.1358.027; Mok CC, 2003, J CLIN PATHOL, V56, P481, DOI 10.1136/jcp.56.7.481; Muller S, 2001, EMBO J, V20, P4337, DOI 10.1093/emboj/20.16.4337; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Palumbo R, 2004, J CELL BIOL, V164, P441, DOI 10.1083/jcb.200304135; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Popovic K, 2005, ARTHRITIS RHEUM, V52, P3639, DOI 10.1002/art.21398; Popovic PJ, 2006, J IMMUNOL, V177, P8701, DOI 10.4049/jimmunol.177.12.8701; Qin SX, 2006, J EXP MED, V203, P1637, DOI 10.1084/jem.20052203; Robak E, 2006, CLIN RHEUMATOL, V25, P225, DOI 10.1007/s10067-005-1163-0; Rong LL, 2004, FASEB J, V18, P1812, DOI 10.1096/fj.04-1899com; Ronnblom L, 2003, AUTOIMMUNITY, V36, P463, DOI 10.1080/08916930310001602128; SANO H, 1989, SCAND J IMMUNOL, V30, P51, DOI 10.1111/j.1365-3083.1989.tb01188.x; Sappington PL, 2002, GASTROENTEROLOGY, V123, P790, DOI 10.1053/gast.2002.35391; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Sorci G, 2004, MOL CELL BIOL, V24, P4880, DOI 10.1128/MCB.24.11.4880-4894.2004; Stott K, 2006, J MOL BIOL, V360, P90, DOI 10.1016/j.jmb.2006.04.059; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; TERBORG EJ, 1990, ARTHRITIS RHEUM-US, V33, P634, DOI 10.1002/art.1780330505; Vallin H, 1999, J IMMUNOL, V163, P6306; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6; WALKER JM, 1977, INT J PEPT PROT RES, V9, P220; Wang H, 2004, J INTERN MED, V255, P320, DOI 10.1111/j.1365-2796.2003.01302.x; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wu CCN, 2004, J BIOL CHEM, V279, P33071, DOI 10.1074/jbc.M311662200; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100	63	1057	1122	5	123	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2007	8	5					487	496		10.1038/ni1457	http://dx.doi.org/10.1038/ni1457			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	158YM	17417641				2022-12-18	WOS:000245831600013
J	Ben-Neriah, Y; Karin, M				Ben-Neriah, Yinon; Karin, Michael			Inflammation meets cancer, with NF-kappa B as the matchmaker	NATURE IMMUNOLOGY			English	Review							TUMOR-NECROSIS-FACTOR; IKK-BETA; TRANSCRIPTION FACTOR; CELL LYMPHOMA; STEM-CELLS; COMPENSATORY PROLIFERATION; EPITHELIAL PROLIFERATION; RHEUMATOID-ARTHRITIS; BACTERIAL-INFECTION; COMBINATION THERAPY	Inflammation is a fundamental protective response that sometimes goes awry and becomes a major cofactor in the pathogenesis of many chronic human diseases, including cancer. Here we review the evolutionary relationship and opposing functions of the transcription factor NF-kappa B in inflammation and cancer. Although it seems to fulfill a distinctly tumor-promoting role in many types of cancer, NF-kappa B has a confounding role in certain tumors. Understanding the activity and function of NF-kappa B in the context of tumorigenesis is critical for its successful taming, an important challenge for modern cancer biology.	[Ben-Neriah, Yinon] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Immunol, Inst Med Res Israel Canada, IL-91010 Jerusalem, Israel; [Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; [Karin, Michael] Univ Calif San Diego, Sch Med, Ctr Canc, La Jolla, CA 92093 USA	Hebrew University of Jerusalem; University of California System; University of California San Diego; University of California System; University of California San Diego	Ben-Neriah, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Immunol, Inst Med Res Israel Canada, IL-91010 Jerusalem, Israel.	yinon@cc.huji.ac.il; karinoffice@ucsd.edu	Ben-Neriah, Yinon/L-6285-2019		Israel Science Foundation; Crohn's & Colitis Foundation of America; German-Israeli Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; US National Institutes of Health; American Cancer Society; Israel Cancer Research Fund	Israel Science Foundation(Israel Science Foundation); Crohn's & Colitis Foundation of America; German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Israel Cancer Research Fund	We thank E. Pikarsky, I. Alkalay-Snir and A. Pribluda for comments and discussions. Supported by the Israel Science Foundation, Israel Cancer Research Fund, the Crohn's & Colitis Foundation of America, the German-Israeli Foundation, Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, the US National Institutes of Health and the American Cancer Society.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Ammirante M, 2010, NATURE, V464, P302, DOI 10.1038/nature08782; Amschler K, 2010, J INVEST DERMATOL, V130, P1073, DOI 10.1038/jid.2009.365; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Apidianakis Y, 2009, P NATL ACAD SCI USA, V106, P20883, DOI 10.1073/pnas.0911797106; Apte RN, 2006, EUR J CANCER, V42, P751, DOI 10.1016/j.ejca.2006.01.010; Augustin R, 2010, SEMIN IMMUNOL, V22, P54, DOI 10.1016/j.smim.2009.11.002; Balkwill F, 2010, CLIN PHARMACOL THER, V87, P401, DOI 10.1038/clpt.2009.312; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; BERENBLUM I, 1985, CANCER RES, V45, P1917; Bettermann K, 2010, CANCER CELL, V17, P481, DOI 10.1016/j.ccr.2010.03.021; Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bivona TG, 2011, NATURE, V471, P523, DOI 10.1038/nature09870; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Bohrer H, 1997, J CLIN INVEST, V100, P972, DOI 10.1172/JCI119648; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bredel M, 2011, NEW ENGL J MED, V364, P627, DOI 10.1056/NEJMoa1006312; Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; Cabanes A, 1999, CLIN CANCER RES, V5, P687; Cao YX, 2007, P NATL ACAD SCI USA, V104, P15852, DOI 10.1073/pnas.0706728104; Cao YX, 2003, J MAMMARY GLAND BIOL, V8, P215, DOI 10.1023/A:1025905008934; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; COLE JW, 1963, CANCER, V16, P998, DOI 10.1002/1097-0142(196308)16:8<998::AID-CNCR2820160806>3.0.CO;2-C; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Cordero JB, 2010, DEV CELL, V18, P999, DOI 10.1016/j.devcel.2010.05.014; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Dhawan S, 1997, EUR J IMMUNOL, V27, P2172, DOI 10.1002/eji.1830270909; Domazet-Loso T, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-66; Duckett CS, 2002, J CLIN INVEST, V109, P579, DOI 10.1172/JCI200215197; Dunleavy K, 2009, BLOOD, V113, P6069, DOI 10.1182/blood-2009-01-199679; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Eaves CJ, 2008, NATURE, V456, P581, DOI 10.1038/456581a; Eckmann L, 2008, P NATL ACAD SCI USA, V105, P15058, DOI 10.1073/pnas.0808216105; Elyada E, 2011, NATURE, V470, P409, DOI 10.1038/nature09673; Erez N, 2011, INT J CANCER, V128, P2536, DOI 10.1002/ijc.26032; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Feng Y, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000562; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Foxwell BMJ, 2000, ANN RHEUM DIS, V59, P54; FRANZOSO G, 1992, NATURE, V359, P339, DOI 10.1038/359339a0; Gasparian AV, 2009, CELL CYCLE, V8, P1559, DOI 10.4161/cc.8.10.8415; Genovese MC, 2004, ARTHRITIS RHEUM-US, V50, P1412, DOI 10.1002/art.20221; Gewirtz AT, 2000, J CLIN INVEST, V105, P79, DOI 10.1172/JCI8066; Gillooly KM, 2009, J PHARMACOL EXP THER, V331, P349, DOI 10.1124/jpet.109.156018; Gilmore Thomas D, 2003, Cancer Treat Res, V115, P241; Gonzalez-Suarez E, 2010, NATURE, V468, P103, DOI 10.1038/nature09495; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haybaeck J, 2009, CANCER CELL, V16, P295, DOI 10.1016/j.ccr.2009.08.021; He GB, 2010, CANCER CELL, V17, P286, DOI 10.1016/j.ccr.2009.12.048; Hemmrich G, 2007, TRENDS IMMUNOL, V28, P449, DOI 10.1016/j.it.2007.08.003; Hertlein E, 2010, BLOOD, V116, P45, DOI 10.1182/blood-2010-01-263756; Hsu LC, 2011, NAT IMMUNOL, V12, P144, DOI 10.1038/ni.1976; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Inokuchi S, 2010, P NATL ACAD SCI USA, V107, P844, DOI 10.1073/pnas.0909781107; Kanarek N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000166; Kanarek N, 2010, GENE DEV, V24, P470, DOI 10.1101/gad.551610; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kiessling MK, 2009, CANCER RES, V69, P2365, DOI 10.1158/0008-5472.CAN-08-3221; Lam LT, 2008, P NATL ACAD SCI USA, V105, P20798, DOI 10.1073/pnas.0806491106; Lam LT, 2005, CLIN CANCER RES, V11, P28; Lange C, 2011, MOL BIOL EVOL, V28, P1687, DOI 10.1093/molbev/msq349; LAROSA FA, 1994, MOL CELL BIOL, V14, P1039, DOI 10.1128/MCB.14.2.1039; Lavon I, 2000, NAT MED, V6, P573, DOI 10.1038/75057; Lavon I, 2003, CANCER RES, V63, P25; Lawrence T, 2001, NAT MED, V7, P1291, DOI 10.1038/nm1201-1291; Lee DF, 2008, CLIN CANCER RES, V14, P5656, DOI 10.1158/1078-0432.CCR-08-0123; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Lizzul PF, 2005, J INVEST DERMATOL, V124, P1275, DOI 10.1111/j.0022-202X.2005.23735.x; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; MacMaster JF, 2003, INFLAMM RES, V52, P508, DOI 10.1007/s00011-003-1206-4; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Markovina S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-176; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Miagkov AV, 1998, P NATL ACAD SCI USA, V95, P13859, DOI 10.1073/pnas.95.23.13859; Midgley RS, 2010, J CLIN ONCOL, V28, P4575, DOI 10.1200/JCO.2010.29.6244; Milhollen MA, 2010, BLOOD, V116, P1515, DOI 10.1182/blood-2010-03-272567; Muller WEG, 2003, BIOMOL ENG, V20, P369, DOI 10.1016/S1389-0344(03)00055-8; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; NERI A, 1991, CELL, V67, P1075, DOI 10.1016/0092-8674(91)90285-7; Neurath MF, 1996, NAT MED, V2, P998, DOI 10.1038/nm0996-998; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Nickols JC, 2003, NAT NEUROSCI, V6, P161, DOI 10.1038/nn995; O'Dea E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000216; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; PFLUEGER D, 2010, GENOME RES; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Pitts WJ, 2008, ANNU REP MED CHEM, V43, P155, DOI 10.1016/S0065-7743(08)00010-9; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Pritchard JR, 2009, MOL CANCER THER, V8, P2183, DOI 10.1158/1535-7163.MCT-08-1203; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Ruland J, 2011, NAT IMMUNOL, V12, P709, DOI 10.1038/ni.2055; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; Sarkar D, 2008, P NATL ACAD SCI USA, V105, P17040, DOI 10.1073/pnas.0804956105; Sasaki Y, 2008, P NATL ACAD SCI USA, V105, P10883, DOI 10.1073/pnas.0805186105; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Schon M, 2008, JNCI-J NATL CANCER I, V100, P862, DOI 10.1093/jnci/djn174; Schopf L, 2006, ARTHRITIS RHEUM-US, V54, P3163, DOI 10.1002/art.22081; Schramek D, 2010, NATURE, V468, P98, DOI 10.1038/nature09387; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Smale ST, 2011, NAT IMMUNOL, V12, P689, DOI 10.1038/ni.2070; Snapper CM, 1996, J IMMUNOL, V156, P183; SQUIRES DF, 1965, SCIENCE, V148, P503, DOI 10.1126/science.148.3669.503; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tak PP, 2001, ARTHRITIS RHEUM, V44, P1897, DOI 10.1002/1529-0131(200108)44:8<1897::AID-ART328>3.0.CO;2-4; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(00)00094-0; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wertz IE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003350; WIEBECKE B, 1974, VIRCHOWS ARCH A, V364, P35, DOI 10.1007/BF01230856; Williams RO, 2007, CURR OPIN PHARMACOL, V7, P412, DOI 10.1016/j.coph.2007.06.001; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; Wright JJ, 2010, CLIN CANCER RES, V16, P4094, DOI 10.1158/1078-0432.CCR-09-2882; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; YIN J, 1993, GASTROENTEROLOGY, V104, P1633, DOI 10.1016/0016-5085(93)90639-T; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	151	1050	1095	4	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2011	12	8					715	723		10.1038/ni.2060	http://dx.doi.org/10.1038/ni.2060			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	794BT	21772280				2022-12-18	WOS:000292870700007
J	Khader, SA; Bell, GK; Pearl, JE; Fountain, JJ; Rangel-Moreno, J; Cilley, GE; Shen, F; Eaton, SM; Gaffen, SL; Swain, SL; Locksley, RM; Haynes, L; Randall, TD; Cooper, AM				Khader, Shabaana A.; Bell, Guy K.; Pearl, John E.; Fountain, Jeffrey J.; Rangel-Moreno, Javier; Cilley, Garth E.; Shen, Fang; Eaton, Sheri M.; Gaffen, Sarah L.; Swain, Susan L.; Locksley, Richard M.; Haynes, Laura; Randall, Troy D.; Cooper, Andrea M.			IL-23 and IL-17 in the establishment of protective pulmonary CD4(+) T cell responses after vaccination and during Mycobacterium tuberculosis challenge	NATURE IMMUNOLOGY			English	Article							COLONY-STIMULATING FACTOR; IN-VIVO; NEUTROPHIL RECRUITMENT; INTERLEUKIN-17 FAMILY; INFLAMMATORY CYTOKINE; DENDRITIC CELLS; HELPER TYPE-1; INFECTION; MICE; IMMUNITY	Interferon-gamma is key in limiting Mycobacterium tuberculosis infection. Here we show that vaccination triggered an accelerated interferon-gamma response by CD4(+) T cells in the lung during subsequent M. tuberculosis infection. Interleukin 23 ( IL-23) was essential for the accelerated response, for early cessation of bacterial growth and for establishment of an IL-17-producing CD4(+) T cell population in the lung. The recall response of the IL-17-producing CD4(+) T cell population occurred concurrently with expression of the chemokines CXCL9, CXCL10 and CXCL11. Depletion of IL-17 during challenge reduced the chemokine expression and accumulation of CD4(+) T cells producing interferon-gamma in the lung. We propose that vaccination induces IL-17-producing CD4(+) T cells that populate the lung and, after challenge, trigger the production of chemokines that recruit CD4(+) T cells producing interferon-c, which ultimately restrict bacterial growth.	Trudeau Inst Inc, Saranac Lake, NY 12983 USA; SUNY Buffalo, Dept Oral Biol, Sch Dent Med, Buffalo, NY 14214 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med Microbiol & Immunol, San Francisco, CA 94143 USA	Trudeau Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Cooper, AM (corresponding author), Trudeau Inst Inc, POB 59, Saranac Lake, NY 12983 USA.	acooper@trudeauinstitute.org	Ibrahim, Essam Hassan/G-1960-2018; Gaffen, Sarah L/B-1560-2009	Ibrahim, Essam Hassan/0000-0003-0130-2257; Gaffen, Sarah L/0000-0001-8511-2041; Pearl, John/0000-0001-7496-6367; A Khader, Shabaana/0000-0002-9545-4982; Cooper, Andrea/0000-0001-6050-3863; Fountain, Jeffrey/0000-0001-9473-7705; Shen, Fang/0000-0003-0084-7933; Rangel-Moreno, Javier/0000-0002-9738-1182	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067723, R01AI030663, P01AI046530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR050458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021054, R21AG028878] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL69409] Funding Source: Medline; NIAID NIH HHS [AI067723, AI030663, AI46530] Funding Source: Medline; NIAMS NIH HHS [AR050458] Funding Source: Medline; NIA NIH HHS [AG21054, AG02160, AG028878] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1; Akahoshi M, 2003, HUM GENET, V112, P237, DOI 10.1007/s00439-002-0873-5; Appelberg R, 2007, TRENDS MICROBIOL, V15, P87, DOI 10.1016/j.tim.2006.11.009; Baekkevold ES, 2005, J EXP MED, V201, P1045, DOI 10.1084/jem.20041059; Belladonna ML, 2002, J IMMUNOL, V168, P5448, DOI 10.4049/jimmunol.168.11.5448; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Byersdorfer CA, 2001, J IMMUNOL, V167, P6756, DOI 10.4049/jimmunol.167.12.6756; Chackerian AA, 2006, INFECT IMMUN, V74, P6092, DOI 10.1128/IAI.00621-06; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Cooper AM, 1997, TUBERCLE LUNG DIS, V78, P67, DOI 10.1016/S0962-8479(97)90017-4; Cooper AM, 2002, J IMMUNOL, V168, P1322, DOI 10.4049/jimmunol.168.3.1322; Cooper AM, 1997, J EXP MED, V186, P39, DOI 10.1084/jem.186.1.39; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Cruz A, 2006, J IMMUNOL, V177, P1416, DOI 10.4049/jimmunol.177.3.1416; Evans Jay T, 2003, Expert Rev Vaccines, V2, P219, DOI 10.1586/14760584.2.2.219; Flano E, 2005, J IMMUNOL, V175, P3225, DOI 10.4049/jimmunol.175.5.3225; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Gaffen SL, 2004, ARTHRITIS RES THER, V6, P240, DOI 10.1186/ar1444; Geisel RE, 2005, J IMMUNOL, V174, P5007, DOI 10.4049/jimmunol.174.8.5007; Ghilardi N, 2004, J IMMUNOL, V172, P2827, DOI 10.4049/jimmunol.172.5.2827; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Holscher C, 2001, J IMMUNOL, V167, P6957, DOI 10.4049/jimmunol.167.12.6957; Jones CE, 2002, AM J RESP CELL MOL, V26, P748, DOI 10.1165/ajrcmb.26.6.4757; Jung YJ, 2005, J EXP MED, V201, P1915, DOI 10.1084/jem.20050265; Khader SA, 2005, J IMMUNOL, V175, P788, DOI 10.4049/jimmunol.175.2.788; Khader SA, 2006, J EXP MED, V203, P1805, DOI 10.1084/jem.20052545; Kim CH, 1999, J LEUKOCYTE BIOL, V65, P6, DOI 10.1002/jlb.65.1.6; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Kolls JK, 2003, AM J RESP CELL MOL, V28, P9, DOI 10.1165/rcmb.2002-0255PS; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Leal IS, 1999, INFECT IMMUN, V67, P5747, DOI 10.1128/IAI.67.11.5747-5754.1999; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Miyamoto M, 2003, J IMMUNOL, V170, P4665, DOI 10.4049/jimmunol.170.9.4665; Moseley TA, 2003, CYTOKINE GROWTH F R, V14, P155, DOI 10.1016/S1359-6101(03)00002-9; Nabeshima Shigeki, 2005, Journal of Infection and Chemotherapy, V11, P18, DOI 10.1007/s10156-004-0357-8; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nakae S, 2003, P NATL ACAD SCI USA, V100, P5986, DOI 10.1073/pnas.1035999100; Olsen AW, 2000, EUR J IMMUNOL, V30, P1724; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Reinhardt RL, 2006, J IMMUNOL, V177, P1618, DOI 10.4049/jimmunol.177.3.1618; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Stobie L, 2000, P NATL ACAD SCI USA, V97, P8427, DOI 10.1073/pnas.160197797; Tso HW, 2004, J INFECT DIS, V190, P913, DOI 10.1086/422693; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Winslow GM, 2003, J IMMUNOL, V170, P2046, DOI 10.4049/jimmunol.170.4.2046; Wozniak TM, 2006, J IMMUNOL, V177, P8684, DOI 10.4049/jimmunol.177.12.8684; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519	56	1048	1089	1	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2007	8	4					369	377		10.1038/ni1449	http://dx.doi.org/10.1038/ni1449			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	148LK	17351619				2022-12-18	WOS:000245075900012
J	Martin-Fontecha, A; Thomsen, LL; Brett, S; Gerard, C; Lipp, M; Lanzavecchia, A; Sallusto, F				Martin-Fontecha, A; Thomsen, LL; Brett, S; Gerard, C; Lipp, M; Lanzavecchia, A; Sallusto, F			Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; CD4(+) T-CELLS; CHEMOKINE RECEPTOR CXCR3; HIGH ENDOTHELIAL VENULES; HUMAN DENDRITIC CELLS; INTERFERON-GAMMA; LEISHMANIA-MAJOR; IMMUNE-RESPONSE; CENTRAL MEMORY; TH1	Naive T cells are stimulated by antigen-presenting dendritic cells (DCs) in secondary lymphoid organs, but whether other types of cell participate in T cell priming is unclear. Here we show in mice that natural killer (NK) cells, which are normally excluded from lymph nodes, are rapidly recruited in a CCR7-independent, CXCR3-dependent manner to lymph nodes on stimulation by the injection of mature DCs. Recruitment of NK cells is also induced by some, but not all, adjuvants and correlates with the induction of T helper cell type 1 (T(H)1) responses. NK cell depletion and reconstitution experiments show that NK cells provide an early source of interferon-gamma (IFN-gamma) that is necessary for T(H)1 polarization. Taken together, our results identify an induced pathway of NK cell migration in antigen-stimulated lymph nodes and a mechanism by which some adjuvants may facilitate T(H)1 responses.	Inst Res Biomed, CH-6500 Bellinzona, Switzerland; Glaxo Smith & Kline, Stevenage SG1 2NY, Herts, England; Childrens Hosp, Ina Sue Perlmutter Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany	Universita della Svizzera Italiana; GlaxoSmithKline; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Martin-Fontecha, A (corresponding author), Inst Res Biomed, CH-6500 Bellinzona, Switzerland.	alfonso.martin-fontecha@irb.unisi.ch; federica.sallusto@irb.unisi.ch	Lipp, Martin/G-2235-2010	Lipp, Martin/0000-0002-0087-2672				Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Alpan O, 2004, NAT IMMUNOL, V5, P615, DOI 10.1038/ni1077; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bjorkdahl O, 2003, IMMUNOLOGY, V110, P170, DOI 10.1046/j.1365-2567.2003.01727.x; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; Cooper MA, 2004, TRENDS IMMUNOL, V25, P47, DOI 10.1016/j.it.2003.10.012; Diefenbach A, 2003, CURR OPIN IMMUNOL, V15, P37, DOI 10.1016/S0952-7915(02)00007-9; Fehniger TA, 2003, BLOOD, V101, P3052, DOI 10.1182/blood-2002-09-2876; Ferlazzo G, 2004, J IMMUNOL, V172, P1455, DOI 10.4049/jimmunol.172.3.1455; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Frigerio S, 2002, NAT MED, V8, P1414, DOI 10.1038/nm792; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Granucci F, 2004, J EXP MED, V200, P287, DOI 10.1084/jem.20040370; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Hancock WW, 2000, J EXP MED, V192, P1515, DOI 10.1084/jem.192.10.1515; HSIEH CS, 1995, J EXP MED, V181, P713, DOI 10.1084/jem.181.2.713; Janatpour MJ, 2001, J EXP MED, V194, P1375, DOI 10.1084/jem.194.9.1375; Jiang DH, 2004, J CLIN INVEST, V114, P291, DOI 10.1172/JCI200416861; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; Mailliard RB, 2003, J IMMUNOL, V171, P2366, DOI 10.4049/jimmunol.171.5.2366; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Medzhitov R, 1999, COLD SPRING HARB SYM, V64, P429, DOI 10.1101/sqb.1999.64.429; Moingeon P, 2001, VACCINE, V19, P4363, DOI 10.1016/S0264-410X(01)00193-1; Moretta A, 2002, NAT REV IMMUNOL, V2, P957, DOI 10.1038/nri956; Moretta L, 2002, EUR J IMMUNOL, V32, P1205, DOI 10.1002/1521-4141(200205)32:5<1205::AID-IMMU1205>3.0.CO;2-Y; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; Noben-Trauth N, 2000, J IMMUNOL, V165, P3620, DOI 10.4049/jimmunol.165.7.3620; O'Hagan DT, 2003, NAT REV DRUG DISCOV, V2, P727, DOI 10.1038/nrd1176; Okada T, 2002, J EXP MED, V196, P65, DOI 10.1084/jem.20020201; Piccioli D, 2002, J EXP MED, V195, P335, DOI 10.1084/jem.20010934; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Satoskar AR, 1999, J IMMUNOL, V162, P6747; SCHARTON TM, 1993, J EXP MED, V178, P567, DOI 10.1084/jem.178.2.567; Scimone ML, 2004, J EXP MED, V199, P1113, DOI 10.1084/jem.20031645; Snijders A, 1998, INT IMMUNOL, V10, P1593, DOI 10.1093/intimm/10.11.1593; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Vitale M, 2004, EUR J IMMUNOL, V34, P1715, DOI 10.1002/eji.200425100; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wakil AE, 1998, J EXP MED, V188, P1651, DOI 10.1084/jem.188.9.1651; Yokoyama WM, 2004, ANNU REV IMMUNOL, V22, P405, DOI 10.1146/annurev.immunol.22.012703.104711; Yoneyama H, 2004, INT IMMUNOL, V16, P915, DOI 10.1093/intimm/dxh093; Yoneyama H, 2002, J EXP MED, V195, P1257, DOI 10.1084/jem.20011983	51	1040	1077	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2004	5	12					1260	1265		10.1038/ni1138	http://dx.doi.org/10.1038/ni1138			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	874MC	15531883				2022-12-18	WOS:000225353500015
J	Iwasaki, A; Medzhitov, R				Iwasaki, Akiko; Medzhitov, Ruslan			Control of adaptive immunity by the innate immune system	NATURE IMMUNOLOGY			English	Review							DENDRITIC CELL SUBSETS; LYMPHOID-CELLS; INFLUENZA-VIRUS; T-CELLS; CYTOKINE PRODUCTION; MEDIATED-IMMUNITY; RECEPTOR FUNCTION; B-CELLS; RECOGNITION; RESPONSES	Microbial infections are recognized by the innate immune system both to elicit immediate defense and to generate long-lasting adaptive immunity. To detect and respond to vastly different groups of pathogens, the innate immune system uses several recognition systems that rely on sensing common structural and functional features associated with different classes of microorganisms. These recognition systems determine microbial location, viability, replication and pathogenicity. Detection of these features by recognition pathways of the innate immune system is translated into different classes of effector responses though specialized populations of dendritic cells. Multiple mechanisms for the induction of immune responses are variations on a common design principle wherein the cells that sense infections produce one set of cytokines to induce lymphocytes to produce another set of cytokines, which in turn activate effector responses. Here we discuss these emerging principles of innate control of adaptive immunity.	[Iwasaki, Akiko; Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University	Iwasaki, A (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06520 USA.	akiko.iwasaki@yale.edu; ruslan.medzhitov@yale.edu	Iwasaki, Akiko/Z-1591-2019	Iwasaki, Akiko/0000-0002-7824-9856	US National Institutes of Health [AI081884, AI062428, AI064705, AI046688, AI089771, DK071754]; Else Kroner-Fresenius-Stiftung; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046688, R01AI054359, R01AI064705, R37AI046688, R56AI062428, R01AI062428, R01AI081884, R01AI089771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071754] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Else Kroner-Fresenius-Stiftung; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Y. Kumamoto for help with Table 1. Supported by the US National Institutes of Health (AI081884, AI062428 and AI064705 to A.I., and AI046688, AI089771 and DK071754 to R.M.), Else Kroner-Fresenius-Stiftung (R.M.) and the Howard Hughes Medical Institute (A.I. and R.M.).	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Ahern PP, 2008, IMMUNOL REV, V226, P147, DOI 10.1111/j.1600-065X.2008.00705.x; Allen JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002003; Alugupalli KR, 2004, IMMUNITY, V21, P379, DOI 10.1016/j.immuni.2004.06.019; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Asselin-Paturel C, 2005, J EXP MED, V201, P1157, DOI 10.1084/jem.20041930; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Ballesteros-Tato A, 2010, NAT IMMUNOL, V11, P216, DOI 10.1038/ni.1838; Barchet W, 2002, J EXP MED, V195, P507, DOI 10.1084/jem.20011666; Barr TA, 2009, J IMMUNOL, V183, P1005, DOI 10.4049/jimmunol.0803706; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Baumgarth N, 2000, J EXP MED, V192, P271, DOI 10.1084/jem.192.2.271; Belkaid Y, 2013, NAT IMMUNOL, V14, P646, DOI 10.1038/ni.2604; Bessa J, 2009, J IMMUNOL, V183, P3788, DOI 10.4049/jimmunol.0804004; Blander JM, 2012, NAT REV IMMUNOL, V12, P215, DOI 10.1038/nri3167; Brestoff JR, 2013, NAT IMMUNOL, V14, P676, DOI 10.1038/ni.2640; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Briseno CG, 2014, CURR OPIN IMMUNOL, V29, P69, DOI 10.1016/j.coi.2014.04.006; Brown GD, 2012, CELL HOST MICROBE, V11, P422, DOI 10.1016/j.chom.2012.04.010; BROWN SJ, 1981, J IMMUNOL, V127, P2163; Browne EP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002293; Buckley KM, 2015, DEV COMP IMMUNOL, V49, P179, DOI 10.1016/j.dci.2014.10.013; Burdette DL, 2013, NAT IMMUNOL, V14, P19, DOI 10.1038/ni.2491; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Casson CN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003400; Cauley LS, 2013, MUCOSAL IMMUNOL, V6, P14, DOI 10.1038/mi.2012.96; Chovatiya R, 2014, MOL CELL, V54, P281, DOI 10.1016/j.molcel.2014.03.030; Chow J, 2010, ADV IMMUNOL, V107, P243, DOI [10.1016/S0065-2776(10)07001-X, 10.1016/B978-0-12-381300-8.00008-3]; Cortez VS, 2015, CURR OPIN IMMUNOL, V32, P71, DOI 10.1016/j.coi.2015.01.004; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; del Rio ML, 2007, J IMMUNOL, V178, P6861, DOI 10.4049/jimmunol.178.11.6861; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Dennehy KM, 2009, EUR J IMMUNOL, V39, P1379, DOI 10.1002/eji.200838543; Desch AN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5674; Desch AN, 2011, J EXP MED, V208, P1789, DOI 10.1084/jem.20110538; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Doody GM, 1996, CURR OPIN IMMUNOL, V8, P378, DOI 10.1016/S0952-7915(96)80128-2; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Edelson BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025660; Edelson BT, 2011, IMMUNITY, V35, P236, DOI 10.1016/j.immuni.2011.06.012; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Guay HM, 2007, J IMMUNOL, V178, P5124, DOI 10.4049/jimmunol.178.8.5124; Gurtler C, 2013, TRENDS MICROBIOL, V21, P413, DOI 10.1016/j.tim.2013.04.004; Guo LY, 2012, TRENDS IMMUNOL, V33, P598, DOI 10.1016/j.it.2012.07.006; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Gururajan M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000863; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Heer AK, 2007, J IMMUNOL, V178, P2182, DOI 10.4049/jimmunol.178.4.2182; Henri S, 2010, J EXP MED, V207, P189, DOI 10.1084/jem.20091964; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Hermesh T, 2010, CELL HOST MICROBE, V7, P343, DOI 10.1016/j.chom.2010.04.006; Hernandez-Santos N, 2012, CELL HOST MICROBE, V11, P425, DOI 10.1016/j.chom.2012.04.008; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hou BD, 2011, IMMUNITY, V34, P375, DOI 10.1016/j.immuni.2011.01.011; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kemper C, 2010, ANNU REV IMMUNOL, V28, P131, DOI 10.1146/annurev-immunol-030409-101250; King IL, 2010, J EXP MED, V207, P953, DOI 10.1084/jem.20091844; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kourepini E, 2014, P NATL ACAD SCI USA, V111, pE856, DOI 10.1073/pnas.1316447111; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Lightfield KL, 2011, INFECT IMMUN, V79, P1606, DOI 10.1128/IAI.01187-10; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mashayekhi M, 2011, IMMUNITY, V35, P249, DOI 10.1016/j.immuni.2011.08.008; McKenzie ANJ, 2014, IMMUNITY, V41, P366, DOI 10.1016/j.immuni.2014.09.006; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Moura-Alves P, 2014, NATURE, V512, P387, DOI 10.1038/nature13684; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Murakami R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073270; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Nish S, 2011, IMMUNITY, V34, P629, DOI 10.1016/j.immuni.2011.05.009; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Pecchi E, 2009, PHYSIOL BEHAV, V97, P279, DOI 10.1016/j.physbeh.2009.02.040; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Pone EJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1769; Rathinam VAK, 2011, CURR OPIN VIROL, V1, P455, DOI 10.1016/j.coviro.2011.11.004; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Raulet DH, 2006, SEMIN IMMUNOL, V18, P145, DOI 10.1016/j.smim.2006.03.003; Reid DM, 2009, CURR OPIN IMMUNOL, V21, P30, DOI 10.1016/j.coi.2009.01.003; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Romani L, 2008, MED MYCOL, V46, P515, DOI 10.1080/13693780801971450; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Segura E, 2012, J EXP MED, V209, P653, DOI 10.1084/jem.20111457; Shin H, 2013, IMMUNOL REV, V255, P165, DOI 10.1111/imr.12087; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Spencer SP, 2012, CURR OPIN IMMUNOL, V24, P379, DOI 10.1016/j.coi.2012.07.006; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Stuart LM, 2013, NAT REV IMMUNOL, V13, P199, DOI 10.1038/nri3398; Tan J, 2014, ADV IMMUNOL, V121, P91, DOI 10.1016/B978-0-12-800100-4.00003-9; Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883; Teichmann LL, 2013, IMMUNITY, V38, P528, DOI 10.1016/j.immuni.2012.11.017; Thomas CJ, 2013, TRENDS IMMUNOL, V34, P317, DOI 10.1016/j.it.2013.02.008; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Venkatesh M, 2014, IMMUNITY, V41, P296, DOI 10.1016/j.immuni.2014.06.014; von Moltke J, 2013, ANNU REV IMMUNOL, V31, P73, DOI 10.1146/annurev-immunol-032712-095944; Wada T, 2010, J CLIN INVEST, V120, P2867, DOI 10.1172/JCI42680; Welty NE, 2013, J EXP MED, V210, P2011, DOI 10.1084/jem.20130728; Wilson SR, 2013, CELL, V155, P285, DOI 10.1016/j.cell.2013.08.057; Wojno EDT, 2012, CELL HOST MICROBE, V12, P445, DOI 10.1016/j.chom.2012.10.003; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yoneyama M, 2015, CURR OPIN IMMUNOL, V32, P48, DOI 10.1016/j.coi.2014.12.012; Zelenay S, 2012, J CLIN INVEST, V122, P1615, DOI 10.1172/JCI60644; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	138	1038	1078	40	436	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2015	16	4					343	353		10.1038/ni.3123	http://dx.doi.org/10.1038/ni.3123			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CD8GR	25789684	Green Accepted			2022-12-18	WOS:000351333700007
J	Levy, BD; Clish, CB; Schmidt, B; Gronert, K; Serhan, CN				Levy, BD; Clish, CB; Schmidt, B; Gronert, K; Serhan, CN			Lipid mediator class switching during acute inflammation: signals in resolution	NATURE IMMUNOLOGY			English	Article							ACTIVATED HUMAN NEUTROPHILS; IN-VIVO; 15-LIPOXYGENASE; LIPOXINS; CYCLOOXYGENASE-2; ACID; PROSTAGLANDINS; BIOSYNTHESIS; PURIFICATION; RECRUITMENT	Leukotrienes (LTs) and prostaglandins (PGs) amplify acute inflammation, whereas lipoxins (LXs) have unique anti-inflammatory actions. Temporal analyses of these eicosanoids in,clinical and experimental exudates showed early coordinate appearance of LT and PG with polymorphonuclear neutrophil (PMN) recruitment. This was followed by LX biosynthesis, which was concurrent with spontaneous resolution. Human peripheral blood PMNs exposed to PGE(2)(as in exudate) switched eicosanoid biosynthesis from predominantly LTB4 and 5-lipoxygenase (5-LO)-initiated pathways to LXA(4), a 15-LO product that "stopped" PMN infiltration. These results indicate that first-phase eicbsanoids promote a shift to anti-inflammatory lipids: functionally distinct lipid-mediator profiles switch during acute exudate formation to "reprogram" the exudate PMNs to promote resolution.	Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Serhan, CN (corresponding author), Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA.		Clish, Clary B/ABB-9374-2021; Clish, Clary/AAB-7124-2019	Clish, Clary B/0000-0001-8259-9245; 	NHLBI NIH HHS [K08-HL03788] Funding Source: Medline; NIAID NIH HHS [F32-AI10389] Funding Source: Medline; NIDCR NIH HHS [P01-DE13499] Funding Source: Medline; NIDDK NIH HHS [K01 DK060583-01, DK50305] Funding Source: Medline; NIGMS NIH HHS [GM-38765] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL003788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI010389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P01DE013499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK060583, P01DK050305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038765, R29GM038765, R01GM038765] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bandeira-Melo C, 2000, J IMMUNOL, V164, P1029, DOI 10.4049/jimmunol.164.2.1029; BEAULIEU AD, 1992, J BIOL CHEM, V267, P426; BORGEAT P, 1990, CLIN BIOCHEM, V23, P459, DOI 10.1016/0009-9120(90)90272-V; BORRELLI E, 1992, Critical Reviews in Oncogenesis, V3, P321; Chavis C, 1996, J EXP MED, V183, P1633, DOI 10.1084/jem.183.4.1633; Chiang N, 1999, J CLIN INVEST, V104, P309, DOI 10.1172/JCI7016; Clish CB, 2000, J BIOL CHEM, V275, P25372, DOI 10.1074/jbc.M002863200; Clish CB, 1999, P NATL ACAD SCI USA, V96, P8247, DOI 10.1073/pnas.96.14.8247; Feinmark SJ, 1997, BIOCHEM PHARMACOL, V54, P953, DOI 10.1016/S0006-2952(97)00135-4; FIORE S, 1990, J EXP MED, V172, P1451, DOI 10.1084/jem.172.5.1451; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Godson C, 2000, J IMMUNOL, V164, P1663, DOI 10.4049/jimmunol.164.4.1663; Herschman HR, 1998, TRENDS CARDIOVAS MED, V8, P145, DOI 10.1016/S1050-1738(98)00004-8; IZUMI T, 1991, EUR J BIOCHEM, V202, P1231, DOI 10.1111/j.1432-1033.1991.tb16495.x; JENKINSON SG, 1982, AM REV RESPIR DIS, V126, P21; Kapff C.T., 1991, BLOOD ATLAS SOURCEBO; Kelavkar U, 1998, MOL BIOL REP, V25, P173, DOI 10.1023/A:1006813009006; Kritzik MR, 1997, BBA-GENE STRUCT EXPR, V1352, P267, DOI 10.1016/S0167-4781(97)00005-5; Krump E, 1997, J EXP MED, V186, P1401, DOI 10.1084/jem.186.8.1401; LEVY BD, 1993, J CLIN INVEST, V92, P1572, DOI 10.1172/JCI116738; Light RW., 1990, PLEURAL DIS, P269; Mayadas TN, 1996, KIDNEY INT, V49, P1342, DOI 10.1038/ki.1996.190; McDonald PP, 1997, BLOOD, V89, P3421, DOI 10.1182/blood.V89.9.3421; MONCADA S, 1973, NATURE, V246, P217, DOI 10.1038/246217a0; Munger KA, 1999, P NATL ACAD SCI USA, V96, P13375, DOI 10.1073/pnas.96.23.13375; NARUMIYA S, 1981, J BIOL CHEM, V256, P9583; Pouliot M, 2000, BIOCHEMISTRY-US, V39, P4761, DOI 10.1021/bi992551b; Pouliot M, 1998, FASEB J, V12, P1109, DOI 10.1096/fasebj.12.12.1109; RAUD J, 1988, P NATL ACAD SCI USA, V85, P2315, DOI 10.1073/pnas.85.7.2315; Samuelsson B, 1982, PRIX NOBEL NOBEL PRI, P153; Sato T, 1997, J INVEST DERMATOL, V109, P334, DOI 10.1111/1523-1747.ep12335935; SERHAN CN, 1995, BIOCHEMISTRY-US, V34, P14609, DOI 10.1021/bi00044a041; SERHAN CN, 1999, INFLAMMATION BASIC P, P373; Shen JH, 1996, J CLIN INVEST, V98, P2201, DOI 10.1172/JCI119029; Shinmura K, 2000, P NATL ACAD SCI USA, V97, P10197, DOI 10.1073/pnas.97.18.10197; Swan SK, 2000, ANN INTERN MED, V133, P1, DOI 10.7326/0003-4819-133-1-200007040-00002; Tessier PA, 1997, J IMMUNOL, V159, P3595; Thiele BJ, 1999, NUCLEIC ACIDS RES, V27, P1828, DOI 10.1093/nar/27.8.1828; WEISSMANN G, 1993, J LIPID MEDIATOR, V6, P275; Xiao GS, 1997, BIOCHEMISTRY-US, V36, P1836, DOI 10.1021/bi962476u	40	1036	1084	3	51	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2001	2	7					612	619		10.1038/89759	http://dx.doi.org/10.1038/89759			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	449JU	11429545				2022-12-18	WOS:000169682100014
J	Stewart, CR; Stuart, LM; Wilkinson, K; van Gils, JM; Deng, JS; Halle, A; Rayner, KJ; Boyer, L; Zhong, RQ; Frazier, WA; Lacy-Hulbert, A; El Khoury, J; Golenbock, DT; Moore, KJ				Stewart, Cameron R.; Stuart, Lynda M.; Wilkinson, Kim; van Gils, Janine M.; Deng, Jiusheng; Halle, Annett; Rayner, Katey J.; Boyer, Laurent; Zhong, Ruiqin; Frazier, William A.; Lacy-Hulbert, Adam; El Khoury, Joseph; Golenbock, Douglas T.; Moore, Kathryn J.			CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer	NATURE IMMUNOLOGY			English	Article							ALZHEIMERS-DISEASE; SCAVENGER RECEPTORS; ASP299GLY POLYMORPHISM; SIGNALING CASCADE; APOLIPOPROTEIN-E; IMMUNE-RESPONSE; INNATE IMMUNITY; LIPID UPTAKE; ATHEROSCLEROSIS; TOLL-LIKE-RECEPTOR-4	In atherosclerosis and Alzheimer's disease, deposition of the altered self components oxidized low-density lipoprotein (LDL) and amyloid-beta triggers a protracted sterile inflammatory response. Although chronic stimulation of the innate immune system is believed to underlie the pathology of these diseases, the molecular mechanisms of activation remain unclear. Here we show that oxidized LDL and amyloid-beta trigger inflammatory signaling through a heterodimer of Toll-like receptors 4 and 6. Assembly of this newly identified heterodimer is regulated by signals from the scavenger receptor CD36, a common receptor for these disparate ligands. Our results identify CD36-TLR4-TLR6 activation as a common molecular mechanism by which atherogenic lipids and amyloid-beta stimulate sterile inflammation and suggest a new model of TLR heterodimerization triggered by coreceptor signaling events.	[Stuart, Lynda M.; Boyer, Laurent; Lacy-Hulbert, Adam] Harvard Univ, Sch Med, Dept Pediat, Massachusetts Gen Hosp,Lab Dev Immunol, Boston, MA 02115 USA; [Halle, Annett; Golenbock, Douglas T.] Univ Massachusetts, Sch Med, Dept Immunol & Infect Dis, Worcester, MA USA; [Zhong, Ruiqin; Frazier, William A.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [El Khoury, Joseph] Harvard Univ, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Sch Med, Charlestown, MA USA; [Stewart, Cameron R.; Wilkinson, Kim; van Gils, Janine M.; Deng, Jiusheng; Rayner, Katey J.; Moore, Kathryn J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med,Lipid Metab Unit, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Worcester; Washington University (WUSTL); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Moore, KJ (corresponding author), NYU, Sch Med, Dept Med, Leon H Charney Div Cardiol, New York, NY 10003 USA.	kathryn.moore@nyumc.org	Rayner, Katey/K-8914-2012; Moore, Kathryn/ABE-6416-2020; Stewart, Cameron R/E-6823-2011; Boyer, laurent/F-8921-2015; BOYER, Laurent/AAH-4543-2021	Moore, Kathryn/0000-0003-2505-2547; Boyer, laurent/0000-0002-1375-1706; BOYER, Laurent/0000-0002-1375-1706; Stewart, Cameron/0000-0002-3395-7859; van Gils, Janine/0000-0003-2429-7462; Lacy-Hulbert, Adam/0000-0003-2162-0156; Rayner, Katey/0000-0001-6230-426X	US National Institutes of Health [R01AG20255, R01NS059005, R01 AG032349]; Ellison Medical Foundation; American Health Assistance Foundation [A2008-130]; Wellcome Trust [068089/Z/02/Z]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020255, R01AG032349] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); American Health Assistance Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Akira (Osaka University) and K. Miyake (Japan Science and Technology Agency) for knockout mice. Supported by the US National Institutes of Health (R01AG20255 to K. J. M.; R01NS059005 to J. E. K.; R01 AG032349 to K. J. M. and J. E. K.), the Ellison Medical Foundation (K. J. M.), the American Health Assistance Foundation (A2008-130 to K. J. M.) and the Wellcome Trust (068089/Z/02/Z to L. M. S.).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ameziane N, 2003, ARTERIOSCL THROM VAS, V23, pE61, DOI 10.1161/01.ATV.0000101191.92392.1D; Aslan M, 2004, CURR ALZHEIMER RES, V1, P111, DOI 10.2174/1567205043332162; Bjorkbacka H, 2004, NAT MED, V10, P416, DOI 10.1038/nm1008; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Chi HH, 2004, CIRCULATION, V110, P1678, DOI 10.1161/01.CIR.0000142085.39015.31; Coraci IS, 2002, AM J PATHOL, V160, P101, DOI 10.1016/S0002-9440(10)64354-4; El Khoury JB, 2003, J EXP MED, V197, P1657, DOI 10.1084/jem.20021546; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gerold G, 2008, NAT IMMUNOL, V9, P761, DOI 10.1038/ni.1618; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Ip WKE, 2008, J EXP MED, V205, P169, DOI 10.1084/jem.20071164; Janabi M, 2000, ARTERIOSCL THROM VAS, V20, P1953, DOI 10.1161/01.ATV.20.8.1953; Jin JJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-23; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Medvedev AE, 2007, J BIOL CHEM, V282, P16042, DOI 10.1074/jbc.M606781200; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Minoretti P, 2006, NEUROSCI LETT, V391, P147, DOI 10.1016/j.neulet.2005.08.047; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Moore KJ, 2000, J IMMUNOL, V165, P4272, DOI 10.4049/jimmunol.165.8.4272; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; Moore KJ, 2002, J BIOL CHEM, V277, P47373, DOI 10.1074/jbc.M208788200; Mullick AE, 2008, J EXP MED, V205, P373, DOI 10.1084/jem.20071096; Mullick AE, 2005, J CLIN INVEST, V115, P3149, DOI 10.1172/JCI25482; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Qi YP, 1997, J NEUROSCI, V17, P1217; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; ROBERSON SM, 1988, CELL IMMUNOL, V116, P341, DOI 10.1016/0008-8749(88)90236-5; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Sun B, 2007, J LIPID RES, V48, P2560, DOI 10.1194/jlr.M700163-JLR200; Visintin A, 2001, P NATL ACAD SCI USA, V98, P12156, DOI 10.1073/pnas.211445098; Walter S, 2007, CELL PHYSIOL BIOCHEM, V20, P947, DOI 10.1159/000110455; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484	42	1023	1068	3	129	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2010	11	2					155	U75		10.1038/ni.1836	http://dx.doi.org/10.1038/ni.1836			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	545KF	20037584	Green Accepted			2022-12-18	WOS:000273730200013
J	Lambrecht, BN; Hammad, H				Lambrecht, Bart N.; Hammad, Hamida			The immunology of asthma	NATURE IMMUNOLOGY			English	Review							INNATE LYMPHOID-CELLS; HOUSE-DUST MITE; ALLERGIC AIRWAY INFLAMMATION; REGULATORY T-CELLS; PLASMACYTOID DENDRITIC CELLS; NATURAL HELPER-CELLS; FC-EPSILON-RI; THYMIC STROMAL LYMPHOPOIETIN; RESPIRATORY VIRAL-INFECTION; AFFINITY IGE RECEPTOR	Asthma is a common disease that affects 300 million people worldwide. Given the large number of eosinophils in the airways of people with mild asthma, and verified by data from murine models, asthma was long considered the hallmark T helper type 2 (T(H)2) disease of the airways. It is now known that some asthmatic inflammation is neutrophilic, controlled by the T(H)17 subset of helper T cells, and that some eosinophilic inflammation is controlled by type 2 innate lymphoid cells (ILC2 cells) acting together with basophils. Here we discuss results from in-depth molecular studies of mouse models in light of the results from the first clinical trials targeting key cytokines in humans and describe the extraordinary heterogeneity of asthma.	[Lambrecht, Bart N.; Hammad, Hamida] Univ Ghent, VIB, Inflammat Res Ctr, B-9000 Ghent, Belgium; [Lambrecht, Bart N.; Hammad, Hamida] Univ Hosp Ghent, Dept Resp Med, Ghent, Belgium; [Lambrecht, Bart N.] Erasmus MC, Dept Pulm Med, Rotterdam, Netherlands	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University Hospital; Erasmus University Rotterdam; Erasmus MC	Lambrecht, BN (corresponding author), Univ Ghent, VIB, Inflammat Res Ctr, B-9000 Ghent, Belgium.	bart.lambrecht@ugent.be; hamida.hammad@ugent.be	Hammad, Hamida/J-9391-2015; Lambrecht, Bart N/K-2484-2014	Hammad, Hamida/0000-0003-3762-8603; Lambrecht, Bart N/0000-0003-4376-6834	European Union European Research Council; European Union Framework Programme 7 (MedALL and EUBIOPRED); University of Ghent Multidisciplinary Research Platform (Group-ID); Fonds Wetenschappelijk Onderzoek Vlaanderen	European Union European Research Council(European Research Council (ERC)European Commission); European Union Framework Programme 7 (MedALL and EUBIOPRED); University of Ghent Multidisciplinary Research Platform (Group-ID); Fonds Wetenschappelijk Onderzoek Vlaanderen(FWO)	Supported by the European Union European Research Council (B.N.L.), the European Union Framework Programme 7 (MedALL and EUBIOPRED to B.N.L.), the University of Ghent Multidisciplinary Research Platform (Group-ID, to B.N.L.) and Fonds Wetenschappelijk Onderzoek Vlaanderen (B.N.L. and H.H.).	Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; Barczyk A, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-22; Barlow JL, 2012, J ALLERGY CLIN IMMUN, V129, P191, DOI 10.1016/j.jaci.2011.09.041; Barnig C, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004812; Barrett NA, 2011, J EXP MED, V208, P593, DOI 10.1084/jem.20100793; Bartemes KR, 2012, J IMMUNOL, V188, P1503, DOI 10.4049/jimmunol.1102832; Bartlett NW, 2008, NAT MED, V14, P199, DOI 10.1038/nm1713; Bel EH, 2014, NEW ENGL J MED, V371, P1189, DOI 10.1056/NEJMoa1403291; Bell BD, 2013, NAT IMMUNOL, V14, P364, DOI 10.1038/ni.2541; Bellini A, 2012, MUCOSAL IMMUNOL, V5, P140, DOI 10.1038/mi.2011.60; BENTLEY AM, 1992, J ALLERGY CLIN IMMUN, V89, P821, DOI 10.1016/0091-6749(92)90437-7; Berry MA, 2006, NEW ENGL J MED, V354, P697, DOI 10.1056/NEJMoa050580; Besnard AG, 2011, EUR J IMMUNOL, V41, P1675, DOI 10.1002/eji.201041033; Besnard AG, 2011, AM J RESP CRIT CARE, V183, P1153, DOI 10.1164/rccm.201008-1383OC; BIEBER T, 1992, J EXP MED, V175, P1285, DOI 10.1084/jem.175.5.1285; Bochkov YA, 2010, MUCOSAL IMMUNOL, V3, P69, DOI 10.1038/mi.2009.109; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; Brandt EB, 2013, J ALLERGY CLIN IMMUN, V132, P1194, DOI 10.1016/j.jaci.2013.06.048; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; BRUSSELLE GG, 1994, CLIN EXP ALLERGY, V24, P73, DOI 10.1111/j.1365-2222.1994.tb00920.x; Brusselle GG, 2013, NAT MED, V19, P977, DOI 10.1038/nm.3300; Brusselle GG, 2011, LANCET, V378, P1015, DOI 10.1016/S0140-6736(11)60988-4; Busse WW, 2013, AM J RESP CRIT CARE, V188, P1294, DOI 10.1164/rccm.201212-2318OC; Caliskan M, 2013, NEW ENGL J MED, V368, P1398, DOI 10.1056/NEJMoa1211592; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Cheng D, 2014, AM J RESP CRIT CARE, V190, P639, DOI 10.1164/rccm.201403-0505OC; Chu DK, 2014, J EXP MED, V211, P1657, DOI 10.1084/jem.20131800; Chu DK, 2013, J ALLERGY CLIN IMMUN, V131, P187, DOI 10.1016/j.jaci.2012.08.002; Cohn L, 1999, J EXP MED, V190, P1309, DOI 10.1084/jem.190.9.1309; Cohn L, 1999, J IMMUNOL, V162, P6178; Cohn L, 1997, J EXP MED, V186, P1737, DOI 10.1084/jem.186.10.1737; Collison A, 2013, NAT MED, V19, P232, DOI 10.1038/nm.3049; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; CORRIGAN CJ, 1990, AM REV RESPIR DIS, V141, P970, DOI 10.1164/ajrccm/141.4_Pt_1.; Corry DB, 1996, J EXP MED, V183, P109, DOI 10.1084/jem.183.1.109; COYLE AJ, 1995, J CLIN INVEST, V95, P1735, DOI 10.1172/JCI117850; COYLE AJ, 1994, J CLIN INVEST, V94, P2301, DOI 10.1172/JCI117594; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; DEMONCHY JGR, 1985, AM REV RESPIR DIS, V131, P373; Djukanovic R, 2014, AM J RESP CRIT CARE, V190, P145, DOI 10.1164/rccm.201312-2235OC; Doherty TA, 2013, J ALLERGY CLIN IMMUN, V132, P205, DOI 10.1016/j.jaci.2013.03.048; Doherty TA, 2012, AM J PHYSIOL-LUNG C, V303, pL577, DOI 10.1152/ajplung.00174.2012; Doherty TA, 2009, AM J PHYSIOL-LUNG C, V296, pL229, DOI 10.1152/ajplung.90543.2008; Dougherty RH, 2010, J ALLERGY CLIN IMMUN, V125, P1046, DOI 10.1016/j.jaci.2010.03.003; Durrani SR, 2012, J ALLERGY CLIN IMMUN, V130, P489, DOI 10.1016/j.jaci.2012.05.023; Dworski R, 2011, J ALLERGY CLIN IMMUN, V127, P1260, DOI 10.1016/j.jaci.2010.12.1103; Edwards MR, 2013, MUCOSAL IMMUNOL, V6, P797, DOI 10.1038/mi.2012.118; Elyaman W, 2012, IMMUNITY, V36, P623, DOI 10.1016/j.immuni.2012.01.020; Erpenbeck VJ, 2003, J ALLERGY CLIN IMMUN, V111, P1319, DOI 10.1067/mai.2003.1485; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Fattouh R, 2011, AM J RESP CRIT CARE, V183, P179, DOI 10.1164/rccm.200905-0736OC; Flood-Page P, 2003, J CLIN INVEST, V112, P1029, DOI 10.1172/JCI200317974; Fogg MI, 2003, J ALLERGY CLIN IMMUN, V112, P796, DOI 10.1016/S0091-6749(03)01715-9; Ford JG, 2001, J IMMUNOL, V167, P1769, DOI 10.4049/jimmunol.167.3.1769; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Gauvreau GM, 2014, NEW ENGL J MED, V370, P2102, DOI 10.1056/NEJMoa1402895; GAVETT SH, 1995, J EXP MED, V182, P1527, DOI 10.1084/jem.182.5.1527; Gill MA, 2010, J IMMUNOL, V184, P5999, DOI 10.4049/jimmunol.0901194; Gold MJ, 2014, J ALLERGY CLIN IMMUN, V133, P1142, DOI 10.1016/j.jaci.2014.02.033; Gorski SA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003615; Grayson MH, 2007, J EXP MED, V204, P2759, DOI 10.1084/jem.20070360; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Halim TYF, 2012, IMMUNITY, V37, P463, DOI 10.1016/j.immuni.2012.06.012; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hansen G, 1999, J CLIN INVEST, V103, P175, DOI 10.1172/JCI5155; Hartl D, 2007, J ALLERGY CLIN IMMUN, V119, P1258, DOI 10.1016/j.jaci.2007.02.023; Heger K, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001762; Herre J, 2013, J IMMUNOL, V191, P1529, DOI 10.4049/jimmunol.1300284; Hessel EM, 1997, AM J RESP CELL MOL, V16, P325, DOI 10.1165/ajrcmb.16.3.9070618; Holgate S, 2009, ALLERGY, V64, P1728, DOI 10.1111/j.1398-9995.2009.02201.x; Hong JY, 2014, J ALLERGY CLIN IMMUN, V134, P429, DOI 10.1016/j.jaci.2014.04.020; Huang MT, 2009, J IMMUNOL, V183, P4745, DOI 10.4049/jimmunol.0804371; Huh JC, 2003, J EXP MED, V198, P19, DOI 10.1084/jem.20021328; Humbert M, 1996, AM J RESP CRIT CARE, V154, P1497, DOI 10.1164/ajrccm.154.5.8912771; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Irvin C, 2014, J ALLERGY CLIN IMMUN, V134, P1175, DOI 10.1016/j.jaci.2014.05.038; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Joller N, 2014, IMMUNITY, V40, P569, DOI 10.1016/j.immuni.2014.02.012; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Juncadella IJ, 2013, NATURE, V493, P547, DOI 10.1038/nature11714; Kabata H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3675; Kaiko GE, 2013, J ALLERGY CLIN IMMUN, V131, P1331, DOI 10.1016/j.jaci.2013.02.041; Kang ZZ, 2012, IMMUNITY, V36, P821, DOI 10.1016/j.immuni.2012.03.021; Kearley J, 2011, AM J RESP CRIT CARE, V183, P865, DOI 10.1164/rccm.200909-1462OC; Kennedy JL, 2014, AM J RESP CRIT CARE, V189, P532, DOI 10.1164/rccm.201310-1767OC; Kerzerho J, 2013, J ALLERGY CLIN IMMUN, V131, P1048, DOI 10.1016/j.jaci.2012.09.027; Khan SH, 2010, J ALLERGY CLIN IMMUN, V125, P265, DOI 10.1016/j.jaci.2009.09.038; Khare A, 2013, J IMMUNOL, V191, P25, DOI 10.4049/jimmunol.1300193; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Kool M, 2011, IMMUNITY, V34, P527, DOI 10.1016/j.immuni.2011.03.015; Kool M, 2009, J IMMUNOL, V183, P1074, DOI 10.4049/jimmunol.0900471; Krug N, 1996, AM J RESP CELL MOL, V14, P319, DOI 10.1165/ajrcmb.14.4.8600935; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Lambrecht BN, 2012, ANNU REV IMMUNOL, V30, P243, DOI 10.1146/annurev-immunol-020711-075021; Laviolette M, 2013, J ALLERGY CLIN IMMUN, V132, P1086, DOI 10.1016/j.jaci.2013.05.020; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Liao W, 2014, P NATL ACAD SCI USA, V111, P3508, DOI 10.1073/pnas.1301138111; Mamessier E, 2008, ALLERGY, V63, P1202, DOI 10.1111/j.1398-9995.2008.01687.x; Manni ML, 2014, MUCOSAL IMMUNOL, V7, P1186, DOI 10.1038/mi.2014.8; Mathur SK, 2013, ANN ALLERG ASTHMA IM, V111, P25, DOI 10.1016/j.anai.2013.05.010; Maurer D, 1996, J IMMUNOL, V157, P607; Maurer D, 1998, J IMMUNOL, V161, P2731; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; McSorley HJ, 2014, MUCOSAL IMMUNOL, V7, P1068, DOI 10.1038/mi.2013.123; Millien VO, 2013, SCIENCE, V341, P792, DOI 10.1126/science.1240342; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Morjaria JB, 2008, THORAX, V63, P584, DOI 10.1136/thx.2007.086314; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Motomura Y, 2014, IMMUNITY, V40, P758, DOI 10.1016/j.immuni.2014.04.013; Norimoto A, 2014, AM J RESP CELL MOL, V51, P201, DOI 10.1165/rcmb.2013-0522OC; Novak N, 2001, J IMMUNOL, V167, P797, DOI 10.4049/jimmunol.167.2.797; O'Garra A, 2008, NAT IMMUNOL, V9, P588, DOI 10.1038/ni0608-588; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Ortega HG, 2014, NEW ENGL J MED, V371, P1198, DOI 10.1056/NEJMoa1403290; Osborne LC, 2014, SCIENCE, V345, P578, DOI 10.1126/science.1256942; Ostroukhova M, 2004, J CLIN INVEST, V114, P28, DOI 10.1172/JC1200420509; Papi A, 2013, J ALLERGY CLIN IMMUN, V132, P1075, DOI 10.1016/j.jaci.2013.05.028; Parker JM, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-14; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Platzer B, 2015, MUCOSAL IMMUNOL, V8, P516, DOI 10.1038/mi.2014.85; Porter PC, 2014, J ALLERGY CLIN IMMUN, V134, P325, DOI 10.1016/j.jaci.2014.04.028; Porter PC, 2011, INFECT IMMUN, V79, P4459, DOI 10.1128/IAI.05209-11; Randolph DA, 1999, J CLIN INVEST, V104, P1021, DOI 10.1172/JCI7631; Raymond M, 2009, J ALLERGY CLIN IMMUN, V124, P1333, DOI 10.1016/j.jaci.2009.07.021; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Sallmann E, 2011, J IMMUNOL, V187, P164, DOI 10.4049/jimmunol.1003392; SCHMITT E, 1994, J IMMUNOL, V153, P3989; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Semmrich M, 2012, MUCOSAL IMMUNOL, V5, P150, DOI 10.1038/mi.2011.61; Shaw DE, 2007, CHEST, V132, P1871, DOI 10.1378/chest.07-1047; Simpson A, 2010, AM J RESP CRIT CARE, V181, P1200, DOI 10.1164/rccm.200907-1101OC; Smyth LJC, 2010, CHEST, V138, P905, DOI 10.1378/chest.09-3079; Song DJ, 2009, J IMMUNOL, V183, P5333, DOI 10.4049/jimmunol.0801421; Spann KM, 2014, THORAX, V69, P918, DOI 10.1136/thoraxjnl-2013-204908; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Sugimoto T, 2004, J EXP MED, V199, P535, DOI 10.1084/jem.20031368; Sutherland TE, 2014, NAT IMMUNOL, V15, P1116, DOI 10.1038/ni.3023; Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883; Thornton EE, 2012, J EXP MED, V209, P1183, DOI 10.1084/jem.20112667; Turner JE, 2013, J EXP MED, V210, P2951, DOI 10.1084/jem.20130071; Tversky JR, 2008, CLIN EXP ALLERGY, V38, P781, DOI 10.1111/j.1365-2222.2008.02954.x; Ullah MA, 2014, J ALLERGY CLIN IMMUN, V134, P440, DOI 10.1016/j.jaci.2013.12.1035; Van Dyken SJ, 2014, IMMUNITY, V40, P414, DOI 10.1016/j.immuni.2014.02.003; van Rijt LS, 2011, AM J RESP CRIT CARE, V184, P303, DOI 10.1164/rccm.201101-0019OC; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; van Rijt LS, 2003, J IMMUNOL, V171, P3372, DOI 10.4049/jimmunol.171.7.3372; Wakahara K, 2013, ALLERGY, V68, P180, DOI 10.1111/all.12072; Wakashin H, 2008, AM J RESP CRIT CARE, V178, P1023, DOI 10.1164/rccm.200801-086OC; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Wang YH, 2010, J EXP MED, V207, P2479, DOI 10.1084/jem.20101376; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Wenzel S, 2013, NEW ENGL J MED, V368, P2455, DOI 10.1056/NEJMoa1304048; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wenzel SE, 2009, AM J RESP CRIT CARE, V179, P549, DOI 10.1164/rccm.200809-1512OC; Whitehead GS, 2012, J ALLERGY CLIN IMMUN, V129, P207, DOI 10.1016/j.jaci.2011.08.009; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Willart MAM, 2012, J EXP MED, V209, P1505, DOI 10.1084/jem.20112691; Williams CMM, 2000, J EXP MED, V192, P455, DOI 10.1084/jem.192.3.455; Williams JW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3990; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wolterink RGJK, 2012, EUR J IMMUNOL, V42, P1106, DOI 10.1002/eji.201142018; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Wu W, 2014, J ALLERGY CLIN IMMUN, V133, P1280, DOI 10.1016/j.jaci.2013.11.042; Xiao X, 2012, NAT IMMUNOL, V13, P981, DOI 10.1038/ni.2390; Xue LZ, 2014, J ALLERGY CLIN IMMUN, V133, P1184, DOI 10.1016/j.jaci.2013.10.056; Yang XXO, 2013, NAT IMMUNOL, V14, P732, DOI 10.1038/ni.2633; Yao WG, 2013, IMMUNITY, V38, P360, DOI 10.1016/j.immuni.2013.01.007; Yasuda K, 2012, P NATL ACAD SCI USA, V109, P3451, DOI 10.1073/pnas.1201042109; Yousefi S, 2012, CURR OPIN IMMUNOL, V24, P736, DOI 10.1016/j.coi.2012.08.010; Yu M, 2011, J CLIN INVEST, V121, P3133, DOI 10.1172/JCI43598; Zaiss DM, 2006, SCIENCE, V314, P1746, DOI 10.1126/science.1133715; Zhao J, 2013, MUCOSAL IMMUNOL, V6, P335, DOI 10.1038/mi.2012.76; Zhu J, 2014, CHEST, V145, P1219, DOI 10.1378/chest.13-1567	185	1018	1070	16	422	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2015	16	1					45	56		10.1038/ni.3049	http://dx.doi.org/10.1038/ni.3049			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AW8ET	25521684				2022-12-18	WOS:000346494200008
J	Manel, N; Unutmaz, D; Littman, DR				Manel, Nicolas; Unutmaz, Derya; Littman, Dan R.			The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor ROR gamma t	NATURE IMMUNOLOGY			English	Article							HUMAN TH17 CELLS; INFLAMMATORY-BOWEL-DISEASE; PEDIATRIC CROHNS-DISEASE; MULTIPLE-SCLEROSIS; CUTTING EDGE; TGF-BETA; AUTOIMMUNE ENCEPHALOMYELITIS; INTERLEUKIN-17 PRODUCTION; IL-17 PRODUCTION; IL-21 RECEPTOR	T(H)-17 cells are interleukin 17 (IL-17)-secreting CD4(+) T helper cells involved in autoimmune disease and mucosal immunity. In naive CD4(+) T cells from mice, IL-17 is expressed in response to a combination of IL-6 or IL-21 and transforming growth factor-beta (TGF-beta) and requires induction of the nuclear receptor ROR gamma t. It has been suggested that the differentiation of human TH-17 cells is independent of TGF-beta and thus differs fundamentally from that in mice. We show here that TGF-beta, IL-1 beta and IL-6, IL-21 or IL-23 in serum-free conditions were necessary and sufficient to induce IL-17 expression in naive human CD4(+) T cells from cord blood. TGF-beta upregulated ROR gamma t expression but simultaneously inhibited its ability to induce IL-17 expression. Inflammatory cytokines relieved this inhibition and increased ROR gamma t-directed IL-17 expression. Other gene products detected in T(H)-17 cells after ROR gamma t induction included the chemokine receptor CCR6, the IL-23 receptor, IL-17F and IL-26. Our studies identify ROR gamma t as having a central function in the differentiation of human TH-17 cells from naive CD4(+) T cells and suggest that similar cytokine pathways are involved in this process in mice and humans.	[Manel, Nicolas; Littman, Dan R.] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA; [Unutmaz, Derya; Littman, Dan R.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Littman, Dan R.] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Littman, Dan R.] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA	New York University; New York University; Howard Hughes Medical Institute; New York University; New York University	Littman, DR (corresponding author), NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA.	littman@saturn.med.nyu.edu	Manel, Nicolas/E-2128-2011	Manel, Nicolas/0000-0002-1481-4430	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065303, R01AI033856, R37AI033303] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI065303-05, R01 AI065303, 5 R37 AI033303, 5 R01 AI033856, R37 AI033303-16, R37 AI033303] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Asao H, 2001, J IMMUNOL, V167, P1, DOI 10.4049/jimmunol.167.1.1; Attur MG, 1997, ARTHRITIS RHEUM, V40, P1050, DOI 10.1002/art.1780400609; Baldassano RN, 2007, CLIN GASTROENTEROL H, V5, P972, DOI 10.1016/j.cgh.2007.04.024; Becker WJ, 2003, CEPHALALGIA, V23, P706; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2007, CURR OPIN IMMUNOL, V19, P652, DOI 10.1016/j.coi.2007.07.020; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Chen Z, 2007, ARTHRITIS RHEUM-US, V56, P2936, DOI 10.1002/art.22866; Cho ML, 2006, J IMMUNOL, V176, P5652, DOI 10.4049/jimmunol.176.9.5652; De Rosa SC, 2001, NAT MED, V7, P245, DOI 10.1038/84701; Dubinsky MC, 2007, INFLAMM BOWEL DIS, V13, P511, DOI 10.1002/ibd.20126; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Evans HG, 2007, P NATL ACAD SCI USA, V104, P17034, DOI 10.1073/pnas.0708426104; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Gerhartz C, 1996, J BIOL CHEM, V271, P12991, DOI 10.1074/jbc.271.22.12991; Glas J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000819; Habib T, 2002, BIOCHEMISTRY-US, V41, P8725, DOI 10.1021/bi0202023; Homey B, 2000, J IMMUNOL, V164, P6621, DOI 10.4049/jimmunol.164.12.6621; Hor S, 2004, J BIOL CHEM, V279, P33343, DOI 10.1074/jbc.M405000200; Igawa D, 2006, MOL IMMUNOL, V43, P999, DOI 10.1016/j.molimm.2005.05.009; Ivanov II, 2007, SEMIN IMMUNOL, V19, P409, DOI 10.1016/j.smim.2007.10.011; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kikly K, 2006, CURR OPIN IMMUNOL, V18, P670, DOI 10.1016/j.coi.2006.09.008; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kryczek I, 2007, J IMMUNOL, V179, P1423, DOI 10.4049/jimmunol.179.3.1423; Kyrtsonis MC, 1998, MED ONCOL, V15, P124, DOI 10.1007/BF02989591; Laurence A, 2007, NAT IMMUNOL, V8, P903, DOI 10.1038/ni0907-903; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lim HW, 2008, J IMMUNOL, V180, P122, DOI 10.4049/jimmunol.180.1.122; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Oliver J, 2007, CLIN GASTROENTEROL H, V5, P977, DOI 10.1016/j.cgh.2007.05.002; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Sato W, 2007, J IMMUNOL, V178, P7525, DOI 10.4049/jimmunol.178.12.7525; SMITH RL, 2007, J INVEST DERMAT 1122; SPORN MB, 1990, CELL REGUL, V1, P875, DOI 10.1091/mbc.1.12.875; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Stockinger B, 2007, SEMIN IMMUNOL, V19, P353, DOI 10.1016/j.smim.2007.10.008; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Sundrud MS, 2003, J IMMUNOL, V171, P3542, DOI 10.4049/jimmunol.171.7.3542; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Unutmaz D, 1999, J EXP MED, V189, P1735, DOI 10.1084/jem.189.11.1735; van Beelen AJ, 2007, IMMUNITY, V27, P660, DOI 10.1016/j.immuni.2007.08.013; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; WIGHT M, 2001, ART SCI, V19, P1; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yang MS, 2007, PSYCHIAT GENET, V17, P39, DOI 10.1097/YPG.0b013e3280115428; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; ZHOU L, 2008, NATURE          0326; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	64	1003	1085	0	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2008	9	6					641	649		10.1038/ni.1610	http://dx.doi.org/10.1038/ni.1610			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	303VB	18454151	Green Accepted			2022-12-18	WOS:000256067900014
J	Kaech, SM; Ahmed, R				Kaech, SM; Ahmed, R			Memory CD8(+) T cell differentiation: initial antigen encounter triggers a developmental program in naive cells	NATURE IMMUNOLOGY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; IN-VIVO; BYSTANDER ACTIVATION; PROTECTIVE IMMUNITY; BACTERIAL-INFECTION; VIRAL PERSISTENCE; EFFECTOR FUNCTION; CUTTING EDGE; EXPRESSION; RESPONSES	The rules that govern memory T cell differentiation are not well understood. This study shows that after antigenic stimulation naive CD8(+)T cells become committed to dividing at least seven times and differentiating into effector and memory cells. Once the parental naive CD8(+) T cell had been activated, this developmental process could not be interrupted and the daughter cells continued to divide and differentiate in the absence of further antigenic stimulation. These data indicate that initial antigen encounter triggers an instructive developmental program that does not require further antigenic stimulation and does not cease until memory CD8(+) T cell formation.	Emory Univ, Sch Med, Vaccine Ctr, Atlanta, GA 30322 USA	Emory University	Ahmed, R (corresponding author), Emory Univ, Sch Med, Vaccine Ctr, 1510 Clifton Rd, Atlanta, GA 30322 USA.	ra@microbio.emory.edu			NIAID NIH HHS [R37 AI030048, AI30048, R37 AI030048-10, N01AI30048] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030048, R37AI030048] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Ahmed R, 1999, FUNDAMENTAL IMMUNOLO, P1295; Bachmann MF, 1999, EUR J IMMUNOL, V29, P291, DOI 10.1002/(SICI)1521-4141(199901)29:01<291::AID-IMMU291>3.0.CO;2-K; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; BIRON CA, 1994, CURR OPIN IMMUNOL, V6, P530, DOI 10.1016/0952-7915(94)90137-6; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Callan MFC, 1996, NAT MED, V2, P906, DOI 10.1038/nm0896-906; Ehl S, 1997, J EXP MED, V185, P1241, DOI 10.1084/jem.185.7.1241; Grayson JM, 2000, J IMMUNOL, V164, P3950, DOI 10.4049/jimmunol.164.8.3950; Harrington LE, 2000, J EXP MED, V191, P1241, DOI 10.1084/jem.191.7.1241; HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Hwang I, 2000, J EXP MED, V191, P1137, DOI 10.1084/jem.191.7.1137; Iezzi G, 1999, EUR J IMMUNOL, V29, P4092, DOI 10.1002/(SICI)1521-4141(199912)29:12<4092::AID-IMMU4092>3.3.CO;2-1; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Jelley-Gibbs DM, 2000, J IMMUNOL, V165, P5017, DOI 10.4049/jimmunol.165.9.5017; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; MATLOUBIAN M, 1990, J EXP MED, V172, P1043, DOI 10.1084/jem.172.4.1043; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; MULLBACHER A, 1994, J EXP MED, V179, P317, DOI 10.1084/jem.179.1.317; Murali-Krishna K, 2000, J IMMUNOL, V165, P1733, DOI 10.4049/jimmunol.165.4.1733; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Murata K, 1996, CELL IMMUNOL, V173, P96, DOI 10.1006/cimm.1996.0255; Oehen S, 1998, J IMMUNOL, V161, P5338; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; PANTALEO G, 1994, NATURE, V370, P463, DOI 10.1038/370463a0; PIRCHER H, 1991, NATURE, V351, P482, DOI 10.1038/351482a0; Shen H, 1998, CELL, V92, P535, DOI 10.1016/S0092-8674(00)80946-0; SUNILCHANDRA NP, 1994, AM J PATHOL, V145, P818; Veiga-Fernandes H, 2000, NAT IMMUNOL, V1, P47, DOI 10.1038/76907; Vijh S, 1997, J IMMUNOL, V158, P3366; WEINTRAUB H, 1977, COLD SPRING HARB SYM, V42, P401, DOI 10.1101/SQB.1978.042.01.042; Wills MR, 1996, J VIROL, V70, P7569, DOI 10.1128/JVI.70.11.7569-7579.1996; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zarozinski CC, 1997, J EXP MED, V185, P1629, DOI 10.1084/jem.185.9.1629; Zimmermann C, 1996, J EXP MED, V183, P1367, DOI 10.1084/jem.183.4.1367	39	987	1007	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2001	2	5					415	422		10.1038/87720	http://dx.doi.org/10.1038/87720			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	429ZZ	11323695	Green Accepted			2022-12-18	WOS:000168549800014
J	Kretschmer, K; Apostolou, I; Hawiger, D; Khazaie, K; Nussenzweig, MC; von Boehmer, H				Kretschmer, K; Apostolou, I; Hawiger, D; Khazaie, K; Nussenzweig, MC; von Boehmer, H			Inducing and expanding regulatory T cell populations by foreign antigen	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR FOXP3; IN-VIVO EXPANSION; DENDRITIC CELLS; AUTOIMMUNE-DISEASE; CUTTING EDGE; INDUCTION; EXPRESSION; TOLERANCE; THYMUS; UNRESPONSIVENESS	Evidence suggests that regulatory T cells expressing the transcription factor Foxp3 develop extrathymically and intrathymically. Mechanisms of extrathymic induction require further scrutiny, especially as proliferation and/or phenotypic changes of preexisting suppressor cells must be distinguished from true de novo generation. Here we report the conversion of truly naive CD4(+) T cells into suppressor cells expressing Foxp3 by targeting of peptide-agonist ligands to dendritic cells and by analysis of Foxp3 expression at the level of single cells. We show that conversion was achieved by minute antigen doses with suboptimal dendritic cell activation. The addition of transforming growth factor-beta or the absence of interleukin 2 production, which reduces proliferation, enhanced the conversion rate. In addition, regulatory T cell populations induced in subimmunogenic conditions could subsequently be expanded by delivery of antigen in immunogenic conditions. The extrathymic generation and proliferation of regulatory T cells may contribute to self-tolerance as well as the poor immunogenicity of tumors and may be exploited clinically to prevent or reverse unwanted immunity.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pathol, Boston, MA 02115 USA; Yale Univ, Sch Med, Immunol Sect, New Haven, CT 06520 USA; Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; Howard Hughes Med Inst, New York, NY 10021 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Yale University; Rockefeller University; Howard Hughes Medical Institute	von Boehmer, H (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pathol, Boston, MA 02115 USA.	harald_von_boehmer@dfci.harvard.edu	Nussenzweig, Michel/AAE-7292-2019; Kretschmer, Karsten/E-8174-2010	Kretschmer, Karsten/0000-0001-6770-4078	NIAID NIH HHS [R37 AI53102] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI053102] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Chen TC, 2004, J CLIN INVEST, V113, P1754, DOI 10.1172/JCI200420569; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; de Lafaille MAC, 2004, J IMMUNOL, V173, P7259, DOI 10.4049/jimmunol.173.12.7259; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Hawiger D, 2004, IMMUNITY, V20, P695, DOI 10.1016/j.immuni.2004.05.002; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Huber S, 2004, J IMMUNOL, V173, P6526, DOI 10.4049/jimmunol.173.11.6526; INABA K, 1995, CELL IMMUNOL, V163, P148, DOI 10.1006/cimm.1995.1109; Itoh M, 1999, J IMMUNOL, V162, P5317; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Klein L, 2003, P NATL ACAD SCI USA, V100, P8886, DOI 10.1073/pnas.1533365100; Liang S, 2005, J EXP MED, V201, P127, DOI 10.1084/jem.20041201; Mahnke K, 2003, BLOOD, V101, P4862, DOI 10.1182/blood-2002-10-3229; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Peng YF, 2004, P NATL ACAD SCI USA, V101, P4572, DOI 10.1073/pnas.0400810101; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; Seddon B, 2000, IMMUNOL TODAY, V21, P95, DOI 10.1016/S0167-5699(99)01559-5; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Thorstenson KM, 2001, J IMMUNOL, V167, P188, DOI 10.4049/jimmunol.167.1.188; Walker LSK, 2003, J EXP MED, V198, P249, DOI 10.1084/jem.20030315; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Zheng SG, 2002, J IMMUNOL, V169, P4183, DOI 10.4049/jimmunol.169.8.4183	31	982	1035	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2005	6	12					1219	1227		10.1038/ni1265	http://dx.doi.org/10.1038/ni1265			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	985IX	16244650				2022-12-18	WOS:000233371900009
J	Xiao, CC; Srinivasan, L; Calado, DP; Patterson, HC; Zhang, BC; Wang, J; Henderson, JM; Kutok, JL; Rajewsky, K				Xiao, Changchun; Srinivasan, Lakshmi; Calado, Dinis Pedro; Patterson, Heide Christine; Zhang, Baochun; Wang, Jing; Henderson, Joel M.; Kutok, Jeffrey L.; Rajewsky, Klaus			Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes	NATURE IMMUNOLOGY			English	Article							KAPPA-B ACTIVITY; CELL PROLIFERATION; MALIGNANT-LYMPHOMA; MICRORNA TARGETS; FEEDBACK LOOP; MUTATION; APOPTOSIS; GENE; BIM; AMPLIFICATION	The genomic region encoding the miR-17-92 microRNA ( miRNA) cluster is often amplified in lymphoma and other cancers, and cancer cells carrying this amplification have higher expression of miRNA in this cluster. Retroviral expression of miR-17-92 accelerates c-Myc-induced lymphoma development, but precisely how higher expression of miR-17-92 promotes lymphomagenesis remains unclear. Here we generated mice with higher expression of miR-17-92 in lymphocytes. These mice developed lymphoproliferative disease and autoimmunity and died prematurely. Lymphocytes from these mice showed more proliferation and less activation-induced cell death. The miR-17-92 miRNA suppressed expression of the tumor suppressor PTEN and the proapoptotic protein Bim. This mechanism probably contributed to the lymphoproliferative disease and autoimmunity of miR-17-92-transgenic mice and contributes to lymphoma development in patients with amplifications of the miR-17-92 coding region.	[Xiao, Changchun; Srinivasan, Lakshmi; Calado, Dinis Pedro; Patterson, Heide Christine; Zhang, Baochun; Wang, Jing; Rajewsky, Klaus] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Henderson, Joel M.; Kutok, Jeffrey L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Brigham & Women's Hospital	Rajewsky, K (corresponding author), Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA.	rajewsky@cbr.med.harvard.edu	Calado, Dinis/U-8379-2019	Calado, Dinis/0000-0001-8239-7184; Zhang, Baochun/0000-0003-1759-1161; Srinivasan, Lakshmi/0000-0003-1351-7407; Rajewsky, Klaus/0000-0002-6633-6370	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064345] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI064345, R01 AI064345-03, R01 AI064345-02, R01 AI064345-01, AI064345] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Chen CZ, 2005, SEMIN IMMUNOL, V17, P155, DOI 10.1016/j.smim.2005.01.001; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; FINKELMAN FD, 1988, J IMMUNOL, V140, P1022; Goodnow CC, 2007, CELL, V130, P25, DOI 10.1016/j.cell.2007.06.033; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; KARALOV SB, CELL; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lindsley RC, 2007, BLOOD, V109, P2521, DOI 10.1182/blood-2006-04-018085; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mendell JT, 2005, CELL CYCLE, V4, P1179, DOI 10.4161/cc.4.9.2032; Murga M, 2001, IMMUNITY, V15, P959, DOI 10.1016/S1074-7613(01)00254-0; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Okkenhaug K, 2001, NAT IMMUNOL, V2, P325, DOI 10.1038/86327; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; PAGES F, 1994, NATURE, V369, P327, DOI 10.1038/369327a0; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Shparago N, 1996, INT IMMUNOL, V8, P781, DOI 10.1093/intimm/8.5.781; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; SNAPPER CM, 1988, J IMMUNOL, V141, P489; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; Strasser A, 2003, IMMUNOL REV, V193, P82, DOI 10.1034/j.1600-065X.2003.00036.x; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Tagawa H, 2005, LEUKEMIA, V19, P2013, DOI 10.1038/sj.leu.2403942; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; TESTI R, 1989, J IMMUNOL, V142, P1854; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhu JW, 2001, MOL CELL BIOL, V21, P8547, DOI 10.1128/MCB.21.24.8547-8564.2001	49	979	1042	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2008	9	4					405	414		10.1038/ni1575	http://dx.doi.org/10.1038/ni1575			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	276ED	18327259	Green Accepted			2022-12-18	WOS:000254123200016
J	Akbari, O; DeKruyff, RH; Umetsu, DT				Akbari, O; DeKruyff, RH; Umetsu, DT			Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen	NATURE IMMUNOLOGY			English	Article							COLONY-STIMULATING FACTOR; MOUSE BONE-MARROW; CD4(+) T-CELLS; IN-VIVO; INTERFERON-GAMMA; IMMUNE DEVIATION; TH2 RESPONSES; INDUCTION; DIFFERENTIATION; INTERLEUKIN-10	Respiratory exposure to allergen induces T cell tolerance and protection against the development of airway hyperreactivity and asthma. However, the specific mechanisms by which tolerance is induced by respiratory allergen are not clear. We report here that pulmonary dendritic cells (DCs) from mice exposed to respiratory antigen transiently produced interleukin 10 (IL-10). These phenotypically mature pulmonary DCs, which were B-7(hi) as well as producing IL-10, stimulated the development of CD4(+)T regulatory I-like cells that also produced high amounts of IL-10. In addition, adoptive transfer of pulmonary DCs from IL-10(+/+), but not IL-10(-/-), mice exposed to respiratory antigen induced antigen-specific unresponsiveness in recipient mice. These studies show that IL-10 production by DCs is critical for the induction of tolerance, and that phenotypically mature pulmonary DCs mediate tolerance induced by respiratory exposure to antigen.	Stanford Univ, Sch Med, Dept Pediat, Div Immunol & Allergy, Stanford, CA 94305 USA	Stanford University	Umetsu, DT (corresponding author), Stanford Univ, Sch Med, Dept Pediat, Div Immunol & Allergy, Stanford, CA 94305 USA.				NHLBI NIH HHS [R01HL62348] Funding Source: Medline; NIAID NIH HHS [AI24571, AI26322] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI024571, R01AI026322, R01AI024571] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ASSENMACHER M, 1994, EUR J IMMUNOL, V24, P1097, DOI 10.1002/eji.1830240513; Borish L, 1998, J ALLERGY CLIN IMMUN, V101, P293, DOI 10.1016/S0091-6749(98)70238-6; Chang CCJ, 2000, J IMMUNOL, V165, P3584, DOI 10.4049/jimmunol.165.7.3584; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; CHEN YH, 1995, NATURE, V376, P177, DOI 10.1038/376177a0; de Saint-Vis B, 1998, J IMMUNOL, V160, P1666; Dong HD, 1999, NAT MED, V5, P1365; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Gutgemann I, 1998, IMMUNITY, V8, P667, DOI 10.1016/S1074-7613(00)80571-3; HOLT PG, 1989, CLIN EXP ALLERGY, V19, P597, DOI 10.1111/j.1365-2222.1989.tb02752.x; HOLT PG, 1988, J EXP MED, V167, P262, DOI 10.1084/jem.167.2.262; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Iwasaki A, 1999, J EXP MED, V190, P229, DOI 10.1084/jem.190.2.229; John M, 1998, AM J RESP CRIT CARE, V157, P256, DOI 10.1164/ajrccm.157.1.9703079; Jonuleit H, 2000, GENE THER, V7, P249, DOI 10.1038/sj.gt.3301077; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Khanna A, 2000, J IMMUNOL, V164, P1346, DOI 10.4049/jimmunol.164.3.1346; Lambrecht BN, 2000, J CLIN INVEST, V106, P551, DOI 10.1172/JCI8107; Lambrecht BN, 2000, J IMMUNOL, V164, P2937, DOI 10.4049/jimmunol.164.6.2937; LEVIN D, 1993, J IMMUNOL, V151, P6742; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Macaulay AE, 1998, J IMMUNOL, V160, P1694; MALONEY DG, 1985, HYBRIDOMA, V4, P191, DOI 10.1089/hyb.1985.4.191; MARRACK P, 1983, J EXP MED, V158, P1635, DOI 10.1084/jem.158.5.1635; McAdam AJ, 2000, J IMMUNOL, V165, P5035, DOI 10.4049/jimmunol.165.9.5035; MCMENAMIN C, 1993, J EXP MED, V178, P889, DOI 10.1084/jem.178.3.889; MCMENAMIN C, 1991, INT ARCH ALLER A IMM, V94, P78, DOI 10.1159/000235331; MELAMED D, 1993, EUR J IMMUNOL, V23, P935, DOI 10.1002/eji.1830230426; POLLARD AM, 1990, J EXP MED, V172, P159, DOI 10.1084/jem.172.1.159; Pulendran B, 1997, J IMMUNOL, V159, P2222; REINER SL, 1993, J IMMUNOL METHODS, V165, P37, DOI 10.1016/0022-1759(93)90104-F; SANDER B, 1991, IMMUNOL REV, V119, P65, DOI 10.1111/j.1600-065X.1991.tb00578.x; SCHEICHER C, 1992, J IMMUNOL METHODS, V154, P253, DOI 10.1016/0022-1759(92)90199-4; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; STOCKINGER B, 1994, INT IMMUNOL, V6, P247, DOI 10.1093/intimm/6.2.247; Stumbles PA, 1998, J EXP MED, V188, P2019, DOI 10.1084/jem.188.11.2019; Tsitoura DC, 1999, J IMMUNOL, V163, P2592; Tsitoura DC, 2000, J ALLERGY CLIN IMMUN, V106, P239; Vremec D, 1997, J IMMUNOL, V159, P565; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Wu L, 1996, J EXP MED, V184, P903, DOI 10.1084/jem.184.3.903; XIA WJ, 1995, J EXP MED, V181, P1275, DOI 10.1084/jem.181.4.1275; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582	44	976	1024	0	31	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2001	2	8					725	731		10.1038/90667	http://dx.doi.org/10.1038/90667			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	459BN	11477409				2022-12-18	WOS:000170230100015
J	Karkkainen, MJ; Haiko, P; Sainio, K; Partanen, J; Taipale, J; Petrova, TV; Jeltsch, M; Jackson, DG; Talikka, M; Rauvala, H; Betsholtz, C; Alitalo, K				Karkkainen, MJ; Haiko, P; Sainio, K; Partanen, J; Taipale, J; Petrova, TV; Jeltsch, M; Jackson, DG; Talikka, M; Rauvala, H; Betsholtz, C; Alitalo, K			Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins	NATURE IMMUNOLOGY			English	Article							RECEPTOR-BINDING; MOUSE; BLOOD; GENE; ANGIOGENESIS; SPECIFICITY; EXPRESSION; DEFICIENT; SYSTEM; PROX1	Lymphatic vessels are essential for immune surveillance, tissue fluid homeostasis and fat absorption. Defects in lymphatic vessel formation or function cause lymphedema. Here we show that the vascular endothelial growth factor C (VEGF-C) is required for the initial steps in lymphatic development. In Vegfc(-/-) mice, endothelial cells commit to the lymphatic lineage but do not sprout to form lymph vessels. Sprouting was rescued by VEGF-C and VEGF-D but not by VEGF, indicating VEGF receptor 3 specificity. The lack of lymphatic vessels resulted in prenatal death due to fluid accumulation in tissues, and Vegfc(+/-) mice developed cutaneous lymphatic hypoplasia and lymphedema. Our results indicate that VEGF-C is the paracrine factor essential for lymphangiogenesis, and show that both Vegfc alleles are required for normal lymphatic development.	Univ Helsinki, Mol Canc Biol Lab, FIN-00014 Helsinki, Finland; Univ Helsinki, Haartman Inst, Ludwig Inst Canc Res, FIN-00014 Helsinki, Finland; Univ Helsinki, Univ Helsinki Hosp, Biomedicum Helsinki, FIN-00014 Helsinki, Finland; Biomedicum Helsinki, Inst Biomed Dev Biol, Helsinki 00029, Finland; HUCH Diagnost, Helsinki 00029, Finland; Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DU, England; Univ Helsinki, Ctr Neurosci, FIN-00014 Helsinki, Finland; Univ Gothenburg, Dept Biochem Med, S-40530 Gothenburg, Sweden	University of Helsinki; Ludwig Institute for Cancer Research; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Oxford; University of Helsinki; University of Gothenburg	Alitalo, K (corresponding author), Univ Helsinki, Mol Canc Biol Lab, POB 63, FIN-00014 Helsinki, Finland.	kari.alitalo@helsinki.fi	Jeltsch, Michael/I-5340-2012; Alitalo, Kari K/J-5013-2014	Jeltsch, Michael/0000-0003-2890-7790; Alitalo, Kari K/0000-0002-7331-0902; , david/0000-0002-4133-9364; Partanen, Juha/0000-0001-8850-4825; Rauvala, Heikki/0000-0001-7809-9811	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037243] Funding Source: NIH RePORTER; NICHD NIH HHS [HD37243] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aase K, 2001, CIRCULATION, V104, P358, DOI 10.1161/01.CIR.104.3.358; Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548; Avantaggiato V, 1998, MECH DEVELOP, V73, P221, DOI 10.1016/S0925-4773(98)00049-5; Baldwin ME, 2001, J BIOL CHEM, V276, P19166, DOI 10.1074/jbc.M100097200; Bellomo D, 2000, CIRC RES, V86, pE29, DOI 10.1161/01.RES.86.2.e29; Breiteneder-Geleff S, 1999, AM J PATHOL, V154, P385, DOI 10.1016/S0002-9440(10)65285-6; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Hong YK, 2002, DEV DYNAM, V225, P351, DOI 10.1002/dvdy.10163; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Joukov V, 1997, EMBO J, V16, P3898, DOI 10.1093/emboj/16.13.3898; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Karkkainen MJ, 2001, P NATL ACAD SCI USA, V98, P12677, DOI 10.1073/pnas.221449198; Karkkainen MJ, 2000, NAT GENET, V25, P153, DOI 10.1038/75997; Kubo H, 2000, BLOOD, V96, P546; Kukk E, 1996, DEVELOPMENT, V122, P3829; Laakkonen P, 2002, NAT MED, V8, P751, DOI 10.1038/nm720; LARSEN WJ, 1993, HUMAN EMBRYOLOGY, P192; Makinen T, 2001, EMBO J, V20, P4762, DOI 10.1093/emboj/20.17.4762; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Oliver G, 2002, GENE DEV, V16, P773, DOI 10.1101/gad.975002; Petrova TV, 2002, EMBO J, V21, P4593, DOI 10.1093/emboj/cdf470; Prevo R, 2001, J BIOL CHEM, V276, P19420, DOI 10.1074/jbc.M011004200; PURI MC, 1995, EMBO J, V14, P5884, DOI 10.1002/j.1460-2075.1995.tb00276.x; Rennert PD, 1996, J EXP MED, V184, P1999, DOI 10.1084/jem.184.5.1999; Rossant J, 2002, ANNU REV CELL DEV BI, V18, P541, DOI 10.1146/annurev.cellbio.18.012502.105825; Saaristo A, 2002, FASEB J, V16, P1041, DOI 10.1096/fj.01-1042com; Sabin FR, 1902, AM J ANAT, V1, P367, DOI 10.1002/aja.1000010310; Sainio K, 1997, DEVELOPMENT, V124, P4077; Sainio K., 2003, KIDNEY NORMAL DEV CO, P327; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Stacker SA, 1999, J BIOL CHEM, V274, P32127, DOI 10.1074/jbc.274.45.32127; VANDERPUTTE SCJ, 1975, ACTA MORPHOL NEER SC, V13, P245; Veikkola T, 2001, EMBO J, V20, P1223, DOI 10.1093/emboj/20.6.1223; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505; Yuan L, 2002, DEVELOPMENT, V129, P4797	44	966	1028	3	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2004	5	1					74	80		10.1038/ni1013	http://dx.doi.org/10.1038/ni1013			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	758LL	14634646				2022-12-18	WOS:000187635800016
J	Travassos, LH; Carneiro, LAM; Ramjeet, M; Hussey, S; Kim, YG; Magalhaes, JG; Yuan, L; Soares, F; Chea, E; Le Bourhis, L; Boneca, IG; Allaoui, A; Jones, NL; Nunez, G; Girardin, SE; Philpott, DJ				Travassos, Leonardo H.; Carneiro, Leticia A. M.; Ramjeet, Mahendrasingh; Hussey, Seamus; Kim, Yun-Gi; Magalhaes, Joao G.; Yuan, Linda; Soares, Fraser; Chea, Evelyn; Le Bourhis, Lionel; Boneca, Ivo G.; Allaoui, Abdelmounaaim; Jones, Nicola L.; Nunez, Gabriel; Girardin, Stephen E.; Philpott, Dana J.			Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry	NATURE IMMUNOLOGY			English	Article							INNATE IMMUNE RECOGNITION; GENOME-WIDE ASSOCIATION; KAPPA-B ACTIVATION; HOST RECOGNITION; CROHN-DISEASE; CELL-DEATH; PEPTIDOGLYCAN; SHIGELLA; LISTERIA; BIOGENESIS	Autophagy is emerging as a crucial defense mechanism against bacteria, but the host intracellular sensors responsible for inducing autophagy in response to bacterial infection remain unknown. Here we demonstrated that the intracellular sensors Nod1 and Nod2 are critical for the autophagic response to invasive bacteria. By a mechanism independent of the adaptor RIP2 and transcription factor NF-kappa B, Nod1 and Nod2 recruited the autophagy protein ATG16L1 to the plasma membrane at the bacterial entry site. In cells homozygous for the Crohn's disease-associated NOD2 frameshift mutation, mutant Nod2 failed to recruit ATG16L1 to the plasma membrane and wrapping of invading bacteria by autophagosomes was impaired. Our results link bacterial sensing by Nod proteins to the induction of autophagy and provide a functional link between Nod2 and ATG16L1, which are encoded by two of the most important genes associated with Crohn's disease.	[Travassos, Leonardo H.; Hussey, Seamus; Magalhaes, Joao G.; Yuan, Linda; Chea, Evelyn; Le Bourhis, Lionel; Philpott, Dana J.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Carneiro, Leticia A. M.; Ramjeet, Mahendrasingh; Soares, Fraser; Girardin, Stephen E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Hussey, Seamus; Jones, Nicola L.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Kim, Yun-Gi; Nunez, Gabriel] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Boneca, Ivo G.] Inst Pasteur, Biol & Genet Bacterial Cell Wall Grp, Paris, France; [Boneca, Ivo G.] INSERM, Avenir Grp, Paris, France; [Allaoui, Abdelmounaaim] Univ Libre Bruxelles, Lab Bacteriol Mol, Brussels, Belgium	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Michigan System; University of Michigan; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Libre de Bruxelles	Philpott, DJ (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	dana.philpott@utoronto.ca	Magalhaes, Joao/AAK-2686-2020; Boneca, Ivo G/H-1677-2014; Nuñez, Gabriel/A-7160-2014; Travassos, Leonardo/G-1925-2012; Hussey, Séamus/F-8810-2015; Carneiro, Leticia/T-8978-2019	Boneca, Ivo G/0000-0001-8122-509X; Travassos, Leonardo/0000-0003-1323-3797; Hussey, Séamus/0000-0002-9362-0465; Carneiro, Leticia/0000-0001-5870-8288; Le Bourhis, Lionel/0000-0002-7524-3539; Soares, Fraser/0000-0002-3977-7939	Canadian Institutes for Health Research [MOP480142, MOP81360]; Canadian Association Gastroenterology; University of Michigan; Fondation Bettencourt-Schueller; Fundacao para Ciencia e Tecnologia de Portugal; National Institutes of Health [DK61707]; Crohn's & Colitis Foundation of Canada [202283-PGN]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061707] Funding Source: NIH RePORTER	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Association Gastroenterology; University of Michigan(University of Michigan System); Fondation Bettencourt-Schueller; Fundacao para Ciencia e Tecnologia de Portugal; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's & Colitis Foundation of Canada; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank K. Croitoru (University of Toronto) for Mode-K cells; N. Mizushima (Tokyo Medical and Dental Center) for ATG5-deficient MEFs; T. Mak (University of Toronto) for NEMO-deficient MEFs; R. Flavell (Yale University) for pEasyFlox; N. Mizushima (Tokyo Medical and Dental University Graduate School) for Flag-.N85-ATG16L1, Flag-.N85-ATG16L1*300A and HA-ATG5; R. Xavier (Harvard Medical School) for FL-ATG16L1-Myc and FL-ATG16L1*300A-Myc; M. D'Amato (Karolinska Institutet) for HA-Nod1-HA, HA-Nod2, HA-Nod2 L1007fs; F. Takeshita (Yokohama City University School of Medicine) for GFP-HA and pHR-SIN-CSGW Delta NotI-GFP-LC3 GFP-Flag; C. Munz (University of Zurich) for rabbit polyclonal antibody to LC3 (anti-LC3 and for pHR-SIN-CSGW Delta NotI-GFP-LC3); T. A. Kufer and E. Kremmer (University of Cologne and University of Munich) for rat monoclonal anti-Nod2; P. Sansonetti (Institute Pasteur) for S. flexneri M90T; D. Portnoy (University of California) for L. monocytogenes 10403S and the listeriolysin O deletion mutant; all other donors for reagents, antibodies, plasmids and bacterial strains; and M. Silverberg and J. Brumell for discussions. Supported by the Canadian Institutes for Health Research (L. H. T. and L. A. M. C.; MOP480142 to D. J. P.; and MOP81360 to S. E. G.), the Canadian Association Gastroenterology (S. H.), the University of Michigan (Y.-G. K.), Fondation Bettencourt-Schueller (J. G. M.), Fundacao para Ciencia e Tecnologia de Portugal (J. G. M.), the National Institutes of Health (DK61707 to G. N.), the Crohn's & Colitis Foundation of Canada (N. L. J., D. J. P. and S. E. G.) European Research Council (202283-PGN from SHAPE to VIR to I. G. B.) and the Howard Hughes Medical Institute (D. J. P.).	Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; ALLAOUI A, 1992, MOL MICROBIOL, V6, P1605, DOI 10.1111/j.1365-2958.1992.tb00885.x; Barnich N, 2005, J CELL BIOL, V170, P21, DOI 10.1083/jcb.200502153; Birmingham CL, 2007, AUTOPHAGY, V3, P442, DOI 10.4161/auto.4450; Birmingham CL, 2006, AUTOPHAGY, V2, P156, DOI 10.4161/auto.2825; Carneiro LAM, 2008, J PATHOL, V214, P136, DOI 10.1002/path.2271; Carneiro LAM, 2009, CELL HOST MICROBE, V5, P123, DOI 10.1016/j.chom.2008.12.011; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Fritz JH, 2007, IMMUNITY, V26, P445, DOI 10.1016/j.immuni.2007.03.009; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hofius D, 2009, CELL, V137, P773, DOI 10.1016/j.cell.2009.02.036; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hussey S, 2009, SEMIN IMMUNOL, V21, P233, DOI 10.1016/j.smim.2009.05.004; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2000, J BIOL CHEM, V275, P27823; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; Kim S, 2003, P NATL ACAD SCI USA, V100, P1203, DOI 10.1073/pnas.0337707100; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kuballa P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003391; Lecine P, 2007, J BIOL CHEM, V282, P15197, DOI 10.1074/jbc.M606242200; Magalhaes JG, 2005, EMBO REP, V6, P1201, DOI 10.1038/sj.embor.7400552; Magalhaes JG, 2008, J IMMUNOL, V181, P7925, DOI 10.4049/jimmunol.181.11.7925; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Marx J, 2006, SCIENCE, V312, P1160, DOI 10.1126/science.312.5777.1160; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Opitz B, 2006, J IMMUNOL, V176, P484, DOI 10.4049/jimmunol.176.1.484; Opitz B, 2005, CIRC RES, V96, P319, DOI 10.1161/01.RES.0000155721.83594.2c; Reggiori F, 2005, CURR OPIN CELL BIOL, V17, P415, DOI 10.1016/j.ceb.2005.06.007; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Till A, 2008, J CELL SCI, V121, P487, DOI 10.1242/jcs.016980; Travassos LH, 2005, J BIOL CHEM, V280, P36714, DOI 10.1074/jbc.M501649200; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012	47	965	1002	5	103	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2010	11	1					55	U67		10.1038/ni.1823	http://dx.doi.org/10.1038/ni.1823			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	533WE	19898471				2022-12-18	WOS:000272855300013
J	Moser, B; Loetscher, P				Moser, B; Loetscher, P			Lymphocyte traffic control by chemokines	NATURE IMMUNOLOGY			English	Review							SKIN-ASSOCIATED CHEMOKINE; EOTAXIN RECEPTOR CCR3; ACTIVATED T-CELLS; CXC CHEMOKINE; CUTTING EDGE; CHEMOTACTIC RESPONSIVENESS; DIFFERENTIAL EXPRESSION; TISSUE CHEMOKINE; DENDRITIC CELLS; UP-REGULATION	In contrast to the remarkable chemokine responses of phagocytes and monocytes that were documented early on, lymphocytes have been considered for a long time to be poor targets for chemokine action. This view has changed dramatically with the discovery that peripheral blood T cells need to be activated before they can migrate in response to inflammatory chemokines. These chemokines do not act on the bulk of resting T cells that are in circulation. The identification of a new group of chemokines that selects resting, as opposed to effector, T and B cells was very exciting. These inflammation-unrelated chemokines affect transendothelial migration and localization of progenitor and mature lymphocytes in lymphoid and nonlymphoid tissues. Here, we summarize the current view of chemokine-mediated lymphocyte traffic and focus on the molecular mechanisms by which T cell responses to chemokines are modulated. Recent developments in this area justify the hypothesis that the distinct migration patterns of lymphocytes throughout their life cycle-that is, during lymphopoiesis, antigen-dependent priming, inflammation and immune surveillance-are finely tuned by changing sets of chemokines that are selective for developmentally regulated chemokine receptors. Thus, the chemokine system assures that cell traffic during inflammatory responses occurs in the proper spatial and temporal fashion and disturbance of this system, therefore, can lead to inflammatory disease.	Univ Bern, Theodor Kocher Inst, CH-3000 Bern 9, Switzerland	University of Bern	Moser, B (corresponding author), Univ Bern, Theodor Kocher Inst, CH-3000 Bern 9, Switzerland.	bernhard.moser@tki.unibe.ch		Moser, Bernhard/0000-0002-4354-4572				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Adema GJ, 1997, NATURE, V387, P713, DOI 10.1038/42716; Agace WW, 2000, CURR BIOL, V10, P325, DOI 10.1016/S0960-9822(00)00380-8; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Bleul CC, 1998, J EXP MED, V187, P753, DOI 10.1084/jem.187.5.753; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Butcher EC, 1999, ADV IMMUNOL, V72, P209, DOI 10.1016/S0065-2776(08)60022-X; Campbell JJ, 1999, J IMMUNOL, V163, P2353; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; Campbell JJ, 1999, NATURE, V400, P776, DOI 10.1038/23495; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Chvatchko Y, 2000, J EXP MED, V191, P1755, DOI 10.1084/jem.191.10.1755; Cook DN, 2000, IMMUNITY, V12, P495, DOI 10.1016/S1074-7613(00)80201-0; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; D'Ambrosio D, 1998, J IMMUNOL, V161, P5111; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Gerber BO, 1997, CURR BIOL, V7, P836, DOI 10.1016/S0960-9822(06)00371-X; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Gunn MD, 1998, NATURE, V391, P799, DOI 10.1038/35876; Gutierrez-Ramos JC, 1999, IMMUNOL TODAY, V20, P500, DOI 10.1016/S0167-5699(99)01522-4; Homey B, 2000, J IMMUNOL, V164, P3465, DOI 10.4049/jimmunol.164.7.3465; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Kim CH, 1999, J LEUKOCYTE BIOL, V65, P6, DOI 10.1002/jlb.65.1.6; Kim CH, 1998, BLOOD, V91, P4434, DOI 10.1182/blood.V91.12.4434.412k45_4434_4443; Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761; Liao F, 1999, J IMMUNOL, V162, P186; Loetscher M, 1997, CURR BIOL, V7, P652, DOI 10.1016/S0960-9822(06)00292-2; Loetscher P, 2000, Adv Immunol, V74, P127; Loetscher P, 1996, J EXP MED, V184, P569, DOI 10.1084/jem.184.2.569; Loetscher P, 1998, NATURE, V391, P344, DOI 10.1038/34814; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Luther SA, 2001, NAT IMMUNOL, V2, P102, DOI 10.1038/84205; Ma Q, 1999, IMMUNITY, V10, P463, DOI 10.1016/S1074-7613(00)80046-1; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Mach F, 1999, J CLIN INVEST, V104, P1041, DOI 10.1172/JCI6993; Mackay CR, 2000, J EXP MED, V192, pF31, DOI 10.1084/jem.192.11.F31; MACKAY CR, 1993, ADV IMMUNOL, V53, P217, DOI 10.1016/S0065-2776(08)60501-5; Matloubian M, 2000, NAT IMMUNOL, V1, P298, DOI 10.1038/79738; Melchers F, 1999, CELL, V99, P351, DOI 10.1016/S0092-8674(00)81521-4; Morales J, 1999, P NATL ACAD SCI USA, V96, P14470, DOI 10.1073/pnas.96.25.14470; Murphy PM, 2000, PHARMACOL REV, V52, P145; Murphy PM, 2001, NAT IMMUNOL, V2, P116, DOI 10.1038/84214; Nagasawa T, 1999, Adv Immunol, V71, P211; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nagira M, 1998, EUR J IMMUNOL, V28, P1516, DOI 10.1002/(SICI)1521-4141(199805)28:05<1516::AID-IMMU1516>3.0.CO;2-J; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Pablos JL, 1999, AM J PATHOL, V155, P1577, DOI 10.1016/S0002-9440(10)65474-0; Pan JL, 2000, J IMMUNOL, V165, P2943, DOI 10.4049/jimmunol.165.6.2943; Pan Y, 1997, NATURE, V387, P611, DOI 10.1038/42491; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Rothenberg ME, 1997, J EXP MED, V185, P785, DOI 10.1084/jem.185.4.785; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Sallusto F, 1997, SCIENCE, V277, P2005, DOI 10.1126/science.277.5334.2005; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Sherry B, 1992, Cytokines, V4, P117; Sorensen TL, 1999, J CLIN INVEST, V103, P807, DOI 10.1172/JCI5150; Stein JV, 2000, J EXP MED, V191, P61, DOI 10.1084/jem.191.1.61; Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Tang HL, 1999, SCIENCE, V284, P819, DOI 10.1126/science.284.5415.819; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wang W, 2000, J BIOL CHEM, V275, P22313, DOI 10.1074/jbc.M001461200; Warnock RA, 2000, J EXP MED, V191, P77, DOI 10.1084/jem.191.1.77; Willimann K, 1998, EUR J IMMUNOL, V28, P2025, DOI 10.1002/(SICI)1521-4141(199806)28:06<2025::AID-IMMU2025>3.0.CO;2-C; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582; Zabel BA, 1999, J EXP MED, V190, P1241, DOI 10.1084/jem.190.9.1241; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	78	962	1009	1	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2001	2	2					123	128		10.1038/84219	http://dx.doi.org/10.1038/84219			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	398WD	11175804				2022-12-18	WOS:000166778700007
J	Fallarino, F; Grohmann, U; Hwang, KW; Orabona, C; Vacca, C; Bianchi, R; Belladonna, ML; Fioretti, MC; Alegre, ML; Puccetti, P				Fallarino, F; Grohmann, U; Hwang, KW; Orabona, C; Vacca, C; Bianchi, R; Belladonna, ML; Fioretti, MC; Alegre, ML; Puccetti, P			Modulation of tryptophan catabolism by regulatory T cells	NATURE IMMUNOLOGY			English	Article							CD8-ALPHA(+) DENDRITIC CELLS; INDOLEAMINE 2,3-DIOXYGENASE; CUTTING EDGE; ANTIGEN 4; IN-VITRO; TOLERANCE; CTLA-4; ACTIVATION; IMMUNITY; EXPRESSION	Regulatory T (T-R) cells manifest constitutive expression of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), but the function of CTLA-4 in mediating the regulatory function of T-R cells is unclear. We show here that mouse CD4(+)CD25(+) cells, either resting or induced to overexpress CTLA-4 by treatment with antibody to CD3, initiated tryptophan catabolism in dendritic cells through a CTLA-4-dependent mechanism. This process required B7 expression and cytokine production by the dendritic cells. In contrast, T-R cells cultured in the presence of bacterial lipopolysaccharide induced tryptophan catabolism by dendritic cells in a CTLA-4-independent but cytokine-dependent way. Thus, regulation of immunosuppressive tryptophan catabolism in dendritic cells might represent a major mechanism of action of T-R cells.	Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Perugia, Dept Expt Med, I-06126 Perugia, Italy	University of Chicago; University of Perugia	Puccetti, P (corresponding author), Univ Perugia, Dept Expt Med, I-06126 Perugia, Italy.	plopcc@tin.it	Fallarino, Francesca/O-3358-2013; Vacca, Carmine/AAE-7046-2019; Grohmann, Ursula/T-6545-2019; Orabona, Ciriana/L-8725-2015	Fallarino, Francesca/0000-0002-8501-2136; Vacca, Carmine/0000-0002-3799-8164; Orabona, Ciriana/0000-0003-3113-0572; Bianchi, Roberta/0000-0001-5914-4701; Belladonna, Maria Laura/0000-0001-6522-0870; Puccetti, Paolo/0000-0001-6674-2128; Grohmann, Ursula/0000-0001-7952-1850				Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Amrani A, 2000, NATURE, V406, P739, DOI 10.1038/35021081; Anderson B, 1999, P NATL ACAD SCI USA, V96, P9311, DOI 10.1073/pnas.96.16.9311; Bach JF, 2001, ANNU REV IMMUNOL, V19, P131, DOI 10.1146/annurev.immunol.19.1.131; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Cederbom L, 2000, EUR J IMMUNOL, V30, P1538, DOI 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X; Chuang E, 1997, J IMMUNOL, V159, P144; Curelli S, 2001, J INTERF CYTOK RES, V21, P431, DOI 10.1089/107999001750277916; Fallarino F, 2002, J IMMUNOL, V169, P1182, DOI 10.4049/jimmunol.169.3.1182; Fallarino F, 2002, INT IMMUNOL, V14, P65, DOI 10.1093/intimm/14.1.65; Finger EB, 2002, NAT IMMUNOL, V3, P1056, DOI 10.1038/ni1102-1056; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Grohmann U, 2000, J IMMUNOL, V165, P1357, DOI 10.4049/jimmunol.165.3.1357; Grohmann U, 2003, J IMMUNOL, V171, P2581, DOI 10.4049/jimmunol.171.5.2581; Grohmann U, 2003, J EXP MED, V198, P153, DOI 10.1084/jem.20030633; Grohmann U, 2003, TRENDS MOL MED, V9, P133, DOI 10.1016/S1471-4914(03)00026-1; Grohmann U, 2001, J IMMUNOL, V167, P708, DOI 10.4049/jimmunol.167.2.708; Grohmann U, 2001, J IMMUNOL, V166, P277, DOI 10.4049/jimmunol.166.1.277; Grohmann U, 2003, TRENDS IMMUNOL, V24, P242, DOI 10.1016/S1471-4906(03)00072-3; Kingsley CI, 2002, J IMMUNOL, V168, P1080, DOI 10.4049/jimmunol.168.3.1080; Levings MK, 2001, J EXP MED, V193, P1295, DOI 10.1084/jem.193.11.1295; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Mellor AL, 2003, J IMMUNOL, V170, P5809, DOI 10.4049/jimmunol.170.12.5809; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Oosterwegel MA, 1999, CURR OPIN IMMUNOL, V11, P294, DOI 10.1016/S0952-7915(99)80047-8; Piccirillo CA, 2001, J IMMUNOL, V167, P1137, DOI 10.4049/jimmunol.167.3.1137; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225; Sansom DM, 2003, TRENDS IMMUNOL, V24, P314, DOI 10.1016/S1471-4906(03)00111-X; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shortman K, 2001, NAT IMMUNOL, V2, P988, DOI 10.1038/ni1101-988; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Thompson CB, 1997, IMMUNITY, V7, P445, DOI 10.1016/S1074-7613(00)80366-0; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183	44	960	1046	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2003	4	12					1206	1212		10.1038/ni1003	http://dx.doi.org/10.1038/ni1003			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	746VZ	14578884				2022-12-18	WOS:000186769500014
J	Litinskiy, MB; Nardelli, B; Hilbert, DM; He, B; Schaffer, A; Casali, P; Cerutti, A				Litinskiy, MB; Nardelli, B; Hilbert, DM; He, B; Schaffer, A; Casali, P; Cerutti, A			DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL	NATURE IMMUNOLOGY			English	Article							NECROSIS-FACTOR FAMILY; B-CELL MATURATION; HUMAN DENDRITIC CELLS; LYMPHOCYTE STIMULATOR; TNF RECEPTOR; CD40 LIGAND; BAFF; ANTIGEN; MEMBER; TACI	Immunoglobulin (Ig) class-switch DNA recombination (CSR) is thought to be highly dependent upon engagement of CD40 on B cells by CD40 ligand on T cells. We show here that dendritic cells upregulate BLyS and APRIL upon exposure to interferon-alpha, interferon-gamma or CD40 ligand. In the presence of interleukin 10 (IL-10) or transforming growth factor-beta, BLyS and APRIL induce CSR from C to C and/or C-alpha genes in B cells, whereas CSR to C-epsilon requires IL-4. Secretion of class-switched antibodies requires additional stimulation by B cell antigen receptor engagement and IL-15. By eliciting CD40-independent Ig class switching and plasmacytoid differentiation, BLyS and APRIL critically link the innate and adaptive immune responses.	Cornell Univ, Div Mol Immunol, Dept Pathol & Lab Med, Joan & Sanford L Weill Med Coll, New York, NY 10021 USA; Human Genome Sci, Rockville, MD 20850 USA	Cornell University; GlaxoSmithKline; Human Genome Sciences Inc	Cerutti, A (corresponding author), Cornell Univ, Div Mol Immunol, Dept Pathol & Lab Med, Joan & Sanford L Weill Med Coll, 1300 York Ave, New York, NY 10021 USA.	acerutti@med.cornell.edu	Casali, Paolo/F-6579-2010	Cerutti, Andrea/0000-0003-3026-4704	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI045011, R01AI045011, R21AI057130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047872, R01AR040908] Funding Source: NIH RePORTER; NIAID NIH HHS [R21 AI057130, R56 AI045011, R01 AI045011, AI 45011] Funding Source: Medline; NIAMS NIH HHS [AR 47872, R01 AR047872, AR 40908, R01 AR040908] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ARMITAGE RJ, 1995, J IMMUNOL, V154, P483; ARPIN C, 1995, SCIENCE, V268, P720, DOI 10.1126/science.7537388; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Cerutti A, 1998, IMMUNITY, V9, P247, DOI 10.1016/S1074-7613(00)80607-X; Cerutti A, 1998, J IMMUNOL, V160, P2145; Cerutti A, 2001, NAT IMMUNOL, V2, P150, DOI 10.1038/84254; Cyster JG, 2000, NAT IMMUNOL, V1, P9, DOI 10.1038/76859; de Vinuesa CG, 2000, J EXP MED, V191, P485, DOI 10.1084/jem.191.3.485; Do RKG, 2000, J EXP MED, V192, P953, DOI 10.1084/jem.192.7.953; Durandy A, 2001, CURR OPIN IMMUNOL, V13, P543, DOI 10.1016/S0952-7915(00)00256-9; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Fagarasan S, 2000, SCIENCE, V290, P89, DOI 10.1126/science.290.5489.89; Fayette J, 1997, J EXP MED, V185, P1909, DOI 10.1084/jem.185.11.1909; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Gross JA, 2001, IMMUNITY, V15, P289, DOI 10.1016/S1074-7613(01)00183-2; Hahne M, 1998, J EXP MED, V188, P1185, DOI 10.1084/jem.188.6.1185; Kinoshita K, 2001, P NATL ACAD SCI USA, V98, P12620, DOI 10.1073/pnas.221454398; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; LIFE P, 1994, J EXP MED, V180, P1775, DOI 10.1084/jem.180.5.1775; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJS, 2001, NAT IMMUNOL, V2, P625, DOI 10.1038/89775; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Matsumoto M, 1996, SCIENCE, V271, P1289, DOI 10.1126/science.271.5253.1289; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.iy.13.040195.003255; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Nardelli B, 2001, BLOOD, V97, P198, DOI 10.1182/blood.V97.1.198; Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727; PAPAVASILIOU FN, 2002, CELL S1, V109, P35; Rennert P, 2000, J EXP MED, V192, P1677, DOI 10.1084/jem.192.11.1677; RENSHAW BR, 1994, J EXP MED, V180, P1889, DOI 10.1084/jem.180.5.1889; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Stavnezer J, 1996, ADV IMMUNOL, V61, P79, DOI 10.1016/S0065-2776(08)60866-4; Stein JV, 2002, J CLIN INVEST, V109, P1587, DOI 10.1172/JCI200215034; Szomolanyi-Tsuda E, 1998, CURR OPIN IMMUNOL, V10, P431, DOI 10.1016/S0952-7915(98)80117-9; Thompson JS, 2000, J EXP MED, V192, P129, DOI 10.1084/jem.192.1.129; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; vonBulow GU, 1997, SCIENCE, V278, P138, DOI 10.1126/science.278.5335.138; Xia XZ, 2000, J EXP MED, V192, P137, DOI 10.1084/jem.192.1.137; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; Yan MH, 2000, NAT IMMUNOL, V1, P37, DOI 10.1038/76889; Yu G, 2000, NAT IMMUNOL, V1, P252, DOI 10.1038/79802	50	956	997	1	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2002	3	9					822	829		10.1038/ni829	http://dx.doi.org/10.1038/ni829			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	588GZ	12154359	Green Accepted			2022-12-18	WOS:000177694900010
J	Galli, SJ; Nakae, S; Tsai, M				Galli, SJ; Nakae, S; Tsai, M			Mast cells in the development of adaptive immune responses	NATURE IMMUNOLOGY			English	Review							TUMOR-NECROSIS-FACTOR; FC-EPSILON-RI; DELAYED-TYPE HYPERSENSITIVITY; AFFINITY IGE RECEPTOR; DEFICIENT W/WV MICE; C-KIT GENE; DENDRITIC CELLS; IN-VIVO; T-CELLS; LYMPH-NODES	Mast cells are so widely recognized as critical effector cells in allergic disorders and other immunoglobulin E-associated acquired immune responses that it can be difficult to think of them in any other context. However, mast cells also can be important as initiators and effectors of innate immunity. In addition, mast cells that are activated during innate immune responses to pathogens, or in other contexts, can secrete products and have cellular functions with the potential to facilitate the development, amplify the magnitude or regulate the kinetics of adaptive immune responses. Thus, mast cells may influence the development, intensity and duration of adaptive immune responses that contribute to host defense, allergy and autoimmunity, rather than simply functioning as effector cells in these settings.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University; Stanford University	Galli, SJ (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	sgalli@stanford.edu		Tsai, Mindy/0000-0002-8421-4721	NCI NIH HHS [CA-72074] Funding Source: Medline; NHLBI NIH HHS [HL-67674] Funding Source: Medline; NIAID NIH HHS [AI-23990] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA072074] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL067674, P50HL067674] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023990, R37AI023990] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alenius H, 2002, J ALLERGY CLIN IMMUN, V109, P106, DOI 10.1067/mai.2002.120553; ASKENASE PW, 1983, J IMMUNOL, V131, P2687; Berrozpe G, 1999, BLOOD, V94, P2658, DOI 10.1182/blood.V94.8.2658.420k23_2658_2666; Biedermann T, 2000, J EXP MED, V192, P1441, DOI 10.1084/jem.192.10.1441; Blank U, 2004, TRENDS IMMUNOL, V25, P266, DOI 10.1016/j.it.2004.03.005; Bryce PJ, 2004, IMMUNITY, V20, P381, DOI 10.1016/S1074-7613(04)00080-9; Caron G, 2001, J IMMUNOL, V167, P3682, DOI 10.4049/jimmunol.167.7.3682; Caron G, 2001, J IMMUNOL, V166, P6000, DOI 10.4049/jimmunol.166.10.6000; Carramolino L, 1999, J LEUKOCYTE BIOL, V66, P837, DOI 10.1002/jlb.66.5.837; Chen RY, 2001, J CLIN INVEST, V108, P1151, DOI 10.1172/jci11494; Clair JMS, 2004, J CLIN INVEST, V113, P628, DOI 10.1172/JCI200419062; Cumberbatch M, 2000, CLIN EXP DERMATOL, V25, P413, DOI 10.1046/j.1365-2230.2000.00678.x; Cumberbatch M, 2001, IMMUNOLOGY, V102, P323, DOI 10.1046/j.1365-2567.2001.01187.x; Di Nardo A, 2003, J IMMUNOL, V170, P2274, DOI 10.4049/jimmunol.170.5.2274; DUTTLINGER R, 1993, DEVELOPMENT, V118, P705; Faveeuw C, 2003, EUR J IMMUNOL, V33, P889, DOI 10.1002/eji.200323330; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Frandji P, 1996, EUR J IMMUNOL, V26, P2517, DOI 10.1002/eji.1830261036; Furuta GT, 1997, GASTROENTEROLOGY, V113, P1560, DOI 10.1053/gast.1997.v113.pm9352858; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; GALLI SJ, 1994, ADV IMMUNOL, V55, P1; GALLI SJ, 1984, SCIENCE, V226, P710, DOI 10.1126/science.6494907; GALLI SJ, 2004, INNATE IMMUNE RESPON, P111; GAUCHAT JF, 1993, NATURE, V365, P340, DOI 10.1038/365340a0; Gonzalez-Espinosa C, 2003, J EXP MED, V197, P1453, DOI 10.1084/jem.20021806; Gosset P, 2003, J IMMUNOL, V170, P4943, DOI 10.4049/jimmunol.170.10.4943; GRIMBALDESTON MA, IN PRESS FASEB J; HA TY, 1986, INT ARCH ALLER A IMM, V80, P85, DOI 10.1159/000234031; HAYASHI SI, 1991, NUCLEIC ACIDS RES, V19, P1267, DOI 10.1093/nar/19.6.1267; Henz BM, 2001, EXP DERMATOL, V10, P1, DOI 10.1034/j.1600-0625.2001.100101.x; Ikeda K, 2003, BLOOD, V101, P3594, DOI 10.1182/blood-2002-09-2817; IOFFREDA MD, 1993, J INVEST DERMATOL, V101, P150, DOI 10.1111/1523-1747.ep12363632; Jawdat DM, 2004, J IMMUNOL, V173, P5275, DOI 10.4049/jimmunol.173.8.5275; Jutel M, 2001, NATURE, V413, P420, DOI 10.1038/35096564; Kabashima K, 2003, NAT MED, V9, P744, DOI 10.1038/nm872; Kalinski P, 1997, J IMMUNOL, V159, P28; Kaser A, 1999, J IMMUNOL, V163, P3232; Kashiwakura J, 2004, J IMMUNOL, V173, P5247, DOI 10.4049/jimmunol.173.8.5247; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; King CL, 1997, J IMMUNOL, V158, P294; KITAMURA Y, 1989, ANNU REV IMMUNOL, V7, P59, DOI 10.1146/annurev.iy.07.040189.000423; Kobayashi T, 2000, J IMMUNOL, V164, P3855, DOI 10.4049/jimmunol.164.7.3855; KUNG TT, 1995, AM J RESP CELL MOL, V12, P404, DOI 10.1165/ajrcmb.12.4.7695919; Lantz CS, 1998, NATURE, V392, P90, DOI 10.1038/32190; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Lin TJ, 2003, INFECT IMMUN, V71, P365, DOI 10.1128/IAI.71.1.365-373.2003; MALAVIYA R, 1994, J IMMUNOL, V152, P1907; Malaviya R, 1996, J IMMUNOL, V156, P1490; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; MARTIN TR, 1993, J IMMUNOL, V151, P367; MARTIN TR, 1989, J CLIN INVEST, V83, P1375, DOI 10.1172/JCI114025; Maurer M, 2004, NATURE, V432, P512, DOI 10.1038/nature03085; Mazzoni A, 2001, J CLIN INVEST, V108, P1865, DOI 10.1172/JCI200113930; McLachlan JB, 2003, NAT IMMUNOL, V4, P1199, DOI 10.1038/ni1005; Mekori YA, 1999, J ALLERGY CLIN IMMUN, V104, P517, DOI 10.1016/S0091-6749(99)70316-7; Mekori YA, 2004, J ALLERGY CLIN IMMUN, V114, P52, DOI 10.1016/j.jaci.2004.04.015; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Mori Y, 2004, INT ARCH ALLERGY IMM, V134, P25, DOI 10.1159/000077789; Nakajima T, 2002, BLOOD, V100, P3861, DOI 10.1182/blood-2002-02-0602; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; Ott VL, 2003, NAT IMMUNOL, V4, P974, DOI 10.1038/ni971; PAUL WE, 1993, ADV IMMUNOL, V53, P1, DOI 10.1016/S0065-2776(08)60496-4; Pawankar R, 1997, J CLIN INVEST, V99, P1492, DOI 10.1172/JCI119311; Pedotti R, 2001, NAT IMMUNOL, V2, P216, DOI 10.1038/85266; Pedotti R, 2003, TRENDS IMMUNOL, V24, P479, DOI 10.1016/S1471-4906(03)00233-3; REITH AD, 1990, GENE DEV, V4, P390, DOI 10.1101/gad.4.3.390; Robbiani DF, 2000, CELL, V103, P757, DOI 10.1016/S0092-8674(00)00179-3; Robbie-Ryan M, 2003, J IMMUNOL, V170, P1630, DOI 10.4049/jimmunol.170.4.1630; Ryzhov S, 2004, J IMMUNOL, V172, P7726, DOI 10.4049/jimmunol.172.12.7726; Sayama Koichi, 2002, BMC Immunol, V3, P5, DOI 10.1186/1471-2172-3-5; Secor VH, 2000, J EXP MED, V191, P813, DOI 10.1084/jem.191.5.813; Skokos D, 2001, J IMMUNOL, V166, P868, DOI 10.4049/jimmunol.166.2.868; Skokos D, 2003, J IMMUNOL, V170, P3037, DOI 10.4049/jimmunol.170.6.3037; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; SOZZANI S, 1995, J IMMUNOL, V155, P3292; Stassen M, 2001, J IMMUNOL, V166, P4391, DOI 10.4049/jimmunol.166.7.4391; Steinman RM, 1999, J LEUKOCYTE BIOL, V66, P205, DOI 10.1002/jlb.66.2.205; STEVENS J, 1982, PROC R SOC SER B-BIO, V215, P405, DOI 10.1098/rspb.1982.0050; Strait RT, 2002, J ALLERGY CLIN IMMUN, V109, P658, DOI 10.1067/mai.2002.123302; Takeda K, 1997, J EXP MED, V186, P449, DOI 10.1084/jem.186.3.449; Tanzola MB, 2003, J IMMUNOL, V171, P4385, DOI 10.4049/jimmunol.171.8.4385; THOMAS WR, 1983, J IMMUNOL, V130, P2565; Tsai M, 2002, INT J HEMATOL, V75, P345, DOI 10.1007/BF02982122; Villa I, 2001, IMMUNOLOGY, V102, P165, DOI 10.1046/j.1365-2567.2001.01178.x; Wang HW, 1998, J CLIN INVEST, V102, P1617, DOI 10.1172/JCI3704; WERSHIL BK, 1991, J CLIN INVEST, V87, P446, DOI 10.1172/JCI115016; Williams CMM, 2000, J EXP MED, V192, P455, DOI 10.1084/jem.192.3.455; Williams CMM, 2000, J ALLERGY CLIN IMMUN, V105, P847, DOI 10.1067/mai.2000.106485; Woolhiser MR, 2004, CLIN IMMUNOL, V110, P172, DOI 10.1016/j.clim.2003.11.007; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; YAMAZAKI M, 1994, BLOOD, V83, P3509; Yamazaki S, 1998, EXP DERMATOL, V7, P35, DOI 10.1111/j.1600-0625.1998.tb00300.x; Yanagihara Y, 1998, CLIN EXP IMMUNOL, V111, P136; Yoshikawa T, 2001, IMMUNOLOGY, V104, P333, DOI 10.1046/j.1365-2567.2001.01320.x	97	949	995	2	89	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2005	6	2					135	142		10.1038/ni1158	http://dx.doi.org/10.1038/ni1158			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	889UL	15662442				2022-12-18	WOS:000226468100016
J	Shi, CS; Shenderov, K; Huang, NN; Kabat, J; Abu-Asab, M; Fitzgerald, KA; Sher, A; Kehrl, JH				Shi, Chong-Shan; Shenderov, Kevin; Huang, Ning-Na; Kabat, Juraj; Abu-Asab, Mones; Fitzgerald, Katherine A.; Sher, Alan; Kehrl, John H.			Activation of autophagy by inflammatory signals limits IL-1 beta production by targeting ubiquitinated inflammasomes for destruction	NATURE IMMUNOLOGY			English	Article							TOLL-LIKE RECEPTORS; KAPPA-B ACTIVATION; ADAPTIVE IMMUNITY; INNATE IMMUNITY; AIM2 INFLAMMASOME; CYTOPLASMIC DNA; DEFENSE; TRAF6; ASC; DEGRADATION	Autophagosomes delivers cytoplasmic constituents to lysosomes for degradation, whereas inflammasomes are molecular platforms activated by infection or stress that regulate the activity of caspase-1 and the maturation of interleukin 1 beta (IL-1 beta) and IL-18. Here we show that the induction of AIM2 or NLRP3 inflammasomes in macrophages triggered activation of the G protein RalB and autophagosome formation. The induction of autophagy did not depend on the adaptor ASC or capase-1 but was dependent on the presence of the inflammasome sensor. Blocking autophagy potentiated inflammasome activity, whereas stimulating autophagy limited it. Assembled inflammasomes underwent ubiquitination and recruited the autophagic adaptor p62, which assisted their delivery to autophagosomes. Our data indicate that autophagy accompanies inflammasome activation to temper inflammation by eliminating active inflammasomes.	[Shi, Chong-Shan; Huang, Ning-Na; Kehrl, John H.] NIAID, Cell Mol Immunol Sect B, Immunoregulat Lab, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Shenderov, Kevin; Sher, Alan] NIAID, Immunobiol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Kabat, Juraj] NIAID, Core Imaging Facil, NIH, Bethesda, MD 20892 USA; [Abu-Asab, Mones] NEI, Immunopathol Sect, NIH, Bethesda, MD 20892 USA; [Fitzgerald, Katherine A.] Univ Massachusetts, Dept Med, Sch Med, Div Infect Dis & Immunol, Worcester, MA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Massachusetts System; University of Massachusetts Worcester	Shi, CS (corresponding author), NIAID, Cell Mol Immunol Sect B, Immunoregulat Lab, US Natl Inst Hlth, 9000 Rockville Pike, Bethesda, MD 20892 USA.	cshi@niaid.nih.gov	Kehrl, John/AAE-6292-2019; Fitzgerald, Katherine/ABE-6317-2020	Kehrl, John/0000-0002-6526-159X; Abu-Asab, Mones/0000-0002-4047-1232; Shenderov, Kevin/0000-0002-5255-6815; Fitzgerald, Kate/0000-0003-3175-609X	US National Institutes of Health (National Institute of Allergy and Infectious Diseases); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI001051, ZIAAI001044, R01AI083713, ZIAAI000739] Funding Source: NIH RePORTER	US National Institutes of Health (National Institute of Allergy and Infectious Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank N. Mizushima (Tokyo Medical and Dental University) for LC3 cDNA; M. Rust for editorial assistance; and A. Fauci for support. Supported by the Intramural Research Program of the US National Institutes of Health (National Institute of Allergy and Infectious Diseases).	Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bodemann BO, 2011, CELL, V144, P253, DOI 10.1016/j.cell.2010.12.018; Bortoluci KR, 2010, CELL MOL LIFE SCI, V67, P1643, DOI 10.1007/s00018-010-0335-5; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Deretic V, 2005, TRENDS IMMUNOL, V26, P523, DOI 10.1016/j.it.2005.08.003; Dupont N, 2009, CELL HOST MICROBE, V6, P137, DOI 10.1016/j.chom.2009.07.005; Fernandes-Alnemri T, 2008, METHOD ENZYMOL, V442, P251, DOI [10.1016/S0076-6S79(08)01413-4, 10.1016/S0076-6879(08)01413-4]; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Gao WT, 2010, J BIOL CHEM, V285, P1371, DOI 10.1074/jbc.M109.054197; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Harris J, 2009, TRANSBOUND EMERG DIS, V56, P248, DOI 10.1111/j.1865-1682.2009.01069.x; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lamkanfi M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000510; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Li H., 1998, CELL, V80, P401; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Ponpuak M, 2010, IMMUNITY, V32, P329, DOI 10.1016/j.immuni.2010.02.009; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; Schmid D, 2007, IMMUNITY, V27, P11, DOI 10.1016/j.immuni.2007.07.004; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Shi CS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000751; Shi CS, 2008, J BIOL CHEM, V283, P33175, DOI 10.1074/jbc.M804478200; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Suzuki T, 2007, PLOS PATHOG, V3, P1082, DOI 10.1371/journal.ppat.0030111; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wooten MW, 2005, J BIOL CHEM, V280, P35625, DOI 10.1074/jbc.C500237200; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yamamoto M, 2004, GENES CELLS, V9, P1055, DOI 10.1111/j.1365-2443.2004.00789.x; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	47	948	998	2	150	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2012	13	3					255	U74		10.1038/ni.2215	http://dx.doi.org/10.1038/ni.2215			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	895QF	22286270	Green Accepted			2022-12-18	WOS:000300510600012
J	Chamaillard, M; Hashimoto, M; Horie, Y; Masumoto, J; Qiu, S; Saab, L; Ogura, Y; Kawasaki, A; Fukase, K; Kusumoto, S; Valvano, MA; Foster, SJ; Mak, TW; Nunez, G; Inohara, N				Chamaillard, M; Hashimoto, M; Horie, Y; Masumoto, J; Qiu, S; Saab, L; Ogura, Y; Kawasaki, A; Fukase, K; Kusumoto, S; Valvano, MA; Foster, SJ; Mak, TW; Nunez, G; Inohara, N			An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid	NATURE IMMUNOLOGY			English	Article							ESCHERICHIA-COLI K-12; NF-KAPPA-B; LIPOPOLYSACCHARIDE; BIOSYNTHESIS; RECEPTORS; PROTEIN; SURFACE; REGION; INNATE; COMMON	Nucleotide-binding oligomerization domain protein 1 (NOD1) belongs to a family that includes multiple members with NOD and leucine-rich repeats in vertebrates and plants. NOD1 has been suggested to have a role in innate immune responses, but the mechanism involved remains unknown. Here we report that NOD1 mediates the recognition of peptidoglycan derived primarily from Gram-negative bacteria. Biochemical and functional analyses using highly purified and synthetic compounds indicate that the core structure recognized by NOD1 is a dipeptide, gamma-D-glutamyl-meso-diaminopimelic acid (iE-DAP). Murine macrophages deficient in NOD1 did not secrete cytokines in response to synthetic iE-DAP and did not prime the lipopolysaccharide response. Thus, NOD1 mediates selective recognition of bacteria through detection of iE-DAP-containing peptidoglycan.	Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; Int Med Ctr Japan, Res Inst, Dept Infect Dis & Trop Med, Tokyo 1628655, Japan; Ontario Canc Inst, Adv Med Discovery Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys & Immunol, Toronto, ON M5G 2C1, Canada; Osaka Univ, Grad Sch Sci, Dept Chem, Osaka 5600043, Japan; Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada; Univ Western Ontario, Dept Med, London, ON N6A 5C1, Canada; Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Center for Global Health & Medicine - Japan; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Osaka University; Western University (University of Western Ontario); Western University (University of Western Ontario); University of Sheffield	Inohara, N (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.		Valvano, Miguel A/G-8759-2012; Chamaillard, Mathias/L-6542-2013; Nuñez, Gabriel/A-7160-2014	Valvano, Miguel A/0000-0001-8229-3641; Chamaillard, Mathias/0000-0002-0243-9717; 				ADAM A, 1985, MODERN CONCEPTS IMMU, V1; Atrih A, 1999, J BACTERIOL, V181, P3956, DOI 10.1128/JB.181.13.3956-3966.1999; Bertin J, 1999, J BIOL CHEM, V274, P12955, DOI 10.1074/jbc.274.19.12955; Forsberg LS, 1998, J BIOL CHEM, V273, P2747, DOI 10.1074/jbc.273.5.2747; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; Girardin SE, 2002, TRENDS MICROBIOL, V10, P193, DOI 10.1016/S0966-842X(02)02334-X; Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; KITAURA Y, 1982, J MED CHEM, V25, P335, DOI 10.1021/jm00346a001; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; KUSUMOTO S, 1976, B CHEM SOC JPN, V49, P533, DOI 10.1246/bcsj.49.533; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; MAROLDA CL, 1995, J BACTERIOL, V177, P5539, DOI 10.1128/jb.177.19.5539-5546.1995; MUTOH N, 1978, J BACTERIOL, V136, P693, DOI 10.1128/JB.136.2.693-699.1978; NEUHARD J, 1976, J BACTERIOL, V126, P999, DOI 10.1128/JB.126.2.999-1001.1976; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Shanahan F, 2000, SCIENCE, V289, P1311, DOI 10.1126/science.289.5483.1311; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; Takeda K, 2001, GENES CELLS, V6, P733, DOI 10.1046/j.1365-2443.2001.00458.x; TAYLOR RL, 1972, BIOCHEMISTRY-US, V11, P1383, DOI 10.1021/bi00758a009; Valvano MA, 2002, MICROBIOL-SGM, V148, P1979, DOI 10.1099/00221287-148-7-1979	27	942	985	2	69	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2003	4	7					702	707		10.1038/ni945	http://dx.doi.org/10.1038/ni945			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	697PN	12796777				2022-12-18	WOS:000183952500019
J	Maloy, KJ; Powrie, F				Maloy, KJ; Powrie, F			Regulatory T cells in the control of immune pathology	NATURE IMMUNOLOGY			English	Review							IMMUNOLOGICAL SELF-TOLERANCE; ANTIGEN-PRESENTING CELLS; GROWTH-FACTOR-BETA; SPONTANEOUS AUTOIMMUNE ENCEPHALOMYELITIS; LYMPHOCYTE-ASSOCIATED ANTIGEN-4; DENDRITIC CELLS; IN-VIVO; TGF-BETA; INTESTINAL INFLAMMATION; EFFECTOR FUNCTION	It is now well established that regulatory T (T-R) cells can inhibit harmful immunopathological responses directed against self or foreign antigens. However, many key aspects of T-R cell biology remain unresolved, especially with regard to their antigen specificities and the cellular and molecular pathways involved in their development and mechanisms of action. We will review here recent findings in these areas, outline a model for how T-R cells may inhibit the development of immune pathology and discuss potential therapeutic benefits that may arise from the manipulation of T-R cell function.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Powrie, F (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	fiona.powrie@path.ox.ac.uk	Calabrese, Massimiliano/I-6195-2012	Maloy, Kevin/0000-0001-5795-7688				Adler AJ, 1998, J EXP MED, V187, P1555, DOI 10.1084/jem.187.10.1555; Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Annacker O, 2001, J IMMUNOL, V166, P3008, DOI 10.4049/jimmunol.166.5.3008; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Buer J, 1998, J EXP MED, V187, P177, DOI 10.1084/jem.187.2.177; Cederbom L, 2000, EUR J IMMUNOL, V30, P1538, DOI 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X; Chai JG, 1999, EUR J IMMUNOL, V29, P686, DOI 10.1002/(SICI)1521-4141(199902)29:02<686::AID-IMMU686>3.0.CO;2-N; Chambers CA, 2001, ANNU REV IMMUNOL, V19, P565, DOI 10.1146/annurev.immunol.19.1.565; Chen WJ, 1998, J EXP MED, V188, P1849, DOI 10.1084/jem.188.10.1849; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; Cobbold S, 1998, CURR OPIN IMMUNOL, V10, P518, DOI 10.1016/S0952-7915(98)80217-3; Cottrez F, 2000, J IMMUNOL, V165, P4848, DOI 10.4049/jimmunol.165.9.4848; COUTINHO A, 1993, IMMUNOL REV, V133, P225, DOI 10.1111/j.1600-065X.1993.tb01518.x; Davies JD, 1999, J IMMUNOL, V163, P5353; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Dieckmann D, 2001, J EXP MED, V193, P1303, DOI 10.1084/jem.193.11.1303; DING L, 1992, J IMMUNOL, V148, P3133; Duchmann R, 1995, CLIN EXP IMMUNOL, V102, P448; FLORENTINO DF, 1991, J IMMUNOL, V146, P3444; Forster I, 1996, EUR J IMMUNOL, V26, P3194, DOI 10.1002/eji.1830261253; FOWELL D, 1993, J EXP MED, V177, P627, DOI 10.1084/jem.177.3.627; Gao QL, 1999, TRANSPLANTATION, V68, P1891, DOI 10.1097/00007890-199912270-00013; GERSHON RK, 1975, TRANSPLANT REV-DENMA, V26, P170; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Groux H, 1996, J EXP MED, V184, P19, DOI 10.1084/jem.184.1.19; HAFLER DA, 1995, IMMUNOL REV, V144, P75, DOI 10.1111/j.1600-065X.1995.tb00066.x; Hara M, 2001, J IMMUNOL, V166, P3789, DOI 10.4049/jimmunol.166.6.3789; Hausmann S, 1997, CURR OPIN IMMUNOL, V9, P831, DOI 10.1016/S0952-7915(97)80186-0; Hemmer B, 1998, IMMUNOL TODAY, V19, P163, DOI 10.1016/S0167-5699(97)01217-6; Herbelin A, 1998, J IMMUNOL, V161, P2620; Hoyne GF, 2000, INT IMMUNOL, V12, P177, DOI 10.1093/intimm/12.2.177; Itoh M, 1999, J IMMUNOL, V162, P5317; JENKINS MK, 1987, J EXP MED, V165, P302, DOI 10.1084/jem.165.2.302; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Jordan MS, 2000, EUR J IMMUNOL, V30, P136, DOI 10.1002/1521-4141(200001)30:1<136::AID-IMMU136>3.3.CO;2-S; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Khoo UY, 1997, J IMMUNOL, V158, P3626; Kitani A, 2000, J EXP MED, V192, P41, DOI 10.1084/jem.192.1.41; Kumanogoh A, 2001, J IMMUNOL, V166, P353, DOI 10.4049/jimmunol.166.1.353; Kuniyasu Y, 2000, INT IMMUNOL, V12, P1145, DOI 10.1093/intimm/12.8.1145; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; LeDouarin N, 1996, IMMUNOL REV, V149, P35; Lepault F, 2000, J IMMUNOL, V164, P240, DOI 10.4049/jimmunol.164.1.240; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Levings MK, 2001, J EXP MED, V193, P1295, DOI 10.1084/jem.193.11.1295; MACKAY CR, 1993, CURR OPIN IMMUNOL, V5, P423, DOI 10.1016/0952-7915(93)90063-X; Malmstrom V, 2001, J IMMUNOL, V166, P6972, DOI 10.4049/jimmunol.166.11.6972; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Mason D, 1998, CURR OPIN IMMUNOL, V10, P649, DOI 10.1016/S0952-7915(98)80084-8; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Miller JFAP, 1996, CURR OPIN IMMUNOL, V8, P815, DOI 10.1016/S0952-7915(96)80010-0; Modigliani Y, 1996, EUR J IMMUNOL, V26, P1807, DOI 10.1002/eji.1830260822; Modigliani Y, 1996, IMMUNOL REV, V149, P155, DOI 10.1111/j.1600-065X.1996.tb00903.x; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; MORDES JP, 1987, DIABETOLOGIA, V30, P22, DOI 10.1007/BF01788902; Neurath MF, 1996, J EXP MED, V183, P2605, DOI 10.1084/jem.183.6.2605; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Olivares-Villagomez D, 2000, J IMMUNOL, V164, P5499, DOI 10.4049/jimmunol.164.10.5499; Olivares-Villagomez D, 1998, J EXP MED, V188, P1883, DOI 10.1084/jem.188.10.1883; Papiernik M, 1998, INT IMMUNOL, V10, P371, DOI 10.1093/intimm/10.4.371; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Roncarolo MG, 2000, CURR OPIN IMMUNOL, V12, P676, DOI 10.1016/S0952-7915(00)00162-X; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2000, CURR OPIN IMMUNOL, V12, P684, DOI 10.1016/S0952-7915(00)00163-1; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Saoudi A, 1996, J EXP MED, V184, P2393, DOI 10.1084/jem.184.6.2393; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Scheerens H, 2001, EUR J IMMUNOL, V31, P1465, DOI 10.1002/1521-4141(200105)31:5<1465::AID-IMMU1465>3.0.CO;2-E; Schwartz RH, 1996, J EXP MED, V184, P1, DOI 10.1084/jem.184.1.1; Seddon B, 1999, J EXP MED, V189, P877, DOI 10.1084/jem.189.5.877; Seddon B, 2000, IMMUNOL TODAY, V21, P95, DOI 10.1016/S0167-5699(99)01559-5; Seddon B, 1999, J EXP MED, V189, P279, DOI 10.1084/jem.189.2.279; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Shevach EM, 2001, J EXP MED, V193, pF41, DOI 10.1084/jem.193.11.F41; Shimizu J, 1999, J IMMUNOL, V163, P5211; SINGH B, 2001, IN PRESS IMMUNOL REV, V182; Steinbrink K, 1997, J IMMUNOL, V159, P4772; Stephens LA, 2000, J IMMUNOL, V165, P3105, DOI 10.4049/jimmunol.165.6.3105; Stephens LA, 2001, EUR J IMMUNOL, V31, P1247, DOI 10.1002/1521-4141(200104)31:4<1247::AID-IMMU1247>3.0.CO;2-M; Stockinger B, 2001, NAT IMMUNOL, V2, P757, DOI 10.1038/ni0901-757; Sundstedt A, 1997, J IMMUNOL, V158, P180; Suri-Payer E, 2001, J AUTOIMMUN, V16, P115, DOI 10.1006/jaut.2000.0473; Suri-Payer E, 1999, EUR J IMMUNOL, V29, P669, DOI 10.1002/(SICI)1521-4141(199902)29:02<669::AID-IMMU669>3.0.CO;2-J; Suri-Payer E, 1998, J IMMUNOL, V160, P1212; Taams LS, 2001, EUR J IMMUNOL, V31, P1122, DOI 10.1002/1521-4141(200104)31:4<1122::AID-IMMU1122>3.0.CO;2-P; Taams LS, 1998, EUR J IMMUNOL, V28, P2902, DOI 10.1002/(SICI)1521-4141(199809)28:09<2902::AID-IMMU2902>3.0.CO;2-B; Taguchi O, 1996, EUR J IMMUNOL, V26, P1608, DOI 10.1002/eji.1830260730; TAGUCHI O, 1994, IMMUNOLOGY, V82, P365; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Takeuchi M, 1998, J IMMUNOL, V160, P1589; Taylor PA, 2001, J EXP MED, V193, P1311, DOI 10.1084/jem.193.11.1311; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; Thorstenson KM, 2001, J IMMUNOL, V167, P188, DOI 10.4049/jimmunol.167.1.188; Van de Keere F, 1998, J EXP MED, V188, P1875, DOI 10.1084/jem.188.10.1875; Vendetti S, 2000, J IMMUNOL, V165, P1175, DOI 10.4049/jimmunol.165.3.1175; Waldmann H, 2001, IMMUNITY, V14, P399, DOI 10.1016/S1074-7613(01)00120-0; Weiner HL, 1997, IMMUNOL TODAY, V18, P335, DOI 10.1016/S0167-5699(97)01053-0; Yamagiwa S, 2001, J IMMUNOL, V166, P7282, DOI 10.4049/jimmunol.166.12.7282; Zhai Y, 1999, CURR OPIN IMMUNOL, V11, P497, DOI 10.1016/S0952-7915(99)00007-2; Zinkernagel RM, 1997, IMMUNOL REV, V156, P199, DOI 10.1111/j.1600-065X.1997.tb00969.x	112	942	991	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2001	2	9					816	822		10.1038/ni0901-816	http://dx.doi.org/10.1038/ni0901-816			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	468WM	11526392				2022-12-18	WOS:000170781200017
J	Oshiumi, H; Matsumoto, M; Funami, K; Akazawa, T; Seya, T				Oshiumi, H; Matsumoto, M; Funami, K; Akazawa, T; Seya, T			TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction	NATURE IMMUNOLOGY			English	Article							DOUBLE-STRANDED-RNA; NF-KAPPA-B; INNATE IMMUNE-RESPONSE; DENDRITIC CELLS; SIGNAL-TRANSDUCTION; DROSOPHILA TOLL; PROTEIN-KINASE; HOST-DEFENSE; ACTIVATION; EXPRESSION	Human Toll-like receptor (TLR) 3 recognizes double-stranded (ds) RNA and induces production of interferon (IFN)-beta independent of the adaptor molecules MyD88 and TIRAP. Thus, another adaptor must exist that preferentially mediates TLR3-dependent production of IFN-beta. We have identified an alternative adaptor, designated Toll-interleukin 1 receptor domain (TIR)-containing adaptor molecule (TICAM)-1, that can physically bind the TIR domain of TLR3 and activate the IFN-beta promoter in response to poly( I): poly( C). Thus, dsRNA-TLR3-dependent production of IFN-beta is mediated mainly by TICAM-1. This TICAM-1-dependent pathway may have a role in other TLR-IFN-beta pathways, which form part of the MyD88-independent cellular immune response.	Osaka Med Ctr Canc & Cardiovasc Dis, Dept Immunol, Higashinari Ku, Osaka, Japan; Nara Inst Sci & Technol, Dept Mol Immunol, Nara 6310101, Japan; JST, CREST, Tokyo 1000013, Japan	Osaka Medical Center for Cancer & Cardiovascular Diseases; Nara Institute of Science & Technology; Japan Science & Technology Agency (JST)	Seya, T (corresponding author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Immunol, Higashinari Ku, Osaka, Japan.		美佐子, 松本/A-4497-2012; Funami, Kenji/A-4284-2012; Seya, Tsukasa/A-4336-2012; Oshiumi, Hiroyuki/G-1645-2012	Oshiumi, Hiroyuki/0000-0003-1567-8722				Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Cella M, 1999, J EXP MED, V189, P821, DOI 10.1084/jem.189.5.821; Chu WM, 1999, IMMUNITY, V11, P721, DOI 10.1016/S1074-7613(00)80146-6; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fearon DT, 1977, NATURE, V388, P323, DOI DOI 10.1038/40967; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; HAZEKI K, IN PRESS EUR J IMMUN; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Imler JL, 2001, TRENDS CELL BIOL, V11, P304, DOI 10.1016/S0962-8924(01)02004-9; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; James P, 1996, GENETICS, V144, P1425; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Maggi LB, 2000, EMBO J, V19, P3630, DOI 10.1093/emboj/19.14.3630; Matsumoto M, 2002, BIOCHEM BIOPH RES CO, V293, P1364, DOI 10.1016/S0006-291X(02)00380-7; Means TK, 1999, J IMMUNOL, V163, P3920; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nishiguchi M, 2001, J IMMUNOL, V166, P2610, DOI 10.4049/jimmunol.166.4.2610; O'Neill LAJ, 2000, IMMUNOL TODAY, V21, P206, DOI 10.1016/S0167-5699(00)01611-X; Oshiumi Hiroyuki, 2002, Nihon Yakurigaku Zasshi, V120, P91; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; Peters KL, 2002, P NATL ACAD SCI USA, V99, P6322, DOI 10.1073/pnas.092133199; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Sherman F., 1986, METHODS YEAST GENETI; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; UEHORI J, IN PRESS INFECT IMMU; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x	44	940	994	0	50	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2003	4	2					161	167		10.1038/ni886	http://dx.doi.org/10.1038/ni886			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	640JW	12539043				2022-12-18	WOS:000180686500016
J	Grohmann, U; Orabona, C; Fallarino, F; Vacca, C; Calcinaro, F; Falorni, A; Candeloro, P; Belladonna, ML; Bianchi, R; Fioretti, MC; Puccetti, P				Grohmann, U; Orabona, C; Fallarino, F; Vacca, C; Calcinaro, F; Falorni, A; Candeloro, P; Belladonna, ML; Bianchi, R; Fioretti, MC; Puccetti, P			CTLA-4-Ig regulates tryptophan catabolism in vivo	NATURE IMMUNOLOGY			English	Article							T-CELL ACTIVATION; NF-KAPPA-B; DENDRITIC CELLS; INTERFERON-GAMMA; INDOLEAMINE 2,3-DIOXYGENASE; ALLOGRAFT-REJECTION; CARDIAC ALLOGRAFTS; IN-VIVO; MICE; EXPRESSION	Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) plays a critical role in peripheral tolerance. However, regulatory pathways initiated by the interactions of CTLA-4 with B7 counterligands expressed on antigen-presenting cells are not completely understood. We show here that long-term survival of pancreatic islet allografts induced by the soluble fusion protein CTLA-4-immunoglobulin (CTLA-4-Ig) is contingent upon effective tryptophan catabolism in the host. In vitro, we show that CTLA-4-Ig regulates cytokine-dependent tryptophan catabolism in B37-expressing dendritic cells. These data suggest that modulation of tryptophan catabolism is a means by which CTLA-4 functions in vivo and that CTLA-4 acts as a ligand for B7 receptor molecules that transduce intracellular signals.	Univ Perugia, Dept Expt Med, I-06126 Perugia, Italy; Univ Perugia, Dept Internal Med, I-06126 Perugia, Italy	University of Perugia; University of Perugia	Grohmann, U (corresponding author), Univ Perugia, Dept Expt Med, I-06126 Perugia, Italy.	ugrohmann@tin.it	Orabona, Ciriana/L-8725-2015; Vacca, Carmine/AAE-7046-2019; Grohmann, Ursula/T-6545-2019; Fallarino, Francesca/O-3358-2013; FALORNI, Alberto/E-5747-2011	Orabona, Ciriana/0000-0003-3113-0572; Vacca, Carmine/0000-0002-3799-8164; Fallarino, Francesca/0000-0002-8501-2136; FALORNI, Alberto/0000-0003-4532-3519; Puccetti, Paolo/0000-0001-6674-2128; Belladonna, Maria Laura/0000-0001-6522-0870; Grohmann, Ursula/0000-0001-7952-1850; Bianchi, Roberta/0000-0001-5914-4701				Babcock TA, 2000, CYTOKINE, V12, P588, DOI 10.1006/cyto.1999.0661; Chang TT, 1999, J EXP MED, V190, P733, DOI 10.1084/jem.190.5.733; Cowan CA, 2002, TRENDS CELL BIOL, V12, P339, DOI 10.1016/S0962-8924(02)02317-6; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Fallarino F, 1999, J IMMUNOL, V163, P4109; Fallarino F, 1998, J EXP MED, V188, P205, DOI 10.1084/jem.188.1.205; Fallarino F, 2002, INT IMMUNOL, V14, P65, DOI 10.1093/intimm/14.1.65; Fallarino I, 2002, CELL DEATH DIFFER, V9, P1069, DOI 10.1038/sj.cdd.4401073; Fecteau S, 2001, NAT IMMUNOL, V2, P58, DOI 10.1038/83175; Frasca L, 2002, J IMMUNOL, V168, P1060, DOI 10.4049/jimmunol.168.3.1060; Gajewski TF, 1996, J IMMUNOL, V156, P2909; Greenwald RJ, 2001, IMMUNITY, V14, P145, DOI 10.1016/S1074-7613(01)00097-8; Grohmann U, 2000, J IMMUNOL, V165, P1357, DOI 10.4049/jimmunol.165.3.1357; Grohmann U., 2002, Current Drug Targets - Inflammation and Allergy, V1, P77, DOI 10.2174/1568010023344869; Grohmann U, 2001, J IMMUNOL, V167, P708, DOI 10.4049/jimmunol.167.2.708; Grohmann U, 1998, IMMUNITY, V9, P315, DOI 10.1016/S1074-7613(00)80614-7; Grohmann U, 2001, J IMMUNOL, V166, P277, DOI 10.4049/jimmunol.166.1.277; HALL BM, 1985, J EXP MED, V162, P1683, DOI 10.1084/jem.162.5.1683; HASSANAIN HH, 1993, J BIOL CHEM, V268, P5077; Judge TA, 1999, J IMMUNOL, V162, P1947; KACKTEIN H, 2001, TRENDS IMMUNOL, V22, P437; Karandikar NJ, 1996, J EXP MED, V184, P783, DOI 10.1084/jem.184.2.783; Latour S, 2001, J IMMUNOL, V167, P2547, DOI 10.4049/jimmunol.167.5.2547; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; LENSCHOW DJ, 1992, SCIENCE, V257, P789, DOI 10.1126/science.1323143; Li W, 2001, TRANSPLANTATION, V72, P1423, DOI 10.1097/00007890-200110270-00016; Lin H, 1998, J EXP MED, V188, P199, DOI 10.1084/jem.188.1.199; Luhder F, 1998, J EXP MED, V187, P427, DOI 10.1084/jem.187.3.427; Mandelbrott DA, 1999, J IMMUNOL, V163, P3753; Mellor AL, 2001, NAT IMMUNOL, V2, P64, DOI 10.1038/83183; Mellor AL, 1999, IMMUNOL TODAY, V20, P469, DOI 10.1016/S0167-5699(99)01520-0; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Nakaseko C, 1999, J EXP MED, V190, P765, DOI 10.1084/jem.190.6.765; Nathan C, 2001, NAT IMMUNOL, V2, P17, DOI 10.1038/83124; O'Connell PJ, 2002, J IMMUNOL, V168, P143, DOI 10.4049/jimmunol.168.1.143; Oosterwegel MA, 1999, CURR OPIN IMMUNOL, V11, P294, DOI 10.1016/S0952-7915(99)80047-8; PERERA D, 1997, NEW ACAD, V6, P17; QIN SX, 1993, SCIENCE, V259, P974, DOI 10.1126/science.8094901; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225; Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412; Suvas S, 2002, J BIOL CHEM, V277, P7766, DOI 10.1074/jbc.M105902200; Suzuki I, 1998, J EXP MED, V187, P123, DOI 10.1084/jem.187.1.123; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; Thompson CB, 1997, IMMUNITY, V7, P445, DOI 10.1016/S1074-7613(00)80366-0; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Tran HM, 1997, J IMMUNOL, V159, P2232; TURKA LA, 1992, P NATL ACAD SCI USA, V89, P11102, DOI 10.1073/pnas.89.22.11102; vanKooten C, 1997, CURR OPIN IMMUNOL, V9, P330, DOI 10.1016/S0952-7915(97)80078-7; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Zhang SM, 2000, J IMMUNOL, V165, P1374, DOI 10.4049/jimmunol.165.3.1374; Zheng XX, 1997, J IMMUNOL, V159, P1169	53	933	982	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2002	3	11					1097	1101		10.1038/ni846	http://dx.doi.org/10.1038/ni846			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612KE	12368911				2022-12-18	WOS:000179073000018
J	Masters, SL; Dunne, A; Subramanian, SL; Hull, RL; Tannahill, GM; Sharp, FA; Becker, C; Franchi, L; Yoshihara, E; Chen, Z; Mullooly, N; Mielke, LA; Harris, J; Coll, RC; Mills, KHG; Mok, KH; Newsholme, P; Nunez, G; Yodoi, J; Kahn, SE; Lavelle, EC; O'Neill, LAJ				Masters, Seth L.; Dunne, Aisling; Subramanian, Shoba L.; Hull, Rebecca L.; Tannahill, Gillian M.; Sharp, Fiona A.; Becker, Christine; Franchi, Luigi; Yoshihara, Eiji; Chen, Zhe; Mullooly, Niamh; Mielke, Lisa A.; Harris, James; Coll, Rebecca C.; Mills, Kingston H. G.; Mok, K. Hun; Newsholme, Philip; Nunez, Gabriel; Yodoi, Junji; Kahn, Steven E.; Lavelle, Ed C.; O'Neill, Luke A. J.			Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1 beta in type 2 diabetes	NATURE IMMUNOLOGY			English	Article							LOW-DENSITY-LIPOPROTEIN; BETA-CELL MASS; NALP3 INFLAMMASOME; TRANSGENIC MICE; MOUSE MODEL; AMYLIN; PROTEIN; CYTOKINE; FIBRILS; GLUCOSE	Interleukin 1 beta (IL-1 beta) is an important inflammatory mediator of type 2 diabetes. Here we show that oligomers of islet amyloid polypeptide (IAPP), a protein that forms amyloid deposits in the pancreas during type 2 diabetes, triggered the NLRP3 inflammasome and generated mature IL-1 beta. One therapy for type 2 diabetes, glyburide, suppressed IAPP-mediated IL-1 beta production in vitro. Processing of IL-1 beta initiated by IAPP first required priming, a process that involved glucose metabolism and was facilitated by minimally oxidized low-density lipoprotein. Finally, mice transgenic for human IAPP had more IL-1 beta in pancreatic islets, which localized together with amyloid and macrophages. Our findings identify previously unknown mechanisms in the pathogenesis of type 2 diabetes and treatment of pathology caused by IAPP.	[Masters, Seth L.; Dunne, Aisling; Mielke, Lisa A.; Harris, James; Mills, Kingston H. G.; Lavelle, Ed C.; O'Neill, Luke A. J.] Trinity Coll Dublin, Sch Biochem & Immunol, Immunol Res Ctr, Dublin, Ireland; [Masters, Seth L.; Tannahill, Gillian M.; Becker, Christine; Coll, Rebecca C.; O'Neill, Luke A. J.] Trinity Coll Dublin, Sch Biochem & Immunol, Inflammat Res Grp, Dublin, Ireland; [Dunne, Aisling; Mielke, Lisa A.; Mills, Kingston H. G.] Trinity Coll Dublin, Sch Biochem & Immunol, Immune Regulat Res Grp, Dublin, Ireland; [Subramanian, Shoba L.; Hull, Rebecca L.; Kahn, Steven E.] VA Puget Sound Hlth Care Syst, Dept Med, Div Metab Endocrinol & Nutr, Seattle, WA USA; [Subramanian, Shoba L.; Hull, Rebecca L.; Kahn, Steven E.] Univ Washington, Seattle, WA 98195 USA; [Sharp, Fiona A.; Harris, James; Lavelle, Ed C.] Trinity Coll Dublin, Adjuvant Res Grp, Sch Biochem & Immunol, Dublin, Ireland; [Franchi, Luigi; Nunez, Gabriel] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Franchi, Luigi; Nunez, Gabriel] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Yoshihara, Eiji; Chen, Zhe; Yodoi, Junji] Kyoto Univ, Dept Biol Responses, Inst Virus Res, Kyoto 6068501, Japan; [Mullooly, Niamh; Newsholme, Philip] Univ Coll Dublin, Sch Biomol & Biomed Sci, Conway Inst, Dublin 2, Ireland; [Mok, K. Hun] Trinity Coll Dublin, Sch Biochem & Immunol, Prot Folding & Biomol NMR Spect Grp, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; Trinity College Dublin; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Kyoto University; University College Dublin; Trinity College Dublin	Masters, SL (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Immunol Res Ctr, Dublin, Ireland.	smasters@tcd.ie	Nuñez, Gabriel/A-7160-2014; Coll, Rebecca/J-2124-2014; Hull-Meichle, Rebecca L./CAG-5879-2022; Lavelle, Ed/A-1716-2008; Mok, K. Hun/C-2607-2009; Mills, Kingston H/F-5684-2013; Yodoi, Junji/F-6189-2011; Chen, Zhe/F-6273-2010; Masters, Seth L/N-2886-2013; Newsholme, Philip/D-4939-2016	Coll, Rebecca/0000-0002-7359-6023; Lavelle, Ed/0000-0002-3167-1080; Mills, Kingston H/0000-0003-3646-8222; Yodoi, Junji/0000-0001-6849-4914; Chen, Zhe/0000-0003-3626-9848; Masters, Seth L/0000-0003-4763-576X; Newsholme, Philip/0000-0002-0500-6984; Hull, Rebecca/0000-0001-9690-4087; dunne, aisling/0000-0002-2342-9518; Mok, K Hun/0000-0003-3663-2002; Mielke, Lisa/0000-0002-9522-9320; Yoshihara, Eiji/0000-0001-6324-6495; Harris, James/0000-0002-5634-9637; Kahn, Steven/0000-0001-7307-9002; O'Neill, Luke/0000-0002-4333-2748	National Health and Medical Research Council [516783]; Science Foundation Ireland; United States Department of Veterans Affairs; US National Institutes of Health [DK-75998, AI063331]; Crohn's and Colitis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI063331, R01AI063331, R56AI063331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075998] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); United States Department of Veterans Affairs(US Department of Veterans Affairs); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Mori for assistance with Nlrp3<SUP>-/-</SUP> mice; J. Tschopp (University of Lausanne) for Nlrp3<SUP>-/-</SUP> mice; and E. Latz (University of Bonn) for YFP-ASC BMDMs. Supported by the National Health and Medical Research Council (516783 to S.L.M.), Science Foundation Ireland (for work at Trinity College Dublin), the United States Department of Veterans Affairs (for work at the VA Puget Sound Health Care System), the US National Institutes of Health (DK-75998 to S.E.K. for work at VA Puget Sound Health Care System, and AI063331 for work at the University of Michigan) and the Crohn's and Colitis Foundation (L.F.).	Abderrahmani A, 2007, DIABETOLOGIA, V50, P1304, DOI 10.1007/s00125-007-0642-z; APOLINARIO E, 2006, INT J ATHEROSCLER, V1, P42; Badman MK, 1998, CELL TISSUE RES, V291, P285, DOI 10.1007/s004410050998; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; BENDTZEN K, 1986, SCIENCE, V232, P1545, DOI 10.1126/science.3086977; Boni-Schnetzler M, 2008, J CLIN ENDOCR METAB, V93, P4065, DOI 10.1210/jc.2008-0396; Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304; Butler AE, 2004, DIABETES, V53, P1509, DOI 10.2337/diabetes.53.6.1509; CLARK A, 1988, DIABETES RES CLIN EX, V9, P151; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; DE KONING EJP, 1998, AMYLOID, V5, P247; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Gitter BD, 2000, NEUROIMMUNOMODULAT, V7, P147, DOI 10.1159/000026432; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hamon Y, 1997, BLOOD, V90, P2911, DOI 10.1182/blood.V90.8.2911; Hay DL, 2005, MOL PHARMACOL, V67, P1655, DOI 10.1124/mol.104.008615; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; HOWARD CF, 1986, DIABETOLOGIA, V29, P301, DOI 10.1007/BF00452067; Hull RL, 2003, DIABETES, V52, P372, DOI 10.2337/diabetes.52.2.372; Janson J, 1996, P NATL ACAD SCI USA, V93, P7283, DOI 10.1073/pnas.93.14.7283; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; Ma Z, 2001, AMYLOID, V8, P242, DOI 10.3109/13506120108993820; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Matveyenko AV, 2006, ILAR J, V47, P225, DOI 10.1093/ilar.47.3.225; Michalska M, 2010, BIOSCIENCE REP, V30, P445, DOI 10.1042/BSR20090138; Miller YI, 2003, J BIOL CHEM, V278, P1561, DOI 10.1074/jbc.M209634200; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Njajou OT, 2009, DIABETES-METAB RES, V25, P733, DOI 10.1002/dmrr.1011; Russell JC, 2007, BRIT J PHARMACOL, V151, P216, DOI 10.1038/sj.bjp.0707226; Seino S, 2001, DIABETOLOGIA, V44, P906, DOI 10.1007/s001250100531; Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Udayasankar J, 2009, DIABETOLOGIA, V52, P145, DOI 10.1007/s00125-008-1185-7; VAN DE VEERDONK FL, 2010, P NATL ACAD SCI USA, V107, P3030; Verchere CB, 1996, P NATL ACAD SCI USA, V93, P3492, DOI 10.1073/pnas.93.8.3492; Wang F, 2001, DIABETES, V50, P2514, DOI 10.2337/diabetes.50.11.2514; Welsh N, 2005, DIABETES, V54, P3238, DOI 10.2337/diabetes.54.11.3238; Westermark GT, 2008, NEW ENGL J MED, V359, P977, DOI 10.1056/NEJMc0802893; WESTERMARK P, 1995, DIABETOLOGIA, V38, P543, DOI 10.1007/s001250050317; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; Yano M, 2004, CLIN CHIM ACTA, V340, P93, DOI 10.1016/j.cccn.2003.09.020; Yates SL, 2000, J NEUROCHEM, V74, P1017, DOI 10.1046/j.1471-4159.2000.0741017.x; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831; Zraika S, 2010, DIABETOLOGIA, V53, P1046, DOI 10.1007/s00125-010-1671-6; Zraika S, 2009, DIABETOLOGIA, V52, P626, DOI 10.1007/s00125-008-1255-x	53	931	968	6	144	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2010	11	10					897	U1501		10.1038/ni.1935	http://dx.doi.org/10.1038/ni.1935			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	651KP	20835230	Green Submitted, Green Accepted			2022-12-18	WOS:000281926900008
J	Langenkamp, A; Messi, M; Lanzavecchia, A; Sallusto, F				Langenkamp, A; Messi, M; Lanzavecchia, A; Sallusto, F			Kinetics of dendritic cell activation: impact on priming of T(H)1, T(H)2 and nonpolarized T cells	NATURE IMMUNOLOGY			English	Article							HELPER CELL; IMMUNOLOGICAL MEMORY; CYTOKINE; INTERLEUKIN-12; MATURATION; IMMUNITY; ANTIGEN; TH1; PHENOTYPE; DIFFERENTIATION	To prime immune responses, dendritic cells (DCs) need to be activated to acquire T cell stimulatory capacity. Although some stimuli trigger interleukin 12 (IL-12) production that leads to T helper cell type 1 (T(H)1) polarization, others fail to do so and favor T(H)2 polarization,We show that after activation by lipopolysaccharide, DCs produced IL-12 only transiently and became refractory to further stimulation,The exhaustion of cytokine production impacted the T cell polarizing process. Soon after stimulation DCs primed strong T(H)1 responses, whereas at later time points the same cells preferentially primed T(H)2 and nonpolarized T cells. These findings indicate that during an immune response, T cell priming conditions may change in the lymph nodes, suggesting another mechanism for the regulation of effector and memory T cells.	Inst Biomed Res, CH-6500 Bellinzona, Switzerland; Basel Inst Immunol, CH-4005 Basel, Switzerland	Universita della Svizzera Italiana	Sallusto, F (corresponding author), Inst Biomed Res, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland.	federica.sallusto@irb.unisi.ch						Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Aliberti J, 2000, NAT IMMUNOL, V1, P83, DOI 10.1038/76957; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; Cella M, 2000, NAT IMMUNOL, V1, P305, DOI 10.1038/79747; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Cella M, 1999, J EXP MED, V189, P821, DOI 10.1084/jem.189.5.821; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; D'Ambrosio D, 1998, J IMMUNOL, V161, P5111; d'Ostiani CF, 2000, J EXP MED, V191, P1661, DOI 10.1084/jem.191.10.1661; DeSmedt T, 1997, EUR J IMMUNOL, V27, P1229, DOI 10.1002/eji.1830270526; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Gagliardi MC, 2000, EUR J IMMUNOL, V30, P2394, DOI 10.1002/1521-4141(2000)30:8<2394::AID-IMMU2394>3.0.CO;2-Y; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Gett AV, 1998, P NATL ACAD SCI USA, V95, P9488, DOI 10.1073/pnas.95.16.9488; Glimcher LH, 1999, CELL, V96, P13, DOI 10.1016/S0092-8674(00)80955-1; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; Iezzi G, 1999, EUR J IMMUNOL, V29, P4092, DOI 10.1002/(SICI)1521-4141(199912)29:12<4092::AID-IMMU4092>3.3.CO;2-1; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9; Kalinski P, 1997, J IMMUNOL, V159, P28; Karp CL, 1998, EUR J IMMUNOL, V28, P3128, DOI 10.1002/(SICI)1521-4141(199810)28:10<3128::AID-IMMU3128>3.0.CO;2-T; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Ma XJ, 2000, J IMMUNOL, V164, P1722, DOI 10.4049/jimmunol.164.4.1722; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Na SY, 1999, J BIOL CHEM, V274, P7674, DOI 10.1074/jbc.274.12.7674; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; PaninaBordignon P, 1997, J CLIN INVEST, V100, P1513, DOI 10.1172/JCI119674; Rescigno M, 1998, J EXP MED, V188, P2175, DOI 10.1084/jem.188.11.2175; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; SAD S, 1994, J IMMUNOL, V153, P3514; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Sallusto F, 1999, EUR J IMMUNOL, V29, P1617, DOI 10.1002/(SICI)1521-4141(199905)29:05<1617::AID-IMMU1617>3.0.CO;2-3; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sallusto F, 1999, J EXP MED, V189, P611, DOI 10.1084/jem.189.4.611; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; TRAUNECKER A, 1991, TRENDS BIOTECHNOL, V9, P109, DOI 10.1016/0167-7799(91)90038-J; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.iy.13.040195.001343; Whelan M, 2000, J IMMUNOL, V164, P6453, DOI 10.4049/jimmunol.164.12.6453; Wong BR, 1997, J EXP MED, V186, P2075, DOI 10.1084/jem.186.12.2075; Zinkernagel RM, 1996, ANNU REV IMMUNOL, V14, P333, DOI 10.1146/annurev.immunol.14.1.333	48	927	1021	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2000	1	4					311	316		10.1038/79758	http://dx.doi.org/10.1038/79758			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364AK	11017102				2022-12-18	WOS:000089869700013
J	Rathinam, VAK; Jiang, ZZ; Waggoner, SN; Sharma, S; Cole, LE; Waggoner, L; Vanaja, SK; Monks, BG; Ganesan, S; Latz, E; Hornung, V; Vogel, SN; Szomolanyi-Tsuda, E; Fitzgerald, KA				Rathinam, Vijay A. K.; Jiang, Zhaozhao; Waggoner, Stephen N.; Sharma, Shruti; Cole, Leah E.; Waggoner, Lisa; Vanaja, Sivapriya Kailasan; Monks, Brian G.; Ganesan, Sandhya; Latz, Eicke; Hornung, Veit; Vogel, Stefanie N.; Szomolanyi-Tsuda, Eva; Fitzgerald, Katherine A.			The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses	NATURE IMMUNOLOGY			English	Article							TOLL-LIKE RECEPTOR; FRANCISELLA-TULARENSIS; MURINE CYTOMEGALOVIRUS; VACCINIA VIRUS; INNATE; ACTIVATION; INFECTION; CASPASE-1; INTERLEUKIN-1; RECOGNITION	Inflammasomes regulate the activity of caspase-1 and the maturation of interleukin 1. (IL-1.) and IL-18. AIM2 has been shown to bind DNA and engage the caspase-1-activating adaptor protein ASC to form a caspase-1-activating inflammasome. Using Aim2-deficient mice, we identify a central role for AIM2 in regulating caspase-1-dependent maturation of IL-1. and IL-18, as well as pyroptosis, in response to synthetic double-stranded DNA. AIM2 was essential for inflammasome activation in response to Francisella tularensis, vaccinia virus and mouse cytomegalovirus and had a partial role in the sensing of Listeria monocytogenes. Moreover, production of IL-18 and natural killer cell-dependent production of interferon-., events critical in the early control of virus replication, were dependent on AIM2 during mouse cytomegalovirus infection in vivo. Collectively, our observations demonstrate the importance of AIM2 in the sensing of both bacterial and viral pathogens and in triggering innate immunity.	[Rathinam, Vijay A. K.; Jiang, Zhaozhao; Sharma, Shruti; Waggoner, Lisa; Monks, Brian G.; Ganesan, Sandhya; Latz, Eicke; Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Waggoner, Stephen N.; Szomolanyi-Tsuda, Eva] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Cole, Leah E.; Vogel, Stefanie N.] Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Vanaja, Sivapriya Kailasan] Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA; [Latz, Eicke; Hornung, Veit] Univ Bonn, Inst Clin Chem & Pharmacol, D-5300 Bonn, Germany	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University System of Maryland; University of Maryland Baltimore; University of Massachusetts System; University of Massachusetts Worcester; University of Bonn	Fitzgerald, KA (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA.	kate.fitzgerald@umassmed.edu	Monks, Brian/B-8362-2015; Fitzgerald, Katherine/ABE-6317-2020; Ganesan, Sandhya/I-1659-2019; Rathinam, Vijay/ABE-7544-2020; Latz, Eicke/H-3951-2014; Ganesan, Sandhya/GZM-8093-2022; Hornung, Veit/C-3565-2012	Monks, Brian/0000-0003-4008-3093; Rathinam, Vijay/0000-0002-8009-3977; Latz, Eicke/0000-0003-1488-5666; Hornung, Veit/0000-0002-4150-194X; Waggoner, Stephen/0000-0001-9658-2874; Fitzgerald, Kate/0000-0003-3175-609X; Ganesan, Sandhya/0000-0001-9372-7169	National Institutes of Health [AI083713, CA66644, AI07349, CA034461, U54 AI-157168]; NATIONAL CANCER INSTITUTE [R01CA066644, R01CA034461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083713, T32AI007349] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Barbalat (University of California at Berkeley) and G. Barton (University of California at Berkeley) for vaccinia virus; R. Welsh (University of Massachusetts Medical School) for mCMV; D. Knipe (Harvard Medical School) for HSV-1; M. O'Riordan (University of Michigan) for S. typhimurium; V. Boyartchuk (University of Massachusetts Medical School) for L. monocytogenes; T. Taniguchi (University of Tokyo) for Irf3<SUP>-/-</SUP> and Irf7<SUP>-/-</SUP> mice; P. Cresswell (Yale University) for antibody to viperin (anti- viperin); A. Cerny for animal husbandry and genotyping; A. Poltorak for guidance and help with genotyping mice; S. Schattgen for assistance with cell-viability assays; M. Pickering and T. Kowolik for discussions; E. Alnemri and T. Fernandez- Alnemri (Thomas Jefferson University) for discussions and polyclonal antibody to AIM2; and E. Lien for critical reading of the manuscript. Supported by the National Institutes of Health (AI083713 to K. A. F. and E. L.; CA66644 to E. T. S.; AI07349 to S. N. W.; CA034461 to R. W.; and U54 AI- 157168 to S. N. V.) and the New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases (V. A. K. R.).	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; ALCAMI A, 1992, CELL, V71, P153, DOI 10.1016/0092-8674(92)90274-G; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; BUKOWSKI JF, 1984, J VIROL, V52, P119, DOI 10.1128/JVI.52.1.119-128.1984; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Cole LE, 2008, J IMMUNOL, V180, P6885, DOI 10.4049/jimmunol.180.10.6885; Cole LE, 2007, INFECT IMMUN, V75, P4127, DOI 10.1128/IAI.01868-06; Daniels KA, 2001, J EXP MED, V194, P29, DOI 10.1084/jem.194.1.29; Dinarello CA, 2003, BLOOD PURIFICAT, V21, P258, DOI 10.1159/000070699; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Elkins KL, 2007, ANN NY ACAD SCI, V1105, P284, DOI 10.1196/annals.1409.014; ELKINS KL, 1992, MICROB PATHOGENESIS, V13, P417, DOI 10.1016/0882-4010(92)90085-3; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2009, NATURE; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Henry T, 2007, CELL MICROBIOL, V9, P2543, DOI 10.1111/j.1462-5822.2007.01022.x; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Huysamen C, 2009, FEMS MICROBIOL LETT, V290, P121, DOI 10.1111/j.1574-6968.2008.01418.x; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Johnston JB, 2005, IMMUNITY, V23, P587, DOI 10.1016/j.immuni.2005.10.003; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Labow M, 1997, J IMMUNOL, V159, P2452; Lamkanfi M, 2009, IMMUNOL REV, V227, P95, DOI 10.1111/j.1600-065X.2008.00730.x; Landolfo S, 1998, BIOCHIMIE, V80, P721, DOI 10.1016/S0300-9084(99)80025-X; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/88247; Li HF, 2006, J LEUKOCYTE BIOL, V80, P766, DOI 10.1189/jlb.0406294; Ludlow LEA, 2005, EXP CELL RES, V308, P1, DOI 10.1016/j.yexcr.2005.03.032; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; McVicar DW, 2002, J IMMUNOL, V169, P1721, DOI 10.4049/jimmunol.169.4.1721; Meixenberger K, 2010, J IMMUNOL, V184, P922, DOI 10.4049/jimmunol.0901346; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Pien GC, 2000, J IMMUNOL, V164, P994, DOI 10.4049/jimmunol.164.2.994; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Rathinam VAK, 2008, MICROBES INFECT, V10, P1316, DOI 10.1016/j.micinf.2008.07.030; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Roberts ZJ, 2007, J EXP MED, V204, P1559, DOI 10.1084/jem.20061845; SCALZO AA, 1995, GENOMICS, V27, P435, DOI 10.1006/geno.1995.1074; SMITH GL, 1991, J GEN VIROL, V72, P511, DOI 10.1099/0022-1317-72-3-511; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Warren SE, 2008, J IMMUNOL, V180, P7558, DOI 10.4049/jimmunol.180.11.7558; Yoneyama M, 2007, CYTOKINE GROWTH F R, V18, P545, DOI 10.1016/j.cytogfr.2007.06.023	53	926	971	1	96	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2010	11	5					395	403		10.1038/ni.1864	http://dx.doi.org/10.1038/ni.1864			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	585TN	20351692	Green Accepted			2022-12-18	WOS:000276852200008
J	Zhou, XY; Bailey-Bucktrout, SL; Jeker, LT; Penaranda, C; Martinez-Llordella, M; Ashby, M; Nakayama, M; Rosenthal, W; Bluestone, JA				Zhou, Xuyu; Bailey-Bucktrout, Samantha L.; Jeker, Lukas T.; Penaranda, Cristina; Martinez-Llordella, Marc; Ashby, Meredith; Nakayama, Maki; Rosenthal, Wendy; Bluestone, Jeffrey A.			Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo	NATURE IMMUNOLOGY			English	Article							DNA METHYLATION; GENE-EXPRESSION; REG-CELLS; LINEAGE; POLYENDOCRINOPATHY; DIFFERENTIATION; AUTOIMMUNITY; ENTEROPATHY; HOMEOSTASIS; DISRUPTION	Regulatory T cells (T-reg cells) are central to the maintenance of immune homeostasis. However, little is known about the stability of T-reg cells in vivo. In this study, we demonstrate that a substantial percentage of cells had transient or unstable expression of the transcription factor Foxp3. These 'exFoxp3' T cells had an activated-memory T cell phenotype and produced inflammatory cytokines. Moreover, exFoxp3 cell numbers were higher in inflamed tissues in autoimmune conditions. Adoptive transfer of autoreactive exFoxp3 cells led to the rapid onset of diabetes. Finally, analysis of the T cell receptor repertoire suggested that exFoxp3 cells developed from both natural and adaptive T-reg cells. Thus, the generation of potentially autoreactive effector T cells as a consequence of Foxp3 instability has important implications for understanding autoimmune disease pathogenesis.	[Zhou, Xuyu; Bailey-Bucktrout, Samantha L.; Jeker, Lukas T.; Penaranda, Cristina; Ashby, Meredith; Rosenthal, Wendy; Bluestone, Jeffrey A.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Zhou, Xuyu; Bailey-Bucktrout, Samantha L.; Jeker, Lukas T.; Penaranda, Cristina; Ashby, Meredith; Rosenthal, Wendy; Bluestone, Jeffrey A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Nakayama, Maki] Univ Colorado, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Colorado System; University of Colorado Anschutz Medical Campus	Bluestone, JA (corresponding author), Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA.	jbluest@diabetes.ucsf.edu	Zhou, Xuyu/L-7422-2019	Zhou, Xuyu/0000-0002-6626-0898; Jeker, Lukas/0000-0002-3359-8796; Penaranda, Cristina/0000-0002-2595-2863; Ashby, Meredith/0000-0002-4385-9486	US National Institutes of Health [P01 AI35297, U19 AI056388, P30 DK63720]; American Diabetes Association; Swiss National Science Foundation [PBBSB-118644]; Roche Research Foundation; Novartis Foundation; US National Institute of General Medical Sciences [1 R25 GM56847]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056388, P01AI035297, R37AI046643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK080885, P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056847] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Roche Research Foundation; Novartis Foundation(Novartis); US National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. J. McArthur, M. Lee, N. Grewal, S. Jiang, J. Beilke and S. Zhu for technical assistance; N. Martinier and D. Fuentes for animal husbandry; and A. Abbas, Q. Tang, M. Anderson, R. Locksley and members of the Bluestone laboratory for discussions and reading the manuscript. Supported by the US National Institutes of Health (P01 AI35297 and U19 AI056388 to J. A. B., and P30 DK63720 for core support), the American Diabetes Association (X. Z.), the Swiss National Science Foundation (PBBSB-118644 to L. T. J.), the Roche Research Foundation (L. T. J.), the Novartis Foundation (formerly Ciba-Geigy Jubilee Foundation; L. T. J.) and the US National Institute of General Medical Sciences (1 R25 GM56847 to C. P.).	Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bennett CL, 2001, CURR OPIN PEDIATR, V13, P533, DOI 10.1097/00008480-200112000-00007; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Bluestone JA, 2008, J CLIN IMMUNOL, V28, P677, DOI 10.1007/s10875-008-9242-z; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hsieh CS, 2005, CURR TOP MICROBIOL, V293, P25, DOI 10.1007/3-540-27702-1_2; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Kishimoto H, 2000, IMMUNOL RES, V21, P315, DOI 10.1385/IR:21:2-3:315; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Lal G, 2009, J IMMUNOL, V182, P259, DOI 10.4049/jimmunol.182.1.259; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Rose NR, 2008, CLIN REV ALLERG IMMU, V34, P279, DOI 10.1007/s12016-007-8049-7; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wong J, 2007, J EXP MED, V204, P2039, DOI 10.1084/jem.20070822; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707	39	921	952	0	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2009	10	9					1000	U104		10.1038/ni.1774	http://dx.doi.org/10.1038/ni.1774			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	485KV	19633673	Green Accepted			2022-12-18	WOS:000269120900014
J	Viala, J; Chaput, C; Boneca, IG; Cardona, A; Girardin, SE; Moran, AP; Athman, R; Memet, S; Huerre, MR; Coyle, AJ; DiStefano, PS; Sansonetti, PJ; Labigne, A; Bertin, J; Philpott, DJ; Ferrero, RL				Viala, J; Chaput, C; Boneca, IG; Cardona, A; Girardin, SE; Moran, AP; Athman, R; Memet, S; Huerre, MR; Coyle, AJ; DiStefano, PS; Sansonetti, PJ; Labigne, A; Bertin, J; Philpott, DJ; Ferrero, RL			Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; GASTRIC EPITHELIAL-CELLS; HOST-CELLS; ACTIVATION; PROTEIN; RECOGNITION; EXPRESSION; MICE; PHOSPHORYLATION; TRANSLOCATION	Epithelial cells can respond to conserved bacterial products that are internalized after either bacterial invasion or liposome treatment of cells. We report here that the noninvasive Gram-negative pathogen Helicobacter pylori was recognized by epithelial cells via Nod1, an intracellular pathogen-recognition molecule with specificity for Gram-negative peptidoglycan. Nod1 detection of H. pylori depended on the delivery of peptidoglycan to host cells by a bacterial type IV secretion system, encoded by the H. pylori cag pathogenicity island. Consistent with involvement of Nod1 in host defense, Nod1-deficient mice were more susceptible to infection by cag pathogenicity island-positive H. pylori than were wild-type mice. We propose that sensing of H. pylori by Nod1 represents a model for host recognition of noninvasive pathogens.	Inst Pasteur, Grp Immun Innee & Signalisat, Paris, France; Inst Pasteur, Unite Pathogenie Bacterienne Muqueuses, Paris, France; Inst Pasteur, Unite Rech & Expertise Histotechnol & Pathol, Paris, France; Inst Pasteur, INSERM, U389, Unite Pathogenie Microbienne Mol, F-75724 Paris, France; Natl Univ Ireland, Dept Microbiol, Galway, Ireland; Inst Pasteur, Unite Biol Mol Express Genique, Paris, France; Millennium Pharmaceut Inc, Cambridge, MA USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Ollscoil na Gaillimhe-University of Galway; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Ferrero, RL (corresponding author), Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia.	Richard.Ferrero@med.monash.edu.au	Boneca, Ivo G/H-1677-2014; Ferrero, Richard/U-1332-2017	Boneca, Ivo G/0000-0001-8122-509X; Memet, Sylvie/0000-0001-6571-4192; Ferrero, Richard/0000-0001-6817-6211				Akopyants NS, 1998, MOL MICROBIOL, V28, P37, DOI 10.1046/j.1365-2958.1998.00770.x; Amieva MR, 2002, CELL MICROBIOL, V4, P677, DOI 10.1046/j.1462-5822.2002.00222.x; Aras RA, 2003, J EXP MED, V198, P1349, DOI 10.1084/jem.20030381; Athman R, 2002, METHOD MICROBIOL, V31, P93, DOI 10.1016/S0580-9517(02)31006-7; Backert S, 2004, INFECT IMMUN, V72, P1043, DOI 10.1128/IAI.72.2.1043-1056.2004; Backhed F, 2003, J INFECT DIS, V187, P829; Backhed F, 2003, MICROBES INFECT, V5, P951, DOI 10.1016/S1286-4579(03)00189-8; Bertin J, 1999, J BIOL CHEM, V274, P12955, DOI 10.1074/jbc.274.19.12955; BLASER MJ, 1995, CANCER RES, V55, P2111; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chevalier C, 1999, MOL MICROBIOL, V31, P1359, DOI 10.1046/j.1365-2958.1999.01271.x; Covacci A, 1998, CURR OPIN MICROBIOL, V1, P96, DOI 10.1016/S1369-5274(98)80148-3; FERRERO RL, 1995, P NATL ACAD SCI USA, V92, P6499, DOI 10.1073/pnas.92.14.6499; Ferrero RL, 1998, INFECT IMMUN, V66, P1349, DOI 10.1128/IAI.66.4.1349-1355.1998; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; Fox JG, 2003, GASTROENTEROLOGY, V124, P1879, DOI 10.1016/S0016-5085(03)00406-2; Garhart CA, 2003, INFECT IMMUN, V71, P910, DOI 10.1128/IAI.71.2.910-921.2003; Gewirtz AT, 2004, J INFECT DIS, V189, P1914, DOI 10.1086/386289; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; Heuermann D, 1998, MOL GEN GENET, V257, P519, DOI 10.1007/s004380050677; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Israel DA, 2001, J CLIN INVEST, V107, P611, DOI 10.1172/JCI11450; Kim DS, 2003, MOL IMMUNOL, V40, P633, DOI 10.1016/j.molimm.2003.07.001; Kim JG, 2004, INFECT IMMUN, V72, P1487, DOI 10.1128/IAI.72.3.1487-1495.2004; Laniece P, 1998, J NEUROSCI METH, V86, P1, DOI 10.1016/S0165-0270(98)00128-9; Lee SK, 2003, MICROBES INFECT, V5, P1345, DOI 10.1016/j.micinf.2003.09.018; Maeda S, 2001, J BIOL CHEM, V276, P44856, DOI 10.1074/jbc.M105381200; MORAN AP, 1992, J BACTERIOL, V174, P1370, DOI 10.1128/jb.174.4.1370-1377.1992; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Odenbreit S, 2002, INT J MED MICROBIOL, V292, P257, DOI 10.1078/1438-4221-00205; Parsonnet J, 1998, GUT, V43, pS6, DOI 10.1136/gut.43.2008.S6; Peek RM, 1995, LAB INVEST, V73, P760; Petersen AM, 2003, FEMS IMMUNOL MED MIC, V36, P117, DOI 10.1016/S0928-8244(03)00020-8; Philpott DJ, 2002, CELL MICROBIOL, V4, P285, DOI 10.1046/j.1462-5822.2002.00189.x; Remick DG, 2001, AM J PATHOL, V159, P1149, DOI 10.1016/S0002-9440(10)61791-9; Rohde M, 2003, MOL MICROBIOL, V49, P219, DOI 10.1046/j.1365-2958.2003.03549.x; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Sakagami T, 1996, GUT, V39, P639, DOI 10.1136/gut.39.5.639; Salama N, 2000, P NATL ACAD SCI USA, V97, P14668, DOI 10.1073/pnas.97.26.14668; Selbach M, 2003, EMBO J, V22, P515, DOI 10.1093/emboj/cdg050; Skouloubris S, 1998, INFECT IMMUN, V66, P4517; Smith MF, 2003, J BIOL CHEM, V278, P32552, DOI 10.1074/jbc.M305536200; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Wang D, 1998, J BIOL CHEM, V273, P29411, DOI 10.1074/jbc.273.45.29411; WIDMER U, 1993, J IMMUNOL, V150, P4996	50	920	956	0	170	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2004	5	11					1166	1174		10.1038/ni1131	http://dx.doi.org/10.1038/ni1131			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	865HG	15489856				2022-12-18	WOS:000224692700014
J	Moser, M; Murphy, KM				Moser, M; Murphy, KM			Dendritic cell regulation of T(H)1-T(H)2 development	NATURE IMMUNOLOGY			English	Review							I INTERFERON RECEPTOR; CD4(+) T-CELLS; ANTIGEN-PRESENTING CELLS; NECROSIS-FACTOR-ALPHA; HELPER TYPE-1 CELLS; TYROSINE PHOSPHORYLATION; SIGNAL TRANSDUCER; GAMMA PRODUCTION; IFN-ALPHA; TH1 CELLS	Understanding the control exerted by cytokines on T helper cell subsets 1 and 2 (T(H)1-T(H)2) development has progressed to a fairly satisfying knowledge of intracellular signals and transcription factors. Less is understood about the molecular basis of T(H)1-T(H)2 development exerted by other parameters, such as how the antigen presenting cell can influence this process. Recent work suggests that dendritic cell subsets contribute significant polarizing influences on T helper differentiation, but how this comes about is less clear. In some cases known pathways may be used, as in the dendritic cell subset 1 exerting T(H)1 polarization by interleukin 12 (IL-12)production and STAT4 activation. In others, the effects are still in need of explanation.	Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol & Immunol, St Louis, MO 63110 USA; Free Univ Brussels, Dept Biol Mol, B-6041 Gosselies, Belgium	Howard Hughes Medical Institute; Washington University (WUSTL)	Murphy, KM (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol & Immunol, 660 S Euclid Ave, St Louis, MO 63110 USA.	murphy@immunology.wustl.edu						ABRAMOVICH C, 1994, EMBO J, V13, P5871, DOI 10.1002/j.1460-2075.1994.tb06932.x; Aliberti J, 2000, NAT IMMUNOL, V1, P83, DOI 10.1038/76957; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Anjuere F, 1999, BLOOD, V93, P590, DOI 10.1182/blood.V93.2.590.402k11_590_598; Austyn JM, 1996, J EXP MED, V183, P1287, DOI 10.1084/jem.183.4.1287; BACON CM, 1995, P NATL ACAD SCI USA, V92, P7307, DOI 10.1073/pnas.92.16.7307; BarrattBoyes SM, 1997, ADV EXP MED BIOL, V417, P71; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; BURSTEIN HJ, 1992, J IMMUNOL, V148, P3687; Carter LL, 1999, J EXP MED, V189, P1355, DOI 10.1084/jem.189.8.1355; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Cho SS, 1996, J IMMUNOL, V157, P4781; Coccia EM, 1999, J BIOL CHEM, V274, P6698, DOI 10.1074/jbc.274.10.6698; Coffman RL, 1999, SCIENCE, V284, P1283, DOI 10.1126/science.284.5418.1283; COLAMONICI O, 1994, MOL CELL BIOL, V14, P8133, DOI 10.1128/MCB.14.12.8133; COLAMONICI OR, 1993, J BIOL CHEM, V268, P10895; Cook JR, 1996, J BIOL CHEM, V271, P13448, DOI 10.1074/jbc.271.23.13448; Cumberbatch M, 1997, ARCH DERMATOL RES, V289, P277, DOI 10.1007/s004030050193; Cumberbatch M, 1997, IMMUNOLOGY, V92, P388, DOI 10.1046/j.1365-2567.1997.00360.x; Cyster JG, 1999, J EXP MED, V189, P447, DOI 10.1084/jem.189.3.447; De Becker G, 1998, EUR J IMMUNOL, V28, P3161, DOI 10.1002/(SICI)1521-4141(199810)28:10<3161::AID-IMMU3161>3.3.CO;2-H; De Smedt T, 1998, J IMMUNOL, V161, P4476; DeSmedt T, 1996, J EXP MED, V184, P1413, DOI 10.1084/jem.184.4.1413; DEWIT D, 1992, J EXP MED, V175, P9, DOI 10.1084/jem.175.1.9; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Domanski P, 1997, J BIOL CHEM, V272, P26388, DOI 10.1074/jbc.272.42.26388; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Farrar JD, 2000, NAT IMMUNOL, V1, P65, DOI 10.1038/76932; Farrar JD, 2000, J BIOL CHEM, V275, P2693, DOI 10.1074/jbc.275.4.2693; Fazekas de St Groth B, 1998, IMMUNOL TODAY, V19, P448, DOI 10.1016/S0167-5699(98)01328-0; Finkelman FD, 2000, J IMMUNOL, V164, P2303, DOI 10.4049/jimmunol.164.5.2303; FREEMAN GJ, 1995, IMMUNITY, V2, P523, DOI 10.1016/1074-7613(95)90032-2; Frucht DM, 2000, J IMMUNOL, V164, P4659, DOI 10.4049/jimmunol.164.9.4659; Gett AV, 1998, P NATL ACAD SCI USA, V95, P9488, DOI 10.1073/pnas.95.16.9488; Gourley T, 1999, IMMUNITY, V10, P377, DOI 10.1016/S1074-7613(00)80037-0; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; HOCHREIN H, 2000, IN PRESS J EXP MED; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; Howard CJ, 1997, J IMMUNOL, V159, P5372; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Iezzi G, 1999, EUR J IMMUNOL, V29, P4092, DOI 10.1002/(SICI)1521-4141(199912)29:12<4092::AID-IMMU4092>3.3.CO;2-1; Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927; Inaba K, 1997, J EXP MED, V186, P665, DOI 10.1084/jem.186.5.665; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; Jankovic D, 2000, J IMMUNOL, V164, P3047, DOI 10.4049/jimmunol.164.6.3047; KADOWOKI N, 2000, IN PRESS J EXP MED, V192; Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9; Kalinski P, 2000, J IMMUNOL, V165, P1877, DOI 10.4049/jimmunol.165.4.1877; Kalinski P, 1999, J IMMUNOL, V162, P3231; Kaplan MH, 1998, J EXP MED, V188, P1191, DOI 10.1084/jem.188.6.1191; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Kapsenberg ML, 1998, CURR OPIN IMMUNOL, V10, P607, DOI 10.1016/S0952-7915(98)80077-0; Kapsenberg ML, 1999, IMMUNOL LETT, V69, P5, DOI 10.1016/S0165-2478(99)00096-6; Kim SH, 1997, GENE, V196, P279, DOI 10.1016/S0378-1119(97)00240-0; Koch F, 1996, J EXP MED, V184, P1591; Kronin V, 1996, J IMMUNOL, V157, P3819; KUPLECWEGLINSKI JW, 1988, J EXP MED, V167, P632; LEUNG S, 1995, MOL CELL BIOL, V15, P1312; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Liu LM, 1998, J IMMUNOL, V161, P1146; Lohoff M, 1997, IMMUNITY, V6, P681, DOI 10.1016/S1074-7613(00)80444-6; Lu HT, 1999, EMBO J, V18, P1845, DOI 10.1093/emboj/18.7.1845; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; MACATONIA SE, 1993, INT IMMUNOL, V5, P1119, DOI 10.1093/intimm/5.9.1119; Maldonado-Lopez R, 1999, J LEUKOCYTE BIOL, V66, P242, DOI 10.1002/jlb.66.2.242; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; MERAD M, 2000, 6 INT S DENDR CELLS, V72; Naramura M, 1998, IMMUNITY, V9, P209, DOI 10.1016/S1074-7613(00)80603-2; NOVICK D, 1994, CELL, V77, P391, DOI 10.1016/0092-8674(94)90154-6; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; OCONNELL P, 2000, 6 INT S DENDR CELLS, V62; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang W, 1999, P NATL ACAD SCI USA, V96, P3888, DOI 10.1073/pnas.96.7.3888; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Owczarek CM, 1997, J BIOL CHEM, V272, P23865, DOI 10.1074/jbc.272.38.23865; PARRONCHI P, 1992, J IMMUNOL, V149, P2977; Pfeffer LM, 1997, SCIENCE, V276, P1418, DOI 10.1126/science.276.5317.1418; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Pulendran B, 1997, J IMMUNOL, V159, P2222; Qureshi SA, 1996, MOL CELL BIOL, V16, P288; Radtke F, 2000, J EXP MED, V191, P1085, DOI 10.1084/jem.191.7.1085; Ranger AM, 1996, INT IMMUNOL, V8, P1549, DOI 10.1093/intimm/8.10.1549; Richter A, 1999, J EXP MED, V190, P1439, DOI 10.1084/jem.190.10.1439; Rincon M, 1998, EMBO J, V17, P2817, DOI 10.1093/emboj/17.10.2817; Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; Riviere I, 1998, IMMUNITY, V9, P217, DOI 10.1016/S1074-7613(00)80604-4; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; Rodriguez-Palmero M, 1999, EUR J IMMUNOL, V29, P3914; Rogge L, 1997, J EXP MED, V185, P825, DOI 10.1084/jem.185.5.825; Rogge L, 1998, J IMMUNOL, V161, P6567; Salomon B, 1998, J IMMUNOL, V160, P708; Santini SM, 2000, J EXP MED, V191, P1777, DOI 10.1084/jem.191.10.1777; SCHMITZ J, 1994, J EXP MED, V179, P1349, DOI 10.1084/jem.179.4.1349; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Snijders A, 1998, INT IMMUNOL, V10, P1593, DOI 10.1093/intimm/10.11.1593; SOH JM, 1994, J BIOL CHEM, V269, P18102; Sousa CRE, 1999, J IMMUNOL, V162, P6552; Sousa CRE, 1997, J EXP MED, V186, P1819, DOI 10.1084/jem.186.11.1819; Sousa CRE, 1999, IMMUNITY, V11, P637, DOI 10.1016/S1074-7613(00)80138-7; Suss G, 1996, J EXP MED, V183, P1789, DOI 10.1084/jem.183.4.1789; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Taki S, 1997, IMMUNITY, V6, P673, DOI 10.1016/S1074-7613(00)80443-4; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; UZE G, 1990, CELL, V60, P225, DOI 10.1016/0092-8674(90)90738-Z; Vieira PL, 2000, J IMMUNOL, V164, P4507, DOI 10.4049/jimmunol.164.9.4507; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Wenner CA, 1996, J IMMUNOL, V156, P1442; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Wong BR, 1997, J EXP MED, V186, P2075, DOI 10.1084/jem.186.12.2075; Wu CY, 1997, J IMMUNOL, V159, P1658; Wu L, 1998, IMMUNITY, V9, P839, DOI 10.1016/S1074-7613(00)80649-4; Wu L, 1996, J EXP MED, V184, P903, DOI 10.1084/jem.184.3.903; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Yan H, 1996, EMBO J, V15, P1064, DOI 10.1002/j.1460-2075.1996.tb00444.x; Yan H, 1996, MOL CELL BIOL, V16, P2074; Yang CH, 1996, J BIOL CHEM, V271, P8057, DOI 10.1074/jbc.271.14.8057; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; Yang JF, 1999, EUR J IMMUNOL, V29, P548, DOI 10.1002/(SICI)1521-4141(199902)29:02<548::AID-IMMU548>3.0.CO;2-Z; Zinkernagel RM, 1997, IMMUNOL REV, V156, P199, DOI 10.1111/j.1600-065X.1997.tb00969.x	124	917	976	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2000	1	3					199	205		10.1038/79734	http://dx.doi.org/10.1038/79734			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BY	10973276				2022-12-18	WOS:000089815100017
J	Selsted, ME; Ouellette, AJ				Selsted, ME; Ouellette, AJ			Mammalian defensins in the antimicrobial immune response	NATURE IMMUNOLOGY			English	Review							HUMAN NEUTROPHIL DEFENSINS; RHESUS-MACAQUE LEUKOCYTES; HUMAN BETA-DEFENSINS; ALPHA-DEFENSIN; EPITHELIAL-CELLS; INNATE IMMUNITY; HOST-DEFENSE; HUMAN BETA-DEFENSIN-2; CANDIDA-ALBICANS; GENE-EXPRESSION	Defensins are peptidic components of the innate immune system of plants and animals. In mammals, defensins have evolved to have a central function in the host defense properties of granulocytic leukocytes, mucosal surfaces, skin and other epithelia. This review focuses on the biological functions of three structural subgroups of mammalian defensins and the evidence for their involvement as effectors of antimicrobial innate immunity.	Univ Calif Irvine, Sch Med, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA; Univ Calif Irvine, Sch Med, Ctr Immunol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Selsted, ME (corresponding author), Univ Calif Irvine, Sch Med, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA.	meselste@uci.edu	Abrams, William R/A-5782-2008					Aarbiou J, 2004, AM J RESP CELL MOL, V30, P193, DOI 10.1165/rcmb.2002-0267OC; Aarbiou J, 2002, J LEUKOCYTE BIOL, V72, P167; Abuja PM, 2004, FEBS LETT, V566, P301, DOI 10.1016/j.febslet.2004.03.112; Ayabe T, 2002, J BIOL CHEM, V277, P3793, DOI 10.1074/jbc.M107507200; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Bader MW, 2003, MOL MICROBIOL, V50, P219, DOI 10.1046/j.1365-2958.2003.03675.x; Befus AD, 1999, J IMMUNOL, V163, P947; BENSCH KW, 1995, FEBS LETT, V368, P331, DOI 10.1016/0014-5793(95)00687-5; Boniotto M, 2003, BIOCHEM J, V374, P707, DOI 10.1042/BJ20030528; Buffy JJ, 2004, BIOCHEMISTRY-US, V43, P9800, DOI 10.1021/bi036243w; Chalifour A, 2004, BLOOD, V104, P1778, DOI 10.1182/blood-2003-08-2820; Chavakis T, 2004, FASEB J, V18, P1306, DOI 10.1096/fj.03-1009fje; Chertov O, 1996, J BIOL CHEM, V271, P2935, DOI 10.1074/jbc.271.6.2935; Chung WO, 2004, J IMMUNOL, V173, P5165, DOI 10.4049/jimmunol.173.8.5165; Cole AM, 2002, P NATL ACAD SCI USA, V99, P1813, DOI 10.1073/pnas.052706399; DAHER KA, 1986, J VIROL, V60, P1068, DOI 10.1128/JVI.60.3.1068-1074.1986; DIAMOND G, 1991, P NATL ACAD SCI USA, V88, P3952, DOI 10.1073/pnas.88.9.3952; DIAMOND G, 1994, CHEST S, V105, P51; Duits LA, 2002, IMMUNOLOGY, V106, P517, DOI 10.1046/j.1365-2567.2002.01430.x; Edgerton M, 2000, ANTIMICROB AGENTS CH, V44, P3310, DOI 10.1128/AAC.44.12.3310-3316.2000; EISENHAUER PB, 1992, INFECT IMMUN, V60, P3446, DOI 10.1128/IAI.60.8.3446-3447.1992; Fang XM, 2003, EUR J CLIN INVEST, V33, P82, DOI 10.1046/j.1365-2362.2003.01076.x; Ganz T, 1986, Semin Respir Infect, V1, P107; GANZ T, 1987, INFECT IMMUN, V55, P568, DOI 10.1128/IAI.55.3.568-571.1987; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Garcia JRC, 2001, FASEB J, V15, P1819, DOI 10.1096/fj.00-0865fje; Garcia JRC, 2001, CELL TISSUE RES, V306, P257, DOI 10.1007/s004410100433; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Harder J, 2005, J LEUKOCYTE BIOL, V77, P476, DOI 10.1189/jlb.0704409; Harder J, 2004, J INVEST DERMATOL, V123, P522, DOI 10.1111/j.0022-202X.2004.23234.x; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Helmerhorst EJ, 1999, J BIOL CHEM, V274, P7286, DOI 10.1074/jbc.274.11.7286; Hertz CJ, 2003, J IMMUNOL, V171, P6820, DOI 10.4049/jimmunol.171.12.6820; Hiratsuka T, 2003, THORAX, V58, P425, DOI 10.1136/thorax.58.5.425; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hristova K, 1997, J BIOL CHEM, V272, P24224, DOI 10.1074/jbc.272.39.24224; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; KAGAN BL, 1990, P NATL ACAD SCI USA, V87, P210, DOI 10.1073/pnas.87.1.210; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; LEHRER RI, 1985, INFECT IMMUN, V49, P207, DOI 10.1128/IAI.49.1.207-211.1985; LEHRER RI, 1988, J CLIN INVEST, V81, P1829, DOI 10.1172/JCI113527; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; Leonova L, 2001, J LEUKOCYTE BIOL, V70, P461; Levy O, 2004, J LEUKOCYTE BIOL, V76, P909, DOI 10.1189/jlb.0604320; Liu LD, 2003, J IMMUNOL, V170, P575, DOI 10.4049/jimmunol.170.1.575; Lohner K, 1997, BIOCHEMISTRY-US, V36, P1525, DOI 10.1021/bi961300p; Lynn DJ, 2004, MOL BIOL EVOL, V21, P819, DOI 10.1093/molbev/msh084; Mackewicz CE, 2003, AIDS, V17, pF23, DOI 10.1097/00002030-200309260-00001; Maemoto A, 2004, J BIOL CHEM, V279, P44188, DOI 10.1074/jbc.M406154200; Mandal M, 2002, J PEPT RES, V59, P95, DOI 10.1034/j.1399-3011.2002.01945.x; Morrison G, 2002, INFECT IMMUN, V70, P3053, DOI 10.1128/IAI.70.6.3053-3060.2002; Moser C, 2002, INFECT IMMUN, V70, P3068, DOI 10.1128/IAI.70.6.3068-3072.2002; Munk C, 2003, AIDS RES HUM RETROV, V19, P875, DOI 10.1089/088922203322493049; MURPHY CJ, 1993, J CELL PHYSIOL, V155, P408, DOI 10.1002/jcp.1041550223; Nguyen TX, 2003, PEPTIDES, V24, P1647, DOI 10.1016/j.peptides.2003.07.023; Niyonsaba F, 2002, INT IMMUNOL, V14, P421, DOI 10.1093/intimm/14.4.421; Nomura I, 2003, J IMMUNOL, V171, P3262, DOI 10.4049/jimmunol.171.6.3262; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; PANYUTICH AV, 1991, J IMMUNOL METHODS, V141, P149, DOI 10.1016/0022-1759(91)90141-2; Patil A, 2004, PHYSIOL GENOMICS, V20, P1, DOI 10.1152/physiolgenomics.00150.2004; Platz J, 2004, J IMMUNOL, V173, P1219, DOI 10.4049/jimmunol.173.2.1219; Proud D, 2004, J IMMUNOL, V172, P4637, DOI 10.4049/jimmunol.172.7.4637; Rodriguez-Jimenez FJ, 2003, GENOMICS, V81, P175, DOI 10.1016/S0888-7543(02)00034-4; Ross DJ, 2004, TRANSPLANTATION, V78, P1222, DOI 10.1097/01.TP.0000137265.18491.75; Rumio C, 2004, AM J PATHOL, V165, P373, DOI 10.1016/S0002-9440(10)63304-4; Sahl HG, 2005, J LEUKOCYTE BIOL, V77, P466, DOI 10.1189/jlb.0804452; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Satchell DP, 2003, J BIOL CHEM, V278, P13838, DOI 10.1074/jbc.M212115200; Schaefer TM, 2005, J IMMUNOL, V174, P992, DOI 10.4049/jimmunol.174.2.992; Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699; Schutte BC, 2002, ANNU REV PHYSIOL, V64, P709, DOI 10.1146/annurev.physiol.64.081501.134340; SELSTED ME, 1993, J BIOL CHEM, V268, P6641; Semple CAM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-r31; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Taudien S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-92; TERRITO MC, 1989, J CLIN INVEST, V84, P2017, DOI 10.1172/JCI114394; Trabi M, 2001, BIOCHEMISTRY-US, V40, P4211, DOI 10.1021/bi002028t; Tran D, 2002, J BIOL CHEM, V277, P3079, DOI 10.1074/jbc.M109117200; Tsutsumi-Ishii Y, 2003, J IMMUNOL, V170, P4226, DOI 10.4049/jimmunol.170.8.4226; VALORE EV, 1992, BLOOD, V79, P1538; Valore EV, 1998, J CLIN INVEST, V101, P1633, DOI 10.1172/JCI1861; Vora P, 2004, J IMMUNOL, V173, P5398, DOI 10.4049/jimmunol.173.9.5398; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Wang W, 2003, J IMMUNOL, V170, P4708, DOI 10.4049/jimmunol.170.9.4708; Wang XR, 2003, FASEB J, V17, P1727, DOI 10.1096/fj.02-0616fje; Weiss TM, 2002, BIOCHEMISTRY-US, V41, P10070, DOI 10.1021/bi025853d; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; WIMLEY WC, 1994, PROTEIN SCI, V3, P1362, DOI 10.1002/pro.5560030902; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wu ER, 1998, PEPTIDES, V19, P793, DOI 10.1016/S0196-9781(98)00016-3; Wu Z, 2003, J PEPT RES, V62, P53, DOI 10.1034/j.1399-3011.2003.00068.x; Wu ZB, 2003, P NATL ACAD SCI USA, V100, P8880, DOI 10.1073/pnas.1533186100; Yang D, 2000, J LEUKOCYTE BIOL, V68, P9; Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Yudin AI, 2003, BIOL REPROD, V69, P1118, DOI 10.1095/biolreprod.103.016105; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; ZEYA HI, 1966, SCIENCE, V154, P1049, DOI 10.1126/science.154.3752.1049; Zhou CX, 2004, NAT CELL BIOL, V6, P458, DOI 10.1038/ncb1127	103	912	988	5	103	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2005	6	6					551	557		10.1038/ni1206	http://dx.doi.org/10.1038/ni1206			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	929ZR	15908936				2022-12-18	WOS:000229385900008
J	Napolitani, G; Rinaldi, A; Bertoni, F; Sallusto, F; Lanzavecchia, A				Napolitani, G; Rinaldi, A; Bertoni, F; Sallusto, F; Lanzavecchia, A			Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells	NATURE IMMUNOLOGY			English	Article							NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; ADAPTIVE IMMUNITY; SIGNALING PATHWAY; INTERFERON-BETA; BACTERIAL-DNA; CPG-DNA; C-JUN; ACTIVATION; LIPOPOLYSACCHARIDE	Toll-like receptors (TLRs) sense microbial products and initiate adaptive immune responses by activating dendritic cells (DCs). As pathogens may contain several TLR agonists, we sought to determine whether different TLRs cooperate in DC activation. In human and mouse DCs, TLR3 and TLR4 potently acted in synergy with TLR7, TLR8 and TLR9 in the induction of a selected set of genes. Synergic TLR stimulation increased production of interleukins 12 and 23 and increased the Delta-4/Jagged-1 ratio, leading to DCs with enhanced and sustained T helper type 1-polarizing capacity. Global gene transcriptional analysis showed that TLR synergy 'boosted' only approximately 1% of the transcripts induced by single TLR agonists. These results identify a 'combinatorial code' by which DCs discriminate pathogens and suggest new strategies for promoting T helper type 1 responses.	Oncol Inst So Switzerland, Inst Res Biomed, CH-6500 Bellinzona, Switzerland; Oncol Inst So Switzerland, Expt Oncol Lab, CH-6500 Bellinzona, Switzerland	Institute of Oncology Research (IOR); Universita della Svizzera Italiana; Institute of Oncology Research (IOR)	Napolitani, G (corresponding author), Oncol Inst So Switzerland, Inst Res Biomed, CH-6500 Bellinzona, Switzerland.	giorgio.napolitani@irb.unisi.ch	Bertoni, Francesco/G-6922-2014	Bertoni, Francesco/0000-0001-5637-8983	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057266] Funding Source: NIH RePORTER; NIAID NIH HHS [U19 AI057266, U19AI057266/01, U19 AI057266-03] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bernasconi NL, 2003, BLOOD, V101, P4500, DOI 10.1182/blood-2002-11-3569; Bin LH, 2003, J BIOL CHEM, V278, P24526, DOI 10.1074/jbc.M303451200; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Edwards AD, 2002, J IMMUNOL, V169, P3652, DOI 10.4049/jimmunol.169.7.3652; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Gao JJ, 1999, J IMMUNOL, V163, P4095; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jarrossay D, 2001, EUR J IMMUNOL, V31, P3388, DOI 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Nakahara T, 2004, INT IMMUNOL, V16, P1701, DOI 10.1093/intimm/dxh171; Napolitani G, 2003, EUR J IMMUNOL, V33, P2832, DOI 10.1002/eji.200324073; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sato S, 2000, J IMMUNOL, V165, P7096, DOI 10.4049/jimmunol.165.12.7096; Sato S, 2002, INT IMMUNOL, V14, P783, DOI 10.1093/intimm/dxf046; Schulz O, 2000, IMMUNITY, V13, P453, DOI 10.1016/S1074-7613(00)00045-5; Snijders A, 1998, INT IMMUNOL, V10, P1593, DOI 10.1093/intimm/10.11.1593; Sousa CRE, 2004, CURR OPIN IMMUNOL, V16, P21, DOI 10.1016/j.coi.2003.11.007; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795; Yi AK, 2001, INT IMMUNOL, V13, P1391, DOI 10.1093/intimm/13.11.1391; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707	46	911	983	2	63	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2005	6	8					769	776		10.1038/ni1223	http://dx.doi.org/10.1038/ni1223			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	947LM	15995707	Green Accepted			2022-12-18	WOS:000230646200017
J	Kagan, JC; Su, T; Horng, T; Chow, A; Akira, S; Medzhitov, R				Kagan, Jonathan C.; Su, Tian; Horng, Tiffany; Chow, Amy; Akira, Shizuo; Medzhitov, Ruslan			TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta	NATURE IMMUNOLOGY			English	Article							DEPENDENT IMMUNE-RESPONSES; TOLL-LIKE RECEPTORS; NF-KAPPA-B; ADAPTER MOLECULE; SIGNALING PATHWAY; STRANDED-RNA; IFN-BETA; RECOGNITION; ACTIVATION; INNATE	Toll-like receptor 4 (TLR4) induces two distinct signaling pathways controlled by the TIRAP-MyD88 and TRAM-TRIF pairs of adaptor proteins, which elicit the production of proinflammatory cytokines and type I interferons, respectively. How TLR4 coordinates the activation of these two pathways is unknown. Here we show that TLR4 activated these two signaling pathways sequentially in a process organized around endocytosis of the TLR4 complex. We propose that TLR4 first induces TIRAP-MyD88 signaling at the plasma membrane and is then endocytosed and activates TRAM-TRIF signaling from early endosomes. Our data emphasize a unifying theme in innate immune recognition whereby all type I interferon-inducing receptors signal from an intracellular location.	[Kagan, Jonathan C.; Su, Tian; Horng, Tiffany; Chow, Amy; Medzhitov, Ruslan] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Kagan, Jonathan C.; Su, Tian; Horng, Tiffany; Chow, Amy; Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Akira, Shizuo] Osaka Univ, Japan Sci & Technol Agcy, ERATO, Microbial Dis Res Inst,Dept Host Def, Osaka, Japan; [Horng, Tiffany] Harvard Univ, Sch Med, Dept Pathol, Immune Dis Inst, Boston, MA 02115 USA; [Chow, Amy] Rochester Inst Technol, Dept Biol Sci, Rochester, NY 14623 USA	Yale University; Howard Hughes Medical Institute; Yale University; Japan Science & Technology Agency (JST); Osaka University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Rochester Institute of Technology	Kagan, JC (corresponding author), Childrens Hosp, GI Cell Biol, 300 Longwood Ave, Boston, MA 02115 USA.	jonathan.kagan@childrens.harvard.edu; ruslan.medzhitov@yale.edu	Akira, Shizuo/C-3134-2009		Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [K99 AI072955, R00 AI072955-02, R01 AI046688, P01 AI44220, 1K99AI072955-01, R37 AI046688, K99 AI072955-01, AI 061360, P01 AI044220, R00 AI072955, U01 AI061360] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI061360, R00AI072955, K99AI072955, P01AI044220, R37AI046688, R01AI046688] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Boll W, 2004, EUR J CELL BIOL, V83, P281, DOI 10.1078/0171-9335-00373; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hirotani T, 2005, BIOCHEM BIOPH RES CO, V328, P383, DOI 10.1016/j.bbrc.2004.12.184; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Hostager BS, 2000, J BIOL CHEM, V275, P15392, DOI 10.1074/jbc.M909520199; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kawai T, 2007, J BIOCHEM, V141, P137, DOI 10.1093/jb/mvm032; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Martin TFJ, 1998, ANNU REV CELL DEV BI, V14, P231, DOI 10.1146/annurev.cellbio.14.1.231; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; RACOOSIN EL, 1993, J CELL BIOL, V121, P1011, DOI 10.1083/jcb.121.5.1011; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; Rowe DC, 2006, P NATL ACAD SCI USA, V103, P6299, DOI 10.1073/pnas.0510041103; Sandilands E, 2007, J CELL SCI, V120, P2555, DOI 10.1242/jcs.003657; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; SEEGER M, 1992, EMBO J, V11, P2811, DOI 10.1002/j.1460-2075.1992.tb05348.x; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Ulrichts P, 2007, FEBS LETT, V581, P629, DOI 10.1016/j.febslet.2007.01.026; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Xu Y, 1996, IMMUNITY, V5, P407, DOI 10.1016/S1074-7613(00)80497-5; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986	50	908	945	2	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2008	9	4					361	368		10.1038/ni1569	http://dx.doi.org/10.1038/ni1569			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	276ED	18297073	Green Accepted			2022-12-18	WOS:000254123200011
J	Chen, Q; Sun, LJ; Chen, ZJJ				Chen, Qi; Sun, Lijun; Chen, Zhijian J.			Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing	NATURE IMMUNOLOGY			English	Review							CYCLIC GMP-AMP; INNATE IMMUNE RECOGNITION; I INTERFERON INDUCTION; SENSOR CGAS; ANTIVIRAL RESPONSE; IFN-BETA; ADAPTER; SYNTHASE; PROTEIN; ACTIVATION	The recognition of microbial nucleic acids is a major mechanism by which the immune system detects pathogens. Cyclic GMP-AMP (cGAMP) synthase (cGAS) is a cytosolic DNA sensor that activates innate immune responses through production of the second messenger cGAMP, which activates the adaptor STING. The cGAS-STING pathway not only mediates protective immune defense against infection by a large variety of DNA-containing pathogens but also detects tumor-derived DNA and generates intrinsic antitumor immunity. However, aberrant activation of the cGAS pathway by self DNA can also lead to autoimmune and inflammatory disease. Thus, the cGAS pathway must be properly regulated. Here we review the recent advances in understanding of the cGAS-STING pathway, focusing on the regulatory mechanisms and roles of this pathway in heath and disease.	[Chen, Qi] Fujian Normal Univ, Coll Life Sci, Biomed Res Ctr South China, Key Lab Innate Immune Biol Fujian Prov, Fuzhou, Peoples R China; [Sun, Lijun; Chen, Zhijian J.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Sun, Lijun; Chen, Zhijian J.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	Fujian Normal University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, ZJJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.; Chen, ZJJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.	zhijian.chen@utsouthwestern.edu	Sun, Lijun/ABD-4470-2021; Chen, Zhijian/C-6039-2012	Chen, Zhijian/0000-0002-8475-8251				Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640; Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Andrade WA, 2016, CELL HOST MICROBE, V20, P49, DOI 10.1016/j.chom.2016.06.003; Andrade WA, 2016, CELL REP, V15, P2438, DOI 10.1016/j.celrep.2016.05.030; Berg RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084513; Bridgeman A, 2015, SCIENCE, V349, P1228, DOI 10.1126/science.aab3632; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Cavlar T, 2013, EMBO J, V32, P1440, DOI 10.1038/emboj.2013.86; Chen Q, 2016, NATURE, V533, P493, DOI 10.1038/nature18268; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Christensen MH, 2016, EMBO J, V35, P1385, DOI 10.15252/embj.201593458; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Collins AC, 2015, CELL HOST MICROBE, V17, P820, DOI 10.1016/j.chom.2015.05.005; Conlon J, 2013, J IMMUNOL, V190, P5216, DOI 10.4049/jimmunol.1300097; Corrales L, 2016, CYTOKINE, V77, P245, DOI 10.1016/j.cyto.2015.08.258; Corrales L, 2015, CELL REP, V11, P1018, DOI 10.1016/j.celrep.2015.04.031; Crow YJ, 2015, CURR OPIN IMMUNOL, V32, P7, DOI 10.1016/j.coi.2014.10.005; Demaria O, 2015, P NATL ACAD SCI USA, V112, P15408, DOI 10.1073/pnas.1512832112; Deng LF, 2014, IMMUNITY, V41, P843, DOI 10.1016/j.immuni.2014.10.019; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Dobbs N, 2015, CELL HOST MICROBE, V18, P157, DOI 10.1016/j.chom.2015.07.001; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fuertes MB, 2013, TRENDS IMMUNOL, V34, P67, DOI 10.1016/j.it.2012.10.004; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gao DX, 2015, P NATL ACAD SCI USA, V112, pE5699, DOI 10.1073/pnas.1516465112; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Gehrke N, 2013, IMMUNITY, V39, P482, DOI 10.1016/j.immuni.2013.08.004; Gentili M, 2015, SCIENCE, V349, P1232, DOI 10.1126/science.aab3628; Gray EE, 2016, IMMUNITY, V45, P255, DOI 10.1016/j.immuni.2016.06.015; Gray EE, 2015, J IMMUNOL, V195, P1939, DOI 10.4049/jimmunol.1500969; Hansen K, 2014, EMBO J, V33, P1654, DOI 10.15252/embj.201488029; Herzner AM, 2015, NAT IMMUNOL, V16, P1025, DOI 10.1038/ni.3267; Holm CK, 2012, NAT IMMUNOL, V13, P737, DOI 10.1038/ni.2350; Huang L, 2013, J IMMUNOL, V191, P3509, DOI 10.4049/jimmunol.1301419; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Kim S, 2013, ACS CHEM BIOL, V8, P1396, DOI 10.1021/cb400264n; Konno H, 2013, CELL, V155, P688, DOI 10.1016/j.cell.2013.09.049; Kranzusch PJ, 2013, CELL REP, V3, P1362, DOI 10.1016/j.celrep.2013.05.008; Lahaye X, 2013, IMMUNITY, V39, P1132, DOI 10.1016/j.immuni.2013.11.002; Land W.J, 2011, INNATE ALLOIMMUNIT 1; Lau L, 2015, SCIENCE, V350, P568, DOI 10.1126/science.aab3291; Lemos H, 2016, CANCER RES, V76, P2076, DOI 10.1158/0008-5472.CAN-15-1456; Li LY, 2014, NAT CHEM BIOL, V10, P1043, DOI [10.1038/NChemBio.1661, 10.1038/nchembio.1661]; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Li X, 2013, IMMUNITY, V39, P1019, DOI 10.1016/j.immuni.2013.10.019; Liang QM, 2014, CELL HOST MICROBE, V15, P228, DOI 10.1016/j.chom.2014.01.009; Lindahl T, 2009, BIOCHEM SOC T, V37, P535, DOI 10.1042/BST0370535; Lio CWJ, 2016, J VIROL, V90, P7789, DOI 10.1128/JVI.01040-16; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Liu XJ, 2015, NAT MED, V21, P1209, DOI 10.1038/nm.3931; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Ma F, 2015, J IMMUNOL, V194, P1545, DOI 10.4049/jimmunol.1402066; Ma Z, 2015, P NATL ACAD SCI USA, V112, pE4306, DOI 10.1073/pnas.1503831112; Mackenzie KJ, 2016, EMBO J, V35, P831, DOI 10.15252/embj.201593339; Mukai K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11932; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Paijo J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005546; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Pandey S, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016246; Pokatayev V, 2016, J EXP MED, V213, P329, DOI 10.1084/jem.20151464; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; Rasaiyaah J, 2013, NATURE, V503, P402, DOI 10.1038/nature12769; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Seo GJ, 2015, CELL REP, V13, P440, DOI 10.1016/j.celrep.2015.09.007; Shang GJ, 2012, NAT STRUCT MOL BIOL, V19, P725, DOI 10.1038/nsmb.2332; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shi HP, 2015, P NATL ACAD SCI USA, V112, P8947, DOI 10.1073/pnas.1507317112; Shu C, 2012, NAT STRUCT MOL BIOL, V19, P722, DOI 10.1038/nsmb.2331; Storek KM, 2015, J IMMUNOL, V194, P3236, DOI 10.4049/jimmunol.1402764; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Thomsen MK, 2016, HEPATOLOGY, V64, P746, DOI 10.1002/hep.28685; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; Tsuchiya Y, 2016, EBIOMEDICINE, V9, P87, DOI 10.1016/j.ebiom.2016.05.039; Wang Q, 2014, IMMUNITY, V41, P919, DOI 10.1016/j.immuni.2014.11.011; Wang YM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005012; Wassermann R, 2015, CELL HOST MICROBE, V17, P799, DOI 10.1016/j.chom.2015.05.003; Watson RO, 2015, CELL HOST MICROBE, V17, P811, DOI 10.1016/j.chom.2015.05.004; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Wu JJ, 2015, CELL HOST MICROBE, V18, P333, DOI 10.1016/j.chom.2015.07.015; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Xia P, 2016, NAT IMMUNOL, V17, P369, DOI 10.1038/ni.3356; Xia TL, 2016, CELL REP, V14, P282, DOI 10.1016/j.celrep.2015.12.029; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Yin Q, 2012, MOL CELL, V46, P735, DOI 10.1016/j.molcel.2012.05.029; Yoh SM, 2015, CELL, V161, P1293, DOI 10.1016/j.cell.2015.04.050; Yoneyama M, 2015, CURR OPIN IMMUNOL, V32, P48, DOI 10.1016/j.coi.2014.12.012; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146; Zeng M, 2014, SCIENCE, V346, P1486, DOI 10.1126/science.346.6216.1486; Zhang GG, 2016, P NATL ACAD SCI USA, V113, pE1034, DOI 10.1073/pnas.1516812113; Zhang J, 2012, J BIOL CHEM, V287, P28646, DOI 10.1074/jbc.M112.362608; Zhang X, 2014, CELL REP, V6, P421, DOI 10.1016/j.celrep.2014.01.003; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhang YG, 2014, J IMMUNOL, V193, P2394, DOI 10.4049/jimmunol.1302718; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008	106	903	936	53	526	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2016	17	10					1142	1149		10.1038/ni.3558	http://dx.doi.org/10.1038/ni.3558			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DX3VD	27648547				2022-12-18	WOS:000384302900005
J	LeibundGut-Landmann, S; Gross, O; Robinson, MJ; Osorio, F; Slack, EC; Tsoni, SV; Schweighoffer, E; Tybulewicz, V; Brown, GD; Ruland, J; Sousa, CRE				LeibundGut-Landmann, Salome; Gross, Olaf; Robinson, Matthew J.; Osorio, Fabiola; Slack, Emma C.; Tsoni, S. Vicky; Schweighoffer, Edina; Tybulewicz, Victor; Brown, Gordon D.; Ruland, Juergen; Sousa, Caetano Reis e			Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17	NATURE IMMUNOLOGY			English	Article							COLONY-STIMULATING FACTOR; C-TYPE LECTINS; CANDIDA-ALBICANS; DENDRITIC CELLS; AUTOIMMUNE ARTHRITIS; FUNGAL-INFECTION; CYTOKINE MILIEU; HOST-DEFENSE; TGF-BETA; DECTIN-1	The C-type lectin dectin-1 binds to yeast and signals through the kinase Syk and the adaptor CARD9 to induce production of interleukin 10 (IL-10) and IL-2 in dendritic cells (DCs). However, whether this pathway promotes full DC activation remains unclear. Here we show that dectin-1-Syk-CARD9 signaling induced DC maturation and the secretion of proinflammatory cytokines, including IL-6, tumor necrosis factor and IL-23, but little IL-12. Dectin-1-activated DCs 'instructed' the differentiation of CD4+ IL-17-producing effector T cells (TH-17 cells) in vitro, and a dectin-1 agonist acted as an adjuvant promoting the differentiation of TH-17 and T helper type 1 cells in vivo. Infection with Candida albicans induced CARD9-dependent TH-17 responses to the organism. Our data indicate that signaling through Syk and CARD9 can couple innate to adaptive immunity independently of Toll-like receptor signals and that CARD9 is required for the development of TH-17 responses to some pathogens.	London Res Inst, Canc Res UK, Lincolns Inn Fields Labs, Immunobiol Lab, London WC2A 3PX, England; Tech Univ Munich, Klinikum Rechts Isar, Med Klin 3, D-81675 Munich, Germany; Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; Natl Inst Med Res, London NW7 1AA, England	Cancer Research UK; Technical University of Munich; University of Cape Town; MRC National Institute for Medical Research	Sousa, CRE (corresponding author), London Res Inst, Canc Res UK, Lincolns Inn Fields Labs, Immunobiol Lab, London WC2A 3PX, England.	caetano@cancer.org.uk	Slack, Emma/AAD-5837-2019; Reis e Sousa, Caetano/ABD-7322-2021; Reis e Sousa, Caetano/O-1657-2014; Osorio, Fabiola/H-4529-2014; Ruland, Jürgen/Q-6680-2018; Slack, Emma/B-1612-2016; Gross, Olaf/E-4570-2010; brown, gordon/B-4249-2012	Slack, Emma/0000-0002-2473-1145; Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119; Osorio, Fabiola/0000-0001-5306-7856; Ruland, Jürgen/0000-0002-8381-3597; Slack, Emma/0000-0002-2473-1145; Gross, Olaf/0000-0001-8660-3619; LeibundGut-Landmann, Salome/0000-0002-5724-4837; brown, gordon/0000-0002-0287-5383; Tybulewicz, Victor/0000-0003-2439-0798	MRC [MC_U117527252] Funding Source: UKRI; Medical Research Council [MC_U117527252] Funding Source: Medline; Swiss National Science Foundation [106884] Funding Source: Medline; Wellcome Trust [086558] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Wellcome Trust(Wellcome Trust)		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Boes M, 2003, J IMMUNOL, V171, P4081, DOI 10.4049/jimmunol.171.8.4081; Cenci E, 1997, INFECT IMMUN, V65, P564, DOI 10.1128/IAI.65.2.564-570.1997; Cenci E, 2000, J IMMUNOL, V165, P381, DOI 10.4049/jimmunol.165.1.381; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hida S, 2006, MICROBIOL IMMUNOL, V50, P453, DOI 10.1111/j.1348-0421.2006.tb03814.x; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Hohl TM, 2006, CURR OPIN IMMUNOL, V18, P465, DOI 10.1016/j.coi.2006.05.003; Holscher C, 2001, J IMMUNOL, V167, P6957, DOI 10.4049/jimmunol.167.12.6957; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Huffnagle GB, 2003, CURR OPIN MICROBIOL, V6, P344, DOI 10.1016/S1369-5274(03)00089-4; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Mackey MF, 2003, EUR J IMMUNOL, V33, P779, DOI 10.1002/eji.200323729; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; Morelli AE, 2001, BLOOD, V98, P1512, DOI 10.1182/blood.V98.5.1512; Overbergh L, 2003, J Biomol Tech, V14, P33; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Perruccio K, 2005, BLOOD, V106, P4397, DOI 10.1182/blood-2005-05-1775; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Rivera A, 2006, IMMUNITY, V25, P665, DOI 10.1016/j.immuni.2006.08.016; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; SHER A, 1992, ANNU REV IMMUNOL, V10, P385, DOI 10.1146/annurev.iy.10.040192.002125; SPACCAPELO R, 1995, J IMMUNOL, V155, P1349; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758	51	887	936	3	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2007	8	6					630	638		10.1038/ni1460	http://dx.doi.org/10.1038/ni1460			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	170YY	17450144	Bronze			2022-12-18	WOS:000246703300017
J	Koch, MA; Tucker-Heard, G; Perdue, NR; Killebrew, JR; Urdahl, KB; Campbell, DJ				Koch, Meghan A.; Tucker-Heard, Glady's; Perdue, Nikole R.; Killebrew, Justin R.; Urdahl, Kevin B.; Campbell, Daniel J.			The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation	NATURE IMMUNOLOGY			English	Article							TARGET GENES; CHEMOKINE; ENTEROPATHY; COMMITMENT; ACTIVATION; EXPRESSION; RETENTION; COLITIS; BINDING; CXCR3	Several subsets of Foxp3(+) regulatory T cells (T-reg cells) work in concert to maintain immune homeostasis. However, the molecular bases underlying the phenotypic and functional diversity of T-reg cells remain obscure. We show that in response to interferon-gamma, Foxp3(+) T-reg cells upregulated the T helper type 1 (T(H)1)-specifying transcription factor T-bet. T-bet promoted expression of the chemokine receptor CXCR3 on T-reg cells, and T-bet(+) T-reg cells accumulated at sites of T(H)1 cell-mediated inflammation. Furthermore, T-bet expression was required for the homeostasis and function of T-reg cells during type 1 inflammation. Thus, in a subset of CD4(+) T cells, the activities of the transcription factors Foxp3 and T-bet are overlaid, which results in T-reg cells with unique homeostatic and migratory properties optimized for the suppression of T(H)1 responses in vivo.	[Koch, Meghan A.; Perdue, Nikole R.; Killebrew, Justin R.; Campbell, Daniel J.] Benaroya Res Inst, Seattle, WA USA; [Koch, Meghan A.; Killebrew, Justin R.; Campbell, Daniel J.] Univ Washington, Sch Med, Dept Immunol, Seattle, WA USA; [Tucker-Heard, Glady's; Urdahl, Kevin B.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA	Benaroya Research Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Campbell, DJ (corresponding author), Benaroya Res Inst, Seattle, WA USA.	campbell@benaroyaresearch.org		Urdahl, Kevin/0000-0003-0088-1066	US National Institutes of Health [DK072295, AI067750, AI069889]; US Department of Defense [W81XWH-07-0246]; Burroughs-Wellcome Fund; Department of Immunology at the University of Washington Medical School [T32-CA009537]; NATIONAL CANCER INSTITUTE [T32CA009537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI067750, R01AI067750, R21AI069889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072295] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); Burroughs-Wellcome Fund(Burroughs Wellcome Fund); Department of Immunology at the University of Washington Medical School; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Weinmann (University of Washington) for Tbx21<SUP>-/-</SUP> mice; A. Rudensky (University of Washington) for Foxp3<SUP>GFP</SUP> mice; S. Ziegler (Benaroya Research Institute) for mice with overexpression of thymic stromal lymphopoietin and for Il4<SUP>-/-</SUP> and Stat6<SUP>-/-</SUP> mice; M. Krishna-Kaja (University of Washington) for splenocytes from Stat1<SUP>-/-</SUP> mice; L. Thompson and K. Smigiel for technical assistance; G. Debes, K. Klonowski and J. Hamerman for comments on the manuscript; and M. Warren for administrative assistance. Supported by the US National Institutes of Health (DK072295, AI067750 and AI069889 to D. J. C.), the US Department of Defense (USAMRAA W81XWH-07-0246 to D. J. C.), the Burroughs-Wellcome Fund (K. B. U.) and the Department of Immunology at the University of Washington Medical School (T32-CA009537 to M. A. K.).	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; Beima KM, 2006, J BIOL CHEM, V281, P11992, DOI 10.1074/jbc.M513613200; Belkaid Y, 2007, NAT REV IMMUNOL, V7, P875, DOI 10.1038/nri2189; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Dudda JC, 2008, J EXP MED, V205, P1559, DOI 10.1084/jem.20072594; FARBER JM, 1990, P NATL ACAD SCI USA, V87, P5238, DOI 10.1073/pnas.87.14.5238; Ferlin WG, 1998, EUR J IMMUNOL, V28, P525, DOI 10.1002/(SICI)1521-4141(199802)28:02&lt;525::AID-IMMU525&gt;3.0.CO;2-M; Finotto S, 2005, INT IMMUNOL, V17, P993, DOI 10.1093/intimm/dxh281; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; GODFREY VL, 1991, AM J PATHOL, V138, P1379; Hancock WW, 2000, J EXP MED, V192, P1515, DOI 10.1084/jem.192.10.1515; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Kursar M, 2007, J IMMUNOL, V178, P2661, DOI 10.4049/jimmunol.178.5.2661; Lee I, 2005, J EXP MED, V201, P1037, DOI 10.1084/jem.20041709; Lord GM, 2005, BLOOD, V106, P3432, DOI 10.1182/blood-2005-04-1393; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Muller M, 2007, J IMMUNOL, V179, P2774, DOI 10.4049/jimmunol.179.5.2774; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Reiner SL, 2007, CELL, V129, P33, DOI 10.1016/j.cell.2007.03.019; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Santodomingo-Garzon T, 2009, HEPATOLOGY, V49, P1267, DOI 10.1002/hep.22761; Sarween N, 2004, J IMMUNOL, V173, P2942, DOI 10.4049/jimmunol.173.5.2942; Sather BD, 2007, J EXP MED, V204, P1335, DOI 10.1084/jem.20070081; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; Siegmund K, 2005, BLOOD, V106, P3097, DOI 10.1182/blood-2005-05-1864; Suffia I, 2005, J IMMUNOL, V174, P5444, DOI 10.4049/jimmunol.174.9.5444; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Yoneyama H, 2002, J EXP MED, V195, P1257, DOI 10.1084/jem.20011983; Yuan Q, 2007, J EXP MED, V204, P1327, DOI 10.1084/jem.20062076; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	50	886	916	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2009	10	6					595	U57		10.1038/ni.1731	http://dx.doi.org/10.1038/ni.1731			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	450EP	19412181	Green Accepted			2022-12-18	WOS:000266384100011
J	Luster, AD; Alon, R; von Andrian, UH				Luster, AD; Alon, R; von Andrian, UH			Immune cell migration in inflammation: present and future therapeutic targets	NATURE IMMUNOLOGY			English	Review							CD8(+) T-CELLS; IN-VIVO; DENDRITIC CELLS; L-SELECTIN; INTEGRIN ACTIVATION; EXTRACELLULAR-MATRIX; PERIPHERAL-TISSUES; ENDOTHELIAL-CELLS; LYMPHOID-TISSUES; INFLAMED TISSUES	The burgeoning field of leukocyte trafficking has created new and exciting opportunities in the clinic. Trafficking signals are being defined that finely control the movement of distinct subsets of immune cells into and out of specific tissues. Because the accumulation of leukocytes in tissues contributes to a wide variety of diseases, these 'molecular codes' have provided new targets for inhibiting tissue-specific inflammation, which have been confirmed in the clinic. However, immune cell migration is also critically important for the delivery of protective immune responses to tissues. Thus, the challenge for the future will be to identify the trafficking molecules that will most specifically inhibit the key subsets of cells that drive disease processes without affecting the migration and function of leukocytes required for protective immunity.	Harvard Univ, Sch Med, Massachusetts Gen Hosp,Ctr Immunol & Inflammatory, Dept Med,Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA; Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Weizmann Institute of Science; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Luster, AD (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp,Ctr Immunol & Inflammatory, Dept Med,Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA.	luster.andrew@mgh.harvard.edu; ronen.alon@weizmann.ac.il; uva@cbr.med.harvard.edu	von Andrian, Ulrich H/A-5775-2008; ALON, RONEN/GRX-6987-2022; Luster, Andrew/ABE-6504-2020	Luster, Andrew/0000-0001-9679-7912; Alon, Ronen/0000-0001-9161-6369				Ancuta P, 2003, J EXP MED, V197, P1701, DOI 10.1084/jem.20022156; Atarashi K, 2005, J IMMUNOL, V174, P1424, DOI 10.4049/jimmunol.174.3.1424; Austrup F, 1997, NATURE, V385, P81, DOI 10.1038/385081a0; Baltus T, 2003, BLOOD, V102, P1985, DOI 10.1182/blood-2003-04-1175; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Barreiro O, 2002, J CELL BIOL, V157, P1233, DOI 10.1083/jcb.200112126; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Calzascia T, 2005, IMMUNITY, V22, P175, DOI 10.1016/j.immuni.2004.12.008; Campbell JJ, 2001, J IMMUNOL, V166, P877, DOI 10.4049/jimmunol.166.2.877; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Carman CV, 2004, J CELL BIOL, V167, P377, DOI 10.1083/jcb.200404129; Cavanagh LL, 2002, IMMUNOL CELL BIOL, V80, P448, DOI 10.1046/j.1440-1711.2002.01119.x; Cook DN, 2000, IMMUNITY, V12, P495, DOI 10.1016/S1074-7613(00)80201-0; Cupedo T, 2003, SEMIN IMMUNOL, V15, P243, DOI 10.1016/j.smim.2003.08.002; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Dangerfield J, 2002, J EXP MED, V196, P1201, DOI 10.1084/jem.20020324; Dangerfield JP, 2005, J LEUKOCYTE BIOL, V77, P159, DOI 10.1189/jlb.0704421; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Dustin ML, 2004, NAT IMMUNOL, V5, P363, DOI 10.1038/ni1057; Feagan BG, 2005, NEW ENGL J MED, V352, P2499, DOI 10.1056/NEJMoa042982; Feng D, 1998, J EXP MED, V187, P903, DOI 10.1084/jem.187.6.903; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ghosh S, 2003, NEW ENGL J MED, V348, P24, DOI 10.1056/NEJMoa020732; Gong JH, 1997, J EXP MED, V186, P131, DOI 10.1084/jem.186.1.131; Goodarzi K, 2003, NAT IMMUNOL, V4, P965, DOI 10.1038/ni972; Hafezi-Moghadam A, 2001, J EXP MED, V193, P863, DOI 10.1084/jem.193.7.863; HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559, DOI 10.1002/jlb.56.5.559; Hjelmstrom P, 2001, J LEUKOCYTE BIOL, V69, P331; Humbles AA, 2002, P NATL ACAD SCI USA, V99, P1479, DOI 10.1073/pnas.261462598; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; Izikson L, 2002, CLIN IMMUNOL, V103, P125, DOI 10.1006/clim.2001.5167; Johnson-Leger C, 2000, J CELL SCI, V113, P921; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kaneider NC, 2005, NAT MED, V11, P661, DOI 10.1038/nm1245; Kim M, 2004, J CELL BIOL, V167, P1241, DOI 10.1083/jcb.200404160; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Kinashi T, 2004, BLOOD, V103, P1033, DOI 10.1182/blood-2003-07-2499; Kunkel EJ, 2000, J IMMUNOL, V164, P3301, DOI 10.4049/jimmunol.164.6.3301; Kunkel EJ, 2003, NAT REV IMMUNOL, V3, P822, DOI 10.1038/nri1203; Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761; Kwon JH, 2002, GUT, V51, P818, DOI 10.1136/gut.51.6.818; Laudanna C, 2002, IMMUNOL REV, V186, P37, DOI 10.1034/j.1600-065X.2002.18604.x; Ley K, 2002, IMMUNOL REV, V186, P8, DOI 10.1034/j.1600-065X.2002.18602.x; Ley K, 2003, MICROCIRCULATION, V10, P289, DOI 10.1038/sj.mn.7800194; Liu SC, 2000, J CELL SCI, V113, P3563; Luster AD, 2004, NAT REV IMMUNOL, V4, P711, DOI 10.1038/nri1438; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Ma W, 2002, J CLIN INVEST, V109, P621, DOI 10.1172/JCI200214097; Mathew A, 2002, J IMMUNOL, V169, P651, DOI 10.4049/jimmunol.169.2.651; Mathew A, 2001, J EXP MED, V193, P1087, DOI 10.1084/jem.193.9.1087; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; Mora JR, 2005, J EXP MED, V201, P303, DOI 10.1084/jem.20041645; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; Nandi A, 2004, IMMUNITY, V20, P455, DOI 10.1016/S1074-7613(04)00077-9; Ray SJ, 2004, IMMUNITY, V20, P167, DOI 10.1016/S1074-7613(04)00021-4; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Reiss Y, 2001, J EXP MED, V194, P1541, DOI 10.1084/jem.194.10.1541; ROMANIC AM, 1994, J CELL BIOL, V125, P1165, DOI 10.1083/jcb.125.5.1165; Rose Mark J., 2004, Current Drug Targets - Inflammation and Allergy, V3, P221, DOI 10.2174/1568010043343589; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; SEKIDO N, 1993, NATURE, V365, P654, DOI 10.1038/365654a0; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Shimaoka M, 2004, CURR TOP MED CHEM, V4, P1485, DOI 10.2174/1568026043387575; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; Sixt M, 2001, J CELL BIOL, V153, P933, DOI 10.1083/jcb.153.5.933; Smith ML, 2004, J EXP MED, V200, P935, DOI 10.1084/jem.20040424; Sperandio M, 2003, J EXP MED, V197, P1355, DOI 10.1084/jem.20021854; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Stolen CM, 2005, IMMUNITY, V22, P105, DOI 10.1016/j.immuni.2004.12.006; Tager AM, 2003, NAT IMMUNOL, V4, P982, DOI 10.1038/ni970; Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5; Ulbrich H, 2003, TRENDS PHARMACOL SCI, V24, P640, DOI 10.1016/j.tips.2003.10.004; Vaday GG, 2001, J LEUKOCYTE BIOL, V69, P885; Vajkoczy P, 2001, J CLIN INVEST, V108, P557; Vestweber D, 2002, CURR OPIN CELL BIOL, V14, P587, DOI 10.1016/S0955-0674(02)00372-1; Vicente-Manzanares M, 2004, NAT REV IMMUNOL, V4, P110, DOI 10.1038/nri1268; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; von Hundelshausen P, 2001, CIRCULATION, V103, P1772, DOI 10.1161/01.CIR.103.13.1772; Vorup-Jensen T, 2005, P NATL ACAD SCI USA, V102, P1614, DOI 10.1073/pnas.0409057102; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Weber C, 1997, J CLIN INVEST, V100, P2085, DOI 10.1172/JCI119742; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wolf K, 2003, BLOOD, V102, P3262, DOI 10.1182/blood-2002-12-3791; Wymann MP, 2005, CURR OPIN CELL BIOL, V17, P141, DOI 10.1016/j.ceb.2005.02.011; Xie HJ, 1999, J EXP MED, V189, P1765, DOI 10.1084/jem.189.11.1765; Yonekawa K, 2005, J LEUKOCYTE BIOL, V77, P129, DOI 10.1189/jlb.0804460	97	885	910	0	86	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2005	6	12					1182	1190		10.1038/ni1275	http://dx.doi.org/10.1038/ni1275			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	985IX	16369557	Bronze			2022-12-18	WOS:000233371900003
J	Baltimore, D; Boldin, MP; O'Connell, RM; Rao, DS; Taganov, KD				Baltimore, David; Boldin, Mark P.; O'Connell, Ryan M.; Rao, Dinesh S.; Taganov, Konstantin D.			MicroRNAs: new regulators of immune cell development and function	NATURE IMMUNOLOGY			English	Review							NF-KAPPA-B; INDUCED CYTIDINE DEAMINASE; GENE-EXPRESSION; POSTTRANSCRIPTIONAL REGULATION; T-CELLS; C-MYB; DIFFERENTIATION; RNA; DICER; TRANSCRIPTION	Decades of research went into understanding immune cell development and function without awareness that consideration of a key element, microRNA (miRNA), was lacking. The discovery of miRNAs as regulators of developmental events in model organisms suggested to many investigators that miRNA might be involved in the immune system. In the past few years, widespread examination of this possibility has produced notable results. Results have shown that miRNAs affect mammalian immune cell differentiation, the outcome of immune responses to infection and the development of diseases of immunological origin. Some miRNAs repress expression of target proteins with well established functions in hematopoiesis. Here we bring together much of this work, which has so far only scratched the surface of this very fertile field of investigation, and show how the results illuminate many historic questions about hematopoiesis and immune function.	[Baltimore, David; Boldin, Mark P.; O'Connell, Ryan M.; Rao, Dinesh S.; Taganov, Konstantin D.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Rao, Dinesh S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	California Institute of Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Baltimore, D (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	baltimo@caltech.edu	Rao, Dinesh/ABG-1257-2021; Rao, Dinesh/AAE-9625-2019	Rao, Dinesh/0000-0002-0794-9337; Boldin, Mark/0000-0003-4593-0669	NATIONAL CANCER INSTITUTE [K08CA133521] Funding Source: NIH RePORTER; NCI NIH HHS [K08 CA133521] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cameron JE, 2008, J VIROL, V82, P1946, DOI 10.1128/JVI.02136-07; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Choong ML, 2007, EXP HEMATOL, V35, P551, DOI 10.1016/j.exphem.2006.12.002; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Emambokus N, 2003, EMBO J, V22, P4478, DOI 10.1093/emboj/cdg434; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fazi F, 2007, CANCER CELL, V12, P457, DOI 10.1016/j.ccr.2007.09.020; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Fulci V, 2007, BLOOD, V109, P4944, DOI 10.1182/blood-2006-12-062398; Garzon R, 2007, ONCOGENE, V26, P4148, DOI 10.1038/sj.onc.1210186; Garzon R, 2006, P NATL ACAD SCI USA, V103, P5078, DOI 10.1073/pnas.0600587103; Garzon R, 2008, P NATL ACAD SCI USA, V105, P3945, DOI 10.1073/pnas.0800135105; Georgantas RW, 2007, P NATL ACAD SCI USA, V104, P2750, DOI 10.1073/pnas.0610983104; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Haasch D, 2002, CELL IMMUNOL, V217, P78, DOI 10.1016/S0008-8749(02)00506-3; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Jiang JM, 2006, GENE CHROMOSOME CANC, V45, P103, DOI 10.1002/gcc.20264; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kluiver J, 2007, ONCOGENE, V26, P3769, DOI 10.1038/sj.onc.1210147; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lim CA, 2007, MOL CELL, V27, P622, DOI 10.1016/j.molcel.2007.06.038; Lin SL, 2008, RNA, V14, P417, DOI 10.1261/rna.874808; Lu J, 2008, DEV CELL, V14, P843, DOI 10.1016/j.devcel.2008.03.012; Masaki S, 2007, BIOCHEM BIOPH RES CO, V364, P509, DOI 10.1016/j.bbrc.2007.10.077; Mendell JT, 2005, CELL CYCLE, V4, P1179, DOI 10.4161/cc.4.9.2032; Montecino-Rodriguez E, 2006, TRENDS IMMUNOL, V27, P428, DOI 10.1016/j.it.2006.07.005; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; Motsch N, 2007, RNA BIOL, V4, P131, DOI 10.4161/rna.4.3.5206; Mrazek J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm244; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Pheasant M, 2007, GENOME RES, V17, P1245, DOI 10.1101/gr.6406307; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rosa A, 2007, P NATL ACAD SCI USA, V104, P19849, DOI 10.1073/pnas.0706963104; Skalsky RL, 2007, J VIROL, V81, P12836, DOI 10.1128/JVI.01804-07; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tam W, 2006, GENE CHROMOSOME CANC, V45, P211, DOI 10.1002/gcc.20282; Tam W, 1997, MOL CELL BIOL, V17, P1490, DOI 10.1128/MCB.17.3.1490; Teng G, 2008, IMMUNITY, V28, P621, DOI 10.1016/j.immuni.2008.03.015; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; van den Berg A, 2003, GENE CHROMOSOME CANC, V37, P20, DOI 10.1002/gcc.10186; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yin QY, 2008, J VIROL, V82, P5295, DOI 10.1128/JVI.02380-07; Zhan M, 2007, EXP HEMATOL, V35, P1015, DOI 10.1016/j.exphem.2007.03.014; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	79	881	930	1	110	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2008	9	8					839	845		10.1038/ni.f.209	http://dx.doi.org/10.1038/ni.f.209			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	328EN	18645592				2022-12-18	WOS:000257780700006
J	Franchi, L; Amer, A; Body-Malapel, M; Kanneganti, TD; Ozoren, N; Jagirdar, R; Inohara, N; Vandenabeele, P; Bertin, J; Coyle, A; Grant, EP; Nunez, G				Franchi, Luigi; Amer, Amal; Body-Malapel, Mathilde; Kanneganti, Thirumala-Devi; Ozoren, Nesrin; Jagirdar, Rajesh; Inohara, Naohiro; Vandenabeele, Peter; Bertin, John; Coyle, Anthony; Grant, Ethan P.; Nunez, Gabriel			Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1 beta in salmonella-infected macrophages	NATURE IMMUNOLOGY			English	Article							INFLAMMATORY CASPASES; GENE-EXPRESSION; BACTERIA; RECEPTOR; PROTEIN; RECOGNITION; MECHANISM; ASC; LIPOPOLYSACCHARIDE; PATHOGENESIS	Gram-negative bacteria that replicate in the cytosol of mammalian macrophages can activate a signaling pathway leading to caspase-1 cleavage and secretion of interleukin 1 beta, a powerful host response factor. Ipaf, a cytosolic pattern-recognition receptor in the family of nucleotide-binding oligomerization domain-leucine-rich repeat proteins, is critical in such a response to salmonella infection, but the mechanism of how Ipaf is activated by the bacterium remains poorly understood. Here we demonstrate that salmonella strains either lacking flagellin or expressing mutant flagellin were deficient in activation of caspase-1 and in interleukin 1b secretion, although transcription factor NF-kappa B-dependent production of interleukin 6 or the chemokine MCP-1 was unimpaired. Delivery of flagellin to the macrophage cytosol induced Ipaf-dependent activation of caspase-1 that was independent of Toll-like receptor 5, required for recognition of extracellular flagellin. In macrophages made tolerant by previous exposure to lipopolysaccharide, which abrogates activation of NF-kappa B and mitogen-activated protein kinases, salmonella infection still activated caspase-1. Thus, detection of flagellin through Ipaf induces caspase-1 activation independently of Toll-like receptor 5 in salmonella-infected and lipopolysaccharide-tolerized macrophages.	Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; Univ Ghent, Dept Mol Biomed Res, Mol Signaling & Cell Death Unit, B-9052 Ghent, Belgium; Millennium Pharmaceut Inc, Cambridge, MA 02139 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Ghent University; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Nunez, G (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	bclx@umich.edu	Ozoren, Nesrin/AAS-3279-2020; Kanneganti, Thirumala-Devi/M-9435-2018; Jagirdar, Rajesh/AAO-2327-2021; Vandenabeele, Peter/AAD-5793-2022; Body-Malapel, Mathilde/K-9981-2018; Amer, Amal/E-2643-2011; Nuñez, Gabriel/A-7160-2014; Kanneganti, Thirumala-Devi/Y-2503-2019; Grant, Ethan/GQP-2720-2022; Vandenabeele, Peter/C-8597-2009	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Jagirdar, Rajesh/0000-0001-7005-7772; Vandenabeele, Peter/0000-0002-6669-8822; Body-Malapel, Mathilde/0000-0003-3392-4229; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; OZOREN, NESRIN/0000-0002-8580-618X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063331, R01AI064748] Funding Source: NIH RePORTER; NHLBI NIH HHS [5/T32/HL007517] Funding Source: Medline; NIAID NIH HHS [R01 AI064748, R01 AI063331] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Burns K, 2003, CURR OPIN IMMUNOL, V15, P26, DOI 10.1016/S0952-7915(02)00017-1; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; Chilcott GS, 2000, MICROBIOL MOL BIOL R, V64, P694, DOI 10.1128/MMBR.64.4.694-708.2000; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; CROSS A, 1995, J CLIN INVEST, V96, P676, DOI 10.1172/JCI118110; DANNER RL, 1991, CHEST, V99, P169, DOI 10.1378/chest.99.1.169; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Dobrovolskaia MA, 2002, MICROBES INFECT, V4, P903, DOI 10.1016/S1286-4579(02)01613-1; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; HAGBERG L, 1984, INFECT IMMUN, V46, P839, DOI 10.1128/IAI.46.3.839-844.1984; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hersh D, 1999, P NATL ACAD SCI USA, V96, P2396, DOI 10.1073/pnas.96.5.2396; Higgins DE, 1999, MOL MICROBIOL, V31, P1631, DOI 10.1046/j.1365-2958.1999.01272.x; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Komoriya K, 1999, MOL MICROBIOL, V34, P767, DOI 10.1046/j.1365-2958.1999.01639.x; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; MARIATHASAN S, 2006, NATURE; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Masumoto J, 2003, BIOCHEM BIOPH RES CO, V303, P69, DOI 10.1016/S0006-291X(03)00309-7; McCaffrey RL, 2004, P NATL ACAD SCI USA, V101, P11386, DOI 10.1073/pnas.0403215101; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; Ozoren N, 2006, J IMMUNOL, V176, P4337, DOI 10.4049/jimmunol.176.7.4337; Perrin AJ, 2004, CURR BIOL, V14, P806, DOI 10.1016/j.cub.2004.04.033; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; RANDOW F, 1995, J EXP MED, V181, P1887, DOI 10.1084/jem.181.5.1887; Sato S, 2002, INT IMMUNOL, V14, P783, DOI 10.1093/intimm/dxf046; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Simberg D, 2004, CRIT REV THER DRUG, V21, P257, DOI 10.1615/CritRevTherDrugCarrierSyst.v21.i4.10; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Ting JPY, 2005, ANNU REV IMMUNOL, V23, P387, DOI 10.1146/annurev.immunol.23.021704.115616; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; West MA, 2002, CRIT CARE MED, V30, pS64, DOI 10.1097/00003246-200201001-00009	45	880	905	0	42	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2006	7	6					576	582		10.1038/ni1346	http://dx.doi.org/10.1038/ni1346			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	045OK	16648852				2022-12-18	WOS:000237751200012
J	Veglia, F; Perego, M; Gabrilovich, D				Veglia, Filippo; Perego, Michela; Gabrilovich, Dmitry			Myeloid-derived suppressor cells coming of age	NATURE IMMUNOLOGY			English	Review							HEPATOCELLULAR-CARCINOMA PATIENTS; REGULATORY T-CELLS; CLINICAL-SIGNIFICANCE; PROGNOSTIC-SIGNIFICANCE; TUMOR MICROENVIRONMENT; DISEASE PROGRESSION; DENDRITIC CELLS; STRESS-RESPONSE; SYNOVIAL-FLUID; POOR-PROGNOSIS	Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of cells generated during a large array of pathologic conditions ranging from cancer to obesity. These cells represent a pathologic state of activation of monocytes and relatively immature neutrophils. MDSCs are characterized by a distinct set of genomic and biochemical features, and can, on the basis of recent findings, be distinguished by specific surface molecules. The salient feature of these cells is their ability to inhibit T cell function and thus contribute to the pathogenesis of various diseases. In this Review, we discuss the origin and nature of these cells; their distinctive features; and their biological roles in cancer, infectious diseases, autoimmunity, obesity and pregnancy.	[Veglia, Filippo; Perego, Michela; Gabrilovich, Dmitry] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA	The Wistar Institute	Gabrilovich, D (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	dgabrilovich@wistar.org	perego, michela/W-4650-2019; Gabrilovich, Dmitry/ABE-7122-2020	perego, michela/0000-0002-5671-928X; Veglia, Filippo/0000-0001-6710-1584	US National Institutes of Health [CA084488, CA100062]; NATIONAL CANCER INSTITUTE [R01CA100062, R01CA084488] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the US National Institutes of Health (grants CA084488 and CA100062 to D.G.). We thank R. Kim for help with the preparation of the manuscript.	Abbasi K, 2008, J CARDIOVASC SURG, V49, P285; Angell TE, 2016, THYROID, V26, P381, DOI 10.1089/thy.2015.0289; Arihara F, 2013, CANCER IMMUNOL IMMUN, V62, P1421, DOI 10.1007/s00262-013-1447-1; Bao Y, 2015, MOL MED REP, V11, P2322, DOI 10.3892/mmr.2014.2927; Barreda DR, 2004, DEV COMP IMMUNOL, V28, P509, DOI 10.1016/j.dci.2003.09.010; Bartmann C, 2016, AM J REPROD IMMUNOL, V75, P539, DOI 10.1111/aji.12492; Boutens L, 2016, DIABETOLOGIA, V59, P879, DOI 10.1007/s00125-016-3904-9; Bozkus CC, 2015, J IMMUNOL, V195, P5237, DOI 10.4049/jimmunol.1500959; Bronte V, 1999, J IMMUNOL, V162, P5728; Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Butterfield LH, 2017, CLIN CANCER RES, V23, P5034, DOI 10.1158/1078-0432.CCR-16-3016; Cai WP, 2013, J CLIN IMMUNOL, V33, P798, DOI 10.1007/s10875-012-9861-2; Casacuberta-Serra S, 2017, IMMUNOL CELL BIOL, V95, P538, DOI 10.1038/icb.2017.4; Casbon AJ, 2015, P NATL ACAD SCI USA, V112, pE566, DOI 10.1073/pnas.1424927112; Chen MF, 2014, ONCOTARGET, V5, P8716, DOI 10.18632/oncotarget.2368; Chen S, 2015, OBES RES CLIN PRACT, V9, P35, DOI 10.1016/j.orcp.2013.12.006; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Condamine T, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaf8943; Condamine T, 2015, J LEUKOCYTE BIOL, V98, P913, DOI 10.1189/jlb.4RI0515-204R; Condamine T, 2014, J CLIN INVEST, V124, P2626, DOI 10.1172/JCI74056; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; Cubillos-Ruiz JR, 2015, CELL, V161, P1527, DOI 10.1016/j.cell.2015.05.025; Damuzzo V, 2015, CYTOM PART B-CLIN CY, V88, P77, DOI [10.1002/cyto.b.21206, 10.1002/cytob.21206]; Davis RJ, 2017, CANCER RES, V77, P2607, DOI 10.1158/0008-5472.CAN-16-2534; de Coana YP, 2017, ONCOTARGET, V8, P21539, DOI 10.18632/oncotarget.15368; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Dietlin TA, 2007, J LEUKOCYTE BIOL, V81, P1205, DOI 10.1189/jlb.1006640; Dolcetti L, 2010, EUR J IMMUNOL, V40, P22, DOI 10.1002/eji.200939903; Dominguez GA, 2017, CLIN CANCER RES, V23, P2942, DOI 10.1158/1078-0432.CCR-16-1784; Donkor MK, 2009, INT IMMUNOPHARMACOL, V9, P937, DOI 10.1016/j.intimp.2009.03.021; Du Four S, 2016, AM J CANCER RES, V6, P2514; Dufait I, 2015, ONCOTARGET, V6, P12369, DOI 10.18632/oncotarget.3682; Dumitru CA, 2012, CANCER IMMUNOL IMMUN, V61, P1155, DOI 10.1007/s00262-012-1294-5; Egelston C, 2012, ARTHRITIS RHEUM-US, V64, P3179, DOI 10.1002/art.34494; Eruslanov EB, 2017, TRENDS CANCER, V3, P149, DOI 10.1016/j.trecan.2016.12.006; Fainaru O, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.060; Fridlender ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031524; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Gabrilovich DI, 2007, CANCER RES, V67, P425, DOI 10.1158/0008-5472.CAN-06-3037; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Galdiero MR, 2016, INT J CANCER, V139, P446, DOI 10.1002/ijc.30076; Galvan GC, 2017, NUTR CANCER, V69, P996, DOI 10.1080/01635581.2017.1359320; Gantt S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00387; Garg A, 2014, J INFECT DIS, V209, P441, DOI 10.1093/infdis/jit469; Gato M, 2016, PROTEOMICS, V16, P367, DOI 10.1002/pmic.201500229; Gato-Canas M, 2015, ONCOTARGET, V6, P27160, DOI 10.18632/oncotarget.4746; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Germano G, 2013, CANCER CELL, V23, P249, DOI 10.1016/j.ccr.2013.01.008; Gervassi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107816; Ghaebi M, 2017, BIOMED PHARMACOTHER, V88, P61, DOI 10.1016/j.biopha.2017.01.016; Goh CC, 2016, J IMMUNOL, V196, P2283, DOI 10.4049/jimmunol.1501881; Goh YS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004604; Grootjans J, 2016, NAT REV IMMUNOL, V16, P469, DOI 10.1038/nri.2016.62; Guan QD, 2013, J LEUKOCYTE BIOL, V94, P803, DOI 10.1189/jlb.0113050; Guo CQ, 2016, ANN RHEUM DIS, V75, P278, DOI 10.1136/annrheumdis-2014-205508; Haile LA, 2010, J IMMUNOL, V185, P203, DOI 10.4049/jimmunol.0903573; Hammami I, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-18; Haverkamp JM, 2014, IMMUNITY, V41, P947, DOI 10.1016/j.immuni.2014.10.020; Heim CE, 2014, J IMMUNOL, V192, P3778, DOI 10.4049/jimmunol.1303408; Heinemann AS, 2017, FASEB J, V31, P1153, DOI 10.1096/fj.201601083R; Highfill SL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007974; Hossain F, 2015, CANCER IMMUNOL RES, V3, P1236, DOI 10.1158/2326-6066.CIR-15-0036; Huang A, 2013, CANCER IMMUNOL IMMUN, V62, P1439, DOI 10.1007/s00262-013-1450-6; Hurt B, 2017, AM J SURG, V214, P938, DOI 10.1016/j.amjsurg.2017.08.003; Iida Y, 2017, CANCER SCI, V108, P1974, DOI 10.1111/cas.13337; Iwata Y, 2010, CLIN EXP NEPHROL, V14, P411, DOI 10.1007/s10157-010-0309-9; Janols H, 2014, J LEUKOCYTE BIOL, V96, P685, DOI 10.1189/jlb.5HI0214-074R; Jiao Z, 2013, SCAND J RHEUMATOL, V42, P85, DOI 10.3109/03009742.2012.716450; Jordan KR, 2013, CANCER IMMUNOL IMMUN, V62, P1711, DOI 10.1007/s00262-013-1475-x; Kamran N, 2017, MOL THER, V25, P232, DOI 10.1016/j.ymthe.2016.10.003; Kang XM, 2016, MOL HUM REPROD, V22, P499, DOI 10.1093/molehr/gaw026; Kang XM, 2016, DNA CELL BIOL, V35, P358, DOI 10.1089/dna.2015.2962; Kawano M, 2015, SCI REP-UK, V5, DOI 10.1038/srep18217; Kim YJ, 2006, PLACENTA, V27, P438, DOI 10.1016/j.placenta.2005.04.011; Kimura T, 2013, CANCER PREV RES, V6, P18, DOI 10.1158/1940-6207.CAPR-12-0275; Kostlin N, 2017, IMMUNOLOGY, V152, P89, DOI 10.1111/imm.12751; Kostlin N, 2014, EUR J IMMUNOL, V44, P2582, DOI 10.1002/eji.201344200; Kontaki E, 2017, AUTOIMMUNITY, V50, P170, DOI 10.1080/08916934.2017.1283405; Kruger P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004651; Kumar V, 2016, IMMUNITY, V44, P303, DOI 10.1016/j.immuni.2016.01.014; Kurko J, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-281; Landskron G, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/149185; Lee BR, 2014, ONCOTARGET, V5, P12331, DOI 10.18632/oncotarget.2589; Lee SE, 2016, CANCER IMMUNOL IMMUN, V65, P983, DOI 10.1007/s00262-016-1861-2; Leiber A, 2017, EUR J IMMUNOL, V47, P1009, DOI 10.1002/eji.201646621; Li X, 2017, ONCOTARGET, V8, P24380, DOI 10.18632/oncotarget.15456; Liu Y, 2015, CELL MOL IMMUNOL, V12, DOI 10.1038/cmi.2014.83; Lu HY, 2011, FASEB J, V25, P358, DOI 10.1096/fj.10-171579; Lu X, 2017, NATURE, V543, P728, DOI 10.1038/nature21676; Ma Y, 2013, IMMUNITY, V38, P729, DOI 10.1016/j.immuni.2013.03.003; Mairhofer DG, 2015, J INVEST DERMATOL, V135, P2785, DOI 10.1038/jid.2015.241; Mandruzzato S, 2016, CANCER IMMUNOL IMMUN, V65, P161, DOI 10.1007/s00262-015-1782-5; Mao YM, 2013, CANCER RES, V73, P3877, DOI 10.1158/0008-5472.CAN-12-4115; Marigo I, 2016, CANCER CELL, V30, P651, DOI 10.1016/j.ccell.2016.09.009; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; Marini O, 2017, BLOOD, V129, P1343, DOI 10.1182/blood-2016-04-713206; Marini O, 2016, ONCOTARGET, V7, P27676, DOI 10.18632/oncotarget.8507; Martens A, 2016, CLIN CANCER RES, V22, P2908, DOI 10.1158/1078-0432.CCR-15-2412; Marvel D, 2015, J CLIN INVEST, V125, P3356, DOI 10.1172/JCI80005; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Nair RR, 2015, AM J REPROD IMMUNOL, V73, P479, DOI 10.1111/aji.12351; Nefedova Y, 2004, J IMMUNOL, V172, P464, DOI 10.4049/jimmunol.172.1.464; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Netherby CS, 2017, J IMMUNOL, V198, P4129, DOI 10.4049/jimmunol.1601722; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Nicholson LB, 2009, CURR MOL MED, V9, P23, DOI 10.2174/156652409787314499; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Okwan-Duodu D, 2013, AM J CANCER RES, V3, P21; Ortiz ML, 2014, CANCER IMMUNOL RES, V2, P50, DOI 10.1158/2326-6066.CIR-13-0129; Ost M, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00037; Ostrand-Rosenberg S, 2017, J LEUKOCYTE BIOL, V101, P1091, DOI 10.1189/jlb.1HI1016-306RR; Pan T, 2016, CLIN EXP IMMUNOL, V185, P86, DOI 10.1111/cei.12790; Pan T, 2016, J LEUKOCYTE BIOL, V100, P499, DOI 10.1189/jlb.1A1015-481RR; Park MJ, 2016, ARTHRITIS RHEUMATOL, V68, P2717, DOI 10.1002/art.39767; Pirvulescu MM, 2014, INT J BIOCHEM CELL B, V50, P29, DOI 10.1016/j.biocel.2014.01.022; Poe SL, 2013, MUCOSAL IMMUNOL, V6, P189, DOI 10.1038/mi.2012.62; Qin AP, 2013, J VIROL, V87, P1477, DOI 10.1128/JVI.01759-12; Quail DF, 2017, NAT CELL BIOL, V19, P974, DOI 10.1038/ncb3578; Raber PL, 2014, INT J CANCER, V134, P2853, DOI 10.1002/ijc.28622; Rader DJ, 2007, AM J MED, V120, pS12, DOI 10.1016/j.amjmed.2007.01.003; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Rebe Cedric, 2013, JAKSTAT, V2, pe23010, DOI 10.4161/jkst.23010; Renehan Andrew G., 2008, Archives of Physiology and Biochemistry, V114, P71, DOI [10.1080/13813450801954303, 10.1080/13813450801954303 ]; Ribechini E, 2017, BLOOD ADV, V1, P947, DOI 10.1182/bloodadvances.2017006858; Rieber N, 2013, CLIN EXP IMMUNOL, V174, P45, DOI 10.1111/cei.12143; Rieber N, 2015, CELL HOST MICROBE, V17, P507, DOI 10.1016/j.chom.2015.02.007; Rodriguez PC, 2005, J EXP MED, V202, P931, DOI 10.1084/jem.20050715; Romano A, 2015, BRIT J HAEMATOL, V168, P689, DOI 10.1111/bjh.13198; Sade-Feldman M, 2016, CLIN CANCER RES, V22, P5661, DOI 10.1158/1078-0432.CCR-15-3104; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Singh Anurag, 2016, Front Microbiol, V7, P1624; Solito S, 2014, ANN NY ACAD SCI, V1319, P47, DOI 10.1111/nyas.12469; Sun HL, 2012, WORLD J GASTROENTERO, V18, P3303, DOI 10.3748/wjg.v18.i25.3303; Tacke RS, 2012, HEPATOLOGY, V55, P343, DOI 10.1002/hep.24700; Tada K, 2016, CANCER IMMUNOL RES, V4, P592, DOI 10.1158/2326-6066.CIR-15-0298; Tebartz C, 2015, J IMMUNOL, V194, P1100, DOI 10.4049/jimmunol.1400196; Tesone AJ, 2016, CELL REP, V14, P1774, DOI 10.1016/j.celrep.2016.01.056; Thevenot PT, 2014, IMMUNITY, V41, P389, DOI 10.1016/j.immuni.2014.08.015; Thomas D, 2017, METABOLISM, V72, P120, DOI 10.1016/j.metabol.2017.04.005; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Tumino N, 2017, JAIDS-J ACQ IMM DEF, V74, P575, DOI 10.1097/QAI.0000000000001283; Tumino N, 2015, AIDS, V29, P2397, DOI 10.1097/QAD.0000000000000871; Uhel F, 2017, AM J RESP CRIT CARE, V196, P315, DOI 10.1164/rccm.201606-1143OC; Ulas T, 2017, NAT IMMUNOL, V18, P622, DOI 10.1038/ni.3745; Umansky V, 2016, VACCINES-BASEL, V4, DOI 10.3390/vaccines4040036; Umansky V, 2013, CANCER MICROENVIRON, V6, P169, DOI 10.1007/s12307-012-0126-7; Veglia F, 2017, CURR OPIN IMMUNOL, V45, P43, DOI 10.1016/j.coi.2017.01.002; Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611; Vlachou K, 2016, ARTHRITIS RHEUMATOL, V68, P449, DOI 10.1002/art.39441; Wang D, 2016, TUMOR BIOL, V37, P10427, DOI 10.1007/s13277-016-4916-2; Wang JH, 2016, BIOMED REP, V5, P208, DOI 10.3892/br.2016.694; Wang L, 2016, AIDS, V30, P1521, DOI 10.1097/QAD.0000000000001083; Wang ZT, 2015, CANCER IMMUNOL IMMUN, V64, P389, DOI 10.1007/s00262-014-1646-4; Weber J, 2016, CANCER IMMUNOL RES, V4, P345, DOI 10.1158/2326-6066.CIR-15-0193; Wu CY, 2015, INT J CLIN EXP MED, V8, P15173; Wu H., 2016, SCI TRANSL MED, V8; Xia S, 2011, J BIOL CHEM, V286, P23591, DOI 10.1074/jbc.M111.237123; Yan DH, 2013, EUR J IMMUNOL, V43, P2943, DOI 10.1002/eji.201343472; Yang GL, 2017, ONCOTARGET, V8, P38378, DOI 10.18632/oncotarget.16386; Yin BJ, 2010, J IMMUNOL, V185, P5828, DOI 10.4049/jimmunol.0903636; Youn JI, 2013, NAT IMMUNOL, V14, P211, DOI 10.1038/ni.2526; Youn JI, 2012, J LEUKOCYTE BIOL, V91, P167, DOI 10.1189/jlb.0311177; Zhai NC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170516; Zhang B, 2013, PLOS ONE, V8; Zhang C, 2012, INFECT IMMUN, V80, P3634, DOI 10.1128/IAI.00668-12; Zhang H, 2017, ONCOGENE, V36, P2095, DOI 10.1038/onc.2016.367; Zhang H, 2015, CLIN IMMUNOL, V157, P175, DOI 10.1016/j.clim.2015.02.001; Zhang S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164514; Zhang Y, 2016, CELL MOL IMMUNOL, V13, P615, DOI 10.1038/cmi.2015.41; Zhang ZN, 2017, JAIDS-J ACQ IMM DEF, V76, P200, DOI 10.1097/QAI.0000000000001471	172	872	909	16	199	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2018	19	2					108	119		10.1038/s41590-017-0022-x	http://dx.doi.org/10.1038/s41590-017-0022-x			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FT8WZ	29348500	Green Accepted			2022-12-18	WOS:000423435200011
J	Martin, M; Rehani, K; Jope, RS; Michalek, SM				Martin, M; Rehani, K; Jope, RS; Michalek, SM			Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; PROTEIN-KINASE; TRANSCRIPTIONAL ACTIVATION; BINDING PROTEIN; GENE-EXPRESSION; PHOSPHORYLATION; REQUIRES; IL-10; TLR4; AKT	The cellular mechanisms that directly regulate the inflammatory response after Toll-like receptor (TLR) stimulation are unresolved at present. Here we report that glycogen synthase kinase 3 (GSK3) differentially regulates TLR-mediated production of pro- and anti-inflammatory cytokines. Stimulation of monocytes or peripheral blood mononuclear cells with TLR2, TLR4, TLR5 or TLR9 agonists induced substantial increases in interleukin 10 production while suppressing the release of proinflammatory cytokines after GSK3 inhibition. GSK3 regulated the inflammatory response by differentially affecting the nuclear amounts of transcription factors NF-kappa B subunit p65 and CREB interacting with the coactivator CBP. Administration of a GSK3 inhibitor potently suppressed the proinflammatory response in mice receiving lipopolysaccharide and mediated protection from endotoxin shock. These findings demonstrate a regulatory function for GSK3 in modulating the inflammatory response.	Univ Alabama Birmingham, Dept Oral Biol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Psychiat, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Martin, M (corresponding author), Univ Alabama Birmingham, Dept Oral Biol, Birmingham, AL 35294 USA.	michmart@uab.edu			NIAID NIH HHS [AI 056460, U01 AI056460] Funding Source: Medline; NIA NIH HHS [R01 AG021045-03, R01 AG021045] Funding Source: Medline; NIDCR NIH HHS [R56 DE014215, DE 08182, R01 DE008182, DE 14215, R01 DE009081, DE 09081, R01 DE014215] Funding Source: Medline; NIMH NIH HHS [R01 MH038752-22A2, R01 MH038752] Funding Source: Medline; NINDS NIH HHS [R01 NS037768-08, R01 NS037768] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI056460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE009081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE014215, R01DE014215, R01DE008182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH038752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021045] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; BERG DJ, 1995, J CLIN INVEST, V96, P2339, DOI 10.1172/JCI118290; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cross DAE, 2001, J NEUROCHEM, V77, P94, DOI 10.1046/j.1471-4159.2001.00251.x; Demarchi F, 2003, J BIOL CHEM, V278, P39583, DOI 10.1074/jbc.M305676200; Demarchi F, 2001, J BIOL CHEM, V276, P31738, DOI 10.1074/jbc.M104457200; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Fukao T, 2002, NAT IMMUNOL, V3, P295, DOI 10.1038/ni768; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Grimes CA, 2001, J NEUROCHEM, V78, P1219, DOI 10.1046/j.1471-4159.2001.00495.x; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Jones BW, 2001, J LEUKOCYTE BIOL, V69, P1036; Kunick C, 2004, BIOORG MED CHEM LETT, V14, P413, DOI 10.1016/j.bmcl.2003.10.062; Lawlor MA, 2001, J CELL SCI, V114, P2903; Martin M, 2003, J IMMUNOL, V171, P717, DOI 10.4049/jimmunol.171.2.717; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Monick MM, 2001, J IMMUNOL, V166, P4713, DOI 10.4049/jimmunol.166.7.4713; Nemeth ZH, 2002, J BIOL CHEM, V277, P7713, DOI 10.1074/jbc.M109711200; O'Brien WT, 2004, J NEUROSCI, V24, P6791, DOI 10.1523/JNEUROSCI.4753-03.2004; O'Neill LAJ, 2000, IMMUNOL TODAY, V21, P206, DOI 10.1016/S0167-5699(00)01611-X; Parker D, 1996, MOL CELL BIOL, V16, P694; Parry GCN, 1997, J IMMUNOL, V159, P5450; Platzer C, 1999, EUR J IMMUNOL, V29, P3098, DOI 10.1002/(SICI)1521-4141(199910)29:10<3098::AID-IMMU3098>3.0.CO;2-H; Pulendran B, 2001, J IMMUNOL, V167, P5067, DOI 10.4049/jimmunol.167.9.5067; Re F, 2001, J BIOL CHEM, V276, P37692, DOI 10.1074/jbc.M105927200; Re F, 2004, J IMMUNOL, V173, P7548, DOI 10.4049/jimmunol.173.12.7548; Rhee SH, 2003, J BIOL CHEM, V278, P22506, DOI 10.1074/jbc.M208633200; Schilling D, 2002, J IMMUNOL, V169, P5874, DOI 10.4049/jimmunol.169.10.5874; Schwabe RF, 2002, AM J PHYSIOL-GASTR L, V283, pG204, DOI 10.1152/ajpgi.00016.2002; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Tapping RI, 2000, J IMMUNOL, V165, P5780, DOI 10.4049/jimmunol.165.10.5780; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	48	872	926	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2005	6	8					777	784		10.1038/ni1221	http://dx.doi.org/10.1038/ni1221			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	947LM	16007092	Green Accepted			2022-12-18	WOS:000230646200018
J	Miao, EA; Leaf, IA; Treuting, PM; Mao, DP; Dors, M; Sarkar, A; Warren, SE; Wewers, MD; Aderem, A				Miao, Edward A.; Leaf, Irina A.; Treuting, Piper M.; Mao, Dat P.; Dors, Monica; Sarkar, Anasuya; Warren, Sarah E.; Wewers, Mark D.; Aderem, Alan			Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria	NATURE IMMUNOLOGY			English	Article							ENTERICA SEROVAR TYPHIMURIUM; INFLUENZA-VIRUS INFECTION; LISTERIA-MONOCYTOGENES; SALMONELLA-ENTERICA; AIM2 INFLAMMASOME; FRANCISELLA-TULARENSIS; IN-VIVO; NLRC4 INFLAMMASOME; SECRETION SYSTEMS; VIRULENCE FACTORS	Macrophages mediate crucial innate immune responses via caspase-1-dependent processing and secretion of interleukin 1 beta (IL-1 beta) and IL-18. Although infection with wild-type Salmonella typhimurium is lethal to mice, we show here that a strain that persistently expresses flagellin was cleared by the cytosolic flagellin-detection pathway through the activation of caspase-1 by the NLRC4 inflammasome; however, this clearance was independent of IL-1 beta and IL-18. Instead, caspase-1-induced pyroptotic cell death released bacteria from macrophages and exposed the bacteria to uptake and killing by reactive oxygen species in neutrophils. Similarly, activation of caspase-1 cleared unmanipulated Legionella pneumophila and Burkholderia thailandensis by cytokine-independent mechanisms. This demonstrates that activation of caspase-1 clears intracellular bacteria in vivo independently of IL-1 beta and IL-18 and establishes pyroptosis as an efficient mechanism of bacterial clearance by the innate immune system.	[Miao, Edward A.; Leaf, Irina A.; Mao, Dat P.; Dors, Monica; Warren, Sarah E.; Aderem, Alan] Inst Syst Biol, Seattle, WA USA; [Treuting, Piper M.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Sarkar, Anasuya; Wewers, Mark D.] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Warren, Sarah E.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA	Institute for Systems Biology (ISB); University of Washington; University of Washington Seattle; University System of Ohio; Ohio State University; University of Washington; University of Washington Seattle	Miao, EA (corresponding author), Inst Syst Biol, Seattle, WA USA.	emiao@systemsbiology.org; aderem@systemsbiology.org	Treuting, Piper M./AAB-2721-2019; Wewers, Mark/AAB-6202-2021	Treuting, Piper M./0000-0002-1812-1519; Miao, Edward/0000-0001-7295-3490	US National Institutes of Health [U54 AI057141, AI052286]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052286, R01AI025032, K08AI065878, U54AI057141] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Rodriguez for managing the mouse colony and members of the Aderem laboratory for critical review of the manuscript. Supported by the US National Institutes of Health (U54 AI057141 and AI052286).	Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Beuzon CR, 2001, MICROBES INFECT, V3, P1345, DOI 10.1016/S1286-4579(01)01496-4; Beuzon CR, 2001, INFECT IMMUN, V69, P7254, DOI 10.1128/IAI.69.12.7254-7261.2001; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Bueno SM, 2007, IMMUNOL LETT, V111, P14, DOI 10.1016/j.imlet.2007.05.003; Case CL, 2009, INFECT IMMUN, V77, P1981, DOI 10.1128/IAI.01382-08; Craven RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007446; Cummings LA, 2006, MOL MICROBIOL, V61, P795, DOI 10.1111/j.1365-2958.2006.05271.x; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Duprez L, 2009, MICROBES INFECT, V11, P1050, DOI 10.1016/j.micinf.2009.08.013; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Fischbach MA, 2006, P NATL ACAD SCI USA, V103, P16502, DOI 10.1073/pnas.0604636103; Franchi L, 2007, EUR J IMMUNOL, V37, P3030, DOI 10.1002/eji.200737532; Gunn JS, 2008, TRENDS MICROBIOL, V16, P284, DOI 10.1016/j.tim.2008.03.007; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Ibarra JA, 2009, CELL MICROBIOL, V11, P1579, DOI 10.1111/j.1462-5822.2009.01368.x; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kim S, 2010, EUR J IMMUNOL, V40, P1545, DOI 10.1002/eji.201040425; KOZAK W, 1995, AM J PHYSIOL-REG I, V269, pR969, DOI 10.1152/ajpregu.1995.269.5.R969; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; Liu BX, 2004, J GEN VIROL, V85, P423, DOI 10.1099/vir.0.19596-0; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Miao EA, 1999, MOL MICROBIOL, V34, P850, DOI 10.1046/j.1365-2958.1999.01651.x; Miao EA, 2007, SEMIN IMMUNOPATHOL, V29, P275, DOI 10.1007/s00281-007-0078-z; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, J CLIN IMMUNOL, V30, P502, DOI 10.1007/s10875-010-9386-5; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Miggin SM, 2007, P NATL ACAD SCI USA, V104, P3372, DOI 10.1073/pnas.0608100104; Munoz-Planillo R, 2009, J IMMUNOL, V183, P3942, DOI 10.4049/jimmunol.0900729; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Raupach B, 2006, INFECT IMMUN, V74, P4922, DOI 10.1128/IAI.00417-06; Sansonetti PJ, 2000, IMMUNITY, V12, P581, DOI 10.1016/S1074-7613(00)80209-5; Sauer JD, 2010, CELL HOST MICROBE, V7, P412, DOI 10.1016/j.chom.2010.04.004; Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005; Schroder K, 2009, CURR BIOL, V19, pR262, DOI 10.1016/j.cub.2009.02.011; Shornick LP, 1996, J EXP MED, V183, P1427, DOI 10.1084/jem.183.4.1427; Sumimoto H, 2005, BIOCHEM BIOPH RES CO, V338, P677, DOI 10.1016/j.bbrc.2005.08.210; Suzuki T, 2007, PLOS PATHOG, V3, P1082, DOI 10.1371/journal.ppat.0030111; Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06; Tsuchiya K, 2010, J IMMUNOL, V185, P1186, DOI 10.4049/jimmunol.1001058; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Van der Sluijs KF, 2005, IMMUNOLOGY, V114, P112, DOI 10.1111/j.1365-2567.2004.02000.x; Warren SE, 2008, J IMMUNOL, V180, P7558, DOI 10.4049/jimmunol.180.11.7558; Warren SE, 2010, J IMMUNOL, V185, P818, DOI 10.4049/jimmunol.1000724; Wu JH, 2010, J CLIN IMMUNOL, V30, P693, DOI 10.1007/s10875-010-9425-2; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; ZYCHLINSKY A, 1992, NATURE, V358, P167, DOI 10.1038/358167a0	49	867	914	5	190	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2010	11	12					1136	U94		10.1038/ni.1960	http://dx.doi.org/10.1038/ni.1960			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	680UX	21057511	Green Accepted, Green Submitted			2022-12-18	WOS:000284262200013
J	Miao, EA; Alpuche-Aranda, CM; Dors, M; Clark, AE; Bader, MW; Miller, SI; Aderem, A				Miao, Edward A.; Alpuche-Aranda, Celia M.; Dors, Monica; Clark, April E.; Bader, Martin W.; Miller, Samuel I.; Aderem, Alan			Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1 beta via Ipaf	NATURE IMMUNOLOGY			English	Article							TOLL-LIKE RECEPTOR-5; III SECRETION; SALMONELLA-TYPHIMURIUM; BACTERIAL PEPTIDOGLYCAN; INFLAMMATORY CASPASES; HOST RECOGNITION; LRR PROTEINS; INNATE; GENES; EXPRESSION	Macrophages respond to Salmonella typhimurium infection via Ipaf, a NACHT-leucine-rich repeat family member that activates caspase-1 and secretion of interleukin 1 beta. However, the specific microbial salmonella-derived agonist responsible for activating Ipaf is unknown. We show here that cytosolic bacterial flagellin activated caspase-1 through Ipaf but was independent of Toll-like receptor 5, a known flagellin sensor. Stimulation of the Ipaf pathway in macrophages after infection required a functional salmonella pathogenicity island 1 type III secretion system but not the flagellar type III secretion system; furthermore, Ipaf activation could be recapitulated by the introduction of purified flagellin directly into the cytoplasm. These observations raise the possibility that the salmonella pathogenicity island 1 type III secretion system cannot completely exclude 'promiscuous' secretion of flagellin and that the host capitalizes on this 'error' by activating a potent host-defense pathway.	Inst Syst Biol, Seattle, WA 98103 USA; Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; Univ Nacl Autonoma Mexico, Sch Med, Hosp Infantil Mexico Federico Gomez, Mexico City 06726, DF, Mexico	Institute for Systems Biology (ISB); University of Washington; University of Washington Seattle; Hospital Infantil de Mexico Federico Gomez; Universidad Nacional Autonoma de Mexico	Aderem, A (corresponding author), Inst Syst Biol, Seattle, WA 98103 USA.	aderem@systemsbiology.org		Miao, Edward/0000-0001-7295-3490				Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Aldridge P, 2002, CURR OPIN MICROBIOL, V5, P160, DOI 10.1016/S1369-5274(02)00302-8; Andrei C, 2004, P NATL ACAD SCI USA, V101, P9745, DOI 10.1073/pnas.0308558101; Applequist SE, 2002, INT IMMUNOL, V14, P1065, DOI 10.1093/intimm/dxf069; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chen LM, 1996, MOL MICROBIOL, V21, P1101, DOI 10.1046/j.1365-2958.1996.471410.x; Chilcott GS, 2000, MICROBIOL MOL BIOL R, V64, P694, DOI 10.1128/MMBR.64.4.694-708.2000; Damiano JS, 2001, GENOMICS, V75, P77, DOI 10.1006/geno.2001.6579; Eichelberg K, 2000, INFECT IMMUN, V68, P2735, DOI 10.1128/IAI.68.5.2735-2743.2000; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Geddes BJ, 2001, BIOCHEM BIOPH RES CO, V284, P77, DOI 10.1006/bbrc.2001.4928; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; Harton JA, 2002, J IMMUNOL, V169, P4088, DOI 10.4049/jimmunol.169.8.4088; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hernandez LD, 2003, J CELL BIOL, V163, P1123, DOI 10.1083/jcb.200309161; Hersh D, 1999, P NATL ACAD SCI USA, V96, P2396, DOI 10.1073/pnas.96.5.2396; Hilbi H, 1998, J BIOL CHEM, V273, P32895, DOI 10.1074/jbc.273.49.32895; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kufer TA, 2005, TRENDS MICROBIOL, V13, P381, DOI 10.1016/j.tim.2005.06.004; Lee SH, 2004, MOL MICROBIOL, V51, P483, DOI 10.1046/j.1365-2958.2003.03840.x; Lloyd SA, 2001, MOL MICROBIOL, V39, P520, DOI 10.1046/j.1365-2958.2001.02271.x; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165; Miao EA, 2000, P NATL ACAD SCI USA, V97, P7539, DOI 10.1073/pnas.97.13.7539; Miao EA, 1999, MOL MICROBIOL, V34, P850, DOI 10.1046/j.1365-2958.1999.01651.x; Miao EA, 2003, MOL MICROBIOL, V48, P401, DOI 10.1046/j.1365-2958.2003.t01-1-03456.x; PEGUES DA, 1995, MOL MICROBIOL, V17, P169, DOI 10.1111/j.1365-2958.1995.mmi_17010169.x; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Roy D, 2004, SCIENCE, V304, P1515, DOI 10.1126/science.1098371; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; van Asten FJAM, 2004, INT J MED MICROBIOL, V294, P395, DOI 10.1016/j.ijmm.2004.07.012; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3	45	865	895	4	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2006	7	6					569	575		10.1038/ni1344	http://dx.doi.org/10.1038/ni1344			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	045OK	16648853	Green Submitted			2022-12-18	WOS:000237751200011
J	Intlekofer, AM; Takemoto, N; Wherry, EJ; Longworth, SA; Northrup, JT; Palanivel, VR; Mullen, AC; Gasink, CR; Kaech, SM; Miller, JD; Gapin, L; Ryan, K; Russ, AP; Lindsten, T; Orange, JS; Goldrath, AW; Ahmed, R; Reiner, SL				Intlekofer, AM; Takemoto, N; Wherry, EJ; Longworth, SA; Northrup, JT; Palanivel, VR; Mullen, AC; Gasink, CR; Kaech, SM; Miller, JD; Gapin, L; Ryan, K; Russ, AP; Lindsten, T; Orange, JS; Goldrath, AW; Ahmed, R; Reiner, SL			Effector and memory CD8(+) T cell fate coupled by T-bet and eomesodermin	NATURE IMMUNOLOGY			English	Article							IFN-GAMMA PRODUCTION; NATURAL-KILLER; CUTTING EDGE; TRANSCRIPTION FACTOR; PROTECTIVE IMMUNITY; EXPRESSION; IL-15; PROLIFERATION; IL-15R-ALPHA; HOMEOSTASIS	Two seemingly unrelated hallmarks of memory CD8(+) T cells are cytokine-driven proliferative renewal after pathogen clearance and a latent effector program in anticipation of rechallenge. Memory CD8(+) T cells and natural killer cells share cytotoxic potential and dependence on the growth factor interleukin 15. We now show that mice with compound mutations of the genes encoding the transcription factors T-bet and eomesodermin were nearly devoid of several lineages dependent on interleukin 15, including memory CD8(+) T cells and mature natural killer cells, and that their cells had defective cytotoxic effector programming. Moreover, T-bet and eomesodermin were responsible for inducing enhanced expression of CD122, the receptor specifying interleukin 15 responsiveness. Therefore, these key transcription factors link the long-term renewal of memory CD8(+) T cells to their characteristic effector potency.	Univ Penn, Abramson Familly Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; Univ Colorado, Hlth Sci Ctr, Natl Jewish Med & Res Ctr, Integrated Dept Immunol, Denver, CO 80206 USA; Univ Oxford, Dept Biochem, Genet Unit, Oxford OX1 3QU, England; Harvard Univ, Sch Med, Brigham & Womens Hosp, Joslin Diabet Ctr,Sect Immunol & Immunogenet, Boston, MA 02215 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Emory University; Emory University; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Oxford; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Reiner, SL (corresponding author), Univ Penn, Abramson Familly Canc Res Inst, Philadelphia, PA 19104 USA.	sreiner@mail.med.upenn.edu	Wherry, John/ABI-1280-2020; Orange, Jordan S/D-5239-2009	Mullen, Alan/0000-0002-4096-3106; Intlekofer, Andrew/0000-0001-9046-6549; orange, jordan/0000-0001-7117-7725	NIAID NIH HHS [AI061699, T32 AI055428, AI042370, AI007532] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007532, T32AI055428, R01AI042370, R01AI061699] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; Burkett PR, 2004, J EXP MED, V200, P825, DOI 10.1084/jem.20041389; Burkett PR, 2003, P NATL ACAD SCI USA, V100, P4724, DOI 10.1073/pnas.0737048100; Conlon FL, 2001, DEVELOPMENT, V128, P3749; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Goldrath AW, 2004, P NATL ACAD SCI USA, V101, P16885, DOI 10.1073/pnas.0407417101; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; HAN KY, 1993, EMBO J, V12, P2723, DOI 10.1002/j.1460-2075.1993.tb05934.x; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Judge AD, 2002, J EXP MED, V196, P935, DOI 10.1084/jem.20020772; Juedes AE, 2004, J EXP MED, V199, P1153, DOI 10.1084/jem.20031873; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Koka R, 2003, J EXP MED, V197, P977, DOI 10.1084/jem.20021836; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Latner DR, 2004, J VIROL, V78, P10953, DOI 10.1128/JVI.78.20.10953-10959.2004; Li Y, 2005, J IMMUNOL, V174, P4019, DOI 10.4049/jimmunol.174.7.4019; LIN JX, 1993, MOL CELL BIOL, V13, P6201, DOI 10.1128/MCB.13.10.6201; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Ryan K, 1996, CELL, V87, P989, DOI 10.1016/S0092-8674(00)81794-8; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Sandau MM, 2004, J IMMUNOL, V173, P6537, DOI 10.4049/jimmunol.173.11.6537; Schluns KS, 2004, BLOOD, V103, P988, DOI 10.1182/blood-2003-08-2814; Schluns KS, 2002, J IMMUNOL, V168, P4827, DOI 10.4049/jimmunol.168.10.4827; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Sullivan BM, 2003, P NATL ACAD SCI USA, V100, P15818, DOI 10.1073/pnas.2636938100; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Svensson A, 2005, J IMMUNOL, V174, P6266, DOI 10.4049/jimmunol.174.10.6266; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Usui T, 2003, IMMUNITY, V18, P415, DOI 10.1016/S1074-7613(03)00057-8; Veiga-Fernandes H, 2004, NAT IMMUNOL, V5, P31, DOI 10.1038/ni1015; Way SS, 2004, J IMMUNOL, V173, P5918, DOI 10.4049/jimmunol.173.10.5918; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057	47	865	876	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2005	6	12					1236	1244		10.1038/ni1268	http://dx.doi.org/10.1038/ni1268			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	985IX	16273099				2022-12-18	WOS:000233371900011
J	Boone, DL; Turer, EE; Lee, EG; Ahmad, RC; Wheeler, MT; Tsui, C; Hurley, P; Chien, M; Chai, S; Hitotsumatsu, O; McNally, E; Pickart, C; Ma, A				Boone, DL; Turer, EE; Lee, EG; Ahmad, RC; Wheeler, MT; Tsui, C; Hurley, P; Chien, M; Chai, S; Hitotsumatsu, O; McNally, E; Pickart, C; Ma, A			The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; ZINC-FINGER PROTEIN; DEUBIQUITINATING ENZYME; NEGATIVE REGULATOR; MACROPHAGE ACTIVATION; ENDOTOXIN TOLERANCE; CYSTEINE PROTEASES; TRAF6; EXPRESSION; GENE	A20 is a cytoplasmic protein required for the termination of tumor necrosis factor (TNF)-induced signals. We show here that mice doubly deficient in either A20 and TNF or A20 and TNF receptor 1 developed spontaneous inflammation, indicating that A20 is also critical for the regulation of TNF-independent signals in vivo. A20 was required for the termination of Toll-like receptor-induced activity of the transcription factor NF-kappaB and proinflammatory gene expression in macrophages, and this function protected mice from endotoxic shock. A20 accomplished this biochemically by directly removing ubiquitin moieties from the signaling molecule TRAF6. The critical function of this deubiquitinating enzyme in the restriction of TLR signals emphasizes the importance of the regulation of ubiquitin conjugation in innate immune cells.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA	University of California System; University of California San Francisco; University of Chicago; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Ma, A (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	ama1@itsa.ucsf.edu	McNally, Elizabeth/W-4909-2019	McNally, Elizabeth/0000-0002-1221-719X; Wheeler, Matthew/0000-0001-8721-3022	NIAID NIH HHS [R01AI53224] Funding Source: Medline; NIDDK NIH HHS [R01DK52751, DK42086] Funding Source: Medline; NIGMS NIH HHS [GM07281] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086, R01DK052751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Balakirev MY, 2003, EMBO REP, V4, P517, DOI 10.1038/sj.embor.embor824; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Beyaert R, 2000, BIOCHEM PHARMACOL, V60, P1143, DOI 10.1016/S0006-2952(00)00404-4; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Burkett PR, 2003, P NATL ACAD SCI USA, V100, P4724, DOI 10.1073/pnas.0737048100; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Chutkow WA, 2002, J CLIN INVEST, V110, P203, DOI 10.1172/JCI200215672; Cooper JT, 1996, J BIOL CHEM, V271, P18068, DOI 10.1074/jbc.271.30.18068; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Evans PC, 2003, J BIOL CHEM, V278, P23180, DOI 10.1074/jbc.M301863200; Evans PC, 2004, BIOCHEM J, V378, P727, DOI 10.1042/BJ20031377; Heyninck K, 1999, FEBS LETT, V442, P147, DOI 10.1016/S0014-5793(98)01645-7; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Makarova KS, 2000, TRENDS BIOCHEM SCI, V25, P50, DOI 10.1016/S0968-0004(99)01530-3; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; OPIPARI AW, 1990, J BIOL CHEM, V265, P14705; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200	41	865	917	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2004	5	10					1052	1060		10.1038/ni1110	http://dx.doi.org/10.1038/ni1110			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	857YO	15334086				2022-12-18	WOS:000224156600029
J	Kamada, N; Chen, GY; Inohara, N; Nunez, G				Kamada, Nobuhiko; Chen, Grace Y.; Inohara, Naohiro; Nunez, Gabriel			Control of pathogens and pathobionts by the gut microbiota	NATURE IMMUNOLOGY			English	Review							CLOSTRIDIUM-DIFFICILE INFECTION; ESCHERICHIA-COLI STRAINS; INTESTINAL MICROBIOTA; ORGANIC-ACIDS; MAINTAIN HOMEOSTASIS; HYDROGEN-SULFIDE; GENOME SEQUENCE; NITRIC-OXIDE; INNATE; HOST	A dense resident microbial community in the gut, referred as the commensal microbiota, coevolved with the host and is essential for many host physiological processes that include enhancement of the intestinal epithelial barrier, development of the immune system and acquisition of nutrients. A major function of the microbiota is protection against colonization by pathogens and overgrowth of indigenous pathobionts that can result from the disruption of the healthy microbial community. The mechanisms that regulate the ability of the microbiota to restrain pathogen growth are complex and include competitive metabolic interactions, localization to intestinal niches and induction of host immune responses. Pathogens, in turn, have evolved strategies to escape from commensal-mediated resistance to colonization. Thus, the interplay between commensals and pathogens or indigenous pathobionts is critical for controlling infection and disease. Understanding pathogen-commensal interactions may lead to new therapeutic approaches to treating infectious diseases.	[Kamada, Nobuhiko; Inohara, Naohiro; Nunez, Gabriel] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Kamada, Nobuhiko; Chen, Grace Y.; Nunez, Gabriel] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Chen, Grace Y.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Nunez, G (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.	gabriel.nunez@umich.edu	Kamada, Nobuhiko/AAW-3299-2020; Nuñez, Gabriel/A-7160-2014	Kamada, Nobuhiko/0000-0002-1980-4178; 	US National Institutes of Health; Bill & Melinda Gates Foundation; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061707, R01DK095782, R01DK091191] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank E. Martens for critical review of the manuscript. Studies on the microbiota in our laboratory are supported by grants from US National Institutes of Health, and the Bill & Melinda Gates Foundation. N.K. is supported by a Research Fellowship from the Crohn's and Colitis Foundation of America.	Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Ayres JS, 2012, NAT MED, V18, P799, DOI 10.1038/nm.2729; Bertin Y, 2011, ENVIRON MICROBIOL, V13, P365, DOI 10.1111/j.1462-2920.2010.02334.x; BOHNHOFF M, 1954, P SOC EXP BIOL MED, V86, P132, DOI 10.3181/00379727-86-21030; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Ceuppens S, 2012, FOODBORNE PATHOG DIS, V9, P1130, DOI 10.1089/fpd.2012.1230; CHERRINGTON CA, 1991, J APPL BACTERIOL, V70, P161, DOI 10.1111/j.1365-2672.1991.tb04442.x; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; Dridi B, 2011, ANAEROBE, V17, P56, DOI 10.1016/j.anaerobe.2011.03.001; Endt K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001097; Fabich AJ, 2008, INFECT IMMUN, V76, P1143, DOI 10.1128/IAI.01386-07; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Fischbach MA, 2006, NAT CHEM BIOL, V2, P132, DOI 10.1038/nchembio771; Franchi L, 2012, NAT IMMUNOL, V13, P449, DOI 10.1038/ni.2263; Frantz AL, 2012, MUCOSAL IMMUNOL, V5, P501, DOI 10.1038/mi.2012.23; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Furne J, 2001, BIOCHEM PHARMACOL, V62, P255, DOI 10.1016/S0006-2952(01)00657-8; Gantois I, 2006, APPL ENVIRON MICROB, V72, P946, DOI 10.1128/AEM.72.1.946-949.2006; Giel JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008740; Hammami R, 2013, CELL MOL LIFE SCI, V70, P2947, DOI 10.1007/s00018-012-1202-3; Hasegawa M, 2012, J IMMUNOL, V189, P3085, DOI 10.4049/jimmunol.1200821; Hasegawa M, 2010, INFECT IMMUN, V78, P639, DOI 10.1128/IAI.01043-09; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kamada N, 2012, SCIENCE, V336, P1325, DOI 10.1126/science.1222195; Kane M, 2011, SCIENCE, V334, P245, DOI 10.1126/science.1210718; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kinnebrew MA, 2010, J INFECT DIS, V201, P534, DOI 10.1086/650203; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kolios G, 2004, IMMUNOLOGY, V113, P427, DOI 10.1111/j.1365-2567.2004.01984.x; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Le Bouguenec C, 2011, INT J MED MICROBIOL, V301, P1, DOI 10.1016/j.ijmm.2010.04.021; Leatham MP, 2009, INFECT IMMUN, V77, P2876, DOI 10.1128/IAI.00059-09; Levitt MD, 1999, J CLIN INVEST, V104, P1107, DOI 10.1172/JCI7712; Li E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026284; Lupp C, 2007, CELL HOST MICROBE, V2, P204, DOI 10.1016/j.chom.2007.08.002; Macpherson AJ, 2012, TRENDS IMMUNOL, V33, P160, DOI 10.1016/j.it.2012.02.002; Marteyn B, 2010, NATURE, V465, P355, DOI 10.1038/nature08970; Matamoros S, 2013, TRENDS MICROBIOL, V21, P167, DOI 10.1016/j.tim.2012.12.001; Momose Y, 2008, ANTON LEEUW INT J G, V94, P165, DOI 10.1007/s10482-008-9222-6; Momose Y, 2008, ANTON LEEUW INT J G, V93, P141, DOI 10.1007/s10482-007-9188-9; Ng J, 2010, GASTROENTEROLOGY, V139, P542, DOI 10.1053/j.gastro.2010.04.005; Oh PL, 2012, AM J TRANSPLANT, V12, P753, DOI 10.1111/j.1600-6143.2011.03860.x; Pacheco AR, 2012, NATURE, V492, P113, DOI 10.1038/nature11623; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; Petrof EO, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-3; Pridmore RD, 2004, P NATL ACAD SCI USA, V101, P2512, DOI 10.1073/pnas.0307327101; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Reeves AE, 2012, INFECT IMMUN, V80, P3786, DOI 10.1128/IAI.00647-12; Reinders CI, 2007, SCAND J GASTROENTERO, V42, P1151, DOI 10.1080/00365520701320505; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Schamberger GP, 2002, J FOOD PROTECT, V65, P1381, DOI 10.4315/0362-028X-65.9.1381; Shin R, 2002, J MED MICROBIOL, V51, P201, DOI 10.1099/0022-1317-51-3-201; Strugnell RA, 2010, NAT REV MICROBIOL, V8, P656, DOI 10.1038/nrmicro2384; Suzuki K, 2010, IMMUNITY, V33, P71, DOI 10.1016/j.immuni.2010.07.003; Thiennimitr P, 2011, P NATL ACAD SCI USA, V108, P17480, DOI 10.1073/pnas.1107857108; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turovskiy Y, 2011, J APPL MICROBIOL, V110, P1105, DOI 10.1111/j.1365-2672.2011.04977.x; Ubeda C, 2013, INFECT IMMUN, V81, P965, DOI 10.1128/IAI.01197-12; Ubeda C, 2012, J EXP MED, V209, P1445, DOI 10.1084/jem.20120504; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Willing B, 2009, INFLAMM BOWEL DIS, V15, P653, DOI 10.1002/ibd.20783; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; Wu LC, 2005, SCIENCE, V309, P774, DOI 10.1126/science.1112422; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	74	862	897	13	298	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2013	14	7					685	690		10.1038/ni.2608	http://dx.doi.org/10.1038/ni.2608			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	165UB	23778796	Green Accepted			2022-12-18	WOS:000320509100007
J	Veldhoen, M; Uyttenhove, C; van Snick, J; Helmby, H; Westendorf, A; Buer, J; Martin, B; Wilhelm, C; Stockinger, B				Veldhoen, Marc; Uyttenhove, Catherine; van Snick, Jacques; Helmby, Helena; Westendorf, Astrid; Buer, Jan; Martin, Bruno; Wilhelm, Christoph; Stockinger, Brigitta			Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset	NATURE IMMUNOLOGY			English	Article							T-CELLS; TGF-BETA; IL-9; TRANSCRIPTION; EXPRESSION; EXPULSION; MEMORY; T(H)1	Since the discovery of T helper type 1 and type 2 effector T cell subsets 20 years ago, inducible regulatory T cells and interleukin 17 (IL-17)-producing T helper cells have been added to the 'portfolio' of helper T cells. It is unclear how many more effector T cell subsets there may be and to what degree their characteristics are fixed or flexible. Here we show that transforming growth factor-beta, a cytokine at the center of the differentiation of IL-17-producing T helper cells and inducible regulatory T cells, 'reprograms' T helper type 2 cells to lose their characteristic profile and switch to IL-9 secretion or, in combination with IL-4, drives the differentiation of 'T-H-9' cells directly. Thus, transforming growth factor-beta constitutes a regulatory 'switch' that in combination with other cytokines can 'reprogram' effector T cell differentiation along different pathways.	[Veldhoen, Marc; Martin, Bruno; Wilhelm, Christoph; Stockinger, Brigitta] Natl Inst Med Res, MRC, Div Mol Immunol, London NW7 1AA, England; [Uyttenhove, Catherine; van Snick, Jacques] Catholic Univ Louvain, Ludwig Inst Canc Res, Brussels Branch, Cellular Genet Unit, B-1200 Brussels, Belgium; [Uyttenhove, Catherine; van Snick, Jacques] Catholic Univ Louvain, Christian de Duve Inst Cellular Pathol, Expt Med Unit, B-1200 Brussels, Belgium; [Helmby, Helena] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Westendorf, Astrid; Buer, Jan] Univ Duisburg Essen, Inst Med Microbiol, D-45122 Essen, Germany	MRC National Institute for Medical Research; Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain; University of London; London School of Hygiene & Tropical Medicine; University of Duisburg Essen	Stockinger, B (corresponding author), Natl Inst Med Res, MRC, Div Mol Immunol, London NW7 1AA, England.	bstocki@nimr.mrc.ac.uk	Westendorf, Astrid M./AAX-1937-2020; Veldhoen, Marc/AAJ-2759-2020; Helmby, Helena/ABE-1649-2020; Veldhoen, Marc/AAM-5357-2021; Wilhelm, Christoph/ABE-7176-2020	Veldhoen, Marc/0000-0002-1478-9562; Helmby, Helena/0000-0003-0761-7348; Wilhelm, Christoph/0000-0002-9839-0291; Stockinger, Brigitta/0000-0001-8781-336X; Buer, Jan/0000-0002-7602-1698; Martin, Bruno/0000-0003-4013-8998	Fonds National de la Recherche Scientifique, Belgium	Fonds National de la Recherche Scientifique, Belgium(Fonds de la Recherche Scientifique - FNRS)	We thank A. Rae and G. Preece for cell sorting; I. Baar for testing the specificity of goat anti-IL-9 by ELISA; and C. Watson (University of Cambridge) for spleens from Stat6<SUP>-/-</SUP> mice on a BALB/c background. Supported by the Fonds National de la Recherche Scientifique, Belgium (C. U. and J.v.S.).	Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Bancroft AJ, 2000, EUR J IMMUNOL, V30, P2083, DOI 10.1002/1521-4141(200007)30:7&lt;2083::AID-IMMU2083&gt;3.0.CO;2-3; Betti M, 2006, ANN ONCOL, V17, P235; Dent AL, 1998, P NATL ACAD SCI USA, V95, P13823, DOI 10.1073/pnas.95.23.13823; Faulkner H, 1998, INFECT IMMUN, V66, P3832, DOI 10.1128/IAI.66.8.3832-3840.1998; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Gorelik L, 2000, J IMMUNOL, V165, P4773, DOI 10.4049/jimmunol.165.9.4773; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Helmby H, 2001, J EXP MED, V194, P355, DOI 10.1084/jem.194.3.355; HOUSSIAU FA, 1995, J IMMUNOL, V154, P2624; Khan WI, 2003, INFECT IMMUN, V71, P2430, DOI 10.1128/IAI.71.5.2430-2438.2003; Krawczyk CM, 2007, J IMMUNOL, V178, P4080, DOI 10.4049/jimmunol.178.7.4080; Letterio JJ, 2005, ONCOGENE, V24, P5701, DOI 10.1038/sj.onc.1208922; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Monteyne P, 1997, J IMMUNOL, V159, P2616; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097; O'Shea John J, 2008, Nat Immunol, V9, P450, DOI 10.1038/ni0508-450; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; SCHMITT E, 1994, J IMMUNOL, V153, P3989; Shoemaker J, 2006, J IMMUNOL, V176, P3470, DOI 10.4049/jimmunol.176.6.3470; Soussi-Gounni A, 2001, J ALLERGY CLIN IMMUN, V107, P575, DOI 10.1067/mai.2001.114238; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Veldhoen M, 2006, TRENDS IMMUNOL, V27, P358, DOI 10.1016/j.it.2006.06.001; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128	31	856	951	1	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2008	9	12					1341	1346		10.1038/ni.1659	http://dx.doi.org/10.1038/ni.1659			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	372FY	18931678				2022-12-18	WOS:000260888700008
J	Codarri, L; Gyulveszi, G; Tosevski, V; Hesske, L; Fontana, A; Magnenat, L; Suter, T; Becher, B				Codarri, Laura; Gyuelveszi, Gabor; Tosevski, Vinko; Hesske, Lysann; Fontana, Adriano; Magnenat, Laurent; Suter, Tobias; Becher, Burkhard			ROR gamma t drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation	NATURE IMMUNOLOGY			English	Article							COLONY-STIMULATING FACTOR; TH17 CELLS; TGF-BETA; IFN-GAMMA; DISTINCT; INFLAMMATION; CNS; IL-23; DIFFERENTIATION; ACTIVATION	Although the role of the T(H)1 and T(H)17 subsets of helper T cells as disease mediators in autoimmune neuroinflammation remains a subject of some debate, none of their signature cytokines are essential for disease development. Here we report that interleukin 23 (IL-23) and the transcription factor ROR gamma t drove expression of the cytokine GM-CSF in helper T cells, whereas IL-12, interferon-gamma (IFN-gamma) and IL-27 acted as negative regulators. Autoreactive helper T cells specifically lacking GM-CSF failed to initiate neuroinflammation despite expression of IL-17A or IFN-gamma, whereas GM-CSF secretion by Ifng(-/-)Il17a(-/-)helper T cells was sufficient to induce experimental autoimmune encephalomyelitis (EAE). During the disease effector phase, GM-CSF sustained neuroinflammation via myeloid cells that infiltrated the central nervous system. Thus, in contrast to all other known helper T cell-derived cytokines, GM-CSF serves a nonredundant function in the initiation of autoimmune inflammation regardless of helper T cell polarization.	[Codarri, Laura; Gyuelveszi, Gabor; Tosevski, Vinko; Fontana, Adriano; Becher, Burkhard] Univ Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland; [Hesske, Lysann; Suter, Tobias] Univ Zurich Hosp, CH-8091 Zurich, Switzerland; [Magnenat, Laurent] Merck Serono Res, Prot Engn & Antibody Technol, Geneva, Switzerland	University of Zurich; University of Zurich; University Zurich Hospital; Merck KGaA; EMD Serono Inc.	Becher, B (corresponding author), Univ Zurich, Inst Expt Immunol, Sternwartstr 2, CH-8091 Zurich, Switzerland.	becher@immunology.uzh.ch	Becher, Burkhard/ABE-4225-2020	Becher, Burkhard/0000-0002-1541-7867; Codarri Deak, Laura/0000-0002-9913-9285; Suter, Tobias/0000-0002-5048-2867	Swiss National Science Foundation [31003AB.131091]; Swiss Multiple Sclerosis Society; Koetser Foundation; Merck-Serono-Geneva; Forschungskredit of the University of Zurich; Gemeinnutzige Hertie-Stiftung	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Multiple Sclerosis Society; Koetser Foundation; Merck-Serono-Geneva; Forschungskredit of the University of Zurich; Gemeinnutzige Hertie-Stiftung	We thank A. Waisman, S. Haak, M. Dreano and and M. Greter for critical review of the manuscript; I. Ivanov and D. Littman (New York University School of Medicine) for the plasmid ROR gamma t-IRES-GFP; V. Kuchroo (Harvard University) for 2D2 mice; and Y. Iwakura (University of Tokyo) for Il17a<SUP>-/-</SUP> mice. Supported by the Swiss National Science Foundation (31003AB.131091 to B.B.), the Swiss Multiple Sclerosis Society (B.B. and T.S.), the Koetser Foundation (B.B.), Merck-Serono-Geneva (B.B.), Forschungskredit of the University of Zurich (L.C.) and Gemeinnutzige Hertie-Stiftung (A.F.).	Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Becher B, 2002, J CLIN INVEST, V110, P493, DOI 10.1172/JCI200215751; Becher B, 2003, J CLIN INVEST, V112, P1186, DOI 10.1172/JCI200319079; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Campbell IK, 1998, J IMMUNOL, V161, P3639; Chu CQ, 2000, J EXP MED, V192, P123, DOI 10.1084/jem.192.1.123; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Diveu C, 2009, J IMMUNOL, V182, P5748, DOI 10.4049/jimmunol.0801162; Fitzgerald DC, 2007, J IMMUNOL, V179, P3268, DOI 10.4049/jimmunol.179.5.3268; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gran B, 2002, J IMMUNOL, V169, P7104, DOI 10.4049/jimmunol.169.12.7104; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Gutcher I, 2007, J CLIN INVEST, V117, P1119, DOI 10.1172/JCI31720; Gyulveszi G, 2009, EUR J IMMUNOL, V39, P1864, DOI 10.1002/eji.200939305; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hofstetter HH, 2005, CELL IMMUNOL, V237, P123, DOI 10.1016/j.cellimm.2005.11.002; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; King IL, 2009, BLOOD, V113, P3190, DOI 10.1182/blood-2008-07-168575; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kreymborg K, 2005, EXPERT OPIN THER TAR, V9, P1123, DOI 10.1517/14728222.9.6.1123; Kreymborg K, 2007, J IMMUNOL, V179, P8098, DOI 10.4049/jimmunol.179.12.8098; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Kroenke MA, 2010, EUR J IMMUNOL, V40, P2340, DOI 10.1002/eji.201040489; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Lugo-Villarino G, 2003, P NATL ACAD SCI USA, V100, P7749, DOI 10.1073/pnas.1332767100; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; McQualter JL, 2001, J EXP MED, V194, P873, DOI 10.1084/jem.194.7.873; Medvedev A, 1996, GENE, V181, P199, DOI 10.1016/S0378-1119(96)00504-5; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Ponomarev ED, 2007, J IMMUNOL, V178, P39, DOI 10.4049/jimmunol.178.1.39; Sonderegger I, 2008, J EXP MED, V205, P2281, DOI 10.1084/jem.20071119; Sonderegger I, 2008, EUR J IMMUNOL, V38, P1833, DOI 10.1002/eji.200838511; STANLEY E, 1994, P NATL ACAD SCI USA, V91, P5592, DOI 10.1073/pnas.91.12.5592; Streeck H, 2008, J IMMUNOL METHODS, V333, P115, DOI 10.1016/j.jim.2008.01.018; Stromnes IM, 2006, NAT PROTOC, V1, P1952, DOI 10.1038/nprot.2006.284; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wensky AK, 2005, J IMMUNOL, V174, P1416, DOI 10.4049/jimmunol.174.3.1416	42	854	914	0	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2011	12	6					560	U248		10.1038/ni.2027	http://dx.doi.org/10.1038/ni.2027			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	765LI	21516112				2022-12-18	WOS:000290707100017
J	Mjosberg, JM; Trifari, S; Crellin, NK; Peters, CP; van Drunen, CM; Piet, B; Fokkens, WJ; Cupedo, T; Spits, H				Mjosberg, Jenny M.; Trifari, Sara; Crellin, Natasha K.; Peters, Charlotte P.; van Drunen, Cornelis M.; Piet, Berber; Fokkens, Wytske J.; Cupedo, Tom; Spits, Hergen			Human IL-25-and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161	NATURE IMMUNOLOGY			English	Article							ROR-GAMMA-T; TISSUE-INDUCER CELLS; NATURAL-KILLER-CELLS; ULCERATIVE-COLITIS; MUCOSAL IMMUNITY; QUANTITATIVE PCR; NKP46(+) CELLS; INTERLEUKIN 22; HOST-DEFENSE; CYTOKINE	Innate lymphoid cells (ILCs) are emerging as a family of effectors and regulators of innate immunity and tissue remodeling. Interleukin 22 (IL-22)- and IL-17-producing ILCs, which depend on the transcription factor ROR gamma t, express CD127 (IL-7 receptor alpha-chain) and the natural killer cell marker CD161. Here we describe another lineage-negative CD127(+)CD161(+) ILC population found in humans that expressed the chemoattractant receptor CRTH2. These cells responded in vitro to IL-2 plus IL-25 and IL-33 by producing IL-13. CRTH2(+) ILCs were present in fetal and adult lung and gut. In fetal gut, these cells expressed IL-13 but not IL-17 or IL-22. There was enrichment for CRTH2(+) ILCs in nasal polyps of chronic rhinosinusitis, a typical type 2 inflammatory disease. Our data identify a unique type of human ILC that provides an innate source of T helper type 2 (T(H)2) cytokines.	[Mjosberg, Jenny M.; Peters, Charlotte P.; Spits, Hergen] Univ Amsterdam, Tytgat Inst Liver & Intestinal Res, Amsterdam, Netherlands; [Trifari, Sara; Crellin, Natasha K.] Genentech Inc, Dept Immunol, San Francisco, CA USA; [van Drunen, Cornelis M.; Fokkens, Wytske J.] Univ Amsterdam, Dept Otorhinolaryngol, Amsterdam, Netherlands; [Piet, Berber] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol & Pulmonol, NL-1105 AZ Amsterdam, Netherlands; [Cupedo, Tom] Erasmus Univ, Med Ctr, Dept Hematol, Rotterdam, Netherlands	University of Amsterdam; Roche Holding; Genentech; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC	Spits, H (corresponding author), Univ Amsterdam, Tytgat Inst Liver & Intestinal Res, Amsterdam, Netherlands.	hergen.spits@amc.uva.nl	Spits, Hergen/N-2581-2019; Piet, Berber/AAD-2746-2020; Cupedo, Tom/GQQ-0614-2022; Fokkens, Wytske WJ/ABF-2185-2020	Spits, Hergen/0000-0003-3269-8338; Piet, Berber/0000-0002-9069-3597; van Drunen, Cornelis M/0000-0001-5503-066X				Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Crellin NK, 2010, IMMUNITY, V33, P752, DOI 10.1016/j.immuni.2010.10.012; Crellin NK, 2010, J EXP MED, V207, P281, DOI 10.1084/jem.20091509; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Fuss IJ, 2004, J CLIN INVEST, V113, P1490, DOI 10.1172/JCI200419836; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Koyasu S, 2011, IMMUNOLOGY, V132, P475, DOI 10.1111/j.1365-2567.2011.03413.x; Loza MJ, 2002, BLOOD, V99, P1273, DOI 10.1182/blood.V99.4.1273; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; PHILLIPS JH, 1992, J EXP MED, V175, P1055, DOI 10.1084/jem.175.4.1055; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Tuomi JM, 2010, METHODS, V50, P313, DOI 10.1016/j.ymeth.2010.02.003; Van Bruaene N, 2008, J ALLERGY CLIN IMMUN, V121, P1435, DOI 10.1016/j.jaci.2008.02.018; Vivier E, 2009, NAT REV IMMUNOL, V9, P229, DOI 10.1038/nri2522; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	38	851	887	2	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2011	12	11					1055	U56		10.1038/ni.2104	http://dx.doi.org/10.1038/ni.2104			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	841GG	21909091				2022-12-18	WOS:000296500100010
J	Aran, D; Looney, AP; Liu, LQ; Wu, E; Fong, V; Hsu, A; Chak, S; Naikawadi, RP; Wolters, PJ; Abate, AR; Butte, AJ; Bhattacharya, M				Aran, Dvir; Looney, Agnieszka P.; Liu, Leqian; Wu, Esther; Fong, Valerie; Hsu, Austin; Chak, Suzanna; Naikawadi, Ram P.; Wolters, Paul J.; Abate, Adam R.; Butte, Atul J.; Bhattacharya, Mallar			Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage	NATURE IMMUNOLOGY			English	Article							PULMONARY-FIBROSIS; GM-CSF; GENE-EXPRESSION; HETEROGENEITY; MONOCYTES; DECONVOLUTION; SIGNATURES; ULTRAFAST; DYNAMICS; PATHWAY	Tissue fibrosis is a major cause of mortality that results from the deposition of matrix proteins by an activated mesenchyme. Macrophages accumulate in fibrosis, but the role of specific subgroups in supporting fibrogenesis has not been investigated in vivo. Here, we used single-cell RNA sequencing (scRNA-seq) to characterize the heterogeneity of macrophages in bleomycin-induced lung fibrosis in mice. A novel computational framework for the annotation of scRNA-seq by reference to bulk transcriptomes (SingleR) enabled the subclustering of macrophages and revealed a disease-associated subgroup with a transitional gene expression profile intermediate between monocyte-derived and alveolar macrophages. These CX3CR1(+)SiglecF(+) transitional macrophages localized to the fibrotic niche and had a profibrotic effect in vivo. Human orthologs of genes expressed by the transitional macrophages were upregulated in samples from patients with idiopathic pulmonary fibrosis. Thus, we have identified a pathological subgroup of transitional macrophages that are required for the fibrotic response to injury.	[Aran, Dvir; Butte, Atul J.] Univ Calif San Francisco, Bakar Computat Hlth Sci Inst, San Francisco, CA 94143 USA; [Looney, Agnieszka P.; Wu, Esther; Fong, Valerie; Chak, Suzanna; Naikawadi, Ram P.; Wolters, Paul J.; Bhattacharya, Mallar] Univ Calif San Francisco, Dept Med, Div Pulm Crit Care Allergy & Sleep Med, San Francisco, CA 94143 USA; [Liu, Leqian; Abate, Adam R.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Hsu, Austin] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Abate, Adam R.] Univ Calif San Francisco, California Inst Quantitat Biosci, San Francisco, CA 94143 USA; [Abate, Adam R.] Chan Zuckerberg Biohub, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Bhattacharya, M (corresponding author), Univ Calif San Francisco, Dept Med, Div Pulm Crit Care Allergy & Sleep Med, San Francisco, CA 94143 USA.	mallar.bhattacharya@ucsf.edu	Aran, Dvir/AAV-5625-2020; Hsu, Austin/GZK-8164-2022; Liu, Leqian/E-9496-2016	Aran, Dvir/0000-0001-6334-5039; Hsu, Austin/0000-0002-4361-4358; Liu, Leqian/0000-0001-7003-0174	UCSF Marcus Award; National Institutes of Health [HL131560, HL139897]; Gruss Lipper Postdoctoral Fellowship; UCSF Nina Ireland Program award; National Institutes of Health award (National Institute of Allergy and Infectious Diseases Bioinformatics) [HHSN272201200028C]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL139897, R01HL131560] Funding Source: NIH RePORTER	UCSF Marcus Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gruss Lipper Postdoctoral Fellowship; UCSF Nina Ireland Program award; National Institutes of Health award (National Institute of Allergy and Infectious Diseases Bioinformatics); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a UCSF Marcus Award to M.B. and A.R.A., a National Institutes of Health grant (HL131560) to M.B., a Gruss Lipper Postdoctoral Fellowship to D.A., a UCSF Nina Ireland Program award to R.P.N. and P.J.W., a National Institutes of Health grant (HL139897) to P.J.W., and a National Institutes of Health award (National Institute of Allergy and Infectious Diseases Bioinformatics Support Contract HHSN272201200028C) to A.J.B. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We thank D. Erle, A. Barczak, W. Eckalbar, and M. Adkisson of the UCSF Functional Genomics Core Facility, the UCSF Center for Advanced Technology, the Gladstone Institutes' Histology & Light Microscopy Core, and D. Sheppard for his insightful comments on the manuscript.	Altboum Z, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134947; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Aran D, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1349-1; Blackwell TS, 2014, AM J RESP CRIT CARE, V189, P214, DOI 10.1164/rccm.201306-1141WS; Chen YT, 2011, KIDNEY INT, V80, P1170, DOI 10.1038/ki.2011.208; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; El Agha E, 2017, CELL STEM CELL, V20, P261, DOI 10.1016/j.stem.2016.10.004; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gibbings SL, 2017, AM J RESP CELL MOL, V57, P66, DOI 10.1165/rcmb.2016-0361OC; Gibbons MA, 2011, AM J RESP CRIT CARE, V184, P569, DOI 10.1164/rccm.201010-1719OC; Gong T, 2013, BIOINFORMATICS, V29, P1083, DOI 10.1093/bioinformatics/btt090; Guilliams M, 2015, IMMUNITY, V42, P988, DOI 10.1016/j.immuni.2015.05.020; Hashimshony T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0938-8; Hayes BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092925; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Horikawa S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17948; Huang L, 2018, J EXP MED, V215, P1135, DOI 10.1084/jem.20172020; Hume DA, 2013, NAT IMMUNOL, V14, P187, DOI 10.1038/ni.2516; Hung C, 2013, AM J RESP CRIT CARE, V188, P820, DOI 10.1164/rccm.201212-2297OC; Iwayama T, 2015, GENE DEV, V29, P1106, DOI 10.1101/gad.260554.115; Kang HM, 2018, NAT BIOTECHNOL, V36, P89, DOI 10.1038/nbt.4042; Kitagawa M, 2012, J BIOL CHEM, V287, P27983, DOI 10.1074/jbc.M112.350074; Lachmann A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03751-6; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li HP, 2017, NAT GENET, V49, P708, DOI 10.1038/ng.3818; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; Naikawadi RP, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86704; Noble PW, 2012, J CLIN INVEST, V122, P2756, DOI 10.1172/JCI60323; Olson LE, 2009, DEV CELL, V16, P303, DOI 10.1016/j.devcel.2008.12.003; Qin D, 2010, NAT PROTOC, V5, P491, DOI 10.1038/nprot.2009.234; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Randolph G, 2013, NAT IMMUNOL, V14, P189, DOI 10.1038/ni.2517; Richeldi L, 2017, LANCET, V389, P1941, DOI 10.1016/S0140-6736(17)30866-8; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Rockey DC, 2015, NEW ENGL J MED, V373, P96, DOI 10.1056/NEJMc1504848; Satoh T, 2017, NATURE, V541, P96, DOI 10.1038/nature20611; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Stunnenberg HG, 2016, CELL, V167, P1145, DOI 10.1016/j.cell.2016.11.007; Tan SYS, 2016, DEVELOPMENT, V143, P1318, DOI 10.1242/dev.129122; Verhaak RGW, 2013, J CLIN INVEST, V123, P517, DOI 10.1172/JCI65833; Ware LB, 2002, LANCET, V360, P619, DOI 10.1016/S0140-6736(02)09774-X; Wollin L, 2015, EUR RESPIR J, V45, P1434, DOI 10.1183/09031936.00174914; Xie T, 2018, CELL REP, V22, P3625, DOI 10.1016/j.celrep.2018.03.010; Yang IV, 2013, THORAX, V68, P1114, DOI 10.1136/thoraxjnl-2012-202943; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; Zhou X, 2018, CELL, V172, P744, DOI 10.1016/j.cell.2018.01.015	54	847	854	26	153	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2019	20	2					163	+		10.1038/s41590-018-0276-y	http://dx.doi.org/10.1038/s41590-018-0276-y			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HI2MK	30643263	Green Accepted, Green Submitted			2022-12-18	WOS:000456279100014
J	Wang, Y; Chen, XD; Cao, W; Shi, YF				Wang, Ying; Chen, Xiaodong; Cao, Wei; Shi, Yufang			Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications	NATURE IMMUNOLOGY			English	Review							VERSUS-HOST-DISEASE; PROLIFERATION IN-VITRO; ACUTE-RENAL-FAILURE; GROWTH-FACTOR-BETA; BONE-MARROW; STROMAL CELLS; LYMPHOCYTE-PROLIFERATION; TGF-BETA; INTERFERON-GAMMA; IMMUNE-RESPONSES	Mesenchymal stem cells (MSCs) are multipotent stromal cells that exist in many tissues and are capable of differentiating into several different cell types. Exogenously administered MSCs migrate to damaged tissue sites, where they participate in tissue repair. Their communication with the inflammatory microenvironment is an essential part of this process. In recent years, much has been learned about the cellular and molecular mechanisms of the interaction between MSCs and various participants in inflammation. Depending on their type and intensity, inflammatory stimuli confer on MSCs the ability to suppress the immune response in some cases or to enhance it in others. Here we review the current findings on the immunoregulatory plasticity of MSCs in disease pathogenesis and therapy.	[Wang, Ying; Chen, Xiaodong; Cao, Wei; Shi, Yufang] Shanghai Jiao Tong Univ, Shanghai Inst Biol Sci, Chinese Acad Sci, Key Lab Stem Cell Biol,Inst Hlth Sci,Sch Med, Shanghai 200030, Peoples R China; [Shi, Yufang] Rutgers Robert Wood Johnson Med Sch, Child Hlth Inst New Jersey, New Brunswick, NJ USA; [Shi, Yufang] Soochow Univ, Soochow Inst Translat Med, Suzhou, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Soochow University - China	Shi, YF (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Biol Sci, Chinese Acad Sci, Key Lab Stem Cell Biol,Inst Hlth Sci,Sch Med, Shanghai 200030, Peoples R China.	yfshi@suda.edu.cn	Shi, Yufang/AAE-4431-2020	Shi, Yufang/0000-0001-8964-319X; wang, ying/0000-0002-2571-9367	Chinese Academy of Science [XDA01040107, XDA01040110]; Ministry of Science and Technology of China [2010CB945600]	Chinese Academy of Science(Chinese Academy of Sciences); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	We thank A. Roberts, A. Rabson and G. Brewer for critically reviewing and discussing the manuscript. Supported by the Scientific Innovation Project of the Chinese Academy of Science (XDA01040107 and XDA01040110) and the Ministry of Science and Technology of China (2010CB945600).	Abumaree MH, 2013, STEM CELL REV REP, V9, P620, DOI 10.1007/s12015-013-9455-2; Agata K, 2003, CURR OPIN GENET DEV, V13, P492, DOI 10.1016/j.gde.2003.08.009; Akiyama K, 2012, CELL STEM CELL, V10, P544, DOI 10.1016/j.stem.2012.03.007; Bai L, 2012, NAT NEUROSCI, V15, P862, DOI 10.1038/nn.3109; Baker M., 2009, NATURE; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Burr SP, 2013, IMMUNOL CELL BIOL, V91, P12, DOI 10.1038/icb.2012.60; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Chan JL, 2006, BLOOD, V107, P4817, DOI 10.1182/blood-2006-01-0057; Chen X, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.537; Cho KA, 2009, CELL BIOL INT, V33, P772, DOI 10.1016/j.cellbi.2009.04.023; Constantin G, 2009, STEM CELLS, V27, P2624, DOI 10.1002/stem.194; Crane JL, 2014, J CLIN INVEST, V124, P466, DOI 10.1172/JCI70050; Dalal J, 2012, PEDIATR RES, V71, P445, DOI 10.1038/pr.2011.56; DelaRosa O, 2009, TISSUE ENG PT A, V15, P2795, DOI [10.1089/ten.tea.2008.0630, 10.1089/ten.TEA.2008.0630]; Deng YA, 2014, STEM CELLS DEV, V23, P2080, DOI 10.1089/scd.2013.0559; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Duijvestein M, 2011, STEM CELLS, V29, P1549, DOI 10.1002/stem.698; Francois M, 2009, BLOOD, V114, P2632, DOI 10.1182/blood-2009-02-207795; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Gao PS, 2014, J IMMUNOL, V192, P4560, DOI 10.4049/jimmunol.1303461; Gieseke F, 2007, BLOOD, V110, P2197, DOI 10.1182/blood-2007-04-083162; Han F, 2012, CELL BIOL INT, V36, P823, DOI 10.1042/CBI20110680; Han X, 2014, CELL DEATH DIFFER, V21, P1758, DOI 10.1038/cdd.2014.85; Hare JM, 2012, JAMA-J AM MED ASSOC, V308, P2369, DOI 10.1001/jama.2012.25321; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Inoue S, 2006, TRANSPLANTATION, V81, P1589, DOI 10.1097/01.tp.0000209919.90630.7b; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; Krampera M, 2011, LEUKEMIA, V25, P1408, DOI 10.1038/leu.2011.108; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Krampera M, 2013, CYTOTHERAPY, V15, P1054, DOI 10.1016/j.jcyt.2013.02.010; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Le Blanc K, 2012, NAT REV IMMUNOL, V12, P383, DOI 10.1038/nri3209; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Li W, 2012, CELL DEATH DIFFER, V19, P1505, DOI 10.1038/cdd.2012.26; Li Z, 2010, J CELL MOL MED, V14, P1338, DOI 10.1111/j.1582-4934.2009.00780.x; Ling WF, 2014, CANCER RES, V74, P1576, DOI 10.1158/0008-5472.CAN-13-1656; Luo Y, 2012, SURGERY, V151, P353, DOI 10.1016/j.surg.2011.09.033; Luz-Crawford P, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt216; Ma S, 2014, CELL DEATH DIFFER, V21, P216, DOI 10.1038/cdd.2013.158; MCINTOSH KR, Patent No. 1999047163; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mills KHG, 2011, NAT REV IMMUNOL, V11, P807, DOI 10.1038/nri3095; Nemeth K, 2010, P NATL ACAD SCI USA, V107, P5652, DOI 10.1073/pnas.0910720107; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Polchert D, 2008, EUR J IMMUNOL, V38, P1745, DOI 10.1002/eji.200738129; Prockop DJ, 2012, MOL THER, V20, P14, DOI 10.1038/mt.2011.211; Prockop DJ, 2010, J CELL MOL MED, V14, P2190, DOI 10.1111/j.1582-4934.2010.01151.x; Qian H, 2008, INT J MOL MED, V22, P325, DOI 10.3892/ijmm_00000026; Rafei M, 2009, J IMMUNOL, V182, P5994, DOI 10.4049/jimmunol.0803962; Raicevic G, 2010, HUM IMMUNOL, V71, P235, DOI 10.1016/j.humimm.2009.12.005; RAN G, 2008, CELL STEM CELL, V2, P141; Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005; Ren GW, 2012, STEM CELL TRANSL MED, V1, P51, DOI 10.5966/sctm.2011-0019; Ren GW, 2009, STEM CELLS, V27, P1954, DOI 10.1002/stem.118; Renner P, 2009, TRANSPL P, V41, P2607, DOI 10.1016/j.transproceed.2009.06.119; Roberts EW, 2013, J EXP MED, V210, P1137, DOI 10.1084/jem.20122344; Rose RA, 2008, STEM CELLS, V26, P2884, DOI 10.1634/stemcells.2008-0329; Sakaida I, 2004, HEPATOLOGY, V40, P1304, DOI 10.1002/hep.20452; Shi YF, 2012, TRENDS IMMUNOL, V33, P136, DOI 10.1016/j.it.2011.11.004; Spaggiari GM, 2006, BLOOD, V107, P1484, DOI 10.1182/blood-2005-07-2775; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Spaggiari GM, 2009, BLOOD, V113, P6576, DOI 10.1182/blood-2009-02-203943; Su J, 2014, CELL DEATH DIFFER, V21, P388, DOI 10.1038/cdd.2013.149; Sudres M, 2006, J IMMUNOL, V176, P7761, DOI 10.4049/jimmunol.176.12.7761; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Sun LY, 2010, ARTHRITIS RHEUM-US, V62, P2467, DOI 10.1002/art.27548; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Tyndall A, 2010, BEST PRACT RES CL RH, V24, P565, DOI 10.1016/j.berh.2010.01.008; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; von Bahr L, 2012, STEM CELLS, V30, P1575, DOI 10.1002/stem.1118; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088; Wolf D, 2009, SCAND CARDIOVASC J, V43, P39, DOI 10.1080/14017430802100280; Xu CL, 2014, J IMMUNOL, V192, P103, DOI 10.4049/jimmunol.1302164; Zhang Z, 2012, J GASTROEN HEPATOL, V27, P112, DOI 10.1111/j.1440-1746.2011.07024.x; Zhao H, 2014, CELL STEM CELL, V14, P160, DOI 10.1016/j.stem.2013.12.013; Zhou BO, 2014, CELL STEM CELL, V15, P154, DOI 10.1016/j.stem.2014.06.008	86	847	911	16	243	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2014	15	11					1009	1016		10.1038/ni.3002	http://dx.doi.org/10.1038/ni.3002			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AR5RH	25329189				2022-12-18	WOS:000343640700006
J	Whitacre, CC				Whitacre, CC			Sex differences in autoimmune disease	NATURE IMMUNOLOGY			English	Editorial Material							SYSTEMIC LUPUS-ERYTHEMATOSUS; MULTIPLE-SCLEROSIS; RHEUMATOID-ARTHRITIS; PREGNANCY; INTERFERON; AGE	Autoimmune diseases are more prevalent in women than men. A new interest in understanding the biology of this difference as well as funding opportunities have focused attention on research priorities in sex differences.	Ohio State Univ, Coll Med & Publ Hlth, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Whitacre, CC (corresponding author), Ohio State Univ, Coll Med & Publ Hlth, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.	Whitacre.3@osu.edu						AMADORI A, 1995, NAT MED, V1, P1279, DOI 10.1038/nm1295-1279; ARANEO BA, 1991, BLOOD, V78, P688, DOI 10.1182/blood.V78.3.688.688; BEESON PB, 1994, AM J MED, V96, P457, DOI 10.1016/0002-9343(94)90173-2; COLLIER E, 1999, NIH PUBLICATION, V2, P93; Confavreux C, 1998, NEW ENGL J MED, V339, P285, DOI 10.1056/NEJM199807303390501; Dalal M, 1997, J IMMUNOL, V159, P3; EIDINGER D, 1972, J EXP MED, V136, P1098, DOI 10.1084/jem.136.5.1098; Fishman JR, 1999, NIH PUBLICATION, V2, P15; Gilmore W, 1997, J IMMUNOL, V158, P446; GRIFFIN AC, 1991, J NEUROIMMUNOL, V35, P53, DOI 10.1016/0165-5728(91)90161-Y; HUYGEN K, 1984, CELL IMMUNOL, V85, P75, DOI 10.1016/0008-8749(84)90279-X; Jansson L, 1998, INFLAMM RES, V47, P290, DOI 10.1007/s000110050332; Jawaheer D, 2001, AM J HUM GENET, V68, P927, DOI 10.1086/319518; Kim S, 1999, NEUROLOGY, V52, P1230, DOI 10.1212/WNL.52.6.1230; LOCKSHIN MD, 1989, ARTHRITIS RHEUM, V32, P665, DOI 10.1002/anr.1780320602; MICHAELS RH, 1971, PEDIATRICS, V47, P120; Nelson JL, 1999, LUPUS, V8, P370, DOI 10.1177/096120339900800508; NELSON JL, 1993, NEW ENGL J MED, V329, P466, DOI 10.1056/NEJM199308123290704; Nelson JL, 1997, RHEUM DIS CLIN N AM, V23, P195, DOI 10.1016/S0889-857X(05)70323-9; *NIH, 2000, NIH REP AUT DIS COOR; PETRI M, 1994, RHEUM DIS CLIN N AM, V20, P87; SILVER RM, 1992, BAILLIERE CLIN OB GY, V6, P565, DOI 10.1016/S0950-3552(05)80011-2; SPECTOR TD, 1989, CLIN RHEUMATOL, V8, P37, DOI 10.1007/BF02031066; VRANCKX R, 1986, VOX SANG, V50, P220, DOI 10.1111/j.1423-0410.1986.tb04885.x; WEINSTEIN Y, 1984, J IMMUNOL, V132, P656; WEIZEMANN TM, 2001, EXPLORING BIOL CONTR; Whitacre CC, 1999, SCIENCE, V283, P1277, DOI 10.1126/science.283.5406.1277; WHITACRE CC, 1999, SCIENCE; WILDER RL, 1995, ANNU REV IMMUNOL, V13, P307; WYNN DR, 1990, NEUROLOGY, V40, P780, DOI 10.1212/WNL.40.5.780	30	839	860	4	82	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2001	2	9					777	780		10.1038/ni0901-777	http://dx.doi.org/10.1038/ni0901-777			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	468WM	11526384				2022-12-18	WOS:000170781200009
J	Krausgruber, T; Blazek, K; Smallie, T; Alzabin, S; Lockstone, H; Sahgal, N; Hussell, T; Feldmann, M; Udalova, IA				Krausgruber, Thomas; Blazek, Katrina; Smallie, Tim; Alzabin, Saba; Lockstone, Helen; Sahgal, Natasha; Hussell, Tracy; Feldmann, Marc; Udalova, Irina A.			IRF5 promotes inflammatory macrophage polarization and T(H)1-T(H)17 responses	NATURE IMMUNOLOGY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; COLLAGEN-INDUCED ARTHRITIS; IFN REGULATORY FACTOR-1; GENE-EXPRESSION; T-CELLS; KAPPA-B; GM-CSF; C-REL; IL-23; IL-12	Polymorphisms in the gene encoding the transcription factor IRF5 that lead to higher mRNA expression are associated with many autoimmune diseases. Here we show that IRF5 expression in macrophages was reversibly induced by inflammatory stimuli and contributed to the plasticity of macrophage polarization. High expression of IRF5 was characteristic of M1 macrophages, in which it directly activated transcription of the genes encoding interleukin 12 subunit p40 (IL-12p40), IL-12p35 and IL-23p19 and repressed the gene encoding IL-10. Consequently, those macrophages set up the environment for a potent T helper type 1 (TH1)-T(H)17 response. Global gene expression analysis demonstrated that exogenous IRF5 upregulated or downregulated expression of established phenotypic markers of M1 or M2 macrophages, respectively. Our data suggest a critical role for IRF5 in M1 macrophage polarization and define a previously unknown function for IRF5 as a transcriptional repressor.	[Krausgruber, Thomas; Blazek, Katrina; Smallie, Tim; Alzabin, Saba; Feldmann, Marc; Udalova, Irina A.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Kennedy Inst, Div Rheumatol, London, England; [Lockstone, Helen; Sahgal, Natasha] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Hussell, Tracy] Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, London, England	Imperial College London; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Imperial College London	Udalova, IA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Kennedy Inst, Div Rheumatol, London, England.	i.udalova@imperial.ac.uk	Krausgruber, Thomas/H-8490-2018; Blazek, Katrina/AAU-6194-2020; Hussell, Tracy/O-4630-2014	Krausgruber, Thomas/0000-0002-1374-0329; Hussell, Tracy/0000-0001-7186-6141; Udalova, Irina/0000-0002-6716-2528; Blazek, Katrina/0000-0002-4439-4756; Alzabin, Saba/0000-0003-3474-1846	Medical Research Council [82189]; European Community [222008]; Arthritis Research UK; MRC [G0700818, G0802752] Funding Source: UKRI; Medical Research Council [G0802752, G0700818, G1000758B, G1000758] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community(European Commission); Arthritis Research UK(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank M. Cavanach for assistance with cell-characterization experiments; D. Barban for microarray hybridizations; F. G. Goh, D. G. Saliba and S. Thomson for advice and suggestions on RNA-mediated interference and chromatin immunoprecipitation; X. Ma (Cornell University) for luciferase constructs driven by the IL12A promoter; and C. Monaco and M. E. Goddard for support with animal experiments. Supported by the Medical Research Council (82189 to I. A. U.), the European Community Seventh Framework Programme FP7/2007-2013 (222008) and Arthritis Research UK.	Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Campbell IK, 1998, J IMMUNOL, V161, P3639; Cook AD, 2001, ARTHRITIS RES, V3, P293, DOI 10.1186/ar318; Dideberg V, 2007, HUM MOL GENET, V16, P3008, DOI 10.1093/hmg/ddm259; Dieguez-Gonzalez R, 2008, ARTHRITIS RHEUM-US, V58, P1264, DOI 10.1002/art.23426; El Chartouni C, 2010, IMMUNOBIOLOGY, V215, P821, DOI 10.1016/j.imbio.2010.05.031; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; Fleetwood AJ, 2009, J LEUKOCYTE BIOL, V86, P411, DOI 10.1189/jlb.1108702; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; Hoeve MA, 2006, EUR J IMMUNOL, V36, P661, DOI 10.1002/eji.200535239; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Krausgruber T, 2010, BLOOD, V115, P4421, DOI 10.1182/blood-2010-01-263020; Kristjansdottir G, 2008, J MED GENET, V45, P362, DOI 10.1136/jmg.2007.055012; Lacaze P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-372; Liu JG, 2003, J EXP MED, V198, P1265, DOI 10.1084/jem.20030026; Mancl ME, 2005, J BIOL CHEM, V280, P21078, DOI 10.1074/jbc.M500543200; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Miceli-Richard C, 2007, ARTHRITIS RHEUM, V56, P3989, DOI 10.1002/art.23142; Mise-Omata S, 2007, J IMMUNOL, V179, P6596, DOI 10.4049/jimmunol.179.10.6596; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Nistala K, 2010, P NATL ACAD SCI USA, V107, P14751, DOI 10.1073/pnas.1003852107; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Ouyang XS, 2007, BIOCHEM BIOPH RES CO, V354, P1045, DOI 10.1016/j.bbrc.2007.01.090; Ponting CP, 2008, NAT REV GENET, V9, P689, DOI 10.1038/nrg2413; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Romagnani P, 2000, EUR CYTOKINE NETW, V11, P510; Romagnani S, 2009, MOL IMMUNOL, V47, P3, DOI 10.1016/j.molimm.2008.12.019; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Sanjabi S, 2000, P NATL ACAD SCI USA, V97, P12705, DOI 10.1073/pnas.230436397; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Schneemann M, 2007, J LEUKOCYTE BIOL, V81, P579, DOI 10.1189/jlb.1106702; Shen H, 2010, J MOL CELL BIOL, V2, P284, DOI 10.1093/jmcb/mjq023; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Ziegler-Heitbrock L, 2003, J IMMUNOL, V171, P285, DOI 10.4049/jimmunol.171.1.285	50	833	888	3	147	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2011	12	3					231	U66		10.1038/ni.1990	http://dx.doi.org/10.1038/ni.1990			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	721KZ	21240265				2022-12-18	WOS:000287354400010
J	Reboldi, A; Coisne, C; Baumjohann, D; Benvenuto, F; Bottinelli, D; Lira, S; Uccelli, A; Lanzavecchia, A; Engelhardt, B; Sallusto, F				Reboldi, Andrea; Coisne, Caroline; Baumjohann, Dirk; Benvenuto, Federica; Bottinelli, Denise; Lira, Sergio; Uccelli, Antonio; Lanzavecchia, Antonio; Engelhardt, Britta; Sallusto, Federica			C-C chemokine receptor 6-regulated entry of T-H-17 cells into the CNS through the choroid plexus is required for the initiation of EAE	NATURE IMMUNOLOGY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; REGULATORY T-CELLS; MULTIPLE-SCLEROSIS; TH17 CELLS; LYMPHOCYTE TRAFFICKING; MOLECULAR-MECHANISMS; LEUKOCYTE MIGRATION; DENDRITIC CELLS	Interleukin 17-producing T helper cells (TH-17 cells) are important in experimental autoimmune encephalomyelitis, but their route of entry into the central nervous system (CNS) and their contribution relative to that of other effector T cells remain to be determined. Here we found that mice lacking CCR6, a chemokine receptor characteristic of TH-17 cells, developed TH-17 responses but were highly resistant to the induction of experimental autoimmune encephalomyelitis. Disease susceptibility was reconstituted by transfer of wild-type T cells that entered into the CNS before disease onset and triggered massive CCR6-independent recruitment of effector T cells across activated parenchymal vessels. The CCR6 ligand CCL20 was constitutively expressed in epithelial cells of choroid plexus in mice and humans. Our results identify distinct molecular requirements and ports of lymphocyte entry into uninflamed versus inflamed CNS and suggest that the CCR6-CCL20 axis in the choroid plexus controls immune surveillance of the CNS.	[Reboldi, Andrea; Baumjohann, Dirk; Bottinelli, Denise; Lanzavecchia, Antonio; Sallusto, Federica] Biomed Res Inst, Bellinzona, Switzerland; [Coisne, Caroline; Engelhardt, Britta] Univ Bern, Theodor Kocher Inst, Bern, Switzerland; [Benvenuto, Federica; Uccelli, Antonio] Univ Genoa, Neuroimmunol Unit, Genoa, Italy; [Benvenuto, Federica; Uccelli, Antonio] Univ Genoa, Ctr Excellence Biomed Res, Genoa, Italy; [Lira, Sergio] Mt Sinai Sch Med, New York, NY USA; [Uccelli, Antonio] Adv Biotechnol Ctr, Genoa, Italy	Universita della Svizzera Italiana; University of Bern; University of Genoa; University of Genoa; Icahn School of Medicine at Mount Sinai	Sallusto, F (corresponding author), Biomed Res Inst, Bellinzona, Switzerland.	federica.sallusto@irb.unisi.ch	Engelhardt, Britta/K-7267-2014; UCCELLI, Antonio/E-7343-2012; Baumjohann, Dirk/C-9047-2009	Engelhardt, Britta/0000-0003-3059-9846; UCCELLI, Antonio/0000-0002-2008-6038; Baumjohann, Dirk/0000-0001-8385-8288	Swiss National Science Foundation [31-101962]; European Commission [LSB-CT-2005-518167 IINOCHEM, LSHG-CT-2005-005203 MUGEN]; US National Multiple Sclerosis Society; Swiss Multiple Sclerosis Society; Italian Foundation for Multiple Sclerosis [2007-2009]; European Union-funded International Graduate Program in Molecular Medicine; Boehringer Ingelheim Fonds; Helmut Horten Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); US National Multiple Sclerosis Society(National Multiple Sclerosis Society); Swiss Multiple Sclerosis Society; Italian Foundation for Multiple Sclerosis; European Union-funded International Graduate Program in Molecular Medicine(European Commission); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Helmut Horten Foundation	We thank D. Jarrossay for cell sorting; T. Perinat and S. Minghelli for immunohistology analysis; E. Mira Cato and L. Perlini for technical assistance; B. Becher (University Hospital Zurich), C. Gerard (Harvard Medical School), J. Kirberg (Max-Plank Institute of Immunobiology) and M. Lipp (Max Delbruck Center) for mouse strains; L. Sallusto for discussions and support; and A. Almeida, A. Martin-Fontecha, G. Napolitani, U. Schenk and M. Uguccioni for discussions. Supported by the Swiss National Science Foundation (31-101962 to F. S.), the European Commission Sixth Framework Programme (LSB-CT-2005-518167 IINOCHEM and LSHG-CT-2005-005203 MUGEN), the US National Multiple Sclerosis Society (B. E. and C. C.), the Swiss Multiple Sclerosis Society, the Italian Foundation for Multiple Sclerosis (Stem Cell Project 2007-2009), the European Union-funded International Graduate Program in Molecular Medicine (A. R.), Boehringer Ingelheim Fonds (D. B.) and the Helmut Horten Foundation (to The Institute for Research in Biomedicine).	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Ambrosini E, 2003, GLIA, V41, P290, DOI 10.1002/glia.10193; Balashov KE, 1999, P NATL ACAD SCI USA, V96, P6873, DOI 10.1073/pnas.96.12.6873; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Brown DA, 2007, J COMP NEUROL, V502, P236, DOI 10.1002/cne.21307; Carrithers MD, 2000, BRAIN, V123, P1092, DOI 10.1093/brain/123.6.1092; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Columba-Cabezas S, 2003, BRAIN PATHOL, V13, P38; Cook DN, 2000, IMMUNITY, V12, P495, DOI 10.1016/S1074-7613(00)80201-0; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Eltayeb S, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-14; Engelhardt B, 2001, MICROSC RES TECHNIQ, V52, P112, DOI 10.1002/1097-0029(20010101)52:1<112::AID-JEMT13>3.0.CO;2-5; Engelhardt B, 1997, BLOOD, V90, P4459, DOI 10.1182/blood.V90.11.4459.4459_4459_4472; Engelhardt B, 2005, TRENDS IMMUNOL, V26, P485, DOI 10.1016/j.it.2005.07.004; Flugel A, 2001, IMMUNITY, V14, P547, DOI 10.1016/s1074-7613(01)00143-1; Franciotta D, 2008, LANCET NEUROL, V7, P852, DOI 10.1016/S1474-4422(08)70192-3; Gaffen SL, 2008, CYTOKINE, V43, P402, DOI 10.1016/j.cyto.2008.07.017; Gaupp S, 2003, AM J PATHOL, V162, P139, DOI 10.1016/S0002-9440(10)63805-9; Giunti D, 2003, J LEUKOCYTE BIOL, V73, P584, DOI 10.1189/jlb.1202598; Greaves DR, 1997, J EXP MED, V186, P837, DOI 10.1084/jem.186.6.837; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Hickey WF, 2001, GLIA, V36, P118, DOI 10.1002/glia.1101; HICKEY WF, 1991, J NEUROSCI RES, V28, P254, DOI 10.1002/jnr.490280213; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hofstetter HH, 2005, CELL IMMUNOL, V237, P123, DOI 10.1016/j.cellimm.2005.11.002; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kivisakk P, 2009, ANN NEUROL, V65, P457, DOI 10.1002/ana.21379; Kleinewietfeld M, 2005, BLOOD, V105, P2877, DOI 10.1182/blood-2004-07-2505; Kohler RE, 2003, J IMMUNOL, V170, P6298, DOI 10.4049/jimmunol.170.12.6298; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Kreymborg K, 2007, J IMMUNOL, V179, P8098, DOI 10.4049/jimmunol.179.12.8098; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lees JR, 2008, J EXP MED, V205, P2633, DOI 10.1084/jem.20080155; Liu LP, 2006, J IMMUNOL, V176, P4399, DOI 10.4049/jimmunol.176.7.4399; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Matsui M, 2002, J NEUROIMMUNOL, V128, P16, DOI 10.1016/S0165-5728(02)00121-2; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; Muller M, 2007, J IMMUNOL, V179, P2774, DOI 10.4049/jimmunol.179.5.2774; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; Pedemonte E, 2006, PHARMACOL THERAPEUT, V111, P555, DOI 10.1016/j.pharmthera.2005.11.007; Piccio L, 2002, J IMMUNOL, V168, P1940, DOI 10.4049/jimmunol.168.4.1940; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Rossi DL, 1997, J IMMUNOL, V158, P1033; Rottman JB, 2000, EUR J IMMUNOL, V30, P2372, DOI 10.1002/1521-4141(2000)30:8<2372::AID-IMMU2372>3.0.CO;2-D; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; Steffen BJ, 1996, AM J PATHOL, V148, P1819; Steinman L, 1996, P NATL ACAD SCI USA, V93, P2253, DOI 10.1073/pnas.93.6.2253; Steinman L, 2008, J EXP MED, V205, P1517, DOI 10.1084/jem.20072066; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Vajkoczy P, 2001, J CLIN INVEST, V108, P557; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0	60	831	855	1	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2009	10	5					514	523		10.1038/ni.1716	http://dx.doi.org/10.1038/ni.1716			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	436EC	19305396				2022-12-18	WOS:000265394400013
J	Linton, PJ; Dorshkind, K				Linton, PJ; Dorshkind, K			Age-related changes in lymphocyte development and function	NATURE IMMUNOLOGY			English	Review							HEMATOPOIETIC STEM-CELLS; BONE-MARROW-TRANSPLANTATION; PRIMARY IMMUNE-RESPONSE; CD8 T-CELLS; PRO-B CELLS; OLD MICE; THYMIC ATROPHY; REPERTOIRE DIVERSITY; ANTIBODY-PRODUCTION; BACTERIAL-ANTIGENS	The effects of aging on the immune system are widespread and extend from hematopoietic stem cells and lymphoid progenitors in the bone marrow and thymus to mature lymphocytes in secondary lymphoid organs. These changes combine to result in a diminution of immune responsiveness in the elderly. This review aims to provide an overview of age-related changes in lymphocyte development and function and discusses current controversies in the field of aging research.	Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Hematopoiet Malignancies Program, Los Angeles, CA 90095 USA; Sidney Kimmel Canc Ctr, San Diego, CA 92121 USA	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Dorshkind, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.	kdorshki@mednet.ucla.edu			NATIONAL INSTITUTE ON AGING [R01AG019249, R01AG021450, P01AG001743] Funding Source: NIH RePORTER; NIA NIH HHS [AG 01743, AG 19249, AG 21450] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; Andrew D, 2002, EXP GERONTOL, V37, P455, DOI 10.1016/S0531-5565(01)00213-3; Andrew D, 2001, J IMMUNOL, V166, P1524, DOI 10.4049/jimmunol.166.3.1524; Aspinall R, 2000, VACCINE, V18, P1629, DOI 10.1016/S0264-410X(99)00498-3; Aspinall R, 1997, J IMMUNOL, V158, P3037; Aspinall R, 2001, CELL IMMUNOL, V212, P150, DOI 10.1006/cimm.2001.1848; BENNER R, 1980, DEV COMP IMMUNOL, V4, P591, DOI 10.1016/S0145-305X(80)80062-0; Blackburn CC, 2002, TRENDS IMMUNOL, V23, P391, DOI 10.1016/S1471-4906(02)02265-2; CALLAHAN JE, 1993, J IMMUNOL, V151, P6657; Cancro MP, 2003, IMMUNOL RES, V27, P141, DOI 10.1385/IR:27:2-3:141; Ceredig R, 2002, NAT REV IMMUNOL, V2, P888, DOI 10.1038/nri937; CHERTKOV JL, 1981, EXP GERONTOL, V16, P195, DOI 10.1016/0531-5565(81)90045-0; Chung JB, 2003, TRENDS IMMUNOL, V24, P343, DOI 10.1016/S1471-4906(03)00119-4; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; de Haan G, 2002, BLOOD, V100, P2056, DOI 10.1182/blood-2002-03-0808; Donskoy E, 2003, J IMMUNOL, V171, P3568, DOI 10.4049/jimmunol.171.7.3568; Dorshkind K, 2003, CLIN IMMUNOL, V109, P197, DOI 10.1016/S1521-6616(03)00181-5; Effros RB, 2003, CRIT REV IMMUNOL, V23, P45, DOI 10.1615/CritRevImmunol.v23.i12.30; Effros RB, 2000, MECH AGEING DEV, V121, P161; Frasca D, 2003, J IMMUNOL, V170, P719, DOI 10.4049/jimmunol.170.2.719; French RA, 2002, ENDOCRINOLOGY, V143, P690, DOI 10.1210/en.143.2.690; Garcia GG, 2001, J IMMUNOL, V166, P3151, DOI 10.4049/jimmunol.166.5.3151; Geiger H, 2002, NAT IMMUNOL, V3, P329, DOI 10.1038/ni0402-329; Gill J, 2002, NAT IMMUNOL, V3, P635, DOI 10.1038/ni812; GOIDL EA, 1976, J EXP MED, V144, P1037, DOI 10.1084/jem.144.4.1037; Grubeck-Loebenstein B, 2002, ADV IMMUNOL, V80, P243, DOI 10.1016/S0065-2776(02)80017-7; Han SS, 2003, J IMMUNOL, V170, P1267, DOI 10.4049/jimmunol.170.3.1267; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; HARRISON DE, 1983, J EXP MED, V157, P1496, DOI 10.1084/jem.157.5.1496; Haynes BF, 2000, ANNU REV IMMUNOL, V18, P529, DOI 10.1146/annurev.immunol.18.1.529; Haynes L, 2003, P NATL ACAD SCI USA, V100, P15053, DOI 10.1073/pnas.2433717100; Henckaerts E, 2002, BLOOD, V99, P3947, DOI 10.1182/blood.V99.11.3947; HIROKAWA K, 1986, CELL IMMUNOL, V100, P443, DOI 10.1016/0008-8749(86)90043-2; Hirokawa K, 1999, EXP GERONTOL, V34, P7, DOI 10.1016/S0531-5565(98)00067-9; HOTTA T, 1980, EXP HEMATOL, V8, P933; Hsu HC, 2003, GENES IMMUN, V4, P402, DOI 10.1038/sj.gene.6363982; Issa JP, 2003, CLIN IMMUNOL, V109, P103, DOI 10.1016/S1521-6616(03)00203-1; JACOBSON EB, 1974, CELL IMMUNOL, V13, P416, DOI 10.1016/0008-8749(74)90261-5; Jamieson BD, 1999, IMMUNITY, V10, P569, DOI 10.1016/S1074-7613(00)80056-4; Johnson KM, 2002, INT IMMUNOL, V14, P1313, DOI 10.1093/intimm/dxf092; Johnson SA, 2002, J IMMUNOL, V168, P5014, DOI 10.4049/jimmunol.168.10.5014; Kapasi ZF, 2002, EUR J IMMUNOL, V32, P1567, DOI 10.1002/1521-4141(200206)32:6<1567::AID-IMMU1567>3.0.CO;2-P; KELLEY KW, 1986, P NATL ACAD SCI USA, V83, P5663, DOI 10.1073/pnas.83.15.5663; Khan N, 2002, J IMMUNOL, V169, P1984, DOI 10.4049/jimmunol.169.4.1984; Kincade PW, 2000, IMMUNOL REV, V175, P128, DOI 10.1034/j.1600-065X.2000.017502.x; Kline GH, 1999, J IMMUNOL, V162, P3342; Klug DB, 2002, J IMMUNOL, V169, P2842, DOI 10.4049/jimmunol.169.6.2842; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; KU CC, 2000, IMMUNOL REV, V180, P139; Lamberts SWJ, 1997, SCIENCE, V278, P419, DOI 10.1126/science.278.5337.419; LeBien TW, 2000, BLOOD, V96, P9, DOI 10.1182/blood.V96.1.9; LERNER A, 1989, EUR J IMMUNOL, V19, P977, DOI 10.1002/eji.1830190604; Li F, 2001, EUR J IMMUNOL, V31, P500, DOI 10.1002/1521-4141(200102)31:2<500::AID-IMMU500>3.0.CO;2-C; Linton PJ, 1996, J EXP MED, V184, P1891, DOI 10.1084/jem.184.5.1891; Lloberas J, 2002, EXP GERONTOL, V37, P1325, DOI 10.1016/S0531-5565(02)00125-0; Mackall CL, 1998, EUR J IMMUNOL, V28, P1886, DOI 10.1002/(SICI)1521-4141(199806)28:06<1886::AID-IMMU1886>3.0.CO;2-M; MAIZELS N, 1985, CELL, V43, P715, DOI 10.1016/0092-8674(85)90244-2; Makinodan T, 1980, Adv Immunol, V29, P287, DOI 10.1016/S0065-2776(08)60047-4; Martin CH, 2003, NAT IMMUNOL, V4, P866, DOI 10.1038/ni965; Miller JP, 2003, J IMMUNOL, V171, P2326, DOI 10.4049/jimmunol.171.5.2326; Miller RA, 1997, IMMUNOL REV, V160, P79, DOI 10.1111/j.1600-065X.1997.tb01029.x; Montecino-Rodriguez E, 1998, ENDOCRINOLOGY, V139, P4120, DOI 10.1210/en.139.10.4120; Morrison SJ, 2002, J IMMUNOL, V168, P635, DOI 10.4049/jimmunol.168.2.635; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Napolitano LA, 2002, AIDS, V16, P1103, DOI 10.1097/00002030-200205240-00003; Nel AE, 2002, J ALLERGY CLIN IMMUN, V109, P901, DOI 10.1067/mai.2002.124965; NICOLETTI C, 1993, J IMMUNOL, V150, P543; NICOLETTI C, 1991, CELL IMMUNOL, V133, P72, DOI 10.1016/0008-8749(91)90180-J; Olsen NJ, 1998, ENDOCRINOLOGY, V139, P748, DOI 10.1210/en.139.2.748; Ortman CL, 2002, INT IMMUNOL, V14, P813, DOI 10.1093/intimm/dxf042; Pawelec G, 1998, J LEUKOCYTE BIOL, V64, P703, DOI 10.1002/jlb.64.6.703; Pinto A, 2003, CRIT REV ONCOL HEMAT, V48, pS3, DOI 10.1016/j.critrevonc.2003.06.006; Po JLZ, 2002, MECH AGEING DEV, V123, P1167, DOI 10.1016/S0047-6374(02)00010-6; Renshaw M, 2002, J IMMUNOL, V169, P4697, DOI 10.4049/jimmunol.169.9.4697; RILEY SC, 1989, J IMMUNOL, V143, P3798; Savino W, 2000, ENDOCR REV, V21, P412, DOI 10.1210/er.21.4.412; Schwab R, 1997, J IMMUNOL, V158, P4493; SHARP A, 1990, EUR J IMMUNOL, V20, P2541, DOI 10.1002/eji.1830201203; Sherwood EM, 2000, MECH AGEING DEV, V118, P45, DOI 10.1016/S0047-6374(00)00157-3; SHORES EW, 1994, INT IMMUNOL, V6, P1393, DOI 10.1093/intimm/6.9.1393; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Solana R, 2000, VACCINE, V18, P1613, DOI 10.1016/S0264-410X(99)00495-8; SPRECHER E, 1990, J INVEST DERMATOL, V94, P247, DOI 10.1111/1523-1747.ep12874586; Stephan RP, 1998, BLOOD, V91, P75, DOI 10.1182/blood.V91.1.75.75_75_88; Stephan RP, 1997, J IMMUNOL, V158, P1598; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Szabo P, 2003, CELL IMMUNOL, V222, P78, DOI 10.1016/S0008-8749(03)00084-4; Takahashi Y, 1998, J EXP MED, V187, P885, DOI 10.1084/jem.187.6.885; Thoman ML, 1997, CELL IMMUNOL, V178, P117, DOI 10.1006/cimm.1997.1133; THOMAN ML, 1995, MECH AGEING DEV, V82, P155, DOI 10.1016/0047-6374(95)01597-S; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; TYAN ML, 1977, J IMMUNOL, V118, P846; UTSUYAMA M, 1989, MECH AGEING DEV, V47, P175, DOI 10.1016/0047-6374(89)90030-4; Uyemura K, 2002, MECH AGEING DEV, V123, P955, DOI 10.1016/S0047-6374(02)00033-7; WHISLER RL, 1993, MECH AGEING DEV, V71, P31, DOI 10.1016/0047-6374(93)90033-N; Yang XH, 1996, J EXP MED, V183, P959, DOI 10.1084/jem.183.3.959; ZHARHARY D, 1977, MECH AGEING DEV, V6, P385, DOI 10.1016/0047-6374(77)90040-9; Zheng B, 1997, IMMUNOL REV, V160, P63, DOI 10.1111/j.1600-065X.1997.tb01028.x	100	828	856	0	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2004	5	2					133	139		10.1038/ni1033	http://dx.doi.org/10.1038/ni1033			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	768DB	14749784				2022-12-18	WOS:000188512000008
J	Taylor, PR; Tsoni, SV; Willment, JA; Dennehy, KM; Rosas, M; Findon, H; Haynes, K; Steele, C; Botto, M; Gordon, S; Brown, GD				Taylor, Philip R.; Tsoni, S. Vicky; Willment, Janet A.; Dennehy, Kevin M.; Rosas, Marcela; Findon, Helen; Haynes, Ken; Steele, Chad; Botto, Marina; Gordon, Siamon; Brown, Gordon D.			Dectin-1 is required for beta-glucan recognition and control of fungal infection	NATURE IMMUNOLOGY			English	Article							TOLL-LIKE RECEPTOR-2; CANDIDA-ALBICANS; DENDRITIC CELLS; MACROPHAGES; IMMUNITY; PHAGOCYTOSIS; NEUTROPHILS; EXPRESSION; INNATE; YEAST	beta-Glucan is one of the most abundant polysaccharides in fungal pathogens, yet its importance in antifungal immunity is unclear. Here we show that deficiency of dectin-1, the myeloid receptor for beta-glucan, rendered mice susceptible to infection with Candida albicans. Dectin-1-deficient leukocytes demonstrated significantly impaired responses to fungi even in the presence of opsonins. Impaired leukocyte responses were manifested in vivo by reduced inflammatory cell recruitment after fungal infection, resulting in substantially increased fungal burdens and enhanced fungal dissemination. Our results establish a fundamental function for beta-glucan recognition by dectin-1 in antifungal immunity and demonstrate a signaling non-Toll-like pattern-recognition receptor required for the induction of protective immune responses.	Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Univ London Imperial Coll Sci Technol & Med, London W12 0NN, England; Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Pediat,Div Pulmonol, Pittsburgh, PA 15213 USA	University of Cape Town; University of Oxford; Imperial College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Brown, GD (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.	gordon.brown@mweb.co.za	Rosas Nexticapa, Marcela/HGU-1088-2022; brown, gordon/B-4249-2012	Willment, Janet/0000-0002-7040-0857; Taylor, Philip/0000-0003-0163-1421; brown, gordon/0000-0002-0287-5383	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080317] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/B/10331] Funding Source: Medline; NHLBI NIH HHS [1R01HL080317, R01 HL080317] Funding Source: Medline; Wellcome Trust [071467, 070579, 055109, 072420, 070018] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Wellcome Trust(Wellcome TrustEuropean Commission)		Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199; Bellocchio S, 2004, J IMMUNOL, V172, P3059, DOI 10.4049/jimmunol.172.5.3059; Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; Borges-Walmsley MI, 2002, TRENDS MICROBIOL, V10, P80, DOI 10.1016/S0966-842X(01)02292-2; Brieland J, 2001, INFECT IMMUN, V69, P5046, DOI 10.1128/IAI.69.8.5046-5055.2001; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; CALDERONE RA, 1991, MICROBIOL REV, V55, P1; Cambi A, 2003, EUR J IMMUNOL, V33, P532, DOI 10.1002/immu.200310029; CROSS CE, 1995, INFECT IMMUN, V63, P2604, DOI 10.1128/IAI.63.7.2604-2611.1995; Decleva E, 2006, J LEUKOCYTE BIOL, V79, P87, DOI 10.1189/jlb.0605338; DICARLO FJ, 1958, SCIENCE, V127, P756, DOI 10.1126/science.127.3301.756-a; Evans SE, 2005, AM J RESP CELL MOL, V32, P490, DOI 10.1165/rcmb.2004-0300OC; Gale CA, 1998, SCIENCE, V279, P1355, DOI 10.1126/science.279.5355.1355; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gersuk GM, 2006, J IMMUNOL, V176, P3717, DOI 10.4049/jimmunol.176.6.3717; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Grunebach F, 2002, EXP HEMATOL, V30, P1309, DOI 10.1016/S0301-472X(02)00928-1; Heinsbroek SEM, 2006, J IMMUNOL, V176, P5513, DOI 10.4049/jimmunol.176.9.5513; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Hong F, 2004, J IMMUNOL, V173, P797, DOI 10.4049/jimmunol.173.2.797; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; MacCallum DM, 2005, MYCOSES, V48, P151, DOI 10.1111/j.1439-0507.2005.01121.x; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; NATHAN CF, 1977, J EXP MED, V146, P1648, DOI 10.1084/jem.146.6.1648; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Reid DM, 2004, J LEUKOCYTE BIOL, V76, P86, DOI 10.1189/jlb.0104031; Rice PJ, 2005, J PHARMACOL EXP THER, V314, P1079, DOI 10.1124/jpet.105.085415; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Ross GD, 1999, IMMUNOPHARMACOLOGY, V42, P61, DOI 10.1016/S0162-3109(99)00013-2; Steele C, 2003, J EXP MED, V198, P1677, DOI 10.1084/jem.20030932; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Taylor PR, 2004, J IMMUNOL, V172, P1157, DOI 10.4049/jimmunol.172.2.1157; Taylor PR, 2003, EUR J IMMUNOL, V33, P2090, DOI 10.1002/eji.200324003; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; Tzianabos AO, 2000, CLIN MICROBIOL REV, V13, P523, DOI 10.1128/CMR.13.4.523-533.2000; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Viriyakosol S., 2005, INFECT IMMUN, V73, P1553; Vonk AG, 2002, J MICROBIOL METH, V49, P55, DOI 10.1016/S0167-7012(01)00348-7; Wheeler RT, 2006, PLOS PATHOG, V2, P328, DOI 10.1371/journal.ppat.0020035; Willment JA, 2005, EUR J IMMUNOL, V35, P1539, DOI 10.1002/eji.200425725; Willment JA, 2001, J BIOL CHEM, V276, P43818, DOI 10.1074/jbc.M107715200; Willment JA, 2003, J IMMUNOL, V171, P4569, DOI 10.4049/jimmunol.171.9.4569	50	826	868	4	121	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2007	8	1					31	38		10.1038/ni1408	http://dx.doi.org/10.1038/ni1408			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	118HZ	17159984	Green Accepted			2022-12-18	WOS:000242934400011
J	Pandiyan, P; Zheng, LX; Ishihara, S; Reed, J; Lenardo, MJ				Pandiyan, Pushpa; Zheng, Lixin; Ishihara, Satoru; Reed, Jennifer; Lenardo, Michael J.			CD4(+) CD25(+) Foxp3(+) regulatory T cells induce cytokine deprivation -mediated apoptosis of effector CD4(+) T cells	NATURE IMMUNOLOGY			English	Article							IN-VIVO; INTESTINAL INFLAMMATION; DENDRITIC CELLS; CUTTING EDGE; SUPPRESSOR FUNCTION; AUTOIMMUNE-DISEASE; INTERLEUKIN-2; IL-2; ACTIVATION; DEATH	A key issue in mammalian immunology is how CD4(+) CD25(+) Foxp3(+) regulatory T cells ( T-reg cells) suppress immune responses. Here we show that Treg cells induced apoptosis of effector CD4+ T cells in vitro and in vivo in a mouse model of inflammatory bowel disease. Treg cells did not affect the early activation or proliferation of effector CD4(+) T cells. Cytokines that signal through the common gamma- chain suppressed T-reg cell- induced apoptosis. T-reg cell-induced effector CD4(+) T cell death required the proapoptotic protein Bim, and effector CD4(+) T cells incubated with T-reg cells showed less activation of the prosurvival kinase Akt and less phosphorylation of the proapoptotic protein Bad. Thus, cytokine deprivation-induced apoptosis is a prominent mechanism by which T-reg cells inhibit effector T cell responses.	NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; NIAID, Cellular & Mol Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lenardo, MJ (corresponding author), NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA.	lenardo@nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000566, Z01AI000566] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Asseman C, 2003, J IMMUNOL, V171, P971, DOI 10.4049/jimmunol.171.2.971; Barthlott T, 2005, INT IMMUNOL, V17, P279, DOI 10.1093/intimm/dxh207; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Grossman WJ, 2004, IMMUNITY, V21, P589, DOI 10.1016/j.immuni.2004.09.002; Harnaha J, 2006, DIABETES, V55, P158, DOI 10.2337/diabetes.55.01.06.db05-0340; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Kataoka H, 2005, INT IMMUNOL, V17, P421, DOI 10.1093/intimm/dxh221; Klein L, 2003, P NATL ACAD SCI USA, V100, P8886, DOI 10.1073/pnas.1533365100; Kullberg MC, 2005, EUR J IMMUNOL, V35, P2886, DOI 10.1002/eji.200526106; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; LINDSTEN T, 1989, SCIENCE, V244, P339, DOI 10.1126/science.2540528; Makita S, 2007, J IMMUNOL, V178, P4937, DOI 10.4049/jimmunol.178.8.4937; Maloy KJ, 2005, NAT IMMUNOL, V6, P1071, DOI 10.1038/ni1105-1071; Martin B, 2004, J IMMUNOL, V172, P3391, DOI 10.4049/jimmunol.172.6.3391; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Pace L, 2005, J IMMUNOL, V174, P7645, DOI 10.4049/jimmunol.174.12.7645; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Read S, 2006, J IMMUNOL, V177, P4376, DOI 10.4049/jimmunol.177.7.4376; Rudensky AY, 2006, J EXP MED, V203, P489, DOI 10.1084/jem.20060214; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Scheffold A, 2005, EUR J IMMUNOL, V35, P1336, DOI 10.1002/eji.200425887; Schimpl A, 2002, CYTOKINE GROWTH F R, V13, P369, DOI 10.1016/S1359-6101(02)00022-9; Sojka DK, 2005, J IMMUNOL, V175, P7274, DOI 10.4049/jimmunol.175.11.7274; Sojka DK, 2004, J IMMUNOL, V172, P6136, DOI 10.4049/jimmunol.172.10.6136; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Strasser A, 2000, ANN NY ACAD SCI, V917, P541; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Thornton AM, 2004, J IMMUNOL, V172, P6519, DOI 10.4049/jimmunol.172.11.6519; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; Thornton AM, 2004, EUR J IMMUNOL, V34, P366, DOI 10.1002/eji.200324455; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Wildey GM, 2003, J BIOL CHEM, V278, P18069, DOI 10.1074/jbc.M211958200; Zheng LX, 1998, J IMMUNOL, V160, P763	50	825	860	4	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2007	8	12					1353	1362		10.1038/ni1536	http://dx.doi.org/10.1038/ni1536			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	235XG	17982458				2022-12-18	WOS:000251267000016
J	Hoffmann, JA; Reichhart, JM				Hoffmann, JA; Reichhart, JM			Drosophila innate immunity: an evolutionary perspective	NATURE IMMUNOLOGY			English	Review							NF-KAPPA-B; ANTIMICROBIAL PEPTIDE GENES; TOLL-LIKE RECEPTORS; COMPLEMENT-LIKE PROTEIN; GENOME-WIDE ANALYSIS; HOST-DEFENSE; ANTIBACTERIAL DEFENSE; EMBRYONIC POLARITY; RESPONSE REQUIRES; SIGNALING PATHWAY	In response to microbial infections, Drosophila mounts a multifaceted immune response involving humoral reactions that culminate in the destruction of invading organisms by lytic peptides. These defense mechanisms are activated via two distinct signaling pathways. One of these, the Toll pathway, controls resistance to fungal and Gram-positive bacterial infections, whereas the Imd pathway is responsible for defense against Gram-negative bacterial infections. Current evidence indicates that recognition of infectious nonself agents results from interactions between microbial wall components and extracellular pattern recognition proteins. We discuss here evolutionary perspectives on our present understanding of the antimicrobial defenses of Drosophila.	CNRS, Inst Mol & Cellular Biol, F-67000 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Hoffmann, JA (corresponding author), CNRS, Inst Mol & Cellular Biol, 15 Rue Descartes, F-67000 Strasbourg, France.	j.hoffmann@ibmc.u-strasbg.fr						Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; ASHIDA M, 1995, P NATL ACAD SCI USA, V92, P10698, DOI 10.1073/pnas.92.23.10698; BarillasMury C, 1996, EMBO J, V15, P4691, DOI 10.1002/j.1460-2075.1996.tb00846.x; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Bergner A, 1997, BIOL CHEM, V378, P283, DOI 10.1515/bchm.1997.378.3-4.283; BREY PT, 1993, P NATL ACAD SCI USA, V90, P6275, DOI 10.1073/pnas.90.13.6275; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; Chen G, 2000, DEVELOPMENT, V127, P5145; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Dushay MS, 1996, P NATL ACAD SCI USA, V93, P10343, DOI 10.1073/pnas.93.19.10343; ELDON E, 1994, DEVELOPMENT, V120, P885; Elrod-Erickson M, 2000, CURR BIOL, V10, P781, DOI 10.1016/S0960-9822(00)00569-8; Engstrom Y, 1999, DEV COMP IMMUNOL, V23, P345, DOI 10.1016/S0145-305X(99)00016-6; ENGSTROM Y, 1993, J MOL BIOL, V232, P327, DOI 10.1006/jmbi.1993.1392; Escoubas JM, 1999, FEBS LETT, V453, P293, DOI 10.1016/S0014-5793(99)00737-1; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; Ferrandon D, 1998, EMBO J, V17, P1217, DOI 10.1093/emboj/17.5.1217; GEISLER R, 1992, CELL, V71, P613, DOI 10.1016/0092-8674(92)90595-4; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; HALFON MS, 1995, DEV BIOL, V169, P151, DOI 10.1006/dbio.1995.1134; Han ZS, 1999, J BIOL CHEM, V274, P21355, DOI 10.1074/jbc.274.30.21355; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hoffmann JA, 1997, TRENDS CELL BIOL, V7, P309, DOI 10.1016/S0962-8924(97)01087-8; Horng T, 2001, P NATL ACAD SCI USA, V98, P12654, DOI 10.1073/pnas.231471798; IP YT, 1993, CELL, V75, P753, DOI 10.1016/0092-8674(93)90495-C; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; KAPPLER C, 1993, EMBO J, V12, P1561, DOI 10.1002/j.1460-2075.1993.tb05800.x; KEITH FJ, 1990, EMBO J, V9, P4299, DOI 10.1002/j.1460-2075.1990.tb07878.x; KIDD S, 1992, CELL, V71, P623, DOI 10.1016/0092-8674(92)90596-5; Kimbrell DA, 2001, NAT REV GENET, V2, P256, DOI 10.1038/35066006; Lagueux M, 2000, P NATL ACAD SCI USA, V97, P11427, DOI 10.1073/pnas.97.21.11427; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Lehrer RI, 1999, CURR OPIN IMMUNOL, V11, P23, DOI 10.1016/S0952-7915(99)80005-3; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; LeMosy EK, 1999, TRENDS CELL BIOL, V9, P102, DOI 10.1016/S0962-8924(98)01494-9; LETSOU A, 1991, P NATL ACAD SCI USA, V88, P810, DOI 10.1073/pnas.88.3.810; Leulier F, 2000, EMBO REP, V1, P353, DOI 10.1093/embo-reports/kvd073; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lu YR, 2001, GENE DEV, V15, P104, DOI 10.1101/gad.856901; Luo CH, 2000, IMMUNOGENETICS, V51, P92, DOI 10.1007/s002510050017; Manfruelli P, 1999, EMBO J, V18, P3380, DOI 10.1093/emboj/18.12.3380; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Meister M, 2000, CURR TOP MICROBIOL, V248, P17; Meng XJ, 1999, GENE DEV, V13, P792, DOI 10.1101/gad.13.7.792; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Mizuguchi K, 1998, TRENDS BIOCHEM SCI, V23, P239, DOI 10.1016/S0968-0004(98)01216-X; MORISATO D, 1994, CELL, V76, P677, DOI 10.1016/0092-8674(94)90507-X; Nappi AJ, 2000, BIOESSAYS, V22, P469, DOI 10.1002/(SICI)1521-1878(200005)22:5<469::AID-BIES9>3.0.CO;2-4; NUSSLEINVOLHARD C, 1980, NATURE, V283, P474, DOI 10.1038/283474a0; Qiu P, 1998, DEVELOPMENT, V125, P1909; Rizki T.M., 1984, P579; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; SHELTON CA, 1993, CELL, V72, P515, DOI 10.1016/0092-8674(93)90071-W; Shen BH, 1998, DEVELOPMENT, V125, P4719; Shiraishi H, 2000, J BIOCHEM-TOKYO, V127, P1127, DOI 10.1093/oxfordjournals.jbchem.a022708; Silverman N, 2000, GENE DEV, V14, P2461, DOI 10.1101/gad.817800; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; STEWARD R, 1987, SCIENCE, V238, P692, DOI 10.1126/science.3118464; Stoven S, 2000, EMBO REP, V1, P347, DOI 10.1093/embo-reports/kvd072; TATEI K, 1995, MOL CELL BIOL, V15, P3627; Tauszig S, 2000, P NATL ACAD SCI USA, V97, P10520, DOI 10.1073/pnas.180130797; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; Tingvall TO, 2001, EMBO REP, V2, P239; Tzou P, 2000, IMMUNITY, V13, P737, DOI 10.1016/S1074-7613(00)00072-8; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; Xiao T, 1999, CELL, V99, P545, DOI 10.1016/S0092-8674(00)81542-1	79	821	873	3	129	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2002	3	2					121	126		10.1038/ni0202-121	http://dx.doi.org/10.1038/ni0202-121			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	516PJ	11812988				2022-12-18	WOS:000173562400011
J	Dardalhon, V; Awasthi, A; Kwon, H; Galileos, G; Gao, W; Sobel, RA; Mitsdoerffer, M; Strom, TB; Elyaman, W; Ho, IC; Khoury, S; Oukka, M; Kuchroo, VK				Dardalhon, Valerie; Awasthi, Amit; Kwon, Hyoung; Galileos, George; Gao, Wenda; Sobel, Raymond A.; Mitsdoerffer, Meike; Strom, Terry B.; Elyaman, Wassim; Ho, I-Cheng; Khoury, Samia; Oukka, Mohamed; Kuchroo, Vijay K.			IL-4 inhibits TGF-beta-induced Foxp3(+) T cells and, together with TGF-beta, generates IL-9(+) IL-10(+) Foxp3(-) effector T cells	NATURE IMMUNOLOGY			English	Article							CONTROL INTESTINAL INFLAMMATION; TRANSCRIPTION FACTOR FOXP3; TRANSGENIC MICE; INTERLEUKIN-10; EXPRESSION; DIFFERENTIATION; INDUCTION; HYPERRESPONSIVENESS; SCHISTOSOMIASIS; PROLIFERATION	Transcription factor Foxp3 is critical for generating regulatory T cells (T-reg cells). Transforming growth factor-beta (TGF-beta) induces Foxp3 and suppressive T-reg cells from naive T cells, whereas interleukin 6 (IL-6) inhibits the generation of inducible Treg cells. Here we show that IL-4 blocked the generation of TGF-beta-induced Foxp3(+) T-reg cells and instead induced a population of T helper cells that produced IL-9 and IL-10. The IL-9(+)IL-10(+) T cells demonstrated no regulatory properties despite producing abundant IL-10. Adoptive transfer of IL-9(+)IL-10(+) T cells into recombination-activating gene 1-deficient mice induced colitis and peripheral neuritis, the severity of which was aggravated if the IL-9(+)IL-10(+) T cells were transferred with CD45RB(hi) CD4(+) effector T cells. Thus IL-9(+)IL-10(+) T cells lack suppressive function and constitute a distinct population of helper-effector T cells that promote tissue inflammation.	[Dardalhon, Valerie; Awasthi, Amit; Kwon, Hyoung; Galileos, George; Mitsdoerffer, Meike; Elyaman, Wassim; Khoury, Samia; Oukka, Mohamed; Kuchroo, Vijay K.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Cambridge, MA 02139 USA; [Gao, Wenda; Strom, Terry B.] Harvard Univ, Sch Med, Beth Israel Hosp, Transplant Res Ctr, Boston, MA 02115 USA; [Sobel, Raymond A.] Stanford Univ, Sch Med, Dept Pathol, Palo Alto, CA 94304 USA; [Sobel, Raymond A.] Stanford Univ, Sch Med, Palo Alto Vet Adm Hlth Care Syst, Palo Alto, CA 94304 USA; [Ho, I-Cheng] Harvard Univ, Sch Med, Dept Pediat Oncol, Div Pediat Hematol Oncol,Childrens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Stanford University; Stanford University; Harvard University; Boston Children's Hospital; Harvard Medical School	Oukka, M (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Cambridge, MA 02139 USA.	moukka@rics.bwh.harvard.edu; vkuchroo@rics.bwh.harvard.edu	Elyaman, Wassim/AAJ-1562-2021; Strom, Terry B./E-9268-2010	Strom, Terry B./0000-0002-7570-0736; khoury, samia/0000-0003-3198-6063; Elyaman, Wassim/0000-0001-7238-374X; Sobel, Raymond/0000-0002-0477-9002	US National Institutes of Health [R01AI073542-01, 1R01NS045937-01, 2R01NS35685-06, 2R37NS30843-11, 1R01A144880-03, 2P01A139671-07, 1P01NS38037-04, 1R01NS046414]; National Multiple Sclerosis Society [RG-2571-D-9, RG-3882-A-1]; Juvenile Diabetes Research Foundation Center for Immunological Tolerance at Harvard Medical School; National Multiple Sclerosis Society, New York; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073542, P01AI073748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035685, P01NS038037, R37NS030843, R01NS046414, R01NS045937] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Juvenile Diabetes Research Foundation Center for Immunological Tolerance at Harvard Medical School(Juvenile Diabetes Research Foundation); National Multiple Sclerosis Society, New York(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Kozoriz, R. Chandwaskar and D. Lee for cell sorting and technical assistance; and R. Flavell (Yale University School of Medicine) for IL-10-GFP mice. Supported by the US National Institutes of Health (R01AI073542-01 to M. O., and 1R01NS045937-01, 2R01NS35685-06, 2R37NS30843-11, 1R01A144880-03, 2P01A139671-07, 1P01NS38037-04, 1R01NS046414 and a Javits Neuroscience Investigator Award to V. K. K.), the National Multiple Sclerosis Society (RG-2571-D-9 to V. K. K. and RG-3882-A-1 to M. O.), the Juvenile Diabetes Research Foundation Center for Immunological Tolerance at Harvard Medical School, and the National Multiple Sclerosis Society, New York (A. A. and V. D.).	Annacker O, 2005, J EXP MED, V202, P1051, DOI 10.1084/jem.20040662; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Battaglia M, 2006, SEMIN IMMUNOL, V18, P120, DOI 10.1016/j.smim.2006.01.007; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Betti M, 2006, ANN ONCOL, V17, P235; Boussiotis VA, 2000, J CLIN INVEST, V105, P1317, DOI 10.1172/JCI9918; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Faulkner H, 1997, EUR J IMMUNOL, V27, P2536, DOI 10.1002/eji.1830271011; GAZZINELLI RT, 1992, J IMMUNOL, V148, P1792; Hoffmann KF, 2000, J IMMUNOL, V164, P6406, DOI 10.4049/jimmunol.164.12.6406; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hori S, 2003, ADV IMMUNOL, V81, P331, DOI 10.1016/S0065-2776(03)81008-8; ISHIDA H, 1994, J EXP MED, V179, P305, DOI 10.1084/jem.179.1.305; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Kaplan MH, 1998, J LEUKOCYTE BIOL, V64, P2, DOI 10.1002/jlb.64.1.2; King CL, 1996, J IMMUNOL, V156, P4715; Korn T, 2007, SEMIN IMMUNOL, V19, P362, DOI 10.1016/j.smim.2007.10.007; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Li C, 1999, INFECT IMMUN, V67, P4435, DOI 10.1128/IAI.67.9.4435-4442.1999; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; LLORENTE L, 1995, J EXP MED, V181, P839, DOI 10.1084/jem.181.3.839; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Makela MJ, 2000, P NATL ACAD SCI USA, V97, P6007, DOI 10.1073/pnas.100118997; Mantel PY, 2007, PLOS BIOL, V5, P2847, DOI 10.1371/journal.pbio.0050329; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Temann UA, 2002, J CLIN INVEST, V109, P29, DOI 10.1172/JCI13696; Temann UA, 1998, J EXP MED, V188, P1307, DOI 10.1084/jem.188.7.1307; TEPPER RI, 1990, CELL, V62, P457, DOI 10.1016/0092-8674(90)90011-3; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; VANSNICK J, 1989, J EXP MED, V169, P363, DOI 10.1084/jem.169.1.363; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wei J, 2007, P NATL ACAD SCI USA, V104, P18169, DOI 10.1073/pnas.0703642104; Wurster AL, 2002, MOL CELL BIOL, V22, P117, DOI 10.1128/MCB.22.1.117-126.2002; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Ziegler-Heitbrock L, 2003, J IMMUNOL, V171, P285, DOI 10.4049/jimmunol.171.1.285	45	818	893	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2008	9	12					1347	1355		10.1038/ni.1677	http://dx.doi.org/10.1038/ni.1677			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	372FY	18997793	Green Accepted			2022-12-18	WOS:000260888700009
J	von Boehmer, H				von Boehmer, H			Mechanisms of suppression by suppressor T cells	NATURE IMMUNOLOGY			English	Review							DOMINANT TRANSPLANTATION TOLERANCE; IN-VIVO; CUTTING EDGE; REGULATORY CELLS; SELF-TOLERANCE; IMMUNE-RESPONSES; DENDRITIC CELLS; RECEPTOR; INTERLEUKIN-2; EXPRESSION	Mechanisms of immunosuppression by CD4(+)CD25(+) suppressor T cells have been addressed using many in vitro and in vivo conditions. However, those studies have not yielded a single mode of action. This review will discuss the mechanisms of suppression, which include the local secretion of cytokines such as TGF-beta and direct cell contact through binding of cell surface molecules such as CTLA-4 on suppressor T cells to CD80 and CD86 molecules on effector T cells. Suppression requires the appropriate colocalization of suppressor and effector T cells in different tissue and may involve the interference with T cell receptor signaling that triggers transcription factors important in regulating effector cell function.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	von Boehmer, H (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA.	harald_von_boehmer@dfci.harvard.edu	Eckhardt, Erik/G-1567-2010		NIAID NIH HHS [R37AI51378] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051378] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Almeida ARM, 2002, J IMMUNOL, V169, P4850, DOI 10.4049/jimmunol.169.9.4850; Annacker O, 2001, J IMMUNOL, V166, P3008, DOI 10.4049/jimmunol.166.5.3008; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; BACCHETTA R, 1994, J EXP MED, V179, P493, DOI 10.1084/jem.179.2.493; Bachmann MF, 1999, J IMMUNOL, V163, P1128; Bachmann MF, 2001, EUR J IMMUNOL, V31, P450, DOI 10.1002/1521-4141(200102)31:2<450::AID-IMMU450>3.3.CO;2-O; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Buer J, 1998, J EXP MED, V187, P177, DOI 10.1084/jem.187.2.177; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Chen TC, 2004, J CLIN INVEST, V113, P1754, DOI 10.1172/JCI200420569; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; Fisson S, 2003, J EXP MED, V198, P737, DOI 10.1084/jem.20030686; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Furtado GC, 2002, J EXP MED, V196, P851, DOI 10.1084/jem.20020190; Gotter J, 2004, CURR OPIN IMMUNOL, V16, P741, DOI 10.1016/j.coi.2004.08.004; Green EA, 2003, P NATL ACAD SCI USA, V100, P10878, DOI 10.1073/pnas.1834400100; Grossman WJ, 2004, IMMUNITY, V21, P589, DOI 10.1016/j.immuni.2004.09.002; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Hu D, 2004, NAT IMMUNOL, V5, P516, DOI 10.1038/ni1063; Huber S, 2004, J IMMUNOL, V173, P6526, DOI 10.4049/jimmunol.173.11.6526; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Jaeckel E, 2005, DIABETES, V54, P306, DOI 10.2337/diabetes.54.2.306; Jonuleit H, 2002, J EXP MED, V196, P255, DOI 10.1084/jem.20020394; Jordan MS, 2000, EUR J IMMUNOL, V30, P136, DOI 10.1002/1521-4141(200001)30:1<136::AID-IMMU136>3.3.CO;2-S; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Klein L, 2003, P NATL ACAD SCI USA, V100, P8886, DOI 10.1073/pnas.1533365100; Lin CY, 2002, NAT IMMUNOL, V3, P1208, DOI 10.1038/ni853; Mahnke K, 2003, BLOOD, V101, P4862, DOI 10.1182/blood-2002-10-3229; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; Onizuka S, 1999, CANCER RES, V59, P3128; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Paust S, 2004, P NATL ACAD SCI USA, V101, P10398, DOI 10.1073/pnas.0403342101; Piccirillo CA, 2001, J IMMUNOL, V167, P1137, DOI 10.4049/jimmunol.167.3.1137; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sarween N, 2004, J IMMUNOL, V173, P2942, DOI 10.4049/jimmunol.173.5.2942; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Stephens GL, 2004, J IMMUNOL, V173, P5008, DOI 10.4049/jimmunol.173.8.5008; Sundstedt A, 2003, J IMMUNOL, V170, P1240, DOI 10.4049/jimmunol.170.3.1240; Suri-Payer E, 2001, J AUTOIMMUN, V16, P115, DOI 10.1006/jaut.2000.0473; Suvas S, 2003, J EXP MED, V198, P889, DOI 10.1084/jem.20030171; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tarbell KV, 2004, J EXP MED, V199, P1467, DOI 10.1084/jem.20040180; Taylor PA, 2004, J IMMUNOL, V172, P34, DOI 10.4049/jimmunol.172.1.34; Thornton AM, 2004, EUR J IMMUNOL, V34, P366, DOI 10.1002/eji.200324455; Thorstenson KM, 2001, J IMMUNOL, V167, P188, DOI 10.4049/jimmunol.167.1.188; Tone M, 2003, P NATL ACAD SCI USA, V100, P15059, DOI 10.1073/pnas.2334901100; Van Parijs L, 1998, SCIENCE, V280, P243; VanParijs L, 1997, J IMMUNOL, V158, P3738; Vieira PL, 2004, J IMMUNOL, V172, P5986, DOI 10.4049/jimmunol.172.10.5986; von Boehmer H, 2003, J EXP MED, V198, P845, DOI 10.1084/jem.20031358; von Boehmer H, 2004, NAT MED, V10, P783, DOI 10.1038/nm0804-783; Walker LSK, 2003, J EXP MED, V198, P249, DOI 10.1084/jem.20030315; Wolf M, 2001, EUR J IMMUNOL, V31, P1637, DOI 10.1002/1521-4141(200106)31:6<1637::AID-IMMU1637>3.0.CO;2-T; Yamazaki S, 2003, J EXP MED, V198, P235, DOI 10.1084/jem.20030422; Yang YP, 2004, NAT IMMUNOL, V5, P508, DOI 10.1038/ni1059	72	817	857	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2005	6	4					338	344		10.1038/ni1180	http://dx.doi.org/10.1038/ni1180			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	909KY	15785759				2022-12-18	WOS:000227860000004
J	Salzman, NH; Hung, KC; Haribhai, D; Chu, HT; Karlsson-Sjoberg, J; Amir, E; Teggatz, P; Barman, M; Hayward, M; Eastwood, D; Stoel, M; Zhou, YJ; Sodergren, E; Weinstock, GM; Bevins, CL; Williams, CB; Bos, NA				Salzman, Nita H.; Hung, Kuiechun; Haribhai, Dipica; Chu, Hiutung; Karlsson-Sjoeberg, Jenny; Amir, Elad; Teggatz, Paul; Barman, Melissa; Hayward, Michael; Eastwood, Daniel; Stoel, Maaike; Zhou, Yanjiao; Sodergren, Erica; Weinstock, George M.; Bevins, Charles L.; Williams, Calvin B.; Bos, Nicolaas A.			Enteric defensins are essential regulators of intestinal microbial ecology	NATURE IMMUNOLOGY			English	Article							SEGMENTED FILAMENTOUS BACTERIA; DISTAL GUT MICROBIOME; PANETH CELL; ANTIMICROBIAL PEPTIDES; IMMUNE-RESPONSE; INNATE IMMUNITY; MOUSE; DISEASE; MICE; COLONIZATION	Antimicrobial peptides are important effectors of innate immunity throughout the plant and animal kingdoms. In the mammalian small intestine, Paneth cell alpha-defensins are antimicrobial peptides that contribute to host defense against enteric pathogens. To determine if alpha-defensins also govern intestinal microbial ecology, we analyzed the intestinal microbiota of mice expressing a human alpha-defensin gene (DEFA5) and in mice lacking an enzyme required for the processing of mouse alpha-defensins. In these complementary models, we detected significant alpha-defensin-dependent changes in microbiota composition, but not in total bacterial numbers. Furthermore, DEFA5-expressing mice had striking losses of segmented filamentous bacteria and fewer interleukin 17 (IL-17)-producing lamina propria T cells. Our data ascribe a new homeostatic role to alpha-defensins in regulating the makeup of the commensal microbiota.	[Salzman, Nita H.; Hung, Kuiechun; Amir, Elad; Teggatz, Paul; Barman, Melissa; Hayward, Michael] Med Coll Wisconsin, Div Gastroenterol, Milwaukee, WI 53226 USA; [Haribhai, Dipica; Williams, Calvin B.] Med Coll Wisconsin, Div Rheumatol, Milwaukee, WI 53226 USA; [Haribhai, Dipica; Williams, Calvin B.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Salzman, Nita H.; Hung, Kuiechun; Haribhai, Dipica; Amir, Elad; Teggatz, Paul; Barman, Melissa; Hayward, Michael; Williams, Calvin B.] Med Coll Wisconsin, Childrens Res Inst, Milwaukee, WI 53226 USA; [Chu, Hiutung; Karlsson-Sjoeberg, Jenny; Bevins, Charles L.] Univ Calif Davis, Sch Med, Dept Microbiol & Immunol, Davis, CA 95616 USA; [Eastwood, Daniel] Med Coll Wisconsin, Div Biostat, Milwaukee, WI 53226 USA; [Stoel, Maaike; Bos, Nicolaas A.] Univ Groningen, Univ Med Ctr Groningen, Immunol Sect, Dept Cell Biol, NL-9700 AB Groningen, Netherlands; [Zhou, Yanjiao; Sodergren, Erica; Weinstock, George M.] Washington Univ, Sch Med, Dept Genet, Genome Ctr, St Louis, MO 63110 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; University of California System; University of California Davis; Medical College of Wisconsin; University of Groningen; Washington University (WUSTL)	Salzman, NH (corresponding author), Med Coll Wisconsin, Div Gastroenterol, Milwaukee, WI 53226 USA.	nsalzman@mcw.edu	Bevins, Charles L/P-4438-2015; Weinstock, George M/C-6314-2013; Bos, Nicolaas/C-1503-2015	Bevins, Charles L/0000-0003-2725-2622; Weinstock, George M/0000-0002-2997-4592; Chu, Hiutung/0000-0001-7489-0446; Salzman, Nita/0000-0003-0939-6139; Bos, Nicolaas/0000-0002-8649-0455; Williams, Calvin/0000-0002-5492-8475	National Institutes of Health [AI057757, AI/DK50843, AI32738]; Crohn's and Colitis Foundation of America; Diabetes Foundation Netherlands; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032738, R01AI085090, R01AI050843, R01AI032738, R01AI057757, R21AI057757] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Diabetes Foundation Netherlands; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Y. Paterson (Department of Microbiology, University of Pennsylvania School of Medicine) for mentorship at the initiation of these studies (N. H. S.); D. Fish, P. Homolka and A. Croswell for technical assistance; the production staff at The Genome Center for sequencing the 16S rRNA genes; and J. A. Eisen and A. L. Hartman for discussions. Supported by the National Institutes of Health (AI057757 to N. H. S., and AI/DK50843 and AI32738 to C. L. B.), the Crohn's and Colitis Foundation of America (N. H. S.) and the Diabetes Foundation Netherlands (N. A. B).	Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Canny G, 2006, METH MOL B, V341, P17; Croswell A, 2009, INFECT IMMUN, V77, P2741, DOI 10.1128/IAI.00006-09; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Gill SE, 2008, INT J BIOCHEM CELL B, V40, P1334, DOI 10.1016/j.biocel.2007.10.024; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Haribhai D, 2004, J EXP MED, V200, P1371, DOI 10.1084/jem.20041226; Heczko U, 2000, J INFECT DIS, V181, P1027, DOI 10.1086/315348; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Jiang HQ, 2001, INFECT IMMUN, V69, P3611, DOI 10.1128/IAI.69.6.3611-3617.2001; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; KLAASEN HLBM, 1993, LAB ANIM-UK, V27, P141, DOI 10.1258/002367793780810441; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; LEY R, 2006, NATURE, V444, P1023; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Nieuwenhuis EES, 2009, J CLIN INVEST, V119, P1241, DOI 10.1172/JCI36509; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; OUELLETTE AJ, 1994, INFECT IMMUN, V62, P5040, DOI 10.1128/IAI.62.11.5040-5047.1994; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Porter EM, 1997, INFECT IMMUN, V65, P2396, DOI 10.1128/IAI.65.6.2396-2401.1997; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Salzman NH, 2002, MICROBIOL-SGM, V148, P3651, DOI 10.1099/00221287-148-11-3651; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; SNEL J, 1995, INT J SYST BACTERIOL, V45, P780, DOI 10.1099/00207713-45-4-780; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Swee M, 2008, J LEUKOCYTE BIOL, V83, P1404, DOI 10.1189/jlb.0108016; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wehkamp J, 2006, FEBS LETT, V580, P5344, DOI 10.1016/j.febslet.2006.08.083; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	50	813	843	11	167	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2010	11	1					76	U1		10.1038/ni.1825	http://dx.doi.org/10.1038/ni.1825			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	533WE	19855381	Green Submitted, Green Accepted			2022-12-18	WOS:000272855300016
J	Hirota, K; Duarte, JH; Veldhoen, M; Hornsby, E; Li, Y; Cua, DJ; Ahlfors, H; Wilhelm, C; Tolaini, M; Menzel, U; Garefalaki, A; Potocnik, AJ; Stockinger, B				Hirota, Keiji; Duarte, Joao H.; Veldhoen, Marc; Hornsby, Eve; Li, Ying; Cua, Daniel J.; Ahlfors, Helena; Wilhelm, Christoph; Tolaini, Mauro; Menzel, Ursula; Garefalaki, Anna; Potocnik, Alexandre J.; Stockinger, Brigitta			Fate mapping of IL-17-producing T cells in inflammatory responses	NATURE IMMUNOLOGY			English	Article							CENTRAL-NERVOUS-SYSTEM; TH17 CELLS; TGF-BETA; HELPER TYPE-1; DIFFERENTIATION; PLASTICITY; LINEAGE; RECEPTOR; AUTOIMMUNITY; EXPRESSION	Here we describe a reporter mouse strain designed to map the fate of cells that have activated interleukin 17A (IL-17A). We found that IL-17-producing helper T cells (T(H)17 cells) had distinct plasticity in different inflammatory settings. Chronic inflammatory conditions in experimental autoimmune encephalomyelitis (EAE) caused a switch to alternative cytokines in T(H)17 cells, whereas acute cutaneous infection with Candida albicans did not result in the deviation of T(H)17 cells to the production of alternative cytokines, although IL-17A production was shut off in the course of the infection. During the development of EAE, interferon-gamma (IFN-gamma) and other proinflammatory cytokines in the spinal cord were produced almost exclusively by cells that had produced IL-17 before their conversion by IL-23 ('ex-T(H)17 cells'). Thus, this model allows the actual functional fate of effector T cells to be related to T(H)17 developmental origin regardless of IL-17 expression.	[Hirota, Keiji; Duarte, Joao H.; Veldhoen, Marc; Hornsby, Eve; Li, Ying; Ahlfors, Helena; Wilhelm, Christoph; Tolaini, Mauro; Menzel, Ursula; Garefalaki, Anna; Potocnik, Alexandre J.; Stockinger, Brigitta] Natl Inst Med Res, MRC, Div Mol Immunol, London NW7 1AA, England; [Cua, Daniel J.] Merck Res Labs, Palo Alto, CA USA	MRC National Institute for Medical Research; Merck & Company	Potocnik, AJ (corresponding author), Natl Inst Med Res, MRC, Div Mol Immunol, Mill Hill, London NW7 1AA, England.	apotocn@nimr.mrc.ac.uk; bstocki@nimr.mrc.ac.uk	Wilhelm, Christoph/ABE-7176-2020; Veldhoen, Marc/AAJ-2759-2020; Veldhoen, Marc/AAM-5357-2021	Wilhelm, Christoph/0000-0002-9839-0291; Veldhoen, Marc/0000-0002-1478-9562; Ahlfors, Helena/0000-0002-8183-0895; Stockinger, Brigitta/0000-0001-8781-336X; Duarte, Joao H./0000-0001-7186-4947; Potocnik, Alexandre/0000-0002-4730-8593; Hirota, Keiji/0000-0002-4737-0661	European Research Council [232782] Funding Source: Medline; Medical Research Council [MC_U117565359, U117512792, U.1175.02.003.00003(60535), MC_U117512792, U117563359] Funding Source: Medline; MRC [MC_U117565359, MC_U117512792] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Bailey-Bucktrout SL, 2008, J IMMUNOL, V180, P6457, DOI 10.4049/jimmunol.180.10.6457; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bettelli E, 2005, J EXP MED, V201, P169, DOI 10.1084/jem.20042279; Boniface K, 2010, J IMMUNOL, V185, P679, DOI 10.4049/jimmunol.1000366; Chang SH, 2009, CYTOKINE, V46, P7, DOI 10.1016/j.cyto.2008.12.024; Croxford AL, 2009, J IMMUNOL, V182, P1237, DOI 10.4049/jimmunol.182.3.1237; de Beaucoudrey L, 2008, J EXP MED, V205, P1543, DOI 10.1084/jem.20080321; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hegazy AN, 2010, IMMUNITY, V32, P116, DOI 10.1016/j.immuni.2009.12.004; Hirota K, 2010, SEMIN IMMUNOPATHOL, V32, P3, DOI 10.1007/s00281-009-0187-y; Isaksson M, 2009, EUR J IMMUNOL, V39, P2925, DOI 10.1002/eji.200839179; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Lees JR, 2008, J EXP MED, V205, P2633, DOI 10.1084/jem.20080155; Lexberg MH, 2008, EUR J IMMUNOL, V38, P2654, DOI 10.1002/eji.200838541; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Martin-Orozco N, 2009, EUR J IMMUNOL, V39, P216, DOI 10.1002/eji.200838475; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; McQualter JL, 2001, J EXP MED, V194, P873, DOI 10.1084/jem.194.7.873; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Ponomarev ED, 2007, J IMMUNOL, V178, P39, DOI 10.4049/jimmunol.178.1.39; Shi GP, 2008, J IMMUNOL, V181, P7205, DOI 10.4049/jimmunol.181.10.7205; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; Shinohara ML, 2008, IMMUNITY, V29, P68, DOI 10.1016/j.immuni.2008.05.008; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Steinman L, 2008, J EXP MED, V205, P1517, DOI 10.1084/jem.20072066; Stevens EA, 2009, IMMUNOLOGY, V127, P299, DOI 10.1111/j.1365-2567.2009.03054.x; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Suryani S, 2007, J NEUROIMMUNOL, V183, P96, DOI 10.1016/j.jneuroim.2006.11.023; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	52	811	831	2	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2011	12	3					255	U95		10.1038/ni.1993	http://dx.doi.org/10.1038/ni.1993			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	721KZ	21278737	Green Accepted, Green Submitted			2022-12-18	WOS:000287354400013
J	Asselin-Paturel, C; Boonstra, A; Dalod, M; Durand, I; Yessaad, N; Dezutter-Dambuyant, C; Vicari, A; O'Garra, A; Biron, C; Briere, F; Trinchieri, G				Asselin-Paturel, C; Boonstra, A; Dalod, M; Durand, I; Yessaad, N; Dezutter-Dambuyant, C; Vicari, A; O'Garra, A; Biron, C; Briere, F; Trinchieri, G			Mouse type IIFN-producing cells are immature APCs with plasmacytoid morphology	NATURE IMMUNOLOGY			English	Article							MURINE BONE-MARROW; INTERFERON-ALPHA/BETA; DENDRITIC CELLS; IN-VIVO; EXPRESSION; ANTIGEN; DIFFERENTIATION; VIRUS; MICE; SUBPOPULATION	dWe show here that mouse interferon-alpha (IFN-alpha)-producing cells (mIPCs) are a unique subset of immature antigen-presenting cells (APCs) that secrete IFN-alpha upon stimulation with viruses.. mIPCs have a plasmacytoid morphology, can be stained with an antibody to Ly6G and Ly6C (anti-Ly6G/C) and are Ly6C(+)B220(+)CDIIc(10)CD4(+); unlike other dendritic cell subsets, however, they do not express CD8 alpha or CDIIb. Although mIPCs undergo apoptosis in vitro, stimulation with viruses, IFN-alpha or CpG oligonucleotides enhanced their survival and T cell stimulatory activity. In vivo, mIPCs were the main producers of IFN-alpha in cytomegalovirus-infected mice, as depletion of Ly6G(+)/C+ cells abrogated IFN-alpha production. mIPCs produced interleukin 12 (IL-12) in response to viruses and CpG oligodeoxynucleotides, but not bacterial products. Although different pathogens can selectively engage various APC subsets for IL-12 production, IFN-alpha production is restricted to mIPCs' response to viral infection.	Schering Plough Corp, Lab Immunol Res, Dardilly, France; DNAX Res Inst Molec & Cellular Biol Inc, Dept Immunobiol, Palo Alto, CA USA; Brown Univ, Dept Mol Microbiol & Immunol, Div Biol & Med, Providence, RI 02912 USA; Ctr Hosp Edouard Herriot, INSERM Unite 346, Lyon, France	Merck & Company; Schering Plough Corporation; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Brown University; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Trinchieri, G (corresponding author), Schering Plough Corp, Lab Immunol Res, Dardilly, France.		Trinchieri, Giorgio/F-9369-2015; Dalod, Marc/AAK-6163-2020; dezutter-dambuyant, colette/F-5962-2013	Trinchieri, Giorgio/0000-0001-5892-7464; Dalod, Marc/0000-0002-6436-7966; dezutter-dambuyant, colette/0000-0002-3866-4537; O'Garra, Anne/0000-0001-9845-6134; Boonstra, Andre/0000-0001-8607-1616	NCI NIH HHS [R01 CA041268, CA41268] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA041268] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BANDYOPADHYAY S, 1986, J EXP MED, V164, P180, DOI 10.1084/jem.164.1.180; Cella M, 2000, NAT IMMUNOL, V1, P305, DOI 10.1038/79747; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; CHEHIMI J, 1989, IMMUNOLOGY, V68, P488; DALOD M, 2001, UNPUB IFN ALPHA BETA; Eloranta ML, 1999, SCAND J IMMUNOL, V49, P391; Eloranta ML, 1997, SCAND J IMMUNOL, V46, P235, DOI 10.1046/j.1365-3083.1997.d01-120.x; Farber DL, 2000, CLIN IMMUNOL, V95, P173, DOI 10.1006/clim.2000.4858; FITZGERALDBOCARSLY P, 1993, PHARMACOL THERAPEUT, V60, P39, DOI 10.1016/0163-7258(93)90021-5; FLEMING TJ, 1993, J IMMUNOL, V151, P2399; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; HESTDAL K, 1991, J IMMUNOL, V147, P22; Hochrein H, 2001, J IMMUNOL, V166, P5448, DOI 10.4049/jimmunol.166.9.5448; JUTILA MA, 1988, EUR J IMMUNOL, V18, P1819, DOI 10.1002/eji.1830181125; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kadowaki N, 2001, J IMMUNOL, V166, P2291, DOI 10.4049/jimmunol.166.4.2291; LAOUAR Y, 1994, J IMMUNOL, V153, P3948; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; PERUSSIA B, 1985, Natural Immunity and Cell Growth Regulation, V4, P120; Pfeffer LM, 1998, CANCER RES, V58, P2489; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; Rolink A, 1996, J EXP MED, V183, P187, DOI 10.1084/jem.183.1.187; Sato N, 1996, IMMUNOL LETT, V54, P5, DOI 10.1016/S0165-2478(96)02632-6; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; STARR SE, 1993, ADV EXP MED BIOL, V329, P173; Steinmann RM, 1999, ANNU REV IMMUNOL, V9, P271; TAKAHAMA Y, 1991, J IMMUNOL, V147, P2883; vandenBroek MF, 1995, IMMUNOL REV, V148, P5; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47	32	809	829	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2001	2	12					1144	1150		10.1038/ni736	http://dx.doi.org/10.1038/ni736			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	497UE	11713464				2022-12-18	WOS:000172473200017
J	Wing, K; Sakaguchi, S				Wing, Kajsa; Sakaguchi, Shimon			Regulatory T cells exert checks and balances on self tolerance and autoimmunity	NATURE IMMUNOLOGY			English	Review							DENDRITIC CELLS; IMMUNE-RESPONSES; CUTTING EDGE; TARGET GENES; REG CELLS; FOXP3(+); ANTIGEN; INDUCTION; THYMUS; SELECTION	Immunological self tolerance is maintained at least in part by regulatory T (T-reg) cells that actively and dominantly control potentially hazardous self-reactive T cells in the periphery. Antigens that stimulate self-reactive T cells may also activate natural T-reg cells, thereby maintaining dominant self tolerance. Conversely, genetic anomalies or environmental agents that specifically or predominantly affect T-reg cells cause or predispose to autoimmunity. With recent advances in our understanding of T-reg cell development in the thymus and periphery and the molecular mechanism of T-reg cell-mediated suppression, new ways of treating immunological diseases by targeting T-reg cells at the cellular and molecular levels are envisaged.	[Wing, Kajsa; Sakaguchi, Shimon] Kyoto Univ, Dept Expt Pathol, Inst Frontier Med Sci, Kyoto, Japan; [Sakaguchi, Shimon] Osaka Univ, WPI, Immunol Frontier Res Ctr, Suita, Osaka, Japan	Kyoto University; Osaka University	Sakaguchi, S (corresponding author), Kyoto Univ, Dept Expt Pathol, Inst Frontier Med Sci, Kyoto, Japan.	shimon@frontier.kyoto-u.ac.jp	Sakaguchi, Shimon/C-9535-2009	Wing, Kajsa/0000-0001-7744-4847	Ministry of Education, Sports and Culture; Ministry of Human Welfare of Japan; King Gustav V's 80-Year Foundation; Swedish Society of Medical Research	Ministry of Education, Sports and Culture; Ministry of Human Welfare of Japan; King Gustav V's 80-Year Foundation; Swedish Society of Medical Research	Supported by the Ministry of Education, Sports and Culture and Ministry of Human Welfare of Japan and (K. W.) King Gustav V's 80-Year Foundation and the Swedish Society of Medical Research.	Akiyama T, 2005, SCIENCE, V308, P248, DOI 10.1126/science.1105677; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Basu S, 2008, J IMMUNOL, V180, P5794, DOI 10.4049/jimmunol.180.9.5794; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Baxter AG, 2007, NAT REV IMMUNOL, V7, P904, DOI 10.1038/nri2190; Bensinger SJ, 2001, J EXP MED, V194, P427, DOI 10.1084/jem.194.4.427; Brusko TM, 2008, IMMUNOL REV, V223, P371, DOI 10.1111/j.1600-065X.2008.00637.x; Burnet FM., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cao XF, 2007, IMMUNITY, V27, P635, DOI 10.1016/j.immuni.2007.08.014; Carneiro-Sampaio M, 2007, ADV IMMUNOL, V95, P51, DOI 10.1016/S0065-2776(07)95002-6; Danke NA, 2005, J AUTOIMMUN, V25, P303, DOI 10.1016/j.jaut.2005.08.007; Danke NA, 2004, J IMMUNOL, V172, P5967, DOI 10.4049/jimmunol.172.10.5967; Dejean AS, 2009, NAT IMMUNOL, V10, P504, DOI 10.1038/ni.1729; DiPaolo RJ, 2009, EUR J IMMUNOL, V39, P234, DOI 10.1002/eji.200838772; Duarte JH, 2009, EUR J IMMUNOL, V39, P948, DOI 10.1002/eji.200839196; Eriksson U, 2003, NAT MED, V9, P1484, DOI 10.1038/nm960; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; Gambineri Eleonora, 2008, J Allergy Clin Immunol, V122, P1105, DOI 10.1016/j.jaci.2008.09.027; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gehring AJ, 2003, INFECT IMMUN, V71, P4487, DOI 10.1128/IAI.71.8.4487-4497.2003; GERSHON RK, 1970, IMMUNOLOGY, V18, P723; Gnjatic S, 2009, CLIN CANCER RES, V15, P2130, DOI 10.1158/1078-0432.CCR-08-2632; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Himmelweit F, 1957, The collected papers of Paul Ehrlich, VII; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Itoh M, 1999, J IMMUNOL, V162, P5317; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kajiura F, 2004, J IMMUNOL, V172, P2067, DOI 10.4049/jimmunol.172.4.2067; Kawahata K, 2002, J IMMUNOL, V168, P4399, DOI 10.4049/jimmunol.168.9.4399; Kekalainen E, 2007, J IMMUNOL, V178, P1208, DOI 10.4049/jimmunol.178.2.1208; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Klein L, 2000, CURR OPIN IMMUNOL, V12, P179, DOI 10.1016/S0952-7915(99)00069-2; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Kuroda N, 2005, J IMMUNOL, V174, P1862, DOI 10.4049/jimmunol.174.4.1862; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Liu GW, 2009, NAT IMMUNOL, V10, P769, DOI 10.1038/ni.1743; Luhder F, 1998, J EXP MED, V187, P427, DOI 10.1084/jem.187.3.427; Luo XR, 2007, P NATL ACAD SCI USA, V104, P2821, DOI 10.1073/pnas.0611646104; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Morris GP, 2005, J IMMUNOL, V174, P3111, DOI 10.4049/jimmunol.174.5.3111; Nagahama K, 2009, INT IMMUNOL, V21, P379, DOI 10.1093/intimm/dxp005; Nossal GJV, 1996, J EXP MED, V183, P1953, DOI 10.1084/jem.183.5.1953; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Pacholczyk R, 2007, IMMUNITY, V27, P493, DOI 10.1016/j.immuni.2007.07.019; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; Pennington DJ, 2006, NATURE, V444, P1073, DOI 10.1038/nature06051; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Reddy J, 2004, P NATL ACAD SCI USA, V101, P15434, DOI 10.1073/pnas.0404444101; Ridgway WM, 2008, ADV IMMUNOL, V100, P151, DOI 10.1016/S0065-2776(08)00806-7; ROSE NR, 1971, J IMMUNOL, V106, P698; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2007, EUR J IMMUNOL, V37, pS116, DOI 10.1002/eji.200737593; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Sawicka E, 2005, J IMMUNOL, V175, P7973, DOI 10.4049/jimmunol.175.12.7973; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Singh B, 2001, IMMUNOL REV, V182, P190, DOI 10.1034/j.1600-065X.2001.1820115.x; Strauss L, 2007, J IMMUNOL, V178, P320, DOI 10.4049/jimmunol.178.1.320; Taams LS, 2002, EUR J IMMUNOL, V32, P1621, DOI 10.1002/1521-4141(200206)32:6<1621::AID-IMMU1621>3.0.CO;2-Q; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wang LQ, 2009, IMMUNOL CELL BIOL, V87, P195, DOI 10.1038/icb.2008.106; Watanabe H, 1999, AUTOIMMUNITY, V31, P273, DOI 10.3109/08916939908994073; Watanabe N, 2005, NATURE, V436, P1181, DOI 10.1038/nature03886; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Wildin RS, 2002, J MED GENET, V39, P537, DOI 10.1136/jmg.39.8.537; Wing K, 2003, EUR J IMMUNOL, V33, P579, DOI 10.1002/eji.200323701; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wing K, 2006, INT IMMUNOL, V18, P991, DOI 10.1093/intimm/dxl044; Wong J, 2007, J IMMUNOL, V178, P7032, DOI 10.4049/jimmunol.178.11.7032; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yang JB, 2008, J AUTOIMMUN, V31, P30, DOI 10.1016/j.jaut.2008.02.001; Zaccone P, 2002, EUR J IMMUNOL, V32, P1021; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	101	801	849	1	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2010	11	1					7	13		10.1038/ni.1818	http://dx.doi.org/10.1038/ni.1818			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	533WE	20016504				2022-12-18	WOS:000272855300003
J	Derbinski, J; Schulte, A; Kyewski, B; Klein, L				Derbinski, J; Schulte, A; Kyewski, B; Klein, L			Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self	NATURE IMMUNOLOGY			English	Article							AMYLOID P-COMPONENT; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ANTIGEN-PRESENTING CELLS; MYELIN BASIC-PROTEIN; REGULATORY T-CELLS; DENDRITIC CELLS; MESSENGER-RNA; STROMAL CELLS; TOLERANCE; TRANSCRIPTION	Expression of peripheral antigens in the thymus has been implicated in T cell tolerance and autoimmunity. Here we identified medullary thymic epithelial cells as being a unique cell type that expresses a diverse range of tissue-specific antigens. We found that this promiscuous gene expression was a cell-autonomous property of medullary epithelial cells and was maintained during the entire period of thymic T cell output. It may facilitate tolerance induction to self-antigens that would otherwise be temporally or spatially secluded from the immune system. However, the array of promiscuously expressed self-antigens appeared random rather than selected and was not confined to secluded self-antigens.	German Canc Res Ctr, Tumor Immunol Program, Div Cellular Immunol, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Kyewski, B (corresponding author), German Canc Res Ctr, Tumor Immunol Program, Div Cellular Immunol, INF 280, D-69120 Heidelberg, Germany.	b.kyewski@dkfz.de						AMARCOSTESEC A, 1994, BIOL CELL, V81, P195, DOI 10.1016/0248-4900(94)90001-9; Anderson AC, 2000, J EXP MED, V191, P761, DOI 10.1084/jem.191.5.761; ANTONIA SJ, 1995, INT IMMUNOL, V7, P715, DOI 10.1093/intimm/7.5.715; Boon T, 1997, IMMUNOL TODAY, V18, P267, DOI 10.1016/S0167-5699(97)80020-5; BORN W, 1981, EUR J CELL BIOL, V25, P76; Botto M, 1997, NAT MED, V3, P855, DOI 10.1038/nm0897-855; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; CHELLY J, 1989, P NATL ACAD SCI USA, V86, P2617, DOI 10.1073/pnas.86.8.2617; de Visser KE, 2000, EUR J IMMUNOL, V30, P1458, DOI 10.1002/(SICI)1521-4141(200005)30:5<1458::AID-IMMU1458>3.0.CO;2-2; DEGERMANN S, 1994, J IMMUNOL, V152, P3254; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Diez J, 2001, DIABETES, V50, P895, DOI 10.2337/diabetes.50.4.895; Egwuagu CE, 1997, J IMMUNOL, V159, P3109; Farr AG, 1998, J EXP MED, V188, P1, DOI 10.1084/jem.188.1.1; GOODNOW CC, 1990, SCIENCE, V248, P1373, DOI 10.1126/science.2356469; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hanahan D, 1998, CURR OPIN IMMUNOL, V10, P656, DOI 10.1016/S0952-7915(98)80085-X; Harrington CJ, 1998, IMMUNITY, V8, P571, DOI 10.1016/S1074-7613(00)80562-2; Heath VL, 1998, J AUTOIMMUN, V11, P309, DOI 10.1006/jaut.1998.0210; HEATH WR, 1992, NATURE, V359, P547, DOI 10.1038/359547a0; HECHT NB, 1995, DEV GENET, V16, P95, DOI 10.1002/dvg.1020160202; Heino M, 1999, BIOCHEM BIOPH RES CO, V257, P821, DOI 10.1006/bbrc.1999.0308; Heino M, 2000, EUR J IMMUNOL, V30, P1884, DOI 10.1002/1521-4141(200007)30:7<1884::AID-IMMU1884>3.0.CO;2-P; Jamieson BD, 1999, IMMUNITY, V10, P569, DOI 10.1016/S1074-7613(00)80056-4; JOLICOEUR C, 1994, P NATL ACAD SCI USA, V91, P6707, DOI 10.1073/pnas.91.14.6707; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Jung M, 1996, J NEUROSCI, V16, P7920; Klein L, 1998, J EXP MED, V188, P5, DOI 10.1084/jem.188.1.5; Klein L, 2000, CURR OPIN IMMUNOL, V12, P179, DOI 10.1016/S0952-7915(99)00069-2; Klein L, 2000, NAT MED, V6, P56, DOI 10.1038/71540; Klein L, 2001, EUR J IMMUNOL, V31, P2476, DOI 10.1002/1521-4141(200108)31:8<2476::AID-IMMU2476>3.0.CO;2-T; Klein L, 2000, J MOL MED, V78, P483, DOI 10.1007/s001090000146; Kojima K, 1997, INT IMMUNOL, V9, P897, DOI 10.1093/intimm/9.6.897; LeDouarin N, 1996, IMMUNOL REV, V149, P35; LINSK R, 1989, SCIENCE, V246, P261, DOI 10.1126/science.2799388; Liu HB, 2001, J NEUROIMMUNOL, V115, P118, DOI 10.1016/S0165-5728(01)00269-7; MILLER JFAP, 1993, IMMUNOL REV, V133, P131, DOI 10.1111/j.1600-065X.1993.tb01514.x; Morgan DJ, 1998, J IMMUNOL, V160, P643; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Naquet P, 1999, SEMIN IMMUNOL, V11, P47, DOI 10.1006/smim.1998.0149; Naspetti M, 1997, EUR J IMMUNOL, V27, P1392, DOI 10.1002/eji.1830270615; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X; PEPYS MB, 1979, IMMUNOLOGY, V37, P637; PEPYS MB, 1979, NATURE, V278, P259, DOI 10.1038/278259a0; PEPYS MB, 1983, ADV IMMUNOL, V34, P141, DOI 10.1016/S0065-2776(08)60379-X; Peterson P, 1998, IMMUNOL TODAY, V19, P384, DOI 10.1016/S0167-5699(98)01293-6; Pugliese A, 1997, NAT GENET, V15, P293, DOI 10.1038/ng0397-293; Pugliese A, 2001, J CLIN INVEST, V107, P555, DOI 10.1172/JCI10860; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; SARKAR G, 1989, SCIENCE, V244, P331, DOI 10.1126/science.2565599; Seddon B, 2000, IMMUNOL TODAY, V21, P95, DOI 10.1016/S0167-5699(99)01559-5; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Smith KM, 1997, INT IMMUNOL, V9, P1355, DOI 10.1093/intimm/9.9.1355; Sospedra M, 1998, J IMMUNOL, V161, P5918; Stockinger B, 1999, Adv Immunol, V71, P229; Targoni OS, 1998, J EXP MED, V187, P2055, DOI 10.1084/jem.187.12.2055; Throsby M, 1998, ENDOCRINOLOGY, V139, P2399, DOI 10.1210/en.139.5.2399; Tuohy VK, 1998, IMMUNOL REV, V164, P93, DOI 10.1111/j.1600-065X.1998.tb01211.x; VAFLADIS P, 1997, NAT GENET, V15, P289; van Ewijk W, 2000, DEVELOPMENT, V127, P1583; Volkmann A, 1997, J IMMUNOL, V158, P693; VONBOEHMER H, 1990, SCIENCE, V248, P1369, DOI 10.1126/science.1972594	63	800	825	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2001	2	11					1032	1039		10.1038/ni723	http://dx.doi.org/10.1038/ni723			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	490JY	11600886				2022-12-18	WOS:000172049800016
J	Maslowski, KM; Mackay, CR				Maslowski, Kendle M.; Mackay, Charles R.			Diet, gut microbiota and immune responses	NATURE IMMUNOLOGY			English	Article							CHAIN FATTY-ACIDS; EUROPE; ASTHMA; MICE	The fields of immunology, microbiology, nutrition and metabolism are rapidly converging. Here we expand on a diet-microbiota model as the basis for the greater incidence of asthma and autoimmunity in developed countries.	[Maslowski, Kendle M.] Garvan Inst Med Res, Sydney, NSW, Australia; [Maslowski, Kendle M.; Mackay, Charles R.] Cooperat Res Ctr Asthma & Airways, Sydney, NSW, Australia; [Maslowski, Kendle M.] Univ New S Wales, Dept Med, St Vincents Clin Sch, Sydney, NSW, Australia; [Mackay, Charles R.] Monash Univ, Dept Immunol, Fac Med Nursing & Hlth Sci, Melbourne, Vic 3004, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney; Monash University	Maslowski, KM (corresponding author), Garvan Inst Med Res, Sydney, NSW, Australia.	charles.mackay@med.monash.edu.au	Maslowski, Kendle M/R-9331-2018; Mackay, Charles R/A-9673-2008	Maslowski, Kendle M/0000-0003-1995-5424; Mackay, Charles R/0000-0002-6338-7340				Chervonsky AV, 2010, NAT IMMUNOL, V11, P28, DOI 10.1038/ni.1801; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; DAOH Y, 2010, CELL, V142, P687; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Devereux G, 2006, NAT REV IMMUNOL, V6, P869, DOI 10.1038/nri1958; Devereux G, 2006, AM J RESP CRIT CARE, V174, P499, DOI 10.1164/rccm.200512-1946OC; Duncan SH, 2007, APPL ENVIRON MICROB, V73, P1073, DOI 10.1128/AEM.02340-06; EEROLA E, 1994, BRIT J RHEUMATOL, V33, P1030; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Galvez J, 2005, MOL NUTR FOOD RES, V49, P601, DOI 10.1002/mnfr.200500013; HOVERSTAD T, 1986, J NUTR, V116, P1772, DOI 10.1093/jn/116.9.1772; Kalliomaki M, 2001, J ALLERGY CLIN IMMUN, V107, P129, DOI 10.1067/mai.2001.111237; Khoruts A, 2010, J CLIN GASTROENTEROL, V44, P354, DOI 10.1097/MCG.0b013e3181c87e02; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; MORLAND B, 1984, INFECT IMMUN, V44, P750; Muller H, 2001, SCAND J RHEUMATOL, V30, P1, DOI 10.1080/030097401750065256; Noverr MC, 2004, TRENDS MICROBIOL, V12, P562, DOI 10.1016/j.tim.2004.10.008; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Quivy V, 2004, BIOCHEM PHARMACOL, V68, P1221, DOI 10.1016/j.bcp.2004.05.039; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Simopoulos AP, 2002, J AM COLL NUTR, V21, P495, DOI 10.1080/07315724.2002.10719248; Sin DD, 2008, THORAX, V63, P1018, DOI 10.1136/thx.2007.086819; Slavin J, 2003, P NUTR SOC, V62, P129, DOI 10.1079/PNS2002221; Strachan David P., 2000, Thorax, V55, pS2, DOI 10.1136/thorax.55.suppl_1.S2; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Vaahtovuo J, 2008, J RHEUMATOL, V35, P1500; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001	30	799	872	3	224	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2011	12	1					5	9		10.1038/ni0111-5	http://dx.doi.org/10.1038/ni0111-5			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	696TU	21169997				2022-12-18	WOS:000285465100004
J	Satoh, T; Takeuchi, O; Vandenbon, A; Yasuda, K; Tanaka, Y; Kumagai, Y; Miyake, T; Matsushita, K; Okazaki, T; Saitoh, T; Honma, K; Matsuyama, T; Yui, K; Tsujimura, T; Standley, DM; Nakanishi, K; Nakai, K; Akira, S				Satoh, Takashi; Takeuchi, Osamu; Vandenbon, Alexis; Yasuda, Koubun; Tanaka, Yoshiaki; Kumagai, Yutaro; Miyake, Tohru; Matsushita, Kazufumi; Okazaki, Toshihiko; Saitoh, Tatsuya; Honma, Kiri; Matsuyama, Toshifumi; Yui, Katsuyuki; Tsujimura, Tohru; Standley, Daron M.; Nakanishi, Kenji; Nakai, Kenta; Akira, Shizuo			The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR IRF4; CD4(+) T-CELLS; KAPPA-B-ZETA; IMMUNE-RESPONSES; GENE-EXPRESSION; TH2 CYTOKINES; ACTIVATION; INFLAMMATION; DIFFERENTIATION; CONTRIBUTES	Polarization of macrophages to M1 or M2 cells is important for mounting responses against bacterial and helminth infections, respectively. Jumonji domain containing-3 (Jmjd3), a histone 3 Lys27 (H3K27) demethylase, has been implicated in the activation of macrophages. Here we show that Jmjd3 is essential for M2 macrophage polarization in response to helminth infection and chitin, though Jmjd3 is dispensable for M1 responses. Furthermore, Jmjd3 (also known as Kdm6b) is essential for proper bone marrow macrophage differentiation, and this function depends on demethylase activity of Jmjd3. Jmjd3 deficiency affected trimethylation of H3K27 in only a limited number of genes. Among them, we identified Irf4 as encoding a key transcription factor that controls M2 macrophage polarization. Collectively, these results show that Jmjd3-mediated H3K27 demethylation is crucial for regulating M2 macrophage development leading to anti-helminth host responses.	[Satoh, Takashi; Takeuchi, Osamu; Kumagai, Yutaro; Miyake, Tohru; Matsushita, Kazufumi; Okazaki, Toshihiko; Saitoh, Tatsuya; Akira, Shizuo] Osaka Univ, Lab Host Def, World Premiere Initiat Immunol Frontier Res Ctr, Osaka, Japan; [Satoh, Takashi; Takeuchi, Osamu; Kumagai, Yutaro; Miyake, Tohru; Matsushita, Kazufumi; Saitoh, Tatsuya; Akira, Shizuo] Osaka Univ, Res Inst Microbial Dis, Osaka, Japan; [Vandenbon, Alexis; Standley, Daron M.] Osaka Univ, World Premiere Int Immunol Frontier Res Ctr, Lab Syst Immunol, Osaka, Japan; [Yasuda, Koubun; Nakanishi, Kenji] Hyogo Coll Med, Dept Immunol & Med Zool, Nishinomiya, Hyogo, Japan; [Tanaka, Yoshiaki] Univ Tokyo, Lab Funct Anal Silico, Ctr Human Genome, Inst Med Sci, Tokyo, Japan; [Honma, Kiri; Matsuyama, Toshifumi; Yui, Katsuyuki; Nakai, Kenta] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Nagasaki 852, Japan; [Tsujimura, Tohru] Hyogo Coll Med, Dept Pathol, Nishinomiya, Hyogo, Japan	Osaka University; Osaka University; Osaka University; Hyogo College of Medicine; University of Tokyo; Nagasaki University; Hyogo College of Medicine	Akira, S (corresponding author), Osaka Univ, Lab Host Def, World Premiere Initiat Immunol Frontier Res Ctr, Osaka, Japan.	sakira@biken.osaka-u.ac.jp	Standley, Daron/D-2343-2009; Vandenbon, Alexis/A-8430-2017; Akira, Shizuo/C-3134-2009; Tanaka, Yoshiaki/AAE-2425-2022; Kumagai, Yutaro/L-7732-2018; Nakai, Kenta/B-7293-2009; Takeuchi, Osamu/AAG-9359-2019; Vandenbon, Alexis/N-4428-2019; Takeuchi, Osamu/D-6007-2011; Yasuda, Koubun/GQA-7622-2022	Tanaka, Yoshiaki/0000-0002-2078-9374; Kumagai, Yutaro/0000-0002-5039-3979; Nakai, Kenta/0000-0002-8721-8883; Takeuchi, Osamu/0000-0002-1260-6232; Miyake, Toru/0000-0003-0947-0116; Yasuda, Koubun/0000-0002-3533-1702	Japanese Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour and Welfare in Japan; Osaka University; Nagasaki University; US National Institutes of Health [P01 AI070167]; Japanese government; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI070167] Funding Source: NIH RePORTER	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan); Osaka University; Nagasaki University; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japanese government; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all the colleagues in our laboratory, E. Kamada for secretarial assistance and Y. Fujiwara, M. Kumagai, R. Abe, N. Kitagaki and S. Yumikura for technical assistance. This work was supported by the Special Coordination Funds of the Japanese Ministry of Education, Culture, Sports, Science and Technology, and grants from the Ministry of Health, Labour and Welfare in Japan, the Global Center of Excellence Programs of Osaka University and Nagasaki University and the US National Institutes of Health (P01 AI070167). Computational time was provided by the Super Computer System at the Human Genome Center, Institute of Medical Science, The University of Tokyo. A. V. was partly supported by a Japanese government scholarship.	Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Ahyi ANN, 2009, J IMMUNOL, V183, P1598, DOI 10.4049/jimmunol.0803302; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Charo IF, 2007, CELL METAB, V6, P96, DOI 10.1016/j.cmet.2007.07.006; DA SILVA CA, 2008, J IMMUNOL, V181, P4279; DE SANTA F, 2009, EMBO J, V28, P3341; DE SANTA F, 2007, CELL, V130, P1083; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; Fleetwood AJ, 2009, J LEUKOCYTE BIOL, V86, P411, DOI 10.1189/jlb.1108702; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Honma K, 2005, P NATL ACAD SCI USA, V102, P16001, DOI 10.1073/pnas.0504226102; Honma K, 2008, P NATL ACAD SCI USA, V105, P15890, DOI 10.1073/pnas.0803171105; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Kayama H, 2008, J BIOL CHEM, V283, P12468, DOI 10.1074/jbc.M709965200; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Kreider T, 2007, CURR OPIN IMMUNOL, V19, P448, DOI 10.1016/j.coi.2007.07.002; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Nair MG, 2006, J IMMUNOL, V177, P1393, DOI 10.4049/jimmunol.177.3.1393; Nair MG, 2005, INFECT IMMUN, V73, P385, DOI 10.1128/IAI.73.1.385-394.2005; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	43	798	839	5	121	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2010	11	10					936	U89		10.1038/ni.1920	http://dx.doi.org/10.1038/ni.1920			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	651KP	20729857				2022-12-18	WOS:000281926900013
J	Migueles, SA; Laborico, AC; Shupert, WL; Sabbaghian, MS; Rabin, R; Hallahan, CW; Van Baarle, D; Kostense, S; Miedema, F; McLaughlin, M; Ehler, L; Metcalf, J; Liu, SY; Connors, M				Migueles, SA; Laborico, AC; Shupert, WL; Sabbaghian, MS; Rabin, R; Hallahan, CW; Van Baarle, D; Kostense, S; Miedema, F; McLaughlin, M; Ehler, L; Metcalf, J; Liu, SY; Connors, M			HIV-specific CD8(+) T cell proliferation is coupled to perforin expression and is maintained in nonprogressors	NATURE IMMUNOLOGY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; CYTOKINE PRODUCTION; IMMUNE-RESPONSES; LYMPHOID-TISSUE; LYMPHOCYTES; MEMORY; EFFECTOR; HLA; MUTATIONS	It is unclear why immunological control of HIV replication is incomplete in most infected individuals. We examined here the CD8(+)T cell response to HIV-infected CD4(+)T cells in rare patients with immunological control of HIV. Although high frequencies of HIV-specific CD8(+)T cells were present in nonprogressors and progressors, only those of nonprogressors maintained a high proliferative capacity. This proliferation was coupled to increases in perforin expression. These results indicated that nonprogressors were differentiated by increased proliferative capacity of HIV-specific CD8(+)T cells linked to enhanced effector function. In addition,the relative absence of these functions in progressors may represent a mechanism by which HIV avoids immunological control.	NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20205 USA; US FDA, Ctr Biol Evaluat & Res, Bethesda, MD USA; CLB Sanquin, Dept Clin Viroimmunol, Amsterdam, Netherlands	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); US Food & Drug Administration (FDA)	Connors, M (corresponding author), NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20205 USA.	mconnors@nih.gov		Rabin, Ronald/0000-0003-3496-0504	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000855, Z01AI000855] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andersson J, 1999, AIDS, V13, P1295, DOI 10.1097/00002030-199907300-00005; Andersson J, 2002, J INFECT DIS, V185, P1355, DOI 10.1086/340124; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Bachmann MF, 1999, EUR J IMMUNOL, V29, P291, DOI 10.1002/(SICI)1521-4141(199901)29:01<291::AID-IMMU291>3.0.CO;2-K; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; Cannavo G, 2001, BLOOD, V97, P1756, DOI 10.1182/blood.V97.6.1756; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Cohen OJ, 1998, J VIROL, V72, P6215, DOI 10.1128/JVI.72.7.6215-6217.1998; Dalod M, 1999, J VIROL, V73, P7108, DOI 10.1128/JVI.73.9.7108-7116.1999; de Quiros JCLB, 2000, J VIROL, V74, P2023, DOI 10.1128/JVI.74.4.2023-2028.2000; Faint JM, 2001, J IMMUNOL, V167, P212, DOI 10.4049/jimmunol.167.1.212; Ferrari G, 1997, P NATL ACAD SCI USA, V94, P1396, DOI 10.1073/pnas.94.4.1396; Flores-Villanueva PO, 2001, P NATL ACAD SCI USA, V98, P5140, DOI 10.1073/pnas.071548198; Gea-Banacloche JC, 2000, J IMMUNOL, V165, P1082, DOI 10.4049/jimmunol.165.2.1082; Goulder PJR, 1996, AIDS RES HUM RETROV, V12, P1691, DOI 10.1089/aid.1996.12.1691; Goulder PJR, 2001, J EXP MED, V193, P181, DOI 10.1084/jem.193.2.181; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Gray CM, 1999, J IMMUNOL, V162, P1780; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; HOLMES JL, 1995, EUR MASS SPECTROM, V1, P23, DOI 10.1255/ejms.156; Imami N, 2001, IMMUNOL LETT, V79, P63, DOI 10.1016/S0165-2478(01)00267-X; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kaslow RA, 2001, J VIROL, V75, P8681, DOI 10.1128/JVI.75.18.8681-8689.2001; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; Kostense S, 2002, BLOOD, V99, P2505, DOI 10.1182/blood.V99.7.2505; LEWIS DE, 1994, J IMMUNOL, V153, P412; Lieberman J, 2001, BLOOD, V98, P1667, DOI 10.1182/blood.V98.6.1667; Liu QH, 1998, IEEE MICROW GUIDED W, V8, P18, DOI 10.1109/75.650975; Lloyd TE, 1997, J IMMUNOL, V158, P1551; McMichael A, 2002, NAT REV IMMUNOL, V2, P283, DOI 10.1038/nri779; McMichael AJ, 2001, NATURE, V410, P980, DOI 10.1038/35073658; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Migueles SA, 2001, IMMUNOL LETT, V79, P141, DOI 10.1016/S0165-2478(01)00276-0; Mueller YM, 2001, IMMUNITY, V15, P871, DOI 10.1016/S1074-7613(01)00246-1; Ogg GS, 1999, J VIROL, V73, P797, DOI 10.1128/JVI.73.1.797-800.1999; OTTEN GR, 1991, SCIENCE, V251, P1228, DOI 10.1126/science.1900952; Oxenius A, 2001, AIDS, V15, P1653, DOI 10.1097/00002030-200109070-00007; Paiardini M, 2001, J VIROL, V75, P10843, DOI 10.1128/JVI.75.22.10843-10855.2001; PANTALEO G, 1990, J IMMUNOL, V144, P1696; PANTALEO G, 1995, NEW ENGL J MED, V332, P209, DOI 10.1056/NEJM199501263320402; Sandberg JK, 2001, J IMMUNOL, V167, P181, DOI 10.4049/jimmunol.167.1.181; Shankar P, 1999, BLOOD, V94, P3084, DOI 10.1182/blood.V94.9.3084.421k02_3084_3093; Sieg SF, 2002, J INFECT DIS, V185, P1401, DOI 10.1086/340509; Slifka MK, 1999, NATURE, V401, P76, DOI 10.1038/43454; Strathdee SA, 1996, AIDS, V10, P959, DOI 10.1097/00002030-199610090-00005; TOBA K, 1995, J IMMUNOL METHODS, V182, P193, DOI 10.1016/0022-1759(95)00050-K	49	795	817	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2002	3	11					1061	1068		10.1038/ni845	http://dx.doi.org/10.1038/ni845			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612KE	12368910				2022-12-18	WOS:000179073000013
J	Belkaid, Y; Rouse, BT				Belkaid, Y; Rouse, BT			Natural regulatory T cells in infectious disease	NATURE IMMUNOLOGY			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; LEISHMANIA-MAJOR INFECTION; TGF-BETA; DENDRITIC CELLS; CUTTING EDGE; IN-VITRO; EX-VIVO; CD4(+); RECEPTOR; SUPPRESSION	This review discusses the control exerted by natural CD4(+)CD25(+) regulatory T cells ( natural T-reg cells) during infectious processes. Natural T-reg cells may limit the magnitude of effector responses, which may result in failure to adequately control infection. However, natural T-reg cells also help limit collateral tissue damage caused by vigorous antimicrobial immune responses. We describe here various situations in which the balance between natural T-reg cells and effector immune functions influences the outcome of infection and discuss how manipulating this equilibrium might be exploited therapeutically.	Cincinnati Childrens Hosp Res Fdn, Div Mol Immunol, Cincinnati, OH 45229 USA; Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University of Tennessee System; University of Tennessee Knoxville	Belkaid, Y (corresponding author), NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.	ybelkaid@niaid.nih.gov		Belkaid, Yasmine/0000-0001-9962-3571	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000955, ZIAAI000955] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aandahl EM, 2004, J VIROL, V78, P2454, DOI 10.1128/JVI.78.5.2454-2459.2004; Andersson J, 2005, J IMMUNOL, V174, P3143, DOI 10.4049/jimmunol.174.6.3143; Aseffa A, 2002, J IMMUNOL, V169, P3232, DOI 10.4049/jimmunol.169.6.3232; Beilharz MW, 2004, J IMMUNOL, V172, P4917, DOI 10.4049/jimmunol.172.8.4917; Belghith M, 2003, NAT MED, V9, P1202, DOI 10.1038/nm924; Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Belkaid Y, 2001, J EXP MED, V194, P1497, DOI 10.1084/jem.194.10.1497; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Boyer O, 2004, BLOOD, V103, P3428, DOI 10.1182/blood-2003-07-2598; Bystry RS, 2001, NAT IMMUNOL, V2, P1126, DOI 10.1038/ni735; Cabrera R, 2004, HEPATOLOGY, V40, P1062, DOI 10.1002/hep.20454; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Choi BK, 2004, J LEUKOCYTE BIOL, V75, P785, DOI 10.1189/jlb.1003491; de Oliveira M R, 1999, Rev Inst Med Trop Sao Paulo, V41, P87, DOI 10.1590/S0036-46651999000200005; Dittmer U, 2004, IMMUNITY, V20, P293, DOI 10.1016/S1074-7613(04)00054-8; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Gane E, 2002, TRANSPLANTATION, V74, P427, DOI 10.1097/00007890-200208270-00001; Gangappa S, 1998, CLIN IMMUNOL IMMUNOP, V86, P88, DOI 10.1006/clin.1997.4460; GOOD MF, IN PRESS ANN REV IMM; Green EA, 2003, P NATL ACAD SCI USA, V100, P10878, DOI 10.1073/pnas.1834400100; He H, 2004, J VIROL, V78, P11641, DOI 10.1128/JVI.78.21.11641-11647.2004; Hesse M, 2004, J IMMUNOL, V172, P3157, DOI 10.4049/jimmunol.172.5.3157; Hisaeda H, 2004, NAT MED, V10, P29, DOI 10.1038/nm975; Hori S, 2002, EUR J IMMUNOL, V32, P3729, DOI 10.1002/1521-4141(200212)32:12<3729::AID-IMMU3729>3.0.CO;2-2; Hori S, 2002, EUR J IMMUNOL, V32, P1282, DOI 10.1002/1521-4141(200205)32:5<1282::AID-IMMU1282>3.0.CO;2-#; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Iellem A, 2001, J EXP MED, V194, P847, DOI 10.1084/jem.194.6.847; Iwashiro M, 2001, P NATL ACAD SCI USA, V98, P9226, DOI 10.1073/pnas.151174198; Joshi A, 2004, VIROLOGY, V321, P307, DOI 10.1016/j.virol.2004.01.014; Kinter AL, 2004, J EXP MED, V200, P331, DOI 10.1084/jem.20032069; Klein L, 2003, P NATL ACAD SCI USA, V100, P8886, DOI 10.1073/pnas.1533365100; Kullberg MC, 2002, J EXP MED, V196, P505, DOI 10.1084/jem.20020556; Kursar M, 2002, J EXP MED, V196, P1585, DOI 10.1084/jem.20011347; Liu HY, 2003, J IMMUNOL, V171, P5012, DOI 10.4049/jimmunol.171.10.5012; Long TTA, 2003, INT J PARASITOL, V33, P175, DOI 10.1016/S0020-7519(02)00261-8; Lundgren A, 2003, INFECT IMMUN, V71, P1755, DOI 10.1128/IAI.71.4.1755-1762.2003; MacDonald AJ, 2002, J INFECT DIS, V185, P720, DOI 10.1086/339340; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; McKee AS, 2004, J IMMUNOL, V173, P1224, DOI 10.4049/jimmunol.173.2.1224; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Mendez S, 2004, J EXP MED, V200, P201, DOI 10.1084/jem.20040298; Mills KHG, 2004, SEMIN IMMUNOL, V16, P107, DOI 10.1016/j.smim.2003.12.006; Montagnoli C, 2002, J IMMUNOL, V169, P6298, DOI 10.4049/jimmunol.169.11.6298; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Murphy ML, 1998, J IMMUNOL, V161, P4153; Netea MG, 2004, J IMMUNOL, V172, P3712, DOI 10.4049/jimmunol.172.6.3712; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Pawelec Graham, 2002, Trends in Immunology, V23, P330, DOI 10.1016/S1471-4906(02)02255-X; Piccirillo CA, 2004, SEMIN IMMUNOL, V16, P81, DOI 10.1016/j.smim.2003.12.003; Powrie Fiona, 2003, Novartis Found Symp, V252, P92; Raghavan S, 2004, SCAND J IMMUNOL, V60, P82, DOI 10.1111/j.0300-9475.2004.01447.x; Raghavan S, 2003, CLIN EXP IMMUNOL, V132, P393, DOI 10.1046/j.1365-2249.2003.02177.x; Rajagopalan S, 2001, CLIN INFECT DIS, V33, P1034, DOI 10.1086/322671; Rouse BT, 2002, REV MED VIROL, V12, P107, DOI 10.1002/rmv.347; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Serra P, 2003, IMMUNITY, V19, P877, DOI 10.1016/S1074-7613(03)00327-3; Shimizu J, 2003, EUR J IMMUNOL, V33, P2449, DOI 10.1002/eji.200324040; Shimizu J, 2003, J IMMUNOL, V170, P1675, DOI 10.4049/jimmunol.170.4.1675; Singer SM, 2000, J INFECT DIS, V181, P1510, DOI 10.1086/315409; Stephens GL, 2004, J IMMUNOL, V173, P5008, DOI 10.4049/jimmunol.173.8.5008; Sugimoto K, 2003, HEPATOLOGY, V38, P1437, DOI 10.1016/j.hep.2003.09.026; Suvas S, 2004, J IMMUNOL, V172, P4123, DOI 10.4049/jimmunol.172.7.4123; Suvas S, 2003, J EXP MED, V198, P889, DOI 10.1084/jem.20030171; Szanya V, 2002, J IMMUNOL, V169, P2461, DOI 10.4049/jimmunol.169.5.2461; Taylor PA, 2002, BLOOD, V99, P3493, DOI 10.1182/blood.V99.10.3493; Toka FN, 2004, J VIROL, V78, P13082, DOI 10.1128/JVI.78.23.13082-13089.2004; Vahlenkamp TW, 2004, J IMMUNOL, V172, P4752, DOI 10.4049/jimmunol.172.8.4752; vonHerrath MG, 1996, IMMUNOL REV, V152, P111; Walker LSK, 2003, J EXP MED, V198, P249, DOI 10.1084/jem.20030315; Weiss L, 2004, BLOOD, V104, P3249, DOI 10.1182/blood-2004-01-0365; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; Xu DM, 2003, J IMMUNOL, V170, P394, DOI 10.4049/jimmunol.170.1.394; Yamazaki S, 2003, J EXP MED, V198, P235, DOI 10.1084/jem.20030422; Zheng SG, 2004, J IMMUNOL, V172, P5213, DOI 10.4049/jimmunol.172.9.5213	80	792	877	2	46	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2005	6	4					353	360		10.1038/ni1181	http://dx.doi.org/10.1038/ni1181			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	909KY	15785761				2022-12-18	WOS:000227860000006
J	Querec, TD; Akondy, RS; Lee, EK; Cao, WP; Nakaya, HI; Teuwen, D; Pirani, A; Gernert, K; Deng, JS; Marzolf, B; Kennedy, K; Wu, HY; Bennouna, S; Oluoch, H; Miller, J; Vencio, RZ; Mulligan, M; Aderem, A; Ahmed, R; Pulendran, B				Querec, Troy D.; Akondy, Rama S.; Lee, Eva K.; Cao, Weiping; Nakaya, Helder I.; Teuwen, Dirk; Pirani, Ali; Gernert, Kim; Deng, Jiusheng; Marzolf, Bruz; Kennedy, Kathleen; Wu, Haiyan; Bennouna, Soumaya; Oluoch, Herold; Miller, Joseph; Vencio, Ricardo Z.; Mulligan, Mark; Aderem, Alan; Ahmed, Rafi; Pulendran, Bali			Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans	NATURE IMMUNOLOGY			English	Article							GENE-EXPRESSION PATTERNS; WEST-NILE-VIRUS; ENDOPLASMIC-RETICULUM; CELL; CLASSIFICATION; TRANSLATION; RESPONSES; MEDICINE; IMMUNITY; TARGETS	A major challenge in vaccinology is to prospectively determine vaccine efficacy. Here we have used a systems biology approach to identify early gene 'signatures' that predicted immune responses in humans vaccinated with yellow fever vaccine YF-17D. Vaccination induced genes that regulate virus innate sensing and type I interferon production. Computational analyses identified a gene signature, including complement protein C1qB and eukaryotic translation initiation factor 2 alpha kinase 4-an orchestrator of the integrated stress response-that correlated with and predicted YF-17D CD8(+) T cell responses with up to 90% accuracy in an independent, blinded trial. A distinct signature, including B cell growth factor TNFRS17, predicted the neutralizing antibody response with up to 100% accuracy. These data highlight the utility of systems biology approaches in predicting vaccine efficacy.	[Querec, Troy D.; Akondy, Rama S.; Cao, Weiping; Nakaya, Helder I.; Deng, Jiusheng; Bennouna, Soumaya; Oluoch, Herold; Miller, Joseph; Mulligan, Mark; Ahmed, Rafi; Pulendran, Bali] Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30329 USA; [Lee, Eva K.] Georgia Inst Technol, Sch Ind & Syst Engn, Ctr Operat Res Med & Healthcare, Atlanta, GA 30332 USA; [Teuwen, Dirk] Sanofi Pasteur, Lyon 07, France; [Pirani, Ali; Gernert, Kim] Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Marzolf, Bruz; Kennedy, Kathleen; Wu, Haiyan; Vencio, Ricardo Z.; Aderem, Alan] Inst Syst Biol, Seattle, WA 98103 USA; [Mulligan, Mark] Hope Clin, Decatur, GA 30030 USA; [Pulendran, Bali] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Emory University; University System of Georgia; Georgia Institute of Technology; Emory University; Institute for Systems Biology (ISB); Emory University	Pulendran, B (corresponding author), Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, 954 Gatewood Rd, Atlanta, GA 30329 USA.	bpulend@rmy.emory.edu	Pulendran, Bali/AAW-9550-2021; Mulligan, Mark/V-9275-2019; Nakaya, Helder I/A-1397-2010; Akondy, Rama/AAC-4656-2020; Vêncio, Ricardo ZN/A-1426-2008; Querec, Troy/AAH-3564-2021; Nakaya, Helder/AAF-1738-2020	Nakaya, Helder I/0000-0001-5297-9108; Vêncio, Ricardo ZN/0000-0003-0425-7877; Querec, Troy/0000-0002-3787-6271; Nakaya, Helder/0000-0001-5297-9108; Cao, Weiping/0000-0002-5794-9685; Pulendran, Bali/0000-0001-6517-4333; Teuwen, Dirk/0000-0003-0668-600X; Akondy, Rama/0000-0003-4737-5240	US National Institutes of Health; Sanofi Pasteur; Bill & Melinda Gates Foundation;  [U19 AI057266];  [R01 AI048638];  [R01 DK057665];  [U54 AI057157];  [N01 AI50019];  [N01 AI50025]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057266, N01AI050025, R01AI048638, U19AI090023, U54AI057157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057665, R01DK057665] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sanofi Pasteur; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); ; ; ; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Connolly at the Luminex Core at Baylor Institute for Immunology Research for doing Luminex analyses, and N. Kozyr (CFAR Virology Core, Emory University) for doing RT-PCR. Supported by the US National Institutes of Health (U19 AI057266, R01 AI048638, R01 DK057665, U54 AI057157, N01 AI50019, N01 AI50025), Sanofi Pasteur and the Bill & Melinda Gates Foundation.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Arimoto KI, 2008, MOL IMMUNOL, V45, P1078, DOI 10.1016/j.molimm.2007.07.021; Atrasheuskaya AV, 2003, CLIN EXP IMMUNOL, V131, P148, DOI 10.1046/j.1365-2249.2003.02050.x; Barba-Spaeth G, 2005, J EXP MED, V202, P1179, DOI 10.1084/jem.20051352; Berlanga JJ, 2006, EMBO J, V25, P1730, DOI 10.1038/sj.emboj.7601073; Brooks JP, 2008, ANN OPER RES, V164, P1; Cancro MP, 2006, ANN RHEUM DIS, V65, P34, DOI 10.1136/ard.2006.058412; Chen JP, 2006, J IMMUNOL, V177, P3185, DOI 10.4049/jimmunol.177.5.3185; Dabney AR, 2005, BIOINFORMATICS, V21, P4148, DOI 10.1093/bioinformatics/bti681; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Gallagher RJ, 1997, ANN OPER RES, V74, P65, DOI 10.1023/A:1018943025993; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Lee EK, 2007, ANN BIOMED ENG, V35, P1095, DOI 10.1007/s10439-007-9317-7; Mehlhop E, 2006, J EXP MED, V203, P1371, DOI 10.1084/jem.20052388; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Monath TP, 2005, EXPERT REV VACCINES, V4, P553, DOI 10.1586/14760584.4.4.553; Monath TP CM, 2008, VACCINES; Pantaleo G, 2008, LANCET INFECT DIS, V8, P82, DOI 10.1016/S1473-3099(07)70266-9; Potti A, 2006, NAT MED, V12, P1294, DOI 10.1038/nm1491; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Shirato K, 2004, J MED VIROL, V74, P507, DOI 10.1002/jmv.20205; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; STAUB O, 2004, SCI STKE, pPE43; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Takeuchi O, 2007, IMMUNOL REV, V220, P214, DOI 10.1111/j.1600-065X.2007.00562.x; Theiler M, 2000, Rev Med Virol, V10, P6; Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787; THEILER M, 2000, REV MED VIROL, V10, P13; Wong JJY, 2006, P NATL ACAD SCI USA, V103, P10735, DOI 10.1073/pnas.0600397103; Woodland RT, 2006, SEMIN IMMUNOL, V18, P318, DOI 10.1016/j.smim.2006.06.001; Zhao FQ, 2007, CURR GENOMICS, V8, P113, DOI 10.2174/138920207780368187	37	791	812	4	99	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2009	10	1					116	125		10.1038/ni.1688	http://dx.doi.org/10.1038/ni.1688			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	385BV	19029902	Green Accepted			2022-12-18	WOS:000261788800019
J	Delgoffe, GM; Pollizzi, KN; Waickman, AT; Heikamp, E; Meyers, DJ; Horton, MR; Xiao, B; Worley, PF; Powell, JD				Delgoffe, Greg M.; Pollizzi, Kristen N.; Waickman, Adam T.; Heikamp, Emily; Meyers, David J.; Horton, Maureen R.; Xiao, Bo; Worley, Paul F.; Powell, Jonathan D.			The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2	NATURE IMMUNOLOGY			English	Article							MAMMALIAN TARGET; TH2 DIFFERENTIATION; IN-VIVO; RAPAMYCIN; EXPRESSION; COMPLEX; PROTEIN; RAPTOR; GROWTH; RHEB	The kinase mTOR has emerged as an important regulator of the differentiation of helper T cells. Here we demonstrate that differentiation into the T(H)1 and T(H)17 subsets of helper T cells was selectively regulated by signaling from mTOR complex 1 (mTORC1) that was dependent on the small GTPase Rheb. Rheb-deficient T cells failed to generate T(H)1 and T(H)17 responses in vitro and in vivo and did not induce classical experimental autoimmune encephalomyelitis (EAE). However, they retained their ability to become T(H)2 cells. Alternatively, when mTORC2 signaling was deleted from T cells, they failed to generate T(H)2 cells in vitro and in vivo but preserved their ability to become T(H)1 and T(H)17 cells. Our data identify mechanisms by which two distinct signaling pathways downstream of mTOR regulate helper cell fate in different ways. These findings define a previously unknown paradigm that links T cell differentiation with selective metabolic signaling pathways.	[Delgoffe, Greg M.; Pollizzi, Kristen N.; Waickman, Adam T.; Heikamp, Emily; Powell, Jonathan D.] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Res Ctr, Baltimore, MD 21205 USA; [Meyers, David J.] Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21205 USA; [Horton, Maureen R.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Xiao, Bo; Worley, Paul F.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Powell, JD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Res Ctr, Baltimore, MD 21205 USA.	poweljo@jhmi.edu	Waickman, Adam/AHB-5028-2022; Heikamp, Emily/K-7158-2016; Delgoffe, Greg M./HCH-2805-2022	Heikamp, Emily/0000-0002-4591-4477; Delgoffe, Greg M./0000-0002-2957-8135; Waickman, Adam/0000-0002-4536-6714; Xiao, Bo/0000-0002-6161-9478	US National Institutes of Health [R01AI077610-01A2]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077610, T32AI007247] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank P.F. Worley (Johns Hopkins University) for mice with loxP-flanked Rheb alleles; M. Magnuson (Vanderbilt University) for mice with loxP-flanked Rictor alleles; S.C. Kozma (University of Cincinnati) for mice with loxP-flanked Mtor alleles; C. Drake (Johns Hopkins University) for vaccinia virus expressing ovalbumin; members of the Powell laboratory; and C. Drake and D. Pardoll for discussions and reagents. Supported by the US National Institutes of Health (R01AI077610-01A2).	Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Ballou LM, 2007, J BIOL CHEM, V282, P24463, DOI 10.1074/jbc.M704741200; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Cobbold SP, 2009, P NATL ACAD SCI USA, V106, P12055, DOI 10.1073/pnas.0903919106; Colombetti S, 2006, J IMMUNOL, V176, P2730, DOI 10.4049/jimmunol.176.5.2730; Dekker RJ, 2006, BLOOD, V107, P4354, DOI 10.1182/blood-2005-08-3465; Delgoffe GM, 2009, MOL IMMUNOL, V46, P2694, DOI 10.1016/j.molimm.2009.05.185; Delgoffe GM, 2009, IMMUNOLOGY, V127, P459, DOI 10.1111/j.1365-2567.2009.03125.x; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Holz MK, 2005, J BIOL CHEM, V280, P26089, DOI 10.1074/jbc.M504045200; Johnson MD, 2009, J NEURO-ONCOL, V92, P129, DOI 10.1007/s11060-008-9746-7; Kang J, 2008, J LEUKOCYTE BIOL, V83, P1230, DOI 10.1189/jlb.1207851; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim S, 2010, NEURON, V66, P69, DOI 10.1016/j.neuron.2010.03.019; Kopf H, 2007, INT IMMUNOPHARMACOL, V7, P1819, DOI 10.1016/j.intimp.2007.08.027; Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Lekmine F, 2004, EXP CELL RES, V295, P173, DOI 10.1016/j.yexcr.2003.12.021; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Ozaki A, 2005, J IMMUNOL, V175, P5489, DOI 10.4049/jimmunol.175.8.5489; Palmer DC, 2009, TRENDS IMMUNOL, V30, P592, DOI 10.1016/j.it.2009.09.009; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Paul WE, 2010, IMMUNOL CELL BIOL, V88, P236, DOI 10.1038/icb.2010.2; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Seki Y, 2002, P NATL ACAD SCI USA, V99, P13003, DOI 10.1073/pnas.202477099; Shu LL, 2009, MOL CELL BIOL, V29, P4691, DOI 10.1128/MCB.00764-09; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Stephenson LM, 2005, J IMMUNOL, V175, P5178, DOI 10.4049/jimmunol.175.8.5178; Valmori D, 2006, J IMMUNOL, V177, P944, DOI 10.4049/jimmunol.177.2.944; Wang B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001856; Wensky AK, 2005, J IMMUNOL, V174, P1416, DOI 10.4049/jimmunol.174.3.1416; YAMAGATA K, 1994, J BIOL CHEM, V269, P16333; Yamamoto K, 2003, BIOCHEM BIOPH RES CO, V310, P1188, DOI 10.1016/j.bbrc.2003.09.140; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; Yee WM, 1997, MOL CELL BIOL, V17, P921, DOI 10.1128/MCB.17.2.921; Yu CR, 2003, J BIOL CHEM, V278, P29752, DOI 10.1074/jbc.M300489200; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104	50	790	827	2	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2011	12	4					295	U117		10.1038/ni.2005	http://dx.doi.org/10.1038/ni.2005			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	737UJ	21358638	Green Accepted			2022-12-18	WOS:000288593400007
J	Nagai, Y; Akashi, S; Nagafuku, M; Ogata, M; Iwakura, Y; Akira, S; Kitamura, T; Kosugi, A; Kimoto, M; Miyake, K				Nagai, Y; Akashi, S; Nagafuku, M; Ogata, M; Iwakura, Y; Akira, S; Kitamura, T; Kosugi, A; Kimoto, M; Miyake, K			Essential role of MD-2 in LPS responsiveness and TLR4 distribution	NATURE IMMUNOLOGY			English	Article							TOLL-LIKE RECEPTOR-4; B-CELL ACTIVATION; CUTTING EDGE; BACTERIAL LIPOPOLYSACCHARIDE; ENDOPLASMIC-RETICULUM; IMMUNE-RESPONSE; INNATE IMMUNITY; DROSOPHILA TOLL; PROTEIN; RECOGNITION	Toll-like receptor 4 (TLR4) mediates lipopolysaccharide (LPS) signaling in a variety of cell types. MD2 is associated with the extracellular domain of TLR4 and augments TLR4-dependent LPS responses in vitro. We show here that MD-2(-/-) mice do not respond to LPS, do survive endotoxic shock but are susceptible to Salmonella typhimurium infection. We found that in MD-2(-/-) embryonic fibroblasts, TLR4 was not able to reach the plasma membrane and predominantly resided in the Golgi apparatus, whereas TLR4 was distributed at the leading edge surface of cells in wild-type embryonic fibroblasts. Thus, MD-2 is essential for correct intracellular distribution and LPS-recognition of TLR4.	Univ Tokyo, Inst Med Sci, Div Infect Genet, Tokyo, Japan; Univ Tokyo, Inst Med Sci, Ctr Med Expt, Tokyo, Japan; Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Tokyo, Japan; Japan Sci & Technol Corp, CREST, Tokyo, Japan; Saga Med Sch, Dept Immunol, Saga, Japan; Osaka Univ, Sch Med, Sch Allied Hlth Sci, Fac Med, Osaka, Japan; Osaka Univ, Sch Med, Dept Oncogenesis, Osaka, Japan; Osaka Univ, Microbial Dis Res Inst, Osaka, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Saga University; Osaka University; Osaka University; Osaka University	Miyake, K (corresponding author), Univ Tokyo, Inst Med Sci, Div Infect Genet, 4-6-1 Shirokanedai, Tokyo, Japan.		Akira, Shizuo/C-3134-2009; Iwakura, Yoichiro/E-5457-2011	Iwakura, Yoichiro/0000-0002-9934-5775				Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akashi S, 2001, INT IMMUNOL, V13, P1595, DOI 10.1093/intimm/13.12.1595; Akashi S, 2000, J IMMUNOL, V164, P3471, DOI 10.4049/jimmunol.164.7.3471; Bernheiden M, 2001, J ENDOTOXIN RES, V7, P447, DOI 10.1179/096805101101533061; Chan VWF, 1998, J EXP MED, V188, P93, DOI 10.1084/jem.188.1.93; Cole L, 2000, J MICROSC-OXFORD, V197, P239, DOI 10.1046/j.1365-2818.2000.00664.x; Correia JD, 2002, J BIOL CHEM, V277, P1845, DOI 10.1074/jbc.M109910200; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Haziot A, 1998, J IMMUNOL, V160, P2570; Hornef MW, 2002, J EXP MED, V195, P559, DOI 10.1084/jem.20011788; Hoshino K, 1999, J IMMUNOL, V162, P3749; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kato K, 2000, BLOOD, V96, P362, DOI 10.1182/blood.V96.1.362.013k23_362_364; Kawasaki K, 2000, J BIOL CHEM, V275, P2251, DOI 10.1074/jbc.275.4.2251; Kawasaki K, 2001, J IMMUNOL, V166, P11, DOI 10.4049/jimmunol.166.1.11; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Miura Y, 1998, BLOOD, V92, P2815, DOI 10.1182/blood.V92.8.2815.420k09_2815_2822; MIYAKE K, 1995, J IMMUNOL, V154, P3333; Miyake K, 1998, J IMMUNOL, V161, P1348; MIYAKE K, 1994, J EXP MED, V180, P1217, DOI 10.1084/jem.180.4.1217; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nagai Y, 2002, BLOOD, V99, P1699, DOI 10.1182/blood.V99.5.1699; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Ogata H, 2000, J EXP MED, V192, P23, DOI 10.1084/jem.192.1.23; Ohnishi T, 2001, J IMMUNOL, V167, P3354, DOI 10.4049/jimmunol.167.6.3354; Poltorak A, 2000, P NATL ACAD SCI USA, V97, P2163, DOI 10.1073/pnas.040565397; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; PUGIN J, 1994, IMMUNITY, V1, P509, DOI 10.1016/1074-7613(94)90093-0; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Schromm AB, 2001, J EXP MED, V194, P79, DOI 10.1084/jem.194.1.79; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Thieblemont N, 1999, J EXP MED, V190, P523, DOI 10.1084/jem.190.4.523; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Viriyakosol S, 2001, J BIOL CHEM, V276, P38044; Visintin A, 2001, P NATL ACAD SCI USA, V98, P12156, DOI 10.1073/pnas.211445098; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; Yang H, 2000, J BIOL CHEM, V275, P20861, DOI 10.1074/jbc.M002896200	44	780	833	0	58	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2002	3	7					667	672		10.1038/ni809	http://dx.doi.org/10.1038/ni809			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	566RH	12055629				2022-12-18	WOS:000176441700017
J	Vignali, DAA; Kuchroo, VK				Vignali, Dario A. A.; Kuchroo, Vijay K.			IL-12 family cytokines: immunological playmakers	NATURE IMMUNOLOGY			English	Review							REGULATORY T-CELLS; CUTTING EDGE; C-MAF; NEGATIVE REGULATION; LINEAGE COMMITMENT; RECEPTOR COMPONENT; INDUCED ARTHRITIS; NATURAL-KILLER; P40 HOMODIMER; IFN-GAMMA	The interleukin 12 (IL-12) family is unique in having the only heterodimeric cytokines, including IL-12, IL-23, IL-27 and IL-35. This feature endows these cytokines with a unique set of connections and functional interactions not shared by other cytokine families. Despite sharing many structural features and molecular partners, cytokines of the IL-12 family mediate surprisingly diverse functional effects. Here we discuss the unique and unusual structural and functional characteristics of this cytokine family. We outline how cells might interpret seemingly similar cytokine signals to give rise to the diverse functional outcomes that characterize this cytokine family. We also discuss the therapeutic implications of this complexity.	[Vignali, Dario A. A.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Kuchroo, Vijay K.] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [Kuchroo, Vijay K.] Harvard Univ, Sch Med, Boston, MA 02115 USA	St Jude Children's Research Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Vignali, DAA (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	vignali.lab@stjude.org			US National Institutes of Health [AI091977, NS30843]; National Cancer Institute [CA21765]; American Asthma Foundation [10-0128]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030843, R29NS030843, R37NS030843] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Asthma Foundation; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by the US National Institutes of Health (AI091977 to D.A.A.V., and NS30843 to V. K. K.), the National Cancer Institute (CA21765 to D.A.A.V.), the American Asthma Foundation (10-0128 to D.A.A.V.) and the American Lebanese Syrian Associated Charities (D.A.A.V.).	Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Bancroft AJ, 2004, J IMMUNOL, V172, P7635, DOI 10.4049/jimmunol.172.12.7635; Batten M, 2008, J IMMUNOL, V180, P2752, DOI 10.4049/jimmunol.180.5.2752; Batten M, 2010, J EXP MED, V207, P2895, DOI 10.1084/jem.20100064; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettini M, 2012, DIABETES, V61, P1519, DOI 10.2337/db11-0784; Beyer BM, 2008, J MOL BIOL, V382, P942, DOI 10.1016/j.jmb.2008.08.001; Boulanger MJ, 2004, J MOL BIOL, V335, P641, DOI 10.1016/j.jmb.2003.10.070; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Canda-Sanchez A, 2009, J MEMBRANE BIOL, V227, P1, DOI 10.1007/s00232-008-9127-3; Castellani ML, 2010, J BIOL REG HOMEOS AG, V24, P131; Chaturvedi V, 2011, J IMMUNOL, V186, P6661, DOI 10.4049/jimmunol.1100315; CHUA AO, 1995, J IMMUNOL, V155, P4286; CHUA AO, 1994, J IMMUNOL, V153, P128; Collison LW, 2008, IMMUNOL REV, V226, P248, DOI 10.1111/j.1600-065X.2008.00704.x; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Collison LW, 2012, NAT IMMUNOL, V13, P290, DOI 10.1038/ni.2227; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Collison LW, 2009, J IMMUNOL, V182, P6121, DOI 10.4049/jimmunol.0803646; Cooper AM, 2007, TRENDS IMMUNOL, V28, P33, DOI 10.1016/j.it.2006.11.002; Cox JH, 2011, J EXP MED, V208, P115, DOI 10.1084/jem.20100410; Crabe S, 2009, J IMMUNOL, V183, P7692, DOI 10.4049/jimmunol.0901464; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Decker T, 1999, CELL MOL LIFE SCI, V55, P1535, DOI 10.1007/s000180050393; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Delgoffe GM, 2011, CURR OPIN IMMUNOL, V23, P632, DOI 10.1016/j.coi.2011.07.013; Dickensheets HL, 2000, J INTERF CYTOK RES, V20, P897, DOI 10.1089/10799900050163271; Diveu C, 2009, J IMMUNOL, V182, P5748, DOI 10.4049/jimmunol.0801162; Dong C, 2008, J IMMUNOTOXICOL, V5, P43, DOI 10.1080/15476910801897953; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; Gately MK, 1996, ANN NY ACAD SCI, V795, P1, DOI 10.1111/j.1749-6632.1996.tb52650.x; GILLESSEN S, 1995, EUR J IMMUNOL, V25, P200, DOI 10.1002/eji.1830250133; Hibbert L, 2003, J INTERF CYTOK RES, V23, P513, DOI 10.1089/10799900360708632; Ho HH, 2006, J BIOL CHEM, V281, P14111, DOI 10.1074/jbc.M511797200; Huang CH, 2011, J IMMUNOL, V187, P462, DOI 10.4049/jimmunol.1100259; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Ihle JN, 1995, ADV IMMUNOL, V60, P1, DOI 10.1016/S0065-2776(08)60582-9; Jones LL, 2012, MOL IMMUNOL, V51, P234, DOI 10.1016/j.molimm.2012.03.025; Jones LL, 2011, IMMUNOL RES, V51, P5, DOI 10.1007/s12026-011-8209-y; Kass DJ, 2011, CYTOKINE, V55, P325, DOI 10.1016/j.cyto.2011.05.021; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Khader SA, 2006, J EXP MED, V203, P1805, DOI 10.1084/jem.20052545; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Kochetkova I, 2010, J IMMUNOL, V184, P7144, DOI 10.4049/jimmunol.0902739; Kreymborg K, 2005, EXPERT OPIN THER TAR, V9, P1123, DOI 10.1517/14728222.9.6.1123; Kuo J, 2011, CLIN VACCINE IMMUNOL, V18, P1125, DOI 10.1128/CVI.00052-11; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Liu F, 2011, CLIN IMMUNOL, V139, P1, DOI 10.1016/j.clim.2010.12.012; Lucas S, 2003, P NATL ACAD SCI USA, V100, P15047, DOI 10.1073/pnas.2536517100; Lupardus PJ, 2008, J MOL BIOL, V382, P931, DOI 10.1016/j.jmb.2008.07.051; Ma XJ, 2001, ADV IMMUNOL, V79, P55; Maldonado RA, 2004, NATURE, V431, P527, DOI 10.1038/nature02916; Maldonado RA, 2009, J EXP MED, V206, P877, DOI 10.1084/jem.20082900; Maloy KJ, 2008, MUCOSAL IMMUNOL, V1, P339, DOI 10.1038/mi.2008.28; Martin-Orozco N, 2009, CURR OPIN INVEST DR, V10, P543; McGeachy MJ, 2007, SEMIN IMMUNOL, V19, P372, DOI 10.1016/j.smim.2007.10.012; Molle C, 2007, J IMMUNOL, V178, P7607, DOI 10.4049/jimmunol.178.12.7607; Molle C, 2010, J IMMUNOL, V184, P1784, DOI 10.4049/jimmunol.0902005; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Murugaiyan G, 2010, P NATL ACAD SCI USA, V107, P11495, DOI 10.1073/pnas.1002099107; Niedbala W, 2007, EUR J IMMUNOL, V37, P3021, DOI 10.1002/eji.200737810; O'Shea JJ, 2002, NAT IMMUNOL, V3, P506, DOI 10.1038/ni0602-506; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Petermann F, 2010, IMMUNITY, V33, P351, DOI 10.1016/j.immuni.2010.08.013; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Pot C, 2011, SEMIN IMMUNOL, V23, P438, DOI 10.1016/j.smim.2011.08.003; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Rogge L, 1997, J EXP MED, V185, P825, DOI 10.1084/jem.185.5.825; Seyer M, 2010, EUR J IMMUNOL, V40, P321, DOI 10.1002/eji.200939527; Stumhofer JS, 2008, IMMUNOL LETT, V117, P123, DOI 10.1016/j.imlet.2008.01.011; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Stumhofer JS, 2010, NAT IMMUNOL, V11, P1119, DOI 10.1038/ni.1957; SZABO SJ, 1995, IMMUNITY, V2, P665, DOI 10.1016/1074-7613(95)90011-X; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Villarino AV, 2007, J EXP MED, V204, P65, DOI 10.1084/jem.20061198; Villarino AV, 2006, J IMMUNOL, V176, P237, DOI 10.4049/jimmunol.176.1.237; Villarino AV, 2005, J IMMUNOL, V174, P7684, DOI 10.4049/jimmunol.174.12.7684; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Whitehead GS, 2012, J ALLERGY CLIN IMMUN, V129, P207, DOI 10.1016/j.jaci.2011.08.009; Wills-Karp M, 2001, J ALLERGY CLIN IMMUN, V107, P9, DOI 10.1067/mai.2001.112265; Wirtz S, 2011, GASTROENTEROLOGY, V141, P1875, DOI 10.1053/j.gastro.2011.07.040; Wojno EDT, 2012, TRENDS IMMUNOL, V33, P91, DOI 10.1016/j.it.2011.11.003; Wojno EDT, 2011, J IMMUNOL, V187, P266, DOI 10.4049/jimmunol.1004182; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958; Yoon C, 2000, EMBO J, V19, P3530, DOI 10.1093/emboj/19.14.3530	96	779	823	18	138	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2012	13	8					722	728		10.1038/ni.2366	http://dx.doi.org/10.1038/ni.2366			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	976GT	22814351	Green Accepted			2022-12-18	WOS:000306569600007
J	Duhen, T; Geiger, R; Jarrossay, D; Lanzavecchia, A; Sallusto, F				Duhen, Thomas; Geiger, Rebekka; Jarrossay, David; Lanzavecchia, Antonio; Sallusto, Federica			Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells	NATURE IMMUNOLOGY			English	Article							ROR-GAMMA-T; CHEMOKINE RECEPTOR EXPRESSION; PLASMACYTOID DENDRITIC CELLS; CYTOKINE GENE-EXPRESSION; GROWTH-FACTOR-BETA; TGF-BETA; TRANSCRIPTION FACTOR; LYMPHOCYTE TRAFFICKING; MEDIATED PATHOLOGY; T(H)17 CYTOKINE	Interleukin 22 (IL-22) is a cytokine produced by the T-H-17 lineage of helper T cells and NK-22 subset of natural killer cells that acts on epithelial cells and keratinocytes and has been linked to skin homeostasis and inflammation. Here we characterize a population of human skin-homing memory CD4(+) T cells that expressed the chemokine receptors CCR10, CCR6 and CCR4 and produced IL-22 but neither IL-17 nor interferon-gamma (IFN-gamma). Clones isolated from this population produced IL-22 only and had low or undetectable expression of the T-H-17 and T helper type 1 (T(H)1) transcription factors ROR gamma t and T-bet. The differentiation of T cells producing only IL-22 was efficiently induced in naive T cells by plasmacytoid dendritic cells in an IL-6- and tumor necrosis factor-dependent way. Our findings delineate a previously unknown subset of human CD4(+) effector T cells dedicated to skin pathophysiology.	[Duhen, Thomas; Geiger, Rebekka; Jarrossay, David; Lanzavecchia, Antonio; Sallusto, Federica] Biomed Res Inst, Bellinzona, Switzerland	Universita della Svizzera Italiana	Sallusto, F (corresponding author), Biomed Res Inst, Bellinzona, Switzerland.	federica.sallusto@irb.unisi.ch			Swiss National Science Foundation [31-101962]; European Commission [LSB-CT-2005-518167]; Helmut Horten Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Helmut Horten Foundation	We thank G. Napolitani for discussions; A. Cavani (Istituto Dermopatico dell'Immacolata) for T cells from psoriatic skin lesions; and M. Roederer (US National Institutes of Health) for the Spice and Pestle software. Supported by the Swiss National Science Foundation (31-101962 to F. S.), the European Commission Framework Programme 6 (Innovative Chemokine-based Therapeutic Strategies for Autoimmunity and Chronic Inflammation; LSB-CT-2005-518167) and the Helmut Horten Foundation (to the Institute for Research in Biomedicine).	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Albanesi C, 2009, J EXP MED, V206, P249, DOI 10.1084/jem.20080129; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Betti M, 2006, ANN ONCOL, V17, P235; Boniface K, 2007, CLIN EXP IMMUNOL, V150, P407, DOI 10.1111/j.1365-2249.2007.03511.x; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Harries-Rees K, 2005, CHEM WORLD-UK, V2, P6; Homey B, 2002, NAT MED, V8, P157, DOI 10.1038/nm0202-157; Hughes T, 2009, BLOOD, V113, P4008, DOI 10.1182/blood-2008-12-192443; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kupper TS, 2004, NAT REV IMMUNOL, V4, P211, DOI 10.1038/nri1310; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lord GM, 2005, BLOOD, V106, P3432, DOI 10.1182/blood-2005-04-1393; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Nograles KE, 2009, J ALLERGY CLIN IMMUN, V123, P1244, DOI 10.1016/j.jaci.2009.03.041; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Reiss Y, 2001, J EXP MED, V194, P1541, DOI 10.1084/jem.194.10.1541; Rivino L, 2004, J EXP MED, V200, P725, DOI 10.1084/jem.20040774; Sallusto F, 2004, CURR OPIN IMMUNOL, V16, P724, DOI 10.1016/j.coi.2004.09.012; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Salmi M, 2005, IMMUNOL REV, V206, P100, DOI 10.1111/j.0105-2896.2005.00285.x; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Singh SP, 2008, J IMMUNOL, V180, P214, DOI 10.4049/jimmunol.180.1.214; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; TRIFARI S, 2009, NAT IMMUNOL     0705, DOI DOI 10.1038/NI1770; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2006, CYTOKINE GROWTH F R, V17, P367, DOI 10.1016/j.cytogfr.2006.09.001; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Yang GH, 2008, PRESENCE-TELEOP VIRT, V17, P29, DOI 10.1162/pres.17.1.29; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	52	779	850	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2009	10	8					857	U72		10.1038/ni.1767	http://dx.doi.org/10.1038/ni.1767			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	472OM	19578369				2022-12-18	WOS:000268141400014
J	Groh, V; Rhinehart, R; Randolph-Habecker, J; Topp, MS; Riddell, SR; Spies, T				Groh, V; Rhinehart, R; Randolph-Habecker, J; Topp, MS; Riddell, SR; Spies, T			Costimulation of CD8 alpha beta T cells by NKG2D via engagement by MIC induced on virus-infected cells	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; NK CELLS; INHIBITORY RECEPTORS; HUMAN CYTOMEGALOVIRUS; PROTEIN PP65; IN-VIVO; ANTIGEN; ACTIVATION; LYMPHOCYTES; CLONES	NKG2D is an activating receptor that stimulates innate immune responses by natural killer cells upon engagement by MIC ligands, which are induced by cellular stress. Because NKG2D is also present on most CD8 alpha beta T cells, it may modulate antigen-specific T cell responses, depending on whether MIC molecules-distant homologs of major histocompatibility complex (MHC) class I with no function in antigen presentation-are induced on the surface of pathogen-infected cells. We found that infection by cytomegalovirus (CMV) resulted in substantial increases in MIC on cultured fibroblast and endothelial cells and was associated with induced MIC expression in interstitial pneumonia, MIC engagement of NKG2D potently augmented T cell antigen receptor (TCR)-dependent cytolytic and cytokine responses by CMV-specific CD28(-) CD8 alpha beta T cells. This function overcame viral interference with MHC class I antigen presentation. Combined triggering of TCR-CD3 complexes and NKG2D induced interleukin 2 production and T cell proliferation. Thus NKG2D functioned as a costimulatory receptor that can substitute for CD28.	Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Groh, V (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1100 Fairview Ave N, Seattle, WA 98109 USA.		Topp, Max/F-2868-2012		NCI NIH HHS [CA18221, CA18029] Funding Source: Medline; NIAID NIH HHS [AI41754] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA018029, P01CA018221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041754] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; AZUMA M, 1993, J IMMUNOL, V150, P1147; Bahram S, 1996, IMMUNOGENETICS, V43, P230, DOI 10.1007/BF00587305; BAHRAM S, 1994, P NATL ACAD SCI USA, V91, P6259, DOI 10.1073/pnas.91.14.6259; Bakker ABH, 1998, J IMMUNOL, V160, P5239; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395; Carena I, 1997, J EXP MED, V186, P1769, DOI 10.1084/jem.186.10.1769; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; CHALUPNY J, 2000, FASEB J, V14, P1018; Chambers CA, 1999, CURR OPIN CELL BIOL, V11, P203, DOI 10.1016/S0955-0674(99)80027-1; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; Gilbert MJ, 1996, NATURE, V383, P720, DOI 10.1038/383720a0; GIMMI CD, 1991, P NATL ACAD SCI USA, V88, P6575, DOI 10.1073/pnas.88.15.6575; GRIBBEN JG, 1995, P NATL ACAD SCI USA, V92, P811, DOI 10.1073/pnas.92.3.811; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; HARA T, 1985, J EXP MED, V161, P1513, DOI 10.1084/jem.161.6.1513; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; HOUCHINS JP, 1991, J EXP MED, V173, P1017, DOI 10.1084/jem.173.4.1017; Ikeda H, 1997, IMMUNITY, V6, P199, DOI 10.1016/S1074-7613(00)80426-4; KAO HT, 1983, MOL CELL BIOL, V3, P2058, DOI 10.1128/MCB.3.11.2058; KHANDJIAN EW, 1983, MOL CELL BIOL, V3, P1; Lanier LL, 2000, J EXP MED, V191, P1259, DOI 10.1084/jem.191.8.1259; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; LATHANGUE NB, 1987, BIOSCIENCE REP, V7, P475, DOI 10.1007/BF01116504; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Li PW, 1999, IMMUNITY, V10, P577, DOI 10.1016/S1074-7613(00)80057-6; LINSLEY PS, 1991, J EXP MED, V173, P721, DOI 10.1084/jem.173.3.721; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; MCLAUGHLINTAYLOR E, 1994, J MED VIROL, V43, P103, DOI 10.1002/jmv.1890430119; Noppen C, 1998, EUR J IMMUNOL, V28, P1134, DOI 10.1002/(SICI)1521-4141(199804)28:04<1134::AID-IMMU1134>3.0.CO;2-G; PARHAM P, 1979, J IMMUNOL, V123, P342; PHILLIPS JH, 1995, SCIENCE, V268, P403, DOI 10.1126/science.7716542; Ploegh HL, 1998, SCIENCE, V280, P248, DOI 10.1126/science.280.5361.248; Posnett DN, 1999, INT IMMUNOL, V11, P229, DOI 10.1093/intimm/11.2.229; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Riddell S R, 1995, Semin Respir Infect, V10, P199; RIDDELL SR, 1992, SCIENCE, V257, P238; SANTOMENNA LD, 1990, J VIROL, V64, P2033, DOI 10.1128/JVI.64.5.2033-2040.1990; THOMPSON CB, 1989, P NATL ACAD SCI USA, V86, P1333, DOI 10.1073/pnas.86.4.1333; WALDMAN WJ, 1989, J MED VIROL, V28, P223; Wills MR, 1996, J VIROL, V70, P7569, DOI 10.1128/JVI.70.11.7569-7579.1996; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730	48	779	841	1	21	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2001	2	3					255	260		10.1038/85321	http://dx.doi.org/10.1038/85321			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	409YT	11224526				2022-12-18	WOS:000167413800019
J	Ayabe, T; Satchell, DP; Wilson, CL; Parks, WC; Selsted, ME; Ouellette, AJ				Ayabe, T; Satchell, DP; Wilson, CL; Parks, WC; Selsted, ME; Ouellette, AJ			Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria	NATURE IMMUNOLOGY			English	Article							INNATE HOST-DEFENSE; ANTIMICROBIAL PEPTIDE; TRANSGENIC MICE; MICROSCOPIC OBSERVATIONS; HUMAN BETA-DEFENSIN-1; PHOSPHOLIPASE A(2); PHAGOCYTIC-CELLS; GENE-EXPRESSION; WISTAR RATS; ANTIBIOTICS	Paneth cells in mouse small intestinal crypts secrete granules rich in microbicidal peptides when exposed to bacteria or bacterial antigens. The dose-dependent secretion occurs within minutes and alpha-defensins, or cryptdins, account for 70% of the released bactericidal peptide activity. Gram-negative bacteria, Gram-positive bacteria, lipopolysaccharide, lipoteichoic acid, lipid A and muramyl dipeptide elicit cryptdin secretion. Live fungi and protozoa, however, do not stimulate degranulation. Thus intestinal Paneth cells contribute to innate immunity by sensing bacteria and bacterial antigens, and discharge microbicidal peptides at effective concentrations accordingly.	Univ Calif Irvine, Coll Med, Dept Pathol, Irvine, CA 92697 USA; Univ Calif Irvine, Coll Med, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Washington University (WUSTL); Washington University (WUSTL)	Ouellette, AJ (corresponding author), Univ Calif Irvine, Coll Med, Dept Pathol, Irvine, CA 92697 USA.		Parks, William C./AAH-6786-2021; Ayabe, Tokiyoshi/F-5264-2011	Ayabe, Tokiyoshi/0000-0002-8631-5593	NHLBI NIH HHS [HL29594] Funding Source: Medline; NIAID NIH HHS [AI 22931] Funding Source: Medline; NIDDK NIH HHS [DK44632] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI022931, R01AI022931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044632, R55DK044632] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALEY SB, 1994, INFECT IMMUN, V62, P5397, DOI 10.1128/IAI.62.12.5397-5403.1994; Bals R, 1999, INFECT IMMUN, V67, P3542, DOI 10.1128/IAI.67.7.3542-3547.1999; Bals R, 1998, INFECT IMMUN, V66, P1225, DOI 10.1128/IAI.66.3.1225-1232.1998; Bals R, 1998, J CLIN INVEST, V102, P874, DOI 10.1172/JCI2410; Bevins CL, 1999, GUT, V45, P911, DOI 10.1136/gut.45.6.911; BJERKNES M, 1981, ANAT REC, V199, P565, DOI 10.1002/ar.1091990412; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; BOMAN HG, 1991, CELL, V65, P205, DOI 10.1016/0092-8674(91)90154-Q; CANOGAUCI DF, 1993, EXP CELL RES, V208, P344, DOI 10.1006/excr.1993.1255; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Diamond G, 1998, CLIN IMMUNOL IMMUNOP, V88, P221, DOI 10.1006/clin.1998.4587; EISENHAUER PB, 1992, INFECT IMMUN, V60, P3556, DOI 10.1128/IAI.60.9.3556-3565.1992; FIELDS PI, 1989, SCIENCE, V243, P1059, DOI 10.1126/science.2646710; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Ganz T, 1997, Curr Opin Hematol, V4, P53; Ganz T, 1999, SCIENCE, V286, P420, DOI 10.1126/science.286.5439.420; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; GHOOS Y, 1971, Histochemical Journal, V3, P175, DOI 10.1007/BF01002560; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; GORDON JI, 1992, FASEB J, V6, P3039, DOI 10.1096/fasebj.6.12.1521737; GORDON JI, 1989, J CELL BIOL, V108, P1187, DOI 10.1083/jcb.108.4.1187; HARWIG SSL, 1995, J CLIN INVEST, V95, P603, DOI 10.1172/JCI117704; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; JONES DE, 1992, J BIOL CHEM, V267, P23216; LEHRER RI, 1991, CELL, V64, P229, DOI 10.1016/0092-8674(91)90632-9; LOEFFLER M, 1986, CELL TISSUE KINET, V19, P627, DOI 10.1111/j.1365-2184.1986.tb00763.x; MACPHEE M, 1995, CELL, V81, P957, DOI 10.1016/0092-8674(95)90015-2; MARTIN E, 1995, J LEUKOCYTE BIOL, V58, P128, DOI 10.1002/jlb.58.2.128; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; OUELLETTE AJ, 1994, INFECT IMMUN, V62, P5040, DOI 10.1128/IAI.62.11.5040-5047.1994; PARDI A, 1988, J MOL BIOL, V201, P625, DOI 10.1016/0022-2836(88)90643-2; PAULUS U, 1993, J CELL SCI, V106, P473; Porter EM, 1997, INFECT IMMUN, V65, P2389, DOI 10.1128/IAI.65.6.2389-2395.1997; Qu XD, 1996, INFECT IMMUN, V64, P5161, DOI 10.1128/IAI.64.12.5161-5165.1996; Quayle AJ, 1998, AM J PATHOL, V152, P1247; SATOH Y, 1995, GASTROENTEROLOGY, V108, P1345, DOI 10.1016/0016-5085(95)90681-9; SATOH Y, 1986, DIGESTION, V34, P115, DOI 10.1159/000199319; SATOH Y, 1986, ANAT EMBRYOL, V173, P317, DOI 10.1007/BF00318915; SCHONWETTER BS, 1995, SCIENCE, V267, P1645, DOI 10.1126/science.7886453; Selsted M E, 1993, Genet Eng (N Y), V15, P131; SELSTED ME, 1986, ANAL BIOCHEM, V155, P270, DOI 10.1016/0003-2697(86)90436-7; SELSTED ME, 1995, TRENDS CELL BIOL, V5, P114, DOI 10.1016/S0962-8924(00)88961-8; SELSTED ME, 1992, J CELL BIOL, V118, P929, DOI 10.1083/jcb.118.4.929; SELSTED ME, 1989, J BIOL CHEM, V264, P4003; Valore EV, 1998, J CLIN INVEST, V101, P1633, DOI 10.1172/JCI1861; Wang MSC, 1997, ANAL BIOCHEM, V253, P225, DOI 10.1006/abio.1997.2347; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113	48	779	823	3	73	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2000	1	2					113	118		10.1038/77783	http://dx.doi.org/10.1038/77783			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BW	11248802				2022-12-18	WOS:000089814900010
J	Kelly, D; Campbell, JI; King, TP; Grant, G; Jansson, EA; Coutts, AGP; Pettersson, S; Conway, S				Kelly, D; Campbell, JI; King, TP; Grant, G; Jansson, EA; Coutts, AGP; Pettersson, S; Conway, S			Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; ACTIVATED RECEPTOR-GAMMA; INTESTINAL EPITHELIAL-CELLS; IMMUNE-RESPONSES; GENE-EXPRESSION; BOWEL-DISEASE; INHIBITION; PROTEINS; THERAPY; COLITIS	The human gut microflora is important in regulating host inflammatory responses and in maintaining immune homeostasis. The cellular and molecular bases of these actions are unknown. Here we describe a unique anti-inflammatory mechanism, activated by nonpathogenic bacteria, that selectively antagonizes transcription factor NF-kappaB. Bacteroides thetaiotaomicron targets transcriptionally active NF-kappaB subunit RelA, enhancing its nuclear export through a mechanism independent of nuclear export receptor Crm-1. Peroxisome proliferator activated receptor-gamma (PPAR-gamma), in complex with nuclear RelA, also undergoes nucleocytoplasmic redistribution in response to B. thetaiotaomicron. A decrease in PPARgamma-abolishes both the nuclear export of RelA and the anti-inflammatory activity of B. thetaiotaomicron. This PPAR-gamma-dependent anti-inflammatory mechanism defines new cellular targets for therapeutic drug design and interventions for the treatment of chronic inflammation.	Rowett Res Inst, Gut Immunol Grp, Aberdeen AB21 9SB, Scotland; Karolinska Inst, Ctr Microbiol & Tumor Biol, Div Mol Pathol, S-17177 Stockholm, Sweden	University of Aberdeen; Karolinska Institutet	Kelly, D (corresponding author), Rowett Res Inst, Gut Immunol Grp, Greenburn Rd, Aberdeen AB21 9SB, Scotland.	D.Kelly@rri.sari.ac.uk	Pettersson, Sven/F-9511-2015					Bunn CF, 2001, MOL ENDOCRINOL, V15, P512, DOI 10.1210/mend.15.4.0619; Campieri M, 1999, GASTROENTEROLOGY, V116, P1246, DOI 10.1016/S0016-5085(99)70029-6; Cario E, 2000, J IMMUNOL, V164, P966, DOI 10.4049/jimmunol.164.2.966; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; CHENG Q, 1994, J BIOL CHEM, V269, P13551; CHIAO PJ, 1994, P NATL ACAD SCI USA, V91, P28, DOI 10.1073/pnas.91.1.28; Chung SW, 2000, J BIOL CHEM, V275, P32681, DOI 10.1074/jbc.M002577200; Cong YZ, 2002, J IMMUNOL, V169, P6112, DOI 10.4049/jimmunol.169.11.6112; De Winter H, 2002, GASTROENTEROLOGY, V122, P1829, DOI 10.1053/gast.2002.33655; Di Leo V, 2002, INT ARCH ALLERGY IMM, V129, P219, DOI 10.1159/000066778; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gurnell M, 2000, J BIOL CHEM, V275, P5754, DOI 10.1074/jbc.275.8.5754; Haller D, 2003, J BIOL CHEM, V278, P23851, DOI 10.1074/jbc.M300075200; Hang L, 1999, J IMMUNOL, V162, P3037; Huang TT, 2000, P NATL ACAD SCI USA, V97, P1014, DOI 10.1073/pnas.97.3.1014; Katayama K, 2003, GASTROENTEROLOGY, V124, P1315, DOI 10.1016/S0016-5085(03)00262-2; Kelly D, 2001, GUT, V49, P612, DOI 10.1136/gut.49.5.612; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Marteau PR, 2001, AM J CLIN NUTR, V73, p430S, DOI 10.1093/ajcn/73.2.430s; May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3; MCCORMICK BA, 1993, J CELL BIOL, V123, P895, DOI 10.1083/jcb.123.4.895; Nakajima A, 2001, GASTROENTEROLOGY, V120, P460, DOI 10.1053/gast.2001.21191; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; PARKOS CA, 1991, J CLIN INVEST, V88, P1605, DOI 10.1172/JCI115473; POWRIE F, 1994, J EXP MED, V179, P589, DOI 10.1084/jem.179.2.589; Rembacken BJ, 1999, LANCET, V354, P635, DOI 10.1016/S0140-6736(98)06343-0; Ricote M, 1999, J LEUKOCYTE BIOL, V66, P733, DOI 10.1002/jlb.66.5.733; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Sartor RB, 1997, RES IMMUNOL, V148, P567, DOI 10.1016/S0923-2494(98)80151-X; Schesser K, 1998, MOL MICROBIOL, V28, P1067, DOI 10.1046/j.1365-2958.1998.00851.x; Schmid JA, 2000, J BIOL CHEM, V275, P17035, DOI 10.1074/jbc.M000291200; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Su CG, 1999, J CLIN INVEST, V104, P383, DOI 10.1172/JCI7145; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Suzawa M, 2003, NAT CELL BIOL, V5, P224, DOI 10.1038/ncb942; Tam WF, 2001, J BIOL CHEM, V276, P7701, DOI 10.1074/jbc.C000916200; Wang NP, 2002, J BIOL CHEM, V277, P34176, DOI 10.1074/jbc.M203436200; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029	43	776	862	3	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2004	5	1					104	112		10.1038/ni1018	http://dx.doi.org/10.1038/ni1018			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	758LL	14691478				2022-12-18	WOS:000187635800020
J	Khong, HT; Restifo, NP				Khong, HT; Restifo, NP			Natural selection of tumor variants in the generation of "tumor escape" phenotypes	NATURE IMMUNOLOGY			English	Review							DENDRITIC CELL MATURATION; ENDOTHELIAL GROWTH-FACTOR; HUMAN-MELANOMA CELLS; EXPRESS FAS LIGAND; REGULATORY T-CELLS; CLASS-I PHENOTYPES; HUMAN NK CELLS; MHC CLASS-I; LEUKOCYTE ANTIGEN; DOWN-REGULATION	The idea that tumors must "escape" from immune recognition contains the implicit assumption that tumors can be destroyed by immune responses either spontaneously or as the result of immunotherapeutic intervention. Simply put, there is no need for tumor escape without immunological pressure. Here, we review evidence supporting the immune escape hypothesis and critically explore the mechanisms that may allow such escape to occur. We discuss the idea that the central engine for generating immunoresistant tumor cell variants is the genomic instability and dysregulation that is characteristic of the transformed genome. "Natural selection" of heterogeneous tumor cells results in the survival and proliferation of variants that happen to possess genetic and epigenetic traits that facilitate their growth and immune evasion. Tumor escape variants are likely to emerge after treatment with increasingly effective immunotherapies.	Natl Canc Inst, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Khong, HT (corresponding author), Natl Canc Inst, NIH, Bethesda, MD 20892 USA.		Restifo, Nicholas Phillip/Z-1614-2019; Restifo, Nicholas P/A-5713-2008; Restifo, Nicholas Phillip/M-6549-2019	Restifo, Nicholas P./0000-0003-4229-4580	Intramural NIH HHS [Z99 CA999999, Z01 BC010763-01] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Algarra I, 1997, INT J CLIN LAB RES, V27, P95, DOI 10.1007/BF02912442; Almand B, 2000, CLIN CANCER RES, V6, P1755; Andreola G, 2002, J EXP MED, V195, P1303, DOI 10.1084/jem.20011624; Antony PA, 2002, J IMMUNOTHER, V25, P202, DOI 10.1097/00002371-200205000-00002; Apte RS, 1997, INVEST OPHTH VIS SCI, V38, P1277; Arai H, 1997, P NATL ACAD SCI USA, V94, P13862, DOI 10.1073/pnas.94.25.13862; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Cabrera T, 1996, HUM IMMUNOL, V50, P127, DOI 10.1016/0198-8859(96)00145-0; Cappello P, 2002, J IMMUNOTHER, V25, P1, DOI 10.1097/00002371-200201000-00001; Carbone E, 1997, J EXP MED, V185, P2053, DOI 10.1084/jem.185.12.2053; Carbone E, 1999, EUR J IMMUNOL, V29, P4022, DOI 10.1002/(SICI)1521-4141(199912)29:12<4022::AID-IMMU4022>3.3.CO;2-F; Chappell DB, 1999, CANCER RES, V59, P59; Chen JJ, 1998, SCIENCE, V282, P1714, DOI 10.1126/science.282.5394.1714; CHEN LP, 1994, J EXP MED, V179, P523, DOI 10.1084/jem.179.2.523; Chen WJ, 2001, IMMUNITY, V14, P715, DOI 10.1016/S1074-7613(01)00147-9; Cormier JN, 1999, INT J CANCER, V80, P781, DOI 10.1002/(SICI)1097-0215(19990301)80:5<781::AID-IJC24>3.0.CO;2-A; Davidson WF, 1998, J EXP MED, V187, P1825, DOI 10.1084/jem.187.11.1825; DeSmedt T, 1997, EUR J IMMUNOL, V27, P1229, DOI 10.1002/eji.1830270526; deVries TJ, 1997, CANCER RES, V57, P3223; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Doran T, 1997, J IMMUNOTHER, V20, P372, DOI 10.1097/00002371-199709000-00006; Drozdzik M, 1998, GENE THER, V5, P1622, DOI 10.1038/sj.gt.3300763; FONTANA A, 1989, J IMMUNOL, V143, P3230; Galea-Lauri J, 1999, J IMMUNOL, V163, P62; Garrido F, 2001, ADV CANCER RES, V83, P117, DOI 10.1016/S0065-230X(01)83005-0; Garrido F, 1997, IMMUNOL TODAY, V18, P89, DOI 10.1016/S0167-5699(96)10075-X; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Girolomoni G, 1997, IMMUNOL TODAY, V18, P102, DOI 10.1016/S0167-5699(97)01030-X; GORSCH SM, 1992, CANCER RES, V52, P6949; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Gronbaek K, 1998, BLOOD, V92, P3018; Hahne M, 1996, SCIENCE, V274, P1363, DOI 10.1126/science.274.5291.1363; Hersey P, 2001, NAT REV CANCER, V1, P142, DOI 10.1038/35101078; Hicklin DJ, 1998, J CLIN INVEST, V101, P2720, DOI 10.1172/JCI498; Hofbauer GFL, 1998, MELANOMA RES, V8, P337, DOI 10.1097/00008390-199808000-00007; Huang M, 1998, CANCER RES, V58, P1208; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Jager E, 1996, INT J CANCER, V66, P470, DOI 10.1002/(SICI)1097-0215(19960516)66:4<470::AID-IJC10>3.0.CO;2-C; Johnsen AK, 2001, INT J CANCER, V91, P366, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1056>3.0.CO;2-K; Kang SM, 1998, TRANSPLANT P, V30, P538, DOI 10.1016/S0041-1345(97)01396-1; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Koopman LA, 1999, J NATL CANCER I, V91, P1669, DOI 10.1093/jnci/91.19.1669; Korkolopoulou P, 1996, BRIT J CANCER, V73, P148, DOI 10.1038/bjc.1996.28; Landowski TH, 1997, BLOOD, V90, P4266, DOI 10.1182/blood.V90.11.4266.4266_4266_4270; Lee KH, 1998, J IMMUNOL, V161, P4183; LUDEWIG B, 1995, EUR J IMMUNOL, V25, P1943, DOI 10.1002/eji.1830250722; MARINCOLA FM, 1994, J IMMUNOTHER, V16, P13, DOI 10.1097/00002371-199407000-00002; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; McHugh RS, 2002, J IMMUNOL, V168, P5979, DOI 10.4049/jimmunol.168.12.5979; Medema JP, 2001, P NATL ACAD SCI USA, V98, P11515, DOI 10.1073/pnas.201398198; Medema JP, 1999, J EXP MED, V190, P1033, DOI 10.1084/jem.190.7.1033; Moodycliffe AM, 2000, NAT IMMUNOL, V1, P521, DOI 10.1038/82782; Niehans GA, 1997, CANCER RES, V57, P1007; OConnell J, 1996, J EXP MED, V184, P1075, DOI 10.1084/jem.184.3.1075; Oyama T, 1998, J IMMUNOL, V160, P1224; Porgador A, 1997, P NATL ACAD SCI USA, V94, P13140, DOI 10.1073/pnas.94.24.13140; Ramal LM, 2000, HUM IMMUNOL, V61, P1001, DOI 10.1016/S0198-8859(00)00171-3; REEN EA, 2002, IMMUNITY, V16, P183; Restifo NP, 1996, J NATL CANCER I, V88, P100, DOI 10.1093/jnci/88.2.100; RESTIFO NP, 1993, J EXP MED, V177, P265, DOI 10.1084/jem.177.2.265; Restifo NP, 2002, SEMIN CANCER BIOL, V12, P81, DOI 10.1006/scbi.2001.0399; Restifo NP, 2000, NAT MED, V6, P493, DOI 10.1038/74955; Restifo NP, 2001, NAT MED, V7, P259, DOI 10.1038/85357; Riker A, 1999, SURGERY, V126, P112, DOI 10.1067/msy.1999.98739; Ristimaki A, 1997, CANCER RES, V57, P1276; Saito H, 1998, BRIT J CANCER, V78, P1573, DOI 10.1038/bjc.1998.725; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; SalazarOnfray F, 1997, J IMMUNOL, V159, P3195; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; SANDA MG, 1995, J NATL CANCER I, V87, P280, DOI 10.1093/jnci/87.4.280; SANO H, 1995, CANCER RES, V55, P3785; Schreiber H, 2002, SEMIN CANCER BIOL, V12, P25, DOI 10.1006/scbi.2001.0401; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; Seliger B, 1997, EXP HEMATOL, V25, P608; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Sharma S, 1999, J IMMUNOL, V163, P5020; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Shin MS, 1999, AM J PATHOL, V154, P1785, DOI 10.1016/S0002-9440(10)65434-X; Shin MS, 2002, BLOOD, V99, P4094, DOI 10.1182/blood.V99.11.4094; Shin MS, 2002, ONCOGENE, V21, P4129, DOI 10.1038/sj.onc.1205527; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; SOONG TW, 1992, J IMMUNOL, V149, P2008; Stoler DL, 1999, P NATL ACAD SCI USA, V96, P15121, DOI 10.1073/pnas.96.26.15121; Strand S, 1996, NAT MED, V2, P1361, DOI 10.1038/nm1296-1361; Straus SE, 2001, BLOOD, V98, P194, DOI 10.1182/blood.V98.1.194; Street SEA, 2002, J EXP MED, V196, P129, DOI 10.1084/jem.20020063; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; Takeda K, 2000, J IMMUNOL, V164, P1741, DOI 10.4049/jimmunol.164.4.1741; Takeda K, 2002, J EXP MED, V195, P161, DOI 10.1084/jem.20011171; Takeda K, 2001, NAT MED, V7, P94, DOI 10.1038/83416; Terabe M, 2000, NAT IMMUNOL, V1, P515, DOI 10.1038/82771; Toi M, 1996, EUR J CANCER, V32A, P2513, DOI 10.1016/S0959-8049(96)00397-8; VERSTEEG R, 1989, J EXP MED, V170, P621, DOI 10.1084/jem.170.3.621; Wolff H, 1998, CANCER RES, V58, P4997; Yue FY, 1997, INT J CANCER, V71, P630, DOI 10.1002/(SICI)1097-0215(19970516)71:4<630::AID-IJC20>3.0.CO;2-E; Zaks TZ, 1999, J IMMUNOL, V162, P3273; Zeidler R, 1997, BLOOD, V90, P2390; Zheng P, 1999, CANCER RES, V59, P3461	100	775	819	3	81	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2002	3	11					999	1005		10.1038/ni1102-999	http://dx.doi.org/10.1038/ni1102-999			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612KE	12407407	Green Accepted			2022-12-18	WOS:000179073000004
J	Gebhardt, T; Wakim, LM; Eidsmo, L; Reading, PC; Heath, WR; Carbone, FR				Gebhardt, Thomas; Wakim, Linda M.; Eidsmo, Liv; Reading, Patrick C.; Heath, William R.; Carbone, Francis R.			Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus	NATURE IMMUNOLOGY			English	Article							NERVOUS-SYSTEM; HSV-1 REACTIVATION; VIRAL-INFECTION; SENSORY GANGLIA; LUNG AIRWAYS; CUTTING EDGE; IN-VIVO; EFFECTOR; LYMPHOCYTES; INTEGRIN	Effective immunity is dependent on long-surviving memory T cells. Various memory subsets make distinct contributions to immune protection, especially in peripheral infection. It has been suggested that T cells in nonlymphoid tissues are important during local infection, although their relationship with populations in the circulation remains poorly defined. Here we describe a unique memory T cell subset present after acute infection with herpes simplex virus that remained resident in the skin and in latently infected sensory ganglia. These T cells were in disequilibrium with the circulating lymphocyte pool and controlled new infection with this virus. Thus, these cells represent an example of tissue-resident memory T cells that can provide protective immunity at points of pathogen entry.	[Gebhardt, Thomas; Wakim, Linda M.; Eidsmo, Liv; Reading, Patrick C.; Heath, William R.; Carbone, Francis R.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia	University of Melbourne	Heath, WR (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia.	wrheath@unimelb.edu.au; fcarbone@unimelb.edu.au	Carbone, Francis/ABF-2141-2020	Gebhardt, Thomas/0000-0002-3768-9468; Eidsmo, Liv/0000-0001-9237-8374; Heath, William/0000-0001-9670-259X; Reading, Patrick/0000-0002-8860-5308; Wakim, Linda/0000-0003-1752-9579	Australian National Health and Medical Research Council; Howard Hughes Medical Institute; German Research Foundation [GE1666/1-1]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Howard Hughes Medical Institute(Howard Hughes Medical Institute); German Research Foundation(German Research Foundation (DFG))	We thank S. Tevethia (Pennsylvania State University) for WSN/NA/gB; P. Doherty (The University of Melbourne) for WSN/NA/OVA; J. Yewdell (U. S. National Institutes of Health) for vaccinia-NP.; D. Masopust for discussions; and H. Kosaka for suggesting that fixed drug eruptions are caused by resident T cells. Supported by the Australian National Health and Medical Research Council, the Howard Hughes Medical Institute and the German Research Foundation (GE1666/1-1 to T. G.).	Bachmann MF, 2005, J IMMUNOL, V175, P4677, DOI 10.4049/jimmunol.175.7.4677; Bachmann MF, 1997, P NATL ACAD SCI USA, V94, P640, DOI 10.1073/pnas.94.2.640; Boyman O, 2004, J EXP MED, V199, P731, DOI 10.1084/jem.20031482; Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Ely KH, 2006, J IMMUNOL, V176, P537, DOI 10.4049/jimmunol.176.1.537; Harris NL, 2002, J EXP MED, V195, P317, DOI 10.1084/jem.20011558; Hawke S, 1998, J EXP MED, V187, P1575, DOI 10.1084/jem.187.10.1575; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; Hikono H, 2006, IMMUNOL REV, V211, P119, DOI 10.1111/j.0105-2896.2006.00385.x; Hogan RJ, 2002, J IMMUNOL, V169, P4976, DOI 10.4049/jimmunol.169.9.4976; Hogan RJ, 2001, J IMMUNOL, V166, P1813, DOI 10.4049/jimmunol.166.3.1813; JENNINGS SR, 1991, CELL IMMUNOL, V133, P234, DOI 10.1016/0008-8749(91)90194-G; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Khanna KM, 2003, IMMUNITY, V18, P593, DOI 10.1016/S1074-7613(03)00112-2; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Knickelbein JE, 2008, SCIENCE, V322, P268, DOI 10.1126/science.1164164; Liu T, 2000, J EXP MED, V191, P1459, DOI 10.1084/jem.191.9.1459; Liu T, 2001, J VIROL, V75, P11178, DOI 10.1128/JVI.75.22.11178-11184.2001; Masopust D, 2004, J IMMUNOL, V172, P4875, DOI 10.4049/jimmunol.172.8.4875; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mintern JD, 2002, J IMMUNOL, V168, P977, DOI 10.4049/jimmunol.168.3.977; Mintern JD, 2007, J IMMUNOL, V179, P7220, DOI 10.4049/jimmunol.179.11.7220; Mizukawa Y, 2002, AM J PATHOL, V161, P1337, DOI 10.1016/S0002-9440(10)64410-0; Mora JR, 2006, TRENDS IMMUNOL, V27, P235, DOI 10.1016/j.it.2006.03.007; Mueller SN, 2002, IMMUNOL CELL BIOL, V80, P156, DOI 10.1046/j.1440-1711.2002.01071.x; NASH AA, 1987, J GEN VIROL, V68, P825, DOI 10.1099/0022-1317-68-3-825; Pauls K, 2001, J INVEST DERMATOL, V117, P569, DOI 10.1046/j.0022-202x.2001.01481.x; Ray SJ, 2004, IMMUNITY, V20, P167, DOI 10.1016/S1074-7613(04)00021-4; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Shiohara T, 1997, J INVEST DERMATOL, V109, P271, DOI 10.1111/1523-1747.ep12335465; SIMMONS A, 1992, J EXP MED, V175, P1337, DOI 10.1084/jem.175.5.1337; SIMMONS A, 1984, J VIROL, V52, P816, DOI 10.1128/JVI.52.3.816-821.1984; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; STANBERRY LR, 1992, CURR TOP MICROBIOL, V179, P15; Stock AT, 2007, IMMUNOL CELL BIOL, V85, P394, DOI 10.1038/sj.icb.7100076; Stock AT, 2006, IMMUNOL CELL BIOL, V84, P543, DOI 10.1111/j.1440-1711.2006.01469.x; van Lint A, 2004, J IMMUNOL, V172, P392, DOI 10.4049/jimmunol.172.1.392; van Lint AL, 2005, J VIROL, V79, P14843, DOI 10.1128/JVI.79.23.14843-14851.2005; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869; Welsh RM, 2004, ANNU REV IMMUNOL, V22, P711, DOI 10.1146/annurev.immunol.22.012703.104527; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Zammit DJ, 2006, IMMUNITY, V24, P439, DOI 10.1016/j.immuni.2006.01.015; Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792	47	771	790	1	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2009	10	5					524	530		10.1038/ni.1718	http://dx.doi.org/10.1038/ni.1718			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	436EC	19305395				2022-12-18	WOS:000265394400014
J	Burckstummer, T; Baumann, C; Bluml, S; Dixit, E; Durnberger, G; Jahn, H; Planyavsky, M; Bilban, M; Colinge, J; Bennett, KL; Superti-Furga, G				Buerckstuemmer, Tilmann; Baumann, Christoph; Blueml, Stephan; Dixit, Evelyn; Duernberger, Gerhard; Jahn, Hannah; Planyavsky, Melanie; Bilban, Martin; Colinge, Jacques; Bennett, Keiryn L.; Superti-Furga, Giulio			An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome	NATURE IMMUNOLOGY			English	Article							INNATE IMMUNE-RESPONSE; PYRIN DOMAIN; DAI DLM-1/ZBP1; ONLY PROTEIN; CELLS; TREX1; OLIGOMERIZATION; RECOGNITION; MOLECULES; LUPUS	Cytoplasmic DNA triggers activation of the innate immune system. Although 'downstream' signaling components have been characterized, the DNA-sensing components remain elusive. Here we present a systematic proteomics screen for proteins that associate with DNA, 'crossed' to a screen for transcripts induced by interferon-beta, which identified AIM2 as a candidate cytoplasmic DNA sensor. AIM2 showed specificity for double-stranded DNA. It also recruited the inflammasome adaptor ASC and localized to ASC 'speckles'. A decrease in AIM2 expression produced by RNA-mediated interference impaired DNA-induced maturation of interleukin 1 beta in THP-1 human monocytic cells, which indicated that endogenous AIM2 is required for DNA recognition. Reconstitution of unresponsive HEK293 cells with AIM2, ASC, caspase-1 and interleukin 1 beta showed that AIM2 was sufficient for inflammasome activation. Our data suggest that AIM2 is a cytoplasmic DNA sensor for the inflammasome.	[Buerckstuemmer, Tilmann; Baumann, Christoph; Blueml, Stephan; Dixit, Evelyn; Duernberger, Gerhard; Jahn, Hannah; Planyavsky, Melanie; Colinge, Jacques; Bennett, Keiryn L.; Superti-Furga, Giulio] Austrian Acad Sci, Res Ctr Mol Med, A-1090 Vienna, Austria; [Blueml, Stephan] Med Univ Vienna, Dept Rheumatol, A-1090 Vienna, Austria; [Bilban, Martin] Med Univ Vienna, Dept Lab Med, A-1090 Vienna, Austria	Austrian Academy of Sciences; Medical University of Vienna; Medical University of Vienna	Superti-Furga, G (corresponding author), Austrian Acad Sci, Res Ctr Mol Med, A-1090 Vienna, Austria.	gsuperti@cemm.oeaw.ac.at	Superti-Furga, Giulio/AAE-5681-2019; Colinge, Jacques/Z-2613-2019; Colinge, Jacques/D-1578-2017; Superti-Furga, Giulio/F-4755-2015	Colinge, Jacques/0000-0003-2466-4824; Colinge, Jacques/0000-0003-2466-4824; Superti-Furga, Giulio/0000-0002-0570-1768; Bluml, Stephan/0000-0002-2758-4400; Bennett, Keiryn L./0000-0001-9356-7708; Burckstummer, Tilmann/0000-0001-5681-8045; Bilban, Martin/0000-0001-7043-7142; Buerckstuemmer, Tilmann/0000-0002-5961-0829	Austrian Academy of Sciences; Austrian Federal Ministry of Science and Research [GZ200.145/I-VI/I/2006]; DRAGON [GZ200.142/I-VI/ I/2006]; European Commission [PIEF-GA-2008-220596]; Austrian Science Fund [FWF W1205]	Austrian Academy of Sciences; Austrian Federal Ministry of Science and Research; DRAGON; European Commission(European CommissionEuropean Commission Joint Research Centre); Austrian Science Fund(Austrian Science Fund (FWF))	We acknowledge O. Hantschel and A. Pichlmair for critical reading of the manuscript, and M. Brehme for help with illustrations. Supported by the Austrian Academy of Sciences (for the Research Center for Molecular Medicine), the GenAU Program of the Austrian Federal Ministry of Science and Research (Austrian Proteomics Platform II (GZ200.145/I-VI/I/2006) and DRAGON (GZ200.142/I-VI/ I/2006)), the European Commission (PIEF-GA-2008-220596 to C. B.) and the Austrian Science Fund (FWF W1205 to E.D.).	Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Albrecht M, 2005, BIOCHEM BIOPH RES CO, V327, P679, DOI 10.1016/j.bbrc.2004.12.056; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Burckstummer T, 2006, NAT METHODS, V3, P1013, DOI 10.1038/nmeth968; Caposio P, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M701846200; Choubey D, 2008, IMMUNOL LETT, V119, P32, DOI 10.1016/j.imlet.2008.06.001; Dorfleutner A, 2007, VIRUS GENES, V35, P685, DOI 10.1007/s11262-007-0141-9; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Johnston JB, 2005, IMMUNITY, V23, P587, DOI 10.1016/j.immuni.2005.10.003; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Masumoto J, 2001, BIOCHEM BIOPH RES CO, V280, P652, DOI 10.1006/bbrc.2000.4190; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Moriya M, 2005, BIOCHEMISTRY-US, V44, P575, DOI 10.1021/bi048374i; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Natarajan A, 2006, J BIOL CHEM, V281, P31863, DOI 10.1074/jbc.M605458200; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; SHINOZUKA K, 1991, NUCL ACIDS S SER, V25, P101; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Wang ZC, 2008, P NATL ACAD SCI USA, V105, P5477, DOI 10.1073/pnas.0801295105; Woerner SM, 2007, GENE CHROMOSOME CANC, V46, P1080, DOI 10.1002/gcc.20493; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007	28	771	811	2	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2009	10	3					266	272		10.1038/ni.1702	http://dx.doi.org/10.1038/ni.1702			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	408SY	19158679				2022-12-18	WOS:000263456500010
J	McFarland, HF; Martin, R				McFarland, Henry F.; Martin, Roland			Multiple sclerosis: a complicated picture of autoimmunity	NATURE IMMUNOLOGY			English	Review							CD8(+) T-CELLS; CENTRAL-NERVOUS-SYSTEM; MYELIN BASIC-PROTEIN; ANTIMYELIN ANTIBODIES; MONONUCLEAR-CELLS; DISEASE-ACTIVITY; CONTROLLED TRIAL; CUTTING EDGE; LESIONS; BLOOD	Understanding of autoimmune diseases, including multiple sclerosis, has expanded considerably in recent years. New insights have been provided by not only animal models but also studies of patients, often in conjunction with experimental therapies. It is accepted that autoimmune T cells mediate the early steps of new multiple sclerosis lesions, and although uncertainties remain about the specific targets of autoreactive T cells, several studies indicate myelin antigens. Recent findings obtained with both animal models and patients with multiple sclerosis indicate involvement of a T helper cell with a T-H-17 phenotype, in contrast to previous data indicating that T helper type 1 cells are critical. Evidence has also been presented for CD8(+) and regulatory T cell populations, although their involvement remains to be established. Despite evidence supporting the idea that autoreactive T cells are involved in disease induction, cells of myeloid lineage, antibodies and complement as well as processes intrinsic to the central nervous system seem to determine the effector stages of tissue damage. Careful analysis of the alterations in immune processes should further advance knowledge of the relationship between the inflammatory component of this disease and the more diffuse degeneration of progressive multiple sclerosis.	NINDS, NIH, Neuroimmunol Branch, Bethesda, MD 20892 USA; Univ Med Ctr Eppendorf, Ctr Mol Neurobiol Hamburg, Inst Neuroimmunol, D-20251 Hamburg, Germany; Univ Med Ctr Eppendorf, Ctr Mol Neurobiol Hamburg, Clin Multiple Sclerosis Res, D-20251 Hamburg, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	McFarland, HF (corresponding author), NINDS, NIH, Neuroimmunol Branch, Bethesda, MD 20892 USA.	mcfarlandh@ninds.nih.gov		Martin, Roland/0000-0002-0982-1329	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002204, Z01NS002204] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Allen IV, 2001, NEUROL SCI, V22, P141, DOI 10.1007/s100720170012; Argaw AT, 2006, J IMMUNOL, V177, P5574, DOI 10.4049/jimmunol.177.8.5574; Avolio C, 2005, MULT SCLER, V11, P441, DOI 10.1191/1352458505ms1193oa; Babbe H, 2000, J EXP MED, V192, P393, DOI 10.1084/jem.192.3.393; Bagnato F, 2003, BRAIN, V126, P1782, DOI 10.1093/brain/awg182; Bailey SL, 2007, NAT IMMUNOL, V8, P172, DOI 10.1038/ni1430; Berger T, 2003, NEW ENGL J MED, V349, P139, DOI 10.1056/NEJMoa022328; Bielekova B, 2000, NAT MED, V6, P1167, DOI 10.1038/80516; Bielekova B, 2006, P NATL ACAD SCI USA, V103, P5941, DOI 10.1073/pnas.0601335103; Bielekova B, 2004, P NATL ACAD SCI USA, V101, P8705, DOI 10.1073/pnas.0402653101; Bielekova B, 2004, J IMMUNOL, V172, P3893, DOI 10.4049/jimmunol.172.6.3893; Brisebois M, 2006, J IMMUNOL, V177, P2403, DOI 10.4049/jimmunol.177.4.2403; Brok HPM, 2002, J IMMUNOL, V169, P6554, DOI 10.4049/jimmunol.169.11.6554; Cabbage SE, 2007, J IMMUNOL, V178, P887, DOI 10.4049/jimmunol.178.2.887; Calabresi PA, 1997, ANN NEUROL, V41, P669, DOI 10.1002/ana.410410517; Cepok S, 2005, J CLIN INVEST, V115, P1352, DOI 10.1172/JCI200523661; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Coles AJ, 1999, ANN NEUROL, V46, P296, DOI 10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-#; Coles AJ, 2007, NEUROLOGY, V68, pA100; Crawford MP, 2004, BLOOD, V103, P4222, DOI 10.1182/blood-2003-11-4025; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Ellmerich S, 2005, J IMMUNOL, V174, P1938, DOI 10.4049/jimmunol.174.4.1938; Farina C, 2005, J NEUROIMMUNOL, V159, P12, DOI 10.1016/j.jneuroim.2004.09.009; FILIPPI M, 1994, NEUROLOGY, V44, P635, DOI 10.1212/WNL.44.4.635; Fujinami RS, 2006, CLIN MICROBIOL REV, V19, P80, DOI 10.1128/CMR.19.1.80-94.2006; Furtado GC, 2006, J IMMUNOL, V177, P6871, DOI 10.4049/jimmunol.177.10.6871; Genain CP, 1995, J CLIN INVEST, V96, P2966, DOI 10.1172/JCI118368; GIJBELS K, 1995, MOL MED, V1, P795, DOI 10.1007/BF03401894; Hartung HP, 2002, LANCET, V360, P2018, DOI 10.1016/S0140-6736(02)12023-X; Hauser S, 2007, NEUROLOGY, V68, pA99; Ho PP, 2005, J IMMUNOL, V175, P6226, DOI 10.4049/jimmunol.175.9.6226; Huh J, 2004, J NEUROIMMUNOL, V151, P94, DOI 10.1016/j.jneuroim.2004.02.015; Hur EM, 2007, NAT IMMUNOL, V8, P74, DOI 10.1038/ni1415; Ito K, 1996, J EXP MED, V183, P2635, DOI 10.1084/jem.183.6.2635; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwakura Y, 2006, J CLIN INVEST, V116, P1218, DOI 10.1172/JCI28508; JI Q, 2007, ANN NY ACAD SCI, V2203, P157; Julia E, 2006, J NEUROIMMUNOL, V180, P147, DOI 10.1016/j.jneuroim.2006.07.001; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Killestein J, 2005, J NEUROL SCI, V233, P113, DOI 10.1016/j.jns.2005.03.011; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Kreijveld E, 2007, AM J TRANSPLANT, V7, P249, DOI 10.1111/j.1600-6143.2006.01604.x; Kuhle J, 2007, NEW ENGL J MED, V356, P371, DOI 10.1056/NEJMoa063602; Li DKB, 2001, NEUROLOGY, V56, P1505, DOI 10.1212/WNL.56.11.1505; Li YH, 2007, BRAIN, V130, P490, DOI 10.1093/brain/awl273; Liao JJ, 2007, J IMMUNOL, V178, P5425, DOI 10.4049/jimmunol.178.9.5425; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Madsen LS, 1999, NAT GENET, V23, P343, DOI 10.1038/15525; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Marshak-Rothstein A, 2007, ANNU REV IMMUNOL, V25, P419, DOI 10.1146/annurev.immunol.22.012703.104514; Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; MCRAE BL, 1995, J EXP MED, V182, P75, DOI 10.1084/jem.182.1.75; Medana I, 2001, AM J PATHOL, V159, P809, DOI 10.1016/S0002-9440(10)61755-5; Meller R, 2005, J CEREBR BLOOD F MET, V25, P217, DOI 10.1038/sj.jcbfm.9600022; Muraro PA, 2005, J EXP MED, V201, P805, DOI 10.1084/jem.20041679; Muraro PA, 2003, BRAIN, V126, P20, DOI 10.1093/brain/awg021; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Oksenberg JR, 2005, NEUROL CLIN, V23, P61, DOI 10.1016/j.ncl.2004.09.006; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Platten M, 2005, SCIENCE, V310, P850, DOI 10.1126/science.1117634; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Ponomarev ED, 2005, J NEUROSCI RES, V81, P374, DOI 10.1002/jnr.20488; Quandt JA, 2004, J EXP MED, V200, P223, DOI 10.1084/jem.20030994; Rebenko-Moll NM, 2006, CURR OPIN IMMUNOL, V18, P683, DOI 10.1016/j.coi.2006.09.005; Saccardi R, 2006, MULT SCLER, V12, P814, DOI 10.1177/1352458506071301; Sakurai K, 2002, J NEUROIMMUNOL, V129, P186, DOI 10.1016/S0165-5728(02)00176-5; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; STONE LA, 1995, NEUROLOGY, V45, P1122, DOI 10.1212/WNL.45.6.1122; STONE LA, 1995, ANN NEUROL, V37, P611, DOI 10.1002/ana.410370511; Stuve O, 1996, ANN NEUROL, V40, P853, DOI 10.1002/ana.410400607; Tennakoon DK, 2006, J IMMUNOL, V176, P7119, DOI 10.4049/jimmunol.176.11.7119; TRAUGOTT U, 1983, SCIENCE, V219, P308, DOI 10.1126/science.6217550; Vaknin-Dembinsky A, 2006, J IMMUNOL, V176, P7768, DOI 10.4049/jimmunol.176.12.7768; van Walderveen MAA, 1998, NEUROLOGY, V50, P1282, DOI 10.1212/WNL.50.5.1282; Vanderlugt CL, 2000, J IMMUNOL, V164, P670, DOI 10.4049/jimmunol.164.2.670; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vollmer T, 2004, LANCET, V363, P1607, DOI 10.1016/S0140-6736(04)16205-3; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158	87	769	793	1	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2007	8	9					913	919		10.1038/ni1507	http://dx.doi.org/10.1038/ni1507			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	202QN	17712344				2022-12-18	WOS:000248918200014
J	Denning, TL; Wang, YC; Patel, SR; Williams, IR; Pulendran, B				Denning, Timothy L.; Wang, Yi-Chong; Patel, Seema R.; Williams, Ifor R.; Pulendran, Bali			Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses	NATURE IMMUNOLOGY			English	Article							EXPERIMENTAL COLITIS; SMALL-INTESTINE; PEYERS PATCH; GENERATION; LOCALIZATION; TOLERANCE; RECEPTOR; MUCOSAL; LYMPHOCYTES; EXPRESSION	The intestinal immune system must elicit robust immunity against harmful pathogens but must also restrain immune responses directed against commensal microbes and dietary antigens. The mechanisms that maintain this dichotomy are poorly understood. Here we describe a population of CD11b(+)F4/80(+)CD11c(-) macrophages in the lamina propria that expressed several anti-inflammatory molecules, including interleukin 10 (IL-10), but little or no proinflammatory cytokines, even after stimulation with Toll-like receptor ligands. These macrophages induced, by a mechanism dependent on IL-10, retinoic acid and exogenous transforming growth factor-beta, the differentiation of Foxp3(+) regulatory T cells. In contrast, lamina propria CD11b(+) dendritic cells elicited IL-17 production. This IL-17 production was suppressed by lamina propria macrophages, indicating that a dynamic interaction between these subsets may influence the balance between immune activation and tolerance.	Emory Univ, Vaccine Res Ctr, Yerkes Reg Primate Res Ctr, Atlanta, GA 30329 USA; Emory Univ, Dept Pathol, Lab Med, Atlanta, GA 30322 USA	Emory University; Emory University	Pulendran, B (corresponding author), Emory Univ, Vaccine Res Ctr, Yerkes Reg Primate Res Ctr, Atlanta, GA 30329 USA.	bpulend@rmy.emory.edu	Eckhardt, Erik/G-1567-2010; Denning, Timothy/F-2271-2011; Pulendran, Bali/AAW-9550-2021; Williams, Ifor R/D-3648-2011	Williams, Ifor R/0000-0002-8810-2911; Denning, Timothy/0000-0002-1072-7444; Pulendran, Bali/0000-0001-6517-4333	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048638, U54AI057157, R21AI050019, R56AI048638, R37AI048638, R01AI050019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007771, R37DK057665, R01DK057665] Funding Source: NIH RePORTER; NIAID NIH HHS [AI048638, AI0564499, AI50019, AI05726601, AI057157] Funding Source: Medline; NIDDK NIH HHS [DK007771-06A1, DK057665] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Annacker O, 2005, J EXP MED, V202, P1051, DOI 10.1084/jem.20040662; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; BARNARD JA, 1993, GASTROENTEROLOGY, V105, P67, DOI 10.1016/0016-5085(93)90011-Z; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Ehirchiou D, 2007, J EXP MED, V204, P1519, DOI 10.1084/jem.20062292; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Groux H, 2004, SEMIN IMMUNOL, V16, P99, DOI 10.1016/j.smim.2003.12.004; HUME DA, 1983, J EXP MED, V158, P1522, DOI 10.1084/jem.158.5.1522; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwasaki A, 1999, J EXP MED, V190, P229, DOI 10.1084/jem.190.2.229; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Johansson-Lindbom B, 2003, J EXP MED, V198, P963, DOI 10.1084/jem.20031244; Johansson-Lindbom B, 2007, IMMUNOL REV, V215, P226, DOI 10.1111/j.1600-065X.2006.00482.x; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Kelsall BL, 1996, J EXP MED, V183, P237, DOI 10.1084/jem.183.1.237; Kelsall BL, 2005, IMMUNOL REV, V206, P132, DOI 10.1111/j.0105-2896.2005.00292.x; Kelsall Brian L, 2004, Nat Immunol, V5, P1091, DOI 10.1038/ni1104-1091; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; Laouar A, 2005, NAT IMMUNOL, V6, P698, DOI 10.1038/ni1212; LEE SH, 1985, J EXP MED, V161, P475, DOI 10.1084/jem.161.3.475; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Maraskovsky E, 1996, J EXP MED, V184, P1953, DOI 10.1084/jem.184.5.1953; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; MOSMANN TR, 1991, IMMUNOL TODAY, V12, P49; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; PAVLI P, 1990, IMMUNOLOGY, V70, P40; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Pulendran B, 2004, IMMUNOL REV, V199, P227, DOI 10.1111/j.0105-2896.2004.00144.x; Qualls JE, 2006, J LEUKOCYTE BIOL, V80, P802, DOI 10.1189/jlb.1205734; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; Salazar-Gonzalez RM, 2006, IMMUNITY, V24, P623, DOI 10.1016/j.immuni.2006.02.015; Schenk M, 2007, SEMIN IMMUNOL, V19, P84, DOI 10.1016/j.smim.2006.09.002; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Stagg AJ, 2002, EUR J IMMUNOL, V32, P1445, DOI 10.1002/1521-4141(200205)32:5<1445::AID-IMMU1445>3.0.CO;2-E; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Zabel BA, 1999, J EXP MED, V190, P1241, DOI 10.1084/jem.190.9.1241	55	768	801	1	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2007	8	10					1086	1094		10.1038/ni1511	http://dx.doi.org/10.1038/ni1511			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	213UA	17873879				2022-12-18	WOS:000249691400023
J	Tang, QZ; Bluestone, JA				Tang, Qizhi; Bluestone, Jeffrey A.			The Foxp3(+) regulatory T cell: a jack of all trades, master of regulation	NATURE IMMUNOLOGY			English	Review							IMMUNOLOGICAL SELF-TOLERANCE; ALLERGIC AIRWAY INFLAMMATION; NONOBESE DIABETIC MOUSE; GROWTH-FACTOR-BETA; FUNCTION IN-VIVO; MEDIATED SUPPRESSION; TGF-BETA; HEME OXYGENASE-1; DENDRITIC CELLS; INTESTINAL INFLAMMATION	The function of regulatory T cells (T-reg cells) has been attributed to a growing number of diverse pathways, molecules and processes. Seemingly contradictory conclusions regarding the mechanisms underlying T-reg cell suppressive activity have revitalized skeptics in the field who challenge the core validity of the idea of T-reg cells as central immune regulators. However, we note that a consensus may be emerging from the data: that multiple T-reg cell functions act either directly or indirectly at the site of antigen presentation to create a regulatory milieu that promotes bystander suppression and infectious tolerance. Thus, the versatility and adaptability of the Foxp3(+) T-reg cells may in fact be the best argument that these cells are 'multitalented masters of immune regulation'.	[Bluestone, Jeffrey A.] Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA 94143 USA; [Tang, Qizhi] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bluestone, JA (corresponding author), Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA 94143 USA.	jbluest@diabetes.ucsf.edu		Tang, Qizhi/0000-0001-7313-3574	NIAID NIH HHS [R37 AI046643, R37 AI046643-11] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI046643] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BACH J-F, 1990, Journal of Autoimmunity, V3, P97; Balasa B, 2000, CELL IMMUNOL, V202, P97, DOI 10.1006/cimm.2000.1658; Belghith M, 2003, NAT MED, V9, P1202, DOI 10.1038/nm924; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Belkaid Y, 2006, IMMUNOL REV, V212, P287, DOI 10.1111/j.0105-2896.2006.00409.x; BENACERRAF B, 1975, TRANSPLANT REV, V26, P21; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Bopp T, 2007, J EXP MED, V204, P1303, DOI 10.1084/jem.20062129; Cao XF, 2007, IMMUNITY, V27, P635, DOI 10.1016/j.immuni.2007.08.014; Chang CC, 2002, NAT IMMUNOL, V3, P237, DOI 10.1038/ni760; Chikuma S, 2007, EUR J IMMUNOL, V37, P1285, DOI 10.1002/eji.200737159; Choi BM, 2005, BIOCHEM BIOPH RES CO, V327, P1066, DOI 10.1016/j.bbrc.2004.12.106; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Dieckmann D, 2002, J EXP MED, V196, P247, DOI 10.1084/jem.20020642; Faria AMC, 2005, IMMUNOL REV, V206, P232, DOI 10.1111/j.0105-2896.2005.00280.x; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; Garin MI, 2007, BLOOD, V109, P2058, DOI 10.1182/blood-2006-04-016451; GERSHON RK, 1970, IMMUNOLOGY, V18, P723; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Green EA, 2003, P NATL ACAD SCI USA, V100, P10878, DOI 10.1073/pnas.1834400100; Grossman WJ, 2004, IMMUNITY, V21, P589, DOI 10.1016/j.immuni.2004.09.002; HALL BM, 1990, J EXP MED, V171, P141, DOI 10.1084/jem.171.1.141; Hara M, 2001, J IMMUNOL, V166, P3789, DOI 10.4049/jimmunol.166.6.3789; Hayday A, 2003, NAT REV IMMUNOL, V3, P233, DOI 10.1038/nri1030; Herbelin A, 1998, J IMMUNOL, V161, P2620; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Jonuleit H, 2002, J EXP MED, V196, P255, DOI 10.1084/jem.20020394; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kearley J, 2005, J EXP MED, V202, P1539, DOI 10.1084/jem.20051166; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kingsley CI, 2002, J IMMUNOL, V168, P1080, DOI 10.4049/jimmunol.168.3.1080; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Kubach J, 2007, BLOOD, V110, P1550, DOI 10.1182/blood-2007-01-069229; Kullberg MC, 2005, EUR J IMMUNOL, V35, P2886, DOI 10.1002/eji.200526106; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Mellor AL, 2004, TRENDS IMMUNOL, V25, P563, DOI 10.1016/j.it.2004.09.001; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Munn DH, 2004, TRENDS MOL MED, V10, P15, DOI 10.1016/j.molmed.2003.11.003; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Pesu M, 2006, BLOOD, V108, P983, DOI 10.1182/blood-2005-09-3824; Piccirillo CA, 2002, J EXP MED, V196, P237, DOI 10.1084/jem.20020590; Piccirillo CA, 2001, J IMMUNOL, V167, P1137, DOI 10.4049/jimmunol.167.3.1137; Puccetti P, 2007, NAT REV IMMUNOL, V7, P817, DOI 10.1038/nri2163; Qin HY, 2006, INT IMMUNOL, V18, P1001, DOI 10.1093/intimm/dxl035; QIN SX, 1993, SCIENCE, V259, P974, DOI 10.1126/science.8094901; Read S, 2006, J IMMUNOL, V177, P4376, DOI 10.4049/jimmunol.177.7.4376; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225; Sato K, 2001, J IMMUNOL, V166, P4185, DOI 10.4049/jimmunol.166.6.4185; Sawitzki B, 2005, J EXP MED, V201, P1925, DOI 10.1084/jem.20050419; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Strauss L, 2007, CLIN CANCER RES, V13, P4345, DOI 10.1158/1078-0432.CCR-07-0472; Suri-Payer E, 2001, J AUTOIMMUN, V16, P115, DOI 10.1006/jaut.2000.0473; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Tang QZ, 2006, CURR OPIN IMMUNOL, V18, P496, DOI 10.1016/j.coi.2006.05.007; Tang QZ, 2004, EUR J IMMUNOL, V34, P2996, DOI 10.1002/eji.200425143; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Tarbell KV, 2007, J EXP MED, V204, P191, DOI 10.1084/jem.20061631; Terness P, 2007, AM J REPROD IMMUNOL, V58, P238, DOI 10.1111/j.1600-0897.2007.00510.x; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Valenzuela HF, 2007, CANCER RES, V67, P6155, DOI 10.1158/0008-5472.CAN-05-4431; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wilson MS, 2005, J EXP MED, V202, P1199, DOI 10.1084/jem.20042572; Xia ZW, 2006, J IMMUNOL, V177, P5936, DOI 10.4049/jimmunol.177.9.5936; You S, 2006, IMMUNOL REV, V212, P185, DOI 10.1111/j.0105-2896.2006.00410.x; Zelenay S, 2007, INT IMMUNOL, V19, P11, DOI 10.1093/intimm/dxl116; Zhang ZX, 2000, NAT MED, V6, P782, DOI 10.1038/77513; Zhao DM, 2006, BLOOD, V107, P3925, DOI 10.1182/blood-2005-11-4502	84	763	835	2	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2008	9	3					239	244		10.1038/ni1572	http://dx.doi.org/10.1038/ni1572			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	266BQ	18285775	Green Accepted			2022-12-18	WOS:000253406700009
J	El-Behi, M; Ciric, B; Dai, H; Yan, YP; Cullimore, M; Safavi, F; Zhang, GX; Dittel, BN; Rostami, A				El-Behi, Mohamed; Ciric, Bogoljub; Dai, Hong; Yan, Yaping; Cullimore, Melissa; Safavi, Farinaz; Zhang, Guang-Xian; Dittel, Bonnie N.; Rostami, Abdolmohamad			The encephalitogenicity of T(H)17 cells is dependent on IL-1-and IL-23-induced production of the cytokine GM-CSF	NATURE IMMUNOLOGY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; COLONY-STIMULATING FACTOR; REGULATORY T-CELLS; ROR-GAMMA-T; TH17 CELLS; CUTTING EDGE; TGF-BETA; INFLAMMATORY RESPONSES; IL-23 RECEPTOR; HELPER-CELLS	Interleukin 17 (IL-17)-producing helper T cells (T(H)17 cells) require exposure to IL-23 to become encephalitogenic, but the mechanism by which IL-23 promotes their pathogenicity is not known. Here we found that IL-23 induced production of the cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF) in T(H)17 cells and that GM-CSF had an essential role in their encephalitogenicity. Our findings identify a chief mechanism that underlies the important role of IL-23 in autoimmune diseases. IL-23 induced a positive feedback loop whereby GM-CSF secreted by T(H)17 cells stimulated the production of IL-23 by antigen-presenting cells. Such cross-regulation of IL-23 and GM-CSF explains the similar pattern of resistance to autoimmunity when either of the two cytokines is absent and identifies T(H)17 cells as a crucial source of GM-CSF in autoimmune inflammation.	[El-Behi, Mohamed; Ciric, Bogoljub; Dai, Hong; Yan, Yaping; Cullimore, Melissa; Safavi, Farinaz; Zhang, Guang-Xian; Rostami, Abdolmohamad] Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA; [Dittel, Bonnie N.] Blood Ctr Wisconsin, Blood Res Inst, Milwaukee, WI USA	Jefferson University; Versiti Blood Center of Wisconsin	Rostami, A (corresponding author), Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA.	a.m.rostami@jefferson.edu	BEHI, Mohamed EL/D-5346-2014; Dai, Hong/J-4087-2016	BEHI, Mohamed EL/0000-0003-2287-2056; Dai, Hong/0000-0002-9562-5577	US National Institutes of Health; National Multiple Sclerosis Society; M.E. Groff Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046782] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); M.E. Groff Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank KaloBios Pharmaceuticals for anti-GM-CSF; P. Gonnella for critical review; K. Regan for editorial assistance; and S. Yu for technical assistance. Supported by the US National Institutes of Health, the National Multiple Sclerosis Society and the M.E. Groff Foundation.	Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen Y, 2006, J CLIN INVEST, V116, P1317, DOI 10.1172/JCI25308; Ciric B, 2009, J IMMUNOL, V182, P5296, DOI 10.4049/jimmunol.0900036; Coquet JM, 2008, J IMMUNOL, V180, P7097, DOI 10.4049/jimmunol.180.11.7097; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Elyaman W, 2009, P NATL ACAD SCI USA, V106, P12885, DOI 10.1073/pnas.0812530106; Eugster HP, 1998, EUR J IMMUNOL, V28, P2178, DOI 10.1002/(SICI)1521-4141(199807)28:07<2178::AID-IMMU2178>3.0.CO;2-D; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gocke AR, 2007, J IMMUNOL, V178, P1341, DOI 10.4049/jimmunol.178.3.1341; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Infante-Duarte C, 2000, J IMMUNOL, V165, P6107, DOI 10.4049/jimmunol.165.11.6107; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kreymborg K, 2007, J IMMUNOL, V179, P8098, DOI 10.4049/jimmunol.179.12.8098; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Li JF, 2003, J NEUROL SCI, V215, P95, DOI 10.1016/S0022-510X(03)00203-X; LuKuo JM, 1996, J BIOL CHEM, V271, P22169, DOI 10.1074/jbc.271.36.22169; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Matsuki T, 2006, INT IMMUNOL, V18, P399, DOI 10.1093/intimm/dxh379; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; McQualter JL, 2001, J EXP MED, V194, P873, DOI 10.1084/jem.194.7.873; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Nowak EC, 2009, J EXP MED, V206, P1653, DOI 10.1084/jem.20090246; PARK LS, 1986, J BIOL CHEM, V261, P4177; Ponomarev ED, 2007, J IMMUNOL, V178, P39, DOI 10.4049/jimmunol.178.1.39; Rachitskaya AV, 2008, J IMMUNOL, V180, P5167, DOI 10.4049/jimmunol.180.8.5167; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Sheibanie AF, 2004, FASEB J, V18, P1318, DOI 10.1096/fj.03-1367fje; Sonderegger I, 2008, J EXP MED, V205, P2281, DOI 10.1084/jem.20071119; Sonderegger I, 2008, EUR J IMMUNOL, V38, P1833, DOI 10.1002/eji.200838511; Uyttenhove C, 2007, ANN NY ACAD SCI, V1110, P330, DOI 10.1196/annals.1423.035; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang YH, 2009, J EXP MED, V206, P1549, DOI 10.1084/jem.20082584	43	762	796	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2011	12	6					568	U241		10.1038/ni.2031	http://dx.doi.org/10.1038/ni.2031			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	765LI	21516111	Green Accepted			2022-12-18	WOS:000290707100018
J	Eberl, G; Marmon, S; Sunshine, MJ; Rennert, PD; Choi, YW; Littman, DR				Eberl, G; Marmon, S; Sunshine, MJ; Rennert, PD; Choi, YW; Littman, DR			An essential function for the nuclear receptor ROR gamma t in the generation of fetal lymphoid tissue inducer cells	NATURE IMMUNOLOGY			English	Article							TUMOR-NECROSIS-FACTOR; LYMPHOTOXIN-BETA-RECEPTOR; PEYERS PATCH ORGANOGENESIS; ORPHAN RECEPTOR; ORGAN DEVELOPMENT; NODE GENESIS; B-CELL; ALPHA; EXPRESSION; ACTIVATION	Lymphoid tissue inducer (LTi) cells are associated with early development of lymph nodes and Peyer's patches. We show here that during fetal life the nuclear hormone receptor RORgammat is expressed exclusively in and is required for the generation of LTi cells. RORgammat(+) LTi cells provide essential factors, among which lymphotoxin-alpha(1)beta(2) is necessary but not sufficient for activation of the mesenchyma in lymph node and Peyer's patch anlagen. This early LTi cell-mediated activation of lymph node and Peyer's patch mesenchyma forms the necessary platform for the subsequent development of mature lymphoid tissues.	NYU, Sch Med, Mol Pathogenesis Program, New York, NY 10016 USA; NYU, Sch Med, Howard Hughes Med Inst, Skirball Inst Biomol Med, New York, NY 10016 USA; Biogen Inc, Dept Immunol, Cambridge, MA 02142 USA; Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	New York University; Howard Hughes Medical Institute; New York University; Biogen; University of Pennsylvania; Pennsylvania Medicine	Eberl, G (corresponding author), Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA.		Eberl, Gerard/A-1160-2013	Eberl, Gerard/0000-0002-1119-5638; Sunshine, Mary Jean/0000-0002-2188-7881				Adachi S, 1997, INT IMMUNOL, V9, P507, DOI 10.1093/intimm/9.4.507; Adachi S, 1998, INT IMMUNOL, V10, P1, DOI 10.1093/intimm/10.1.1; Alcamo E, 2002, J EXP MED, V195, P233, DOI 10.1084/jem.20011885; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Bachmann MF, 1999, J EXP MED, V189, P1025, DOI 10.1084/jem.189.7.1025; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Cupedo T, 2002, IMMUNOL REV, V189, P41, DOI 10.1034/j.1600-065X.2002.18905.x; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Delassus S, 1998, J IMMUNOL, V160, P3274; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Eberl G, 2003, IMMUNOL REV, V195, P81, DOI 10.1034/j.1600-065X.2003.00074.x; Finke D, 2002, IMMUNITY, V17, P363, DOI 10.1016/S1074-7613(02)00395-3; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Fukuyama S, 2002, IMMUNITY, V17, P31, DOI 10.1016/S1074-7613(02)00339-4; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Guo J, 2002, NAT IMMUNOL, V3, P469, DOI 10.1038/ni791; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; He YW, 1998, IMMUNITY, V9, P797, DOI 10.1016/S1074-7613(00)80645-7; Honda K, 2001, J EXP MED, V193, P621, DOI 10.1084/jem.193.5.621; Kim D, 2000, J EXP MED, V192, P1467, DOI 10.1084/jem.192.10.1467; Korner H, 1997, EUR J IMMUNOL, V27, P2600, DOI 10.1002/eji.1830271020; Kurebayashi S, 2000, P NATL ACAD SCI USA, V97, P10132, DOI 10.1073/pnas.97.18.10132; Luther SA, 2003, J EXP MED, V197, P1191, DOI 10.1084/jem.20021294; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Mebius RE, 1996, P NATL ACAD SCI USA, V93, P11019, DOI 10.1073/pnas.93.20.11019; Medvedev A, 1997, GENOMICS, V46, P93, DOI 10.1006/geno.1997.4980; Medvedev A, 1996, GENE, V181, P199, DOI 10.1016/S0378-1119(96)00504-5; MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224; Neumann B, 1996, J EXP MED, V184, P259, DOI 10.1084/jem.184.1.259; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Ohl L, 2003, J EXP MED, V197, P1199, DOI 10.1084/jem.20030169; Rennert PD, 1996, J EXP MED, V184, P1999, DOI 10.1084/jem.184.5.1999; Rennert PD, 1998, IMMUNITY, V9, P71, DOI 10.1016/S1074-7613(00)80589-0; Ross GD, 2002, IMMUNOL RES, V25, P219, DOI 10.1385/IR:25:3:219; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Villey I, 1999, EUR J IMMUNOL, V29, P4072, DOI 10.1002/(SICI)1521-4141(199912)29:12<4072::AID-IMMU4072>3.0.CO;2-E; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643; Yoshida H, 2002, IMMUNITY, V17, P823, DOI 10.1016/S1074-7613(02)00479-X	43	762	821	0	46	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2004	5	1					64	73		10.1038/ni1022	http://dx.doi.org/10.1038/ni1022			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	758LL	14691482	Green Published			2022-12-18	WOS:000187635800015
J	Yamamoto, M; Sato, S; Hemmi, H; Uematsu, S; Hoshino, K; Kaisho, T; Takeuchi, O; Takeda, K; Akira, S				Yamamoto, M; Sato, S; Hemmi, H; Uematsu, S; Hoshino, K; Kaisho, T; Takeuchi, O; Takeda, K; Akira, S			TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway	NATURE IMMUNOLOGY			English	Article							DOMAIN-CONTAINING ADAPTER; CUTTING EDGE; IMMUNE-RESPONSE; GENE-EXPRESSION; CPG-DNA; LIPOPOLYSACCHARIDE; ACTIVATION; PROTEIN; TLR4; RECOGNITION	Recognition of pathogens by Toll-like receptors (TLRs) triggers innate immune responses through signaling pathways mediated by Toll-interleukin 1 receptor (TIR) domain-containing adaptors such as MyD88, TIRAP and TRIF. MyD88 is a common adaptor that is essential for proinflammatory cytokine production, whereas TRIF mediates the MyD88-independent pathway from TLR3 and TLR4. Here we have identified a fourth TIR domain-containing adaptor, TRIF-related adaptor molecule (TRAM), and analyzed its physiological function by gene targeting. TRAM-deficient mice showed defects in cytokine production in response to the TLR4 ligand, but not to other TLR ligands. TLR4- but not TLR3-mediated MyD88-independent interferon-production and activation of signaling cascades were abolished in TRAM-deficient cells. Thus, TRAM provides specificity for the MyD88-independent component of TLR4 signaling.	Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; ERATO, Japan Sci & Technol Corp, Suita, Osaka 5650871, Japan; RIKEN, Res Ctr Allergy & Immunol, Tsurumi Ku, Kanagawa 2300045, Japan	Osaka University; Japan Science & Technology Agency (JST); RIKEN	Akira, S (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp	Hoshino, Katsuaki/L-9162-2014; Hoshino, Katsuaki/AAE-2830-2022; Takeuchi, Osamu/AAG-9359-2019; Akira, Shizuo/C-3134-2009; Kaisho, Tsuneyasu/B-4130-2012; Takeuchi, Osamu/D-6007-2011; Takeda, Kiyoshi/C-9331-2009	Hoshino, Katsuaki/0000-0003-0493-4815; Hoshino, Katsuaki/0000-0003-0493-4815; Takeuchi, Osamu/0000-0002-1260-6232; Sato, Shintaro/0000-0001-5156-3354				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Alexopoulou L, 2002, NAT MED, V8, P878, DOI 10.1038/nm732; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bin LH, 2003, J BIOL CHEM, V278, P24526, DOI 10.1074/jbc.M303451200; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Grosshans J, 1999, MECH DEVELOP, V81, P127, DOI 10.1016/S0925-4773(98)00236-6; Hacker H, 2000, J EXP MED, V192, P595, DOI 10.1084/jem.192.4.595; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Hoshino K, 1999, J IMMUNOL, V162, P3749; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4; Jensen LE, 2003, FEBS LETT, V545, P199, DOI 10.1016/S0014-5793(03)00533-7; Jensen LE, 2003, J IMMUNOL, V171, P1500, DOI 10.4049/jimmunol.171.3.1500; Jiang ZF, 2003, J BIOL CHEM, V278, P10952, DOI 10.1074/jbc.M212112200; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kopydlowski KM, 1999, J IMMUNOL, V163, P1537; Mink M, 2001, GENOMICS, V74, P234, DOI 10.1006/geno.2001.6548; O'Neill LAJ, 2003, TRENDS IMMUNOL, V24, P287, DOI 10.1016/S1471-4906(03)00115-7; Ohmori Y, 2001, J LEUKOCYTE BIOL, V69, P598; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato S, 2002, INT IMMUNOL, V14, P783, DOI 10.1093/intimm/dxf046; Schnare M, 2000, CURR BIOL, V10, P1139, DOI 10.1016/S0960-9822(00)00700-4; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Vasilakos JP, 2000, CELL IMMUNOL, V204, P64, DOI 10.1006/cimm.2000.1689; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yu KY, 2002, J IMMUNOL, V169, P4075, DOI 10.4049/jimmunol.169.8.4075	46	762	820	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2003	4	11					1144	1150		10.1038/ni986	http://dx.doi.org/10.1038/ni986			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	737PN	14556004				2022-12-18	WOS:000186241100019
J	de Jonge, WJ; van der Zanden, EP; O The, F; Bijlsma, MF; van Westerloo, DJ; Bennink, RJ; Berthoud, HR; Uematsu, S; Akira, S; van den Wijngaard, RM; Boeckxstaens, GE				de Jonge, WJ; van der Zanden, EP; O The, F; Bijlsma, MF; van Westerloo, DJ; Bennink, RJ; Berthoud, HR; Uematsu, S; Akira, S; van den Wijngaard, RM; Boeckxstaens, GE			Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway	NATURE IMMUNOLOGY			English	Article							FACTOR-KAPPA-B; NICOTINIC ACETYLCHOLINE-RECEPTORS; POSTOPERATIVE ILEUS; INFLAMMATORY RESPONSE; MUSCULARIS EXTERNA; ALPHA-7 SUBUNIT; SMALL-INTESTINE; MYELOID CELLS; MUSCLE LAYERS; NITRIC-OXIDE	Acetylcholine released by efferent vagus nerves inhibits macrophage activation. Here we show that the anti-inflammatory action of nicotinic receptor activation in peritoneal macrophages was associated with activation of the transcription factor STAT3. STAT3 was phosphorylated by the tyrosine kinase Jak2 that was recruited to the alpha 7 subunit of the nicotinic acetylcholine receptor. The anti-inflammatory effect of nicotine required the ability of phosphorylated STAT3 to bind and transactivate its DNA response elements. In a mouse model of intestinal manipulation, stimulation of the vagus nerve ameliorated surgery-induced inflammation and postoperative ileus by activating STAT3 in intestinal macrophages. We conclude that the vagal antiinflammatory pathway acts by alpha 7 subunit-mediated Jak2-STAT3 activation.	Acad Med Ctr, Div Gastroenterol & Hepatol, Amsterdam, Netherlands; Acad Med Ctr, Lab Expt Internal Med, Amsterdam, Netherlands; Louisiana State Univ, Pennington Biomed Res Ctr, Neurobiol Nutr Lab, Baton Rouge, LA 70808 USA; Osaka Univ, Res Inst Microbial Dis, Dept Host Def, Suita, Osaka 5650871, Japan	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Osaka University	de Jonge, WJ (corresponding author), Acad Med Ctr, Div Gastroenterol & Hepatol, Amsterdam, Netherlands.	w.j.dejonge@amc.uva.nl	Berthoud, Hans-Rudolf/N-1950-2017; Akira, Shizuo/C-3134-2009; van den Wijngaard, Rene M/D-2116-2011; Boeckxstaens, Guy/AAP-2502-2020		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057242] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK4738, DK57242] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Bauer AJ, 2004, NEUROGASTROENT MOTIL, V16, P54, DOI 10.1111/j.1743-3150.2004.00558.x; Bennink RJ, 2003, J NUCL MED, V44, P1099; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; De Jonge WJ, 2004, GASTROENTEROLOGY, V127, P535, DOI 10.1053/j.gastro.2004.04.017; De Jonge WJ, 2003, GASTROENTEROLOGY, V125, P1137, DOI 10.1016/S0016-5085(03)01197-1; de Koning JP, 2000, ONCOGENE, V19, P3290, DOI 10.1038/sj.onc.1203627; Drisdel RC, 2000, J NEUROSCI, V20, P133, DOI 10.1523/JNEUROSCI.20-01-00133.2000; George MS, 2000, PSYCHIAT CLIN N AM, V23, P757, DOI 10.1016/S0193-953X(05)70196-9; Kalff JC, 1999, GASTROENTEROLOGY, V117, P378, DOI 10.1053/gast.1999.0029900378; Kalff JC, 2003, ANN SURG, V237, P301, DOI 10.1097/00000658-200303000-00003; Kontoyiannis D, 2001, EMBO J, V20, P3760, DOI 10.1093/emboj/20.14.3760; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; LIVINGSTON EH, 1990, DIGEST DIS SCI, V35, P121, DOI 10.1007/BF01537233; LONGO WE, 1993, DIS COLON RECTUM, V36, P696, DOI 10.1007/BF02238599; Lukas RJ, 1999, PHARMACOL REV, V51, P397; Matsunaga K, 2001, J IMMUNOL, V167, P6518, DOI 10.4049/jimmunol.167.11.6518; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; MIKKELSEN HB, 1995, HISTOL HISTOPATHOL, V10, P719; MIKKELSEN HB, 1988, CELL TISSUE RES, V252, P301; Ozaki H, 2004, NEUROGASTROENT MOTIL, V16, P39, DOI 10.1046/j.1365-2982.2003.00461.x; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Schottelius AJG, 1999, J BIOL CHEM, V274, P31868, DOI 10.1074/jbc.274.45.31868; Shaw S, 2002, J BIOL CHEM, V277, P44920, DOI 10.1074/jbc.M204610200; Shimozaki K, 1997, J BIOL CHEM, V272, P25184, DOI 10.1074/jbc.272.40.25184; TAKAHASHI T, 1995, J PHYSIOL-LONDON, V484, P481, DOI 10.1113/jphysiol.1995.sp020680; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; WANG P, 1995, J BIOL CHEM, V270, P9558, DOI 10.1074/jbc.270.16.9558; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Welte T, 2003, P NATL ACAD SCI USA, V100, P1879, DOI 10.1073/PNAS.0237137100; Williams LM, 2004, IMMUNOLOGY, V113, P281, DOI 10.1111/j.1365-2567.2004.01988.x; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Yu ZY, 2002, BIOCHEM J, V367, P97, DOI 10.1042/BJ20020588	38	761	811	5	78	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2005	6	8					844	851		10.1038/ni1229	http://dx.doi.org/10.1038/ni1229			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	947LM	16025117				2022-12-18	WOS:000230646200026
J	Yu, X; Harden, K; Gonzalez, LC; Francesco, M; Chiang, E; Irving, B; Tom, I; Ivelja, S; Refino, CJ; Clark, H; Eaton, D; Grogan, JL				Yu, Xin; Harden, Kristin; Gonzalez, Lino C.; Francesco, Michelle; Chiang, Eugene; Irving, Bryan; Tom, Irene; Ivelja, Sinisa; Refino, Canio J.; Clark, Hilary; Eaton, Dan; Grogan, Jane L.			The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells	NATURE IMMUNOLOGY			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; TRANSCRIPTION FACTOR FOXP3; NECTIN-LIKE MOLECULES; IN-VIVO; CUTTING EDGE; TNF RECEPTOR; PVR CD155; ANTIGEN 4; DC-SIGN; ADHESION	Here we have identified a surface protein, TIGIT, containing an immunoglobulin variable domain, a transmembrane domain and an immunoreceptor tyrosine-based inhibitory motif that was expressed on regulatory, memory and activated T cells. Poliovirus receptor, which is expressed on dendritic cells, bound TIGIT with high affinity. A TIGIT-Fc fusion protein inhibited T cell activation in vitro, and this was dependent on the presence of dendritic cells. The binding of poliovirus receptor to TIGIT on human dendritic cells enhanced the production of interleukin 10 and diminished the production of interleukin 12p40. Knockdown of TIGIT with small interfering RNA in human memory T cells did not affect T cell responses. TIGIT-Fc inhibited delayed-type hypersensitivity reactions in wild-type but not interleukin 10-deficient mice. Our data suggest that TIGIT exerts immunosuppressive effects by binding to poliovirus receptor and modulating cytokine production by dendritic cells.	[Yu, Xin; Francesco, Michelle; Chiang, Eugene; Irving, Bryan; Ivelja, Sinisa; Refino, Canio J.; Grogan, Jane L.] Genentech Inc, Dept Immunol, San Francisco, CA USA; [Harden, Kristin; Gonzalez, Lino C.; Tom, Irene; Eaton, Dan] Genentech Inc, Dept Prot Chem, San Francisco, CA USA; [Clark, Hilary] Genentech Inc, Dept Bioinformat, San Francisco, CA USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Grogan, JL (corresponding author), Genentech Inc, Dept Immunol, San Francisco, CA USA.	jgrogan@gene.com	Gonzalez, Lino/E-4102-2012	Gonzalez, Lino/0000-0003-3817-6450				Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Ahn JS, 2007, INT IMMUNOL, V19, P227, DOI 10.1093/intimm/dxl139; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; Bruder D, 2004, EUR J IMMUNOL, V34, P623, DOI 10.1002/eji.200324799; Burshtyn DN, 1997, J BIOL CHEM, V272, P13066, DOI 10.1074/jbc.272.20.13066; Caparros E, 2006, BLOOD, V107, P3950, DOI 10.1182/blood-2005-03-1252; Chieppa M, 2003, J IMMUNOL, V171, P4552, DOI 10.4049/jimmunol.171.9.4552; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; Coombes JL, 2005, IMMUNOL REV, V204, P184, DOI 10.1111/j.0105-2896.2005.00250.x; Dardalhon V, 2005, J IMMUNOL, V175, P1558, DOI 10.4049/jimmunol.175.3.1558; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Fehervari Z, 2004, CURR OPIN IMMUNOL, V16, P203, DOI 10.1016/j.coi.2004.01.004; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fuchs A, 2004, J IMMUNOL, V172, P3994, DOI 10.4049/jimmunol.172.7.3994; Fuchs A, 2006, SEMIN CANCER BIOL, V16, P359, DOI 10.1016/j.semcancer.2006.07.002; Gonzalez LC, 2005, P NATL ACAD SCI USA, V102, P1116, DOI 10.1073/pnas.0409071102; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; He YN, 2003, J VIROL, V77, P4827, DOI 10.1128/JVI.77.8.4827-4835.2003; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Ikeda W, 2003, J BIOL CHEM, V278, P28167, DOI 10.1074/jbc.M303586200; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; Kashiwada M, 2001, J IMMUNOL, V167, P6382, DOI 10.4049/jimmunol.167.11.6382; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; LINSLEY PS, 1992, SCIENCE, V257, P792, DOI 10.1126/science.1496399; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Osheroff PL, 1999, GROWTH FACTORS, V16, P241, DOI 10.3109/08977199909002133; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Reymond N, 2004, J EXP MED, V199, P1331, DOI 10.1084/jem.20032206; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakisaka T, 2004, CURR OPIN CELL BIOL, V16, P513, DOI 10.1016/j.ceb.2004.07.007; Satoh-Horikawa K, 2000, J BIOL CHEM, V275, P10291, DOI 10.1074/jbc.275.14.10291; Serra P, 2003, IMMUNITY, V19, P877, DOI 10.1016/S1074-7613(03)00327-3; Seshasayee D, 2007, J CLIN INVEST, V117, P3868, DOI 10.1172/JCI33559; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Steinman RM, 2003, ANN NY ACAD SCI, V987, P15, DOI 10.1111/j.1749-6632.2003.tb06029.x; Tahara-Hanaoka S, 2004, INT IMMUNOL, V16, P533, DOI 10.1093/intimm/dxh059; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Tarbell KV, 2004, J EXP MED, V199, P1467, DOI 10.1084/jem.20040180; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; Wakkach A, 2003, IMMUNITY, V18, P605, DOI 10.1016/S1074-7613(03)00113-4; Wiesmann C, 2001, CELL MOL LIFE SCI, V58, P748, DOI 10.1007/PL00000898; Xia CQ, 2003, SCAND J IMMUNOL, V58, P23, DOI 10.1046/j.1365-3083.2003.01268.x; Yamazaki S, 2006, P NATL ACAD SCI USA, V103, P2758, DOI 10.1073/pnas.0510606103	47	760	838	3	93	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2009	10	1					48	57		10.1038/ni.1674	http://dx.doi.org/10.1038/ni.1674			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	385BV	19011627				2022-12-18	WOS:000261788800011
J	Horng, T; Barton, GM; Medzhitov, R				Horng, T; Barton, GM; Medzhitov, R			TIRAP: an adapter molecule in the Toll signaling pathway	NATURE IMMUNOLOGY			English	Article							INNATE IMMUNE-RESPONSE; PROTEIN-KINASE PKR; ACTIVATION; RECOGNITION; RECEPTORS; ENDOTOXIN; PATHOGENS; SYSTEM; FAMILY; MYD88	Mammalian Toll-like receptors (TLRs) recognize conserved products of microbial metabolism and activate NF-kappaB and other signaling pathways through the adapter protein MyD88. Although some cellular responses are completely abolished in MyD88-deficient mice, TLR4, but not TLR9, can activate NF-KB and mitogen-activated protein kinases and induce dendritic cell maturation in the absence of MyD88. These differences suggest that another adapter must exist that can mediate MyD88-independent signaling in response to TLR4 ligation. We have identified and characterized a Toll-interleukin I receptor (TIR) domain-containing adapter protein (TIRAP) and have shown that it controls activation of MyD88-independent signaling pathways downstream of TLR4. We have also shown that the double-stranded RNA-binding protein kinase PKR is a component of both the TIRAP- and MyD88-dependent signaling pathways.	Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, 333 Cedar St, New Haven, CT 06520 USA.			Barton, Gregory/0000-0002-3793-0100	NIAID NIH HHS [AI44220-01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044220] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Derossi D, 1998, TRENDS CELL BIOL, V8, P84, DOI 10.1016/S0962-8924(97)01214-2; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kopp EB, 1999, CURR OPIN IMMUNOL, V11, P13, DOI 10.1016/S0952-7915(99)80003-X; LEE TG, 1994, MOL CELL BIOL, V14, P2331, DOI 10.1128/MCB.14.4.2331; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Schnare M, 2000, CURR BIOL, V10, P1139, DOI 10.1016/S0960-9822(00)00700-4; Takeuchi O, 2000, J IMMUNOL, V164, P554, DOI 10.4049/jimmunol.164.2.554; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600	19	760	808	3	39	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2001	2	9					835	841		10.1038/ni0901-835	http://dx.doi.org/10.1038/ni0901-835			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	468WM	11526399				2022-12-18	WOS:000170781200023
J	McGeachy, MJ; Chen, Y; Tato, CM; Laurence, A; Joyce-Shaikh, B; Blumenschein, WM; McClanahan, TK; O'Shea, JJ; Cua, DJ				McGeachy, Mandy J.; Chen, Yi; Tato, Cristina M.; Laurence, Arian; Joyce-Shaikh, Barbara; Blumenschein, Wendy M.; McClanahan, Terrill K.; O'Shea, John J.; Cua, Daniel J.			The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo	NATURE IMMUNOLOGY			English	Article							TGF-BETA; CYTOKINE; IL-23; MEMORY; INFLAMMATION; GENERATION; DISTINCT; LINEAGE; STAT3; IL-17	Interleukin 23 (IL-23) is required for autoimmune inflammation mediated by IL-17-producing helper T cells (T-H-17 cells) and has been linked to many human immune disorders. Here we restricted deficiency in the IL-23 receptor to defined cell populations in vivo to investigate the requirement for IL-23 signaling in the development and function of T-H-17 cells in autoimmunity, inflammation and infection. In the absence of IL-23, T-H-17 development was stalled at the early activation stage. T-H-17 cells failed to downregulate IL-2 and also failed to maintain IL-17 production or upregulate expression of the IL-7 receptor alpha-chain. These defects were associated with less proliferation; consequently, fewer effector T-H-17 cells were produced in the lymph nodes and hence available to emigrate to the bloodstream and tissues.	[McGeachy, Mandy J.; Chen, Yi; Tato, Cristina M.; Joyce-Shaikh, Barbara; Blumenschein, Wendy M.; McClanahan, Terrill K.; Cua, Daniel J.] Schering Plough Biopharma, Palo Alto, CA 94304 USA; [Laurence, Arian; O'Shea, John J.] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA	Merck & Company; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Cua, DJ (corresponding author), Schering Plough Biopharma, Palo Alto, CA 94304 USA.	daniel.cua@spcorp.com	Laurence, Arian/H-5534-2019; Laurence, Arian/A-8770-2009	Laurence, Arian/0000-0003-0942-8292; Laurence, Arian/0000-0003-0942-8292; Tato, Cristina M./0000-0002-0614-756X	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041159] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 AR999999] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Betti M, 2006, ANN ONCOL, V17, P235; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Boyman O, 2007, CURR OPIN IMMUNOL, V19, P320, DOI 10.1016/j.coi.2007.04.015; Chackerian AA, 2006, INFECT IMMUN, V74, P6092, DOI 10.1128/IAI.00621-06; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dooms H, 2007, J EXP MED, V204, P547, DOI 10.1084/jem.20062381; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Elson CO, 2007, GASTROENTEROLOGY, V132, P2359, DOI 10.1053/j.gastro.2007.03.104; Fritsch RD, 2005, J IMMUNOL, V175, P6489, DOI 10.4049/jimmunol.175.10.6489; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kondrack RM, 2003, J EXP MED, V198, P1797, DOI 10.1084/jem.20030735; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Li JC, 2003, J EXP MED, V198, P1807, DOI 10.1084/jem.20030725; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lieberman LA, 2004, J IMMUNOL, V173, P1887, DOI 10.4049/jimmunol.173.3.1887; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; MILLER SD, 1995, IMMUNOL REV, V144, P225, DOI 10.1111/j.1600-065X.1995.tb00071.x; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Smith RL, 2008, J INVEST DERMATOL, V128, P1325, DOI 10.1038/sj.jid.5701140; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Villarino AV, 2007, J EXP MED, V204, P65, DOI 10.1084/jem.20061198; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	48	759	804	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2009	10	3					314	324		10.1038/ni.1698	http://dx.doi.org/10.1038/ni.1698			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	408SY	19182808	Green Accepted			2022-12-18	WOS:000263456500016
J	Sheedy, FJ; Palsson-McDermott, E; Hennessy, EJ; Martin, C; O'Leary, JJ; Ruan, QG; Johnson, DS; Chen, YH; O'Neill, LAJ				Sheedy, Frederick J.; Palsson-McDermott, Eva; Hennessy, Elizabeth J.; Martin, Cara; O'Leary, John J.; Ruan, Qingguo; Johnson, Derek S.; Chen, Youhai; O'Neill, Luke A. J.			Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; INITIATION-FACTOR 4E; PROGRAMMED CELL-DEATH-4; IMMUNE-RESPONSES; GENE-EXPRESSION; TRANSLATION INITIATION; AP-1 TRANSACTIVATION; SPLICE VARIANT; MESSENGER-RNA; CELLS	The tumor suppressor PDCD4 is a proinflammatory protein that promotes activation of the transcription factor NF-kappa B and suppresses interleukin 10 (IL-10). Here we found that mice deficient in PDCD4 were protected from lipopolysaccharide (LPS)-induced death. The induction of NF-kappa B and IL-6 by LPS required PDCD4, whereas LPS enhanced IL-10 induction in cells lacking PDCD4. Treatment of human peripheral blood mononuclear cells with LPS resulted in lower PDCD4 expression, which was due to induction of the microRNA miR-21 via the adaptor MyD88 and NF-kappa B. Transfection of cells with a miR-21 precursor blocked NF-kappa B activity and promoted IL-10 production in response to LPS, whereas transfection with antisense oligonucleotides to miR-21 or targeted protection of the miR-21 site in Pdcd4 mRNA had the opposite effect. Thus, miR-21 regulates PDCD4 expression after LPS stimulation.	[Sheedy, Frederick J.; Palsson-McDermott, Eva; Hennessy, Elizabeth J.; O'Neill, Luke A. J.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland; [Martin, Cara; O'Leary, John J.] Coombe Womens Hosp, Dept Pathol, Dublin, Ireland; [Martin, Cara; O'Leary, John J.] Trinity Coll Dublin, Sch Med, Dept Histopathol, Dublin, Ireland; [Ruan, Qingguo; Johnson, Derek S.; Chen, Youhai] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; University of Pennsylvania	O'Neill, LAJ (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland.	laoneill@tcd.ie	Chen, Youhai/AAJ-4031-2021; Hennessy, Elizabeth/AAJ-4800-2021	Hennessy, Elizabeth/0000-0002-1231-5777; O'Leary, John/0000-0001-7311-9326; Sheedy, Frederick/0000-0002-4722-3135; Martin, Cara/0000-0001-8411-8564; Sheedy, Frederick/0000-0003-2645-8493; O'Neill, Luke/0000-0002-4333-2748	Science Foundation Ireland; Irish Research Council for Science, Engineering and Technology [RS/2005/190]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR)	We thank D. Golenbock (University of Massachusetts) for wild-type, MyD88-deficient and TRIF-deficient BMDMs immortalized by retrovirus; R. Hay (University of St. Andrews) for p65-deficient and matched wild-type control mouse embryonic fibroblasts and for HA-tagged ubiquitin; R. Hofmeister (Universitaet Regensburg) for 5x NF-kappa B reporter luciferase plasmid; A. M. Cheng (Ambion) for the pMIR-REPORT miR-21 reporter luciferase plasmid; and A. Bowie (Trinity College, Dublin) for the Il10 promoter-luciferase plasmid. Supported by Science Foundation Ireland and the Irish Research Council for Science, Engineering and Technology (RS/2005/190).	Alsaleh G, 2009, J IMMUNOL, V182, P5088, DOI 10.4049/jimmunol.0801613; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chen XM, 2007, J BIOL CHEM, V282, P28929, DOI 10.1074/jbc.M702633200; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Cmarik JL, 1999, P NATL ACAD SCI USA, V96, P14037, DOI 10.1073/pnas.96.24.14037; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Graff JR, 1997, BIOCHEM BIOPH RES CO, V240, P15, DOI 10.1006/bbrc.1997.7592; Hilliard A, 2006, J IMMUNOL, V177, P8095, DOI 10.4049/jimmunol.177.11.8095; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; Iwami K, 2000, J IMMUNOL, V165, P6682, DOI 10.4049/jimmunol.165.12.6682; Janssens S, 2003, FEBS LETT, V548, P103, DOI 10.1016/S0014-5793(03)00747-6; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; LIU G, 2009, P NATL ACAD SCI US; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; Loh PG, 2009, EMBO J, V28, P274, DOI 10.1038/emboj.2008.278; Lu TX, 2009, J IMMUNOL, V182, P4994, DOI 10.4049/jimmunol.0803560; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Moschos SA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-240; Murray PJ, 2006, BIOCHEM SOC T, V34, P1028, DOI 10.1042/BST0341028; NAORA H, 1994, J IMMUNOL, V152, P5691; Nemeth ZH, 2005, J IMMUNOL, V175, P8260, DOI 10.4049/jimmunol.175.12.8260; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Onishi Y, 1998, GENE, V215, P453, DOI 10.1016/S0378-1119(98)00313-8; Palsson-McDermott EM, 2009, NAT IMMUNOL, V10, P579, DOI 10.1038/ni.1727; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rousseau D, 1996, P NATL ACAD SCI USA, V93, P1065, DOI 10.1073/pnas.93.3.1065; Schmid T, 2008, CANCER RES, V68, P1254, DOI 10.1158/0008-5472.CAN-07-1719; Sharma A, 2009, P NATL ACAD SCI USA, V106, P5761, DOI 10.1073/pnas.0808743106; Shibahara K, 1995, GENE, V166, P297, DOI 10.1016/0378-1119(95)00607-9; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Talotta F, 2009, ONCOGENE, V28, P73, DOI 10.1038/onc.2008.370; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; van Duin D, 2006, TRENDS IMMUNOL, V27, P49, DOI 10.1016/j.it.2005.11.005; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Yang HS, 2003, ONCOGENE, V22, P3712, DOI 10.1038/sj.onc.1206433; Yang HS, 2001, ONCOGENE, V20, P669, DOI 10.1038/sj.onc.1204137; Yang Ling, 2003, Asian Pac J Cancer Prev, V4, P23; Zhang ZY, 2008, LAB INVEST, V88, P1358, DOI 10.1038/labinvest.2008.94	51	755	822	6	118	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2010	11	2					141	U59		10.1038/ni.1828	http://dx.doi.org/10.1038/ni.1828			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	545KF	19946272				2022-12-18	WOS:000273730200011
J	Jurk, M; Heil, F; Vollmer, J; Schetter, C; Krieg, AM; Wagner, H; Lipford, G; Bauer, S				Jurk, M; Heil, F; Vollmer, J; Schetter, C; Krieg, AM; Wagner, H; Lipford, G; Bauer, S			Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848	NATURE IMMUNOLOGY			English	Letter							RECOGNITION		Coley Pharmaceut GmbH, Elisabeth Selbert Str 9, D-40764 Langenfeld, Germany; Coley Pharmaceut Grp Inc, Wellesley, MA 02481 USA; Inst Med Microbiol Hyg & Immunol, D-81675 Munich, Germany	Coley Pharmaceutical Group; Coley Pharmaceutical Group	Jurk, M (corresponding author), Coley Pharmaceut GmbH, Elisabeth Selbert Str 9, D-40764 Langenfeld, Germany.	stefan.bauer@lrz.tum.de	Krieg, Arthur M/K-8109-2019; Krieg, Art/R-6166-2019	Bauer, Stefan/0000-0002-8462-1845				Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3	10	755	873	4	63	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2002	3	6					499	499		10.1038/ni0602-499	http://dx.doi.org/10.1038/ni0602-499			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	556XR	12032557	Bronze			2022-12-18	WOS:000175874700002
J	Fontenot, JD; Rudensky, AY				Fontenot, JD; Rudensky, AY			A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3	NATURE IMMUNOLOGY			English	Review							IMMUNOLOGICAL SELF-TOLERANCE; SCURFY SF MOUSE; TGF-BETA; LYMPHORETICULAR DISEASE; CUTTING EDGE; IMMUNE DYSREGULATION; AUTOIMMUNE-DISEASE; THYMIC SELECTION; IN-VITRO; CD25(+)	The random generation of antigen receptors in developing lymphocytes results in a considerable risk of autoimmunity. Regulatory T cells (T-reg cells) act in a dominant, trans-acting way to actively suppress immune activation and maintain immune tolerance. Here, we discuss the principal advances in our understanding of the molecular mechanisms of T-reg cell development and function with particular emphasis on the forkhead transcription factor Foxp3. Accumulating evidence suggests that T-reg cells represent a dedicated T cell lineage and that Foxp3 functions as the T-reg cell lineage specification factor. The aggressive early- onset lymphoproliferative syndrome resulting from Foxp3 deficiency identifies T-reg cells as vital mediators of immunological tolerance to self and Foxp3 as the mediator of the genetic mechanism of dominant tolerance.	Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Fontenot, JD (corresponding author), Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA.	fontenot@u.washington.edu; aruden@u.washington.edu						Annacker O, 2001, J IMMUNOL, V166, P3008, DOI 10.4049/jimmunol.166.5.3008; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Barthlott T, 2003, J EXP MED, V197, P451, DOI 10.1084/jem.20021387; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bensinger SJ, 2001, J EXP MED, V194, P427, DOI 10.1084/jem.194.4.427; BLAIR PJ, 1994, J IMMUNOL, V153, P3764; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; BURNET F. M., 1957, AUSTRALIAN JOUR SCI, V20, P67; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Clark LB, 1999, J IMMUNOL, V162, P2546; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; de Lafaille MAC, 2004, J IMMUNOL, V173, P7259, DOI 10.4049/jimmunol.173.12.7259; DORF ME, 1984, ANNU REV IMMUNOL, V2, P127, DOI 10.1146/annurev.iy.02.040184.001015; Dujardin HC, 2004, P NATL ACAD SCI USA, V101, P14473, DOI 10.1073/pnas.0403303101; Ehrlich P., 1910, COLLECTED STUDIES IM; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Fehervari Z, 2004, CURR OPIN IMMUNOL, V16, P203, DOI 10.1016/j.coi.2004.01.004; Fisson S, 2003, J EXP MED, V198, P737, DOI 10.1084/jem.20030686; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; FONTENOT JD, IN PRESS IMMUNITY; Furtado GC, 2002, J EXP MED, V196, P851, DOI 10.1084/jem.20020190; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; GERSHON RK, 1971, IMMUNOLOGY, V21, P903; GODFREY VL, 1994, AM J PATHOL, V145, P281; GODFREY VL, 1991, P NATL ACAD SCI USA, V88, P5528, DOI 10.1073/pnas.88.13.5528; GODFREY VL, 1991, AM J PATHOL, V138, P1379; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Green EA, 2003, P NATL ACAD SCI USA, V100, P10878, DOI 10.1073/pnas.1834400100; Green EA, 2002, IMMUNITY, V16, P183, DOI 10.1016/S1074-7613(02)00279-0; Grossman WJ, 2004, IMMUNITY, V21, P589, DOI 10.1016/j.immuni.2004.09.002; Hernandez-Hoyos G, 2000, IMMUNITY, V12, P313, DOI 10.1016/S1074-7613(00)80184-3; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; HSIEH CS, IN PRESS CURR TOP MI; Huber S, 2004, J IMMUNOL, V173, P6526, DOI 10.4049/jimmunol.173.11.6526; Itoh M, 1999, J IMMUNOL, V162, P5317; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kaestner KH, 2000, GENE DEV, V14, P142; Kanangat S, 1996, EUR J IMMUNOL, V26, P161, DOI 10.1002/eji.1830260125; Kawahata K, 2002, J IMMUNOL, V168, P4399, DOI 10.4049/jimmunol.168.9.4399; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Khattri R, 2001, J IMMUNOL, V167, P6312, DOI 10.4049/jimmunol.167.11.6312; Klein L, 2003, P NATL ACAD SCI USA, V100, P8886, DOI 10.1073/pnas.1533365100; Kyewski B, 2004, NAT REV IMMUNOL, V4, P688, DOI 10.1038/nri1436; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; MODIGLIANI Y, 1995, P NATL ACAD SCI USA, V92, P7555, DOI 10.1073/pnas.92.16.7555; Modigliani Y, 1996, EUR J IMMUNOL, V26, P1807, DOI 10.1002/eji.1830260822; MOLLER G, 1988, SCAND J IMMUNOL, V27, P247, DOI 10.1111/j.1365-3083.1988.tb02344.x; NISHIZUK.Y, 1969, SCIENCE, V166, P753, DOI 10.1126/science.166.3906.753; Olivares-Villagomez D, 1998, J EXP MED, V188, P1883, DOI 10.1084/jem.188.10.1883; Pacholczyk R, 2002, J IMMUNOL, V168, P613, DOI 10.4049/jimmunol.168.2.613; Papiernik M, 1998, INT IMMUNOL, V10, P371, DOI 10.1093/intimm/10.4.371; Park HB, 2004, INT IMMUNOL, V16, P1203, DOI 10.1093/intimm/dxh123; Paust S, 2004, P NATL ACAD SCI USA, V101, P10398, DOI 10.1073/pnas.0403342101; Piccirillo CA, 2002, J EXP MED, V196, P237, DOI 10.1084/jem.20020590; Read S, 1998, EUR J IMMUNOL, V28, P3435, DOI 10.1002/(SICI)1521-4141(199811)28:11<3435::AID-IMMU3435>3.3.CO;2-G; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Schmidt-Supprian M, 2004, P NATL ACAD SCI USA, V101, P4566, DOI 10.1073/pnas.0400885101; Schmidt-Supprian M, 2003, IMMUNITY, V19, P377, DOI 10.1016/S1074-7613(03)00237-1; Schramm C, 2004, INT IMMUNOL, V16, P1241, DOI 10.1093/intimm/dxh126; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; Seddon B, 2000, IMMUNOL TODAY, V21, P95, DOI 10.1016/S0167-5699(99)01559-5; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Stephens LA, 2000, J IMMUNOL, V165, P3105, DOI 10.4049/jimmunol.165.6.3105; Stockinger B, 2001, NAT IMMUNOL, V2, P757, DOI 10.1038/ni0901-757; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; TALMAGE DW, 1957, ANNU REV MED, V8, P239, DOI 10.1146/annurev.me.08.020157.001323; Tang QZ, 2004, EUR J IMMUNOL, V34, P2996, DOI 10.1002/eji.200425143; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Thornton AM, 2004, J IMMUNOL, V172, P6519, DOI 10.4049/jimmunol.172.11.6519; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; Viret C, 2003, J IMMUNOL, V170, P201, DOI 10.4049/jimmunol.170.1.201; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Walker LSK, 2003, J EXP MED, V198, P249, DOI 10.1084/jem.20030315; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165; Zheng SG, 2004, J IMMUNOL, V172, P5213, DOI 10.4049/jimmunol.172.9.5213	93	751	868	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2005	6	4					331	337		10.1038/ni1179	http://dx.doi.org/10.1038/ni1179			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	909KY	15785758				2022-12-18	WOS:000227860000003
J	Mackay, LK; Rahimpour, A; Ma, JZ; Collins, N; Stock, AT; Hafon, ML; Vega-Ramos, J; Lauzurica, P; Mueller, SN; Stefanovic, T; Tscharke, DC; Heath, WR; Inouye, M; Carbone, FR; Gebhardt, T				Mackay, Laura K.; Rahimpour, Azad; Ma, Joel Z.; Collins, Nicholas; Stock, Angus T.; Hafon, Ming-Li; Vega-Ramos, Javier; Lauzurica, Pilar; Mueller, Scott N.; Stefanovic, Tijana; Tscharke, David C.; Heath, William R.; Inouye, Michael; Carbone, Francis R.; Gebhardt, Thomas			The developmental pathway for CD103(+)CD8(+) tissue-resident memory T cells of skin	NATURE IMMUNOLOGY			English	Article							LYMPHOCYTE EGRESS; CD103 EXPRESSION; LOCAL IMMUNITY; CUTTING EDGE; RM CELLS; MIGRATION; EFFECTOR; ANTIGEN; DIFFERENTIATION; LOCALIZATION	Tissue-resident memory T cells (TRM cells) provide superior protection against infection in extralymphoid tissues. Here we found that CD103(+)CD8(+) TRM cells developed in the skin from epithelium-infiltrating precursor cells that lacked expression of the effector-cell marker KLRG1. A combination of entry into the epithelium plus local signaling by interleukin 15 (IL-15) and transforming growth factor-beta (TGF-beta) was required for the formation of these long-lived memory cells. Notably, differentiation into TRM cells resulted in the progressive acquisition of a unique transcriptional profile that differed from that of circulating memory cells and other types of T cells that permanently reside in skin epithelium. We provide a comprehensive molecular framework for the local differentiation of a distinct peripheral population of memory cells that forms a first-line immunological defense system in barrier tissues.	[Mackay, Laura K.; Rahimpour, Azad; Ma, Joel Z.; Collins, Nicholas; Stock, Angus T.; Hafon, Ming-Li; Vega-Ramos, Javier; Mueller, Scott N.; Heath, William R.; Inouye, Michael; Carbone, Francis R.; Gebhardt, Thomas] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Lauzurica, Pilar] Inst Salud Carlos III, Madrid, Spain; [Stefanovic, Tijana; Tscharke, David C.] Australian Natl Univ, Res Sch Biol, Div Biomed Sci & Biochem, Canberra, ACT, Australia; [Inouye, Michael] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia	University of Melbourne; Instituto de Salud Carlos III; Australian National University; University of Melbourne	Carbone, FR (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia.	fcarbone@unimelb.edu.au; gebhardt@unimelb.edu.au	Vega-Ramos, Javier/A-9931-2015; Carbone, Francis/ABF-2141-2020; Mueller, Scott N/B-1918-2012; Mackay, Laura K/HGC-6580-2022; Tscharke, David/C-9133-2009	Vega-Ramos, Javier/0000-0002-9516-3624; Mueller, Scott N/0000-0002-3838-3989; Mackay, Laura K/0000-0002-8496-6632; Tscharke, David/0000-0001-6825-9172; Heath, William/0000-0001-9670-259X; Ma, Joel/0000-0002-0448-6744; lauzurica, pilar/0000-0001-6579-1948; Inouye, Michael/0000-0001-9413-6520; Gebhardt, Thomas/0000-0002-3768-9468	National Health and Medical Research Council of Australia; Australian Research Council	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	We thank W. Weninger (University of Sydney) for Ccr7<SUP>-/-</SUP> mice; N. Hunt (University of Sydney) for Cxcr3<SUP>-/-</SUP> mice; M. Bevan (University of Washington) for Tgfbr2<SUP>f/f</SUP>dLck-Cre OT-I mice; I. Frazer (University of Queensland) for Tcrd<SUP>-/-</SUP> mice; members of the Carbone and Heath laboratories for discussions; and N. McBain and J. Smith for technical assistance. Supported by National Health and Medical Research Council of Australia and Australian Research Council.	Bevan MJ, 2011, EUR J IMMUNOL, V41, P1192, DOI 10.1002/eji.201041377; Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Cuburu N, 2012, J CLIN INVEST, V122, P4606, DOI 10.1172/JCI63287; Debes GF, 2004, J VIROL, V78, P7528, DOI 10.1128/JVI.78.14.7528-7535.2004; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Druey KM, 1996, NATURE, V379, P742, DOI 10.1038/379742a0; El-Asady R, 2005, J EXP MED, V201, P1647, DOI 10.1084/jem.20041044; Gebhardt T, 2013, TRENDS IMMUNOL, V34, P27, DOI 10.1016/j.it.2012.08.008; Gebhardt T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00340; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Hofmann M, 2011, P NATL ACAD SCI USA, V108, P16741, DOI 10.1073/pnas.1107200108; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Jenne CN, 2009, J EXP MED, V206, P2469, DOI 10.1084/jem.20090525; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; KANE CJM, 1990, J CELL PHYSIOL, V144, P144, DOI 10.1002/jcp.1041440119; Kim SK, 1997, J IMMUNOL, V159, P4295; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; KOYAMA S, 1989, J CLIN INVEST, V83, P1768, DOI 10.1172/JCI114080; Kundig TM, 1996, P NATL ACAD SCI USA, V93, P9716, DOI 10.1073/pnas.93.18.9716; Lee YT, 2011, J VIROL, V85, P4085, DOI 10.1128/JVI.02493-10; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Obar JJ, 2010, INT IMMUNOL, V22, P619, DOI 10.1093/intimm/dxq053; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Sharp LL, 2005, NAT IMMUNOL, V6, P73, DOI 10.1038/ni1152; Sheridan BS, 2011, NAT IMMUNOL, V12, P485, DOI 10.1038/ni.2029; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; SPANGRUDE GJ, 1985, J IMMUNOL, V135, P4135; Tang VA, 2010, J REPROD IMMUNOL, V87, P39, DOI 10.1016/j.jri.2010.06.155; TRIPP RA, 1995, J IMMUNOL, V154, P5870; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Waithman J, 2008, J IMMUNOL, V180, P5789, DOI 10.4049/jimmunol.180.9.5789; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869; Wakim LM, 2012, J IMMUNOL, V189, P3462, DOI 10.4049/jimmunol.1201305; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Wang DH, 2004, J IMMUNOL, V172, P214, DOI 10.4049/jimmunol.172.1.214; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Woodland DL, 2009, NAT REV IMMUNOL, V9, P153, DOI 10.1038/nri2496; Yang LL, 2011, BLOOD, V118, P3039, DOI 10.1182/blood-2011-04-349746	53	749	763	6	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2013	14	12					1294	+		10.1038/ni.2744	http://dx.doi.org/10.1038/ni.2744			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	254FG	24162776	Green Submitted			2022-12-18	WOS:000327149400015
J	Lee, Y; Awasthi, A; Yosef, N; Quintana, FJ; Xiao, S; Peters, A; Wu, C; Kleinewietfeld, M; Kunder, S; Hafler, DA; Sobel, RA; Regev, A; Kuchroo, VK				Lee, Youjin; Awasthi, Amit; Yosef, Nir; Quintana, Francisco J.; Xiao, Sheng; Peters, Anneli; Wu, Chuan; Kleinewietfeld, Markus; Kunder, Sharon; Hafler, David A.; Sobel, Raymond A.; Regev, Aviv; Kuchroo, Vijay K.			Induction and molecular signature of pathogenic T(H)17 cells	NATURE IMMUNOLOGY			English	Article							T-CELLS; IFN-GAMMA; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; AUTOIMMUNE ENCEPHALOMYELITIS; INTERLEUKIN-7 RECEPTOR; TRANSCRIPTION FACTOR; DIFFERENTIATION; CYTOKINE; TH1	Interleukin 17 (IL-17)-producing helper T cells (T(H)17 cells) are often present at the sites of tissue inflammation in autoimmune diseases, which has led to the conclusion that T(H)17 cells are main drivers of autoimmune tissue injury. However, not all T(H)17 cells are pathogenic; in fact, T(H)17 cells generated with transforming growth factor-beta 1 (TGF-beta 1) and IL-6 produce IL-17 but do not readily induce autoimmune disease without further exposure to IL-23. Here we found that the production of TGF-beta 3 by developing T(H)17 cells was dependent on IL-23, which together with IL-6 induced very pathogenic T(H)17 cells. Moreover, TGF-beta 3-induced T(H)17 cells were functionally and molecularly distinct from TGF-beta 1-induced T(H)17 cells and had a molecular signature that defined pathogenic effector T(H)17 cells in autoimmune disease.	[Lee, Youjin; Awasthi, Amit; Yosef, Nir; Quintana, Francisco J.; Xiao, Sheng; Peters, Anneli; Wu, Chuan; Kunder, Sharon; Kuchroo, Vijay K.] Harvard Univ, Brigham & Womens Hosp, Ctr Neurol Dis, Sch Med, Boston, MA 02115 USA; [Yosef, Nir; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA USA; [Kleinewietfeld, Markus; Hafler, David A.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Sobel, Raymond A.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Sobel, Raymond A.] Stanford Univ, Palo Alto Vet Adm Hlth Care Syst, Sch Med, Stanford, CA 94305 USA; [Regev, Aviv] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Yale University; Stanford University; Stanford University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Kuchroo, VK (corresponding author), Harvard Univ, Brigham & Womens Hosp, Ctr Neurol Dis, Sch Med, Boston, MA 02115 USA.	aawasthi@thsti.res.in; vkuchroo@rics.bwh.harvard.edu	Quintana, Francisco Javier/AAB-6915-2020; Kleinewietfeld, Markus/AAI-4497-2021; Wu, Chuan/H-6379-2013	Wu, Chuan/0000-0003-2288-353X; Sobel, Raymond/0000-0002-0477-9002; Kleinewietfeld, Markus/0000-0002-2832-3149	US National Institutes of Health [NS030843, NS045937, AI073748, AI045757, AI075285, AI093903, 1P01HG005062-01, DP1-OD003958-01, K01DK090105]; National Multiple Sclerosis Society [RG2571, RG4111A1]; Crohn's and Colitis Foundation of America; Merkin Foundation for Stem Cell Research at the Broad Institute; National Human Genome Research Institute; Howard Hughes Medical Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG005062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K99AI075285, R00AI075285, P01AI045757, P01AI073748, R01AI091568, R01AI093903, P01AI039671, R56AI093903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK090105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS030843, R01NS045937, R37NS030843, R01NS030843] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003958] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Crohn's and Colitis Foundation of America; Merkin Foundation for Stem Cell Research at the Broad Institute; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank R. Bomireddy (University of Arizona) for mice with loxP-flanked Tgfb3 alleles; and D. Kozoriz for cell sorting. Supported by the US National Institutes of Health (NS030843, NS045937, AI073748 and AI045757 to V.K.K.; AI075285 and AI093903 to F.J.Q.; 1P01HG005062-01 and DP1-OD003958-01 to A.R.; and KO1DK090105 to S.X.), the National Multiple Sclerosis Society (RG2571; RG4111A1 to F.J.Q.), the Crohn's and Colitis Foundation of America (A.A.), the Merkin Foundation for Stem Cell Research at the Broad Institute, the National Human Genome Research Institute and the Howard Hughes Medical Institute.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Ferber IA, 1996, J IMMUNOL, V156, P5; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gocke AR, 2007, J IMMUNOL, V178, P1341, DOI 10.4049/jimmunol.178.3.1341; GRAYCAR JL, 1989, MOL ENDOCRINOL, V3, P1977, DOI 10.1210/mend-3-12-1977; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kuchroo VK, 2002, ANNU REV IMMUNOL, V20, P101, DOI 10.1146/annurev.immunol.20.081701.141316; Liu XB, 2010, NAT MED, V16, P191, DOI 10.1038/nm.2077; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; LYONS RM, 1991, MOL ENDOCRINOL, V5, P1887, DOI 10.1210/mend-5-12-1887; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; McQualter JL, 2001, J EXP MED, V194, P873, DOI 10.1084/jem.194.7.873; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; Park IK, 2005, J IMMUNOL, V175, P5666, DOI 10.4049/jimmunol.175.9.5666; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Rahman P, 2008, ARTHRITIS RHEUM-US, V58, P1020, DOI 10.1002/art.23389; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Walline CC, 2011, GENES IMMUN, V12, P1, DOI 10.1038/gene.2010.49; Wildbaum G, 1998, J IMMUNOL, V161, P6368; Yang LT, 2008, GENESIS, V46, P112, DOI 10.1002/dvg.20372; Yang YH, 2009, J EXP MED, V206, P1549, DOI 10.1084/jem.20082584; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	46	749	779	2	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2012	13	10					991	999		10.1038/ni.2416	http://dx.doi.org/10.1038/ni.2416			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	009PV	22961052	Green Submitted, Green Accepted			2022-12-18	WOS:000309038600015
J	Franchi, L; Munoz-Planillo, R; Nunez, G				Franchi, Luigi; Munoz-Planillo, Raul; Nunez, Gabriel			Sensing and reacting to microbes through the inflammasomes	NATURE IMMUNOLOGY			English	Review							NOD-LIKE RECEPTORS; NLRP3 INFLAMMASOME; CASPASE-1 ACTIVATION; LISTERIA-MONOCYTOGENES; HOST-DEFENSE; DIFFERENTIAL REQUIREMENT; NALP3 INFLAMMASOME; CELL-DEATH; INTERLEUKIN-1-BETA RELEASE; NEUTROPHIL RECRUITMENT	Inflammasomes are multiprotein complexes that activate caspase-1, which leads to maturation of the proinflammatory cytokines interleukin 1 beta (IL-1 beta) and IL-18 and the induction of pyroptosis. Members of the Nod-like receptor (NLR) family, including NLRP1, NLRP3 and NLRC4, and the cytosolic receptor AIM2 are critical components of inflammasomes and link microbial and endogenous danger signals to the activation of caspase-1. In response to microbial infection, activation of the inflammasomes contributes to host protection by inducing immune responses that limit microbial invasion, but deregulated activation of inflanimasomes is associated with autoinflammatory syndromes and other pathologies. Thus, understanding inflammasome pathways may provide insight into the mechanisms of host defense against microbes and the development of inflammatory disorders.	[Nunez, Gabriel] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Nunez, G (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.	bclx@umich.edu	Nuñez, Gabriel/A-7160-2014		US National Institutes of Health [R01 AI0647748, R01 Al063331, R01 DK61707]; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063331, R01AI064748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091191, R01DK061707] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank G. Chen for critically reading the manuscript. Supported by the US National Institutes of Health (R01 AI0647748, R01 Al063331 and R01 DK61707) and the Crohn's and Colitis Foundation of America (L.F.).	Akhter A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000361; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Archer KA, 2010, INFECT IMMUN, V78, P2477, DOI 10.1128/IAI.00243-10; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Bauernfeind F, 2011, CELL MOL LIFE SCI, V68, P765, DOI 10.1007/s00018-010-0567-4; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Brereton CF, 2011, J IMMUNOL, V186, P5896, DOI 10.4049/jimmunol.1003789; Brodsky IE, 2010, CELL HOST MICROBE, V7, P376, DOI 10.1016/j.chom.2010.04.009; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chu J, 2009, J LEUKOCYTE BIOL, V86, P1227, DOI 10.1189/jlb.0309164; Crisan TO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018666; D'Osualdo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027396; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Dostert C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006510; Duncan JA, 2009, J IMMUNOL, V182, P6460, DOI 10.4049/jimmunol.0802696; Dunne A, 2010, J IMMUNOL, V185, P1711, DOI 10.4049/jimmunol.1000105; Embry CA, 2011, SCI SIGNAL, V4, P20, DOI 10.1126/scisignal.2001486; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Ferrari D, 1997, J EXP MED, V185, P579, DOI 10.1084/jem.185.3.579; Fink SL, 2007, CELL MICROBIOL, V9, P2562, DOI 10.1111/j.1462-5822.2007.01036.x; Franchi L, 2007, EUR J IMMUNOL, V37, P3030, DOI 10.1002/eji.200737532; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Franchi L, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00008; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Franchi L, 2010, EUR J IMMUNOL, V40, P611, DOI 10.1002/eji.200940180; Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Galle M, 2008, J CELL MOL MED, V12, P1767, DOI 10.1111/j.1582-4934.2007.00190.x; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Hara H, 2008, J IMMUNOL, V180, P7859, DOI 10.4049/jimmunol.180.12.7859; Harder J, 2009, J IMMUNOL, V183, P5823, DOI 10.4049/jimmunol.0900444; Harris J, 2011, J BIOL CHEM, V286, P9587, DOI 10.1074/jbc.M110.202911; He XB, 2010, J IMMUNOL, V184, P5743, DOI 10.4049/jimmunol.0903937; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Hoegen T, 2011, J IMMUNOL, V187, P5440, DOI 10.4049/jimmunol.1100790; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Joly S, 2009, J IMMUNOL, V183, P3578, DOI 10.4049/jimmunol.0901323; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kim S, 2010, EUR J IMMUNOL, V40, P1545, DOI 10.1002/eji.201040425; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Koo IC, 2008, CELL MICROBIOL, V10, P1866, DOI 10.1111/j.1462-5822.2008.01177.x; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lamkanfi M, 2007, J IMMUNOL, V178, P8022, DOI 10.4049/jimmunol.178.12.8022; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; Lightfield KL, 2011, INFECT IMMUN, V79, P1606, DOI 10.1128/IAI.01187-10; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Marina-Garcia N, 2008, J IMMUNOL, V180, P4050, DOI 10.4049/jimmunol.180.6.4050; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; McNeela EA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001191; Meixenberger K, 2010, J IMMUNOL, V184, P922, DOI 10.4049/jimmunol.0901346; Miao EA, 2008, P NATL ACAD SCI USA, V105, P2562, DOI 10.1073/pnas.0712183105; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Miller LS, 2007, J IMMUNOL, V179, P6933, DOI 10.4049/jimmunol.179.10.6933; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Mishra BB, 2010, CELL MICROBIOL, V12, P1046, DOI 10.1111/j.1462-5822.2010.01450.x; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Munoz-Planillo R, 2009, J IMMUNOL, V183, P3942, DOI 10.4049/jimmunol.0900729; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Ng J, 2010, GASTROENTEROLOGY, V139, P542, DOI 10.1053/j.gastro.2010.04.005; Nour AM, 2011, J BIOL CHEM, V286, P17921, DOI 10.1074/jbc.M110.210575; Nour AM, 2009, INFECT IMMUN, V77, P1262, DOI 10.1128/IAI.01032-08; Ozoren N, 2006, J IMMUNOL, V176, P4337, DOI 10.4049/jimmunol.176.7.4337; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Perregaux DG, 1998, AM J PHYSIOL-CELL PH, V275, pC1538, DOI 10.1152/ajpcell.1998.275.6.C1538; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Raupach B, 2006, INFECT IMMUN, V74, P4922, DOI 10.1128/IAI.00417-06; Reimer T, 2010, EUR J IMMUNOL, V40, P764, DOI 10.1002/eji.200939996; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Said-Sadier N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010008; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Sansonetti PJ, 2000, IMMUNITY, V12, P581, DOI 10.1016/S1074-7613(00)80209-5; Sauer JD, 2011, P NATL ACAD SCI USA, V108, P12419, DOI 10.1073/pnas.1019041108; Shimada K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021477; Shio MT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000559; Smith PD, 2011, MUCOSAL IMMUNOL, V4, P31, DOI 10.1038/mi.2010.66; Sun YH, 2007, J BIOL CHEM, V282, P33897, DOI 10.1074/jbc.C700181200; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Suzuki T, 2007, PLOS PATHOG, V3, P1082, DOI 10.1371/journal.ppat.0030111; Terra JK, 2010, J IMMUNOL, V184, P17, DOI 10.4049/jimmunol.0903114; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Toma C, 2010, J IMMUNOL, V184, P5287, DOI 10.4049/jimmunol.0903536; Tomalka J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002379; Tsuchiya K, 2010, J IMMUNOL, V185, P1186, DOI 10.4049/jimmunol.1001058; Tsuji NM, 2004, INT IMMUNOL, V16, P335, DOI 10.1093/intimm/dxh041; Warren SE, 2008, J IMMUNOL, V180, P7558, DOI 10.4049/jimmunol.180.11.7558; Warren SE, 2011, EUR J IMMUNOL, V41, P1934, DOI 10.1002/eji.201041214; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009; Willingham SB, 2009, J IMMUNOL, V183, P2008, DOI 10.4049/jimmunol.0900138; Witzenrath M, 2011, J IMMUNOL, V187, P434, DOI 10.4049/jimmunol.1003143; Wu JH, 2010, J CLIN IMMUNOL, V30, P693, DOI 10.1007/s10875-010-9425-2; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510; Zheng Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002026; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	119	748	784	10	167	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2012	13	4					325	332		10.1038/ni.2231	http://dx.doi.org/10.1038/ni.2231			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	913OH	22430785	Green Accepted			2022-12-18	WOS:000301886800006
J	Volpe, E; Servant, N; Zollinger, R; Bogiatzi, SI; Hupe, P; Barillot, E; Soumelis, V				Volpe, Elisabetta; Servant, Nicolas; Zollinger, Raphael; Bogiatzi, Sofia I.; Hupe, Philippe; Barillot, Emmanuel; Soumelis, Vassili			A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T-H-17 responses	NATURE IMMUNOLOGY			English	Article							T-HELPER-CELLS; TH17 CELLS; AUTOIMMUNE ENCEPHALOMYELITIS; DENDRITIC CELLS; T(H)17 CELLS; TGF-BETA; DIFFERENTIATION; INFLAMMATION; IL-23; IL-17	Interleukin 17 (IL-17)-producing T helper 17 cells (T-H-17 cells) have been described as a T helper cell subset distinct from T helper type 1 (T(H)1) and T(H)2 ells, with specific functions in antimicrobial defense and autoimmunity. The factors driving human T-H-17 differentiation remain controversial. Using a systematic approach combining experimental and computational methods, we show here that transforming growth factor-beta, interleukin 23 (IL-23) and proinflammatory cytokines (IL-1b and IL-6) were all essential for human T-H-17 differentiation. However, individual T-H-17 cell-derived cytokines, such as IL-17, IL-21, IL-22 and IL-6, as well as the global T-H-17 cytokine profile, were differentially modulated by T-H-17-promoting cytokines. Transforming growth factor-beta was critical, and its absence induced a shift from a T-H-17 profile to a T(H)1-like profile. Our results shed new light on the regulation of human T-H-17 differentiation and provide a framework for the global analysis of T helper responses.	[Volpe, Elisabetta; Zollinger, Raphael; Bogiatzi, Sofia I.; Soumelis, Vassili] INSERM, U653, F-75248 Paris, France; [Volpe, Elisabetta; Zollinger, Raphael; Bogiatzi, Sofia I.; Soumelis, Vassili] Inst Curie, Clin Immunol Lab, F-75248 Paris, France; [Servant, Nicolas; Hupe, Philippe; Barillot, Emmanuel] INSERM, U900, F-75248 Paris, France; [Servant, Nicolas; Hupe, Philippe; Barillot, Emmanuel] ParisTech, Ecole Mines Paris, F-77300 Fontainebleau, France; [Hupe, Philippe] CNRS, UMR144, F-75248 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Universite Paris Cite	Soumelis, V (corresponding author), INSERM, U653, F-75248 Paris, France.	vassili.soumelis@curie.net	Volpe, Elisabetta/J-8589-2016; Hupe, Philippe/T-8793-2017	Hupe, Philippe/0000-0001-8468-3424; Servant, Nicolas/0000-0003-1678-7410; BARILLOT, Emmanuel/0000-0003-2724-2002				Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Auja SJ, 2007, SEMIN IMMUNOL, V19, P377, DOI 10.1016/j.smim.2007.10.009; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen Z, 2008, IMMUNOL RES, V41, P87, DOI 10.1007/s12026-007-8014-9; Chen Z, 2007, ARTHRITIS RHEUM-US, V56, P2936, DOI 10.1002/art.22866; Evans HG, 2007, P NATL ACAD SCI USA, V104, P17034, DOI 10.1073/pnas.0708426104; Gorelik L, 2002, J EXP MED, V195, P1499, DOI 10.1084/jem.20012076; Gurney AL, 2004, INT IMMUNOPHARMACOL, V4, P669, DOI 10.1016/j.intimp.2004.01.016; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Ivanov II, 2007, SEMIN IMMUNOL, V19, P409, DOI 10.1016/j.smim.2007.10.011; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jankovic D, 2007, NAT IMMUNOL, V8, P1281, DOI 10.1038/ni1207-1281; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kreymborg K, 2007, J IMMUNOL, V179, P8098, DOI 10.4049/jimmunol.179.12.8098; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Laurence A, 2007, NAT IMMUNOL, V8, P903, DOI 10.1038/ni0907-903; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Leonard WJ, 2005, NAT REV IMMUNOL, V5, P688, DOI 10.1038/nri1688; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lin JT, 2005, J IMMUNOL, V174, P5950, DOI 10.4049/jimmunol.174.10.5950; MANEL N, IN PRESS NAT IMMUNOL; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Trinchieri G, 2007, J EXP MED, V204, P239, DOI 10.1084/jem.20070104; van Beelen AJ, 2007, IMMUNITY, V27, P660, DOI 10.1016/j.immuni.2007.08.013; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Xie MH, 2000, J BIOL CHEM, V275, P31335, DOI 10.1074/jbc.M005304200; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zaba LC, 2007, J EXP MED, V204, P3183, DOI 10.1084/jem.20071094; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	48	745	790	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2008	9	6					650	657		10.1038/ni.1613	http://dx.doi.org/10.1038/ni.1613			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	303VB	18454150				2022-12-18	WOS:000256067900015
J	Kawai, T; Sato, S; Ishii, KJ; Coban, C; Hemmi, H; Yamamoto, M; Terai, K; Matsuda, M; Inoue, J; Uematsu, S; Takeuchi, O; Akira, S				Kawai, T; Sato, S; Ishii, KJ; Coban, C; Hemmi, H; Yamamoto, M; Terai, K; Matsuda, M; Inoue, J; Uematsu, S; Takeuchi, O; Akira, S			Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; DOMAIN-CONTAINING ADAPTER; IFN-REGULATORY FACTOR-3; TANK-BINDING KINASE-1; DOUBLE-STRANDED-RNA; SIGNALING PATHWAY; CUTTING EDGE; TRANSCRIPTION FACTORS; VIRUS-INFECTION; DENDRITIC CELLS	Toll-like receptors (TLRs) are involved in the recognition of microbial pathogens. A subset of TLRs, TLR7, TLR8 and TLR9, induces antiviral responses by producing interferon-alpha (IFN-alpha). Production of IFN-alpha is dependent on the Toll-interleukin-1 receptor domain-containing adaptor MyD88. Here we show that MyD88 formed a complex with the transcription factor IRF7 but not with IRF3. The death domain of MyD88 interacted with an inhibitory domain of IRF7, and this interaction resulted in activation of the IFN-alpha-dependent promoters. Furthermore, the adaptor molecule TRAF6 also bound and activated IRF7. Ubiquitin ligase activity of TRAF6 was required for IRF7 activation. These results indicate that TLR-mediated IFN-alpha induction requires the formation of a complex consisting of MyD88, TRAF6 and IRF7 as well as TRAF6-dependent ubiquitination.	Japan Sci & Technol Agcy, Akira Innate Immun Program, ERATO, Suita, Osaka 5650871, Japan; Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; Osaka Univ, Microbial Dis Res Inst, Dept Tumor Virol, Suita, Osaka 5650871, Japan; Univ Tokyo, Inst Med Sci, Dept Canc Biol, Div Cellular & Mol Biol,Minato Ku, Tokyo 1088639, Japan	Japan Science & Technology Agency (JST); Osaka University; Osaka University; University of Tokyo	Akira, S (corresponding author), Japan Sci & Technol Agcy, Akira Innate Immun Program, ERATO, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp	COBAN, Cevayir/P-1928-2019; Akira, Shizuo/C-3134-2009; Coban, Cevayir/B-2129-2012; Takeuchi, Osamu/D-6007-2011; Takeuchi, Osamu/AAG-9359-2019; 寺井, 健太/AFQ-7663-2022; Ishii, Ken J/B-1685-2012	COBAN, Cevayir/0000-0002-4467-7799; Takeuchi, Osamu/0000-0002-1260-6232; 寺井, 健太/0000-0001-7638-3720; Ishii, Ken J/0000-0002-6728-3872; Matsuda, Michiyuki/0000-0002-5876-9969; Kawai, Taro/0000-0001-7510-4662; Sato, Shintaro/0000-0001-5156-3354				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hemmi H, 2003, J IMMUNOL, V170, P3059, DOI 10.4049/jimmunol.170.6.3059; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Hoshino K, 2002, INT IMMUNOL, V14, P1225, DOI 10.1093/intimm/dxf089; Hoshino K, 1999, J IMMUNOL, V162, P3749; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Izaguirre A, 2003, J LEUKOCYTE BIOL, V74, P1125, DOI 10.1189/jlb.0603255; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kerkmann M, 2003, J IMMUNOL, V170, P4465, DOI 10.4049/jimmunol.170.9.4465; Lin RT, 2000, J BIOL CHEM, V275, P34320, DOI 10.1074/jbc.M002814200; Marie I, 2000, MOL CELL BIOL, V20, P8803, DOI 10.1128/MCB.20.23.8803-8814.2000; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Tagawa Y, 1997, J IMMUNOL, V159, P1418; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Verthelyi D, 2001, J IMMUNOL, V166, P2372, DOI 10.4049/jimmunol.166.4.2372; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yeow WS, 2000, J BIOL CHEM, V275, P6313, DOI 10.1074/jbc.275.9.6313; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	50	745	789	1	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2004	5	10					1061	1068		10.1038/ni1118	http://dx.doi.org/10.1038/ni1118			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	857YO	15361868				2022-12-18	WOS:000224156600030
J	Trifari, S; Kaplan, CD; Tran, EH; Crellin, NK; Spits, H				Trifari, Sara; Kaplan, Charles D.; Tran, Elise H.; Crellin, Natasha K.; Spits, Hergen			Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T-H-17, T(H)1 and T(H)2 cells	NATURE IMMUNOLOGY			English	Article							ROR-GAMMA-T; GROWTH-FACTOR-BETA; ARYL-HYDROCARBON RECEPTOR; TISSUE-INDUCER CELLS; SKIN INFLAMMATION; LYMPHOCYTE TRAFFICKING; ATOPIC-DERMATITIS; NKP46(+) CELLS; PSORIATIC SKIN; MOUSE MODEL	Interleukin 22 (IL-22) is a member of the IL-10 cytokine family that is involved in inflammatory and wound healing processes. Originally considered a T helper type 1 (T(H)1)-associated cytokine, IL-22 has since been shown to be produced mainly by IL-17-producing helper T cells (T-H-17 cells). Here we describe a previously uncharacterized IL-22-producing human helper T cell population that coexpressed the chemokine receptor CCR6 and the skin-homing receptors CCR4 and CCR10. These cells were distinct from both T-H-17 cells and T(H)1 cells. Downregulation of either the aryl hydrocarbon receptor (AHR) or the transcription factor RORC by RNA-mediated interference affected IL-22 production, whereas IL-17 production was affected only by downregulation of RORC by RNA-mediated interference. AHR agonists substantially altered the balance of IL-22-versus IL-17-producing cells. This subset of IL-22-producing cells may be important in skin homeostasis and pathology.	[Trifari, Sara; Kaplan, Charles D.; Tran, Elise H.; Crellin, Natasha K.; Spits, Hergen] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA	Roche Holding; Genentech	Spits, H (corresponding author), Univ Amsterdam, Acad Med Ctr, NL-1012 WX Amsterdam, Netherlands.	hergen.spits@amc.uva.nl	Spits, Hergen/N-2581-2019	Spits, Hergen/0000-0003-3269-8338				Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Akdis M, 1997, J IMMUNOL, V159, P4611; Boniface K, 2007, CLIN EXP IMMUNOL, V150, P407, DOI 10.1111/j.1365-2249.2007.03511.x; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chung YS, 2006, CELL RES, V16, P902, DOI 10.1038/sj.cr.7310106; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Dumoutier L, 2002, EUR CYTOKINE NETW, V13, P5; Dumoutier L, 2000, P NATL ACAD SCI USA, V97, P10144, DOI 10.1073/pnas.170291697; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Goto M, 2009, CELL IMMUNOL, V254, P81, DOI 10.1016/j.cellimm.2008.10.002; Gurney AL, 2004, INT IMMUNOPHARMACOL, V4, P669, DOI 10.1016/j.intimp.2004.01.016; Homey B, 2002, NAT MED, V8, P157, DOI 10.1038/nm0202-157; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kagami S, 2008, EUR J IMMUNOL, V38, P647, DOI 10.1002/eji.200737685; Kreymborg K, 2007, J IMMUNOL, V179, P8098, DOI 10.4049/jimmunol.179.12.8098; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Nograles KE, 2009, J ALLERGY CLIN IMMUN, V123, P1244, DOI 10.1016/j.jaci.2009.03.041; O'Garra A, 2008, NAT IMMUNOL, V9, P588, DOI 10.1038/ni0608-588; Okey Allan B, 2005, Toxicol Appl Pharmacol, V207, P43, DOI 10.1016/j.taap.2004.12.028; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Pene J, 2008, J IMMUNOL, V180, P7423, DOI 10.4049/jimmunol.180.11.7423; Piskin G, 2006, J IMMUNOL, V176, P1908, DOI 10.4049/jimmunol.176.3.1908; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Reiss Y, 2001, J EXP MED, V194, P1541, DOI 10.1084/jem.194.10.1541; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Soler D, 2003, BLOOD, V101, P1677, DOI 10.1182/blood-2002-07-2348; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wincent E, 2009, J BIOL CHEM, V284, P2690, DOI 10.1074/jbc.M808321200; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2005, GENES IMMUN, V6, P8, DOI 10.1038/sj.gene.6364144; Wolk K, 2006, CYTOKINE GROWTH F R, V17, P367, DOI 10.1016/j.cytogfr.2006.09.001; Yang GH, 2008, PRESENCE-TELEOP VIRT, V17, P29, DOI 10.1162/pres.17.1.29; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zheng T, 2009, J INVEST DERMATOL, V129, P742, DOI 10.1038/jid.2008.295; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	49	743	810	0	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2009	10	8					864	U73		10.1038/ni.1770	http://dx.doi.org/10.1038/ni.1770			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	472OM	19578368				2022-12-18	WOS:000268141400015
J	Stumhofer, JS; Laurence, A; Wilson, EH; Huang, E; Tato, CM; Johnson, LM; Villarino, AV; Huang, QL; Yoshimura, A; Sehy, D; Saris, CJM; O'Shea, JJ; Hennighausen, L; Ernst, M; Hunter, CA				Stumhofer, Jason S.; Laurence, Arian; Wilson, Emma H.; Huang, Elaine; Tato, Cristina M.; Johnson, Leanne M.; Villarino, Alejandro V.; Huang, Qiulong; Yoshimura, Akihiko; Sehy, David; Saris, Christiaan J. M.; O'Shea, John J.; Hennighausen, Lothar; Ernst, Matthias; Hunter, Christopher A.			Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system	NATURE IMMUNOLOGY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; I CYTOKINE RECEPTOR; TOXOPLASMIC ENCEPHALITIS; KLEBSIELLA-PNEUMONIAE; JOINT INFLAMMATION; IL-2 PRODUCTION; DEFICIENT MICE; CUTTING EDGE; BONE EROSION; IFN-GAMMA	Studies have focused on the events that influence the development of interleukin 17 (IL-17)-producing T helper cells (T-H-17 cells) associated with autoimmunity, such as experimental autoimmune encephalitis, but relatively little is known about the cytokines that antagonize T-H-17 cell effector responses. Here we show that IL-27 receptor-deficient mice chronically infected with Toxoplasma gondii developed severe neuroinflammation that was CD4(+) T cell dependent and was associated with a prominent IL-17 response. In vitro, treatment of naive primary T cells with IL-27 suppressed the development T-H-17 cells induced by IL-6 and transforming growth factor-beta, which was dependent on the intracellular signaling molecule STAT1 but was independent of inhibition of IL-6 signaling mediated by the suppressor protein SOCS3. Thus IL-27, a potent inhibitor of T-H-17 cell development, may be a useful target for treating inflammatory diseases mediated by these cells.	Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; eBiosci, New Technol Dept, San Diego, CA 92121 USA; Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Fukuoka 8128582, Japan; Amgen Corp, Dept Inflammat Res, Newbury Pk, CA 91320 USA; NIDDKD, Lab Genet & Physiol, NIH, Bethesda, MD 20892 USA; Ludwig Inst Canc Res, Melbourne, Vic 3050, Australia	University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Kyushu University; Amgen; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Ludwig Institute for Cancer Research	Hunter, CA (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA.	chunter@vet.upenn.edu	Yoshimura, Akihiko/K-5515-2013; Laurence, Arian/A-8770-2009; Villarino, Alejandro/AAE-3517-2020; Laurence, Arian/H-5534-2019; Hunter, Christopher/H-1970-2011; Ernst, Matthias/D-5111-2012	Laurence, Arian/0000-0003-0942-8292; Villarino, Alejandro/0000-0001-8068-2176; Laurence, Arian/0000-0003-0942-8292; Ernst, Matthias/0000-0002-6399-1177; Hennighausen, Lothar/0000-0001-8319-9841; Tato, Cristina M./0000-0002-0614-756X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041158, T32AI055428, R01AI042334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK061000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072298] Funding Source: NIH RePORTER; NIAID NIH HHS [AI42334, AI41158, 1-T32-AI-055428, R01 AI041158] Funding Source: Medline; NINDS NIH HHS [R01 NS072298] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Artis D, 2004, J IMMUNOL, V173, P5626, DOI 10.4049/jimmunol.173.9.5626; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Bettelli E, 2005, J EXP MED, V201, P169, DOI 10.1084/jem.20042279; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; CHEN, 2006, J CLIN INVEST, V116, P1317; Chen Q, 2000, NATURE, V407, P916, DOI 10.1038/35038103; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Cho ML, 2006, J IMMUNOL, V176, P5652, DOI 10.4049/jimmunol.176.9.5652; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Egen JG, 2002, NAT IMMUNOL, V3, P611, DOI 10.1038/ni0702-611; GAZZINELLI R, 1992, J IMMUNOL, V149, P175; Hamano S, 2003, IMMUNITY, V19, P657, DOI 10.1016/S1074-7613(03)00298-X; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hashimoto K, 2005, J ALLERGY CLIN IMMUN, V116, P550, DOI 10.1016/j.jaci.2005.03.051; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Hellings PW, 2003, AM J RESP CELL MOL, V28, P42, DOI 10.1165/rcmb.4832; Hibbert L, 2003, J INTERF CYTOK RES, V23, P513, DOI 10.1089/10799900360708632; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; ISRAELSKI DM, 1989, J IMMUNOL, V142, P954; Kamiya S, 2004, J IMMUNOL, V173, P3871, DOI 10.4049/jimmunol.173.6.3871; Kelly MN, 2005, INFECT IMMUN, V73, P617, DOI 10.1128/IAI.73.1.617-621.2005; Koenders MI, 2005, AM J PATHOL, V167, P141, DOI 10.1016/S0002-9440(10)62961-6; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee CK, 2000, J IMMUNOL, V164, P1286, DOI 10.4049/jimmunol.164.3.1286; Li JF, 2005, J NEUROL SCI, V232, P3, DOI 10.1016/j.jns.2004.12.013; Lieberman LA, 2004, J IMMUNOL, V172, P457, DOI 10.4049/jimmunol.172.1.457; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Lucas S, 2003, P NATL ACAD SCI USA, V100, P15047, DOI 10.1073/pnas.2536517100; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nguyen KB, 2000, NAT IMMUNOL, V1, P70, DOI 10.1038/76940; Owaki T, 2006, J IMMUNOL, V176, P2773, DOI 10.4049/jimmunol.176.5.2773; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Rosas LE, 2006, AM J PATHOL, V168, P158, DOI 10.2353/ajpath.2006.050013; SHARMA SD, 1983, J IMMUNOL, V131, P977; Sonobe Y, 2005, BRAIN RES, V1040, P202, DOI 10.1016/j.brainres.2005.01.100; Sprecher CA, 1998, BIOCHEM BIOPH RES CO, V246, P82, DOI 10.1006/bbrc.1998.8576; SUZUKI Y, 1989, J IMMUNOL, V143, P2045; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Villarino AV, 2006, J IMMUNOL, V176, P237, DOI 10.4049/jimmunol.176.1.237; Villarino AV, 2004, ARTHRITIS RES THER, V6, P225, DOI 10.1186/ar1227; Villarino AV, 2005, J IMMUNOL, V174, P7684, DOI 10.4049/jimmunol.174.12.7684; Villegas EN, 2000, INFECT IMMUN, V68, P2837, DOI 10.1128/IAI.68.5.2837-2844.2000; Watford WT, 2004, IMMUNOL REV, V202, P139, DOI 10.1111/j.0105-2896.2004.00211.x; Wilson EH, 2005, J NEUROIMMUNOL, V165, P63, DOI 10.1016/j.jneuroim.2005.04.018; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Yoshida H, 2001, IMMUNITY, V15, P569, DOI 10.1016/S1074-7613(01)00206-0	60	730	804	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2006	7	9					937	945		10.1038/ni1376	http://dx.doi.org/10.1038/ni1376			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	076FL	16906166				2022-12-18	WOS:000239942300012
J	Sonnenberg, GF; Fouser, LA; Artis, D				Sonnenberg, Gregory F.; Fouser, Lynette A.; Artis, David			Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22	NATURE IMMUNOLOGY			English	Review							NATURAL-KILLER-CELLS; HYPER-IGE SYNDROME; INNATE LYMPHOID-CELLS; ROR-GAMMA-T; CHRONIC MUCOCUTANEOUS CANDIDIASIS; PROINFLAMMATORY GENE-EXPRESSION; TH17 CYTOKINE INTERLEUKIN-22; ACTIVE CROHNS-DISEASE; INDUCER CELLS; INDUCIBLE FACTOR	The maintenance of barrier function at exposed surfaces of the mammalian body is essential for limiting exposure to environmental stimuli, preventing systemic dissemination of commensal and pathogenic microbes and retaining normal homeostasis of the entire body. Indeed, dysregulated barrier function is associated with many infectious and inflammatory diseases, including psoriasis, influenza, inflammatory bowel disease and human immunodeficiency virus, which collectively afflict millions of people worldwide. Studies have shown that interleukin 22 (IL-22) is expressed at barrier surfaces and that its expression is dysregulated in certain human diseases, which suggests a critical role in the maintenance of normal barrier homeostasis. Consistent with that, studies of mouse model systems have identified a critical role for signaling by IL-22 through its receptor (IL-22R) in the promotion of antimicrobial immunity, inflammation and tissue repair at barrier surfaces. In this review we will discuss how the expression of IL-22 and IL-22R is regulated, the functions of the IL-22-IL-22R pathway in regulating immunity, inflammation and tissue homeostasis, and the therapeutic potential of targeting this pathway in human disease.	[Sonnenberg, Gregory F.; Artis, David] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Sonnenberg, Gregory F.; Artis, David] Univ Penn, Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Sonnenberg, Gregory F.; Artis, David] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Fouser, Lynette A.] Pfizer Worldwide Res & Dev, Biotherapeut Res & Dev, Inflammat & Immunol Res Unit, Cambridge, MA USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pfizer	Artis, D (corresponding author), Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	dartis@mail.med.upenn.edu		Artis, David/0000-0002-1753-4100	US National Institutes of Health [AI61570, AI74878, AI087990, AI083480, T32AI007532-08]; Burroughs Wellcome Fund; University of Pennsylvania (Veterinary Center of Infectious Diseases); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074878, R21AI083480, T32AI007532, R21AI087990, R01AI061570] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); University of Pennsylvania (Veterinary Center of Infectious Diseases); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all members of the Artis laboratory, in particular L. A. Monticelli, M. G. Nair and S. A. Saenz, for discussions and critical reading of the manuscript. Supported by the US National Institutes of Health (AI61570, AI74878, AI087990 and AI083480 to D. A., and T32AI007532-08 to G. F. S.), the Burroughs Wellcome Fund (D. A.) and the University of Pennsylvania (Veterinary Center of Infectious Diseases, Penn Genome Frontiers Institute and University Research Fund to D. A.).	Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Boniface K, 2007, CLIN EXP IMMUNOL, V150, P407, DOI 10.1111/j.1365-2249.2007.03511.x; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Bonnet F, 2007, HIV MED, V8, P547, DOI 10.1111/j.1468-1293.2007.00508.x; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Ciric B, 2009, J IMMUNOL, V182, P5296, DOI 10.4049/jimmunol.0900036; Colin EM, 2010, ARTHRITIS RHEUM-US, V62, P132, DOI 10.1002/art.25043; Crellin NK, 2010, IMMUNITY, V33, P752, DOI 10.1016/j.immuni.2010.10.012; Crellin NK, 2010, J EXP MED, V207, P281, DOI 10.1084/jem.20091509; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; de Jong A, 2010, NAT IMMUNOL, V11, P1102, DOI 10.1038/ni.1956; De Luca A, 2010, MUCOSAL IMMUNOL, V3, P361, DOI 10.1038/mi.2010.22; Doisne JM, 2011, J IMMUNOL, V186, P662, DOI 10.4049/jimmunol.1002725; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Dumoutier L, 2000, P NATL ACAD SCI USA, V97, P10144, DOI 10.1073/pnas.170291697; Dumoutier L, 2000, J IMMUNOL, V164, P1814, DOI 10.4049/jimmunol.164.4.1814; Dumoutier L, 2001, J IMMUNOL, V166, P7090, DOI 10.4049/jimmunol.166.12.7090; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eisenring M, 2010, NAT IMMUNOL, V11, P1030, DOI 10.1038/ni.1947; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Fujita H, 2009, P NATL ACAD SCI USA, V106, P21795, DOI 10.1073/pnas.0911472106; Geboes L, 2009, ARTHRITIS RHEUM-US, V60, P390, DOI 10.1002/art.24220; Goto M, 2009, CELL IMMUNOL, V254, P81, DOI 10.1016/j.cellimm.2008.10.002; Guilloteau K, 2010, J IMMUNOL, V184, P5263, DOI 10.4049/jimmunol.0902464; Guo HL, 2010, J VIROL, V84, P7750, DOI 10.1128/JVI.00187-10; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Hughes T, 2010, IMMUNITY, V32, P803, DOI 10.1016/j.immuni.2010.06.007; Hughes T, 2009, BLOOD, V113, P4008, DOI 10.1182/blood-2008-12-192443; Ikeuchi H, 2005, ARTHRITIS RHEUM-US, V52, P1037, DOI 10.1002/art.20965; Kauffman CL, 2004, J INVEST DERMATOL, V123, P1037, DOI 10.1111/j.0022-202X.2004.23448.x; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; Kotenko SV, 2001, J IMMUNOL, V166, P7096, DOI 10.4049/jimmunol.166.12.7096; Kotenko SV, 2001, J BIOL CHEM, V276, P2725, DOI 10.1074/jbc.M007837200; Kreymborg K, 2007, J IMMUNOL, V179, P8098, DOI 10.4049/jimmunol.179.12.8098; Kuang DM, 2010, J IMMUNOL, V185, P1544, DOI 10.4049/jimmunol.0904094; Lejeune D, 2002, J BIOL CHEM, V277, P33676, DOI 10.1074/jbc.M204204200; Lewden C, 2008, JAIDS-J ACQ IMM DEF, V48, P590, DOI 10.1097/QAI.0b013e31817efb54; Li J, 2004, INT IMMUNOPHARMACOL, V4, P693, DOI 10.1016/j.intimp.2004.01.010; Liang SC, 2007, J IMMUNOL, V179, P7791, DOI 10.4049/jimmunol.179.11.7791; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Liang SC, 2010, J IMMUNOL, V185, P5531, DOI 10.4049/jimmunol.0904091; Liu H, 2007, J HUAZHONG U SCI-MED, V27, P605, DOI 10.1007/s11596-007-0533-z; Logsdon NJ, 2002, J INTERF CYTOK RES, V22, P1099, DOI 10.1089/10799900260442520; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; Marchesi F, 2009, MUCOSAL IMMUNOL, V2, P486, DOI 10.1038/mi.2009.113; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Meier D, 2007, IMMUNITY, V26, P643, DOI 10.1016/j.immuni.2007.04.009; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; Ness-Schwickerath KJ, 2010, J IMMUNOL, V184, P7268, DOI 10.4049/jimmunol.1000600; Nograles KE, 2009, J ALLERGY CLIN IMMUN, V123, P1244, DOI 10.1016/j.jaci.2009.03.041; Pan HN, 2004, CELL MOL IMMUNOL, V1, P43; Pene J, 2008, J IMMUNOL, V180, P7423, DOI 10.4049/jimmunol.180.11.7423; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Pitta MGR, 2009, J CLIN INVEST, V119, P2379, DOI 10.1172/JCI38813; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; Res PCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014108; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Satoh-Takayama N, 2010, J EXP MED, V207, P273, DOI 10.1084/jem.20092029; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Schmechel S, 2008, INFLAMM BOWEL DIS, V14, P204, DOI 10.1002/ibd.20315; Schmutz S, 2009, J IMMUNOL, V183, P2217, DOI 10.4049/jimmunol.0802911; Sekikawa A, 2010, LAB INVEST, V90, P496, DOI 10.1038/labinvest.2009.147; Shen H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/art.24568; Simonian PL, 2010, J EXP MED, V207, P2239, DOI 10.1084/jem.20100061; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Tachiiri A, 2003, GENES IMMUN, V4, P153, DOI 10.1038/sj.gene.6363934; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Volpe E, 2009, BLOOD, V114, P3610, DOI 10.1182/blood-2009-05-223768; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Wahl C, 2009, J IMMUNOL, V182, P4521, DOI 10.4049/jimmunol.0802810; WALLACE JM, 1993, AM REV RESPIR DIS, V148, P1523, DOI 10.1164/ajrccm/148.6_Pt_1.1523; Wilson MS, 2010, J IMMUNOL, V184, P4378, DOI 10.4049/jimmunol.0903416; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2007, J IMMUNOL, V178, P5973, DOI 10.4049/jimmunol.178.9.5973; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Xie MH, 2000, J BIOL CHEM, V275, P31335, DOI 10.1074/jbc.M005304200; Xu WF, 2001, P NATL ACAD SCI USA, V98, P9511, DOI 10.1073/pnas.171303198; Yamamoto-Furusho JK, 2010, INFLAMM BOWEL DIS, V16, P1823, DOI 10.1002/ibd.21235; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	110	725	760	3	100	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2011	12	5					383	390		10.1038/ni.2025	http://dx.doi.org/10.1038/ni.2025			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	752CT	21502992				2022-12-18	WOS:000289666600008
J	Carroll, MC				Carroll, MC			The complement system in regulation of adaptive immunity	NATURE IMMUNOLOGY			English	Review							FOLLICULAR DENDRITIC CELLS; CLASSICAL PATHWAY COMPLEMENT; ANAPHYLATOXIN C3A RECEPTOR; INFLUENZA-VIRUS INFECTION; TH2 EFFECTOR FUNCTIONS; HERPES-SIMPLEX-VIRUS; TOLL-LIKE RECEPTORS; INNATE IMMUNITY; NATURAL ANTIBODY; HUMORAL RESPONSE	The serum complement system, which represents a chief component of innate immunity, not only participates in inflammation but also acts to enhance the adaptive immune response. Specific activation of complement via innate recognition proteins or secreted antibody releases cleavage products that interact with a wide range of cell surface receptors found on myeloid, lymphoid and stromal cells. This intricate interaction among complement activation products and cell surface receptors provides a basis for the regulation of both B and T cell responses. This review highlights fundamental events, explaining how complement links innate and adaptive immunity as well as describing more recent studies on how this large family of proteins functions locally in peripheral lymph nodes to enhance B and T cell responses.	Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Carroll, MC (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res, 800 Huntington Ave, Boston, MA 02115 USA.	carroll@cbr.med.harvard.edu			NIAID NIH HHS [AI36389-08, AI53570-02, AI52343-03, AI39246-09] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI052343, R01AI053570, R01AI039246, R01AI036389] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahearn JM, 1996, IMMUNITY, V4, P251, DOI 10.1016/S1074-7613(00)80433-1; Ames RS, 1996, J BIOL CHEM, V271, P20231, DOI 10.1074/jbc.271.34.20231; ARNOLD LW, 1994, J EXP MED, V179, P1585, DOI 10.1084/jem.179.5.1585; Barrington RA, 2002, J EXP MED, V196, P1189, DOI 10.1084/jem.20021110; Barton GM, 2002, CURR TOP MICROBIOL, V270, P81; Baumgarth N, 1999, P NATL ACAD SCI USA, V96, P2250, DOI 10.1073/pnas.96.5.2250; Baumgarth N, 2000, J EXP MED, V192, P271, DOI 10.1084/jem.192.2.271; Boes M, 1998, J EXP MED, V188, P2381, DOI 10.1084/jem.188.12.2381; Bordet J., 1901, ANN I PASTEUR PARIS, V15, P289; Campos RA, 2003, J EXP MED, V198, P1785, DOI 10.1084/jem.20021562; Carroll MC, 2004, MOL IMMUNOL, V41, P141, DOI 10.1016/j.molimm.2004.03.017; CARSETTI R, 1995, J EXP MED, V181, P2129, DOI 10.1084/jem.181.6.2129; CARTER RH, 1992, SCIENCE, V256, P105, DOI 10.1126/science.1373518; COLTEN HR, 1986, BIOCHEM SOC SYMP, P37; CUTLER A, 2002, J EXP MED, V187, P1789; Cyster JG, 2000, IMMUNOL REV, V176, P181; Da Costa XJ, 1999, P NATL ACAD SCI USA, V96, P12708, DOI 10.1073/pnas.96.22.12708; DAHA MR, 1976, J IMMUNOL, V117, P630; Drouin SM, 2002, J IMMUNOL, V169, P5926, DOI 10.4049/jimmunol.169.10.5926; Drouin SM, 2001, J IMMUNOL, V167, P4141, DOI 10.4049/jimmunol.167.8.4141; Epstein J, 1996, CURR OPIN IMMUNOL, V8, P29, DOI 10.1016/S0952-7915(96)80101-4; Fang YF, 1998, J IMMUNOL, V160, P5273; Fearon DT, 2000, ANNU REV IMMUNOL, V18, P393, DOI 10.1146/annurev.immunol.18.1.393; FEARON DT, 1975, J IMMUNOL, V115, P1357; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; FEARON DT, 1995, ANNU REV IMMUNOL, V13, P127, DOI 10.1146/annurev.immunol.13.1.127; Fischer MB, 1998, J IMMUNOL, V160, P2619; Fischer MB, 1996, J IMMUNOL, V157, P549; Fleming SD, 2002, J IMMUNOL, V169, P2126, DOI 10.4049/jimmunol.169.4.2126; Fujita T, 2004, IMMUNOL REV, V198, P185, DOI 10.1111/j.0105-2896.2004.0123.x; Gadieva M, 2002, J IMMUNOL, V169, P5489, DOI 10.4049/jimmunol.169.10.5489; GERARD NP, 1991, NATURE, V349, P614, DOI 10.1038/349614a0; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; GUSTAVSSON S, 1995, J IMMUNOL, V154, P6524; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; HERZENBERG LA, 1993, IMMUNOL TODAY, V14, P79, DOI 10.1016/0167-5699(93)90063-Q; Hopken UE, 1996, NATURE, V383, P86, DOI 10.1038/383086a0; HOSEA SW, 1980, J INFECT DIS, V142, P903, DOI 10.1093/infdis/142.6.903; ISENMAN DE, 1983, ANN NY ACAD SCI, V421, P277, DOI 10.1111/j.1749-6632.1983.tb18115.x; Janeway CA, 1999, CURR BIOL, V9, pR879, DOI 10.1016/S0960-9822(00)80073-1; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Karlsson MCI, 2003, J EXP MED, V198, P333, DOI 10.1084/jem.20030684; Karp CL, 1996, SCIENCE, V273, P228, DOI 10.1126/science.273.5272.228; Karp CL, 2000, NAT IMMUNOL, V1, P221, DOI 10.1038/79759; Kemper C, 2003, NATURE, V421, P388, DOI 10.1038/nature01315; Kildsgaard J, 2000, J IMMUNOL, V165, P5406, DOI 10.4049/jimmunol.165.10.5406; Kopf M, 2002, NAT MED, V8, P373, DOI 10.1038/nm0402-373; Korb LC, 1997, J IMMUNOL, V158, P4525; KURTZ CB, 1990, J IMMUNOL, V144, P3581; LACHMANN PJ, 1984, SPRINGER SEMIN IMMUN, V7, P143, DOI 10.1007/BF01893018; LAW SK, 1980, P NATL ACAD SCI-BIOL, V77, P7194, DOI 10.1073/pnas.77.12.7194; LISZEWSKI MK, 1991, ANNU REV IMMUNOL, V9, P431, DOI 10.1146/annurev.iy.09.040191.002243; Liu YJ, 1996, INT REV CYTOL, V166, P139, DOI 10.1016/S0074-7696(08)62508-5; MATSUMOTO AK, 1991, J EXP MED, V173, P55, DOI 10.1084/jem.173.1.55; Matsushita M, 2002, IMMUNOBIOLOGY, V205, P490, DOI 10.1078/0171-2985-00149; MOLINA H, 1990, J IMMUNOL, V145, P2974; Molina H, 1996, P NATL ACAD SCI USA, V93, P3357, DOI 10.1073/pnas.93.8.3357; MOLINA H, 1994, J IMMUNOL, V153, P789; NORVELL A, 1995, J IMMUNOL, V154, P4404; NUSSENZWEIG V, 1971, PROGR IMMUNOLOGY, V59, P73; Ochsenbein AF, 1999, J EXP MED, V190, P1165, DOI 10.1084/jem.190.8.1165; PAPAMICHAIL M, 1975, SCAND J IMMUNOL, V4, P343, DOI 10.1111/j.1365-3083.1975.tb02635.x; Pasare C, 2003, CURR OPIN IMMUNOL, V15, P677, DOI 10.1016/j.coi.2003.09.002; PEPYS MB, 1976, TRANSPLANT REV-DENMA, V32, P93; Petry F, 2001, J IMMUNOL, V167, P4033, DOI 10.4049/jimmunol.167.7.4033; Pozdnyakova O, 2003, J IMMUNOL, V170, P84, DOI 10.4049/jimmunol.170.1.84; REID KBM, 1981, ANNU REV BIOCHEM, V50, P433, DOI 10.1146/annurev.bi.50.070181.002245; REID KBM, 1994, SPRINGER SEMIN IMMUN, V15, P307, DOI 10.1007/BF01837363; Reid RR, 1997, J IMMUNOL, V159, P970; Reid RR, 2002, J IMMUNOL, V169, P5433, DOI 10.4049/jimmunol.169.10.5433; SCHWAEBLE W, 1995, J IMMUNOL, V155, P4971; Stager S, 2003, NAT MED, V9, P1287, DOI 10.1038/nm933; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; Szalai AJ, 1997, IMMUNOL RES, V16, P127, DOI 10.1007/BF02786357; TACK BF, 1980, P NATL ACAD SCI-BIOL, V77, P5764, DOI 10.1073/pnas.77.10.5764; Taylor PR, 2000, J EXP MED, V192, P359, DOI 10.1084/jem.192.3.359; Tsuji RF, 2002, J EXP MED, V196, P1277, DOI 10.1084/jem.20020649; Verschoor A, 2003, J IMMUNOL, V171, P5363, DOI 10.4049/jimmunol.171.10.5363; Verschoor A, 2001, J IMMUNOL, V167, P2446, DOI 10.4049/jimmunol.167.5.2446; Wittmann M, 1999, J IMMUNOL, V162, P6763	80	725	772	0	112	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2004	5	10					981	986		10.1038/ni1113	http://dx.doi.org/10.1038/ni1113			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	857YO	15454921				2022-12-18	WOS:000224156600004
J	Afkarian, M; Sedy, JR; Yang, J; Jacobson, NG; Cereb, N; Yang, SY; Murphy, TL; Murphy, KM				Afkarian, M; Sedy, JR; Yang, J; Jacobson, NG; Cereb, N; Yang, SY; Murphy, TL; Murphy, KM			T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4(+) T cells	NATURE IMMUNOLOGY			English	Article							IFN-GAMMA PRODUCTION; INTERFERON-GAMMA; TH2 CELLS; PHENOTYPE DEVELOPMENT; TRANSCRIPTION FACTOR; LINEAGE COMMITMENT; SIGNAL TRANSDUCER; CHAIN EXPRESSION; RECEPTOR; DIFFERENTIATION	T helper type 1 (T(H)1) cell development involves interferon-gamma (IFN-gamma) signaling through signal transducer and activator of transcription 1 (STAT1) and interleukin-12 (IL-12) signaling through STAT4 activation. We examined here T-bet regulation and evaluated the actions of T-bet in STAT1- and STAT4-dependent T(H)1 development processes. We found that T-bet expression during T cell activation was strongly dependent on IFN-gamma signaling and STAT1 activation, but was independent of STAT4. Ectopic T-bet expression strongly increased IFN-gamma production in T(H)2 cells activated by PMA-ionomycin, but weakly increased IFN-gamma production in T(H)2 cells stimulated by IL-12-IL-18 or OVA peptide-antigen-presenting cell stimulation. In contrast, IL-12-IL-18-induced IFN-gamma production remained STAT4-dependent despite ectopic T-bet expression. Ectopic T-bet expression selectively induced expression of IL-12Rbeta2, but not IL-18Ralpha in wild-type and STAT1(-/-) T(H)2 cells, but did not extinguish expression of GATA-3 and T(H)2 cytokines. Finally, ectopic T-bet did not directly induce expression of endogenous T-bet independently of IFN-gamma or STAT1. Thus, T-bet is induced by IFN-gamma and STAT1 signaling during T cell activation. In addition, T-bet mediates STAT1- dependent processes of T(H)1 development, including the induction of IL-12Rbeta2.	Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol & Immunol, St Louis, MO 63110 USA; Histogenet Inc, Hawthorne, NY 10532 USA; Ctr Genet Polymorphism, Hawthorne, NY 10532 USA	Howard Hughes Medical Institute; Washington University (WUSTL)	Murphy, KM (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol & Immunol, Box 8118,660 S Euclid Ave, St Louis, MO 63110 USA.			Sedy, John/0000-0002-6428-1054				Ahn HJ, 1997, J IMMUNOL, V159, P2125; ASSENMACHER M, 1994, EUR J IMMUNOL, V24, P1097, DOI 10.1002/eji.1830240513; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Carter LL, 1999, J EXP MED, V189, P1355, DOI 10.1084/jem.189.8.1355; Farrar JD, 2000, NAT IMMUNOL, V1, P65, DOI 10.1038/76932; Glimcher LH, 2000, GENE DEV, V14, P1693; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; HSIEH CS, 1993, INT IMMUNOL, V5, P371; Jacobson NG, 1995, RES IMMUNOL, V146, P446, DOI 10.1016/0923-2494(96)83014-8; Kaplan MH, 1999, J IMMUNOL, V163, P6536; Kaplan MH, 1998, J EXP MED, V188, P1191, DOI 10.1084/jem.188.6.1191; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Lawless VA, 2000, J IMMUNOL, V165, P6803, DOI 10.4049/jimmunol.165.12.6803; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; MANETTI R, 1994, J EXP MED, V179, P1273, DOI 10.1084/jem.179.4.1273; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Nishikomori R, 2000, J EXP MED, V191, P847, DOI 10.1084/jem.191.5.847; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang W, 1999, P NATL ACAD SCI USA, V96, P3888, DOI 10.1073/pnas.96.7.3888; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Ranganath S, 1998, J IMMUNOL, V161, P3822; Ranganath S, 2001, MOL CELL BIOL, V21, P2716, DOI 10.1128/MCB.21.8.2716-2725.2001; Rao A, 2000, BRIT MED BULL, V56, P969, DOI 10.1258/0007142001903634; Rengarajan J, 2000, IMMUNOL TODAY, V21, P479, DOI 10.1016/S0167-5699(00)01712-6; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; Smeltz RB, 2001, J EXP MED, V194, P143, DOI 10.1084/jem.194.2.143; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Wenner CA, 1996, J IMMUNOL, V156, P1442; Wittwer CT, 1997, BIOTECHNIQUES, V22, P130, DOI 10.2144/97221bi01; Wittwer CT, 1997, BIOTECHNIQUES, V22, P176, DOI 10.2144/97221pf02; Wu CY, 2000, J IMMUNOL, V165, P6221, DOI 10.4049/jimmunol.165.11.6221; Xu DM, 1998, J EXP MED, V188, P1485, DOI 10.1084/jem.188.8.1485; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264; Yang JF, 1999, EUR J IMMUNOL, V29, P548, DOI 10.1002/(SICI)1521-4141(199902)29:02<548::AID-IMMU548>3.0.CO;2-Z; Yoshimoto T, 1998, J IMMUNOL, V161, P3400; Zhang WX, 2000, GENOMICS, V70, P41, DOI 10.1006/geno.2000.6361; Zhou MX, 2001, J EXP MED, V194, P1461, DOI 10.1084/jem.194.10.1461	44	722	759	0	24	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2002	3	6					549	557		10.1038/ni794	http://dx.doi.org/10.1038/ni794			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	556XR	12006974				2022-12-18	WOS:000175874700014
J	Merad, M; Manz, MG; Karsunky, H; Wagers, A; Peters, W; Charo, I; Weissman, IL; Cyster, JG; Engleman, EG				Merad, M; Manz, MG; Karsunky, H; Wagers, A; Peters, W; Charo, I; Weissman, IL; Cyster, JG; Engleman, EG			Langerhans cells renew in the skin throughout life under steady-state conditions	NATURE IMMUNOLOGY			English	Article							BEARING DENDRITIC CELLS; MEMORY T-CELLS; CHEMOKINE RECEPTOR; MACROPHAGE RECRUITMENT; KNOCKOUT MICE; LYMPH-NODES; EXPRESSION; MIGRATION; ORIGIN; CCR2	Langerhans cells (LCs) are bone marrow (BM)-derived epidermal dendritic cells (DCs) that represent a critical immunologic barrier to the external environment, but little is known about their life cycle. Here, we show that in lethally irradiated mice that had received BM transplants, LCs of host origin remained for at least 18 months, whereas DCs in other organs were almost completely replaced by donor cells within 2 months. In parabiotic mice with separate organs, but a shared blood circulation, there was no mixing of LCs. However, in skin exposed to ultraviolet light, LCs rapidly disappeared and were replaced by circulating LC precursors within 2 weeks. The recruitment of new LCs was dependent on their expression of the CCR2 chemokine receptor and on the secretion of CCR2-binding chemokines by inflamed skin. These data indicate that under steady-state conditions, LCs are maintained locally, but inflammatory changes in the skin result in their replacement by blood-borne LC progenitors.	Stanford Univ, Sch Med, Dept Pathol, Palo Alto, CA 94304 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA; Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, Cardiovasc Res Inst, San Francisco, CA 94141 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Merad, M (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Palo Alto, CA 94304 USA.	meradm@stanford.edu	Manz, Markus G/C-7588-2011	Manz, Markus/0000-0002-4676-7931	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057443] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL057443] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; BARKER JNWN, 1991, J IMMUNOL, V146, P1192; Belperio JA, 2001, J CLIN INVEST, V108, P547, DOI 10.1172/JCI200112214; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Campbell JJ, 1999, NATURE, V400, P776, DOI 10.1038/23495; CAUX C, 1992, NATURE, V360, P258, DOI 10.1038/360258a0; CUMBERBATCH M, 1991, IMMUNOLOGY, V74, P139; CZERNIELEWSKI J, 1985, J INVEST DERMATOL, V84, P424, DOI 10.1111/1523-1747.ep12265523; CZERNIELEWSKI JM, 1987, J INVEST DERMATOL, V88, P17, DOI 10.1111/1523-1747.ep12464659; del Hoyo GM, 2002, NATURE, V415, P1043, DOI 10.1038/4151043a; Dieu-Nosjean MC, 2000, J EXP MED, V192, P705, DOI 10.1084/jem.192.5.705; Flier J, 2001, J PATHOL, V194, P398, DOI 10.1002/1096-9896(200108)194:4<397::AID-PATH899>3.0.CO;2-S; FOSSUM S, 1989, RES IMMUNOL, V140, P883, DOI 10.1016/0923-2494(89)90048-5; FOSTER CA, 1986, J INVEST DERMATOL, V86, P240, DOI 10.1111/1523-1747.ep12285201; Geissmann F, 1998, J EXP MED, V187, P961, DOI 10.1084/jem.187.6.961; Ghaznawie M, 1999, BRIT J DERMATOL, V141, P57; Ghaznawie M, 1999, BRIT J DERMATOL, V141, P206; Hemmi H, 2001, INT IMMUNOL, V13, P695, DOI 10.1093/intimm/13.5.695; HOLT PG, 1994, J IMMUNOL, V153, P256; HSIAO L, 1989, J INVEST DERMATOL, V93, P780, DOI 10.1111/1523-1747.ep12284420; Jakob T, 2001, J ALLERGY CLIN IMMUN, V108, P688, DOI 10.1067/mai.2001.118797; Katou F, 2001, AM J PATHOL, V158, P1263, DOI 10.1016/S0002-9440(10)64077-1; KATZ SI, 1979, NATURE, V282, P324, DOI 10.1038/282324a0; KOBAYASHI M, 1987, CELL TISSUE RES, V248, P315; KRUEGER GG, 1984, J INVEST DERMATOL, V82, P613, DOI 10.1111/1523-1747.ep12261453; KRUEGER GG, 1983, P NATL ACAD SCI-BIOL, V80, P1650, DOI 10.1073/pnas.80.6.1650; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; Larregina AT, 2001, NAT IMMUNOL, V2, P1151, DOI 10.1038/ni731; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; MIYAUCHI S, 1987, J INVEST DERMATOL, V88, P703, DOI 10.1111/1523-1747.ep12470379; Morales J, 1999, P NATL ACAD SCI USA, V96, P14470, DOI 10.1073/pnas.96.25.14470; NAKAMURA K, 1995, J INVEST DERMATOL, V105, P635, DOI 10.1111/1523-1747.ep12324061; Nakayama T, 2001, INT IMMUNOL, V13, P95, DOI 10.1093/intimm/13.1.95; Nieto M, 1997, J EXP MED, V186, P153, DOI 10.1084/jem.186.1.153; Pablos JL, 1999, AM J PATHOL, V155, P1577, DOI 10.1016/S0002-9440(10)65474-0; Peters W, 2000, J IMMUNOL, V165, P7072, DOI 10.4049/jimmunol.165.12.7072; PUGH CW, 1983, J EXP MED, V157, P1758, DOI 10.1084/jem.157.6.1758; Sato N, 2000, J EXP MED, V192, P205, DOI 10.1084/jem.192.2.205; SCHULER G, 1993, ADV EXP MED BIOL, V329, P243; SCHULER G, 1985, J EXP MED, V161, P526, DOI 10.1084/jem.161.3.526; Sebastiani S, 2002, ARCH DERMATOL RES, V293, P552, DOI 10.1007/s00403-001-0276-9; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; STINGL G, 1980, IMMUNOL REV, V53, P149, DOI 10.1111/j.1600-065X.1980.tb01043.x; TAMAKI K, 1980, J INVEST DERMATOL, V74, P309, DOI 10.1111/1523-1747.ep12543533; Tensen CP, 1999, J INVEST DERMATOL, V112, P716, DOI 10.1046/j.1523-1747.1999.00581.x; Vanbervliet A, 2002, EUR J IMMUNOL, V32, P231, DOI 10.1002/1521-4141(200201)32:1<231::AID-IMMU231>3.0.CO;2-8; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; YING S, 1995, J EXP MED, V181, P2153, DOI 10.1084/jem.181.6.2153; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	51	718	734	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2002	3	12					1135	1141		10.1038/ni852	http://dx.doi.org/10.1038/ni852			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	619GP	12415265	Green Accepted			2022-12-18	WOS:000179467800010
J	Hope, KJ; Jin, LQ; Dick, JE				Hope, KJ; Jin, LQ; Dick, JE			Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity	NATURE IMMUNOLOGY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; ABILITY IN-VITRO; BONE-MARROW; IMMUNODEFICIENT MICE; PROGENITOR CELLS; ENGRAFTMENT; CANCER; IDENTIFICATION; HEMATOPOIESIS; GROWTH	Emerging evidence suggests cancer stem cells sustain neoplasms; however, little is understood of the normal cell initially targeted and the resultant cancer stem cells. We show here, by tracking individual human leukemia stem cells (LSCs) in nonobese diabetic-severe combined immunodeficiency mice serially transplanted with acute myeloid leukemia cells, that LSCs are not functionally homogeneous but, like the normal hematopoietic stem cell (HSC) compartment, comprise distinct hierarchically arranged LSC classes. Distinct LSC fates derived from heterogeneous self-renewal potential. Some LSCs emerged only in recipients of serial transplantation, indicating they divided rarely and underwent self-renewal rather than commitment after cell division within primary recipients. Heterogeneity in LSC self-renewal potential supports the hypothesis that they derive from normal HSCs. Furthermore, normal developmental processes are not completely abolished during leukemogenesis. The existence of multiple stem cell classes shows the need for LSC-targeted therapies.	Univ Toronto, Univ Hlth Network, Div Cell & Mol Biol, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Mol Genet & Microbiol, Toronto, ON M5G 2C1, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Dick, JE (corresponding author), Univ Toronto, Univ Hlth Network, Div Cell & Mol Biol, 620 Univ Ave, Toronto, ON M5G 2C1, Canada.	jdick@uhnres.utoronto.ca		Dick, John/0000-0002-9527-8317; Hope, Kristin/0000-0003-1449-4948				Ailles LE, 1999, BLOOD, V94, P1761, DOI 10.1182/blood.V94.5.1761.417k23_1761_1772; Ailles LE, 1999, EXP HEMATOL, V27, P1609, DOI 10.1016/S0301-472X(99)00099-5; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; [Anonymous], J MEC THEOR APPL; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Bhatia M, 1997, P NATL ACAD SCI USA, V94, P5320, DOI 10.1073/pnas.94.10.5320; Blair A, 1997, BLOOD, V89, P3104, DOI 10.1182/blood.V89.9.3104; Blair A, 1998, BLOOD, V92, P4325, DOI 10.1182/blood.V92.11.4325; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brendel C, 1999, LEUKEMIA, V13, P1770, DOI 10.1038/sj.leu.2401543; Conneally E, 1997, P NATL ACAD SCI USA, V94, P9836, DOI 10.1073/pnas.94.18.9836; Dick JE, 2003, P NATL ACAD SCI USA, V100, P3547, DOI 10.1073/pnas.0830967100; Dick JE, 2003, NATURE, V423, P231, DOI 10.1038/423231a; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; GREAVES MF, 1986, SCIENCE, V234, P697, DOI 10.1126/science.3535067; GRIFFIN JD, 1986, BLOOD, V68, P1185; Guan YH, 2003, BLOOD, V101, P3142, DOI 10.1182/blood-2002-10-3062; Guenechea G, 2000, MOL THER, V1, P566, DOI 10.1006/mthe.2000.0077; Guenechea G, 1999, BLOOD, V93, P1097, DOI 10.1182/blood.V93.3.1097.403k04_1097_1105; Guzman ML, 2001, BLOOD, V98, P2301, DOI 10.1182/blood.V98.8.2301; Guzman ML, 2002, P NATL ACAD SCI USA, V99, P16220, DOI 10.1073/pnas.252462599; Jordan CT, 2000, LEUKEMIA, V14, P1777, DOI 10.1038/sj.leu.2401903; KAMELREID S, 1991, BLOOD, V78, P2973; KAMELREID S, 1988, SCIENCE, V242, P1706, DOI 10.1126/science.2904703; KAMELREID S, 1989, SCIENCE, V246, P1597, DOI 10.1126/science.2595371; LAPIDOT T, 1992, SCIENCE, V255, P1137, DOI 10.1126/science.1372131; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Larochelle A, 1996, NAT MED, V2, P1329, DOI 10.1038/nm1296-1329; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Marx J, 2003, SCIENCE, V301, P1308, DOI 10.1126/science.301.5638.1308; Mazurier F, 2004, BLOOD, V103, P545, DOI 10.1182/blood-2003-05-1558; MCCULLOCH EA, 1983, BLOOD, V62, P1; Miyoshi H, 1999, SCIENCE, V283, P682, DOI 10.1126/science.283.5402.682; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rombouts WJC, 2000, LEUKEMIA, V14, P889, DOI 10.1038/sj.leu.2401777; SINGH S, 2003, CANCER RES, V63, P5281; Terpstra W, 1996, BLOOD, V88, P1944, DOI 10.1182/blood.V88.6.1944.bloodjournal8861944; TERPSTRA W, 1995, LEUKEMIA, V9, P1573; TILL JE, 1980, BIOCHIM BIOPHYS ACTA, V605, P431, DOI 10.1016/0304-419X(80)90009-8	39	712	781	0	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2004	5	7					738	743		10.1038/ni1080	http://dx.doi.org/10.1038/ni1080			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	833IO	15170211				2022-12-18	WOS:000222331200027
J	Sato, S; Sanjo, H; Takeda, K; Ninomiya-Tsuji, J; Yamamoto, M; Kawai, T; Matsumoto, K; Takeuchi, O; Akira, S				Sato, S; Sanjo, H; Takeda, K; Ninomiya-Tsuji, J; Yamamoto, M; Kawai, T; Matsumoto, K; Takeuchi, O; Akira, S			Essential function for the kinase TAK1 in innate and adaptive immune responses	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; SEVERE LIVER DEGENERATION; EMBRYONIC LETHALITY; SIGNAL-TRANSDUCTION; MICE LACKING; LYMPHOCYTE DEVELOPMENT; ACTIVATION; PROTEIN; PATHWAY; TAB3	Transforming growth factor-beta-activated kinase 1 (TAK1) has been linked to interleukin 1 receptor and tumor necrosis factor receptor signaling. Here we generated mouse strains with conditional expression of a Map3k7 allele encoding part of TAK1. TAK1-deficient embryonic fibroblasts demonstrated loss of responses to interleukin 1 beta and tumor necrosis factor. Studies of mice with B cell-specific TAK1 deficiency showed that TAK1 was indispensable for cellular responses to Toll-like receptor ligands, CD40 and B cell receptor crosslinking. In addition, antigen-induced immune responses were considerably impaired in mice with B cell-specific TAK1 deficiency. TAK1-deficient cells failed to activate transcription factor NF-kappa B and mitogen-activated protein kinases in response to interleukin 1 beta, tumor necrosis factor and Toll-like receptor ligands. However, TAK1-deficient B cells were able to activate NF-kappa B but not the kinase Jnk in response to B cell receptor stimulation. These results collectively indicate that TAK1 is key in the cellular response to a variety of stimuli.	Japan Sci & Technol Agcy, Exploratory Res Adv Technol, Akira Innate Immun Project, Suita, Osaka 5650871, Japan; Osaka Univ, Dept Host Def, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; RIKEN Res Ctr Allergy & Immunol, Kanagawa 2300045, Japan; Kyushu Univ, Med Inst Bioregulat, Dept Mol Genet, Fukuoka 8128582, Japan; N Carolina State Univ, Dept Environm & Mol Toxicol, Raleigh, NC 27695 USA; Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Nagoya, Aichi 4648602, Japan	Japan Science & Technology Agency (JST); Osaka University; RIKEN; Kyushu University; University of North Carolina; North Carolina State University; Nagoya University	Akira, S (corresponding author), Japan Sci & Technol Agcy, Exploratory Res Adv Technol, Akira Innate Immun Project, Suita, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp	Takeda, Kiyoshi/C-9331-2009; Takeuchi, Osamu/AAG-9359-2019; Takeuchi, Osamu/D-6007-2011; Akira, Shizuo/C-3134-2009	Takeuchi, Osamu/0000-0002-1260-6232; Takeda, Kiyoshi/0000-0002-1778-6332; Kawai, Taro/0000-0001-7510-4662; Ninomiya-Tsuji, Jun/0000-0002-5584-0176; Sato, Shintaro/0000-0001-5156-3354				Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Cheung PCF, 2004, BIOCHEM J, V378, P27, DOI 10.1042/BJ20031794; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Irie T, 2000, FEBS LETT, V467, P160, DOI 10.1016/S0014-5793(00)01146-7; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Jin G, 2004, P NATL ACAD SCI USA, V101, P2028, DOI 10.1073/pnas.0307314101; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Komatsu Y, 2002, MECH DEVELOP, V119, P239, DOI 10.1016/S0925-4773(02)00391-X; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Munoz-Sanjuan I, 2002, DEVELOPMENT, V129, P5529, DOI 10.1242/dev.00097; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Ohkawara B, 2004, GENE DEV, V18, P381, DOI 10.1101/gad.1166904; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Rudolph D, 2000, GENE DEV, V14, P854; Ruefli-Brasse AA, 2003, SCIENCE, V302, P1581, DOI 10.1126/science.1090769; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Sakai K, 1995, BIOCHEM BIOPH RES CO, V217, P393, DOI 10.1006/bbrc.1995.2789; Sanjo H, 2003, MOL CELL BIOL, V23, P1231, DOI 10.1128/MCB.23.4.1231-1238.2003; Sato S, 2000, J IMMUNOL, V165, P7096, DOI 10.4049/jimmunol.165.12.7096; Sato S, 2002, INT IMMUNOL, V14, P783, DOI 10.1093/intimm/dxf046; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Sidorova EV, 2003, IMMUNOL LETT, V88, P37, DOI 10.1016/S0165-2478(03)00055-5; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; Wagner M, 2004, J IMMUNOL, V172, P954, DOI 10.4049/jimmunol.172.2.954; Wan J, 2004, MOL CELL BIOL, V24, P192, DOI 10.1128/MCB.24.1.192-199.2004; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Xue LQ, 2003, NAT IMMUNOL, V4, P857, DOI 10.1038/ni963; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	47	706	735	2	51	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2005	6	11					1087	1095		10.1038/ni1255	http://dx.doi.org/10.1038/ni1255			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	977WD	16186825				2022-12-18	WOS:000232833300009
J	van Stipdonk, MJB; Lemmens, EE; Schoenberger, SP				van Stipdonk, MJB; Lemmens, EE; Schoenberger, SP			Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation	NATURE IMMUNOLOGY			English	Article							T-CELL RECEPTOR; IN-VIVO; DENDRITIC CELLS; BYSTANDER ACTIVATION; PRESENTING CELLS; VIRAL-INFECTION; MATURATION; LYMPHOCYTES; RESPONSES; TOLERANCE	In defense of the host, the immune system must often raise an effective cytotoxic T lymphocyte (CTL) response from a small number of clonal precursors. The degree to which activation stimuli regulate the expansion and differentiation of naive CTLs, however, remains unknown. Using an engineered antigen-presenting cell (APC) system that allows control over antigenic stimulation, we studied the signaling duration requirements for priming and clonal expansion of naive CTLs, We found that naive CTLs become committed after as little as 2 h of exposure to APCs and that their subsequent division and differentiation can occur without the need for further antigenic stimulation of the daughter cells, whether priming is in vitro or in vivo. These data show that after a brief interaction with stimulatory APCs, naive CTLs initiate a program for their autonomous clonal expansion and development into functional effecters.	La Jolla Inst Allergy & Immunol, Div Immune Regulat, San Diego, CA 92121 USA	La Jolla Institute for Immunology	Schoenberger, SP (corresponding author), La Jolla Inst Allergy & Immunol, Div Immune Regulat, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.	sps@liai.org						Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bennett SRM, 1997, J EXP MED, V186, P65, DOI 10.1084/jem.186.1.65; BEVAN MJ, 1995, J EXP MED, V182, P639, DOI 10.1084/jem.182.3.639; Binder RJ, 2000, J IMMUNOL, V165, P6029, DOI 10.4049/jimmunol.165.11.6029; Borriello F, 1997, IMMUNITY, V6, P303, DOI 10.1016/S1074-7613(00)80333-7; Bronstein-Sitton N, 1999, J BIOL CHEM, V274, P23659, DOI 10.1074/jbc.274.33.23659; Cella M, 1999, J EXP MED, V189, P821, DOI 10.1084/jem.189.5.821; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Garza KM, 2000, J EXP MED, V191, P2021, DOI 10.1084/jem.191.11.2021; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; Heath WR, 1998, J EXP MED, V187, P1549, DOI 10.1084/jem.187.10.1549; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Hwang I, 2000, J EXP MED, V191, P1137, DOI 10.1084/jem.191.7.1137; Jelley-Gibbs DM, 2000, J IMMUNOL, V165, P5017, DOI 10.4049/jimmunol.165.9.5017; Jose ES, 2000, IMMUNITY, V12, P161, DOI 10.1016/S1074-7613(00)80169-7; KARTTUNEN J, 1991, P NATL ACAD SCI USA, V88, P3972, DOI 10.1073/pnas.88.9.3972; KEENE JA, 1982, J EXP MED, V155, P768, DOI 10.1084/jem.155.3.768; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; LAFFERTY KJ, 1975, AUST J EXP BIOL MED, V53, P27, DOI 10.1038/icb.1975.3; Lanzavecchia A, 1998, RES IMMUNOL, V149, P626, DOI 10.1016/S0923-2494(99)80027-3; Lanzavecchia A, 1999, Haematologica, V84 Suppl EHA-4, P23; Lanzavecchia A, 2000, CURR OPIN IMMUNOL, V12, P92, DOI 10.1016/S0952-7915(99)00056-4; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Lyons AB, 1999, IMMUNOL CELL BIOL, V77, P509, DOI 10.1046/j.1440-1711.1999.00864.x; MATZINGER P, 1991, J IMMUNOL METHODS, V145, P185, DOI 10.1016/0022-1759(91)90325-A; McAdam AJ, 2000, J VIROL, V74, P203, DOI 10.1128/JVI.74.1.203-208.2000; McAdam AJ, 2000, J IMMUNOL, V165, P3088, DOI 10.4049/jimmunol.165.6.3088; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Murali-Krishna K, 1998, ADV EXP MED BIOL, V452, P123; NIKOLICZUGIC J, 1990, NATURE, V344, P65, DOI 10.1038/344065a0; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; SANDERSON S, 1994, INT IMMUNOL, V6, P369, DOI 10.1093/intimm/6.3.369; Santra S, 2000, J IMMUNOL, V165, P6791, DOI 10.4049/jimmunol.165.12.6791; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Schoenberger SP, 1998, CANCER RES, V58, P3094; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Slavik JM, 1999, IMMUNOL RES, V19, P1, DOI 10.1007/BF02786473; Sotomayor EM, 1999, NAT MED, V5, P780, DOI 10.1038/10503; Staudt LM, 2000, ANNU REV IMMUNOL, V18, P829, DOI 10.1146/annurev.immunol.18.1.829; SWAIN SL, 1991, CURR OPIN IMMUNOL, V3, P304, DOI 10.1016/0952-7915(91)90028-Y; Veiga-Fernandes H, 2000, NAT IMMUNOL, V1, P47, DOI 10.1038/76907; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; ZHANG J, 1988, IMMUNOL LETT, V18, P297, DOI 10.1016/0165-2478(88)90178-2	47	700	709	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2001	2	5					423	429		10.1038/87730	http://dx.doi.org/10.1038/87730			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	429ZZ	11323696				2022-12-18	WOS:000168549800015
J	Apostolou, I; Sarukhan, A; Klein, L; von Boehmer, H				Apostolou, I; Sarukhan, A; Klein, L; von Boehmer, H			Origin of regulatory T cells with known specificity for antigen	NATURE IMMUNOLOGY			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; IN-VIVO; THYMIC EPITHELIUM; EFFECTOR FUNCTION; TRANSGENIC MICE; IMMUNE-RESPONSE; B-CELLS; RECEPTOR; SELECTION; UNRESPONSIVENESS	T cell receptor agonists can induce the differentiation of regulatory T (T-R) cells. We report here that the immunoglobulin kappa-controlled expression of an agonist in different cell types correlated with the phenotype of the generated TR cells. We found that aberrant expression on thymic stroma yielded predominantly CD4(+)CD25(+) T-R cells, which-under physiological conditions-may be induced by ectopically expressed organ-specific antigens and thus prevent organ-specific autoimmunity. Expression of the agonist antigen by nonactivated hematopoietic cells produced mostly CD4(+)CD25(-) T-R cells. This subset can be derived from mature monospecific T cells without "tutoring" by other T cells and can be generated in the absence of a functioning thymus. Suppression of CD4(+)T cell proliferative responses by both CD25(+) and CD25(-) subsets was interleukin 10 (IL-10)-independent and was overcome by IL-2. These data suggest that distinct pathways can be exploited to interfere with unwanted immune responses.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Fac Necker, INSERM, U345, F-75730 Paris 15, France	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	von Boehmer, H (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.		Klein, Ludger/G-8785-2011	Klein, Ludger/0000-0003-2054-071X; Sarukhan, Adelaida/0000-0003-3747-6304				Bensinger SJ, 2001, J EXP MED, V194, P427, DOI 10.1084/jem.194.4.427; Buer J, 1998, J EXP MED, V187, P177, DOI 10.1084/jem.187.2.177; BURNET FM, 1959, CLONAL SELECTION THE; CHILLER JM, 1971, SCIENCE, V171, P813, DOI 10.1126/science.171.3973.813; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Itoh M, 1999, J IMMUNOL, V162, P5317; Jooss K, 2001, P NATL ACAD SCI USA, V98, P8738, DOI 10.1073/pnas.151088898; Jordan MS, 2000, EUR J IMMUNOL, V30, P136, DOI 10.1002/1521-4141(200001)30:1<136::AID-IMMU136>3.3.CO;2-S; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kalberer CP, 1997, EUR J IMMUNOL, V27, P2400, DOI 10.1002/eji.1830270939; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KIRBERG J, 1994, J EXP MED, V180, P25, DOI 10.1084/jem.180.1.25; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Klein L, 2001, EUR J IMMUNOL, V31, P2476, DOI 10.1002/1521-4141(200108)31:8<2476::AID-IMMU2476>3.0.CO;2-T; Lanoue A, 1997, J EXP MED, V185, P405, DOI 10.1084/jem.185.3.405; Lechner O, 2001, CURR BIOL, V11, P587, DOI 10.1016/S0960-9822(01)00160-9; LEDERBERG J, 1959, SCIENCE, V129, P1649, DOI 10.1126/science.129.3364.1649; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; MITCHISON NA, 1964, PROC R SOC SER B-BIO, V161, P275, DOI 10.1098/rspb.1964.0093; Modigliani Y, 1996, EUR J IMMUNOL, V26, P1807, DOI 10.1002/eji.1830260822; Modigliani Y, 1996, IMMUNOL REV, V149, P155, DOI 10.1111/j.1600-065X.1996.tb00903.x; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; OHKI H, 1987, SCIENCE, V237, P1032, DOI 10.1126/science.3616623; Olivares-Villagomez D, 2000, J IMMUNOL, V164, P5499, DOI 10.4049/jimmunol.164.10.5499; Pennisi E, 1996, SCIENCE, V271, P1665, DOI 10.1126/science.271.5256.1665; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; ROCHA B, 1991, SCIENCE, V251, P1225, DOI 10.1126/science.1900951; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; SALAUN J, 1990, SCIENCE, V247, P1471, DOI 10.1126/science.2321009; Stephens LA, 2000, J IMMUNOL, V165, P3105, DOI 10.4049/jimmunol.165.6.3105; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531; Waldmann H, 2001, IMMUNITY, V14, P399, DOI 10.1016/S1074-7613(01)00120-0	40	692	720	1	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2002	3	8					756	763		10.1038/ni816	http://dx.doi.org/10.1038/ni816			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	578LF	12089509				2022-12-18	WOS:000177118500015
J	Chapoval, AI; Ni, J; Lau, JS; Wilcox, RA; Flies, DB; Liu, D; Dong, HD; Sica, GL; Zhu, GF; Tamada, K; Chen, LP				Chapoval, AI; Ni, J; Lau, JS; Wilcox, RA; Flies, DB; Liu, D; Dong, HD; Sica, GL; Zhu, GF; Tamada, K; Chen, LP			B7-H3: A costimulatory molecule for T cell activation and IFN-gamma production	NATURE IMMUNOLOGY			English	Article							CO-STIMULATION; B7 FAMILY; ENGAGEMENT; EXPRESSION; RECEPTOR; CTLA-4; MEMBER; CD28; IDENTIFICATION; PROLIFERATION	We describe here a newly identified member of the human B7 family, designated B7 homolog 3 (B7-H3), that shares 20-27% amino acid identity with other B7 family members, B7-H3 mRNA is not detectable in peripheral blood mononuclear cells, although it is found in various normal tissues and in several tumor cell lines. Expression of B7-H3 protein, however, can be induced on dendritic cells (DCs) and monocytes by inflammatory cytokines and a combination of phorbol myristate acetate (PMA) + ionomycin, Soluble B7-H3 protein binds a putative counter-receptor on activated T cells that is distinct from CD28, cytotoxic T lymphocyte antigen 4 (CTLA-4), inducible costimulator (ICOS) and PD-1. B7-H3 costimulates proliferation of both CD4(+) and CD8(+) T cells, enhances the induction of cytotoxic T cells and selectively stimulates interferon gamma (IFN-gamma) production in the presence of T cell receptor signaling. In contrast, inclusion of antisense B7-H3 oligonucleotides decreases the expression of B7-H3 on DCs and inhibits IFN-gamma production by DC-stimutated allogeneic T cells. Thus, we describe a newly identified costimulatory pathway that may participate in the regulation of cell-mediated immune responses.	Mayo Clin & Mayo Fdn, Mayo Grad Sch, Dept Immunol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Mayo Med Sch, Dept Immunol, Rochester, MN 55905 USA; Human Genome Sci Inc, Rockville, MD 20850 USA	Mayo Clinic; Mayo Clinic; GlaxoSmithKline; Human Genome Sciences Inc	Chen, LP (corresponding author), Mayo Clin & Mayo Fdn, Mayo Grad Sch, Dept Immunol, 200 1st St SW, Rochester, MN 55905 USA.	chen.lieping@mayo.edu	Chapoval, Andrei/N-9568-2013	Chapoval, Andrei/0000-0002-3426-1036; Chen, Lieping/0000-0002-6825-3069; Dong, Haidong/0000-0002-5782-2983	NCI NIH HHS [CA09127] Funding Source: Medline; NIAID NIH HHS [AI07425] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI007425] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aicher A, 2000, J IMMUNOL, V164, P4689, DOI 10.4049/jimmunol.164.9.4689; BOISE LH, 1995, CURR OPIN IMMUNOL, V7, P620, DOI 10.1016/0952-7915(95)80067-0; Brodie D, 2000, CURR BIOL, V10, P333, DOI 10.1016/S0960-9822(00)00383-3; Chambers CA, 1997, CURR OPIN IMMUNOL, V9, P396, DOI 10.1016/S0952-7915(97)80087-8; Chapoval AI, 1998, J IMMUNOL, V161, P6977; Chapoval AI, 2000, BLOOD, V95, P2346, DOI 10.1182/blood.V95.7.2346.007k05_2346_2351; Chapoval AI, 2000, METH MOLEC MED, V45, P247, DOI 10.1385/1-59259-079-9:247; Dong HD, 1999, NAT MED, V5, P1365; FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Henry J, 1999, IMMUNOL TODAY, V20, P285, DOI 10.1016/S0167-5699(98)01418-2; Hurley R, 1999, STUD RELIG-SCI RELIG, V28, P263, DOI 10.1177/000842989902800238; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; KAYAGAKI N, 1995, J EXP MED, V182, P1777, DOI 10.1084/jem.182.6.1777; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; LENSCHOW DJ, 1994, J IMMUNOL, V153, P1990; LINDSTROM RL, 1993, CURR OPIN OPHTHALMOL, V4, P1, DOI 10.1097/00055735-199302000-00001; Ling V, 2000, J IMMUNOL, V164, P1653, DOI 10.4049/jimmunol.164.4.1653; LINSLEY PS, 1994, PROTEIN SCI, V3, P1341, DOI 10.1002/pro.5560030820; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; LINSLEY PS, 1992, J EXP MED, V176, P1595, DOI 10.1084/jem.176.6.1595; Mages HW, 2000, EUR J IMMUNOL, V30, P1040, DOI 10.1002/(SICI)1521-4141(200004)30:4<1040::AID-IMMU1040>3.0.CO;2-6; Pechhold K, 1997, J IMMUNOL, V158, P4921; Rathmell JC, 1999, ANNU REV IMMUNOL, V17, P781, DOI 10.1146/annurev.immunol.17.1.781; Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X; Tamada K, 2000, J IMMUNOL, V164, P4105, DOI 10.4049/jimmunol.164.8.4105; Walunas TL, 1996, J EXP MED, V183, P2541, DOI 10.1084/jem.183.6.2541; Wang SD, 2000, BLOOD, V96, P2808; Yoshinaga SK, 2000, INT IMMUNOL, V12, P1439, DOI 10.1093/intimm/12.10.1439; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582	31	691	855	6	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2001	2	3					269	274		10.1038/85339	http://dx.doi.org/10.1038/85339			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	409YT	11224528				2022-12-18	WOS:000167413800021
J	Diefenbach, A; Jamieson, AM; Liu, SD; Shastri, N; Raulet, DH				Diefenbach, A; Jamieson, AM; Liu, SD; Shastri, N; Raulet, DH			Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; MAJOR HISTOCOMPATIBILITY COMPLEX; INDUCIBLE CDNA CLONES; CLASS-I MOLECULE; T-CELL; SURFACE PROTEINS; F9 CELLS; RECOGNITION; FAMILY; CYTOTOXICITY	Natural killer (NK) cells attack tumor and infected cells, but the receptors and ligands that stimulate them are poorly understood. Here we report the expression cloning of two murine ligands for the lectin-like receptor NKG2D. The two ligands, H-60 and Rae1 beta, are distant relatives of major histocompatibility complex class I molecules. NKG2D ligands are not expressed by most normal cells but are up-regulated on numerous tumor cells. We show that mouse NKG2D is expressed by NK cells, activated CD8(+) T cells and activated macrophages. Expression of either NKG2D ligand by target cells triggers NK cell cytotoxicity and interferon-gamma secretion by NK cells, as well as nitric oxide release and tumor necrosis factor a transcription by macrophages. Thus, through their interaction with NKG2D, H-60 and Rae1 beta are newly identified potent stimulators of innate immunity.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Raulet, DH (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	raulet@uclink4.berkeley.edu	Diefenbach, Andreas/T-2589-2018; Jamieson, Amanda/U-7169-2019	Diefenbach, Andreas/0000-0002-9176-9530; Jamieson, Amanda/0000-0002-5781-9231; Raulet, David/0000-0002-1257-8649				Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Amadou C, 1999, IMMUNOL REV, V167, P211, DOI 10.1111/j.1600-065X.1999.tb01394.x; BAHRAM S, 1994, P NATL ACAD SCI USA, V91, P6259, DOI 10.1073/pnas.91.14.6259; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Brown MH, 1998, J EXP MED, V188, P2083, DOI 10.1084/jem.188.11.2083; Chalupny J, 2000, FASEB J, V14, pA1018; Cosman D, 2000, FASEB J, V14, pA1018; Crowley MP, 2000, SCIENCE, V287, P314, DOI 10.1126/science.287.5451.314; Crowley MP, 1997, J EXP MED, V185, P1223, DOI 10.1084/jem.185.7.1223; Diefenbach A, 1998, IMMUNITY, V8, P77, DOI 10.1016/S1074-7613(00)80460-4; ELLIOTT JF, 1990, P NATL ACAD SCI USA, V87, P6363, DOI 10.1073/pnas.87.16.6363; FORSTER E, 1994, BIOTECHNIQUES, V16, P18; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Hanke T, 1999, IMMUNITY, V11, P67, DOI 10.1016/S1074-7613(00)80082-5; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; HO ASY, 1993, P NATL ACAD SCI USA, V90, P11267, DOI 10.1073/pnas.90.23.11267; Ho EL, 1998, P NATL ACAD SCI USA, V95, P6320, DOI 10.1073/pnas.95.11.6320; Hong WK, 1997, SCIENCE, V278, P1073, DOI 10.1126/science.278.5340.1073; HOUCHINS JP, 1991, J EXP MED, V173, P1017, DOI 10.1084/jem.173.4.1017; HOUCHINS JP, 1990, J MOL CELL IMMUNOL, V4, P295; Kang JS, 1998, IMMUNITY, V8, P713, DOI 10.1016/S1074-7613(00)80576-2; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Lazetic S, 1996, J IMMUNOL, V157, P4741; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Malarkannan S, 1998, J IMMUNOL, V161, P3501; Miyazaki T, 1996, SCIENCE, V272, P405, DOI 10.1126/science.272.5260.405; Nomura M, 1996, J BIOCHEM-TOKYO, V120, P987; NOMURA M, 1994, DIFFERENTIATION, V57, P39, DOI 10.1046/j.1432-0436.1994.5710039.x; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Ranganath S, 1998, J IMMUNOL, V161, P3822; RYAN JC, 1995, J EXP MED, V181, P1911, DOI 10.1084/jem.181.5.1911; Sivori S, 1999, EUR J IMMUNOL, V29, P1656, DOI 10.1002/(SICI)1521-4141(199905)29:05<1656::AID-IMMU1656>3.0.CO;2-1; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Vance RE, 1997, EUR J IMMUNOL, V27, P3236, DOI 10.1002/eji.1830271222; Vance RE, 1999, J EXP MED, V190, P1801, DOI 10.1084/jem.190.12.1801; Vance RE, 1998, J EXP MED, V188, P1841, DOI 10.1084/jem.188.10.1841; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Zou ZH, 1996, J BIOCHEM-TOKYO, V119, P319	41	691	720	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2000	1	2					119	126		10.1038/77793	http://dx.doi.org/10.1038/77793			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BW	11248803				2022-12-18	WOS:000089814900011
J	Sokol, CL; Barton, GM; Farr, AG; Medzhitov, R				Sokol, Caroline L.; Barton, Gregory M.; Farr, Andrew G.; Medzhitov, Ruslan			A mechanism for the initiation of allergen-induced T helper type 2 responses	NATURE IMMUNOLOGY			English	Article							THYMIC STROMAL LYMPHOPOIETIN; DUST-MITE ALLERGEN; MAST-CELLS; TH2 DIFFERENTIATION; CYTOKINE PRODUCTION; NEMATODE PARASITES; DENDRITIC CELLS; IL-4 EXPRESSION; LYMPH-NODES; IN-VIVO	Both metazoan parasites and simple protein allergens induce T helper type 2 (T(H)2) immune responses, but the mechanisms by which the innate immune system senses these stimuli are unknown. In addition, the cellular source of cytokines that control T(H)2 differentiation in vivo has not been defined. Here we showed that basophils were activated and recruited to the draining lymph nodes specifically in response to T(H)2-inducing allergen challenge. Furthermore, we demonstrate that the basophil was the accessory cell type required for T(H)2 induction in response to protease allergens. Finally, we show that basophils were directly activated by protease allergens and produced T(H)2-inducing cytokines, including interleukin 4 and thymic stromal lymphopoietin, which are involved in T(H)2 differentiation in vivo.	[Sokol, Caroline L.; Medzhitov, Ruslan] Yale Univ, Sch Med, Immunobiol Sect, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Barton, Gregory M.] Univ Calif Berkeley, Dept Mol Cell Biol, Berkeley, CA 94720 USA; [Farr, Andrew G.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA	Howard Hughes Medical Institute; Yale University; University of California System; University of California Berkeley; University of Washington; University of Washington Seattle	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06510 USA.	ruslan.medzhitov@yale.edu		Barton, Gregory/0000-0002-3793-0100	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055502] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI055502, AI 055502] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Al-Shami A, 2005, J EXP MED, V202, P829, DOI 10.1084/jem.20050199; Al-Shami A, 2004, J EXP MED, V200, P159, DOI 10.1084/jem.20031975; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Chambers L, 1998, BIOCHEM BIOPH RES CO, V253, P837, DOI 10.1006/bbrc.1998.9862; CHUA KY, 1988, J EXP MED, V167, P175, DOI 10.1084/jem.167.1.175; Cote-Sierra J, 2004, P NATL ACAD SCI USA, V101, P3880, DOI 10.1073/pnas.0400339101; Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084; Else KJ, 1998, INT J PARASITOL, V28, P1145, DOI 10.1016/S0020-7519(98)00087-3; FINKELMAN FD, 1992, PARASITOL TODAY, V8, P311, DOI 10.1016/0169-4758(92)90105-B; FRIEND SL, 1994, EXP HEMATOL, V22, P321; Gessner A, 2005, J IMMUNOL, V174, P1063, DOI 10.4049/jimmunol.174.2.1063; Ghaemmaghami AM, 2002, CLIN EXP ALLERGY, V32, P1468, DOI 10.1046/j.1365-2745.2002.01504.x; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Gough L, 1999, J EXP MED, V190, P1897, DOI 10.1084/jem.190.12.1897; Grobe K, 1999, EUR J BIOCHEM, V263, P33, DOI 10.1046/j.1432-1327.1999.00462.x; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kheradmand F, 2002, J IMMUNOL, V169, P5904, DOI 10.4049/jimmunol.169.10.5904; Khodoun MV, 2004, J EXP MED, V200, P857, DOI 10.1084/jem.20040598; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Liu ZG, 2005, J IMMUNOL, V174, P2242, DOI 10.4049/jimmunol.174.4.2242; Luccioli S, 2002, J ALLERGY CLIN IMMUN, V110, P117, DOI 10.1067/mai.2002.125828; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; McKerrow JH, 2006, ANNU REV PATHOL-MECH, V1, P497, DOI 10.1146/annurev.pathol.1.110304.100151; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Mowen KA, 2004, IMMUNOL REV, V202, P203, DOI 10.1111/j.0105-2896.2004.00209.x; Mukai K, 2005, IMMUNITY, V23, P191, DOI 10.1016/j.immuni.2005.06.011; Noben-Trauth N, 2000, J IMMUNOL, V165, P3620, DOI 10.4049/jimmunol.165.7.3620; NOVEY HS, 1979, J ALLERGY CLIN IMMUN, V63, P98, DOI 10.1016/0091-6749(79)90198-2; Oh K, 2007, BLOOD, V109, P2921, DOI 10.1182/blood-2006-07-037739; Ohshima Y, 1998, BLOOD, V92, P3338, DOI 10.1182/blood.V92.9.3338.421k19_3338_3345; Omori M, 2007, J IMMUNOL, V178, P1396, DOI 10.4049/jimmunol.178.3.1396; PARK LS, 1990, J EXP MED, V171, P1073, DOI 10.1084/jem.171.4.1073; Phillips C, 2003, J LEUKOCYTE BIOL, V73, P165, DOI 10.1189/jlb.0702356; Shakib F, 1998, IMMUNOL TODAY, V19, P313, DOI 10.1016/S0167-5699(98)01284-5; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; URBAN JF, 1992, IMMUNOL REV, V127, P205, DOI 10.1111/j.1600-065X.1992.tb01415.x; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3; Wedemeyer J, 2000, CURR OPIN IMMUNOL, V12, P624, DOI 10.1016/S0952-7915(00)00154-0; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247; Zingoni A, 1998, J IMMUNOL, V161, P547	49	684	717	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2008	9	3					310	318		10.1038/ni1558	http://dx.doi.org/10.1038/ni1558			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	266BQ	18300366	Green Accepted			2022-12-18	WOS:000253406700017
J	Bernink, JH; Peters, CP; Munneke, M; te Velde, AA; Meijer, SL; Weijer, K; Hreggvidsdottir, HS; Heinsbroek, SE; Legrand, N; Buskens, CJ; Bemelman, WA; Mjosberg, JM; Spits, H				Bernink, Jochem H.; Peters, Charlotte P.; Munneke, Marius; te Velde, Anje A.; Meijer, Sybren L.; Weijer, Kees; Hreggvidsdottir, Hulda S.; Heinsbroek, Sigrid E.; Legrand, Nicolas; Buskens, Christianne J.; Bemelman, Willem A.; Mjosberg, Jenny M.; Spits, Hergen			Human type 1 innate lymphoid cells accumulate in inflamed mucosa! tissues	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR GATA3; NATURAL-KILLER; T-BET; INDUCER CELLS; EXPRESSION; CYTOKINES; GAMMA; DISTINCT; MICE	Innate lymphoid cells (ILCs) are effectors of innate immunity and regulators of tissue modeling. Recently identified ILC populations have a cytokine expression pattern that resembles that of the helper T cell subsets T(H)2, T(H)17 and T(H)22. Here we describe a distinct ILC subset similar to T(H)1 cells, which we call 'ILC1'. ILC1 cells expressed the transcription factor T-bet and responded to interleukin 12 (IL-12) by producing interferon-gamma (IFN-gamma). ILC1 cells were distinct from natural killer (NK) cells as they lacked perforin, granzyme B and the NK cell markers CD56, CD16 and CD94, and could develop from ROR gamma t(+) ILC3 under the influence of IL-12. The frequency of the ILC1 subset was much higher in inflamed intestine of people with Crohn's disease, which indicated a role for these IFN-gamma-producing ILC1 cells in the pathogenesis of gut mucosal inflammation.	[Bernink, Jochem H.; Peters, Charlotte P.; te Velde, Anje A.; Hreggvidsdottir, Hulda S.; Heinsbroek, Sigrid E.; Mjosberg, Jenny M.; Spits, Hergen] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 AZ Amsterdam, Netherlands; [Peters, Charlotte P.] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands; [Munneke, Marius] Univ Amsterdam, Acad Med Ctr, Dept Hematol, NL-1105 AZ Amsterdam, Netherlands; [Munneke, Marius; Weijer, Kees; Legrand, Nicolas] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands; [Meijer, Sybren L.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Hreggvidsdottir, Hulda S.] Univ Amsterdam, Acad Med Ctr, Dept Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands; [Buskens, Christianne J.; Bemelman, Willem A.] Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands; [Mjosberg, Jenny M.] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Dept Med,Ctr Infect Med, Stockholm, Sweden	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Karolinska Institutet; Karolinska University Hospital	Spits, H (corresponding author), Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	hergen.spits@amc.uva.nl	Spits, Hergen/N-2581-2019; Legrand, Nicolas/B-1794-2009; Bemelman, Wilhelmus Adrianus/AAA-1635-2021; Legrand, Nicolas/B-1794-2009	Spits, Hergen/0000-0003-3269-8338; Legrand, Nicolas/0000-0002-0236-7653; Bemelman, Wilhelmus Adrianus/0000-0002-1037-9945; Legrand, Nicolas/0000-0002-0900-3051; Meijer, Sybren/0000-0002-6953-2406				Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Blom B, 2006, ANNU REV IMMUNOL, V24, P287, DOI 10.1146/annurev.immunol.24.021605.090612; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Crellin NK, 2010, IMMUNITY, V33, P752, DOI 10.1016/j.immuni.2010.10.012; Crellin NK, 2010, J EXP MED, V207, P281, DOI 10.1084/jem.20091509; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Freud AG, 2006, J EXP MED, V203, P1033, DOI 10.1084/jem.20052507; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Gimeno R, 2004, BLOOD, V104, P3886, DOI 10.1182/blood-2004-02-0656; Gramaglia I, 1999, J IMMUNOL, V162, P1333; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hoorweg K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00072; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Hughes T, 2009, BLOOD, V113, P4008, DOI 10.1182/blood-2008-12-192443; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kim HY, 2012, J ALLERGY CLIN IMMUN, V129, P216, DOI 10.1016/j.jaci.2011.10.036; Klose C.S., NATURE IN PRESS; Lazarevic V, 2011, NAT IMMUNOL, V12, P597, DOI 10.1038/ni.2059; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Lord GM, 2005, BLOOD, V106, P3432, DOI 10.1182/blood-2005-04-1393; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Mjosberg J, 2012, EUR J IMMUNOL, V42, P1916, DOI 10.1002/eji.201242639; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Satoh-Takayama N, 2009, J IMMUNOL, V183, P6579, DOI 10.4049/jimmunol.0901935; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Schulz EG, 2009, IMMUNITY, V30, P673, DOI 10.1016/j.immuni.2009.03.013; Sonnenberg GF, 2012, IMMUNITY, V37, P601, DOI 10.1016/j.immuni.2012.10.003; Spits H., NAT REV IMM IN PRESS; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395	49	680	709	1	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2013	14	3					221	229		10.1038/ni.2534	http://dx.doi.org/10.1038/ni.2534			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	091QR	23334791				2022-12-18	WOS:000315065400011
J	Rathinam, VAK; Vanaja, SK; Fitzgerald, KA				Rathinam, Vijay A. K.; Vanaja, Sivapriya Kailasan; Fitzgerald, Katherine A.			Regulation of inflammasome signaling	NATURE IMMUNOLOGY			English	Review							NF-KAPPA-B; INNATE IMMUNE RECOGNITION; NLRP3 INFLAMMASOME; CASPASE-1 ACTIVATION; NALP3 INFLAMMASOME; CUTTING EDGE; HOST-DEFENSE; LISTERIA-MONOCYTOGENES; AIM2 INFLAMMASOME; ONLY PROTEIN-2	Innate immune responses have the ability to both combat infectious microbes and drive pathological inflammation. Inflammasome complexes are a central component of these processes through their regulation of interleukin 1 beta (IL-1 beta), IL-18 and pyroptosis. Inflammasomes recognize microbial products or endogenous molecules released from damaged or dying cells both through direct binding of ligands and indirect mechanisms. The potential of the IL-1 family of cytokines to cause tissue damage and chronic inflammation emphasizes the importance of regulating inflammasomes. Many regulatory mechanisms have been identified that act as checkpoints for attenuating inflammasome signaling at multiple steps. Here we discuss the various regulatory mechanisms that have evolved to keep inflammasome signaling in check to maintain immunological balance.	[Rathinam, Vijay A. K.; Vanaja, Sivapriya Kailasan; Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Vanaja, Sivapriya Kailasan] Tufts Sch Med, Dept Microbiol, Boston, MA USA	University of Massachusetts System; University of Massachusetts Worcester	Fitzgerald, KA (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA.	kate.fitzgerald@umassmed.edu	Fitzgerald, Katherine/ABE-6317-2020; Rathinam, Vijay/ABE-7544-2020	Rathinam, Vijay/0000-0002-8009-3977; Fitzgerald, Kate/0000-0003-3175-609X	US National Institutes of Health [AI083713, AI079293, AI067497]; New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases (US National Institutes of Health, National Institute of Allergy and Infectious Diseases) [U54 AI057159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083713, R01AI067497, U54AI057159, R01AI079293, R56AI067497] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases (US National Institutes of Health, National Institute of Allergy and Infectious Diseases); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the US National Institutes of Health (AI083713, AI079293 and AI067497 to K.A.F.) and the New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases (US National Institutes of Health, National Institute of Allergy and Infectious Diseases U54 AI057159 to V.A.K.R. and S.K.V.).	Abdelaziz DH, 2011, J BIOL CHEM, V286, P3203, DOI 10.1074/jbc.M110.197681; Aksentijevich I, 1997, CELL, V90, P797; Ali SR, 2011, IMMUNITY, V35, P34, DOI 10.1016/j.immuni.2011.04.015; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Andrea D., 2010, J INFLAMM, V7, P7; Arthur JC, 2010, J IMMUNOL, V185, P4515, DOI 10.4049/jimmunol.1002227; Bedoya F, 2007, J IMMUNOL, V178, P3837, DOI 10.4049/jimmunol.178.6.3837; Bernot A, 1997, NAT GENET, V17, P25; Brodsky IE, 2010, CELL HOST MICROBE, V7, P376, DOI 10.1016/j.chom.2010.04.009; Broz P, 2011, IMMUNOL REV, V243, P174, DOI 10.1111/j.1600-065X.2011.01041.x; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; Bryan NB, 2009, J IMMUNOL, V182, P3173, DOI 10.4049/jimmunol.0802367; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; BUMP NJ, 1995, SCIENCE, V269, P1885, DOI 10.1126/science.7569933; Chae JJ, 2011, IMMUNITY, V34, P755, DOI 10.1016/j.immuni.2011.02.020; Choubey D, 2010, J INTERF CYTOK RES, V30, P371, DOI 10.1089/jir.2009.0096; Crisan TO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018666; D'Osualdo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027396; da Cunha JPC, 2008, J MOL EVOL, V66, P591, DOI 10.1007/s00239-008-9110-8; de Alba E, 2009, J BIOL CHEM, V284, P32932, DOI 10.1074/jbc.M109.024273; Dombrowski Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002001; Dorfleutner A, 2007, INFECT IMMUN, V75, P1484, DOI 10.1128/IAI.01315-06; Duncan JA, 2009, J IMMUNOL, V182, P6460, DOI 10.4049/jimmunol.0802696; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Fang RD, 2011, J IMMUNOL, V187, P4890, DOI 10.4049/jimmunol.1100381; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Galle M, 2008, J CELL MOL MED, V12, P1767, DOI 10.1111/j.1582-4934.2007.00190.x; Gasse P, 2009, AM J RESP CRIT CARE, V179, P903, DOI 10.1164/rccm.200808-1274OC; Gregory SM, 2011, SCIENCE, V331, P330, DOI 10.1126/science.1199478; Grenier JM, 2002, FEBS LETT, V530, P73, DOI 10.1016/S0014-5793(02)03416-6; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Guarda G, 2009, NATURE, V460, P269, DOI 10.1038/nature08100; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Harris J, 2011, J BIOL CHEM, V286, P9587, DOI 10.1074/jbc.M110.202911; Hawkins PN, 2003, NEW ENGL J MED, V348, P2583, DOI 10.1056/NEJM200306193482523; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Hu Y, 2010, J IMMUNOL, V185, P7699, DOI 10.4049/jimmunol.1001099; Huang MTH, 2010, J IMMUNOL, V185, P5476, DOI 10.4049/jimmunol.1002154; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Ippagunta SK, 2011, NAT IMMUNOL, V12, P1010, DOI 10.1038/ni.2095; Jeru I, 2008, P NATL ACAD SCI USA, V105, P1614, DOI 10.1073/pnas.0708616105; Jeru I, 2011, ARTHRITIS RHEUM-US, V63, P2142, DOI 10.1002/art.30378; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Jin CC, 2010, J CLIN IMMUNOL, V30, P628, DOI 10.1007/s10875-010-9440-3; Johnston JB, 2005, IMMUNITY, V23, P587, DOI 10.1016/j.immuni.2005.10.003; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kanneganti TD, 2010, NAT REV IMMUNOL, V10, P688, DOI 10.1038/nri2851; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kerur N, 2011, CELL HOST MICROBE, V9, P363, DOI 10.1016/j.chom.2011.04.008; Kettle S, 1997, J GEN VIROL, V78, P677, DOI 10.1099/0022-1317-78-3-677; Kim S, 2010, EUR J IMMUNOL, V40, P1545, DOI 10.1002/eji.201040425; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Lachmann HJ, 2009, J EXP MED, V206, P1029, DOI 10.1084/jem.20082481; Lamkanfi M, 2011, NAT REV IMMUNOL, V11, P213, DOI 10.1038/nri2936; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lich JD, 2007, MICROBES INFECT, V9, P672, DOI 10.1016/j.micinf.2007.01.018; Lich JD, 2007, J IMMUNOL, V178, P1256, DOI 10.4049/jimmunol.178.3.1256; Littmann M, 2009, EMBO MOL MED, V1, P211, DOI 10.1002/emmm.200900025; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Masters SL, 2010, EMBO REP, V11, P640, DOI 10.1038/embor.2010.93; Mayer-Barber KD, 2011, IMMUNITY, V35, P1023, DOI 10.1016/j.immuni.2011.12.002; McNeela EA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001191; Meixenberger K, 2010, J IMMUNOL, V184, P922, DOI 10.4049/jimmunol.0901346; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Munding C, 2006, CELL DEATH DIFFER, V13, P1938, DOI 10.1038/sj.cdd.4401896; Munoz-Planillo R, 2009, J IMMUNOL, V183, P3942, DOI 10.4049/jimmunol.0900729; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Newman ZL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000906; Newman ZL, 2009, INFECT IMMUN, V77, P4327, DOI 10.1128/IAI.00730-09; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Petit F, 1996, J VIROL, V70, P5860, DOI 10.1128/JVI.70.9.5860-5866.1996; Rahman MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000635; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Saleh M, 2006, NATURE, V440, P1064, DOI 10.1038/nature04656; Schattgen SA, 2011, IMMUNOL REV, V243, P109, DOI 10.1111/j.1600-065X.2011.01053.x; Schotte P, 2004, J BIOL CHEM, V279, P25134, DOI 10.1074/jbc.M401245200; Stasakova J, 2005, J GEN VIROL, V86, P185, DOI 10.1099/vir.0.80422-0; Stehlik C, 2003, BIOCHEM J, V373, P101, DOI 10.1042/BJ20030304; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Ulland TK, 2010, J IMMUNOL, V185, P2670, DOI 10.4049/jimmunol.1001610; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Veeranki S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027040; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Williams KL, 2005, J BIOL CHEM, V280, P39914, DOI 10.1074/jbc.M502820200; Willingham SB, 2009, J IMMUNOL, V183, P2008, DOI 10.4049/jimmunol.0900138; Witzenrath M, 2011, J IMMUNOL, V187, P434, DOI 10.4049/jimmunol.1003143; Yamasaki K, 2009, J BIOL CHEM, V284, P12762, DOI 10.1074/jbc.M806084200; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146; Young JL, 2000, J EXP MED, V191, P1535, DOI 10.1084/jem.191.9.1535; Zaki MH, 2011, CANCER CELL, V20, P649, DOI 10.1016/j.ccr.2011.10.022; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	112	680	710	6	188	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2012	13	4					333	342		10.1038/ni.2237	http://dx.doi.org/10.1038/ni.2237			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	913OH	22430786	Green Published, Green Accepted			2022-12-18	WOS:000301886800007
J	Martinon, F; Chen, X; Lee, AH; Glimcher, LH				Martinon, Fabio; Chen, Xi; Lee, Ann-Hwee; Glimcher, Laurie H.			TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages	NATURE IMMUNOLOGY			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; LIVE VACCINE STRAIN; FRANCISELLA-TULARENSIS INFECTION; INFLAMMATORY RESPONSE; ER STRESS; NEGATIVE REGULATOR; SYSTEMS BIOLOGY; HOST-DEFENSE; PATHWAY	Sensors of pathogens, such as Toll-like receptors (TLRs), detect microbes to activate transcriptional programs that orchestrate adaptive responses to specific insults. Here we report that TLR4 and TLR2 specifically activated the endoplasmic reticulum ( ER) stress sensor kinase IRE1. and its downstream target, the transcription factor XBP1. Previously described ER-stress target genes of XBP1 were not induced by TLR signaling. Instead, TLR-activated XBP1 was required for optimal and sustained production of proinflammatory cytokines in macrophages. Consistent with that finding, activation of IRE1. by ER stress acted in synergy with TLR activation for cytokine production. Moreover, XBP1 deficiency resulted in a much greater bacterial burden in mice infected with the TLR2-activating human intracellular pathogen Francisella tularensis. Our findings identify an unsuspected critical function for XBP1 in mammalian host defenses.	[Martinon, Fabio; Chen, Xi; Lee, Ann-Hwee; Glimcher, Laurie H.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Lee, Ann-Hwee; Glimcher, Laurie H.] Harvard Univ, Sch Med, Dept Med, MIT & Harvard, Boston, MA USA; [Glimcher, Laurie H.] Harvard Univ, Sch Med, Ragon Inst MGH, MIT & Harvard, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Ragon Institute	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	lglimche@hsph.harvard.edu	Chen, Xi/C-6889-2012; Martinon, Fabio/A-5575-2009	Martinon, Fabio/0000-0002-6969-822X; Chen, Xi/0000-0002-7995-6202	National Institutes of Health [AI32412, AI56296]; Leukemia and Lymphoma Society; Human Frontier Science Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032412, P01AI056296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Greenblatt, M. Wein, V. Lazarevic and C. Hetz for comments on the manuscript; D. Malhotra for assistance with the experiments in Figures 3 and 4; A. Bolm for technical assistance; G. Chu for analysis of liver histology, V. Lazarevic, I. Kramnik and R. Pollack for help with the F. tularensis aerosol setup; S. Akira (Osaka University) and D. Goldstein (Yale University) for MyD88deficient mice; R. Medzhitov (Yale University) for TIRAP- knockout mice; K. Mori (Kyoto University) for antibody to ATF6 alpha (anti-ATF6 alpha); J. Tschopp (University of Lausanne) for anti-pro-IL-1 beta; John Patterson (MannKind) for the active recombinant IRE1a fragment; and the Broad Institute for reagents. Supported by the National Institutes of Health (AI32412 and AI56296), the Ragon Institute of MGH, MIT and Harvard (L.H.G.), the American Heart Association (A.-H.L.), the Leukemia and Lymphoma Society (X.C.) and the Human Frontier Science Program (F.M.).	Abplanalp AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007920; Bhoj VG, 2008, CELL, V134, P569, DOI 10.1016/j.cell.2008.08.010; Bischof LJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000176; Blumenthal A, 2005, INFECT IMMUN, V73, P3330, DOI 10.1128/IAI.73.6.3330-3341.2005; Cole LE, 2007, INFECT IMMUN, V75, P4127, DOI 10.1128/IAI.01868-06; Cole LE, 2006, J IMMUNOL, V176, P6888, DOI 10.4049/jimmunol.176.11.6888; Delay ML, 2009, ARTHRITIS RHEUM-US, V60, P2633, DOI 10.1002/art.24763; Elkins KL, 2007, ANN NY ACAD SCI, V1105, P284, DOI 10.1196/annals.1409.014; Elkins KL, 1999, INFECT IMMUN, V67, P6002, DOI 10.1128/IAI.67.11.6002-6007.1999; Endo M, 2005, J BIOCHEM, V138, P501, DOI 10.1093/jb/mvi143; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Goodall JC, 2007, RHEUMATOLOGY, V46, P232, DOI 10.1093/rheumatology/kel226; Grandvaux N, 2007, BIOCHIMIE, V89, P1113, DOI 10.1016/j.biochi.2007.04.008; Ha YJ, 2004, J IMMUNOL, V172, P231, DOI 10.4049/jimmunol.172.1.231; Honma K, 2005, P NATL ACAD SCI USA, V102, P16001, DOI 10.1073/pnas.0504226102; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Ishiai M, 2008, NAT STRUCT MOL BIOL, V15, P1138, DOI 10.1038/nsmb.1504; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Katz J, 2006, INFECT IMMUN, V74, P2809, DOI 10.1128/IAI.74.5.2809-2816.2006; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Lyons CR, 2007, ANN NY ACAD SCI, V1105, P238, DOI 10.1196/annals.1409.003; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Malik M, 2006, INFECT IMMUN, V74, P3657, DOI 10.1128/IAI.02030-05; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Ravasi T, 2007, BIOESSAYS, V29, P1215, DOI 10.1002/bies.20683; Roach JC, 2007, P NATL ACAD SCI USA, V104, P16245, DOI 10.1073/pnas.0707757104; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sansonetti PJ, 2006, NAT IMMUNOL, V7, P1237, DOI 10.1038/ni1420; Schroder M, 2004, EMBO J, V23, P2281, DOI 10.1038/sj.emboj.7600233; Schurr JR, 2005, INFECT IMMUN, V73, P532, DOI 10.1128/IAI.73.1.532-545.2005; Sha HB, 2009, CELL METAB, V9, P556, DOI 10.1016/j.cmet.2009.04.009; Smith JA, 2008, EUR J IMMUNOL, V38, P1194, DOI 10.1002/eji.200737882; Summerton JE, 2005, ANN NY ACAD SCI, V1058, P62, DOI 10.1196/annals.1359.012; Takeshita F, 2005, EUR J IMMUNOL, V35, P2477, DOI 10.1002/eji.200526151; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Woo CW, 2009, NAT CELL BIOL, V11, P1473, DOI 10.1038/ncb1996; Xue X, 2005, J BIOL CHEM, V280, P33917, DOI 10.1074/jbc.M505818200; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	54	680	706	2	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2010	11	5					411	U71		10.1038/ni.1857	http://dx.doi.org/10.1038/ni.1857			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	585TN	20351694	Green Accepted			2022-12-18	WOS:000276852200010
J	Thery, C; Duban, L; Segura, E; Veron, P; Lantz, O; Amigorena, S				Thery, C; Duban, L; Segura, E; Veron, P; Lantz, O; Amigorena, S			Indirect activation of naive CD4(+) T cells by dendritic cell-derived exosomes	NATURE IMMUNOLOGY			English	Article							SURFACE; MOLECULES; VESICLES; ANTIGENS	Dendritic cells (DCs) secrete vesicles of endosomal origin, called exosomes, that bear major histocompatibility complex (MHC) and T cell costimulatory molecules. Here, we found that injection of antigen- or peptide-bearing exosomes induced antigen- specific naive CD4+ T cell activation in vivo. In vitro, exosomes did not induce antigen- dependent T cell stimulation unless mature CD8alpha(-) DCs were also present in the cultures. These mature DCs could be MHC class II-negative, but had to bear CD80 and CD86. Therefore, in addition to carrying antigen, exosomes promote the exchange of functional peptide-MHC complexes between DCs. Such a mechanism may increase the number of DCs bearing a particular peptide, thus amplifying the initiation of primary adaptive immune responses.	Inst Curie, INSERM, U520, F-75005 Paris, France; Inst Curie, Lab Immunol Preclin, F-75005 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Amigorena, S (corresponding author), Inst Curie, INSERM, U520, 12 Rue Lhomond, F-75005 Paris, France.		Lantz, Olivier J/J-4960-2012; thery, clotilde/F-6373-2013; Veron, Philippe/P-9557-2018; Segura, Elodie/K-7614-2017	Lantz, Olivier J/0000-0003-3161-7719; thery, clotilde/0000-0001-8294-6884; Veron, Philippe/0000-0002-0751-304X; Segura, Elodie/0000-0003-1795-1921; Amigorena, Sebastian/0000-0001-8583-8416				Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; De Smedt T, 2001, J LEUKOCYTE BIOL, V69, P951; Denzer K, 2000, J IMMUNOL, V165, P1259, DOI 10.4049/jimmunol.165.3.1259; Gahmberg CG, 1997, CURR OPIN CELL BIOL, V9, P643, DOI 10.1016/S0955-0674(97)80117-2; GRAY D, 1991, INT IMMUNOL, V3, P141, DOI 10.1093/intimm/3.2.141; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; Kumaraguru U, 2000, J IMMUNOL, V165, P750, DOI 10.4049/jimmunol.165.2.750; Lantz O, 2000, NAT IMMUNOL, V1, P54, DOI 10.1038/76917; Mack M, 2000, NAT MED, V6, P769, DOI 10.1038/77498; Maldonado-Lopez R, 2001, SEMIN IMMUNOL, V13, P275, DOI 10.1006/smim.2001.0323; Moron G, 2002, J EXP MED, V195, P1233, DOI 10.1084/jem.20011930; Prina E, 1996, J IMMUNOL, V156, P4318; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Scott D, 2000, IMMUNITY, V12, P711, DOI 10.1016/S1074-7613(00)80221-6; SHARROW SO, 1981, J IMMUNOL, V126, P1327; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Sjostrom A, 2001, J EXP MED, V194, P1519, DOI 10.1084/jem.194.10.1519; Srivastava P, 2002, ANNU REV IMMUNOL, V20, P395, DOI 10.1146/annurev.immunol.20.100301.064801; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; STUBBS JD, 1990, P NATL ACAD SCI USA, V87, P8417, DOI 10.1073/pnas.87.21.8417; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741; Zimmer J, 2001, J EXP MED, V194, P1531, DOI 10.1084/jem.194.10.1531; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	30	674	692	4	50	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2002	3	12					1156	1162		10.1038/ni854	http://dx.doi.org/10.1038/ni854			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	619GP	12426563				2022-12-18	WOS:000179467800013
J	Chomarat, P; Banchereau, J; Davoust, J; Palucka, AK				Chomarat, P; Banchereau, J; Davoust, J; Palucka, AK			IL-6 switches the differentiation of monocytes from dendritic cells to macrophages	NATURE IMMUNOLOGY			English	Article							COLONY-STIMULATING FACTOR; INTERLEUKIN-6; MICE; PROGENITORS; EXPRESSION; RECEPTOR; CLONING; BLOOD	Monocytes can give rise to either antigen presenting dendritic cells (DCs) or scavenging macrophages. This differentiation is initiated when monocytes cross the endothelium. But the regulation of DC and macrophage differentiation in tissues remains elusive. When stimulated with granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-4 (IL-4), monocytes yield DCs, However, we show here that the addition of fibroblasts switches differentiation to macrophages. On contact with monocytes, fibroblasts release IL-6, which up-regulates the expression of functional M-CSF receptors on monocytes. This allows the monocytes to consume their autocrine M-CSF, Thus, the interplay between IL-6 and M-CSF switches monocyte differentiation to macrophages rather than DCs, and IL-6 is an essential factor in the molecular control of antigen presenting cell development.	Baylor Inst Immunol Res, Dallas, TX 75204 USA	Baylor Scott & White Health	Palucka, AK (corresponding author), Baylor Inst Immunol Res, 3434 Live Oak, Dallas, TX 75204 USA.		Li, Chia Cheng/D-9906-2015; Davoust, Jean/ABB-6720-2020	Davoust, Jean/0000-0002-3098-7665	NATIONAL CANCER INSTITUTE [R01CA078846] Funding Source: NIH RePORTER; NCI NIH HHS [CA-78846-01A1] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BECKER S, 1987, J IMMUNOL, V139, P3703; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Ladel CH, 1997, INFECT IMMUN, V65, P4843, DOI 10.1128/IAI.65.11.4843-4849.1997; Mekori YA, 2000, IMMUNOL REV, V173, P131, DOI 10.1034/j.1600-065X.2000.917305.x; Menetrier-Caux C, 1998, BLOOD, V92, P4778, DOI 10.1182/blood.V92.12.4778; Mitani H, 2000, BRIT J HAEMATOL, V109, P288, DOI 10.1046/j.1365-2141.2000.02020.x; Palucka KA, 1998, J IMMUNOL, V160, P4587; Peters M, 1996, J EXP MED, V183, P1399, DOI 10.1084/jem.183.4.1399; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Steinmann RM, 1999, ANNU REV IMMUNOL, V9, P271; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; YAMASAKI K, 1988, SCIENCE, V241, P825, DOI 10.1126/science.3136546; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588	18	674	697	1	39	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2000	1	6					510	514		10.1038/82763	http://dx.doi.org/10.1038/82763			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	380VR	11101873				2022-12-18	WOS:000165724600015
J	Dillon, SR; Sprecher, C; Hammond, A; Bilsborough, J; Rosenfeld-Franklin, M; Presnell, SR; Haugen, HS; Maurer, M; Harder, B; Johnston, J; Bort, S; Mudri, S; Kuijper, JL; Bukowski, T; Shea, P; Dong, DL; Dasovich, M; Grant, FJ; Lockwood, L; Levin, SD; LeCiel, C; Waggie, K; Day, H; Topouzis, S; Kramer, J; Kuestner, R; Chen, Z; Foster, D; Parrish-Novak, J; Gross, JA				Dillon, SR; Sprecher, C; Hammond, A; Bilsborough, J; Rosenfeld-Franklin, M; Presnell, SR; Haugen, HS; Maurer, M; Harder, B; Johnston, J; Bort, S; Mudri, S; Kuijper, JL; Bukowski, T; Shea, P; Dong, DL; Dasovich, M; Grant, FJ; Lockwood, L; Levin, SD; LeCiel, C; Waggie, K; Day, H; Topouzis, S; Kramer, J; Kuestner, R; Chen, Z; Foster, D; Parrish-Novak, J; Gross, JA			Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice	NATURE IMMUNOLOGY			English	Article							ATOPIC-DERMATITIS; AUTOIMMUNE-DISEASE; IMMUNE-RESPONSES; SKIN-DISEASE; EXPRESSION; RECEPTOR; ANTIGEN; KERATINOCYTES; LYMPHOCYTES; MECHANISMS	T cell-derived cytokines are important in the development of an effective immune response, but when dysregulated they can promote disease. Here we identify a four-helix bundle cytokine we have called interleukin 31 (IL-31), which is preferentially produced by T helper type 2 cells. IL-31 signals through a receptor composed of IL-31 receptor A and oncostatin M receptor. Expression of IL-31 receptor A and oncostatin M receptor mRNA was induced in activated monocytes, whereas epithelial cells expressed both mRNAs constitutively. Transgenic mice overexpressing IL-31 developed severe pruritis, alopecia and skin lesions. Furthermore, IL-31 receptor expression was increased in diseased tissues derived from an animal model of airway hypersensitivity. These data indicate that IL-31 may be involved in promoting the dermatitis and epithelial responses that characterize allergic and non-allergic diseases.	Zymogenet Inc, Dept Immunol, Seattle, WA 98102 USA; Zymogenet Inc, Dept Cytokine Biol, Seattle, WA 98102 USA; Zymogenet Inc, Dept Preclin Dev, Seattle, WA 98102 USA; Zymogenet Inc, Dept Comp Sci, Seattle, WA 98102 USA; Zymogenet Inc, Dept Genet, Seattle, WA 98102 USA; Zymogenet Inc, Dept Prot Biochem, Seattle, WA 98102 USA; Zymogenet Inc, Dept In Vitro Biol, Seattle, WA 98102 USA	Zymogenet Inc.; Zymogenet Inc.; Zymogenet Inc.; Zymogenet Inc.; Zymogenet Inc.; Zymogenet Inc.; Zymogenet Inc.	Gross, JA (corresponding author), Zymogenet Inc, Dept Immunol, 1201 Eastlake Ave E, Seattle, WA 98102 USA.	grossj@zgi.com						Akdis CA, 1999, J INVEST DERMATOL, V113, P628, DOI 10.1046/j.1523-1747.1999.00720.x; Boulay JL, 2003, IMMUNITY, V19, P159, DOI 10.1016/S1074-7613(03)00211-5; Chan LS, 2001, J INVEST DERMATOL, V117, P977, DOI 10.1046/j.0022-202x.2001.01484.x; Chtanova T, 2001, J IMMUNOL, V167, P3057, DOI 10.4049/jimmunol.167.6.3057; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; Dabbagh K, 2002, J IMMUNOL, V168, P4524, DOI 10.4049/jimmunol.168.9.4524; Diveu C, 2003, J BIOL CHEM, V278, P49850, DOI 10.1074/jbc.M307286200; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Ghilardi N, 2002, J BIOL CHEM, V277, P16831, DOI 10.1074/jbc.M201140200; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Gross JA, 2001, IMMUNITY, V15, P289, DOI 10.1016/S1074-7613(01)00183-2; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; Hwang S T, 2001, Adv Dermatol, V17, P211; Iritani BM, 1997, EMBO J, V16, P7019, DOI 10.1093/emboj/16.23.7019; Konishi H, 2002, P NATL ACAD SCI USA, V99, P11340, DOI 10.1073/pnas.152337799; Leung DYM, 2003, LANCET, V361, P151, DOI 10.1016/S0140-6736(03)12193-9; LOK S, 1994, NATURE, V369, P565, DOI 10.1038/369565a0; Matsuda H, 1997, INT IMMUNOL, V9, P461, DOI 10.1093/intimm/9.3.461; Matsushima H, 2003, J DERMATOL SCI, V32, P223, DOI 10.1016/S0923-1811(03)00106-3; NICKOLOFF BJ, 1994, J AM ACAD DERMATOL, V30, P535, DOI 10.1016/S0190-9622(94)70059-1; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; Raby BA, 2003, HUM MOL GENET, V12, P1973, DOI 10.1093/hmg/ddg208; Robert C, 1999, NEW ENGL J MED, V341, P1817, DOI 10.1056/NEJM199912093412407; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; SPRANG SR, 1993, CURR OPIN STRUC BIOL, V3, P815, DOI 10.1016/0959-440X(93)90144-A; Stander S, 2002, EXP DERMATOL, V11, P12, DOI 10.1034/j.1600-0625.2002.110102.x; Taboit-Dameron F, 1999, TRANSGENIC RES, V8, P223, DOI 10.1023/A:1008919925303; Tomkinson A, 2001, J IMMUNOL, V166, P5792, DOI 10.4049/jimmunol.166.9.5792; Trautmann A, 2001, TRENDS IMMUNOL, V22, P530, DOI 10.1016/S1471-4906(01)02004-X; Uzel G, 2001, CLIN IMMUNOL, V100, P270, DOI 10.1006/clim.2001.5078; Vestergaard C, 2000, J INVEST DERMATOL, V115, P640, DOI 10.1046/j.1523-1747.2000.00115.x; Warshamana GS, 2001, EXP MOL PATHOL, V71, P13, DOI 10.1006/exmp.2001.2376; Wilkins MF, 1996, COMPUT APPL BIOSCI, V12, P9; Williams IR, 1997, J IMMUNOL, V159, P3044; Woodward AL, 2001, J ALLERGY CLIN IMMUN, V107, P359, DOI 10.1067/mai.2001.112695	37	671	759	5	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2004	5	7					752	760		10.1038/ni1084	http://dx.doi.org/10.1038/ni1084			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	833IO	15184896				2022-12-18	WOS:000222331200029
J	Fritz, JH; Ferrero, RL; Philpott, DJ; Girardin, SE				Fritz, Jorg H.; Ferrero, Richard L.; Philpott, Dana J.; Girardin, Stephen E.			Nod-like proteins in immunity, inflammation and disease	NATURE IMMUNOLOGY			English	Review							NF-KAPPA-B; INTESTINAL EPITHELIAL-CELLS; LEGIONELLA-PNEUMOPHILA INFECTION; PATTERN-RECOGNITION RECEPTOR; TOLL-LIKE RECEPTORS; CROHNS-DISEASE; DIAMINOPIMELIC ACID; INNATE IMMUNITY; OLIGOMERIZATION DOMAIN-2; BACTERIAL PEPTIDOGLYCAN	The intracellular Nod-like proteins or receptors are a family of sensors of intracellularly encountered microbial motifs and 'danger signals' that have emerged as being critical components of the innate immune responses and of inflammation in mammals. Several Nod-like receptors, including Nod 1, Nod2, NALP3, lpaf and Naip, are strongly associated with host responses to intracellular invasion by bacteria or the intracellular presence of specific bacterial products. An additional key function of Nod-like receptors is in inflammatory conditions, which has been emphasized by the identification of several different mutations in the genes encoding Nod1, Nod2 and NALP3 that are associated with susceptibility to inflammatory disorders. Those and other issues related to the Nod-like receptor family are discussed here.	Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada	University of Toronto; Monash University; University of Toronto	Philpott, DJ (corresponding author), Univ Toronto, Dept Immunol, Med Sci Bldg, Toronto, ON M5S 1A8, Canada.	dana.philpott@utoronto.ca	Ferrero, Richard/U-1332-2017	Ferrero, Richard/0000-0001-6817-6211				Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Barnich N, 2005, J CELL BIOL, V170, P21, DOI 10.1083/jcb.200502153; Barnich N, 2005, J BIOL CHEM, V280, P19021, DOI 10.1074/jbc.M413776200; Belkhadir Y, 2004, CURR OPIN PLANT BIOL, V7, P391, DOI 10.1016/j.pbi.2004.05.009; Boughan PK, 2006, J BIOL CHEM, V281, P11637, DOI 10.1074/jbc.M510275200; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chen CM, 2004, J BIOL CHEM, V279, P25876, DOI 10.1074/jbc.M400682200; Derre I, 2004, INFECT IMMUN, V72, P6221, DOI 10.1128/IAI.72.11.6221-6229.2004; DEYOUNG B, 2006, NAT IMMUNOL, V7; Diez E, 2003, NAT GENET, V33, P55, DOI 10.1038/ng1065; Dufner A, 2006, P NATL ACAD SCI USA, V103, P988, DOI 10.1073/pnas.0510380103; Ferwerda G, 2005, PLOS PATHOG, V1, P279, DOI 10.1371/journal.ppat.0010034; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Glomski IJ, 2007, CELL MICROBIOL, V9, P502, DOI 10.1111/j.1462-5822.2006.00806.x; Greene CM, 2005, J IMMUNOL, V174, P1638, DOI 10.4049/jimmunol.174.3.1638; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Hasegawa M, 2005, J BIOL CHEM, V280, P15122, DOI 10.1074/jbc.M412284200; Hasegawa M, 2006, J BIOL CHEM, V281, P29054, DOI 10.1074/jbc.M602638200; HIBINO T, 2006, DEV BIOL        0903, DOI DOI 10.1016/J.YDB23.2006.08.065; Hirata Y, 2006, J IMMUNOL, V176, P3796, DOI 10.4049/jimmunol.176.6.3796; Hisamatsu T, 2003, GASTROENTEROLOGY, V124, P993, DOI 10.1053/gast.2003.50153; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hysi P, 2005, HUM MOL GENET, V14, P935, DOI 10.1093/hmg/ddi087; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kim JG, 2004, INFECT IMMUN, V72, P1487, DOI 10.1128/IAI.72.3.1487-1495.2004; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kufer TA, 2006, INFECT IMMUN, V74, P3115, DOI 10.1128/IAI.00035-06; Kufer TA, 2005, TRENDS MICROBIOL, V13, P381, DOI 10.1016/j.tim.2005.06.004; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; LeibundGut-Landmann S, 2004, EUR J IMMUNOL, V34, P1513, DOI 10.1002/eji.200424964; Li J, 2004, HUM MOL GENET, V13, P1715, DOI 10.1093/hmg/ddh182; Li LY, 2005, J CELL SCI, V118, P555, DOI 10.1242/jcs.01641; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Magalhaes JG, 2005, EMBO REP, V6, P1201, DOI 10.1038/sj.embor.7400552; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Marks DJB, 2006, LANCET, V367, P668, DOI 10.1016/S0140-6736(06)68265-2; Marriott I, 2005, INFECT IMMUN, V73, P2967, DOI 10.1128/IAI.73.5.2967-2973.2005; Martel-Pelletier J, 2004, J RHEUMATOL, V31, P14; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Martinon F, 2006, J CLIN INVEST, V116, P2073, DOI 10.1172/JCI29404; Masumoto J, 2006, J EXP MED, V203, P203, DOI 10.1084/jem.20051229; McDonald C, 2005, J BIOL CHEM, V280, P40301, DOI 10.1074/jbc.M508538200; McGovern DPB, 2005, HUM MOL GENET, V14, P1245, DOI 10.1093/hmg/ddi135; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Netea MG, 2005, J BIOL CHEM, V280, P35859, DOI 10.1074/jbc.M504924200; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Opitz B, 2006, J IMMUNOL, V176, P484, DOI 10.4049/jimmunol.176.1.484; Opitz B, 2005, CIRC RES, V96, P319, DOI 10.1161/01.RES.0000155721.83594.2c; Opitz B, 2004, J BIOL CHEM, V279, P36426, DOI 10.1074/jbc.M403861200; Otte JM, 2003, GASTROENTEROLOGY, V124, P1866, DOI 10.1016/S0016-5085(03)00403-7; Pauleau AL, 2003, MOL CELL BIOL, V23, P7531, DOI 10.1128/MCB.23.21.7531-7539.2003; Phillips C, 2000, CANCER PRACT, V8, P165, DOI 10.1046/j.1523-5394.2000.84009.x; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Schafer ZT, 2006, DEV CELL, V10, P549, DOI 10.1016/j.devcel.2006.04.008; Sterka D, 2006, GLIA, V53, P322, DOI 10.1002/glia.20286; Sterka D, 2006, J NEUROIMMUNOL, V179, P65, DOI 10.1016/j.jneuroim.2006.06.009; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Travassos LH, 2005, J BIOL CHEM, V280, P36714, DOI 10.1074/jbc.M501649200; Uehara A, 2005, CELL MICROBIOL, V7, P53, DOI 10.1111/j.1462-5822.2004.00433.x; Uehara A, 2006, J IMMUNOL, V177, P1796, DOI 10.4049/jimmunol.177.3.1796; Uematsu S, 2006, J MOL MED-JMM, V84, P712, DOI 10.1007/s00109-006-0084-y; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Watanabe T, 2006, IMMUNITY, V25, P473, DOI 10.1016/j.immuni.2006.06.018; Welter-Stahl L, 2006, CELL MICROBIOL, V8, P1047, DOI 10.1111/j.1462-5822.2006.00686.x; Werts C, 2006, CELL DEATH DIFFER, V13, P798, DOI 10.1038/sj.cdd.4401890; Wright EK, 2003, CURR BIOL, V13, P27, DOI 10.1016/S0960-9822(02)01359-3; Wright KL, 2006, TRENDS IMMUNOL, V27, P405, DOI 10.1016/j.it.2006.07.007; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305	84	669	704	1	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2006	7	12					1250	1257		10.1038/ni1412	http://dx.doi.org/10.1038/ni1412			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	106TU	17110941				2022-12-18	WOS:000242125200004
J	Hooper, LV; Stappenbeck, TS; Hong, CV; Gordon, JI				Hooper, LV; Stappenbeck, TS; Hong, CV; Gordon, JI			Angiogenins: a new class of microbicidal proteins involved in innate immunity	NATURE IMMUNOLOGY			English	Article							RIBONUCLEOLYTIC ACTIVITY; ESCHERICHIA-COLI; MESSENGER-RNA; PANETH CELLS; PURIFICATION; EXPRESSION; DEFENSINS; INTESTINE; FAMILY; TUMOR	Although angiogenins have been implicated in tumor-associated angiogenesis, their normal physiologic function remains unclear. We show that a previously uncharacterized angiogenin, Ang4, is produced by mouse Paneth cells, is secreted into the gut lumen and has bactericidal activity against intestinal microbes. Ang4 expression is induced by Bacteroides thetaiotaomicron, a predominant member of the gut microflora, revealing a mechanism whereby intestinal commensal bacteria influence gut microbial ecology and shape innate immunity. Furthermore, mouse Ang1 and human angiogenin, circulating proteins induced during inflammation, exhibit microbicidal activity against systemic bacterial and fungal pathogens, suggesting that they contribute to systemic responses to infection. These results establish angiogenins as a family of endogenous antimicrobial proteins.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL)	Gordon, JI (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA.				NIDDK NIH HHS [DK02954, P30 DK52574, DK30292] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002954, R01DK030292, R37DK030292, P30DK052574] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; FETT JW, 1985, BIOCHEMISTRY-US, V24, P5480, DOI 10.1021/bi00341a030; Fu XY, 1999, GROWTH FACTORS, V17, P125, DOI 10.3109/08977199909103521; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Glaser P, 2001, SCIENCE, V294, P849; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Holloway DE, 2001, PROTEIN EXPRES PURIF, V22, P307, DOI 10.1006/prep.2001.1434; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Kao RYT, 2002, P NATL ACAD SCI USA, V99, P10066, DOI 10.1073/pnas.152342999; LEHRER RI, 1993, ANNU REV IMMUNOL, V11, P105, DOI 10.1146/annurev.iy.11.040193.000541; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Nobile V, 1996, P NATL ACAD SCI USA, V93, P4331, DOI 10.1073/pnas.93.9.4331; Olson KA, 1998, BIOCHEM BIOPH RES CO, V242, P480, DOI 10.1006/bbrc.1997.7990; PANYUTICH AV, 1995, AM J RESP CELL MOL, V12, P351, DOI 10.1165/ajrcmb.12.3.7873202; PANYUTICH AV, 1994, FEBS LETT, V356, P169, DOI 10.1016/0014-5793(94)01261-X; Putsep K, 2000, J BIOL CHEM, V275, P40478, DOI 10.1074/jbc.M007816200; ROSENBERG HF, 1995, J BIOL CHEM, V270, P7876, DOI 10.1074/jbc.270.14.7876; Rosenberg HF, 2001, J LEUKOCYTE BIOL, V70, P691; RYBAK SM, 1987, BIOCHEM BIOPH RES CO, V146, P1240, DOI 10.1016/0006-291X(87)90781-9; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; SAXENA SK, 1992, J BIOL CHEM, V267, P21982; SHAPIRO R, 1987, P NATL ACAD SCI USA, V84, P8783, DOI 10.1073/pnas.84.24.8783; Strydom DJ, 1998, CELL MOL LIFE SCI, V54, P811, DOI 10.1007/s000180050210; WEINER HL, 1987, SCIENCE, V237, P280, DOI 10.1126/science.2440105; Zhang JZ, 2002, MOL BIOL EVOL, V19, P438, DOI 10.1093/oxfordjournals.molbev.a004099	29	668	720	3	72	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2003	4	3					269	273		10.1038/ni888	http://dx.doi.org/10.1038/ni888			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	649HH	12548285				2022-12-18	WOS:000181201000016
J	Galli, SJ; Borregaard, N; Wynn, TA				Galli, Stephen J.; Borregaard, Niels; Wynn, Thomas A.			Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils	NATURE IMMUNOLOGY			English	Review							ALTERNATIVELY ACTIVATED MACROPHAGES; COLONY-STIMULATING FACTOR; NF-KAPPA-B; SUPPRESSOR-CELLS; HEMATOPOIETIC STEM; ADIPOSE-TISSUE; DENDRITIC CELLS; M2 MACROPHAGES; CUTTING EDGE; I EXPRESSION	Hematopoietic cells, including lymphoid and myeloid cells, can develop into phenotypically distinct 'subpopulations' with different functions. However, evidence indicates that some of these subpopulations can manifest substantial plasticity (that is, undergo changes in their phenotype and function). Here we focus on the occurrence of phenotypically distinct subpopulations in three lineages of myeloid cells with important roles in innate and acquired immunity: macrophages, mast cells and neutrophils. Cytokine signals, epigenetic modifications and other microenvironmental factors can substantially and, in some cases, rapidly and reversibly alter the phenotype of these cells and influence their function. This suggests that regulation of the phenotype and function of differentiated hematopoietic cells by microenvironmental factors, including those generated during immune responses, represents a common mechanism for modulating innate or adaptive immunity.	[Galli, Stephen J.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Galli, Stephen J.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Borregaard, Niels] Univ Copenhagen, Dept Hematol, Natl Univ Hosp, Copenhagen, Denmark; [Wynn, Thomas A.] NIAID, Parasit Dis Lab, Program Barrier Immun & Repair, Bethesda, MD 20892 USA	Stanford University; Stanford University; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Galli, SJ (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	sgalli@stanford.edu; borregaard@rh.dk; twynn@niaid.nih.gov	Wynn, Thomas A/AAO-3523-2021; Wynn, Thomas A/C-2797-2011	Wynn, Thomas A/0000-0002-7244-8731; 	US National Institutes of Health [AI70813, AI23990, CA72074]; Danish National Research Council; National Institute of Allergy and Infectious Diseases, US National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA072074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023990, R37AI023990, ZIAAI001019] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish National Research Council(Danmarks Grundforskningsfond); National Institute of Allergy and Infectious Diseases, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Tsai and J. Kalesnikoff for discussions; and J. Lilla for help with Figure 2. Supported by the US National Institutes of Health (AI70813, AI23990 and CA72074 to S.J.G.), the Danish National Research Council (N.B.) and the intramural research program of the National Institute of Allergy and Infectious Diseases, US National Institutes of Health (T.A.W.).	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Ahn K, 2000, J ALLERGY CLIN IMMUN, V106, P321, DOI 10.1067/mai.2000.108107; Akahoshi M, 2011, J CLIN INVEST, V121, P4180, DOI 10.1172/JCI46139; Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1451; Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Blank U, 2004, TRENDS IMMUNOL, V25, P266, DOI 10.1016/j.it.2004.03.005; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Boyce JA, 2007, IMMUNOL REV, V217, P168, DOI 10.1111/j.1600-065X.2007.00512.x; Bryce PJ, 2004, IMMUNITY, V20, P381, DOI 10.1016/S1074-7613(04)00080-9; Carson WF, 2011, EPIGENETICS-US, V6, P273, DOI 10.4161/epi.6.3.14017; Caughey GH, 2007, IMMUNOL REV, V217, P141, DOI 10.1111/j.1600-065X.2007.00509.x; Chen CW, 2011, J LEUKOCYTE BIOL, V90, P221, DOI 10.1189/jlb.0111006; Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938; Corzo CA, 2009, J IMMUNOL, V182, P5693, DOI 10.4049/jimmunol.0900092; CRAIG SS, 1989, IMMUNOL RES, V8, P130, DOI 10.1007/BF02919075; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Cuenca AG, 2011, MOL MED, V17, P281, DOI 10.2119/molmed.2010.00178; Curran JN, 2006, WOUND REPAIR REGEN, V14, P376, DOI 10.1111/j.1743-6109.2006.00151.x; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Delano MJ, 2007, J EXP MED, V204, P1463, DOI 10.1084/jem.20062602; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Dudeck A, 2011, IMMUNITY, V34, P973, DOI 10.1016/j.immuni.2011.03.028; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Elkabets M, 2010, EUR J IMMUNOL, V40, P3347, DOI 10.1002/eji.201041037; Feuk-Lagerstedt E, 1999, J IMMUNOL, V163, P5592; Fridlender ZG, 2010, CANCER RES, V70, P109, DOI 10.1158/0008-5472.CAN-09-2326; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Friend DS, 1996, J CELL BIOL, V135, P279, DOI 10.1083/jcb.135.1.279; Gabrilovich DI, 2007, CANCER RES, V67, P425, DOI 10.1158/0008-5472.CAN-06-3037; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; Galli SJ, 2010, EUR J IMMUNOL, V40, P1843, DOI 10.1002/eji.201040559; Gebhardt T, 2005, GUT, V54, P928, DOI 10.1136/gut.2004.054650; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; GOLDSCHMEDING R, 1992, BRIT J HAEMATOL, V81, P336, DOI 10.1111/j.1365-2141.1992.tb08237.x; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Grimbaldeston MA, 2007, NAT IMMUNOL, V8, P1095, DOI 10.1038/ni1503; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Hirahara K, 2010, CYTOKINE GROWTH F R, V21, P425, DOI 10.1016/j.cytogfr.2010.10.006; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Imtiyaz HZ, 2010, CURR TOP MICROBIOL, V345, P105, DOI 10.1007/82_2010_74; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Jerke U, 2011, J BIOL CHEM, V286, P7070, DOI 10.1074/jbc.M110.171256; Johnson BA, 2010, P NATL ACAD SCI USA, V107, P10644, DOI 10.1073/pnas.0914347107; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; KANAKURA Y, 1988, BLOOD, V72, P877; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Kawanishi N, 2010, EXERC IMMUNOL REV, V16, P105; Kelly-Scumpia KM, 2010, J EXP MED, V207, P319, DOI 10.1084/jem.20091959; Kirshenbaum AS, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-45; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Krutzik SR, 2005, NAT MED, V11, P653, DOI 10.1038/nm1246; Kuroda E, 2009, J IMMUNOL, V183, P3652, DOI 10.4049/jimmunol.0900864; Kusmartsev S, 2005, J IMMUNOL, V175, P4583, DOI 10.4049/jimmunol.175.7.4583; Landau G, 2010, J BIOL CHEM, V285, P12474, DOI 10.1074/jbc.M110.106419; LEVISCHAFFER F, 1986, P NATL ACAD SCI USA, V83, P6485, DOI 10.1073/pnas.83.17.6485; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; London A, 2011, J EXP MED, V208, P23, DOI 10.1084/jem.20101202; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mahabeleshwar GH, 2011, IMMUNITY, V34, P715, DOI 10.1016/j.immuni.2011.04.014; Maizels RM, 2009, J EXP MED, V206, P2059, DOI 10.1084/jem.20091903; Mancuso G, 2007, J IMMUNOL, V178, P3126, DOI 10.4049/jimmunol.178.5.3126; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; MARY JY, 1985, BIOMED PHARMACOTHER, V39, P66; Maurer M, 2004, NATURE, V432, P512, DOI 10.1038/nature03085; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; Moritz E, 2009, AN ACAD BRAS CIENC, V81, P559, DOI 10.1590/S0001-37652009000300019; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; MURAKAMI M, 1995, J BIOL CHEM, V270, P3239, DOI 10.1074/jbc.270.7.3239; Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409; Mylonas KJ, 2009, J IMMUNOL, V182, P3084, DOI 10.4049/jimmunol.0803463; Nardin A, 2008, FRONT BIOSCI-LANDMRK, V13, P3494; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Ninck S, 2003, INT J CANCER, V106, P34, DOI 10.1002/ijc.11188; Norman MU, 2008, AM J PATHOL, V172, P1638, DOI 10.2353/ajpath.2008.070559; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Palucka K, 2010, IMMUNITY, V33, P464, DOI 10.1016/j.immuni.2010.10.007; Pan H, 2010, IMMUNITY, V33, P620, DOI 10.1016/j.immuni.2010.10.009; Panopoulos AD, 2008, CYTOKINE, V42, P277, DOI 10.1016/j.cyto.2008.03.002; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; Pesce J, 2006, J CLIN INVEST, V116, P2044, DOI 10.1172/JCI27727; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Piliponsky AM, 2008, NAT MED, V14, P392, DOI 10.1038/nm1738; Piliponsky AM, 2010, AM J PATHOL, V176, P926, DOI 10.2353/ajpath.2010.090342; Pillay J, 2010, BLOOD, V116, P625, DOI 10.1182/blood-2010-01-259028; Rodriguez PC, 2008, IMMUNOL REV, V222, P180, DOI 10.1111/j.1600-065X.2008.00608.x; Rutschman R, 2001, J IMMUNOL, V166, P2173, DOI 10.4049/jimmunol.166.4.2173; Ryan JJ, 2007, CRIT REV IMMUNOL, V27, P15, DOI 10.1615/CritRevImmunol.v27.i1.20; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Sawanobori Y, 2008, BLOOD, V111, P5457, DOI 10.1182/blood-2008-01-136895; Sayed BA, 2008, ANNU REV IMMUNOL, V26, P705, DOI 10.1146/annurev.immunol.26.021607.090320; Schmidl C, 2011, EUR J IMMUNOL, V41, P1491, DOI 10.1002/eji.201041067; Schneider LA, 2007, J EXP MED, V204, P2629, DOI 10.1084/jem.20071262; Scumpia PO, 2010, J IMMUNOL, V184, P2247, DOI 10.4049/jimmunol.0903652; Serhan CN, 2008, ANNU REV PATHOL-MECH, V3, P279, DOI 10.1146/annurev.pathmechdis.3.121806.151409; Shizuru JA, 2005, ANNU REV MED, V56, P509, DOI 10.1146/annurev.med.54.101601.152334; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233; Srivastava MK, 2010, CANCER RES, V70, P68, DOI 10.1158/0008-5472.CAN-09-2587; Stevens RL, 2007, IMMUNOL REV, V217, P155, DOI 10.1111/j.1600-065X.2007.00525.x; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Thakurdas SM, 2007, J BIOL CHEM, V282, P20809, DOI 10.1074/jbc.M611842200; Theilgaard-Monch K, 2004, J IMMUNOL, V172, P7684, DOI 10.4049/jimmunol.172.12.7684; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; Toru H, 1998, BLOOD, V91, P187, DOI 10.1182/blood.V91.1.187.187_187_195; Ueda Y, 2005, J EXP MED, V201, P1771, DOI 10.1084/jem.20041419; Ueda Y, 2009, J IMMUNOL, V182, P6477, DOI 10.4049/jimmunol.0803961; Uutela M, 2004, BLOOD, V104, P3198, DOI 10.1182/blood-2004-04-1485; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; von Vietinghoff S, 2007, BLOOD, V109, P4487, DOI 10.1182/blood-2006-10-055327; Wasiuk A, 2009, CLIN EXP IMMUNOL, V155, P140, DOI 10.1111/j.1365-2249.2008.03840.x; Wilson MS, 2010, J EXP MED, V207, P535, DOI 10.1084/jem.20092121; Wolff J, 2003, BLOOD, V102, P731, DOI 10.1182/blood-2002-09-2831; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Xia HZ, 1997, J IMMUNOL, V159, P2911; Yamaguchi M, 1999, J IMMUNOL, V162, P5455; Yu M, 2011, J CLIN INVEST, V121, P3133, DOI 10.1172/JCI43598; Zhang HY, 2010, BLOOD, V116, P2462, DOI 10.1182/blood-2009-12-259630; Zhu JF, 2010, CELL RES, V20, P4, DOI 10.1038/cr.2009.138	140	664	684	1	153	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2011	12	11					1035	1044		10.1038/ni.2109	http://dx.doi.org/10.1038/ni.2109			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	841GG	22012443	Green Accepted			2022-12-18	WOS:000296500100008
J	Batten, M; Li, J; Yi, S; Kljavin, NM; Danilenko, DM; Lucas, S; Lee, J; de Sauvage, FJ; Ghilardi, N				Batten, Marcel; Li, Ji; Yi, Sothy; Kljavin, Noelyn M.; Danilenko, Dimitry M.; Lucas, Sophie; Lee, James; de Sauvage, Frederic J.; Ghilardi, Nico			Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells	NATURE IMMUNOLOGY			English	Article							I CYTOKINE RECEPTOR; TOXOPLASMA-GONDII; TRYPANOSOMA-CRUZI; IL-2 PRODUCTION; INFLAMMATION; WSX-1; MICE; INFECTION; RESISTANCE; DIFFERENTIATION	Interleukin 27 (IL-27) was first characterized as a proinflammatory cytokine with T helper type 1-inducing activity. However, subsequent work has demonstrated that mice deficient in IL-27 receptor (IL-27Ra) show exacerbated inflammatory responses to a variety of challenges, suggesting that IL-27 has important immunoregulatory functions in vivo. Here we demonstrate that IL-27Ra-deficient mice were hypersusceptible to experimental autoimmune encephalomyelitis and generated more IL-17-producing T helper cells. IL-27 acted directly on effector T cells to suppress the development of IL-17-producing T helper cells mediated by IL-6 and transforming growth factor-beta. This suppressive activity was dependent on the transcription factor STAT1 and was independent of interferon-gamma. Finally, IL-27 suppressed IL-6-mediated T cell proliferation. These data provide a mechanistic explanation for the IL-27-mediated immune suppression noted in several in vivo models of inflammation.	Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; Catholic Univ Louvain, Christian Duve Inst Cellular Pathol, B-3000 Louvain, Belgium	Roche Holding; Genentech; Roche Holding; Genentech; Universite Catholique Louvain	Ghilardi, N (corresponding author), Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA.	ghilardi@gene.com	de Sauvage, Frederic/ABE-8400-2020	de Sauvage, Frederic/0000-0002-5275-2584; Danilenko, Dimitry/0000-0002-8326-1921; Ghilardi, Nico/0000-0003-4945-3097; Lucas, Sophie/0000-0003-1287-7996; Batten, Marcel/0000-0002-3726-3790				Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Artis D, 2004, J IMMUNOL, V173, P5626, DOI 10.4049/jimmunol.173.9.5626; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen Q, 2000, NATURE, V407, P916, DOI 10.1038/35038103; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Cho ML, 2006, J IMMUNOL, V176, P5652, DOI 10.4049/jimmunol.176.9.5652; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Doganci A, 2005, CLIN REV ALLERG IMMU, V28, P257, DOI 10.1385/CRIAI:28:3:257; Gao WD, 2002, INT J PARASITOL, V32, P167, DOI 10.1016/S0020-7519(01)00322-8; Hamano S, 2003, IMMUNITY, V19, P657, DOI 10.1016/S1074-7613(03)00298-X; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hibbert L, 2003, J INTERF CYTOK RES, V23, P513, DOI 10.1089/10799900360708632; Holscher C, 2005, J IMMUNOL, V174, P3534, DOI 10.4049/jimmunol.174.6.3534; Honda K, 2005, INFLAMM BOWEL DIS, V11, P1044, DOI 10.1097/01.MIB.0000191611.05466.1f; Infante-Duarte C, 2000, J IMMUNOL, V165, P6107, DOI 10.4049/jimmunol.165.11.6107; Jebbari H, 1998, PARASITE IMMUNOL, V20, P231, DOI 10.1046/j.1365-3024.1998.00152.x; Kelly MN, 2005, INFECT IMMUN, V73, P617, DOI 10.1128/IAI.73.1.617-621.2005; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lucas S, 2003, P NATL ACAD SCI USA, V100, P15047, DOI 10.1073/pnas.2536517100; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; McQualter JL, 2001, J EXP MED, V194, P873, DOI 10.1084/jem.194.7.873; Miyazaki Y, 2005, J IMMUNOL, V175, P2401, DOI 10.4049/jimmunol.175.4.2401; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Owaki T, 2006, J IMMUNOL, V176, P2773, DOI 10.4049/jimmunol.176.5.2773; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Pearl JE, 2004, J IMMUNOL, V173, P7490, DOI 10.4049/jimmunol.173.12.7490; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Samoilova EB, 1998, J IMMUNOL, V161, P6480; Schimpl A, 2002, CYTOKINE GROWTH F R, V13, P369, DOI 10.1016/S1359-6101(02)00022-9; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Sergejeva S, 2005, AM J RESP CELL MOL, V33, P248, DOI 10.1165/rcmb.2004-0213OC; Sprecher CA, 1998, BIOCHEM BIOPH RES CO, V246, P82, DOI 10.1006/bbrc.1998.8576; Suzuki Y, 1997, INFECT IMMUN, V65, P2339, DOI 10.1128/IAI.65.6.2339-2345.1997; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Villarino AV, 2006, J IMMUNOL, V176, P237, DOI 10.4049/jimmunol.176.1.237; Yamanaka A, 2004, J IMMUNOL, V172, P3590, DOI 10.4049/jimmunol.172.6.3590; Yoshida H, 2001, IMMUNITY, V15, P569, DOI 10.1016/S1074-7613(01)00206-0	44	663	717	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2006	7	9					929	936		10.1038/ni1375	http://dx.doi.org/10.1038/ni1375			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	076FL	16906167				2022-12-18	WOS:000239942300011
J	Cook, DN; Pisetsky, DS; Schwartz, DA				Cook, DN; Pisetsky, DS; Schwartz, DA			Toll-like receptors in the pathogenesis of human disease	NATURE IMMUNOLOGY			English	Article							ANHIDROTIC ECTODERMAL DYSPLASIA; REGULATORY T-CELLS; TOLL-LIKE-RECEPTOR-2 TLR2; BACTERIAL-INFECTIONS; LEPROMATOUS LEPROSY; PROFOUND DEPLETION; ENDOTHELIAL-CELLS; INNATE IMMUNITY; B-CELLS; ENDOTOXIN	Members of the Toll-like receptor (TLR) family are key regulators of both innate and adaptive immune responses. The function of TLRs in various human diseases has been investigated by comparison of the incidence of disease among people having different polymorphisms in genes that participate in TLR signaling. These studies have shown that TLR function affects several diseases, including sepsis, immunodeficiencies, atherosclerosis and asthma. As this body of data grows, it will provide new insights into disease pathogenesis as well as valuable information on the merits of various therapeutic options.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Vet Adm Med Ctr, Durham, NC 27710 USA	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Cook, DN (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	donald.cook@duke.edu	Cook, Donald/E-5079-2019	Cook, Donald/0000-0002-0052-3755	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066604, U01HL066611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES011961, Z01ES101946, U19ES011375, R01ES007498] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL66604, HL66611] Funding Source: Medline; NIEHS NIH HHS [ES011961, ES012496, ES11375, ES07498] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Agnese DM, 2002, J INFECT DIS, V186, P1522, DOI 10.1086/344893; Ameziane N, 2003, ARTERIOSCL THROM VAS, V23, pE61, DOI 10.1161/01.ATV.0000101191.92392.1D; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Bannerman DD, 2002, BIOCHEM BIOPH RES CO, V295, P157, DOI 10.1016/S0006-291X(02)00638-1; Bannerman DD, 2002, J BIOL CHEM, V277, P8048, DOI 10.1074/jbc.M111249200; Ben-Ali M, 2004, CLIN DIAGN LAB IMMUN, V11, P625, DOI 10.1128/CDLI.11.3.625-626.2004; Bjorkbacka H, 2004, NAT MED, V10, P416, DOI 10.1038/nm1008; Bochud PY, 2003, J IMMUNOL, V170, P3451, DOI 10.4049/jimmunol.170.7.3451; Boekholdt SM, 2003, CIRCULATION, V107, P2416, DOI 10.1161/01.CIR.0000068311.40161.28; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Bulut Y, 2002, J IMMUNOL, V168, P1435, DOI 10.4049/jimmunol.168.3.1435; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Child NJA, 2003, BIOCHEM SOC T, V31, P652, DOI 10.1042/bst0310652; Courtois G, 2003, J CLIN INVEST, V112, P1108, DOI 10.1172/JCI200318714; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; DONNELLY JJ, 1990, J IMMUNOL, V145, P3071; Eriksson U, 2003, NAT MED, V9, P1484, DOI 10.1038/nm960; Escoll P, 2003, BIOCHEM BIOPH RES CO, V311, P465, DOI 10.1016/j.bbrc.2003.10.019; Feterowski C, 2003, IMMUNOLOGY, V109, P426, DOI 10.1046/j.1365-2567.2003.01674.x; Gehring U, 2002, AM J RESP CRIT CARE, V166, P939, DOI 10.1164/rccm.200203-256OC; Gursel I, 2003, J IMMUNOL, V171, P1393, DOI 10.4049/jimmunol.171.3.1393; Hahn BH, 1998, NEW ENGL J MED, V338, P1359, DOI 10.1056/NEJM199805073381906; Higgins SC, 2003, J IMMUNOL, V171, P3119, DOI 10.4049/jimmunol.171.6.3119; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Jain A, 2001, NAT IMMUNOL, V2, P223, DOI 10.1038/85277; Jiang WW, 2003, CURR OPIN MOL THER, V5, P180; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kang TJ, 2001, FEMS IMMUNOL MED MIC, V31, P53, DOI 10.1111/j.1574-695X.2001.tb01586.x; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Latz E, 2004, J IMMUNOL, V172, P2431, DOI 10.4049/jimmunol.172.4.2431; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Leinonen M, 2002, LANCET INFECT DIS, V2, P11, DOI 10.1016/S1473-3099(01)00168-2; Lorenz E, 2000, INFECT IMMUN, V68, P6398, DOI 10.1128/IAI.68.11.6398-6401.2000; Lorenz E, 2002, ARCH INTERN MED, V162, P1028, DOI 10.1001/archinte.162.9.1028; Medvedev AE, 2003, J EXP MED, V198, P521, DOI 10.1084/jem.20030701; Medvedev AE, 2002, J IMMUNOL, V169, P5209, DOI 10.4049/jimmunol.169.9.5209; Michel O, 1996, AM J RESP CRIT CARE, V154, P1641, DOI 10.1164/ajrccm.154.6.8970348; MICHEL O, 1989, J APPL PHYSIOL, V66, P1059, DOI 10.1152/jappl.1989.66.3.1059; Ogus AC, 2004, EUR RESPIR J, V23, P219, DOI 10.1183/09031936.03.00061703; Orange JS, 2002, J CLIN INVEST, V109, P1501, DOI 10.1172/JCI200214858; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Puel A, 2004, CURR OPIN IMMUNOL, V16, P34, DOI 10.1016/j.coi.2003.11.013; Raby BA, 2002, AM J RESP CRIT CARE, V166, P1449, DOI 10.1164/rccm.200207-634OC; Read RC, 2001, J INFECT DIS, V184, P640, DOI 10.1086/322798; Saleh M, 2004, NATURE, V429, P75, DOI 10.1038/nature02451; Smahi A, 2000, NATURE, V405, P466; Smirnova I, 2003, P NATL ACAD SCI USA, V100, P6075, DOI 10.1073/pnas.1031605100; Tinsley KW, 2003, J IMMUNOL, V171, P909, DOI 10.4049/jimmunol.171.2.909; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6; WENZEL RP, 1992, NEW ENGL J MED, V326, P1151, DOI 10.1056/NEJM199204233261710; Werner M, 2003, J ALLERGY CLIN IMMUN, V112, P323, DOI 10.1067/mai.2003.1648; Xu XH, 2001, CIRCULATION, V104, P3103, DOI 10.1161/hc5001.100631; Yang IA, 2004, GENES IMMUN, V5, P41, DOI 10.1038/sj.gene.6364037	53	663	723	5	63	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2004	5	10					975	979		10.1038/ni1116	http://dx.doi.org/10.1038/ni1116			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	857YO	15454920				2022-12-18	WOS:000224156600003
J	Mackay, CR				Mackay, CR			Chemokines: immunology's high impact factors	NATURE IMMUNOLOGY			English	Article							SKIN-ASSOCIATED CHEMOKINE; C-C CHEMOKINE; T-CELLS; CUTTING EDGE; RECEPTOR CCR3; DIFFERENTIAL EXPRESSION; DEVELOPMENTAL SWITCHES; SELECTIVE RECRUITMENT; DENDRITIC CELLS; MICE LACKING	Chemokines facilitate leukocyte migration and positioning as well as other processes such as angiogenesis and leukocyte degranulation. The burgeoning knowledge on chemokines and their receptors has influenced many aspects of immunology, in part because cell migration is; intimately related to leukocyte function. This overview assesses the impact that chemokines have had on our understanding of immunology and infectious diseases. These include the role of chemokines in leukocyte-endothelial cell interactions; dendritic cell function; T cell differentiation and function; inflammatory diseases; mucosal and subcutaneous immunity; and subversion of immune responses by viruses, including HIV-1. This knowledge heralds new opportunities fbr the manipulation of immune responses and the development of new anti-inflammatory therapies. It has also provided a new perspective on the functioning of the immune system.	Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia	Garvan Institute of Medical Research	Mackay, CR (corresponding author), Garvan Inst Med Res, 384 Victoria St, Darlinghurst, NSW 2010, Australia.	c.mackay@garvan.unsw.edu.au	Mackay, Charles R/A-9673-2008	Mackay, Charles R/0000-0002-6338-7340				Adema GJ, 1997, NATURE, V387, P713, DOI 10.1038/42716; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Baggiolini M, 1997, J EXP MED, V186, P1189, DOI 10.1084/jem.186.8.1189; Balashov KE, 1999, P NATL ACAD SCI USA, V96, P6873, DOI 10.1073/pnas.96.12.6873; BARGATZE RF, 1993, J EXP MED, V178, P367, DOI 10.1084/jem.178.1.367; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Blanpain C, 2000, BLOOD, V96, P1638, DOI 10.1182/blood.V96.5.1638.h8001638_1638_1645; Bleul CC, 1998, J EXP MED, V187, P753, DOI 10.1084/jem.187.5.753; Bleul CC, 2000, EUR J IMMUNOL, V30, P3371, DOI 10.1002/1521-4141(2000012)30:12<3371::AID-IMMU3371>3.0.CO;2-L; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Boshoff C, 1997, SCIENCE, V278, P290, DOI 10.1126/science.278.5336.290; Bowman EP, 2000, J EXP MED, V191, P1303, DOI 10.1084/jem.191.8.1303; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Cameron MJ, 2000, J IMMUNOL, V165, P1102, DOI 10.4049/jimmunol.165.2.1102; Campbell JJ, 1999, J IMMUNOL, V163, P2353; Campbell JJ, 1999, NATURE, V400, P776, DOI 10.1038/23495; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Cook DN, 2000, IMMUNITY, V12, P495, DOI 10.1016/S1074-7613(00)80201-0; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; Dabbagh K, 2000, J IMMUNOL, V165, P3418, DOI 10.4049/jimmunol.165.6.3418; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cellbio.4.1.649; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Gao W, 2000, J CLIN INVEST, V105, P35, DOI 10.1172/JCI8126; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Gerszten RE, 1999, NATURE, V398, P718, DOI 10.1038/19546; Gomez-Reino JJ, 1999, ARTHRITIS RHEUM-US, V42, P989, DOI 10.1002/1529-0131(199905)42:5<989::AID-ANR18>3.0.CO;2-U; Gonzalo JA, 1998, J EXP MED, V188, P157, DOI 10.1084/jem.188.1.157; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Gunn MD, 1998, NATURE, V391, P799, DOI 10.1038/35876; Gunn MD, 1998, P NATL ACAD SCI USA, V95, P258, DOI 10.1073/pnas.95.1.258; Heath DB, 1997, J ROY ANTHROPOL INST, V3, P178, DOI 10.2307/3034391; Heath WR, 1998, J EXP MED, V187, P1549, DOI 10.1084/jem.187.10.1549; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; Homey B, 2000, J IMMUNOL, V164, P3465, DOI 10.4049/jimmunol.164.7.3465; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Kitayama J, 1998, J CLIN INVEST, V101, P2017, DOI 10.1172/JCI2688; Kledal TN, 1997, SCIENCE, V277, P1656, DOI 10.1126/science.277.5332.1656; Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761; Lalani AS, 1999, SCIENCE, V286, P1968, DOI 10.1126/science.286.5446.1968; Li L, 1999, J IMMUNOL, V162, P2477; Lin CL, 2000, J EXP MED, V192, P587, DOI 10.1084/jem.192.4.587; Lloyd CM, 2000, J EXP MED, V191, P265, DOI 10.1084/jem.191.2.265; Loetscher P, 1998, NATURE, V391, P344, DOI 10.1038/34814; Lukacs NW, 1997, AM J PATHOL, V150, P1861; Luther SA, 2000, IMMUNITY, V12, P471, DOI 10.1016/S1074-7613(00)80199-5; Mackay CR, 2000, J EXP MED, V192, pF31, DOI 10.1084/jem.192.11.F31; McDermott DH, 1998, LANCET, V352, P866, DOI 10.1016/S0140-6736(98)04158-0; Moore JP, 1997, SCIENCE, V276, P51, DOI 10.1126/science.276.5309.51; Morales J, 1999, P NATL ACAD SCI USA, V96, P14470, DOI 10.1073/pnas.96.25.14470; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Murphy PM, 2000, PHARMACOL REV, V52, P145; MURPHY PM, 2001, NATURE IMMUNOL, V2, P159; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Ochi H, 1999, J EXP MED, V190, P267, DOI 10.1084/jem.190.2.267; Ponath PD, 1996, J CLIN INVEST, V97, P604, DOI 10.1172/JCI118456; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Randolph DA, 1999, SCIENCE, V286, P2159, DOI 10.1126/science.286.5447.2159; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sallusto F, 1998, IMMUNOL TODAY, V19, P568, DOI 10.1016/S0167-5699(98)01346-2; Sallusto F, 1999, J EXP MED, V189, P611, DOI 10.1084/jem.189.4.611; Sallusto F, 1997, SCIENCE, V277, P2005, DOI 10.1126/science.277.5334.2005; Sauty A, 1999, J IMMUNOL, V162, P3549; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Sellebjerg F, 2000, J NEUROIMMUNOL, V102, P98, DOI 10.1016/S0165-5728(99)00166-6; Shinkai A, 1999, J IMMUNOL, V163, P1602; Sozzani S, 1998, BLOOD, V92, P4036, DOI 10.1182/blood.V92.11.4036.423k17_4036_4039; Sozzani S, 1998, J IMMUNOL, V161, P1083; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stein JV, 2000, J EXP MED, V191, P61, DOI 10.1084/jem.191.1.61; Strieter RM, 1996, J IMMUNOL, V156, P3583; TANAKA Y, 1993, NATURE, V361, P79, DOI 10.1038/361079a0; Tesch GH, 1999, J EXP MED, V190, P1813, DOI 10.1084/jem.190.12.1813; Teuscher C, 1999, J IMMUNOL, V163, P2262; Uguccioni M, 1997, J CLIN INVEST, V100, P1137, DOI 10.1172/JCI119624; Warnock RA, 2000, J EXP MED, V191, P77, DOI 10.1084/jem.191.1.77; Wu LJ, 1997, J EXP MED, V185, P1681, DOI 10.1084/jem.185.9.1681; Ying S, 1997, EUR J IMMUNOL, V27, P3507, DOI 10.1002/eji.1830271252; Yoshie O, 1997, J LEUKOCYTE BIOL, V62, P634, DOI 10.1002/jlb.62.5.634; YOSHIMURA T, 1987, P NATL ACAD SCI USA, V84, P9233, DOI 10.1073/pnas.84.24.9233; Zabel BA, 1999, J EXP MED, V190, P1241, DOI 10.1084/jem.190.9.1241; Zingoni A, 1998, J IMMUNOL, V161, P547; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	99	663	703	3	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2001	2	2					95	101		10.1038/84298	http://dx.doi.org/10.1038/84298			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	398WD	11175800				2022-12-18	WOS:000166778700003
J	Iwakoshi, NN; Lee, AH; Vallabhajosyula, P; Otipoby, KL; Rajewsky, K; Glimcher, LH				Iwakoshi, NN; Lee, AH; Vallabhajosyula, P; Otipoby, KL; Rajewsky, K; Glimcher, LH			Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1	NATURE IMMUNOLOGY			English	Article							ENDOPLASMIC-RETICULUM; MESSENGER-RNA; TRANSMEMBRANE PROTEIN; ER STRESS; MULTIPLE-MYELOMA; BINDING-PROTEIN; B-CELLS; KINASE; INDUCTION; IRE1P	The transcription factor X-box binding protein 1 (XBP-1) is essential for the differentiation of plasma cells and the unfolded protein response (UPR). Here we show that UPR-induced splicing of XBP-1 by the transmembrane endonuclease IRE1 is required to restore production of immunoglobulin in XBP-1(-/-) mouse B cells, providing an integral link between XBP-1, the UPR and plasma cell differentiation. Signals involved in plasma cell differentiation, specifically interleukin-4, control the transcription of XBP-1, whereas its post-transcriptional processing is dependent on synthesis of immunoglobulins during B cell differentiation. We also show that XBP-1 is involved in controlling the production of interleukin-6, a cytokine that is essential for plasma cell survival. Thus, signals upstream and downstream of XBP-1 integrate plasma cell differentiation with the UPR.	Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 651 Huntington Ave, Boston, MA 02115 USA.	lglimche@hsph.harvard.edu	Longo, Kenneth A/A-5631-2010	Rajewsky, Klaus/0000-0002-6633-6370				Akira S, 1997, ADV IMMUNOL, V65, P1, DOI 10.1016/S0065-2776(08)60740-3; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; BLACKMAN MA, 1986, CELL, V47, P609, DOI 10.1016/0092-8674(86)90625-2; Brewer JW, 1997, EMBO J, V16, P7207, DOI 10.1093/emboj/16.23.7207; BURDIN N, 1995, J IMMUNOL, V154, P2533; Calame KL, 2001, NAT IMMUNOL, V2, P1103, DOI 10.1038/ni1201-1103; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; CLAUSS IM, 1993, DEV DYNAM, V197, P146, DOI 10.1002/aja.1001970207; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Gass JN, 2002, J BIOL CHEM, V277, P49047, DOI 10.1074/jbc.M205011200; Gonzalez TN, 1999, EMBO J, V18, P3119, DOI 10.1093/emboj/18.11.3119; HAAS IG, 1983, NATURE, V306, P387, DOI 10.1038/306387a0; Hallek M, 1998, BLOOD, V91, P3, DOI 10.1182/blood.V91.1.3.3_3_21; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hirano T, 1989, Prog Growth Factor Res, V1, P133, DOI 10.1016/0955-2235(89)90007-0; Kawahara T, 1998, J BIOL CHEM, V273, P1802, DOI 10.1074/jbc.273.3.1802; KISHIMOTO T, 1989, BLOOD, V74, P1, DOI 10.1182/blood.V74.1.1.1; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kopf M, 1995, IMMUNOL REV, V148, P45, DOI 10.1111/j.1600-065X.1995.tb00093.x; Kovalchuk AL, 2002, P NATL ACAD SCI USA, V99, P1509, DOI 10.1073/pnas.022643999; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lemaire C, 1999, BIOCHEM PHARMACOL, V58, P85, DOI 10.1016/S0006-2952(99)00082-9; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; LIOU HC, 1990, SCIENCE, V247, P1581, DOI 10.1126/science.2321018; Liu CY, 2002, J BIOL CHEM, V277, P18346, DOI 10.1074/jbc.M112454200; MORI K, 1993, CELL, V74, P743; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Reimold AM, 1996, J EXP MED, V183, P393, DOI 10.1084/jem.183.2.393; Reimold AM, 2000, GENE DEV, V14, P152; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Rengarajan J, 2000, IMMUNITY, V12, P293, DOI 10.1016/S1074-7613(00)80182-X; Rudge EU, 2002, J EXP MED, V195, P1079, DOI 10.1084/jem.20011435; Ruegsegger U, 2001, CELL, V107, P103, DOI 10.1016/S0092-8674(01)00505-0; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Urano F, 2000, J CELL SCI, V113, P3697; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Welihinda AA, 1996, J BIOL CHEM, V271, P18181, DOI 10.1074/jbc.271.30.18181; Wen XY, 1999, INT J ONCOL, V15, P173; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741	54	661	696	2	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2003	4	4					321	329		10.1038/ni907	http://dx.doi.org/10.1038/ni907			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	663CG	12612580				2022-12-18	WOS:000181987700010
J	Ausubel, FM				Ausubel, FM			Are innate immune signaling pathways in plants and animals conserved?	NATURE IMMUNOLOGY			English	Article							TOLL-LIKE RECEPTORS; BACTERIAL ELICITOR FLAGELLIN; CAENORHABDITIS-ELEGANS; PEPTIDOGLYCAN RECOGNITION; DISEASE RESISTANCE; DROSOPHILA TOLL; GENE FAMILY; ANTIBACTERIAL DEFENSE; ARABIDOPSIS-THALIANA; OXIDASE GP91(PHOX)	Although adaptive immunity is unique to vertebrates, the innate immune response seems to have ancient origins. Common features of innate immunity in vertebrates, invertebrate animals and plants include defined receptors for microbe-associated molecules, conserved mitogen-associated protein kinase signaling cascades and the production of antimicrobial peptides. It is commonly reported that these similarities in innate immunity represent a process of divergent evolution from an ancient unicellular eukaryote that pre-dated the divergence of the plant and animal kingdoms. However, at present, data suggest that the seemingly analogous regulatory modules used in plant and animal innate immunity are a consequence of convergent evolution and reflect inherent constraints on how an innate immune system can be constructed.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Ausubel, FM (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA.	ausubel@molbio.mgh.harvard.edu						Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Anderson A F, 2000, Am J Knee Surg, V13, P19; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Athman R, 2004, CURR OPIN MICROBIOL, V7, P25, DOI 10.1016/j.mib.2003.12.013; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Bais HP, 2005, NATURE, V434, P217, DOI 10.1038/nature03356; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Beutler B, 2002, CURR TOP MICROBIOL, V270, P1; Brennan CA, 2004, ANNU REV IMMUNOL, V22, P457, DOI 10.1146/annurev.immunol.22.012703.104626; Burdman S, 2004, MOL PLANT MICROBE IN, V17, P602, DOI 10.1094/MPMI.2004.17.6.602; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chamaillard M, 2003, CELL MICROBIOL, V5, P581, DOI 10.1046/j.1462-5822.2003.00304.x; Couillault C, 2004, NAT IMMUNOL, V5, P488, DOI 10.1038/ni1060; da Silva FG, 2004, MOL PLANT MICROBE IN, V17, P593, DOI 10.1094/MPMI.2004.17.6.593; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Diez E, 2003, NAT GENET, V33, P55, DOI 10.1038/ng1065; Donnelly MA, 2002, J BIOL CHEM, V277, P40456, DOI 10.1074/jbc.M206851200; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Fitzgerald HA, 2005, PLANT J, V43, P335, DOI 10.1111/j.1365-313X.2005.02457.x; Friedman R, 2002, IMMUNOGENETICS, V53, P964, DOI 10.1007/s00251-001-0399-3; GAY NJ, 1991, NATURE, V351, P355, DOI 10.1038/351355b0; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2004, EUR J IMMUNOL, V34, P1777, DOI 10.1002/eji.200425095; Glazebrook J, 2001, CURR OPIN PLANT BIOL, V4, P301, DOI 10.1016/S1369-5266(00)00177-1; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Gravato-Nobre MJ, 2005, CELL MICROBIOL, V7, P741, DOI 10.1111/j.1462-5822.2005.00523.x; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; He P, 2004, PLANT J, V37, P589, DOI 10.1111/j.1365-313X.2003.01986.x; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Holt J, 2003, PUBL ASTRON SOC AUST, V20, P25, DOI 10.1071/AS02038; Hotson A, 2003, MOL MICROBIOL, V50, P377, DOI 10.1046/j.1365-2958.2003.03730.x; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Keller T, 1998, PLANT CELL, V10, P255, DOI 10.1105/tpc.10.2.255; Kim DH, 2005, CURR OPIN IMMUNOL, V17, P4, DOI 10.1016/j.coi.2004.11.007; Kim DH, 2004, P NATL ACAD SCI USA, V101, P10990, DOI 10.1073/pnas.0403546101; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kim MG, 2005, CELL, V121, P749, DOI 10.1016/j.cell.2005.03.025; Kurz CL, 2003, NAT REV GENET, V4, P380, DOI 10.1038/nrg1067; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Liberati NT, 2004, P NATL ACAD SCI USA, V101, P6593, DOI 10.1073/pnas.0308625101; Luo CH, 2000, IMMUNOGENETICS, V51, P92, DOI 10.1007/s002510050017; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Medzhitov R, 2000, TRENDS MICROBIOL, V8, P452, DOI 10.1016/S0966-842X(00)01845-X; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Medzhitov R, 1998, CURR OPIN IMMUNOL, V10, P12, DOI 10.1016/S0952-7915(98)80024-1; Meindl T, 2000, PLANT CELL, V12, P1783, DOI 10.1105/tpc.12.9.1783; Meyerowitz EM, 2002, SCIENCE, V295, P1482, DOI 10.1126/science.1066609; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Millet ACM, 2004, CURR OPIN IMMUNOL, V16, P4, DOI 10.1016/j.coi.2003.11.005; Mochida Y, 2000, J BIOL CHEM, V275, P32747, DOI 10.1074/jbc.M003042200; Nimchuk Z, 2003, ANNU REV GENET, V37, P579, DOI 10.1146/annurev.genet.37.110801.142628; Nurnberger T, 2005, MOL PLANT PATHOL, V6, P335, DOI 10.1111/j.1364-3703.2005.00279.x; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Philpott DJ, 2004, MOL IMMUNOL, V41, P1099, DOI 10.1016/j.molimm.2004.06.012; Pieterse CM, 2004, CURR OPIN PLANT BIOL, V7, P456, DOI 10.1016/j.pbi.2004.05.006; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Royet J, 2004, MOL IMMUNOL, V41, P1063, DOI 10.1016/j.molimm.2004.06.009; Schulenburg H, 2004, IMMUNOL REV, V198, P36, DOI 10.1111/j.0105-2896.2004.0125.x; Shen YW, 2002, MOL MICROBIOL, V44, P37, DOI 10.1046/j.1365-2958.2002.02862.x; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Steiner H, 2004, IMMUNOL REV, V198, P83, DOI 10.1111/j.0105-2896.2004.0120.x; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; SUN SC, 1991, EUR J BIOCHEM, V196, P247, DOI 10.1111/j.1432-1033.1991.tb15811.x; Ting JPY, 2005, ANNU REV IMMUNOL, V23, P387, DOI 10.1146/annurev.immunol.23.021704.115616; Torres MA, 1998, PLANT J, V14, P365, DOI 10.1046/j.1365-313X.1998.00136.x; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Viala M, 2004, CR BIOL, V327, P551, DOI 10.1016/j.crvi.2004.02.010; Wright EK, 2003, CURR BIOL, V13, P27, DOI 10.1016/S0960-9822(02)01359-3; Zhao YF, 2003, PLANT J, V36, P485, DOI 10.1046/j.1365-313X.2003.01895.x; Zhou T, 2004, MOL GENET GENOMICS, V271, P402, DOI 10.1007/s00438-004-0990-z; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	90	659	702	5	199	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2005	6	10					973	979		10.1038/ni1253	http://dx.doi.org/10.1038/ni1253			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	966NR	16177805				2022-12-18	WOS:000232027200015
J	Egen, JG; Kuhns, MS; Allison, JP				Egen, JG; Kuhns, MS; Allison, JP			CTLA-4: new insights into its biological function and use in tumor immunotherapy	NATURE IMMUNOLOGY			English	Review							LYMPHOCYTE-ASSOCIATED ANTIGEN-4; T-CELL RESPONSES; COLONY-STIMULATING FACTOR; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; KINASE PHOSPHATIDYLINOSITOL 3-KINASE; MULTIORGAN TISSUE DESTRUCTION; CLATHRIN-ASSOCIATED PROTEIN; IN-VIVO; ANTITUMOR IMMUNITY; PROSTATE-CANCER	The discovery of multiple costimulatory cell surface molecules that influence the course of T cell activation has increased our appreciation of the complexity of the T cell response. It remains clear, however, that CD28 and cytotoxic T lymphocyte antigen 4 (CTLA-4) are the critical costimulatory receptors that determine the early outcome of stimulation through the T cell antigen receptor (TCR). Details of how the T cell integrates TCR stimulation with the costimulatory signals of CD28 and the inhibitory signals of CTLA-4 remain to be established, but unique features of the cell biology of CTLA-4 provide important insights into its function. We summarize here recent findings that suggest a previously unrecognized role for CTLA-4 in the regulation of T cell responses. We also describe preclinical and clinical results that indicate manipulation of CTLA-4 has considerable promise as a strategy for the immunotherapy of cancer.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Canc Res Lab, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Allison, JP (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Canc Res Lab, Berkeley, CA 94720 USA.	jallison@uclink4.berkeley.edu		Egen, Jackson/0000-0003-2053-0837; Allison, James/0000-0001-8980-5697	NATIONAL CANCER INSTITUTE [R01CA057986, R37CA040041, R01CA040041] Funding Source: NIH RePORTER; NCI NIH HHS [CA40041, CA57986] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Bachmann MF, 1999, J IMMUNOL, V163, P1128; Bachmann MF, 2001, EUR J IMMUNOL, V31, P450, DOI 10.1002/1521-4141(200102)31:2<450::AID-IMMU450>3.3.CO;2-O; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Bousso P, 1999, J EXP MED, V189, P1591, DOI 10.1084/jem.189.10.1591; Bradshaw JD, 1997, BIOCHEMISTRY-US, V36, P15975, DOI 10.1021/bi971762i; BRUNET JF, 1987, NATURE, V328, P267, DOI 10.1038/328267a0; Brunner MC, 1999, J IMMUNOL, V162, P5813; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Chambers CA, 1999, P NATL ACAD SCI USA, V96, P8603, DOI 10.1073/pnas.96.15.8603; Chambers CA, 1996, IMMUNOL REV, V153, P27, DOI 10.1111/j.1600-065X.1996.tb00919.x; Chambers CA, 1997, IMMUNITY, V7, P885, DOI 10.1016/S1074-7613(00)80406-9; Chambers CA, 2001, ANNU REV IMMUNOL, V19, P565, DOI 10.1146/annurev.immunol.19.1.565; CHEN LP, 1992, CELL, V71, P1093, DOI 10.1016/S0092-8674(05)80059-5; Chuang E, 1997, J IMMUNOL, V159, P144; Doyle AM, 2001, J EXP MED, V194, P893, DOI 10.1084/jem.194.7.893; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Egen JG, 2002, IMMUNITY, V16, P23, DOI 10.1016/S1074-7613(01)00259-X; Fallarino F, 1998, J EXP MED, V188, P205, DOI 10.1084/jem.188.1.205; Gajewski TF, 2001, J IMMUNOL, V166, P3900, DOI 10.4049/jimmunol.166.6.3900; Greenwald RJ, 2002, EUR J IMMUNOL, V32, P366, DOI 10.1002/1521-4141(200202)32:2<366::AID-IMMU366>3.0.CO;2-5; Greenwald RJ, 2001, IMMUNITY, V14, P145, DOI 10.1016/S1074-7613(01)00097-8; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; Hung K, 1998, J EXP MED, V188, P2357, DOI 10.1084/jem.188.12.2357; Hurwitz AA, 1997, J NEUROIMMUNOL, V73, P57, DOI 10.1016/S0165-5728(96)00168-3; Hurwitz AA, 2000, CANCER RES, V60, P2444; Hurwitz AA, 1998, P NATL ACAD SCI USA, V95, P10067, DOI 10.1073/pnas.95.17.10067; Hurwitz AA, 2002, P NATL ACAD SCI USA, V99, P3013, DOI 10.1073/pnas.042684699; HURWITZ AA, 1999, CYTOTOXIC CELLS BASI, P385; Iida T, 2000, J IMMUNOL, V165, P5062, DOI 10.4049/jimmunol.165.9.5062; Karandikar NJ, 1996, J EXP MED, V184, P783, DOI 10.1084/jem.184.2.783; KEARNEY ER, 1995, J IMMUNOL, V155, P1032; Kedl RM, 2000, J EXP MED, V192, P1105, DOI 10.1084/jem.192.8.1105; Krummel MF, 1996, INT IMMUNOL, V8, P519, DOI 10.1093/intimm/8.4.519; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Kuhns MS, 2000, P NATL ACAD SCI USA, V97, P12711, DOI 10.1073/pnas.220423597; KUPFER A, 1987, J EXP MED, V165, P1565, DOI 10.1084/jem.165.6.1565; Kwon ED, 1997, P NATL ACAD SCI USA, V94, P8099, DOI 10.1073/pnas.94.15.8099; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; LEUNG HT, 1995, J BIOL CHEM, V270, P25107, DOI 10.1074/jbc.270.42.25107; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; LINDSTEN T, 1993, J IMMUNOL, V151, P3489; LINSLEY PS, 1994, IMMUNITY, V1, P793, DOI 10.1016/S1074-7613(94)80021-9; LINSLEY PS, 1991, J EXP MED, V174, P561, DOI 10.1084/jem.174.3.561; Linsley PS, 1996, IMMUNITY, V4, P535, DOI 10.1016/S1074-7613(00)80480-X; LINSLEY PS, 1992, J EXP MED, V176, P1595, DOI 10.1084/jem.176.6.1595; Luhder F, 1998, J EXP MED, V187, P427, DOI 10.1084/jem.187.3.427; Malhotra V, 2000, J AM SOC ECHOCARDIOG, V13, P771, DOI 10.1067/mje.2000.106078; Mandelbrot DA, 1999, J EXP MED, V189, P435, DOI 10.1084/jem.189.2.435; Masteller EL, 2000, J IMMUNOL, V164, P5319, DOI 10.4049/jimmunol.164.10.5319; McCoy K, 1997, J EXP MED, V186, P183, DOI 10.1084/jem.186.2.183; Mercader M, 2001, P NATL ACAD SCI USA, V98, P14565, DOI 10.1073/pnas.251140998; Mokyr MB, 1998, CANCER RES, V58, P5301; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; Murphy ML, 1998, J IMMUNOL, V161, P4153; Oki S, 1999, INT IMMUNOL, V11, P1563, DOI 10.1093/intimm/11.9.1563; Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8; Perrin PJ, 1996, J IMMUNOL, V157, P1333; PRASAD KVS, 1994, P NATL ACAD SCI USA, V91, P2834, DOI 10.1073/pnas.91.7.2834; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Rogers PR, 1999, J IMMUNOL, V163, P1205; Rosenberg SA, 1996, J IMMUNOTHER, V19, P81, DOI 10.1097/00002371-199601000-00009; Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Schneider H, 1999, J IMMUNOL, V163, P1868; SCHNEIDER H, 1995, J EXP MED, V181, P351, DOI 10.1084/jem.181.1.351; Schwartz JCD, 2002, NAT IMMUNOL, V3, P427, DOI 10.1038/ni0502-427; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Shiratori T, 1997, IMMUNITY, V6, P583, DOI 10.1016/S1074-7613(00)80346-5; Shrikant P, 1999, IMMUNITY, V11, P483, DOI 10.1016/S1074-7613(00)80123-5; Sotomayor EM, 1999, P NATL ACAD SCI USA, V96, P11476, DOI 10.1073/pnas.96.20.11476; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Tivol EA, 1997, J IMMUNOL, V158, P5091; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; TOWNSEND SE, 1993, SCIENCE, V259, P368, DOI 10.1126/science.7678351; TRUITT KE, 1994, J EXP MED, V179, P1071, DOI 10.1084/jem.179.3.1071; van Elsas A, 1999, J EXP MED, V190, P355, DOI 10.1084/jem.190.3.355; van Elsas A, 2001, J EXP MED, V194, P481, DOI 10.1084/jem.194.4.481; Vanasek TL, 2001, J IMMUNOL, V167, P5636, DOI 10.4049/jimmunol.167.10.5636; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; Walunas TL, 1996, J EXP MED, V183, P2541, DOI 10.1084/jem.183.6.2541; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Yang YF, 1997, CANCER RES, V57, P4036; Zhang Y, 1997, P NATL ACAD SCI USA, V94, P9273, DOI 10.1073/pnas.94.17.9273	90	657	714	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2002	3	7					611	618		10.1038/ni0702-611	http://dx.doi.org/10.1038/ni0702-611			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	566RH	12087419				2022-12-18	WOS:000176441700010
J	Link, A; Vogt, TK; Favre, S; Britschgi, MR; Acha-Orbea, H; Hinz, B; Cyster, JG; Luther, SA				Link, Alexander; Vogt, Tobias K.; Favre, Stephanie; Britschgi, Mirjam R.; Acha-Orbea, Hans; Hinz, Boris; Cyster, Jason G.; Luther, Sanjiv A.			Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells	NATURE IMMUNOLOGY			English	Article							CHEMOKINE RECEPTOR CCR7; SMOOTH MUSCLE ACTIN; DENDRITIC CELLS; STROMAL CELLS; IN-VIVO; LYMPHOCYTES; EXPRESSION; MIGRATION; SURVIVAL; ORGANS	Interleukin 7 is essential for the survival of naive T lymphocytes. Despite its importance, its cellular source in the periphery remains poorly defined. Here we report a critical function for lymph node access in T cell homeostasis and identify T zone fibroblastic reticular cells in these organs as the main source of interleukin 7. In vitro, T zone fibroblastic reticular cells were able to prevent the death of naive T lymphocytes but not of B lymphocytes by secreting interleukin 7 and the CCR7 ligand CCL19. Using gene-targeted mice, we demonstrate a nonredundant function for CCL19 in T cell homeostasis. Our data suggest that lymph nodes and T zone fibroblastic reticular cells have a key function in naive CD4(+) and CD8(+) T cell homeostasis by providing a limited reservoir of survival factors.	Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; Ecole Polytech Fed Lausanne, Lab Cell Biophys, CH-1015 Lausanne, Switzerland; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Luther, SA (corresponding author), Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland.	sanjiv.luther@unil.ch	Luther, Sanjiv A/B-4380-2016; Luther, Sanjiv/AAP-6525-2020; , Sanjiv/B-4380-2016	Luther, Sanjiv A/0000-0002-8758-957X; Luther, Sanjiv/0000-0002-8758-957X; Hinz, Boris/0000-0002-0526-393X; , Sanjiv/0000-0002-0614-561X	NIAID NIH HHS [AI45073] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045073] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Berlin-Rufenach C, 1999, J EXP MED, V189, P1467, DOI 10.1084/jem.189.9.1467; Cinalli RM, 2005, EUR J IMMUNOL, V35, P786, DOI 10.1002/eji.200425729; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Dai ZH, 2001, J IMMUNOL, V167, P6711, DOI 10.4049/jimmunol.167.12.6711; Dummer W, 2001, J IMMUNOL, V166, P2460, DOI 10.4049/jimmunol.166.4.2460; Endharti AT, 2005, EUR J IMMUNOL, V35, P86, DOI 10.1002/eji.200425340; FARR AG, 1992, J EXP MED, V176, P1477, DOI 10.1084/jem.176.5.1477; Feuillet V, 2005, EUR J IMMUNOL, V35, P2563, DOI 10.1002/eji.200526127; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Hara T, 2006, INT IMMUNOL, V18, P301, DOI 10.1093/intimm/dxh369; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Hinz B, 2003, CURR OPIN BIOTECH, V14, P538, DOI 10.1016/j.copbio.2003.08.006; Honda K, 2001, J EXP MED, V193, P621, DOI 10.1084/jem.193.5.621; Jiang Q, 2005, CYTOKINE GROWTH F R, V16, P513, DOI 10.1016/j.cytogfr.2005.05.004; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; Kim JW, 2005, CLIN CANCER RES, V11, P7901, DOI 10.1158/1078-0432.CCR-05-1346; KIMURA K, 1991, J IMMUNOL, V146, P2618; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; LEPAULT F, 1994, EUR J IMMUNOL, V24, P3106, DOI 10.1002/eji.1830241229; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Lo CG, 2003, J EXP MED, V197, P353, DOI 10.1084/jem.20021569; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; Luther SA, 2002, J IMMUNOL, V169, P424, DOI 10.4049/jimmunol.169.1.424; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Mackay F, 2003, CYTOKINE GROWTH F R, V14, P311, DOI 10.1016/S1359-6101(03)00023-6; Marrack P, 2004, ANNU REV IMMUNOL, V22, P765, DOI 10.1146/annurev.immunol.22.012703.104554; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Nakano H, 1998, BLOOD, V91, P2886, DOI 10.1182/blood.V91.8.2886.2886_2886_2895; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Okada T, 2007, J IMMUNOL, V178, P2973, DOI 10.4049/jimmunol.178.5.2973; Ploix C, 2001, J IMMUNOL, V167, P6724, DOI 10.4049/jimmunol.167.12.6724; Sanchez-Sanchez N, 2004, BLOOD, V104, P619, DOI 10.1182/blood-2003-11-3943; Sanchez-Sanchez N, 2006, J IMMUNOL, V176, P5153, DOI 10.4049/jimmunol.176.9.5153; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Surh CD, 2005, SEMIN IMMUNOL, V17, P183, DOI 10.1016/j.smim.2005.02.007; Trinder PKE, 2003, CYTOKINE HDB, P305; Ueno T, 2002, IMMUNITY, V16, P205, DOI 10.1016/S1074-7613(02)00267-4; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706; Zamisch M, 2005, J IMMUNOL, V174, P60, DOI 10.4049/jimmunol.174.1.60; Zhou YW, 2003, IMMUNOLOGY, V109, P496, DOI 10.1046/j.1365-2567.2003.01693.x	50	656	669	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2007	8	11					1255	1265		10.1038/ni1513	http://dx.doi.org/10.1038/ni1513			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	222ZR	17893676				2022-12-18	WOS:000250338900018
J	Watanabe, T; Kitani, A; Murray, PJ; Strober, W				Watanabe, T; Kitani, A; Murray, PJ; Strober, W			NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; INTESTINAL EPITHELIAL-CELLS; CROHNS-DISEASE; C-REL; MURAMYL DIPEPTIDE; BACTERIAL PEPTIDOGLYCAN; HOST RECOGNITION; GENE; ACTIVATION	The mechanism by which mutations in CARD15, which encodes nucleotide-binding oligomerization domain 2 (NOD2), cause Crohn disease is poorly understood. Because signaling via mutated NOD2 proteins leads to defective activation of the transcription factor NF-kappaB, one proposal is that mutations cause deficient NF-kappaB-dependent T helper type 1 (T(H)1) responses and increased susceptibility to infection. However, this idea is inconsistent with the increased T(H)1 responses characteristic of Crohn disease. Here we used Card15(-/-) mice to show that intact NOD2 signaling inhibited Toll-like receptor 2-driven activation of NFkappaB, particularly of the NF-kappaB subunit c-Rel. Moreover, NOD2 deficiency or the presence of a Crohn disease-like Card15 mutation increased Toll-like receptor 2-mediated activation of NF-kappaB-c-Rel, and T(H)1 responses were enhanced. Thus, CARD15 mutations may lead to disease by causing excessive T(H)1 responses.	NIAID, Mucosal Immun Sect, Host Def Lab, NIH, Bethesda, MD 20892 USA; St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); St Jude Children's Research Hospital	Strober, W (corresponding author), NIAID, Mucosal Immun Sect, Host Def Lab, NIH, Bldg 10 Room 11N238,10 Ctr Dr, Bethesda, MD 20892 USA.	wstrober@niaid.nih.gov	Watanabe, Tomohiro/ABA-4712-2021; Murray, Peter J/K-4725-2018	Murray, Peter J/0000-0001-6329-9802	NCI NIH HHS [P30 CA21765] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000354, ZIAAI000354] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Bonen DK, 2003, GASTROENTEROLOGY, V124, P140, DOI 10.1053/gast.2003.50019; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Campbell IK, 2000, J CLIN INVEST, V105, P1799, DOI 10.1172/JCI8298; Cario E, 2000, J IMMUNOL, V164, P966, DOI 10.4049/jimmunol.164.2.966; Chamaillard M, 2003, P NATL ACAD SCI USA, V100, P3455, DOI 10.1073/pnas.0530276100; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chamaillard M, 2003, CELL MICROBIOL, V5, P581, DOI 10.1046/j.1462-5822.2003.00304.x; Cuthbert AP, 2002, GASTROENTEROLOGY, V122, P867, DOI 10.1053/gast.2002.32415; Fisette PL, 2003, J BIOL CHEM, V278, P46252, DOI 10.1074/jbc.M306587200; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Girardin SE, 2003, TRENDS IMMUNOL, V24, P652, DOI 10.1016/j.it.2003.10.007; Grumont R, 2001, J EXP MED, V194, P1021, DOI 10.1084/jem.194.8.1021; Gutierrez O, 2002, J BIOL CHEM, V277, P41701, DOI 10.1074/jbc.M206473200; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Harton JA, 2002, J IMMUNOL, V169, P4088, DOI 10.4049/jimmunol.169.8.4088; Hilliard BA, 2002, J CLIN INVEST, V110, P843, DOI 10.1172/JCI200215254; Hisamatsu T, 2003, GASTROENTEROLOGY, V124, P993, DOI 10.1053/gast.2003.50153; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Iwanaga Y, 2003, INFLAMM RES, V52, P272, DOI 10.1007/s00011-003-1170-z; Kanai T, 2000, GASTROENTEROLOGY, V119, P1514, DOI 10.1053/gast.2000.20260; Kitani A, 2003, J EXP MED, V198, P1179, DOI 10.1084/jem.20030917; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kobayashi M, 2003, J CLIN INVEST, V111, P1297, DOI 10.1172/JCI200317085; Liu JJ, 2003, J IMMUNOL, V170, P4489, DOI 10.4049/jimmunol.170.9.4489; Monteleone G, 1997, GASTROENTEROLOGY, V112, P1169, DOI 10.1016/S0016-5085(97)70128-8; Nakayama K, 2004, J BIOL CHEM, V279, P6629, DOI 10.1074/jbc.M308620200; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; Nishikomori R, 2000, J EXP MED, V191, P847, DOI 10.1084/jem.191.5.847; O'Sullivan BJ, 2002, J IMMUNOL, V168, P5491, DOI 10.4049/jimmunol.168.11.5491; Obermeier F, 2002, EUR J IMMUNOL, V32, P2084, DOI 10.1002/1521-4141(200207)32:7<2084::AID-IMMU2084>3.0.CO;2-Q; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Parronchi P, 1997, AM J PATHOL, V150, P823; Pauleau AL, 2003, MOL CELL BIOL, V23, P7531, DOI 10.1128/MCB.23.21.7531-7539.2003; Sanjabi S, 2000, P NATL ACAD SCI USA, V97, P12705, DOI 10.1073/pnas.230436397; Shimamura M, 2003, BIOCHEM BIOPH RES CO, V300, P464, DOI 10.1016/S0006-291X(02)02807-3; Smith MF, 2003, J BIOL CHEM, V278, P32552, DOI 10.1074/jbc.M305536200; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Takada H, 2002, J ENDOTOXIN RES, V8, P337, DOI 10.1179/096805102125000669; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Watanabe T, 2002, J IMMUNOL, V168, P2188, DOI 10.4049/jimmunol.168.5.2188; Wolfert MA, 2002, J BIOL CHEM, V277, P39179, DOI 10.1074/jbc.M204885200; Yang SH, 2001, INFECT IMMUN, V69, P2045, DOI 10.1128/IAI.69.4.2045-2053.2001	49	654	674	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2004	5	8					800	808		10.1038/ni1092	http://dx.doi.org/10.1038/ni1092			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	841TX	15220916				2022-12-18	WOS:000222955600011
J	Bain, CC; Bravo-Blas, A; Scott, CL; Perdiguero, EG; Geissmann, F; Henri, S; Malissen, B; Osborne, LC; Artis, D; Mowat, AM				Bain, Calum C.; Bravo-Blas, Alberto; Scott, Charlotte L.; Perdiguero, Elisa Gomez; Geissmann, Frederic; Henri, Sandrine; Malissen, Bernard; Osborne, Lisa C.; Artis, David; Mowat, Allan Mci			Constant replenishment from circulating monocytes maintains the macrophage pool in the intestine of adult mice	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELLS; TISSUE MACROPHAGES; STEADY-STATE; BONE-MARROW; RECEPTOR; MICROGLIA; GUT; DIFFERENTIATION; RESPONSES; REVEALS	The paradigm that macrophages that reside in steady-state tissues are derived from embryonic precursors has never been investigated in the intestine, which contains the largest pool of macrophages. Using fate-mapping models and monocytopenic mice, together with bone marrow chimera and parabiotic models, we found that embryonic precursor cells seeded the intestinal mucosa and demonstrated extensive in situ proliferation during the neonatal period. However, these cells did not persist in the intestine of adult mice. Instead, they were replaced around the time of weaning by the chemokine receptor CCR2-dependent influx of Ly6C(hi) monocytes that differentiated locally into mature, anti-inflammatory macrophages. This process was driven largely by the microbiota and had to be continued throughout adult life to maintain a normal intestinal macrophage pool.	[Bain, Calum C.; Bravo-Blas, Alberto; Scott, Charlotte L.; Mowat, Allan Mci] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Perdiguero, Elisa Gomez; Geissmann, Frederic] Kings Coll London, Ctr Mol & Cellular Biol Inflammat, London, England; [Perdiguero, Elisa Gomez] Kings Coll London, Peter Gorer Dept Immunobiol, London, England; [Henri, Sandrine; Malissen, Bernard] Aix Marseille Univ, Ctr Immunol Marseille Luminy, Marseille, France; [Henri, Sandrine; Malissen, Bernard] INSERM, U1104, F-13258 Marseille, France; [Henri, Sandrine; Malissen, Bernard; Artis, David] CNRS, UMR7280, Marseille, France; [Osborne, Lisa C.; Artis, David] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Osborne, Lisa C.; Artis, David] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Scott, Charlotte L.] Univ Ghent VIB, Inflammat Res Ctr, Immunoregulat Lab, Ghent, Belgium	University of Glasgow; University of London; King's College London; University of London; King's College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Flanders Institute for Biotechnology (VIB); Ghent University	Mowat, AM (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.	allan.mowat@glasgow.ac.uk	Henri, Sandrine/O-3045-2016; Mowat, Allan M/H-7932-2016; Perdiguero, Elisa Gomez/U-2120-2018; Osborne, Lisa/K-3027-2015; Scott, Charlotte/K-3563-2014; Malissen, Bernard/AAK-4659-2020	Mowat, Allan M/0000-0001-9389-3079; Perdiguero, Elisa Gomez/0000-0002-7717-7897; Osborne, Lisa/0000-0002-7170-3235; Artis, David/0000-0002-1753-4100; geissmann, frederic/0000-0001-5029-2468; Bain, Calum/0000-0001-8884-327X; Scott, Charlotte/0000-0003-4914-6580; HENRI, Sandrine/0000-0002-8980-9193; Malissen, Bernard/0000-0003-1340-9342	Wellcome Trust; Medical Research Council UK; Conacyt; Tenovus Scotland; EE-ASI European Collaborative Research Project; Agence National de Recherche; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097333] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Tenovus Scotland; EE-ASI European Collaborative Research Project; Agence National de Recherche(French National Research Agency (ANR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Vaughan for help with flow cytometry; B. McColl (Roslin Institute, Edinburgh) for the CCR2-reporter mice; and V. Cerovic for critical reading of the manuscript. Supported by The Wellcome Trust (C.C.B., A.M.M. and C.L.S.), the Medical Research Council UK (C.C.B., A.M.M. and C.L.S.), Conacyt (A.B.-B.), Tenovus Scotland (A.B.-B.), the EE-ASI European Collaborative Research Project (S.H. and B.M.) and the Agence National de Recherche (S.H. and B.M.).	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Bain CC, 2014, IMMUNOL REV, V260, P102, DOI 10.1111/imr.12192; Bain CC, 2012, IMMUNOBIOLOGY, V217, P643, DOI 10.1016/j.imbio.2011.11.004; Benz C, 2008, J EXP MED, V205, P1187, DOI 10.1084/jem.20072168; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Davies LC, 2011, EUR J IMMUNOL, V41, P2155, DOI 10.1002/eji.201141817; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Ghigo C, 2013, J EXP MED, V210, P1657, DOI 10.1084/jem.20130403; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; GRIMM MC, 1995, J GASTROEN HEPATOL, V10, P387, DOI 10.1111/j.1440-1746.1995.tb01589.x; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Jakubzick C, 2013, IMMUNITY, V39, P599, DOI 10.1016/j.immuni.2013.08.007; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kennedy DW, 1997, BLOOD, V90, P986, DOI 10.1182/blood.V90.3.986.986_986_993; LEE SH, 1985, J EXP MED, V161, P475, DOI 10.1084/jem.161.3.475; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Muller AJ, 2012, CELL HOST MICROBE, V11, P19, DOI 10.1016/j.chom.2011.11.013; Nagashima R, 1996, J HISTOCHEM CYTOCHEM, V44, P721, DOI 10.1177/44.7.8675993; Niess JH, 2010, J IMMUNOL, V184, P2026, DOI 10.4049/jimmunol.0901936; Platt AM, 2010, J IMMUNOL, V184, P6843, DOI 10.4049/jimmunol.0903987; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Smythies LE, 2006, J LEUKOCYTE BIOL, V80, P492, DOI 10.1189/jlb.1005566; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; Ueda Y, 2010, INT IMMUNOL, V22, P953, DOI 10.1093/intimm/dxq449; VANFURTH R, 1972, B WORLD HEALTH ORGAN, V46, P845; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	42	653	659	6	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2014	15	10					929	U236		10.1038/ni.2967	http://dx.doi.org/10.1038/ni.2967			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AQ1TR	25151491	Green Submitted, Green Accepted			2022-12-18	WOS:000342564800008
J	Toshchakov, V; Jones, BW; Perera, PY; Thomas, K; Cody, MJ; Zhang, SL; Williams, BRG; Major, J; Hamilton, TA; Fenton, MJ; Vogel, SN				Toshchakov, V; Jones, BW; Perera, PY; Thomas, K; Cody, MJ; Zhang, SL; Williams, BRG; Major, J; Hamilton, TA; Fenton, MJ; Vogel, SN			TLR4, but not TLR2, mediates IFN-beta-induced STAT1 alpha/beta-dependent gene expression in macrophages	NATURE IMMUNOLOGY			English	Article							TOLL-LIKE RECEPTOR-2; CUTTING EDGE; LIPOPOLYSACCHARIDE; INTERFERON; INDUCTION; ACTIVATION; MICE; IRF-1; REQUIREMENT; TOLERANCE	Toll-like receptor 2 (TLR2) agonists induce a subset of TLR4-inducible proinflammatory genes, which suggests the use of differential signaling pathways. Murine macrophages stimulated with the TLR4 agonist Escherichia coli lipopolysaccharide (LPS), but not with TLR2 agonists, induced phosphorylation of signal transducer and activator of transcription 1alpha (STAT1alpha) and STAT1beta, which was blocked by antibodies to interferon beta (IFN-beta) but not IFN-alpha. All TLR2 agonists poorly induced IFN-beta, which is encoded by an immediate early LPS-inducible gene. Thus, the failure of TLR2 agonists to induce STAT1-dependent genes resulted, in part, from their inability to express IFN-beta. TLR4-induced IFN-beta mRNA was MyD88- and PKR (double-stranded RNA-dependent protein kinase)-independent, but TIRAP (Toll-interleukin 1 receptor domain-containing adapter protein)-dependent. Together, these findings provide the first mechanistic basis for differential patterns of gene expression activated by TLR4 and TLR2 agonists.	Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA; Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; Cleveland Clin Res Fdn, Dept Immunol, Cleveland, OH 44195 USA	Uniformed Services University of the Health Sciences - USA; Boston University; Cleveland Clinic Foundation	Vogel, SN (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA.	vogel@bob.usuhs.mil	Hamilton, Thomas A/A-7756-2009; Toshchakov, Vladimir/C-2798-2014; Hamilton, Thomas Edward/GQB-4837-2022; Williams, Bryan R. G./A-5021-2009	Toshchakov, Vladimir/0000-0002-7942-2294; Williams, Bryan R. G./0000-0002-4969-1151; Hamilton, Thomas/0000-0002-9817-242X	NATIONAL CANCER INSTITUTE [P01CA062220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034039, R21AI047233, R01AI018797, R37AI018797, R21AI034039, R01AI047233] Funding Source: NIH RePORTER; NCI NIH HHS [CA-62220] Funding Source: Medline; NIAID NIH HHS [AI-34039, AI-47233, AI-18797] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; BARBER SA, 1995, INFECT IMMUN, V63, P601, DOI 10.1128/IAI.63.2.601-608.1995; DeFranco AL, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P473; Falvo JV, 2000, MOL CELL BIOL, V20, P4814, DOI 10.1128/MCB.20.13.4814-4825.2000; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; FULTZ MJ, 1993, INT IMMUNOL, V5, P1383, DOI 10.1093/intimm/5.11.1383; Gao JJ, 1998, J IMMUNOL, V161, P4803; Hattori Y, 1996, BIOCHEM MOL BIOL INT, V40, P889; HELDWEIN KA, 2001, MOD ASP IMMUNOBIOL, V1, P249; Henneke P, 2001, NAT IMMUNOL, V2, P828, DOI 10.1038/ni0901-828; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Hoshino K, 1999, J IMMUNOL, V162, P3749; Jones BW, 2001, J LEUKOCYTE BIOL, V69, P1036; JONES BW, 2002, IN PRESS ANN RHEUM D; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kopydlowski KM, 1999, J IMMUNOL, V163, P1537; LEADBETTER EA, 2002, IN PRESS NATURE; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; MANTHEY CL, 1994, J IMMUNOL, V152, P825; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; Means TK, 1999, J IMMUNOL, V163, P6748; Means TK, 2001, J IMMUNOL, V166, P4074, DOI 10.4049/jimmunol.166.6.4074; Medvedev AE, 2001, J IMMUNOL, V167, P2257, DOI 10.4049/jimmunol.167.4.2257; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; Nguyen Hannah, 1997, Cytokine and Growth Factor Reviews, V8, P293, DOI 10.1016/S1359-6101(97)00019-1; Ohmori Y, 2001, J LEUKOCYTE BIOL, V69, P598; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; Re F, 2001, J BIOL CHEM, V276, P37692, DOI 10.1074/jbc.M105927200; Salkowski CA, 1998, INFECT IMMUN, V66, P3569, DOI 10.1128/IAI.66.8.3569-3578.1998; Sato M, 2001, CYTOKINE GROWTH F R, V12, P133, DOI 10.1016/S1359-6101(00)00032-0; Sato S, 2000, J IMMUNOL, V165, P7096, DOI 10.4049/jimmunol.165.12.7096; Senger K, 2000, MOL CELL, V6, P931, DOI 10.1016/S1097-2765(05)00081-X; Servant MJ, 2001, J BIOL CHEM, V276, P355, DOI 10.1074/jbc.M007790200; Sing A, 2000, INFECT IMMUN, V68, P1600, DOI 10.1128/IAI.68.3.1600-1607.2000; TANIGUCHI T, 1989, J INTERFERON RES, V9, P633, DOI 10.1089/jir.1989.9.633; VOGEL SN, 1992, BACTERIAL ENDOTOXIC, P165; Warren TL, 2000, J IMMUNOL, V165, P6244, DOI 10.4049/jimmunol.165.11.6244; Weinstein SL, 2000, J LEUKOCYTE BIOL, V67, P405, DOI 10.1002/jlb.67.3.405; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x	42	650	666	2	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2002	3	4					392	398		10.1038/ni774	http://dx.doi.org/10.1038/ni774			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	535BD	11896392				2022-12-18	WOS:000174623600021
J	Guillerey, C; Huntington, ND; Smyth, MJ				Guillerey, Camille; Huntington, Nicholas D.; Smyth, Mark J.			Targeting natural killer cells in cancer immunotherapy	NATURE IMMUNOLOGY			English	Review							ACUTE MYELOID-LEUKEMIA; DEPENDENT CELLULAR CYTOTOXICITY; POTENT ANTITUMOR-ACTIVITY; ACTIVATES NK CELLS; T-CELLS; MULTIPLE-MYELOMA; PHASE-1 TRIAL; CUTTING EDGE; KIR ANTIBODY; RECEPTOR POLYMORPHISMS	Alteration in the expression of cell-surface proteins is a common consequence of malignant transformation. Natural killer (NK) cells use an array of germline-encoded activating and inhibitory receptors that scan for altered protein-expression patterns, but tumor evasion of detection by the immune system is now recognized as one of the hallmarks of cancer. NK cells display rapid and potent immunity to metastasis or hematological cancers, and major efforts are now being undertaken to fully exploit NK cell anti-tumor properties in the clinic. Diverse approaches encompass the development of large-scale NK cell-expansion protocols for adoptive transfer, the establishment of a microenvironment favorable to NK cell activity, the redirection of NK cell activity against tumor cells and the release of inhibitory signals that limit NK cell function. In this Review we detail recent advances in NK cell based immunotherapies and discuss the advantages and limitations of these strategies.	[Guillerey, Camille; Smyth, Mark J.] QIMR Berghofer Med Res Inst, Immunol Canc & Infect Lab, Herston, Qld, Australia; [Guillerey, Camille; Smyth, Mark J.] Univ Queensland, Sch Med, Herston, Qld, Australia; [Huntington, Nicholas D.] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Huntington, Nicholas D.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia	QIMR Berghofer Medical Research Institute; University of Queensland; Walter & Eliza Hall Institute; University of Melbourne	Smyth, MJ (corresponding author), QIMR Berghofer Med Res Inst, Immunol Canc & Infect Lab, Herston, Qld, Australia.; Smyth, MJ (corresponding author), Univ Queensland, Sch Med, Herston, Qld, Australia.	mark.smyth@qimrberghofer.edu.au	Smyth, Mark J/H-8709-2014; Huntington, NICHOLAS/AAV-4704-2020; Guillerey, Camille/N-1061-2014	Smyth, Mark J/0000-0001-7098-7240; Huntington, NICHOLAS/0000-0002-5267-7211; Guillerey, Camille/0000-0002-7917-2432	National Health and Medical Research Council of Australia [1078671, 1098960, 1093566, 1107417, 1027472, 1049407, 1066770, 1057852]; National Health and Medical Research Council of Australia (Independent Research Institute Infrastructure Support Scheme grant); Cancer Research Institute (CLIP grant); Cancer Council of Queensland [1083776]; Victorian State Government (Operational Infrastructure Scheme grant); Harry J Lloyd Charitable Trust	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia (Independent Research Institute Infrastructure Support Scheme grant)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Research Institute (CLIP grant); Cancer Council of Queensland(Cancer Council Queensland); Victorian State Government (Operational Infrastructure Scheme grant); Harry J Lloyd Charitable Trust	We thank members of our laboratory for contributions in this area. Supported by the National Health and Medical Research Council of Australia (1078671, 1098960 and 1093566 to M.J.S.; 1107417 to C.G.; 1027472, 1049407, 1066770 and 1057852 to N.D.H.; and an Independent Research Institute Infrastructure Support Scheme grant to N.D.H.), the Cancer Research Institute (CLIP grant to M.J.S.), the Cancer Council of Queensland (1083776 to M.J.S.), the Victorian State Government (Operational Infrastructure Scheme grant to N.D.H.) and the Harry J Lloyd Charitable Trust (N.D.H.).	Bachanova V, 2014, BLOOD, V123, P3855, DOI 10.1182/blood-2013-10-532531; Baessler T, 2010, BLOOD, V115, P3058, DOI 10.1182/blood-2009-06-227934; Bakema JE, 2014, CURR TOP MICROBIOL, V382, P373, DOI 10.1007/978-3-319-07911-0_17; Beavis PA, 2013, P NATL ACAD SCI USA, V110, P14711, DOI 10.1073/pnas.1308209110; Becker PSA, 2016, CANCER IMMUNOL IMMUN, V65, P477, DOI 10.1007/s00262-016-1792-y; Benson DM, 2012, BLOOD, V120, P4324, DOI 10.1182/blood-2012-06-438028; Benson DM, 2011, BLOOD, V118, P6387, DOI 10.1182/blood-2011-06-360255; Bernardini Giovanni, 2014, Critical Reviews in Oncogenesis, V19, P77; Besse B, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1071008; Bishara A, 2004, TISSUE ANTIGENS, V63, P204, DOI 10.1111/j.0001-2815.2004.00182.x; Blake SJ, 2016, CANCER DISCOV, V6, P446, DOI 10.1158/2159-8290.CD-15-0944; Boltz A, 2011, J BIOL CHEM, V286, P21896, DOI 10.1074/jbc.M111.238261; Borg C, 2004, J CLIN INVEST, V114, P379, DOI 10.1172/jci20041102; Bowles JA, 2006, BLOOD, V108, P2648, DOI 10.1182/blood-2006-04-020057; Burns LJ, 2003, BONE MARROW TRANSPL, V32, P177, DOI 10.1038/sj.bmt.1704086; Chan CJ, 2014, NAT IMMUNOL, V15, P431, DOI 10.1038/ni.2850; Chan CJ, 2010, J IMMUNOL, V184, P902, DOI 10.4049/jimmunol.0903225; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Conlon KC, 2015, J CLIN ONCOL, V33, P74, DOI 10.1200/JCO.2014.57.3329; Cortez VS, 2014, J IMMUNOL, V192, P4487, DOI 10.4049/jimmunol.1303469; Curti A, 2011, BLOOD, V118, P3273, DOI 10.1182/blood-2011-01-329508; da Silva IP, 2014, CANCER IMMUNOL RES, V2, P410, DOI 10.1158/2326-6066.CIR-13-0171; Davies FE, 2001, BLOOD, V98, P210, DOI 10.1182/blood.V98.1.210; Davies SM, 2002, BLOOD, V100, P3825, DOI 10.1182/blood-2002-04-1197; Delahaye NF, 2011, NAT MED, V17, P700, DOI 10.1038/nm.2366; Delconte RB, 2016, NAT IMMUNOL, V17, P816, DOI 10.1038/ni.3470; Delconte RB, 2016, IMMUNITY, V44, P103, DOI 10.1016/j.immuni.2015.12.007; Delgado DC, 2010, CANCER RES, V70, P9554, DOI 10.1158/0008-5472.CAN-10-2211; Deng WW, 2015, SCIENCE, V348, P136, DOI 10.1126/science.1258867; Fuchs A, 2004, J IMMUNOL, V172, P3994, DOI 10.4049/jimmunol.172.7.3994; Genssler S, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1119354; Gerdes CA, 2013, CLIN CANCER RES, V19, P1126, DOI 10.1158/1078-0432.CCR-12-0989; Ghiringhelli F, 2005, J EXP MED, V202, P1075, DOI 10.1084/jem.20051511; Gill S, 2015, IMMUNOL REV, V263, P68, DOI 10.1111/imr.12243; Gleason MK, 2012, MOL CANCER THER, V11, P2674, DOI 10.1158/1535-7163.MCT-12-0692; Glienke W, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00021; Gluck WL, 2004, CLIN CANCER RES, V10, P2253, DOI 10.1158/1078-0432.CCR-1087-3; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Grossenbacher SK, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0124-2; Guillerey C, 2016, CURR TOP MICROBIOL, V395, P115, DOI 10.1007/82_2015_446; Guillerey C, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1027468; Guillerey C, 2015, J CLIN INVEST, V125, P2077, DOI 10.1172/JCI77181; Han JF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11483; Hartmann F, 1997, BLOOD, V89, P2042, DOI 10.1182/blood.V89.6.2042; Hayakawa Y, 2006, IMMUNOL REV, V214, P47, DOI 10.1111/j.1600-065X.2006.00454.x; Huang BY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134715; Huntington ND, 2007, NAT REV IMMUNOL, V7, P703, DOI 10.1038/nri2154; Huntington ND, 2014, IMMUNOL CELL BIOL, V92, P210, DOI 10.1038/icb.2014.1; Huntington ND, 2010, NATURAL KILLER CELLS: AT THE FOREFRONT OF MODERN IMMUNOLOGY, P39, DOI 10.1007/978-3-642-02309-5_2; Iannello A, 2013, J EXP MED, V210, P2057, DOI 10.1084/jem.20130783; Imamura M, 2014, BLOOD, V124, P1081, DOI 10.1182/blood-2014-02-556837; Jardine L, 2013, LEUKEMIA LYMPHOMA, V54, P167, DOI 10.3109/10428194.2012.708026; Jones Benjamin S, 2014, Front Pharmacol, V5, P254, DOI 10.3389/fphar.2014.00254; Kellner C, 2012, LEUKEMIA, V26, P830, DOI 10.1038/leu.2011.288; Kim PS, 2016, ONCOTARGET, V7, P16130, DOI 10.18632/oncotarget.7470; Klingemann H, 2015, CYTOTHERAPY, V17, P245, DOI 10.1016/j.jcyt.2014.09.007; Klingemann H, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28147; Knorr DA, 2014, SEMIN IMMUNOL, V26, P161, DOI 10.1016/j.smim.2014.02.002; Kohrt HE, 2014, J CLIN INVEST, V124, P2668, DOI 10.1172/JCI73014; Kohrt HE, 2014, BLOOD, V123, P678, DOI 10.1182/blood-2013-08-519199; Kohrt HE, 2011, BLOOD, V117, P2423, DOI 10.1182/blood-2010-08-301945; Korde N, 2014, HAEMATOLOGICA, V99, pE81, DOI 10.3324/haematol.2013.103085; Krasnova Y., 2015, CLIN IMMUNOL; Krieg S, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00388; Lanier LL, 2015, CANCER IMMUNOL RES, V3, P575, DOI 10.1158/2326-6066.CIR-15-0098; Leong JW, 2014, BIOL BLOOD MARROW TR, V20, P463, DOI 10.1016/j.bbmt.2014.01.006; Lesokhin AM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010274; Li Y, 2016, CURR TOP MICROBIOL, V395, P191, DOI 10.1007/82_2015_488; Lundqvist A, 2009, BLOOD, V113, P6120, DOI 10.1182/blood-2008-11-190421; Maghazachi AA, 2010, CURR TOP MICROBIOL, V341, P37, DOI 10.1007/82_2010_20; Makkouk A, 2016, EUR J CANCER, V54, P112, DOI 10.1016/j.ejca.2015.09.026; Marais A, 2014, NAT IMMUNOL, V15, P749, DOI 10.1038/ni.2936; Marquardt N, 2015, J IMMUNOL, V194, P2467, DOI 10.4049/jimmunol.1402756; Martinet L, 2015, CELL REP, V11, P85, DOI 10.1016/j.celrep.2015.03.006; Martinet L, 2015, NAT REV IMMUNOL, V15, P243, DOI 10.1038/nri3799; Miller JS, 2005, BLOOD, V105, P3051, DOI 10.1182/blood-2004-07-2974; Mittal D, 2014, CANCER RES, V74, P3652, DOI 10.1158/0008-5472.CAN-14-0957; Mocellin S, 2004, GENES IMMUN, V5, P621, DOI 10.1038/sj.gene.6364135; Moga E, 2008, EXP HEMATOL, V36, P69, DOI 10.1016/j.exphem.2007.08.012; Nguyen S, 2009, BONE MARROW TRANSPL, V43, P693, DOI 10.1038/bmt.2008.380; Nowak J, 2015, BIOL BLOOD MARROW TR, V21, P829, DOI 10.1016/j.bbmt.2015.01.018; Paolino M, 2014, NATURE, V507, P508, DOI 10.1038/nature12998; Parameswaran R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11154; Parkhurst MR, 2011, CLIN CANCER RES, V17, P6287, DOI 10.1158/1078-0432.CCR-11-1347; Perez-Martinez A, 2015, CYTOTHERAPY, V17, P1594, DOI 10.1016/j.jcyt.2015.07.011; Porrata LF, 2008, BIOL BLOOD MARROW TR, V14, P807, DOI 10.1016/j.bbmt.2008.04.013; Porrata LF, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/914945; Putz EM, 2013, CELL REP, V4, P437, DOI 10.1016/j.celrep.2013.07.012; Raulet DH, 2006, NAT REV IMMUNOL, V6, P520, DOI 10.1038/nri1863; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Roberti MP, 2012, BREAST CANCER RES TR, V136, P659, DOI 10.1007/s10549-012-2287-y; Rodriguez J, 2012, EUR J CANCER, V48, P1774, DOI 10.1016/j.ejca.2012.01.007; Romagne F, 2009, BLOOD, V114, P2667, DOI 10.1182/blood-2009-02-206532; Romanski A, 2016, J CELL MOL MED, V20, P1287, DOI 10.1111/jcmm.12810; Romee R, 2014, SCIENTIFICA, V2014, DOI 10.1155/2014/205796; Romee R, 2013, BLOOD, V121, P3599, DOI 10.1182/blood-2012-04-425397; Rossi LE, 2012, J LEUKOCYTE BIOL, V91, P321, DOI 10.1189/jlb.0711339; Rubnitz JE, 2010, J CLIN ONCOL, V28, P955, DOI 10.1200/JCO.2009.24.4590; Rueff Jessica, 2014, Biol Blood Marrow Transplant, V20, P896, DOI 10.1016/j.bbmt.2014.03.007; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Sahm C, 2012, CANCER IMMUNOL IMMUN, V61, P1451, DOI 10.1007/s00262-012-1212-x; Sakamoto N, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0632-8; Sanmamed MF, 2015, SEMIN ONCOL, V42, P640, DOI 10.1053/j.seminoncol.2015.05.014; Schmiedel BJ, 2011, INT J CANCER, V128, P2911, DOI 10.1002/ijc.25635; Schmohl J.U., 2015, TARGET ONCOL; Schonfeld K, 2015, MOL THER, V23, P330, DOI [10.1038/mt.2014.21, 10.1038/mt.2014.219]; Sconocchia G, 2012, CANCER RES, V72, P5428, DOI 10.1158/0008-5472.CAN-12-1181; Semeraro M, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2327; Shah NN, 2015, BLOOD, V125, P784, DOI 10.1182/blood-2014-07-592881; Shahied LS, 2004, J BIOL CHEM, V279, P53907, DOI 10.1074/jbc.M407888200; Smyth MJ, 2006, J IMMUNOL, V176, P1582, DOI 10.4049/jimmunol.176.3.1582; Sojka DK, 2014, SEMIN IMMUNOL, V26, P127, DOI 10.1016/j.smim.2014.01.010; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Stacey MA, 2011, J IMMUNOL, V187, P2944, DOI 10.4049/jimmunol.1101021; Stanietsky N, 2013, EUR J IMMUNOL, V43, P2138, DOI 10.1002/eji.201243072; Stanietsky N, 2009, P NATL ACAD SCI USA, V106, P17858, DOI 10.1073/pnas.0903474106; Steele N, 2012, BRIT J CANCER, V106, P793, DOI 10.1038/bjc.2011.599; Stojanovic A, 2014, J IMMUNOL, V192, P4184, DOI 10.4049/jimmunol.1302091; Sungur Can M., 2014, Critical Reviews in Oncogenesis, V19, P57; Tarek N, 2012, J CLIN INVEST, V122, P3260, DOI 10.1172/JCI62749; Tonn T, 2013, CYTOTHERAPY, V15, P1563, DOI 10.1016/j.jcyt.2013.06.017; Vallera D.A., 2016, CLIN CANC RES; Vey N, 2012, BLOOD, V120, P4317, DOI 10.1182/blood-2012-06-437558; Viaud S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004942; Viel S, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad1884; Vitale M, 2014, EUR J IMMUNOL, V44, P1582, DOI 10.1002/eji.201344272; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; von Strandmann EP, 2006, BLOOD, V107, P1955, DOI 10.1182/blood-2005-05-2177; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; Waldmann TA, 2014, EXPERT REV CLIN IMMU, V10, P1689, DOI 10.1586/1744666X.2014.973856; Wang XL, 2009, HAEMATOL-HEMATOL J, V94, P470, DOI 10.3324/haematol.13783; Wang ZX, 2015, IMMUNOL INVEST, V44, P578, DOI 10.3109/08820139.2015.1052145; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Weng WK, 2003, J CLIN ONCOL, V21, P3940, DOI 10.1200/JCO.2003.05.013; Westin JR, 2014, LANCET ONCOL, V15, P69, DOI 10.1016/S1470-2045(13)70551-5; Wiernik A, 2013, CLIN CANCER RES, V19, P3844, DOI 10.1158/1078-0432.CCR-13-0505; Wieten L, 2014, TISSUE ANTIGENS, V84, P523, DOI 10.1111/tan.12478; Wu L, 2008, CLIN CANCER RES, V14, P4650, DOI 10.1158/1078-0432.CCR-07-4405; Xu LY, 2015, INT IMMUNOPHARMACOL, V29, P635, DOI 10.1016/j.intimp.2015.09.017; Yang RK, 2013, CANCER IMMUNOL IMMUN, V62, P1303, DOI 10.1007/s00262-013-1430-x; Young A, 2014, CANCER DISCOV, V4, P879, DOI 10.1158/2159-8290.CD-14-0341; Zamora A.E., 2015, CURR PROTOC IMMUNOL, V110, P11; Zhang C., 2015, JNCI-J NATL CANCER I, V108; Zhou Q, 2013, CLIN EXP IMMUNOL, V173, P131, DOI 10.1111/cei.12095	144	648	664	19	308	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2016	17	9					1025	1036		10.1038/ni.3518	http://dx.doi.org/10.1038/ni.3518			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DT9OO	27540992				2022-12-18	WOS:000381832000006
J	Ablasser, A; Bauernfeind, F; Hartmann, G; Latz, E; Fitzgerald, KA; Hornung, V				Ablasser, Andrea; Bauernfeind, Franz; Hartmann, Gunther; Latz, Eicke; Fitzgerald, Katherine A.; Hornung, Veit			RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate	NATURE IMMUNOLOGY			English	Article							ANTIVIRAL SIGNALING PROTEIN; INNATE IMMUNE-RESPONSES; EPSTEIN-BARR-VIRUS; NF-KAPPA-B; IFN-BETA; RIBONUCLEIC-ACIDS; ADAPTER PROTEIN; RECOGNITION; DNA; INFLAMMASOME	RNA is sensed by Toll-like receptor 7 (TLR7) and TLR8 or by the RNA helicases LGP2, Mda5 and RIG-I to trigger antiviral responses. Much less is known about sensors for DNA. Here we identify a novel DNA-sensing pathway involving RNA polymerase III and RIG-I. In this pathway, AT-rich double-stranded DNA (dsDNA) served as a template for RNA polymerase III and was transcribed into double-stranded RNA (dsRNA) containing a 5'-triphosphate moiety. Activation of RIG-I by this dsRNA induced production of type I interferon and activation of the transcription factor NF-kappa B. This pathway was important in the sensing of Epstein-Barr virus-encoded small RNAs, which were transcribed by RNA polymerase III and then triggered RIG-I activation. Thus, RNA polymerase III and RIG-I are pivotal in sensing viral DNA.	[Ablasser, Andrea; Bauernfeind, Franz; Hartmann, Gunther; Hornung, Veit] Univ Bonn, Inst Clin Chem & Pharmacol, D-5300 Bonn, Germany; [Latz, Eicke; Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA USA	University of Bonn; University of Massachusetts System; University of Massachusetts Worcester	Hornung, V (corresponding author), Univ Bonn, Inst Clin Chem & Pharmacol, D-5300 Bonn, Germany.	veit.hornung@uni-bonn.de	Hartmann, Gunther/P-7492-2017; Latz, Eicke/H-3951-2014; Fitzgerald, Katherine/ABE-6317-2020; Bauernfeind, Franz-Georg/ABF-1148-2020; Hornung, Veit/C-3565-2012	Hartmann, Gunther/0000-0003-1021-2018; Latz, Eicke/0000-0003-1488-5666; Hornung, Veit/0000-0002-4150-194X; Fitzgerald, Kate/0000-0003-3175-609X	Deutsche Forschungsgemeinschaft [Ho2783/2-1]; US National Institutes of Health [AI-065483, AI-067497, AI-083713]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI067497, R01AI065483, R01AI083713, R01AI067497, R56AI067497] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Silverman (Lerner Research Institute, Cleveland Clinic) for Rnasel<SUP>-/-</SUP> MEFs and their respective controls; and G. Bornkamm and M. Schlee for discussions. Supported by the Deutsche Forschungsgemeinschaft (Ho2783/2-1 V. H.) and the US National Institutes of Health (AI-065483 to E.L.; AI-067497 to K.A.F.; AI-083713 to K.A.F. and E.L.).	Ablasser A, 2009, J IMMUNOL, V182, P6824, DOI 10.4049/jimmunol.0803001; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Charrel-Dennis M, 2008, CELL HOST MICROBE, V4, P543, DOI 10.1016/j.chom.2008.11.002; Cheng GF, 2007, P NATL ACAD SCI USA, V104, P9035, DOI 10.1073/pnas.0703285104; Chessler ADC, 2008, J IMMUNOL, V181, P7917, DOI 10.4049/jimmunol.181.11.7917; Deng L, 2008, J VIROL, V82, P10735, DOI 10.1128/JVI.01305-08; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; HUET J, 1985, J BIOL CHEM, V260, P5304; Huysamen C, 2009, FEMS MICROBIOL LETT, V290, P121, DOI 10.1111/j.1574-6968.2008.01418.x; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; LERNER MR, 1981, P NATL ACAD SCI-BIOL, V78, P805, DOI 10.1073/pnas.78.2.805; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; Opitz B, 2006, J BIOL CHEM, V281, P36173, DOI 10.1074/jbc.M604638200; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; ROSA MD, 1981, MOL CELL BIOL, V1, P785, DOI 10.1128/MCB.1.9.785; Roux CM, 2007, CELL MICROBIOL, V9, P1851, DOI 10.1111/j.1462-5822.2007.00922.x; Samanta M, 2006, EMBO J, V25, P4207, DOI 10.1038/sj.emboj.7601314; Sanchez DJ, 2008, J VIROL, V82, P2208, DOI 10.1128/JVI.01718-07; SCHLEE M, 2009, IMMUNITY        0702, DOI DOI 10.1016/J.IMMUNI.2009.05.008; Schlee M, 2007, ADV CANCER RES, V97, P167, DOI 10.1016/S0065-230X(06)97007-9; Schlee M, 2007, INT J CANCER, V120, P1387, DOI 10.1002/ijc.22372; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Stanley SA, 2007, J IMMUNOL, V178, P3143, DOI 10.4049/jimmunol.178.5.3143; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Takaoka A, 2008, ADV DRUG DELIVER REV, V60, P847, DOI 10.1016/j.addr.2007.12.002; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Thuillier V, 1996, EMBO J, V15, P618, DOI 10.1002/j.1460-2075.1996.tb00394.x; Wang ZX, 1997, GENE DEV, V11, P1315, DOI 10.1101/gad.11.10.1315; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2007, CYTOKINE GROWTH F R, V18, P545, DOI 10.1016/j.cytogfr.2007.06.023; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146; Zaros C, 2005, MOL MICROBIOL, V55, P104, DOI 10.1111/j.1365-2958.2004.04375.x	49	646	693	2	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2009	10	10					1065	U40		10.1038/ni.1779	http://dx.doi.org/10.1038/ni.1779			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	496VG	19609254	Green Submitted, Green Accepted			2022-12-18	WOS:000270006900009
J	Williams, LM; Rudensky, AY				Williams, Luke M.; Rudensky, Alexander Y.			Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3	NATURE IMMUNOLOGY			English	Article							SELF; TOLERANCE; PATHWAYS; SCURFIN	The transcription factor Foxp3 is required for the development of regulatory T cells (T-reg cell). Here we report that induced ablation of a loxP-flanked Foxp3 allele in mature T-reg cells resulted in the loss of their suppressive function in vivo and acquisition of the ability to produce interleukin 2 and T helper type 1 cytokines. Furthermore, after adoptive transfer in the absence of functional T-reg cells into lymphopenic hosts, T-reg cells with deletion of Foxp3 proliferated and were predominant among tissue-infiltrating T cells. In agreement with those results, we found deregulation of Foxp3 target gene expression after Foxp3 deletion. Thus, continued Foxp3 expression in mature T-reg cells is needed to maintain the transcriptional and functional program established during T-reg cell development.	Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Rudensky, AY (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	aruden@u.washington.edu						Asseman C, 2000, AM J RESP CRIT CARE, V162, pS185, DOI 10.1164/ajrccm.162.supplement_3.15tac9; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chan CWY, 2003, J IMMUNOL, V170, P4036, DOI 10.4049/jimmunol.170.8.4036; Drakes ML, 2005, J LEUKOCYTE BIOL, V78, P1291, DOI 10.1189/jlb.0605342; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; GAVIN MA, IN PRESS NATURE; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Ho IC, 2002, CELL, V109, pS109, DOI 10.1016/S0092-8674(02)00705-5; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Khattri R, 2001, J IMMUNOL, V167, P6312, DOI 10.4049/jimmunol.167.11.6312; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kobie JJ, 2006, J IMMUNOL, V177, P6780, DOI 10.4049/jimmunol.177.10.6780; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Martins GA, 2005, J IMMUNOL, V175, P5981, DOI 10.4049/jimmunol.175.9.5981; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Pai SY, 2004, P NATL ACAD SCI USA, V101, P1993, DOI 10.1073/pnas.0308697100; Paust S, 2004, P NATL ACAD SCI USA, V101, P10398, DOI 10.1073/pnas.0403342101; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Yegutkin GG, 2002, BIOCHEM J, V367, P121, DOI 10.1042/BJ20020439; Zhang JH, 2005, CELL MOL IMMUNOL, V2, P271; ZHENG Y, IN PRESS NATURE; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128	37	638	702	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2007	8	3					277	284		10.1038/ni1437	http://dx.doi.org/10.1038/ni1437			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	137EF	17220892				2022-12-18	WOS:000244275100013
J	Croker, BA; Krebs, DL; Zhang, JG; Wormald, S; Willson, TA; Stanley, EG; Robb, L; Greenhalgh, CJ; Forster, I; Clausen, BE; Nicola, NA; Metcalf, D; Hilton, DJ; Roberts, AW; Alexander, WS				Croker, BA; Krebs, DL; Zhang, JG; Wormald, S; Willson, TA; Stanley, EG; Robb, L; Greenhalgh, CJ; Forster, I; Clausen, BE; Nicola, NA; Metcalf, D; Hilton, DJ; Roberts, AW; Alexander, WS			SOCS3 negatively regulates IL-6 signaling in vivo	NATURE IMMUNOLOGY			English	Article							MICE LACKING SUPPRESSOR; ACUTE-PHASE RESPONSE; IN-VIVO; INTERLEUKIN-6-DEFICIENT MICE; CYTOKINE SIGNALING-3; GAMMA; STAT3; LIVER; ACTIVATION; EXPRESSION	Members of the suppressor of cytokine signaling (SOCS) family are potentially key physiological negative regulators of interleukin-6 (IL-6) signaling. To examine whether SOCS3 is involved in regulating this signaling, we have used conditional gene targeting to generate mice lacking Socs3 in the liver or in macrophages. We show that Socs3 deficiency results in prolonged activation of signal transducer and activator of transcription 1 (STAT1) and STAT3 after IL-6 stimulation but normal activation of STAT1 after stimulation with interferon-gamma (IFN-gamma). Conversely, IL-6-induced STAT activation is normal in Socs1-deficient cells, whereas STAT1 activation induced by IFN-gamma is prolonged. Microarray analysis shows that the pattern of gene expression induced by IL-6 in Socs3-deficient livers mimics that induced by IFN-gamma. Our data indicate that SOCS3 and SOCS1 have reciprocal functions in IL-6 and IFN-gamma regulation and imply that SOCS3 has a role in preventing IFN-gamma-like responses in cells stimulated by IL-6.	Walter & Eliza Hall Inst Med Res, Canc & Haematol Div, Parkville, Vic 3050, Australia; Cooperrat Res Ctr Cellular Growth Factors, Parkville, Vic 3050, Australia; Monash Med Ctr, Monash Inst Reprod & Dev, Clayton, Vic 3168, Australia; Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands	Walter & Eliza Hall Institute; Monash University; Technical University of Munich; University of Amsterdam; Academic Medical Center Amsterdam	Alexander, WS (corresponding author), Walter & Eliza Hall Inst Med Res, Canc & Haematol Div, 1G Royal Parade, Parkville, Vic 3050, Australia.		Hilton, Douglas J/C-7250-2013; CLAUSEN, Björn Erik/A-8229-2010; Roberts, Andrew W./C-6736-2012; Nicola, Nicos/D-2989-2011; Förster, Irmgard/P-8545-2016; Stanley, Ed G/A-2985-2013	Hilton, Douglas J/0000-0002-7698-2392; CLAUSEN, Björn Erik/0000-0002-2484-7842; Roberts, Andrew W./0000-0002-7341-5720; Nicola, Nicos/0000-0003-1054-7889; Förster, Irmgard/0000-0002-7644-5642; Stanley, Ed G/0000-0002-6389-3665; Croker, Ben/0000-0002-0885-3599; Krebs, Danielle/0000-0002-6522-7308	NATIONAL CANCER INSTITUTE [R37CA022556, R01CA022556] Funding Source: NIH RePORTER; NCI NIH HHS [CA22556] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alexander WS, 2002, NAT REV IMMUNOL, V2, P410, DOI 10.1038/nri818; Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Alonzi T, 2001, MOL CELL BIOL, V21, P1621, DOI 10.1128/MCB.21.5.1621-1632.2001; BERNAD A, 1994, IMMUNITY, V1, P725, DOI 10.1016/S1074-7613(94)80014-6; Bertolino P, 1998, EUR J IMMUNOL, V28, P221, DOI 10.1002/(SICI)1521-4141(199801)28:01<221::AID-IMMU221>3.3.CO;2-6; Brysha M, 2001, J BIOL CHEM, V276, P22086, DOI 10.1074/jbc.M102737200; Campbell JS, 2001, J CLIN INVEST, V107, P1285, DOI 10.1172/JCI11867; CASCIO S, 1991, DEVELOPMENT, V113, P217; Cassatella MA, 1999, BLOOD, V94, P2880, DOI 10.1182/blood.V94.8.2880.420k31_2880_2889; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Costa-Pereira AP, 2002, P NATL ACAD SCI USA, V99, P8043, DOI 10.1073/pnas.122236099; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; FATTORI E, 1994, J EXP MED, V180, P1243, DOI 10.1084/jem.180.4.1243; FINBLOOM DS, 1995, J IMMUNOL, V155, P1079; Hemmann U, 1996, J BIOL CHEM, V271, P12999, DOI 10.1074/jbc.271.22.12999; HILBERT DM, 1995, J EXP MED, V182, P243, DOI 10.1084/jem.182.1.243; Hong F, 2002, J CLIN INVEST, V110, P1503, DOI 10.1172/JCI200215841; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; LANG R, 2003, NAT IMMUNOL; Lee CK, 2002, IMMUNITY, V17, P63, DOI 10.1016/S1074-7613(02)00336-9; Marine JC, 1999, CELL, V98, P617, DOI 10.1016/S0092-8674(00)80049-5; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Metcalf D, 2000, NATURE, V405, P1069, DOI 10.1038/35016611; Nicholson SE, 1999, EMBO J, V18, P375, DOI 10.1093/emboj/18.2.375; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; RAMSAY AJ, 1994, SCIENCE, V264, P561, DOI 10.1126/science.8160012; Roberts AW, 2001, P NATL ACAD SCI USA, V98, P9324, DOI 10.1073/pnas.161271798; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Song MM, 1998, J BIOL CHEM, V273, P35056, DOI 10.1074/jbc.273.52.35056; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Stoiber D, 1999, J IMMUNOL, V163, P2640; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; Takahashi Y, 2003, EMBO J, V22, P372, DOI 10.1093/emboj/cdg057; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; VAN SJ, 1990, ANNU REV IMMUNOL, V8, P253; Xaus J, 1999, IMMUNITY, V11, P103, DOI 10.1016/S1074-7613(00)80085-0; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324	38	637	657	0	41	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2003	4	6					540	545		10.1038/ni931	http://dx.doi.org/10.1038/ni931			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	683XC	12754505				2022-12-18	WOS:000183175500012
J	Sanos, SL; Bui, VL; Mortha, A; Oberle, K; Heners, C; Johner, C; Diefenbach, A				Sanos, Stephanie L.; Bui, Viet L.; Mortha, Arthur; Oberle, Karin; Heners, Charlotte; Johner, Caroline; Diefenbach, Andreas			ROR gamma t and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46(+) cells	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; INNATE IMMUNITY; NK-CELLS; INTESTINAL-MUCOSA; LYMPHOID-TISSUES; INDUCIBLE FACTOR; RECOGNITION; EXPRESSION; CYTOKINE; GUT	The mucosal immune system of the intestine is separated from a vast array of microbes by a single layer of epithelial cells. Cues from the commensal microflora are needed to maintain epithelial homeostasis, but the molecular and cellular identities of these cues are unclear. Here we provide evidence that signals from the commensal microflora contribute to the differentiation of a lymphocyte population coexpressing stimulatory natural killer cell receptors and the transcription factor ROR gamma t that produced interleukin 22 ( IL-22). The emergence of these IL-22-producing ROR gamma t(hi)NKp46(+)NK1.1(int) cells depended on ROR gamma t expression, which indicated that these cells may have been derived from lymphoid tissue-inducer cells. IL-22 released by these cells promoted the production of antimicrobial molecules important in the maintenance of mucosal homeostasis.	[Sanos, Stephanie L.; Bui, Viet L.; Mortha, Arthur; Oberle, Karin; Heners, Charlotte; Diefenbach, Andreas] Univ Freiburg, Inst Med Microbiol & Hyg, D-79104 Freiburg, Germany; [Sanos, Stephanie L.; Bui, Viet L.; Diefenbach, Andreas] NYU, Sch Med, Skirball Inst Biomol Med, Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Johner, Caroline] Max Planck Inst Immunobiol, D-79108 Freiburg, Germany	University of Freiburg; New York University; Max Planck Society	Diefenbach, A (corresponding author), Univ Freiburg, Inst Med Microbiol & Hyg, D-79104 Freiburg, Germany.	andreas.diefenbach@uniklinik-freiburg.de	Diefenbach, Andreas/T-2589-2018; Mortha, Arthur/ABE-6250-2020	Diefenbach, Andreas/0000-0002-9176-9530; Bui, Viet/0000-0002-8211-4911; Mortha, Arthur/0000-0003-2673-0485	Deutsche Forschungsgemeinschaft [Di 764/2-2, GRK1104, SFB620]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007308] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Kist for support; M. Lucas, H. Pircher, W. Schachterle and C. Vonarbourg for critical comments on the manuscript; M. Schnare for discussions; K. Geiger and M. Follo for cell sorting; D. Littman ( New York University) for Rorc(gamma t)<SUP>GFP/+</SUP> mice; B. Stockinger (National Institute for Medical Research Mill Hill) for support and reagents; M. Kopf ( Swiss Federal Institute of Technology Zurich) for Il6<SUP>-/-</SUP> mice on a B6 background; J.-C. Renauld ( Ludwig Institute for Cancer Research Brussels) for anti-IL-22; and N. Goeppert for technical assistance. Supported by Deutsche Forschungsgemeinschaft (Di 764/2-2, GRK1104 ( A. M.) and SFB620).	Arase H, 2001, J IMMUNOL, V167, P1141, DOI 10.4049/jimmunol.167.3.1141; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; CUPEDO T, 2008, NAT IMMUNOL     1123, DOI DOI 10.1038/NI1668; Di Santo JP, 2006, ANNU REV IMMUNOL, V24, P257, DOI 10.1146/annurev.immunol.24.021605.090700; Diefenbach A, 2003, CURR OPIN IMMUNOL, V15, P37, DOI 10.1016/S0952-7915(02)00007-9; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; Dumoutier L, 2000, P NATL ACAD SCI USA, V97, P10144, DOI 10.1073/pnas.170291697; Dumoutier L, 2000, J IMMUNOL, V164, P1814, DOI 10.4049/jimmunol.164.4.1814; Eberl G, 2005, NAT REV IMMUNOL, V5, P413, DOI 10.1038/nri1600; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; GIBSON PR, 1985, CLIN EXP IMMUNOL, V61, P160; Graf R, 2006, J SURG RES, V133, P113, DOI 10.1016/j.jss.2005.09.030; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; HOGAN PG, 1985, J IMMUNOL, V135, P1731; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kanamori Y, 1996, J EXP MED, V184, P1449, DOI 10.1084/jem.184.4.1449; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kurebayashi S, 2000, P NATL ACAD SCI USA, V97, P10132, DOI 10.1073/pnas.97.18.10132; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; LUCI C, 2008, NAT IMMUNOL     1123, DOI DOI 10.1038/NI1681; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Newberry RD, 2005, IMMUNOL REV, V206, P6, DOI 10.1111/j.0105-2896.2005.00282.x; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Saito H, 1998, SCIENCE, V280, P275, DOI 10.1126/science.280.5361.275; Sivori S, 1997, J EXP MED, V186, P1129, DOI 10.1084/jem.186.7.1129; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Suzuki K, 2000, IMMUNITY, V13, P691, DOI 10.1016/S1074-7613(00)00068-6; TAGLIABUE A, 1982, J EXP MED, V155, P1785, DOI 10.1084/jem.155.6.1785; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Xie MH, 2000, J BIOL CHEM, V275, P31335, DOI 10.1074/jbc.M005304200; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	47	635	659	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2009	10	1					83	91		10.1038/ni.1684	http://dx.doi.org/10.1038/ni.1684			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	385BV	19029903	Green Accepted			2022-12-18	WOS:000261788800015
J	Meylan, E; Burns, K; Hofmann, K; Blancheteau, V; Martinon, F; Kelliher, M; Tschopp, J				Meylan, E; Burns, K; Hofmann, K; Blancheteau, V; Martinon, F; Kelliher, M; Tschopp, J			RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation	NATURE IMMUNOLOGY			English	Article							DOMAIN-CONTAINING ADAPTER; IFN-REGULATORY FACTOR-3; TOLL-LIKE RECEPTORS; SIGNALING PATHWAY; INTERFERON-BETA; KINASE RIP; CUTTING EDGE; IDENTIFICATION; APOPTOSIS; FAMILY	Stimulation of Toll-like receptors (TLRs) initiates potent innate immune responses through Toll-interleukin 1 receptor (TIR) domain-containing adaptors such as MyD88 and Trif. Analysis of Trif-deficient mice has shown that TLR3-dependent activation of the transcription factor NF-kappaB by the TLR3 ligand double-stranded RNA is Trif dependent. Here we investigated the 'downstream' signaling events that regulate TLR3-dependent Trif-induced NF-kappaB activation. Trif recruited the kinases receptor interacting protein(RIP)-1 and RIP3 through its RIP homotypic interaction motif. In the absence of RIP1, TLR3-mediated signals activating NF-kappaB, but not the kinase JNK or interferon-beta,were abolished, suggesting that RIP1 mediates Trif-induced NF-kappaB activation. In contrast, the presence of RIP3 negatively regulated the Trif-RIP1-induced NF-kappaB pathway. Therefore, in contrast to other TLRs, which use interleukin 1 receptor-associated kinase (IRAK) proteins to activate NF-kappaB, TLR 3-induced NF-kappaB activation is dependent on RIP kinases.	Univ Lausanne, Dept Biochem, BIL Biomed Res Ctr, CH-1066 Epalinges, Switzerland; MEMOREC Stoffel GmbH, D-50829 Cologne, Germany; Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA	University of Lausanne; University of Massachusetts System; University of Massachusetts Worcester	Tschopp, J (corresponding author), Univ Lausanne, Dept Biochem, BIL Biomed Res Ctr, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.	jurg.tschopp@ib.unil.ch	Hofmann, Kay/D-6714-2011; Martinon, Fabio/A-5575-2009	Hofmann, Kay/0000-0002-2289-9083; Martinon, Fabio/0000-0002-6969-822X; Meylan, Etienne/0000-0002-0899-2230	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061298] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM061298] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Cusson N, 2002, J EXP MED, V196, P15, DOI 10.1084/jem.20011470; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Hoshino K, 2002, INT IMMUNOL, V14, P1225, DOI 10.1093/intimm/dxf089; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Meylan E, 2002, EMBO REP, V3, P1201, DOI 10.1093/embo-reports/kvf236; O'Neill LAJ, 2000, IMMUNOL TODAY, V21, P206, DOI 10.1016/S0167-5699(00)01611-X; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Sun XQ, 2002, J BIOL CHEM, V277, P9505, DOI 10.1074/jbc.M109488200; Sun XQ, 1999, J BIOL CHEM, V274, P16871, DOI 10.1074/jbc.274.24.16871; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yu PW, 1999, CURR BIOL, V9, P539, DOI 10.1016/S0960-9822(99)80239-5	32	634	665	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2004	5	5					503	507		10.1038/ni1061	http://dx.doi.org/10.1038/ni1061			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	816HN	15064760	Green Published			2022-12-18	WOS:000221101100014
J	Tang, QZ; Adams, JY; Tooley, AJ; Bi, MY; Fife, BT; Serra, P; Santamaria, P; Locksley, RM; Krummel, MF; Bluestone, JA				Tang, QZ; Adams, JY; Tooley, AJ; Bi, MY; Fife, BT; Serra, P; Santamaria, P; Locksley, RM; Krummel, MF; Bluestone, JA			Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELLS; LYMPH-NODES; INTESTINAL INFLAMMATION; ANTIGEN PRESENTATION; EFFECTOR FUNCTION; IN-VITRO; DISTINCT; INTERLEUKIN-10; ACTIVATION; TOLERANCE	The in vivo mechanism of regulatory T cell (T-reg cell) function in controlling autoimmunity remains controversial. Here we have used two-photon laser-scanning microscopy to analyze lymph node priming of diabetogenic T cells and to delineate the mechanisms of T-reg cell control of autoimmunity in vivo. Islet antigen-specific CD4(+)CD25(-) T helper cells (T-H cells) and T-reg cells swarmed and arrested in the presence of autoantigens. These T-H cell activities were progressively inhibited in the presence of increasing numbers of T-reg cells. There were no detectable stable associations between T-reg and T-H cells during active suppression. In contrast, T-reg cells directly interacted with dendritic cells bearing islet antigen. Such persistent T-reg cell-dendritic cell contacts preceded the inhibition of T-H cell activation by dendritic cells, supporting the idea that dendritic cells are central to T-reg cell function in vivo.	Univ Calif San Francisco, Ctr Diabet, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calgary, Julia McFarlane Diabet Res Ctr, Calgary, AB T2N 4N1, Canada; Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB T2N 4N1, Canada	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Calgary; University of Calgary	Bluestone, JA (corresponding author), Univ Calif San Francisco, Ctr Diabet, Dept Med, San Francisco, CA 94143 USA.	jbluest@diabetes.ucsf.edu	Fife, Brian T/D-2042-2013; Santamaria, Pere/ABF-6823-2021	Fife, Brian T/0000-0001-9826-5637; Tang, Qizhi/0000-0001-7313-3574	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI066097, R01AI030663, R37AI046643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NIAID NIH HHS [R37 AI46643, R21 AI066097, R37 AI046643, R01 AI030663, R21 AI066097-01, AI30663, R21 AI066097-02] Funding Source: Medline; NIDDK NIH HHS [P30 DK063720] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Chatenoud L, 2001, IMMUNOL REV, V182, P149, DOI 10.1034/j.1600-065X.2001.1820112.x; de Lafaille MAC, 2002, CURR OPIN IMMUNOL, V14, P771; Dieckmann D, 2001, J EXP MED, V193, P1303, DOI 10.1084/jem.193.11.1303; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; Gunzer M, 2004, BLOOD, V104, P2801, DOI 10.1182/blood-2004-03-1193; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Iezzi G, 1999, EUR J IMMUNOL, V29, P4092, DOI 10.1002/(SICI)1521-4141(199912)29:12<4092::AID-IMMU4092>3.3.CO;2-1; Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Kingsley CI, 2002, J IMMUNOL, V168, P1080, DOI 10.4049/jimmunol.168.3.1080; Levings MK, 2001, J EXP MED, V193, P1295, DOI 10.1084/jem.193.11.1295; Levings MK, 2002, J EXP MED, V196, P1335, DOI 10.1084/jem.20021139; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Piccirillo CA, 2002, J EXP MED, V196, P237, DOI 10.1084/jem.20020590; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Sanderson MJ, 2003, METHOD ENZYMOL, V360, P447; Scheinecker C, 2002, J EXP MED, V196, P1079, DOI 10.1084/jem.20020991; Schmidt D, 1997, J EXP MED, V186, P1059, DOI 10.1084/jem.186.7.1059; Serra P, 2003, IMMUNITY, V19, P877, DOI 10.1016/S1074-7613(03)00327-3; Singh B, 2001, IMMUNOL REV, V182, P190, DOI 10.1034/j.1600-065X.2001.1820115.x; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tarbell KV, 2004, J EXP MED, V199, P1467, DOI 10.1084/jem.20040180; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027	40	632	659	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2006	7	1					83	92		10.1038/ni1289	http://dx.doi.org/10.1038/ni1289			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	995XZ	16311599	Green Accepted			2022-12-18	WOS:000234139700022
J	Cella, M; Facchetti, F; Lanzavecchia, A; Colonna, M				Cella, M; Facchetti, F; Lanzavecchia, A; Colonna, M			Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent THI polarization	NATURE IMMUNOLOGY			English	Article; Proceedings Paper	Workshop on Lymphoid Organogenesis	NOV 05-06, 1999	BASEL INST IMMUNOL, BASEL, SWITZERLAND		BASEL INST IMMUNOL		ALPHA-PRODUCING CELLS; T-CELLS; INTERFERON-ALPHA; HUMAN BLOOD; INTERLEUKIN-12; PRECURSOR; IMMUNITY; CYTOKINE; RECEPTOR; HELPER	Plasmacytoid dendritic cells (PDCs) are a subset of dendritic cells present in human blood and inflamed lymph nodes. Here we show that blood PDCs, when stimulated with influenza virus and CD40L in vitro, undergo a maturation process characterized by up-regulation of major histocompatibility complex proteins and adhesion and costimulatory molecules. In addition, PDCs down-regulate CXCR3 and L-selectin, which mediate migration and homing of these cells into the lymph node. Mature PDCs efficiently stimulate T cells and drive a potent THI polarization in vitro, which is mediated by the synergistic effect of interleukin 12 and type I interferon. In vivo, mature PDCs are found in secondary lymphoid organs, where they represent the principal source of type I interferon during inflammation. Thus, PDCs probably participate in antiviral and pro-inflammatory responses, rather than in T(H)2 polarization and tolerance induction.	Basel Inst Immunol, Spedali Civili Brescia, CH-4005 Basel, Switzerland; Univ Brescia, Ist Anat Patol, Spedali Civili Brescia, Brescia, Italy; Inst Biomed Res, Bellinzona, Switzerland	University of Brescia; Universita della Svizzera Italiana	Cella, M (corresponding author), Basel Inst Immunol, Spedali Civili Brescia, CH-4005 Basel, Switzerland.	colonna@bii.ch	Cella, Marina/ABA-8564-2020; Facchetti, Fabio/E-7190-2010; Cella, Marina/G-8850-2011	Facchetti, Fabio/0000-0003-4975-2388; Cella, Marina/0000-0003-1230-1313; Colonna, Marco/0000-0001-5222-4987				Arpinati M, 2000, BLOOD, V95, P2484, DOI 10.1182/blood.V95.8.2484; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bjorck P, 1997, EUR J IMMUNOL, V27, P1266, DOI 10.1002/eji.1830270531; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Cella M, 1999, J EXP MED, V189, P821, DOI 10.1084/jem.189.5.821; CHEHIMI J, 1989, IMMUNOLOGY, V68, P486; Cyster JG, 1999, J EXP MED, V189, P447, DOI 10.1084/jem.189.3.447; FACCHETTI F, 1989, HUM PATHOL, V20, P588, DOI 10.1016/0046-8177(89)90248-7; FACCHETTI F, 1988, AM J PATHOL, V133, P15; Facchetti F, 1999, AM J PATHOL, V154, P145, DOI 10.1016/S0002-9440(10)65261-3; FACCHETTI F, 1988, HUM PATHOL, V19, P1085, DOI 10.1016/S0046-8177(88)80091-1; Facchetti F, 1991, Sarcoidosis, V8, P170; Farber JM, 1997, J LEUKOCYTE BIOL, V61, P246, DOI 10.1002/jlb.61.3.246; FELDMAN M, 1990, J INTERFERON RES, V10, P435, DOI 10.1089/jir.1990.10.435; FITZGERALDBOCARSLY P, 1993, PHARMACOL THERAPEUT, V60, P39, DOI 10.1016/0163-7258(93)90021-5; FITZGERALDBOCARSLY P, 1988, J LEUKOCYTE BIOL, V43, P323, DOI 10.1002/jlb.43.4.323; Gerosa F, 1999, CLIN IMMUNOL, V92, P224, DOI 10.1006/clim.1999.4752; Gerosa F, 1996, J EXP MED, V183, P2559, DOI 10.1084/jem.183.6.2559; GIRARD JP, 1995, IMMUNOL TODAY, V16, P449, DOI 10.1016/0167-5699(95)80023-9; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Grouard G, 1996, NATURE, V384, P364, DOI 10.1038/384364a0; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Ito T, 1999, J IMMUNOL, V163, P1409; Iwasaki A, 1999, J EXP MED, V190, P229, DOI 10.1084/jem.190.2.229; Khanna A, 2000, J IMMUNOL, V164, P1346, DOI 10.4049/jimmunol.164.3.1346; Kohrgruber N, 1999, J IMMUNOL, V163, P3250; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Liu YJ, 2000, BLOOD, V95, P2482, DOI 10.1182/blood.V95.8.2482.008a38_2482_2483; ODOHERTY U, 1994, IMMUNOLOGY, V82, P487; ODOHERTY U, 1993, J EXP MED, V178, P1067, DOI 10.1084/jem.178.3.1067; Olweus J, 1997, P NATL ACAD SCI USA, V94, P12551, DOI 10.1073/pnas.94.23.12551; Parronchi P, 1996, EUR J IMMUNOL, V26, P697, DOI 10.1002/eji.1830260328; PERUSSIA B, 1985, Natural Immunity and Cell Growth Regulation, V4, P120; Piali L, 1998, EUR J IMMUNOL, V28, P961, DOI 10.1002/(SICI)1521-4141(199803)28:03<961::AID-IMMU961>3.0.CO;2-4; Res PCM, 1999, BLOOD, V94, P2647, DOI 10.1182/blood.V94.8.2647.420k06_2647_2657; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; Robinson SP, 1999, EUR J IMMUNOL, V29, P2769, DOI 10.1002/(SICI)1521-4141(199909)29:09<2769::AID-IMMU2769>3.0.CO;2-2; Rogge L, 1997, J EXP MED, V185, P825, DOI 10.1084/jem.185.5.825; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Strobl H, 1998, J IMMUNOL, V161, P740; Stumbles PA, 1998, J EXP MED, V188, P2019, DOI 10.1084/jem.188.11.2019; Trinchieri G, 1998, ADV IMMUNOL, V70, P83, DOI 10.1016/S0065-2776(08)60387-9; VOLLENWEIDER R, 1983, VIRCHOWS ARCH B, V44, P1, DOI 10.1007/BF02890155	48	632	652	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2000	1	4					305	310		10.1038/79747	http://dx.doi.org/10.1038/79747			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Immunology	364AK	11017101				2022-12-18	WOS:000089869700012
J	Duncan, AW; Rattis, FM; DiMascio, LN; Congdon, KL; Pazianos, G; Zhao, C; Yoon, K; Cook, JM; Willert, K; Gaiano, N; Reya, T				Duncan, AW; Rattis, FM; DiMascio, LN; Congdon, KL; Pazianos, G; Zhao, C; Yoon, K; Cook, JM; Willert, K; Gaiano, N; Reya, T			Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance	NATURE IMMUNOLOGY			English	Article							BETA-CATENIN; SELF-RENEWAL; IN-VIVO; COLON-CARCINOMA; BONE-MARROW; GENE FAMILY; CYCLIN D1; DIFFERENTIATION; ACTIVATION; DROSOPHILA	A fundamental question in hematopoietic stem cell (HSC) biology is how self-renewal is controlled. Here we show that the molecular regulation of two critical elements of self-renewal, inhibition of differentiation and induction of proliferation, can be uncoupled, and we identify Notch signaling as a key factor in inhibiting differentiation. Using transgenic Notch reporter mice, we found that Notch signaling was active in HSCs in vivo and downregulated as HSCs differentiated. Inhibition of Notch signaling led to accelerated differentiation of HSCs in vitro and depletion of HSCs in vivo. Finally, intact Notch signaling was required for Wnt-mediated maintenance of undifferentiated HSCs but not for survival or entry into the cell cycle in vitro. These data suggest that Notch signaling has a dominant function in inhibiting differentiation and provide a model for how HSCs may integrate multiple signals to maintain the stem cell state.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA	Duke University; Johns Hopkins University; Johns Hopkins University	Reya, T (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	t.reya@duke.edu		Duncan, Andrew/0000-0003-4962-4191; Yoon, Keejung/0000-0002-2361-9039	NIDDK NIH HHS [DK63031] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063031] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Allman D, 2002, CELL, V109, pS1, DOI 10.1016/S0092-8674(02)00689-X; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Aster JC, 2001, CURR OPIN HEMATOL, V8, P237, DOI 10.1097/00062752-200107000-00010; Austin TW, 1997, BLOOD, V89, P3624, DOI 10.1182/blood.V89.10.3624.3624_3624_3635; Bjornsson JM, 2003, MOL CELL BIOL, V23, P3872, DOI 10.1128/MCB.23.11.3872-3883.2003; CADIGAN KM, 1997, GENE DEV, V11, P3296; Callahan R, 2001, J MAMMARY GLAND BIOL, V6, P23, DOI 10.1023/A:1009512414430; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Chambers CB, 2001, DEVELOPMENT, V128, P689; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; COUSO JP, 1994, CELL, V79, P259, DOI 10.1016/0092-8674(94)90195-3; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; Espinosa L, 2003, J BIOL CHEM, V278, P32227, DOI 10.1074/jbc.M304001200; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hadland BK, 2004, BLOOD, V104, P3097, DOI 10.1182/blood-2004-03-1224; Harper JA, 2003, CLIN GENET, V64, P461, DOI 10.1046/j.1399-0004.2003.00194.x; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Karanu FN, 2001, BLOOD, V97, P1960, DOI 10.1182/blood.V97.7.1960; Karanu FN, 2000, J EXP MED, V192, P1365, DOI 10.1084/jem.192.9.1365; Kim JY, 2004, EUR J HAEMATOL, V73, P75, DOI 10.1111/j.1600-0609.2004.00268.x; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kumano K, 2003, IMMUNITY, V18, P699, DOI 10.1016/S1074-7613(03)00117-1; Maillard I, 2003, IMMUNITY, V19, P781, DOI 10.1016/S1074-7613(03)00325-X; Matsuzaki Y, 2004, IMMUNITY, V20, P87, DOI 10.1016/S1074-7613(03)00354-6; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Murdoch B, 2003, P NATL ACAD SCI USA, V100, P3422, DOI 10.1073/pnas.0130233100; OKA C, 1995, DEVELOPMENT, V121, P3291; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; REYA T, IN PRESS NATURE; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Stier S, 2002, BLOOD, V99, P2369, DOI 10.1182/blood.V99.7.2369; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tekmal R.R., 1997, FRONT BIOSCI, V2, P519; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; UCHIDA N, 1992, J EXP MED, V175, P175, DOI 10.1084/jem.175.1.175; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Van den Berg DJ, 1998, BLOOD, V92, P3189, DOI 10.1182/blood.V92.9.3189.421k45_3189_3202; Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390; VERCAUTEREN SM, 2004, BLOOD, V1, P3; VISSER JWM, 1984, J EXP MED, V159, P1576, DOI 10.1084/jem.159.6.1576; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Wettstein DA, 1997, DEVELOPMENT, V124, P693; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P4720, DOI 10.1021/bi982562p; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhu AJ, 1999, DEVELOPMENT, V126, P2285	70	630	686	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2005	6	3					314	322		10.1038/ni1164	http://dx.doi.org/10.1038/ni1164			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899AN	15665828				2022-12-18	WOS:000227117400024
J	Lindquist, RL; Shakhar, G; Dudziak, D; Wardemann, H; Eisenreich, T; Dustin, ML; Nussenzweig, MC				Lindquist, RL; Shakhar, G; Dudziak, D; Wardemann, H; Eisenreich, T; Dustin, ML; Nussenzweig, MC			Visualizing dendritic cell networks in vivo	NATURE IMMUNOLOGY			English	Article							STEADY-STATE CONDITIONS; LYMPH-NODES; ANTIGEN PRESENTATION; T-CELLS; POPULATIONS; ACTIVATION; COMPLEX; DYNAMICS; PROTEIN; AREAS	In the steady state, dendritic cells (DCs) in the lymph node induce T cell tolerance to self antigens. Innate signals trigger the maturation of tissue DCs, which migrate into lymph nodes and activate T cells. To examine DCs in vivo, we produced transgenic mice whose DCs expressed enhanced yellow fluorescent protein. Two-photon microscopy of lymph nodes in live mice showed that most of the steady-state DCs were enmeshed in an extensive network and remained in place while actively probing adjacent T cells with their processes. Mature DCs were more motile than steady-state DCs and were rapidly dispersed and integrated into the sessile network, facilitating their interaction with migrating T cells.	Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; NYU, Sch Med, Program Mol Pathogenesis, New York, NY 10016 USA; NYU, Sch Med, Dept Pathol, Skirball Inst Biomol Med, New York, NY 10016 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; New York University; New York University	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.	dustin@saturn.med.nyu.edu; nussen@mail.rockefeller.edu	Dustin, Michael/AAM-4611-2020; Nussenzweig, Michel/AAE-7292-2019; Dudziak, Diana/B-2432-2017	Dudziak, Diana/0000-0001-9358-134X; Wardemann, Hedda/0000-0003-3921-5933; Dustin, Michael/0000-0003-4983-6389	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI051573, R21AI055037, R01AI055037] Funding Source: NIH RePORTER; NIAID NIH HHS [AI051573, AI55037] Funding Source: Medline; NIGMS NIH HHS [GM07739] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bajenoff M, 2003, J EXP MED, V198, P715, DOI 10.1084/jem.20030167; Banchereau J, 2004, IMMUNITY, V20, P539, DOI 10.1016/S1074-7613(04)00108-6; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; Benvenuti F, 2004, SCIENCE, V305, P1150, DOI 10.1126/science.1099159; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Brocker T, 1997, ADV EXP MED BIOL, V417, P55; BUJDOSO R, 1989, J EXP MED, V170, P1285, DOI 10.1084/jem.170.4.1285; CROWLEY M, 1990, J EXP MED, V172, P383, DOI 10.1084/jem.172.1.383; Cyster JG, 1999, J EXP MED, V189, P447, DOI 10.1084/jem.189.3.447; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; FOSSUM S, 1988, SCAND J IMMUNOL, V27, P97, DOI 10.1111/j.1365-3083.1988.tb02326.x; FRIESS A, 1976, CELL TISSUE RES, V170, P43; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Hadjantonakis Anna-Katerina, 2002, BMC Biotechnol, V2, P11, DOI 10.1186/1472-6750-2-11; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; HOLT PG, 1988, J EXP MED, V167, P262, DOI 10.1084/jem.167.2.262; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Inaba K, 1997, J EXP MED, V186, P665, DOI 10.1084/jem.186.5.665; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Kaldjian EP, 2001, INT IMMUNOL, V13, P1243, DOI 10.1093/intimm/13.10.1243; Kang YS, 2003, INT IMMUNOL, V15, P177, DOI 10.1093/intimm/dxg019; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; LIU LM, 1993, J EXP MED, V177, P1299, DOI 10.1084/jem.177.5.1299; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Manickasingham S, 2000, J IMMUNOL, V165, P5027, DOI 10.4049/jimmunol.165.9.5027; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; Wilson NS, 2003, BLOOD, V102, P2187, DOI 10.1182/blood-2003-02-0513	47	630	642	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2004	5	12					1243	1250		10.1038/ni1139	http://dx.doi.org/10.1038/ni1139			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	874MC	15543150				2022-12-18	WOS:000225353500013
J	Stumhofer, JS; Silver, JS; Laurence, A; Porrett, PM; Harris, TH; Turka, LA; Ernst, M; Saris, CJM; O'Shea, JJ; Hunter, CA				Stumhofer, Jason S.; Silver, Jonathan S.; Laurence, Arian; Porrett, Paige M.; Harris, Tajie H.; Turka, Laurence A.; Ernst, Matthias; Saris, Christiaan J. M.; O'Shea, John J.; Hunter, Christopher A.			Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10	NATURE IMMUNOLOGY			English	Article							GROWTH-FACTOR-BETA; CYTOKINE PRODUCTION; REGULATORY FUNCTION; TOXOPLASMA-GONDII; TRYPANOSOMA-CRUZI; INTERFERON-GAMMA; AUTOIMMUNE ENCEPHALOMYELITIS; TRANSCRIPTION FACTOR; T(H)17 CELLS; IL-10 LOCUS	Interleukin 10 (IL-10) has a prominent function in regulating the balance between protective and pathological T cell responses. Consistent with that activity, many sources of this cytokine are found in vivo, including from myeloid cells and a variety of T cell subsets. However, although there are many pathways that regulate innate production of IL-10, the factors that govern its synthesis by the adaptive response are poorly understood. Here we report that IL-27 and IL-6 induced T helper type 1 and type 2 cells, as well as T helper cells that produce IL-17, to secrete IL-10. This effect was dependent on the transcription factors STAT1 and STAT3 for IL-27 and on STAT3 for IL-6. Our studies identify a previously unknown pathway that allows the immune system to temper inflammatory responses.	Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Ludwig Inst Canc Res, Parkville, Vic 3050, Australia; Amgen Inc, Dept Inflammat Res, Thousand Oaks, CA 91320 USA	University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Pennsylvania; Ludwig Institute for Cancer Research; Amgen	Hunter, CA (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA.	chunter@vet.upenn.edu	Laurence, Arian/H-5534-2019; Ernst, Matthias/D-5111-2012; Porrett, Paige/AAU-8992-2020; Laurence, Arian/A-8770-2009	Laurence, Arian/0000-0003-0942-8292; Ernst, Matthias/0000-0002-6399-1177; Laurence, Arian/0000-0003-0942-8292; Harris, Tajie/0000-0002-1355-2109	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI043620, T32AI007532, R01AI041158, T32AI055428, R01AI042334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041159, Z01AR041159] Funding Source: NIH RePORTER; NIAID NIH HHS [AI42334, AI41158, 1-T32-AI-055428, 1-T32-AI-07532, AI 43620] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brightbill HD, 2000, J IMMUNOL, V164, P1940, DOI 10.4049/jimmunol.164.4.1940; Chen Q, 2000, NATURE, V407, P916, DOI 10.1038/35038103; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; COHEN SBA, 1995, ARTHRITIS RHEUM, V38, P946, DOI 10.1002/art.1780380710; DEL PG, 1993, J IMMUNOL, V150, P353; ESPEVIK T, 1987, J EXP MED, V166, P571, DOI 10.1084/jem.166.2.571; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Gerosa F, 1999, CLIN IMMUNOL, V92, P224, DOI 10.1006/clim.1999.4752; Gerosa F, 1996, J EXP MED, V183, P2559, DOI 10.1084/jem.183.6.2559; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Grunig G, 1997, J EXP MED, V185, P1089, DOI 10.1084/jem.185.6.1089; Hamano S, 2003, IMMUNITY, V19, P657, DOI 10.1016/S1074-7613(03)00298-X; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; HUNTER CA, 1995, EUR J IMMUNOL, V25, P994, DOI 10.1002/eji.1830250420; Hunter CA, 1997, J IMMUNOL, V158, P3311; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lee CK, 2002, IMMUNITY, V17, P63, DOI 10.1016/S1074-7613(02)00336-9; Liu YW, 2006, CELL SIGNAL, V18, P1492, DOI 10.1016/j.cellsig.2005.12.001; Lucas M, 2005, J IMMUNOL, V175, P469, DOI 10.4049/jimmunol.175.1.469; Lucas S, 2003, P NATL ACAD SCI USA, V100, P15047, DOI 10.1073/pnas.2536517100; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; MOORE KW, 1990, SCIENCE, V248, P1230, DOI 10.1126/science.2161559; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Neufert C, 2007, EUR J IMMUNOL, V37, P1809, DOI 10.1002/eji.200636896; O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pohl-Koppe A, 1998, J IMMUNOL, V160, P1804; RICH S, 1995, J IMMUNOL, V155, P609; Rosas LE, 2006, AM J PATHOL, V168, P158, DOI 10.2353/ajpath.2006.050013; SHARMA SD, 1983, J IMMUNOL, V131, P977; Shoemaker J, 2006, J IMMUNOL, V176, P3470, DOI 10.4049/jimmunol.176.6.3470; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; SILVA JS, 1991, J EXP MED, V174, P539, DOI 10.1084/jem.174.3.539; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056; Trinchieri G, 2007, J EXP MED, V204, P239, DOI 10.1084/jem.20070104; Vieira PL, 2004, J IMMUNOL, V172, P5986, DOI 10.4049/jimmunol.172.10.5986; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Villarino AV, 2005, J IMMUNOL, V174, P7684, DOI 10.4049/jimmunol.174.12.7684; Wilson EH, 2005, J NEUROIMMUNOL, V165, P63, DOI 10.1016/j.jneuroim.2005.04.018; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zhang XM, 2004, INT IMMUNOL, V16, P249, DOI 10.1093/intimm/dxh029; Ziegler-Heitbrock L, 2003, J IMMUNOL, V171, P285, DOI 10.4049/jimmunol.171.1.285	58	628	662	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2007	8	12					1363	U5		10.1038/ni1537	http://dx.doi.org/10.1038/ni1537			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	235XG	17994025				2022-12-18	WOS:000251267000017
J	Le Bon, A; Etchart, N; Rossmann, C; Ashton, M; Hou, S; Gewert, D; Borrow, P; Tough, DF				Le Bon, A; Etchart, N; Rossmann, C; Ashton, M; Hou, S; Gewert, D; Borrow, P; Tough, DF			Cross-priming of CD8(+) T cells stimulated by virus-induced type I interferon	NATURE IMMUNOLOGY			English	Article							DNA-BASED VACCINES; DENDRITIC CELLS; ANTIGEN PRESENTATION; EXOGENOUS ANTIGEN; CD8-T-CELL MEMORY; SOLUBLE-ANTIGEN; CD4-T-CELL HELP; SELF-ANTIGENS; TUMOR-CELLS; HUMAN BLOOD	CD8(+) T cell responses can be generated against antigens that are not expressed directly within antigen-presenting cells (APCs), through a process known as cross-priming. To initiate cross-priming, APCs must both capture extracellular antigen and receive specific activation signals. We have investigated the nature of APC activation signals associated with virus infection that stimulate cross-priming. We show that infection with lymphocytic choriomeningitis virus induces cross-priming by a mechanism dependent on type I interferon (IFN-alpha/beta). Activation of cross-priming by IFN-alpha/beta was independent of CD4(+) T cell help or interaction of CD40 and CD40 ligand, and involved direct stimulation of dendritic cells. These data identify expression of IFN-alpha/beta as a mechanism for the induction of cross-priming during virus infections.	Edward Jenner Inst Vaccine Res, Newbury RG20 7NN, Berks, England; Acambis, Cambridge CB1 9PT, England; BioLauncher, Cambridge CB4 3PE, England	Sanofi-Aventis	Tough, DF (corresponding author), Edward Jenner Inst Vaccine Res, Newbury RG20 7NN, Berks, England.		Le Bon, Agnes/L-3237-2017	Le Bon, Agnes/0000-0003-4204-8136; Borrow, Persephone/0000-0002-3877-9780				Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bennett SRM, 1997, J EXP MED, V186, P65, DOI 10.1084/jem.186.1.65; BEVAN MJ, 1989, NATURE, V342, P478, DOI 10.1038/342478a0; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; CARBONE FR, 1990, J EXP MED, V171, P377, DOI 10.1084/jem.171.2.377; CHAKRABARTI S, 1985, MOL CELL BIOL, V5, P3403, DOI 10.1128/MCB.5.12.3403; Cho HJ, 2002, J IMMUNOL, V168, P4907, DOI 10.4049/jimmunol.168.10.4907; Cho HJ, 2000, NAT BIOTECHNOL, V18, P509, DOI 10.1038/75365; DUTKO FJ, 1983, J GEN VIROL, V64, P1689, DOI 10.1099/0022-1317-64-8-1689; FERRANTINI M, 1994, J IMMUNOL, V153, P4604; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; GOODING LR, 1980, J IMMUNOL, V124, P1258; GORDON RD, 1976, J EXP MED, V144, P810, DOI 10.1084/jem.144.3.810; Hamilton SE, 2001, J IMMUNOL, V167, P5603, DOI 10.4049/jimmunol.167.10.5603; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Ito T, 2001, J IMMUNOL, V166, P2961, DOI 10.4049/jimmunol.166.5.2961; Jamaluddin M, 2001, AM J PHYSIOL-LUNG C, V280, pL248, DOI 10.1152/ajplung.2001.280.2.L248; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Josien R, 2000, J EXP MED, V191, P495, DOI 10.1084/jem.191.3.495; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; KORNGOLD R, 1983, J IMMUNOL, V130, P2236; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Kurts C, 2001, J IMMUNOL, V166, P1439, DOI 10.4049/jimmunol.166.3.1439; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Lefrancois L, 2000, J IMMUNOL, V164, P725, DOI 10.4049/jimmunol.164.2.725; Liu K, 2002, J EXP MED, V196, P1091, DOI 10.1084/jem.20021215; Lu ZB, 2000, J EXP MED, V191, P541, DOI 10.1084/jem.191.3.541; Luft T, 1998, J IMMUNOL, V161, P1947; Mazzaccaro RJ, 1996, P NATL ACAD SCI USA, V93, P11786, DOI 10.1073/pnas.93.21.11786; MERIGAN TC, 1977, NATURE, V268, P67, DOI 10.1038/268067a0; Montoya M, 2002, BLOOD, V99, P3263, DOI 10.1182/blood.V99.9.3263; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; Mueller SN, 2002, J EXP MED, V195, P651, DOI 10.1084/jem.20012023; RESTIFO NP, 1995, J IMMUNOL, V154, P4414; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Rodriguez A, 1999, NAT CELL BIOL, V1, P362, DOI 10.1038/14058; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Sigal LJ, 1999, NATURE, V398, P77, DOI 10.1038/18038; Simmons CP, 1999, J IMMUNOL, V163, P6502; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; Van Uden JH, 2001, EUR J IMMUNOL, V31, P3281; VONHOEGEN P, 1990, CELL IMMUNOL, V126, P80, DOI 10.1016/0008-8749(90)90302-8; Zhan YF, 2000, J IMMUNOL, V165, P3612, DOI 10.4049/jimmunol.165.7.3612	50	628	649	0	13	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2003	4	10					1009	1015		10.1038/ni978	http://dx.doi.org/10.1038/ni978			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	726GG	14502286				2022-12-18	WOS:000185590100017
J	Huang, SCC; Everts, B; Ivanova, Y; O'Sullivan, D; Nascimento, M; Smith, AM; Beatty, W; Love-Gregory, L; Lam, WY; O'Neil, CM; Yan, C; Du, H; Abumrad, NA; Urban, JF; Artyomov, MN; Pearce, EL; Pearce, EJ				Huang, Stanley Ching-Cheng; Everts, Bart; Ivanova, Yulia; O'Sullivan, David; Nascimento, Marcia; Smith, Amber M.; Beatty, Wandy; Love-Gregory, Latisha; Lam, Wing Y.; O'Neil, Christina M.; Yan, Cong; Du, Hong; Abumrad, Nada A.; Urban, Joseph F., Jr.; Artyomov, Maxim N.; Pearce, Erika L.; Pearce, Edward J.			Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages	NATURE IMMUNOLOGY			English	Article							LIPID-METABOLISM; ACID LIPASE; FOAM CELLS; IN-VIVO; EXPRESSION; GENE; ATHEROSCLEROSIS; DIFFERENTIATION; INTERLEUKIN-4; INFLAMMATION	Alternative (M2) activation of macrophages driven via the a-chain of the receptor for interleukin 4 (IL-4R alpha) is important for immunity to parasites, wound healing, the prevention of atherosclerosis and metabolic homeostasis. M2 polarization is dependent on fatty acid oxidation (FAO), but the source of the fatty acids that support this metabolic program has not been clear. We found that the uptake of triacylglycerol substrates via the scavenger receptor CD36 and their subsequent lipolysis by lysosomal acid lipase (LAL) was important for the engagement of elevated oxidative phosphorylation, enhanced spare respiratory capacity (SRC), prolonged survival and expression of genes that together define M2 activation. Inhibition of lipolysis suppressed M2 activation during infection with a parasitic helminth and blocked protective responses to this pathogen. Our findings delineate a critical role for cell-intrinsic lysosomal lipolysis in M2 activation.	[Huang, Stanley Ching-Cheng; Everts, Bart; Ivanova, Yulia; O'Sullivan, David; Nascimento, Marcia; Smith, Amber M.; Lam, Wing Y.; O'Neil, Christina M.; Artyomov, Maxim N.; Pearce, Erika L.; Pearce, Edward J.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Beatty, Wandy] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO USA; [Love-Gregory, Latisha; Abumrad, Nada A.] Washington Univ, Sch Med, Dept Med & Cell Biol, St Louis, MO USA; [Yan, Cong; Du, Hong] Indiana Univ, Sch Med, Dept Pathol & Lab Med, Indiana, PA USA; [Urban, Joseph F., Jr.] US Dept Agr, Agr Res Serv, Beltsville Human Nutr Res Ctr, Genom & Immunol Lab, Beltsville, MD USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Pennsylvania State System of Higher Education (PASSHE); Indiana University of Pennsylvania; United States Department of Agriculture (USDA)	Pearce, EJ (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	edwardpearce@path.wustl.edu	Huang, Stanley Ching-Cheng/AAE-7866-2019; Everts, Bart/H-6986-2016	Huang, Stanley Ching-Cheng/0000-0002-6557-3737; Everts, Bart/0000-0002-3764-5131; Urban, Joseph/0000-0002-1590-8869	US National Institutes of Health [AI32573, CA164062, AI091965, CA158823, DK060022, HL087001, CA138759, CA152099]; NATIONAL CANCER INSTITUTE [R21CA158823, P30CA082709, R01CA138759, R01CA164062, R01CA152099] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI032573, R01AI091965, R01AI032573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060022, P30DK056341, R01DK033301, P30DK020579] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank G. Haemmerle and R. Zechner for permission to use Pnpla2<SUP>-/-</SUP>mice; C. Semenkovich (Washington University in St. Louis) and R. Gross (Washington University in St. Louis) for Pnpla2<SUP>-/-</SUP> mice; H. Virgin, E.L. Gautier and S. Ivanov for discussions; and the staff of the Department of Pathology & Immunology Flow Cytometry Core and the Metabolomics Core of the Diabetic Cardiovascular Disease Center for technical assistance. Supported by the US National Institutes of Health (AI32573 and CA164062 to E.J.P.; AI091965 and CA158823 to E.L.P.; DK060022 to N.A.A.; HL087001 to H.D.; and CA138759 and CA152099 to C.Y.).	Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1451; Bharadwaj KG, 2010, J BIOL CHEM, V285, P37976, DOI 10.1074/jbc.M110.174458; Bie JH, 2011, AM J PHYSIOL-REG I, V301, pR967, DOI 10.1152/ajpregu.00277.2011; Brignull LM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-853; Cardilo-Reis L, 2012, EMBO MOL MED, V4, P1072, DOI 10.1002/emmm.201201374; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Du H, 2001, J LIPID RES, V42, P489; Feng JW, 2000, J LIPID RES, V41, P688; Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; HADVARY P, 1991, J BIOL CHEM, V266, P2021; HARMON CM, 1991, J MEMBRANE BIOL, V121, P261, DOI 10.1007/BF01951559; Heck AM, 2000, PHARMACOTHERAPY, V20, P270, DOI 10.1592/phco.20.4.270.34882; Jenkins SJ, 2013, J EXP MED, V210, P2477, DOI 10.1084/jem.20121999; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kienesberger PC, 2013, J MOL CELL CARDIOL, V55, P101, DOI 10.1016/j.yjmcc.2012.06.018; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; May P, 2013, CELL TISSUE RES, V354, P887, DOI 10.1007/s00441-013-1699-2; McLaren JE, 2011, PROG LIPID RES, V50, P331, DOI 10.1016/j.plipres.2011.04.002; Nicholls David G, 2010, J Vis Exp, DOI 10.3791/2511; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Oh J, 2012, J BIOL CHEM, V287, P11629, DOI 10.1074/jbc.M111.338673; Ouimet M, 2011, CELL METAB, V13, P655, DOI 10.1016/j.cmet.2011.03.023; Pearce EL, 2010, CURR OPIN IMMUNOL, V22, P314, DOI 10.1016/j.coi.2010.01.018; Reynolds LA, 2012, SEMIN IMMUNOPATHOL, V34, P829, DOI 10.1007/s00281-012-0347-3; Ries S, 1998, J LIPID RES, V39, P2125; Rios FJ, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/198193; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Sekiya M, 2009, CELL METAB, V10, P219, DOI 10.1016/j.cmet.2009.08.004; SHERIFF S, 1995, J BIOL CHEM, V270, P27766, DOI 10.1074/jbc.270.46.27766; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Stohr R, 2013, BIOCHEM J, V454, P1, DOI 10.1042/BJ20130121; Su X, 2009, TRENDS ENDOCRIN MET, V20, P72, DOI 10.1016/j.tem.2008.11.001; Thomas GD, 2012, BLOOD, V120, pE93, DOI 10.1182/blood-2012-07-442640; Tolar J, 2009, BONE MARROW TRANSPL, V43, P21, DOI 10.1038/bmt.2008.273; Tsao CH, 2014, J LIPID RES, V55, P385, DOI 10.1194/jlr.M041392; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Vargas-Alarcon G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074703; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Wild PS, 2011, CIRC-CARDIOVASC GENE, V4, P403, DOI 10.1161/CIRCGENETICS.110.958728; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xu XY, 2013, CELL METAB, V18, P816, DOI 10.1016/j.cmet.2013.11.001; Yan C, 2006, AM J PATHOL, V169, P916, DOI 10.2353/ajpath.2006.051327; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018	49	626	647	13	104	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2014	15	9					846	855		10.1038/ni.2956	http://dx.doi.org/10.1038/ni.2956			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AN6WP	25086775	Green Submitted, Green Accepted, Green Published			2022-12-18	WOS:000340739400012
J	Thurston, TLM; Ryzhakov, G; Bloor, S; von Muhlinen, N; Randow, F				Thurston, Teresa L. M.; Ryzhakov, Grigory; Bloor, Stuart; von Muhlinen, Natalia; Randow, Felix			The TBK1 adaptor and autophagy receptor NDP52 restricts the proliferation of ubiquitin-coated bacteria	NATURE IMMUNOLOGY			English	Article							KINASE-RELATED KINASES; KAPPA-B; ENDOPLASMIC-RETICULUM; PROTEIN; BINDING; RECOGNITION; INNATE; DOMAIN; HOST; IKK	Cell-autonomous innate immune responses against bacteria attempting to colonize the cytosol of mammalian cells are incompletely understood. Polyubiquitylated proteins can accumulate on the surface of such bacteria, and bacterial growth is restricted by Tank-binding kinase (TBK1). Here we show that NDP52, not previously known to contribute to innate immunity, recognizes ubiquitin-coated Salmonella enterica in human cells and, by binding the adaptor proteins Nap1 and Sintbad, recruits TBK1. Knockdown of NDP52 and TBK1 facilitated bacterial proliferation and increased the number of cells containing ubiquitin-coated salmonella. NDP52 also recruited LC3, an autophagosomal marker, and knockdown of NDP52 impaired autophagy of salmonella. We conclude that human cells utilize the ubiquitin system and NDP52 to activate autophagy against bacteria attempting to colonize their cytosol.	[Thurston, Teresa L. M.; Ryzhakov, Grigory; Bloor, Stuart; von Muhlinen, Natalia; Randow, Felix] MRC, Mol Biol Lab, Div Prot & Nucle Acid Chem, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Randow, F (corresponding author), MRC, Mol Biol Lab, Div Prot & Nucle Acid Chem, Hills Rd, Cambridge CB2 2QH, England.	randow@mrc-lmb.cam.ac.uk	Thurston, Teresa/AAZ-9938-2020	Thurston, Teresa/0000-0001-6139-3723	Medical Research Council [MC_U105170648] Funding Source: Medline; MRC [MC_U105170648] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Beuzon CR, 2002, MICROBIOL-SGM, V148, P2705, DOI 10.1099/00221287-148-9-2705; BIELECKI J, 1990, NATURE, V345, P175, DOI 10.1038/345175a0; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bloor S, 2008, P NATL ACAD SCI USA, V105, P1279, DOI 10.1073/pnas.0706552105; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Coburn B, 2007, IMMUNOL CELL BIOL, V85, P112, DOI 10.1038/sj.icb.7100007; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fujita F, 2003, MOL CELL BIOL, V23, P7780, DOI 10.1128/MCB.23.21.7780-7793.2003; Goetz M, 2001, P NATL ACAD SCI USA, V98, P12221, DOI 10.1073/pnas.211106398; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; Gurung R, 2003, J BIOL CHEM, V278, P11376, DOI 10.1074/jbc.M209991200; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hiemstra PS, 1999, J LEUKOCYTE BIOL, V66, P423, DOI 10.1002/jlb.66.3.423; Iha H, 2008, EMBO J, V27, P629, DOI 10.1038/emboj.2008.5; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Kirkin V, 2009, AUTOPHAGY, V5, P732, DOI 10.4161/auto.5.5.8566; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; KORIOTH F, 1995, J CELL BIOL, V130, P1, DOI 10.1083/jcb.130.1.1; Krumbach R, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.139pt7; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Morriswood B, 2007, J CELL SCI, V120, P2574, DOI 10.1242/jcs.007005; Morton S, 2008, FEBS LETT, V582, P997, DOI 10.1016/j.febslet.2008.02.047; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Perrin AJ, 2004, CURR BIOL, V14, P806, DOI 10.1016/j.cub.2004.04.033; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Puls A, 1997, P NATL ACAD SCI USA, V94, P6191, DOI 10.1073/pnas.94.12.6191; Radtke AL, 2008, CELL MICROBIOL, V10, P2197, DOI 10.1111/j.1462-5822.2008.01199.x; Radtke AL, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030029; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Randow Felix, 2006, Subcell Biochem, V40, P383; Ray K, 2009, NAT REV MICROBIOL, V7, P333, DOI 10.1038/nrmicro2112; Ryzhakov G, 2007, EMBO J, V26, P3180, DOI 10.1038/sj.emboj.7601743; Sanchez P, 1998, MOL CELL BIOL, V18, P3069, DOI 10.1128/MCB.18.5.3069; Sasai M, 2005, J IMMUNOL, V174, P27, DOI 10.4049/jimmunol.174.1.27; Sasai M, 2006, J IMMUNOL, V177, P8676, DOI 10.4049/jimmunol.177.12.8676; Sternsdorf T, 1997, J CELL BIOL, V138, P435, DOI 10.1083/jcb.138.2.435; Virgin HW, 2009, NAT IMMUNOL, V10, P461, DOI 10.1038/ni.1726; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465	50	626	633	1	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2009	10	11					1215	U103		10.1038/ni.1800	http://dx.doi.org/10.1038/ni.1800			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	508SO	19820708				2022-12-18	WOS:000270955900015
J	Hoebe, K; Janssen, E; Beutler, B				Hoebe, K; Janssen, E; Beutler, B			The interface between innate and adaptive immunity	NATURE IMMUNOLOGY			English	Review							BACTERIAL LIPOPOLYSACCHARIDE LPS; SINGLE-STRANDED RNA; IMMUNOLOGICAL-PROPERTIES; RECOGNITION; SUSCEPTIBILITY; MUTATIONS; ADJUVANT; MICE	This focus analyzes some of the ways the innate immune system influences adaptive immune responses. Here the main principles and themes that govern this intricate relationship are discussed.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; La Jolla Inst Allergy & Immunol, Dept Dev Immunol, San Diego, CA 92121 USA	Scripps Research Institute; La Jolla Institute for Immunology	Beutler, B (corresponding author), Scripps Res Inst, Dept Immunol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	bruce@scripps.edu		Hoebe, Kasper/0000-0002-3626-8098; janssen, edith/0000-0001-7881-6307				Aderem A, 2003, J INFECT DIS, V187, pS340, DOI 10.1086/374747; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; CONDIE RM, 1955, P SOC EXP BIOL MED, V90, P355, DOI 10.3181/00379727-90-22032; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; Crozat K, 2004, P NATL ACAD SCI USA, V101, P6835, DOI 10.1073/pnas.0401347101; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dutton R W, 1967, Adv Immunol, V6, P253, DOI 10.1016/S0065-2776(08)60524-6; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Honda K, 2003, P NATL ACAD SCI USA, V100, P10872, DOI 10.1073/pnas.1934678100; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; SKIDMORE BJ, 1975, J IMMUNOL, V114, P770; SKIDMORE BJ, 1976, J EXP MED, V143, P143, DOI 10.1084/jem.143.1.143; Smirnova I, 2003, P NATL ACAD SCI USA, V100, P6075, DOI 10.1073/pnas.1031605100; UNANUE ER, 1968, IMMUNOLOGY, V15, P287	19	626	661	3	85	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2004	5	10					971	974		10.1038/ni1004-971	http://dx.doi.org/10.1038/ni1004-971			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	857YO	15454919				2022-12-18	WOS:000224156600002
J	Burton, DR; Desrosiers, RC; Doms, RW; Koff, WC; Kwong, PD; Moore, JP; Nabel, GJ; Sodroski, J; Wilson, IA; Wyatt, RT				Burton, DR; Desrosiers, RC; Doms, RW; Koff, WC; Kwong, PD; Moore, JP; Nabel, GJ; Sodroski, J; Wilson, IA; Wyatt, RT			HIV vaccine design and the neutralizing antibody problem	NATURE IMMUNOLOGY			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; ENVELOPE GLYCOPROTEIN; TYPE-1; BINDING; GP120; SELECTIVITY; RECOGNITION; ANTIGENS; REGION; GP41	Eliciting broadly neutralizing antibodies to human immunodeficiency virus could bring closer the goal of a successful AIDS vaccine. Here the International AIDS Vaccine Initiative Neutralizing Antibody Consortium discusses current approaches to overcome the problems faced.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Harvard Univ, New England Reg Primate Res Ctr, Sch Med, Div Microbiol, Southborough, MA 01772 USA; Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA; Int AIDS Vaccine Initiat, New York, NY USA; NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA; Cornell Univ, Weill Med Ctr, Dept Microbiol & Immunol, New York, NY USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Harvard University; University of Pennsylvania; International AIDS Vaccine Initiative; National Institutes of Health (NIH) - USA; Cornell University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Scripps Research Institute	Burton, DR (corresponding author), Scripps Res Inst, Dept Immunol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	burton@scripps.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI005068, ZIAAI005068, ZIAAI005069, Z01AI005078, ZIAAI005024, Z01AI005069, ZIAAI005078, Z01AI005024, ZIAAI005002, Z01AI005002] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Choe H, 2003, CELL, V114, P161, DOI 10.1016/S0092-8674(03)00508-7; Fouts T, 2002, P NATL ACAD SCI USA, V99, P11842, DOI 10.1073/pnas.182412199; Golding H, 2002, J VIROL, V76, P6780, DOI 10.1128/JVI.76.13.6780-6790.2002; Grundner C, 2002, J VIROL, V76, P3511, DOI 10.1128/JVI.76.7.3511-3521.2002; Johnson WE, 2002, ANNU REV MED, V53, P499, DOI 10.1146/annurev.med.53.082901.104053; Klausner RD, 2003, SCIENCE, V300, P2036, DOI 10.1126/science.1086916; Kwong PD, 2000, J VIROL, V74, P1961, DOI 10.1128/JVI.74.4.1961-1972.2000; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Pantophlet R, 2003, J VIROL, V77, P5889, DOI 10.1128/JVI.77.10.5889-5901.2003; Parren PWHI, 2001, ADV IMMUNOL, V77, P195, DOI 10.1016/S0065-2776(01)77018-6; Proudfoot AEI, 2001, J BIOL CHEM, V276, P10620, DOI 10.1074/jbc.M010867200; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; SELVARAJAH S, IN PRESS ACCELERATIN; Sharon M, 2003, STRUCTURE, V11, P225, DOI 10.1016/S0969-2126(03)00011-X; Srivastava IK, 2003, J VIROL, V77, P11244, DOI 10.1128/JVI.77.20.11244-11259.2003; STANFIELD RL, IN PRESS STRUCTURE; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yang XZ, 2001, J VIROL, V75, P1165, DOI 10.1128/JVI.75.3.1165-1171.2001; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	21	625	701	0	60	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2004	5	3					233	236		10.1038/ni0304-233	http://dx.doi.org/10.1038/ni0304-233			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	779ZV	14985706				2022-12-18	WOS:000189344600002
J	Everts, B; Amiel, E; Huang, SCC; Smith, AM; Chang, CH; Lam, WY; Redmann, V; Freitas, TC; Blagih, J; van der Windt, GJW; Artyomov, MN; Jones, RG; Pearce, EL; Pearce, EJ				Everts, Bart; Amiel, Eyal; Huang, Stanley Ching-Cheng; Smith, Amber M.; Chang, Chih-Hao; Lam, Wing Y.; Redmann, Veronika; Freitas, Tori C.; Blagih, Julianna; van der Windt, Gerritje J. W.; Artyomov, Maxim N.; Jones, Russell G.; Pearce, Erika L.; Pearce, Edward J.			TLR-driven early glycolytic reprogramming via the kinases TBK1-IKK epsilon supports the anabolic demands of dendritic cell activation	NATURE IMMUNOLOGY			English	Article							NITRIC-OXIDE; AKT; METABOLISM; MACROPHAGES; MEMORY; ACCUMULATION; INHIBITION; PROTECTION; RECEPTORS; REGULATOR	The ligation of Toll-like receptors (TLRs) leads to rapid activation of dendritic cells (DCs). However, the metabolic requirements that support this process remain poorly defined. We found that DC glycolytic flux increased within minutes of exposure to TLR agonists and that this served an essential role in supporting the de novo synthesis of fatty acids for the expansion of the endoplasmic reticulum and Golgi required for the production and secretion of proteins that are integral to DC activation. Signaling via the kinases TBK1, IKK. and Akt was essential for the TLR-induced increase in glycolysis by promoting the association of the glycolytic enzyme HK-II with mitochondria. In summary, we identified the rapid induction of glycolysis as an integral component of TLR signaling that is essential for the anabolic demands of the activation and function of DCs.	[Everts, Bart; Huang, Stanley Ching-Cheng; Smith, Amber M.; Chang, Chih-Hao; Lam, Wing Y.; Redmann, Veronika; van der Windt, Gerritje J. W.; Artyomov, Maxim N.; Pearce, Erika L.; Pearce, Edward J.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Amiel, Eyal] Univ Vermont, Dept Med Lab & Radiat Sci, Burlington, VT USA; [Freitas, Tori C.; Blagih, Julianna] Trudeau Inst Inc, Saranac Lake, NY USA; [Jones, Russell G.] McGill Univ, Dept Physiol, Montreal, PQ, Canada	Washington University (WUSTL); University of Vermont; Trudeau Institute; McGill University	Pearce, EJ (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	edwardpearce@path.wustl.edu	Huang, Stanley Ching-Cheng/AAE-7866-2019; Jones, Russell Graham/ABD-5261-2021; Jones, Russell/AAC-2861-2022; Everts, Bart/H-6986-2016	Huang, Stanley Ching-Cheng/0000-0002-6557-3737; Jones, Russell Graham/0000-0003-2250-4675; Everts, Bart/0000-0002-3764-5131; CHANG, CHIH-HAO/0000-0002-0139-7439	US National Institutes of Health [AI53825, CA164062, AI091965, CA158823, AI049823]; Netherlands Organisation for Scientific Research; Arthritis Society of Canada; NATIONAL CANCER INSTITUTE [R01CA164062, R21CA158823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091965, T32AI049823, R01AI053825] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Arthritis Society of Canada; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Pearce laboratory for discussions; H. Virgin for support of the <SUP>14</SUP>C-glucose-tracing experiments; W. Beatty and the Molecular Microbiology Imaging Facility for technical assistance with electron microscopy; and G. Bridon and B. Faubert for help with the glucose-tracing experiments. Some observations reported here were made while B.E., E.A., T.C.F., G.J.W.v.d.W., E.L.P. and E.J.P. were at the Trudeau Institute; we thank the institute for its support during that time. Supported by the US National Institutes of Health (AI53825 and CA164062 to E.J.P.; AI091965 and CA158823 to E.L.P.; and AI049823 to E.A.), the Netherlands Organisation for Scientific Research (B.E. and G.J.W.v.d.W.) and The Arthritis Society of Canada (R.G.J.).	Abu-Hamad S, 2008, J BIOL CHEM, V283, P13482, DOI 10.1074/jbc.M708216200; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Clark K, 2011, P NATL ACAD SCI USA, V108, P17093, DOI 10.1073/pnas.1114194108; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; Everts B, 2012, BLOOD, V120, P1422, DOI 10.1182/blood-2012-03-419747; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Fayard E, 2010, CURR TOP MICROBIOL, V346, P31, DOI 10.1007/82_2010_58; Feingold KR, 2012, J LEUKOCYTE BIOL, V92, P829, DOI 10.1189/jlb.1111537; FUNK JL, 1993, ATHEROSCLEROSIS, V98, P67, DOI 10.1016/0021-9150(93)90224-I; GROSSBARD L, 1966, J BIOL CHEM, V241, P3546; Guo JP, 2011, J BIOL CHEM, V286, P37389, DOI 10.1074/jbc.M111.287433; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Ibrahim J, 2012, GASTROENTEROLOGY, V143, P1061, DOI 10.1053/j.gastro.2012.06.003; Im SS, 2011, CELL METAB, V13, P540, DOI 10.1016/j.cmet.2011.04.001; Infantino V, 2011, BIOCHEM J, V438, P433, DOI 10.1042/BJ20111275; Jantsch J, 2008, J IMMUNOL, V180, P4697, DOI 10.4049/jimmunol.180.7.4697; Jensen-Urstad APL, 2012, BBA-MOL CELL BIOL L, V1821, P747, DOI 10.1016/j.bbalip.2011.09.017; Jin HK, 2009, BIOL PHARM BULL, V32, P988, DOI 10.1248/bpb.32.988; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; John S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017674; Khabar KSA, 2005, J INTERF CYTOK RES, V25, P1, DOI 10.1089/jir.2005.25.1; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Lisi L, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-1; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Miyamoto S, 2008, CELL DEATH DIFFER, V15, P521, DOI 10.1038/sj.cdd.4402285; Mor I, 2011, COLD SH Q B, V76, P211, DOI 10.1101/sqb.2011.76.010868; Nagy L, 2012, PHYSIOL REV, V92, P739, DOI 10.1152/physrev.00004.2011; Nicolaou G, 2012, J ATHEROSCLER THROMB, V19, P137, DOI 10.5551/jat.10249; Ou YH, 2011, MOL CELL, V41, P458, DOI 10.1016/j.molcel.2011.01.019; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082; Robey RB, 2009, SEMIN CANCER BIOL, V19, P25, DOI 10.1016/j.semcancer.2008.11.010; Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; Stiles BL, 2009, ADV DRUG DELIVER REV, V61, P1276, DOI 10.1016/j.addr.2009.07.017; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wagner A, 2005, MOL BIOL EVOL, V22, P1365, DOI 10.1093/molbev/msi126; Ward PS, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006783; Xie XD, 2011, P NATL ACAD SCI USA, V108, P6474, DOI 10.1073/pnas.1016132108; Xu QW, 2011, J BIOMOL NMR, V49, P207, DOI 10.1007/s10858-011-9482-8	48	622	659	5	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2014	15	4					323	+		10.1038/ni.2833	http://dx.doi.org/10.1038/ni.2833			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AD4WL	24562310	Green Accepted, Green Published			2022-12-18	WOS:000333252000007
J	Harris, DP; Haynes, L; Sayles, PC; Duso, DK; Eaton, SM; Lepak, NM; Johnson, LL; Swain, SL; Lund, FE				Harris, DP; Haynes, L; Sayles, PC; Duso, DK; Eaton, SM; Lepak, NM; Johnson, LL; Swain, SL; Lund, FE			Reciprocal regulation of polarized cytokine production by effector B and T cells	NATURE IMMUNOLOGY			English	Article							DEFICIENT MICE; PROTECTIVE IMMUNITY; INTERFERON-GAMMA; VIRUS-INFECTION; HELPER-CELL; LYMPHOCYTES; INDUCE; RESPONSES; DIFFERENTIATION; INTERLEUKIN-2	Although B cells produce cytokines it is not known whether B cells can differentiate into effector subsets that secrete polarized arrays of cytokines. We have identified two populations of "effector" B cells (Bel and Be2) that produce distinct patterns of cytokines depending on the cytokine environment in which the cells were stimulated during their primary encounter with antigen and T cells. These effector B cell subsets subsequently regulate the differentiation of naive CD4(+)T cells to T(H)1 and T(H)2 cells through production of polarizing cytokines such as interleukin 4 and interferon gamma. In addition, Eel and Be2 cells could, be identified in animals that were infected with pathogens that preferentially induce a Type I or Type 2 immune response. Together these results suggest that, in addition to their well defined role in antibody production, B cells may regulate immune responses to infectious pathogens through their production of cytokines.	Trudeau Inst Inc, Saranac Lake, NY 12983 USA	Trudeau Institute	Lund, FE (corresponding author), Trudeau Inst Inc, POB 59, Saranac Lake, NY 12983 USA.	flund@trudeauinstitute.org			NIAID NIH HHS [AI43629, AI22125] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043629, R37AI022125, R01AI022125] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Bastien Y, 1999, J IMMUNOL, V162, P5498; CHESNUT RW, 1981, J IMMUNOL, V126, P1075; CHESNUT RW, 1982, J IMMUNOL, V128, P1764; COYLE AJ, 1995, J EXP MED, V181, P1229, DOI 10.1084/jem.181.3.1229; CROFT M, 1994, J EXP MED, V180, P1715, DOI 10.1084/jem.180.5.1715; Denkers EY, 1999, MICROBES INFECT, V1, P699, DOI 10.1016/S1286-4579(99)80071-9; Elkins KL, 1999, INFECT IMMUN, V67, P6002, DOI 10.1128/IAI.67.11.6002-6007.1999; Endres R, 1999, J EXP MED, V189, P159, DOI 10.1084/jem.189.1.159; Ferru I, 1998, SCAND J IMMUNOL, V48, P233; Finkelman FD, 1997, ANNU REV IMMUNOL, V15, P505, DOI 10.1146/annurev.immunol.15.1.505; Fu YX, 1998, J EXP MED, V187, P1009, DOI 10.1084/jem.187.7.1009; Gonzalez M, 1998, J EXP MED, V187, P997, DOI 10.1084/jem.187.7.997; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; HARDING FA, 1993, J EXP MED, V177, P1791, DOI 10.1084/jem.177.6.1791; Haynes L, 1999, J EXP MED, V190, P1013, DOI 10.1084/jem.190.7.1013; HEINZEL FP, 1993, J IMMUNOL, V150, P3924; Homann D, 1998, J VIROL, V72, P9208, DOI 10.1128/JVI.72.11.9208-9216.1998; JACOBSON RH, 1982, J PARASITOL, V68, P1053, DOI 10.2307/3281091; JOHNSON LL, 1992, INFECT IMMUN, V60, P3719, DOI 10.1128/IAI.60.9.3719-3724.1992; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KINDLER V, 1995, EUR J IMMUNOL, V25, P1239, DOI 10.1002/eji.1830250516; Kouskoff V, 1998, J EXP MED, V188, P1453, DOI 10.1084/jem.188.8.1453; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; Langhorne J, 1998, P NATL ACAD SCI USA, V95, P1730, DOI 10.1073/pnas.95.4.1730; Leef M, 2000, J EXP MED, V191, P1841, DOI 10.1084/jem.191.11.1841; Lund FE, 1996, J IMMUNOL, V157, P1455; Mastroeni P, 2000, INFECT IMMUN, V68, P46, DOI 10.1128/IAI.68.1.46-53.2000; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Mozdzanowska K, 2000, J IMMUNOL, V164, P2635, DOI 10.4049/jimmunol.164.5.2635; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; OGARRA A, 1990, INT IMMUNOL, V2, P821, DOI 10.1093/intimm/2.9.821; Ohnishi E, 1997, J INTERF CYTOK RES, V17, P597, DOI 10.1089/jir.1997.17.597; Okamura H, 1998, CURR OPIN IMMUNOL, V10, P259, DOI 10.1016/S0952-7915(98)80163-5; OPENSHAW P, 1995, J EXP MED, V182, P1357, DOI 10.1084/jem.182.5.1357; Peritt D, 1998, J IMMUNOL, V161, P5821; Pistoia V, 1997, IMMUNOL TODAY, V18, P343, DOI 10.1016/S0167-5699(97)01080-3; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; SAD S, 1995, IMMUNITY, V2, P271, DOI 10.1016/1074-7613(95)90051-9; Sartori A, 1997, METHODS, V11, P116, DOI 10.1006/meth.1996.0395; Schultze JL, 1999, J EXP MED, V189, P1, DOI 10.1084/jem.189.1.1; TAIRA S, 1987, J IMMUNOL, V139, P2957; VAN SJ, 1990, ANNU REV IMMUNOL, V8, P253; Ware C F, 1995, Curr Top Microbiol Immunol, V198, P175; Yang X, 1998, J IMMUNOL, V161, P1439; Yap GS, 1999, IMMUNOBIOLOGY, V201, P240, DOI 10.1016/S0171-2985(99)80064-3	46	622	657	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2000	1	6					475	482		10.1038/82717	http://dx.doi.org/10.1038/82717			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	380VR	11101868				2022-12-18	WOS:000165724600010
J	Miller, BC; Sen, DR; Al Abosy, R; Bi, K; Virkud, YV; LaFleur, MW; Yates, KB; Lako, A; Felt, K; Naik, GS; Manos, M; Gjini, E; Kuchroo, JR; Ishizuka, JJ; Collier, JL; Griffin, GK; Maleri, S; Comstock, DE; Weiss, SA; Brown, FD; Panda, A; Zimmer, MD; Manguso, RT; Hodi, FS; Rodig, SJ; Sharpe, AH; Haining, WN				Miller, Brian C.; Sen, Debattama R.; Al Abosy, Rose; Bi, Kevin; Virkud, Yamini V.; LaFleur, Martin W.; Yates, Kathleen B.; Lako, Ana; Felt, Kristen; Naik, Girish S.; Manos, Michael; Gjini, Evisa; Kuchroo, Juhi R.; Ishizuka, Jeffrey J.; Collier, Jenna L.; Griffin, Gabriel K.; Maleri, Seth; Comstock, Dawn E.; Weiss, Sarah A.; Brown, Flavian D.; Panda, Arpit; Zimmer, Margaret D.; Manguso, Robert T.; Hodi, F. Stephen; Rodig, Scott J.; Sharpe, Arlene H.; Haining, W. Nicholas			Subsets of exhausted CD8(+) T cells differentially mediate tumor control and respond to checkpoint blockade	NATURE IMMUNOLOGY			English	Article							ANALYSIS REVEALS; DYSFUNCTION; PD-1; EXPRESSION; CHROMATIN; PERSISTENCE; INFECTION; APOPTOSIS; PATHWAYS; SURVIVAL	T cell dysfunction is a hallmark of many cancers, but the basis for T cell dysfunction and the mechanisms by which antibody blockade of the inhibitory receptor PD-1 (anti-PD-1) reinvigorates T cells are not fully understood. Here we show that such therapy acts on a specific subpopulation of exhausted CD8(+) tumor-infiltrating lymphocytes (TILs). Dysfunctional CD8(+) TILs possess canonical epigenetic and transcriptional features of exhaustion that mirror those seen in chronic viral infection. Exhausted CD8(+) TILs include a subpopulation of 'progenitor exhausted' cells that retain polyfunctionality, persist long term and differentiate into 'terminally exhausted' TILs. Consequently, progenitor exhausted CD8(+) TILs are better able to control tumor growth than are terminally exhausted T cells. Progenitor exhausted TILs can respond to anti-PD-1 therapy, but terminally exhausted TILs cannot. Patients with melanoma who have a higher percentage of progenitor exhausted cells experience a longer duration of response to checkpoint-blockade therapy. Thus, approaches to expand the population of progenitor exhausted CD8(+) T cells might be an important component of improving the response to checkpoint blockade.	[Miller, Brian C.; Sen, Debattama R.; Al Abosy, Rose; Bi, Kevin; LaFleur, Martin W.; Yates, Kathleen B.; Ishizuka, Jeffrey J.; Collier, Jenna L.; Griffin, Gabriel K.; Comstock, Dawn E.; Weiss, Sarah A.; Brown, Flavian D.; Panda, Arpit; Haining, W. Nicholas] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Miller, Brian C.; Manos, Michael; Gjini, Evisa; Ishizuka, Jeffrey J.; Hodi, F. Stephen] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Miller, Brian C.; Sen, Debattama R.; Al Abosy, Rose; Bi, Kevin; LaFleur, Martin W.; Yates, Kathleen B.; Ishizuka, Jeffrey J.; Collier, Jenna L.; Griffin, Gabriel K.; Comstock, Dawn E.; Weiss, Sarah A.; Brown, Flavian D.; Panda, Arpit; Zimmer, Margaret D.; Manguso, Robert T.; Sharpe, Arlene H.; Haining, W. Nicholas] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Miller, Brian C.; LaFleur, Martin W.; Kuchroo, Juhi R.; Collier, Jenna L.; Brown, Flavian D.; Sharpe, Arlene H.] Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA USA; [Miller, Brian C.; LaFleur, Martin W.; Kuchroo, Juhi R.; Collier, Jenna L.; Brown, Flavian D.; Sharpe, Arlene H.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Miller, Brian C.; LaFleur, Martin W.; Kuchroo, Juhi R.; Collier, Jenna L.; Maleri, Seth; Brown, Flavian D.; Sharpe, Arlene H.] Harvard Med Sch, Blavatnik Inst, Dept Immunol, Boston, MA USA; [Sen, Debattama R.; LaFleur, Martin W.; Kuchroo, Juhi R.; Collier, Jenna L.; Comstock, Dawn E.; Weiss, Sarah A.; Brown, Flavian D.; Sharpe, Arlene H.; Haining, W. Nicholas] Harvard Med Sch, Div Med Sci, Boston, MA 02115 USA; [Virkud, Yamini V.] Massachusetts Gen Hosp, Div Pediat Allergy & Immunol, Boston, MA 02114 USA; [Lako, Ana; Felt, Kristen; Naik, Girish S.; Manos, Michael; Gjini, Evisa; Hodi, F. Stephen; Rodig, Scott J.] Dana Farber Canc Inst, Ctr Immunooncol, Boston, MA 02115 USA; [Griffin, Gabriel K.; Rodig, Scott J.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital	Haining, WN (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.; Haining, WN (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Haining, WN (corresponding author), Harvard Med Sch, Div Med Sci, Boston, MA 02115 USA.	wnhaining@gmail.com	Rodig, Scott/Y-3889-2019; Sen, Debattama/AAC-5679-2020	Sen, Debattama/0000-0002-0947-8284; Zimmer, Margaret/0000-0002-3317-6569; Al Abosy, Rose/0000-0001-5400-1306; Miller, Brian/0000-0001-5931-4184; Comstock, Dawn/0000-0002-3718-8372	NIAID [R01 AI115712, U19 AI133524, P01 AI56299, K23 AI130408]; Parker Institute for Cancer Immunotherapy; Mathers Charitable Trust; Ludwig Center at Harvard Medical School; 2016 AACR-Bristol-Myers Squibb Fellowship in Translational Immuno-oncology grant [16-40-15-MILL]; Wong Family Awards in Translational Oncology; National Center for Advancing Translational Sciences/National Institutes of Health Award [KL2 TR002542]; NCI [T32 CA009172, T32 CA207021]; Jane C. Wright, MD, Endowed Young Investigator Award from ASCO; NIGMS [T32 GM007753]; NHLBI [T32 HL007627]; Center for Immuno-Oncology at DFCI; NATIONAL CANCER INSTITUTE [T32CA009172, T32CA207021] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR002542] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI130408, P01AI056299, U19AI133524, R01AI115712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Parker Institute for Cancer Immunotherapy; Mathers Charitable Trust; Ludwig Center at Harvard Medical School; 2016 AACR-Bristol-Myers Squibb Fellowship in Translational Immuno-oncology grant; Wong Family Awards in Translational Oncology; National Center for Advancing Translational Sciences/National Institutes of Health Award; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Jane C. Wright, MD, Endowed Young Investigator Award from ASCO; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Center for Immuno-Oncology at DFCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	W.N.H. received support from NIAID R01 AI115712, NIAID U19 AI133524, Parker Institute for Cancer Immunotherapy, and Mathers Charitable Trust. A.H.S. was supported by NIAID P01 AI56299 and funding from the Ludwig Center at Harvard Medical School. B.C.M. was supported by the 2016 AACR-Bristol-Myers Squibb Fellowship in Translational Immuno-oncology grant number 16-40-15-MILL, Wong Family Awards in Translational Oncology, National Center for Advancing Translational Sciences/National Institutes of Health Award KL2 TR002542, NCI T32 CA009172, and the Jane C. Wright, MD, Endowed Young Investigator Award from ASCO. J.J.I. received funding from NCI T32 CA009172. Y.V.V. received funding from NIAID K23 AI130408. M.W.L. received funding from NCI T32 CA207021. J.R.K. and S.A.W. were supported by NIGMS T32 GM007753. G.K.G. received funding from NHLBI T32 HL007627. This work was supported, in part, by the Center for Immuno-Oncology at DFCI. We would like to thank the Dana-Farber Flow Cytometry Core for their assistance.	Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Brummelman J, 2018, J EXP MED, V215, P2520, DOI 10.1084/jem.20180684; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Carey CD, 2017, BLOOD, V130, P2420, DOI 10.1182/blood-2017-03-770719; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; DeTomaso D, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1176-5; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Ferreira V, 1999, J IMMUNOL, V162, P6442; FIDLER IJ, 1975, CANCER RES, V35, P218; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Horton BL, 2018, CANCER IMMUNOL RES, V6, P14, DOI 10.1158/2326-6066.CIR-17-0249; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Jenkins MH, 2014, PIGM CELL MELANOMA R, V27, P495, DOI 10.1111/pcmr.12220; Leong YA, 2016, NAT IMMUNOL, V17, P1187, DOI 10.1038/ni.3543; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; Mognol GP, 2017, P NATL ACAD SCI USA, V114, pE2776, DOI 10.1073/pnas.1620498114; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Sade-Feldman M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01062-w; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schietinger A, 2016, IMMUNITY, V45, P389, DOI 10.1016/j.immuni.2016.07.011; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Singer M, 2016, CELL, V166, P1500, DOI 10.1016/j.cell.2016.08.052; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thommen DS, 2018, NAT MED, V24, P994, DOI 10.1038/s41591-018-0057-z; Thommen DS, 2018, CANCER CELL, V33, P547, DOI 10.1016/j.ccell.2018.03.012; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Waltman L, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40829-0; Wang RQ, 2011, J IMMUNOL, V187, P5964, DOI 10.4049/jimmunol.1101205; Wei SC, 2017, CELL, V170, P1120, DOI 10.1016/j.cell.2017.07.024; Welsh R. M., 2008, CURR PROTOC MICROBIO, V8; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593; Yates K, 2018, P NATL ACAD SCI USA, V115, P2162, DOI 10.1073/pnas.1720447115; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	50	621	629	15	134	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2019	20	3					326	+		10.1038/s41590-019-0312-6	http://dx.doi.org/10.1038/s41590-019-0312-6			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL7CA	30778252	Green Accepted			2022-12-18	WOS:000458893600017
J	Rimoldi, M; Chieppa, M; Salucci, V; Avogadri, F; Sonzogni, A; Sampietro, GM; Nespoli, A; Viale, G; Allavena, P; Rescigno, M				Rimoldi, M; Chieppa, M; Salucci, V; Avogadri, F; Sonzogni, A; Sampietro, GM; Nespoli, A; Viale, G; Allavena, P; Rescigno, M			Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells	NATURE IMMUNOLOGY			English	Article							THYMIC STROMAL LYMPHOPOIETIN; ALLERGIC INFLAMMATION; BACTERIAL CLEARANCE; COMMENSAL BACTERIA; TOXOPLASMA-GONDII; T-CELLS; B-CELLS; RESPONSES; INFECTION; GAMMA	The control of damaging inflammation by the mucosal immune system in response to commensal and harmful ingested bacteria is unknown. Here we show epithelial cells conditioned mucosal dendritic cells through the constitutive release of thymic stromal lymphopoietin and other mediators, resulting in the induction of 'noninflammatory' dendritic cells. Epithelial cell-conditioned dendritic cells released interleukins 10 and 6 but not interleukin 12, and they promoted the polarization of T cells toward a 'classical' noninflammatory T helper type 2 response, even after exposure to a T helper type 1-inducing pathogen. This control of immune responses seemed to be lost in patients with Crohn disease. Thus, the intimate interplay between intestinal epithelial cells and dendritic cells may help to maintain gut immune homeostasis.	European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy; Ist Ric Farmacol Mario Negri, Dept Immunol, I-20157 Milan, Italy; European Inst Oncol, Dept Pathol & Lab Med, I-20141 Milan, Italy; Univ Milan, Div Gen Surg, I-20157 Milan, Italy; Luigi Sacco Hosp, I-20157 Milan, Italy; Univ Milano Bicocca, I-20052 Milan, Italy; Osped San Gerardo, I-20052 Milan, Italy; Univ Milan, Sch Med, I-20141 Milan, Italy	IRCCS European Institute of Oncology (IEO); Istituto di Ricerche Farmacologiche Mario Negri IRCCS; IRCCS European Institute of Oncology (IEO); University of Milan; University of Milan; Luigi Sacco Hospital; University of Milano-Bicocca; San Gerardo Hospital; University of Milan	Rescigno, M (corresponding author), European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy.	maria.rescigno@ifom-ieo-campus.it	Sonzogni, Angelica/C-1193-2017; Chieppa, Marcello/K-4846-2012; Sampietro, Gianluca/AAB-2846-2019; Chieppa, Marcello/I-8447-2018; Viale, Giuseppe/AAE-8921-2019; Chieppa, Marcello/AAG-9835-2019; Allavena, Paola/HHM-5218-2022; Rescigno, Maria/J-9704-2012	Sonzogni, Angelica/0000-0002-4769-4316; Sampietro, Gianluca/0000-0001-7168-441X; Chieppa, Marcello/0000-0001-9819-0823; Chieppa, Marcello/0000-0001-9819-0823; Allavena, Paola/0000-0002-6697-6028; Rescigno, Maria/0000-0002-6464-509X; Rimoldi, Monica/0000-0002-8333-7420				Akbari O, 2001, NAT IMMUNOL, V2, P725, DOI 10.1038/90667; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alpan O, 2001, J IMMUNOL, V166, P4843, DOI 10.4049/jimmunol.166.8.4843; Anjuere F, 2003, J IMMUNOL, V170, P1586, DOI 10.4049/jimmunol.170.3.1586; Bilsborough J, 2004, GASTROENTEROLOGY, V127, P300, DOI 10.1053/j.gastro.2004.01.028; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Dieu-Nosjean MC, 2000, J EXP MED, V192, P705, DOI 10.1084/jem.192.5.705; Eckmann L, 2001, MICROBES INFECT, V3, P1191, DOI 10.1016/S1286-4579(01)01479-4; George A, 1996, INFECT IMMUN, V64, P4606, DOI 10.1128/IAI.64.11.4606-4611.1996; Gilliet M, 2003, J EXP MED, V197, P1059, DOI 10.1084/jem.20030240; Hess J, 1996, J IMMUNOL, V156, P3321; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Iwasaki A, 2001, J IMMUNOL, V166, P4884, DOI 10.4049/jimmunol.166.8.4884; Jang MH, 2004, P NATL ACAD SCI USA, V101, P6110, DOI 10.1073/pnas.0400969101; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Liesenfeld O, 1997, INFECT IMMUN, V65, P4682, DOI 10.1128/IAI.65.11.4682-4689.1997; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Mastroeni P, 2003, J MED MICROBIOL, V52, P453, DOI 10.1099/jmm.0.05173-0; McWilliam AS, 1996, J EXP MED, V184, P2429, DOI 10.1084/jem.184.6.2429; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Neutra MR, 2001, NAT IMMUNOL, V2, P1004, DOI 10.1038/ni1101-1004; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reche PA, 2001, J IMMUNOL, V167, P336, DOI 10.4049/jimmunol.167.1.336; Rescigno M, 2002, TRENDS MICROBIOL, V10, P425, DOI 10.1016/S0966-842X(02)02425-3; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rimoldi M, 2004, ANN NY ACAD SCI, V1029, P66, DOI 10.1196/annals.1309.009; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sato A, 2003, J IMMUNOL, V171, P3684, DOI 10.4049/jimmunol.171.7.3684; Sierro F, 2001, P NATL ACAD SCI USA, V98, P13722, DOI 10.1073/pnas.241308598; Soumelis V, 2004, SPRINGER SEMIN IMMUN, V25, P325, DOI 10.1007/s00281-003-0152-0; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Vanbervliet A, 2002, EUR J IMMUNOL, V32, P231, DOI 10.1002/1521-4141(200201)32:1<231::AID-IMMU231>3.0.CO;2-8; Vossenkamper A, 2004, EUR J IMMUNOL, V34, P3197, DOI 10.1002/eji.200424993; Watanabe N, 2004, NAT IMMUNOL, V5, P426, DOI 10.1038/ni1048; WHITHER RNA, 2003, NAT CELL BIOL, V5, P489; Zhang MH, 2004, NAT IMMUNOL, V5, P1124, DOI 10.1038/ni1130	42	621	665	2	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2005	6	5					507	514		10.1038/ni1192	http://dx.doi.org/10.1038/ni1192			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	919RC	15821737				2022-12-18	WOS:000228634300023
J	Le Bourhis, L; Martin, E; Peguillet, I; Guihot, A; Froux, N; Core, M; Levy, E; Dusseaux, M; Meyssonnier, V; Premel, V; Ngo, C; Riteau, B; Duban, L; Robert, D; Rottman, M; Soudais, C; Lantz, O				Le Bourhis, Lionel; Martin, Emmanuel; Peguillet, Isabelle; Guihot, Amelie; Froux, Nathalie; Core, Maxime; Levy, Eva; Dusseaux, Mathilde; Meyssonnier, Vanina; Premel, Virginie; Ngo, Charlotte; Riteau, Beatrice; Duban, Livine; Robert, Delphine; Rottman, Martin; Soudais, Claire; Lantz, Olivier			Antimicrobial activity of mucosal-associated invariant T cells	NATURE IMMUNOLOGY			English	Article							NKT CELLS; ANTIGEN PRESENTATION; NALP3 INFLAMMASOME; DENDRITIC CELLS; ADAPTER PROTEIN; KAPPA-B; ACTIVATION; MR1; IDENTIFICATION; PEPTIDOGLYCAN	Mucosal-associated invariant T lymphocytes (MAIT lymphocytes) are characterized by two evolutionarily conserved features: an invariant T cell antigen receptor (TCR)alpha-chain and restriction by the major histocompatibility complex (MHC)-related protein MR1. Here we show that MAIT cells were activated by cells infected with various strains of bacteria and yeast, but not cells infected with virus, in both humans and mice. This activation required cognate interaction between the invariant TCR and MR1, which can present a bacteria-derived ligand. In humans, we observed considerably fewer MAIT cells in blood from patients with bacterial infections such as tuberculosis. In the mouse, MAIT cells protected against infection by Mycobacterium abscessus or Escherichia coli. Thus, MAIT cells are evolutionarily conserved innate-like lymphocytes that sense and help fight off microbial infection.	[Le Bourhis, Lionel; Martin, Emmanuel; Peguillet, Isabelle; Core, Maxime; Levy, Eva; Dusseaux, Mathilde; Premel, Virginie; Duban, Livine; Robert, Delphine; Soudais, Claire; Lantz, Olivier] Inst Curie, Dept Biol Tumeurs, Paris, France; [Le Bourhis, Lionel; Martin, Emmanuel; Core, Maxime; Levy, Eva; Dusseaux, Mathilde; Premel, Virginie; Duban, Livine; Soudais, Claire; Lantz, Olivier] INSERM, U932, Paris, France; [Peguillet, Isabelle; Robert, Delphine; Lantz, Olivier] Inst Gustave Roussy, Ctr Invest Clin Biotherapie 507, Villejuif, France; [Peguillet, Isabelle; Robert, Delphine; Lantz, Olivier] Inst Curie, Villejuif, France; [Peguillet, Isabelle; Robert, Delphine; Lantz, Olivier] Inst Gustave Roussy, Ctr Invest Clin Biotherapie 507, Paris, France; [Peguillet, Isabelle; Robert, Delphine; Lantz, Olivier] Inst Curie, Paris, France; Univ Paris, Univ Paris 06, INSERM, UMR 945, F-75252 Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Lantz, O (corresponding author), Inst Curie, Dept Biol Tumeurs, Paris, France.	olivier.lantz@curie.net	Rottman, Martin/AAD-9075-2021; Lantz, Olivier J/J-4960-2012; Martin, Emmanuel/F-9743-2016; Rottman, Martin/I-3005-2012; soudais, claire/F-9756-2016	Lantz, Olivier J/0000-0003-3161-7719; Martin, Emmanuel/0000-0003-4211-7373; Rottman, Martin/0000-0001-5953-3344; soudais, claire/0000-0002-4387-6649; Huang, Shouxiong/0000-0001-7797-3626; Ngo, Charlotte/0000-0002-6225-8803; Le Bourhis, Lionel/0000-0002-7524-3539; Levy, Eva/0000-0002-4710-4830	Institut National de la Sante et de la Recherche Medicale; Centre d'Investigation Clinique en Biotherapie 507 Institut National de la Sante et de la Recherche Medicale; Agence National de Recherches	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre d'Investigation Clinique en Biotherapie 507 Institut National de la Sante et de la Recherche Medicale; Agence National de Recherches	We thank T. Hansen (Washington University in St. Louis) for anti-MR1 and cell lines overexpressing MR1; J. Cadranel (Tenon Hospital) for lung biopsies; M. Chignard (Institut Pasteur) for MyD88-deficient bone marrow; L. Alexopoulou (Centre d'Immunologie de Marseille-Luminy) for TRIF-deficient bone marrow; D. Philpott (University of Toronto) for Nod1-Nod2-deficient bone marrow; J. Tschopp (University of Lausanne) for NLRP3-ASC-deficient bone marrow; M. Albert (Institut Pasteur) for IPS-1-deficient bone marrow; the microbiology department of the Curie Institute for bacterial strains; V. Sancho-Shimizu (Facult, Necker-Institut National de la Sante et de la Recherche Medicale U550) for viruses; M. Garcia, C. Billerit, S. Boissel and I. Grandjean for managing the mouse colonies; Z. Maciorowski and A. Viguier for cell sorting; and L. Guerri, V. Soumelis and S. Amigorena for critical reading of the manuscript. Supported by Institut National de la Sante et de la Recherche Medicale, Centre d'Investigation Clinique en Biotherapie 507 Institut National de la Sante et de la Recherche Medicale and Agence National de Recherches.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Bendelac A, 2001, NAT REV IMMUNOL, V1, P177, DOI 10.1038/35105052; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Chen L, 2009, SCAND J IMMUNOL, V70, P431, DOI 10.1111/j.1365-3083.2009.02315.x; Croxford JL, 2006, NAT IMMUNOL, V7, P987, DOI 10.1038/ni1370; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Fritz JH, 2007, IMMUNITY, V26, P445, DOI 10.1016/j.immuni.2007.03.009; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Gulden PH, 1996, IMMUNITY, V5, P73, DOI 10.1016/S1074-7613(00)80311-8; Hayday A, 2003, NAT REV IMMUNOL, V3, P233, DOI 10.1038/nri1030; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Huang SX, 2008, J EXP MED, V205, P1201, DOI 10.1084/jem.20072579; Huang SX, 2009, P NATL ACAD SCI USA, V106, P8290, DOI 10.1073/pnas.0903196106; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jouanguy E, 1999, CURR OPIN IMMUNOL, V11, P346, DOI 10.1016/S0952-7915(99)80055-7; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kawachi I, 2006, J IMMUNOL, V176, P1618, DOI 10.4049/jimmunol.176.3.1618; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kearney JF, 2005, SPRINGER SEMIN IMMUN, V26, P377, DOI 10.1007/s00281-004-0184-0; Lenz LL, 1996, IMMUNITY, V5, P63, DOI 10.1016/S1074-7613(00)80310-6; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Montecino-Rodriguez E, 2006, TRENDS IMMUNOL, V27, P428, DOI 10.1016/j.it.2006.07.005; Paget C, 2007, IMMUNITY, V27, P597, DOI 10.1016/j.immuni.2007.08.017; Paz S, 2006, CELL MOL BIOL, V52, P17, DOI 10.1170/T694; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Riegert P, 1998, J IMMUNOL, V161, P4066; Rottman M, 2007, INFECT IMMUN, V75, P5898, DOI 10.1128/IAI.00014-07; Santos-Sierra S, 2006, J ENDOTOXIN RES, V12, P307, DOI 10.1179/096805106X118762; Schumann J, 2007, EUR J IMMUNOL, V37, P1431, DOI 10.1002/eji.200737160; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shimamura M, 2007, EUR J IMMUNOL, V37, P1836, DOI 10.1002/eji.200636689; Stober D, 2002, EUR J IMMUNOL, V32, P1099, DOI 10.1002/1521-4141(200204)32:4<1099::AID-IMMU1099>3.3.CO;2-#; Texereau J, 2005, CLIN INFECT DIS, V41, pS408, DOI 10.1086/431990; Tilloy F, 1999, J EXP MED, V189, P1907, DOI 10.1084/jem.189.12.1907; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yao YX, 2005, J EXP MED, V201, P1899, DOI 10.1084/jem.20050324; Zhang FX, 1999, J BIOL CHEM, V274, P7611, DOI 10.1074/jbc.274.12.7611	46	620	625	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2010	11	8					701	U66		10.1038/ni.1890	http://dx.doi.org/10.1038/ni.1890			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	628UX	20581831	Green Submitted			2022-12-18	WOS:000280149400011
J	O'Leary, JG; Goodarzi, M; Drayton, DL; von Andrian, UH				O'Leary, JG; Goodarzi, M; Drayton, DL; von Andrian, UH			T cell- and B cell-independent adaptive immunity mediated by natural killer cells	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELLS; NK CELLS; DELAYED-HYPERSENSITIVITY; CONTACT HYPERSENSITIVITY; IN-VIVO; NKG2D IMMUNORECEPTOR; MICE DEFICIENT; LYMPH-NODES; GAMMA-DELTA; ALPHA-BETA	It is commonly believed that only T lymphocytes and B lymphocytes expressing recombination-dependent antigen-specific receptors mediate contact hypersensitivity responses to haptens. Here we found that mice devoid of T cells and B cells demonstrated substantial contact hypersensitivity responses to 2,4-dinitrofluorobenzene and oxazolone. Those responses were adaptive in nature, as they persisted for at least 4 weeks and were elicited only by haptens to which mice were previously sensitized. No contact hypersensitivity was induced in mice lacking all lymphocytes, including natural killer cells. Contact hypersensitivity responses were acquired by such mice after adoptive transfer of natural killer cells from sensitized donors. Transferable hapten-specific memory resided in a Ly49C-I+ natural killer subpopulation localized specifically in donor livers. These observations indicate that natural killer cells can mediate long-lived, antigen-specific adaptive recall responses independent of B cells and T cells.	Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	von Andrian, UH (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA.	uva@cbr.med.harvard.edu	von Andrian, Ulrich H/A-5775-2008		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066987, P01HL056949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR042689, T32AR007098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007191] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL066987, HL56949, P01 HL056949] Funding Source: Medline; NIAID NIH HHS [AI061663] Funding Source: Medline; NIAMS NIH HHS [T32 AR07098-31, AR42689] Funding Source: Medline; NIDDK NIH HHS [T32 DK007191] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andrews DM, 2003, NAT IMMUNOL, V4, P175, DOI 10.1038/ni880; ASHERSON GL, 1968, IMMUNOLOGY, V15, P405; Askenase PW, 2001, CLIN EXP IMMUNOL, V125, P345, DOI 10.1046/j.1365-2249.2001.01619.x; Bajory Z, 2002, UROL RES, V30, P148, DOI 10.1007/s00240-002-0251-8; Bangert C, 2003, J INVEST DERMATOL, V121, P1409, DOI 10.1111/j.1523-1747.2003.12623.x; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Biedermann T, 2000, J EXP MED, V192, P1441, DOI 10.1084/jem.192.10.1441; Bloch B, 1929, ARCH DERMATOL SYPH, V19, P175, DOI 10.1001/archderm.1929.02380200003001; Boehncke WH, 2005, EXP DERMATOL, V14, P70, DOI 10.1111/j.0906-6705.2005.290b.x; BOUR H, 1995, EUR J IMMUNOL, V25, P3006, DOI 10.1002/eji.1830251103; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Catalina MD, 1996, J EXP MED, V184, P2341, DOI 10.1084/jem.184.6.2341; Cumberbatch M, 2003, APMIS, V111, P797, DOI 10.1034/j.1600-0463.2003.11107811.x; Degli-Esposti MA, 2005, NAT REV IMMUNOL, V5, P112, DOI 10.1038/nri1549; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; GALLI SJ, 1984, SCIENCE, V226, P710, DOI 10.1126/science.6494907; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Goldman JP, 1998, BRIT J HAEMATOL, V103, P335, DOI 10.1046/j.1365-2141.1998.00980.x; Grabbe S, 2002, J CLIN INVEST, V109, P183, DOI 10.1172/JCI11703; Hanke T, 1999, IMMUNITY, V11, P67, DOI 10.1016/S1074-7613(00)80082-5; HERZOG WR, 1989, J IMMUNOL, V142, P1803; HOCHGESCHWENDER U, 1987, NATURE, V326, P307, DOI 10.1038/326307a0; Hunger RE, 1999, BRIT J DERMATOL, V141, P565; IGLESIAS A, 1992, EUR J IMMUNOL, V22, P335, DOI 10.1002/eji.1830220208; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jung D, 2004, CELL, V116, P299, DOI 10.1016/S0092-8674(04)00039-X; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kurtz J, 2005, TRENDS IMMUNOL, V26, P186, DOI 10.1016/j.it.2005.02.001; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; MACDOUGALL JR, 1990, CELL IMMUNOL, V130, P106, DOI 10.1016/0008-8749(90)90165-N; MARCHAL G, 1982, J IMMUNOL, V129, P954; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Morris MA, 2004, CURR MOL MED, V4, P431, DOI 10.2174/1566524043360609; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; PHANUPHAK P, 1974, J IMMUNOL, V112, P115; Proteau MF, 2004, GENOMICS, V84, P669, DOI 10.1016/j.ygeno.2004.05.004; Raff M C, 1970, Nature, V226, P1257, DOI 10.1038/2261257a0; Raulet DH, 2004, NAT IMMUNOL, V5, P996, DOI 10.1038/ni1114; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Rennert PD, 2001, J EXP MED, V193, P1227, DOI 10.1084/jem.193.11.1227; Robert C, 1999, NEW ENGL J MED, V341, P1817, DOI 10.1056/NEJM199912093412407; Schott E, 2003, J EXP MED, V198, P1213, DOI 10.1084/jem.20030918; Shaw SG, 1998, J IMMUNOL, V161, P2817; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SNIPPE H, 1975, IMMUNOLOGY, V28, P897; Staite ND, 1996, BLOOD, V88, P2973, DOI 10.1182/blood.V88.8.2973.bloodjournal8882973; Szczepanik M, 1996, J EXP MED, V184, P2129, DOI 10.1084/jem.184.6.2129; Vermijlen D, 2004, EUR J IMMUNOL, V34, P2529, DOI 10.1002/eji.200324712; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wang BH, 2001, J LEUKOCYTE BIOL, V70, P185; Weninger W, 2000, IMMUNITY, V12, P665, DOI 10.1016/S1074-7613(00)80217-4; YOUNG WW, 1980, J IMMUNOL, V124, P199; Zhao Y, 2003, J IMMUNOL, V170, P5398, DOI 10.4049/jimmunol.170.11.5398	56	620	651	0	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2006	7	5					507	516		10.1038/ni1332	http://dx.doi.org/10.1038/ni1332			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	035NT	16617337				2022-12-18	WOS:000237008800016
J	Watanabe, N; Gavrieli, M; Sedy, JR; Yang, JF; Fallarino, F; Loftin, SK; Hurchla, MA; Zimmerman, N; Sim, J; Zang, XX; Murphy, TL; Russell, JH; Allison, JP; Murphy, KM				Watanabe, N; Gavrieli, M; Sedy, JR; Yang, JF; Fallarino, F; Loftin, SK; Hurchla, MA; Zimmerman, N; Sim, J; Zang, XX; Murphy, TL; Russell, JH; Allison, JP; Murphy, KM			BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1	NATURE IMMUNOLOGY			English	Article							B-CELL RECEPTOR; T-CELLS; CUTTING EDGE; ANTIGEN RECEPTOR; EXPRESSION; LIGAND; ACTIVATION; MOLECULE; PATHWAYS; FAMILY	During activation, T cells express receptors for receiving positive and negative costimulatory signals. Here we identify the B and T lymphocyte attenuator (BTLA), an immunoglobulin domain-containing glycoprotein with two immunoreceptor tyrosine-based inhibitory motifs. BTLA is not expressed by naive T cells, but it is induced during activation and remains expressed on T helper type 1 (T(H)1) but not T(H)2 cells. Crosslinking BTLA with antigen receptors induces its tyrosine phosphorylation and association with the Src homology domain 2 (SH2)-containing protein tyrosine phosphatases SHP-1 and SHP-2, and attenuates production of interleukin 2 (IL-2). BTLA-deficient T cells show increased proliferation, and BTLA-deficient mice have increased specific antibody responses and enhanced sensitivity to experimental autoimmune encephalomyelitis. B7x, a peripheral homolog of B7, is a ligand of BTLA. Thus, BTLA is a third inhibitory receptor on T lymphocytes with similarities to cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and programmed death 1 (PD-1).	Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol & Immunol, St Louis, MO 63110 USA; Univ Perugia, Dept Expt Med, I-06122 Perugia, Italy; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Canc Res Lab, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; Washington University (WUSTL); University of Perugia; Washington University (WUSTL); Howard Hughes Medical Institute; University of California System; University of California Berkeley	Murphy, KM (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol & Immunol, Box 8118,660 S Euclid Ave, St Louis, MO 63110 USA.	murphy@immunology.wustl.edu	Fallarino, Francesca/O-3358-2013	Fallarino, Francesca/0000-0002-8501-2136; Russell, John/0000-0002-3680-9587; Zang, Xingxing/0000-0001-5380-1942; Sedy, John/0000-0002-6428-1054; Allison, James/0000-0001-8980-5697				Abiru N, 2002, DIABETES-METAB RES, V18, P357, DOI 10.1002/dmrr.323; Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Bachmann MF, 1999, J IMMUNOL, V163, P1128; Bachmann MF, 2001, EUR J IMMUNOL, V31, P450, DOI 10.1002/1521-4141(200102)31:2<450::AID-IMMU450>3.3.CO;2-O; Bennett F, 2003, J IMMUNOL, V170, P711, DOI 10.4049/jimmunol.170.2.711; Bolland S, 1999, ADV IMMUNOL, V72, P149, DOI 10.1016/S0065-2776(08)60019-X; Brodie D, 2000, CURR BIOL, V10, P333, DOI 10.1016/S0960-9822(00)00383-3; Brunner MC, 1999, J IMMUNOL, V162, P5813; Carter LL, 2002, EUR J IMMUNOL, V32, P634, DOI 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9; Chambers CA, 1998, EUR J IMMUNOL, V28, P3137, DOI 10.1002/(SICI)1521-4141(199810)28:10<3137::AID-IMMU3137>3.0.CO;2-X; Chapoval AI, 2001, NAT IMMUNOL, V2, P269, DOI 10.1038/85339; Coyle AJ, 2001, NAT IMMUNOL, V2, P203, DOI 10.1038/85251; Dong HD, 1999, NAT MED, V5, P1365; Finger EB, 2002, NAT IMMUNOL, V3, P1056, DOI 10.1038/ni1102-1056; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Greenwald RJ, 2001, IMMUNITY, V14, P145, DOI 10.1016/S1074-7613(01)00097-8; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; HASKINS K, 1983, J EXP MED, V157, P1149, DOI 10.1084/jem.157.4.1149; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Liang L, 2002, J EXP MED, V196, P97, DOI 10.1084/jem.20020298; Liang L, 2002, CURR OPIN IMMUNOL, V14, P384, DOI 10.1016/S0952-7915(02)00342-4; Ling V, 2000, J IMMUNOL, V164, P1653, DOI 10.4049/jimmunol.164.4.1653; Luhder F, 2000, P NATL ACAD SCI USA, V97, P12204, DOI 10.1073/pnas.200348397; Luhder F, 1998, J EXP MED, V187, P427, DOI 10.1084/jem.187.3.427; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Nishizawa M, 1998, ELECTROCHEM SOLID ST, V1, P10, DOI 10.1149/1.1390618; Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598; Oosterwegel MA, 1999, J IMMUNOL, V163, P2634; Ranganath S, 1998, J IMMUNOL, V161, P3822; Sabelko-Downes KA, 1999, J EXP MED, V189, P1195, DOI 10.1084/jem.189.8.1195; SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Shiratori T, 1997, IMMUNITY, V6, P583, DOI 10.1016/S1074-7613(00)80346-5; Shlapatska LM, 2001, J IMMUNOL, V166, P5480, DOI 10.4049/jimmunol.166.9.5480; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Sun MY, 2002, J IMMUNOL, V168, P6294, DOI 10.4049/jimmunol.168.12.6294; Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X; Tivol EA, 2002, J IMMUNOL, V169, P1852, DOI 10.4049/jimmunol.169.4.1852; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Tomasello E, 2000, SEMIN IMMUNOL, V12, P139, DOI 10.1006/smim.2000.0216; Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839; UEDA H, 2003, NATURE          0430, DOI DOI 10.1038/NATURE01621; Wang SD, 2000, BLOOD, V96, P2808; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582; Zhang Y, 1997, P NATL ACAD SCI USA, V94, P9273, DOI 10.1073/pnas.94.17.9273	51	618	706	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2003	4	7					670	679		10.1038/ni944	http://dx.doi.org/10.1038/ni944			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	697PN	12796776				2022-12-18	WOS:000183952500015
J	Zhou, BH; Comeau, MR; De Smedt, T; Liggitt, HD; Dahl, ME; Lewis, DB; Gyarmati, D; Aye, T; Campbell, DJ; Ziegler, SF				Zhou, BH; Comeau, MR; De Smedt, T; Liggitt, HD; Dahl, ME; Lewis, DB; Gyarmati, D; Aye, T; Campbell, DJ; Ziegler, SF			Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice	NATURE IMMUNOLOGY			English	Article							B-CELL DEVELOPMENT; TRANSGENIC MICE; BRONCHIAL HYPERRESPONSIVENESS; CHEMOKINE RECEPTORS; DENDRITIC CELLS; GROWTH-FACTOR; IN-VITRO; T-CELLS; ASTHMA; EXPRESSION	The cytokine thymic stromal lymphopoietin ( TSLP) has been linked to human allergic inflammatory diseases. We show here that TSLP expression was increased in the lungs of mice with antigen-induced asthma, whereas TSLP receptor - deficient mice had considerably attenuated disease. Lung-specific expression of a Tslp transgene induced airway inflammation and hyperreactivity characterized by T helper type 2 cytokines and increased immunoglobulin E. The lungs of Tslp-transgenic mice showed massive infiltration of leukocytes, goblet cell hyperplasia and subepithelial fibrosis. TSLP was capable of activating bone marrow - derived dendritic cells to upregulate costimulatory molecules and produce the T helper type 2 cell - attracting chemokine CCL17. These findings suggest that TSLP is an important factor necessary and sufficient for the initiation of allergic airway inflammation.	Benaroya Res Inst, Program Immunol, Seattle, WA 98101 USA; Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; Immune Regulat Grp, Seattle, WA 98119 USA; Univ Washington, Sch Med, Dept Comparat Med, Seattle, WA 98195 USA; Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA	Benaroya Research Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Stanford University; Stanford University	Ziegler, SF (corresponding author), Benaroya Res Inst, Program Immunol, Seattle, WA 98101 USA.	sziegler@benaroyaresearch.org			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044259] Funding Source: NIH RePORTER; NIAID NIH HHS [AI44259] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Al-Shami A, 2004, J EXP MED, V200, P159, DOI 10.1084/jem.20031975; Bochner BS, 2003, J ALLERGY CLIN IMMUN, V112, P930, DOI 10.1016/j.jaci.2003.08.012; Brawand P, 2002, J IMMUNOL, V169, P6711, DOI 10.4049/jimmunol.169.12.6711; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; Campbell JJ, 2001, J IMMUNOL, V166, P2842, DOI 10.4049/jimmunol.166.4.2842; Carpino N, 2004, MOL CELL BIOL, V24, P2584, DOI 10.1128/MCB.24.6.2584-2592.2004; Cohn L, 1999, J IMMUNOL, V162, P6178; Corry DB, 1999, NATURE, V402, pB18; COYLE AJ, 1995, AM J RESP CELL MOL, V13, P54, DOI 10.1165/ajrcmb.13.1.7598937; Elias JA, 1999, J CLIN INVEST, V104, P1001, DOI 10.1172/JCI8124; FRIEND SL, 1994, EXP HEMATOL, V22, P321; Hogan SP, 1996, MED RES REV, V16, P407; Jeffery PK, 2001, AM J RESP CRIT CARE, V164, pS28, DOI 10.1164/ajrccm.164.supplement_2.2106061; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Kim CH, 2001, J CLIN INVEST, V108, P1331, DOI 10.1172/JCI200113543; Lambrecht BN, 2003, NAT REV IMMUNOL, V3, P994, DOI 10.1038/nri1249; Lee JJ, 1997, J EXP MED, V185, P2143, DOI 10.1084/jem.185.12.2143; Osborn MJ, 2004, BLOOD, V103, P843, DOI 10.1182/blood-2003-05-1557; Panina-Bordignon P, 2001, J CLIN INVEST, V107, P1357, DOI 10.1172/JCI12655; Quentmeier H, 2001, LEUKEMIA, V15, P1286, DOI 10.1038/sj.leu.2402175; Rankin JA, 1996, P NATL ACAD SCI USA, V93, P7821, DOI 10.1073/pnas.93.15.7821; Ray RJ, 1996, EUR J IMMUNOL, V26, P10, DOI 10.1002/eji.1830260103; Riffo-Vasquez Y, 2002, PHARMACOL THERAPEUT, V94, P185, DOI 10.1016/S0163-7258(02)00217-6; Sims JE, 2000, J EXP MED, V192, P671, DOI 10.1084/jem.192.5.671; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Sugawara N, 2002, ALLERGY, V57, P180, DOI 10.1034/j.1398-9995.2002.1n3503.x; Taneda S, 2001, AM J PATHOL, V159, P2355, DOI 10.1016/S0002-9440(10)63085-4; Temann UA, 2002, J CLIN INVEST, V109, P29, DOI 10.1172/JCI13696; Temann UA, 1998, J EXP MED, V188, P1307, DOI 10.1084/jem.188.7.1307; Townsend MJ, 2000, IMMUNITY, V13, P573, DOI 10.1016/S1074-7613(00)00056-X; Tsitoura DC, 2000, J IMMUNOL, V165, P3484, DOI 10.4049/jimmunol.165.6.3484; Umetsu DT, 2002, NAT IMMUNOL, V3, P715, DOI 10.1038/ni0802-715; WALKER C, 1992, AM REV RESPIR DIS, V146, P109, DOI 10.1164/ajrccm/146.1.109; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	34	616	676	1	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2005	6	10					1047	1053		10.1038/ni1247	http://dx.doi.org/10.1038/ni1247			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	966NR	16142237				2022-12-18	WOS:000232027200024
J	Okazaki, T; Chikuma, S; Iwai, Y; Fagarasan, S; Honjo, T				Okazaki, Taku; Chikuma, Shunsuke; Iwai, Yoshiko; Fagarasan, Sidonia; Honjo, Tasuku			A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application	NATURE IMMUNOLOGY			English	Review							T-CELLS; REGULATORY T; DILATED CARDIOMYOPATHY; PROGRAMMED DEATH-1; TUMOR-IMMUNOTHERAPY; NEGATIVE REGULATOR; CRYSTAL-STRUCTURE; EFFECTOR PHASE; CUTTING EDGE; TGF-BETA	PD-1, a negative coreceptor expressed on antigen-stimulated T cells and B cells, seems to serve as a 'rheostat' of the immune response. The molecular mechanisms of the functions of PD-1, in conjunction with the mild, chronic and strain-specific autoimmune phenotypes of PD-1-deficient mice, in contrast to the devastating fatal autoimmune disease of mice deficient in the immunomodulatory receptor CTLA-4, suggest that immunoregulation by PD-1 is rather antigen specific and is mainly cell intrinsic. Such unique properties make PD-1 a powerful target for immunological therapy, with highly effective clinical applications for cancer treatment.	[Okazaki, Taku] Univ Tokushima, Inst Genome Res, Div Immune Regulat, Tokushima 770, Japan; [Chikuma, Shunsuke; Honjo, Tasuku] Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Kyoto, Japan; [Iwai, Yoshiko] Univ Occupat & Environm Hlth, Sch Med, Dept Mol Biol, Kitakyushu, Fukuoka 807, Japan; [Fagarasan, Sidonia] RIKEN Yokohama Inst, Ctr Integrat Med Sci IMS RCAI, Lab Mucosal Immun, Yokohama, Kanagawa, Japan	Tokushima University; Kyoto University; University of Occupational & Environmental Health - Japan; RIKEN	Honjo, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Kyoto, Japan.	honjo@mfour.med.kyoto-u.ac.jp	Fagarasan, Sidonia/A-5258-2016; Honjo, Tasuku/N-4470-2016; Chikuma, Shunsuke/Y-1016-2019	Fagarasan, Sidonia/0000-0003-2086-6402; Okazaki, Taku/0000-0003-4790-1925	Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency; Japanese Ministry of Education, Culture, Sports, Science and Technology [23790534, 25460363]; Senri Life Science Foundation; RIKEN; Grants-in-Aid for Scientific Research [25460363, 24659151] Funding Source: KAKEN	Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Senri Life Science Foundation; RIKEN; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank N. Minato and colleagues at Kyoto University for scientific expertise. Supported by Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency (T.O.), Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (23790534 and 25460363 to S. C.), the Senri Life Science Foundation (S. C.) and Grants-in-Aid for Scientific Research in Priority Areas and RIKEN's President Discretionary Fund (S.F.).	Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Bachmann MF, 1999, J IMMUNOL, V163, P1128; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Blank C, 2004, CANCER RES, V64, P1140, DOI 10.1158/0008-5472.CAN-03-3259; Bour-Jordan H, 2011, IMMUNOL REV, V241, P180, DOI 10.1111/j.1600-065X.2011.01011.x; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Chikuma S, 2009, J IMMUNOL, V182, P6682, DOI 10.4049/jimmunol.0900080; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Fagarasan S, 2000, SCIENCE, V290, P89, DOI 10.1126/science.290.5489.89; Felix SB, 2006, INT J CARDIOL, V112, P30, DOI 10.1016/j.ijcard.2006.05.014; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Haas KM, 2011, J IMMUNOL, V187, P5183, DOI 10.4049/jimmunol.1101990; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hirano F, 2005, CANCER RES, V65, P1089; Huard B, 1997, P NATL ACAD SCI USA, V94, P5744, DOI 10.1073/pnas.94.11.5744; Huber S, 2006, FRONT BIOSCI-LANDMRK, V11, P1014, DOI 10.2741/1859; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Iwai Y, 2005, INT IMMUNOL, V17, P133, DOI 10.1093/intimm/dxh194; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Iwai YH, 2003, J EXP MED, V198, P39, DOI 10.1084/jem.20022235; James ES, 2005, GENES IMMUN, V6, P430, DOI 10.1038/sj.gene.6364223; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Kawamoto S, 2012, SCIENCE, V336, P485, DOI 10.1126/science.1217718; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; Kuchen S, 2007, J IMMUNOL, V179, P5886, DOI 10.4049/jimmunol.179.9.5886; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Lazar-Molnar E, 2008, P NATL ACAD SCI USA, V105, P10483, DOI 10.1073/pnas.0804453105; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Liang SC, 2003, EUR J IMMUNOL, V33, P2706, DOI 10.1002/eji.200324228; Lin DYW, 2008, P NATL ACAD SCI USA, V105, P3011, DOI 10.1073/pnas.0712278105; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Martin F, 2001, CURR OPIN IMMUNOL, V13, P195, DOI 10.1016/S0952-7915(00)00204-1; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Moll M, 2009, EUR J IMMUNOL, V39, P902, DOI 10.1002/eji.200838780; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nielsen C, 2003, TISSUE ANTIGENS, V62, P492, DOI 10.1046/j.1399-0039.2003.00136.x; Nishimura H, 1998, INT IMMUNOL, V10, P1563, DOI 10.1093/intimm/10.10.1563; Nishimura H, 1996, INT IMMUNOL, V8, P773, DOI 10.1093/intimm/8.5.773; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Nurieva RI, 2012, J BIOL CHEM, V287, P11234, DOI 10.1074/jbc.M111.324046; Oestreich KJ, 2008, J IMMUNOL, V181, P4832, DOI 10.4049/jimmunol.181.7.4832; Okazaki T, 2005, J EXP MED, V202, P1643, DOI 10.1084/jem.20051984; Okazaki T, 2003, NAT MED, V9, P1477, DOI 10.1038/nm955; Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598; Okazaki T, 2007, INT IMMUNOL, V19, P813, DOI 10.1093/intimm/dxm057; Okazaki T, 2011, J EXP MED, V208, P395, DOI 10.1084/jem.20100466; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Ribas A, 2012, NEW ENGL J MED, V366, P2517, DOI 10.1056/NEJMe1205943; Rui YX, 2013, P NATL ACAD SCI USA, V110, P16073, DOI 10.1073/pnas.1315828110; Sage PT, 2013, NAT IMMUNOL, V14, P152, DOI 10.1038/ni.2496; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Schwartz JCD, 2001, NATURE, V410, P604, DOI 10.1038/35069112; Sheppard KA, 2004, FEBS LETT, V574, P37, DOI 10.1016/j.febslet.2004.07.083; Shimatani K, 2009, P NATL ACAD SCI USA, V106, P15807, DOI 10.1073/pnas.0908805106; Shiratori T, 1997, IMMUNITY, V6, P583, DOI 10.1016/S1074-7613(00)80346-5; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Smyk-Pearson SK, 2003, CLIN EXP IMMUNOL, V133, P193, DOI 10.1046/j.1365-2249.2003.02217.x; Song MY, 2011, J IMMUNOTHER, V34, P297, DOI 10.1097/CJI.0b013e318210ed0e; Sotomayor EM, 1996, CRIT REV ONCOGENESIS, V7, P433, DOI 10.1615/CritRevOncog.v7.i5-6.30; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; Strome SE, 2003, CANCER RES, V63, P6501; Terawaki S, 2011, J IMMUNOL, V186, P2772, DOI 10.4049/jimmunol.1003208; Thompson RH, 2004, P NATL ACAD SCI USA, V101, P17174, DOI 10.1073/pnas.0406351101; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Utzschneider DT, 2013, NAT IMMUNOL, V14, P603, DOI 10.1038/ni.2606; Walker LSK, 2013, J AUTOIMMUN, V45, P49, DOI 10.1016/j.jaut.2013.06.006; Wang J, 2005, P NATL ACAD SCI USA, V102, P11823, DOI 10.1073/pnas.0505497102; Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Workman CJ, 2002, J IMMUNOL, V169, P5392, DOI 10.4049/jimmunol.169.10.5392; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741; Yoshida T, 2008, P NATL ACAD SCI USA, V105, P3533, DOI 10.1073/pnas.0710951105; Youngblood B, 2011, IMMUNITY, V35, P400, DOI 10.1016/j.immuni.2011.06.015; Zhang XW, 2004, IMMUNITY, V20, P337, DOI 10.1016/S1074-7613(04)00051-2; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	90	615	668	2	140	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2013	14	12					1212	1218		10.1038/ni.2762	http://dx.doi.org/10.1038/ni.2762			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	254FG	24240160	Green Published			2022-12-18	WOS:000327149400006
J	Pulendran, B; Ahmed, R				Pulendran, Bali; Ahmed, Rafi			Immunological mechanisms of vaccination	NATURE IMMUNOLOGY			English	Review							DENDRITIC CELL SUBSETS; YELLOW-FEVER VACCINE; CD8 T-CELLS; CXC CHEMOKINE RECEPTOR-5; ANTIGEN-SPECIFIC MEMORY; VARICELLA-ZOSTER-VIRUS; INNATE IMMUNE-SYSTEM; NATURAL-KILLER-CELLS; TOLL-LIKE RECEPTORS; IN-VIVO	Vaccines represent one of the greatest triumphs of modern medicine. Despite the common origins of vaccinology and immunology more than 200 years ago, the two disciplines have evolved along such different trajectories that most of the highly successful vaccines have been made empirically, with little or no immunological insight. Recent advances in innate immunity have offered new insights about the mechanisms of vaccine-induced immunity and have facilitated a more rational approach to vaccine design. Here we will discuss these advances and emerging themes on the immunology of vaccination.	[Pulendran, Bali; Ahmed, Rafi] Emory Univ, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Pulendran, Bali] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA; [Ahmed, Rafi] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Pulendran, B (corresponding author), Emory Univ, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.	bpulend@emory.edu	Pulendran, Bali/AAW-9550-2021	Pulendran, Bali/0000-0001-6517-4333	US National Institutes of Health; Bill & Melinda Gates Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090023, R01AI030048, R37AI048638, R56AI048638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057665] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Plotkin for discussions; F. Sallusto for sharing the table on which Figure 1 is based; and M. Kwissa and H. Nakaya for helping with the formatting and art work for the figures. Supported by the US National Institutes of Health and the Bill & Melinda Gates Foundation.	Abboud N, 2010, J EXP MED, V207, P2395, DOI 10.1084/jem.20100995; Ahmed R, 2011, IMMUNOL CELL BIOL, V89, P340, DOI 10.1038/icb.2010.155; ANDREONI J, 1993, J INFECT DIS, V168, P227, DOI 10.1093/infdis/168.1.227; [Anonymous], 2013, VACCINES-BASEL; Arvin AM, 2008, J INFECT DIS, V197, pS58, DOI 10.1086/522123; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; BANG BG, 1972, AM J PATHOL, V68, P147; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Bunde T, 2005, J EXP MED, V201, P1031, DOI 10.1084/jem.20042384; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Celli S, 2007, IMMUNITY, V27, P625, DOI 10.1016/j.immuni.2007.08.018; Chen K, 2010, IMMUNITY, V33, P479, DOI 10.1016/j.immuni.2010.09.013; Chen WH, 2009, TRENDS IMMUNOL, V30, P351, DOI 10.1016/j.it.2009.05.002; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Cooper MA, 2009, P NATL ACAD SCI USA, V106, P1915, DOI 10.1073/pnas.0813192106; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; Deenick EK, 2011, CURR OPIN IMMUNOL, V23, P111, DOI 10.1016/j.coi.2010.10.007; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; DOWDLE WR, 1973, POSTGRAD MED J, V49, P159, DOI 10.1136/pgmj.49.569.159; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Duthie MS, 2011, IMMUNOL REV, V239, P178, DOI 10.1111/j.1600-065X.2010.00978.x; Einstein MH, 2009, HUM VACCINES, V5, P705, DOI 10.4161/hv.5.10.9518; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Delgado MF, 2009, NAT MED, V15, P34, DOI 10.1038/nm.1894; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Ganguly S, 2011, MUCOSAL IMMUNOL, V4, P528, DOI 10.1038/mi.2011.1; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Geeraedts F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000138; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Germain RN, 2010, IMMUNITY, V33, P441, DOI 10.1016/j.immuni.2010.09.014; Giannini SL, 2006, VACCINE, V24, P5937, DOI 10.1016/j.vaccine.2006.06.005; Gomez MR, 2010, J IMMUNOL, V185, P7180, DOI 10.4049/jimmunol.1002319; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Harper DM, 2009, EXPERT REV VACCINES, V8, P1663, DOI [10.1586/erv.09.123, 10.1586/ERV.09.123]; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Hoft DF, 2008, LANCET, V372, P164, DOI 10.1016/S0140-6736(08)61036-3; IPSEN J, 1946, J IMMUNOL, V54, P325; Iwasaki A, 2001, J IMMUNOL, V166, P4884, DOI 10.4049/jimmunol.166.8.4884; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Iwata M, 2009, SEMIN IMMUNOL, V21, P8, DOI 10.1016/j.smim.2008.09.002; Jack AD, 1999, J INFECT DIS, V179, P489, DOI 10.1086/314578; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Jiang BM, 2008, VACCINE, V26, P6754, DOI 10.1016/j.vaccine.2008.10.008; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Jordan MB, 2004, SCIENCE, V304, P1808, DOI 10.1126/science.1089926; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Koyama S, 2007, J IMMUNOL, V179, P4711, DOI 10.4049/jimmunol.179.7.4711; Koyama S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000759; Lang J, 1999, AM J TROP MED HYG, V60, P1045, DOI 10.4269/ajtmh.1999.60.1045; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Levin MJ, 2008, J INFECT DIS, V197, P825, DOI 10.1086/528696; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Lindsay RWB, 2010, J IMMUNOL, V185, P1513, DOI 10.4049/jimmunol.1000338; LOONEY JM, 1956, NEW ENGL J MED, V254, P6, DOI 10.1056/NEJM195601052540102; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Mbow ML, 2010, CURR OPIN IMMUNOL, V22, P411, DOI 10.1016/j.coi.2010.04.004; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Menges M, 2002, J EXP MED, V195, P15, DOI 10.1084/jem.20011341; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Moore SE, 2003, ACTA PAEDIATR, V92, P170, DOI 10.1111/j.1651-2227.2003.tb00522.x; Mosca F, 2008, P NATL ACAD SCI USA, V105, P10501, DOI 10.1073/pnas.0804699105; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; MOSTOW SR, 1973, POSTGRAD MED J, V49, P152, DOI 10.1136/pgmj.49.569.152; Nagai T, 2003, J IMMUNOL, V171, P5233, DOI 10.4049/jimmunol.171.10.5233; Nagarajan T, 2008, CURR TOP MICROBIOL, V317, P67; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Phan TG, 2009, CURR OPIN IMMUNOL, V21, P258, DOI 10.1016/j.coi.2009.05.006; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006; Pulendran B, 2010, NAT IMMUNOL, V11, P647, DOI 10.1038/ni.1894; Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Reyes-Sandoval A, 2009, CURR OPIN MOL THER, V11, P72; Rhee EG, 2011, J VIROL, V85, P315, DOI 10.1128/JVI.01597-10; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; Romero-Steiner S, 2006, CLIN VACCINE IMMUNOL, V13, P165, DOI 10.1128/CVI.13.2.165-169.2006; Romero-Steiner S, 1999, CLIN INFECT DIS, V29, P281, DOI 10.1086/520200; Saenz SA, 2010, TRENDS IMMUNOL, V31, P407, DOI 10.1016/j.it.2010.09.001; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Sester M, 2001, TRANSPLANTATION, V71, P1287, DOI 10.1097/00007890-200105150-00018; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Soares H, 2007, J EXP MED, V204, P1095, DOI 10.1084/jem.20070176; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Steinman RM, 2008, IMMUNITY, V29, P319, DOI 10.1016/j.immuni.2008.08.001; Stephensen CB, 2001, ANNU REV NUTR, V21, P167, DOI 10.1146/annurev.nutr.21.1.167; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Tan LKK, 2010, NEW ENGL J MED, V362, P1511, DOI 10.1056/NEJMra0906357; Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883; Ting JPY, 2010, SCIENCE, V327, P286, DOI 10.1126/science.1184004; Tsuji S, 2000, INFECT IMMUN, V68, P6883, DOI 10.1128/IAI.68.12.6883-6890.2000; Ubol S, 2010, CLIN VACCINE IMMUNOL, V17, P1829, DOI 10.1128/CVI.00316-10; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Ueno H, 2010, IMMUNOL REV, V234, P199, DOI 10.1111/j.0105-2896.2009.00884.x; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; WHEELOCK EF, 1965, NEW ENGL J MED, V273, P194, DOI 10.1056/NEJM196507222730404; Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	136	614	636	1	192	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2011	12	6					509	517		10.1038/ni.2039	http://dx.doi.org/10.1038/ni.2039			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	765LI	21739679	Green Accepted			2022-12-18	WOS:000290707100009
J	Spits, H; Di Santo, JP				Spits, Hergen; Di Santo, James P.			The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling	NATURE IMMUNOLOGY			English	Review							NATURAL-KILLER-CELL; ROR-GAMMA-T; INDUCER CELLS; NK CELLS; TRANS-PRESENTATION; INTERFERON-GAMMA; INTERLEUKIN 22; DIFFERENTIATION; CYTOKINE; EXPRESSION	Research has identified what can be considered a family of innate lymphoid cells (ILCs) that includes not only natural killer (NK) cells and lymphoid tissue-inducer (LTi) cells but also cells that produce interleukin 5 (IL-5), IL-13, IL-17 and/or IL-22. These ILC subsets are developmentally related, requiring expression of the transcriptional repressor Id2 and cytokine signals through the common gamma-chain of the IL-2 receptor. The functional differentiation of ILC subsets is orchestrated by distinct transcription factors. Analogous to helper T cell subsets, these evolutionarily conserved yet distinct ILCs seem to have important roles in protective immunity, and their dysregulation can promote immune pathology.	[Spits, Hergen] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 AZ Amsterdam, Netherlands; [Di Santo, James P.] Inst Pasteur, Innate Immun Unit, Paris, France; [Di Santo, James P.] Inst Natl Sante & Rech Med, U668, Paris, France	University of Amsterdam; Academic Medical Center Amsterdam; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Spits, H (corresponding author), Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	hergen.spits@amc.uva.nl	Di Santo, James P/M-4298-2014; Spits, Hergen/N-2581-2019	Di Santo, James P/0000-0002-7146-1862; Spits, Hergen/0000-0003-3269-8338	Institut Pasteur; Institut National de la Sante et de la Recherche Medicale; Agence National de Recherches	Institut Pasteur(European Commission); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence National de Recherches	We thank T. Cupedo, N. Crellin, S. Trifari and C. Kaplan for contributions and collaborations; and G. Eberl, N. Satoh-Takayama and C. Vosshenrich for collaborations. Supported by the Institut Pasteur (J.P.D.), Institut National de la Sante et de la Recherche Medicale (J.P.D.) and the Agence National de Recherches (J.P.D.).	Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Aliahmad P, 2010, NAT IMMUNOL, V11, P945, DOI 10.1038/ni.1930; Arase H, 2002, MICROBES INFECT, V4, P1505, DOI 10.1016/S1286-4579(02)00033-3; Ashkar AA, 2000, J EXP MED, V192, P259, DOI 10.1084/jem.192.2.259; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Blaho VA, 2009, J IMMUNOL, V183, P5644, DOI 10.4049/jimmunol.0901499; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Burkett PR, 2004, J EXP MED, V200, P825, DOI 10.1084/jem.20041389; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Crellin NK, 2010, IMMUNITY, V33, P752, DOI 10.1016/j.immuni.2010.10.012; Crellin NK, 2010, J EXP MED, V207, P281, DOI 10.1084/jem.20091509; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Di Santo JP, 2008, NAT IMMUNOL, V9, P473, DOI 10.1038/ni.f.201; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Eisenring M, 2010, NAT IMMUNOL, V11, P1030, DOI 10.1038/ni.1947; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Fauriat C, 2010, BLOOD, V115, P2167, DOI 10.1182/blood-2009-08-238469; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Freud AG, 2006, J EXP MED, V203, P1033, DOI 10.1084/jem.20052507; Freud AG, 2005, IMMUNITY, V22, P295, DOI 10.1016/j.immuni.2005.01.013; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Gur C, 2010, NAT IMMUNOL, V11, P121, DOI 10.1038/ni.1834; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; Hayakawa Y, 2006, IMMUNOL REV, V214, P47, DOI 10.1111/j.1600-065X.2006.00454.x; Heemskerk MHM, 1997, J EXP MED, V186, P1597, DOI 10.1084/jem.186.9.1597; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Hughes T, 2010, IMMUNITY, V32, P803, DOI 10.1016/j.immuni.2010.06.007; Hughes T, 2009, BLOOD, V113, P4008, DOI 10.1182/blood-2008-12-192443; Huntington ND, 2007, NAT REV IMMUNOL, V7, P703, DOI 10.1038/nri2154; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kamizono S, 2009, J EXP MED, V206, P2977, DOI 10.1084/jem.20092176; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; Khalturin K, 2004, MOL IMMUNOL, V41, P1077, DOI 10.1016/j.molimm.2004.06.010; Koka R, 2003, J EXP MED, V197, P977, DOI 10.1084/jem.20021836; Lane P, 2008, SEMIN IMMUNOL, V20, P159, DOI 10.1016/j.smim.2008.02.002; Lane PJL, 2005, NAT REV IMMUNOL, V5, P655, DOI 10.1038/nri1665; LANIER LL, 1986, J IMMUNOL, V136, P4480; Loza MJ, 2002, BLOOD, V99, P1273, DOI 10.1182/blood.V99.4.1273; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Mortier E, 2008, J EXP MED, V205, P1213, DOI 10.1084/jem.20071913; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nishikawa SI, 2003, IMMUNOL REV, V195, P72, DOI 10.1034/j.1600-065X.2003.00063.x; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Owyang AM, 2006, J EXP MED, V203, P843, DOI 10.1084/jem.20051496; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Puel A, 1998, NAT GENET, V20, P394, DOI 10.1038/3877; Ribeiro VSG, 2010, J IMMUNOL, V185, P4993, DOI 10.4049/jimmunol.1002273; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Satoh-Takayama N, 2010, J EXP MED, V207, P273, DOI 10.1084/jem.20092029; Satoh-Takayama N, 2009, J IMMUNOL, V183, P6579, DOI 10.4049/jimmunol.0901935; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Schmutz S, 2009, J IMMUNOL, V183, P2217, DOI 10.4049/jimmunol.0802911; Spits H, 2000, J EXP MED, V192, P1775, DOI 10.1084/jem.192.12.1775; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; Wilkinson B, 2002, NAT IMMUNOL, V3, P272, DOI 10.1038/ni767; Wincent E, 2009, J BIOL CHEM, V284, P2690, DOI 10.1074/jbc.M808321200; Wolk K, 2010, SEMIN IMMUNOPATHOL, V32, P17, DOI 10.1007/s00281-009-0188-x; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yoshida H, 2002, IMMUNITY, V17, P823, DOI 10.1016/S1074-7613(02)00479-X; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	84	614	634	1	124	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2011	12	1					21	27		10.1038/ni.1962	http://dx.doi.org/10.1038/ni.1962			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	696TU	21113163				2022-12-18	WOS:000285465100009
J	Awasthi, A; Carrier, Y; Peron, JPS; Bettelli, E; Kamanaka, M; Flavell, RA; Kuchroo, VK; Oukka, M; Weiner, HL				Awasthi, Amit; Carrier, Yijun; Peron, Jean P. S.; Bettelli, Estelle; Kamanaka, Masahito; Flavell, Richard A.; Kuchroo, Vijay K.; Oukka, Mohamed; Weiner, Howard L.			A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells	NATURE IMMUNOLOGY			English	Article							PLASMACYTOID DENDRITIC CELLS; AUTOIMMUNE ENCEPHALOMYELITIS; TRANSCRIPTION FACTOR; TRANSGENIC MICE; CUTTING EDGE; HELPER-CELLS; IFN-GAMMA; IL-10; TOLERANCE; EXPRESSION	Regulatory T cells (T-reg cells) expressing the transcription factor Foxp3 are key in maintaining the balance of immune homeostasis. However, distinct induced T regulatory type 1 ( Tr1) cells that lack Foxp3 expression also regulate T cell function, mainly by producing the immunosuppressive cytokine interleukin 10 (IL-10). However, the factors required for the induction of IL-10-producing suppressive T cells are not fully understood. Here we demonstrate that dendritic cells modified by Treg cells induced the generation of IL-10-producing Tr1 cells. The differentiation of naive CD4(+) T cells into IL-10-producing cells was mediated by IL-27 produced by the T-reg cell-modified dendritic cells, and transforming growth factor-beta amplified the generation of induced IL-10(+) Tr1 cells by IL-27. Thus, IL-27 and transforming growth factor-beta promote the generation of IL-10-producing Tr1 cells.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Cambridge, MA 02139 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, BR-05508900 Sao Paulo, Brazil; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Universidade de Sao Paulo; Yale University	Oukka, M (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Cambridge, MA 02139 USA.	moukka@rics.bwh.harvard.edu; hweiner@rics.bwh.harvard.edu	Peron, Jean Pierre S/F-9248-2012		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043458, R01AI073542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045937, R01NS059996, R01NS035685, R01NS046414, R37NS030843, P01NS038037] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI073542-01, R01 AI073542, AI043458, R01AI073542-01] Funding Source: Medline; NINDS NIH HHS [2R01NS35685-06, R01 NS059996, 1P01NS38037-04, 1R01NS045937-01, NS038037, 2R37NS30843-11, 1R01NS046414] Funding Source: Medline; PHS HHS [1R01A144880-03, 2P01A139671-07] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Battaglia M, 2006, SEMIN IMMUNOL, V18, P120, DOI 10.1016/j.smim.2006.01.007; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; BEISSERT S, 1995, J IMMUNOL, V154, P1280; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Carrier Y, 2007, J IMMUNOL, V178, P179, DOI 10.4049/jimmunol.178.1.179; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Gilliet M, 2002, J EXP MED, V195, P695, DOI 10.1084/jem.20011603; Gorelik L, 2000, J IMMUNOL, V165, P4773, DOI 10.4049/jimmunol.165.9.4773; Greve B, 2004, J IMMUNOL, V173, P157, DOI 10.4049/jimmunol.173.1.157; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Kaplan MH, 1998, J LEUKOCYTE BIOL, V64, P2, DOI 10.1002/jlb.64.1.2; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lohr J, 2005, IMMUNOL REV, V204, P116, DOI 10.1111/j.0105-2896.2005.00241.x; Lucas S, 2003, P NATL ACAD SCI USA, V100, P15047, DOI 10.1073/pnas.2536517100; MALEFYT RD, 1991, J EXP MED, V174, P915; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Mathur RK, 2004, NAT MED, V10, P540, DOI 10.1038/nm1045; Molle C, 2007, J IMMUNOL, V178, P7607, DOI 10.4049/jimmunol.178.12.7607; Neufert C, 2007, EUR J IMMUNOL, V37, P1809, DOI 10.1002/eji.200636896; NICHOLSON LB, 1995, IMMUNITY, V3, P397, DOI 10.1016/1074-7613(95)90169-8; O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097; Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Rakoff-Nahoum S, 2006, IMMUNITY, V25, P319, DOI 10.1016/j.immuni.2006.06.010; Re F, 2004, J IMMUNOL, V173, P7548, DOI 10.4049/jimmunol.173.12.7548; Reiner SL, 2007, CELL, V129, P33, DOI 10.1016/j.cell.2007.03.019; Shoemaker J, 2006, J IMMUNOL, V176, P3470, DOI 10.4049/jimmunol.176.6.3470; Staples KJ, 2007, J IMMUNOL, V178, P4779, DOI 10.4049/jimmunol.178.8.4779; Steinbrink K, 1997, J IMMUNOL, V159, P4772; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Sullivan BM, 2005, J IMMUNOL, V175, P4593, DOI 10.4049/jimmunol.175.7.4593; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Vieira PL, 2004, J IMMUNOL, V172, P5986, DOI 10.4049/jimmunol.172.10.5986; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Wakkach A, 2003, IMMUNITY, V18, P605, DOI 10.1016/S1074-7613(03)00113-4; Weiner HL, 1997, IMMUNOL TODAY, V18, P335, DOI 10.1016/S0167-5699(97)01053-0; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Ziegler-Heitbrock L, 2003, J IMMUNOL, V171, P285, DOI 10.4049/jimmunol.171.1.285	50	612	649	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2007	8	12					1380	1389		10.1038/ni1541	http://dx.doi.org/10.1038/ni1541			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	235XG	17994022				2022-12-18	WOS:000251267000019
J	Jenne, CN; Kubes, P				Jenne, Craig N.; Kubes, Paul			Immune surveillance by the liver	NATURE IMMUNOLOGY			English	Review							SINUSOIDAL-ENDOTHELIAL-CELLS; HEPATIC STELLATE CELLS; KILLER DENDRITIC CELLS; CD8(+) T-CELLS; ANTIGEN-PRESENTING CELLS; PRODUCE IFN-GAMMA; KUPFFER CELLS; RAT-LIVER; MANNOSE RECEPTOR; INFLAMED LIVER	Receiving both portal vein blood and arterial blood, the liver is an important and critical component in the defense against blood-borne infection. To accomplish this role, the liver contains numerous innate and adaptive immune cells that specialize in detection and capture of pathogens from the blood. Further, these immune cells participate in coordinated immune responses leading to pathogen clearance, leukocyte recruitment and antigen presentation to lymphocytes within the vasculature. Finally, this role in host defense must be tightly regulated to ensure that inappropriate immune responses are not raised against nonpathogenic exogenous blood-borne molecules, such as those derived from food. It is this balance between activation and tolerance that characterizes the liver as a frontline immunological organ.	[Jenne, Craig N.; Kubes, Paul] Univ Calgary, Calvin Phoebe & Joan Snyder Inst Chron Dis, Calgary, AB, Canada; [Jenne, Craig N.] Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada; [Kubes, Paul] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary	Kubes, P (corresponding author), Univ Calgary, Calvin Phoebe & Joan Snyder Inst Chron Dis, Calgary, AB, Canada.	pkubes@ucalgary.ca	Jenne, Craig/HCH-3413-2022					Abo T, 2000, IMMUNOL REV, V174, P135, DOI 10.1034/j.1600-0528.2002.017415.x; Aspinall AI, 2010, HEPATOLOGY, V51, P2030, DOI 10.1002/hep.23591; Balam S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051875; Bamboat ZM, 2009, J IMMUNOL, V182, P1901, DOI 10.4049/jimmunol.0803404; Berg M, 2006, EUR J IMMUNOL, V36, P2960, DOI 10.1002/eji.200636033; Berg Rodney D., 1995, Trends in Microbiology, V3, P149, DOI 10.1016/S0966-842X(00)88906-4; Bertolino P, 2002, IMMUNOL CELL BIOL, V80, P84, DOI 10.1046/j.0818-9641.2001.01048.x; Bertolino P, 2001, J IMMUNOL, V166, P5430, DOI 10.4049/jimmunol.166.9.5430; Bhatia A, 1998, IMMUNOLOGY, V94, P56; Bilzer M, 2006, LIVER INT, V26, P1175, DOI 10.1111/j.1478-3231.2006.01342.x; Bode JG, 2012, EUR J CELL BIOL, V91, P496, DOI 10.1016/j.ejcb.2011.09.008; Bomble M, 2010, BIOCHEM BIOPH RES CO, V396, P342, DOI 10.1016/j.bbrc.2010.04.094; Bonder CS, 2005, IMMUNITY, V23, P153, DOI 10.1016/j.immuni.2005.06.007; BOUWENS L, 1986, HEPATOLOGY, V6, P718, DOI 10.1002/hep.1840060430; Brennan PJ, 2013, NAT REV IMMUNOL, V13, P101, DOI 10.1038/nri3369; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Campos RA, 2003, J EXP MED, V198, P1785, DOI 10.1084/jem.20021562; Campos RA, 2006, J IMMUNOL, V177, P3686, DOI 10.4049/jimmunol.177.6.3686; Chang J, 2013, HEPATOL RES, V43, P658, DOI 10.1111/j.1872-034X.2012.01111.x; Chaudhry UI, 2006, CANCER RES, V66, P10497, DOI 10.1158/0008-5472.CAN-06-1908; Chen L, 2007, J LEUKOCYTE BIOL, V81, P1422, DOI 10.1189/jlb.1106674; Chen M, 2005, J IMMUNOL, V175, P1047, DOI 10.4049/jimmunol.175.2.1047; Crispe IN, 2011, J HEPATOL, V54, P357, DOI 10.1016/j.jhep.2010.10.005; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; Diehl L, 2008, HEPATOLOGY, V47, P296, DOI 10.1002/hep.21965; Doherty DG, 2000, IMMUNOL REV, V174, P5, DOI 10.1034/j.1600-0528.2002.017416.x; Dreux M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000310; Ebe Y, 1999, PATHOL INT, V49, P519, DOI 10.1046/j.1440-1827.1999.00910.x; Eksioglu EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021186; Eyre NS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001130; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; FRANCO A, 1988, HEPATOLOGY, V8, P449, DOI 10.1002/hep.1840080302; GALE RP, 1978, SCIENCE, V201, P937, DOI 10.1126/science.356266; Ganesan LP, 2012, J IMMUNOL, V189, P4981, DOI 10.4049/jimmunol.1202017; Gao B, 2008, HEPATOLOGY, V47, P729, DOI 10.1002/hep.22034; Gao XL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009281; Geerts A, 2001, SEMIN LIVER DIS, V21, P311, DOI 10.1055/s-2001-17550; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Goddard S, 2004, AM J PATHOL, V164, P511, DOI 10.1016/S0002-9440(10)63141-0; Gorgani NN, 2008, J IMMUNOL, V181, P7902, DOI 10.4049/jimmunol.181.11.7902; Gregory SH, 1996, J IMMUNOL, V157, P2514; Grozovsky R, 2010, CURR OPIN HEMATOL, V17, P585, DOI 10.1097/MOH.0b013e32833e7561; He JQ, 2013, J LEUKOCYTE BIOL, V93, P301, DOI 10.1189/jlb.0612311; Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039; Huang LR, 2013, NAT IMMUNOL, V14, P574, DOI 10.1038/ni.2573; Ichikawa S, 2011, J IMMUNOL, V186, P5549, DOI 10.4049/jimmunol.1003917; IIAI T, 1992, IMMUNOLOGY, V77, P556; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; Jenne CN, 2013, INT J LAB HEMATOL, V35, P254, DOI 10.1111/ijlh.12084; Jenne CN, 2013, CELL HOST MICROBE, V13, P169, DOI 10.1016/j.chom.2013.01.005; Jenne CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025109; KEMPKA G, 1988, EXP CELL RES, V176, P38, DOI 10.1016/0014-4827(88)90118-8; Kerrigan AM, 2009, IMMUNOBIOLOGY, V214, P562, DOI 10.1016/j.imbio.2008.11.003; Kingham TP, 2007, HEPATOLOGY, V45, P445, DOI 10.1002/hep.21457; KNOLLE P, 1995, J HEPATOL, V22, P226, DOI 10.1016/0168-8278(95)80433-1; Knolle PA, 1998, CLIN EXP IMMUNOL, V114, P427; Knolle PA, 2003, SWISS MED WKLY, V133, P501; Knolle PA, 1999, J IMMUNOL, V162, P1401; KOSUGI I, 1992, J HEPATOL, V16, P106, DOI 10.1016/S0168-8278(05)80102-3; Kudo S, 1997, J EXP MED, V185, P777, DOI 10.1084/jem.185.4.777; Lee WY, 2010, NAT IMMUNOL, V11, P295, DOI 10.1038/ni.1855; Limmer A, 2005, EUR J IMMUNOL, V35, P2970, DOI 10.1002/eji.200526034; Limmer A, 2000, NAT MED, V6, P1348, DOI 10.1038/82161; Lohse AW, 1996, GASTROENTEROLOGY, V110, P1175, DOI 10.1053/gast.1996.v110.pm8613007; Lovdal T, 2001, CELL BIOL INT, V25, P821, DOI 10.1006/cbir.2001.0761; LUMSDEN AB, 1988, HEPATOLOGY, V8, P232, DOI 10.1002/hep.1840080207; MAGNUSSON S, 1989, BIOCHEM J, V257, P651, DOI 10.1042/bj2570651; Marques PE, 2012, HEPATOLOGY, V56, P1971, DOI 10.1002/hep.25801; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Matsuno K, 1996, J EXP MED, V183, P1865, DOI 10.1084/jem.183.4.1865; McDonald B, 2008, J EXP MED, V205, P915, DOI 10.1084/jem.20071765; McDonald B, 2012, CELL HOST MICROBE, V12, P324, DOI 10.1016/j.chom.2012.06.011; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Menezes GB, 2009, J IMMUNOL, V183, P7557, DOI 10.4049/jimmunol.0901786; Monteiro RC, 2003, ANNU REV IMMUNOL, V21, P177, DOI 10.1146/annurev.immunol.21.120601.141011; Muhanna N, 2007, CLIN EXP IMMUNOL, V148, P338, DOI 10.1111/j.1365-2249.2007.03353.x; Nemeth E, 2009, SEMIN IMMUNOPATHOL, V31, P333, DOI 10.1007/s00281-009-0173-4; Notas G, 2009, CLIN IMMUNOL, V130, P16, DOI 10.1016/j.clim.2008.08.008; Oda M, 2003, CLIN HEMORHEOL MICRO, V29, P167; Pannen B H, 1995, New Horiz, V3, P183; Parker GA, 2005, TOXICOL PATHOL, V33, P52, DOI 10.1080/01926230590522365; Parker GA, 2012, TOXICOL PATHOL, V40, P237, DOI 10.1177/0192623311428475; Paulos CM, 2007, J CLIN INVEST, V117, P2197, DOI 10.1172/JCI32205; Pillarisetty VG, 2005, J IMMUNOL, V174, P2612, DOI 10.4049/jimmunol.174.5.2612; Pillarisetty VG, 2004, J IMMUNOL, V172, P1009, DOI 10.4049/jimmunol.172.2.1009; Qian S, 2001, TRANSPLANT P, V33, P226, DOI 10.1016/S0041-1345(00)01985-0; Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Sana G, 2014, CELL TRANSPLANT, V23, P1127, DOI 10.3727/096368913X666421; Sarma JV, 2011, CELL TISSUE RES, V343, P227, DOI 10.1007/s00441-010-1034-0; Sato T, 1998, CELL TISSUE RES, V294, P503, DOI 10.1007/s004410051201; Schafer G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008448; Schildberg FA, 2008, EUR J IMMUNOL, V38, P957, DOI 10.1002/eji.200738060; Scott MJ, 2010, J HEPATOL, V53, P693, DOI 10.1016/j.jhep.2010.04.026; Seki E, 2008, HEPATOLOGY, V48, P322, DOI 10.1002/hep.22306; SEKI S, 1991, J IMMUNOL, V147, P1214; Sheth K, 2001, Curr Opin Crit Care, V7, P99, DOI 10.1097/00075198-200104000-00008; Shi JL, 2001, BLOOD, V98, P1226, DOI 10.1182/blood.V98.4.1226; Shi JL, 1996, HEPATOLOGY, V24, P1256; SKOGH T, 1985, IMMUNOLOGY, V55, P585; SMEDSROD B, 1990, BIOCHEM J, V266, P313, DOI 10.1042/bj2660313; Son G, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/453563; Sorensen KK, 2012, AM J PHYSIOL-REG I, V303, pR1217, DOI 10.1152/ajpregu.00686.2011; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; STEFFAN AM, 1986, HEPATOLOGY, V6, P830, DOI 10.1002/hep.1840060505; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Tang ED, 2009, J VIROL, V83, P3420, DOI 10.1128/JVI.02623-08; Taniguchi H, 1996, NAT MED, V2, P198, DOI 10.1038/nm0296-198; TAVASSOLI M, 1986, J CELL BIOL, V102, P1298, DOI 10.1083/jcb.102.4.1298; Thomas SY, 2011, J EXP MED, V208, P1179, DOI 10.1084/jem.20102630; Tokita D, 2008, J HEPATOL, V49, P1008, DOI 10.1016/j.jhep.2008.07.028; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Vinas O, 2003, HEPATOLOGY, V38, P919, DOI 10.1053/jhep.2003.50392; Wahl C, 2008, GASTROENTEROLOGY, V135, P980, DOI 10.1053/j.gastro.2008.05.076; Warren A, 2006, HEPATOLOGY, V44, P1182, DOI 10.1002/hep.21378; WATANABE H, 1995, J IMMUNOL, V155, P2972; Winau F, 2008, CURR OPIN IMMUNOL, V20, P68, DOI 10.1016/j.coi.2007.10.006; Winau F, 2007, IMMUNITY, V26, P117, DOI 10.1016/j.immuni.2006.11.011; WISSE E, 1985, HEPATOLOGY, V5, P683, DOI 10.1002/hep.1840050427; Wisse E, 1996, TOXICOL PATHOL, V24, P100, DOI 10.1177/019262339602400114; Wong CHY, 2013, NAT IMMUNOL, V14, P785, DOI 10.1038/ni.2631; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301; Wong J, 1997, J CLIN INVEST, V99, P2782, DOI 10.1172/JCI119468; Wu J, 2010, IMMUNOLOGY, V129, P363, DOI 10.1111/j.1365-2567.2009.03179.x; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; You Q, 2008, HEPATOLOGY, V48, P978, DOI 10.1002/hep.22395; Yu B, 2012, HEPATOLOGY, V56, P1532, DOI 10.1002/hep.25795; Yu MC, 2004, HEPATOLOGY, V40, P1312, DOI 10.1002/hep.20488; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhang XY, 2009, CELL MICROBIOL, V11, P1624, DOI 10.1111/j.1462-5822.2009.01353.x	132	611	633	6	141	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2013	14	10					996	1006		10.1038/ni.2691	http://dx.doi.org/10.1038/ni.2691			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	220LH	24048121				2022-12-18	WOS:000324584700004
J	Dejnirattisai, W; Supasa, P; Wongwiwat, W; Rouvinski, A; Barba-Spaeth, G; Duangchinda, T; Sakuntabhai, A; Cao-Lormeau, VM; Malasit, P; Rey, FA; Mongkolsapaya, J; Screaton, GR				Dejnirattisai, Wanwisa; Supasa, Piyada; Wongwiwat, Wiyada; Rouvinski, Alexander; Barba-Spaeth, Giovanna; Duangchinda, Thaneeya; Sakuntabhai, Anavaj; Cao-Lormeau, Van-Mai; Malasit, Prida; Rey, Felix A.; Mongkolsapaya, Juthathip; Screaton, Gavin R.			Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus	NATURE IMMUNOLOGY			English	Article							NEUTRALIZING ANTIBODIES; CHIKUNGUNYA VIRUS; OUTBREAK; BRAZIL; BRAIN	Zika virus (ZIKV) was discovered in 1947 and was thought to lead to relatively mild disease. The recent explosive outbreak of ZIKV in South America has led to widespread concern, with reports of neurological sequelae ranging from Guillain Barre syndrome to microcephaly. ZIKV infection has occurred in areas previously exposed to dengue virus (DENV), a flavivirus closely related to ZIKV. Here we investigated the serological cross-reaction between the two viruses. Plasma immune to DENV showed substantial cross-reaction to ZIKV and was able to drive antibody-dependent enhancement (ADE) of ZIKV infection. Using a panel of human monoclonal antibodies (mAbs) to DENV, we showed that most antibodies that reacted to DENV envelope protein also reacted to ZIKV. Antibodies to linear epitopes, including the immunodominant fusion-loop epitope, were able to bind ZIKV but were unable to neutralize the virus and instead promoted ADE. Our data indicate that immunity to DENV might drive greater ZIKV replication and have clear implications for disease pathogenesis and future vaccine programs for ZIKV and DENV.	[Dejnirattisai, Wanwisa; Supasa, Piyada; Wongwiwat, Wiyada; Mongkolsapaya, Juthathip; Screaton, Gavin R.] Imperial Coll London, Dept Med, Div Immunol & Inflammat, Hammersmith Campus, London, England; [Supasa, Piyada; Mongkolsapaya, Juthathip] Mahidol Univ, Siriraj Hosp, Dengue Hemorrhag Fever Res Unit, Off Res & Dev,Fac Med, Bangkok, Thailand; [Supasa, Piyada] Mahidol Univ, Siriraj Hosp, Dept Immunol, Fac Med,Grad Program Immunol, Bangkok, Thailand; [Rouvinski, Alexander; Barba-Spaeth, Giovanna; Rey, Felix A.] Inst Pasteur, Dept Virol, Unite Virol Struct, Paris, France; [Rouvinski, Alexander; Barba-Spaeth, Giovanna; Rey, Felix A.] CNRS UMR 3569 Virol, Paris, France; [Duangchinda, Thaneeya; Malasit, Prida] Natl Sci & Technol Dev Agcy, Med Biotechnol Unit, Natl Ctr Genet Engn & Biotechnol, Pathum Thani, Thailand; [Sakuntabhai, Anavaj] Inst Pasteur, Funct Genet Infect Dis Unit, Paris, France; [Sakuntabhai, Anavaj] CNRS URA3012, Paris, France; [Cao-Lormeau, Van-Mai] Inst Louis Malarde, Unit Emerging Infect Dis, Papeete, France	Imperial College London; Mahidol University; Mahidol University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Mongkolsapaya, J; Screaton, GR (corresponding author), Imperial Coll London, Dept Med, Div Immunol & Inflammat, Hammersmith Campus, London, England.; Mongkolsapaya, J (corresponding author), Mahidol Univ, Siriraj Hosp, Dengue Hemorrhag Fever Res Unit, Off Res & Dev,Fac Med, Bangkok, Thailand.	j.mongkolsapaya@imperial.ac.uk; g.screaton@imperial.ac.uk	Wongwiwat, Wiyada/AAJ-8936-2021; Rey, Felix/B-6497-2012; Cao-Lormeau, Van-Mai/H-4879-2018	Cao-Lormeau, Van-Mai/0000-0001-5606-7480; Barba Spaeth, Giovanna/0000-0003-2069-9501; Rey, Felix/0000-0002-9953-7988; Wongwiwat, Wiyada/0000-0002-5889-0929; Screaton, Gavin/0000-0002-3549-4309	Medical Research Council, UK; Wellcome Trust, UK; National Institute for Health Research Biomedical Research Centre; European Commission [282 378]; Laboratory of Excellence Integrative Biology of Emerging Infectious Diseases [ANR-10-LABX-62-IBEID]; Agence Nationale de la Recherche [FlaviStem/I1378]; Thailand Research Fund through the Royal Golden Jubilee PhD; MRC [G0801508, G0400720] Funding Source: UKRI; Medical Research Council [G0801508, G0400720] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust, UK(Wellcome Trust); National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Laboratory of Excellence Integrative Biology of Emerging Infectious Diseases; Agence Nationale de la Recherche(French National Research Agency (ANR)); Thailand Research Fund through the Royal Golden Jubilee PhD; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Armed Forces Research Institute of Medical Sciences, Thailand for Vero cells, C6/36 cells, mAb 4G2 to DENV envelope protein, and viruses DENV-1, DENV-2 and DENV-3; and M. Nguyen-De Bernon for technical assistance. Supported by the Medical Research Council, UK, the Wellcome Trust, UK (G.R.S.), the National Institute for Health Research Biomedical Research Centre, Funding Scheme, European Commission Seventh Framework Programme (FP7/2007-2013) for the DENFREE project (under grant agreement 282 378), Laboratory of Excellence Integrative Biology of Emerging Infectious Diseases (ANR-10-LABX-62-IBEID to F.A.R.), Agence Nationale de la Recherche (FlaviStem/I1378 to F.A.R.) and the Thailand Research Fund through the Royal Golden Jubilee PhD (P.S. and J.M.).	Barba-Spaeth G., NATURE IN PRESS; Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021; BRANDT WE, 1982, INFECT IMMUN, V36, P1036, DOI 10.1128/IAI.36.3.1036-1041.1982; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022; Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5; Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI [10.3201/eid2006.140138, 10.3201/eid2011.141380]; Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167; Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367; Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; Dang J., 2016, CELL STEM CELL, DOI [10.1016/jstem.2016.04.014, DOI 10.1016/JSTEM.2016.04.014]; Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058; Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116; Guzman MG, 2007, EMERG INFECT DIS, V13, P282, DOI 10.3201/eid1302.060539; Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0; HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16; Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017; Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1; Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1; Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14; Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15; Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9; Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72; Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130; SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30; Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517; Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916; Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06; Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113; Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727; Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035; WHO, 2016, ZIK VIR FACT SHEET; World Health Organization, 2016, ZIK EM; World Health Organization (WHO), 2016, DENG VACC; Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192; Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062	47	609	638	5	156	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2016	17	9					1102	1108		10.1038/ni.3515	http://dx.doi.org/10.1038/ni.3515			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DT9OO	27339099	Green Submitted, Green Accepted, Bronze			2022-12-18	WOS:000381832000014
J	Chang, CC; Ciubotariu, R; Manavalan, JS; Yuan, J; Colovai, AI; Piazza, F; Lederman, S; Colonna, M; Cortesini, R; Dalla-Favera, R; Suciu-Foca, N				Chang, CC; Ciubotariu, R; Manavalan, JS; Yuan, J; Colovai, AI; Piazza, F; Lederman, S; Colonna, M; Cortesini, R; Dalla-Favera, R; Suciu-Foca, N			Tolerization of dendritic cells by T-S cells: the crucial role of inhibitory receptors ILT3 and ILT4	NATURE IMMUNOLOGY			English	Article							ANTIGEN-PRESENTING CELLS; IG-LIKE RECEPTORS; REGULATORY PROPERTIES; MODULATE FUNCTION; IN-VITRO; INDUCTION; LYMPHOCYTES; GENERATION; EXPRESSION; GENE	Immunoglobulin-like transcript 3 (ILT3) and ILT4 belong to a family of inhibitory receptors expressed by human monocytes and dendritic cells. We show here that CD8(+)CD28(-) alloantigen-specific T suppressor (T-S) cells induce the up-regulation of ILT3 and ILT4 on monocytes and dendritic cells, rendering these antigen-presenting cells (APCs) tolerogenic. Tolerogenic APCs show reduced expression of costimulatory molecules and induce antigen-specific unresponsiveness in CD4(+)T helper cells. Studies of human heart transplant recipients showed that rejection-free patients have circulating T-S cells, which induce the up-regulation of ILT3 and ILT4 in donor APCs. These findings demonstrate an important mechanism of immune regulation.	Columbia Univ, Dept Pathol, New York, NY 10032 USA; Columbia Univ, Lab Mol Immunol, New York, NY 10032 USA; Washington Univ, Sch Med, St Louis, MO 63110 USA; Univ Roma La Sapienza, Rome, Italy	Columbia University; Columbia University; Washington University (WUSTL); Sapienza University Rome	Suciu-Foca, N (corresponding author), Columbia Univ, Dept Pathol, New York, NY 10032 USA.	ns20@columbia.edu		Lederman, Seth/0000-0003-2781-1455; Colonna, Marco/0000-0001-5222-4987				BAHNSON AB, 1995, J VIROL METHODS, V54, P131, DOI 10.1016/0166-0934(95)00035-S; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bender A, 1996, J IMMUNOL METHODS, V196, P121, DOI 10.1016/0022-1759(96)00079-8; Berzofsky JA, 2001, NAT REV IMMUNOL, V1, P209, DOI 10.1038/35105075; Cella M, 1997, J EXP MED, V185, P1743, DOI 10.1084/jem.185.10.1743; CHANG CC, 1995, MOL CELL BIOL, V15, P5180; Cherry SR, 2000, MOL CELL BIOL, V20, P7419, DOI 10.1128/MCB.20.20.7419-7426.2000; Ciubotariu R, 1998, J IMMUNOL, V161, P5193; Ciubotariu R, 1998, J CLIN INVEST, V101, P398, DOI 10.1172/JCI1117; Ciubotariu R, 2001, HUM IMMUNOL, V62, P15, DOI 10.1016/S0198-8859(00)00226-3; Colonna M, 2000, SEMIN IMMUNOL, V12, P121, DOI 10.1006/smim.2000.0214; Colonna M, 1999, J LEUKOCYTE BIOL, V66, P375, DOI 10.1002/jlb.66.3.375; Colonna M, 1998, J IMMUNOL, V160, P3096; Colovai AI, 2000, TRANSPLANTATION, V69, P1304, DOI 10.1097/00007890-200004150-00016; Cortesini NSF, 2001, HUM IMMUNOL, V62, P1065, DOI 10.1016/S0198-8859(01)00310-X; DAMLE NK, 1983, J IMMUNOL, V131, P2296; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; GarciaAlonso AM, 1997, HUM IMMUNOL, V53, P64, DOI 10.1016/S0198-8859(97)00026-8; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; JENKINS MK, 1987, J EXP MED, V165, P302, DOI 10.1084/jem.165.2.302; Jiang SP, 1998, HUM IMMUNOL, V59, P690, DOI 10.1016/S0198-8859(98)00073-1; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Lanzavecchia A, 1998, NATURE, V393, P413, DOI 10.1038/30845; Lechler R, 2001, IMMUNITY, V14, P357, DOI 10.1016/S1074-7613(01)00116-9; Levings MK, 2001, J EXP MED, V193, P1295, DOI 10.1084/jem.193.11.1295; Li JF, 1999, J IMMUNOL, V163, P6386; Liu Z, 1998, INT IMMUNOL, V10, P775, DOI 10.1093/intimm/10.6.775; Liu ZR, 1999, HUM IMMUNOL, V60, P568, DOI 10.1016/S0198-8859(99)00044-0; Lutz MB, 2000, EUR J IMMUNOL, V30, P1813, DOI 10.1002/1521-4141(200007)30:7<1813::AID-IMMU1813>3.0.CO;2-8; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Rea D, 2000, BLOOD, V95, P3162, DOI 10.1182/blood.V95.10.3162.010k18_3162_3167; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Romani N, 1996, J IMMUNOL METHODS, V196, P137, DOI 10.1016/0022-1759(96)00078-6; Roncarolo MG, 2001, J EXP MED, V193, pF5, DOI 10.1084/jem.193.2.F5; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Schwartz RH, 1996, J EXP MED, V184, P1, DOI 10.1084/jem.184.1.1; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Shevach EM, 2001, J EXP MED, V193, pF41, DOI 10.1084/jem.193.11.F41; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; St Louis DC, 1999, J IMMUNOL, V162, P3237; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; WONG H, 1994, ANAL BIOCHEM, V223, P251, DOI 10.1006/abio.1994.1581; YELLIN MJ, 1994, J IMMUNOL, V153, P666	49	609	687	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2002	3	3					237	243		10.1038/ni760	http://dx.doi.org/10.1038/ni760			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	525LV	11875462				2022-12-18	WOS:000174074000011
J	Nold, MF; Nold-Petry, CA; Zepp, JA; Palmer, BE; Bufler, P; Dinarello, CA				Nold, Marcel F.; Nold-Petry, Claudia A.; Zepp, Jarod A.; Palmer, Brent E.; Bufler, Philip; Dinarello, Charles A.			IL-37 is a fundamental inhibitor of innate immunity	NATURE IMMUNOLOGY			English	Article							GROWTH-FACTOR-BETA; DENDRITIC-CELL-FUNCTION; IFN-GAMMA PRODUCTION; RECEPTOR EXPRESSION; TGF-BETA; T-CELLS; BINDING-PROTEIN; IN-VIVO; CYTOKINE; SMAD3	The function of interleukin 37 (IL-37; formerly IL-1 family member 7) has remained elusive. Expression of IL-37 in macrophages or epithelial cells almost completely suppressed production of pro-inflammatory cytokines, whereas the abundance of these cytokines increased with silencing of endogenous IL-37 in human blood cells. Anti-inflammatory cytokines were unaffected. Mice with transgenic expression of IL-37 were protected from lipopolysaccharide-induced shock, and showed markedly improved lung and kidney function and reduced liver damage after treatment with lipopolysaccharide. Transgenic mice had lower concentrations of circulating and tissue cytokines (72-95% less) than wild-type mice and showed less dendritic cell activation. IL-37 interacted intracellularly with Smad3 and IL-37-expressing cells and transgenic mice showed less cytokine suppression when endogenous Smad3 was depleted. IL-37 thus emerges as a natural suppressor of innate inflammatory and immune responses.	[Nold, Marcel F.; Nold-Petry, Claudia A.; Zepp, Jarod A.; Palmer, Brent E.; Dinarello, Charles A.] Univ Colorado Denver, Dept Med, Aurora, CO USA; [Nold, Marcel F.; Nold-Petry, Claudia A.] Monash Univ, Ritchie Ctr, Monash Inst Med Res, Melbourne, Vic 3004, Australia; [Bufler, Philip] Univ Munich, Childrens Hosp, D-8000 Munich, Germany	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Monash University; University of Munich	Dinarello, CA (corresponding author), Univ Colorado Denver, Dept Med, Aurora, CO USA.	cdinarello@mac.com	Dinarello, Charles/C-8524-2013	Nold, Marcel/0000-0001-9682-4618; Nold, Claudia/0000-0002-7439-3834; Bufler, Philip/0000-0002-5742-8273	US National Institutes of Health [AI-15614, CA-04 6934]; Deutsche Forschungsgemeinschaft [747/1-1, Bu 1222/3-1, 3-2, 3-3]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015614, R37AI015614] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank F. Gamboni-Robertson and F. Eckerdt (both University of Colorado, Denver) for advice on immunofluorescence; T. Azam, T. Goncharov (both University of Colorado, Denver) and M. Fink (Ludwig-Maximilians University Munich) for assistance; L. Joosten (Radboud University Nijmegen) for performing immunohistochemistry; D. Finkel (R&D Systems) for assistance regarding the protein arrays; and P. Pagel (University of Technology Munich) for database research for IL-37-interacting molecules. Supported by the US National Institutes of Health (AI-15614 and CA-04 6934 to C.A.D.) and the Deutsche Forschungsgemeinschaft (747/1-1 to M.F.N. and Bu 1222/3-1, 3-2 and 3-3 to P.B.).	Andre S, 2009, AM J PATHOL, V174, P1575, DOI 10.2353/ajpath.2009.080987; Bayry J, 2007, J IMMUNOL, V178, P4184, DOI 10.4049/jimmunol.178.7.4184; Bufler P, 2004, BIOCHEM J, V381, P503, DOI 10.1042/BJ20040217; Bufler P, 2002, P NATL ACAD SCI USA, V99, P13723, DOI 10.1073/pnas.212519099; Busfield SJ, 2000, GENOMICS, V66, P213, DOI 10.1006/geno.2000.6184; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; COHEN I, P NATL ACAD SCI US, V107, P2574; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Dunn E, 2001, TRENDS IMMUNOL, V22, P533, DOI 10.1016/S1471-4906(01)02034-8; Fogel-Petrovic M, 2007, INT IMMUNOPHARMACOL, V7, P1924, DOI 10.1016/j.intimp.2007.07.003; Foster LC, 2000, FASEB J, V14, P368, DOI 10.1096/fasebj.14.2.368; Grimsby S, 2004, FEBS LETT, V577, P93, DOI 10.1016/j.febslet.2004.09.069; Imai K, 2000, INFECT IMMUN, V68, P2418, DOI 10.1128/IAI.68.5.2418-2423.2000; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kjellman C, 2004, GENE, V327, P141, DOI 10.1016/j.gene.2003.11.026; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Kumar S, 2000, J BIOL CHEM, V275, P10308, DOI 10.1074/jbc.275.14.10308; Kumar S, 2002, CYTOKINE, V18, P61, DOI 10.1006/cyto.2002.0873; Lai JP, 2006, P NATL ACAD SCI USA, V103, P7771, DOI 10.1073/pnas.0602563103; Laouar Y, 2008, P NATL ACAD SCI USA, V105, P10865, DOI 10.1073/pnas.0805058105; Larmonier N, 2007, CANCER IMMUNOL IMMUN, V56, P48, DOI 10.1007/s00262-006-0160-8; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; McCartney-Francis N, 2004, J IMMUNOL, V172, P3814, DOI 10.4049/jimmunol.172.6.3814; Misra N, 2004, J IMMUNOL, V172, P4676, DOI 10.4049/jimmunol.172.8.4676; MUSSO T, 1990, BLOOD, V76, P2466; Nold M, 2003, BIOCHEM PHARMACOL, V66, P505, DOI 10.1016/S0006-2952(03)00294-6; Nold MF, 2008, J IMMUNOL, V181, P557, DOI 10.4049/jimmunol.181.1.557; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; Pan GH, 2001, CYTOKINE, V13, P1, DOI 10.1006/cyto.2000.0799; PRIESTLE JP, 1989, P NATL ACAD SCI USA, V86, P9667, DOI 10.1073/pnas.86.24.9667; Schieven GL, 2005, CURR TOP MED CHEM, V5, P921, DOI 10.2174/1568026054985902; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Sharma S, 2008, J IMMUNOL, V180, P5477, DOI 10.4049/jimmunol.180.8.5477; Smith DE, 2000, J BIOL CHEM, V275, P1169, DOI 10.1074/jbc.275.2.1169; Taylor SL, 2002, GENOMICS, V79, P726, DOI 10.1006/geno.2002.6752; Trotta R, 2008, J IMMUNOL, V181, P3784, DOI 10.4049/jimmunol.181.6.3784; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; Werman A, 2004, P NATL ACAD SCI USA, V101, P2434, DOI 10.1073/pnas.0308705101; Werner F, 2000, J BIOL CHEM, V275, P36653, DOI 10.1074/jbc.M004536200; Wilson KC, 2002, BIOCHEMISTRY-US, V41, P14306, DOI 10.1021/bi020163v; Yang H, 2001, SHOCK, V15, P247, DOI 10.1097/00024382-200115040-00001; Zauberman A, 2001, J BIOL CHEM, V276, P24719, DOI 10.1074/jbc.M005813200	45	608	680	0	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2010	11	11					1014	U64		10.1038/ni.1944	http://dx.doi.org/10.1038/ni.1944			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	666PI	20935647	Green Accepted			2022-12-18	WOS:000283127800011
J	Murai, M; Turovskaya, O; Kim, G; Madan, R; Karp, CL; Cheroutre, H; Kronenberg, M				Murai, Masako; Turovskaya, Olga; Kim, Gisen; Madan, Rajat; Karp, Christopher L.; Cheroutre, Hilde; Kronenberg, Mitchell			Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis	NATURE IMMUNOLOGY			English	Article							IMMUNE-RESPONSES; CUTTING EDGE; TOLERANCE; INDUCE; INFLAMMATION; GENERATION; LINEAGE; IL-10; CURE	Regulatory T cells (T-reg cells) that express the transcription factor Foxp3 suppress the activity of other cells. Here we show that interleukin 10 (IL-10) produced by CD11b(+) myeloid cells in recombination-activating gene 1-deficient (Rag1(-/-)) recipient mice was needed to prevent the colitis induced by transferred CD4(+)CD45RB(hi) T cells. In Il10(-/-)Rag1(-/-) mice, T-reg cells failed to maintain Foxp3 expression and regulatory activity. The loss of Foxp3 expression occurred only in recipients with colitis, which indicates that the requirement for IL-10 is manifested in the presence of inflammation. IL-10 receptor-deficient (Il10rb(-/-)) T-reg cells also failed to maintain Foxp3 expression, which suggested that host IL-10 acted directly on the T-reg cells. Our data indicate that IL-10 released from myeloid cells acts in a paracrine manner on T-reg cells to maintain Foxp3 expression.	[Murai, Masako; Turovskaya, Olga; Kim, Gisen; Cheroutre, Hilde; Kronenberg, Mitchell] La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA USA; [Madan, Rajat; Karp, Christopher L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Madan, Rajat; Karp, Christopher L.] Cincinnati Childrens Hosp, Med Ctr, Div Mol Immunol, Cincinnati, OH USA	La Jolla Institute for Immunology; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Kronenberg, M (corresponding author), La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA USA.	mitch@liai.org	Kronenberg, Mitchell/AAT-6078-2021; Madan, Rajat/V-6168-2019	Madan, Rajat/0000-0002-9821-1257; Karp, Christopher/0000-0002-0832-2659	US National Institutes of Health [PO1 DK46763, RO1 AI057992, RO1 AI50265]; Crohn's & Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050265, R01AI057992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK046763] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's & Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Steinberg and D. Mucida for critical reading of this manuscript, members of the Kronenberg and Cheroutre laboratories for discussions; Y. Wang-Zhu for genotyping mice; L. Fernandez, C. Kim and B. Sears for assistance with cell sorting; P. Allen (Washington University) for Il10rb<SUP>-/-</SUP> mice; and A. Rudensky (Memorial Sloan Kettering Cancer Center) for Foxp3<SUP>gfp</SUP> mice. Supported by US National Institutes of Health (PO1 DK46763 to M. K., RO1 AI057992 to C. L. K. and RO1 AI50265 to H. C.) and the Crohn's & Colitis Foundation of America (M. K. and M. M.).	Annacker O, 2001, J IMMUNOL, V166, P3008, DOI 10.4049/jimmunol.166.5.3008; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Asseman C, 2003, J IMMUNOL, V171, P971, DOI 10.4049/jimmunol.171.2.971; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; De Winter H, 2002, GASTROENTEROLOGY, V122, P1829, DOI 10.1053/gast.2002.33655; Degauque N, 2008, J CLIN INVEST, V118, P735, DOI 10.1172/JCI32562; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Donnelly RP, 2004, J LEUKOCYTE BIOL, V76, P314, DOI 10.1189/jlb.0204117; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Grimbaldeston MA, 2007, NAT IMMUNOL, V8, P1095, DOI 10.1038/ni1503; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hagenbaugh A, 1997, J EXP MED, V185, P2101, DOI 10.1084/jem.185.12.2101; Kim G, 2007, J IMMUNOL, V178, P5563, DOI 10.4049/jimmunol.178.9.5563; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Madan R, 2009, J IMMUNOL, V183, P2312, DOI 10.4049/jimmunol.0900185; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Mizoguchi A, 2002, IMMUNITY, V16, P219, DOI 10.1016/S1074-7613(02)00274-1; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; POWRIE F, 1994, J EXP MED, V179, P589, DOI 10.1084/jem.179.2.589; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Roers A, 2004, J EXP MED, V200, P1289, DOI 10.1084/jem.20041789; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Spencer SD, 1998, J EXP MED, V187, P571, DOI 10.1084/jem.187.4.571; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	36	608	637	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2009	10	11					1178	U61		10.1038/ni.1791	http://dx.doi.org/10.1038/ni.1791			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	508SO	19783988	Green Accepted			2022-12-18	WOS:000270955900010
J	Ishii, KJ; Coban, C; Kato, H; Takahashi, K; Torii, Y; Takeshita, F; Ludwig, H; Sutter, G; Suzuki, K; Hemmi, H; Sato, S; Yamamoto, M; Uematsu, S; Kawai, T; Takeuchi, O; Akira, S				Ishii, KJ; Coban, C; Kato, H; Takahashi, K; Torii, Y; Takeshita, F; Ludwig, H; Sutter, G; Suzuki, K; Hemmi, H; Sato, S; Yamamoto, M; Uematsu, S; Kawai, T; Takeuchi, O; Akira, S			A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA	NATURE IMMUNOLOGY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; INTERFERON-ALPHA INDUCTION; ACTIVATES DENDRITIC CELLS; RIG-I; PLASMID DNA; KAPPA-B; IMMUNE-RECOGNITION; SIGNALING PATHWAY; VIRAL-INFECTION; NUCLEIC-ACIDS	The innate immune system recognizes nucleic acids during infection or tissue damage; however, the mechanisms of intracellular recognition of DNA have not been fully elucidated. Here we show that intracellular administration of double-stranded B-form DNA (B-DNA) triggered antiviral responses including production of type I interferons and chemokines independently of Toll-like receptors or the helicase RIG-I. B-DNA activated transcription factor IRF3 and the promoter of the gene encoding interferon-beta through a signaling pathway that required the kinases TBK1 and IKKi, whereas there was substantial activation of transcription factor NF-kappa B independent of both TBK and IKKi. IPS-1, an adaptor molecule linking RIG-I and TBK1, was involved in B-DNA-induced activation of interferon-beta and NF-kappa B. B-DNA signaling by this pathway conferred resistance to viral infection in a way dependent on both TBK1 and IKKi. These results suggest that both TBK1 and IKKi are required for innate immune activation by B-DNA, which might be important in antiviral innate immunity and other DNA-associated immune disorders.	Osaka Univ, Exploratory Res Adv Technol, Japan Sci & Technol Agcy, Suita, Osaka 5650871, Japan; Osaka Univ, Dept Host Def, Suita, Osaka 5650871, Japan; Osaka Univ, 21 Century COE, Combined Program Microbiol & Immunol, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; Yokohama City Univ, Grad Sch Med, Dept Mol Biodef Res, Yokohama, Kanagawa 2360004, Japan; Paul Ehrlich Inst, Abt Virol, D-63225 Langen, Germany; Natl Inst Infect Dis, Leprosy Res Ctr, Dept Host Def, Tokyo 1890002, Japan	Japan Science & Technology Agency (JST); Osaka University; Osaka University; Osaka University; Yokohama City University; Paul Ehrlich Institute; National Institute of Infectious Diseases (NIID)	Akira, S (corresponding author), Osaka Univ, Exploratory Res Adv Technol, Japan Sci & Technol Agcy, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp	Akira, Shizuo/C-3134-2009; Takeuchi, Osamu/D-6007-2011; COBAN, Cevayir/P-1928-2019; Coban, Cevayir/B-2129-2012; Takeuchi, Osamu/AAG-9359-2019; Ishii, Ken J/B-1685-2012; Suzuki, Koichi/C-4177-2013	COBAN, Cevayir/0000-0002-4467-7799; Takeuchi, Osamu/0000-0002-1260-6232; Ishii, Ken J/0000-0002-6728-3872; Sutter, Gerd/0000-0001-6143-082X; Sato, Shintaro/0000-0001-5156-3354; Suzuki, Koichi/0000-0001-8659-4660; Kawai, Taro/0000-0001-7510-4662				Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Babiuk S, 2004, IMMUNOLOGY, V113, P114, DOI 10.1111/j.1365-2567.2004.01938.x; Bauer M, 2001, J IMMUNOL, V166, P5000, DOI 10.4049/jimmunol.166.8.5000; Boule MW, 2004, J EXP MED, V199, P1631, DOI 10.1084/jem.20031942; Braun CS, 2003, BIOPHYS J, V84, P1114, DOI 10.1016/S0006-3495(03)74927-3; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Decker P, 2005, J IMMUNOL, V174, P3326, DOI 10.4049/jimmunol.174.6.3326; Drexler I, 2003, P NATL ACAD SCI USA, V100, P217, DOI 10.1073/pnas.262668999; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gursel M, 2002, J LEUKOCYTE BIOL, V71, P813; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Hornemann S, 2003, J VIROL, V77, P8394, DOI 10.1128/JVI.77.15.8394-8407.2003; ISAACS A, 1963, LANCET, V2, P113; Ishii KJ, 2005, INT J CANCER, V117, P517, DOI 10.1002/ijc.21402; Ishii KJ, 2001, J IMMUNOL, V167, P2602, DOI 10.4049/jimmunol.167.5.2602; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kawane K, 2003, NAT IMMUNOL, V4, P138, DOI 10.1038/ni881; Kim YG, 2004, P NATL ACAD SCI USA, V101, P1514, DOI 10.1073/pnas.0308260100; Kim YG, 2003, P NATL ACAD SCI USA, V100, P6974, DOI 10.1073/pnas.0431131100; Kimura T, 2004, J ORG CHEM, V69, P1169, DOI 10.1021/jo035194q; Kovacsovics M, 2002, CURR BIOL, V12, P838, DOI 10.1016/S0960-9822(02)00842-4; Li SL, 2005, MOL THER, V11, P112, DOI 10.1016/j.ymthe.2004.09.008; MEYLAN E, 2005, NATURE; MOLLER A, 1984, BIOCHEMISTRY-US, V23, P54, DOI 10.1021/bi00296a009; Ogasawara K, 2002, GENES CELLS, V7, P309, DOI 10.1046/j.1365-2443.2002.00515.x; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Rich A, 2003, NAT REV GENET, V4, P566, DOI 10.1038/nrg1115; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Smith EJ, 2001, J BIOL CHEM, V276, P8951, DOI 10.1074/jbc.M008717200; Spies B, 2003, J IMMUNOL, V171, P5908, DOI 10.4049/jimmunol.171.11.5908; Sugiyama T, 2005, J IMMUNOL, V174, P2273, DOI 10.4049/jimmunol.174.4.2273; Suzuki K, 1999, P NATL ACAD SCI USA, V96, P2285, DOI 10.1073/pnas.96.5.2285; Takeshita S, 2000, CELL IMMUNOL, V206, P101, DOI 10.1006/cimm.2000.1735; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; TOKUNAGA T, 1984, J NATL CANCER I, V72, P955; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Vallin H, 1999, J IMMUNOL, V163, P6306; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yasuda K, 2005, J IMMUNOL, V174, P6129, DOI 10.4049/jimmunol.174.10.6129; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146	50	608	652	1	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2006	7	1					40	48		10.1038/ni1282	http://dx.doi.org/10.1038/ni1282			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	995XZ	16286919				2022-12-18	WOS:000234139700017
J	Seder, RA; Ahmed, R				Seder, RA; Ahmed, R			Similarities and differences in CD4(+) and CD8(+) effector and memory T cell generation	NATURE IMMUNOLOGY			English	Review							CYTOKINE GENE-EXPRESSION; IN-VIVO; INTERFERON-GAMMA; CUTTING EDGE; CLONAL EXPANSION; LYMPHOCYTE RESPONSES; LINEAGE COMMITMENT; CD8-T-CELL MEMORY; LEISHMANIA-MAJOR; CD4-T-CELL HELP	Naive CD4(+) and CD8(+) T cells undergo unique developmental programs after activation, resulting in the generation of effector and long-lived memory T cells. Recent evidence indicates that both cell-intrinsic and cell-extrinsic factors regulate memory T cell differentiation. This review compares and contrasts how naive CD4(+) and CD8(+) T cells make the transition to effector and/or memory cells and discusses the implications of these findings for vaccine development.	NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Emory University	Seder, RA (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	rseder@mail.nih.gov						Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Ahmadzadeh M, 2001, J IMMUNOL, V166, P926, DOI 10.4049/jimmunol.166.2.926; Badovinac VP, 2000, SCIENCE, V290, P1354, DOI 10.1126/science.290.5495.1354; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Baron V, 2003, IMMUNITY, V18, P193, DOI 10.1016/S1074-7613(03)00020-7; Belkaid Y, 2002, J IMMUNOL, V168, P3992, DOI 10.4049/jimmunol.168.8.3992; Blattman JN, 2003, NAT MED, V9, P540, DOI 10.1038/nm866; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; BUCY RP, 1994, J EXP MED, V180, P1251, DOI 10.1084/jem.180.4.1251; Cauley LS, 2002, J IMMUNOL, V169, P6655, DOI 10.4049/jimmunol.169.12.6655; Chambers CA, 1997, IMMUNITY, V7, P885, DOI 10.1016/S1074-7613(00)80406-9; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Chu CQ, 2000, J EXP MED, V192, P123, DOI 10.1084/jem.192.1.123; Dalton DK, 2000, J EXP MED, V192, P117, DOI 10.1084/jem.192.1.117; Davenport MP, 2002, J IMMUNOL, V168, P3309, DOI 10.4049/jimmunol.168.7.3309; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Gudmundsdottir H, 1999, J IMMUNOL, V162, P5212; Harbertson J, 2002, J IMMUNOL, V168, P1095, DOI 10.4049/jimmunol.168.3.1095; Harrington LE, 2002, J VIROL, V76, P3329, DOI 10.1128/JVI.76.7.3329-3337.2002; Harty JT, 2002, CURR OPIN IMMUNOL, V14, P360, DOI 10.1016/S0952-7915(02)00333-3; Hildeman DA, 2002, CURR OPIN IMMUNOL, V14, P354, DOI 10.1016/S0952-7915(02)00335-7; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Hu H, 2001, NAT IMMUNOL, V2, P705, DOI 10.1038/90643; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Jelley-Gibbs DM, 2000, J IMMUNOL, V165, P5017, DOI 10.4049/jimmunol.165.9.5017; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kelso A, 1999, INT IMMUNOL, V11, P617, DOI 10.1093/intimm/11.4.617; Kim CH, 2001, J CLIN INVEST, V108, P1331, DOI 10.1172/JCI200113543; Lantz O, 2000, NAT IMMUNOL, V1, P54, DOI 10.1038/76917; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; Lee WT, 2002, J IMMUNOL, V168, P1682, DOI 10.4049/jimmunol.168.4.1682; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Lima KM, 2001, VACCINE, V19, P3518, DOI 10.1016/S0264-410X(01)00042-1; Maini MK, 2000, J IMMUNOL, V165, P5729, DOI 10.4049/jimmunol.165.10.5729; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mendez S, 2001, J IMMUNOL, V166, P5122, DOI 10.4049/jimmunol.166.8.5122; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; OPENSHAW P, 1995, J EXP MED, V182, P1357, DOI 10.1084/jem.182.5.1357; Panus JF, 2000, J EXP MED, V192, P1301, DOI 10.1084/jem.192.9.1301; Ravkov EV, 2003, J IMMUNOL, V170, P2461, DOI 10.4049/jimmunol.170.5.2461; Refaeli Y, 2002, J EXP MED, V196, P999, DOI 10.1084/JEM.20020666; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Rogers PR, 2001, IMMUNITY, V15, P445, DOI 10.1016/S1074-7613(01)00191-1; Roman E, 2002, J EXP MED, V196, P957, DOI 10.1084/jem.20021052; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Seddon B, 2003, NAT IMMUNOL, V4, P680, DOI 10.1038/ni946; Selin LK, 1999, IMMUNITY, V11, P733, DOI 10.1016/S1074-7613(00)80147-8; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Silva CL, 1999, IMMUNOLOGY, V97, P573; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Unsoeld H, 2002, J IMMUNOL, V169, P638, DOI 10.4049/jimmunol.169.2.638; van Stipdonk MJB, 2003, NAT IMMUNOL, V4, P361, DOI 10.1038/ni912; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Varga SM, 2001, J IMMUNOL, V166, P1554, DOI 10.4049/jimmunol.166.3.1554; Wang XW, 2001, J EXP MED, V194, P1069, DOI 10.1084/jem.194.8.1069; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Whitmire JK, 2000, CURR OPIN IMMUNOL, V12, P448, DOI 10.1016/S0952-7915(00)00119-9; Winslow GM, 2003, J IMMUNOL, V170, P2046, DOI 10.4049/jimmunol.170.4.2046; Wong P, 2001, J IMMUNOL, V166, P5864, DOI 10.4049/jimmunol.166.10.5864; Wu CY, 2002, NAT IMMUNOL, V3, P852, DOI 10.1038/ni832; Xu HJ, 2002, J EXP MED, V195, P881, DOI 10.1084/jem.20011174; Zhang XH, 1997, J EXP MED, V185, P1837, DOI 10.1084/jem.185.10.1837	75	604	645	1	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2003	4	9					835	842		10.1038/ni969	http://dx.doi.org/10.1038/ni969			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	715YN	12942084	Bronze			2022-12-18	WOS:000185002200009
J	Zhang, ZQ; Yuan, B; Bao, MS; Lu, N; Kim, T; Liu, YJ				Zhang, Zhiqiang; Yuan, Bin; Bao, Musheng; Lu, Ning; Kim, Taeil; Liu, Yong-Jun			The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells	NATURE IMMUNOLOGY			English	Article							INNATE IMMUNE-RESPONSES; DOUBLE-STRANDED-RNA; RIG-I; FRANCISELLA-TULARENSIS; AIM2 INFLAMMASOME; CYTOPLASMIC DNA; DAI DLM-1/ZBP1; CYTOSOLIC DNA; VIRUSES; RECOGNITION	The recognition of pathogenic DNA is important to the initiation of antiviral responses. Here we report the identification of DDX41, a member of the DEXDc family of helicases, as an intracellular DNA sensor in myeloid dendritic cells (mDCs). Knockdown of DDX41 expression by short hairpin RNA blocked the ability of mDCs to mount type I interferon and cytokine responses to DNA and DNA viruses. Overexpression of both DDX41 and the membrane-associated adaptor STING together had a synergistic effect in promoting Ifnb promoter activity. DDX41 bound both DNA and STING and localized together with STING in the cytosol. Knockdown of DDX41 expression blocked activation of the mitogen-activated protein kinase TBK1 and the transcription factors NF-kappa B and IRF3 by B-form DNA. Our results suggest that DDX41 is an additional DNA sensor that depends on STING to sense pathogenic DNA.	[Zhang, Zhiqiang; Yuan, Bin; Bao, Musheng; Lu, Ning; Kim, Taeil; Liu, Yong-Jun] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Ctr Canc Immunol Res, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Liu, YJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Ctr Canc Immunol Res, Houston, TX 77030 USA.	yjliu@mdanderson.org			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI091947] Funding Source: NIH RePORTER; NIAID NIH HHS [R37 AI091947] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Cheng GF, 2007, P NATL ACAD SCI USA, V104, P9035, DOI 10.1073/pnas.0703285104; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kim T, 2010, P NATL ACAD SCI USA, V107, P15181, DOI 10.1073/pnas.1006539107; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Pippig DA, 2009, NUCLEIC ACIDS RES, V37, P2014, DOI 10.1093/nar/gkp059; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeuchi O, 2007, IMMUNOL REV, V220, P214, DOI 10.1111/j.1600-065X.2007.00562.x; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wang ZC, 2008, P NATL ACAD SCI USA, V105, P5477, DOI 10.1073/pnas.0801295105; Zhang ZQ, 2011, IMMUNITY, V34, P866, DOI 10.1016/j.immuni.2011.03.027; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	28	602	640	7	98	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2011	12	10					959	U62		10.1038/ni.2091	http://dx.doi.org/10.1038/ni.2091			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	822XS	21892174	Green Accepted			2022-12-18	WOS:000295084500011
J	Du, CS; Liu, C; Kang, JH; Zhao, GX; Ye, ZQ; Huang, SC; Li, ZX; Wu, ZY; Pei, G				Du, Changsheng; Liu, Chang; Kang, Jiuhong; Zhao, Guixian; Ye, Zhiqiang; Huang, Shichao; Li, Zhenxin; Wu, Zhiying; Pei, Gang			MicroRNA miR-326 regulates T-H-17 differentiation and is associated with the pathogenesis of multiple sclerosis	NATURE IMMUNOLOGY			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; NEUROMYELITIS-OPTICA; CELL-DIFFERENTIATION; IMMUNE-SYSTEM; TH17 CELLS; T-CELLS; C-MYB; DISEASE; INTERLEUKIN-17; AUTOIMMUNITY	Interleukin 17 (IL-17)-producing T helper cells (T-H-17 cells) are increasingly recognized as key participants in various autoimmune diseases, including multiple sclerosis. Although sets of transcription factors and cytokines are known to regulate T-H-17 differentiation, the role of noncoding RNA is poorly understood. Here we identify a T-H-17 cell-associated microRNA, miR-326, whose expression was highly correlated with disease severity in patients with multiple sclerosis and mice with experimental autoimmune encephalomyelitis (EAE). In vivo silencing of miR-326 resulted in fewer T-H-17 cells and mild EAE, and its overexpression led to more T-H-17 cells and severe EAE. We also found that miR-326 promoted T-H-17 differentiation by targeting Ets-1, a negative regulator of T-H-17 differentiation. Our data show a critical role for microRNA in T-H-17 differentiation and the pathogenesis of multiple sclerosis.	[Du, Changsheng; Liu, Chang; Kang, Jiuhong; Huang, Shichao; Pei, Gang] Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Lab Mol Cell Biol,Inst Biochem & Cell Biol, Shanghai, Peoples R China; [Kang, Jiuhong; Pei, Gang] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Zhao, Guixian; Li, Zhenxin; Wu, Zhiying] Huashan Hosp, Shanghai Med Coll, Dept Neurol, Shanghai, Peoples R China; [Zhao, Guixian; Li, Zhenxin; Wu, Zhiying] Huashan Hosp, Shanghai Med Coll, Inst Neurol, Shanghai, Peoples R China; [Ye, Zhiqiang] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Tongji University; Fudan University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Pei, G (corresponding author), Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Lab Mol Cell Biol,Inst Biochem & Cell Biol, Shanghai, Peoples R China.	gpei@sibs.ac.cn	Du, Changsheng/E-1552-2011; Ye, Zhi-Qiang/N-8513-2014	Ye, Zhi-Qiang/0000-0002-8822-6148	Ministry of Science and Technology [2005CB522406, 2009CB941100]; National Natural Science Foundation of China [30621091, 30625014, 30623003, 30871285, 90713047, 90919028]; Shanghai Municipal Commission for Science and Technology [07PJ14099]; Chinese Academy of Sciences [2007KIP204, SIBS2008001]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission for Science and Technology; Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank C. Dong (Anderson Cancer Center, Houston) for retrovector RV-GFP; X. Liu (Shanghai Institute for Biological Sciences) for fluorescein isothiocyanate -conjugated antibody to mouse T cell antigen receptor gamma delta; C. Wu (Sun Yat-sen University) for phycoerythrin-conjugated antibody to human CCR6; J. Zhao, L. Wei, Y. Shi, Q. Jing and G. Gao for discussions; and J. Zou, S. Xin, X. Zeng and S. Chen for technical assistance. Supported by the Ministry of Science and Technology (2005CB522406 and 2009CB941100), the National Natural Science Foundation of China (30621091, 30625014, 30623003, 30871285, 90713047 and 90919028), the Shanghai Municipal Commission for Science and Technology (07PJ14099) and the Chinese Academy of Sciences (2007KIP204 and SIBS2008001).	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Brusaferri F, 2000, J NEUROL, V247, P435, DOI 10.1007/s004150070172; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Hoefig KP, 2008, CURR OPIN IMMUNOL, V20, P281, DOI 10.1016/j.coi.2008.05.005; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; John Bino, 2006, V342, P101, DOI 10.1385/1-59745-123-1:101; Kantarci OH, 2008, SEMIN NEUROL, V28, P7, DOI 10.1055/s-2007-1019125; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lin YC, 2008, MOL BIOL EVOL, V25, P2189, DOI 10.1093/molbev/msn165; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Moisan J, 2007, J EXP MED, V204, P2825, DOI 10.1084/jem.20070994; Pan D, 2002, MOL THER, V6, P19, DOI 10.1006/mthe.2002.0630; PETTINELLI CB, 1981, J IMMUNOL, V127, P1420; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Schrempf W, 2007, AUTOIMMUN REV, V6, P469, DOI 10.1016/j.autrev.2007.02.003; Slack FJ, 2008, NEW ENGL J MED, V359, P2720, DOI 10.1056/NEJMe0808667; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou L, 2009, CURR OPIN IMMUNOL, V21, P146, DOI 10.1016/j.coi.2009.03.001; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707	41	602	662	1	100	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2009	10	12					1252	U4		10.1038/ni.1798	http://dx.doi.org/10.1038/ni.1798			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	520TX	19838199	Green Published			2022-12-18	WOS:000271872800008
J	Yasukawa, H; Ohishi, M; Mori, H; Murakami, M; Chinen, T; Aki, D; Hanada, T; Takeda, K; Akira, S; Hoshijima, M; Hirano, T; Chien, KR; Yoshimura, A				Yasukawa, H; Ohishi, M; Mori, H; Murakami, M; Chinen, T; Aki, D; Hanada, T; Takeda, K; Akira, S; Hoshijima, M; Hirano, T; Chien, KR; Yoshimura, A			IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages	NATURE IMMUNOLOGY			English	Article							CYTOKINE SIGNALING-3; MESSENGER-RNA; RECEPTOR; STAT3; DIFFERENTIATION; INTERLEUKIN-10; ACTIVATION; SUPPRESSOR; GROWTH; REGULATOR	Whereas interleukin-6 (IL-6) is a proinflammatory cytokine, IL-10 is an anti-inflammatory cytokine. Although signal transducer and activator of transcription 3 (STAT3) is essential for the function of both IL-6 and IL-10, it is unclear how these two cytokines have such opposing functions. Here we show that suppressor of cytokine signaling 3 (SOCS3) is a key regulator of the divergent action of these two cytokines. In macrophages lacking the Socs3 gene or carrying a mutation of the SOCS3-binding site in gp130, the lipopolysaccharide-induced production of tumor necrosis factor (TNF) and IL-12 is suppressed by both IL-10 and IL-6. SOCS3 specifically prevents activation of STAT3 by IL-6 but not IL-10. Taken together, these data indicate that SOCS3 selectively blocks signaling by IL-6, thereby preventing its ability to inhibit LPS signaling.	Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Inst Mol Med, La Jolla, CA 92093 USA; Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Higashi Ku, Fukuoka 8128582, Japan; Osaka Univ, Grad Sch Med, Dept Mol Oncol C7, Suita, Osaka 5650871, Japan; Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; Kyushu University; Osaka University; Osaka University	Yoshimura, A (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yakihiko@bioreg.kyushu-u.ac.jp	Yoshimura, Akihiko/K-5515-2013; Hirano, Toshio/C-8194-2009; Akira, Shizuo/C-3134-2009; MORI, HIROYUKI/D-3343-2013; Takeda, Kiyoshi/C-9331-2009	, Masaaki/0000-0001-7159-7279				Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alonzi T, 1998, J EXP MED, V187, P461, DOI 10.1084/jem.187.4.461; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Atsumi T, 2002, J EXP MED, V196, P979, DOI 10.1084/jem.20020619; Berlato C, 2002, J IMMUNOL, V168, P6404, DOI 10.4049/jimmunol.168.12.6404; Bode JG, 1999, FEBS LETT, V463, P365, DOI 10.1016/S0014-5793(99)01662-2; Cassatella MA, 1999, BLOOD, V94, P2880, DOI 10.1182/blood.V94.8.2880.420k31_2880_2889; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Huber TS, 2000, SHOCK, V13, P425, DOI 10.1097/00024382-200006000-00002; Ishihara K, 2002, CYTOKINE GROWTH F R, V13, P357, DOI 10.1016/S1359-6101(02)00027-8; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kuo HC, 1999, DEVELOPMENT, V126, P4223; Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240; Lehmann U, 2003, J BIOL CHEM, V278, P661, DOI 10.1074/jbc.M210552200; Masuhara M, 1997, BIOCHEM BIOPH RES CO, V239, P439, DOI 10.1006/bbrc.1997.7484; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; Nicholson SE, 2000, P NATL ACAD SCI USA, V97, P6493, DOI 10.1073/pnas.100135197; Niemand C, 2003, J IMMUNOL, V170, P3263, DOI 10.4049/jimmunol.170.6.3263; Riley JK, 1999, J BIOL CHEM, V274, P16513, DOI 10.1074/jbc.274.23.16513; Roberts AW, 2001, P NATL ACAD SCI USA, V98, P9324, DOI 10.1073/pnas.161271798; Sasaki A, 2000, J BIOL CHEM, V275, P29338, DOI 10.1074/jbc.M003456200; Sasaki A, 2003, J BIOL CHEM, V278, P2432, DOI 10.1074/jbc.C200608200; Shouda T, 2001, J CLIN INVEST, V108, P1781, DOI 10.1172/JCI13568; Stoiber D, 1999, J IMMUNOL, V163, P2640; Suzuki R, 1998, ONCOGENE, V17, P2271, DOI 10.1038/sj.onc.1202143; Takahashi Y, 2003, EMBO J, V22, P372, DOI 10.1093/emboj/cdg057; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; WeberNordt RM, 1996, J BIOL CHEM, V271, P27954, DOI 10.1074/jbc.271.44.27954; Yamanaka Y, 1996, EMBO J, V15, P1557, DOI 10.1002/j.1460-2075.1996.tb00500.x; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143; Yokouchi M, 1997, ONCOGENE, V15, P7, DOI 10.1038/sj.onc.1201163	36	602	620	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2003	4	6					551	556		10.1038/ni938	http://dx.doi.org/10.1038/ni938			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	683XC	12754507				2022-12-18	WOS:000183175500014
J	O'Connor, W; Kamanaka, M; Booth, CJ; Town, T; Nakae, S; Iwakura, Y; Kolls, JK; Flavell, RA				O'Connor, William, Jr.; Kamanaka, Masahito; Booth, Carmen J.; Town, Terrence; Nakae, Susumu; Iwakura, Yoichiro; Kolls, Jay K.; Flavell, Richard A.			A protective function for interleukin 17A in T cell-mediated intestinal inflammation	NATURE IMMUNOLOGY			English	Article							BOWEL-DISEASE; AUTOIMMUNE INFLAMMATION; NEUTROPHIL RECRUITMENT; INTERFERON-GAMMA; IL-23; MICE; EXPRESSION; DISTINCT; IL-17; RESPONSES	Interleukin 23 (IL-23) and IL-17 have been linked to the pathogenesis of several chronic inflammatory disorders, including inflammatory bowel disease. Yet as an important function for IL-23 is emerging, the function of IL-17 in inflammatory bowel disease remains unclear. Here we demonstrate IL-17A-mediated protection in the CD45RB(hi) transfer model of colitis. An accelerated wasting disease elicited by T cells deficient in IL-17A correlated with higher expression of genes encoding T helper type 1-type cytokines in colon tissue. IL-17A also modulated T helper type 1 polarization in vitro. Furthermore, T cells deficient in the IL-17 receptor elicited an accelerated, aggressive wasting disease relative to that elicited by wild-type T cells in recipient mice. Our data demonstrate a protective function for IL-17 and identify T cells as not only the source but also a target of IL-17 in vivo.	[O'Connor, William, Jr.; Kamanaka, Masahito; Town, Terrence; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunol, New Haven, CT 06520 USA; [Booth, Carmen J.] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06510 USA; [Nakae, Susumu; Iwakura, Yoichiro] Univ Tokyo, Ctr Med Expt, Tokyo, Japan; [Kolls, Jay K.] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; [Flavell, Richard A.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06511 USA	Yale University; Yale University; University of Tokyo; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Howard Hughes Medical Institute; Yale University	Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunol, New Haven, CT 06520 USA.	richard.flavell@yale.edu	Iwakura, Yoichiro/E-5457-2011; Kolls, Jay/AAH-1829-2019	Iwakura, Yoichiro/0000-0002-9934-5775; Kolls, Jay/0000-0001-5151-6304	National Multiple Sclerosis Society; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL079142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG029726] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank G. Tokmoulina for assistance with flow cytometry cell sorting; E. Esplugues for critical reading of the manuscript and comments; A. Lin for assistance with statistical analyses; and F. Manzo for administrative assistance. Supported by the National Multiple Sclerosis Society (W.O.) and the Howard Hughes Medical Institute (R. A. F.).	Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Boismenu R, 1999, MICROBES INFECT, V1, P235, DOI 10.1016/S1286-4579(99)80039-2; BREESE E, 1993, IMMUNOLOGY, V78, P127; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dubinsky MC, 2007, INFLAMM BOWEL DIS, V13, P511, DOI 10.1002/ibd.20126; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Harries-Rees K, 2005, CHEM WORLD-UK, V2, P6; Honorati MC, 2001, RHEUMATOLOGY, V40, P522, DOI 10.1093/rheumatology/40.5.522; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Ito H, 1997, J AUTOIMMUN, V10, P455, DOI 10.1016/S0896-8411(97)90152-9; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; KOLLOCH RE, 2004, PERFUSION-GERMANY, V17, P467; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Laan M, 1999, J IMMUNOL, V162, P2347; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Montgomery RR, 2007, INFECT IMMUN, V75, P613, DOI 10.1128/IAI.00685-06; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; O'Regan AW, 2000, J LEUKOCYTE BIOL, V68, P495; Ogawa A, 2004, CLIN IMMUNOL, V110, P55, DOI 10.1016/j.clim.2003.09.013; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Renkl AC, 2005, BLOOD, V106, P946, DOI 10.1182/blood-2004-08-3228; Schwarzenberger P, 1998, J IMMUNOL, V161, P6383; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Tlaskalova-Hogenova H, 2005, ANN NY ACAD SCI, V1051, P787, DOI 10.1196/annals.1361.122; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zhang JP, 2006, POLYM ADVAN TECHNOL, V17, P12, DOI 10.1002/pat.676; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	35	601	611	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2009	10	6					603	U65		10.1038/ni.1736	http://dx.doi.org/10.1038/ni.1736			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	450EP	19448631	Green Accepted			2022-12-18	WOS:000266384100012
J	Collison, LW; Chaturvedi, V; Henderson, AL; Giacomin, PR; Guy, C; Bankoti, J; Finkelstein, D; Forbes, K; Workman, CJ; Brown, SA; Rehg, JE; Jones, ML; Ni, HT; Artis, D; Turk, MJ; Vignali, DAA				Collison, Lauren W.; Chaturvedi, Vandana; Henderson, Abigail L.; Giacomin, Paul R.; Guy, Cliff; Bankoti, Jaishree; Finkelstein, David; Forbes, Karen; Workman, Creg J.; Brown, Scott A.; Rehg, Jerold E.; Jones, Michael L.; Ni, Hsiao-Tzu; Artis, David; Turk, Mary Jo; Vignali, Dario A. A.			IL-35-mediated induction of a potent regulatory T cell population	NATURE IMMUNOLOGY			English	Article							INFECTIOUS TOLERANCE; TUMOR-IMMUNITY; CUTTING EDGE; ACTIVATION; ENCEPHALOMYELITIS; CONTRIBUTES; EXPRESSION; GENERATION; RESPONSES; EFFECTOR	Regulatory T cells (T-reg cells) have a critical role in the maintenance of immunological self-tolerance. Here we show that treatment of naive human or mouse T cells with IL-35 induced a regulatory population, which we call 'iT(R)35 cells', that mediated suppression via IL-35 but not via the inhibitory cytokines IL-10 or transforming growth factor-beta (TGF-beta). We found that iT(R)35 cells did not express or require the transcription factor Foxp3, and were strongly suppressive and stable in vivo. T-reg cells induced the generation of iT(R)35 cells in an IL-35- and IL-10-dependent manner in vitro and induced their generation in vivo under inflammatory conditions in intestines infected with Trichuris muris and within the tumor microenvironment (B16 melanoma and MC38 colorectal adenocarcinoma), where they contributed to the regulatory milieu. Thus, iT(R)35 cells constitute a key mediator of infectious tolerance and contribute to T-reg cell-mediated tumor progression. Furthermore, iT(R)35 cells generated ex vivo might have therapeutic utility.	[Collison, Lauren W.; Chaturvedi, Vandana; Henderson, Abigail L.; Guy, Cliff; Bankoti, Jaishree; Forbes, Karen; Workman, Creg J.; Brown, Scott A.; Vignali, Dario A. A.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Giacomin, Paul R.; Artis, David] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; [Giacomin, Paul R.; Artis, David] Univ Penn, Dept Pathobiol, Philadelphia, PA 19104 USA; [Finkelstein, David] St Jude Childrens Res Hosp, Dept Bioinformat, Memphis, TN 38105 USA; [Rehg, Jerold E.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Jones, Michael L.] Shenandoah Biotechnol, Monroe, OH USA; [Ni, Hsiao-Tzu] R&D Syst, Dept Antibody Applicat, Minneapolis, MN USA; [Turk, Mary Jo] Dartmouth Med Sch, Dept Microbiol & Immunol, Lebanon, NH USA	St Jude Children's Research Hospital; University of Pennsylvania; University of Pennsylvania; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Dartmouth College	Vignali, DAA (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	vignali.lab@stjude.org	Rehg, Jerold E/N-8111-2018	Artis, David/0000-0002-1753-4100; Giacomin, Paul/0000-0002-6326-6792	National Institutes of Health [R01 AI39480, R01 AI61570, R01 AI74878, F32 AI072816]; Australian National Health and Medical Research Council; National Cancer Institute Comprehensive Cancer Center [CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA023108, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074878, R01AI091977, R01AI061570, R01AI095466, F32AI072816, R01AI039480] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Cancer Institute Comprehensive Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Blumberg and T. Kuo (Brigham and Women's Hospital) for Ebi3<SUP>-/-</SUP>mice; A. Rudensky (Memorial Sloan-Kettering Cancer Center) for Foxp3<SUP>gfp</SUP> mice; J. Ihle (St. Jude Children's Research Hospital; with permission from A. Rudensky) for Foxp3<SUP>-/-</SUP> mice; T. Geiger (St. Jude Children's Research Hospital) for Il10<SUP>-/-</SUP> mice; B. Triplett, D. Regan, M. Howard and M. McKenna (St. Louis Cord Blood Bank) for cord blood samples; D. Campana (St. Jude Children's Research Hospital) for the proprietary permeabilization buffer; A. Korman and M. Selby (Medarex- Bristol Myers Squibb) for MC38 colorectal adenocarcinoma cells; and S. Burns, H. Chi, R. Cross, K. Forbes, D. Green, G. Lennon, L. Jones, A. Krause, T. Moore, S. Morgan, A. Szymczak- Workman and K. Vignali for discussions and assistance. Supported by the National Institutes of Health (R01 AI39480 to D. A. A. V.; R01 AI61570 and R01 AI74878 to D. A.; and F32 AI072816 to L. W. C.), the Australian National Health and Medical Research Council Overseas Biomedical Fellowship Program (P. R. G.), the National Cancer Institute Comprehensive Cancer Center (CA21765 subaward to D. A. A. V.) and the American Lebanese Syrian Associated Charities (D. A. A. V.).	Allan SE, 2008, EUR J IMMUNOL, V38, P3282, DOI 10.1002/eji.200838373; Andersson J, 2008, J EXP MED, V205, P1975, DOI 10.1084/jem.20080308; Annacker O, 2001, IMMUNOL REV, V182, P5, DOI 10.1034/j.1600-065X.2001.1820101.x; Artis D, 2004, J IMMUNOL, V173, P5626, DOI 10.4049/jimmunol.173.9.5626; Bardel E, 2008, J IMMUNOL, V181, P6898, DOI 10.4049/jimmunol.181.10.6898; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Collison LW, 2009, J IMMUNOL, V182, P6121, DOI 10.4049/jimmunol.0803646; D'Elia R, 2009, J IMMUNOL, V182, P2340, DOI 10.4049/jimmunol.0802767; Di Stasi A, 2009, BLOOD, V113, P6392, DOI 10.1182/blood-2009-03-209650; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Horwitz DA, 2004, SEMIN IMMUNOL, V16, P135, DOI 10.1016/j.smim.2003.12.009; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Huter EN, 2008, EUR J IMMUNOL, V38, P1814, DOI 10.1002/eji.200838346; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Jonuleit H, 2002, J EXP MED, V196, P255, DOI 10.1084/jem.20020394; Kemper C, 2003, NATURE, V421, P388, DOI 10.1038/nature01315; Kocak E, 2006, CANCER RES, V66, P7276, DOI 10.1158/0008-5472.CAN-05-2128; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; Milojevic Diana, 2008, Pediatr Rheumatol Online J, V6, P20, DOI 10.1186/1546-0096-6-20; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Nguyen KD, 2009, AM J RESP CRIT CARE, V180, P823, DOI 10.1164/rccm.200905-0761OC; NORTH RJ, 1984, J EXP MED, V159, P1295, DOI 10.1084/jem.159.5.1295; Olkhanud PB, 2009, CANCER RES, V69, P5996, DOI 10.1158/0008-5472.CAN-08-4619; Peggs KS, 2009, J EXP MED, V206, P1717, DOI 10.1084/jem.20082492; Rocke DM, 2003, BIOINFORMATICS, V19, P966, DOI 10.1093/bioinformatics/btg107; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Schwartz RH, 1996, J EXP MED, V184, P1, DOI 10.1084/jem.184.1.1; Selvaraj RK, 2008, J IMMUNOL, V180, P2830, DOI 10.4049/jimmunol.180.5.2830; Shevach EM, 2006, IMMUNITY, V25, P195, DOI 10.1016/j.immuni.2006.08.003; Turk MJ, 2004, J EXP MED, V200, P771, DOI 10.1084/jem.20041130; Verbsky JW, 2007, CURR OPIN RHEUMATOL, V19, P252, DOI 10.1097/BOR.0b013e3280ad46bb; Vignali DAA, 1999, J IMMUNOL, V162, P1431; Waldmann H, 2008, NAT IMMUNOL, V9, P1001, DOI 10.1038/ni0908-1001; Waldmann H, 2006, IMMUNOL REV, V212, P301, DOI 10.1111/j.0105-2896.2006.00406.x; Workman CJ, 2004, J IMMUNOL, V172, P5450, DOI 10.4049/jimmunol.172.9.5450; WORKMAN CJ, REGULATORY IN PRESS; Workman CJ, 2009, CELL MOL LIFE SCI, V66, P2603, DOI 10.1007/s00018-009-0026-2; Zhang PS, 2007, CANCER RES, V67, P6468, DOI 10.1158/0008-5472.CAN-07-1264; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	50	599	662	1	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2010	11	12					1093	U97		10.1038/ni.1952	http://dx.doi.org/10.1038/ni.1952			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	680UX	20953201	Green Accepted			2022-12-18	WOS:000284262200008
J	Lahouassa, H; Daddacha, W; Hofmann, H; Ayinde, D; Logue, EC; Dragin, L; Bloch, N; Maudet, C; Bertrand, M; Gramberg, T; Pancino, G; Priet, S; Canard, B; Laguette, N; Benkirane, M; Transy, C; Landau, NR; Kim, B; Margottin-Goguet, F				Lahouassa, Hichem; Daddacha, Waaqo; Hofmann, Henning; Ayinde, Diana; Logue, Eric C.; Dragin, Loic; Bloch, Nicolin; Maudet, Claire; Bertrand, Matthieu; Gramberg, Thomas; Pancino, Gianfranco; Priet, Stephane; Canard, Bruno; Laguette, Nadine; Benkirane, Monsef; Transy, Catherine; Landau, Nathaniel R.; Kim, Baek; Margottin-Goguet, Florence			SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates	NATURE IMMUNOLOGY			English	Article							HUMAN DENDRITIC CELLS; MITOCHONDRIAL-DNA DEPLETION; AICARDI-GOUTIERES-SYNDROME; INNATE IMMUNE-RESPONSE; REVERSE-TRANSCRIPTASE; RIBONUCLEOTIDE REDUCTASE; MONONUCLEAR PHAGOCYTES; HUMAN MACROPHAGES; BINDING PROTEIN; VPX	SAMHD1 restricts the infection of dendritic and other myeloid cells by human immunodeficiency virus type 1 (HIV-1), but in lentiviruses of the simian immunodeficiency virus of sooty mangabey (SIVsm)-HIV-2 lineage, SAMHD1 is counteracted by the virion-packaged accessory protein Vpx. Here we found that SAMHD1 restricted infection by hydrolyzing intracellular deoxynucleoside triphosphates (dNTPs), lowering their concentrations to below those required for the synthesis of the viral DNA by reverse transcriptase (RT). SAMHD1-mediated restriction was alleviated by the addition of exogenous deoxynucleosides. An HIV-1 with a mutant RT with low affinity for dNTPs was particularly sensitive to SAMHD1-mediated restriction. Vpx prevented the SAMHD1-mediated decrease in dNTP concentration and induced the degradation of human and rhesus macaque SAMHD1 but had no effect on mouse SAMHD1. Nucleotide-pool depletion could be a general mechanism for protecting cells from infectious agents that replicate through a DNA intermediate.	[Hofmann, Henning; Logue, Eric C.; Bloch, Nicolin; Landau, Nathaniel R.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Lahouassa, Hichem; Ayinde, Diana; Dragin, Loic; Maudet, Claire; Bertrand, Matthieu; Transy, Catherine; Margottin-Goguet, Florence] Inst Natl Sante & Rech Med U1016, Inst Cochin, Paris, France; [Lahouassa, Hichem; Ayinde, Diana; Dragin, Loic; Maudet, Claire; Bertrand, Matthieu; Transy, Catherine; Margottin-Goguet, Florence] Ctr Natl Rech Sci, UMR8104, Paris, France; [Lahouassa, Hichem; Ayinde, Diana; Dragin, Loic; Maudet, Claire; Bertrand, Matthieu; Transy, Catherine; Margottin-Goguet, Florence] Univ Paris 05, Paris, France; [Daddacha, Waaqo; Kim, Baek] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Gramberg, Thomas] Univ Erlangen Nurnberg, Inst Virol, D-91054 Erlangen, Germany; [Pancino, Gianfranco] Inst Pasteur, Unite Regulat Infect Retrovirales, Paris, France; [Priet, Stephane; Canard, Bruno] Univ Aix Marseille, Lab Architecture & Fonct Macromol Biol, UMR6098, Ctr Natl Rech Sci, Marseille, France; [Laguette, Nadine; Benkirane, Monsef] Ctr Natl Rech Sci UPR1142, Inst Genet Humaine, Mol Virol Lab, Montpellier, France; Kyung Hee Univ, Dept Pharm, Seoul, South Korea	New York University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Rochester; University of Erlangen Nuremberg; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Kyung Hee University	Landau, NR (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.	nathaniel.landau@med.nyu.edu; baek_kim@urmc.rochester.edu; florence.margottin-goguet@inserm.fr	Priet, Stéphane/N-7952-2017; Maudet, Claire/AAH-1728-2019; Laguette, Nadine/A-2764-2019; Priet, Stéphane/ABD-4869-2020; Gramberg, Thomas/AAW-8706-2020; Margottin-Goguet, Florence/F-9272-2013	Priet, Stéphane/0000-0001-7102-3654; Maudet, Claire/0000-0001-8856-0819; Priet, Stéphane/0000-0001-7102-3654; Margottin-Goguet, Florence/0000-0002-3124-6690; Canard, Bruno/0000-0003-4924-1991; Laguette, Nadine/0000-0001-8072-5607	Agence Nationale de la Recherche sur le SIDA et les Hepatites Virales; SIDACTION; Fondation de France, Mairie de Paris; American Foundation for AIDS Research; US National Institutes of Health [AI049781, A1077401, A1067059, F31 GM095190]; European Research Council [250333]; Paris Diderot University; Ministere de l'Enseignement Superieur et de la Recherche; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049781, R56AI049781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104198, F31GM095190] Funding Source: NIH RePORTER	Agence Nationale de la Recherche sur le SIDA et les Hepatites Virales(ANRSFrench National Research Agency (ANR)); SIDACTION; Fondation de France, Mairie de Paris; American Foundation for AIDS Research; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); Paris Diderot University; Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Stouvenel, K. Labroquere and M. Andrieu for flow cytometry, and J. Hollenbaugh and S. Dewhurst for critical reading of the manuscript. Supported by the Agence Nationale de la Recherche sur le SIDA et les Hepatites Virales (M.Ben., F.M.-G. and H.L.), SIDACTION (M.Ber., F.M.-G. and N.L.), Fondation de France, Mairie de Paris, the American Foundation for AIDS Research, the US National Institutes of Health (AI049781 and A1077401 to B.K.; A1067059 to N.R.L.; and F31 GM095190 to W. D.), the European Research Council (250333 to M.Ben.), Paris Diderot University (C.M. and D.A.) and the Ministere de l'Enseignement Superieur et de la Recherche (C.M. and D.A.).	Berger G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002221; Berger G, 2011, NAT PROTOC, V6, P806, DOI 10.1038/nprot.2011.327; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Brahimi N, 2009, MOL GENET METAB, V97, P221, DOI 10.1016/j.ymgme.2009.03.007; Chowdhury K, 1996, BIOCHEMISTRY-US, V35, P16610, DOI 10.1021/bi961462l; COLLIN M, 1994, VIROLOGY, V200, P114, DOI 10.1006/viro.1994.1169; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; Diamond TL, 2003, J BIOL CHEM, V278, P29913, DOI 10.1074/jbc.M211754200; Fletcher TM, 1996, EMBO J, V15, P6155, DOI 10.1002/j.1460-2075.1996.tb01003.x; Furge LL, 1997, BIOCHEMISTRY-US, V36, P6475, DOI 10.1021/bi9627267; GIBBS JS, 1995, J VIROL, V69, P2378, DOI 10.1128/JVI.69.4.2378-2383.1995; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goujon C, 2006, GENE THER, V13, P991, DOI 10.1038/sj.gt.3302753; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; Goujon C, 2008, J VIROL, V82, P12335, DOI 10.1128/JVI.01181-08; Gramberg T, 2010, J VIROL, V84, P1387, DOI 10.1128/JVI.01437-09; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Jamburuthugoda VK, 2006, J BIOL CHEM, V281, P13388, DOI 10.1074/jbc.M600291200; KAWAMURA M, 1994, MICROBIOL IMMUNOL, V38, P871, DOI 10.1111/j.1348-0421.1994.tb02140.x; Kennedy EM, 2010, J BIOL CHEM, V285, P39380, DOI 10.1074/jbc.M110.178582; LAFUSE WP, 1995, J LEUKOCYTE BIOL, V57, P477, DOI 10.1002/jlb.57.3.477; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Lembo D, 2009, TRENDS BIOCHEM SCI, V34, P25, DOI 10.1016/j.tibs.2008.09.008; Leshinsky-Silver E, 2011, EUR J HUM GENET, V19, P287, DOI 10.1038/ejhg.2010.213; Li N, 2000, IMMUNOL LETT, V74, P221, DOI 10.1016/S0165-2478(00)00276-5; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Mangeot PE, 2002, MOL THER, V5, P283, DOI 10.1006/mthe.2002.0541; MEYERHANS A, 1994, J VIROL, V68, P535, DOI 10.1128/JVI.68.1.535-540.1994; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; OBRIEN WA, 1994, J VIROL, V68, P1258, DOI 10.1128/JVI.68.2.1258-1263.1994; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Schrofelbauer B, 2007, P NATL ACAD SCI USA, V104, P4130, DOI 10.1073/pnas.0610167104; Sharova N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000057; Shi QL, 2002, BIOCHEMISTRY-US, V41, P14831, DOI 10.1021/bi0258389; Skasko M, 2008, J VIROL, V82, P7716, DOI 10.1128/JVI.00120-08; Sunseri N, 2011, J VIROL, V85, P6263, DOI 10.1128/JVI.00346-11; Triques K, 2004, J VIROL, V78, P5523, DOI 10.1128/JVI.78.10.5523-5527.2004; UENO T, 1995, J BIOL CHEM, V270, P23605, DOI 10.1074/jbc.270.40.23605; Vorontsov II, 2011, J BIOL CHEM, V286, P33158, DOI 10.1074/jbc.M111.250456; Woodside AM, 2002, BIOCHEMISTRY-US, V41, P1027, DOI 10.1021/bi011495n; WU XY, 1994, J VIROL, V68, P6161, DOI 10.1128/JVI.68.10.6161-6169.1994; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Zhang Y, 2001, J VIROL, V75, P10511, DOI 10.1128/JVI.75.21.10511-10514.2001; Zimmerman MD, 2008, J MOL BIOL, V378, P215, DOI 10.1016/j.jmb.2008.02.036	49	593	611	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2012	13	3					223	+		10.1038/ni.2236	http://dx.doi.org/10.1038/ni.2236			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	895QF	22327569	Green Accepted			2022-12-18	WOS:000300510600008
J	Chang, YJ; Kim, HY; Albacker, LA; Baumgarth, N; McKenzie, ANJ; Smith, DE; DeKruyff, RH; Umetsu, DT				Chang, Ya-Jen; Kim, Hye Young; Albacker, Lee A.; Baumgarth, Nicole; McKenzie, Andrew N. J.; Smith, Dirk E.; DeKruyff, Rosemarie H.; Umetsu, Dale T.			Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity	NATURE IMMUNOLOGY			English	Article							T-CELLS; VIRAL-INFECTION; VIRUS-INFECTION; IN-VIVO; IL-33; RECEPTOR; ASTHMA; EXPRESSION; CYTOKINE; T1/ST2	Patients with asthma, a major public health problem, are at high risk for serious disease from influenza virus infection, but the pathogenic mechanisms by which influenza A causes airway disease and asthma are not fully known. We show here in a mouse model that influenza infection acutely induced airway hyper-reactivity (AHR), a cardinal feature of asthma, independently of T helper type 2 (TH2) cells and adaptive immunity. Instead, influenza infection induced AHR through a previously unknown pathway that required the interleukin 13 (IL-13)-IL-33 axis and cells of the non-T cell, non-B cell innate lymphoid type called 'natural helper cells'. Infection with influenza A virus, which activates the NLRP3 inflammasome, resulted in much more production of IL-33 by alveolar macrophages, which in turn activated natural helper cells producing substantial IL-13.	[Chang, Ya-Jen; Kim, Hye Young; Albacker, Lee A.; DeKruyff, Rosemarie H.; Umetsu, Dale T.] Harvard Univ, Childrens Hosp, Sch Med, Div Immunol & Allergy, Boston, MA 02115 USA; [Baumgarth, Nicole] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [McKenzie, Andrew N. J.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Smith, Dirk E.] Amgen Inc, Dept Inflammat Res, Seattle, WA USA	Harvard University; Boston Children's Hospital; Harvard Medical School; University of California System; University of California Davis; MRC Laboratory Molecular Biology; Amgen	Umetsu, DT (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Div Immunol & Allergy, Boston, MA 02115 USA.	dale.umetsu@childrens.harvard.edu	Kim, Hye Young/AAF-7609-2020; Chang, Ya-Jen/O-1584-2018; Baumgarth, Nicole/AAI-6949-2020	Kim, Hye Young/0000-0001-5978-512X; Chang, Ya-Jen/0000-0003-1377-6142; Albacker, Lee/0000-0002-5070-1783	US National Institutes of Health [R01 AI068085, R01 HL62348, R01 051354]; MRC [MC_U105178805] Funding Source: UKRI; Medical Research Council [MC_U105178805] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL099839, R01HL062348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026322, R01AI068085] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Grusby (Harvard School of Public Health) for CD1d-deficient mice (backcrossed to the BALB/c strain) and Z. Luo for technical support. Supported by the US National Institutes of Health (R01 AI068085, R01 HL62348 and R01 051354).	Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; BAUMGARTH N, 1994, J VIROL, V68, P7575, DOI 10.1128/JVI.68.11.7575-7581.1994; Bortoluci KR, 2010, CELL MOL LIFE SCI, V67, P1643, DOI 10.1007/s00018-010-0335-5; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Cherry WB, 2008, J ALLERGY CLIN IMMUN, V121, P1484, DOI 10.1016/j.jaci.2008.04.005; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hansen G, 1999, J CLIN INVEST, V103, P175, DOI 10.1172/JCI5155; Hoshino K, 1999, J EXP MED, V190, P1541, DOI 10.1084/jem.190.10.1541; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Johnston RA, 2007, AM J RESP CRIT CARE, V176, P650, DOI 10.1164/rccm.200702-323OC; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kearley J, 2005, J EXP MED, V202, P1539, DOI 10.1084/jem.20051166; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Kondo Y, 2008, INT IMMUNOL, V20, P791, DOI 10.1093/intimm/dxn037; Kurowska-Stolarska M., 2009, J IMMUNOL, V183, P6469; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Mangan NE, 2007, EUR J IMMUNOL, V37, P1302, DOI 10.1002/eji.200636520; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Oboki Keisuke, 2008, Allergol Int, V57, P121, DOI 10.2332/allergolint.R-07-160; Pichavant M, 2008, J EXP MED, V205, P385, DOI 10.1084/jem.20071507; Prefontaine D, 2010, J ALLERGY CLIN IMMUN, V125, P752, DOI 10.1016/j.jaci.2009.12.935; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Silver MR, 2010, INFLAMM RES, V59, P207, DOI 10.1007/s00011-009-0088-5; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Walzl G, 2001, J EXP MED, V193, P785, DOI 10.1084/jem.193.7.785; Wood IS, 2009, BIOCHEM BIOPH RES CO, V384, P105, DOI 10.1016/j.bbrc.2009.04.081; Wright RJ, 2005, J ALLERGY CLIN IMMUN, V116, P1301, DOI 10.1016/j.jaci.2005.09.050; Xu DM, 1998, J EXP MED, V188, P1485, DOI 10.1084/jem.188.8.1485; Zhao WH, 2010, CELL MOL IMMUNOL, V7, P260, DOI 10.1038/cmi.2010.3	40	591	614	1	99	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2011	12	7					631	U186		10.1038/ni.2045	http://dx.doi.org/10.1038/ni.2045			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	781MJ	21623379	Green Accepted			2022-12-18	WOS:000291936400011
J	Saccani, S; Pantano, S; Natoli, G				Saccani, S; Pantano, S; Natoli, G			p38-dependent marking of inflammatory genes for increased NF-kappa B recruitment	NATURE IMMUNOLOGY			English	Article							HISTONE H3 PHOSPHORYLATION; CHROMOSOME CONDENSATION; SIGNAL-TRANSDUCTION; DENDRITIC CELLS; KINASE; TRANSCRIPTION; ACETYLATION; ACTIVATION; INDUCTION; PROTEINS	We found that inflammatory stimuli induce p38 mitogen-activated protein kinase-dependent phosphorylation and phosphoacetylation of histone H3; this selectively occurred on the promoters of a subset of stimulus-induced cytokine and chemokine genes. p38 activity was required to enhance the accessibility of the cryptic NF-kappaB binding sites contained in H3 phosphorylated promoters, which indicated that p38-dependent H3 phosphorylation may mark promoters for increased NF-kappaB recruitment. These results show that p38 plays an additional role in the induction of the inflammatory and immune response: the regulation of NF-kappaB recruitment to selected chromatin targets.	Inst Res Biomed, CH-6501 Bellinzona, Switzerland	Universita della Svizzera Italiana	Natoli, G (corresponding author), Inst Res Biomed, Via Vela 6, CH-6501 Bellinzona, Switzerland.		Natoli, gioacchino/J-2100-2018; Natoli, gioacchino/ABB-8679-2020	Saccani, Simona/0000-0001-7572-3308; Natoli, Gioacchino/0000-0003-0711-2411				Alepuz PM, 2001, MOL CELL, V7, P767, DOI 10.1016/S1097-2765(01)00221-0; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; Chadee DN, 1999, J BIOL CHEM, V274, P24914, DOI 10.1074/jbc.274.35.24914; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; English J, 1999, EXP CELL RES, V253, P255, DOI 10.1006/excr.1999.4687; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hecht A, 1999, METHOD ENZYMOL, V304, P399; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hwang KK, 2001, P NATL ACAD SCI USA, V98, P11423, DOI 10.1073/pnas.211303598; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Lo WS, 2001, SCIENCE, V293, P1142, DOI 10.1126/science.1062322; MAHADEVAN LC, 1991, CELL, V65, P775, DOI 10.1016/0092-8674(91)90385-C; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Nowak SJ, 2000, GENE DEV, V14, P3003, DOI 10.1101/gad.848800; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Parvin JD, 1998, CURR OPIN GENET DEV, V8, P565, DOI 10.1016/S0959-437X(98)80012-9; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Thomson S, 1999, SEMIN CELL DEV BIOL, V10, P205, DOI 10.1006/scdb.1999.0302; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Van Hooser A, 1998, J CELL SCI, V111, P3497; Vandel L, 2001, MOL CELL BIOL, V21, P6484, DOI 10.1128/MCB.21.19.6484-6494.2001; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Weinmann AS, 1999, IMMUNITY, V11, P665, DOI 10.1016/S1074-7613(00)80141-7; Weinmann AS, 2001, NAT IMMUNOL, V2, P51, DOI 10.1038/83168	46	591	620	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2002	3	1					69	75		10.1038/ni748	http://dx.doi.org/10.1038/ni748			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	509LF	11743587				2022-12-18	WOS:000173148700017
J	Reth, M				Reth, M			Hydrogen peroxide as second messenger in lymphocyte activation	NATURE IMMUNOLOGY			English	Review							PROTEIN-TYROSINE PHOSPHATASES; CHRONIC GRANULOMATOUS-DISEASE; NF-KAPPA-B; ANTIGEN RECEPTOR; REDOX REGULATION; NADPH OXIDASE; SIGNAL-TRANSDUCTION; NITRIC-OXIDE; CATALYTIC ANTIBODIES; OXIDATIVE STRESS	Oxidants such as H2O2 are connected to lymphocyte activation, but the molecular mechanisms behind this phenomenon are less clear. Here, I review data suggesting that by inhibiting protein tyrosine phosphatases, H2O2 plays an important role as a secondary messenger in the initiation and amplification of signaling at the antigen receptor. These findings explain why exposure of lymphocytes to H2O2 can mimic the effect of antigen. In addition, more recent data show that antigen receptors themselves are H2O2-generating enzymes and that the oxidative burst in macrophages seems to play a role not only in pathogen killing but also in the activation of these as well as neighboring cells. Thus, by controlling the activity of the negative regulatory phosphatases inside the cell, H2O2 can set and influence critical thresholds for lymphocyte activation.	Univ Freiburg, Max Planck Inst Immunbiol, Abt Mol Immunol, D-79108 Freiburg, Germany	Max Planck Society; University of Freiburg	Reth, M (corresponding author), Univ Freiburg, Max Planck Inst Immunbiol, Abt Mol Immunol, Stuebeweg 51, D-79108 Freiburg, Germany.	reth@immunbio.mpg.de						Adler V, 1999, ONCOGENE, V18, P6104, DOI 10.1038/sj.onc.1203128; Amital H, 1995, Methods Mol Biol, V51, P203; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Barford D, 1998, STRUCTURE, V6, P249, DOI 10.1016/S0969-2126(98)00027-6; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bokoch GM, 2002, NAT IMMUNOL, V3, P340, DOI 10.1038/ni0402-340; Bootman MD, 2001, SEMIN CELL DEV BIOL, V12, P3, DOI 10.1006/scdb.2000.0211; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; BUFFINTON GD, 1992, FREE RADICAL RES COM, V16, P99, DOI 10.3109/10715769209049163; BUTTKE TM, 1995, FREE RADICAL RES, V22, P389, DOI 10.3109/10715769509147548; CAMBIER JC, 1995, IMMUNOL TODAY, V16, P110, DOI 10.1016/0167-5699(95)80105-7; Caselli A, 1998, J BIOL CHEM, V273, P32554, DOI 10.1074/jbc.273.49.32554; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Colamussi ML, 1999, BLOOD, V93, P2395, DOI 10.1182/blood.V93.7.2395.407a22_2395_2403; Datta D, 2002, P NATL ACAD SCI USA, V99, P2636, DOI 10.1073/pnas.052709399; De Deken X, 2000, J BIOL CHEM, V275, P23227, DOI 10.1074/jbc.M000916200; Dekaris I, 1998, IMMUNOPHARM IMMUNOT, V20, P103, DOI 10.3109/08923979809034811; DeLeo FR, 1998, J CLIN INVEST, V101, P455, DOI 10.1172/JCI949; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; Diebold BA, 2001, NAT IMMUNOL, V2, P211, DOI 10.1038/85259; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Finkel T, 2001, IUBMB LIFE, V52, P3, DOI 10.1080/15216540252774694; Finkel T, 1999, J LEUKOCYTE BIOL, V65, P337, DOI 10.1002/jlb.65.3.337; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; FURUKAWA K, 1992, SCAND J IMMUNOL, V35, P561, DOI 10.1111/j.1365-3083.1992.tb03255.x; Futterer K, 1998, J MOL BIOL, V281, P523, DOI 10.1006/jmbi.1998.1964; Gamaley IA, 1999, INT REV CYTOL, V188, P203; Goitsuka R, 1998, J IMMUNOL, V161, P5804; Gulati P, 2001, IUBMB LIFE, V52, P25, DOI 10.1080/15216540252774720; Healy JI, 1998, ANNU REV IMMUNOL, V16, P645, DOI 10.1146/annurev.immunol.16.1.645; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Inanami O, 1998, J BIOL CHEM, V273, P9539, DOI 10.1074/jbc.273.16.9539; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; Kawahara Tsukasa, 2001, Journal of Medical Investigation, V48, P190; Kurosaki T, 1998, INT J MOL MED, V1, P515; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; Lassegue B, 2001, CIRC RES, V88, P888, DOI 10.1161/hh0901.090299; Mahadev K, 2001, J BIOL CHEM, V276, P21938, DOI 10.1074/jbc.C100109200; Matko J, 2002, IMMUNOL LETT, V82, P3, DOI 10.1016/S0165-2478(02)00011-1; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Neel BG, 1997, CURR OPIN CELL BIOL, V9, P193, DOI 10.1016/S0955-0674(97)80063-4; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Peterhans E, 1997, BIOL TRACE ELEM RES, V56, P107, DOI 10.1007/BF02778986; Pierce SK, 2002, NAT REV IMMUNOL, V2, P96, DOI 10.1038/nri726; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Reeves EP, 1999, BIOCHEM J, V344, P859, DOI 10.1042/0264-6021:3440859; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Rhee S G, 2000, Sci STKE, V2000, ppe1; ROTH S, 1987, CELL IMMUNOL, V108, P417, DOI 10.1016/0008-8749(87)90224-3; ROWLEY RB, 1995, J BIOL CHEM, V270, P11590, DOI 10.1074/jbc.270.19.11590; Roy A, 2000, BRAIN RES, V872, P188, DOI 10.1016/S0006-8993(00)02458-6; Rutault K, 1999, FREE RADICAL BIO MED, V26, P232, DOI 10.1016/S0891-5849(98)00194-4; Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0; SCHIEVEN GL, 1993, BLOOD, V82, P1212, DOI 10.1182/blood.V82.4.1212.bloodjournal8241212; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Segal AW, 1997, ANN NY ACAD SCI, V832, P215, DOI 10.1111/j.1749-6632.1997.tb46249.x; SHIUE L, 1995, J BIOL CHEM, V270, P10498, DOI 10.1074/jbc.270.18.10498; Sorescu D, 2002, CIRCULATION, V105, P1429, DOI 10.1161/01.CIR.0000012917.74432.66; STAAL FJT, 1994, P NATL ACAD SCI USA, V91, P3619, DOI 10.1073/pnas.91.9.3619; Sun Y, 1996, FREE RADICAL BIO MED, V21, P335, DOI 10.1016/0891-5849(96)00109-8; Tamir I, 2000, CURR OPIN IMMUNOL, V12, P307, DOI 10.1016/S0952-7915(00)00092-3; Tsunawaki S, 2000, J BIOCHEM-TOKYO, V128, P777, DOI 10.1093/oxfordjournals.jbchem.a022815; UCKUN FM, 1992, P NATL ACAD SCI USA, V89, P9005, DOI 10.1073/pnas.89.19.9005; van der Veen RC, 2000, J IMMUNOL, V164, P5177, DOI 10.4049/jimmunol.164.10.5177; Verhoeven AJ, 1997, ANN NY ACAD SCI, V832, P85, DOI 10.1111/j.1749-6632.1997.tb46239.x; Verveer PJ, 2000, SCIENCE, V290, P1567, DOI 10.1126/science.290.5496.1567; Weiss A, 1998, CELL, V94, P277, DOI 10.1016/S0092-8674(00)81469-5; Wentworth AD, 2000, P NATL ACAD SCI USA, V97, P10930, DOI 10.1073/pnas.97.20.10930; Wentworth P, 2001, SCIENCE, V293, P1806, DOI 10.1126/science.1062722; Wentworth P, 2001, CELL BIOCHEM BIOPHYS, V35, P63, DOI 10.1385/CBB:35:1:63; Wienands J, 1996, P NATL ACAD SCI USA, V93, P7865, DOI 10.1073/pnas.93.15.7865; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791; Xu D, 2002, DEV CELL, V2, P251, DOI 10.1016/S1534-5807(02)00132-6; Yang S, 2001, J BIOL CHEM, V276, P5452, DOI 10.1074/jbc.M001004200; Zhang Y, 1998, EMBO J, V17, P7304, DOI 10.1093/emboj/17.24.7304; Zola H, 1997, IMMUNOL CELL BIOL, V75, P587, DOI 10.1038/icb.1997.92	82	588	612	2	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2002	3	12					1129	1134		10.1038/ni1202-1129	http://dx.doi.org/10.1038/ni1202-1129			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	619GP	12447370				2022-12-18	WOS:000179467800009
J	Naik, SH; Sathe, P; Park, HY; Metcalf, D; Proietto, AI; Dakic, A; Carotta, S; O'Keeffe, M; Bahlo, M; Papenfuss, A; Kwak, JY; Wu, L; Shortman, K				Naik, Shalin H.; Sathe, Priyanka; Park, Hae-Young; Metcalf, Donald; Proietto, Anna I.; Dakic, Aleksander; Carotta, Sebastian; O'Keeffe, Meredith; Bahlo, Melanie; Papenfuss, Anthony; Kwak, Jong-Young; Wu, Li; Shortman, Ken			Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo	NATURE IMMUNOLOGY			English	Article							FLT3 LIGAND; STEADY-STATE; PROGENITORS; MONOCYTES; DISTINCT; MICE; FLT3-LIGAND; GENERATION	The development of functionally specialized subtypes of dendritic cells ( DCs) can be modeled through the culture of bone marrow with the ligand for the cytokine receptor Flt3. Such cultures produce DCs resembling spleen plasmacytoid DCs ( pDCs), CD8(+) conventional DCs (cDCs) and CD8(-) cDCs. Here we isolated two sequential DC-committed precursor cells from such cultures: dividing 'pro-DCs', which gave rise to transitional 'pre-DCs' en route to differentiating into the three distinct DC subtypes (pDCs, CD8(+) cDCs and CD8(-) cDCs). We also isolated an in vivo equivalent of the DC-committed pro-DC precursor cell, which also gave rise to the three DC subtypes. Clonal analysis of the progeny of individual pro-DC precursors demonstrated that some pro-DC precursors gave rise to all three DC subtypes, some produced cDCs but not pDCs, and some were fully committed to a single DC subtype. Thus, commitment to particular DC subtypes begins mainly at this pro-DC stage.	Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; Netherlands Cancer Institute; University of Melbourne	Naik, SH (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	s.naik@nki.nl; shortman@wehi.edu.au	Naik, Shalin/AFD-5605-2022; Papenfuss, Anthony T/C-6297-2008; O'Keeffe, Meredith/U-9347-2017; Dakic, Aleksandar/B-8290-2013; Naik, Shalin/B-1148-2008	Papenfuss, Anthony T/0000-0002-1102-8506; O'Keeffe, Meredith/0000-0002-0779-4654; Naik, Shalin/0000-0003-0299-3301; Bahlo, Melanie/0000-0001-5132-0774				Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Brasel K, 2000, BLOOD, V96, P3029, DOI 10.1182/blood.V96.9.3029.h8003029_3029_3039; Brawand P, 2002, J IMMUNOL, V169, P6711, DOI 10.4049/jimmunol.169.12.6711; Carotta S, 2006, EUR J IMMUNOL, V36, P3294, DOI 10.1002/eji.200636325; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; Dettke M, 2001, J HEMATOTH STEM CELL, V10, P317, DOI 10.1089/15258160151135105; Diao J, 2004, J IMMUNOL, V173, P1826, DOI 10.4049/jimmunol.173.3.1826; Diao J, 2006, J IMMUNOL, V176, P7196, DOI 10.4049/jimmunol.176.12.7196; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Franchini M, 2004, J IMMUNOL, V172, P6304, DOI 10.4049/jimmunol.172.10.6304; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gilliet M, 2002, J EXP MED, V195, P953, DOI 10.1084/jem.20020045; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Haidar JH, 2002, J HEMATOTH STEM CELL, V11, P533, DOI 10.1089/15258160260090997; Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101; Janssen E, 2006, IMMUNITY, V24, P787, DOI 10.1016/j.immuni.2006.03.024; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Laouar Y, 2003, IMMUNITY, V19, P903, DOI 10.1016/S1074-7613(03)00332-7; LYMAN SD, 1995, BLOOD, V86, P4091, DOI 10.1182/blood.V86.11.4091.bloodjournal86114091; Manz MG, 2001, BLOOD, V97, P3333, DOI 10.1182/blood.V97.11.3333; Maraskovsky E, 1996, J EXP MED, V184, P1953, DOI 10.1084/jem.184.5.1953; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Metcalf D, 2002, STEM CELLS, V20, P552, DOI 10.1002/stem.200552; Naik S, 2003, BLOOD, V102, P601, DOI 10.1182/blood-2002-10-3186; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Nikolic T, 2003, INT IMMUNOL, V15, P515, DOI 10.1093/intimm/dxg050; ONAI N, 2007, IN PRESS NAT IMMUNOL; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Wu L, 2001, BLOOD, V98, P3376, DOI 10.1182/blood.V98.12.3376	36	586	622	0	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2007	8	11					1217	1226		10.1038/ni1522	http://dx.doi.org/10.1038/ni1522			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	222ZR	17922015				2022-12-18	WOS:000250338900014
J	Goldmann, T; Wieghofer, P; Jordao, MJC; Prutek, F; Hagemeyer, N; Frenzel, K; Amann, L; Staszewski, O; Kierdorf, K; Krueger, M; Locatelli, G; Hochgerner, H; Zeiser, R; Epelman, S; Geissmann, F; Priller, J; Rossi, FMV; Bechmann, I; Kerschensteiner, M; Linnarsson, S; Jung, S; Prinz, M				Goldmann, Tobias; Wieghofer, Peter; Jordao, Marta Joana Costa; Prutek, Fabiola; Hagemeyer, Nora; Frenzel, Kathrin; Amann, Lukas; Staszewski, Ori; Kierdorf, Katrin; Krueger, Martin; Locatelli, Giuseppe; Hochgerner, Hannah; Zeiser, Robert; Epelman, Slava; Geissmann, Frederic; Priller, Josef; Rossi, Fabio M. V.; Bechmann, Ingo; Kerschensteiner, Martin; Linnarsson, Sten; Jung, Steffen; Prinz, Marco			Origin, fate and dynamics of macrophages at central nervous system interfaces	NATURE IMMUNOLOGY			English	Article							MYELOID CELLS; CHOROID-PLEXUS; CARDIAC MACROPHAGES; MICROGLIAL CELLS; SELF-RENEWAL; STEADY-STATE; CNS; MONOCYTES; RESIDENT; REVEALS	Perivascular, subdural meningeal and choroid plexus macrophages are non-parenchymal macrophages that mediate immune responses at brain boundaries. Although the origin of parenchymal microglia has recently been elucidated, much less is known about the precursors, the underlying transcriptional program and the dynamics of the other macrophages in the central nervous system (CNS). It was assumed that they have a high turnover from blood-borne monocytes. However, using parabiosis and fate-mapping approaches in mice, we found that CNS macrophages arose from hematopoietic precursors during embryonic development and established stable populations, with the notable exception of choroid plexus macrophages, which had dual origins and a shorter life span. The generation of CNS macrophages relied on the transcription factor PU.1, whereas the MYB, BATF3 and NR4A1 transcription factors were not required.	[Goldmann, Tobias; Wieghofer, Peter; Jordao, Marta Joana Costa; Prutek, Fabiola; Hagemeyer, Nora; Frenzel, Kathrin; Amann, Lukas; Staszewski, Ori; Kierdorf, Katrin; Prinz, Marco] Univ Freiburg, Med Ctr, Inst Neuropathol, Freiburg, Germany; [Wieghofer, Peter; Jordao, Marta Joana Costa; Frenzel, Kathrin; Amann, Lukas] Univ Freiburg, Fac Biol, Hugstetter Str 55, D-79106 Freiburg, Germany; [Krueger, Martin; Bechmann, Ingo] Univ Leipzig, Inst Anat, D-04109 Leipzig, Germany; [Locatelli, Giuseppe; Kerschensteiner, Martin] Univ Munich, Inst Klin Neuroimmunol, Munich, Germany; [Hochgerner, Hannah; Linnarsson, Sten] Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Neurobiol, Stockholm, Sweden; [Zeiser, Robert] Univ Freiburg, Med Ctr, Dept Hematol & Oncol, Freiburg, Germany; [Zeiser, Robert; Prinz, Marco] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, Hugstetter Str 55, D-79106 Freiburg, Germany; [Epelman, Slava] Univ Hlth Network Toronto, Peter Munk Cardiac Ctr, Toronto, ON, Canada; [Geissmann, Frederic] Kings Coll London, Ctr Mol & Cellular Biol Inflammat, London, England; [Priller, Josef] Charite, Dept Neuropsychiat, D-13353 Berlin, Germany; [Priller, Josef] Charite, Lab Mol Psychiat, D-13353 Berlin, Germany; [Priller, Josef] DZNE, Cluster Excellence NeuroCure, Berlin, Germany; [Priller, Josef] BIH, Berlin, Germany; [Rossi, Fabio M. V.] Univ British Columbia, Fac Med, Biomed Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Kerschensteiner, Martin] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	University of Freiburg; University of Freiburg; Leipzig University; University of Munich; Karolinska Institutet; University of Freiburg; University of Freiburg; University of Toronto; Peter Munk Cardiac Centre; University Toronto Affiliates; University Health Network Toronto; University of London; King's College London; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Berlin Institute of Health; University of British Columbia; University of Munich; Weizmann Institute of Science	Prinz, M (corresponding author), Univ Freiburg, Med Ctr, Inst Neuropathol, Freiburg, Germany.; Prinz, M (corresponding author), Univ Freiburg, BIOSS Ctr Biol Signaling Studies, Hugstetter Str 55, D-79106 Freiburg, Germany.	marco.prinz@uniklinik-freiburg.de	Priller, Josef/ABW-3835-2022; Wieghofer, Peter/AAV-9572-2020; Kierdorf, Katrin/AAO-6288-2021; Epelman, Slava/AAO-1728-2020; Linnarsson, Sten/HCH-3909-2022; Jung, Steffen/K-1409-2012	Epelman, Slava/0000-0003-3400-4475; Jung, Steffen/0000-0003-4290-5716; Amann, Lukas/0000-0002-8363-373X; Locatelli, Giuseppe/0000-0002-2179-4407; Hochgerner, Hannah/0000-0002-7739-666X; Priller, Josef/0000-0001-7596-0979; Zeiser, Robert/0000-0001-6565-3393; Goldmann, Tobias/0000-0001-9754-9144; Staszewski, Ori/0000-0002-0579-6701; Kierdorf, Katrin/0000-0002-9272-4780	DFG [SFB 992, SFB 1160, PR 577/8-1, ZE872/3-1, FOR1336]; Fritz-Thyssen Foundation; European Union [607962]; Gemeinnutzige Hertie Foundation; Sobek Foundation; BMBF; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); Fritz-Thyssen Foundation; European Union(European Commission); Gemeinnutzige Hertie Foundation; Sobek Foundation; BMBF(Federal Ministry of Education & Research (BMBF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Oberle, M. Ditter and T. el Gaz for excellent technical assistance and T. Leng Tay for critical reading of the manuscript. Supported by the DFG (SFB 992, SFB 1160, PR 577/8-1, Reinhart Koselleck Grant for M.P.; SFB 1160, ZE872/3-1 for R.Z.; and FOR1336 for J.P., I.B., M.P. and S.J.), the Fritz-Thyssen Foundation (M.P.), the European Union's Seventh Framework Program FP7 under Grant agreement 607962 (nEUROinflammation for M.P.), the Gemeinnutzige Hertie Foundation (GHST for M.P.), the Sobek Foundation (M.P.) and the BMBF-funded Competence Network on Multiple Sclerosis (KKNMS for M.P. and M. Kerschensteiner).	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Anandasabapathy N, 2011, J EXP MED, V208, P1695, DOI 10.1084/jem.20102657; Axtell RC, 2009, NAT IMMUNOL, V10, P453, DOI 10.1038/ni0509-453; Barr CM, 2015, NEUROSCI LETT, V588, P196, DOI 10.1016/j.neulet.2015.01.023; Bechmann I, 2001, EXP NEUROL, V168, P242, DOI 10.1006/exnr.2000.7618; Brendecke SM, 2015, SEMIN IMMUNOPATHOL, V37, P591, DOI 10.1007/s00281-015-0520-6; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Engelhardt B, 2001, MICROSC RES TECHNIQ, V52, P112, DOI 10.1002/1097-0029(20010101)52:1<112::AID-JEMT13>3.0.CO;2-5; Ensan S, 2016, NAT IMMUNOL, V17, P159, DOI 10.1038/ni.3343; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Galea I, 2005, GLIA, V49, P375, DOI 10.1002/glia.20124; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goldmann T, 2015, EMBO J, V34, P1612, DOI 10.15252/embj.201490791; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; HICKEY WF, 1992, J NEUROPATH EXP NEUR, V51, P246, DOI 10.1097/00005072-199205000-00002; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Jamieson AR, 2010, MED PHYS, V37, P339, DOI 10.1118/1.3267037; Kierdorf K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058544; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Kim JV, 2009, NATURE, V457, P191, DOI 10.1038/nature07591; Kivisakk P, 2009, ANN NEUROL, V65, P457, DOI 10.1002/ana.21379; Kunis G, 2013, BRAIN, V136, P3427, DOI 10.1093/brain/awt259; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Mildner A, 2011, J NEUROSCI, V31, P11159, DOI 10.1523/JNEUROSCI.6209-10.2011; Misgeld T, 2007, NAT PROTOC, V2, P263, DOI 10.1038/nprot.2007.24; Molawi K, 2014, J EXP MED, V211, P2151, DOI 10.1084/jem.20140639; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Romanelli E, 2013, NAT PROTOC, V8, P481, DOI 10.1038/nprot.2013.022; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Sheng JP, 2015, IMMUNITY, V43, P382, DOI 10.1016/j.immuni.2015.07.016; Wieghofer P, 2015, GLIA, V63, P1, DOI 10.1002/glia.22727; Yang Y, 2013, EXP MOL PATHOL, V95, P7, DOI 10.1016/j.yexmp.2013.03.010; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934	51	583	586	3	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2016	17	7					797	+		10.1038/ni.3423	http://dx.doi.org/10.1038/ni.3423			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP1XR	27135602	Green Accepted, Green Submitted			2022-12-18	WOS:000378283200012
J	Tone, Y; Furuuchi, K; Kojima, Y; Tykocinski, ML; Greene, MI; Tone, M				Tone, Yukiko; Furuuchi, Keiji; Kojima, Yoshitsugu; Tykocinski, Mark L.; Greene, Mark I.; Tone, Masahide			Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer	NATURE IMMUNOLOGY			English	Article							REGULATORY T-CELLS; TRANSCRIPTION FACTOR FOXP3; GENE-EXPRESSION; NUCLEAR FACTOR; CUTTING EDGE; KAPPA-B; MECHANISMS; TOLERANCE; SCURFIN; SITES	The transcription factor Foxp3 is involved in the differentiation, function and survival of CD4(+) CD25(+) regulatory T (T-reg) cells. Details of the mechanism underlying the induction of Foxp3 expression remain unknown, because studies of the transcriptional regulation of the Foxp3 gene are limited by the small number of T-reg cells in mononuclear cell populations. Here we have generated a model system for analyzing Foxp3 induction and, by using this system with primary T cells, we have identified an enhancer element in this gene. The transcription factors Smad3 and NFAT are required for activity of this Foxp3 enhancer, and both factors are essential for histone acetylation in the enhancer region and induction of Foxp3. These biochemical properties that define Foxp3 expression explain many of the effects of transforming growth factor-beta on the function of Foxp3(+) T-reg cells.	[Tone, Yukiko; Furuuchi, Keiji; Kojima, Yoshitsugu; Tykocinski, Mark L.; Greene, Mark I.; Tone, Masahide] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Tone, M (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	mtone@mail.med.upenn.edu						Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cobbold SP, 2004, J IMMUNOL, V172, P6003, DOI 10.4049/jimmunol.172.10.6003; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Licona-Limon P, 2007, IMMUNOL LETT, V109, P1, DOI 10.1016/j.imlet.2006.12.010; Mantel PY, 2006, J IMMUNOL, V176, P3593, DOI 10.4049/jimmunol.176.6.3593; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Peters N, 2006, IMMUNOL REV, V213, P159, DOI 10.1111/j.1600-065X.2006.00432.x; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Tone M, 2000, J IMMUNOL, V165, P286, DOI 10.4049/jimmunol.165.1.286; Tone Y, 2007, J IMMUNOL, V179, P1760, DOI 10.4049/jimmunol.179.3.1760; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	31	582	611	2	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2008	9	2					194	202		10.1038/ni1549	http://dx.doi.org/10.1038/ni1549			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	253FB	18157133				2022-12-18	WOS:000252503000016
J	Sheedy, FJ; Grebe, A; Rayner, KJ; Kalantari, P; Ramkhelawon, B; Carpenter, SB; Becker, CE; Ediriweera, HN; Mullick, AE; Golenbock, DT; Stuart, LM; Latz, E; Fitzgerald, KA; Moore, KJ				Sheedy, Frederick J.; Grebe, Alena; Rayner, Katey J.; Kalantari, Parisa; Ramkhelawon, Bhama; Carpenter, Susan B.; Becker, Christine E.; Ediriweera, Hasini N.; Mullick, Adam E.; Golenbock, Douglas T.; Stuart, Lynda M.; Latz, Eicke; Fitzgerald, Katherine A.; Moore, Kathryn J.			CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation	NATURE IMMUNOLOGY			English	Article							SCAVENGER-RECEPTOR-A; AMYLOID-BETA; ALZHEIMERS-DISEASE; CHOLESTEROL CRYSTALS; NALP3 INFLAMMASOME; MICE; CELLS; PROTEIN; MACROPHAGES; PEPTIDE	Particulate ligands, including cholesterol crystals and amyloid fibrils, induce production of interleukin 1 beta (IL-1 beta) dependent on the cytoplasmic sensor NLRP3 in atherosclerosis, Alzheimer's disease and diabetes. Soluble endogenous ligands, including oxidized low-density lipoprotein (LDL), amyloid-beta and amylin peptides, accumulate in such diseases. Here we identify an endocytic pathway mediated by the pattern-recognition receptor CD36 that coordinated the intracellular conversion of those soluble ligands into crystals or fibrils, which resulted in lysosomal disruption and activation of the NLRP3 inflammasome. Consequently, macrophages that lacked CD36 failed to elicit IL-1 beta production in response to those ligands, and targeting CD36 in atherosclerotic mice resulted in lower serum concentrations of IL-1 beta and accumulation of cholesterol crystals in plaques. Collectively, our findings highlight the importance of CD36 in the accrual and nucleation of NLRP3 ligands from within the macrophage and position CD36 as a central regulator of inflammasome activation in sterile inflammation.	[Sheedy, Frederick J.; Rayner, Katey J.; Ramkhelawon, Bhama; Ediriweera, Hasini N.; Moore, Kathryn J.] NYU, Sch Med, Marc & Ruti Bell Program Vasc Biol & Dis, Dept Med,Leon H Charney Div Cardiol, New York, NY 10012 USA; [Grebe, Alena; Latz, Eicke] Univ Bonn, Inst Innate Immun, Bonn, Germany; [Kalantari, Parisa; Carpenter, Susan B.; Golenbock, Douglas T.; Latz, Eicke; Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Infect Dis & Immunol, Worcester, MA USA; [Becker, Christine E.; Stuart, Lynda M.] Harvard Univ, Sch Med, Dept Pediat, Lab Dev Immunol,Massachusetts Gen Hosp, Boston, MA 02115 USA; [Mullick, Adam E.] ISIS Pharmaceut, Carlsbad, CA 92008 USA; [Latz, Eicke] German Ctr Neurodegenerat Dis, Bonn, Germany	New York University; University of Bonn; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School; Massachusetts General Hospital; Isis Pharmaceuticals Inc; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Moore, KJ (corresponding author), NYU, Sch Med, Marc & Ruti Bell Program Vasc Biol & Dis, Dept Med,Leon H Charney Div Cardiol, New York, NY 10012 USA.	kathryn.moore@nyumc.edu	Fitzgerald, Katherine/ABE-6317-2020; Moore, Kathryn/ABE-6416-2020; Latz, Eicke/H-3951-2014	Moore, Kathryn/0000-0003-2505-2547; Latz, Eicke/0000-0003-1488-5666; Sheedy, Frederick/0000-0003-2645-8493; Mullick, Adam/0000-0003-4600-961X; Fitzgerald, Kate/0000-0003-3175-609X; Rayner, Katey/0000-0001-6230-426X; Sheedy, Frederick/0000-0002-4722-3135	US National Institutes of Health [R01HL117334, R01AG032349, U24 AI082660, R01 AI079198, 5R01HL093262-02, 1R01HL112661-01, AI083713]; American Heart Association [11POST7400075]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093262, R01HL117334, R01HL112661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079198, U24AI082660, R01AI083713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032349] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank F. Maxfield (Weill Cornell Medical College) for Lalistat. Supported by the US National Institutes of Health (R01HL117334 and R01AG032349 to K.J.M.; U24 AI082660 to L.M.S. and K.J.M.; R01 AI079198 to L.M.S.; 5R01HL093262-02 and 1R01HL112661-01 to E.L.; and AI083713 to K.A.F. and E.L.) and the American Heart Association (11POST7400075 to F.J.S.).	Abela GS, 2010, J CLIN LIPIDOL, V4, P156, DOI 10.1016/j.jacl.2010.03.003; Badman MK, 1998, CELL TISSUE RES, V291, P285, DOI 10.1007/s004410050998; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; BOLTZNITULESCU G, 1987, J LEUKOCYTE BIOL, V41, P83, DOI 10.1002/jlb.41.1.83; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; CLARK A, 1987, LANCET, V2, P231; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; de Koning EJP, 1998, AMYLOID, V5, P247, DOI 10.3109/13506129809007297; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; El Khoury JB, 2003, J EXP MED, V197, P1657, DOI 10.1084/jem.20021546; Embry CA, 2011, SCI SIGNAL, V4, P20, DOI 10.1126/scisignal.2001486; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Friedrich RP, 2010, P NATL ACAD SCI USA, V107, P1942, DOI 10.1073/pnas.0904532106; Goudriaan JR, 2003, J LIPID RES, V44, P2270, DOI 10.1194/jlr.M300143-JLR200; Guarda G, 2010, IMMUNOLOGY, V130, P329, DOI 10.1111/j.1365-2567.2010.03283.x; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; Hajri T, 2002, J CLIN INVEST, V109, P1381, DOI [10.1172/JCI200214596, 10.1172/JCI0214596]; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kamari Y, 2011, BIOCHEM BIOPH RES CO, V405, P197, DOI 10.1016/j.bbrc.2011.01.008; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kennedy DJ, 2011, CARDIOVASC RES, V89, P604, DOI 10.1093/cvr/cvq360; KIRSCHNER DA, 1987, P NATL ACAD SCI USA, V84, P6953, DOI 10.1073/pnas.84.19.6953; Kuchibhotla S, 2008, CARDIOVASC RES, V78, P185, DOI 10.1093/cvr/cvm093; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Lim RS, 2011, J LIPID RES, V52, P2177, DOI 10.1194/jlr.M018077; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; Moore KJ, 2002, J BIOL CHEM, V277, P47373, DOI 10.1074/jbc.M208788200; MOYER CF, 1991, AM J PATHOL, V138, P951; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; RASMUSSEN LT, 1989, SCAND J IMMUNOL, V29, P477, DOI 10.1111/j.1365-3083.1989.tb01147.x; Rosenbaum AI, 2009, BBA-MOL CELL BIOL L, V1791, P1155, DOI 10.1016/j.bbalip.2009.08.005; Schmitz G, 2009, BBA-MOL CELL BIOL L, V1791, P524, DOI 10.1016/j.bbalip.2008.12.007; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; THOMAS CE, 1994, J LIPID RES, V35, P417; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Westermark GT, 2008, NEW ENGL J MED, V359, P977, DOI 10.1056/NEJMc0802893; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; Wilkinson K, 2011, J BIOL CHEM, V286, P34914, DOI 10.1074/jbc.M111.232116; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	54	577	612	10	131	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2013	14	8					812	+		10.1038/ni.2639	http://dx.doi.org/10.1038/ni.2639			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185ZN	23812099	Green Accepted, Green Submitted			2022-12-18	WOS:000322010600010
J	Langhorne, J; Ndungu, FM; Sponaas, AM; Marsh, K				Langhorne, Jean; Ndungu, Francis M.; Sponaas, Anne-Marit; Marsh, Kevin			Immunity to malaria: more questions than answers	NATURE IMMUNOLOGY			English	Review							TUMOR-NECROSIS-FACTOR; ERYTHROCYTE-MEMBRANE PROTEIN-1; PLASMODIUM-FALCIPARUM MALARIA; CD4(+) T-CELLS; CHABAUDI-CHABAUDI INFECTION; GROWTH-FACTOR-BETA; DENDRITIC CELLS; FACTOR-ALPHA; MEDIATED PROTECTION; ACQUIRED-IMMUNITY	Malaria is one of the main health problems facing developing countries today. At present, preventative and treatment strategies are continuously hampered by the issues of the ever-emerging parasite resistance to newly introduced drugs, considerable costs and logistical problems. The main hope for changing this situation would be the development of effective malaria vaccines. An important part of this process is understanding the mechanisms of naturally acquired immunity to malaria. This review will highlight key aspects of immunity to malaria, about which surprisingly little is known and which will prove critical in the search for effective malaria vaccines.	[Langhorne, Jean; Ndungu, Francis M.; Sponaas, Anne-Marit] Natl Inst Med Res, Div Parasitol, London NW7 1AA, England; [Marsh, Kevin] Kenya Govt Med Res Ctr, Wellcome Trust Collaborat Project, Kilifi, Kenya	MRC National Institute for Medical Research; Kenya Medical Research Institute	Langhorne, J (corresponding author), Natl Inst Med Res, Div Parasitol, London NW7 1AA, England.	jlangho@nimr.mrc.ac.uk	Ndungu, Francis Maina/C-2199-2019	Ndungu, Francis Maina/0000-0002-8977-0030; Langhorne, Jean/0000-0002-2257-9733	Medical Research Council [MC_U117584248] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [MC_U117584248] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Achtman AH, 2005, CURR TOP MICROBIOL, V297, P71; Adachi K, 2001, J IMMUNOL, V167, P5928, DOI 10.4049/jimmunol.167.10.5928; Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Awandare GA, 2006, J INFECT DIS, V194, P1438, DOI 10.1086/508547; Baruch DI, 1996, P NATL ACAD SCI USA, V93, P3497, DOI 10.1073/pnas.93.8.3497; Bayley JP, 2004, GENES IMMUN, V5, P315, DOI 10.1038/sj.gene.6364055; Berenzon D, 2003, J IMMUNOL, V171, P2024, DOI 10.4049/jimmunol.171.4.2024; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; BOUHAROUNTAYOUN H, 1995, J EXP MED, V182, P409, DOI 10.1084/jem.182.2.409; BRUCE-CHWATT L. J., 1963, W AFRICAN MED JOUR, V12, P141; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Carpenter D, 2007, HUM IMMUNOL, V68, P165, DOI 10.1016/j.humimm.2006.12.002; Carvalho LH, 2002, NAT MED, V8, P166, DOI 10.1038/nm0202-166; Chakravarty S, 2007, NAT MED, V13, P1035, DOI 10.1038/nm1628; Ciuca M., 1934, Transactions of the Royal Society of Tropical Medicine and Hygiene London, V27, P619, DOI 10.1016/S0035-9203(34)90111-5; CLARK IA, 1978, LANCET, V2, P75; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Collins WE, 2003, AM J TROP MED HYG, V68, P410, DOI 10.4269/ajtmh.2003.68.410; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; DELORON P, 1992, PARASITOL TODAY, V8, P375, DOI 10.1016/0169-4758(92)90174-Z; Dorfman JR, 2005, J INFECT DIS, V191, P1623, DOI 10.1086/429671; Elliott SR, 2007, INFECT IMMUN, V75, P3621, DOI 10.1128/IAI.00095-07; Engwerda CR, 2005, CURR OPIN IMMUNOL, V17, P381, DOI 10.1016/j.coi.2005.05.010; Engwerda CR, 2002, J EXP MED, V195, P1371, DOI 10.1084/jem.20020128; Fonseca L, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-77; Foulds KE, 2006, IMMUNOL REV, V211, P58, DOI 10.1111/j.0105-2896.2006.00400.x; Franklin BS, 2007, MICROBES INFECT, V9, P881, DOI 10.1016/j.micinf.2007.03.007; Gray JC, 2007, CLIN CHEM, V53, P1244, DOI 10.1373/clinchem.2006.081695; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; Henri S, 2002, GENES IMMUN, V3, P1, DOI 10.1038/sj.gene.6363809; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Imler JL, 2003, NAT IMMUNOL, V4, P105, DOI 10.1038/ni0203-105; Jafarshad A, 2007, J IMMUNOL, V178, P3099, DOI 10.4049/jimmunol.178.5.3099; John CC, 2006, J INFECT DIS, V194, P837, DOI 10.1086/506623; Juliger S, 2003, IMMUNOGENETICS, V54, P675, DOI 10.1007/s00251-002-0516-y; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Kinyanjui SM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-82; Krause DR, 2007, INFECT IMMUN, V75, P5967, DOI 10.1128/IAI.00327-07; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Kurtzhals JAL, 1998, LANCET, V351, P1768, DOI 10.1016/S0140-6736(97)09439-7; Kurtzhals JAL, 1999, J INFECT DIS, V180, P1753, DOI 10.1086/315077; KWIATKOWSKI D, 1990, IMMUNOL LETT, V25, P213, DOI 10.1016/0165-2478(90)90117-9; Lamb Tracey J., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010581; Lamikanra AA, 2007, BLOOD, V110, P18, DOI 10.1182/blood-2006-09-018069; Langhorne J, 1998, P NATL ACAD SCI USA, V95, P1730, DOI 10.1073/pnas.95.4.1730; Li C, 2003, INFECT IMMUN, V71, P4850, DOI 10.1128/IAI.71.9.4850-4856.2003; Li C, 1999, INFECT IMMUN, V67, P4435, DOI 10.1128/IAI.67.9.4435-4442.1999; Lyke KE, 2004, INFECT IMMUN, V72, P5630, DOI 10.1128/IAI.72.10.5630-5637.2004; Mackinnon MJ, 2002, INFECT GENET EVOL, V1, P287, DOI 10.1016/S1567-1348(02)00039-4; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; McIntosh RS, 2007, PLOS PATHOG, V3, P647, DOI 10.1371/journal.ppat.0030072; MIGOT F, 1993, AM J TROP MED HYG, V48, P432, DOI 10.4269/ajtmh.1993.48.432; Miller JM, 2000, AM J TROP MED HYG, V62, P115, DOI 10.4269/ajtmh.2000.62.115; Mockenhaupt FP, 2006, P NATL ACAD SCI USA, V103, P177, DOI 10.1073/pnas.0506803102; Mockenhaupt FP, 2006, J INFECT DIS, V194, P184, DOI 10.1086/505152; Moran M., 2007, MALARIA PRODUCT PIPE; Morrot A, 2005, J EXP MED, V202, P551, DOI 10.1084/jem.20042463; Mount AM, 2004, LANCET, V363, P1860, DOI 10.1016/S0140-6736(04)16354-X; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; Ndungu FM, 2006, J IMMUNOL, V176, P5504, DOI 10.4049/jimmunol.176.9.5504; Nebl T, 2005, PARASITOLOGY, V130, pS45, DOI 10.1017/S0031182005008152; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ocana-Morgner C, 2003, J EXP MED, V197, P143, DOI 10.1084/jem.20021072; Ochiel DO, 2005, INFECT IMMUN, V73, P4190, DOI 10.1128/IAI.73.7.4190-4197.2005; Omer FM, 2003, J IMMUNOL, V171, P5430, DOI 10.4049/jimmunol.171.10.5430; Owusu-Agyei S, 2001, AM J TROP MED HYG, V65, P197, DOI 10.4269/ajtmh.2001.65.197; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Pombo DJ, 2002, LANCET, V360, P610, DOI 10.1016/S0140-6736(02)09784-2; Prakash D, 2006, J INFECT DIS, V194, P198, DOI 10.1086/504720; Radziewicz H, 2007, J VIROL, V81, P2545, DOI 10.1128/JVI.02021-06; Rotman HL, 1998, J IMMUNOL, V161, P1908; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Sano G, 2001, J EXP MED, V194, P173, DOI 10.1084/jem.194.2.173; SCHELLER LF, 1995, P NATL ACAD SCI USA, V92, P4066, DOI 10.1073/pnas.92.9.4066; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Seixas E, 2001, EUR J IMMUNOL, V31, P2970, DOI 10.1002/1521-4141(2001010)31:10&lt;2970::AID-IMMU2970&gt;3.0.CO;2-S; Skorokhod OA, 2004, J IMMUNOL, V173, P4066, DOI 10.4049/jimmunol.173.6.4066; Snow RW, 2001, TRENDS PARASITOL, V17, P593, DOI 10.1016/S1471-4922(01)02031-1; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Sponaas AM, 2006, J EXP MED, V203, P1427, DOI 10.1084/jem.20052450; Stephens R, 2005, BLOOD, V106, P1676, DOI 10.1182/blood-2004-10-4047; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; TAVERNE J, 1987, CLIN EXP IMMUNOL, V67, P1; Taylor A, 2006, IMMUNOLOGY, V117, P433, DOI 10.1111/j.1365-2567.2006.02321.x; Taylor PR, 2001, INFECT IMMUN, V69, P3853, DOI 10.1128/IAI.69.6.3853-3859.2001; Togbe D, 2007, AM J PATHOL, V170, P1640, DOI 10.2353/ajpath.2007.060889; Urban BC, 2001, BLOOD, V98, P2859, DOI 10.1182/blood.V98.9.2859; Urban BC, 1999, NATURE, V400, P73, DOI 10.1038/21900; Urban BC, 2001, P NATL ACAD SCI USA, V98, P8750, DOI 10.1073/pnas.151028698; Vanderberg J, 2007, AM J PATHOL, V171, P1405, DOI 10.2353/ajpath.2007.070661; Veldhoen M, 2006, TRENDS IMMUNOL, V27, P358, DOI 10.1016/j.it.2006.06.001; Were T, 2006, HAEMATOLOGICA, V91, P1396; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; Wykes MN, 2007, J IMMUNOL, V179, P3982, DOI 10.4049/jimmunol.179.6.3982; Wykes MN, 2005, J IMMUNOL, V175, P2510, DOI 10.4049/jimmunol.175.4.2510; Xiang Z, 2007, NAT IMMUNOL, V8, P419, DOI 10.1038/ni1440; Xu HJ, 2002, J EXP MED, V195, P881, DOI 10.1084/jem.20011174; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893	105	576	586	0	101	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2008	9	7					725	732		10.1038/ni.f.205	http://dx.doi.org/10.1038/ni.f.205			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	315UE	18563083				2022-12-18	WOS:000256904900009
J	Liston, A; Lesage, S; Wilson, J; Peltonen, L; Goodnow, CC				Liston, A; Lesage, S; Wilson, J; Peltonen, L; Goodnow, CC			Aire regulates negative selection of organ-specific T cells	NATURE IMMUNOLOGY			English	Article							AUTOIMMUNE REGULATOR; TRANSGENIC MICE; B-CELLS; CENTRAL TOLERANCE; SELF-TOLERANCE; HUMAN THYMUS; PROTEIN; ANTIGEN; EXPRESSION; INDUCTION	Autoimmune polyendocrinopathy syndrome type 1 is a recessive Mendelian disorder resulting from mutations in a novel gene, AIRE, and is characterized by a spectrum of organ-specific autoimmune diseases. It is not known what tolerance mechanisms are defective as a result of AIRE mutation. By tracing the fate of autoreactive CD4(+) T cells with high affinity for a pancreatic antigen in transgenic mice with an Aire mutation, we show here that Aire deficiency causes almost complete failure to delete the organ-specific cells in the thymus. These results indicate that autoimmune polyendocrinopathy syndrome I is caused by failure of a specialized mechanism for deleting forbidden T cell clones, establishing a central role for this tolerance mechanism.	Australian Natl Univ, John Curtin Sch Med Res, Med Genome Ctr, ACRF Genet Lab, Canberra, ACT 2601, Australia; Univ Helsinki, Dept Med Genet & Mol Med, FIN-00014 Helsinki, Finland; Natl Publ Hlth Inst, Helsinki, Finland	Australian National University; John Curtin School of Medical Research; University of Helsinki; Finland National Institute for Health & Welfare	Goodnow, CC (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Med Genome Ctr, ACRF Genet Lab, Canberra, ACT 2601, Australia.	chris.goodnow@anu.edu.au	Goodnow, Christopher C/V-8108-2018; Liston, Adrian/G-8606-2013; Liston, Adrian/A-2478-2008	Goodnow, Christopher C/0000-0001-5296-6155; Liston, Adrian/0000-0002-6272-4085; Lesage, Sylvie/0000-0002-0968-2795				Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; ADELSTEIN S, 1991, SCIENCE, V251, P1223, DOI 10.1126/science.1900950; Akkaraju S, 1997, IMMUNITY, V7, P255, DOI 10.1016/S1074-7613(00)80528-2; Akkaraju S, 1997, J EXP MED, V186, P2005, DOI 10.1084/jem.186.12.2005; Anderson AC, 2000, J EXP MED, V191, P761, DOI 10.1084/jem.191.5.761; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Betterle C, 1998, J CLIN ENDOCR METAB, V83, P1049, DOI 10.1210/jc.83.4.1049; Bjorses P, 2000, AM J HUM GENET, V66, P378, DOI 10.1086/302765; Bjorses P, 1999, HUM MOL GENET, V8, P259, DOI 10.1093/hmg/8.2.259; Goverman J, 1999, IMMUNOL REV, V169, P147, DOI 10.1111/j.1600-065X.1999.tb01313.x; Greenwald RJ, 2001, IMMUNITY, V14, P145, DOI 10.1016/S1074-7613(01)00097-8; HAMMERLING GJ, 1991, IMMUNOL REV, V122, P47, DOI 10.1111/j.1600-065X.1991.tb00596.x; Hanahan D, 1998, CURR OPIN IMMUNOL, V10, P656, DOI 10.1016/S0952-7915(98)80085-X; Heino M, 1999, BIOCHEM BIOPH RES CO, V257, P821, DOI 10.1006/bbrc.1999.0308; Heino M, 2000, EUR J IMMUNOL, V30, P1884, DOI 10.1002/1521-4141(200007)30:7<1884::AID-IMMU1884>3.0.CO;2-P; Hernandez J, 2001, J EXP MED, V194, P707, DOI 10.1084/jem.194.6.707; HO WY, 1994, J EXP MED, V179, P1539, DOI 10.1084/jem.179.5.1539; HOFFMANN MW, 1995, P NATL ACAD SCI USA, V92, P9851, DOI 10.1073/pnas.92.21.9851; JOLICOEUR C, 1994, P NATL ACAD SCI USA, V91, P6707, DOI 10.1073/pnas.91.14.6707; Jooss K, 2001, P NATL ACAD SCI USA, V98, P8738, DOI 10.1073/pnas.151088898; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; Kishimoto H, 2001, NAT IMMUNOL, V2, P1025, DOI 10.1038/ni726; Klein L, 1998, J EXP MED, V188, P5, DOI 10.1084/jem.188.1.5; Klein L, 2000, NAT MED, V6, P56, DOI 10.1038/71540; Kyewski B, 2002, TRENDS IMMUNOL, V23, P364, DOI 10.1016/S1471-4906(02)02248-2; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; Lambolez F, 2002, EUR J IMMUNOL, V32, P2588, DOI 10.1002/1521-4141(200209)32:9<2588::AID-IMMU2588>3.0.CO;2-1; LeDouarin N, 1996, IMMUNOL REV, V149, P35; Lesage S, 2002, J EXP MED, V196, P1175, DOI 10.1084/jem.20020735; LOMBARDI G, 1994, SCIENCE, V264, P1587, DOI 10.1126/science.8202711; Mason D, 2001, IMMUNOL REV, V182, P80, DOI 10.1034/j.1600-065X.2001.1820106.x; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; Pitkanen J, 2000, J BIOL CHEM, V275, P16802, DOI 10.1074/jbc.M908944199; Pugliese A, 1997, NAT GENET, V15, P293, DOI 10.1038/ng0397-293; Ramsey C, 2002, HUM MOL GENET, V11, P397, DOI 10.1093/hmg/11.4.397; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; SCOTT B, 1994, IMMUNITY, V1, P73, DOI 10.1016/1074-7613(94)90011-6; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Stockinger B, 1999, Adv Immunol, V71, P229; Taams LS, 1998, EUR J IMMUNOL, V28, P2902, DOI 10.1002/(SICI)1521-4141(199809)28:09<2902::AID-IMMU2902>3.0.CO;2-B; Ueno T, 2002, IMMUNITY, V16, P205, DOI 10.1016/S1074-7613(02)00267-4; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; Van Parijs L, 1998, IMMUNITY, V8, P265, DOI 10.1016/S1074-7613(00)80478-1; Vendetti S, 2000, J IMMUNOL, V165, P1175, DOI 10.4049/jimmunol.165.3.1175; Waldner H, 2000, P NATL ACAD SCI USA, V97, P3412, DOI 10.1073/pnas.97.7.3412	50	576	590	0	45	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2003	4	4					350	354		10.1038/ni906	http://dx.doi.org/10.1038/ni906			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	663CG	12612579				2022-12-18	WOS:000181987700014
J	Branzk, N; Lubojemska, A; Hardison, SE; Wang, Q; Gutierrez, MG; Brown, GD; Papayannopoulos, V				Branzk, Nora; Lubojemska, Aleksandra; Hardison, Sarah E.; Wang, Qian; Gutierrez, Maximiliano G.; Brown, Gordon D.; Papayannopoulos, Venizelos			Neutrophils sense microbe size and selectively release neutrophil extracellular traps in response to large pathogens	NATURE IMMUNOLOGY			English	Article							CANDIDA-ALBICANS; MYELOPEROXIDASE DEFICIENCY; PHAGOSOME MATURATION; DECTIN-1; ELASTASE; PHAGOCYTOSIS; MECHANISMS; RECOGNITION; YEAST; ACTIVATION	Neutrophils are critical for antifungal defense, but the mechanisms that clear hyphae and other pathogens that are too large to be phagocytosed remain unknown. We found that neutrophils sensed microbe size and selectively released neutrophil extracellular traps (NETs) in response to large pathogens, such as Candida albicans hyphae and extracellular aggregates of Mycobacterium bovis, but not in response to small yeast or single bacteria. NETs were fundamental in countering large pathogens in vivo. Phagocytosis via dectin-1 acted as a sensor of microbe size and prevented NET release by downregulating the translocation of neutrophil elastase (NE) to the nucleus. Dectin-1 deficiency led to aberrant NET release and NET-mediated tissue damage during infection. Size-tailored neutrophil responses cleared large microbes and minimized pathology when microbes were small enough to be phagocytosed.	[Branzk, Nora; Lubojemska, Aleksandra; Wang, Qian; Papayannopoulos, Venizelos] Natl Inst Med Res, MRC, Div Mol Immunol, London NW7 1AA, England; [Hardison, Sarah E.; Brown, Gordon D.] Univ Aberdeen, Aberdeen Fungal Grp, Inst Med Sci, Aberdeen, Scotland; [Gutierrez, Maximiliano G.] Natl Inst Med Res, MRC, Div Mycobacterial Res, London NW7 1AA, England	MRC National Institute for Medical Research; University of Aberdeen; MRC National Institute for Medical Research	Papayannopoulos, V (corresponding author), Natl Inst Med Res, MRC, Div Mol Immunol, Mill Hill, London NW7 1AA, England.	vpapaya@nimr.mrc.ac.uk	Hardison, Sarah/ABB-1606-2021; Hardison, Sarah E./AAC-7510-2019	brown, gordon/0000-0002-0287-5383; Papayannopoulos, Venizelos/0000-0002-3741-8190; Branzk, Nora/0000-0002-5707-855X; Gutierrez, Maximiliano/0000-0003-3199-0337	Medical Research Council (UK) [MC_UP_1202/13, MC_UP_1202/11]; Wellcome Trust; MRC [MC_UP_1202/11, MC_UP_1202/13] Funding Source: UKRI; Medical Research Council [MC_UP_1202/13, MC_UP_1202/11] Funding Source: researchfish	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the blood donors; Y. Wang (Institute of Molecular and Cell Biology of the Agency for Science, Technology and Research) and N. Gow (University of Aberdeen) for the hgc1 Delta C. albicans strain; G. Stockinger, M. Wilson and A. Zychlinsky for comments on the manuscript; E. Bernard for help with the M. bovis preparation; D. Bell for advice on microscopy; and A. Adekoya and K. Mathers for support with animal experiments. Supported by the Medical Research Council (UK) (MC_UP_1202/13 for V.P., and MC_UP_1202/11 for M.G.G.) and the Wellcome Trust.	Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Arendrup MC, 2010, CURR OPIN CRIT CARE, V16, P445, DOI 10.1097/MCC.0b013e32833e84d2; Bernut A, 2014, P NATL ACAD SCI USA, V111, pE943, DOI 10.1073/pnas.1321390111; Bianchi M, 2009, BLOOD, V114, P2619, DOI 10.1182/blood-2009-05-221606; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Branzk N, 2013, SEMIN IMMUNOPATHOL, V35, P513, DOI 10.1007/s00281-013-0384-6; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Carmona-Rivera C, 2015, ANN RHEUM DIS, V74, P1417, DOI 10.1136/annrheumdis-2013-204837; Caza T, 2014, INT REV IMMUNOL, V33, P330, DOI 10.3109/08830185.2013.863305; Deretic V, 2008, FUTURE MICROBIOL, V3, P517, DOI 10.2217/17460913.3.5.517; Domenech M, 2013, INFECT IMMUN, V81, P2606, DOI 10.1128/IAI.00491-13; Drummond RA, 2011, EUR J IMMUNOL, V41, P276, DOI 10.1002/eji.201041252; Fossati-Jimack L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057082; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fujie K, 1999, EUR J PHARMACOL, V374, P117, DOI 10.1016/S0014-2999(99)00268-X; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Gow NAR, 2012, NAT REV MICROBIOL, V10, P112, DOI 10.1038/nrmicro2711; Grinberg N, 2008, INFECT IMMUN, V76, P2802, DOI 10.1128/IAI.00051-08; Gupta AK, 2010, FEBS LETT, V584, P3193, DOI 10.1016/j.febslet.2010.06.006; Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI [10.1038/nchembio.496, 10.1038/NCHEMBIO.496]; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Ishii T, 2010, AM J PATHOL, V177, P1665, DOI 10.2353/ajpath.2010.090793; Joly S, 2009, J IMMUNOL, V183, P3578, DOI 10.4049/jimmunol.0901323; Kaplan MJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4325; Kawabata K, 2002, EUR J PHARMACOL, V451, P1, DOI 10.1016/S0014-2999(02)02182-9; Kennedy AD, 2007, EUR J IMMUNOL, V37, P467, DOI 10.1002/eji.200636653; Kusner DJ, 2005, CLIN IMMUNOL, V114, P239, DOI 10.1016/j.clim.2004.07.016; LEHRER RI, 1969, J CLIN INVEST, V48, P1478, DOI 10.1172/JCI106114; Low Chian-Yong, 2011, F1000 Med Rep, V3, P14, DOI 10.3410/M3-14; Martchenko M, 2004, MOL BIOL CELL, V15, P456, DOI 10.1091/mbc.E03-03-0179; Martinez-Gomariz M, 2009, PROTEOMICS, V9, P2230, DOI 10.1002/pmic.200700594; McAdow M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002307; Metzler KD, 2014, CELL REP, V8, P883, DOI 10.1016/j.celrep.2014.06.044; Metzler KD, 2011, BLOOD, V117, P953, DOI 10.1182/blood-2010-06-290171; Mollinedo F, 2006, J IMMUNOL, V177, P2831, DOI 10.4049/jimmunol.177.5.2831; Mori Y, 2012, J BIOL CHEM, V287, P10472, DOI 10.1074/jbc.M111.280321; Nordenfelt P, 2011, J LEUKOCYTE BIOL, V90, P271, DOI 10.1189/jlb.0810457; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; PARRY MF, 1981, ANN INTERN MED, V95, P293, DOI 10.7326/0003-4819-95-3-293; Prashar A, 2013, J CELL BIOL, V203, P1081, DOI 10.1083/jcb.201304095; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Saitoh T, 2012, CELL HOST MICROBE, V12, P109, DOI 10.1016/j.chom.2012.05.015; Salazar-Aldrete C, 2013, J CLIN IMMUNOL, V33, P368, DOI 10.1007/s10875-012-9821-x; Scianimanico S, 1999, CELL MICROBIOL, V1, P19, DOI 10.1046/j.1462-5822.1999.00002.x; Simeone R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002507; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450; Walker JN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003819; Watson RWG, 1996, J IMMUNOL, V156, P3986; Wong KW, 2013, J INFECT DIS, V208, P109, DOI 10.1093/infdis/jit097; Zheng XD, 2004, EMBO J, V23, P1845, DOI 10.1038/sj.emboj.7600195	54	575	598	8	104	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2014	15	11					1017	1025		10.1038/ni.2987	http://dx.doi.org/10.1038/ni.2987			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AR5RH	25217981	Green Accepted			2022-12-18	WOS:000343640700007
J	Nakaya, HI; Wrammert, J; Lee, EK; Racioppi, L; Marie-Kunze, S; Haining, WN; Means, AR; Kasturi, SP; Khan, N; Li, GM; McCausland, M; Kanchan, V; Kokko, KE; Li, SZ; Elbein, R; Mehta, AK; Aderem, A; Subbarao, K; Ahmed, R; Pulendran, B				Nakaya, Helder I.; Wrammert, Jens; Lee, Eva K.; Racioppi, Luigi; Marie-Kunze, Stephanie; Haining, W. Nicholas; Means, Anthony R.; Kasturi, Sudhir P.; Khan, Nooruddin; Li, Gui-Mei; McCausland, Megan; Kanchan, Vibhu; Kokko, Kenneth E.; Li, Shuzhao; Elbein, Rivka; Mehta, Aneesh K.; Aderem, Alan; Subbarao, Kanta; Ahmed, Rafi; Pulendran, Bali			Systems biology of vaccination for seasonal influenza in humans	NATURE IMMUNOLOGY			English	Article							YELLOW-FEVER VACCINE; PROTEIN-KINASE-IV; PLASMA-CELL DIFFERENTIATION; IMMUNE-RESPONSES; TRANSCRIPTION FACTOR; ANTIBODY-RESPONSES; CUTTING EDGE; T-CELLS; LIVE; CHILDREN	Here we have used a systems biology approach to study innate and adaptive responses to vaccination against influenza in humans during three consecutive influenza seasons. We studied healthy adults vaccinated with trivalent inactivated influenza vaccine (TIV) or live attenuated influenza vaccine (LAIV). TIV induced higher antibody titers and more plasmablasts than LAIV did. In subjects vaccinated with TIV, early molecular signatures correlated with and could be used to accurately predict later antibody titers in two independent trials. Notably, expression of the kinase CaMKIV at day 3 was inversely correlated with later antibody titers. Vaccination of CaMKIV-deficient mice with TIV induced enhanced antigen-specific antibody titers, which demonstrated an unappreciated role for CaMKIV in the regulation of antibody responses. Thus, systems approaches can be used to predict immunogenicity and provide new mechanistic insights about vaccines.	[Nakaya, Helder I.; Wrammert, Jens; Marie-Kunze, Stephanie; Kasturi, Sudhir P.; Khan, Nooruddin; Li, Gui-Mei; McCausland, Megan; Kanchan, Vibhu; Li, Shuzhao; Ahmed, Rafi; Pulendran, Bali] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Nakaya, Helder I.; Marie-Kunze, Stephanie; Kasturi, Sudhir P.; Khan, Nooruddin; Li, Shuzhao; Pulendran, Bali] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Wrammert, Jens; Li, Gui-Mei; McCausland, Megan; Kanchan, Vibhu; Ahmed, Rafi] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Lee, Eva K.] Georgia Inst Technol, Sch Ind & Syst Engn, Ctr Operat Res Med & Healthcare, Atlanta, GA 30332 USA; [Racioppi, Luigi] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC USA; [Racioppi, Luigi; Means, Anthony R.] Univ Naples Federico II, Dept Cellular & Mol Biol & Pathol, Naples, Italy; [Haining, W. Nicholas] Dana Farber Canc Inst, Boston, MA 02115 USA; [Kokko, Kenneth E.] Emory Univ, Sch Med, Dept Med, Div Nephrol, Atlanta, GA USA; [Elbein, Rivka; Mehta, Aneesh K.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA; [Aderem, Alan] Inst Syst Biol, Seattle, WA USA; [Subbarao, Kanta] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA; [Pulendran, Bali] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; University System of Georgia; Georgia Institute of Technology; Duke University; University of Naples Federico II; Harvard University; Dana-Farber Cancer Institute; Emory University; Emory University; Institute for Systems Biology (ISB); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Emory University	Pulendran, B (corresponding author), Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	bpulend@emory.edu	racioppi, luigi/AGB-8665-2022; Pulendran, Bali/AAW-9550-2021; Nakaya, Helder I/A-1397-2010; Nakaya, Helder/AAF-1738-2020; Mehta, Aneesh/B-8054-2012; racioppi, luigi/GNP-0349-2022; Khan, Nooruddin/AAF-5417-2019	Nakaya, Helder I/0000-0001-5297-9108; Nakaya, Helder/0000-0001-5297-9108; Mehta, Aneesh/0000-0002-6552-9162; racioppi, luigi/0000-0002-9207-6752; Li, Shuzhao/0000-0002-7386-2539; Pulendran, Bali/0000-0001-6517-4333; Subbarao, Kanta/0000-0003-1713-3056	US National Institutes of Health [U19AI090023, HHSN266200700006C, U54AI057157, R37AI48638, R01DK057665, U19AI057266, N01 AI50025, AI30048, AI057266, DK074701, UL1 RR025008]; Bill & Melinda Gates Foundation [38645]; National Science Foundation (E.K.L. laboratory); Centers for Disease Control (E.K.L. laboratory); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057266, R37AI048638, U19AI090023, R37AI030048, U54AI057157, R01AI030048, N01AI050025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057665, R01DK074701, R01DK057665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033976] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Science Foundation (E.K.L. laboratory)(National Science Foundation (NSF)); Centers for Disease Control (E.K.L. laboratory)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B.T. Rouse and R. Compans for discussion and comments on the manuscript, and H. Oluoch for technical assistance. Supported the US National Institutes of Health (U19AI090023, HHSN266200700006C, U54AI057157, R37AI48638, R01DK057665, U19AI057266 and N01 AI50025 for the B. P. laboratory; AI30048 and AI057266 for the R.A. laboratory; DK074701 for the A.R.M. laboratory; Intramural Research Program of the National Institute of Allergy and Infectious Diseases for the K.S. laboratory; and UL1 RR025008 from the Clinical and Translational Science Award program, National Center for Research Resources for clinical work), the Bill & Melinda Gates Foundation (Collaboration for AIDS Vaccine Discovery 38645 to the R.A. and B.P. laboratories), the National Science Foundation (E.K.L. laboratory) and the Centers for Disease Control (E.K.L. laboratory).	Anderson KA, 2002, MOL CELL BIOL, V22, P23, DOI 10.1128/MCB.22.1.23-29.2002; Anderson KJ, 2009, IMMUNOLOGY, V127, P8, DOI 10.1111/j.1365-2567.2009.03097.x; Apostolou A, 2008, EXP CELL RES, V314, P2454, DOI 10.1016/j.yexcr.2008.05.001; Avery DT, 2003, J CLIN INVEST, V112, P286, DOI 10.1172/JCI200318025; Barrett ADT, 2009, CURR OPIN IMMUNOL, V21, P308, DOI 10.1016/j.coi.2009.05.018; Belshe RB, 2004, VIRUS RES, V103, P177, DOI 10.1016/j.virusres.2004.02.031; Beyer WEP, 2002, VACCINE, V20, P1340, DOI 10.1016/S0264-410X(01)00471-6; Brooks JP, 2010, ANN OPER RES, V174, P147, DOI 10.1007/s10479-008-0424-0; Brown D, 2004, TISSUE ANTIGENS, V64, P215, DOI 10.1111/j.0001-2815.2004.00290.x; Chen GL, 2010, VIROLOGY, V398, P109, DOI 10.1016/j.virol.2009.12.003; CLEMENTS ML, 1986, J CLIN MICROBIOL, V24, P157, DOI 10.1128/JCM.24.1.157-160.1986; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Deaglio S, 2001, LEUKEMIA RES, V25, P1, DOI 10.1016/S0145-2126(00)00093-X; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; He XS, 2006, J VIROL, V80, P11756, DOI 10.1128/JVI.01460-06; Hirota Y, 1997, VACCINE, V15, P962, DOI 10.1016/S0264-410X(96)00302-7; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Illario M, 2008, BLOOD, V111, P723, DOI 10.1182/blood-2007-05-091173; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Iwakoshi NN, 2003, IMMUNOL REV, V194, P29, DOI 10.1034/j.1600-065X.2003.00057.x; JOHNSON PR, 1985, J MED VIROL, V17, P325, DOI 10.1002/jmv.1890170405; Kitsos CM, 2005, J BIOL CHEM, V280, P33101, DOI 10.1074/jbc.M505208200; Krebs J, 1997, BIOCHEM BIOPH RES CO, V241, P383, DOI 10.1006/bbrc.1997.7823; Le Bon A, 2006, J IMMUNOL, V176, P2074, DOI 10.4049/jimmunol.176.4.2074; Lee EK, 2007, ANN BIOMED ENG, V35, P1095, DOI 10.1007/s10439-007-9317-7; Liu B, 2008, BLOOD, V112, P1223, DOI 10.1182/blood-2008-03-143107; MOLDOVEANU Z, 1995, VACCINE, V13, P1006, DOI 10.1016/0264-410X(95)00016-T; Monath TP, 2005, EXPERT REV VACCINES, V4, P553, DOI 10.1586/14760584.4.4.553; Park SW, 2010, NAT MED, V16, P429, DOI 10.1038/nm.2099; POTTER CW, 1979, BRIT MED BULL, V35, P69, DOI 10.1093/oxfordjournals.bmb.a071545; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006; Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sasaki S, 2007, J VIROL, V81, P215, DOI 10.1128/JVI.01957-06; Sasaki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002975; Sato K, 2006, NAT MED, V12, P1410, DOI 10.1038/nm1515; Shen-Orr SS, 2010, NAT METHODS, V7, P287, DOI [10.1038/NMETH.1439, 10.1038/nmeth.1439]; Shubinsky G, 1997, IMMUNITY, V7, P315, DOI 10.1016/S1074-7613(00)80353-2; Sullivan SJ, 2010, EXPERT REV VACCINES, V9, P1127, DOI [10.1586/erv.10.117, 10.1586/ERV.10.117]; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Talbot HK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014442; Thomas R, 2010, CLIN REV ALLERG IMMU, V38, P159, DOI 10.1007/s12016-009-8148-8; Treanor JJ, 2010, VACCINE, V28, P8268, DOI 10.1016/j.vaccine.2010.10.009; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ueda Y, 2003, HUM IMMUNOL, V64, P1144, DOI 10.1016/j.humimm.2003.08.342; *US DEP HLTH HUM S, 2007, GUID IND CLIN DAT NE; Wang SL, 2001, CELL GROWTH DIFFER, V12, P351; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wu JY, 2000, NAT GENET, V25, P448, DOI 10.1038/78153; Zeman AM, 2007, PEDIATR INFECT DIS J, V26, P107, DOI 10.1097/01.inf.0000253251.03785.9b	54	574	582	0	107	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2011	12	8					786	U149		10.1038/ni.2067	http://dx.doi.org/10.1038/ni.2067			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	794BT	21743478	Green Accepted, Bronze			2022-12-18	WOS:000292870700017
J	Traver, D; Paw, BH; Poss, KD; Penberthy, WT; Lin, S; Zon, LI				Traver, D; Paw, BH; Poss, KD; Penberthy, WT; Lin, S; Zon, LI			Transplantation and in vivo imaging of multilineage engraftment in zebrafish bloodless mutants	NATURE IMMUNOLOGY			English	Article							HEMATOPOIETIC STEM-CELLS; TRANSCRIPTION FACTOR GATA-1; CYPRINUS-CARPIO L; ONCORHYNCHUS-MYKISS; RAINBOW-TROUT; IMMUNOCYTOCHEMICAL ANALYSIS; MONOCLONAL-ANTIBODIES; ERYTHROID DEVELOPMENT; TRANSGENIC ZEBRAFISH; EARLY MACROPHAGES	The zebrafish is firmly established as a genetic model for the study of vertebrate blood development. Here we have characterized the blood-forming system of adult zebrafish. Each major blood lineage can be isolated by flow cytometry, and with these lineal profiles, defects in zebrafish blood mutants can be quantified. We developed hematopoietic cell transplantation to study cell autonomy of mutant gene function and to establish a hematopoietic stem cell assay. Hematopoietic cell transplantation can rescue multilineage hematopoiesis in embryonic lethal gata1(-/-) mutants for over 6 months. Direct visualization of fluorescent donor cells in embryonic recipients allows engraftment and homing events to be imaged in real time. These results provide a cellular context in which to study the genetics of hematopoiesis.	Childrens Hosp Boston, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Univ Calif Los Angeles, Los Angeles, CA 90095 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Duke University; University of California System; University of California Los Angeles	Zon, LI (corresponding author), Childrens Hosp Boston, 320 Longwood Ave,Enders 720, Boston, MA 02115 USA.			Poss, Kenneth/0000-0002-6743-5709; Paw, Barry/0000-0002-0492-1419				Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; ALADHAMI MA, 1977, DEV GROWTH DIFFER, V19, P171; Amatruda JF, 1999, DEV BIOL, V216, P1, DOI 10.1006/dbio.1999.9462; Bennett CM, 2001, BLOOD, V98, P643, DOI 10.1182/blood.V98.3.643; Bowden LA, 1997, COMP BIOCHEM PHYS C, V117, P291, DOI 10.1016/S0742-8413(97)00005-4; Burns CE, 2002, EXP HEMATOL, V30, P1381, DOI 10.1016/S0301-472X(02)00955-4; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Danilova N, 2002, P NATL ACAD SCI USA, V99, P13711, DOI 10.1073/pnas.212515999; FLEISCHMAN RA, 1982, CELL, V30, P351, DOI 10.1016/0092-8674(82)90233-1; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Hoover KB, 2000, CURR OPIN CELL BIOL, V12, P229, DOI 10.1016/S0955-0674(99)00080-0; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jagadeeswaran P, 1999, BRIT J HAEMATOL, V107, P731, DOI 10.1046/j.1365-2141.1999.01763.x; Kalev-Zylinska ML, 2002, DEVELOPMENT, V129, P2015; Kollner B, 2001, FISH SHELLFISH IMMUN, V11, P127, DOI 10.1006/fsim.2000.0300; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Langenau DM, 2003, SCIENCE, V299, P887, DOI 10.1126/science.1080280; Liao EC, 1998, GENE DEV, V12, P621, DOI 10.1101/gad.12.5.621; Liao EC, 2002, DEVELOPMENT, V129, P649; Liao EC, 2000, DEVELOPMENT, V127, P5123; Lieschke GJ, 2001, BLOOD, V98, P3087, DOI 10.1182/blood.V98.10.3087; Long QM, 1997, DEVELOPMENT, V124, P4105; Lux SE, 1995, BLOOD PRINCIPLES PRA, P1701; Lyons SE, 2002, P NATL ACAD SCI USA, V99, P5454, DOI 10.1073/pnas.082695299; Miller N, 1998, IMMUNOL REV, V166, P187, DOI 10.1111/j.1600-065X.1998.tb01263.x; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Parker L, 1999, DEVELOPMENT, V126, P2643; Paw BH, 2003, NAT GENET, V34, P59, DOI 10.1038/ng1137; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Ransom DG, 1996, DEVELOPMENT, V123, P311; ROMBOUT JHWM, 1993, DEV COMP IMMUNOL, V17, P55, DOI 10.1016/0145-305X(93)90015-I; SECOMBES CJ, 1983, IMMUNOLOGY, V48, P165; Shafizadeh E, 2002, DEVELOPMENT, V129, P4359; SHAPIRO HM, 2002, PRACTICAL FLOW CYTOM, P271; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; SLIERENDRECHT WJ, 1995, VET IMMUNOL IMMUNOP, V46, P349, DOI 10.1016/0165-2427(94)05362-V; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Tanner MJA, 2002, CURR OPIN HEMATOL, V9, P133, DOI 10.1097/00062752-200203000-00009; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; Traver D, 2002, CELL, V108, P731, DOI 10.1016/S0092-8674(02)00686-4; Trede NS, 1998, DEV COMP IMMUNOL, V22, P253, DOI 10.1016/S0145-305X(98)00009-3; Trede NS, 2001, TRENDS IMMUNOL, V22, P302, DOI 10.1016/S1471-4906(01)01939-1; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; WARREN AJ, 1994, CELL, V78, P45, DOI 10.1016/0092-8674(94)90571-1; Weinstein BM, 1996, DEVELOPMENT, V123, P303; WEISS MJ, 1994, GENE DEV, V8, P1184, DOI 10.1101/gad.8.10.1184; Westerfield M, 1994, ZEBRAFISH BOOK GUIDE; Willett CE, 1999, DEV DYNAM, V214, P323, DOI 10.1002/(SICI)1097-0177(199904)214:4<323::AID-AJA5>3.0.CO;2-3; Willett CE, 1997, DEV BIOL, V182, P331, DOI 10.1006/dbio.1996.8446; Yamada Y, 1998, P NATL ACAD SCI USA, V95, P3890, DOI 10.1073/pnas.95.7.3890; ZAPATA A, 1979, DEV COMP IMMUNOL, V3, P55, DOI 10.1016/S0145-305X(79)80006-3; ZON LI, 1993, BLOOD, V81, P3234	57	574	586	3	52	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2003	4	12					1238	1246		10.1038/ni1007	http://dx.doi.org/10.1038/ni1007			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	746VZ	14608381				2022-12-18	WOS:000186769500018
J	Smyth, MJ; Godfrey, DI; Trapani, JA				Smyth, MJ; Godfrey, DI; Trapani, JA			A fresh look at tumor immunosurveillance and immunotherapy	NATURE IMMUNOLOGY			English	Review							T-CELL RESPONSES; IMMUNE SURVEILLANCE; NKG2D RECEPTOR; NKT CELLS; RECOGNITION; PERFORIN; CANCER; ANTIGENS; IMMUNODEFICIENCY; CYTOTOXICITY	Despite major advances in our understanding of adaptive immunity and dendritic cells, consistent and durable responses to cancer vaccines remain elusive and active immunotherapy is still not an established treatment modality. The key to developing an effective anti-tumor response is understanding why, initially, the immune system is unable to detect transformed cells and is subsequently tolerant of tumor growth and metastasis. Ineffective antigen presentation limits the adaptive immune response; however, we are now learning that the host's innate immune system may first fail to recognize the tumor as posing a danger. Recent descriptions of stress-induced ligands on tumor cells recognized by innate effector cells, new subsets of T cells that regulate tumor tolerance and the development of spontaneous tumors in mice that lack immune effector molecules, beckon a reflection on our current perspectives on the interaction of transformed cells with the immune system and offer new hope of stimulating therapeutic immunity to cancer.	Peter MacCallum Canc Inst, Trescowthick Labs, Melbourne, Vic 8006, Australia; Alfred Hosp, Monash Med Sch, Dept Pathol & Immunol, Prahran, Vic 3181, Australia	Peter Maccallum Cancer Center; Florey Institute of Neuroscience & Mental Health; Monash University	Smyth, MJ (corresponding author), Peter MacCallum Canc Inst, Trescowthick Labs, Locked Bag 1,ABeckett St, Melbourne, Vic 8006, Australia.	m.smyth@pmci.unimelb.edu.au; dale.godfrey@med.monash.edu.au; j.trapani@pmci.unimelb.edu.au	Smyth, Mark J/H-8709-2014	Smyth, Mark J/0000-0001-7098-7240; Godfrey, Dale/0000-0002-3009-5472; Trapani, Joseph/0000-0003-0983-1532				Ada G, 1999, IMMUNOL CELL BIOL, V77, P180, DOI 10.1046/j.1440-1711.1999.00803.x; Aguilar Laura K., 1999, Current Opinion in Oncology, V11, P96, DOI 10.1097/00001622-199903000-00004; Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Badovinac VP, 2000, SCIENCE, V290, P1354, DOI 10.1126/science.290.5495.1354; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Blachere NE, 1997, J EXP MED, V186, P1315, DOI 10.1084/jem.186.8.1315; Braud VM, 1999, CURR TOP MICROBIOL, V244, P85; BURNET FM, 1967, LANCET, V1, P1171; BURNET M, 1957, BRIT MED J, V1, P779, DOI 10.1136/bmj.1.5022.779; Cannon M, 2000, SEMIN ONCOL, V27, P409; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Chiodoni C, 1999, J EXP MED, V190, P125, DOI 10.1084/jem.190.1.125; Coley WB, 1893, AM J MED SCI, V105, P487, DOI [DOI 10.1097/00000441-189305000-00001, 10.1097/00000441-189305000-00001]; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Davidson WF, 1998, J EXP MED, V187, P1825, DOI 10.1084/jem.187.11.1825; Davis ID, 2000, IMMUNOL CELL BIOL, V78, P179, DOI 10.1046/j.1440-1711.2000.00906.x; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; DIGHE AS, 1994, IMMUNITY, V1, P447, DOI 10.1016/1074-7613(94)90087-6; Elgert KD, 1998, J LEUKOCYTE BIOL, V64, P275, DOI 10.1002/jlb.64.3.275; FERRONE S, 1995, IMMUNOL TODAY, V16, P487, DOI 10.1016/0167-5699(95)80033-6; Fuchs E J, 1996, Semin Immunol, V8, P271, DOI 10.1006/smim.1996.0035; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; GATTI RA, 1971, CANCER-AM CANCER SOC, V28, P89, DOI 10.1002/1097-0142(197107)28:1<89::AID-CNCR2820280117>3.0.CO;2-Q; GERSHWIN ME, 1983, J IMMUNOL, V131, P2069; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Greten TF, 1999, J CLIN ONCOL, V17, P1047, DOI 10.1200/JCO.1999.17.3.1047; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; HALIOTIS T, 1985, INT J CANCER, V35, P505, DOI 10.1002/ijc.2910350414; Hammond KJL, 1998, J EXP MED, V187, P1047, DOI 10.1084/jem.187.7.1047; Hanninen A, 2000, IMMUNOL REV, V173, P109, DOI 10.1034/j.1600-065X.2000.917303.x; HARDING C, 1984, EUR J CELL BIOL, V35, P256; HOUGHTON AN, 1994, J EXP MED, V180, P1, DOI 10.1084/jem.180.1.1; Jager E, 1999, CANCER METAST REV, V18, P143, DOI 10.1023/A:1006220707618; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Lopez-Botet M, 2000, SEMIN IMMUNOL, V12, P109, DOI 10.1006/smim.2000.0213; MARCUS A, 1983, IEEE COMPUT GRAPH, V3, P63, DOI 10.1109/MCG.1983.263148; Matloubian M, 1999, J VIROL, V73, P2527, DOI 10.1128/JVI.73.3.2527-2536.1999; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; McClain K L, 1997, Cancer Treat Res, V92, P39; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Melcher A, 1998, NAT MED, V4, P581, DOI 10.1038/nm0598-581; Moretta A, 2000, IMMUNOL TODAY, V21, P228, DOI 10.1016/S0167-5699(00)01596-6; Nomura M, 1996, J BIOCHEM-TOKYO, V120, P987; Onizuka S, 1999, CANCER RES, V59, P3128; Otley CC, 2000, LIVER TRANSPLANT, V6, P253, DOI 10.1053/lv.2000.6352; PALLER AS, 1995, DERMATOL CLIN, V13, P65, DOI 10.1016/S0733-8635(18)30108-6; Park SH, 2000, NATURE, V406, P788, DOI 10.1038/35021233; Pfreundschuh M, 2000, CANCER CHEMOTH PHARM, V46, pS3, DOI 10.1007/PL00014046; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; Ridge JP, 1996, SCIENCE, V271, P1723, DOI 10.1126/science.271.5256.1723; Robert J, 1998, IMMUNOL REV, V166, P231, DOI 10.1111/j.1600-065X.1998.tb01266.x; Rosenberg SA, 1998, NAT MED, V4, P321, DOI 10.1038/nm0398-321; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Sakaguchi S, 2000, CURR OPIN IMMUNOL, V12, P684, DOI 10.1016/S0952-7915(00)00163-1; Salcedo M, 1999, CURR TOP MICROBIOL, V244, P97; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Seo N, 1999, J IMMUNOL, V163, P242; SHAUKARAN V, 2001, NATURE; Shimizu J, 1999, J IMMUNOL, V163, P5211; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Shustov A, 2000, J CLIN INVEST, V106, pR39, DOI 10.1172/JCI8876; Smyth MJ, 2000, J EXP MED, V191, P661, DOI 10.1084/jem.191.4.661; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; Smyth MJ, 2000, NAT IMMUNOL, V1, P459, DOI 10.1038/82698; SMYTH MJ, 2001, IN PRESS INT IMMUNOL, V13; Strander H, 1996, BIOTHERAPY, V8, P213, DOI 10.1007/BF01877207; Street SEA, 2001, BLOOD, V97, P192, DOI 10.1182/blood.V97.1.192; Stutman O, 1975, Adv Cancer Res, V22, P261; Takei F, 1997, IMMUNOL REV, V155, P67, DOI 10.1111/j.1600-065X.1997.tb00940.x; Tamura Y, 1997, SCIENCE, V278, P117, DOI 10.1126/science.278.5335.117; Terabe M, 2000, NAT IMMUNOL, V1, P515, DOI 10.1038/82771; vandenBroek MF, 1996, J EXP MED, V184, P1781, DOI 10.1084/jem.184.5.1781; VandenEynde BJ, 1997, CURR OPIN IMMUNOL, V9, P684, DOI 10.1016/S0952-7915(97)80050-7; Walker PR, 1998, CURR OPIN IMMUNOL, V10, P564, DOI 10.1016/S0952-7915(98)80225-2; Wang RF, 1999, IMMUNOL REV, V170, P85, DOI 10.1111/j.1600-065X.1999.tb01331.x; WHITESIDE TL, 1995, CURR OPIN IMMUNOL, V7, P704, DOI 10.1016/0952-7915(95)80080-8; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730	85	574	614	2	94	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2001	2	4					293	299		10.1038/86297	http://dx.doi.org/10.1038/86297			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	420AZ	11276199				2022-12-18	WOS:000167982900009
J	Uematsu, S; Fujimoto, K; Jang, MH; Yang, BG; Jung, YJ; Nishiyama, M; Sato, S; Tsujimura, T; Yamamoto, M; Yokota, Y; Kiyono, H; Miyasaka, M; Ishii, KJ; Akira, S				Uematsu, Satoshi; Fujimoto, Kosuke; Jang, Myoung Ho; Yang, Bo-Gie; Jung, Yun-Jae; Nishiyama, Mika; Sato, Shintaro; Tsujimura, Tohru; Yamamoto, Masafumi; Yokota, Yoshifumi; Kiyono, Hiroshi; Miyasaka, Masayuki; Ishii, Ken J.; Akira, Shizuo			Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5	NATURE IMMUNOLOGY			English	Article							IGA PLASMA-CELLS; RETINOIC-ACID; T-CELLS; INTESTINAL BACTERIA; COMMENSAL BACTERIA; ORAL TOLERANCE; PEYER PATCHES; B-CELLS; DIFFERENTIATION; INDUCE	The intestinal cell types responsible for defense against pathogenic organisms remain incompletely characterized. Here we identify a subset of CD11c(hi)CD11b(hi) lamina propria dendritic cells (LPDCs) that expressed Toll-like receptor 5 (TLR5) in the small intestine. When stimulated by the TLR5 ligand flagellin, TLR5(+) LPDCs induced the differentiation of naive B cells into immunoglobulin A-producing plasma cells by a mechanism independent of gut-associated lymphoid tissue. In addition, by a mechanism dependent on TLR5 stimulation, these LPDCs promoted the differentiation of antigen-specific interleukin 17-producing T helper cells and type 1 T helper cells. Unlike spleen DCs, the LPDCs specifically produced retinoic acid, which, in a dose-dependent way, supported the generation and retention of immunoglobulin A-producing cells in the lamina propria and positively regulated the differentiation interleukin 17-producing T helper cells. Our findings demonstrate unique properties of LPDCs and the importance of TLR5 for adaptive immunity in the intestine.	[Uematsu, Satoshi; Fujimoto, Kosuke; Yang, Bo-Gie; Ishii, Ken J.; Akira, Shizuo] Osaka Univ, Host Def Lab, Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Uematsu, Satoshi; Fujimoto, Kosuke; Akira, Shizuo] Osaka Univ, Dept Host Def, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Jang, Myoung Ho] Osaka Univ, Lab Gastrointestinal Immunol, Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Jung, Yun-Jae] Gachon Med Sch, Dept Microbiol, Inchon 405760, South Korea; [Nishiyama, Mika; Miyasaka, Masayuki] Osaka Univ, Grad Sch Med, Lab Immunodynam, Dept Microbiol & Immunol, Suita, Osaka 5650871, Japan; [Sato, Shintaro; Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Div Mucosal Immunol, Tokyo 1088639, Japan; [Tsujimura, Tohru] Hyogo Coll Med, Dept Pathol, Nishinomiya, Hyogo 6638501, Japan; [Yamamoto, Masafumi] Nihon Univ, Sch Dent Matsudo, Dept Microbiol & Immunol, Chiba 2718587, Japan; [Yokota, Yoshifumi] Univ Fukui, Fac Med Sci, Sch Med, Div Mol Genet, Fukui 9101193, Japan; [Ishii, Ken J.; Akira, Shizuo] Japan Sci & Technol Corp, Exploratory Res Adv Technol, Suita, Osaka 5650871, Japan; [Ishii, Ken J.] Osaka Univ, Microbial Dis Res Inst, Dept Mol Protozool, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University; Gachon University; Osaka University; University of Tokyo; Hyogo College of Medicine; Nihon University; University of Fukui; Japan Science & Technology Agency (JST); Osaka University	Akira, S (corresponding author), Osaka Univ, Host Def Lab, Immunol Frontier Res Ctr, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp	Ishii, Ken J/B-1685-2012; Akira, Shizuo/C-3134-2009; Kiyono, Hiroshi/AAC-6735-2022; Miyasaka, Masayuki/AAM-6343-2020; Jang, Myoung Ho/D-1714-2009	Ishii, Ken J/0000-0002-6728-3872; Jang, Myoung Ho/0000-0001-8909-4725; Yang, Bo-Gie/0000-0002-1538-8488; JUNG, YUNJAE/0000-0002-1574-696X; Sato, Shintaro/0000-0001-5156-3354	NIAID NIH HHS [AI070167] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Annacker O, 2005, J EXP MED, V202, P1051, DOI 10.1084/jem.20040662; Asselin-Paturel C, 2003, J IMMUNOL, V171, P6466, DOI 10.4049/jimmunol.171.12.6466; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bilsborough J, 2003, IMMUNOLOGY, V108, P481, DOI 10.1046/j.1365-2567.2003.01606.x; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Coombes JL, 2007, SEMIN IMMUNOL, V19, P116, DOI 10.1016/j.smim.2007.01.001; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Hieshima K, 2004, J IMMUNOL, V173, P3668, DOI 10.4049/jimmunol.173.6.3668; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwasaki A, 1999, J EXP MED, V190, P229, DOI 10.1084/jem.190.2.229; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Jang MH, 2006, J IMMUNOL, V176, P803, DOI 10.4049/jimmunol.176.2.803; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Kang HS, 2002, NAT IMMUNOL, V3, P576, DOI 10.1038/ni795; Kelsall BL, 2005, IMMUNOL REV, V206, P132, DOI 10.1111/j.0105-2896.2005.00292.x; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kunisawa J, 2007, BLOOD, V109, P3749, DOI 10.1182/blood-2006-08-041582; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; MACPHERSON GG, 1995, J IMMUNOL, V154, P1317; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; PAVLI P, 1990, IMMUNOLOGY, V70, P40; Schambach F, 2007, EUR J IMMUNOL, V37, P2396, DOI 10.1002/eji.200737621; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Suzuki K, 2005, P NATL ACAD SCI USA, V102, P2482, DOI 10.1073/pnas.0409539102; Suzuki K, 2007, SEMIN IMMUNOL, V19, P127, DOI 10.1016/j.smim.2006.10.001; Tezuka H, 2007, NATURE, V448, P929, DOI 10.1038/nature06033; TSENG J, 1981, J IMMUNOL, V127, P2039; TSENG J, 1984, J IMMUNOL, V132, P2730; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; van Egmond M, 2001, TRENDS IMMUNOL, V22, P205, DOI 10.1016/S1471-4906(01)01873-7; Viney JL, 1998, J IMMUNOL, V160, P5815; Williamson E, 1999, J IMMUNOL, V163, P3668; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	50	566	585	0	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2008	9	7					769	776		10.1038/ni.1622	http://dx.doi.org/10.1038/ni.1622			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	315UE	18516037				2022-12-18	WOS:000256904900015
J	Reinhardt, RL; Liang, HE; Locksley, RM				Reinhardt, R. Lee; Liang, Hong-Erh; Locksley, Richard M.			Cytokine-secreting follicular T cells shape the antibody repertoire	NATURE IMMUNOLOGY			English	Article							INDUCED CYTIDINE DEAMINASE; CENTER B-CELLS; PRIMARY IMMUNE-RESPONSE; GERMINAL-CENTER; HELPER-CELLS; AFFINITY MATURATION; IN-VIVO; INDUCIBLE COSTIMULATOR; GENE-EXPRESSION; DENDRITIC CELLS	High-affinity antibodies are critical for host protection and underlie successful vaccines. The generation of such antibodies requires T cell-dependent help, which mediates germinal center reactions in which mutation and selection of B cells occurs. Using an interleukin 4-reporter system, we show here that CD4(+) follicular helper T cells constituted essentially all of the cytokine-secreting T cells in lymph nodes and were functionally distinct from T cells secreting the same cytokine in peripheral tissues. Follicular helper T cells with different cytokine profiles could be isolated as conjugates with B cells undergoing cytokine-specific immunoglobulin class switching with evidence of somatic hypermutation. Our findings support a model in which B cells compete for cytokines produced by follicular helper T cells that shape the affinity and isotype of the antibody response.	[Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Locksley, RM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	locksley@medicine.ucsf.edu			National Institutes of Allergy and Infectious Diseases [AI026918, AI077439]; Howard Hughes Medical Institute; Sandler Asthma Basic Research Center; Juvenile Diabetes Research Foundation Irvington Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI026918, R01AI026918, R01AI030663, U19AI077439] Funding Source: NIH RePORTER	National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Sandler Asthma Basic Research Center; Juvenile Diabetes Research Foundation Irvington Institute(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank G. Kelsoe (Duke University), M. Nussenzweig (Rockefeller University), K. McBride (Rockefeller University) and A. N. McKenzie (Trinity College, Dublin) for reagents and suggestions; J. Cyster, A. DeFranco and C. Allen for review and comments; and N. Flores, L. Stowring and C. McArthur for technical expertise. Supported by the National Institutes of Allergy and Infectious Diseases (AI026918 and AI077439), the Howard Hughes Medical Institute, the Sandler Asthma Basic Research Center of the University of California San Francisco and the Juvenile Diabetes Research Foundation Irvington Institute (R. L. R.).	Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; Andoh A, 2000, IMMUNOL LETT, V73, P35, DOI 10.1016/S0165-2478(00)00202-9; BOTHWELL ALM, 1981, CELL, V24, P625, DOI 10.1016/0092-8674(81)90089-1; CasamayorPalleja M, 1996, INT IMMUNOL, V8, P737, DOI 10.1093/intimm/8.5.737; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Dal Porto JM, 1998, J IMMUNOL, V161, P5373; de Leval L, 2007, BLOOD, V109, P4952, DOI 10.1182/blood-2006-10-055145; Dedeoglu F, 2004, INT IMMUNOL, V16, P395, DOI 10.1093/intimm/dxh042; Dong C, 2001, J IMMUNOL, V166, P3659, DOI 10.4049/jimmunol.166.6.3659; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Fang YF, 1998, J IMMUNOL, V160, P5273; Fazilleau N, 2007, CURR OPIN IMMUNOL, V19, P259, DOI 10.1016/j.coi.2007.04.003; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Hannum LG, 2000, J EXP MED, V192, P931, DOI 10.1084/jem.192.7.931; Huntington ND, 2006, NAT IMMUNOL, V7, P190, DOI 10.1038/ni1292; Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957; JACOB J, 1993, J EXP MED, V178, P1293, DOI 10.1084/jem.178.4.1293; Jolly CJ, 1997, NUCLEIC ACIDS RES, V25, P1913, DOI 10.1093/nar/25.10.1913; Kelsoe G, 1996, IMMUNITY, V4, P107, DOI 10.1016/S1074-7613(00)80675-5; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; LALOR PA, 1992, EUR J IMMUNOL, V22, P3001, DOI 10.1002/eji.1830221136; Loke P, 2005, P NATL ACAD SCI USA, V102, P9872, DOI 10.1073/pnas.0503961102; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Maldonado RA, 2004, NATURE, V431, P527, DOI 10.1038/nature02916; Meyer-Hermann ME, 2006, MATH MED BIOL, V23, P255, DOI 10.1093/imammb/dql012; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Phan TG, 2006, J EXP MED, V203, P2419, DOI 10.1084/jem.20061254; Reichert P, 2001, J IMMUNOL, V166, P4278, DOI 10.4049/jimmunol.166.7.4278; REINER SL, 1994, J EXP MED, V179, P447, DOI 10.1084/jem.179.2.447; Reitmayer H, 2002, PLANT BIOLOGY, V4, P228, DOI 10.1055/s-2002-25731; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Shinkai K, 2002, NATURE, V420, P825, DOI 10.1038/nature01202; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Takahashi Y, 1998, J EXP MED, V187, P885, DOI 10.1084/jem.187.6.885; Tarlinton DM, 2008, IMMUNOL CELL BIOL, V86, P133, DOI 10.1038/sj.icb.7100148; VAJDY M, 1995, J EXP MED, V181, P41, DOI 10.1084/jem.181.1.41; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Zangani MM, 2007, J EXP MED, V204, P1181, DOI 10.1084/jem.20061220; Zhou C, 2003, J IMMUNOL, V170, P1887, DOI 10.4049/jimmunol.170.4.1887	50	565	586	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2009	10	4					385	393		10.1038/ni.1715	http://dx.doi.org/10.1038/ni.1715			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	422KE	19252490	Green Accepted			2022-12-18	WOS:000264425800012
J	Klose, CSN; Artis, D				Klose, Christoph S. N.; Artis, David			Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis	NATURE IMMUNOLOGY			English	Review							NATURAL-KILLER-CELLS; GENOME-WIDE ASSOCIATION; FACTOR T-BET; ROR-GAMMA-T; HOST-DEFENSE; INTESTINAL HOMEOSTASIS; MUCOSAL IMMUNITY; TYPE-2 IMMUNITY; INDUCER CELLS; HELPER-CELLS	Research over the last 7 years has led to the formal identification of innate lymphoid cells (ILCs), increased the understanding of their tissue distribution and has established essential functions of ILCs in diverse physiological processes. These include resistance to pathogens, the regulation of autoimmune inflammation, tissue remodeling, cancer and metabolic homeostasis. Notably, many ILC functions appear to be regulated by mechanisms distinct from those of other innate and adaptive immune cells. In this Review, we focus on how group 2 ILC (ILC2) and group 3 ILC (ILC3) responses are regulated and how these cells interact with other immune and non-immune cells to mediate their functions. We highlight experimental evidence from mouse models and patient-based studies that have elucidated the effects of ILCs on the maintenance of tissue homeostasis and the consequences for health and disease.	[Klose, Christoph S. N.; Artis, David] Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Joan & Sanford I Weill Dept Med, Dept Microbiol & Immunol,Weill Cornell Med, New York, NY 10021 USA	Cornell University	Artis, D (corresponding author), Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Joan & Sanford I Weill Dept Med, Dept Microbiol & Immunol,Weill Cornell Med, New York, NY 10021 USA.	dartis@med.cornell.edu	Klose, Christoph/ABE-6396-2020	Artis, David/0000-0002-1753-4100	US National Institutes of Health [AI061570, AI087990, AI074878, AI083480, AI095466, AI095608, AI102942, AI097333]; Burroughs Wellcome Fund; Crohn's & Colitis Foundation of America	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Crohn's & Colitis Foundation of America	We thank T. Mahlakoiv, L.C. Rankin and A.-L. Flamar for critical reading of the manuscript. Supported by the US National Institutes of Health (AI061570, AI087990, AI074878, AI083480, AI095466, AI095608, AI102942, and AI097333 for the Artis laboratory), the Burroughs Wellcome Fund (Artis laboratory) and the Crohn's & Colitis Foundation of America (Artis laboratory).	Aparicio-Domingo P, 2015, J EXP MED, V212, P1783, DOI 10.1084/jem.20150318; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bando Jennifer K, 2015, Nat Immunol, V16, P153, DOI 10.1038/ni.3057; Bando JK, 2016, NAT IMMUNOL, V17, P783, DOI 10.1038/ni.3484; Barnig C, 2015, EUR RESPIR REV, V24, P141, DOI 10.1183/09059180.00012514; Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Boyd A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108649; Brestoff JR, 2015, CELL, V161, P146, DOI 10.1016/j.cell.2015.02.022; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Carrega P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9280; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Cording S, 2016, NAT IMMUNOL, V17, P755, DOI 10.1038/ni.3448; Crellin NK, 2010, J EXP MED, V207, P281, DOI 10.1084/jem.20091509; Dadi S, 2016, CELL, V164, P365, DOI 10.1016/j.cell.2016.01.002; Diefenbach A, 2003, CURR OPIN IMMUNOL, V15, P37, DOI 10.1016/S0952-7915(02)00007-9; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Doherty TA, 2013, J ALLERGY CLIN IMMUN, V132, P205, DOI 10.1016/j.jaci.2013.03.048; Dudakov JA, 2012, SCIENCE, V336, P91, DOI 10.1126/science.1218004; Duerr CU, 2016, NAT IMMUNOL, V17, P65, DOI 10.1038/ni.3308; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Duffin R, 2016, SCIENCE, V351, P1333, DOI 10.1126/science.aad9903; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Eisenring M, 2010, NAT IMMUNOL, V11, P1030, DOI 10.1038/ni.1947; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Fan X, 2016, CELL, V164, P1198, DOI 10.1016/j.cell.2016.02.048; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Gasteiger G, 2013, J EXP MED, V210, P1179, DOI 10.1084/jem.20122571; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Giacomin PR, 2015, J EXP MED, V212, P1513, DOI 10.1084/jem.20141831; Gladiator A, 2013, J IMMUNOL, V190, P521, DOI 10.4049/jimmunol.1202924; Glatzer T, 2013, IMMUNITY, V38, P1223, DOI 10.1016/j.immuni.2013.05.013; Goto Y, 2014, SCIENCE, V345, P1310, DOI 10.1126/science.1254009; Grundemann C, 2010, EUR J IMMUNOL, V40, P1303, DOI 10.1002/eji.200939771; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Halim TYF, 2016, INT IMMUNOL, V28, P13, DOI 10.1093/intimm/dxv050; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hams E, 2013, J IMMUNOL, V191, P5349, DOI 10.4049/jimmunol.1301176; Hanash AM, 2012, IMMUNITY, V37, P339, DOI 10.1016/j.immuni.2012.05.028; Hepworth MR, 2015, SCIENCE, V348, P1031, DOI 10.1126/science.aaa4812; Hernandez PP, 2015, NAT IMMUNOL, V16, P698, DOI 10.1038/ni.3180; Howitt MR, 2016, SCIENCE, V351, P1329, DOI 10.1126/science.aaf1648; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Hughes T, 2010, IMMUNITY, V32, P803, DOI 10.1016/j.immuni.2010.06.007; Ikutani M, 2012, J IMMUNOL, V188, P703, DOI 10.4049/jimmunol.1101270; Imai Y, 2013, P NATL ACAD SCI USA, V110, P13921, DOI 10.1073/pnas.1307321110; Ishizuka IE, 2016, NAT IMMUNOL, V17, P269, DOI 10.1038/ni.3344; Jovanovic IP, 2014, INT J CANCER, V134, P1669, DOI 10.1002/ijc.28481; Karo JM, 2014, CELL, V159, P94, DOI 10.1016/j.cell.2014.08.026; Kim BS, 2014, J IMMUNOL, V193, P3717, DOI 10.4049/jimmunol.1401307; Kim BS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005374; Kim HY, 2014, NAT MED, V20, P54, DOI 10.1038/nm.3423; Kim MH, 2015, IMMUNITY, V43, P107, DOI 10.1016/j.immuni.2015.06.009; Kirchberger S, 2013, J EXP MED, V210, P917, DOI 10.1084/jem.20122308; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Krishnamoorthy N, 2015, J IMMUNOL, V194, P863, DOI 10.4049/jimmunol.1402534; Kruglov AA, 2013, SCIENCE, V342, P1243, DOI 10.1126/science.1243364; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Li JY, 2015, CURR OPIN ALLERGY CL, V15, P33, DOI 10.1097/ACI.0000000000000124; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; Longman RS, 2014, J EXP MED, V211, P1571, DOI 10.1084/jem.20140678; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Maazi H, 2015, IMMUNITY, V42, P538, DOI 10.1016/j.immuni.2015.02.007; Magri G, 2014, NAT IMMUNOL, V15, P354, DOI 10.1038/ni.2830; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Mchedlidze T, 2013, IMMUNITY, V39, P357, DOI 10.1016/j.immuni.2013.07.018; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Meylan F, 2014, MUCOSAL IMMUNOL, V7, P958, DOI 10.1038/mi.2013.114; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Molofsky AB, 2015, IMMUNITY, V43, P161, DOI 10.1016/j.immuni.2015.05.019; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Monticelli LA, 2015, P NATL ACAD SCI USA, V112, P10762, DOI 10.1073/pnas.1509070112; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro K, 2016, NAT IMMUNOL, V17, P76, DOI 10.1038/ni.3309; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Motomura Y, 2014, IMMUNITY, V40, P758, DOI 10.1016/j.immuni.2014.04.013; Nausch N, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003627; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Okada S, 2015, SCIENCE, V349, P606, DOI 10.1126/science.aaa4282; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Ota N, 2011, NAT IMMUNOL, V12, P941, DOI 10.1038/ni.2089; Paclik D, 2015, EUR J IMMUNOL, V45, P2766, DOI 10.1002/eji.201545635; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Powell N, 2012, IMMUNITY, V37, P674, DOI 10.1016/j.immuni.2012.09.008; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Rak GD, 2016, J INVEST DERMATOL, V136, P487, DOI 10.1038/JID.2015.406; Rankin LC, 2016, NAT IMMUNOL, V17, P179, DOI 10.1038/ni.3332; Rankin LC, 2013, NAT IMMUNOL, V14, P389, DOI 10.1038/ni.2545; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Roediger B, 2013, NAT IMMUNOL, V14, P564, DOI 10.1038/ni.2584; Saenz SA, 2013, J EXP MED, V210, P1823, DOI 10.1084/jem.20122332; Salimi M, 2016, J IMMUNOL, V196, P45, DOI 10.4049/jimmunol.1501102; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Satoh-Takayama N, 2014, IMMUNITY, V41, P776, DOI 10.1016/j.immuni.2014.10.007; Satoh-Takayama N, 2009, J IMMUNOL, V183, P6579, DOI 10.4049/jimmunol.0901935; Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Song C, 2015, J EXP MED, V212, P1869, DOI 10.1084/jem.20151403; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Sparber F, 2015, PATHOGENS, V4, P606, DOI 10.3390/pathogens4030606; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Spits H, 2016, NAT IMMUNOL, V17, P758, DOI 10.1038/ni.3482; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Teunissen MBM, 2014, J INVEST DERMATOL, V134, P2351, DOI 10.1038/jid.2014.146; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Tumanov AV, 2011, CELL HOST MICROBE, V10, P44, DOI 10.1016/j.chom.2011.06.002; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; Veldhoen M, 2012, NAT REV IMMUNOL, V12, P696, DOI 10.1038/nri3299; Villanova F, 2014, J INVEST DERMATOL, V134, P984, DOI 10.1038/jid.2013.477; von Burg N, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00416; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Wang XT, 2014, NATURE, V514, P237, DOI 10.1038/nature13564; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Wojno EDT, 2015, MUCOSAL IMMUNOL, V8, P1313, DOI 10.1038/mi.2015.21; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Yasuda K, 2012, P NATL ACAD SCI USA, V109, P3451, DOI 10.1073/pnas.1201042109; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Zaiss DM, 2006, SCIENCE, V314, P1746, DOI 10.1126/science.1133715; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zhang BY, 2014, SCIENCE, V346, P861, DOI 10.1126/science.1256999; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	146	564	592	13	227	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2016	17	7					765	774		10.1038/ni.3489	http://dx.doi.org/10.1038/ni.3489			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP1XR	27328006				2022-12-18	WOS:000378283200008
J	Wang, YM; Szretter, KJ; Vermi, W; Gilfillan, S; Rossini, C; Cella, M; Barrow, AD; Diamond, MS; Colonna, M				Wang, Yaming; Szretter, Kristy J.; Vermi, William; Gilfillan, Susan; Rossini, Cristina; Cella, Marina; Barrow, Alexander D.; Diamond, Michael S.; Colonna, Marco			IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia	NATURE IMMUNOLOGY			English	Article							COLONY-STIMULATING-FACTOR; LANGERIN(+) DENDRITIC CELLS; STEADY-STATE; MYELOID CELLS; FACTOR-I; T-CELLS; IDENTIFICATION; MONOCYTES; RECEPTOR; SKIN	The differentiation of bone marrow-derived progenitor cells into monocytes, tissue macrophages and some dendritic cell (DC) subtypes requires the growth factor CSF1 and its receptor, CSF1R. Langerhans cells (LCs) and microglia develop from embryonic myeloid precursor cells that populate the epidermis and central nervous system (CNS) before birth. Notably, LCs and microglia are present in CSF1-deficient mice but absent from CSF1R-deficient mice. Here we investigated whether an alternative CSF1R ligand, interleukin 34 (IL-34), is responsible for this discrepancy. Through the use of IL-34-deficient (Il34(LacZ/LacZ)) reporter mice, we found that keratinocytes and neurons were the main sources of IL-34. Il34(LacZ/LacZ) mice selectively lacked LCs and microglia and responded poorly to skin antigens and viral infection of the CNS. Thus, IL-34 specifically directs the differentiation of myeloid cells in the skin epidermis and CNS.	[Wang, Yaming; Szretter, Kristy J.; Vermi, William; Gilfillan, Susan; Cella, Marina; Barrow, Alexander D.; Diamond, Michael S.; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Szretter, Kristy J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Szretter, Kristy J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Vermi, William; Rossini, Cristina] Univ Brescia, Dept Pathol, Brescia, Italy; [Barrow, Alexander D.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Brescia; University of Cambridge	Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	mcolonna@pathology.wustl.edu	Diamond, Michael/AAH-1733-2019; Cella, Marina/ABA-8564-2020	Diamond, Michael/0000-0002-8791-3165; Szretter, Kristy/0000-0003-0391-2307; VERMI, WILLIAM/0000-0002-2291-2997; Colonna, Marco/0000-0001-5222-4987; Cella, Marina/0000-0003-1230-1313; Barrow, Alexander/0000-0001-5833-0537	National Heart, Lung and Blood Institute [2T32HL007317-31]; Fondazione Beretta; Programma di Ricerca di interesse Nazionale of the Ministero dell'Istruzione dell'Universite della Ricerca; European Commission; US National Institutes of Health [GM77279, HL097805]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007317, R01HL097805] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077279] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Fondazione Beretta; Programma di Ricerca di interesse Nazionale of the Ministero dell'Istruzione dell'Universite della Ricerca; European Commission(European CommissionEuropean Commission Joint Research Centre); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Swiecki for help with flow cytometry and confocal microscopy; the European Conditional Mouse Mutagenesis Consortium for generating embryonic stem clones with the targeted allele Il34<SUP>tm1a(EUCOMM)Wtsi</SUP>; M. White for injection of Il34<SUP>tm1a(EUCOMM)Wtsi</SUP> embryonic stem cells; and T. Doering (Department of Molecular Microbiology, Washington University School of Medicine) for C. albicans strain SC5314. Supported by the National Heart, Lung and Blood Institute (2T32HL007317-31 to Y.W.), Fondazione Beretta (C.R.), Programma di Ricerca di interesse Nazionale of the Ministero dell'Istruzione dell'Universite della Ricerca, 2009 (W.V.), the European Commission Seventh Framework Programme (A.D.B.) and the US National Institutes of Health (GM77279 and HL097805 to M.Co.).	Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Anandasabapathy N, 2011, J EXP MED, V208, P1695, DOI 10.1084/jem.20102657; Bacci S, 1997, EUR J IMMUNOL, V27, P442, DOI 10.1002/eji.1830270214; Bennett CL, 2005, J CELL BIOL, V169, P569, DOI 10.1083/jcb.200501071; Bennett CL, 2007, J IMMUNOL, V179, P6830, DOI 10.4049/jimmunol.179.10.6830; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Chihara T, 2010, CELL DEATH DIFFER, V17, P1917, DOI 10.1038/cdd.2010.60; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Choi JH, 2011, IMMUNITY, V35, P819, DOI 10.1016/j.immuni.2011.09.014; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; Christensen AD, 2012, APMIS, V120, P1, DOI 10.1111/j.1600-0463.2011.02832.x; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; ENK AH, 1992, J INVEST DERMATOL, V99, pS39, DOI 10.1111/1523-1747.ep12668608; Fuchs A, 2011, VIROLOGY, V412, P101, DOI 10.1016/j.virol.2011.01.003; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Ginhoux F, 2007, J EXP MED, V204, P3133, DOI 10.1084/jem.20071733; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Ginhoux F, 2010, IMMUNOL CELL BIOL, V88, P387, DOI 10.1038/icb.2010.38; Girardi M, 2002, J EXP MED, V195, P855, DOI 10.1084/jem.20012000; Gordon S, 2011, EUR J IMMUNOL, V41, P2470, DOI 10.1002/eji.201141988; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; Kanki H, 2006, EXP ANIM TOKYO, V55, P137, DOI 10.1538/expanim.55.137; Kaplan DH, 2010, TRENDS IMMUNOL, V31, P446, DOI 10.1016/j.it.2010.08.006; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; Ma XL, 2012, STRUCTURE, V20, P676, DOI 10.1016/j.str.2012.02.010; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Merad M, 2009, BLOOD, V113, P3418, DOI 10.1182/blood-2008-12-180646; Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Poulin LF, 2007, J EXP MED, V204, P3119, DOI 10.1084/jem.20071724; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Romani N, 2012, J INVEST DERMATOL, V132, P872, DOI 10.1038/jid.2011.437; Romani N, 2010, IMMUNOL REV, V234, P120, DOI 10.1111/j.0105-2896.2009.00886.x; Ruedl C, 2000, J IMMUNOL, V165, P4910, DOI 10.4049/jimmunol.165.9.4910; Samuel MA, 2007, J VIROL, V81, P2614, DOI 10.1128/JVI.02311-06; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Szretter KJ, 2009, J VIROL, V83, P9329, DOI 10.1128/JVI.00836-09; Takahara K, 2002, INT IMMUNOL, V14, P433, DOI 10.1093/intimm/14.5.433; TAKAHASHI K, 1992, J INVEST DERMATOL, V99, pS46, DOI 10.1111/1523-1747.ep12668982; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Valladeau J, 2002, J IMMUNOL, V168, P782, DOI 10.4049/jimmunol.168.2.782; Vogt MR, 2009, J VIROL, V83, P6494, DOI 10.1128/JVI.00286-09; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822; WITMERPACK MD, 1993, J CELL SCI, V104, P1021; Xu H, 1996, J EXP MED, V183, P1001, DOI 10.1084/jem.183.3.1001; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0	59	562	585	4	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2012	13	8					753	+		10.1038/ni.2360	http://dx.doi.org/10.1038/ni.2360			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	976GT	22729249	Green Accepted			2022-12-18	WOS:000306569600011
J	Zhang, YA; Salinas, I; Li, J; Parra, D; Bjork, S; Xu, Z; LaPatra, SE; Bartholomew, J; Sunyer, JO				Zhang, Yong-An; Salinas, Irene; Li, Jun; Parra, David; Bjork, Sarah; Xu, Zhen; LaPatra, Scott E.; Bartholomew, Jerri; Sunyer, J. Oriol			IgT, a primitive immunoglobulin class specialized in mucosal immunity	NATURE IMMUNOLOGY			English	Article							TROUT ONCORHYNCHUS-MYKISS; RAINBOW-TROUT; MONOCLONAL-ANTIBODIES; CERATOMYXA-SHASTA; FISH; RESPONSES; LYMPHOCYTES; VERTEBRATES; PARASITE; ISOTYPE	Teleost fish are the most primitive bony vertebrates that contain immunoglobulins. In contrast to mammals and birds, these species are devoid of immunoglobulin A (IgA) or a functional equivalent. This observation suggests that specialization of immunoglobulin isotypes into mucosal and systemic responses took place during tetrapod evolution. Challenging that paradigm, here we show that IgT, an immunoglobulin isotype of unknown function, acts like a mucosal antibody. We detected responses of rainbow trout IgT to an intestinal parasite only in the gut, whereas IgM responses were confined to the serum. IgT coated most intestinal bacteria. As IgT and IgA are phylogenetically distant immunoglobulins, their specialization into mucosal responses probably occurred independently by a process of convergent evolution.	[Zhang, Yong-An; Salinas, Irene; Li, Jun; Parra, David; Xu, Zhen; Sunyer, J. Oriol] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Bjork, Sarah; Bartholomew, Jerri] Oregon State Univ, Dept Microbiol, Ctr Fish Dis Res, Corvallis, OR 97331 USA; [LaPatra, Scott E.] Clear Springs Foods, Div Res, Buhl, ID USA	University of Pennsylvania; Oregon State University	Sunyer, JO (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA.	sunyer@vet.upenn.edu	Parra, David/J-6234-2014	Parra, David/0000-0002-3634-7087; Zhang, Yong-An/0000-0002-9956-3879; Li, Jun/0000-0002-5190-0733	National Science Foundation [NSF-MCB-0719599]; US National Institutes of Health [R01GM085207-01]; United States Department of Agriculture [USDA-NRI 2006-01619, USDA-NRI 2007-01719]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085207] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Warr (National Science Foundation) for anti-trout IgM; D. Artis and P. Boudinot for critical reading of the manuscript; the Morphology Core of the Center for Molecular Studies in Digestive and Liver Diseases of the University of Pennsylvania, especially G. Swain, for help and advice on immunohistochemistry; C. Pletcher and the staff of the Flow Cytometry and Cell Sorting Facility of the University of Pennsylvania for cell sorting; and Y. Liu, L. Zhang and C. Zhou for technical assistance in cell transfection and immunofluorescence microscopy analyses. Supported by the National Science Foundation (NSF-MCB-0719599 to J.O.S.), the US National Institutes of Health (R01GM085207-01 to J.O.S.) and the United States Department of Agriculture (USDA-NRI 2006-01619 and USDA-NRI 2007-01719 to J.O.S.).	Alder MN, 2008, NAT IMMUNOL, V9, P319, DOI 10.1038/ni1562; BARTHOLOMEW JL, 1989, J FISH DIS, V12, P509, DOI 10.1111/j.1365-2761.1989.tb00561.x; Bernard D, 2006, J IMMUNOL, V176, P3942, DOI 10.4049/jimmunol.176.7.3942; Brandtzaeg P, 2009, SCAND J IMMUNOL, V70, P505, DOI 10.1111/j.1365-3083.2009.02319.x; Bromage ES, 2004, J IMMUNOL, V173, P7317, DOI 10.4049/jimmunol.173.12.7317; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; Chen K, 2009, NAT IMMUNOL, V10, P889, DOI 10.1038/ni.1748; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; Danilova N, 2005, NAT IMMUNOL, V6, P295, DOI 10.1038/ni1166; Feng LN, 2009, COMP BIOCHEM PHYS B, V154, P282, DOI 10.1016/j.cbpb.2009.07.003; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Flajnik MF, 2005, NAT IMMUNOL, V6, P229, DOI 10.1038/ni0305-229; Flajnik MF, 2002, NAT REV IMMUNOL, V2, P688, DOI 10.1038/nri889; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Hamuro K, 2007, J IMMUNOL, V178, P5682, DOI 10.4049/jimmunol.178.9.5682; Hansen JD, 2005, P NATL ACAD SCI USA, V102, P6919, DOI 10.1073/pnas.0500027102; HART S, 1988, DEV COMP IMMUNOL, V12, P453, DOI 10.1016/0145-305X(88)90065-1; Jansson E, 2003, FISH SHELLFISH IMMUN, V14, P239, DOI 10.1006/fsim.2002.0434; Kaattari S, 1998, IMMUNOL REV, V166, P133, DOI 10.1111/j.1600-065X.1998.tb01258.x; Kim DH, 2007, J APPL MICROBIOL, V102, P1654, DOI 10.1111/j.1365-2672.2006.03185.x; Kollner B, 2002, TOXICOL LETT, V131, P83, DOI 10.1016/S0378-4274(02)00044-9; Li J, 2006, NAT IMMUNOL, V7, P1116, DOI 10.1038/ni1389; Mason KL, 2008, ADV EXP MED BIOL, V635, P1, DOI 10.1007/978-0-387-09550-9_1; Miyadai T, 2004, FISH SHELLFISH IMMUN, V17, P211, DOI 10.1016/j.fsi.2004.03.005; Mussmann R, 1996, EUR J IMMUNOL, V26, P2823, DOI 10.1002/eji.1830261205; NASH PV, 1988, J PARASITOL, V74, P144, DOI 10.2307/3282491; RINEHART JJ, 1977, J LAB CLIN MED, V90, P737; ROMBOUT JHWM, 1993, DEV COMP IMMUNOL, V17, P55, DOI 10.1016/0145-305X(93)90015-I; ROSE ME, 1984, PARASITE IMMUNOL, V6, P1, DOI 10.1111/j.1365-3024.1984.tb00777.x; Snoeck V, 2006, VET RES, V37, P455, DOI 10.1051/vetres:2006010; Solem ST, 2006, DEV COMP IMMUNOL, V30, P57, DOI 10.1016/j.dci.2005.06.007; Sommerset I, 2005, EXPERT REV VACCINES, V4, P89, DOI 10.1586/14760584.4.1.89; Stocking RW, 2006, J AQUAT ANIM HEALTH, V18, P194, DOI 10.1577/H05-036.1; STOKES CR, 1975, NATURE, V255, P745, DOI 10.1038/255745a0; Suzuki K, 2007, SEMIN IMMUNOL, V19, P127, DOI 10.1016/j.smim.2006.10.001; vanderWaaij LA, 1996, GUT, V38, P348, DOI 10.1136/gut.38.3.348; Woof JM, 2006, J PATHOL, V208, P270, DOI 10.1002/path.1877; Zapata A, 2006, FISH SHELLFISH IMMUN, V20, P126, DOI 10.1016/j.fsi.2004.09.005; Zapata A, 2000, CURR TOP MICROBIOL, V248, P67; Zhang YA, 2009, J IMMUNOL, V183, P83, DOI 10.4049/jimmunol.0900605	40	560	593	8	180	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2010	11	9					827	U82		10.1038/ni.1913	http://dx.doi.org/10.1038/ni.1913			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	641HN	20676094	Green Accepted			2022-12-18	WOS:000281115500011
J	Claudio, E; Brown, K; Park, S; Wang, HS; Siebenlist, U				Claudio, E; Brown, K; Park, S; Wang, HS; Siebenlist, U			BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; TRANSCRIPTION FACTORS; ACTIVATION; RECEPTOR; ALPHA; MICE; DIFFERENTIATION; MATURATION; SURVIVAL	NF-kappaB is usually activated by signal-induced, ubiquitin-mediated degradation of its inhibitor, IkappaB. This process is initiated by phosphorylation of IkappaB by the IkappaB kinase (IKK) complex, predominantly by the IKKbeta catalytic subunit, and requires the regulatory subunit IKKgamma (NEMO). Another activation pathway, with no known physiological inducers, involves ubiquitin-mediated processing of the NF-kappaB2 inhibitory protein p100 and is dependent on phosphorylation of p100 by IKKalpha. We show here that B cell-activating factor (BAFF) activates this second pathway and that this requires the BAFF receptor (BAFF-R), the NF-kappaB-inducing kinase (NIK) and protein synthesis, but not NEMO. This NEMO-independent cascade is physiologically relevant for the survival and, hence, progression of maturing splenic B cells.	NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Siebenlist, U (corresponding author), NIAID, Immunoregulat Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	us2n@nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000722, Z01AI000723, Z01AI000722] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; Caamano J, 2002, CLIN MICROBIOL REV, V15, P414, DOI 10.1128/CMR.15.3.414-429.2002; Caamano JH, 1998, J EXP MED, V187, P185, DOI 10.1084/jem.187.2.185; Cariappa A, 2000, J EXP MED, V192, P1175, DOI 10.1084/jem.192.8.1175; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Do RKG, 2000, J EXP MED, V192, P953, DOI 10.1084/jem.192.7.953; Do RKG, 2002, CYTOKINE GROWTH F R, V13, P19, DOI 10.1016/S1359-6101(01)00025-9; Dorner T, 2001, ARTHRITIS RES, V3, P197, DOI 10.1186/ar299; EllingerZiegelbauer H, 1997, J BIOL CHEM, V272, P2668, DOI 10.1074/jbc.272.5.2668; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Groom J, 2002, J CLIN INVEST, V109, P59, DOI 10.1172/JCI200214121; Grossmann M, 2000, EMBO J, V19, P6351, DOI 10.1093/emboj/19.23.6351; Gugasyan R, 2000, IMMUNOL REV, V176, P134; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Kaisho T, 2001, J EXP MED, V193, P417, DOI 10.1084/jem.193.4.417; KANNO T, 1994, P NATL ACAD SCI USA, V91, P12634, DOI 10.1073/pnas.91.26.12634; Khan WN, 2001, IMMUNOL RES, V23, P147, DOI 10.1385/IR:23:2-3:147; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; Krappmann D, 1996, EMBO J, V15, P6716, DOI 10.1002/j.1460-2075.1996.tb01061.x; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Mackay F, 2002, NAT REV IMMUNOL, V2, P465, DOI 10.1038/nri844; Mackay F, 2002, TRENDS IMMUNOL, V23, P113, DOI 10.1016/S1471-4906(01)02159-7; Rolink AG, 2002, CURR OPIN IMMUNOL, V14, P266, DOI 10.1016/S0952-7915(02)00332-1; Rolink AG, 2000, J EXP MED, V191, P23, DOI 10.1084/jem.191.1.23; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Solan NJ, 2002, J BIOL CHEM, V277, P1405, DOI 10.1074/jbc.M109619200; Su TT, 2002, J IMMUNOL, V168, P2101, DOI 10.4049/jimmunol.168.5.2101; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yamada T, 2000, J IMMUNOL, V165, P804, DOI 10.4049/jimmunol.165.2.804; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X	34	560	590	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2002	3	10					958	965		10.1038/ni842	http://dx.doi.org/10.1038/ni842			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	597VU	12352969				2022-12-18	WOS:000178242100017
J	Villarino, AV; Kanno, Y; O'Shea, JJ				Villarino, Alejandro V.; Kanno, Yuka; O'Shea, John J.			Mechanisms and consequences of Jak-STAT signaling in the immune system	NATURE IMMUNOLOGY			English	Review							TRANSCRIPTION FACTOR STAT3; IFN-GAMMA; CELL-DEVELOPMENT; DNA-BINDING; PSEUDOKINASE-DOMAIN; GENE-REGULATION; T-CELLS; CHROMATIN IMMUNOPRECIPITATION; MYELOPROLIFERATIVE NEOPLASMS; TYROSINE PHOSPHORYLATION	Kinases of the Jak ('Janus kinase') family and transcription factors (TFs) of the STAT ('signal transducer and activator of transcription') family constitute a rapid membrane-to-nucleus signaling module that affects every aspect of the mammalian immune system. Research on this paradigmatic pathway has experienced breakneck growth in the quarter century since its discovery and has yielded a stream of basic and clinical insights that have profoundly influenced modern understanding of human health and disease, exemplified by the bench-to-bedside success of Jak inhibitors ('jakinibs') and pathway-targeting drugs. Here we review recent advances in Jak-STAT biology, focusing on immune cell function, disease etiology and therapeutic intervention, as well as broader principles of gene regulation and signal-dependent TFs.	[Villarino, Alejandro V.; Kanno, Yuka; O'Shea, John J.] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	O'Shea, JJ (corresponding author), NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA.	john.oshea@nih.gov	Villarino, Alejandro/AAE-3517-2020; Kanno, Yuka/B-5802-2013	Villarino, Alejandro/0000-0001-8068-2176; Kanno, Yuka/0000-0001-5668-9319	National Institute of Arthritis, Musculoskeletal and Skin Diseases; US National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041106, ZIAAR041159, ZIAAR041167] Funding Source: NIH RePORTER	National Institute of Arthritis, Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank members of the O'Shea laboratory for discussions about Jak-STAT biology, and C. Hunter and L. Hennighausen for critical reading of this manuscript. Supported by the National Institute of Arthritis, Musculoskeletal and Skin Diseases and the US National Institutes of Health (intramural funding).	Akaishi H, 1998, INT IMMUNOL, V10, P1747, DOI 10.1093/intimm/10.11.1747; Arenas-Ramirez N, 2015, TRENDS IMMUNOL, V36, P763, DOI 10.1016/j.it.2015.10.003; BANCEREK J, 2008, IMMUNITY, V38, P250, DOI DOI 10.1016/J.IMMUNI.38; Bandaranayake RM, 2012, NAT STRUCT MOL BIOL, V19, P754, DOI 10.1038/nsmb.2348; Basu R, 2015, NAT IMMUNOL, V16, P286, DOI 10.1038/ni.3099; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Begitt A, 2014, NAT IMMUNOL, V15, P168, DOI 10.1038/ni.2794; Begitt A, 2011, BLOOD, V118, P1002, DOI 10.1182/blood-2011-04-347930; Beier UH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002873; BELL BD, 2000, NAT IMMUNOL, V14, P1; Benci JL, 2016, CELL, V167, P1540, DOI 10.1016/j.cell.2016.11.022; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Bezbradica JS, 2014, NAT IMMUNOL, V15, P333, DOI 10.1038/ni.2845; Bhattacharya S, 1996, NATURE, V383, P344, DOI 10.1038/383344a0; Blouin CM, 2016, CELL, V166, P920, DOI 10.1016/j.cell.2016.07.003; Bohmer Frank-D, 2014, JAKSTAT, V3, pe28087, DOI 10.4161/jkst.28087; Boisson-Dupuis S, 2012, CURR OPIN IMMUNOL, V24, P364, DOI 10.1016/j.coi.2012.04.011; Britschgi A, 2012, CANCER CELL, V22, P796, DOI 10.1016/j.ccr.2012.10.023; Brooks AJ, 2014, SCIENCE, V344, P710, DOI 10.1126/science.1249783; Carbognin E, 2016, EMBO J, V35, P618, DOI 10.15252/embj.201592629; Casanova JL, 2012, IMMUNITY, V36, P515, DOI 10.1016/j.immuni.2012.03.016; Chen E, 2012, IMMUNITY, V36, P529, DOI 10.1016/j.immuni.2012.03.017; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chen XM, 2003, PROTEIN SCI, V12, P361, DOI 10.1110/ps.0218903; Cheng FD, 2003, IMMUNITY, V19, P425, DOI 10.1016/S1074-7613(03)00232-2; Cheon H, 2011, J INTERF CYTOK RES, V31, P33, DOI 10.1089/jir.2010.0100; Cheon H, 2009, P NATL ACAD SCI USA, V106, P9373, DOI 10.1073/pnas.0903487106; Chmielecki J, 2013, NAT GENET, V45, P131, DOI 10.1038/ng.2522; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Costa-Pereira AP, 2002, P NATL ACAD SCI USA, V99, P8043, DOI 10.1073/pnas.122236099; Crescenzo R, 2015, CANCER CELL, V27, P516, DOI 10.1016/j.ccell.2015.03.006; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Cui WG, 2011, IMMUNITY, V35, P792, DOI 10.1016/j.immuni.2011.09.017; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dasgupta M, 2015, P NATL ACAD SCI USA, V112, P3985, DOI 10.1073/pnas.1503152112; Decker T, 1997, J INTERF CYTOK RES, V17, P121, DOI 10.1089/jir.1997.17.121; Delconte RB, 2016, IMMUNITY, V44, P103, DOI 10.1016/j.immuni.2015.12.007; DELGOFFE GM, 2014, JAK STAT, V2; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Dong S, 2002, BLOOD, V99, P2637, DOI 10.1182/blood.V99.8.2637; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Eckelhart E, 2011, BLOOD, V117, P1565, DOI 10.1182/blood-2010-06-291633; Esashi E, 2008, IMMUNITY, V28, P509, DOI 10.1016/j.immuni.2008.02.013; Farlik M, 2010, IMMUNITY, V33, P25, DOI 10.1016/j.immuni.2010.07.001; Ferrao R, 2016, STRUCTURE, V24, P897, DOI 10.1016/j.str.2016.03.023; Floss DM, 2016, MOL BIOL CELL, V27, P2301, DOI 10.1091/mbc.E14-12-1645; Friedbichler K, 2010, BLOOD, V116, P1548, DOI 10.1182/blood-2009-12-258913; Gao SZP, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aac8460; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Gay G, 2016, J EXP MED, V213, P1779, DOI 10.1084/jem.20160340; Geyer HL, 2014, BLOOD, V124, P3529, DOI 10.1182/blood-2014-05-577635; Ghoreschi K, 2009, NAT IMMUNOL, V10, P356, DOI 10.1038/ni.1701; Gil MP, 2012, BLOOD, V120, P3718, DOI 10.1182/blood-2012-05-428672; Gough DJ, 2014, BLOOD, V124, P2252, DOI 10.1182/blood-2013-02-484196; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; GUAN KL, 1991, NATURE, V350, P359, DOI 10.1038/350359a0; Guo XH, 2014, IMMUNITY, V40, P25, DOI 10.1016/j.immuni.2013.10.021; Hirahara K, 2015, IMMUNITY, V42, P877, DOI 10.1016/j.immuni.2015.04.014; Hossain DMS, 2013, IMMUNITY, V39, P1057, DOI 10.1016/j.immuni.2013.11.005; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; Jaitin DA, 2016, CELL, V167, P1883, DOI 10.1016/j.cell.2016.11.039; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jenkins BJ, 2005, NAT MED, V11, P845, DOI 10.1038/nm1282; Jerez A, 2012, BLOOD, V120, P3048, DOI 10.1182/blood-2012-06-435297; John S, 1999, MOL CELL BIOL, V19, P1910; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Kanai T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00234; Kang K, 2014, MOL CELL BIOL, V34, P464, DOI 10.1128/MCB.00988-13; Kang K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-4; Kershaw NJ, 2013, NAT STRUCT MOL BIOL, V20, P469, DOI 10.1038/nsmb.2519; Kiel MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9470; Kim TK, 1996, SCIENCE, V273, P1717, DOI 10.1126/science.273.5282.1717; Koppikar P, 2012, NATURE, V489, P155, DOI 10.1038/nature11303; Koskela HLM, 2012, NEW ENGL J MED, V366, P1905, DOI 10.1056/NEJMoa1114885; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; Langlais D, 2016, J EXP MED, V213, P585, DOI 10.1084/jem.20151764; Langlais D, 2012, MOL CELL, V47, P38, DOI 10.1016/j.molcel.2012.04.021; Laouar Y, 2003, IMMUNITY, V19, P903, DOI 10.1016/S1074-7613(03)00332-7; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lefranc MP, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00022; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li J, 2016, P NATL ACAD SCI USA, V113, P13015, DOI 10.1073/pnas.1611228113; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; Lin JX, 2012, IMMUNITY, V36, P586, DOI 10.1016/j.immuni.2012.02.017; Lischke A, 1998, J BIOL CHEM, V273, P31222, DOI 10.1074/jbc.273.47.31222; Liu B, 2004, NAT IMMUNOL, V5, P891, DOI 10.1038/ni1104; Liu B, 2010, SCIENCE, V330, P521, DOI 10.1126/science.1193787; Lu D, 2015, NAT IMMUNOL, V16, P1263, DOI 10.1038/ni.3278; Luckey MA, 2014, NAT IMMUNOL, V15, P638, DOI 10.1038/ni.2917; LUO H, 1995, EMBO J, V14, P1412, DOI 10.1002/j.1460-2075.1995.tb07127.x; Lupardus PJ, 2011, STRUCTURE, V19, P45, DOI 10.1016/j.str.2010.10.010; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; Mandal M, 2011, NAT IMMUNOL, V12, P1212, DOI 10.1038/ni.2136; Mao X, 2005, MOL CELL, V17, P761, DOI 10.1016/j.molcel.2005.02.021; Metser G, 2016, NUCLEIC ACIDS RES, V44, P1052, DOI 10.1093/nar/gkv999; Miklossy G, 2013, NAT REV DRUG DISCOV, V12, P611, DOI 10.1038/nrd4088; Mitchell DM, 2013, J IMMUNOL, V190, P3390, DOI 10.4049/jimmunol.1202674; Miyagi T, 2007, J EXP MED, V204, P2383, DOI 10.1084/jem.20070401; Moodley D, 2016, P NATL ACAD SCI USA, V113, P9852, DOI 10.1073/pnas.1610253113; Morrison TE, 2001, IMMUNITY, V15, P787, DOI 10.1016/S1074-7613(01)00226-6; Mostafavi S, 2016, CELL, V164, P564, DOI 10.1016/j.cell.2015.12.032; Nagashima H, 2014, NAT IMMUNOL, V15, P449, DOI 10.1038/ni.2863; Nakajima H, 1997, IMMUNITY, V7, P691, DOI 10.1016/S1074-7613(00)80389-1; Neculai D, 2005, J BIOL CHEM, V280, P40782, DOI 10.1074/jbc.M507682200; Neri D, 2016, CURR OPIN IMMUNOL, V40, P96, DOI 10.1016/j.coi.2016.03.006; Neumann C, 2014, J EXP MED, V211, P1807, DOI 10.1084/jem.20131548; Nguyen KB, 2002, SCIENCE, V297, P2063, DOI 10.1126/science.1074900; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; O'Shea JJ, 2015, ANNU REV MED, V66, P311, DOI 10.1146/annurev-med-051113-024537; O'Shea JJ, 2014, CELL, V157, P227, DOI 10.1016/j.cell.2014.03.010; O'Sullivan A, 2004, J BIOL CHEM, V279, P7339, DOI 10.1074/jbc.M309979200; Ohtani T, 2000, IMMUNITY, V12, P95, DOI 10.1016/S1074-7613(00)80162-4; Olias P, 2016, CELL HOST MICROBE, V20, P72, DOI 10.1016/j.chom.2016.06.006; Ong YC, 2010, J BIOL CHEM, V285, P28731, DOI 10.1074/jbc.M110.112359; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Park HJ, 2016, EMBO J, V35, P580, DOI 10.15252/embj.201592383; Park JH, 2010, NAT IMMUNOL, V11, P257, DOI 10.1038/ni.1840; Pellegrini M, 2011, CELL, V144, P601, DOI 10.1016/j.cell.2011.01.011; Pilati C, 2011, J EXP MED, V208, P1359, DOI 10.1084/jem.20110283; Poholek AC, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaf8612; Putz EM, 2013, CELL REP, V4, P437, DOI 10.1016/j.celrep.2013.07.012; Qiao Y, 2016, CELL REP, V16, P3121, DOI 10.1016/j.celrep.2016.08.051; Qiao Y, 2013, IMMUNITY, V39, P454, DOI 10.1016/j.immuni.2013.08.009; Qing YL, 2004, J BIOL CHEM, V279, P41679, DOI 10.1074/jbc.M406413200; Rajala HLM, 2013, BLOOD, V121, P4541, DOI 10.1182/blood-2012-12-474577; Ray JP, 2014, IMMUNITY, V40, P367, DOI 10.1016/j.immuni.2014.02.005; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Robinson DR, 2013, NAT GENET, V45, P180, DOI 10.1038/ng.2509; Ross SH, 2016, IMMUNITY, V45, P685, DOI 10.1016/j.immuni.2016.07.022; RUSSELL B, 1968, B RUSSELL SELECTION, P41; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Sahoo A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5732; SCHAEFER TS, 1995, P NATL ACAD SCI USA, V92, P9097, DOI 10.1073/pnas.92.20.9097; SCHINDLER U, 1995, IMMUNITY, V2, P689, DOI 10.1016/1074-7613(95)90013-6; SEIDEL HM, 1995, P NATL ACAD SCI USA, V92, P3041, DOI 10.1073/pnas.92.7.3041; Sen Malabika, 2012, JAKSTAT, V1, P285, DOI 10.4161/jkst.22312; Shan YB, 2014, NAT STRUCT MOL BIOL, V21, P579, DOI 10.1038/nsmb.2849; Shin HY, 2016, NAT GENET, V48, P904, DOI 10.1038/ng.3606; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Smith GA, 2016, NAT CHEM BIOL, V12, P373, DOI [10.1038/NCHEMBIO.2056, 10.1038/nchembio.2056]; Spangler JB, 2015, ANNU REV IMMUNOL, V33, P139, DOI 10.1146/annurev-immunol-032713-120211; Spence S, 2013, IMMUNITY, V38, P66, DOI 10.1016/j.immuni.2012.09.013; Springuel L, 2014, BLOOD, V124, P3924, DOI 10.1182/blood-2014-05-576652; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Steward-Tharp SM, 2014, BLOOD, V123, P2978, DOI 10.1182/blood-2013-09-523167; Stocklin E, 1996, NATURE, V383, P726, DOI 10.1038/383726a0; Stritesky GL, 2011, IMMUNITY, V34, P39, DOI 10.1016/j.immuni.2010.12.013; Takahashi R, 2011, J EXP MED, V208, P2055, DOI 10.1084/jem.20110428; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Tanaka T, 2005, IMMUNITY, V22, P729, DOI 10.1016/j.immuni.2005.04.008; Tanaka T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001637; Tasian SK, 2017, BLOOD, V129, P177, DOI 10.1182/blood-2016-05-707653; Tiedt R, 2008, BLOOD, V111, P3931, DOI 10.1182/blood-2007-08-107748; Toffalini F, 2010, BLOOD, V116, P2429, DOI 10.1182/blood-2010-04-279752; Toms AV, 2013, NAT STRUCT MOL BIOL, V20, P1221, DOI 10.1038/nsmb.2673; Ungureanu D, 2011, NAT STRUCT MOL BIOL, V18, P971, DOI 10.1038/nsmb.2099; UPTON C, 1992, SCIENCE, V258, P1369, DOI 10.1126/science.1455233; Usui T, 2003, IMMUNITY, V18, P415, DOI 10.1016/S1074-7613(03)00057-8; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Varinou L, 2003, IMMUNITY, V19, P793, DOI 10.1016/S1074-7613(03)00322-4; VEALS SA, 1992, MOL CELL BIOL, V12, P3315, DOI 10.1128/MCB.12.8.3315; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Villarino A, 2016, ELIFE, V5, DOI 10.7554/eLife.08384; Villarino AV, 2007, J EXP MED, V204, P65, DOI 10.1084/jem.20061198; Villarino AV, 2015, J IMMUNOL, V194, P21, DOI 10.4049/jimmunol.1401867; Villarino AV, 2010, J IMMUNOL, V185, P6461, DOI 10.4049/jimmunol.1001343; Vinkemeier U, 1998, SCIENCE, V279, P1048, DOI 10.1126/science.279.5353.1048; Walker SR, 2013, MOL CELL BIOL, V33, P2879, DOI 10.1128/MCB.01620-12; Wallweber HJA, 2014, NAT STRUCT MOL BIOL, V21, P443, DOI 10.1038/nsmb.2807; Wan CK, 2015, P NATL ACAD SCI USA, V112, P9394, DOI 10.1073/pnas.1511711112; Wan CK, 2013, IMMUNITY, V38, P514, DOI 10.1016/j.immuni.2013.02.011; Wang Yaming, 2012, JAKSTAT, V1, P23, DOI 10.4161/jkst.19418; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Willi M, 2016, NUCLEIC ACIDS RES, V44, P10277, DOI 10.1093/nar/gkw844; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Witte Steven, 2014, JAKSTAT, V3, pe28055, DOI 10.4161/jkst.28055; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yang XXO, 2013, NAT IMMUNOL, V14, P732, DOI 10.1038/ni.2633; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Yi ZA, 2014, NAT IMMUNOL, V15, P866, DOI 10.1038/ni.2944; Yildiz M, 2015, BLOOD, V125, P668, DOI 10.1182/blood-2014-06-582650; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhang D, 2016, J MOL BIOL, V428, P4651, DOI 10.1016/j.jmb.2016.10.005; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	200	558	591	15	207	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2017	18	4					374	384		10.1038/ni.3691	http://dx.doi.org/10.1038/ni.3691			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6PU	28323260				2022-12-18	WOS:000396815800005
J	Hsu, HC; Yang, P; Wang, J; Wu, Q; Myers, R; Chen, J; Yi, J; Guentert, T; Tousson, A; Stanus, AL; Le, TVL; Lorenz, RG; Xu, H; Kolls, JK; Carter, RH; Chaplin, DD; Williams, RW; Mountz, JD				Hsu, Hui-Chen; Yang, PingAr; Wang, John; Wu, Qi; Myers, Riley; Chen, Jian; Yi, John; Guentert, Tanja; Tousson, Albert; Stanus, Andrea L.; Le, Thuc-vy L.; Lorenz, Robin G.; Xu, Hui; Kolls, Jay K.; Carter, Robert H.; Chaplin, David D.; Williams, Robert W.; Mountz, John D.			Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice	NATURE IMMUNOLOGY			English	Article							SPONTANEOUS EROSIVE ARTHRITIS; GTPASE-ACTIVATING PROTEINS; INDUCED CYTIDINE DEAMINASE; COLLAGEN-INDUCED ARTHRITIS; INBRED MOUSE STRAINS; B-CELLS; PATHOGENIC AUTOANTIBODIES; AFFINITY MATURATION; FAMILY-MEMBERS; ALPHA-SUBUNITS	Interleukin 17 (IL-17) is a cytokine associated with inflammation, autoimmunity and defense against some bacteria. Here we show that IL-17 can promote autoimmune disease through a mechanism distinct from its proinflammatory effects. As compared with wild-type mice, autoimmune BXD2 mice express more IL-17 and show spontaneous development of germinal centers (GCs) before they increase production of pathogenic autoantibodies. We show that blocking IL-17 signaling disrupts CD4(+) T cell and B cell interactions required for the formation of GCs and that mice lacking the IL-17 receptor have reduced GC B cell development and humoral responses. Production of IL-17 correlates with upregulated expression of the genes Rgs13 and Rgs16, which encode regulators of G-protein signaling, and results in suppression of the B cell chemotactic response to the chemokine CXCL12. These findings suggest a mechanism by which IL-17 drives autoimmune responses by promoting the formation of spontaneous GCs.	[Hsu, Hui-Chen; Yang, PingAr; Wang, John; Wu, Qi; Myers, Riley; Chen, Jian; Guentert, Tanja; Carter, Robert H.; Mountz, John D.] Univ Alabama, Dept Med, Birmingham, AL 35294 USA; [Yi, John; Le, Thuc-vy L.; Chaplin, David D.] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA; [Tousson, Albert] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA; [Stanus, Andrea L.; Lorenz, Robin G.] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Xu, Hui] Univ Alabama, Dept Dermatol, Birmingham, AL 35294 USA; [Kolls, Jay K.] Childrens Hosp Pittsburgh, Dept Pediat Pulmonol, Pittsburgh, PA 15213 USA; [Carter, Robert H.; Mountz, John D.] Vet Adm Med Ctr, Birmingham, AL 35233 USA; [Williams, Robert W.] Univ Tennessee, Dept Anat & Neurobiol, Memphis, TN 38152 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Tennessee System; University of Tennessee Health Science Center	Hsu, HC (corresponding author), Univ Alabama, Dept Med, Birmingham, AL 35294 USA.	huichen.hsu@ccc.uab.edu; john.mountz@ccc.uab.edu	Xu, Hui/A-8167-2009; Kolls, Jay/AAH-1829-2019; Lorenz, Robin G/AAJ-1499-2021; Yi, John/I-1784-2019; Williams, Robert W./H-8789-2016	Kolls, Jay/0000-0001-5151-6304; Lorenz, Robin G/0000-0002-2514-9819; Yi, John/0000-0001-7777-2437; Chaplin, David/0000-0002-1354-3069; Hsu, Hui-Chen/0000-0002-0317-5725; Williams, Robert W./0000-0001-8924-4447	NIDDK NIH HHS [R24 DK64400] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064400] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Armengol MP, 2003, J IMMUNOL, V170, P6320, DOI 10.4049/jimmunol.170.12.6320; Bave U, 2003, J IMMUNOL, V171, P3296, DOI 10.4049/jimmunol.171.6.3296; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Cassese G, 2001, EUR J IMMUNOL, V31, P2726, DOI 10.1002/1521-4141(200109)31:9<2726::AID-IMMU2726>3.0.CO;2-H; Duan BY, 2007, LAB INVEST, V87, P14, DOI 10.1038/labinvest.3700497; Estes JD, 2004, J IMMUNOL, V173, P6169, DOI 10.4049/jimmunol.173.10.6169; Fu YX, 2002, SCIENCE, V297, P2006, DOI 10.1126/science.1077011; Han JI, 2006, J LEUKOCYTE BIOL, V79, P1357, DOI 10.1189/jlb.1105693; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hsu HC, 2006, ARTHRITIS RHEUM-US, V54, P343, DOI 10.1002/art.21550; Hsu HC, 2007, J IMMUNOL, V178, P5357, DOI 10.4049/jimmunol.178.8.5357; Koelle MR, 1997, CURR OPIN CELL BIOL, V9, P143, DOI 10.1016/S0955-0674(97)80055-5; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Lubberts E, 2003, J IMMUNOL, V170, P2655, DOI 10.4049/jimmunol.170.5.2655; Lubberts E, 2005, ARTHRITIS RES THER, V7, P29, DOI 10.1186/ar1478; Luzina IG, 2001, J LEUKOCYTE BIOL, V70, P578; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Marion Tony N, 2003, Curr Dir Autoimmun, V6, P123; Meyers JA, 2006, CYTOKINE, V35, P235, DOI 10.1016/j.cyto.2006.09.001; Moratz C, 2000, J IMMUNOL, V164, P1829, DOI 10.4049/jimmunol.164.4.1829; Moratz C, 2004, METHOD ENZYMOL, V389, P15; Moratz C, 2004, MOL CELL BIOL, V24, P5767, DOI 10.1128/MCB.24.13.5767-5775.2004; Mountz JD, 2005, SCAND J IMMUNOL, V61, P128, DOI 10.1111/j.0300-9475.2005.01548.x; Munthe LA, 2005, J IMMUNOL, V175, P2391, DOI 10.4049/jimmunol.175.4.2391; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nordstrom E, 2000, SCAND J IMMUNOL, V52, P477, DOI 10.1046/j.1365-3083.2000.00800.x; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Raza K, 2005, ARTHRITIS RES THER, V7, pR784, DOI 10.1186/ar1733; Schwarzenberger P, 1998, J IMMUNOL, V161, P6383; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Shi GX, 2002, J IMMUNOL, V169, P2507, DOI 10.4049/jimmunol.169.5.2507; SMITH KGC, 1994, IMMUNITY, V1, P803, DOI 10.1016/S1074-7613(94)80022-7; Sonderegger I, 2006, EUR J IMMUNOL, V36, P2849, DOI 10.1002/eji.200636484; Taylor BA, 1999, MAMM GENOME, V10, P335, DOI 10.1007/s003359900998; Teunissen MBM, 1998, J INVEST DERMATOL, V111, P645, DOI 10.1046/j.1523-1747.1998.00347.x; Walker LSK, 2003, J IMMUNOL, V170, P91, DOI 10.4049/jimmunol.170.1.91; Wang Y, 2005, IMMUNITY, V22, P749, DOI 10.1016/j.immuni.2005.04.012; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; William J, 2002, SCIENCE, V297, P2066, DOI 10.1126/science.1073924; Williams RW, 2004, MAMM GENOME, V15, P637, DOI 10.1007/s00335-004-2380-6; Wu YL, 2005, ARTHRITIS RHEUM-US, V52, P3257, DOI 10.1002/art.21354; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519	46	558	607	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2008	9	2					166	175		10.1038/ni1552	http://dx.doi.org/10.1038/ni1552			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	253FB	18157131				2022-12-18	WOS:000252503000013
J	Hendriks, J; Gravestein, LA; Tesselaar, K; van Lier, RAW; Schumacher, TNM; Borst, J				Hendriks, J; Gravestein, LA; Tesselaar, K; van Lier, RAW; Schumacher, TNM; Borst, J			CD27 is required for generation and long-term maintenance of T cell immunity	NATURE IMMUNOLOGY			English	Article							TUMOR-NECROSIS-FACTOR; KAPPA-B ACTIVATION; FACTOR RECEPTOR FAMILY; TNF RECEPTOR; TARGETED DISRUPTION; CD28-DEFICIENT MICE; 4-1BB LIGAND; MEMBER CD27; MURINE CD27; CD40 LIGAND	The Traf-linked tumor necrosis factor receptor family member CD27 is known as a T cell costimulatory molecule. We generated CD27(-/-) mice and found that CD27 makes essential contributions to mature CD4(+) and CD8(+) T cell function: CD27 supported antigen-specific expansion (but not effector cell maturation) of naive T cells, independent of the cell cycle-promoting activities of CD28 and interleukin 2. Primary CD4(+) and CD8(+) T cell responses to influenza virus were impaired in CD27(-/-) mice. Effects of deleting the gene encoding CD27 were most profound on T cell memory, reflected by delayed response kinetics and reduction of CD8(+) virus-specific T cell numbers to the level seen in the primary response. This demonstrates the requirement for a costimulatory receptor in the generation of T cell memory.	Netherlands Canc Inst, Div Cellular Biochem, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands; Lab Netherlands Red Cross, Blood Transfus Serv, Dept Immunobiol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Borst, J (corresponding author), Netherlands Canc Inst, Div Cellular Biochem, NL-1066 CX Amsterdam, Netherlands.		Schumacher, Ton/Y-2432-2019	Schumacher, Ton/0000-0003-0517-8804; Borst, Jannie/0000-0002-8043-5009; Tesselaar, Kiki/0000-0002-9847-0814; van Lier, Rene/0000-0002-3201-7144				Agematsu K, 1998, BLOOD, V91, P173, DOI 10.1182/blood.V91.1.173; Akiba H, 2000, J EXP MED, V191, P375, DOI 10.1084/jem.191.2.375; Akiba H, 1998, J BIOL CHEM, V273, P13353, DOI 10.1074/jbc.273.21.13353; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Borrow P, 1996, J EXP MED, V183, P2129, DOI 10.1084/jem.183.5.2129; BOWMAN MR, 1994, J IMMUNOL, V152, P1756; BROWN GR, 1995, J IMMUNOL, V154, P3686; CAMERINI D, 1991, J IMMUNOL, V147, P3165; CHEN WZ, 1989, J VASC MED BIOL, V1, P1; DeBenedette MA, 1999, J IMMUNOL, V163, P4833; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; GOODWIN RG, 1993, CELL, V73, P447, DOI 10.1016/0092-8674(93)90133-B; Gravestein LA, 1996, J EXP MED, V184, P675, DOI 10.1084/jem.184.2.675; Gravestein LA, 1998, EUR J IMMUNOL, V28, P2208, DOI 10.1002/(SICI)1521-4141(199807)28:07<2208::AID-IMMU2208>3.0.CO;2-L; GRAVESTEIN LA, 1993, EUR J IMMUNOL, V23, P943, DOI 10.1002/eji.1830230427; GRAVESTEIN LA, 1995, INT IMMUNOL, V7, P551, DOI 10.1093/intimm/7.4.551; Gravestein LA, 1998, SEMIN IMMUNOL, V10, P423, DOI 10.1006/smim.1998.0144; Grell M, 1999, EMBO J, V18, P3034, DOI 10.1093/emboj/18.11.3034; GREWAL IS, 1995, NATURE, V378, P617, DOI 10.1038/378617a0; Haanen JBAG, 1999, J EXP MED, V190, P1319, DOI 10.1084/jem.190.9.1319; HAMANN D, 1997, J EXP MED, V186, P1; HINTZEN RQ, 1994, INT IMMUNOL, V6, P477, DOI 10.1093/intimm/6.3.477; HINTZEN RQ, 1995, J IMMUNOL, V154, P2612; HINTZEN RQ, 1994, IMMUNOL TODAY, V15, P307, DOI 10.1016/0167-5699(94)90077-9; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; KOBATA T, 1994, J IMMUNOL, V153, P5422; Koch F, 1996, J EXP MED, V184, P741, DOI 10.1084/jem.184.2.741; Kopf M, 1999, IMMUNITY, V11, P699, DOI 10.1016/S1074-7613(00)80144-2; Lee SY, 1997, IMMUNITY, V7, P703, DOI 10.1016/S1074-7613(00)80390-8; Lens SMA, 1998, SEMIN IMMUNOL, V10, P491, DOI 10.1006/smim.1998.0154; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Liu Y, 1997, J EXP MED, V185, P251, DOI 10.1084/jem.185.2.251; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Lumsden JM, 2000, J IMMUNOL, V164, P79, DOI 10.4049/jimmunol.164.1.79; MAURER D, 1992, J IMMUNOL, V148, P3700; Maxwell JR, 2000, J IMMUNOL, V164, P107, DOI 10.4049/jimmunol.164.1.107; Murata K, 2000, J EXP MED, V191, P365, DOI 10.1084/jem.191.2.365; Nakano H, 1999, P NATL ACAD SCI USA, V96, P9803, DOI 10.1073/pnas.96.17.9803; Oshima H, 1998, INT IMMUNOL, V10, P517, DOI 10.1093/intimm/10.4.517; Oxenius A, 1996, J EXP MED, V183, P2209, DOI 10.1084/jem.183.5.2209; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Tan JT, 1999, J IMMUNOL, V163, P4859; Tesselaar K, 1997, J IMMUNOL, V159, P4959; VANLIER RAW, 1987, J IMMUNOL, V139, P1589; Vinay DS, 1998, SEMIN IMMUNOL, V10, P481, DOI 10.1006/smim.1998.0157; Walker LSK, 1999, J EXP MED, V190, P1115, DOI 10.1084/jem.190.8.1115; Weinberg AD, 1998, SEMIN IMMUNOL, V10, P471, DOI 10.1006/smim.1998.0146; Whitmire JK, 1996, J VIROL, V70, P8375, DOI 10.1128/JVI.70.12.8375-8381.1996; Xu Y, 1996, IMMUNITY, V5, P407, DOI 10.1016/S1074-7613(00)80497-5; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X	54	554	575	0	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2000	1	5					433	440		10.1038/80877	http://dx.doi.org/10.1038/80877			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	369PL	11062504				2022-12-18	WOS:000165076100017
J	Luther, SA; Cyster, JG				Luther, SA; Cyster, JG			Chemokines as regulators of T cell differentiation	NATURE IMMUNOLOGY			English	Review							MACROPHAGE-INFLAMMATORY PROTEIN-1-ALPHA; MONOCYTE CHEMOATTRACTANT PROTEIN-1; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; GERMINAL-CENTER FORMATION; RECEPTOR EXPRESSION; DENDRITIC CELLS; MICE LACKING; CYTOKINE EXPRESSION; CC-CHEMOKINES; CUTTING EDGE	Chemokines play well established roles as attractants of naive and effector T cells. New studies indicate that chemokines also have roles in regulating T cell differentiation. Blocking G(i) protein-coupled receptor signaling by pertussis toxin as well as deficiencies in G alpha (i2), chemokine receptor 2 (CCR2), CCR5, chemokine ligand 2 (CCL2, also known as monocyte chemoattractant protein 1, or MCP-1), CCL3 (macrophage inflammatory protein 1 alpha, or MIP-1 alpha) and CCL5 (RANTES) have all been found to have effects on the magnitude and cytokine polarity of the T cell response. Here we focus on findings in the CCL2-CCR2 and CCL3-CCR5 ligand-receptor systems. The roles of these molecules in regulating T cell fate include possible indirect effects on antigen-presenting cells and direct effects on differentiating T cells. Models to account for the action of chemokines and G protein-coupled receptor signals in regulating T cell differentiation are discussed.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Luther, SA (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 513 Parnassus Ave, San Francisco, CA 94143 USA.	sluther@itso.ucsf.edu; cyster@itsa.ucsf.edu	Luther, Sanjiv A/B-4380-2016; Luther, Sanjiv/AAP-6525-2020; , Sanjiv/B-4380-2016	Luther, Sanjiv A/0000-0002-8758-957X; Luther, Sanjiv/0000-0002-8758-957X; , Sanjiv/0000-0002-0614-561X				Aliberti J, 2000, NAT IMMUNOL, V1, P83, DOI 10.1038/76957; AMIEL SA, 1976, BRIT J EXP PATHOL, V57, P653; Andres PG, 2000, J IMMUNOL, V164, P6303, DOI 10.4049/jimmunol.164.12.6303; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; BENBARUCH A, 1995, J BIOL CHEM, V270, P22123, DOI 10.1074/jbc.270.38.22123; Blanpain C, 1999, BLOOD, V94, P1899; Blease K, 2000, J IMMUNOL, V165, P2603, DOI 10.4049/jimmunol.165.5.2603; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Brady MT, 1998, IMMUNOL TODAY, V19, P534, DOI 10.1016/S0167-5699(98)01359-0; Braun MC, 2000, J IMMUNOL, V164, P3009, DOI 10.4049/jimmunol.164.6.3009; Braun SE, 2000, J IMMUNOL, V164, P4025, DOI 10.4049/jimmunol.164.8.4025; Byrnes HD, 1999, J IMMUNOL, V163, P4715; Campbell EM, 1999, J IMMUNOL, V163, P2160; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; Campbell JJ, 1999, NATURE, V400, P776, DOI 10.1038/23495; Chensue SW, 1996, J IMMUNOL, V157, P4602; Chensue SW, 1999, J IMMUNOL, V163, P165; COOK DN, 1995, SCIENCE, V269, P1583, DOI 10.1126/science.7667639; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; D'Ambrosio D, 1998, J IMMUNOL, V161, P5111; D'Amico G, 2000, NAT IMMUNOL, V1, P387, DOI 10.1038/80819; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Devalaraja RM, 2000, J INVEST DERMATOL, V115, P234, DOI 10.1046/j.1523-1747.2000.00034.x; Domachowske JB, 2000, J IMMUNOL, V165, P2677, DOI 10.4049/jimmunol.165.5.2677; Doucet C, 1998, INT IMMUNOL, V10, P1421, DOI 10.1093/intimm/10.10.1421; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Foti M, 1999, INT IMMUNOL, V11, P979, DOI 10.1093/intimm/11.6.979; Galli G, 2000, EUR J IMMUNOL, V30, P204, DOI 10.1002/1521-4141(200001)30:1<204::AID-IMMU204>3.0.CO;2-G; Gao JL, 1997, J EXP MED, V185, P1959, DOI 10.1084/jem.185.11.1959; Gao W, 2000, J CLIN INVEST, V105, P35, DOI 10.1172/JCI8126; Gong XQ, 1997, J BIOL CHEM, V272, P11682, DOI 10.1074/jbc.272.18.11682; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Hadida F, 1998, J EXP MED, V188, P609, DOI 10.1084/jem.188.3.609; He JP, 2000, J EXP MED, V191, P1605, DOI 10.1084/jem.191.9.1605; Hopken UE, 1996, NATURE, V383, P86, DOI 10.1038/383086a0; Hornquist CE, 1997, J IMMUNOL, V158, P1068; Iellem A, 2000, EUR J IMMUNOL, V30, P1030, DOI 10.1002/(SICI)1521-4141(200004)30:4<1030::AID-IMMU1030>3.0.CO;2-8; Imai T, 1999, INT IMMUNOL, V11, P81, DOI 10.1093/intimm/11.1.81; Inngjerdingen M, 2000, J IMMUNOL, V164, P4048, DOI 10.4049/jimmunol.164.8.4048; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Jordan NJ, 1999, J CLIN INVEST, V104, P1061, DOI 10.1172/JCI6685; Karpus WJ, 1997, J IMMUNOL, V158, P4129; Karpus WJ, 1998, J EXP MED, V187, P733, DOI 10.1084/jem.187.5.733; KARPUS WJ, 1995, J IMMUNOL, V155, P5003; Karpus WJ, 1997, J LEUKOCYTE BIOL, V62, P681, DOI 10.1002/jlb.62.5.681; Kawai T, 1999, J IMMUNOL, V163, P3269; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Lalani AS, 2000, IMMUNOL TODAY, V21, P100, DOI 10.1016/S0167-5699(99)01556-X; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Li L, 1999, J IMMUNOL, V162, P2477; Lieberam I, 1999, EUR J IMMUNOL, V29, P2684, DOI 10.1002/(SICI)1521-4141(199909)29:09<2684::AID-IMMU2684>3.3.CO;2-P; Lippert U, 1998, J IMMUNOL, V161, P2600; Littman DR, 1998, CELL, V93, P677, DOI 10.1016/S0092-8674(00)81429-4; Liu HL, 1999, P NATL ACAD SCI USA, V96, P4581, DOI 10.1073/pnas.96.8.4581; Loetscher P, 1996, J EXP MED, V184, P569, DOI 10.1084/jem.184.2.569; Loetscher P, 1998, NATURE, V391, P344, DOI 10.1038/34814; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; LUKACS NW, 1993, J EXP MED, V177, P1551, DOI 10.1084/jem.177.6.1551; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; Mahon BP, 1996, INFECT IMMUN, V64, P5295, DOI 10.1128/IAI.64.12.5295-5301.1996; Matloubian M, 2000, NAT IMMUNOL, V1, P298, DOI 10.1038/79738; Mekori YA, 1999, J ALLERGY CLIN IMMUN, V104, P517, DOI 10.1016/S0091-6749(99)70316-7; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; MUNOZ JJ, 1984, CELL IMMUNOL, V83, P92, DOI 10.1016/0008-8749(84)90228-4; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; O'Garra A, 1998, CURR BIOL, V8, pR646, DOI 10.1016/S0960-9822(07)00413-7; Peters W, 2000, J IMMUNOL, V165, P7072, DOI 10.4049/jimmunol.165.12.7072; POST TW, 1995, J IMMUNOL, V155, P5299; Qin SX, 1996, EUR J IMMUNOL, V26, P640, DOI 10.1002/eji.1830260320; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Rossi DL, 1997, J IMMUNOL, V158, P1033; Rottman JB, 2000, EUR J IMMUNOL, V30, P2372, DOI 10.1002/1521-4141(2000)30:8<2372::AID-IMMU2372>3.0.CO;2-D; RUDOLPH U, 1995, NAT GENET, V10, P143, DOI 10.1038/ng0695-143; RUTLEDGE BJ, 1995, J IMMUNOL, V155, P4838; Salazar-Mather TP, 1998, J EXP MED, V187, P1, DOI 10.1084/jem.187.1.1; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Sallusto F, 1999, EUR J IMMUNOL, V29, P1617, DOI 10.1002/(SICI)1521-4141(199905)29:05<1617::AID-IMMU1617>3.0.CO;2-3; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Sallusto F, 1998, IMMUNOL TODAY, V19, P568, DOI 10.1016/S0167-5699(98)01346-2; Sato N, 1999, J IMMUNOL, V163, P5519; Sato N, 2000, J EXP MED, V192, P205, DOI 10.1084/jem.192.2.205; Schrum S, 1996, J IMMUNOL, V157, P3598; Sozzani S, 1998, BLOOD, V92, P4036, DOI 10.1182/blood.V92.11.4036.423k17_4036_4039; Stine JT, 2000, BLOOD, V95, P1151, DOI 10.1182/blood.V95.4.1151.004k37_1151_1157; Tang HL, 1999, SCIENCE, V284, P819, DOI 10.1126/science.284.5415.819; Toney LM, 2000, NAT IMMUNOL, V1, P214, DOI 10.1038/79749; Topham PS, 1999, J CLIN INVEST, V104, P1549, DOI 10.1172/JCI7707; Traynor TR, 2000, J IMMUNOL, V164, P2021, DOI 10.4049/jimmunol.164.4.2021; Tumpey TM, 1998, J VIROL, V72, P3705, DOI 10.1128/JVI.72.5.3705-3710.1998; Van Coillie E, 1999, CYTOKINE GROWTH F R, V10, P61, DOI 10.1016/S1359-6101(99)00005-2; Warmington KS, 1999, AM J PATHOL, V154, P1407, DOI 10.1016/S0002-9440(10)65394-1; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wittmann M, 1999, J IMMUNOL, V162, P6763; Yamamoto T, 2000, J IMMUNOL, V164, P6174, DOI 10.4049/jimmunol.164.12.6174; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Zhang SM, 2000, J IMMUNOL, V165, P10, DOI 10.4049/jimmunol.165.1.10; Zhou YH, 1998, J IMMUNOL, V160, P4018; Zingoni A, 1998, J IMMUNOL, V161, P547; Zisman DA, 1997, J CLIN INVEST, V99, P2832, DOI 10.1172/JCI119475; Zou WP, 2000, J IMMUNOL, V165, P4388, DOI 10.4049/jimmunol.165.8.4388	108	552	579	2	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2001	2	2					102	107		10.1038/84205	http://dx.doi.org/10.1038/84205			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	398WD	11175801				2022-12-18	WOS:000166778700004
J	Terabe, M; Matsui, S; Noben-Trauth, N; Chen, HJ; Watson, C; Donaldson, DD; Carbone, DP; Paul, WE; Berzofsky, JA				Terabe, M; Matsui, S; Noben-Trauth, N; Chen, HJ; Watson, C; Donaldson, DD; Carbone, DP; Paul, WE; Berzofsky, JA			NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway	NATURE IMMUNOLOGY			English	Article							IMMUNOGLOBULIN-E PRODUCTION; RECEPTOR GAMMA-CHAIN; TOXIC LYMPHOCYTES-T; CLASS-I MOLECULES; INTERLEUKIN-4 RECEPTOR; DENDRITIC CELLS; TH2 CELLS; EXPRESSION; RESPONSES; COMPLEX	Using a mouse model in which tumors show a growth-regression-recurrence pattern, we investigated the mechanisms for down-regulation of cytotoxic T lymphocyte-mediated tumor immunosurveillance. We found that interleukin 4 receptor (IL-4R) knockout and downstream signal transducer and activator of transcription 6 (STAT6) knockout, but not IL-4 knockout, mice resisted tumor recurrence, which implicated IL-13, the only other cytokine that uses the IL-4R-STAT6 pathway,We confirmed this by IL-13 inhibitor (sIL-13R alpha2-Fc) treatment. Loss of natural killer T eel Is (NKT cells) in CDI knockout mice resulted in decreased IL-13 production and resistance to recurrence, Thus, NKT cells and IL-13, possibly produced by NKT cells and signaling through the IL-4R-STAT6 pathway, are necessary for down-regulation of tumor immunosurveillance. IL-13 inhibitors may prove to be a useful tool in cancer immunotherapy.	NCI, Metab Branch, Mol Immunogenet & Vaccine Res Sect, Bethesda, MD 20892 USA; NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; Genet Inst, Andover, MA 01810 USA; Vanderbilt Univ, Sch Med, Vanderbilt Canc Ctr, Dept Med, Nashville, TN 37232 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Vanderbilt University	Berzofsky, JA (corresponding author), NCI, Metab Branch, Mol Immunogenet & Vaccine Res Sect, Bethesda, MD 20892 USA.				NATIONAL CANCER INSTITUTE [Z01SC004020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000493, ZIAAI000493] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bancroft AJ, 1998, J IMMUNOL, V160, P3453; Bellone G, 1999, AM J PATHOL, V155, P537, DOI 10.1016/S0002-9440(10)65149-8; BENDELAC A, 1994, SCIENCE, V263, P1774, DOI 10.1126/science.7907820; Chen YH, 1997, IMMUNITY, V6, P459, DOI 10.1016/S1074-7613(00)80289-7; Chenoweth C, 1997, Curr Opin Pulm Med, V3, P159, DOI 10.1097/00063198-199703000-00013; Chiaramonte MG, 1999, J IMMUNOL, V162, P920; Chiu YH, 1999, J EXP MED, V189, P103, DOI 10.1084/jem.189.1.103; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Donaldson DD, 1998, J IMMUNOL, V161, P2317; Gabrilovich DI, 1996, CELL IMMUNOL, V170, P101, DOI 10.1006/cimm.1996.0139; Graber P, 1998, EUR J IMMUNOL, V28, P4286, DOI 10.1002/(SICI)1521-4141(199812)28:12<4286::AID-IMMU4286>3.0.CO;2-H; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; HE YW, 1995, J IMMUNOL, V155, P9; Hung K, 1998, J EXP MED, V188, P2357, DOI 10.1084/jem.188.12.2357; Kalams SA, 1998, J EXP MED, V188, P2199, DOI 10.1084/jem.188.12.2199; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; KEENE JA, 1982, J EXP MED, V155, P768, DOI 10.1084/jem.155.3.768; Kitamura H, 1999, J EXP MED, V189, P1121, DOI 10.1084/jem.189.7.1121; Kobayashi M, 1998, J IMMUNOL, V160, P5869; KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076; Kurokohchi K, 1996, HEPATOLOGY, V23, P1181; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; Matsui S, 1999, J IMMUNOL, V163, P184; Matthews DJ, 2000, J IMMUNOL, V164, P1458, DOI 10.4049/jimmunol.164.3.1458; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; NobenTrauth N, 1996, TRANSGENIC RES, V5, P487, DOI 10.1007/BF01980214; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; OConnell J, 1996, J EXP MED, V184, P1075, DOI 10.1084/jem.184.3.1075; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; SCALZO AA, 1995, IMMUNOGENETICS, V41, P148, DOI 10.1007/BF00182328; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; SHIRAI M, 1994, J IMMUNOL, V152, P549; Smiley ST, 1997, SCIENCE, V275, P977, DOI 10.1126/science.275.5302.977; Smyth MJ, 2000, J EXP MED, V191, P661, DOI 10.1084/jem.191.4.661; SWALN SL, 1990, J IMMUNOL, V145, P3796; TAKAHASHI H, 1988, P NATL ACAD SCI USA, V85, P3105, DOI 10.1073/pnas.85.9.3105; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Taniguchi M, 1996, P NATL ACAD SCI USA, V93, P11025, DOI 10.1073/pnas.93.20.11025; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; WARD PL, 1990, CANCER RES, V50, P3851; WILDE DB, 1983, J IMMUNOL, V131, P2178; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; YOKOTA T, 1986, P NATL ACAD SCI USA, V83, P5894, DOI 10.1073/pnas.83.16.5894; YOSHIMOTO T, 1995, SCIENCE, V270, P1845, DOI 10.1126/science.270.5243.1845; ZURAWSKI G, 1994, IMMUNOL TODAY, V15, P19, DOI 10.1016/0167-5699(94)90021-3; ZURAWSKI SM, 1993, EMBO J, V12, P2663, DOI 10.1002/j.1460-2075.1993.tb05927.x; ZURAWSKI SM, 1995, J BIOL CHEM, V270, P13869, DOI 10.1074/jbc.270.23.13869	50	552	602	1	22	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2000	1	6					515	520		10.1038/82771	http://dx.doi.org/10.1038/82771			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	380VR	11101874				2022-12-18	WOS:000165724600016
J	Bauquet, AT; Jin, HL; Paterson, AM; Mitsdoerffer, M; Ho, IC; Sharpe, AH; Kuchroo, VK				Bauquet, Aurelie T.; Jin, Hulin; Paterson, Alison M.; Mitsdoerffer, Meike; Ho, I-Cheng; Sharpe, Arlene H.; Kuchroo, Vijay K.			The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and T-H-17 cells	NATURE IMMUNOLOGY			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; DEPENDENT IMMUNE-RESPONSES; INDUCIBLE COSTIMULATOR; AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; GERMINAL-CENTERS; MESSENGER-RNA; CUTTING EDGE; IN-VIVO; B-CELLS	The inducible costimulatory molecule ICOS has been suggested to be important in the development of interleukin 17 (IL-17)producing helper T cells (T-H-17 cells) and of follicular helper T cells (T-FH cells). Here we show that ICOS-deficient mice had no defect in T-H-17 differentiation but had fewer T-H-17 cells after IL-23 stimulation and fewer TFH cells. We also show that TFH cells produced IL-17 and that TFH cells in ICOS-deficient mice were defective in IL-17 production. Both T-H-17 and TFH cells had higher expression of the transcription factor c-Maf. Genetic loss of c-Maf resulted in a defect in IL-21 production and fewer T-H-17 and T-FH cells. Thus our data suggest that ICOS-induced c-Maf regulates IL-21 production that in turn regulates the expansion of T-H-17 and T-FH cells.	[Bauquet, Aurelie T.; Jin, Hulin; Mitsdoerffer, Meike; Kuchroo, Vijay K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Paterson, Alison M.; Sharpe, Arlene H.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Ho, I-Cheng] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Ho, I-Cheng] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kuchroo, VK (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.	vkuchroo@rics.bwh.harvard.edu		Sharpe, Arlene/0000-0002-9736-2109	National Institutes of Health [1R01NS045937-01, 2R01NS35685-06, 2R37NS30843-11, 1R01A144880-03, P01NS38037-04, 1R01NS046414, 2P01A139671-07, 1P01AI56299, R37 AI38310]; Javits Neuroscience Investigator Award; National Multiple Sclerosis Society [RG-2571-D-9]; European Commission; Deutsche Forschungsgemeinschaft; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039671, P01AI056299, R37AI038310, R01AI044880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045937, R01NS046414, R37NS030843, R01NS035685, P01NS038037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Javits Neuroscience Investigator Award; National Multiple Sclerosis Society(National Multiple Sclerosis Society); European Commission(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Kozoriz for cell sorting, and A. Jaeger, S. Liu and L. Francisco for comments. A. H. S. and V. K. K. are joint senior authors. Supported by the National Institutes of Health (1R01NS045937-01, 2R01NS35685-06, 2R37NS30843-11, 1R01A144880-03, P01NS38037-04 and 1R01NS046414 to V. K. K.; 2P01A139671-07 and 1P01AI56299 to V. K. K. and A. H. S.; R37 AI38310 to A. H. S.; Javits Neuroscience Investigator Award to V. K. K.), the National Multiple Sclerosis Society (RG-2571-D-9), the European Commission (A. T. B.) and the Deutsche Forschungsgemeinschaft (M. M.).	Aarvak T, 1999, J IMMUNOL, V162, P1246; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Akiba H, 2005, J IMMUNOL, V175, P2340, DOI 10.4049/jimmunol.175.4.2340; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Betti M, 2006, ANN ONCOL, V17, P235; Bonhagen K, 2003, EUR J IMMUNOL, V33, P392, DOI 10.1002/immu.200310013; Bossaller L, 2006, J IMMUNOL, V177, P4927, DOI 10.4049/jimmunol.177.7.4927; Bryant VL, 2007, J IMMUNOL, V179, P8180, DOI 10.4049/jimmunol.179.12.8180; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dong C, 2001, J IMMUNOL, V166, P3659, DOI 10.4049/jimmunol.166.6.3659; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Greenwald RJ, 2002, J IMMUNOL, V168, P991, DOI 10.4049/jimmunol.168.3.991; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Ito T, 2007, J EXP MED, V204, P105, DOI 10.1084/jem.20061660; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Liu YJ, 1996, IMMUNITY, V4, P241, DOI 10.1016/S1074-7613(00)80432-X; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Lohning M, 2003, J EXP MED, V197, P181, DOI 10.1084/jem.20020632; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Mak TW, 2003, NAT IMMUNOL, V4, P765, DOI 10.1038/ni947; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nurieva RI, 2003, IMMUNITY, V18, P801, DOI 10.1016/S1074-7613(03)00144-4; O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097; Ozkaynak E, 2001, NAT IMMUNOL, V2, P591, DOI 10.1038/89731; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Rasheed AU, 2006, EUR J IMMUNOL, V36, P1892, DOI 10.1002/eji.200636136; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Sonderegger I, 2006, EUR J IMMUNOL, V36, P2849, DOI 10.1002/eji.200636484; Sperling AI, 2001, NAT IMMUNOL, V2, P573, DOI 10.1038/89709; Teunissen MBM, 1998, J INVEST DERMATOL, V111, P645, DOI 10.1046/j.1523-1747.1998.00347.x; Usui Y, 2006, EUR J IMMUNOL, V36, P3071, DOI 10.1002/eji.200636138; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Warnatz K, 2006, BLOOD, V107, P3045, DOI 10.1182/blood-2005-07-2955; Wong SC, 2003, BLOOD, V102, P1381, DOI 10.1182/blood-2002-08-2416; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	49	551	586	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2009	10	2					167	175		10.1038/ni.1690	http://dx.doi.org/10.1038/ni.1690			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	404UM	19098919	Green Accepted			2022-12-18	WOS:000263178500010
J	Kalesnikoff, J; Galli, SJ				Kalesnikoff, Janet; Galli, Stephen J.			New developments in mast cell biology	NATURE IMMUNOLOGY			English	Review							IN-VIVO; ALLERGIC INFLAMMATION; CRAC CHANNEL; MICE LACKING; ANAPHYLACTIC RESPONSES; NEUTROPHIL RECRUITMENT; TRICHINELLA-SPIRALIS; HEMATOPOIETIC-CELLS; IMMUNE-RESPONSES; PLASMA-MEMBRANE	Mast cells can function as effector and immunoregulatory cells in immunoglobulin E-associated allergic disorders, as well as in certain innate and adaptive immune responses. This review focuses on exciting new developments in the field of mast cell biology published in the past year. We highlight advances in the understanding of Fc epsilon RI-mediated signaling and mast cell-activation events, as well as in the use of genetic models to study mast cell function in vivo. Finally, we discuss newly identified functions for mast cells or individual mast cell products, such as proteases and interleukin 10, in host defense, cardiovascular disease and tumor biology and in settings in which mast cells have anti-inflammatory or immunosuppressive functions.	[Kalesnikoff, Janet] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Galli, Stephen J.] Stanford Univ, Sch Med, Dept Immunol & Microbiol, Stanford, CA 94305 USA	Stanford University; Stanford University	Kalesnikoff, J (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	jkalesni@stanford.edu; sgalli@stanford.edu			NCI NIH HHS [R01 CA072074, R01 CA072074-15] Funding Source: Medline; NIAID NIH HHS [R01 AI070813, R01 AI023990, R01 AI023990-20, R01 AI070813-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA072074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070813, R01AI023990] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allakhverdi Z, 2007, J IMMUNOL, V179, P2051, DOI 10.4049/jimmunol.179.4.2051; ASKENASE PW, 1983, J IMMUNOL, V131, P2687; Baba Y, 2008, NAT IMMUNOL, V9, P81, DOI 10.1038/ni1546; Bansal G, 2008, NAT IMMUNOL, V9, P73, DOI 10.1038/ni1533; Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; Blank U, 2002, MOL IMMUNOL, V38, P1341, DOI 10.1016/S0161-5890(02)00085-8; Bot I, 2007, CIRCULATION, V115, P2516, DOI 10.1161/CIRCULATIONAHA.106.660472; Bryce PJ, 2004, IMMUNITY, V20, P381, DOI 10.1016/S1074-7613(04)00080-9; Byrne SN, 2008, J IMMUNOL, V180, P4648, DOI 10.4049/jimmunol.180.7.4648; Chen RY, 2001, J CLIN INVEST, V108, P1151, DOI 10.1172/jci11494; Christy AL, 2007, J IMMUNOL, V179, P2673, DOI 10.4049/jimmunol.179.5.2673; Costa JJ, 1996, J EXP MED, V183, P2681, DOI 10.1084/jem.183.6.2681; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Depinay N, 2006, J IMMUNOL, V176, P4141, DOI 10.4049/jimmunol.176.7.4141; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; GALLI SJ, 1984, SCIENCE, V226, P710, DOI 10.1126/science.6494907; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Gounaris E, 2007, P NATL ACAD SCI USA, V104, P19977, DOI 10.1073/pnas.0704620104; Gregory GD, 2006, J CLIN INVEST, V116, P1327, DOI 10.1172/JCI27227; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Grimbaldeston MA, 2007, NAT IMMUNOL, V8, P1095, DOI 10.1038/ni1503; Guo ZH, 1998, CELL, V94, P537, DOI 10.1016/S0092-8674(00)81594-9; Gurish MF, 2001, J EXP MED, V194, pF1, DOI 10.1084/jem.194.1.F1; Hart PH, 1998, J EXP MED, V187, P2045, DOI 10.1084/jem.187.12.2045; Hepp G, 2005, J BIOL CHEM, V280, P6610, DOI 10.1074/jbc.M412126200; Hernandez-Hansen V, 2004, J IMMUNOL, V173, P100, DOI 10.4049/jimmunol.173.1.100; Hibi T, 2000, BIOCHEM BIOPH RES CO, V271, P36, DOI 10.1006/bbrc.2000.2591; Higashio H, 2008, J IMMUNOL, V180, P4774, DOI 10.4049/jimmunol.180.7.4774; Ho LH, 2007, J LEUKOCYTE BIOL, V82, P1481, DOI 10.1189/jlb.0407200; Hong H, 2007, BLOOD, V110, P2511, DOI 10.1182/blood-2007-01-066092; Iikura M, 2007, LAB INVEST, V87, P971, DOI 10.1038/labinvest.3700663; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Jawdat DM, 2004, J IMMUNOL, V173, P5275, DOI 10.4049/jimmunol.173.8.5275; Kalesnikoff J, 2007, BLOOD, V109, P5308, DOI 10.1182/blood-2007-01-067363; Kambayashi T, 2008, BLOOD, V111, P1489, DOI 10.1182/blood-2007-07-102111; Kambayashi T, 2007, J ALLERGY CLIN IMMUN, V119, P544, DOI 10.1016/j.jaci.2007.01.017; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; KITAMURA Y, 1978, BLOOD, V52, P447; KITAMURA Y, 1989, ANNU REV IMMUNOL, V7, P59, DOI 10.1146/annurev.iy.07.040189.000423; Knight PA, 2000, J EXP MED, V192, P1849, DOI 10.1084/jem.192.12.1849; Kopp HG, 2006, CURR OPIN HEMATOL, V13, P175, DOI 10.1097/01.moh.0000219664.26528.da; Kovanen PT, 2007, BIOCHEM SOC T, V35, P857, DOI 10.1042/BST0350857; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Laffargue M, 2002, IMMUNITY, V16, P441, DOI 10.1016/S1074-7613(02)00282-0; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Liao Y, 2007, P NATL ACAD SCI USA, V104, P4682, DOI 10.1073/pnas.0611692104; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Logan MR, 2003, J ALLERGY CLIN IMMUN, V111, P923, DOI 10.1067/mai.2003.1573; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; LYON MF, 1982, GENET RES, V39, P315, DOI 10.1017/S001667230002098X; Ma HT, 2008, J IMMUNOL, V180, P2233, DOI 10.4049/jimmunol.180.4.2233; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; Marone Gianni, 2002, Trends in Immunology, V23, P425, DOI 10.1016/S1471-4906(02)02274-3; Maurer M, 2004, NATURE, V432, P512, DOI 10.1038/nature03085; McLachlan JB, 2008, NAT MED, V14, P536, DOI 10.1038/nm1757; Mekori YA, 2000, IMMUNOL REV, V173, P131, DOI 10.1034/j.1600-065X.2000.917305.x; Melendez AJ, 2007, NAT MED, V13, P1375, DOI 10.1038/nm1654; Metz M, 2007, IMMUNOL REV, V217, P304, DOI 10.1111/j.1600-065X.2007.00520.x; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; MOHR FC, 1987, J CELL BIOL, V104, P783, DOI 10.1083/jcb.104.3.783; Moritz DR, 1998, J IMMUNOL, V161, P4866; Moulin D, 2007, CYTOKINE, V40, P216, DOI 10.1016/j.cyto.2007.09.013; Musch W, 2008, GENESIS, V46, P163, DOI 10.1002/dvg.20378; Nakae S, 2006, J IMMUNOL, V176, P2238, DOI 10.4049/jimmunol.176.4.2238; Nakae S, 2007, BLOOD, V109, P3640, DOI 10.1182/blood-2006-09-046128; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; Neeft M, 2005, MOL BIOL CELL, V16, P731, DOI 10.1091/mbc.E04-10-0923; Nishida K, 2005, J CELL BIOL, V170, P115, DOI 10.1083/jcb.200501111; Norman MU, 2008, AM J PATHOL, V172, P1638, DOI 10.2353/ajpath.2008.070559; Odom S, 2004, J EXP MED, V199, P1491, DOI 10.1084/jem.20040382; Orinska Z, 2007, NAT MED, V13, P927, DOI 10.1038/nm1615; Paumet F, 2000, J IMMUNOL, V164, P5850, DOI 10.4049/jimmunol.164.11.5850; Piliponsky AM, 2008, NAT MED, V14, P392, DOI 10.1038/nm1738; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Puri N, 2008, P NATL ACAD SCI USA, V105, P2580, DOI 10.1073/pnas.0707854105; Rauter I, 2008, J ALLERGY CLIN IMMUN, V121, P197, DOI 10.1016/j.jaci.2007.08.015; RIOS EJ, 2008, BLOOD           0812, DOI DOI 10.1182/BLOOD-2008-04-152660; Rivera J, 2007, IMMUNOL REV, V217, P255, DOI 10.1111/j.1600-065X.2007.00505.x; Rivera J, 2006, J ALLERGY CLIN IMMUN, V117, P1214, DOI 10.1016/j.jaci.2006.04.015; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Sander LE, 2008, EUR J IMMUNOL, V38, P855, DOI 10.1002/eji.200737634; Saxon A, 2008, J ALLERGY CLIN IMMUN, V121, P320, DOI 10.1016/j.jaci.2007.10.017; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Schneider LA, 2007, J EXP MED, V204, P2629, DOI 10.1084/jem.20071262; Scholten J, 2008, TRANSGENIC RES, V17, P307, DOI 10.1007/s11248-007-9153-4; Shin K, 2008, J IMMUNOL, V180, P4885, DOI 10.4049/jimmunol.180.7.4885; Sinnamon MJ, 2008, CARCINOGENESIS, V29, P880, DOI 10.1093/carcin/bgn040; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; Sun J, 2007, J CLIN INVEST, V117, P3359, DOI 10.1172/JCI31311; Sun JS, 2007, NAT MED, V13, P719, DOI 10.1038/nm1601; Suto H, 2006, J IMMUNOL, V176, P4102, DOI 10.4049/jimmunol.176.7.4102; Suzuki K, 2008, CELL, V134, P485, DOI 10.1016/j.cell.2008.05.050; Tam SY, 2004, NAT IMMUNOL, V5, P844, DOI 10.1038/ni1093; Thakurdas SM, 2007, J BIOL CHEM, V282, P20809, DOI 10.1074/jbc.M611842200; Tiwari N, 2008, BLOOD, V111, P3665, DOI 10.1182/blood-2007-07-103309; Tsai M, 2000, P NATL ACAD SCI USA, V97, P9186, DOI 10.1073/pnas.160254997; Tsuruda T, 2008, CIRC RES, V102, P1368, DOI 10.1161/CIRCRESAHA.108.173682; Vennekens R, 2007, NAT IMMUNOL, V8, P312, DOI 10.1038/ni1441; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Wedemeyer J, 2005, LAB INVEST, V85, P388, DOI 10.1038/labinvest.3700232; Wolters PJ, 2005, CLIN EXP ALLERGY, V35, P82, DOI 10.1111/j.1365-2222.2005.02136.x; Xu D, 2008, P NATL ACAD SCI USA, V105, P10913, DOI 10.1073/pnas.0801898105; Yamashita Y, 2007, J IMMUNOL, V179, P740, DOI 10.4049/jimmunol.179.2.740; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Zhou JS, 2007, J EXP MED, V204, P2797, DOI 10.1084/jem.20071391	112	548	576	4	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2008	9	11					1215	1223		10.1038/ni.f.216	http://dx.doi.org/10.1038/ni.f.216			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363EA	18936782	Green Accepted			2022-12-18	WOS:000260248600008
J	Matsuzawa, A; Saegusa, K; Noguchi, T; Sadamitsu, C; Nishitoh, H; Nagai, S; Koyasu, S; Matsumoto, K; Takeda, K; Ichijo, H				Matsuzawa, A; Saegusa, K; Noguchi, T; Sadamitsu, C; Nishitoh, H; Nagai, S; Koyasu, S; Matsumoto, K; Takeda, K; Ichijo, H			ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTORS; REGULATING KINASE 1; DENDRITIC CELLS; CUTTING EDGE; APOPTOSIS; ASK1; INTERLEUKIN-1; PHOSPHORYLATION; THIOREDOXIN	Apoptosis signal - regulating kinase 1 (ASK1) is an evolutionarily conserved mitogen-activated protein 3-kinase that activates both Jnk and p38 mitogen-activated protein kinases. Here we used ASK1-deficient mice to show that ASK1 was selectively required for lipopolysaccharide-induced activation of p38 but not of Jnk or the transcription factor NF-kappa B. ASK1 was required for the induction of proinflammatory cytokines dependent on Toll-like receptor 4 (TLR4) but not TLR2 or other TLRs. Consistent with this, ASK1-deficient mice were resistant to lipopolysaccharide-induced septic shock. Lipopolysaccharide induced the production of intracellular reactive oxygen species, which was required for the formation of a complex of the adaptor molecule TRAF6 and ASK1 and subsequent activation of the ASK1-p38 pathway. Our data demonstrate that the reactive oxygen species - dependent TRAF6-ASK1-p38 axis is crucial for TLR4-mediated mammalian innate immunity.	Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Bunkyo Ku, Tokyo 1130033, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Bunkyo Ku, Tokyo 1130033, Japan; Ctr Excellence Program, Strateg Approach Drug Discovery & Dev Pharmaceut, Bunkyo Ku, Tokyo 1130033, Japan; Tokyo Med & Dent Univ, Grad Sch, Lab Cell Signaling, Bunkyo Ku, Tokyo 1138549, Japan; Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1608582, Japan; Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Grp Signal Transduct,Chikusa Ku, Aichi 4648602, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Tokyo Medical & Dental University (TMDU); Keio University; Nagoya University	Ichijo, H (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	ichijo@mol.f.u-tokyo.ac.jp	Matsuzawa, Atsushi/GLU-1387-2022; Noguchi, Takuya/T-6767-2019; Koyasu, Shigeo/J-5583-2015	Noguchi, Takuya/0000-0001-6187-6645; Koyasu, Shigeo/0000-0001-9585-3038; Nishitoh, Hideki/0000-0002-8652-4109; Matsuzawa, Atsushi/0000-0001-8303-3905; Ichijo, Hidenori/0000-0002-5005-6438; Takeda, Kohsuke/0000-0002-8359-8399; Nagai, Shigenori/0000-0002-5018-5942				Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alcamo E, 2001, J IMMUNOL, V167, P1592, DOI 10.4049/jimmunol.167.3.1592; Chin AI, 2002, NATURE, V416, P190, DOI 10.1038/416190a; Frevel MAE, 2003, MOL CELL BIOL, V23, P425, DOI 10.1128/MCB.23.2.425-436.2003; Gohda J, 2004, J IMMUNOL, V173, P2913, DOI 10.4049/jimmunol.173.5.2913; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Hsu HY, 2002, J BIOL CHEM, V277, P22131, DOI 10.1074/jbc.M111883200; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kobayashi T, 2003, IMMUNITY, V19, P353, DOI 10.1016/S1074-7613(03)00230-9; Liu H, 2000, MOL CELL BIOL, V20, P2198, DOI 10.1128/MCB.20.6.2198-2208.2000; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Mochida Y, 2000, J BIOL CHEM, V275, P32747, DOI 10.1074/jbc.M003042200; Morelli AE, 2000, J VIROL, V74, P9617, DOI 10.1128/JVI.74.20.9617-9628.2000; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Rousseau S, 2002, EMBO J, V21, P6505, DOI 10.1093/emboj/cdf639; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Senftleben U, 2001, IMMUNITY, V14, P217, DOI 10.1016/S1074-7613(01)00104-2; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Swantek JL, 2000, J IMMUNOL, V164, P4301, DOI 10.4049/jimmunol.164.8.4301; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	35	547	570	1	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2005	6	6					587	592		10.1038/ni1200	http://dx.doi.org/10.1038/ni1200			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	929ZR	15864310				2022-12-18	WOS:000229385900013
J	Arbibe, L; Mira, JP; Teusch, N; Kline, L; Guha, M; Mackman, N; Godowski, PJ; Ulevitch, RJ; Knaus, UG				Arbibe, L; Mira, JP; Teusch, N; Kline, L; Guha, M; Mackman, N; Godowski, PJ; Ulevitch, RJ; Knaus, UG			Toll-like receptor 2-mediated NF-kappa B activation requires a RacI-dependent pathway	NATURE IMMUNOLOGY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; HUMAN NEUTROPHILS; CELL ACTIVATION; CUTTING EDGE; HOST-DEFENSE; RHO FAMILY; CDC42; INTERLEUKIN-1; PHOSPHORYLATION; PHAGOCYTOSIS	Mammalian Toll-like receptors (TLRs) are expressed on innate immune cells and respond to the membrane components of Gram-positive or Gram-negative bacteria. When activated, they convey signals to transcription factors that orchestrate the inflammatory response. However, the intracellular signaling events following TLR activation are largely unknown. Here we show that TLR2 stimulation by Staphylococcus aureus induces a fast and transient activation of the Rho GTPases Rad and Cdc42 in the human monocytic cell line THP-I and in 293 cells expressing TLR2. Dominant-negative RacIN17,but not dominant-negative Cdc42N17, block nuclear factor-kappaB (NF-kappaB) transactivation. S, aureus stimulation causes the recruitment of active Rad and phosphatidylinositol-3 kinase (PI3K) to the TLR2 cytosolic domain. Tyrosine phosphorylation of TLR2 is required for assembly of a multiprotein complex that is necessary for subsequent NF-kappaB transcriptional activity. A signaling cascade composed of Rad, PI3K and Akt targets nuclear p65 transactivation independently of I kappaB alpha degradation, Thus Rad controls a second, I kappaB-independent, pathway to NF-kappaB activation and is essential in innate immune cell signaling via TLR2.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA	Scripps Research Institute; Roche Holding; Genentech	Ulevitch, RJ (corresponding author), Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA.	ulevitch@scripps.edu	Teusch, Nicole/AAZ-8239-2020; Ulevitch, Richard J/Q-3393-2017	Teusch, Nicole/0000-0002-9030-1493; Arbibe, Laurence/0000-0001-7102-346X	NHLBI NIH HHS [HL48872] Funding Source: Medline; NIAID NIH HHS [AI 15136] Funding Source: Medline; NIGMS NIH HHS [GM 28485, GM 37696] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM037696, R01GM028485, R37GM028485] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bird TA, 1997, J BIOL CHEM, V272, P32606, DOI 10.1074/jbc.272.51.32606; Bokoch GM, 1996, BIOCHEM J, V315, P775, DOI 10.1042/bj3150775; Bowie A, 2000, J LEUKOCYTE BIOL, V67, P508, DOI 10.1002/jlb.67.4.508; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Carpenter CL, 1996, CURR OPIN CELL BIOL, V8, P153, DOI 10.1016/S0955-0674(96)80060-3; Chen LM, 1996, SCIENCE, V274, P2115, DOI 10.1126/science.274.5295.2115; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Irie T, 2000, FEBS LETT, V467, P160, DOI 10.1016/S0014-5793(00)01146-7; Jefferies CA, 2000, J BIOL CHEM, V275, P3114, DOI 10.1074/jbc.275.5.3114; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; KNAUS UG, 1991, SCIENCE, V254, P1512, DOI 10.1126/science.1660188; Kopp EB, 1999, CURR OPIN IMMUNOL, V11, P13, DOI 10.1016/S0952-7915(99)80003-X; Lee DJ, 2000, J BIOL CHEM, V275, P141, DOI 10.1074/jbc.275.1.141; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Mercurio F, 1999, CURR OPIN CELL BIOL, V11, P226, DOI 10.1016/S0955-0674(99)80030-1; Mira JP, 2000, P NATL ACAD SCI USA, V97, P185, DOI 10.1073/pnas.97.1.185; Montaner S, 1998, J BIOL CHEM, V273, P12779, DOI 10.1074/jbc.273.21.12779; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Ozes ON, 1999, NATURE, V401, P82; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Puls A, 1999, J CELL SCI, V112, P2983; Reddy SAG, 1997, J BIOL CHEM, V272, P29167, DOI 10.1074/jbc.272.46.29167; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; SAHL B, 1998, J IMMUNOL, V161, P6947; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Schiff DE, 1997, J LEUKOCYTE BIOL, V62, P786, DOI 10.1002/jlb.62.6.786; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Singh R, 1999, J CLIN INVEST, V103, P1561, DOI 10.1172/JCI5754; Sizemore N, 1999, MOL CELL BIOL, V19, P4798; Sulciner DJ, 1996, MOL CELL BIOL, V16, P7115; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Vollebregt M, 1998, FEBS LETT, V432, P40, DOI 10.1016/S0014-5793(98)00821-7; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Yoshimura A, 1999, J IMMUNOL, V163, P1; Zandi E, 1999, MOL CELL BIOL, V19, P4547; Zenke FT, 1999, J BIOL CHEM, V274, P32565, DOI 10.1074/jbc.274.46.32565; ZHENG Y, 1994, J BIOL CHEM, V269, P18727; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6	49	547	559	2	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2000	1	6					533	540		10.1038/82797	http://dx.doi.org/10.1038/82797			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	380VR	11101877				2022-12-18	WOS:000165724600019
J	Grimbacher, B; Hutloff, A; Schlesier, M; Glocker, E; Warnatz, K; Drager, R; Eibel, H; Fischer, B; Schaffer, AA; Mages, HW; Kroczek, RA; Peter, HH				Grimbacher, B; Hutloff, A; Schlesier, M; Glocker, E; Warnatz, K; Drager, R; Eibel, H; Fischer, B; Schaffer, AA; Mages, HW; Kroczek, RA; Peter, HH			Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency	NATURE IMMUNOLOGY			English	Article							CD4(+) T-CELLS; B-CELLS; IGA DEFICIENCY; INDUCIBLE COSTIMULATOR; GERMINAL CENTER; BONE-MARROW; CD40 LIGAND; MEMORY; DIFFERENTIATION; ACTIVATION	No genetic defect is known to cause common variable immunodeficiency (CVID), a heterogeneous human disorder leading to adult-onset panhypogammaglobulinemia. In a search for CVID candidate proteins, we found four of 32 patients to lack ICOS, the "inducible costimulator" on activated T cells, due to an inherited homozygous deletion in the ICOS gene. T cells from these individuals were normal with regard to subset distribution, activation, cytokine production and proliferation. In contrast, naive, switched and memory B cells were reduced. The phenotype of human ICOS deficiency, which differs in key aspects from that of the ICOS-/- mouse, suggests a critical involvement of ICOS in T cell help for late B cell differentiation, class-switching and memory B cell generation.	Univ Freiburg, Sch Med, Div Clin Immunol & Rheumatol, D-79106 Freiburg, Germany; Robert Koch Inst, D-13353 Berlin, Germany; Univ Hosp Freiburg, Clin Res Unit Rheumatol, D-79106 Freiburg, Germany; NIH, Natl Ctr Biotechnol Informat, Dept Hlth & Human Serv, Bethesda, MD 20894 USA	University of Freiburg; Robert Koch Institute; University of Freiburg; National Institutes of Health (NIH) - USA	Peter, HH (corresponding author), Univ Freiburg, Sch Med, Div Clin Immunol & Rheumatol, Hugstetter Str 55, D-79106 Freiburg, Germany.		Warnatz, Klaus/AAD-3464-2022; Schaffer, Alejandro/N-1222-2019; Schaffer, Alejandro A/F-2902-2012; Hutloff, Andreas/D-1781-2014	Hutloff, Andreas/0000-0002-0572-8151	NATIONAL LIBRARY OF MEDICINE [ZIALM000097, Z01LM000097] Funding Source: NIH RePORTER	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		[Anonymous], 1999, CLIN EXP IMMUNOL, V118, P1; Antonarakis S. E., 2001, METABOLIC MOL BASES, P343; ARTUS U, 1995, IMMUN INFEKT, V23, P69; Beier KC, 2000, EUR J IMMUNOL, V30, P3707, DOI 10.1002/1521-4141(200012)30:12<3707::AID-IMMU3707>3.0.CO;2-Q; Boncristiano M, 2000, EUR J IMMUNOL, V30, P2632, DOI 10.1002/1521-4141(200009)30:9<2632::AID-IMMU2632>3.0.CO;2-C; Brouet JC, 2000, EUR J IMMUNOL, V30, P2516, DOI 10.1002/1521-4141(200009)30:9<2516::AID-IMMU2516>3.0.CO;2-Z; BRYANT A, 1990, CLIN IMMUNOL IMMUNOP, V56, P239, DOI 10.1016/0090-1229(90)90145-G; Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; Chambers CA, 1999, CURR OPIN CELL BIOL, V11, P203, DOI 10.1016/S0955-0674(99)80027-1; Choe J, 1998, EUR J IMMUNOL, V28, P508, DOI 10.1002/(SICI)1521-4141(199802)28:02<508::AID-IMMU508>3.0.CO;2-I; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; Denz A, 2000, EUR J IMMUNOL, V30, P1069, DOI 10.1002/(SICI)1521-4141(200004)30:4<1069::AID-IMMU1069>3.0.CO;2-M; Dong C, 2001, J IMMUNOL, V166, P3659, DOI 10.4049/jimmunol.166.6.3659; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; EISENSTEIN EM, 1995, ADV EXP MED BIOL, V371, P699; FARRINGTON M, 1994, P NATL ACAD SCI USA, V91, P1099, DOI 10.1073/pnas.91.3.1099; Fischer MB, 1996, EUR J IMMUNOL, V26, P231, DOI 10.1002/eji.1830260136; FLAVELL DJ, 1995, BRIT J CANCER, V72, P1373, DOI 10.1038/bjc.1995.517; Ghia P, 1996, J EXP MED, V184, P2217, DOI 10.1084/jem.184.6.2217; Hammarstrom L, 2000, CLIN EXP IMMUNOL, V120, P225, DOI 10.1046/j.1365-2249.2000.01131.x; HERBST EW, 1994, CLIN EXP IMMUNOL, V95, P215; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Jacquot S, 2001, INT IMMUNOL, V13, P871, DOI 10.1093/intimm/13.7.871; JAFFE JS, 1993, BLOOD, V82, P192, DOI 10.1182/blood.V82.1.192.bloodjournal821192; Khayyamian S, 2002, P NATL ACAD SCI USA, V99, P6198, DOI 10.1073/pnas.092576699; KIKUTANI H, 1986, J EXP MED, V164, P1455, DOI 10.1084/jem.164.5.1455; Kindler V, 1997, J IMMUNOL, V159, P2085; Kondratenko I, 1997, CLIN EXP IMMUNOL, V108, P9, DOI 10.1046/j.1365-2249.1997.d01-993.x; KROCZEK RA, 1994, IMMUNOL REV, V138, P39, DOI 10.1111/j.1600-065X.1994.tb00846.x; KROCZEK RA, 1990, ANAL BIOCHEM, V184, P90, DOI 10.1016/0003-2697(90)90017-4; Levy Y, 1998, P NATL ACAD SCI USA, V95, P13135, DOI 10.1073/pnas.95.22.13135; Liang L, 2002, CURR OPIN IMMUNOL, V14, P384, DOI 10.1016/S0952-7915(02)00342-4; Lohning M, 2003, J EXP MED, V197, P181, DOI 10.1084/jem.20020632; Mages HW, 2000, EUR J IMMUNOL, V30, P1040, DOI 10.1002/(SICI)1521-4141(200004)30:4<1040::AID-IMMU1040>3.0.CO;2-6; McAdam AJ, 2000, J IMMUNOL, V165, P5035, DOI 10.4049/jimmunol.165.9.5035; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; NORTH ME, 1991, CLIN EXP IMMUNOL, V85, P198; NOTARANGELO L D, 1992, Immunodeficiency Reviews, V3, P101; Ott J, 1999, ANAL HUMAN GENETIC L; PASTORELLI G, 1989, CLIN EXP IMMUNOL, V78, P334; ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890; RUMP JA, 1992, CLIN EXP IMMUNOL, V89, P204; Spickett GP, 1997, IMMUNOL TODAY, V18, P325, DOI 10.1016/S0167-5699(97)01086-4; Spickett GP, 2001, CLIN EXP ALLERGY, V31, P536, DOI 10.1046/j.1365-2222.2001.01117.x; Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Thon V, 1997, CLIN EXP IMMUNOL, V110, P174; Vorechovsky I, 1999, AM J HUM GENET, V64, P1096, DOI 10.1086/302326; Vorechovsky I, 2000, J IMMUNOL, V164, P4408, DOI 10.4049/jimmunol.164.8.4408; Wahl P, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017901.77985F; Warnatz K, 2002, BLOOD, V99, P1544, DOI 10.1182/blood.V99.5.1544; Witsch EJ, 2002, EUR J IMMUNOL, V32, P2680, DOI 10.1002/1521-4141(200209)32:9<2680::AID-IMMU2680>3.0.CO;2-6; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582; Zhang JG, 1996, CLIN EXP IMMUNOL, V104, P275, DOI 10.1046/j.1365-2249.1996.37744.x	54	543	564	1	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2003	4	3					261	268		10.1038/ni902	http://dx.doi.org/10.1038/ni902			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	649HH	12577056				2022-12-18	WOS:000181201000015
J	Brestoff, JR; Artis, D				Brestoff, Jonathan R.; Artis, David			Commensal bacteria at the interface of host metabolism and the immune system	NATURE IMMUNOLOGY			English	Review							CHAIN FATTY-ACIDS; NF-KAPPA-B; HUMAN LARGE-INTESTINE; BILE-SALT HYDROLASE; GUT MICROBIOTA; PPAR-GAMMA; X RECEPTOR; T-CELLS; BUTYRATE; INFLAMMATION	The mammalian gastrointestinal tract, the site of digestion and nutrient absorption, harbors trillions of beneficial commensal microbes from all three domains of life. Commensal bacteria, in particular, are key participants in the digestion of food, and are responsible for the extraction and synthesis of nutrients and other metabolites that are essential for the maintenance of mammalian health. Many of these nutrients and metabolites derived from commensal bacteria have been implicated in the development, homeostasis and function of the immune system, suggesting that commensal bacteria may influence host immunity via nutrient- and metabolite-dependent mechanisms. Here we review the current knowledge of how commensal bacteria regulate the production and bioavailability of immunomodulatory, diet-dependent nutrients and metabolites and discuss how these commensal bacteria-derived products may regulate the development and function of the mammalian immune system.	[Brestoff, Jonathan R.; Artis, David] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Brestoff, Jonathan R.] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Artis, David] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Artis, D (corresponding author), Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	dartis@mail.med.upenn.edu	Brestoff, Jonathan R./I-7000-2019	Brestoff, Jonathan R./0000-0002-7018-7400; Artis, David/0000-0002-1753-4100	US National Institutes of Health [AI061570, AI074878, AI083480, AI087990, AI095466, AI095608, AI097333, AI102942]; Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award; Crohn's and Colitis Foundation of America; National Institutes of Health [T32-AI060516]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102942, R01AI097333, T32AI060516, R01AI074878, U01AI095608, R21AI087990, R01AI095466, R01AI061570, R21AI083480] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award; Crohn's and Colitis Foundation of America; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all members of the Artis laboratory for discussions and critical reading of the manuscript. Supported by US National Institutes of Health grants (AI061570, AI074878, AI083480, AI087990, AI095466, AI095608, AI097333 and AI102942 to D. A.), the Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award (D. A.) and the Crohn's and Colitis Foundation of America (D. A.). J.R.B. is supported by National Institutes of Health grant T32-AI060516.	Abraham C, 2011, GASTROENTEROLOGY, V140, P1729, DOI 10.1053/j.gastro.2011.02.012; Abt MC, 2013, CURR OPIN MICROBIOL, V16, P4, DOI 10.1016/j.mib.2012.12.002; Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Are A, 2008, P NATL ACAD SCI USA, V105, P1943, DOI 10.1073/pnas.0711734105; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bailon E, 2010, IMMUNOBIOLOGY, V215, P863, DOI 10.1016/j.imbio.2010.01.001; Bellahcene M, 2013, BRIT J NUTR, V109, P1755, DOI 10.1017/S0007114512003923; Berndt BE, 2012, AM J PHYSIOL-GASTR L, V303, pG1384, DOI 10.1152/ajpgi.00540.2011; Bhaskaram P, 2002, NUTR REV, V60, pS40, DOI 10.1301/00296640260130722; Bjursell M, 2011, AM J PHYSIOL-ENDOC M, V300, pE211, DOI 10.1152/ajpendo.00229.2010; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cantorna MT, 2004, AM J CLIN NUTR, V80, p1717S, DOI 10.1093/ajcn/80.6.1717S; Chang KO, 2004, P NATL ACAD SCI USA, V101, P8733, DOI 10.1073/pnas.0401126101; Chang KO, 2007, J VIROL, V81, P9633, DOI 10.1128/JVI.00795-07; Cheng CH, 2006, EUR J CLIN NUTR, V60, P1207, DOI 10.1038/sj.ejcn.1602439; Chinen T, 2012, IMMUNOL REV, V245, P45, DOI 10.1111/j.1600-065X.2011.01083.x; Cipriani S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025637; Claus SP, 2011, MBIO, V2, DOI 10.1128/mBio.00271-10; Claus SP, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.56; Cobbold SP, 2009, P NATL ACAD SCI USA, V106, P12055, DOI 10.1073/pnas.0903919106; COUSENS LS, 1979, J BIOL CHEM, V254, P1716; Cox MA, 2009, WORLD J GASTROENTERO, V15, P5549, DOI 10.3748/wjg.15.5549; CUMMINGS JH, 1983, LANCET, V1, P1206; CUMMINGS JH, 1991, J APPL BACTERIOL, V70, P443, DOI 10.1111/j.1365-2672.1991.tb02739.x; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Das P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000899; David M, 1996, J BIOL CHEM, V271, P4585; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Diao HY, 2004, IMMUNITY, V21, P539, DOI 10.1016/j.immuni.2004.08.012; Donohoe DR, 2012, MOL CELL, V48, P612, DOI 10.1016/j.molcel.2012.08.033; Donohoe DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046589; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Duboc H, 2013, GUT, V62, P531, DOI 10.1136/gutjnl-2012-302578; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; EFTIMIADI C, 1991, ORAL MICROBIOL IMMUN, V6, P17, DOI 10.1111/j.1399-302X.1991.tb00446.x; Fiorucci S, 2009, TRENDS PHARMACOL SCI, V30, P570, DOI 10.1016/j.tips.2009.08.001; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Gadaleta RM, 2011, GUT, V60, P463, DOI 10.1136/gut.2010.212159; Ganal SC, 2012, IMMUNITY, V37, P171, DOI 10.1016/j.immuni.2012.05.020; Gerriets VA, 2012, TRENDS IMMUNOL, V33, P168, DOI 10.1016/j.it.2012.01.010; Gilbert KM, 2006, LIFE SCI, V78, P2159, DOI 10.1016/j.lfs.2005.09.047; Haschemi A, 2012, CELL METAB, V15, P813, DOI 10.1016/j.cmet.2012.04.023; Hashimoto T, 2012, NATURE, V487, P477, DOI 10.1038/nature11228; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hill DA, 2010, ANNU REV IMMUNOL, V28, P623, DOI 10.1146/annurev-immunol-030409-101330; Hinnebusch BF, 2002, J NUTR, V132, P1012, DOI 10.1093/jn/132.5.1012; Holmes E, 2011, TRENDS MICROBIOL, V19, P349, DOI 10.1016/j.tim.2011.05.006; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Hong C, 2012, J CLIN INVEST, V122, P337, DOI 10.1172/JCI58393; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; HOVERSTAD T, 1986, J NUTR, V116, P1772, DOI 10.1093/jn/116.9.1772; Huang N, 1997, CYTOKINE, V9, P27, DOI 10.1006/cyto.1996.0132; Hudson BD, 2012, J BIOL CHEM, V287, P41195, DOI 10.1074/jbc.M112.396259; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Ito K, 2012, NAT MED, V18, P1350, DOI 10.1038/nm.2882; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Karlsson FH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2266; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kidani Y, 2012, IMMUNOL REV, V249, P72, DOI 10.1111/j.1600-065X.2012.01153.x; Kimura I, 2011, P NATL ACAD SCI USA, V108, P8030, DOI 10.1073/pnas.1016088108; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Kobayashi M, 2007, DIABETES, V56, P239, DOI 10.2337/db06-0353; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Kunisawa J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032094; Le Bourhis L, 2013, CURR OPIN IMMUNOL, V25, P174, DOI 10.1016/j.coi.2013.01.005; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Lee EH, 1998, INFECT IMMUN, V66, P2514, DOI 10.1128/IAI.66.6.2514-2520.1998; LENZ K, 1976, SCAND J GASTROENTERO, V11, P769; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Littman DR, 2011, CELL HOST MICROBE, V10, P311, DOI 10.1016/j.chom.2011.10.004; Liu L, 2012, CELL IMMUNOL, V277, P66, DOI 10.1016/j.cellimm.2012.05.011; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; Martin FPJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100153; Martin FPJ, 2010, J PROTEOME RES, V9, P5284, DOI 10.1021/pr100554m; Martin FPJ, 2009, J PROTEOME RES, V8, P2090, DOI 10.1021/pr801068x; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Matsumoto M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00233; McGaha TL, 2012, IMMUNOL REV, V249, P135, DOI 10.1111/j.1600-065X.2012.01149.x; Mencarelli A, 2009, J IMMUNOL, V183, P6657, DOI 10.4049/jimmunol.0901347; Mestdagh R, 2012, J PROTEOME RES, V11, P620, DOI 10.1021/pr200938v; Meydani SN, 1997, JAMA-J AM MED ASSOC, V277, P1380, DOI 10.1001/jama.277.17.1380; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; MILLER TL, 1979, AM J CLIN NUTR, V32, P164, DOI 10.1093/ajcn/32.1.164; Molloy MJ, 2012, SEMIN IMMUNOL, V24, P58, DOI 10.1016/j.smim.2011.11.008; Morris SM, 2012, CURR OPIN CLIN NUTR, V15, P64, DOI 10.1097/MCO.0b013e32834d1a08; Mukundan L, 2009, NAT MED, V15, P1266, DOI 10.1038/nm.2048; Muller O, 2005, CAN MED ASSOC J, V173, P279, DOI 10.1503/cmaj.050342; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Nijmeijer RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023745; Nilsson NE, 2003, BIOCHEM BIOPH RES CO, V303, P1047, DOI 10.1016/S0006-291X(03)00488-1; Nowak EC, 2012, J EXP MED, V209, P2127, DOI 10.1084/jem.20120408; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Odegaard JI, 2013, IMMUNITY, V38, P644, DOI 10.1016/j.immuni.2013.04.001; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Patel KK, 2013, ANNU REV PHYSIOL, V75, P241, DOI 10.1146/annurev-physiol-030212-183658; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pellicciari R, 2009, J MED CHEM, V52, P7958, DOI 10.1021/jm901390p; Pols TWH, 2011, CELL METAB, V14, P747, DOI 10.1016/j.cmet.2011.11.006; PRETORIUS PJ, 1962, AM J CLIN NUTR, V10, P379, DOI 10.1093/ajcn/10.5.379; Puccetti P, 2007, NAT REV IMMUNOL, V7, P817, DOI 10.1038/nri2163; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Renga B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054472; Resta SC, 2009, J PHYSIOL-LONDON, V587, P4169, DOI 10.1113/jphysiol.2009.176370; Rice AL, 2000, B WORLD HEALTH ORGAN, V78, P1207; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Rodriguez PC, 2004, CANCER RES, V64, P5839, DOI 10.1158/0008-5472.CAN-04-0465; Rossjohn J, 2012, NAT REV IMMUNOL, V12, P845, DOI 10.1038/nri3328; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; RUTGEERTS P, 1979, GUT, V20, P1072, DOI 10.1136/gut.20.12.1072; Savy M, 2009, J NUTR, V139, p2154S, DOI 10.3945/jn.109.105312; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; SCHEPPACH W, 1992, GASTROENTEROLOGY, V103, P51, DOI 10.1016/0016-5085(92)91094-K; SCRIMSHAW NEVIN S., 1960, JOUR TROP PEDIAT, V6, P37; Segain JP, 2000, GUT, V47, P397, DOI 10.1136/gut.47.3.397; Semova I, 2012, CELL HOST MICROBE, V12, P277, DOI 10.1016/j.chom.2012.08.003; Shakespear MR, 2011, TRENDS IMMUNOL, V32, P335, DOI 10.1016/j.it.2011.04.001; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; Sina C, 2009, J IMMUNOL, V183, P7514, DOI 10.4049/jimmunol.0900063; Smiricky-Tjardes MR, 2003, J ANIM SCI, V81, P2505; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393; Spencer SP, 2012, CURR OPIN IMMUNOL, V24, P379, DOI 10.1016/j.coi.2012.07.006; Swann JR, 2011, P NATL ACAD SCI USA, V108, P4523, DOI 10.1073/pnas.1006734107; Tamura J, 1999, CLIN EXP IMMUNOL, V116, P28; Tanaka H, 2000, APPL ENVIRON MICROB, V66, P2502, DOI 10.1128/AEM.66.6.2502-2512.2000; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Trauner M, 2003, PHYSIOL REV, V83, P633, DOI 10.1152/physrev.00027.2002; Trehan I, 2013, NEW ENGL J MED, V368, P425, DOI 10.1056/NEJMoa1202851; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vavassori P, 2009, J IMMUNOL, V183, P6251, DOI 10.4049/jimmunol.0803978; Venkatraman A, 2003, AM J PHYSIOL-GASTR L, V285, pG177, DOI 10.1152/ajpgi.00307.2002; Vinolo MAR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021205; Virgin HW, 2009, NAT IMMUNOL, V10, P461, DOI 10.1038/ni.1726; Waldecker M, 2008, J NUTR BIOCHEM, V19, P587, DOI 10.1016/j.jnutbio.2007.08.002; Walker LJ, 2012, BLOOD, V119, P422, DOI 10.1182/blood-2011-05-353789; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Wang YD, 2011, HEPATOLOGY, V54, P1421, DOI 10.1002/hep.24525; Wei B, 2010, J IMMUNOL, V184, P1218, DOI 10.4049/jimmunol.0902620; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; WHITT DD, 1975, APPL MICROBIOL, V30, P609, DOI 10.1128/AEM.30.4.609-615.1975; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Zimmerman MA, 2012, AM J PHYSIOL-GASTR L, V302, pG1405, DOI 10.1152/ajpgi.00543.2011	159	542	570	25	247	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2013	14	7					676	684		10.1038/ni.2640	http://dx.doi.org/10.1038/ni.2640			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	165UB	23778795	Green Accepted			2022-12-18	WOS:000320509100006
J	Binder, RJ; Han, DK; Srivastava, PK				Binder, RJ; Han, DK; Srivastava, PK			CD91: a receptor for heat shock protein gp96	NATURE IMMUNOLOGY			English	Article							ACTIVATOR INHIBITOR TYPE-1; ALPHA-2-MACROGLOBULIN RECEPTOR; GROWTH-FACTOR; IN-VIVO; PLASMINOGEN-ACTIVATOR; T-CELLS; ANTIGEN; PEPTIDES; COMPLEX; BINDING	Antigen presenting cells (APCs) can take up exogenous antigenic peptides chaperoned by heat shock protein gp96 and re-present them through the endogenous pathway on their major histocompatibility class I molecules. The high efficiency of this process has been attributed previously to a receptor for gp96 on APCs, The CD91 molecule (also called alpha(2)-macroglobulin receptor or the low density lipoprotein-related protein) is shown here to be a cell surface receptor for the heat shock protein gp96, CD91 binds gp96 directly, rather than through another ligand for CD91. The previously known CD91 ligand, alpha(2)-macroglobulin, inhibits re-presentation of gp96-chaperoned antigenic peptides by macrophages, as do antibodies to CD91. As gp96 is exclusively intracellular and is released as a result of necrotic but not apoptotic cell death, we propose that CD91 acts as a sensor for necrotic cell death.	Univ Connecticut, Sch Med, Ctr Immunotherapy Canc & Infect Dis, Farmington, CT 06030 USA; Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA	University of Connecticut; University of Washington; University of Washington Seattle	Srivastava, PK (corresponding author), Univ Connecticut, Sch Med, Ctr Immunotherapy Canc & Infect Dis, Farmington, CT 06030 USA.				NATIONAL CANCER INSTITUTE [R01CA084479, R01CA064394] Funding Source: NIH RePORTER; NCI NIH HHS [CA84479, CA64394] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARNOLD D, 1995, J EXP MED, V182, P885, DOI 10.1084/jem.182.3.885; Arnold-Schild D, 1999, J IMMUNOL, V162, P3757; BASU S, 2000, UNPUB INT IMMUNOL; BEVAN MJ, 1995, J EXP MED, V182, P639, DOI 10.1084/jem.182.3.639; BINDER RJ, 2000, IN PRESS J IMMUNOL; BINDER RJ, 2000, UNPUB J IMMUNOL; BINDER RJ, 1998, CELL STRESS CHAPERON, V3, P2; BLACHERE NE, 1997, J EXP MED, V186, P1183; Breloer M, 1998, EUR J IMMUNOL, V28, P1016, DOI 10.1002/(SICI)1521-4141(199803)28:03<1016::AID-IMMU1016>3.0.CO;2-G; DENNIS PA, 1989, J BIOL CHEM, V264, P7210; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Greenstone HL, 1998, P NATL ACAD SCI USA, V95, P1800, DOI 10.1073/pnas.95.4.1800; HILLIKER C, 1992, GENOMICS, V13, P472, DOI 10.1016/0888-7543(92)90276-X; Huang AYC, 1996, P NATL ACAD SCI USA, V93, P9730, DOI 10.1073/pnas.93.18.9730; HUANG JS, 1984, P NATL ACAD SCI-BIOL, V81, P342, DOI 10.1073/pnas.81.2.342; Ishii T, 1999, J IMMUNOL, V162, P1303; JENSEN PEH, 1989, BIOCHEM ARCH, V5, P171; KRISTENSEN T, 1990, FEBS LETT, V276, P151, DOI 10.1016/0014-5793(90)80530-V; MAKI RG, 1993, SOMAT CELL MOLEC GEN, V19, P73, DOI 10.1007/BF01233956; Matzinger P, 1998, SEMIN IMMUNOL, V10, P399, DOI 10.1006/smim.1998.0143; Menoret A, 1999, BIOCHEM BIOPH RES CO, V262, P813, DOI 10.1006/bbrc.1999.1306; NYKJAER A, 1992, J BIOL CHEM, V267, P14543; OCONNORMCCOURT MD, 1987, J BIOL CHEM, V262, P14090; ORTH K, 1992, P NATL ACAD SCI USA, V89, P7422, DOI 10.1073/pnas.89.16.7422; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; Singh-Jasuja H, 2000, J EXP MED, V191, P1965, DOI 10.1084/jem.191.11.1965; Srivastava PK, 1998, IMMUNITY, V8, P657, DOI 10.1016/S1074-7613(00)80570-1; SRIVASTAVA PK, 1986, P NATL ACAD SCI USA, V83, P3407, DOI 10.1073/pnas.83.10.3407; SRIVASTAVA PK, 1994, IMMUNOGENETICS, V39, P93; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; SUTO R, 1995, SCIENCE, V269, P1585, DOI 10.1126/science.7545313; Tamura Y, 1997, SCIENCE, V278, P117, DOI 10.1126/science.278.5335.117; UDONO H, 1994, P NATL ACAD SCI USA, V91, P3077, DOI 10.1073/pnas.91.8.3077; VANLEUVEN F, 1993, BIOCHIM BIOPHYS ACTA, V1173, P71, DOI 10.1016/0167-4781(93)90244-8; Wassenberg JJ, 1999, J CELL SCI, V112, P2167	35	542	586	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2000	1	2					151	155		10.1038/77835	http://dx.doi.org/10.1038/77835			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BW	11248808				2022-12-18	WOS:000089814900016
J	Misawa, T; Takahama, M; Kozaki, T; Lee, H; Zou, J; Saitoh, T; Akira, S				Misawa, Takuma; Takahama, Michihiro; Kozaki, Tatsuya; Lee, Hanna; Zou, Jian; Saitoh, Tatsuya; Akira, Shizuo			Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome	NATURE IMMUNOLOGY			English	Article							NALP3 INFLAMMASOME; CATHEPSIN-B; AUTOPHAGY; INHIBITORS; LYSOSOMES; IL-1-BETA; CRYSTALS; DYNAMICS; GOUT	NLRP3 forms an inflammasome with its adaptor ASC, and its excessive activation can cause inflammatory diseases. However, little is known about the mechanisms that control assembly of the inflammasome complex. Here we show that microtubules mediated assembly of the NLRP3 inflammasome. Inducers of the NLRP3 inflammasome caused aberrant mitochondrial homeostasis to diminish the concentration of the coenzyme NAD(+), which in turn inactivated the NAD(+)-dependent alpha-tubulin deacetylase sirtuin 2; this resulted in the accumulation of acetylated alpha-tubulin. Acetylated alpha-tubulin mediated the dynein-dependent transport of mitochondria and subsequent apposition of ASC on mitochondria to NLRP3 on the endoplasmic reticulum. Therefore, in addition to direct activation of NLRP3, the creation of optimal sites for signal transduction by microtubules is required for activation of the entire NLRP3 inflammasome.	[Misawa, Takuma; Takahama, Michihiro; Kozaki, Tatsuya; Lee, Hanna; Zou, Jian; Saitoh, Tatsuya; Akira, Shizuo] Osaka Univ, Host Def Lab, World Premier Int Res Ctr, Immunol Frontier Res Ctr, Osaka, Japan; [Misawa, Takuma; Takahama, Michihiro; Kozaki, Tatsuya; Lee, Hanna; Zou, Jian; Saitoh, Tatsuya; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Osaka, Japan	Osaka University; Osaka University	Saitoh, T (corresponding author), Osaka Univ, Host Def Lab, World Premier Int Res Ctr, Immunol Frontier Res Ctr, Osaka, Japan.	tatsuya@biken.osaka-u.ac.jp; sakira@biken.osaka-u.ac.jp	Akira, Shizuo/C-3134-2009	Takahama, Michihiro/0000-0003-0457-3669	Japan Society for the Promotion of Science; Japan Society for the Promotion of Science Funding Program for World-Leading Innovative R&D on Science and Technology 'FIRST Program'; Japan Science and Technology Agency Core Research for Evolutional Science and Technology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI070167] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science Funding Program for World-Leading Innovative R&D on Science and Technology 'FIRST Program'(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency Core Research for Evolutional Science and Technology(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. Kitamura (Tokyo University) for Plat-E packaging cells; H. Osada and T. Saito (RIKEN Natural Products Depository) for the authentic chemical compound library of the RIKEN Natural Products Depository; T. Yoshimori and K. Ikegami for critical reading of the manuscript; and members of the Laboratory of Host Defense for assistance. Supported by Japan Society for the Promotion of Science Grant-in-Aid for Specially Promoted Research (S. A.), Japan Society for the Promotion of Science Funding Program for World-Leading Innovative R&D on Science and Technology 'FIRST Program' (S. A.) and Japan Science and Technology Agency Core Research for Evolutional Science and Technology (T. S.).	Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; ALLEN JN, 1991, AM J PHYSIOL, V261, pL315, DOI 10.1152/ajplung.1991.261.4.L315; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Carta S, 2006, BLOOD, V108, P1618, DOI 10.1182/blood-2006-03-014126; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Cronstein BN, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1908; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; Friedman JR, 2010, J CELL BIOL, V190, P363, DOI 10.1083/jcb.200911024; Garcia-Marcos M, 2005, FEBS LETT, V579, P5407, DOI 10.1016/j.febslet.2005.08.074; Hentze H, 2003, CELL DEATH DIFFER, V10, P956, DOI 10.1038/sj.cdd.4401264; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Itakura E, 2012, J CELL SCI, V125, P1488, DOI 10.1242/jcs.094110; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376; Li Z., 2011, HEPATOLOGY, V47, P1495; Li ZZ, 2008, HEPATOLOGY, V47, P1495, DOI 10.1002/hep.22183; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; McGuire KA, 2011, J VIROL, V85, P10806, DOI 10.1128/JVI.00675-11; Naik E, 2011, J EXP MED, V208, P417, DOI 10.1084/jem.20110367; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Nunez G, 2011, IMMUNOL REV, V243, P5, DOI 10.1111/j.1600-065X.2011.01058.x; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Saitoh T, 2010, J CELL BIOL, V189, P925, DOI 10.1083/jcb.201002021; Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141; Sorbara MT, 2011, CELL RES, V21, P558, DOI 10.1038/cr.2011.20; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Tanaka A, 2010, FEBS LETT, V584, P1386, DOI 10.1016/j.febslet.2010.02.060; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Wloga D, 2010, J CELL SCI, V123, P3447, DOI 10.1242/jcs.063727; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	44	541	561	4	95	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2013	14	5					454	+		10.1038/ni.2550	http://dx.doi.org/10.1038/ni.2550			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	127XL	23502856				2022-12-18	WOS:000317732100010
J	Lee, JS; Cella, M; McDonald, KG; Garlanda, C; Kennedy, GD; Nukaya, M; Mantovani, A; Kopan, R; Bradfield, CA; Newberry, RD; Colonna, M				Lee, Jacob S.; Cella, Marina; McDonald, Keely G.; Garlanda, Cecilia; Kennedy, Gregory D.; Nukaya, Manabu; Mantovani, Alberto; Kopan, Raphael; Bradfield, Christopher A.; Newberry, Rodney D.; Colonna, Marco			AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch	NATURE IMMUNOLOGY			English	Article							ARYL-HYDROCARBON RECEPTOR; ROR-GAMMA-T; INTESTINAL HOMEOSTASIS; DIFFERENTIATION; INFLAMMATION; LIGAND; IL-22; MOUSE; IL-17; ACTIVATION	Innate lymphoid cells (ILCs) of the ILC22 type protect the intestinal mucosa from infection by secreting interleukin 22 (IL-22). ILC22 cells include NKp46(+) and lymphoid tissue-inducer (LTi)-like subsets that express the aryl hydrocarbon receptor (AHR). Here we found that Ahr(-/-) mice had a considerable deficit in ILC22 cells that resulted in less secretion of IL-22 and inadequate protection against intestinal bacterial infection. Ahr(-/-) mice also lacked postnatally 'imprinted' cryptopatches and isolated lymphoid follicles (ILFs), but not embryonically 'imprinted' Peyer's patches. AHR induced the transcription factor Notch, which was required for NKp46(+) ILCs, whereas LTi-like ILCs, cryptopatches and ILFs were partially dependent on Notch signaling. Thus, AHR was essential for ILC22 cells and postnatal intestinal lymphoid tissues. Moreover, ILC22 subsets were heterogeneous in their requirement for Notch and their effect on the generation of intestinal lymphoid tissues.	[Lee, Jacob S.; Cella, Marina; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [McDonald, Keely G.; Newberry, Rodney D.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Garlanda, Cecilia; Mantovani, Alberto] Inst Ricovero & Cura Carattere Sci, Ist Clin Humanitas, Lab Immunol & Inflammat, Rozzano, Italy; [Kennedy, Gregory D.; Nukaya, Manabu] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Madison, WI USA; [Mantovani, Alberto] Univ Milan, Dept Translat Med, Rozzano, Italy; [Kopan, Raphael] Washington Univ, Sch Med, Dept Dev Biol & Med, St Louis, MO USA; [Bradfield, Christopher A.] Univ Wisconsin, McArdle Lab Canc Res, Sch Med & Publ Hlth, Madison, WI 53706 USA	Washington University (WUSTL); Washington University (WUSTL); IRCCS Humanitas Research Hospital; University of Wisconsin System; University of Wisconsin Madison; University of Milan; Washington University (WUSTL); University of Wisconsin System; University of Wisconsin Madison	Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	mcolonna@pathology.wustl.edu	Cella, Marina/ABA-8564-2020; Kopan, Raphael/AFG-3275-2022; Kennedy, Gregory/S-2433-2016; Mantovani, Alberto/HCI-7449-2022; Kopan, Raphael/AAF-1357-2022; Garlanda, Cecilia/K-4601-2016	Kennedy, Gregory/0000-0002-5981-3917; Mantovani, Alberto/0000-0001-5578-236X; Garlanda, Cecilia/0000-0002-1510-7703; Nukaya, Manabu/0000-0002-6204-0978; Kopan, Raphael/0000-0002-0350-2730; Colonna, Marco/0000-0001-5222-4987; Newberry, Rodney/0000-0002-4152-5191; Cella, Marina/0000-0003-1230-1313	National Institute of Diabetes and Digestive and Kidney Disease [P30DK052574]; US National Institutes of Health (Kirschstein-National Research Service) [R01 DE021255-01, R01 DK064798]; National Institute of Allergy and Infectious Diseases Center for HIV/AIDS Vaccine Immunology [A1067854]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, R01DK064798, P30DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES005703, K08ES017283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055479] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); US National Institutes of Health (Kirschstein-National Research Service); National Institute of Allergy and Infectious Diseases Center for HIV/AIDS Vaccine Immunology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Gilfillan and P. Ahern for critical comments; R. D. Schreiber (Washington University), T. Honjo (Kyoto University) and A. Tumanov (Trudeau Institute) for mouse strains; J. Gordon (Washington University) for germ-free mice (funded by the National Institute of Diabetes and Digestive and Kidney Disease (Digestive Disease Research Core Center grant P30DK052574)); and D. O'Donnell and M. Karlsson for germ-free husbandry. Supported by the US National Institutes of Health (Kirschstein-National Research Service Award to J. S. L., R01 DE021255-01 to M.Co., and R01 DK064798 to R.D.N.) and the National Institute of Allergy and Infectious Diseases Center for HIV/AIDS Vaccine Immunology (A1067854 to M.Co.).	Alam MS, 2010, P NATL ACAD SCI USA, V107, P5943, DOI 10.1073/pnas.0911755107; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Asquith M, 2010, J EXP MED, V207, P1573, DOI 10.1084/jem.20101330; Boverhof DR, 2006, TOXICOL SCI, V94, P398, DOI 10.1093/toxsci/kfl100; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Dere E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-365; Eberl G, 2003, IMMUNOL REV, V195, P81, DOI 10.1034/j.1600-065X.2003.00074.x; Eberl G, 2009, MUCOSAL IMMUNOL, V2, P478, DOI 10.1038/mi.2009.114; Esser C, 2009, TRENDS IMMUNOL, V30, P447, DOI 10.1016/j.it.2009.06.005; Finke D, 2009, SEMIN IMMUNOPATHOL, V31, P151, DOI 10.1007/s00281-009-0163-6; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; Hand T, 2010, CURR OPIN IMMUNOL, V22, P63, DOI 10.1016/j.coi.2010.01.008; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Hughes T, 2010, IMMUNITY, V32, P803, DOI 10.1016/j.immuni.2010.06.007; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Keerthivasan S, 2011, J IMMUNOL, V187, P692, DOI 10.4049/jimmunol.1003658; Kerkvliet NI, 2009, BIOCHEM PHARMACOL, V77, P746, DOI 10.1016/j.bcp.2008.11.021; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Lugering A, 2010, CLIN EXP IMMUNOL, V160, P440, DOI 10.1111/j.1365-2249.2010.04103.x; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Mukherjee S, 2009, J IMMUNOL, V182, P7381, DOI 10.4049/jimmunol.0804322; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Nguyen NT, 2010, P NATL ACAD SCI USA, V107, P19961, DOI 10.1073/pnas.1014465107; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Ota N, 2011, NAT IMMUNOL, V12, P941, DOI 10.1038/ni.2089; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Quintana FJ, 2010, P NATL ACAD SCI USA, V107, P20768, DOI 10.1073/pnas.1009201107; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Satoh-Takayama N, 2010, J EXP MED, V207, P273, DOI 10.1084/jem.20092029; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Shibata K, 2011, BLOOD, V118, P586, DOI 10.1182/blood-2011-02-334995; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Stevens EA, 2009, IMMUNOLOGY, V127, P299, DOI 10.1111/j.1365-2567.2009.03054.x; Stockinger B, 2011, SEMIN IMMUNOL, V23, P99, DOI 10.1016/j.smim.2011.01.008; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Wang CH, 2008, J IMMUNOL, V181, P4052, DOI 10.4049/jimmunol.181.6.4052; Zenewicz LA, 2008, EUR J IMMUNOL, V38, P3265, DOI 10.1002/eji.200838655; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	50	539	556	1	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2012	13	2					144	U58		10.1038/ni.2187	http://dx.doi.org/10.1038/ni.2187			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	879FL	22101730	Green Accepted			2022-12-18	WOS:000299315000011
J	Dustin, ML; Cooper, JA				Dustin, ML; Cooper, JA			The immunological synapse and the actin cytoskeleton: molecular hardware for T cell signaling	NATURE IMMUNOLOGY			English	Review							ALDRICH-SYNDROME PROTEIN; PEPTIDE-MHC COMPLEXES; TYROSINE KINASE; ANTIGEN RECEPTOR; LYMPHOID-CELLS; LISTERIA-MONOCYTOGENES; ADHESION RECEPTORS; LEUKOCYTE ADHESION; ADP-RIBOSYLATION; SCAFFOLD PROTEIN	The actin cytoskeleton seems to play two critical roles in the activation of T cells. One of these roles is T cell shape development and movement, including formation of the immunological synapse. The other is the formation of a scaffold for signaling components. This review focuses on the recent convergence of cell biology and immunology studies to explain the role of the actin cytoskeleton in creating the molecular basis for immunological synapse formation and T cell signaling.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Dustin, ML (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid Ave, St Louis, MO 63110 USA.	dustin@immunology.wustl.edu	Cooper, John/E-9389-2012; Dustin, Michael/AAM-4611-2020; Cooper, John/D-4448-2014	Cooper, John/0000-0002-0933-4571; Dustin, Michael/0000-0003-4983-6389	NIGMS NIH HHS [R01 GM038542-12, R01 GM038542] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038542] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBRECHT DL, 1990, J IMMUNOL, V144, P3251; Angkachatchai V, 1999, J IMMUNOL, V163, P3819; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Borisy GG, 2000, CURR OPIN CELL BIOL, V12, P104, DOI 10.1016/S0955-0674(99)00063-0; BOURGUIGNON LYW, 1977, P NATL ACAD SCI USA, V74, P5031, DOI 10.1073/pnas.74.11.5031; BRAUN J, 1978, J CELL BIOL, V79, P409, DOI 10.1083/jcb.79.2.409; Bresnick AR, 1999, CURR OPIN CELL BIOL, V11, P26, DOI 10.1016/S0955-0674(99)80004-0; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Campbell JJ, 1996, J CELL BIOL, V134, P255, DOI 10.1083/jcb.134.1.255; CHAN AC, 1994, ANNU REV IMMUNOL, V12, P555, DOI 10.1146/annurev.iy.12.040194.003011; CHAN PY, 1992, MOL BIOL CELL, V3, P157, DOI 10.1091/mbc.3.2.157; CHANG TW, 1979, P NATL ACAD SCI USA, V76, P2917, DOI 10.1073/pnas.76.6.2917; Cherry RJ, 1998, J CELL BIOL, V140, P71, DOI 10.1083/jcb.140.1.71; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; CYSTER JG, 1991, EMBO J, V10, P893, DOI 10.1002/j.1460-2075.1991.tb08022.x; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; Delon J, 1998, EUR J IMMUNOL, V28, P716, DOI 10.1002/(SICI)1521-4141(199802)28:02<716::AID-IMMU716>3.0.CO;2-E; Delon J, 1998, IMMUNITY, V9, P467, DOI 10.1016/S1074-7613(00)80630-5; DIANZANI U, 1992, J IMMUNOL, V148, P678; Dustin ML, 1997, J BIOL CHEM, V272, P15782, DOI 10.1074/jbc.272.25.15782; Dustin ML, 1996, J IMMUNOL, V157, P2014; Dustin ML, 1996, J CELL BIOL, V132, P465, DOI 10.1083/jcb.132.3.465; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; ELSON EL, 1990, BIORHEOLOGY, V27, P849; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Felsenfeld DP, 1996, NATURE, V383, P438, DOI 10.1038/383438a0; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Frischknecht F, 1999, NATURE, V401, P926, DOI 10.1038/44860; FROLOV V A, 1985, Journal of Hygiene Epidemiology Microbiology and Immunology (Prague), V29, P185; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Harder T, 1999, EUR J IMMUNOL, V29, P556, DOI 10.1002/(SICI)1521-4141(199902)29:02<556::AID-IMMU556>3.0.CO;2-2; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Hwang ST, 1996, J EXP MED, V184, P1343, DOI 10.1084/jem.184.4.1343; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; KEANE MM, 1995, ONCOGENE, V10, P2367; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Krause M, 2000, J CELL BIOL, V149, P181, DOI 10.1083/jcb.149.1.181; KUCIK DF, 1991, J CELL BIOL, V114, P1029, DOI 10.1083/jcb.114.5.1029; Kucik DF, 1996, J CLIN INVEST, V97, P2139, DOI 10.1172/JCI118651; Lanzavecchia A, 1997, J EXP MED, V185, P1717, DOI 10.1084/jem.185.10.1717; Laudanna C, 1996, SCIENCE, V271, P981, DOI 10.1126/science.271.5251.981; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Lowin-Kropf B, 1998, J CELL BIOL, V140, P861, DOI 10.1083/jcb.140.4.861; Lub M, 1997, MOL BIOL CELL, V8, P341, DOI 10.1091/mbc.8.2.341; MARTZ E, 1987, HUM IMMUNOL, V18, P3, DOI 10.1016/0198-8859(87)90110-8; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; MUSTELIN T, 1995, EUR J IMMUNOL, V25, P942, DOI 10.1002/eji.1830250413; Nauert JB, 1997, CURR BIOL, V7, P52, DOI 10.1016/S0960-9822(06)00027-3; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; NERMUT MV, 1988, EMBO J, V7, P4093, DOI 10.1002/j.1460-2075.1988.tb03303.x; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Peternell M, 1999, COMPUT AIDED DESIGN, V31, P17, DOI 10.1016/S0010-4485(98)00077-3; Plas DR, 1996, SCIENCE, V272, P1173, DOI 10.1126/science.272.5265.1173; Raab M, 1997, IMMUNITY, V6, P155, DOI 10.1016/S1074-7613(00)80422-7; Ramesh N, 1997, P NATL ACAD SCI USA, V94, P14671, DOI 10.1073/pnas.94.26.14671; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; Sampath R, 1998, J BIOL CHEM, V273, P33588, DOI 10.1074/jbc.273.50.33588; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Sedwick CE, 1999, J IMMUNOL, V162, P1367; Serrador JM, 1998, BLOOD, V91, P4632, DOI 10.1182/blood.V91.12.4632.412k17_4632_4644; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; Snapper SB, 1999, ANNU REV IMMUNOL, V17, P905, DOI 10.1146/annurev.immunol.17.1.905; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; SPRINGER TA, 1995, ANNU REV PHYSIOL, V57, P827, DOI 10.1146/annurev.ph.57.030195.004143; STAUNTON DE, 1990, CELL, V61, P243, DOI 10.1016/0092-8674(90)90805-O; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; Stewart MP, 1996, J IMMUNOL, V156, P1810; Stewart MP, 1998, J CELL BIOL, V140, P699, DOI 10.1083/jcb.140.3.699; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; TOMINAGA T, 1993, J CELL BIOL, V120, P1529, DOI 10.1083/jcb.120.6.1529; UNANUE ER, 1972, J EXP MED, V136, P885, DOI 10.1084/jem.136.4.885; Underhill DM, 1999, J EXP MED, V190, P1909, DOI 10.1084/jem.190.12.1909; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Verkhovsky AB, 1999, BIOCHEM SOC SYMP, V65, P207; Verkhovsky AB, 1999, CURR BIOL, V9, P11, DOI 10.1016/S0960-9822(99)80042-6; Villalba M, 2000, IMMUNITY, V12, P151, DOI 10.1016/S1074-7613(00)80168-5; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; VONANDRIAN UH, 1995, CELL, V82, P989, DOI 10.1016/0092-8674(95)90278-3; Wang J, 1999, CELL, V97, P791, DOI 10.1016/S0092-8674(00)80790-4; Wardenburg JB, 1996, J BIOL CHEM, V271, P19641, DOI 10.1074/jbc.271.33.19641; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; Wei XB, 1999, P NATL ACAD SCI USA, V96, P8471, DOI 10.1073/pnas.96.15.8471; Welch MD, 1998, SCIENCE, V281, P105, DOI 10.1126/science.281.5373.105; Wild MK, 1999, J EXP MED, V190, P31, DOI 10.1084/jem.190.1.31; WILKINSON PC, 1986, IMMUNOLOGY, V57, P281; Wulfing C, 1998, P NATL ACAD SCI USA, V95, P6302, DOI 10.1073/pnas.95.11.6302; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	119	539	559	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2000	1	1					23	29		10.1038/76877	http://dx.doi.org/10.1038/76877			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BV	10881170				2022-12-18	WOS:000089814800009
J	Fife, BT; Pauken, KE; Eagar, TN; Obu, T; Wu, J; Tang, QZ; Azuma, M; Krummel, MF; Bluestone, JA				Fife, Brian T.; Pauken, Kristen E.; Eagar, Todd N.; Obu, Takashi; Wu, Jenny; Tang, Qizhi; Azuma, Miyuki; Krummel, Matthew F.; Bluestone, Jeffrey A.			Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal	NATURE IMMUNOLOGY			English	Article							T-CELL-ACTIVATION; NONOBESE DIABETIC MICE; LYMPH-NODES; IN-VIVO; DENDRITIC CELLS; NEGATIVE REGULATOR; PROGRAMMED DEATH-1; IMMUNE-SYSTEM; CTLA-4; EXPRESSION	Programmed death 1 (PD-1) is an inhibitory molecule expressed on activated T cells; however, the biological context in which PD-1 controls T cell tolerance remains unclear. Using two-photon laser-scanning microscopy, we show here that unlike naive or activated islet antigen-specific T cells, tolerized islet antigen-specific T cells moved freely and did not swarm around antigen-bearing dendritic cells (DCs) in pancreatic lymph nodes. Inhibition of T cell antigen receptor (TCR)-driven stop signals depended on continued interactions between PD-1 and its ligand, PD-L1, as antibody blockade of PD-1 or PD-L1 resulted in lower T cell motility, enhanced T cell-DC contacts and caused autoimmune diabetes. Blockade of the immunomodulatory receptor CTLA-4 did not alter T cell motility or abrogate tolerance. Thus, PD-1-PD-L1 interactions maintain peripheral tolerance by mechanisms fundamentally distinct from those of CTLA-4.	[Fife, Brian T.; Eagar, Todd N.; Wu, Jenny; Tang, Qizhi; Bluestone, Jeffrey A.] Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA 94143 USA; [Fife, Brian T.; Pauken, Kristen E.; Obu, Takashi] Univ Minnesota, Dept Med, Ctr Immunol, Minneapolis, MN 55455 USA; [Eagar, Todd N.] Univ Texas SW, Dept Neurol, Dallas, TX USA; [Tang, Qizhi] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Azuma, Miyuki] Tokyo Med & Dent Univ, Dept Mol Immunol, Tokyo, Japan; [Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA USA	University of California System; University of California San Francisco; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Francisco; Tokyo Medical & Dental University (TMDU); University of California System; University of California San Francisco	Fife, BT (corresponding author), Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA 94143 USA.	bfife@umn.edu	Fife, Brian T/D-2042-2013; Azuma, Miyuki/AAT-8928-2021; Pauken, Kristen E./ABA-9363-2020	Fife, Brian T/0000-0001-9826-5637; Azuma, Miyuki/0000-0002-3529-4585; Tang, Qizhi/0000-0001-7313-3574	LifeScan; US National Institutes of Health [AI35297, P30 DK63720]; Juvenile Diabetes Research Foundation [10-2006-799]; American Diabetes Association [7-09-JF-21]; University of Minnesota Medical School; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER	LifeScan; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); American Diabetes Association(American Diabetes Association); University of Minnesota Medical School; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Hara and G. Bell (University of Chicago) for C57BL/6 MIP.eGFP mice; M. Nussenzweig (Rockefeller University) for C57BL/6 CD11c-YFP mice; A. Sharpe (Harvard Medical School) for C57BL/6 PD-L1-deficient mice; C. Benoist and D. Mathis (Harvard Medical School) for NOD BDC2.5 TCR-transgenic mice; R. Locksley (University of California, San Francisco) for Yeti (IFN-gamma reporter) mice; N. Martenier for animal care; C. Allen, E. Finger, E. Peterson, R. Freidman, K. Hogquist, C. Penaranda and X. Zhou for scientific discussions; G. Szot and P. Koudria for islet transplantation; C. McArthur for cell sorting; and A. Bullen and M. Jenkins for multiphoton imaging support. Supported by LifeScan, the US National Institutes of Health (AI35297 to J. A. B., and P30 DK63720 for core support), the Juvenile Diabetes Research Foundation (10-2006-799 to B. T. F.), the American Diabetes Association (7-09-JF-21 to B. T. F.) and the University of Minnesota Medical School (B. T. F.).	Ansari MJI, 2003, J EXP MED, V198, P63, DOI 10.1084/jem.20022125; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Benvenuti F, 2004, J IMMUNOL, V172, P292, DOI 10.4049/jimmunol.172.1.292; Bousso P, 2004, IMMUNITY, V21, P349, DOI 10.1016/j.immuni.2004.08.005; Breart B, 2006, CURR OPIN IMMUNOL, V18, P483, DOI 10.1016/j.coi.2006.05.006; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Cahalan MD, 2002, NAT REV IMMUNOL, V2, P872, DOI 10.1038/nri935; Celli S, 2007, IMMUNITY, V27, P625, DOI 10.1016/j.immuni.2007.08.018; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Chikuma S, 2003, IMMUNOL RES, V28, P241, DOI 10.1385/IR:28:3:241; Chikuma S, 2003, J EXP MED, V197, P129, DOI 10.1084/jem.20021646; Downey J, 2008, IMMUNOL LETT, V115, P70, DOI 10.1016/j.imlet.2007.09.004; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; Fife BT, 2008, IMMUNOL REV, V224, P166, DOI 10.1111/j.1600-065X.2008.00662.x; Fife BT, 2006, J EXP MED, V203, P2737, DOI 10.1084/jem.20061577; Germain RN, 2006, NAT REV IMMUNOL, V6, P497, DOI 10.1038/nri1884; Hale MB, 2006, CURR OPIN MOL THER, V8, P215; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Hugues S, 2004, NAT IMMUNOL, V5, P1235, DOI 10.1038/ni1134; Hurez V, 2003, J EXP MED, V198, P123, DOI 10.1084/jem.20022230; Ishida M, 2002, IMMUNOL LETT, V84, P57, DOI 10.1016/S0165-2478(02)00142-6; Judkowski V, 2001, J IMMUNOL, V166, P908, DOI 10.4049/jimmunol.166.2.908; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; LENSCHOW DJ, 1995, TRANSPLANTATION, V60, P1171, DOI 10.1097/00007890-199511270-00019; Li W, 1996, SCIENCE, V271, P1272, DOI 10.1126/science.271.5253.1272; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Luhder F, 2000, P NATL ACAD SCI USA, V97, P12204, DOI 10.1073/pnas.200348397; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Morton AM, 2007, J IMMUNOL, V179, P8026, DOI 10.4049/jimmunol.179.12.8026; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Nishimura H, 1998, INT IMMUNOL, V10, P1563, DOI 10.1093/intimm/10.10.1563; Nishimura H, 1996, INT IMMUNOL, V8, P773, DOI 10.1093/intimm/8.5.773; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Schneider H, 2000, BIOCHEM BIOPH RES CO, V269, P279, DOI 10.1006/bbrc.2000.2234; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078; Scholer A, 2008, IMMUNITY, V28, P258, DOI 10.1016/j.immuni.2007.12.016; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; Szot GL, 2007, JOVE-J VIS EXP, V9, P404, DOI DOI 10.3791/404; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538; Zambricki E, 2006, AM J TRANSPLANT, V6, P2572, DOI 10.1111/j.1600-6143.2006.01517.x	50	538	578	4	78	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2009	10	11					1185	U70		10.1038/ni.1790	http://dx.doi.org/10.1038/ni.1790			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	508SO	19783989	Green Accepted, Green Submitted			2022-12-18	WOS:000270955900011
J	Brigl, M; Bry, L; Kent, SC; Gumperz, JE; Brenner, MB				Brigl, M; Bry, L; Kent, SC; Gumperz, JE; Brenner, MB			Mechanism of CD1d-restricted natural killer T cell activation during microbial infection	NATURE IMMUNOLOGY			English	Article							NKT CELLS; SALMONELLA-TYPHIMURIUM; ALPHA-GALACTOSYLCERAMIDE; VIRUS TYPE-1; MICE; RECOGNITION; CD1D; RECEPTOR; TCR; REQUIREMENTS	CD1d-restricted natural killer T (NKT) cells are important for host defense against a variety of microbial pathogens. How and when these T cells become activated physiologically during infection remains unknown. Our data support a model in which NKT cells use a unique activation mechanism not requiring their recognition of microbial antigens. Instead, weak responses to CD1d-presented self antigens were amplified by interleukin 12 made by dendritic cells in response to microbial products, resulting in potent interferon-gamma secretion. NKT cells were among the first lymphocytes to respond during Salmonella typhimurium infection, and their activation in vivo also depended on interleukin 12 and CD1d recognition. We propose this mechanism of activation as a major pathway responsible for the rapid activation of NKT cells in different microbial infections.	Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Brenner, MB (corresponding author), Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, 75 Francis St, Boston, MA 02115 USA.			Bry, Lynn/0000-0002-8792-8527	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048932, R37AI029873] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL071590] Funding Source: Medline; NIAID NIH HHS [R37AI29873, R01AI48932] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BALK SP, 1989, P NATL ACAD SCI USA, V86, P252, DOI 10.1073/pnas.86.1.252; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Carnaud C, 1999, J IMMUNOL, V163, P4647; Davodeau F, 1997, J IMMUNOL, V158, P5603; DEFRANCO AL, 1999, FUNDAMENTAL IMMUNOLO, P225; DELLABONA P, 1994, J EXP MED, V180, P1171, DOI 10.1084/jem.180.3.1171; Duthie MS, 2002, INFECT IMMUN, V70, P36, DOI 10.1128/IAI.70.1.36-48.2002; Eberl G, 1998, IMMUNITY, V9, P345, DOI 10.1016/S1074-7613(00)80617-2; Exley M, 1997, J EXP MED, V186, P109, DOI 10.1084/jem.186.1.109; Exley MA, 2001, J LEUKOCYTE BIOL, V69, P713; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; Grubor-Bauk B, 2003, J IMMUNOL, V170, P1430, DOI 10.4049/jimmunol.170.3.1430; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; Hamilton S., 1992, LIPID ANALYS PRACT A, P13; Ishigami M, 1999, HEPATOLOGY, V29, P1799, DOI 10.1002/hep.510290605; Johnson TR, 2002, J VIROL, V76, P4294, DOI 10.1128/JVI.76.9.4294-4303.2002; Kawakami K, 2001, INFECT IMMUN, V69, P213, DOI 10.1128/IAI.69.1.213-220.2001; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; LOZZIO BB, 1979, LEUKEMIA RES, V3, P363, DOI 10.1016/0145-2126(79)90033-X; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; McSorley SJ, 2002, IMMUNITY, V16, P365, DOI 10.1016/S1074-7613(02)00289-3; McSorley SJ, 2000, J IMMUNOL, V164, P986, DOI 10.4049/jimmunol.164.2.986; Medzhitov R, 2000, TRENDS MICROBIOL, V8, P452, DOI 10.1016/S0966-842X(00)01845-X; MICHETTI P, 1992, INFECT IMMUN, V60, P1786, DOI 10.1128/IAI.60.5.1786-1792.1992; Mittrucker HW, 2000, J LEUKOCYTE BIOL, V67, P457, DOI 10.1002/jlb.67.4.457; Moody DB, 2000, NATURE, V404, P884, DOI 10.1038/35009119; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; Nieuwenhuis EES, 2002, NAT MED, V8, P588, DOI 10.1038/nm0602-588; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Osman Y, 2000, EUR J IMMUNOL, V30, P1919, DOI 10.1002/1521-4141(200007)30:7<1919::AID-IMMU1919>3.0.CO;2-3; Park SH, 2000, EUR J IMMUNOL, V30, P620, DOI 10.1002/1521-4141(200002)30:2<620::AID-IMMU620>3.0.CO;2-4; SHIMIZU Y, 1989, J IMMUNOL, V142, P3320; Skold M, 2003, INFECT IMMUN, V71, P5447, DOI 10.1128/IAI.71.10.5447-5455.2003; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; van der Vliet HJJ, 2000, BLOOD, V95, P2440, DOI 10.1182/blood.V95.7.2440.007k35_2440_2442; Vincent MS, 2003, NAT IMMUNOL, V4, P517, DOI 10.1038/ni0603-517	41	538	556	0	14	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2003	4	12					1230	1237		10.1038/ni1002	http://dx.doi.org/10.1038/ni1002			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	746VZ	14578883				2022-12-18	WOS:000186769500017
J	Nauseef, WM; Borregaard, N				Nauseef, William M.; Borregaard, Niels			Neutrophils at work	NATURE IMMUNOLOGY			English	Review							CHRONIC GRANULOMATOUS-DISEASE; NADPH OXIDASE ACTIVATION; LEUKOCYTE ADHESION DEFICIENCIES; EXTRACELLULAR TRAP FORMATION; HEMATOPOIETIC STEM-CELLS; IN-VIVO; POLYMORPHONUCLEAR NEUTROPHILS; PROTON CHANNELS; DENDRITIC CELLS; BONE-MARROW	In this Review we discuss data demonstrating recently recognized aspects of neutrophil homeostasis in the steady state, granulopoiesis in 'emergency' conditions and interactions of neutrophils with the adaptive immune system. We explore in vivo observations of the recruitment of neutrophils from blood to tissues in models of blood-borne infections versus bacterial invasion through epithelial linings. We examine data on novel aspects of the activation of NADPH oxidase and the heterogeneity of phagosomes and, finally, consider the importance of two neutrophil-derived biological agents: neutrophil extracellular traps and ectosomes.	[Nauseef, William M.] Univ Iowa, Dept Med, Roy J & Lucille A Carver Coll Med, Inflammat Program, Iowa City, IA 52242 USA; [Nauseef, William M.] Vet Adm Med Ctr, Iowa City, IA USA; [Borregaard, Niels] Univ Copenhagen, Natl Univ Hosp, Dept Hematol, Granulocyte Res Lab, Copenhagen, Denmark	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Copenhagen	Nauseef, WM (corresponding author), Univ Iowa, Dept Med, Roy J & Lucille A Carver Coll Med, Inflammat Program, Iowa City, IA 52242 USA.	william-nauseef@uiowa.edu; borregaard@rh.dk		Nauseef, William/0000-0003-4032-757X	Danish Medical Research Council; US National Institutes of Health [AI070958, AI044642]; Merit Review program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044642, R01AI116546, R01AI070958, R56AI070958] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000513] Funding Source: NIH RePORTER	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merit Review program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	Supported by grants from The Danish Medical Research Council (N.B.), the US National Institutes of Health (AI070958 and AI044642 to W.M.N.), the Merit Review program and use of facilities at the Iowa City Department of Veterans Affairs Medical Center (the Nauseef laboratory).	A-Gonzalez N, 2009, IMMUNITY, V31, P245, DOI 10.1016/j.immuni.2009.06.018; Aiken ML, 2012, FREE RADICAL BIO MED, V53, P2308, DOI 10.1016/j.freeradbiomed.2012.10.542; Allingham MJ, 2007, J IMMUNOL, V179, P4053, DOI 10.4049/jimmunol.179.6.4053; Angelillo-Scherrer A, 2012, CIRC RES, V110, P356, DOI 10.1161/CIRCRESAHA.110.233403; ATHENS JW, 1961, J CLIN INVEST, V40, P989, DOI 10.1172/JCI104338; Autenrieth SE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002552; Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Beauvillain C, 2011, BLOOD, V117, P1196, DOI 10.1182/blood-2009-11-254490; Berna-Erro A, 2012, J CELL MOL MED, V16, P407, DOI 10.1111/j.1582-4934.2011.01395.x; Bianchi M, 2009, BLOOD, V114, P2619, DOI 10.1182/blood-2009-05-221606; BIERMAN HR, 1951, SCIENCE, V114, P276, DOI 10.1126/science.114.2959.276; BIERMAN HR, 1952, BLOOD, V7, P683, DOI 10.1182/blood.V7.7.683.683; Bissonnette SA, 2008, J BIOL CHEM, V283, P2108, DOI 10.1074/jbc.M706639200; Blomgran R, 2011, J IMMUNOL, V186, P7110, DOI 10.4049/jimmunol.1100001; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; BOXER LA, 1980, J CLIN INVEST, V66, P268, DOI 10.1172/JCI109853; BRIHEIM G, 1988, INFLAMMATION, V12, P141, DOI 10.1007/BF00916397; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Broermann A, 2011, J EXP MED, V208, P2393, DOI 10.1084/jem.20110525; Bugl S, 2013, BLOOD, V121, P723, DOI 10.1182/blood-2012-05-429589; Bugl S, 2012, ANN NY ACAD SCI, V1266, P171, DOI 10.1111/j.1749-6632.2012.06607.x; Campbell EL, 2014, IMMUNITY, V40, P66, DOI 10.1016/j.immuni.2013.11.020; Casanova-Acebes M, 2013, CELL, V153, P1025, DOI 10.1016/j.cell.2013.04.040; Christenson K, 2011, J LEUKOCYTE BIOL, V90, P1055, DOI 10.1189/jlb.0111051; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Conway KL, 2012, J IMMUNOL, V189, P3631, DOI 10.4049/jimmunol.1103746; Dalli J, 2008, BLOOD, V112, P2512, DOI 10.1182/blood-2008-02-140533; Dalli J, 2014, EMBO MOL MED, V6, P27, DOI 10.1002/emmm.201303503; Dalli J, 2013, MOL CELL PROTEOMICS, V12, P2205, DOI 10.1074/mcp.M113.028589; De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217; DeCoursey TE, 2003, NATURE, V422, P531, DOI 10.1038/nature01523; DeCoursey TE, 2013, PHYSIOL REV, V93, P599, DOI 10.1152/physrev.00011.2012; Dengler V, 2013, AM J RESP CELL MOL, V49, P1, DOI 10.1165/rcmb.2012-0472TR; Devi S, 2013, J EXP MED, V210, P2321, DOI 10.1084/jem.20130056; Dewitt S, 2003, J CELL SCI, V116, P2857, DOI 10.1242/jcs.00499; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Duffy D, 2012, IMMUNITY, V37, P917, DOI 10.1016/j.immuni.2012.07.015; Efron PA, 2004, J IMMUNOL, V173, P3035, DOI 10.4049/jimmunol.173.5.3035; Eken C, 2013, IMMUNOBIOLOGY, V218, P382, DOI 10.1016/j.imbio.2012.05.021; Eken C, 2010, J BIOL CHEM, V285, P39914, DOI 10.1074/jbc.M110.126748; El Chemaly A., 2014, J LEUKOC BIOL; El Chemaly A, 2010, J EXP MED, V207, P129, DOI 10.1084/jem.20091837; Ellson CD, 2001, NAT CELL BIOL, V3, P679, DOI 10.1038/35083076; Ellson C, 2006, EMBO J, V25, P4468, DOI 10.1038/sj.emboj.7601346; Ellson CD, 2006, J EXP MED, V203, P1927, DOI 10.1084/jem.20052069; Feske S, 2012, NAT REV IMMUNOL, V12, P532, DOI 10.1038/nri3233; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Gasser O, 2004, BLOOD, V104, P2543, DOI 10.1182/blood-2004-01-0361; Gasser O, 2003, EXP CELL RES, V285, P243, DOI 10.1016/S0014-4827(03)00055-7; Geng S, 2013, BLOOD, V121, P1690, DOI 10.1182/blood-2012-07-445197; Greenlee-Wacker MC, 2014, J IMMUNOL, V192, P4709, DOI 10.4049/jimmunol.1302692; Griffiths G, 2004, TRENDS CELL BIOL, V14, P343, DOI 10.1016/j.tcb.2004.05.010; Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI [10.1038/nchembio.496, 10.1038/NCHEMBIO.496]; HANEKE E, 1979, HUM GENET, V51, P1, DOI 10.1007/BF00278288; Hanna S, 2012, ANN NY ACAD SCI, V1250, P50, DOI 10.1111/j.1749-6632.2011.06389.x; Harris ES, 2013, CURR OPIN HEMATOL, V20, P16, DOI 10.1097/MOH.0b013e32835a0091; Hayes E, 2011, ARCH IMMUNOL THER EX, V59, P97, DOI 10.1007/s00005-011-0113-6; Hess C, 1999, J IMMUNOL, V163, P4564; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Hirai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054862; Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6; Holland SM, 2013, HEMATOL ONCOL CLIN N, V27, P89, DOI 10.1016/j.hoc.2012.11.002; Hopman RK, 2014, BLOOD REV, V28, P31, DOI 10.1016/j.blre.2014.01.001; Hyun YM, 2012, J EXP MED, V209, P1349, DOI 10.1084/jem.20111426; JACONI MEE, 1990, J CELL BIOL, V110, P1555, DOI 10.1083/jcb.110.5.1555; Jaeger BN, 2012, J EXP MED, V209, P565, DOI 10.1084/jem.20111908; Jankowski A, 1999, J BIOL CHEM, V274, P26098, DOI 10.1074/jbc.274.37.26098; Jenne CN, 2013, CELL HOST MICROBE, V13, P169, DOI 10.1016/j.chom.2013.01.005; Jiao JJ, 2014, J IMMUNOL, V192, P3374, DOI 10.4049/jimmunol.1300237; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Kaplan MJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4325; Kim MH, 2011, BLOOD, V117, P3343, DOI 10.1182/blood-2010-07-296970; Klebanoff SJ, 2013, J LEUKOCYTE BIOL, V93, P185, DOI 10.1189/jlb.0712349; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kreisel D, 2010, P NATL ACAD SCI USA, V107, P18073, DOI 10.1073/pnas.1008737107; KUHNS DB, 1995, J IMMUNOL, V154, P6556; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; LESLEY J, 1992, J EXP MED, V175, P257, DOI 10.1084/jem.175.1.257; LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Liu GQ, 2012, BLOOD, V120, P1942, DOI 10.1182/blood-2011-12-397430; MALAWISTA SE, 1982, J CELL BIOL, V95, P960, DOI 10.1083/jcb.95.3.960; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Manz MG, 2014, NAT REV IMMUNOL, V14, P302, DOI 10.1038/nri3660; Marks DJB, 2009, AM J GASTROENTEROL, V104, P117, DOI 10.1038/ajg.2008.72; Matsushima H, 2013, BLOOD, V121, P1677, DOI 10.1182/blood-2012-07-445189; Matute JD, 2009, BLOOD, V114, P3309, DOI 10.1182/blood-2009-07-231498; McDonald B, 2013, AM J PHYSIOL-GASTR L, V305, pG797, DOI 10.1152/ajpgi.00058.2013; McDonald B, 2012, CELL HOST MICROBE, V12, P324, DOI 10.1016/j.chom.2012.06.011; Menegazzi R, 2012, BLOOD, V119, P1214, DOI 10.1182/blood-2011-07-364604; Mesri M, 1999, J BIOL CHEM, V274, P23111, DOI 10.1074/jbc.274.33.23111; Metzler KD, 2011, BLOOD, V117, P953, DOI 10.1182/blood-2010-06-290171; Misselwitz B, 2012, SWISS MED WKLY, V141, DOI [10.4414/smw.2011.13324, 10.4414/smw.2012.13324]; Miyake Y, 2012, ADV EXP MED BIOL, V738, P144, DOI 10.1007/978-1-4614-1680-7_9; Moreland JG, 2006, J BIOL CHEM, V281, P12277, DOI 10.1074/jbc.M511030200; Moriceau S, 2010, J INNATE IMMUN, V2, P260, DOI 10.1159/000295791; Muller I, 2009, TRENDS IMMUNOL, V30, P522, DOI 10.1016/j.it.2009.07.007; Nauseef WM, 2008, J BIOL CHEM, V283, P16961, DOI 10.1074/jbc.R700045200; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; Nunes P, 2012, CURR BIOL, V22, P1990, DOI 10.1016/j.cub.2012.08.049; Odobasic D, 2013, BLOOD, V121, P4195, DOI 10.1182/blood-2012-09-456483; Okochi Y, 2009, BIOCHEM BIOPH RES CO, V382, P274, DOI 10.1016/j.bbrc.2009.03.036; Painter RG, 2006, BIOCHEMISTRY-US, V45, P10260, DOI 10.1021/bi060490t; Painter RG, 2010, J LEUKOCYTE BIOL, V87, P933, DOI 10.1189/jlb.1009655; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Parker H, 2012, J LEUKOCYTE BIOL, V91, P369, DOI 10.1189/jlb.0711387; PETERS JH, 1993, ADV EXP MED BIOL, V329, P275; Petheo GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014081; Pillay J, 2012, J CLIN INVEST, V122, P327, DOI 10.1172/JCI57990; Pliyev BK, 2014, CYTOKINE, V65, P126, DOI 10.1016/j.cyto.2013.11.010; Pluskota E, 2008, BLOOD, V112, P2327, DOI 10.1182/blood-2007-12-127183; Proebstl D, 2012, J EXP MED, V209, P1219, DOI 10.1084/jem.20111622; Puga I, 2012, NAT IMMUNOL, V13, P170, DOI 10.1038/ni.2194; Ramachandran V, 2004, P NATL ACAD SCI USA, V101, P13519, DOI 10.1073/pnas.0403608101; Ramsey IS, 2009, P NATL ACAD SCI USA, V106, P7642, DOI 10.1073/pnas.0902761106; Roller J, 2013, INFLAMM RES, V62, P275, DOI 10.1007/s00011-012-0575-y; ROOS D, 1983, J CELL BIOL, V97, P368, DOI 10.1083/jcb.97.2.368; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Rossaint J, 2014, BLOOD, V123, P2573, DOI 10.1182/blood-2013-07-516484; Rossaint J, 2013, J INNATE IMMUN, V5, P348, DOI 10.1159/000345943; Sadallah S, 2011, CLIN EXP IMMUNOL, V163, P26, DOI 10.1111/j.1365-2249.2010.04271.x; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Saitoh T, 2012, CELL HOST MICROBE, V12, P109, DOI 10.1016/j.chom.2012.05.015; Sangaletti S, 2012, BLOOD, V120, P3007, DOI 10.1182/blood-2012-03-416156; Sapey E, 2014, BLOOD, V123, P239, DOI 10.1182/blood-2013-08-519520; SAWYER DW, 1985, SCIENCE, V230, P663, DOI 10.1126/science.4048951; Scheiermann C, 2012, IMMUNITY, V37, P290, DOI 10.1016/j.immuni.2012.05.021; Schiwon M, 2014, CELL, V156, P456, DOI 10.1016/j.cell.2014.01.006; Schlam D, 2013, J BIOL CHEM, V288, P23090, DOI 10.1074/jbc.M113.457606; Schramm R, 2004, INFLAMM RES, V53, P644, DOI 10.1007/s00011-004-1307-8; Schwartz J, 2009, J IMMUNOL, V183, P2632, DOI 10.4049/jimmunol.0804110; Stark K, 2013, NAT IMMUNOL, V14, P41, DOI 10.1038/ni.2477; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Stasia MJ, 2013, EUR J HUM GENET, V21, P1079, DOI 10.1038/ejhg.2012.310; Steinckwich N, 2011, J IMMUNOL, V186, P2182, DOI 10.4049/jimmunol.1001338; Strydom N, 2013, J INNATE IMMUN, V5, P304, DOI 10.1159/000350282; Sun YT, 2012, J PHYSIOL-LONDON, V590, P3231, DOI 10.1113/jphysiol.2011.225300; Sundd P, 2012, NATURE, V488, P399, DOI 10.1038/nature11248; Theilgaard-Monch K, 2004, J IMMUNOL, V172, P7684, DOI 10.4049/jimmunol.172.12.7684; Timar CI, 2013, BLOOD, V121, P510, DOI 10.1182/blood-2012-05-431114; Tittel AP, 2012, NAT METHODS, V9, P385, DOI [10.1038/NMETH.1905, 10.1038/nmeth.1905]; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; van de Vijver E, 2013, HEMATOL ONCOL CLIN N, V27, P101, DOI 10.1016/j.hoc.2012.10.001; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; VOETMAN AA, 1981, J CLIN INVEST, V67, P1541, DOI 10.1172/JCI110185; von Vietinghoff S, 2009, J IMMUNOL, V183, P865, DOI 10.4049/jimmunol.0804080; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Watanabe JJ, 2003, J BIOL CHEM, V278, P33161, DOI 10.1074/jbc.M305321200; Weisel KC, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/790174; WIENTJES FB, 1993, BIOCHEM J, V296, P557, DOI 10.1042/bj2960557; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003; Woodfin A, 2011, NAT IMMUNOL, V12, P761, DOI 10.1038/ni.2062; Woodfin A, 2010, CURR OPIN HEMATOL, V17, P9, DOI 10.1097/MOH.0b013e3283333930; Yang CW, 2013, J EXP MED, V210, P375, DOI 10.1084/jem.20122183; Yang CW, 2010, J IMMUNOL, V185, P2927, DOI 10.4049/jimmunol.1001289; Yipp BG, 2013, BLOOD, V122, P2784, DOI 10.1182/blood-2013-04-457671; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847; Yoshioka Y, 2013, ARTHRITIS RHEUM-US, V65, P1160, DOI 10.1002/art.37861; Zandman-Goddard G, 2005, AUTOIMMUNITY, V38, P473, DOI 10.1080/08916930500285352; Zhang H, 2014, BLOOD, V123, P2238, DOI 10.1182/blood-2012-08-450403; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200	162	537	556	8	143	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2014	15	7					602	611		10.1038/ni.2921	http://dx.doi.org/10.1038/ni.2921			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AJ5IJ	24940954	Bronze			2022-12-18	WOS:000337715600006
J	Fernandes-Alnemri, T; Yu, JW; Juliana, C; Solorzano, L; Kang, S; Wu, JH; Datta, P; McCormick, M; Huang, L; McDermott, E; Eisenlohr, L; Landel, CP; Alnemri, ES				Fernandes-Alnemri, Teresa; Yu, Je-Wook; Juliana, Christine; Solorzano, Leobaldo; Kang, Seokwon; Wu, Jianghong; Datta, Pinaki; McCormick, Margaret; Huang, Lan; McDermott, Erin; Eisenlohr, Laurence; Landel, Carlisle P.; Alnemri, Emad S.			The AIM2 inflammasome is critical for innate immunity to Francisella tularensis	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; PATHOGEN RECOGNITION; NALP3 INFLAMMASOME; PHAGOSOMAL ESCAPE; ASC PYROPTOSOME; CYTOPLASMIC DNA; CELL-DEATH; ACTIVATION; CASPASE-1; PYRIN	Francisella tularensis, the causative agent of tularemia, infects host macrophages, which triggers production of the proinflammatory cytokines interleukin 1 beta (IL-1 beta) and IL-18. We elucidate here how host macrophages recognize F. tularensis and elicit this proinflammatory response. Using mice deficient in the DNA-sensing inflammasome component AIM2, we demonstrate here that AIM2 is required for sensing F. tularensis. AIM2-deficient mice were extremely susceptible to F. tularensis infection, with greater mortality and bacterial burden than that of wild-type mice. Caspase-1 activation, IL-1 beta secretion and cell death were absent in Aim2(-/-) macrophages in response to F. tularensis infection or the presence of cytoplasmic DNA. Our study identifies AIM2 as a crucial sensor of F. tularensis infection and provides genetic proof of its critical role in host innate immunity to intracellular pathogens.	[Fernandes-Alnemri, Teresa; Yu, Je-Wook; Juliana, Christine; Solorzano, Leobaldo; Kang, Seokwon; Wu, Jianghong; Datta, Pinaki; McCormick, Margaret; Alnemri, Emad S.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Huang, Lan; McDermott, Erin; Eisenlohr, Laurence; Landel, Carlisle P.] Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; [Fernandes-Alnemri, Teresa; Yu, Je-Wook; Juliana, Christine; Solorzano, Leobaldo; Kang, Seokwon; Wu, Jianghong; Datta, Pinaki; McCormick, Margaret; Huang, Lan; McDermott, Erin; Eisenlohr, Laurence; Landel, Carlisle P.; Alnemri, Emad S.] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University; Jefferson University	Alnemri, ES (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.	ealnemri@mail.jci.tju.edu	Alnemri, Emad S/B-4526-2010	Yu, Je-Wook/0000-0001-5943-4071; Juliana, Christine/0000-0002-4314-1407	National Institutes of Health [AG14357, AR055398, T32-CA09678]; NATIONAL CANCER INSTITUTE [T32CA009678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014357] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank D. L. Kastner (National Institutes of Health) for pyrin-deficient mice; J. Sagara (Shinshu University) for antibody to mouse ASC; J. Yuan (Harvard University) for antibody to mouse caspase-1; G. Nunez (University of Michigan) for S. typhimurium; D. M. Monack (Stanford University) for wild-type F. tularensis; K. Fitzgerald (University of Massachusetts) for immortalized Ifnar1-/-and Irf3-/mouse bone marrow macrophages; and M. Covarrubias for technical assistance with confocal microscopy. Supported by the National Institutes of Health (AG14357 and AR055398 to E. S. A., and T32-CA09678 to L. S.).	Abplanalp AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007920; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Araki M, 2009, CURR PHARM BIOTECHNO, V10, P221, DOI 10.2174/138920109787315006; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bidani A, 2000, LUNG, V178, P91, DOI 10.1007/s004080000012; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Brodsky IE, 2009, SEMIN IMMUNOL, V21, P199, DOI 10.1016/j.smim.2009.05.007; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Chae JJ, 2006, P NATL ACAD SCI USA, V103, P9982, DOI 10.1073/pnas.0602081103; Chae JJ, 2003, MOL CELL, V11, P591, DOI 10.1016/S1097-2765(03)00056-X; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Chong A, 2008, INFECT IMMUN, V76, P5488, DOI 10.1128/IAI.00682-08; Clemens DL, 2009, INFECT IMMUN, V77, P1757, DOI 10.1128/IAI.01485-08; Clemens DL, 2004, INFECT IMMUN, V72, P3204, DOI 10.1128/IAI.72.6.3204-3217.2004; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2008, METHOD ENZYMOL, V442, P251, DOI [10.1016/S0076-6S79(08)01413-4, 10.1016/S0076-6879(08)01413-4]; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Frankenberg T, 2008, EUR J IMMUNOL, V38, P204, DOI 10.1002/eji.200737379; Gavrilin MA, 2009, J IMMUNOL, V182, P7982, DOI 10.4049/jimmunol.0803073; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Henry T, 2007, CELL MICROBIOL, V9, P2543, DOI 10.1111/j.1462-5822.2007.01022.x; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Juliana C, 2010, J BIOL CHEM, V285, P9792, DOI 10.1074/jbc.M109.082305; Katz J, 2006, INFECT IMMUN, V74, P2809, DOI 10.1128/IAI.74.5.2809-2816.2006; Kumar H, 2009, BIOCHEM J, V420, P1, DOI 10.1042/BJ20090272; Malik M, 2006, INFECT IMMUN, V74, P3657, DOI 10.1128/IAI.02030-05; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Papin S, 2007, CELL DEATH DIFFER, V14, P1457, DOI 10.1038/sj.cdd.4402142; Ray K, 2009, NAT REV MICROBIOL, V7, P333, DOI 10.1038/nrmicro2112; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Santic M, 2005, CELL MICROBIOL, V7, P969, DOI 10.1111/j.1462-5822.2005.00526.x; Santic M, 2008, INFECT IMMUN, V76, P2671, DOI 10.1128/IAI.00185-08; Skarnes WC, 2004, NAT GENET, V36, P543, DOI 10.1038/ng0604-543; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Yu JW, 2007, MOL CELL, V28, P214, DOI 10.1016/j.molcel.2007.08.029; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734	45	536	561	2	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2010	11	5					385	394		10.1038/ni.1859	http://dx.doi.org/10.1038/ni.1859			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	585TN	20351693	Green Accepted, Green Submitted			2022-12-18	WOS:000276852200007
J	Zheng, Y; Rudensky, AY				Zheng, Ye; Rudensky, Alexander Y.			Foxp3 in control of the regulatory T cell lineage	NATURE IMMUNOLOGY			English	Review							TRANSCRIPTION FACTOR FOXP3; NF-KAPPA-B; HELPER-CELLS; TARGET GENES; EXPRESSION; SCURFY; MOUSE; SELF; MICE; DIFFERENTIATION	Foxp3, an X chromosome-encoded forkhead transcription factor family member, is indispensable for the differentiation of regulatory T cells. These cells have a vital role in preventing autoimmunity and pathology inflicted by uncontrolled immune responses to infections. Deficiency or mutation in Foxp3 in humans and mice leads to an early onset, highly aggressive and fatal autoimmune disease affecting various tissues. Here, we review recent advances in our understanding of the Foxp3-dependent molecular and functional program and the role of Foxp3 in regulatory T cell biology.	Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Rudensky, AY (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	aruden@u.washington.edu	Zheng, Ye/G-4866-2015	Zheng, Ye/0000-0001-5012-4309				Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Bochtler P, 2006, J IMMUNOL, V177, P8307, DOI 10.4049/jimmunol.177.12.8307; Bosco N, 2006, J IMMUNOL, V177, P5014, DOI 10.4049/jimmunol.177.8.5014; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chang X, 2005, J EXP MED, V202, P1141, DOI 10.1084/jem.20050157; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Chen CX, 2006, J BIOL CHEM, V281, P36828, DOI 10.1074/jbc.M608848200; Chen ZB, 2005, J EXP MED, V202, P1387, DOI 10.1084/jem.20051409; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; GODFREY VL, 1994, AM J PATHOL, V145, P281; Grant C, 2006, PLOS PATHOG, V2, P303, DOI 10.1371/journal.ppat.0020033; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim C, 2006, J HIGH ENERGY PHYS; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; LISTON A, IN PRESS J EXP MED; LISTON A, IN PRESS CURR OPIN I; Lopes JE, 2006, J IMMUNOL, V177, P3133, DOI 10.4049/jimmunol.177.5.3133; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; Pennington DJ, 2006, NATURE, V444, P1073, DOI 10.1038/nature06051; Ramsdell F, 2003, IMMUNITY, V19, P165, DOI 10.1016/S1074-7613(03)00207-3; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	48	535	574	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2007	8	5					457	462		10.1038/ni1455	http://dx.doi.org/10.1038/ni1455			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	158YM	17440451				2022-12-18	WOS:000245831600006
J	Sanchez-Fueyo, A; Tian, J; Picarella, D; Domenig, C; Zheng, XX; Sabatos, CA; Manlongat, N; Bender, O; Kamradt, T; Kuchroo, VK; Gutierrez-Ramos, JC; Coyle, AJ; Strom, TB				Sanchez-Fueyo, A; Tian, J; Picarella, D; Domenig, C; Zheng, XX; Sabatos, CA; Manlongat, N; Bender, O; Kamradt, T; Kuchroo, VK; Gutierrez-Ramos, JC; Coyle, AJ; Strom, TB			Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance	NATURE IMMUNOLOGY			English	Article							DONOR-SPECIFIC TRANSFUSION; COSTIMULATORY PATHWAYS; ISLET ALLOGRAFTS; B-CELLS; CD4(+)CD25(+); INDUCTION; MICE; SUPPRESSION; ACTIVATION; MECHANISMS	Although T helper (T-H) cell-mediated immunity is required to effectively eliminate pathogens, unrestrained T-H activity also contributes to tissue injury in many inflammatory and autoimmune diseases. We report here that the T-H type 1 (T(H)1)-specific Tim-3 (T cell immunoglobulin domain, mucin domain) protein functions to inhibit aggressive T(H)1-mediated auto- and alloimmune responses. Tim-3 pathway blockade accelerated diabetes in nonobese diabetic mice and prevented acquisition of transplantation tolerance induced by costimulation blockade. These effects were mediated, at least in part, by dampening of the antigen-specific immunosuppressive function of CD4(+) CD25(+) regulatory T cell populations. Our data indicate that the Tim-3 pathway provides an important mechanism to down-regulate T(H)1-dependent immune responses and to facilitate the development of immunological tolerance.	Millennium Pharmaceut Inc, Div Expt Med, Inflammat Dept, Cambridge, MA 02116 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Immunol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02215 USA; Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Dept Haematol,Div Investigat Sci, London W12 0NN, England; Deutsch Rheumaforsch Zentrum, D-10117 Berlin, Germany	Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Imperial College London; Deutsches Rheuma-Forschungszentrum (DRFZ)	Strom, TB (corresponding author), Millennium Pharmaceut Inc, Div Expt Med, Inflammat Dept, Cambridge, MA 02116 USA.	tstrom@bidmc.harvard.edu	Strom, Terry B./E-9268-2010; Kamradt, Thomas/E-9971-2018	Strom, Terry B./0000-0002-7570-0736; Domenig, Christoph/0000-0001-5240-5331; Kamradt, Thomas/0000-0001-8443-5893				ANDERSON GP, 1994, TRENDS PHARMACOL SCI, V15, P324, DOI 10.1016/0165-6147(94)90027-2; AV AM, 2002, J IMMUNOL, V169, P5401; BUHLMANN JE, 1995, IMMUNITY, V2, P645; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; CHRISTIANSON SW, 1993, DIABETES, V42, P44, DOI 10.2337/diabetes.42.1.44; Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X; DEKRUYFF RH, 1992, J IMMUNOL, V149, P3468; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; Foy TM, 1996, ANNU REV IMMUNOL, V14, P591, DOI 10.1146/annurev.immunol.14.1.591; Graca L, 2002, J IMMUNOL, V168, P5558, DOI 10.4049/jimmunol.168.11.5558; Hollander GA, 1996, P NATL ACAD SCI USA, V93, P4994, DOI 10.1073/pnas.93.10.4994; Iwakoshi NN, 2000, J IMMUNOL, V164, P512, DOI 10.4049/jimmunol.164.1.512; Judge TA, 1996, J IMMUNOL, V156, P2294; Kamradt T, 2001, NEW ENGL J MED, V344, P655, DOI 10.1056/NEJM200103013440907; Kingsley CI, 2002, J IMMUNOL, V168, P1080, DOI 10.4049/jimmunol.168.3.1080; Kishimoto K, 2000, J CLIN INVEST, V106, P63, DOI 10.1172/JCI9586; Kuchroo VK, 2003, NAT REV IMMUNOL, V3, P454, DOI 10.1038/nri1111; Kundig TM, 1996, IMMUNITY, V5, P41, DOI 10.1016/S1074-7613(00)80308-8; Lee RS, 2001, J IMMUNOL, V166, P1572, DOI 10.4049/jimmunol.166.3.1572; Li XC, 1998, J IMMUNOL, V161, P2241; Li XC, 1998, J IMMUNOL, V161, P890; Li YS, 1999, NAT MED, V5, P1298, DOI 10.1038/15256; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Martin E, 2003, IMMUNITY, V18, P155, DOI 10.1016/S1074-7613(02)00503-4; McIntire JJ, 2001, NAT IMMUNOL, V2, P1109, DOI 10.1038/ni739; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; PARKER DC, 1995, P NATL ACAD SCI USA, V92, P9560, DOI 10.1073/pnas.92.21.9560; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Quezada SA, 2003, BLOOD, V102, P1920, DOI 10.1182/blood-2003-02-0586; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; ROMAGNANI S, 1994, ANNU REV IMMUNOL, V12, P227, DOI 10.1146/annurev.iy.12.040194.001303; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; SAKAGUCHI S, 1990, J EXP MED, V172, P537, DOI 10.1084/jem.172.2.537; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Sanchez-Fueyo A, 2002, J IMMUNOL, V168, P2274, DOI 10.4049/jimmunol.168.5.2274; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Sho M, 2002, J IMMUNOL, V169, P3744, DOI 10.4049/jimmunol.169.7.3744; STEIGER J, 1995, J IMMUNOL, V155, P489; Strom TB, 1996, CURR OPIN IMMUNOL, V8, P688, DOI 10.1016/S0952-7915(96)80087-2; Waaga AM, 2001, J CLIN INVEST, V107, P909, DOI 10.1172/JCI11427; Walker LSK, 2003, J EXP MED, V198, P249, DOI 10.1084/jem.20030315; Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Yamazaki S, 2003, J EXP MED, V198, P235, DOI 10.1084/jem.20030422; Yoon JW, 1999, SCIENCE, V284, P1183, DOI 10.1126/science.284.5417.1183; Zheng XX, 1999, J IMMUNOL, V162, P4983	48	535	602	2	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2003	4	11					1093	1101		10.1038/ni987	http://dx.doi.org/10.1038/ni987			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	737PN	14556005				2022-12-18	WOS:000186241100013
J	Yokosuka, T; Sakata-Sogawa, K; Kobayashi, W; Hiroshima, M; Hashimoto-Tane, A; Tokunaga, M; Dustin, ML; Saito, T				Yokosuka, T; Sakata-Sogawa, K; Kobayashi, W; Hiroshima, M; Hashimoto-Tane, A; Tokunaga, M; Dustin, ML; Saito, T			Newly generated T cell receptor microclusters initiate and sustain T cell activation by recruitment of Zap70 and SLP-76	NATURE IMMUNOLOGY			English	Article							INTERNAL-REFLECTION FLUORESCENCE; IMMUNOLOGICAL SYNAPSE FORMATION; ACTIN CYTOSKELETON; SIGNALING PROTEINS; RECOGNITION; TCR; RESPONSES; COSTIMULATION; POLARIZATION; LIGATION	T cell receptor (TCR) activation and signaling precede immunological synapse formation and are sustained for hours after initiation. However, the precise physical sites of the initial and sustained TCR signaling are not definitively known. We report here that T cell activation was initiated and sustained in TCR-containing microclusters generated at the initial contact sites and the periphery of the mature immunological synapse. Microclusters containing TCRs, the tyrosine kinase Zap70 and the adaptor molecule SLP-76 were continuously generated at the periphery. TCR microclusters migrated toward the central supramolecular cluster, whereas Zap70 and SLP-76 dissociated from these microclusters before the microclusters coalesced with the TCR-rich central supramolecular cluster. Tyrosine phosphorylation and calcium influx were induced as microclusters formed at the initial contact sites. Inhibition of signaling prevented recruitment of Zap70 into the microclusters. These results indicated that TCR-rich microclusters initiate and sustain TCR signaling.	RIKEN, Ctr Allergy & Immunol, Lab Cell Signalling, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; RIKEN, Ctr Allergy & Immunol, Single Mol Immunoimaging, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Grad Univ Adv Studies, Struct Biol Ctr, Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; Grad Univ Adv Studies, Dept Genet, Mishima, Shizuoka 4118540, Japan; NYU, Sch Med, Skirball Inst Biomol Med, Program Mol Pathogenesis, New York, NY 10021 USA; NYU, Sch Med, Dept Pathol, Program Mol Pathogenesis, New York, NY 10021 USA	RIKEN; RIKEN; Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; New York University; New York University	Saito, T (corresponding author), RIKEN, Ctr Allergy & Immunol, Lab Cell Signalling, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan.	saito@rcai.riken.jp	Dustin, Michael/AAM-4611-2020; Saito, Takashi/C-9684-2009	Saito, Takashi/0000-0001-9495-3547; Tokunaga, Makio/0000-0003-4586-8922; Hashimoto-Tane, Akiko/0000-0001-8519-266X; Dustin, Michael/0000-0003-4983-6389	NIAID NIH HHS [AI044931, AI043542] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI043542, R01AI044931, R01AI043542, R56AI044931] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allenspach EJ, 2001, IMMUNITY, V15, P739, DOI 10.1016/S1074-7613(01)00224-2; AXELROD D, 1981, J CELL BIOL, V89, P141, DOI 10.1083/jcb.89.1.141; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Blanchard N, 2002, IMMUNITY, V17, P389, DOI 10.1016/S1074-7613(02)00421-1; Brossard C, 2005, EUR J IMMUNOL, V35, P1741, DOI 10.1002/eji.200425857; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; Davis SJ, 2001, CURR BIOL, V11, pR289, DOI 10.1016/S0960-9822(01)00165-8; Delon J, 2001, IMMUNITY, V15, P691, DOI 10.1016/S1074-7613(01)00231-X; Delon J, 2000, CURR BIOL, V10, pR923, DOI 10.1016/S0960-9822(00)00870-8; Depoil D, 2005, IMMUNITY, V22, P185, DOI 10.1016/j.immuni.2004.12.010; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Dustin ML, 2004, IMMUNITY, V21, P305, DOI 10.1016/j.immuni.2004.08.016; Dustin ML, 1999, SCIENCE, V283, P649, DOI 10.1126/science.283.5402.649; Faroudi M, 2003, J IMMUNOL, V171, P1128, DOI 10.4049/jimmunol.171.3.1128; Freiberg BA, 2002, NAT IMMUNOL, V3, P911, DOI 10.1038/ni836; Gelkop S, 1999, J BIOL CHEM, V274, P21519, DOI 10.1074/jbc.274.31.21519; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Griffiths EK, 2002, CURR OPIN IMMUNOL, V14, P317, DOI 10.1016/S0952-7915(02)00334-5; Hailman E, 2002, IMMUNITY, V16, P839, DOI 10.1016/S1074-7613(02)00326-6; Harriague J, 2002, NAT IMMUNOL, V3, P1090, DOI 10.1038/ni847; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Krause M, 2000, J CELL BIOL, V149, P181, DOI 10.1083/jcb.149.1.181; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Krummel MF, 2002, CURR OPIN IMMUNOL, V14, P66, DOI 10.1016/S0952-7915(01)00299-0; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Maldonado RA, 2004, NATURE, V431, P527, DOI 10.1038/nature02916; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Purtic B, 2005, P NATL ACAD SCI USA, V102, P2904, DOI 10.1073/pnas.0406867102; Sasahara Y, 2002, MOL CELL, V10, P1269, DOI 10.1016/S1097-2765(02)00728-1; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Tokunaga M, 1997, BIOCHEM BIOPH RES CO, V235, P47, DOI 10.1006/bbrc.1997.6732; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; van Stipdonk MJB, 2003, NAT IMMUNOL, V4, P361, DOI 10.1038/ni912; Vicente-Manzanares M, 2004, NAT REV IMMUNOL, V4, P110, DOI 10.1038/nri1268; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741; Zeng R, 2003, J IMMUNOL, V171, P1360, DOI 10.4049/jimmunol.171.3.1360	45	534	548	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2005	6	12					1253	1262		10.1038/ni1272	http://dx.doi.org/10.1038/ni1272			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	985IX	16273097				2022-12-18	WOS:000233371900014
J	Werts, C; Tapping, RI; Mathison, JC; Chuang, TH; Kravchenko, V; Saint Girons, I; Haake, DA; Godowski, PJ; Hayashi, F; Ozinsky, A; Underhill, DM; Kirschning, CJ; Wagner, H; Aderem, A; Tobias, PS; Ulevitch, RJ				Werts, C; Tapping, RI; Mathison, JC; Chuang, TH; Kravchenko, V; Saint Girons, I; Haake, DA; Godowski, PJ; Hayashi, F; Ozinsky, A; Underhill, DM; Kirschning, CJ; Wagner, H; Aderem, A; Tobias, PS; Ulevitch, RJ			Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism	NATURE IMMUNOLOGY			English	Article							TOLL-LIKE RECEPTOR-2; BORRELIA-BURGDORFERI LIPOPROTEINS; INTERROGANS SEROVAR COPENHAGENI; NF-KAPPA-B; OUTER-MEMBRANE; CUTTING EDGE; BACTERIAL LIPOPOLYSACCHARIDE; TREPONEMA-PALLIDUM; MAMMALIAN INFECTION; PATHWAY DISTINCT	Leptospira interrogans are zoonotic pathogens that have been linked to a recent increased incidence of morbidity and mortality in highly populated tropical urban centers. They are unique among invasive spirochetes in that they contain outer membrane lipopolysaccharide (LPS) as well as lipoproteins. Here we show that both these leptospiral outer membrane constituents activate macrophages through CD14 and the Toll-like receptor 2 (TLR2). Conversely, it seems that TLR4, a central component for recognition of Gram-negative LPS, is not involved in cellular responses to L. interrogans. We also show that for intact L. interrogans, it is LPS, not lipoprotein, that constitutes the predominant signaling component for macrophages through a TLR2 pathway. These data provide a basis for understanding the innate immune response caused by leptospirosis and demonstrate a new ligand specificity for TLR2.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Inst Pasteur, Unite Bacteriol Mol & Med, F-75724 Paris 15, France; Vet Affairs Greater Los Angeles Hlth Care Syst, Div Infect Dis, Los Angeles, CA 90073 USA; Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany	Scripps Research Institute; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Roche Holding; Genentech; University of Washington; University of Washington Seattle; Technical University of Munich	Ulevitch, RJ (corresponding author), Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA.		Chuang, Tsung-Hsien/F-9679-2010; Ulevitch, Richard J/Q-3393-2017; UNDERHILL, DAVID/ABE-2185-2021; WERTS, Catherine/AAD-5447-2020	WERTS, Catherine/0000-0003-3079-5476; Underhill, David/0000-0002-2989-658X	NIAID NIH HHS [R29 AI034431, AI-15136, R29 AI034431-05] Funding Source: Medline; NIGMS NIH HHS [GM-28485, GM-37696] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI034431, R01AI015136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028485, R01GM028485, P01GM037696] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; ADLER B, 1978, J MED MICROBIOL, V11, P387, DOI 10.1099/00222615-11-4-387; Akashi S, 2000, J IMMUNOL, V164, P3471, DOI 10.4049/jimmunol.164.7.3471; AREAN VM, 1962, AM J PATHOL, V40, P393; BARIL C, 1990, FEMS MICROBIOL LETT, V71, P100; Barnett JK, 1999, INFECT IMMUN, V67, P853, DOI 10.1128/IAI.67.2.853-861.1999; Beutler B, 2000, CURR OPIN MICROBIOL, V3, P23, DOI 10.1016/S1369-5274(99)00046-6; Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Bulach DM, 2000, J MOL MICROB BIOTECH, V2, P375; Bulach DM, 2000, INFECT IMMUN, V68, P3793, DOI 10.1128/IAI.68.7.3793-3798.2000; Chu KM, 1998, J INFECT DIS, V177, P1314, DOI 10.1086/515273; DESOUZA L, 1992, CAN J MICROBIOL, V38, P284, DOI 10.1139/m92-047; ELLINGHAUSEN HC, 1965, AM J VET RES, V26, P45; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000; Haake DA, 1998, INFECT IMMUN, V66, P1579, DOI 10.1128/IAI.66.4.1579-1587.1998; Heine H, 1999, J IMMUNOL, V162, P6971; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hoshino K, 1999, J IMMUNOL, V162, P3749; ISOGAI E, 1986, ZBL BAKT-INT J MED M, V261, P65, DOI 10.1016/S0176-6724(86)80063-3; JOHNSON RC, 1967, J BACTERIOL, V94, P27, DOI 10.1128/JB.94.1.27-31.1967; Kalambaheti T, 1999, MICROB PATHOGENESIS, V27, P105, DOI 10.1006/mpat.1999.0285; KIRKLAND TN, 1993, J BIOL CHEM, V268, P24818; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; KRAVCHENKO VV, 1995, J BIOL CHEM, V270, P14928, DOI 10.1074/jbc.270.25.14928; Kravchenko VV, 1996, SHOCK, V5, P194, DOI 10.1097/00024382-199603000-00005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee CH, 1999, ANAL BIOCHEM, V267, P161, DOI 10.1006/abio.1998.2961; Leturcq DJ, 1996, J CLIN INVEST, V98, P1533, DOI 10.1172/JCI118945; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Manthey CL, 1994, J ENDOTOXIN RES, V1, P84; MATHISON JC, 1990, J CLIN INVEST, V85, P1108, DOI 10.1172/JCI114542; Mitchison M, 1997, J BACTERIOL, V179, P1262, DOI 10.1128/jb.179.4.1262-1267.1997; Norgard MV, 1996, INFECT IMMUN, V64, P3845, DOI 10.1128/IAI.64.9.3845-3852.1996; Pereira MM, 2000, J CLIN MICROBIOL, V38, P450; Poltorak A, 2000, P NATL ACAD SCI USA, V97, P2163, DOI 10.1073/pnas.040565397; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pugin J, 1998, INFECT IMMUN, V66, P1174, DOI 10.1128/IAI.66.3.1174-1180.1998; RADOLF JD, 1991, J IMMUNOL, V147, P1968; Sellati TJ, 1998, J IMMUNOL, V160, P5455; Shang ES, 1996, INFECT IMMUN, V64, P2322, DOI 10.1128/IAI.64.6.2322-2330.1996; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tapping RI, 2000, J IMMUNOL, V165, P5780, DOI 10.4049/jimmunol.165.10.5780; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Ulevitch RJ, 1999, NAT MED, V5, P144, DOI 10.1038/5504; Ulevitch RJ, 1999, NATURE, V401, P755, DOI 10.1038/44490; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Vinetz JM, 1996, ANN INTERN MED, V125, P794, DOI 10.7326/0003-4819-125-10-199611150-00002; VINH T, 1986, J GEN MICROBIOL, V132, P103; VINH TU, 1989, J GEN MICROBIOL, V135, P2663; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; ZUERNER RL, 1991, MICROB PATHOGENESIS, V10, P311, DOI 10.1016/0882-4010(91)90014-2	57	533	553	1	24	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2001	2	4					346	352		10.1038/86354	http://dx.doi.org/10.1038/86354			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	420AZ	11276206				2022-12-18	WOS:000167982900016
J	Gavin, MA; Clarke, SR; Negrou, E; Gallegos, A; Rudensky, A				Gavin, MA; Clarke, SR; Negrou, E; Gallegos, A; Rudensky, A			Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo	NATURE IMMUNOLOGY			English	Article							POSITIVE SELECTION; EFFECTOR FUNCTION; IN-VIVO; AUTOIMMUNE-DISEASES; SIGNAL-TRANSDUCTION; NEGATIVE SELECTION; KINASE ACTIVATION; GENE-EXPRESSION; FACTOR RECEPTOR; NUCLEAR FACTOR	CD4(+)CD25(+) suppressor T (T-5) cells play a critical role in the maintenance of peripheral tolerance. We examined here proliferative and functional responses as well as differential gene expression in T-s cells. We found that Ts cells were hyporesponsive to antigenic stimuli in vivo and unable to flux Ca2+ upon T cell receptor (TCR) engagement. However, T-s cells were not impaired in their proliferative response to lymphopenia, which was dependent on major histocompatibility complex class 11 expression. Homeostatic proliferation did not abolish T-s cell anergy; rather, it substantially augmented T-s cell function. DNA array analyses identified genes that may inhibit responsiveness at a number of levels in multiple signaling cascades in T-s cells, as well as several anti-apoptotic genes that may mediate their survival.	Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Gavin, MA (corresponding author), Univ Washington, Howard Hughes Med Inst, Box 357370, Seattle, WA 98195 USA.							AlberolaIla J, 1996, J EXP MED, V184, P9, DOI 10.1084/jem.184.1.9; ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; Annacker O, 2000, J IMMUNOL, V164, P3573, DOI 10.4049/jimmunol.164.7.3573; Annacker O, 2001, J IMMUNOL, V166, P3008, DOI 10.4049/jimmunol.166.5.3008; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bielekova B, 2000, J IMMUNOL, V164, P1117, DOI 10.4049/jimmunol.164.2.1117; Bodor J, 2001, J LEUKOCYTE BIOL, V69, P1053; Bourguignon LYW, 2000, J BIOL CHEM, V275, P1829, DOI 10.1074/jbc.275.3.1829; Bowman EP, 1998, J BIOL CHEM, V273, P28040, DOI 10.1074/jbc.273.43.28040; Cho BK, 2000, J EXP MED, V192, P549, DOI 10.1084/jem.192.4.549; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; Clarke SRM, 2000, J IMMUNOL, V165, P2458, DOI 10.4049/jimmunol.165.5.2458; Dey BR, 1998, J BIOL CHEM, V273, P24095, DOI 10.1074/jbc.273.37.24095; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Goldrath AW, 2000, J EXP MED, V192, P557, DOI 10.1084/jem.192.4.557; Hardy CFJ, 1997, P NATL ACAD SCI USA, V94, P3151, DOI 10.1073/pnas.94.7.3151; Hurtado JC, 1997, J IMMUNOL, V158, P2600; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kim CH, 1999, J LEUKOCYTE BIOL, V65, P6, DOI 10.1002/jlb.65.1.6; Kimura M, 2000, INT IMMUNOL, V12, P817, DOI 10.1093/intimm/12.6.817; Kuniyasu Y, 2000, INT IMMUNOL, V12, P1145, DOI 10.1093/intimm/12.8.1145; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Lechner O, 2001, CURR BIOL, V11, P587, DOI 10.1016/S0960-9822(01)00160-9; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; Lewis KA, 2000, NATURE, V404, P411, DOI 10.1038/35006129; Luo L, 1999, NAT MED, V5, P117, DOI 10.1038/4806; Mamane Y, 2000, IMMUNITY, V12, P129, DOI 10.1016/S1074-7613(00)80166-1; Mason D, 1998, CURR OPIN IMMUNOL, V10, P649, DOI 10.1016/S0952-7915(98)80084-8; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Metcalf D, 2000, NATURE, V405, P1069, DOI 10.1038/35016611; Michiels F, 1999, BIOCHEM SOC SYMP, V65, P125; Minamoto S, 1997, BIOCHEM BIOPH RES CO, V237, P79, DOI 10.1006/bbrc.1997.7080; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Murali-Krishna K, 2000, J IMMUNOL, V165, P1733, DOI 10.4049/jimmunol.165.4.1733; Nicholson SE, 1999, EMBO J, V18, P375, DOI 10.1093/emboj/18.2.375; Nocentini G, 1997, P NATL ACAD SCI USA, V94, P6216, DOI 10.1073/pnas.94.12.6216; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; OShea CC, 1996, EUR J IMMUNOL, V26, P2350, DOI 10.1002/eji.1830261012; Papiernik M, 1998, INT IMMUNOL, V10, P371, DOI 10.1093/intimm/10.4.371; Perez-Villar JJ, 1999, MOL CELL BIOL, V19, P2903; Piccirillo CA, 2001, J IMMUNOL, V167, P1137, DOI 10.4049/jimmunol.167.3.1137; Powell JD, 1999, J IMMUNOL, V163, P6631; Ram PA, 1999, J BIOL CHEM, V274, P35553, DOI 10.1074/jbc.274.50.35553; Ramstad C, 2000, CELL SIGNAL, V12, P557, DOI 10.1016/S0898-6568(00)00097-8; Rogers PR, 2001, IMMUNITY, V15, P445, DOI 10.1016/S1074-7613(01)00191-1; ROSEN S, 1998, PRIMER3; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sathish JG, 2001, J IMMUNOL, V166, P1763, DOI 10.4049/jimmunol.166.3.1763; SATO T, 1995, SCIENCE, V268, P411, DOI 10.1126/science.7536343; SCHALL TJ, 1988, J IMMUNOL, V141, P1018; Schwenger GTF, 1999, J ALLERGY CLIN IMMUN, V104, P820, DOI 10.1016/S0091-6749(99)70293-9; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Silveira PA, 1999, J IMMUNOL, V162, P5106; Suri-Payer E, 1998, J IMMUNOL, V160, P1212; SWAN KA, 1995, EMBO J, V14, P276, DOI 10.1002/j.1460-2075.1995.tb07001.x; Szondy Z, 1998, CELL DEATH DIFFER, V5, P4, DOI 10.1038/sj.cdd.4400313; Taams LS, 2001, EUR J IMMUNOL, V31, P1122, DOI 10.1002/1521-4141(200104)31:4<1122::AID-IMMU1122>3.0.CO;2-P; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; TAN JT, 2001, P NATL ACAD SCI USA, V10, P10; Tanchot C, 2001, EUR J IMMUNOL, V31, P2256, DOI 10.1002/1521-4141(200108)31:8<2256::AID-IMMU2256>3.0.CO;2-8; Teague TK, 1999, P NATL ACAD SCI USA, V96, P12691, DOI 10.1073/pnas.96.22.12691; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; Utting O, 2000, J IMMUNOL, V164, P2881, DOI 10.4049/jimmunol.164.6.2881; Vang T, 2001, J EXP MED, V193, P497, DOI 10.1084/jem.193.4.497; Viret C, 1999, IMMUNITY, V10, P559, DOI 10.1016/S1074-7613(00)80055-2; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Whitehurst CE, 1996, J IMMUNOL, V156, P1020; Wong P, 2000, J IMMUNOL, V164, P6252, DOI 10.4049/jimmunol.164.12.6252; Wong P, 2001, J EXP MED, V193, P1179, DOI 10.1084/jem.193.10.1179; Wotton D, 1999, CELL, V97, P29, DOI 10.1016/S0092-8674(00)80712-6; Ye JP, 1996, MOL CELL BIOL, V16, P4744	74	530	562	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2002	3	1					33	41		10.1038/ni743	http://dx.doi.org/10.1038/ni743			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	509LF	11740498				2022-12-18	WOS:000173148700012
J	Sabbah, A; Chang, TH; Harnack, R; Frohlich, V; Tominaga, K; Dube, PH; Xiang, Y; Bose, S				Sabbah, Ahmed; Chang, Te Hung; Harnack, Rosalinda; Frohlich, Victoria; Tominaga, Kaoru; Dube, Peter H.; Xiang, Yan; Bose, Santanu			Activation of innate immune antiviral responses by Nod2	NATURE IMMUNOLOGY			English	Article							RESPIRATORY SYNCYTIAL VIRUS; TOLL-LIKE RECEPTORS; NF-KAPPA-B; RIG-I; EPITHELIAL-CELLS; RNA VIRUSES; PARAINFLUENZA VIRUS; VIRAL-INFECTION; INFLUENZA-VIRUS; HOST-DEFENSE	Pattern-recognition receptors (PRRs), including Toll-like receptors (TLRs) and RIG-like helicase (RLH) receptors, are involved in innate immune antiviral responses. Here we show that nucleotide-binding oligomerization domain 2 (Nod2) can also function as a cytoplasmic viral PRR by triggering activation of interferon-regulatory factor 3 (IRF3) and production of interferon-beta (IFN-beta). After recognition of a viral ssRNA genome, Nod2 used the adaptor protein MAVS to activate IRF3. Nod2-deficient mice failed to produce interferon efficiently and showed enhanced susceptibility to virus-induced pathogenesis. Thus, the function of Nod2 as a viral PRR highlights the important function of Nod2 in host antiviral defense mechanisms.	[Sabbah, Ahmed; Chang, Te Hung; Harnack, Rosalinda; Dube, Peter H.; Xiang, Yan; Bose, Santanu] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Frohlich, Victoria; Tominaga, Kaoru] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Tominaga, Kaoru] Univ Texas Hlth Sci Ctr San Antonio, Sam & Ann Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Bose, S (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.	bose@uthscsa.edu	Tominaga, Kaoru/AAL-4250-2020	Tominaga, Kaoru/0000-0001-8799-528X; , Santanu/0000-0002-5501-3293; Xiang, Yan/0000-0002-7633-1629	National Institutes of Health [P30 CA54174, P30 AG013319, P01AG19316, AI069062, CA129246, T32-DE14318, AI067716]; American Lung Association [AI067716, RG-49629-N]; NATIONAL CANCER INSTITUTE [R21CA129246, P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067716, R21AI069062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE014318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG019316, P30AG013319] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank K. Li (University of Tennessee Health Science Center) for reagents; A. Garcia-Sastre (Mount Sinai School of Medicine) for influenza A virus; Z.J. Chen (University of Texas Southwestern Medical Center) for MAVS-deficient MEFs; the Core Optical Imaging Facility (University of Texas Health Science Center at San Antonio) for confocal images; and K. Moncada Gorena and C. Thomas in the Flow Cytometry Core Facility (supported by the National Institutes of Health (P30 CA54174 to the San Antonio Cancer Institute; P30 AG013319 to the Nathan Shock Center; and P01AG19316)) for flow cytometry. Supported by National Institutes of Health (AI069062 to S. B., CA129246 to S. B. and T32-DE14318 to A. S. and AI067716 to P. H. D.) and the American Lung Association (RG-49629-N to S. B. and AI067716 to P. H. D.).	Abbott DW, 2007, MOL CELL BIOL, V27, P6012, DOI 10.1128/MCB.00270-07; Basler CF, 2007, NAT CHEM BIOL, V3, P20, DOI 10.1038/nchembio0107-20; Bolger G, 2005, CAN J PHYSIOL PHARM, V83, P198, DOI 10.1139/Y05-007; Bose S, 2003, J INTERF CYTOK RES, V23, P401, DOI 10.1089/107999003322277810; Bose S, 2003, P NATL ACAD SCI USA, V100, P10890, DOI 10.1073/pnas.1832775100; Bose S, 2001, J VIROL, V75, P1984, DOI 10.1128/JVI.75.4.1984-1989.2001; Bubeck SS, 2007, INFECT IMMUN, V75, P697, DOI 10.1128/IAI.00403-06; Castro SM, 2006, AM J RESP CRIT CARE, V174, P1361, DOI 10.1164/rccm.200603-319OC; Chavez-Bueno S, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-46; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Franchi L, 2008, CELL MICROBIOL, V10, P1, DOI 10.1111/j.1462-5822.2007.01059.x; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Guerrero-Plata A, 2005, J VIROL, V79, P10190, DOI 10.1128/JVI.79.16.10190-10199.2005; Guerrero-Plata A, 2005, J VIROL, V79, P14992, DOI 10.1128/JVI.79.23.14992-14997.2005; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; Hippenstiel S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-97; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Inohara N, 2002, CURR OPIN MICROBIOL, V5, P76, DOI 10.1016/S1369-5274(02)00289-8; Jafri HS, 2004, J INFECT DIS, V189, P1856, DOI 10.1086/386372; Jamaluddin M, 2001, AM J PHYSIOL-LUNG C, V280, pL248, DOI 10.1152/ajplung.2001.280.2.L248; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kota S, 2008, J BIOL CHEM, V283, P22417, DOI 10.1074/jbc.M710415200; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Liu P, 2007, J VIROL, V81, P1401, DOI 10.1128/JVI.01740-06; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Matikainen S, 2006, J VIROL, V80, P3515, DOI 10.1128/JVI.80.7.3515-3522.2006; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; Opitz B, 2004, J BIOL CHEM, V279, P36426, DOI 10.1074/jbc.M403861200; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pletneva LM, 2008, J GEN VIROL, V89, P261, DOI 10.1099/vir.0.83294-0; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Tominaga K, 2005, MOL CELL BIOL, V25, P2924, DOI 10.1128/MCB.25.8.2924-2937.2005; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Voss E, 2006, J BIOL CHEM, V281, P2005, DOI 10.1074/jbc.M511044200; Wang J, 2008, J IMMUNOL, V180, P8011, DOI 10.4049/jimmunol.180.12.8011; Wang SZ, 1998, EUR RESPIR J, V12, P612, DOI 10.1183/09031936.98.12030612; Wang YB, 2000, DRUG DISCOV TODAY, V5, P10, DOI 10.1016/S1359-6446(99)01433-6; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Welliver TP, 2007, J INFECT DIS, V195, P1126, DOI 10.1086/512615; Wilmott RW, 1998, AM J RESP CELL MOL, V18, P429, DOI 10.1165/ajrcmb.18.3.2983; Yasui K, 2005, PEDIATR INT, V47, P190, DOI 10.1111/j.1442-200x.2005.02039.x	50	528	556	3	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2009	10	10					1073	U49		10.1038/ni.1782	http://dx.doi.org/10.1038/ni.1782			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	496VG	19701189	Green Accepted			2022-12-18	WOS:000270006900010
J	Yu, KF; Chedin, F; Hsieh, CL; Wilson, TE; Lieber, MR				Yu, KF; Chedin, F; Hsieh, CL; Wilson, TE; Lieber, MR			R-loops at immunoglobulin class switch regions in the chromosomes of stimulated B cells	NATURE IMMUNOLOGY			English	Article							RNA-DNA HYBRID; V(D)J RECOMBINATION; TRANSCRIPTION; REPLICATION; MECHANISM; ORIGIN; TOPOISOMERASES; HYPERMUTATION; SPECIFICITY; ACTIVATION	The mechanism responsible for immunoglobulin class switch recombination is unknown. Previous work has shown that class switch sequences have the unusual property of forming RNA-DNA hybrids when transcribed in vitro. Here we show that the RNA-DNA hybrid structure that forms in vitro is an R-loop with a displaced guanine (G)-rich strand that is single-stranded. This R-loop structure exists in vivo in B cells that have been stimulated to transcribe the gamma3 or the gamma2b switch region. The length of the R-loops can exceed I kilobase. We propose that this distinctive DNA structure is important in the class switch recombination mechanism	Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA	University of Southern California	Lieber, MR (corresponding author), Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Room 5428,1441 Eastlake Ave,MC 9176, Los Angeles, CA 90033 USA.	lieber@usc.edu		Chedin, Frederic/0000-0002-1306-5335; Lieber, Michael/0000-0001-8809-0909; Lieber, Michael/0000-0003-3700-6345				BAKER TA, 1988, CELL, V55, P113, DOI 10.1016/0092-8674(88)90014-1; BOTTARO A, 1994, EMBO J, V13, P665, DOI 10.1002/j.1460-2075.1994.tb06305.x; CarlesKinch K, 1997, J MOL BIOL, V266, P915, DOI 10.1006/jmbi.1996.0844; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; COFFMAN RL, 1993, ADV IMMUNOL, V54, P229, DOI 10.1016/S0065-2776(08)60536-2; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Daniels GA, 1995, NUCLEIC ACIDS RES, V23, P5006, DOI 10.1093/nar/23.24.5006; DANIELS GA, 1995, P NATL ACAD SCI USA, V92, P5625, DOI 10.1073/pnas.92.12.5625; Dempsey LA, 1999, J BIOL CHEM, V274, P1066, DOI 10.1074/jbc.274.2.1066; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365; FORD JE, 1994, GENE, V142, P279, DOI 10.1016/0378-1119(94)90275-5; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Gellert M, 1997, ADV IMMUNOL, V64, P39, DOI 10.1016/S0065-2776(08)60886-X; GOUGH GW, 1986, EMBO J, V5, P191, DOI 10.1002/j.1460-2075.1986.tb04195.x; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; GRITZMACHER CA, 1989, CRIT REV IMMUNOL, V9, P173; Hein K, 1998, J EXP MED, V188, P2369, DOI 10.1084/jem.188.12.2369; HSIEH CL, 1992, J BIOL CHEM, V267, P15613; Hsieh CL, 1997, MOL CELL BIOL, V17, P5897, DOI 10.1128/MCB.17.10.5897; Kinoshita K, 2000, CURR OPIN IMMUNOL, V12, P195, DOI 10.1016/S0952-7915(99)00072-2; Lee CG, 2001, J EXP MED, V194, P365, DOI 10.1084/jem.194.3.365; Lee DY, 1996, J BIOL CHEM, V271, P24262, DOI 10.1074/jbc.271.39.24262; LIEBER MR, 1991, FASEB J, V5, P2934, DOI 10.1096/fasebj.5.14.1752360; Lieber MR, 1998, AM J PATHOL, V153, P1323, DOI 10.1016/S0002-9440(10)65716-1; LORENZ M, 1995, SCIENCE, V267, P1825, DOI 10.1126/science.7892607; LUTZKER S, 1988, CELL, V53, P177, DOI 10.1016/0092-8674(88)90379-0; Masse E, 1997, J BIOL CHEM, V272, P12816, DOI 10.1074/jbc.272.19.12816; MASUKATA H, 1990, CELL, V62, P331, DOI 10.1016/0092-8674(90)90370-T; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; PEERSENMAHRT SK, 2002, NATURE, V418, P99; Phoenix P, 1997, J BIOL CHEM, V272, P1473, DOI 10.1074/jbc.272.3.1473; Prichard MN, 1998, J VIROL, V72, P6997, DOI 10.1128/JVI.72.9.6997-7004.1998; RATMEYER L, 1994, BIOCHEMISTRY-US, V33, P5298, DOI 10.1021/bi00183a037; REABAN ME, 1994, J BIOL CHEM, V269, P21850; REABAN ME, 1990, NATURE, V348, P342, DOI 10.1038/348342a0; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; ROBERTS RW, 1992, SCIENCE, V258, P1463, DOI 10.1126/science.1279808; ROTHMAN P, 1990, INT IMMUNOL, V2, P621, DOI 10.1093/intimm/2.7.621; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Shinkura R, 2003, NAT IMMUNOL, V4, P435, DOI 10.1038/ni918; SNAPPER CM, 1999, FUNDAMENTAL IMMUNOLO, P831; Stavnezer J, 1996, ADV IMMUNOL, V61, P79, DOI 10.1016/S0065-2776(08)60866-4; STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95, DOI 10.1002/j.1460-2075.1986.tb04182.x; SZUREK P, 1985, J IMMUNOL, V135, P620; Tashiro J, 2001, INT IMMUNOL, V13, P495, DOI 10.1093/intimm/13.4.495; Tian M, 2000, J BIOL CHEM, V275, P24163, DOI 10.1074/jbc.M003343200; Tracy RB, 2000, SCIENCE, V288, P1058, DOI 10.1126/science.288.5468.1058; Tracy RB, 2000, EMBO J, V19, P1055, DOI 10.1093/emboj/19.5.1055; XU LX, 1993, P NATL ACAD SCI USA, V90, P3705, DOI 10.1073/pnas.90.8.3705	50	526	534	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2003	4	5					442	451		10.1038/ni919	http://dx.doi.org/10.1038/ni919			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	674YN	12679812				2022-12-18	WOS:000182665400011
J	Baroja-Mazo, A; Martin-Sanchez, F; Gomez, AI; Martinez, CM; Amores-Iniesta, J; Compan, V; Barbera-Cremades, M; Yague, J; Ruiz-Ortiz, E; Anton, J; Bujan, S; Couillin, I; Brough, D; Arostegui, JI; Pelegrin, P				Baroja-Mazo, Alberto; Martin-Sanchez, Fatima; Gomez, Ana I.; Martinez, Carlos M.; Amores-Iniesta, Joaquin; Compan, Vincent; Barbera-Cremades, Maria; Yaguee, Jordi; Ruiz-Ortiz, Estibaliz; Anton, Jordi; Bujan, Segundo; Couillin, Isabelle; Brough, David; Arostegui, Juan I.; Pelegrin, Pablo			The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response	NATURE IMMUNOLOGY			English	Article							NALP3 INFLAMMASOME; ACTIVATION; CASPASE-1; ASC; IL-1-BETA; MECHANISM; PURIFICATION; EXPRESSION; SECRETION; AUTOPHAGY	Assembly of the NLRP3 inflammasome activates caspase-1 and mediates the processing and release of the leaderless cytokine IL-1 beta and thereby serves a central role in the inflammatory response and in diverse human diseases. Here we found that upon activation of caspase-1, oligomeric NLRP3 inflammasome particles were released from macrophages. Recombinant oligomeric protein particles composed of the adaptor ASC or the p.D303N mutant form of NLRP3 associated with cryopyrin-associated periodic syndromes (CAPS) stimulated further activation of caspase-1 extracellularly, as well as intracellularly after phagocytosis by surrounding macrophages. We found oligomeric ASC particles in the serum of patients with active CAPS but not in that of patients with other inherited autoinflammatory diseases. Our findings support a model whereby the NLRP3 inflammasome, acting as an extracellular oligomeric complex, amplifies the inflammatory response.	[Baroja-Mazo, Alberto; Martin-Sanchez, Fatima; Gomez, Ana I.; Martinez, Carlos M.; Amores-Iniesta, Joaquin; Barbera-Cremades, Maria; Pelegrin, Pablo] Clin Univ Hosp Virgen de la Arrixaca, Inst Biohlth Res Murcia, CIBERehd, Inflammat & Expt Surg Unit, Murcia, Spain; [Compan, Vincent; Brough, David; Pelegrin, Pablo] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Yaguee, Jordi; Ruiz-Ortiz, Estibaliz; Arostegui, Juan I.] Hosp Clin Barcelona, Dept Immunol CDB, Barcelona, Spain; [Anton, Jordi] Hosp St Joan de Deu, Reumathol Pediat Unit, Barcelona, Spain; [Bujan, Segundo] Hosp Valle De Hebron, Dept Internal Med, Barcelona, Spain; [Couillin, Isabelle] Univ Orleans, CNRS UMR 7355, Orleans, France	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Clinico Universitario Virgen de la Arrixaca; University of Manchester; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Universitari Vall d'Hebron; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Orleans	Pelegrin, P (corresponding author), Clin Univ Hosp Virgen de la Arrixaca, Inst Biohlth Res Murcia, CIBERehd, Inflammat & Expt Surg Unit, Murcia, Spain.	pablo.pelegrin@ffis.es	Pelegrin, Pablo/M-2007-2014; Compan, Vincent/M-6977-2017; Martinez, Carlos M./E-4986-2016; Anton, Jordi/A-9848-2017; Baroja-Mazo, Alberto/E-6270-2016	Pelegrin, Pablo/0000-0002-9688-1804; Compan, Vincent/0000-0001-6805-1179; Martinez, Carlos M./0000-0003-3307-1326; Anton, Jordi/0000-0002-8792-4219; Baroja-Mazo, Alberto/0000-0001-5212-5006; YAGUE, JORDI/0000-0001-8210-1929; Brough, David/0000-0002-2250-2381; Joaquin, Amores-Iniesta/0000-0002-4125-2250; Arostegui, Juan Ignacio/0000-0003-4757-504X; Yague Ribes, Jordi/0000-0002-1935-4488; RUIZ-ORTIZ, ESTIBALIZ/0000-0002-3003-934X	Wellcome Trust; Instituto Salud Carlos III [CD12/00523, CD13/00059]; Instituto Salud Carlos III-Fondo Europeo de Desarrollo Regional [EMER07/049, PS09/00120, PI13/00174, PS09/01182]; Fundacion Seneca [11922/PI/09]; Fundacion Mutua Madrilena [ID98FMM013]	Wellcome Trust(Wellcome TrustEuropean Commission); Instituto Salud Carlos III(Instituto de Salud Carlos III); Instituto Salud Carlos III-Fondo Europeo de Desarrollo Regional; Fundacion Seneca(Fundacion Seneca); Fundacion Mutua Madrilena(Instituto de Salud Carlos III)	We thank E. Latz (Institute of Innate Immunity) for immortalized ASC-mCherry, ASC-deficient and NLRP3-deficient mouse bone marrow macrophages and for the expression vector encoding red fluorescent protein-tagged ASC; V. Dixit (Genentech) for Pycard<SUP>-/-</SUP> mice; M.C. Banos and J.J. Martinez for technical assistance with both molecular and cellular analyses; L. Martinez-Alarcon for extraction of blood from healthy donors; M. Martinez-Villanueva for analysis of CRP; and C. de Torre for support with proteomics. Supported by the Wellcome Trust (V.C.), Instituto Salud Carlos III (CD12/00523 and CD13/00059 to F.M.-S. and J.A.-I.), Instituto Salud Carlos III-Fondo Europeo de Desarrollo Regional (EMER07/049, PS09/00120 and PI13/00174 to P.P. and PS09/01182 to J.Y.), Fundacion Seneca (11922/PI/09 to P. P.) and Fundacion Mutua Madrilena (ID98FMM013 to A.B.-M.).	Adamczak S, 2012, J NEUROSURG, V117, P1119, DOI 10.3171/2012.9.JNS12815; Babelova A, 2009, J BIOL CHEM, V284, P24035, DOI 10.1074/jbc.M109.014266; Balci-Peynircioglu B, 2008, EXP BIOL MED, V233, P1324, DOI 10.3181/0803-RM-106; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; Compan V, 2012, IMMUNITY, V37, P487, DOI 10.1016/j.immuni.2012.06.013; Dinarello CA, 2010, CURR OPIN ENDOCRINOL, V17, P314, DOI 10.1097/MED.0b013e32833bf6dc; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2008, METHOD ENZYMOL, V442, P251, DOI [10.1016/S0076-6S79(08)01413-4, 10.1016/S0076-6879(08)01413-4]; Garcia-Calvo M, 1999, CELL DEATH DIFFER, V6, P362, DOI 10.1038/sj.cdd.4400497; Gross Olaf, 2012, Immunity, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hoffman HM, 2008, ARTHRITIS RHEUM, V58, P2443, DOI 10.1002/art.23687; Hoffman HM, 2004, LANCET, V364, P1779, DOI 10.1016/S0140-6736(04)17401-1; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kahlenberg JM, 2013, J IMMUNOL, V190, P1217, DOI 10.4049/jimmunol.1202388; Kahlenberg JM, 2005, J IMMUNOL, V175, P7611, DOI 10.4049/jimmunol.175.11.7611; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lachmann HJ, 2009, NEW ENGL J MED, V360, P2416, DOI 10.1056/NEJMoa0810787; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Lopez-Castejon G, 2013, J BIOL CHEM, V288, P2721, DOI 10.1074/jbc.M112.422238; Lopez-Castejon G, 2011, CYTOKINE GROWTH F R, V22, P189, DOI 10.1016/j.cytogfr.2011.10.001; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Murakami T, 2012, P NATL ACAD SCI USA, V109, P11282, DOI 10.1073/pnas.1117765109; Nakagawa K, 2015, ANN RHEUM DIS, V74, P603, DOI 10.1136/annrheumdis-2013-204361; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Neven B, 2004, BLOOD, V103, P2809, DOI 10.1182/blood-2003-07-2531; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Rajamaki K, 2013, J BIOL CHEM, V288, P13410, DOI 10.1074/jbc.M112.426254; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Shmagel KV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P469, DOI 10.1134/S0006297909050010; Tanaka N, 2011, ARTHRITIS RHEUM-US, V63, P3625, DOI 10.1002/art.30512; Yazdi AS, 2010, P NATL ACAD SCI USA, V107, P19449, DOI 10.1073/pnas.1008155107; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	49	525	548	2	111	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2014	15	8					738	+		10.1038/ni.2919	http://dx.doi.org/10.1038/ni.2919			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AL7OF	24952504				2022-12-18	WOS:000339323000009
J	Sinclair, LV; Rolf, J; Emslie, E; Shi, YB; Taylor, PM; Cantrell, DA				Sinclair, Linda V.; Rolf, Julia; Emslie, Elizabeth; Shi, Yun-Bo; Taylor, Peter M.; Cantrell, Doreen A.			Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation	NATURE IMMUNOLOGY			English	Article							TRANSFER-RNA SYNTHETASE; HEAVY-CHAIN GENE; MAMMALIAN TARGET; MTOR; EXPRESSION; KINASE; MEMORY; ACTIVATION; GENERATION; CD98HC	T lymphocytes must regulate nutrient uptake to meet the metabolic demands of an immune response. Here we show that the intracellular supply of large neutral amino acids (LNAAs) in T cells was regulated by pathogens and the T cell antigen receptor (TCR). T cells responded to antigen by upregulating expression of many amino-acid transporters, but a single System L ('leucine-preferring system') transporter, Slc7a5, mediated uptake of LNAAs in activated T cells. Slc7a5-null T cells were unable to metabolically reprogram in response to antigen and did not undergo clonal expansion or effector differentiation. The metabolic catastrophe caused by loss of Slc7a5 reflected the requirement for sustained uptake of the LNAA leucine for activation of the serine-threonine kinase complex mTORC1 and for expression of the transcription factor c-Myc. Control of expression of the System L transporter by pathogens is thus a critical metabolic checkpoint for T cells.	[Sinclair, Linda V.; Rolf, Julia; Emslie, Elizabeth; Taylor, Peter M.; Cantrell, Doreen A.] Univ Dundee, Div Cell Signalling & Immunol, Dundee, Scotland; [Shi, Yun-Bo] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Cellular Regulat & Metab, NIH, Bethesda, MD USA	University of Dundee; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Cantrell, DA (corresponding author), Univ Dundee, Div Cell Signalling & Immunol, Dundee, Scotland.	d.a.cantrell@dundee.ac.uk		Shi, Yun-Bo/0000-0002-6330-0639; Cantrell, Doreen/0000-0001-7525-3350	Wellcome Trust [065975/Z/01/A, 097418/Z/11Z, WT094226]; Intramural Research Program of the National Institute Child Health and Human Development of the US National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008858] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Intramural Research Program of the National Institute Child Health and Human Development of the US National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank G. Holman (University of Bath) for anti-Glut1; H. Shen (University of Pennsylvania) for L. monocytogenes; L. Chen for help in the initial characterization of amino-acid transporters expressed by CTLs; members of the Biological Services Unit; R. Clarke of the Flow Cytometry Facility; and members of the D. A. C. laboratory and S. Arthur for critical reading of the manuscript. Supported by the Wellcome Trust (065975/Z/01/A and 097418/Z/11Z to D. A. C., and WT094226 to P. M. T.) and the Intramural Research Program of the National Institute Child Health and Human Development of the US National Institutes of Health.	Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Beugnet A, 2003, BIOCHEM J, V372, P555, DOI 10.1042/BJ20021266; Bonfils G, 2012, MOL CELL, V46, P105, DOI 10.1016/j.molcel.2012.02.009; Cantor J, 2011, J IMMUNOL, V187, P851, DOI 10.4049/jimmunol.1100002; Cantor J, 2009, NAT IMMUNOL, V10, P412, DOI 10.1038/ni.1712; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; GOTTESDIENER KM, 1988, MOL CELL BIOL, V8, P3809, DOI 10.1128/MCB.8.9.3809; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; HANN SR, 1983, CELL, V34, P789, DOI 10.1016/0092-8674(83)90535-4; HANN SR, 1984, MOL CELL BIOL, V4, P2486, DOI 10.1128/MCB.4.11.2486; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; HOLMAN GD, 1990, J BIOL CHEM, V265, P18172; Kopf H, 2007, INT IMMUNOPHARMACOL, V7, P1819, DOI 10.1016/j.intimp.2007.08.027; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; LINDSTEN T, 1988, MOL CELL BIOL, V8, P3820, DOI 10.1128/MCB.8.9.3820; Liu Z, 2012, TRANSPLANTATION, V93, P1116, DOI 10.1097/TP.0b013e31824fd7cd; Navarro MN, 2012, BIOCHEM J, V442, P649, DOI 10.1042/BJ20111700; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Ogilvy S, 1999, BLOOD, V94, P1855; PARMACEK MS, 1989, NUCLEIC ACIDS RES, V17, P1915, DOI 10.1093/nar/17.5.1915; Pearce EL, 2007, J IMMUNOL, V179, P2074, DOI 10.4049/jimmunol.179.4.2074; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Powell JD, 2010, IMMUNITY, V33, P301, DOI 10.1016/j.immuni.2010.09.002; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Sato Y, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-7; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Schriever SC, 2013, J NUTR BIOCHEM, V24, P824, DOI 10.1016/j.jnutbio.2012.04.018; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; SMITH KA, 1985, P NATL ACAD SCI USA, V82, P864, DOI 10.1073/pnas.82.3.864; Tsumura H, 2003, BIOCHEM BIOPH RES CO, V308, P847, DOI 10.1016/S0006-291X(03)01473-6; Usui T, 2006, CHEM BIOL, V13, P1153, DOI 10.1016/j.chembiol.2006.09.006; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Zheng Y, 2009, J IMMUNOL, V183, P6095, DOI 10.4049/jimmunol.0803510	41	525	537	4	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2013	14	5					500	+		10.1038/ni.2556	http://dx.doi.org/10.1038/ni.2556			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	127XL	23525088	Green Accepted			2022-12-18	WOS:000317732100015
J	Markiewski, MM; DeAngelis, RA; Benencia, F; Ricklin-Lichtsteiner, SK; Koutoulaki, A; Gerard, C; Coukos, G; Lambris, JD				Markiewski, Maciej M.; DeAngelis, Robert A.; Benencia, Fabian; Ricklin-Lichtsteiner, Salome K.; Koutoulaki, Anna; Gerard, Craig; Coukos, George; Lambris, John D.			Modulation of the antitumor immune response by complement	NATURE IMMUNOLOGY			English	Article							IMMATURE MYELOID CELLS; CD8(+) T-CELLS; C5A RECEPTOR; CANCER-IMMUNOTHERAPY; REGULATORY PROTEINS; ACQUIRED-IMMUNITY; TUMOR-DEVELOPMENT; INFLAMMATION; C3; ACTIVATION	The involvement of complement-activation products in promoting tumor growth has not yet been recognized. Here we show that the generation of complement C5a in a tumor microenvironment enhanced tumor growth by suppressing the antitumor CD8(+) T cell-mediated response. This suppression was associated with the recruitment of myeloid-derived suppressor cells into tumors and augmentation of their T cell-directed suppressive abilities. Amplification of the suppressive capacity of myeloid-derived suppressor cells by C5a occurred through regulation of the production of reactive oxygen and nitrogen species. Pharmacological blockade of the C5a receptor considerably impaired tumor growth to a degree similar to the effect produced by the anticancer drug paclitaxel. Thus, our study demonstrates a therapeutic function for complement inhibition in the treatment of cancer.	[Markiewski, Maciej M.; DeAngelis, Robert A.; Ricklin-Lichtsteiner, Salome K.; Koutoulaki, Anna; Lambris, John D.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Benencia, Fabian; Coukos, George] Univ Penn, Dept Obstet & Gynecol, Ctr Res Reprod & Womens Hlth, Philadelphia, PA 19104 USA; [Gerard, Craig] Childrens Hosp, Div Pulm, Boston, MA 02215 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Boston Children's Hospital	Lambris, JD (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	lambris@upenn.edu	Coukos, George/ABG-7389-2020; Lambris, John/Q-5633-2018; Benencia, Fabian/AAH-1613-2020	Lambris, John/0000-0002-9370-5776; Benencia, Fabian/0000-0003-3049-6150; Coukos, George/0000-0001-8813-7367	US National Institutes of Health [CA112162-03, GM62134, A1068730]; NATIONAL CANCER INSTITUTE [R01CA112162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI068730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062134] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. A. Wetsel (University of Texas, Houston) for C3 and factor B-deficient mice; D. Ricklin and C. Tsoukas for critical review of the manuscript; D. McClellan for editorial assistance; the Morphology Core of the Penn Center for Molecular Studies in Digestive and Liver Diseases for technical assistance; Hycult Biotechnology for mAb to C3; and P. Magotti (University of Pennsylvania, Philadelphia) for mouse C5a and for characterizing the C5aR antagonist and control peptide. Supported by the US National Institutes of Health (CA112162-03, GM62134 and A1068730 to J.D.L.).	Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bhardwaj N, 2007, J CLIN INVEST, V117, P1130, DOI 10.1172/JCI32136; Blank C, 2004, CANCER RES, V64, P1140, DOI 10.1158/0008-5472.CAN-03-3259; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Circolo A, 1999, IMMUNOPHARMACOLOGY, V42, P135, DOI 10.1016/S0162-3109(99)00021-1; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Daniel DS, 2006, J IMMUNOL, V177, P4688, DOI 10.4049/jimmunol.177.7.4688; de Visser KE, 2004, NEOPLASIA, V6, P768, DOI 10.1593/neo.04250; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Donin N, 2003, CLIN EXP IMMUNOL, V131, P254, DOI 10.1046/j.1365-2249.2003.02066.x; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Finch AM, 1999, J MED CHEM, V42, P1965, DOI 10.1021/jm9806594; Gallina G, 2006, J CLIN INVEST, V116, P2777, DOI 10.1172/JCI28828; Gelderman KA, 2004, TRENDS IMMUNOL, V25, P158, DOI 10.1016/j.it.2004.01.008; Gorter A, 1999, IMMUNOL TODAY, V20, P576, DOI 10.1016/S0167-5699(99)01537-6; Guo RF, 2003, FASEB J, V17, P1889, DOI 10.1096/fj.03-0009fje; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hawlisch H, 2006, MOL IMMUNOL, V43, P13, DOI 10.1016/j.molimm.2005.06.028; Holland M Claire H, 2004, Curr Opin Investig Drugs, V5, P1164; Holtz DO, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-2; Hopken UE, 1996, NATURE, V383, P86, DOI 10.1038/383086a0; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Johswich K, 2006, J BIOL CHEM, V281, P39088, DOI 10.1074/jbc.M609734200; Karp CL, 2000, NAT IMMUNOL, V1, P221, DOI 10.1038/79759; Kim AHJ, 2004, J IMMUNOL, V173, P2524, DOI 10.4049/jimmunol.173.4.2524; Koehl J, 2006, CURR OPIN MOL THER, V8, P529; Kohl J, 2006, J CLIN INVEST, V116, P783, DOI 10.1172/JCI26582; Kohl J, 2007, MOL IMMUNOL, V44, P44, DOI 10.1016/j.molimm.2006.06.016; Kusmartsev S, 2005, J IMMUNOL, V175, P4583, DOI 10.4049/jimmunol.175.7.4583; Kusmartsev S, 2004, J IMMUNOL, V172, P989, DOI 10.4049/jimmunol.172.2.989; Lin KY, 1996, CANCER RES, V56, P21; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Liu JN, 2005, J EXP MED, V201, P567, DOI 10.1084/jem.20040863; Macor P, 2007, IMMUNOL LETT, V111, P6, DOI 10.1016/j.imlet.2007.04.014; Mantovani A, 2008, LANCET, V371, P771, DOI 10.1016/S0140-6736(08)60241-X; Markiewski MM, 2007, AM J PATHOL, V171, P715, DOI 10.2353/ajpath.2007.070166; Marx J, 2008, SCIENCE, V319, P154, DOI 10.1126/science.319.5860.154; Mastellos D, 2004, MOL IMMUNOL, V40, P1213, DOI 10.1016/j.molimm.2003.10.019; Mastellos D, 2002, TRENDS IMMUNOL, V23, P485, DOI 10.1016/S1471-4906(02)02287-1; Matsumoto M, 1997, P NATL ACAD SCI USA, V94, P8720, DOI 10.1073/pnas.94.16.8720; Mollnes TE, 2002, BLOOD, V100, P1869; Monk PN, 2007, BRIT J PHARMACOL, V152, P429, DOI 10.1038/sj.bjp.0707332; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; NICULESCU F, 1992, AM J PATHOL, V140, P1039; Peng T, 2005, J CLIN INVEST, V115, P1590, DOI 10.1172/JCI22906; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Sahu A, 1998, IMMUNOL RES, V17, P109, DOI 10.1007/BF02786436; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; Strey CW, 2003, J EXP MED, V198, P913, DOI 10.1084/jem.20030374; Suresh M, 2003, J IMMUNOL, V170, P788, DOI 10.4049/jimmunol.170.2.788; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490	55	525	553	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2008	9	11					1225	1235		10.1038/ni.1655	http://dx.doi.org/10.1038/ni.1655			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363EA	18820683	Green Accepted			2022-12-18	WOS:000260248600009
J	Miller, JC; Brown, BD; Shay, T; Gautier, EL; Jojic, V; Cohain, A; Pandey, G; Leboeuf, M; Elpek, KG; Helft, J; Hashimoto, D; Chow, A; Price, J; Greter, M; Bogunovic, M; Bellemare-Pelletier, A; Frenette, PS; Randolph, GJ; Turley, SJ; Merad, M				Miller, Jennifer C.; Brown, Brian D.; Shay, Tal; Gautier, Emmanuel L.; Jojic, Vladimir; Cohain, Ariella; Pandey, Gaurav; Leboeuf, Marylene; Elpek, Kutlu G.; Helft, Julie; Hashimoto, Daigo; Chow, Andrew; Price, Jeremy; Greter, Melanie; Bogunovic, Milena; Bellemare-Pelletier, Angelique; Frenette, Paul S.; Randolph, Gwendalyn J.; Turley, Shannon J.; Merad, Miriam		Immunological Genome Consortium	Deciphering the transcriptional network of the dendritic cell lineage	NATURE IMMUNOLOGY			English	Article							IN-VIVO; LYMPH-NODES; IMMUNE REGULATION; BONE-MARROW; FLT3 LIGAND; RECEPTOR; EXPRESSION; MICE; HETEROGENEITY; HEMATOPOIESIS	Although much progress has been made in the understanding of the ontogeny and function of dendritic cells (DCs), the transcriptional regulation of the lineage commitment and functional specialization of DCs in vivo remains poorly understood. We made a comprehensive comparative analysis of CD8(+), CD103(+), CD11b(+) and plasmacytoid DC subsets, as well as macrophage DC precursors and common DC precursors, across the entire immune system. Here we characterized candidate transcriptional activators involved in the commitment of myeloid progenitor cells to the DC lineage and predicted regulators of DC functional diversity in tissues. We identified a molecular signature that distinguished tissue DCs from macrophages. We also identified a transcriptional program expressed specifically during the steady-state migration of tissue DCs to the draining lymph nodes that may control tolerance to self tissue antigens.	[Miller, Jennifer C.; Brown, Brian D.; Gautier, Emmanuel L.; Leboeuf, Marylene; Helft, Julie; Hashimoto, Daigo; Chow, Andrew; Price, Jeremy; Greter, Melanie; Bogunovic, Milena; Randolph, Gwendalyn J.; Merad, Miriam] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA; [Miller, Jennifer C.; Leboeuf, Marylene; Helft, Julie; Hashimoto, Daigo; Chow, Andrew; Price, Jeremy; Greter, Melanie; Bogunovic, Milena; Merad, Miriam] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA; [Brown, Brian D.; Cohain, Ariella; Pandey, Gaurav] Mt Sinai Sch Med, Inst Genom & Multiscale Biol, Dept Genet & Genom Sci, New York, NY USA; [Shay, Tal] Broad Inst, Cambridge, MA USA; [Gautier, Emmanuel L.; Randolph, Gwendalyn J.] Mt Sinai Sch Med, Dept Regenerat Biol, New York, NY USA; [Gautier, Emmanuel L.; Randolph, Gwendalyn J.] Washington Univ, Dept Pathol & Immunol, St Louis, MO USA; [Jojic, Vladimir; Greter, Melanie] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Elpek, Kutlu G.; Bellemare-Pelletier, Angelique; Turley, Shannon J.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Chow, Andrew; Frenette, Paul S.] Albert Einstein Coll Med, Bronx, NY 10467 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Icahn School of Medicine at Mount Sinai; Washington University (WUSTL); Stanford University; Harvard University; Dana-Farber Cancer Institute; Yeshiva University; Albert Einstein College of Medicine	Merad, M (corresponding author), Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA.	miriam.merad@mssm.edu	Frenette, Paul S/J-8272-2012; Heng, Tracy/AAR-5712-2021; Hashimoto, Daigo/O-1013-2013; Gazit, Roi/J-3352-2017; Shay, Tal/J-4028-2016; Helft, Julie/ABE-6179-2020; Price, Jeremy G/G-1612-2013; Heng, Tracy/B-9847-2015; Gautier, Emmanuel L./E-2259-2017	Frenette, Paul S/0000-0003-0862-9922; Heng, Tracy/0000-0003-4147-8986; Hashimoto, Daigo/0000-0001-9489-9704; Shay, Tal/0000-0003-0755-1350; Helft, Julie/0000-0002-2733-1972; Price, Jeremy G/0000-0003-0491-3176; Heng, Tracy/0000-0003-4147-8986; Gautier, Emmanuel L./0000-0003-2976-7566; Fletcher, Anne/0000-0003-1534-1142; Tata, Nageswara Rao/0000-0002-9928-5944; Chow, Andrew/0000-0003-1151-2450; Gazit, Roi/0000-0002-0548-2147; Greter, Melanie/0000-0002-7220-5369; Kim, Charles/0000-0001-6474-8227; Malhotra, Deepali/0000-0002-8215-7639; kang, joonsoo/0000-0001-8419-7995	National Institute of Allergy and Infectious Diseases of the US National Institutes of Health [R24 AI072073, AI080884, HL086899, JDRF172010770, DP2DK083052-01, DK074500, AI045757, HL69438, DK056638, HL097819, HL097700, U54CA149145]; NATIONAL CANCER INSTITUTE [R01CA173861, U54CA149145, R01CA154947] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069438, R01HL086899, R01HL097819, R01HL097700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI045757, R01AI080884, R24AI072073, R01AI104848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK083052, R01DK056638, R01DK074500] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank colleagues of the ImmGen Project, especially the technical team, including M. Painter, J. Ericson and S. Davis, for contributions; C. Benoist for contributions to the design and writing of the manuscript; and eBioscience and Affymetrix for support of the ImmGen Project. Supported by the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health (R24 AI072073 to the ImmGen Project (led by C. Benoist); AI080884 and HL086899 to M.M.; JDRF172010770 and DP2DK083052-01 to B.D.B.; DK074500 and AI045757 to S.J.T.; HL69438, DK056638, HL097819 and HL097700 to P.S.F.; and U54CA149145 to V.J.).	Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; BROXMEYER HE, 1991, CANCER CELL-MON REV, V3, P480; Carotta S, 2010, IMMUNITY, V32, P628, DOI 10.1016/j.immuni.2010.05.005; Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Cyster JG, 1999, J EXP MED, V189, P447, DOI 10.1084/jem.189.3.447; del Rio ML, 2010, J LEUKOCYTE BIOL, V87, P223, DOI 10.1189/jlb.0809590; DiMartino JF, 2001, BLOOD, V98, P618, DOI 10.1182/blood.V98.3.618; Dorner BG, 2009, IMMUNITY, V31, P823, DOI 10.1016/j.immuni.2009.08.027; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Helft J, 2010, IMMUNOL REV, V234, P55, DOI 10.1111/j.0105-2896.2009.00885.x; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; Hochrein H, 2001, J IMMUNOL, V166, P5448, DOI 10.4049/jimmunol.166.9.5448; Jelinek I, 2011, J IMMUNOL, V186, P2422, DOI 10.4049/jimmunol.1002845; Laouar Y, 2003, IMMUNITY, V19, P903, DOI 10.1016/S1074-7613(03)00332-7; Lauterbach H, 2010, J EXP MED, V207, P2703, DOI 10.1084/jem.20092720; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; LYMAN SD, 1995, ONCOGENE, V10, P149; Malhotra D, 2012, NAT IMMUNOL, V13, P499, DOI 10.1038/ni.2262; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Minas K, 2006, CRIT REV IMMUNOL, V26, P213, DOI 10.1615/CritRevImmunol.v26.i3.20; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Ohtsuka H, 2011, J IMMUNOL, V186, P255, DOI 10.4049/jimmunol.0903714; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Posselt G, 2011, J IMMUNOL, V187, P2875, DOI 10.4049/jimmunol.1003348; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Reizis B, 2010, CURR OPIN IMMUNOL, V22, P206, DOI 10.1016/j.coi.2010.01.005; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Varol C, 2010, NAT REV IMMUNOL, V10, P415, DOI 10.1038/nri2778; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Wu L, 1997, IMMUNITY, V7, P483, DOI 10.1016/S1074-7613(00)80370-2; Yagil Z, 2010, TRENDS IMMUNOL, V31, P199, DOI 10.1016/j.it.2010.01.005	58	523	529	1	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2012	13	9					888	899		10.1038/ni.2370	http://dx.doi.org/10.1038/ni.2370			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	993MK	22797772	Green Submitted, Green Accepted			2022-12-18	WOS:000307863600018
J	Zust, R; Cervantes-Barragan, L; Habjan, M; Maier, R; Neuman, BW; Ziebuhr, J; Szretter, KJ; Baker, SC; Barchet, W; Diamond, MS; Siddell, SG; Ludewig, B; Thiel, V				Zuest, Roland; Cervantes-Barragan, Luisa; Habjan, Matthias; Maier, Reinhard; Neuman, Benjamin W.; Ziebuhr, John; Szretter, Kristy J.; Baker, Susan C.; Barchet, Winfried; Diamond, Michael S.; Siddell, Stuart G.; Ludewig, Burkhard; Thiel, Volker			Ribose 2 '-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5	NATURE IMMUNOLOGY			English	Article							MOUSE HEPATITIS-VIRUS; RIG-I; SARS-CORONAVIRUS; INNATE IMMUNITY; STRANDED-RNA; VACCINIA VIRUS; INTERFERON; PROTEIN; RECOGNITION; INFECTION	The 5' cap structures of higher eukaryote mRNAs have ribose 2'-O-methylation. Likewise, many viruses that replicate in the cytoplasm of eukaryotes have evolved 2'-O-methyltransferases to autonomously modify their mRNAs. However, a defined biological role for 2'-O-methylation of mRNA remains elusive. Here we show that 2'-O-methylation of viral mRNA was critically involved in subverting the induction of type I interferon. We demonstrate that human and mouse coronavirus mutants lacking 2'-O-methyltransferase activity induced higher expression of type I interferon and were highly sensitive to type I interferon. Notably, the induction of type I interferon by viruses deficient in 2'-O-methyltransferase was dependent on the cytoplasmic RNA sensor Mda5. This link between Mda5-mediated sensing of viral RNA and 2'-O-methylation of mRNA suggests that RNA modifications such as 2'-O-methylation provide a molecular signature for the discrimination of self and non-self mRNA.	[Zuest, Roland; Cervantes-Barragan, Luisa; Habjan, Matthias; Maier, Reinhard; Ludewig, Burkhard; Thiel, Volker] Kantonal Hosp St Gallen, Inst Immunobiol, St Gallen, Switzerland; [Neuman, Benjamin W.] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Ziebuhr, John] Queens Univ Belfast, Ctr Infect & Immun, Belfast, Antrim, North Ireland; [Ziebuhr, John] Univ Giessen, Inst Med Virol, Giessen, Germany; [Szretter, Kristy J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, Dept Med, St Louis, MO 63110 USA; [Szretter, Kristy J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Baker, Susan C.] Loyola Univ, Stritch Sch Med, Dept Microbiol & Immunol, Maywood, IL 60153 USA; [Barchet, Winfried] Univ Bonn, Univ Hosp, Inst Clin Chem & Pharmacol, D-5300 Bonn, Germany; [Siddell, Stuart G.] Univ Bristol, Sch Med & Vet Sci, Dept Cellular & Mol Med, Bristol, Avon, England; [Ludewig, Burkhard; Thiel, Volker] Univ Zurich, Vetsuisse Fac, Zurich, Switzerland	Kantonsspital St. Gallen; University of Reading; Queens University Belfast; Justus Liebig University Giessen; Washington University (WUSTL); Washington University (WUSTL); Loyola University Chicago; University of Bonn; University of Bristol; University of Zurich	Thiel, V (corresponding author), Kantonal Hosp St Gallen, Inst Immunobiol, St Gallen, Switzerland.	volker.thiel@kssg.ch	Thiel, Volker/AAI-2391-2019; Maier, Reinhard/AAH-5159-2020; Diamond, Michael/AAH-1733-2019; Ziebuhr, John/G-7669-2015	Diamond, Michael/0000-0002-8791-3165; Neuman, Benjamin/0000-0003-1240-8954; Szretter, Kristy/0000-0003-0391-2307; Ziebuhr, John/0000-0002-5741-8825; Thiel, Volker/0000-0002-5783-0887; Habjan, Matthias/0000-0002-3623-4496; Siddell, Stuart/0000-0002-8702-7868; Barchet, Winfried/0000-0002-6745-6606	Swiss National Science Foundation; European Commission (TOLERAGE); Novartis Foundation for Biomedical Research, Switzerland; German Ministry of Education and Research; Austrian Science Fund [FWF J3044]; Deutsche Forschungsgemeinschaft; National Institutes of Health [AI060915, AI085089, U54 AI081680]; Medical Research Council; Wellcome Trust; Biotechnology and Biological Sciences Research Council [BB/G012067/1] Funding Source: researchfish; BBSRC [BB/G012067/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI081680, R01AI085089, P01AI060915] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Commission (TOLERAGE)(European CommissionEuropean Commission Joint Research Centre); Novartis Foundation for Biomedical Research, Switzerland; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Austrian Science Fund(Austrian Science Fund (FWF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank V. Lohmann (University of Heidelberg) for Huh-7 cells; G. L. Smith (Imperial College, London) for D980R cells; S. G. Sawicki (Medical University of Ohio) for 17Cl1 cells; M. Pelegrin (Institut de Genetique Moleculaire de Montpellier) for LL171 cells; L. Onder for assistance with fluorescence microscopy; and R. de Giuli, B. Schelle and N. Karl for technical assistance. This study was supported by the Swiss National Science Foundation, the European Commission (TOLERAGE), the Novartis Foundation for Biomedical Research, Switzerland, the German Ministry of Education and Research (V. T.), the Austrian Science Fund (FWF J3044 to M. H.), Deutsche Forschungsgemeinschaft (J.Z.), the National Institutes of Health (AI060915 and AI085089 to S. C. B.; U54 AI081680 (Pacific Northwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research to M. S. D), the Medical Research Council (B. W. N.) and the Wellcome Trust (S.G.S.).	Bocharov G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001017; Bouvet M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000863; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Cervantes-Barragan L, 2007, BLOOD, V109, P1131, DOI 10.1182/blood-2006-05-023770; Cervantes-Barragan L, 2009, J IMMUNOL, V182, P1099, DOI 10.4049/jimmunol.182.2.1099; Chen Y, 2009, P NATL ACAD SCI USA, V106, P3484, DOI 10.1073/pnas.0808790106; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Decroly E, 2008, J VIROL, V82, P8071, DOI 10.1128/JVI.00407-08; Eriksson Klara Kristin, 2008, V454, P237, DOI 10.1007/978-1-59745-181-9_18; FAUMAN EB, 1999, S ADENOSYLMETHIONINE, P1, DOI DOI 10.1142/9789812813077_0001; Feder M, 2003, GENE, V302, P129, DOI 10.1016/S0378-1119(02)01097-1; Fensterl V, 2011, J INTERF CYTOK RES, V31, P71, DOI 10.1089/jir.2010.0101; Ghosh A, 2010, WIRES RNA, V1, P152, DOI 10.1002/wrna.19; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Gosert R, 2002, J VIROL, V76, P3697, DOI 10.1128/JVI.76.8.3697-3708.2002; Haller O, 2007, CURR TOP MICROBIOL, V316, P315; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hui DJ, 2005, J BIOL CHEM, V280, P3433, DOI 10.1074/jbc.M406700200; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Le Gall O, 2008, ARCH VIROL, V153, P715, DOI 10.1007/s00705-008-0041-x; Loo YM, 2007, CURR TOP MICROBIOL, V316, P295; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Morin B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001038; Nallagatla SR, 2008, RNA, V14, P1201, DOI 10.1261/rna.1007408; Nallagatla SR, 2008, RNA BIOL, V5, P140, DOI 10.4161/rna.5.3.6839; NOMOTO A, 1977, NATURE, V268, P208, DOI 10.1038/268208a0; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; QI X, 2010, NATURE          1117, DOI DOI 10.1038/NATURE09605; Reguera J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001101; Rose KM, 2010, J VIROL, V84, P5656, DOI 10.1128/JVI.00211-10; Roth-Cross JK, 2008, J VIROL, V82, P9829, DOI 10.1128/JVI.01199-08; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; SCHNIERLE BS, 1992, P NATL ACAD SCI USA, V89, P2897, DOI 10.1073/pnas.89.7.2897; Shuman S, 2002, NAT REV MOL CELL BIO, V3, P619, DOI 10.1038/nrm880; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Terenzi F, 2006, J BIOL CHEM, V281, P34064, DOI 10.1074/jbc.M605771200; Thiel V, 2008, CYTOKINE GROWTH F R, V19, P121, DOI 10.1016/j.cytogfr.2008.01.001; UZE G, 1994, J MOL BIOL, V243, P245, DOI 10.1006/jmbi.1994.1651; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wunschmann S, 2002, J VIROL, V76, P4350, DOI 10.1128/JVI.76.9.4350-4356.2002; Zhou HX, 2010, MBIO, V1, DOI 10.1128/mBio.00219-10; Zust R, 2007, PLOS PATHOG, V3, P1062, DOI 10.1371/journal.ppat.0030109	46	523	547	1	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2011	12	2					137	U46		10.1038/ni.1979	http://dx.doi.org/10.1038/ni.1979			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	708QF	21217758	Bronze, Green Published, Green Accepted			2022-12-18	WOS:000286378400007
J	van Kooyk, Y; Rabinovich, GA				van Kooyk, Yvette; Rabinovich, Gabriel A.			Protein-glycan interactions in the control of innate and adaptive immune responses	NATURE IMMUNOLOGY			English	Review							C-TYPE LECTIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ANTIGEN-PRESENTING CELLS; N-LINKED GLYCANS; DENDRITIC CELLS; T-CELLS; DC-SIGN; LANGERHANS CELLS; DIFFERENTIAL GLYCOSYLATION; CARBOHYDRATE-RECOGNITION	The importance of protein glycosylation in the migration of immune cells throughout the body has been extensively appreciated. However, our awareness of the impact of glycosylation on the regulation of innate and adaptive immune responses is relatively new. An increasing number of studies reveal the relevance of glycosylation to pathogen recognition, to the modulation of the innate immune system and to the control of immune cell homeostasis and inflammation. Similarly important is the effect of glycan-containing 'information' in the development of autoimmune diseases and cancer. In this review, we provide an overview of these new directions and their impact in the field of glycoimmunology.	[van Kooyk, Yvette] Vrije Univ Amsterdam Med Ctr, Dept Mol Cell Biol & Immunol, NL-1081 BT Amsterdam, Netherlands; [Rabinovich, Gabriel A.] Natl Council Sci & Technol Res, Immunopathol Lab, Inst Biol & Med Expt, Ciudad De Buenos Aires, Spain	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	van Kooyk, Y (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Mol Cell Biol & Immunol, Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.	y.vankooyk@vumc.nl; gabyrabi@ciudad.com.ar		Van Kooyk, Yvette/0000-0001-5997-3665				Aarnoudse CA, 2006, CURR OPIN IMMUNOL, V18, P105, DOI 10.1016/j.coi.2005.11.001; Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Appelmelk BJ, 2003, J IMMUNOL, V170, P1635, DOI 10.4049/jimmunol.170.4.1635; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Bax M, 2007, J IMMUNOL, V179, P8216, DOI 10.4049/jimmunol.179.12.8216; Bergman M, 2006, NAT REV MICROBIOL, V4, P151, DOI 10.1038/nrmicro1344; Blasius AL, 2006, TRENDS IMMUNOL, V27, P255, DOI 10.1016/j.it.2006.04.005; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Blixt O, 2003, J BIOL CHEM, V278, P31007, DOI 10.1074/jbc.M304331200; Blois SM, 2007, NAT MED, V13, P1450, DOI 10.1038/nm1680; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Buzas EI, 2006, AUTOIMMUNITY, V39, P691, DOI 10.1080/08916930601061470; Chen HY, 2006, J IMMUNOL, V177, P4991, DOI 10.4049/jimmunol.177.8.4991; Chung CD, 2000, J IMMUNOL, V165, P3722, DOI 10.4049/jimmunol.165.7.3722; Collins BE, 2004, P NATL ACAD SCI USA, V101, P6104, DOI 10.1073/pnas.0400851101; Collins BE, 2006, NAT IMMUNOL, V7, P199, DOI 10.1038/ni1283; Comelli EM, 2006, J IMMUNOL, V177, P2431, DOI 10.4049/jimmunol.177.4.2431; Correa SG, 2003, GLYCOBIOLOGY, V13, P119, DOI 10.1093/glycob/cwg010; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Crocker PR, 2005, CURR OPIN PHARMACOL, V5, P431, DOI 10.1016/j.coph.2005.03.003; Dai SY, 2005, J IMMUNOL, V175, P2974, DOI 10.4049/jimmunol.175.5.2974; Daniels MA, 2002, NAT IMMUNOL, V3, P903, DOI 10.1038/ni1002-903; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Feinberg H, 2007, J BIOL CHEM, V282, P4202, DOI 10.1074/jbc.M609689200; Feizi T, 2004, NAT REV MOL CELL BIO, V5, P582, DOI 10.1038/nrm1428; Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723; Fukumori T, 2003, CANCER RES, V63, P8302; Fulcher JA, 2006, J IMMUNOL, V177, P216, DOI 10.4049/jimmunol.177.1.216; Garcia-Vallejo JJ, 2008, MOL IMMUNOL, V45, P2359, DOI 10.1016/j.molimm.2007.11.001; Garin MI, 2007, BLOOD, V109, P2058, DOI 10.1182/blood-2006-04-016451; Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Green RS, 2007, IMMUNITY, V27, P308, DOI 10.1016/j.immuni.2007.06.008; Grewal PK, 2006, MOL CELL BIOL, V26, P4970, DOI 10.1128/MCB.00308-06; Grigorian A, 2007, J BIOL CHEM, V282, P20027, DOI 10.1074/jbc.M701890200; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Han S, 2005, NAT CHEM BIOL, V1, P93, DOI 10.1038/nchembio713; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Hodges A, 2007, NAT IMMUNOL, V8, P569, DOI 10.1038/ni1470; Hoffmann A, 2007, NAT IMMUNOL, V8, P694, DOI 10.1038/ni1480; Hokama A, 2004, IMMUNITY, V20, P681, DOI 10.1016/j.immuni.2004.05.009; Idoyaga J, 2008, J IMMUNOL, V180, P3647, DOI 10.4049/jimmunol.180.6.3647; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Juszczynski P, 2007, P NATL ACAD SCI USA, V104, P13134, DOI 10.1073/pnas.0706017104; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kawamura YI, 2005, CANCER RES, V65, P6220, DOI 10.1158/0008-5472.CAN-05-0639; Kel J, 2007, AM J PATHOL, V170, P272, DOI 10.2353/ajpath.2007.060335; Kubach J, 2007, BLOOD, V110, P1550, DOI 10.1182/blood-2007-01-069229; La M, 2003, AM J PATHOL, V163, P1505, DOI 10.1016/S0002-9440(10)63507-9; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Luca ME, 2005, J NEUROIMMUNOL, V160, P178, DOI 10.1016/j.jneuroim.2004.11.014; MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650; Meyer S, 2005, J BIOL CHEM, V280, P37349, DOI 10.1074/jbc.M507100200; Miyazaki K, 2004, CANCER RES, V64, P4498, DOI 10.1158/0008-5472.CAN-03-3614; Morgan R, 2004, J IMMUNOL, V173, P7200, DOI 10.4049/jimmunol.173.12.7200; Nieminen J, 2005, J LEUKOCYTE BIOL, V78, P1127; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Paclik D, 2008, J MOL MED, V86, P1395, DOI 10.1007/s00109-007-0290-2; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Paulson JC, 2006, NAT CHEM BIOL, V2, P238, DOI 10.1038/nchembio785; Pelletier I, 2003, J BIOL CHEM, V278, P22223, DOI 10.1074/jbc.M302693200; Perone MJ, 2006, J IMMUNOL, V177, P5278, DOI 10.4049/jimmunol.177.8.5278; POWELL LD, 1993, J BIOL CHEM, V268, P7019; Rabinovich GA, 2000, EUR J IMMUNOL, V30, P1331, DOI 10.1002/(SICI)1521-4141(200005)30:5<1331::AID-IMMU1331>3.3.CO;2-8; Rabinovich GA, 2007, CURR OPIN STRUC BIOL, V17, P513, DOI 10.1016/j.sbi.2007.09.002; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Rossi B, 2006, J IMMUNOL, V177, P796, DOI 10.4049/jimmunol.177.2.796; Rubinstein N, 2004, CANCER CELL, V5, P241, DOI 10.1016/S1535-6108(04)00024-8; Saeland E, 2007, CANCER IMMUNOL IMMUN, V56, P1225, DOI 10.1007/s00262-006-0274-z; Stambach NS, 2003, GLYCOBIOLOGY, V13, P401, DOI 10.1093/glycob/cwg045; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Stowell SR, 2007, BLOOD, V109, P219, DOI 10.1182/blood-2006-03-007153; Tacken PJ, 2007, NAT REV IMMUNOL, V7, P790, DOI 10.1038/nri2173; Takada A, 2004, J VIROL, V78, P2943, DOI 10.1128/JVI.78.6.2943-2947.2004; Tateno H, 2007, MOL CELL BIOL, V27, P5699, DOI 10.1128/MCB.00383-07; Taylor ME, 2007, CURR OPIN CELL BIOL, V19, P572, DOI 10.1016/j.ceb.2007.09.004; Togayachi A, 2007, P NATL ACAD SCI USA, V104, P15829, DOI 10.1073/pnas.0707426104; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Toscano MA, 2006, J IMMUNOL, V176, P6323, DOI 10.4049/jimmunol.176.10.6323; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Valenzuela HF, 2007, CANCER RES, V67, P6155, DOI 10.1158/0008-5472.CAN-05-4431; van den Berg TK, 2004, J IMMUNOL, V173, P1902, DOI 10.4049/jimmunol.173.3.1902; van der Leij J, 2007, MOL IMMUNOL, V44, P506, DOI 10.1016/j.molimm.2006.02.011; van Die I, 2006, CHEM IMMUNOL ALLERGY, V90, P91, DOI 10.1159/000088883; Van Dyken SJ, 2007, MOL CELL BIOL, V27, P1096, DOI 10.1128/MCB.01750-06; van Gisbergen KPJM, 2005, TRENDS IMMUNOL, V26, P626, DOI 10.1016/j.it.2005.09.007; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; van Liempt E, 2007, MOL IMMUNOL, V44, P2605, DOI 10.1016/j.molimm.2006.12.012; van Vliet SJ, 2008, TRENDS IMMUNOL, V29, P83, DOI 10.1016/j.it.2007.10.010; van Vliet SJ, 2006, NAT IMMUNOL, V7, P1200, DOI 10.1038/ni1390; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; York MR, 2007, ARTHRITIS RHEUM-US, V56, P1010, DOI 10.1002/art.22382; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	109	519	529	5	161	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2008	9	6					593	601		10.1038/ni.f.203	http://dx.doi.org/10.1038/ni.f.203			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	303VB	18490910	Bronze			2022-12-18	WOS:000256067900009
J	Kubo, M; Hanada, T; Yoshimura, A				Kubo, M; Hanada, T; Yoshimura, A			Suppressors of cytokine signaling and immunity	NATURE IMMUNOLOGY			English	Review							MICE LACKING SUPPRESSOR; STAT INHIBITOR-1 (SSI-1)/SUPPRESSOR; RECEPTOR SUBUNIT GP130; SOCS-BOX MOTIF; IN-VIVO; NEGATIVE REGULATION; T-CELLS; INFLAMMATORY ARTHRITIS; INTERFERON-GAMMA; KINASE-ACTIVITY	The suppressors of cytokine signaling (SOCS) and cytokine-inducible SH2 protein are key physiological regulators of the immune system. Principally, SOCS1 and SOCS3 regulate T cells as well as antigen-presenting cells, including macrophages and dendritic cells. Here we review the function of SOCS1 and SOCS3 in innate and adaptive immunity, with particular emphasis on the relationship between immune regulation and SOCS.	Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Higashi Ku, Fukuoka 8128582, Japan; Tokyo Univ Sci, Res Inst Biol Sci, Dept Immunobiol, Noda, Chiba 2780022, Japan	Kyushu University; Tokyo University of Science	Yoshimura, A (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yakihiko@bioreg.kyushu-u.ac.jp	Yoshimura, Akihiko/K-5515-2013					Alexander WS, 2002, NAT REV IMMUNOL, V2, P410, DOI 10.1038/nri818; Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Atsumi T, 2002, J EXP MED, V196, P979, DOI 10.1084/jem.20020619; Banerjee A, 2002, J IMMUNOL, V168, P4277, DOI 10.4049/jimmunol.168.9.4277; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; Bode JG, 1999, FEBS LETT, V463, P365, DOI 10.1016/S0014-5793(99)01662-2; Brod SA, 2002, J INTERF CYTOK RES, V22, P1153, DOI 10.1089/10799900260475669; Bullen DVR, 2001, IMMUNOLOGY, V104, P92, DOI 10.1046/j.1365-2567.2001.01294.x; Cheng FD, 2003, IMMUNITY, V19, P425, DOI 10.1016/S1074-7613(03)00232-2; Chong MMW, 2003, IMMUNITY, V18, P475, DOI 10.1016/S1074-7613(03)00078-5; Cohney SJ, 1999, MOL CELL BIOL, V19, P4980; COMISH AL, 2003, J BIOL CHEM, V278, P22755; Cornish AL, 2003, J IMMUNOL, V170, P878, DOI 10.4049/jimmunol.170.2.878; CREPSO A, 2000, BIOCHEM J, V349, P99; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Dalpke AH, 2001, J IMMUNOL, V166, P7082, DOI 10.4049/jimmunol.166.12.7082; De Sepulveda P, 1999, EMBO J, V18, P904; De Souza D, 2002, BIOCHEMISTRY-US, V41, P9229, DOI 10.1021/bi0259507; Diehl S, 2000, IMMUNITY, V13, P805, DOI 10.1016/S1074-7613(00)00078-9; Egan PJ, 2003, J CLIN INVEST, V111, P915, DOI 10.1172/JCI200316156; Egwuagu CE, 2002, J IMMUNOL, V168, P3181, DOI 10.4049/jimmunol.168.7.3181; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Eyles JL, 2002, J BIOL CHEM, V277, P43735, DOI 10.1074/jbc.M208586200; Favre H, 1999, FEBS LETT, V453, P63, DOI 10.1016/S0014-5793(99)00681-X; Frantsve J, 2001, MOL CELL BIOL, V21, P3547, DOI 10.1128/MCB.21.10.3547-3557.2001; Fujimoto M, 2002, INT IMMUNOL, V14, P1343, DOI 10.1093/intimm/dxf094; Giordanetto F, 2003, PROTEIN ENG, V16, P115, DOI 10.1093/proeng/gzg015; Greenhalgh CJ, 2002, GASTROENTEROLOGY, V123, P2064, DOI 10.1053/gast.2002.37068; Greenhalgh CJ, 2002, MOL ENDOCRINOL, V16, P1394, DOI 10.1210/me.16.6.1394; Greenhalgh CJ, 2002, J BIOL CHEM, V277, P40181, DOI 10.1074/jbc.C200450200; Haan S, 2003, J BIOL CHEM, V278, P31972, DOI 10.1074/jbc.M303170200; Hanada T, 2003, IMMUNITY, V19, P437, DOI 10.1016/S1074-7613(03)00240-1; Hortner M, 2002, EUR J BIOCHEM, V269, P2516, DOI 10.1046/j.1432-1033.2002.02916.x; Howard M, 1994, GUIDEBOOK CYTOKINES; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Ilangumaran S, 2003, BLOOD, V102, P4115, DOI 10.1182/blood-2003-01-0175; Ilangumaran S, 2003, J IMMUNOL, V171, P2435, DOI 10.4049/jimmunol.171.5.2435; Kamizono S, 2001, J BIOL CHEM, V276, P12530, DOI 10.1074/jbc.M010074200; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Kawazoe Y, 2001, J EXP MED, V193, P263, DOI 10.1084/jem.193.2.263; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Krebs DL, 2002, MOL CELL BIOL, V22, P4567, DOI 10.1128/MCB.22.13.4567-4578.2002; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; Lehmann U, 2003, J BIOL CHEM, V278, P661, DOI 10.1074/jbc.M210552200; LEWIS DB, 1991, J EXP MED, V173, P89, DOI 10.1084/jem.173.1.89; Li SL, 2000, J EXP MED, V191, P985, DOI 10.1084/jem.191.6.985; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Matsumoto A, 1999, MOL CELL BIOL, V19, P6396; Matsumoto A, 2003, J EXP MED, V197, P425, DOI 10.1084/jem.20020939; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Metcalf D, 2003, P NATL ACAD SCI USA, V100, P8436, DOI 10.1073/pnas.1032925100; Metcalf D, 2002, P NATL ACAD SCI USA, V99, P943, DOI 10.1073/pnas.022628499; Metcalf D, 2000, NATURE, V405, P1069, DOI 10.1038/35016611; Morita Y, 2000, P NATL ACAD SCI USA, V97, P5405, DOI 10.1073/pnas.090084797; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Naka T, 2001, IMMUNITY, V14, P535, DOI 10.1016/S1074-7613(01)00132-7; Naka T, 1998, P NATL ACAD SCI USA, V95, P15577, DOI 10.1073/pnas.95.26.15577; NAKA T, IN PRESS INT IMMUNOL; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Nicholson SE, 2000, P NATL ACAD SCI USA, V97, P6493, DOI 10.1073/pnas.100135197; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Ram PA, 1999, J BIOL CHEM, V274, P35553, DOI 10.1074/jbc.274.50.35553; Roberts AW, 2001, P NATL ACAD SCI USA, V98, P9324, DOI 10.1073/pnas.161271798; Sasaki A, 2000, J BIOL CHEM, V275, P29338, DOI 10.1074/jbc.M003456200; Seki Y, 2003, NAT MED, V9, P1047, DOI 10.1038/nm896; Seki Y, 2002, P NATL ACAD SCI USA, V99, P13003, DOI 10.1073/pnas.202477099; Shouda T, 2001, J CLIN INVEST, V108, P1781, DOI 10.1172/JCI13568; Sporri B, 2001, BLOOD, V97, P221, DOI 10.1182/blood.V97.1.221; Starr R, 1998, P NATL ACAD SCI USA, V95, P14395, DOI 10.1073/pnas.95.24.14395; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Takahashi Y, 2003, EMBO J, V22, P372, DOI 10.1093/emboj/cdg057; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071; Zhang JG, 2001, P NATL ACAD SCI USA, V98, P13261, DOI 10.1073/pnas.231486498	81	517	553	4	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2003	4	12					1169	1176		10.1038/ni1012	http://dx.doi.org/10.1038/ni1012			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	746VZ	14639467				2022-12-18	WOS:000186769500009
J	Brustle, A; Heink, S; Huber, M; Rosenplanter, C; Stadelmann, C; Yu, P; Arpaia, E; Mak, TW; Kamradt, T; Lohoff, M				Bruestle, Anne; Heink, Sylvia; Huber, Magdalena; Rosenplaenter, Christine; Stadelmann, Christine; Yu, Philipp; Arpaia, Enrico; Mak, Tak W.; Kamradt, Thomas; Lohoff, Michael			The development of inflammatory T-H-17 cells requires interferon-regulatory factor 4	NATURE IMMUNOLOGY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TRANSCRIPTION FACTOR FOXP3; SEQUENCE-BINDING PROTEIN; T-HELPER TYPE-1; IN-VIVO; IMMUNE-RESPONSES; FACTOR FAMILY; TGF-BETA; DIFFERENTIATION; INDUCTION	Interferon-regulatory factor 4 (IRF4) is essential for the development of T helper type 2 cells. Here we show that IRF4 is also critical for the generation of interleukin 17-producing T helper cells (T-H-17 cells), which are associated with experimental autoimmune encephalomyelitis. IRF4-deficient (Irf4(-/-)) mice did not develop experimental autoimmune encephalomyelitis, and T helper cells from such mice failed to differentiate into T-H-17 cells. Transfer of wild-type T helper cells into Irf4(-/-) mice rendered the mice susceptible to experimental autoimmune encephalomyelitis. Irf4(-/-) T helper cells had less expression of ROR gamma t and more expression of Foxp3, transcription factors important for the differentiation of T-H-17 and regulatory T cells, respectively. Altered regulation of both transcription factors contributed to the phenotype of Irf4(-/-) T helper cells. Our data position IRF4 at the center of T helper cell development, influencing not only T helper type 2 but also T-H-17 differentiation.	Inst Med Mikrobiol & Krankenhaushyg, D-35043 Marburg, Germany; Univ Jena, Inst Immunol, D-07740 Jena, Germany; Univ Gottingen, Inst Neuropathol, D-37075 Gottingen, Germany; Inst Immunol, D-35043 Marburg, Germany; Univ Toronto, Adv Med Discovery Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada	Friedrich Schiller University of Jena; University of Gottingen; University of Toronto; University of Toronto; University of Toronto	Lohoff, M (corresponding author), Inst Med Mikrobiol & Krankenhaushyg, D-35043 Marburg, Germany.	lohoff@med.uni-marburg.de	Huber, Magdalena/ABD-1810-2020; Kamradt, Thomas/E-9971-2018	Huber, Magdalena/0000-0002-2963-0693; Heink, Sylvia/0000-0002-3276-6313; Bruestle, Anne/0000-0002-3842-5683; Stadelmann, Christine/0000-0003-1766-5458; Kamradt, Thomas/0000-0001-8443-5893				Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Diehl S, 2000, IMMUNITY, V13, P805, DOI 10.1016/S1074-7613(00)00078-9; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Giese NA, 1997, J EXP MED, V186, P1535, DOI 10.1084/jem.186.9.1535; Grogan JL, 1999, J IMMUNOL, V163, P3764; Gupta S, 1999, J EXP MED, V190, P1837, DOI 10.1084/jem.190.12.1837; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hu CM, 2002, J BIOL CHEM, V277, P49238, DOI 10.1074/jbc.M205895200; Infante-Duarte C, 2000, J IMMUNOL, V165, P6107, DOI 10.4049/jimmunol.165.11.6107; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lohoff M, 2000, J EXP MED, V192, P325, DOI 10.1084/jem.192.3.325; Lohoff M, 2005, NAT REV IMMUNOL, V5, P125, DOI 10.1038/nri1552; Lohoff M, 2004, J EXP MED, V200, P247, DOI 10.1084/jem.20040182; Lohoff M, 2002, P NATL ACAD SCI USA, V99, P11808, DOI 10.1073/pnas.182425099; Lohoff M, 1997, IMMUNITY, V6, P681, DOI 10.1016/S1074-7613(00)80444-6; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mantel PY, 2006, J IMMUNOL, V176, P3593, DOI 10.4049/jimmunol.176.6.3593; Nessler S, 2006, J NEUROIMMUNOL, V179, P1, DOI 10.1016/j.jneuroim.2006.06.026; Nogai A, 2005, J IMMUNOL, V175, P959, DOI 10.4049/jimmunol.175.2.959; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461; SchartonKersten T, 1997, J EXP MED, V186, P1523, DOI 10.1084/jem.186.9.1523; Taki S, 1997, IMMUNITY, V6, P673, DOI 10.1016/S1074-7613(00)80443-4; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; ZHOU L, 2007, NAT IMMUNOL     0620; Zorn E, 2006, BLOOD, V108, P1571, DOI 10.1182/blood-2006-02-004747	38	516	546	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2007	8	9					958	966		10.1038/ni1500	http://dx.doi.org/10.1038/ni1500			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	202QN	17676043				2022-12-18	WOS:000248918200019
J	Cupedo, T; Crellin, NK; Papazian, N; Rombouts, EJ; Weijer, K; Grogan, JL; Fibbe, WE; Cornelissen, JJ; Spits, H				Cupedo, Tom; Crellin, Natasha K.; Papazian, Natalie; Rombouts, Elwin J.; Weijer, Kees; Grogan, Jane L.; Fibbe, Willem E.; Cornelissen, Jan J.; Spits, Hergen			Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127(+) natural killer-like cells	NATURE IMMUNOLOGY			English	Article							COLONY-STIMULATING FACTOR; T-CELL; B-CELL; AUTOIMMUNE-DISEASE; ORGAN DEVELOPMENT; GENE-EXPRESSION; PEYERS-PATCHES; NK-CELLS; GAMMA-T; SPI-B	The human body contains over 500 individual lymph nodes, yet the biology of their formation is poorly understood. Here we identify human lymphoid tissue-inducer cells (LTi cells) as lineage-negative RORC+ CD127(+) cells with the functional ability to interact with mesenchymal cells through lymphotoxin and tumor necrosis factor. Human LTi cells were committed natural killer (NK) cell precursors that produced interleukin 17 (IL-17) and IL-22. In vitro, LTi cells gave rise to RORC+ CD127+ NK cells that retained the ability to produce IL-17 and IL-22. Postnatally, similar populations of LTi cell-like cells and RORC+ CD127+ NK cells were present in tonsils, and both secreted IL-17 and IL-22 but no interferon-gamma. Our data indicate that lymph node organogenesis is controlled by an NK cell precursor population with adaptive immune features and demonstrate a previously unappreciated link between the innate and adaptive immune systems.	[Cupedo, Tom; Papazian, Natalie; Rombouts, Elwin J.; Cornelissen, Jan J.] Erasmus Univ, Med Ctr, Dept Hematol, NL-3000 CA Rotterdam, Netherlands; [Cupedo, Tom; Weijer, Kees; Spits, Hergen] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands; [Crellin, Natasha K.; Grogan, Jane L.; Spits, Hergen] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Fibbe, Willem E.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2300 RC Leiden, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; Roche Holding; Genentech; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Cupedo, T (corresponding author), Erasmus Univ, Med Ctr, Dept Hematol, NL-3000 CA Rotterdam, Netherlands.	t.cupedo@erasmusmc.nl	Spits, Hergen/N-2581-2019; Cupedo, Tom/GQQ-0614-2022	Spits, Hergen/0000-0003-3269-8338; 	The Netherlands Organization for Scientific Research [916.66.018]	The Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	We thank the staff of the Centers for Contraception, Sexual Health and Abortion in Leiden and Rotterdam and the Bloemenhove clinic in Heemstede for collection of fetal tissues; Y. Simons-Oosterhuis for help with quantitative PCR; M. Kuijf for acquiring tonsil tissue; and J. Samsom, R. Mebius, L. Lanier, L. Meyaard and members of the Hematology department of the Erasmus University Medical Center for critical reading of the manuscript. Supported by The Netherlands Organization for Scientific Research (VENI grant 916.66.018 to T. C.).	Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Anker PSI, 2003, HAEMATOLOGICA, V88, P845; Armengol MP, 2001, AM J PATHOL, V159, P861, DOI 10.1016/S0002-9440(10)61762-2; Boehm T, 2007, NAT IMMUNOL, V8, P131, DOI 10.1038/ni1435; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Coles MC, 2006, P NATL ACAD SCI USA, V103, P13457, DOI 10.1073/pnas.0604183103; Cupedo T, 2004, J IMMUNOL, V173, P4889, DOI 10.4049/jimmunol.173.8.4889; DERIE MA, 1988, LEUKEMIA RES, V12, P135, DOI 10.1016/0145-2126(88)90073-2; Dontje W, 2006, BLOOD, V107, P2446, DOI 10.1182/blood-2005-05-2090; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Facchetti F, 1998, SPRINGER SEMIN IMMUN, V19, P459, DOI 10.1007/BF00792602; Freud AG, 2006, J EXP MED, V203, P1033, DOI 10.1084/jem.20052507; Freud AG, 2005, IMMUNITY, V22, P295, DOI 10.1016/j.immuni.2005.01.013; Freud AG, 2006, IMMUNOL REV, V214, P56, DOI 10.1111/j.1600-065X.2006.00451.x; HIROSE T, 1994, BIOCHEM BIOPH RES CO, V205, P1976, DOI 10.1006/bbrc.1994.2902; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jones CE, 2002, AM J RESP CELL MOL, V26, P748, DOI 10.1165/ajrcmb.26.6.4757; Kurebayashi S, 2000, P NATL ACAD SCI USA, V97, P10132, DOI 10.1073/pnas.97.18.10132; KYRIAZIS AA, 1970, ARCH PATHOL, V90, P348; LUCI C, 2008, NAT IMMUNOL     1123, DOI DOI 10.1038/NI1681; MARKGRAF R, 1982, CELL TISSUE RES, V225, P387, DOI 10.1007/BF00214691; McAllister F, 2005, J IMMUNOL, V175, P404, DOI 10.4049/jimmunol.175.1.404; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Mebius RE, 2001, J IMMUNOL, V166, P6593, DOI 10.4049/jimmunol.166.11.6593; Nishikawa S, 2000, CURR OPIN IMMUNOL, V12, P342, DOI 10.1016/S0952-7915(00)00097-2; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Pahal GS, 2000, AM J OBSTET GYNECOL, V183, P1029, DOI 10.1067/mob.2000.106976; Park SY, 1995, IMMUNITY, V3, P771, DOI 10.1016/1074-7613(95)90066-7; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; SANOS SL, 2008, NAT IMMUNOL     1123, DOI DOI 10.1038/NI1684; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Schotte R, 2003, BLOOD, V101, P1015, DOI 10.1182/blood-2002-02-0438; SPENCER J, 1986, CLIN EXP IMMUNOL, V64, P536; SPENCER JO, 1986, GUT, V27, P405, DOI 10.1136/gut.27.4.405; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Weninger W, 2003, J IMMUNOL, V170, P4638, DOI 10.4049/jimmunol.170.9.4638; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yoshida H, 2002, IMMUNITY, V17, P823, DOI 10.1016/S1074-7613(02)00479-X	43	515	530	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2009	10	1					66	74		10.1038/ni.1668	http://dx.doi.org/10.1038/ni.1668			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	385BV	19029905				2022-12-18	WOS:000261788800013
J	Bedoui, S; Whitney, PG; Waithman, J; Eidsmo, L; Wakim, L; Caminschi, I; Allan, RS; Wojtasiak, M; Shortman, K; Carbone, FR; Brooks, AG; Heath, WR				Bedoui, Sammy; Whitney, Paul G.; Waithman, Jason; Eidsmo, Liv; Wakim, Linda; Caminschi, Irina; Allan, Rhys S.; Wojtasiak, Magdalena; Shortman, Ken; Carbone, Francis R.; Brooks, Andrew G.; Heath, William R.			Cross-presentation of viral and self antigens by skin-derived CD103(+) dendritic cells	NATURE IMMUNOLOGY			English	Article							HERPES-SIMPLEX-VIRUS; CD8(+) T-CELLS; LANGERHANS CELLS; IN-VIVO; CUTTING EDGE; STEADY-STATE; CONTACT HYPERSENSITIVITY; LYMPH-NODES; IMMUNITY; INFECTION	Skin-derived dendritic cells (DCs) include Langerhans cells, classical dermal DCs and a langerin-positive CD103(+) dermal subset. We examined their involvement in the presentation of skin-associated viral and self antigens. Only the CD103(+) subset efficiently presented antigens of herpes simplex virus type 1 to naive CD8(+) T cells, although all subsets presented these antigens to CD4(+) T cells. This showed that CD103+ DCs were the migratory subset most efficient at processing viral antigens into the major histocompatibility complex class I pathway, potentially through cross-presentation. This was supported by data showing only CD103(+) DCs efficiently cross-presented skin-derived self antigens. This indicates CD103(+) DCs are the main migratory subtype able to cross-present viral and self antigens, which identifies another level of specialization for skin DCs.	[Bedoui, Sammy; Whitney, Paul G.; Waithman, Jason; Eidsmo, Liv; Wakim, Linda; Allan, Rhys S.; Wojtasiak, Magdalena; Carbone, Francis R.; Brooks, Andrew G.; Heath, William R.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Bedoui, Sammy; Waithman, Jason; Caminschi, Irina; Shortman, Ken; Heath, William R.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia	University of Melbourne; Royal Melbourne Hospital; Walter & Eliza Hall Institute	Heath, WR (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia.	fcarbone@unimelb.edu.au; agbrooks@unimelb.edu.au; wrheath@unimelb.edu.au	Carbone, Francis/ABF-2141-2020	Allan, Rhys/0000-0003-0906-2980; Caminschi, Irina/0000-0002-9027-2098; Wakim, Linda/0000-0003-1752-9579; Waithman, Jason/0000-0003-4940-0155; Eidsmo, Liv/0000-0001-9237-8374; Whitney, Paul/0000-0003-3836-7601; BEDOUI, SAMMY/0000-0002-7443-0543; Brooks, Andrew/0000-0002-4085-9683; Heath, William/0000-0001-9670-259X	Deutsche Forschungsgemeinschaft [BE 3285-1/2]; National Health and Medical Research Council of Australia; Howard Hughes Medical Institute	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank the flow cytometry facilities and animal facility staff of the Walter and Eliza Hall Institute of Medical Research and K. Field; we also thank B. Davies and J. Langley for technical assistance. Supported by Deutsche Forschungsgemeinschaft (BE 3285-1/2 to S. B.), the National Health and Medical Research Council of Australia (W. R. H., F. R. C., A. G. B. and P. G. W.) and the Howard Hughes Medical Institute (W. R. H.).	Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Azukizawa H, 2003, EUR J IMMUNOL, V33, P1879, DOI 10.1002/eji.200323630; Belz GT, 2007, NAT IMMUNOL, V8, P1060, DOI 10.1038/ni1505; Belz GT, 2005, J IMMUNOL, V175, P196, DOI 10.4049/jimmunol.175.1.196; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Bennett CL, 2005, J CELL BIOL, V169, P569, DOI 10.1083/jcb.200501071; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; del Rio ML, 2007, J IMMUNOL, V178, P6861, DOI 10.4049/jimmunol.178.11.6861; den Haan JMM, 2002, J EXP MED, V196, P817, DOI 10.1084/jem.20020295; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Ginhoux F, 2007, J EXP MED, V204, P3133, DOI 10.1084/jem.20071733; He YK, 2006, IMMUNITY, V24, P643, DOI 10.1016/j.immuni.2006.03.014; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Jakubzick C, 2008, J IMMUNOL METHODS, V337, P121, DOI 10.1016/j.jim.2008.07.005; Jakubzick C, 2008, J EXP MED, V205, P2839, DOI 10.1084/jem.20081430; Jones CA, 2003, J VIROL, V77, P11139, DOI 10.1128/JVI.77.20.11139-11149.2003; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kruse M, 2000, J VIROL, V74, P7127, DOI 10.1128/JVI.74.15.7127-7136.2000; Lee HK, 2009, J EXP MED, V206, P359, DOI 10.1084/jem.20080601; Mueller SN, 2002, IMMUNOL CELL BIOL, V80, P156, DOI 10.1046/j.1440-1711.2002.01071.x; Poulin LF, 2007, J EXP MED, V204, P3119, DOI 10.1084/jem.20071724; Salio M, 1999, EUR J IMMUNOL, V29, P3245, DOI 10.1002/(SICI)1521-4141(199910)29:10<3245::AID-IMMU3245>3.3.CO;2-O; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; SIMMONS A, 1984, J VIROL, V52, P816, DOI 10.1128/JVI.52.3.816-821.1984; Smith CM, 2003, J IMMUNOL, V170, P4437, DOI 10.4049/jimmunol.170.9.4437; Steinman RM, 2007, NAT MED, V13, P1155, DOI 10.1038/nm1643; Stock AT, 2004, J IMMUNOL, V173, P2241, DOI 10.4049/jimmunol.173.4.2241; Stoitzner P, 2006, P NATL ACAD SCI USA, V103, P7783, DOI 10.1073/pnas.0509307103; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; van Lint A, 2004, J IMMUNOL, V172, P392, DOI 10.4049/jimmunol.172.1.392; Villadangos JA, 2005, SEMIN IMMUNOL, V17, P262, DOI 10.1016/j.smim.2005.05.015; Waithman J, 2007, J IMMUNOL, V179, P4535, DOI 10.4049/jimmunol.179.7.4535; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869; Wakim LM, 2008, IMMUNOL CELL BIOL, V86, P666, DOI 10.1038/icb.2008.47; Wilson NS, 2006, NAT IMMUNOL, V7, P165, DOI 10.1038/ni1300; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109	48	514	530	0	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2009	10	5					488	495		10.1038/ni.1724	http://dx.doi.org/10.1038/ni.1724			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	436EC	19349986				2022-12-18	WOS:000265394400010
J	Barton, GM; Kagan, JC; Medzhitov, R				Barton, GM; Kagan, JC; Medzhitov, R			Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA	NATURE IMMUNOLOGY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; BACTERIAL-DNA; CPG-DNA; SUBCELLULAR-LOCALIZATION; DENDRITIC CELLS; B-CELLS; ACTIVATION; TLR4; MICE; MUTATIONS	Toll-like receptors (TLRs) sense infection by detecting molecular structures of microbial origin. TLR3, TLR7 and TLR9 recognize nucleic acids and are localized to intracellular compartments where they normally respond to viral nucleic acids. The purpose for this intracellular localization, however, is not clear. Here we describe a chimeric TLR9 receptor that localized to the cell surface and responded normally to synthetic TLR9 ligands but not to viral nucleic acids. However, the 'relocated' chimeric TLR9 receptor was able to recognize self DNA, which does not stimulate wild-type TLR9. These data demonstrated that intracellular localization of TLR9 was not required for ligand recognition. Instead, localization of the nucleic acid-sensing TLRs is critical in discriminating between self and nonself nucleic acid.	Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; Yale University; University of California System; University of California Berkeley	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA.	ruslan.medzhitov@yale.edu		Barton, Gregory/0000-0002-3793-0100	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055502, R01AI046688, R37AI046688, T32AI007019] Funding Source: NIH RePORTER; NIAID NIH HHS [AI055502, AI07019, AI46688] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Barton GM, 2002, P NATL ACAD SCI USA, V99, P14943, DOI 10.1073/pnas.242594499; Boule MW, 2004, J EXP MED, V199, P1631, DOI 10.1084/jem.20031942; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Funami K, 2004, INT IMMUNOL, V16, P1143, DOI 10.1093/intimm/dxh115; Gilliet M, 2002, J EXP MED, V195, P953, DOI 10.1084/jem.20020045; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Nishiya T, 2004, J BIOL CHEM, V279, P19008, DOI 10.1074/jbc.M311618200; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Reggiori F, 2002, NAT CELL BIOL, V4, P117, DOI 10.1038/ncb743; Shlomchik MJ, 2001, NAT REV IMMUNOL, V1, P147, DOI 10.1038/35100573; SPITZER S, 1988, NUCLEIC ACIDS RES, V16, P11691, DOI 10.1093/nar/16.24.11691; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070	34	514	565	2	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2006	7	1					49	56		10.1038/ni1280	http://dx.doi.org/10.1038/ni1280			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	995XZ	16341217				2022-12-18	WOS:000234139700018
J	Klein, U; Casola, S; Cattoretti, G; Shen, Q; Lia, M; Mo, TW; Ludwig, T; Rajewsky, K; Dalla-Favera, R				Klein, Ulf; Casola, Stefano; Cattoretti, Giorgio; Shen, Qiong; Lia, Marie; Mo, Tongwei; Ludwig, Thomas; Rajewsky, Klaus; Dalla-Favera, Riccardo			Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination	NATURE IMMUNOLOGY			English	Article							CENTER B-CELLS; GERMINAL-CENTER FORMATION; REGULATORY FACTOR FAMILY; GENE-EXPRESSION; TERMINAL DIFFERENTIATION; SOMATIC HYPERMUTATION; PRIMARY IMMUNIZATION; AFFINITY MATURATION; BLIMP-1 EXPRESSION; HODGKIN LYMPHOMA	B cells producing high-affinity antibodies are destined to differentiate into memory B cells and plasma cells, but the mechanisms leading to those differentiation pathways are mostly unknown. Here we report that the transcription factor IRF4 is required for the generation of plasma cells. Transgenic mice with conditional deletion of Irf4 in germinal center B cells lacked post-germinal center plasma cells and were unable to differentiate memory B cells into plasma cells. Plasma cell differentiation required IRF4 as well as the transcriptional repressor Blimp-1, which both acted 'upstream' of the transcription factor XBP-1. In addition, IRF4-deficient B cells had impaired expression of activation-induced deaminase and lacked class-switch recombination, suggesting an independent function for IRF4 in this process. These results identify IRF4 as a crucial transcriptional 'switch' in the generation of functionally competent plasma cells.	Columbia Univ, Inst Canc Genet, Dept Pathol, New York, NY 10032 USA; Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA	Columbia University; Columbia University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Dalla-Favera, R (corresponding author), Columbia Univ, Inst Canc Genet, Dept Pathol, New York, NY 10032 USA.	rd10@columbia.edu	Casola, Stefano/O-3922-2014; Cattoretti, Giorgio/H-2340-2011; Casola, Stefano/AAN-8319-2021; Ludwig, Thomas/Q-6484-2016	Casola, Stefano/0000-0001-5580-0986; Ludwig, Thomas/0000-0003-3461-2585; Cattoretti, Giorgio/0000-0003-3799-3221; Rajewsky, Klaus/0000-0002-6633-6370	NCI NIH HHS [CA92625, CA098285, CA37295] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA092625, R37CA037295, U01CA037295, R01CA037295, R01CA098285] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Angelin-Duclos C, 2000, J IMMUNOL, V165, P5462, DOI 10.4049/jimmunol.165.10.5462; Basso K, 2004, BLOOD, V104, P4088, DOI 10.1182/blood-2003-12-4291; Blink EJ, 2005, J EXP MED, V201, P545, DOI 10.1084/jem.20042060; Casola S, 2006, P NATL ACAD SCI USA, V103, P7396, DOI 10.1073/pnas.0602353103; Cattoretti G, 2005, J PATHOL, V206, P76, DOI 10.1002/path.1752; Cattoretti G, 2006, BLOOD, V107, P3967, DOI 10.1182/blood-2005-10-4170; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Eisenberg L, 1977, Cult Med Psychiatry, V1, P9, DOI 10.1007/BF00114808; Faili A, 2002, NAT IMMUNOL, V3, P815, DOI 10.1038/ni826; Falini B, 2000, BLOOD, V95, P2084, DOI 10.1182/blood.V95.6.2084; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Fornek JL, 2006, BLOOD, V107, P1085, DOI 10.1182/blood-2005-07-2871; Gonda H, 2003, J EXP MED, V198, P1427, DOI 10.1084/jem.20030802; Gupta S, 1999, J EXP MED, V190, P1837, DOI 10.1084/jem.190.12.1837; Hasbold J, 2004, NAT IMMUNOL, V5, P55, DOI 10.1038/ni1016; Hasbold J, 1998, EUR J IMMUNOL, V28, P1040, DOI 10.1002/(SICI)1521-4141(199803)28:03<1040::AID-IMMU1040>3.3.CO;2-0; Iida S, 1997, NAT GENET, V17, P226, DOI 10.1038/ng1097-226; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Kinoshita K, 2001, P NATL ACAD SCI USA, V98, P12620, DOI 10.1073/pnas.221454398; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Klein U, 2002, EUR J IMMUNOL, V32, P316, DOI 10.1002/1521-4141(200202)32:2<316::AID-IMMU316>3.0.CO;2-P; Knodel M, 2001, EUR J IMMUNOL, V31, P1972; KRAAL G, 1982, NATURE, V298, P377, DOI 10.1038/298377a0; LAYTON JE, 1984, J EXP MED, V160, P1850, DOI 10.1084/jem.160.6.1850; Lee CH, 2006, J EXP MED, V203, P63, DOI 10.1084/jem.20051450; Lohoff M, 2004, J EXP MED, V200, P247, DOI 10.1084/jem.20040182; Lu RQ, 2003, GENE DEV, V17, P1703, DOI 10.1101/gad.1104803; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Mamane Y, 1999, GENE, V237, P1, DOI 10.1016/S0378-1119(99)00262-0; Marecki S, 2002, J INTERF CYTOK RES, V22, P121, DOI 10.1089/107999002753452737; MATSUYAMA T, 1995, NUCLEIC ACIDS RES, V23, P2127, DOI 10.1093/nar/23.12.2127; MCHEYZERWILLIAMS MG, 1993, J EXP MED, V178, P295, DOI 10.1084/jem.178.1.295; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Pernis AB, 2002, J INTERF CYTOK RES, V22, P111, DOI 10.1089/107999002753452728; Raaphorst FM, 2000, J IMMUNOL, V164, P1, DOI 10.4049/jimmunol.164.1.1; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Randall TD, 1998, IMMUNITY, V8, P733, DOI 10.1016/S1074-7613(00)80578-6; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Ridderstad A, 1998, J IMMUNOL, V160, P4688; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; SANDERSON RD, 1989, CELL REGUL, V1, P27, DOI 10.1091/mbc.1.1.27; Savage KJ, 2003, BLOOD, V102, P3871, DOI 10.1182/blood-2003-06-1841; Scheeren FA, 2005, NAT IMMUNOL, V6, P303, DOI 10.1038/ni1172; Sciammas R, 2004, J IMMUNOL, V172, P5427, DOI 10.4049/jimmunol.172.9.5427; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; van der Stoep N, 2004, BLOOD, V104, P2849, DOI 10.1182/blood-2004-03-0790; WEISS U, 1990, J EXP MED, V172, P1681, DOI 10.1084/jem.172.6.1681; Yamagata T, 1996, MOL CELL BIOL, V16, P1283; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161	53	513	518	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2006	7	7					773	782		10.1038/ni1357	http://dx.doi.org/10.1038/ni1357			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	054LH	16767092				2022-12-18	WOS:000238377700023
J	Apetoh, L; Quintana, FJ; Pot, C; Joller, N; Xiao, S; Kumar, D; Burns, EJ; Sherr, DH; Weiner, HL; Kuchroo, VK				Apetoh, Lionel; Quintana, Francisco J.; Pot, Caroline; Joller, Nicole; Xiao, Sheng; Kumar, Deepak; Burns, Evan J.; Sherr, David H.; Weiner, Howard L.; Kuchroo, Vijay K.			The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27	NATURE IMMUNOLOGY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; AH RECEPTOR; CUTTING EDGE; GENE-EXPRESSION; T-H-17 CELLS; ACTIVATION; INDUCTION; IL-10; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; INTERLEUKIN-27	Type 1 regulatory T cells (Tr1 cells) that produce interleukin 10 (IL-10) are instrumental in the prevention of tissue inflammation, autoimmunity and graft-versus-host disease. The transcription factor c-Maf is essential for the induction of IL-10 by Tr1 cells, but the molecular mechanisms that lead to the development of these cells remain unclear. Here we show that the ligand-activated transcription factor aryl hydrocarbon receptor (AhR), which was induced by IL-27, acted in synergy with c-Maf to promote the development of Tr1 cells. After T cell activation under Tr1-skewing conditions, the AhR bound to c-Maf and promoted transactivation of the Il10 and Il21 promoters, which resulted in the generation of Tr1 cells and the amelioration of experimental autoimmune encephalomyelitis. Manipulating AhR signaling could therefore be beneficial in the resolution of excessive inflammatory responses.	[Apetoh, Lionel; Quintana, Francisco J.; Pot, Caroline; Joller, Nicole; Xiao, Sheng; Burns, Evan J.; Weiner, Howard L.; Kuchroo, Vijay K.] Harvard Univ, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [Sherr, David H.] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Boston University	Kuchroo, VK (corresponding author), Harvard Univ, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA.	hweiner@rics.bwh.harvard.edu; vkuchroo@rics.bwh.harvard.edu	Kalra, D/H-6661-2019; Apetoh, Lionel/G-3310-2014; Pot, Caroline/O-8590-2016; Joller, Nicole/G-7897-2015; Apetoh, Lionel/AIC-2384-2022; Quintana, Francisco Javier/AAB-6915-2020	Kalra, D/0000-0001-5254-4067; Apetoh, Lionel/0000-0002-2774-438X; Pot, Caroline/0000-0002-1146-3129; Joller, Nicole/0000-0003-1996-1672; Apetoh, Lionel/0000-0002-2774-438X; Sherr, David/0000-0003-3353-0553	US National Institutes of Health [R37NS030843, P01NS038037, P01AI056299, P01AI039671, AI435801, NS38037, 1K99AI075285, PO1-ES11624]; National Multiple Sclerosis Society [RG4111A1]; European Molecular Biology Organization; Harvard Medical School Office for Diversity and Community Partnership; Swiss National Science Foundation; SFGBM/PASMA [118720/1]; Novartis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R00AI075285, P01AI039671, R56AI093903, R01AI093903, K99AI075285, P01AI056299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011624] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038037, R37NS030843, R01NS030843] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Harvard Medical School Office for Diversity and Community Partnership; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SFGBM/PASMA; Novartis Foundation(Novartis); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. C. Miaw (National Taiwan University College of Medicine) for the IL-21 reporter construct; J. Xu (Mount Sinai School of Medicine) for the IL-10 reporter construct; I-C. Ho (Brigham and Women's Hospital, Harvard Medical School) for Maf-transgenic mice; D. Littman (The Kimmel Center for Biology and Medicine of the Skirball Institute, New York University School of Medicine) for the vector overexpressing AhR-GFP; C. Karp (Cincinnati Children's Hospital Research Foundation and the University of Cincinnati College of Medicine) for IL-10-enhanced green fluorescent protein reporter mice; and D. Kozoriz for cell sorting. Supported by the US National Institutes of Health (R37NS030843, P01NS038037, P01AI056299 and P01AI039671 to V. K. K.; AI435801 and NS38037 to H.L.W.; 1K99AI075285 to F.J.Q.; and PO1-ES11624 to D.H.S.), the National Multiple Sclerosis Society (RG4111A1 to F.J.Q.), the European Molecular Biology Organization (L.A.), the Harvard Medical School Office for Diversity and Community Partnership (F.J.Q.), the Swiss National Science Foundation (N.J., and SFGBM/PASMA 118720/1 to C.P.) and the Novartis Foundation (C.P.).	Allan LL, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-15; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Camacho IA, 2002, ARCH TOXICOL, V76, P570, DOI 10.1007/s00204-002-0390-2; Chiaro CR, 2008, BIOCHEMISTRY-US, V47, P8445, DOI 10.1021/bi800712f; Coquet JM, 2008, J IMMUNOL, V180, P7097, DOI 10.4049/jimmunol.180.11.7097; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Fitzgerald DC, 2007, J IMMUNOL, V179, P3268, DOI 10.4049/jimmunol.179.5.3268; Funatake CJ, 2005, J IMMUNOL, V175, P4184, DOI 10.4049/jimmunol.175.7.4184; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; Head JL, 2009, BIOCHEM PHARMACOL, V77, P642, DOI 10.1016/j.bcp.2008.10.031; Heath-Pagliuso S, 1998, BIOCHEMISTRY-US, V37, P11508, DOI 10.1021/bi980087p; Hibbert L, 2003, J INTERF CYTOK RES, V23, P513, DOI 10.1089/10799900360708632; Ho IC, 1998, J EXP MED, V188, P1859, DOI 10.1084/jem.188.10.1859; JONES PBC, 1985, SCIENCE, V227, P1499, DOI 10.1126/science.3856321; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Kerkvliet NI, 2009, IMMUNOTHERAPY-UK, V1, P539, DOI 10.2217/IMT.09.24; Kim DW, 2000, ONCOGENE, V19, P5498, DOI 10.1038/sj.onc.1203945; Klinge CM, 2000, ARCH BIOCHEM BIOPHYS, V373, P163, DOI 10.1006/abbi.1999.1552; Kobayashi S, 2008, RHEUMATOLOGY, V47, P1317, DOI 10.1093/rheumatology/ken259; KONG LY, 1994, AM J RESP CRIT CARE, V150, P1123, DOI 10.1164/ajrccm.150.4.7921446; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Marshall NB, 2008, J IMMUNOL, V181, P2382, DOI 10.4049/jimmunol.181.4.2382; Monteiro P, 2007, BIOCHEM BIOPH RES CO, V358, P442, DOI 10.1016/j.bbrc.2007.04.111; Morari J, 2010, METABOLISM, V59, P215, DOI 10.1016/j.metabol.2009.07.020; Murugaiyan G, 2009, J IMMUNOL, V183, P2435, DOI 10.4049/jimmunol.0900568; NICHOLSON LB, 1995, IMMUNITY, V3, P397, DOI 10.1016/1074-7613(95)90169-8; OKEY AB, 1989, MOL PHARMACOL, V35, P823; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pot C, 2010, J INTERF CYTOK RES, V30, P381, DOI 10.1089/jir.2010.0047; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Quintana FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009478; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Ryu HY, 2005, MOL PHARMACOL, V68, P1087, DOI 10.1124/mol.105.014712; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Schneider D, 2009, TOXICOL SCI, V108, P377, DOI 10.1093/toxsci/kfp028; Singh NP, 2008, MOL PHARMACOL, V73, P1722, DOI 10.1124/mol.107.043406; Spolski R, 2009, J IMMUNOL, V182, P2859, DOI 10.4049/jimmunol.0802978; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Whitlock JP, 1999, ANNU REV PHARMACOL, V39, P103, DOI 10.1146/annurev.pharmtox.39.1.103; Wolk K, 2010, SEMIN IMMUNOPATHOL, V32, P17, DOI 10.1007/s00281-009-0188-x; Wurster AL, 2002, J EXP MED, V196, P969, DOI 10.1084/jem.20020620; Xu JN, 2009, J IMMUNOL, V182, P6226, DOI 10.4049/jimmunol.0900123; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	51	512	542	2	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2010	11	9					854	U112		10.1038/ni.1912	http://dx.doi.org/10.1038/ni.1912			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	641HN	20676095	Green Accepted			2022-12-18	WOS:000281115500014
J	Tabeta, K; Hoebe, K; Janssen, EM; Du, X; Georgel, P; Crozat, K; Mudd, S; Mann, N; Sovath, S; Goode, J; Shamel, L; Herskovits, AA; Portnoy, DA; Cooke, M; Tarantino, LM; Wiltshire, T; Steinberg, BE; Grinstein, S; Beutler, B				Tabeta, K; Hoebe, K; Janssen, EM; Du, X; Georgel, P; Crozat, K; Mudd, S; Mann, N; Sovath, S; Goode, J; Shamel, L; Herskovits, AA; Portnoy, DA; Cooke, M; Tarantino, LM; Wiltshire, T; Steinberg, BE; Grinstein, S; Beutler, B			The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9	NATURE IMMUNOLOGY			English	Article							DOUBLE-STRANDED-RNA; IMMUNOSTIMULATORY CPG-OLIGODEOXYNUCLEOTIDES; AUTOREACTIVE B-CELLS; MHC CLASS-I; CYTOMEGALOVIRUS-INFECTION; CAENORHABDITIS-ELEGANS; MUSCLE-CONTRACTION; ACTIVATION; GENE; RESPONSES	Here we have identified 'triple D' (3d), a recessive N-ethyl-N-nitrosourea-induced mutation and phenotype in which no signaling occurs via the intracellular Toll-like receptors 3, 7 and 9 (sensors for double-stranded RNA, single-stranded RNA and unmethylated DNA, respectively). The 3d mutation also prevented cross-presentation and diminished major histocompatibility complex class II presentation of exogenous antigen; it also caused hypersusceptibility to infection by mouse cytomegalovirus and other microbes. By positional identification, we found 3d to be a missense allele of Unc93b1, which encodes the 12-membrane-spanning protein UNC-93B, a highly conserved molecule found in the endoplasmic reticulum with multiple paralogs in mammals. Innate responses to nucleic acids and exogenous antigen presentation, which both initiate in endosomes, thus seem to depend on an endoplasmic reticulum-resident protein, which suggests communication between these organellar systems.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92121 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Hosp Sick Children, Div Cell Biol, Toronto, ON M5G 1X8, Canada	Scripps Research Institute; La Jolla Institute for Immunology; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Novartis; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Beutler, B (corresponding author), Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA.	bruce@scripps.edu	Crozat, Karine/L-7297-2019; TABTA, KOICHI/AAG-6481-2020; georgel, philippe/P-5676-2016	Crozat, Karine/0000-0003-4761-3675; TABTA, KOICHI/0000-0002-7019-1872; georgel, philippe/0000-0001-6853-7080; Hoebe, Kasper/0000-0002-3626-8098				Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; AZUMA M, 1992, J EXP MED, V175, P353, DOI 10.1084/jem.175.2.353; Bayliss Douglas A, 2003, Mol Interv, V3, P205, DOI 10.1124/mi.3.4.205; Beutler B, 2005, IMMUNOGENETICS, V57, P385, DOI 10.1007/s00251-005-0011-3; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Borriello F, 1997, IMMUNITY, V6, P303, DOI 10.1016/S1074-7613(00)80333-7; CHEN LP, 1992, CELL, V71, P1093, DOI 10.1016/S0092-8674(05)80059-5; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; de Bouteiller O, 2005, J BIOL CHEM, V280, P38133, DOI 10.1074/jbc.M507163200; de la Cruz IP, 2003, J NEUROSCI, V23, P9133; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Edelson BT, 2002, J IMMUNOL, V169, P3869, DOI 10.4049/jimmunol.169.7.3869; Funami K, 2004, INT IMMUNOL, V16, P1143, DOI 10.1093/intimm/dxh115; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; GREENWALD IS, 1980, GENETICS, V96, P147; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Hoebe K, 2003, J ENDOTOXIN RES, V9, P250, DOI 10.1179/096805103225001459; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Jankowski A, 2002, J BIOL CHEM, V277, P6059, DOI 10.1074/jbc.M110059200; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; JENKINS MK, 1991, J IMMUNOL, V147, P2461; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Leadbetter Elizabeth A, 2003, Curr Dir Autoimmun, V6, P105; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; LEVIN JZ, 1992, J CELL BIOL, V117, P143, DOI 10.1083/jcb.117.1.143; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Macfarlane DE, 1998, J IMMUNOL, V160, P1122; Manzel L, 1999, J PHARMACOL EXP THER, V291, P1337; Martinson JJ, 1997, NAT GENET, V16, P100, DOI 10.1038/ng0597-100; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; McCaffrey RL, 2004, P NATL ACAD SCI USA, V101, P11386, DOI 10.1073/pnas.0403215101; Orange JS, 1996, J IMMUNOL, V156, P4746; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Schapiro FB, 2000, J BIOL CHEM, V275, P21025, DOI 10.1074/jbc.M002386200; Serbina NV, 2003, IMMUNITY, V19, P891, DOI 10.1016/S1074-7613(03)00330-3; Sureau A, 1997, NUCLEIC ACIDS RES, V25, P4513, DOI 10.1093/nar/25.22.4513; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Takeuchi O, 2000, J IMMUNOL, V164, P554, DOI 10.4049/jimmunol.164.2.554; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6	55	512	528	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2006	7	2					156	164		10.1038/ni1297	http://dx.doi.org/10.1038/ni1297			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	005DB	16415873				2022-12-18	WOS:000234801700016
J	Bhardwaj, G; Murdoch, B; Wu, D; Baker, DP; Williams, KP; Chadwick, K; Ling, LE; Karanu, FN; Bhatia, M				Bhardwaj, G; Murdoch, B; Wu, D; Baker, DP; Williams, KP; Chadwick, K; Ling, LE; Karanu, FN; Bhatia, M			Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation	NATURE IMMUNOLOGY			English	Article							STEM-CELLS; MULTILINEAGE HEMATOPOIESIS; DEVELOPMENTAL BIOLOGY; SIGNAL-TRANSDUCTION; DIFFERENTIATION; IDENTIFICATION; BLOOD; INDUCTION; EXPANSION; PROTEINS	A pool of stem cells that arise from the mesoderm during embryogenesis initiates hematopoiesis. However, factors that regulate the expansion of blood stem cells are poorly understood. We show here that cytokine-induced proliferation of primitive human hematopoietic cells could be inhibited with antibodies to hedgehog (Hh). Conversely, Sonic hedgehog (Shh) treatment induced the expansion of pluripotent human hematopoietic repopulating cells detected in immunodeficient mice. Noggin, a specific inhibitor of bone morphogenetic protein 4 (BMP-4), was capable of inhibiting Shh-induced proliferation in a similar manner to anti-Hh; however, anti-Hh had no effect on BMP-4-induced proliferation. Our study shows that Shh functions as a regulator of primitive hematopoietic cells via mechanisms that are dependent on downstream BMP signals.	John P Robarts Res Inst, London, ON N6A 5K8, Canada; Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada; Biogen Inc, Boston, MA USA	Western University (University of Western Ontario); Western University (University of Western Ontario); Biogen	Bhatia, M (corresponding author), John P Robarts Res Inst, 100 Perth Dr, London, ON N6A 5K8, Canada.	mbhatia@rri.on.ca						Altaba ARI, 1997, CELL, V90, P193, DOI 10.1016/S0092-8674(00)80325-6; Bhatia M, 1999, J EXP MED, V189, P1139, DOI 10.1084/jem.189.7.1139; Bhatia M, 1997, J EXP MED, V186, P619, DOI 10.1084/jem.186.4.619; Bhatia M, 1997, P NATL ACAD SCI USA, V94, P5320, DOI 10.1073/pnas.94.10.5320; Bonnet D, 1999, BONE MARROW TRANSPL, V23, P203, DOI 10.1038/sj.bmt.1701564; Cashman JD, 1997, BLOOD, V89, P4307, DOI 10.1182/blood.V89.12.4307; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Dale L, 1999, BIOESSAYS, V21, P751, DOI 10.1002/(SICI)1521-1878(199909)21:9<751::AID-BIES6>3.0.CO;2-I; Dick JE, 2000, NAT MED, V6, P624, DOI 10.1038/76188; Dick JE, 1997, STEM CELLS, V15, P199, DOI 10.1002/stem.5530150826; Dieterlen-Lievre F, 1998, CURR BIOL, V8, pR727, DOI 10.1016/S0960-9822(98)70460-9; DieterlenLievre F, 1997, INT ARCH ALLERGY IMM, V112, P3, DOI 10.1159/000237423; Domen J, 1999, MOL MED TODAY, V5, P201, DOI 10.1016/S1357-4310(99)01464-1; Dosch R, 1997, DEVELOPMENT, V124, P2325; Eaves C, 1999, ANN NY ACAD SCI, V872, P1, DOI 10.1111/j.1749-6632.1999.tb08447.x; Farrington SM, 1997, MECH DEVELOP, V62, P197, DOI 10.1016/S0925-4773(97)00664-3; Gallacher L, 2000, BLOOD, V96, P1740, DOI 10.1182/blood.V96.5.1740.h8001740_1740_1747; Gallacher L, 2000, BLOOD, V95, P2813, DOI 10.1182/blood.V95.9.2813.009k20_2813_2820; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hahn H, 1996, J BIOL CHEM, V271, P12125, DOI 10.1074/jbc.271.21.12125; Halene S, 2000, HUM GENE THER, V11, P1259, DOI 10.1089/10430340050032366; Hammerschmidt M, 1997, TRENDS GENET, V13, P14, DOI 10.1016/S0168-9525(96)10051-2; Holyoake TL, 1999, EXP HEMATOL, V27, P1418, DOI 10.1016/S0301-472X(99)00078-8; Ingham PW, 1998, EMBO J, V17, P3505, DOI 10.1093/emboj/17.13.3505; Ingham PW, 1998, NATURE, V394, P16, DOI 10.1038/27764; Iwamoto M, 1999, CRIT REV ORAL BIOL M, V10, P477, DOI 10.1177/10454411990100040401; LAPIDOT T, 1992, SCIENCE, V255, P1137, DOI 10.1126/science.1372131; Larochelle A, 1996, NAT MED, V2, P1329, DOI 10.1038/nm1296-1329; Maeno M, 1996, BLOOD, V88, P1965, DOI 10.1182/blood.V88.6.1965.bloodjournal8861965; Marigo V, 1996, BIOCHEM SOC SYMP, P51; Mathey-Prevot B, 1998, CELL, V92, P697, DOI 10.1016/S0092-8674(00)81396-3; McMahon AP, 2000, CELL, V100, P185, DOI 10.1016/S0092-8674(00)81555-X; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; Mead P E, 1998, Curr Opin Hematol, V5, P156; Miyazono K, 2000, J CELL SCI, V113, P1101; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; Motoyama J, 1998, NAT GENET, V20, P54, DOI 10.1038/1711; MULLIGAN RC, 1993, SCIENCE, V260, P926, DOI 10.1126/science.8493530; Murone M, 1999, EXP CELL RES, V253, P25, DOI 10.1006/excr.1999.4676; Murtaugh LC, 1999, GENE DEV, V13, P225, DOI 10.1101/gad.13.2.225; OGAWA M, 1993, BLOOD, V81, P2844; Ohlmeyer JT, 1998, NATURE, V396, P749, DOI 10.1038/25533; OSHIMA A, 1987, P NATL ACAD SCI USA, V84, P685, DOI 10.1073/pnas.84.3.685; Outram SV, 2000, IMMUNITY, V13, P187, DOI 10.1016/S1074-7613(00)00019-4; Perler FB, 1998, CELL, V92, P1, DOI 10.1016/S0092-8674(00)80892-2; PERRIMON N, 1995, CELL, V80, P517, DOI 10.1016/0092-8674(95)90503-0; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; ROBERTS DJ, 1995, DEVELOPMENT, V121, P3163; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Wang LC, 2000, J INVEST DERMATOL, V114, P901, DOI 10.1046/j.1523-1747.2000.00951.x; WANGER JE, 1998, LEUKEMIA, V12, pS30; Weed M, 1997, MATRIX BIOL, V16, P53, DOI 10.1016/S0945-053X(97)90072-X; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; WILLIAMS DA, 1993, BLOOD, V81, P3169; ZON LI, 1995, BLOOD, V86, P2876	57	511	558	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2001	2	2					172	180		10.1038/84282	http://dx.doi.org/10.1038/84282			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	398WD	11175816				2022-12-18	WOS:000166778700018
J	Onai, N; Obata-Onai, A; Schmid, MA; Ohteki, T; Jarrossay, D; Manz, MG				Onai, Nobuyuki; Obata-Onai, Aya; Schmid, Michael A.; Ohteki, Toshiaki; Jarrossay, David; Manz, Markus G.			Identification of clonogenic common Flt3(+) M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow	NATURE IMMUNOLOGY			English	Article							COLONY-STIMULATING FACTOR; MYELOID PROGENITORS; NATURAL-KILLER; FACTOR-1 RECEPTOR; LANGERHANS CELLS; LYMPHOID ORGANS; MICE LACKING; STEM-CELLS; IN-VIVO; LIGAND	Lymphoid tissue plasmacytoid and conventional dendritic cells (DCs) are continuously regenerated from hematopoietic stem cells. The cytokine dependence and biology of plasmacytoid and conventional DCs suggest that regeneration might proceed through common DC-restricted developmental intermediates. By selecting for cytokine receptor expression relevant to DC development, we identify here highly cycling Lin(-)c-Kit(int)Flt3(+)M-CSFR+ cells with a distinct gene-expression profile in mouse bone marrow that, on a clonal level in vitro and as a population both in vitro and in vivo, efficiently generated plasmacytoid and conventional DCs but no other lineages, which increased in number after in vivo injection of the cytokine Flt3 ligand. These clonogenic common DC progenitors thus define a cytokine-regulated DC developmental pathway that ensures the supply of various DC populations.	Inst Res Biomed, CH-6500 Bellinzona, Switzerland; Akita Univ, Grad Sch Med, Dept Immunol, Akita 0108543, Japan	Universita della Svizzera Italiana; Akita University	Manz, MG (corresponding author), Inst Res Biomed, CH-6500 Bellinzona, Switzerland.	manz@irb.unisi.ch	Manz, Markus G/C-7588-2011	Schmid, Michael A./0000-0002-1137-9322; Manz, Markus/0000-0002-4676-7931; Onai, Nobuyuki/0000-0003-2246-4917				Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bruno L, 2001, EUR J IMMUNOL, V31, P3403, DOI 10.1002/1521-4141(200111)31:11<3403::AID-IMMU3403>3.0.CO;2-T; Caux C, 1996, J EXP MED, V184, P695, DOI 10.1084/jem.184.2.695; Chicha L, 2004, J EXP MED, V200, P1519, DOI 10.1084/jem.20040809; Chklovskaia E, 2004, BLOOD, V103, P3860, DOI 10.1182/blood-2003-04-1200; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Cook DN, 2001, MOL CELL BIOL, V21, P3159, DOI 10.1128/MCB.21.9.3159-3165.2001; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; del Hoyo GM, 2002, NATURE, V415, P1043, DOI 10.1038/4151043a; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; GALY A, 1995, IMMUNITY, V3, P459, DOI 10.1016/1074-7613(95)90175-2; Gilliet M, 2002, J EXP MED, V195, P953, DOI 10.1084/jem.20020045; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kabashima K, 2005, IMMUNITY, V22, P439, DOI 10.1016/j.immuni.2005.02.007; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; Kanno Y, 2005, J INTERF CYTOK RES, V25, P770, DOI 10.1089/jir.2005.25.770; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Laouar Y, 2003, IMMUNITY, V19, P903, DOI 10.1016/S1074-7613(03)00332-7; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Lyman SD, 1998, BLOOD, V91, P1101, DOI 10.1182/blood.V91.4.1101; MacDonald KPA, 2005, J IMMUNOL, V175, P1399, DOI 10.4049/jimmunol.175.3.1399; Manz MG, 2001, BLOOD, V97, P3333, DOI 10.1182/blood.V97.11.3333; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; Maraskovsky E, 1996, J EXP MED, V184, P1953, DOI 10.1084/jem.184.5.1953; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Mende I, 2006, BLOOD, V107, P1383, DOI 10.1182/blood-2005-05-1878; Miller G, 2003, J IMMUNOL, V170, P3554, DOI 10.4049/jimmunol.170.7.3554; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Olweus J, 1997, P NATL ACAD SCI USA, V94, P12551, DOI 10.1073/pnas.94.23.12551; Onai N, 2006, J EXP MED, V203, P227, DOI 10.1084/jem.20051645; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schotte R, 2004, J EXP MED, V200, P1503, DOI 10.1084/jem.20041231; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Traver D, 2000, SCIENCE, V290, P2152, DOI 10.1126/science.290.5499.2152; Tussiwand R, 2005, J IMMUNOL, V175, P3674, DOI 10.4049/jimmunol.175.6.3674; Vremec D, 1997, EUR J IMMUNOL, V27, P40, DOI 10.1002/eji.1830270107; WALLNY HJ, 1995, EUR J IMMUNOL, V25, P1262, DOI 10.1002/eji.1830250520; WITMERPACK MD, 1993, J CELL SCI, V104, P1021; Zenke M, 2006, TRENDS IMMUNOL, V27, P140, DOI 10.1016/j.it.2005.12.007	49	510	519	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2007	8	11					1207	1216		10.1038/ni1518	http://dx.doi.org/10.1038/ni1518			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	222ZR	17922016				2022-12-18	WOS:000250338900013
J	Drayton, DL; Liao, S; Mounzer, RH; Ruddle, NH				Drayton, DL; Liao, S; Mounzer, RH; Ruddle, NH			Lymphoid organ development: from ontogeny to neogenesis	NATURE IMMUNOLOGY			English	Review							HIGH ENDOTHELIAL VENULES; NONOBESE DIABETIC MICE; CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HEV-RESTRICTED SULFOTRANSFERASE; VASCULAR ADDRESSIN MADCAM-1; LYMPHOTOXIN-BETA RECEPTOR; PERIPHERAL NODE ADDRESSIN; ALPHA-DEFICIENT MICE; T-CELL AREAS	The development of lymphoid organs can be viewed as a continuum. At one end are the `canonical' secondary lymphoid organs, including lymph nodes and spleen; at the other end are `ectopic' or tertiary lymphoid organs, which are cellular accumulations arising during chronic inflammation by the process of lymphoid neogenesis. Secondary lymphoid organs are genetically `preprogrammed' and `prepatterned' during ontogeny, whereas tertiary lymphoid organs arise under environmental influences and are not restricted to specific developmental `windows' or anatomic locations. Between these two boundaries are other types of lymphoid tissues that are less developmentally but more environmentally regulated, such as Peyer's patches, nasal-associated lymphoid tissue, bronchial-associated lymphoid tissue and inducible bronchial-associated lymphoid tissue. Their regulation, functions and potential effects are discussed here.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA	Yale University; Yale University	Ruddle, NH (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA.	nancy.ruddle@yale.edu			NATIONAL CANCER INSTITUTE [R01CA016885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK057731, R01DK057731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM020919] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA 16885] Funding Source: Medline; NIAID NIH HHS [AI 44453] Funding Source: Medline; NIDDK NIH HHS [DK 57731] Funding Source: Medline; NIGMS NIH HHS [F31 GM 20919] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Aguzzi A, 2005, IMMUNITY, V22, P145, DOI 10.1016/j.immuni.2004.12.007; Alimzhanov MB, 1997, P NATL ACAD SCI USA, V94, P9302, DOI 10.1073/pnas.94.17.9302; Amft N, 2001, ARTHRITIS RHEUM-US, V44, P2633, DOI 10.1002/1529-0131(200111)44:11<2633::AID-ART443>3.0.CO;2-9; Armengol MP, 2001, AM J PATHOL, V159, P861, DOI 10.1016/S0002-9440(10)61762-2; Armengol MP, 2003, J IMMUNOL, V170, P6320, DOI 10.4049/jimmunol.170.12.6320; Baddoura FK, 2005, AM J TRANSPLANT, V5, P510, DOI 10.1111/j.1600-6143.2004.00714.x; Bai YL, 2002, J IMMUNOL, V168, P1579, DOI 10.4049/jimmunol.168.4.1579; Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; BANKS TA, 1995, J IMMUNOL, V155, P1685; Barone F, 2005, ARTHRITIS RHEUM-US, V52, P1773, DOI 10.1002/art.21062; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; Bistrup A, 2004, AM J PATHOL, V164, P1635, DOI 10.1016/S0002-9440(10)63722-4; Bistrup A, 1999, J CELL BIOL, V145, P899, DOI 10.1083/jcb.145.4.899; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Bouneaud C, 2000, IMMUNITY, V13, P829, DOI 10.1016/S1074-7613(00)00080-7; Browning JL, 2005, IMMUNITY, V23, P539, DOI 10.1016/j.immuni.2005.10.002; BROWNING JL, 1993, CELL, V72, P847, DOI 10.1016/0092-8674(93)90574-A; CAHILL RNP, 1976, J EXP MED, V143, P870, DOI 10.1084/jem.143.4.870; CANNELLA B, 1990, J EXP MED, V172, P1521, DOI 10.1084/jem.172.5.1521; CARLSEN HS, 2004, BLOOD; Cavanagh LL, 2002, IMMUNOL CELL BIOL, V80, P448, DOI 10.1046/j.1440-1711.2002.01119.x; Chen SC, 2002, J IMMUNOL, V168, P1001, DOI 10.4049/jimmunol.168.3.1001; Columba-Cabezas S, 2003, BRAIN PATHOL, V13, P38; Constant SL, 2002, J CLIN INVEST, V110, P1441, DOI 10.1172/JCI200216109; CROWE PD, 1994, SCIENCE, V264, P707, DOI 10.1126/science.8171323; Cupedo T, 2004, IMMUNITY, V21, P655, DOI 10.1016/j.immuni.2004.09.006; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Cyster JG, 2003, IMMUNOL REV, V195, P5, DOI 10.1034/j.1600-065X.2003.00075.x; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Dogan A, 1997, AM J PATHOL, V151, P1361; Dorner Thomas, 2002, Autoimmun Rev, V1, P119, DOI 10.1016/S1568-9972(02)00029-0; Drayton DL, 2003, J EXP MED, V197, P1153, DOI 10.1084/jem.20021761; DUIJVESTIJN AM, 1988, AM J PATHOL, V130, P147; Eberl G, 2005, NAT REV IMMUNOL, V5, P413, DOI 10.1038/nri1600; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; EIKELENBOOM P, 1978, ANAT RECORD, V190, P201, DOI 10.1002/ar.1091900204; Fan L, 2000, J IMMUNOL, V164, P3955, DOI 10.4049/jimmunol.164.8.3955; Fava RA, 2003, J IMMUNOL, V171, P115, DOI 10.4049/jimmunol.171.1.115; Finke D, 2002, IMMUNITY, V17, P363, DOI 10.1016/S1074-7613(02)00395-3; FORCE WR, 1995, J IMMUNOL, V155, P5280; FRENI MA, 1995, HEPATOLOGY, V22, P389, DOI 10.1002/hep.1840220203; Fukuyama S, 2002, IMMUNITY, V17, P31, DOI 10.1016/S1074-7613(02)00339-4; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; GAUSE A, 1995, EUR J IMMUNOL, V25, P2775, DOI 10.1002/eji.1830251010; Ghosh S, 2005, J IMMUNOL, V174, P2860, DOI 10.4049/jimmunol.174.5.2860; GIRARD JP, 1995, IMMUNOL TODAY, V16, P449, DOI 10.1016/0167-5699(95)80023-9; GOERINGER GC, 1987, OTOLARYNG CLIN N AM, V20, P207; HALL JG, 1971, IMMUNOLOGY, V21, P69; HALL JG, 1980, IMMUNOLOGY, V39, P141; HAMELEERS DMH, 1989, CELL TISSUE RES, V256, P431, DOI 10.1007/BF00218901; Hanninen A, 1998, J IMMUNOL, V160, P6018; Harmsen A, 2002, J IMMUNOL, V168, P986, DOI 10.4049/jimmunol.168.3.986; HAY JB, 1974, CELL IMMUNOL, V10, P145, DOI 10.1016/0008-8749(74)90158-0; HAY JB, 1977, J EXP MED, V145, P31, DOI 10.1084/jem.145.1.31; He CF, 2002, J APPL PHYSIOL, V93, P966, DOI 10.1152/japplphysiol.00212.2002; Heikenwalder M, 2005, SCIENCE, V307, P1107, DOI 10.1126/science.1106460; HEMMERICH S, 1994, J EXP MED, V180, P2219, DOI 10.1084/jem.180.6.2219; Hemmi H, 2001, INT IMMUNOL, V13, P695, DOI 10.1093/intimm/13.5.695; Hillan KJ, 1999, LIVER, V19, P509, DOI 10.1111/j.1478-3231.1999.tb00084.x; Hiraoka N, 1999, IMMUNITY, V11, P79, DOI 10.1016/S1074-7613(00)80083-7; Hjelmstrom P, 2000, AM J PATHOL, V156, P1133, DOI 10.1016/S0002-9440(10)64981-4; Hjelmstrom P, 2001, J LEUKOCYTE BIOL, V69, P331; HOKE D, 1995, CURR BIOL, V5, P670, DOI 10.1016/S0960-9822(95)00132-1; Homeister JW, 2001, IMMUNITY, V15, P115, DOI 10.1016/S1074-7613(01)00166-2; Houtkamp MA, 2001, J PATHOL, V193, P263, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH774>3.0.CO;2-N; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Huntington GS, 1910, AM J ANAT, V10, P177, DOI 10.1002/aja.1000100108; Kaiserling E, 2001, LYMPHOLOGY, V34, P22; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; Katakai T, 2003, J IMMUNOL, V171, P4359, DOI 10.4049/jimmunol.171.8.4359; KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0; Kerjaschki D, 2004, J AM SOC NEPHROL, V15, P603, DOI 10.1097/01.ASN.0000113316.52371.2E; Kim HJ, 1999, J IMMUNOL, V162, P3053; Kobayashi M, 2004, P NATL ACAD SCI USA, V101, P17807, DOI 10.1073/pnas.0407503101; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; Kratz A, 1996, J EXP MED, V183, P1461, DOI 10.1084/jem.183.4.1461; Legler DF, 1998, J EXP MED, V187, P655, DOI 10.1084/jem.187.4.655; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lorenz RG, 2004, ANN NY ACAD SCI, V1029, P44, DOI 10.1196/annals.1309.006; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; Luther SA, 2003, J EXP MED, V197, P1191, DOI 10.1084/jem.20021294; Luther SA, 2002, J IMMUNOL, V169, P424, DOI 10.4049/jimmunol.169.1.424; Magliozzi R, 2004, J NEUROIMMUNOL, V148, P11, DOI 10.1016/j.jneuroim.2003.10.056; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; Martin AP, 2004, J IMMUNOL, V173, P4791, DOI 10.4049/jimmunol.173.8.4791; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Mazzucchelli L, 1999, J CLIN INVEST, V104, pR49, DOI 10.1172/JCI7830; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Mebius RE, 1996, P NATL ACAD SCI USA, V93, P11019, DOI 10.1073/pnas.93.20.11019; MEBIUS RE, 1990, IMMUNOLOGY, V71, P423; Miyasaka M, 2004, NAT REV IMMUNOL, V4, P360, DOI 10.1038/nri1354; MOOIJ P, 1993, CLIN IMMUNOL IMMUNOP, V69, P189, DOI 10.1006/clin.1993.1169; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Murai H, 1997, J NEUROIMMUNOL, V76, P61, DOI 10.1016/S0165-5728(97)00030-1; MYKING AO, 1980, VIRCHOWS ARCH B, V35, P63, DOI 10.1007/BF02889149; Narayan K, 2005, ANN NEUROL, V57, P813, DOI 10.1002/ana.20486; Newberry RD, 2005, IMMUNOL REV, V206, P6, DOI 10.1111/j.0105-2896.2005.00282.x; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Oliver G, 2004, NAT REV IMMUNOL, V4, P35, DOI 10.1038/nri1258; OTTAWAY CA, 1979, J EXP MED, V150, P218, DOI 10.1084/jem.150.2.218; Paavonen K, 2002, J RHEUMATOL, V29, P39; Pablos JL, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-6; Pashenkov M, 2003, J NEUROIMMUNOL, V135, P154, DOI 10.1016/S0165-5728(02)00441-1; PRINEAS JW, 1979, SCIENCE, V203, P1123, DOI 10.1126/science.424741; PRINEAS JW, 1978, LAB INVEST, V38, P409; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Rennert PD, 1997, INT IMMUNOL, V9, P1627, DOI 10.1093/intimm/9.11.1627; Rennert PD, 1996, J EXP MED, V184, P1999, DOI 10.1084/jem.184.5.1999; Rosen SD, 1999, AM J PATHOL, V155, P1013, DOI 10.1016/S0002-9440(10)65201-7; Rupprecht TA, 2005, NEUROLOGY, V65, P448, DOI 10.1212/01.wnl.0000171349.06645.79; Sabin FR, 1902, AM J ANAT, V1, P367, DOI 10.1002/aja.1000010310; Sabin FR, 1904, AM J ANAT, V3, P183, DOI 10.1002/aja.1000030205; Sacca R, 1997, J IMMUNOL, V159, P4252; Sacca R, 1998, J IMMUNOL, V160, P485; Saeki H, 1999, J IMMUNOL, V162, P2472; Salomonsson S, 2002, SCAND J IMMUNOL, V55, P336, DOI 10.1046/j.1365-3083.2002.01058.x; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; Scheinecker C, 2002, J EXP MED, V196, P1079, DOI 10.1084/jem.20020991; Schrama D, 2001, IMMUNITY, V14, P111, DOI 10.1016/S1074-7613(09)00094-6; Schroder AE, 1996, P NATL ACAD SCI USA, V93, P221, DOI 10.1073/pnas.93.1.221; Seeger H, 2005, SCIENCE, V310, P324, DOI 10.1126/science.1118829; Serafini B, 2004, BRAIN PATHOL, V14, P164, DOI 10.1111/j.1750-3639.2004.tb00049.x; Shi KR, 2001, J IMMUNOL, V166, P650, DOI 10.4049/jimmunol.166.1.650; Shomer NH, 2003, INFECT IMMUN, V71, P3572, DOI 10.1128/IAI.71.6.3572-3577.2003; Sims GP, 2001, J IMMUNOL, V167, P1935, DOI 10.4049/jimmunol.167.4.1935; Soderberg KA, 2004, J IMMUNOL, V173, P1908, DOI 10.4049/jimmunol.173.3.1908; Soderberg KA, 2005, P NATL ACAD SCI USA, V102, P16315, DOI 10.1073/pnas.0506190102; SODERSTROM N, 1974, SCAND J IMMUNOL, V3, P295, DOI 10.1111/j.1365-3083.1974.tb01260.x; STEERE AC, 1988, ARTHRITIS RHEUM, V31, P487, DOI 10.1002/art.1780310405; Steinman RM, 2003, ANN NY ACAD SCI, V987, P15, DOI 10.1111/j.1749-6632.2003.tb06029.x; Stoitzner P, 2005, J INVEST DERMATOL, V125, P116, DOI 10.1111/j.0022-202X.2005.23757.x; Stott DI, 1998, J CLIN INVEST, V102, P938, DOI 10.1172/JCI3234; STREETER PR, 1988, J CELL BIOL, V107, P1853, DOI 10.1083/jcb.107.5.1853; Swarte VVR, 1998, EUR J IMMUNOL, V28, P3040, DOI 10.1002/(SICI)1521-4141(199810)28:10<3040::AID-IMMU3040>3.0.CO;2-5; Takemura S, 2001, J IMMUNOL, V167, P1072, DOI 10.4049/jimmunol.167.2.1072; Thaunat O, 2005, P NATL ACAD SCI USA, V102, P14723, DOI 10.1073/pnas.0507223102; Tsubaki T, 2005, CLIN EXP IMMUNOL, V141, P363, DOI 10.1111/j.1365-2249.2005.02850.x; Vermi W, 2005, BLOOD; Ware C F, 1995, Curr Top Microbiol Immunol, V198, P175; West CA, 2001, J IMMUNOL, V166, P1517, DOI 10.4049/jimmunol.166.3.1517; Weyand CM, 2005, ARTHRITIS RES THER, V7, pS9, DOI 10.1186/ar1737; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505; Wilson NS, 2004, BLOOD, V103, P2187, DOI 10.1182/blood-2003-08-2729; Wilson NS, 2004, IMMUNOL CELL BIOL, V82, P91, DOI 10.1111/j.1440-1711.2004.01216.x; Wilson NS, 2003, BLOOD, V102, P2187, DOI 10.1182/blood-2003-02-0513; WOTHERSPOON AC, 1993, LANCET, V342, P575, DOI 10.1016/0140-6736(93)91409-F; Wu Q, 2001, J EXP MED, V193, P1327, DOI 10.1084/jem.193.11.1327; Yang XD, 1997, DIABETES, V46, P1542, DOI 10.2337/diabetes.46.10.1542; Yeaman GR, 1997, J LEUKOCYTE BIOL, V61, P427, DOI 10.1002/jlb.61.4.427; Ying XY, 2005, AM J PATHOL, V166, P135, DOI 10.1016/S0002-9440(10)62239-0; Yoneyama H, 2001, J EXP MED, V193, P35, DOI 10.1084/jem.193.1.35; Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643; Yoshida H, 2001, J IMMUNOL, V167, P2511, DOI 10.4049/jimmunol.167.5.2511; YOUNG CL, 1984, ARTHRITIS RHEUM, V27, P32, DOI 10.1002/art.1780270106; Yu P, 2004, NAT IMMUNOL, V5, P141, DOI 10.1038/ni1029; Zvaifler N J, 1973, Adv Immunol, V16, P265, DOI 10.1016/S0065-2776(08)60299-0	159	510	526	3	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2006	7	4					344	353		10.1038/ni1330	http://dx.doi.org/10.1038/ni1330			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	024BX	16550197				2022-12-18	WOS:000236171000005
J	Ginhoux, F; Tacke, F; Angeli, V; Bogunovic, M; Loubeau, M; Dai, XM; Stanley, ER; Randolph, GJ; Merad, M				Ginhoux, F; Tacke, F; Angeli, V; Bogunovic, M; Loubeau, M; Dai, XM; Stanley, ER; Randolph, GJ; Merad, M			Langerhans cells arise from monocytes in vivo	NATURE IMMUNOLOGY			English	Article							COLONY-STIMULATING-FACTOR; HEMATOPOIETIC STEM-CELLS; HUMAN PERIPHERAL-BLOOD; REGIONAL LYMPH-NODES; DENDRITIC CELLS; GROWTH-FACTOR; STEADY-STATE; FACTOR CSF-1; OP/OP MOUSE; T-CELLS	Langerhans cells (LCs) are the only dendritic cells of the epidermis and constitute the first immunological barrier against pathogens and environmental insults. The factors regulating LC homeostasis remain elusive and the direct circulating LC precursor has not yet been identified in vivo. Here we report an absence of LCs in mice deficient in the receptor for colony-stimulating factor 1 (CSF-1) in steady-state conditions. Using bone marrow chimeric mice, we have established that CSF-1 receptor-deficient hematopoietic precursors failed to reconstitute the LC pool in inflamed skin. Furthermore, monocytes with high expression of the monocyte marker Gr-1 (also called Ly-6c/G) were specifically recruited to the inflamed skin, proliferated locally and differentiated into LCs. These results identify Gr-1(hi) monocytes as the direct precursors for LCs in vivo and establish the importance of the CSF-1 receptor in this process.	Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA	Icahn School of Medicine at Mount Sinai; Yeshiva University; Albert Einstein College of Medicine	Merad, M (corresponding author), Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA.	miriam.merad@mssm.edu	Stanley, Evan R/J-9154-2013; Tacke, Frank/ABF-2212-2020	Stanley, Evan R/0000-0002-2910-2065; Loubeau, Martine/0000-0003-4629-7850	NCI NIH HHS [R01 CA032551, CA26504, R37 CA026504, CA32551, R01 CA026504] Funding Source: Medline; NIAID NIH HHS [R01 AI049653, AI49653] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA032551, R01CA026504, R37CA026504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049653] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Banchereau J, 2001, CANCER RES, V61, P6451; Bennett CL, 2005, J CELL BIOL, V169, P569, DOI 10.1083/jcb.200501071; Beverley PCL, 2005, NAT REV CANCER, V5, P488, DOI 10.1038/nrc1632; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Borkowski TA, 1996, J EXP MED, V184, P2417, DOI 10.1084/jem.184.6.2417; Bruno L, 2001, EUR J IMMUNOL, V31, P3403, DOI 10.1002/1521-4141(200111)31:11<3403::AID-IMMU3403>3.0.CO;2-T; BYRNE PV, 1981, J CELL BIOL, V91, P848, DOI 10.1083/jcb.91.3.848; Caux C, 1996, J EXP MED, V184, P695, DOI 10.1084/jem.184.2.695; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Cook DN, 2000, IMMUNITY, V12, P495, DOI 10.1016/S1074-7613(00)80201-0; Dai XM, 2004, J BONE MINER RES, V19, P1441, DOI 10.1359/JBMR.040514; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; del Hoyo GM, 2002, NATURE, V415, P1043, DOI 10.1038/4151043a; ELBE A, 1989, J IMMUNOL, V143, P2431; Geissmann F, 1998, J EXP MED, V187, P961, DOI 10.1084/jem.187.6.961; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; HANNUM C, 1994, NATURE, V368, P643, DOI 10.1038/368643a0; Hemmi H, 2001, INT IMMUNOL, V13, P695, DOI 10.1093/intimm/13.5.695; HUME DA, 1988, J IMMUNOL, V141, P3405; HUME DA, 1995, J INTERF CYTOK RES, V15, P279, DOI 10.1089/jir.1995.15.279; Ito T, 1999, J IMMUNOL, V163, P1409; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; KORN A P, 1973, Experimental Hematology (Charlottesville), V1, P362; KRIPKE ML, 1990, J IMMUNOL, V145, P2833; Lagasse E, 1997, CELL, V89, P1021, DOI 10.1016/S0092-8674(00)80290-1; Larregina AT, 2001, NAT IMMUNOL, V2, P1151, DOI 10.1038/ni731; Mayerova D, 2004, IMMUNITY, V21, P391, DOI 10.1016/j.immuni.2004.07.019; MENDE I, 2005, BLOOD; Merad M, 2004, NAT MED, V10, P510, DOI 10.1038/nm1038; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; METCALF D, 1985, SCIENCE, V229, P16, DOI 10.1126/science.2990035; NAKAHATA T, 1982, J CELL PHYSIOL, V113, P455, DOI 10.1002/jcp.1041130314; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Qu CF, 2004, J EXP MED, V200, P1231, DOI 10.1084/jem.20032152; Randolph GJ, 2002, J EXP MED, V196, P517, DOI 10.1084/jem.20011608; Rolland A, 2005, J IMMUNOL, V174, P3067, DOI 10.4049/jimmunol.174.5.3067; ROMANI N, 1986, J INVEST DERMATOL, V86, P129, DOI 10.1111/1523-1747.ep12284135; Roth P, 1992, Curr Top Microbiol Immunol, V181, P141; Ryan GR, 2001, BLOOD, V98, P74, DOI 10.1182/blood.V98.1.74; Schaerli P, 2005, IMMUNITY, V23, P331, DOI 10.1016/j.immuni.2005.08.012; SCHULER G, 1985, J EXP MED, V161, P526, DOI 10.1084/jem.161.3.526; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; TACKE F, IN PRESS IMMATURE MO; TAKAHASHI K, 1992, J INVEST DERMATOL, V99, pS46, DOI 10.1111/1523-1747.ep12668982; Tang HL, 1999, SCIENCE, V284, P819, DOI 10.1126/science.284.5415.819; Tripp CH, 2004, J INVEST DERMATOL, V122, P670, DOI 10.1111/j.0022-202X.2004.22337.x; TUSHINSKI RJ, 1982, CELL, V28, P71, DOI 10.1016/0092-8674(82)90376-2; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; WiktorJedrzejczak W, 1996, PHYSIOL REV, V76, P927, DOI 10.1152/physrev.1996.76.4.927; WIKTORJEDRZEJCZAK W, 1982, J EXP MED, V156, P1516, DOI 10.1084/jem.156.5.1516; WITMERPACK MD, 1993, J CELL SCI, V104, P1021	53	509	520	3	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2006	7	3					265	273		10.1038/ni1307	http://dx.doi.org/10.1038/ni1307			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	012SR	16444257	Green Accepted			2022-12-18	WOS:000235360400011
J	Allen, CDC; Ansel, KM; Low, C; Lesley, R; Tamamura, H; Fujii, N; Cyster, JG				Allen, CDC; Ansel, KM; Low, C; Lesley, R; Tamamura, H; Fujii, N; Cyster, JG			Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5	NATURE IMMUNOLOGY			English	Article							FOLLICULAR DENDRITIC CELLS; HUMAN-B-CELLS; CHEMOKINE RECEPTOR; BONE-MARROW; PLASMA-CELL; LYMPH-NODES; FACTOR-I; T-CELLS; EXPRESSION; DIFFERENTIATION	Germinal center (GC) dark and light zones segregate cells undergoing somatic hypermutation and antigen-driven selection, respectively, yet the factors guiding this organization are unknown. We report here that GC organization was absent from mice deficient in the chemokine receptor CXCR4. Centroblasts had high expression of CXCR4 and GC B cells migrated toward the CXCR4 ligand SDF-1 (CXCL12), which was more abundant in the dark zone than in the light zone. CXCR4-deficient cells were excluded from the dark zone in the context of a wild-type GC. These findings establish that GC organization depends on sorting of centroblasts by CXCR4 into the dark zone. In contrast, CXCR5 helped direct cells to the light zone and deficiency in CXCL13 was associated with aberrant light zone localization.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Kyoto University	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	cyster@itsa.ucsf.edu		Allen, Christopher/0000-0002-1879-9047	NIAID NIH HHS [AI40098, AI45073] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045073, R37AI040098, R01AI040098] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amara A, 1999, J BIOL CHEM, V274, P23916, DOI 10.1074/jbc.274.34.23916; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Ara T, 2003, J IMMUNOL, V170, P4649, DOI 10.4049/jimmunol.170.9.4649; Balogh P, 2002, ANAT REC, V268, P160, DOI 10.1002/ar.10148; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Bleul CC, 1998, J EXP MED, V187, P753, DOI 10.1084/jem.187.5.753; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Bowman EP, 2000, J EXP MED, V191, P1303, DOI 10.1084/jem.191.8.1303; Casamayor-Palleja M, 2002, BLOOD, V99, P1913, DOI 10.1182/blood.V99.6.1913; Casamayor-Palleja M, 2001, BLOOD, V97, P3992, DOI 10.1182/blood.V97.12.3992; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Corcione A, 2000, J NATL CANCER I, V92, P628, DOI 10.1093/jnci/92.8.628; Cyster JG, 2000, IMMUNOL REV, V176, P181; Egawa T, 2001, IMMUNITY, V15, P323, DOI 10.1016/S1074-7613(01)00185-6; Estes JD, 2002, J IMMUNOL, V169, P2313, DOI 10.4049/jimmunol.169.5.2313; Forster R, 1998, J IMMUNOL, V160, P1522; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; FREEDMAN AS, 1990, SCIENCE, V249, P1030, DOI 10.1126/science.1697696; Guinamard R, 1999, J EXP MED, V189, P1461, DOI 10.1084/jem.189.9.1461; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; Kelsoe G, 1996, IMMUNITY, V4, P107, DOI 10.1016/S1074-7613(00)80675-5; KOBURG E, 1966, GERMINAL CTR IMMUNE, P177; KOOPMAN G, 1991, J EXP MED, V173, P1297, DOI 10.1084/jem.173.6.1297; Krug A, 2002, J IMMUNOL, V169, P6079, DOI 10.4049/jimmunol.169.11.6079; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Luther SA, 1997, J EXP MED, V185, P551, DOI 10.1084/jem.185.3.551; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; MAEDA K, 1992, J IMMUNOL, V148, P2340; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2; McHeyzer-Williams MG, 1999, CURR OPIN IMMUNOL, V11, P172, DOI 10.1016/S0952-7915(99)80029-6; Ngo VN, 1998, J EXP MED, V188, P181, DOI 10.1084/jem.188.1.181; NIEUWENHUIS P, 1984, AM J ANAT, V170, P421, DOI 10.1002/aja.1001700315; Okada T, 2002, J EXP MED, V196, P65, DOI 10.1084/jem.20020201; Plotkin J, 2003, J IMMUNOL, V171, P4521, DOI 10.4049/jimmunol.171.9.4521; Rohlich K., 1930, Zeitschrift fuer Mikroskopisch-Anatomische Forschung, V20, P287; Roy MP, 2002, J IMMUNOL, V169, P1676, DOI 10.4049/jimmunol.169.4.1676; SECORD EA, 1995, AM J PATHOL, V147, P422; Shinall SM, 2000, J IMMUNOL, V164, P5729, DOI 10.4049/jimmunol.164.11.5729; Smith KGC, 2000, J EXP MED, V191, P475, DOI 10.1084/jem.191.3.475; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; Tamamura H, 2003, ORG BIOMOL CHEM, V1, P3663, DOI 10.1039/b306613b; Voigt I, 2000, EUR J IMMUNOL, V30, P560, DOI 10.1002/1521-4141(200002)30:2<560::AID-IMMU560>3.0.CO;2-T; VONDERHEIDE RH, 1990, IMMUNOLOGY, V69, P487; Wehrli N, 2001, EUR J IMMUNOL, V31, P609, DOI 10.1002/1521-4141(200102)31:2<609::AID-IMMU609>3.0.CO;2-9; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	48	506	515	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2004	5	9					943	952		10.1038/ni1100	http://dx.doi.org/10.1038/ni1100			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	850LI	15300245				2022-12-18	WOS:000223612500023
J	Russell, DG; Cardona, PJ; Kim, MJ; Allain, S; Altare, F				Russell, David G.; Cardona, Pere-Joan; Kim, Mi-Jeong; Allain, Sophie; Altare, Frederic			Foamy macrophages and the progression of the human tuberculosis granuloma	NATURE IMMUNOLOGY			English	Review							BACILLUS-CALMETTE-GUERIN; MYCOBACTERIUM-BOVIS BCG; TUMOR-NECROSIS-FACTOR; CELL-WALL LIPIDS; INFECTED MACROPHAGES; IMMUNE-RESPONSE; T-CELLS; IN-VIVO; MICE; GROWTH	The progression of tuberculosis from a latent, subclinical infection to active disease that culminates in the transmission of infectious bacilli is determined locally at the level of the granuloma. This progression takes place even in the face of a robust immune response that, although it contains infection, is unable to eliminate the bacterium. The factors or environmental conditions that influence this progression remain to be determined. Recent advances have indicated that pathogen-induced dysregulation of host lipid synthesis and sequestration serves a critical role in this transition. The foamy macrophage seems to be a key participant in both sustaining persistent bacteria and contributing to the tissue pathology that leads to cavitation and the release of infectious bacilli.	[Russell, David G.; Kim, Mi-Jeong] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; [Cardona, Pere-Joan] Univ Autonoma Barcelona, Inst Germans Trias & Pujol, Unitat TB Expt, Badalona, Catalonia, Spain; [Cardona, Pere-Joan] Ctr Invest Biomed Red Enfermedades Resp, Palma de Mallorca, Spain; [Allain, Sophie; Altare, Frederic] INSERM, U892, Inst Rech Therapeut, Nantes, France	Cornell University; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Institut National de la Sante et de la Recherche Medicale (Inserm)	Russell, DG (corresponding author), Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA.	dgr8@cornell.edu; frederic.altare@inserm.fr	Russell, David G/N-5280-2019; altare, frederic/K-8664-2015; Cardona, Pere-Joan/A-5258-2011; Russell, David G/D-4533-2009	Russell, David G/0000-0002-9748-750X; altare, frederic/0000-0002-5077-4616; Cardona, Pere-Joan/0000-0001-5623-7873; Russell, David G/0000-0002-9748-750X; Allain, Sophie/0000-0003-2241-5736	European Union Framework Programme [Health-2007-200999]; Bill and Melinda Gates Foundation Grand Challenges in Global Health; Institut National de la Sante et de la Recherche Medicale; Agence Nationale de la Recherche [ANR-06-MIME A05115KS, ANR-06-MIME-037-01]; US Public Health Services; US National Institutes of Health [HL055936, AI064430]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064430] Funding Source: NIH RePORTER	European Union Framework Programme(European Commission); Bill and Melinda Gates Foundation Grand Challenges in Global Health(Bill & Melinda Gates Foundation); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de la Recherche(French National Research Agency (ANR)); US Public Health Services(United States Department of Health & Human ServicesUnited States Public Health Service); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. de Chastellier and J.-F. Emile for the electron microscopy and histology in Figures 1 and 3. Supported by the European Union Framework Programme (Consortiums StopLATENT-TB Health-2007-200999 to P.-J. C.), the Bill and Melinda Gates Foundation Grand Challenges in Global Health (D. G. R., and GC12# 82 to P.-J. C.), Institut National de la Sante et de la Recherche Medicale (Programme Interface to F. A.), Agence Nationale de la Recherche (ANR-06-MIME A05115KS and ANR-06-MIME-037-01 to F. A.), the US Public Health Services (D. G. R.) and the US National Institutes of Health (HL055936 and AI064430 to D. G. R.).	Alatas F, 2004, CHEST, V125, P2156, DOI 10.1378/chest.125.6.2156; Algood HMS, 2005, CLIN INFECT DIS, V41, pS189, DOI 10.1086/429994; Andersen P, 1997, SCAND J IMMUNOL, V45, P115, DOI 10.1046/j.1365-3083.1997.d01-380.x; Baldan A, 2008, J IMMUNOL, V180, P3560, DOI 10.4049/jimmunol.180.5.3560; Beatty WL, 2000, TRAFFIC, V1, P235, DOI 10.1034/j.1600-0854.2000.010306.x; Beatty WL, 2001, EUR J CELL BIOL, V80, P31, DOI 10.1078/0171-9335-00131; Bowdish DME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000474; Caceres N, 2009, TUBERCULOSIS, V89, P175, DOI 10.1016/j.tube.2008.11.001; Cardona PJ, 2000, SCAND J IMMUNOL, V52, P156, DOI 10.1046/j.1365-3083.2000.00763.x; Cardona PJ, 2003, INFECT IMMUN, V71, P5845, DOI 10.1128/IAI.71.10.5845-5854.2003; Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; Chackerian AA, 2002, INFECT IMMUN, V70, P4501, DOI 10.1128/IAI.70.8.4501-4509.2002; Cocchiaro JL, 2008, P NATL ACAD SCI USA, V105, P9379, DOI 10.1073/pnas.0712241105; D'Avila H, 2008, INT IMMUNOPHARMACOL, V8, P1308, DOI 10.1016/j.intimp.2008.01.035; D'Avila H, 2006, J IMMUNOL, V176, P3087, DOI 10.4049/jimmunol.176.5.3087; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Dhillon J, 1996, ANTIMICROB AGENTS CH, V40, P552, DOI 10.1128/AAC.40.3.552; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; Elvang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005139; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Gan HX, 2008, NAT IMMUNOL, V9, P1189, DOI 10.1038/ni.1654; Geisel RE, 2005, J IMMUNOL, V174, P5007, DOI 10.4049/jimmunol.174.8.5007; Gil O, 2006, MICROBES INFECT, V8, P628, DOI 10.1016/j.micinf.2005.08.014; GOHN A, 1912, PRIMARE LUNGENHERD B; GORDON S, 2008, CLIN TUBERCULOSIS, P145; Hunter RL, 2007, TUBERCULOSIS, V87, P267, DOI 10.1016/j.tube.2006.11.003; Kalayoglu MV, 1998, J INFECT DIS, V177, P725, DOI 10.1086/514241; Kaplan G, 2003, INFECT IMMUN, V71, P7099, DOI 10.1128/IAI.71.12.7099-7108.2003; Keane J, 1997, INFECT IMMUN, V65, P298, DOI 10.1128/IAI.65.1.298-304.1997; KINDLER V, 1989, CELL, V56, P731, DOI 10.1016/0092-8674(89)90676-4; Lazarevic V, 2002, AM J RESP CRIT CARE, V166, P1116, DOI 10.1164/rccm.2204027; Lee J, 2009, YONSEI MED J, V50, P1, DOI 10.3349/ymj.2009.50.1.1; Lipman M, 2006, CURR OPIN INFECT DIS, V19, P20, DOI 10.1097/01.qco.0000200543.80712.01; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; MILICEMILI J, 2005, PHYSL BASIS RESP DIS, P133; Munoz-Elias EJ, 2005, INFECT IMMUN, V73, P546, DOI 10.1128/IAI.73.1.546-551.2005; Munoz-Elias EJ, 2006, MOL MICROBIOL, V60, P1109, DOI 10.1111/j.1365-2958.2006.05155.x; Neyrolles O, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000043; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Ordway D, 2005, J IMMUNOL, V175, P3873, DOI 10.4049/jimmunol.175.6.3873; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; PARK MK, 1992, CLIN INFECT DIS, V14, P720, DOI 10.1093/clinids/14.3.720; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Portugal LR, 2008, MICROBES INFECT, V10, P276, DOI 10.1016/j.micinf.2007.12.001; Puissegur MP, 2007, J IMMUNOL, V178, P3161, DOI 10.4049/jimmunol.178.5.3161; REES RJ, 1961, BRIT J EXP PATHOL, V42, P83; Rhoades E, 2003, MOL MICROBIOL, V48, P875, DOI 10.1046/j.1365-2958.2003.03473.x; Rhoades ER, 2005, TUBERCULOSIS, V85, P159, DOI 10.1016/j.tube.2004.10.001; Roach DR, 2002, J IMMUNOL, V168, P4620, DOI 10.4049/jimmunol.168.9.4620; Rohde K, 2007, IMMUNOL REV, V219, P37, DOI 10.1111/j.1600-065X.2007.00547.x; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Saita N, 2000, INFECT IMMUN, V68, P5991, DOI 10.1128/IAI.68.10.5991-5997.2000; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Saunders BM, 2000, IMMUNOL CELL BIOL, V78, P334, DOI 10.1046/j.1440-1711.2000.00933.x; SILVA AR, 2009, BIOCH BIOPHYS ACTA; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Ulrichs T, 2005, J INFECT DIS, V192, P89, DOI 10.1086/430621; Ulrichs T, 2004, J PATHOL, V204, P217, DOI 10.1002/path.1628; Velmurugan K, 2007, PLOS PATHOG, V3, P972, DOI 10.1371/journal.ppat.0030110; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001; Wolf AJ, 2008, J EXP MED, V205, P105, DOI 10.1084/jem.20071367; Yang XX, 2009, BIOCHEMISTRY-US, V48, P3819, DOI 10.1021/bi9005418	64	505	526	3	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2009	10	9					943	948		10.1038/ni.1781	http://dx.doi.org/10.1038/ni.1781			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	485KV	19692995	Green Accepted			2022-12-18	WOS:000269120900007
J	Ochando, JC; Homma, C; Yang, Y; Hidalgo, A; Garin, A; Tacke, F; Angeli, V; Li, YS; Boros, P; Ding, YZ; Jessberger, R; Trinchieri, G; Lira, SA; Randolph, GJ; Bromberg, JS				Ochando, Jordi C.; Homma, Chiho; Yang, Yu; Hidalgo, Andres; Garin, Alexandre; Tacke, Frank; Angeli, Veronique; Li, Yansui; Boros, Peter; Ding, Yaozhong; Jessberger, Rolf; Trinchieri, Giorgio; Lira, Sergio A.; Randolph, Gwendalyn J.; Bromberg, Jonathan S.			Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts	NATURE IMMUNOLOGY			English	Article							REGULATORY T-CELLS; HIGH-ENDOTHELIAL VENULES; TRANSCRIPTION FACTOR FOXP3; SECONDARY LYMPHOID-TISSUE; ACTIVATION IN-VIVO; ALLOGRAFT-REJECTION; L-SELECTIN; BLOOD-TRANSFUSION; ANTIGEN; CD4(+)	The induction of alloantigen-specific unresponsiveness remains an elusive goal in organ transplantation. Here we identify plasmacytoid dendritic cells (pDCs) as phagocytic antigen-presenting cells essential for tolerance to vascularized cardiac allografts. Tolerizing pDCs acquired alloantigen in the allograft and then moved through the blood to home to peripheral lymph nodes. In the lymph node, alloantigen-presenting pDCs induced the generation of CCR4(+)CD4(+)CD25(+)Foxp3(+) regulatory T cells (T-reg cells). Depletion of pDCs or prevention of pDC lymph node homing inhibited peripheral Treg cell development and tolerance induction, whereas adoptive transfer of tolerized pDCs induced Treg cell development and prolonged graft survival. Thus, alloantigen-presenting pDCs home to the lymph nodes in tolerogenic conditions, where they mediate alloantigen-specific Treg cell development and allograft tolerance.	CUNY Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Hematol Ctr, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Immunobiol Ctr, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Recanati Miller Transplantat Inst, New York, NY 10029 USA; Dresden Univ Technol, Dept Physiol Chem, D-8027 Dresden, Germany; NIAID, Parasit Dis Lab, Bethesda, MD 20892 USA; CUNY Mt Sinai Sch Med, Dept Surg, New York, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Technische Universitat Dresden; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Ochando, JC (corresponding author), CUNY Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA.	jordi.ochando@mssm.edu; jon.bromberg@msnyuhealth.org	Ochando, Jordi/B-6219-2008; Tacke, Frank/ABF-2212-2020; Trinchieri, Giorgio/F-9369-2015; Hidalgo, Andrés/L-5643-2014; Ochando, jordi/ABE-2358-2020	Ochando, Jordi/0000-0001-7037-1681; Trinchieri, Giorgio/0000-0001-5892-7464; Hidalgo, Andrés/0000-0001-5513-555X; Ochando, jordi/0000-0001-7037-1681	NIAID NIH HHS [AI44929, AI62765, R01 AI41428] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044929, R01AI041428, R01AI062765] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abe M, 2005, AM J TRANSPLANT, V5, P1808, DOI 10.1111/j.1600-6143.2005.00954.x; Alferink J, 2003, J EXP MED, V197, P585, DOI 10.1084/jem.20021859; Asselin-Paturel C, 2003, J IMMUNOL, V171, P6466, DOI 10.4049/jimmunol.171.12.6466; Bai YL, 2002, J IMMUNOL, V168, P1579, DOI 10.4049/jimmunol.168.4.1579; Bajenoff M, 2003, J EXP MED, V198, P715, DOI 10.1084/jem.20030167; BALDWIN WM, 1991, TRANSPLANTATION, V51, P481, DOI 10.1097/00007890-199102000-00040; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BERG EL, 1993, NATURE, V366, P695, DOI 10.1038/366695a0; Brandt M, 1997, TRANSPLANT INT, V10, P141; Cella M, 2000, NAT IMMUNOL, V1, P305, DOI 10.1038/79747; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen Y, 2003, J IMMUNOL, V171, P6510, DOI 10.4049/jimmunol.171.12.6510; Cobbold SP, 2004, J IMMUNOL, V172, P6003, DOI 10.4049/jimmunol.172.10.6003; Corbascio M, 2002, TRANSPL IMMUNOL, V10, P55, DOI 10.1016/S0966-3274(02)00014-X; CORRY RJ, 1973, TRANSPLANTATION, V16, P343, DOI 10.1097/00007890-197310000-00010; CROWLEY M, 1990, J EXP MED, V172, P383, DOI 10.1084/jem.172.1.383; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; Dzionek A, 2001, J EXP MED, V194, P1823, DOI 10.1084/jem.194.12.1823; Ellyard JI, 2004, BLOOD, V103, P3805, DOI 10.1182/blood-2003-09-3109; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; HAN SH, 1995, J IMMUNOL, V155, P556; Hancock WW, 2003, IMMUNOL REV, V196, P37, DOI 10.1046/j.1600-065X.2003.00084.x; Hara M, 2001, J IMMUNOL, V166, P3789, DOI 10.4049/jimmunol.166.6.3789; He CS, 2004, AM J TRANSPLANT, V4, P698, DOI 10.1111/j.1600-6143.2004.00416.x; Iellem A, 2001, J EXP MED, V194, P847, DOI 10.1084/jem.194.6.847; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Jahnsen FL, 2000, J IMMUNOL, V165, P4062, DOI 10.4049/jimmunol.165.7.4062; Josien R, 1998, BLOOD, V92, P4539, DOI 10.1182/blood.V92.12.4539.424k40_4539_4544; Kandula S, 2004, J IMMUNOL, V173, P4443, DOI 10.4049/jimmunol.173.7.4443; Karim M, 2004, J IMMUNOL, V172, P923, DOI 10.4049/jimmunol.172.2.923; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Krieger NR, 1996, J EXP MED, V184, P2013, DOI 10.1084/jem.184.5.2013; Lakkis FG, 2000, NAT MED, V6, P686, DOI 10.1038/76267; LIU YJ, 1988, EUR J IMMUNOL, V18, P355, DOI 10.1002/eji.1830180306; Miyasaka M, 2004, NAT REV IMMUNOL, V4, P360, DOI 10.1038/nri1354; Moseman EA, 2004, J IMMUNOL, V173, P4433, DOI 10.4049/jimmunol.173.7.4433; MURPHY DB, 1989, NATURE, V338, P765, DOI 10.1038/338765a0; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Ochando JC, 2005, J IMMUNOL, V174, P6993, DOI 10.4049/jimmunol.174.11.6993; Pachynski RK, 1998, J IMMUNOL, V161, P952; Quezada SA, 2005, J IMMUNOL, V175, P771, DOI 10.4049/jimmunol.175.2.771; Reed AJ, 2003, J IMMUNOL, V171, P6502, DOI 10.4049/jimmunol.171.12.6502; Rosen SD, 1999, AM J PATHOL, V155, P1013, DOI 10.1016/S0002-9440(10)65201-7; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Salio M, 2004, J EXP MED, V199, P567, DOI 10.1084/jem.20031059; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Sayegh MH, 2003, AM J TRANSPLANT, V3, P381, DOI 10.1034/j.1600-6143.2003.00062.x; Schenk S, 2005, J IMMUNOL, V174, P3741, DOI 10.4049/jimmunol.174.6.3741; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Shinohara M, 2002, NATURE, V416, P759, DOI 10.1038/416759a; Sivalenka RR, 2004, MOL CELL BIOL, V24, P10277, DOI 10.1128/MCB.24.23.10277-10288.2004; STAMPER HB, 1976, J EXP MED, V144, P828, DOI 10.1084/jem.144.3.828; Wagers AJ, 2000, J IMMUNOL, V165, P5011, DOI 10.4049/jimmunol.165.9.5011; Yamada A, 2003, AM J TRANSPLANT, V3, P23, DOI 10.1034/j.1600-6143.2003.30105.x; Yoneyama H, 2004, INT IMMUNOL, V16, P915, DOI 10.1093/intimm/dxh093	56	505	527	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2006	7	6					652	662		10.1038/ni1333	http://dx.doi.org/10.1038/ni1333			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	045OK	16633346				2022-12-18	WOS:000237751200021
J	Matloubian, M; David, A; Engel, S; Ryan, JE; Cyster, JG				Matloubian, M; David, A; Engel, S; Ryan, JE; Cyster, JG			A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo	NATURE IMMUNOLOGY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELLS; DENDRITIC CELLS; B-CELLS; RECEPTORS; EXPRESSION; PROTEIN; MIGRATION; PATTERNS; STRL33	We describe a protein with the hallmarks of a chemokine, designated CXCL16, that is made by dendritic cells (DCs) in lymphoid organ T cell zones and by cells in the splenic red pulp. CXCL16 contains a transmembrane domain and both membrane-bound and soluble forms are produced. Naive CD8 T cells, natural killer T cells and a subset of memory CD4 T cells bind CXCL16, and activated T cells migrated chemotactically to the soluble chemokine. By expression cloning, Bonzo (also known as STRL33 and TYMSTR) was identified as a CXCL16 receptor. CXCL16 may function in promoting interactions between DCs and CD8T cells and in guiding T cell movements in the splenic red pulp. CXCL16 was also found in the thymic medulla and in some nonlymphoid tissues, indicating roles in thymocyte development and effector T cell trafficking.	VA Med Ctr, Dept Immunol & Med, San Francisco, CA 94121 USA; Compugen Ltd, IL-69512 Tel Aviv, Israel; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Cyster, JG (corresponding author), VA Med Ctr, Dept Immunol & Med, San Francisco, CA 94121 USA.	cyster@itsa.ucsf.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007304] Funding Source: NIH RePORTER; NIAID NIH HHS [AI45073] Funding Source: Medline; NIAMS NIH HHS [AR07304] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ABDULLAH KM, 1992, INFECT IMMUN, V60, P56, DOI 10.1128/IAI.60.1.56-62.1992; Alkhatib G, 1997, NATURE, V388, P238, DOI 10.1038/40789; Amichay D, 1996, J IMMUNOL, V157, P4511; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Balazs M, 1999, HYBRIDOMA, V18, P177, DOI 10.1089/hyb.1999.18.177; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; BORDESSOULE D, 1990, J CLIN PATHOL, V43, P461, DOI 10.1136/jcp.43.6.461; CYSTER JG, 1991, EMBO J, V10, P893, DOI 10.1002/j.1460-2075.1991.tb08022.x; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; Deng HK, 1997, NATURE, V388, P296, DOI 10.1038/40894; Edinger AL, 1998, VIROLOGY, V249, P367, DOI 10.1006/viro.1998.9306; Haanen JBAG, 1999, EUR J IMMUNOL, V29, P1168, DOI 10.1002/(SICI)1521-4141(199904)29:04<1168::AID-IMMU1168>3.0.CO;2-J; Hofmann K, 1999, NUCLEIC ACIDS RES, V27, P215, DOI 10.1093/nar/27.1.215; Holder N, 1999, DEVELOPMENT, V126, P2033; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; Kanazawa N, 1999, EUR J IMMUNOL, V29, P1925, DOI 10.1002/(SICI)1521-4141(199906)29:06<1925::AID-IMMU1925>3.0.CO;2-U; LANE P, 1992, EUR J IMMUNOL, V22, P2573, DOI 10.1002/eji.1830221016; Lanzavecchia A, 1998, NATURE, V393, P413, DOI 10.1038/30845; Liao F, 1997, J EXP MED, V185, P2015, DOI 10.1084/jem.185.11.2015; Loetscher M, 1997, CURR BIOL, V7, P652, DOI 10.1016/S0960-9822(06)00292-2; Muehlhoefer A, 2000, J IMMUNOL, V164, P3368, DOI 10.4049/jimmunol.164.6.3368; Ngo VN, 1998, J EXP MED, V188, P181, DOI 10.1084/jem.188.1.181; OHMORI Y, 1993, AM J PATHOL, V142, P861; OPPENHEIM JJ, 1991, ANNU REV IMMUNOL, V9, P617, DOI 10.1146/annurev.iy.09.040191.003153; Pan Y, 1997, NATURE, V389, P100, DOI 10.1038/38048; Papadopoulos EJ, 1999, EUR J IMMUNOL, V29, P2551, DOI 10.1002/(SICI)1521-4141(199908)29:08<2551::AID-IMMU2551>3.0.CO;2-T; PELLAS TC, 1990, AM J ANAT, V187, P355, DOI 10.1002/aja.1001870405; Pohlmann S, 1999, J GEN VIROL, V80, P1241, DOI 10.1099/0022-1317-80-5-1241; Potsch C, 1999, EUR J IMMUNOL, V29, P3562, DOI 10.1002/(SICI)1521-4141(199911)29:11<3562::AID-IMMU3562>3.0.CO;2-R; Reif K, 1996, CURR BIOL, V6, P1445, DOI 10.1016/S0960-9822(96)00749-X; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Sallusto F, 1999, EUR J IMMUNOL, V29, P1617, DOI 10.1002/(SICI)1521-4141(199905)29:05<1617::AID-IMMU1617>3.0.CO;2-3; Smith KGC, 1996, EUR J IMMUNOL, V26, P444, DOI 10.1002/eji.1830260226; Tang HL, 1999, SCIENCE, V284, P819, DOI 10.1126/science.284.5415.819; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Unutmaz D, 1998, SEMIN IMMUNOL, V10, P225, DOI 10.1006/smim.1998.0134; Van Vactor D, 1999, CURR BIOL, V9, pR201; Zhang YJ, 1999, J VIROL, V73, P3443, DOI 10.1128/JVI.73.4.3443-3448.1999; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Zlotnik A, 1999, CRIT REV IMMUNOL, V19, P1; [No title captured]	42	501	543	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2000	1	4					298	304		10.1038/79738	http://dx.doi.org/10.1038/79738			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364AK	11017100				2022-12-18	WOS:000089869700011
J	Chiba, S; Baghdadi, M; Akiba, H; Yoshiyama, H; Kinoshita, I; Dosaka-Akita, H; Fujioka, Y; Ohba, Y; Gorman, JV; Colgan, JD; Hirashima, M; Uede, T; Takaoka, A; Yagita, H; Jinushi, M				Chiba, Shigeki; Baghdadi, Muhammad; Akiba, Hisaya; Yoshiyama, Hironori; Kinoshita, Ichiro; Dosaka-Akita, Hirotoshi; Fujioka, Yoichiro; Ohba, Yusuke; Gorman, Jacob V.; Colgan, John D.; Hirashima, Mitsuomi; Uede, Toshimitsu; Takaoka, Akinori; Yagita, Hideo; Jinushi, Masahisa			Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELLS; TOLL-LIKE; RIG-I; ANTITUMOR IMMUNITY; T-CELLS; INFLAMMATION; BINDING; PHOSPHATIDYLSERINE; PHAGOCYTOSIS; ACTIVATION	The mechanisms by which tumor microenvironments modulate nucleic acid mediated innate immunity remain unknown. Here we identify the receptor TIM-3 as key in circumventing the stimulatory effects of nucleic acids in tumor immunity. Tumor-associated dendritic cells (DCs) in mouse tumors and patients with cancer had high expression of TIM-3. DC-derived TIM-3 suppressed innate immune responses through the recognition of nucleic acids by Toll-like receptors and cytosolic sensors via a galectin-9-independent mechanism. In contrast, TIM-3 interacted with the alarmin HMGB1 to interfere with the recruitment of nucleic acids into DC endosomes and attenuated the therapeutic efficacy of DNA vaccination and chemotherapy by diminishing the immunogenicity of nucleic acids released from dying tumor cells. Our findings define a mechanism whereby tumor microenvironments suppress antitumor immunity mediated by nucleic acids.	[Chiba, Shigeki; Baghdadi, Muhammad; Yoshiyama, Hironori; Jinushi, Masahisa] Hokkaido Univ, Inst Med Genet, Res Ctr Infect Associated Canc, Sapporo, Hokkaido, Japan; [Baghdadi, Muhammad; Takaoka, Akinori] Hokkaido Univ, Inst Med Genet, Div Signaling Canc & Immunol, Sapporo, Hokkaido, Japan; [Baghdadi, Muhammad; Kinoshita, Ichiro; Dosaka-Akita, Hirotoshi] Hokkaido Univ, Grad Sch Med, Dept Med Oncol, Sapporo, Hokkaido, Japan; [Akiba, Hisaya; Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan; [Fujioka, Yoichiro; Ohba, Yusuke] Hokkaido Univ, Grad Sch Med, Dept Pathophysiol & Signal Transduct, Sapporo, Hokkaido, Japan; [Gorman, Jacob V.; Colgan, John D.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Hirashima, Mitsuomi] Kagawa Univ, Fac Med, Dept Immunol & Immunopathol, Takamatsu, Kagawa 760, Japan; [Uede, Toshimitsu] Hokkaido Univ, Inst Med Genet, Div Mol Immunol, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Juntendo University; Hokkaido University; University of Iowa; Kagawa University; Hokkaido University	Jinushi, M (corresponding author), Hokkaido Univ, Inst Med Genet, Res Ctr Infect Associated Canc, Sapporo, Hokkaido, Japan.	jinushi@igm.hokudai.ac.jp	Ohba, Yusuke/E-7944-2011; Yoshiyama, Hironori/H-5674-2019; Fujioka, Yoichiro/AAF-3313-2019	Yoshiyama, Hironori/0000-0001-7588-278X; Fujioka, Yoichiro/0000-0002-5760-9357; Yoshiyama, Hironori/0000-0002-9904-0736; Baghdadi, Muhammad/0000-0002-2347-8889; Colgan, John/0000-0001-9273-2644	Ministry of Education, Culture, Sports, Science and Technology of Japan; National Cancer Center Research and Development Fund; Institute for Genetic Medicine of Hokkaido University; Takeda Science Foundation; Sumitomo Foundation; Terumo Life Science Foundation; Senshin Medical Research Foundation; Japan Leukemia Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093737, R01AI067489] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23659196, 11J04616] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Institute for Genetic Medicine of Hokkaido University; Takeda Science Foundation(Takeda Science Foundation (TSF)); Sumitomo Foundation; Terumo Life Science Foundation(Terumo Life Science Foundation); Senshin Medical Research Foundation(SENSHIN Medical Research Foundation); Japan Leukemia Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Bianchi (San Raffaele University) for MEFs deficient in HMGB1 and HMGB2; O. Takeuchi and S. Akira (Osaka University) for mice deficient in both TBK1 and TNF; J. Wolchok (Memorial Sloan-Kettering Cancer Center) for plasmids encoding gp100 and TRP-2; G. Dranoff for comments on the manuscript; and T. Yamashina for assistance with animal care. Supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (H. Yagita and M.J.), the National Cancer Center Research and Development Fund (H.Ya.), the Institute for Genetic Medicine of Hokkaido University (M.J., M.H. and H.Ya.), the Takeda Science Foundation (M.J.), the Sumitomo Foundation (M.J.), Terumo Life Science Foundation (M.J.), Senshin Medical Research Foundation (M.J.) and Japan Leukemia Research Foundation (M.J.).	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Besch R, 2009, J CLIN INVEST, V119, P2399, DOI 10.1172/JCI37155; Bindea G, 2010, CURR OPIN IMMUNOL, V22, P215, DOI 10.1016/j.coi.2010.02.006; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Bowne WB, 1999, J EXP MED, V190, P1717, DOI 10.1084/jem.190.11.1717; Cao EH, 2007, IMMUNITY, V26, P311, DOI 10.1016/j.immuni.2007.01.016; Dardalhon V, 2010, J IMMUNOL, V185, P1383, DOI 10.4049/jimmunol.0903275; DeKruyff RH, 2010, J IMMUNOL, V184, P1918, DOI 10.4049/jimmunol.0903059; Dougan M, 2009, ANNU REV IMMUNOL, V27, P83, DOI 10.1146/annurev.immunol.021908.132544; Drake CG, 2006, ADV IMMUNOL, V90, P51, DOI 10.1016/S0065-2776(06)90002-9; Drobits B, 2012, J CLIN INVEST, V122, P575, DOI 10.1172/JCI61034; Fujioka Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016324; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jan M, 2011, P NATL ACAD SCI USA, V108, P5009, DOI 10.1073/pnas.1100551108; Jayaraman P, 2010, J EXP MED, V207, P2343, DOI 10.1084/jem.20100687; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Kikushige Y, 2010, CELL STEM CELL, V7, P708, DOI 10.1016/j.stem.2010.11.014; Kuchroo VK, 2008, NAT REV IMMUNOL, V8, P577, DOI 10.1038/nri2366; Lin Y, 2011, J CLIN INVEST, V121, P1574, DOI 10.1172/JCI44581; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; Nagahara K, 2008, J IMMUNOL, V181, P7660, DOI 10.4049/jimmunol.181.11.7660; Nakayama M, 2009, BLOOD, V113, P3821, DOI 10.1182/blood-2008-10-185884; Ngiow SF, 2011, CANCER RES, V71, P3540, DOI 10.1158/0008-5472.CAN-11-0096; Nobumoto A, 2009, CLIN IMMUNOL, V130, P322, DOI 10.1016/j.clim.2008.09.014; Norian LA, 2009, CANCER RES, V69, P3086, DOI 10.1158/0008-5472.CAN-08-2826; Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401; Poeck H, 2008, NAT MED, V14, P1256, DOI 10.1038/nm.1887; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Santiago C, 2007, IMMUNITY, V27, P941, DOI 10.1016/j.immuni.2007.11.008; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599; Zhou Q, 2011, BLOOD, V117, P4501, DOI 10.1182/blood-2010-10-310425; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	47	498	560	2	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2012	13	9					832	842		10.1038/ni.2376	http://dx.doi.org/10.1038/ni.2376			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	993MK	22842346	Green Accepted, Green Submitted			2022-12-18	WOS:000307863600011
J	Ma, F; Xu, S; Liu, XG; Zhang, Q; Xu, XF; Liu, MF; Hua, MM; Li, N; Yao, HP; Cao, XT				Ma, Feng; Xu, Sheng; Liu, Xingguang; Zhang, Qian; Xu, Xiongfei; Liu, Mofang; Hua, Minmin; Li, Nan; Yao, Hangping; Cao, Xuetao			The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-gamma	NATURE IMMUNOLOGY			English	Article							MYCOBACTERIUM-TUBERCULOSIS INFECTION; TH1 RESPONSES; CELL; EXPRESSION; DIFFERENTIATION; SUPPRESSION; MECHANISM; ABSENCE; RNAS	Interferon-gamma (IFN-gamma) has a critical role in immune responses to intracellular bacterial infection. MicroRNAs (miRNAs) are important in the regulation of innate and adaptive immunity. However, whether miRNAs can directly target IFN-gamma and regulate IFN-gamma production post-transcriptionally remains unknown. Here we show that infection of mice with Listeria monocytogenes or Mycobacterium bovis bacillus Calmette-Guerin (BCG) downregulated miR-29 expression in IFN-gamma-producing natural killer cells, CD4(+) T cells and CD8(+) T cells. Moreover, miR-29 suppressed IFN-gamma production by directly targeting IFN-gamma mRNA. We developed mice with transgenic expression of a 'sponge' target to compete with endogenous miR-29 targets (GS29 mice). We found higher serum concentrations of IFN-gamma and lower L. monocytogenes burdens in L. monocytogenes-infected GS29 mice than in their littermates. GS29 mice had enhanced T helper type 1 (T(H)1) responses and greater resistance to infection with BCG or Mycobacterium tuberculosis. Therefore, miR-29 suppresses immune responses to intracellular pathogens by targeting IFN-gamma.	[Ma, Feng; Xu, Sheng; Liu, Xingguang; Zhang, Qian; Xu, Xiongfei; Li, Nan; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China; [Ma, Feng; Yao, Hangping; Cao, Xuetao] Zhejiang Univ, Inst Immunol, Sch Med, Hangzhou 310027, Peoples R China; [Liu, Mofang; Hua, Minmin] Chinese Acad Sci, Natl Key Lab Med Mol Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Cao, Xuetao] Chinese Acad Med Sci, Natl Key Lab Med Mol Biol, Beijing 100730, Peoples R China; [Ma, Feng; Xu, Sheng; Liu, Xingguang; Zhang, Qian; Xu, Xiongfei; Li, Nan; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai, Peoples R China	Naval Medical University; Zhejiang University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Naval Medical University	Cao, XT (corresponding author), Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China.	caoxt@immunol.org	Ma, Feng/E-7927-2015	xu, sheng/0000-0002-9547-8052; Xu, Xiongfei/0000-0001-9532-4582	National Key Basic Research Program of China [2007CB512403, 2009CB521902]; National Natural Science Foundation of China [30721091, 30731160623]; Shanghai Committee of Science and Technology [10dz1910300]; National High Biotechnology Development Program of China [2009ZX09503-003, 2009ZX09503-023]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); National High Biotechnology Development Program of China(National High Technology Research and Development Program of China)	We thank T. Chen, J. Hou and C. Han for discussions; Y. Li and M. Jin for technical support; C. Ni for pathological analysis; and H. Shen (University of Pennsylvania School of medicine) for L. monocytogenes. Supported by the National Key Basic Research Program of China (2007CB512403 and 2009CB521902), the National Natural Science Foundation of China (30721091, 30731160623), the Shanghai Committee of Science and Technology (10dz1910300) and the National High Biotechnology Development Program of China (2009ZX09503-003, 2009ZX09503-023).	Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bezman NA, 2010, J IMMUNOL, V185, P3835, DOI 10.4049/jimmunol.1000980; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Dai RJ, 2008, BLOOD, V112, P4591, DOI 10.1182/blood-2008-04-152488; Dorhoi A, 2010, J EXP MED, V207, P777, DOI 10.1084/jem.20090067; Du CS, 2009, NAT IMMUNOL, V10, P1252, DOI 10.1038/ni.1798; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ebert PJR, 2009, NAT IMMUNOL, V10, P1162, DOI 10.1038/ni.1797; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Gebeshuber CA, 2009, EMBO REP, V10, P400, DOI 10.1038/embor.2009.9; Gentner B, 2009, NAT METHODS, V6, P63, DOI [10.1038/NMETH.1277, 10.1038/nmeth.1277]; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Loya CM, 2009, NAT METHODS, V6, P897, DOI 10.1038/nmeth.1402; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Nathans R, 2009, MOL CELL, V34, P696, DOI 10.1016/j.molcel.2009.06.003; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Redford PS, 2010, EUR J IMMUNOL, V40, P2200, DOI 10.1002/eji.201040433; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang P, 2010, J IMMUNOL, V185, P6226, DOI 10.4049/jimmunol.1000491; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Young HA, 2007, CURR TOP MICROBIOL, V316, P97	44	498	558	5	134	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2011	12	9					861	U5		10.1038/ni.2073	http://dx.doi.org/10.1038/ni.2073			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	814NA	21785411				2022-12-18	WOS:000294461200010
J	Glaser, R; Harder, J; Lange, H; Bartels, J; Christophers, E; Schroder, JM				Glaser, R; Harder, J; Lange, H; Bartels, J; Christophers, E; Schroder, JM			Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection	NATURE IMMUNOLOGY			English	Article							ZINC SUPEROXIDE-DISMUTASE; HUMAN KERATINOCYTES; PERIPLASMIC COPPER; IN-VITRO; EXPRESSION; PEPTIDES; PROTEINS; DEFENSE; CLONING	Human healthy skin is continuously exposed to bacteria, but is particularly resistant to the common gut bacterium Escherichia coli. We show here that keratinocytes secrete, as the main E. coli-killing compound, the S100 protein psoriasin in vitro and in vivo in a site-dependent way. In vivo treatment of human skin with antibodies to psoriasin inhibited its E. coli-killing properties. Psoriasin was induced in keratinocytes in vitro and in vivo by E. coli, indicating that its focal expression in skin may derive from local microbial induction. Zn2+-saturated psoriasin showed diminished antimicrobial activity, suggesting that Zn2+ sequestration could be a possible antimicrobial mechanism. Thus, psoriasin may be key to the resistance of skin against E. coli.	Univ Hosp Schleswig Holstein, Dept Dermatol, Climat Res Unit, Kiel, Germany; Univ Kiel, Inst Biochem, D-24098 Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel	Schroder, JM (corresponding author), Univ Hosp Schleswig Holstein, Dept Dermatol, Climat Res Unit, Campus Kiel, Kiel, Germany.	jschroeder@dermatology.uni-kiel.de	Schroeder, Jens M/B-3994-2009; Harder, Jürgen/B-3162-2010; Gläser, Regine/B-3168-2010; Bartels, Joachim H./B-2802-2009	Bartels, Joachim/0000-0003-4395-4552; Harder, Jurgen/0000-0002-4075-4603				Ashoori M, 1999, MICROBIOL IMMUNOL, V43, P311, DOI 10.1111/j.1348-0421.1999.tb02410.x; Benov L, 1997, ARCH BIOCHEM BIOPHYS, V340, P305, DOI 10.1006/abbi.1997.9940; Brodersen DE, 1999, BIOCHEMISTRY-US, V38, P1695, DOI 10.1021/bi982483d; BURGISSER DM, 1995, BIOCHEM BIOPH RES CO, V217, P257, DOI 10.1006/bbrc.1995.2772; CASEWELL MW, 1983, J HOSP INFECT, V4, P350, DOI 10.1016/0195-6701(83)90005-1; Celis JE, 1996, J UROLOGY, V155, P2105, DOI 10.1016/S0022-5347(01)66118-4; CLOHESSY PA, 1995, SCAND J IMMUNOL, V42, P551, DOI 10.1111/j.1365-3083.1995.tb03695.x; Cole AM, 2001, FEBS LETT, V504, P5, DOI 10.1016/S0014-5793(01)02731-4; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; Frohm M, 1997, J BIOL CHEM, V272, P15258, DOI 10.1074/jbc.272.24.15258; Gort AS, 1999, MOL MICROBIOL, V32, P179, DOI 10.1046/j.1365-2958.1999.01343.x; Hagens G, 1999, BIOCHEM J, V339, P419, DOI 10.1042/0264-6021:3390419; Harder J, 2002, J BIOL CHEM, V277, P46779, DOI 10.1074/jbc.M207587200; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; KLENHA J, 1967, J INVEST DERMATOL, V49, P396, DOI 10.1038/jid.1967.155; Kulski JK, 2003, J MOL EVOL, V56, P397, DOI 10.1007/s00239-002-2410-5; LAGASSE E, 1988, MOL CELL BIOL, V8, P2402, DOI 10.1128/MCB.8.6.2402; Lange H, 1996, EUR J IMMUNOL, V26, P2234, DOI 10.1002/eji.1830260940; Lange H, 2002, EUR J IMMUNOL, V32, P3133, DOI 10.1002/1521-4141(200211)32:11<3133::AID-IMMU3133>3.0.CO;2-0; Leygue E, 1996, CANCER RES, V56, P4606; MADSEN P, 1991, J INVEST DERMATOL, V97, P701, DOI 10.1111/1523-1747.ep12484041; MURTHY ARK, 1993, J IMMUNOL, V151, P6291; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Noble W C, 1992, SKIN MICROFLORA MICR, P210; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Sampson B, 2002, LANCET, V360, P1742, DOI 10.1016/S0140-6736(02)11683-7; Schittek B, 2001, NAT IMMUNOL, V2, P1133, DOI 10.1038/ni732; Schroder JM, 1997, METHOD ENZYMOL, V288, P266; Shumaker DK, 1998, CELL CALCIUM, V23, P151, DOI 10.1016/S0143-4160(98)90114-2; Sohnle PG, 2000, J INFECT DIS, V182, P1272, DOI 10.1086/315810; Steinberg D A, 1997, Methods Mol Biol, V78, P169; STEINMAN HM, 1993, J BACTERIOL, V175, P1198, DOI 10.1128/JB.175.4.1198-1202.1993; Travis SM, 2000, INFECT IMMUN, V68, P2748, DOI 10.1128/IAI.68.5.2748-2755.2000; van der Merwe D, 2002, ANN CLIN BIOCHEM, V39, P39, DOI 10.1258/0004563021901711; Wiedow O, 1998, BIOCHEM BIOPH RES CO, V248, P904, DOI 10.1006/bbrc.1998.9069; Yoshio H, 2003, PEDIATR RES, V53, P211, DOI 10.1203/01.PDR.0000047471.47777.B0; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	40	495	513	3	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2005	6	1					57	64		10.1038/ni1142	http://dx.doi.org/10.1038/ni1142			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	881SA	15568027				2022-12-18	WOS:000225888500018
J	Imai, K; Slupphaug, G; Lee, WI; Revy, P; Nonoyama, S; Catalan, N; Yel, L; Forveille, M; Kavli, B; Krokan, HE; Ochs, HD; Fischer, A; Durandy, A				Imai, K; Slupphaug, G; Lee, WI; Revy, P; Nonoyama, S; Catalan, N; Yel, L; Forveille, M; Kavli, B; Krokan, HE; Ochs, HD; Fischer, A; Durandy, A			Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination	NATURE IMMUNOLOGY			English	Article							HYPER-IGM SYNDROME; CYTIDINE DEAMINASE AID; DOUBLE-STRAND BREAKS; X-LINKED IMMUNODEFICIENCY; AUTOSOMAL RECESSIVE FORM; SOMATIC HYPERMUTATION; CD40 LIGAND; B-CELLS; UNG GENE; ANTIBODY DIVERSIFICATION	Activation-induced cytidine deaminase (AID) is a 'master molecule' in immunoglobulin (Ig) class-switch recombination (CSR) and somatic hypermutation (SHM) generation, AID deficiencies are associated with hyper-IgM phenotypes in humans and mice. We show here that recessive mutations of the gene encoding uracil-DNA glycosylase (UNG) are associated with profound impairment in CSR at a DNA precleavage step and with a partial disturbance of the SHM pattern in three patients with hyper-IgM syndrome. Together with the finding that nuclear UNG expression was induced in activated B cells, these data support a model of CSR and SHM in which AID deaminates cytosine into uracil in targeted DNA (immunoglobulin switch or variable regions), followed by uracil removal by UNG.	Hop Necker Enfants Malad, INSERM, U429, F-75015 Paris, France; Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7489 Trondheim, Norway; Univ Washington, Dept Pediat, Seattle, WA 98195 USA; Chang Gung Childrens Hosp & Univ, Dept Pediat, Taoyuan 333, Taiwan; Natl Def Med Coll, Dept Pediat, Saitama 3598513, Japan; Univ Calif Irvine, Dept Med, Div Basic & Clin Immunol, Irvine, CA 92697 USA; Hop Necker Enfants Malad, Unite Immunol Hematol & Rhumatol Pediat, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Norwegian University of Science & Technology (NTNU); University of Washington; University of Washington Seattle; Chang Gung Memorial Hospital; National Defense Medical College - Japan; University of California System; University of California Irvine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Durandy, A (corresponding author), Hop Necker Enfants Malad, INSERM, U429, F-75015 Paris, France.	durandy@necker.fr	Imai, Kohsuke/Q-2602-2015; Slupphaug, Geir/AAN-3794-2020; Durandy, Anne/H-7475-2017; Revy, Patrick/H-8137-2017	Imai, Kohsuke/0000-0003-2132-8403; Durandy, Anne/0000-0001-7706-8466; Revy, Patrick/0000-0003-0758-8022; Slupphaug, Geir/0000-0002-7498-3500	NICHD NIH HHS [HD 17427-33] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD017427, R01HD017427] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALLEN RC, 1993, SCIENCE, V259, P990, DOI 10.1126/science.7679801; ARUFFO A, 1993, CELL, V72, P291, DOI 10.1016/0092-8674(93)90668-G; Bardwell PD, 2003, J IMMUNOL, V170, P1620, DOI 10.4049/jimmunol.170.4.1620; Bougeard L, 2003, AM J HUM GENET, V72, P213, DOI 10.1086/345297; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Bross L, 2002, J EXP MED, V195, P1187, DOI 10.1084/jem.20011749; CASTIGLI E, 1994, P NATL ACAD SCI USA, V91, P12135, DOI 10.1073/pnas.91.25.12135; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; DISANTO JP, 1993, NATURE, V361, P541, DOI 10.1038/361541a0; Doi T, 2003, P NATL ACAD SCI USA, V100, P2634, DOI 10.1073/pnas.0437710100; Durandy A, 1997, J IMMUNOL, V158, P2576; Durandy A, 2002, BIOCHEM SOC T, V30, P815, DOI 10.1042/bst0300815; Ehrenstein MR, 1999, EMBO J, V18, P3484, DOI 10.1093/emboj/18.12.3484; Ferrari S, 2001, P NATL ACAD SCI USA, V98, P12614, DOI 10.1073/pnas.221456898; Fugmann SD, 2003, NAT IMMUNOL, V4, P429, DOI 10.1038/ni0503-429; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Imai K, 2003, J CLIN INVEST, V112, P136, DOI 10.1172/JCI200318161; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kinoshita K, 2001, NAT REV MOL CELL BIO, V2, P493, DOI 10.1038/35080033; KORTHAUER U, 1993, NATURE, V361, P539, DOI 10.1038/361539a0; Kvaloy K, 2001, MUTAT RES-DNA REPAIR, V461, P325, DOI 10.1016/S0921-8777(00)00063-X; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; MULLER SJ, 1991, BIOCHIM BIOPHYS ACTA, V1088, P197, DOI 10.1016/0167-4781(91)90055-Q; MULLER SJ, 1993, J BIOL CHEM, V268, P1310; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Neddermann P, 1996, J BIOL CHEM, V271, P12767, DOI 10.1074/jbc.271.22.12767; Nilsen H, 1997, NUCLEIC ACIDS RES, V25, P750, DOI 10.1093/nar/25.4.750; Nilsen H, 2001, EMBO J, V20, P4278, DOI 10.1093/emboj/20.15.4278; Otterlei M, 1998, NUCLEIC ACIDS RES, V26, P4611, DOI 10.1093/nar/26.20.4611; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Schrader CE, 1999, J EXP MED, V190, P323, DOI 10.1084/jem.190.3.323; Shinkura R, 2003, NAT IMMUNOL, V4, P435, DOI 10.1038/ni918; SLUPPHAUG G, 1995, BIOCHEMISTRY-US, V34, P128, DOI 10.1021/bi00001a016; Vilkki S, 2001, CANCER RES, V61, P4541; Wang Q, 1999, CANCER RES, V59, P294; Whiteside D, 2002, CANCER RES, V62, P359; Wuerffel RA, 1997, J IMMUNOL, V159, P4139; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919	47	495	504	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2003	4	10					1023	1028		10.1038/ni974	http://dx.doi.org/10.1038/ni974			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	726GG	12958596				2022-12-18	WOS:000185590100019
J	Jiang, ZF; Georgel, P; Du, X; Shamel, L; Sovath, S; Mudd, S; Huber, M; Kalis, C; Keck, S; Galanos, C; Freudenberg, M; Beutler, B				Jiang, ZF; Georgel, P; Du, X; Shamel, L; Sovath, S; Mudd, S; Huber, M; Kalis, C; Keck, S; Galanos, C; Freudenberg, M; Beutler, B			CD14 is required for MyD88-independent LPS signaling	NATURE IMMUNOLOGY			English	Article							LIPOPOLYSACCHARIDE BINDING-PROTEIN; GENETIC-CONTROL; RECEPTOR; MICE; TLR4; IDENTIFICATION; RECOGNITION; ACTIVATION; ENDOTOXIN; PATHWAY	The recessive mutation 'Heedless' (hdl) was detected in third-generation N-ethyl-N-nitrosourea-mutated mice that showed defective responses to microbial inducers. Macrophages from Heedless homozygotes signaled by the MyD88-dependent pathway in response to rough lipopolysaccharide (LPS) and lipid A, but not in response to smooth LPS. In addition, the Heedless mutation prevented TRAM-TRIF-dependent signaling in response to all LPS chemotypes. Heedless also abolished macrophage responses to vesicular stomatitis virus and substantially inhibited responses to specific ligands for the Toll-like receptor 2 ( TLR2)-TLR6 heterodimer. The Heedless phenotype was positionally ascribed to a premature stop codon in Cd14. Our data suggest that the TLR4-MD-2 complex distinguishes LPS chemotypes, but CD14 nullifies this distinction. Thus, the TLR4-MD-2 complex receptor can function in two separate modes: one in which full signaling occurs and one limited to MyD88-dependent signaling.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Max Planck Inst Immunbiol, D-79108 Freiburg, Germany; Univ Freiburg, Dept Mol Immunol, Inst Biol 3, D-79108 Freiburg, Germany	Scripps Research Institute; Max Planck Society; University of Freiburg	Beutler, B (corresponding author), Scripps Res Inst, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	bruce@scripps.edu	georgel, philippe/P-5676-2016	georgel, philippe/0000-0001-6853-7080; Freudenberg, Marina Alexandra/0000-0001-5894-1805	NIAID NIH HHS [AI050241] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050241] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; GALANOS C, 1984, EUR J BIOCHEM, V140, P221, DOI 10.1111/j.1432-1033.1984.tb08090.x; GALANOS C, 1985, EUR J BIOCHEM, V148, P1, DOI 10.1111/j.1432-1033.1985.tb08798.x; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Jiang ZF, 2004, P NATL ACAD SCI USA, V101, P3533, DOI 10.1073/pnas.0308496101; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; OBRIEN AD, 1980, J IMMUNOL, V124, P20; Poltorak A, 2000, P NATL ACAD SCI USA, V97, P2163, DOI 10.1073/pnas.040565397; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; ROSENSTREICH DL, 1982, CRC CR REV IMMUNOL, V3, P263; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; TOBIAS PS, 1988, J BIOL CHEM, V263, P13479; TOBIAS PS, 1989, J BIOL CHEM, V264, P10867; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986	24	494	518	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2005	6	6					565	570		10.1038/ni1207	http://dx.doi.org/10.1038/ni1207			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	929ZR	15895089				2022-12-18	WOS:000229385900010
J	Franklin, BS; Bossaller, L; De Nardo, D; Ratter, JM; Stutz, A; Engels, G; Brenker, C; Nordhoff, M; Mirandola, SR; Al-Amoudi, A; Mangan, MS; Zimmer, S; Monks, BG; Fricke, M; Schmidt, RE; Espevik, T; Jones, B; Jarnicki, AG; Hansbro, PM; Busto, P; Marshak-Rothstein, A; Hornemann, S; Aguzzi, A; Kastenmuller, W; Latz, E				Franklin, Bernardo S.; Bossaller, Lukas; De Nardo, Dominic; Ratter, Jacqueline M.; Stutz, Andrea; Engels, Gudrun; Brenker, Christoph; Nordhoff, Mark; Mirandola, Sandra R.; Al-Amoudi, Ashraf; Mangan, Matthew S.; Zimmer, Sebastian; Monks, Brian G.; Fricke, Martin; Schmidt, Reinhold E.; Espevik, Terje; Jones, Bernadette; Jarnicki, Andrew G.; Hansbro, Philip M.; Busto, Patricia; Marshak-Rothstein, Ann; Hornemann, Simone; Aguzzi, Adriano; Kastenmueller, Wolfgang; Latz, Eicke			The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation	NATURE IMMUNOLOGY			English	Article							INNATE IMMUNE-RESPONSE; TOLL-LIKE RECEPTORS; NALP3 INFLAMMASOME; STERILE INFLAMMATION; CASPASE-1 ACTIVATION; SIGNAL-TRANSDUCTION; NLRP3 INFLAMMASOME; CELL-DEATH; PROTEIN; POLYMERIZATION	Microbes or danger signals trigger inflammasome sensors, which induce polymerization of the adaptor ASC and the assembly of ASC specks. ASC specks recruit and activate caspase-1, which induces maturation of the cytokine interleukin 1 beta (IL-1 beta) and pyroptotic cell death. Here we found that after pyroptosis, ASC specks accumulated in the extracellular space, where they promoted further maturation of IL-1 beta. In addition, phagocytosis of ASC specks by macrophages induced lysosomal damage and nucleation of soluble ASC, as well as activation of IL-1 beta in recipient cells. ASC specks appeared in bodily fluids from inflamed tissues, and autoantibodies to ASC specks developed in patients and mice with autoimmune pathologies. Together these findings reveal extracellular functions of ASC specks and a previously unknown form of cell-to-cell communication.	[Franklin, Bernardo S.; De Nardo, Dominic; Ratter, Jacqueline M.; Stutz, Andrea; Engels, Gudrun; Mangan, Matthew S.; Monks, Brian G.; Latz, Eicke] Univ Bonn, Univ Hosp, Inst Innate Immun, Bonn, Germany; [Bossaller, Lukas; Fricke, Martin; Schmidt, Reinhold E.] Hannover Med Sch, Dept Immunol & Rheumatol, Hannover, Germany; [Bossaller, Lukas; Monks, Brian G.; Busto, Patricia; Marshak-Rothstein, Ann; Latz, Eicke] Univ Massachusetts, Sch Med, Dept Immunol & Infect Dis, Worcester, MA USA; [Brenker, Christoph; Nordhoff, Mark; Mirandola, Sandra R.; Al-Amoudi, Ashraf; Mangan, Matthew S.; Latz, Eicke] German Ctr Neurodegenerat Dis, Bonn, Germany; [Zimmer, Sebastian] Univ Bonn, Univ Hosp, Dept Med Cardiol, Bonn, Germany; [Espevik, Terje; Latz, Eicke] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, Ctr Mol Inflammat Res, N-7034 Trondheim, Norway; [Jones, Bernadette; Jarnicki, Andrew G.; Hansbro, Philip M.] Univ Newcastle, Ctr Asthma & Resp Dis, Newcastle, NSW 2300, Australia; [Hornemann, Simone; Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Kastenmueller, Wolfgang] Univ Bonn, Univ Hosp, Inst Mol Med & Expt Immunol, Bonn, Germany	University of Bonn; Hannover Medical School; University of Massachusetts System; University of Massachusetts Worcester; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; Norwegian University of Science & Technology (NTNU); University of Newcastle; University of Zurich; University Zurich Hospital; University of Bonn	Latz, E (corresponding author), Univ Bonn, Univ Hosp, Inst Innate Immun, Bonn, Germany.	eicke.latz@uni-bonn.de	Hansbro, Phil/G-7486-2013; Ratter-Rieck, Jacqueline M/G-6301-2016; Franklin, Bernardo S/G-8186-2012; Monks, Brian/B-8362-2015; Latz, Eicke/H-3951-2014	Hansbro, Phil/0000-0002-4741-3035; Ratter-Rieck, Jacqueline M/0000-0002-3807-9442; Franklin, Bernardo S/0000-0003-2591-9833; Monks, Brian/0000-0003-4008-3093; Latz, Eicke/0000-0003-1488-5666; Aguzzi, Adriano/0000-0002-0344-6708; De Nardo, Dominic/0000-0002-7045-4695; Jones-Freeman, Bernadette/0000-0003-4613-7865; Bossaller, Lukas/0000-0003-0789-4062	Deutsche Forschungsgemeinschaft [SFB670]; US National Institutes of Health [R01-HL093262, R01-HL112661, R01-AI083713]; Alexander von Humboldt Foundation; intramural BONFOR research support at the University of Bonn; European Research Council; European Union (NEURINOX); Swiss National Foundation; Novartis Research Foundation; Clinical Research Priority Program "Small RNAs" of the University of Zurich; ImmunoSensation cluster of Excellence in Bonn; German Center for Infection Research; Clinical Research Priority Program "Mechanisms of Human Hemato-Lymphatic Diseases" of the University of Zurich; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112661, R01HL093262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083713] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); intramural BONFOR research support at the University of Bonn; European Research Council(European Research Council (ERC)European Commission); European Union (NEURINOX); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Novartis Research Foundation; Clinical Research Priority Program "Small RNAs" of the University of Zurich; ImmunoSensation cluster of Excellence in Bonn; German Center for Infection Research; Clinical Research Priority Program "Mechanisms of Human Hemato-Lymphatic Diseases" of the University of Zurich; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Tiberi and P.-I. Chiang for technical support. Supported by Deutsche Forschungsgemeinschaft (SFB670 to E.L.), the US National Institutes of Health (R01-HL093262, R01-HL112661 and R01-AI083713 to E.L.), the Alexander von Humboldt Foundation (B.S.F.), intramural BONFOR research support at the University of Bonn (B.S.F.), the European Research Council (Advanced Grant to A.A.), the European Union (NEURINOX to A.A.), the Swiss National Foundation (Sinergia grant to A.A.), the Novartis Research Foundation (A.A.), the Clinical Research Priority Programs "Small RNAs" and "Mechanisms of Human Hemato-Lymphatic Diseases" of the University of Zurich (A.A.), the ImmunoSensation cluster of Excellence in Bonn (E.L.) and the German Center for Infection Research (E.L.).	Adamczak S, 2012, J NEUROSURG, V117, P1119, DOI 10.3171/2012.9.JNS12815; Aguzzi A, 2013, NAT REV IMMUNOL, V13, P888, DOI 10.1038/nri3553; Aguzzi A, 2012, NAT NEUROSCI, V15, P936, DOI 10.1038/nn.3120; Aguzzi A, 2009, NATURE, V459, P924, DOI 10.1038/459924a; Bakele M, 2014, J BIOL CHEM, V289, P5320, DOI 10.1074/jbc.M113.505636; Balci-Peynircioglu B, 2008, EXP BIOL MED, V233, P1324, DOI 10.3181/0803-RM-106; Beckett EL, 2013, J ALLERGY CLIN IMMUN, V131, P752, DOI 10.1016/j.jaci.2012.11.053; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Botelho FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028457; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; De Nardo D, 2014, AM J PATHOL, V184, P42, DOI 10.1016/j.ajpath.2013.09.007; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duewell Peter, 2013, Methods Mol Biol, V1040, P19, DOI 10.1007/978-1-62703-523-1_3; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2008, METHOD ENZYMOL, V442, P251, DOI [10.1016/S0076-6S79(08)01413-4, 10.1016/S0076-6879(08)01413-4]; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hofmann JP, 2013, P NATL ACAD SCI USA, V110, P5951, DOI 10.1073/pnas.1217321110; Holmes BB, 2012, CURR OPIN NEUROL, V25, P721, DOI 10.1097/WCO.0b013e32835a3ee0; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Jakobs C., 2012, METHOD MOL BIOL, V1040, P103; Kastenmuller W, 2012, CELL, V150, P1235, DOI 10.1016/j.cell.2012.07.021; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Leiss H., 2012, CORD C P, V22, P778; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Lima DS, 2013, NAT MED, V19, P909, DOI 10.1038/nm.3221; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Matsushita K, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/287387; Meissner F, 2008, NAT IMMUNOL, V9, P866, DOI 10.1038/ni.1633; Proell M, 2013, BIOCHEM J, V449, P613, DOI 10.1042/BJ20121198; Sheedy FJ, 2013, NAT IMMUNOL, V14, P812, DOI 10.1038/ni.2639; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Stutz Andrea, 2013, Methods Mol Biol, V1040, P91, DOI 10.1007/978-1-62703-523-1_8; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Vaccari JPD, 2009, J CEREBR BLOOD F MET, V29, P1251, DOI 10.1038/jcbfm.2009.46; Wang X, 2008, J BIOL CHEM, V283, P21530, DOI 10.1074/jbc.M800466200; Westwell-Roper Clara, 2013, Methods Mol Biol, V1040, P9, DOI 10.1007/978-1-62703-523-1_2; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048; Wu H, 2013, CELL, V153, P287, DOI 10.1016/j.cell.2013.03.013	48	492	505	4	111	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2014	15	8					727	+		10.1038/ni.2913	http://dx.doi.org/10.1038/ni.2913			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AL7OF	24952505	Green Accepted			2022-12-18	WOS:000339323000008
J	Smith, KD; Andersen-Nissen, E; Hayashi, F; Strobe, K; Bergman, MA; Barrett, SLR; Cookson, BT; Aderem, A				Smith, KD; Andersen-Nissen, E; Hayashi, F; Strobe, K; Bergman, MA; Barrett, SLR; Cookson, BT; Aderem, A			Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility	NATURE IMMUNOLOGY			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; EPITHELIAL-CELLS; IMMUNE-RESPONSE; CUTTING EDGE; T-CELLS; INFECTION; ENTERITIDIS; ACTIVATION	Toll-like receptor 5 (TLR5) recognizes bacterial flagellin and activates host inflammatory responses. In this study, we examine the nature of the TLR5-flagellin interaction. With deletional, insertional and alanine-scanning mutagenesis, we precisely mapped the TLR5 recognition site on flagellin to a cluster of 13 amino acid residues that participate in intermolecular interactions within flagellar protofilaments and that are required for bacterial motility. The recognition site is buried in the flagellar filament, and monomeric flagellin, but not the filamentous molecule, stimulated TLR5. Finally, flagellin coprecipitated with TLR5, indicating close physical interaction between the molecules. These studies demonstrate the exquisite ability of the innate immune system to precisely target a conserved site on flagellin that is essential for bacterial motility.	Inst Syst Biol, Seattle, WA 98103 USA; Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; Univ Washington, Dept Immunol, Seattle, WA 98195 USA	Institute for Systems Biology (ISB); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Smith, KD (corresponding author), Inst Syst Biol, 1441 N 34th St, Seattle, WA 98103 USA.	kelsmith@u.washington.edu		Andersen-Nissen, Erica/0000-0001-9213-920X	NIAID NIH HHS [K08AI01751, R01AI047242, R01AI032972, R01AI52286, R37AI025032] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047242, R01AI032972, R37AI025032, R01AI052286, K08AI001751] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arora SK, 2001, P NATL ACAD SCI USA, V98, P9342, DOI 10.1073/pnas.161249198; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; BERG HC, 1973, NATURE, V245, P380, DOI 10.1038/245380a0; Burnens AP, 1997, MICROBIOL-UK, V143, P1539, DOI 10.1099/00221287-143-5-1539; Chua KL, 2003, INFECT IMMUN, V71, P1622, DOI 10.1128/IAI.71.4.1622-1629.2003; Cookson BT, 1997, J IMMUNOL, V158, P4310; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dibb-Fuller MP, 1999, MICROBIOL-SGM, V145, P1023, DOI 10.1099/13500872-145-5-1023; Dietrich C, 2001, INFECT IMMUN, V69, P2116, DOI 10.1128/IAI.69.4.2116-2122.2001; Donnelly MA, 2002, J BIOL CHEM, V277, P40456, DOI 10.1074/jbc.M206851200; Eaves-Pyles TD, 2001, J IMMUNOL, V167, P7009, DOI 10.4049/jimmunol.167.12.7009; Feldman M, 1998, INFECT IMMUN, V66, P43, DOI 10.1128/IAI.66.1.43-51.1998; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Gewirtz AT, 2000, J CLIN INVEST, V105, P79, DOI 10.1172/JCI8066; Gewirtz AT, 2001, J CLIN INVEST, V107, P99, DOI 10.1172/JCI10501; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gomez-Gomez L, 2001, PLANT CELL, V13, P1155, DOI 10.1105/tpc.13.5.1155; HACKETT J, 1988, J INFECT DIS, V157, P78, DOI 10.1093/infdis/157.1.78; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Ikeda JS, 2001, INFECT IMMUN, V69, P3021, DOI 10.1128/IAI.69.5.3021-3030.2001; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; KAMIYA R, 1980, NATURE, V286, P628, DOI 10.1038/286628a0; Kavermann H, 2003, J EXP MED, V197, P813, DOI 10.1084/jem.20021531; LARSEN SH, 1974, NATURE, V249, P74, DOI 10.1038/249074a0; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Manoil C, 1997, J MOL BIOL, V267, P250, DOI 10.1006/jmbi.1996.0881; McDermott PF, 2000, INFECT IMMUN, V68, P5525, DOI 10.1128/IAI.68.10.5525-5529.2000; McSorley SJ, 2002, J IMMUNOL, V169, P3914, DOI 10.4049/jimmunol.169.7.3914; Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Mobley HLT, 1996, INFECT IMMUN, V64, P5332, DOI 10.1128/IAI.64.12.5332-5340.1996; Ogushi K, 2001, J BIOL CHEM, V276, P30521, DOI 10.1074/jbc.M011618200; Poltorak A, 2000, P NATL ACAD SCI USA, V97, P2163, DOI 10.1073/pnas.040565397; Robertson JMC, 2003, J MED MICROBIOL, V52, P91, DOI 10.1099/jmm.0.04901-0; SAMAKOVLIS C, 1992, BIOCHEM BIOPH RES CO, V188, P1169, DOI 10.1016/0006-291X(92)91354-S; Samatey FA, 2001, NATURE, V410, P331, DOI 10.1038/35066504; Schmitt CK, 2001, INFECT IMMUN, V69, P5619, DOI 10.1128/IAI.69.9.5619-5625.2001; Smith K D, 1993, PCR Methods Appl, V2, P253; Steiner TS, 2000, J CLIN INVEST, V105, P1769, DOI 10.1172/JCI8892; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeshita F, 2001, J IMMUNOL, V167, P3555, DOI 10.4049/jimmunol.167.7.3555; Thibault P, 2001, J BIOL CHEM, V276, P34862, DOI 10.1074/jbc.M104529200; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Van Asten FJAM, 2000, FEMS MICROBIOL LETT, V185, P175, DOI 10.1111/j.1574-6968.2000.tb09058.x; VINYAKOSOL S, 2001, J BIOL CHEM, V10, P10; Yamashita I, 1998, NAT STRUCT BIOL, V5, P125; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830	51	492	547	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2003	4	12					1247	1253		10.1038/ni1011	http://dx.doi.org/10.1038/ni1011			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	746VZ	14625549				2022-12-18	WOS:000186769500019
J	Zhang, Q; Bi, JC; Zheng, XD; Chen, YY; Wang, H; Wu, WY; Wang, ZG; Wu, Q; Peng, H; Wei, HM; Sun, R; Tian, ZG				Zhang, Qing; Bi, Jiacheng; Zheng, Xiaodong; Chen, Yongyan; Wang, Hua; Wu, Wenyong; Wang, Zhengguang; Wu, Qiang; Peng, Hui; Wei, Haiming; Sun, Rui; Tian, Zhigang			Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity	NATURE IMMUNOLOGY			English	Article							REGULATORY T; COMBINATION IMMUNOTHERAPY; ACTIVATION; EXPANSION; RESPONSES; CANCER; INTERLEUKIN-15; EFFECTOR; THERAPY; CTLA-4	Checkpoint blockade enhances effector T cell function and has elicited long-term remission in a subset of patients with a broad spectrum of cancers. TIGIT is a checkpoint receptor thought to be involved in mediating T cell exhaustion in tumors; however, the relevance of TIGIT to the dysfunction of natural killer (NK) cells remains poorly understood. Here we found that TIGIT, but not the other checkpoint molecules CTLA-4 and PD-1, was associated with NK cell exhaustion in tumor-bearing mice and patients with colon cancer. Blockade of TIGIT prevented NK cell exhaustion and promoted NK cell-dependent tumor immunity in several tumor-bearing mouse models. Furthermore, blockade of TIGIT resulted in potent tumor-specific T cell immunity in an NK cell-dependent manner, enhanced therapy with antibody to the PD-1 ligand PD-L1 and sustained memory immunity in tumor re-challenge models. This work demonstrates that TIGIT constitutes a previously unappreciated checkpoint in NK cells and that targeting TIGIT alone or in combination with other checkpoint receptors is a promising anti-cancer therapeutic strategy.	[Zhang, Qing; Wei, Haiming; Sun, Rui; Tian, Zhigang] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China; [Zhang, Qing; Bi, Jiacheng; Zheng, Xiaodong; Chen, Yongyan; Peng, Hui; Wei, Haiming; Sun, Rui; Tian, Zhigang] Univ Sci & Technol China, Inst Immunol, Hefei, Anhui, Peoples R China; [Zhang, Qing; Bi, Jiacheng; Zheng, Xiaodong; Chen, Yongyan; Peng, Hui; Wei, Haiming; Sun, Rui; Tian, Zhigang] Univ Sci & Technol China, CAS Key Lab Innate Immun & Chron Dis, Sch Life Sci, Hefei, Anhui, Peoples R China; [Zhang, Qing; Bi, Jiacheng; Zheng, Xiaodong; Chen, Yongyan; Peng, Hui; Wei, Haiming; Sun, Rui; Tian, Zhigang] Univ Sci & Technol China, Med Ctr, Hefei, Anhui, Peoples R China; [Bi, Jiacheng] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Biotechnol, Shenzhen Lab Fully Humanized Antibody Engn, Shenzhen, Peoples R China; [Wang, Hua; Wu, Wenyong; Wang, Zhengguang; Wu, Qiang] Anhui Med Univ, Affiliated Hosp 1, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Anhui Medical University	Sun, R; Tian, ZG (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China.; Sun, R; Tian, ZG (corresponding author), Univ Sci & Technol China, Inst Immunol, Hefei, Anhui, Peoples R China.; Sun, R; Tian, ZG (corresponding author), Univ Sci & Technol China, CAS Key Lab Innate Immun & Chron Dis, Sch Life Sci, Hefei, Anhui, Peoples R China.; Sun, R; Tian, ZG (corresponding author), Univ Sci & Technol China, Med Ctr, Hefei, Anhui, Peoples R China.	sunr@ustc.edu.cn; tzg@ustc.edu.cn	Tian, Zhigang/J-3512-2013; Zheng, Xiaodong/N-2830-2013	Bi, Jiacheng/0000-0001-5646-0119; Wang, Hua/0000-0002-2605-5697	Natural Science Foundation of China [81788101, 431570893, 81501355]; Chinese Academy of Science [XDPB030301]; Ministry of Science & Technology of China [2017ZX10203206003, 2017ZX10202203-002-001]; Science and Technology Innovation Fund of Shenzhen [JCYJ20150521094519472, MX120150630114942288]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences); Ministry of Science & Technology of China(Ministry of Science and Technology, China); Science and Technology Innovation Fund of Shenzhen	We acknowledged funding support from the following sources: Natural Science Foundation of China (#81788101 to Z.T., 431570893 to R.S., and #81501355 to J.B.); Chinese Academy of Science (XDPB030301 to Z.T.); the Ministry of Science & Technology of China (2017ZX10203206003 to R.S., 2017ZX10202203-002-001 to Y.C.); the Science and Technology Innovation Fund of Shenzhen (JCYJ20150521094519472 and MX120150630114942288 to J.B.). We thank Bristol-Myers Squibb for Tigit mice; T. W. Mak. (University of Toronto) for the NIP3- mice; N Su (Shantou University) for GK. mice; L. Bai and Z. Lion (University of Science and Technology of China) for C57BL16 J Cd4- - mice; X. Wang (Inner Mongolia University) for Rag2 mice; E. Vivier (INSERM) for Ned mice; and Z. Fan (Institute of Biophysics Chinese Academy of Sciences) for Tigite4 mice.	Bi JC, 2014, HEPATOLOGY, V60, P1389, DOI 10.1002/hep.27245; Bi JC, 2014, HEPATOLOGY, V59, P1715, DOI 10.1002/hep.26968; Chan CJ, 2014, NAT IMMUNOL, V15, P431, DOI 10.1038/ni.2850; Chauvin JM, 2015, J CLIN INVEST, V125, P2046, DOI 10.1172/JCI80445; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Curran MA, 2009, CANCER RES, V69, P7747, DOI 10.1158/0008-5472.CAN-08-3289; Dong J, 2002, CANCER BIOL THER, V1, P486, DOI 10.4161/cbt.1.5.161; Gur C, 2015, IMMUNITY, V42, P344, DOI 10.1016/j.immuni.2015.01.010; Hou S, 2007, CANCER IMMUNOL IMMUN, V56, P1605, DOI 10.1007/s00262-007-0306-3; Hou X, 2017, CELL MOL IMMUNOL, V14, P675, DOI 10.1038/cmi.2015.111; Johnston RJ, 2014, CANCER CELL, V26, P923, DOI 10.1016/j.ccell.2014.10.018; Joller N, 2014, IMMUNITY, V40, P569, DOI 10.1016/j.immuni.2014.02.012; Kong YX, 2016, CLIN CANCER RES, V22, P3057, DOI 10.1158/1078-0432.CCR-15-2626; Kurtulus S, 2015, J CLIN INVEST, V125, P4053, DOI 10.1172/JCI81187; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Li B, 2009, CLIN CANCER RES, V15, P1623, DOI 10.1158/1078-0432.CCR-08-1825; Lin SJ, 2000, PEDIATR ALLERGY IMMU, V11, P168; Liu Y, 2018, CELL MOL IMMUNOL, V15, P827, DOI 10.1038/cmi.2017.10; Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005; Nagamura-Inoue T, 2004, EXP HEMATOL, V32, P202, DOI 10.1016/j.exphem.2003.10.013; Ngiow SF, 2011, CANCER RES, V71, P3540, DOI 10.1158/0008-5472.CAN-11-0096; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Segal N. H., 2014, ASCO ANN M P, V2014; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Stanietsky N, 2013, EUR J IMMUNOL, V43, P2138, DOI 10.1002/eji.201243072; Stanietsky N, 2009, P NATL ACAD SCI USA, V106, P17858, DOI 10.1073/pnas.0903474106; Twyman-Saint Victor C, 2015, NATURE, V520, P373, DOI 10.1038/nature14292; van Elsas A, 1999, J EXP MED, V190, P355, DOI 10.1084/jem.190.3.355; Yang XM, 2014, CANCER CELL, V25, P37, DOI 10.1016/j.ccr.2013.12.004; Yang YF, 1997, CANCER RES, V57, P4036; Yu X, 2009, NAT IMMUNOL, V10, P48, DOI 10.1038/ni.1674; Zhang QF, 2017, CELL MOL IMMUNOL, V14, P819, DOI 10.1038/cmi.2016.28; Zheng MJ, 2016, J IMMUNOL, V196, P4122, DOI 10.4049/jimmunol.1500846; Zou WP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7118; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	39	491	525	28	230	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2018	19	7					723	+		10.1038/s41590-018-0132-0	http://dx.doi.org/10.1038/s41590-018-0132-0			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK6ZD	29915296				2022-12-18	WOS:000436341300017
J	Kinjo, Y; Tupin, E; Wu, D; Fujio, M; Garcia-Navarro, R; Benhnia, MREI; Zajonc, DM; Ben-Menachem, G; Ainge, GD; Painter, GF; Khurana, A; Hoebe, K; Behar, SM; Beutler, B; Wilson, IA; Tsuji, M; Sellati, TJ; Wong, CH; Kronenberg, M				Kinjo, Yuki; Tupin, Emmanuel; Wu, Douglass; Fujio, Masakazu; Garcia-Navarro, Raquel; Benhnia, Mohammed Rafii-El-Idrissi; Zajonc, Dirk M.; Ben-Menachem, Gil; Ainge, Gary D.; Painter, Gavin F.; Khurana, Archana; Hoebe, Kasper; Behar, Samuel M.; Beutler, Bruce; Wilson, Ian A.; Tsuji, Moriya; Sellati, Timothy J.; Wong, Chi-Huey; Kronenberg, Mitchell			Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria	NATURE IMMUNOLOGY			English	Article							BORRELIA-BURGDORFERI; NKT CELLS; ALPHA-GALACTOSYLCERAMIDE; CHOLESTERYL GALACTOSIDE; CRYSTAL-STRUCTURE; CD1D TETRAMERS; IDENTIFICATION; GLYCOSPHINGOLIPIDS; ACTIVATION; INFECTION	Natural killer T ( NKT) cells recognize glycosphingolipids presented by CD1d molecules and have been linked to defense against microbial infections. Previously defined foreign glycosphingolipids recognized by NKT cells are uniquely found in nonpathogenic sphingomonas bacteria. Here we show that mouse and human NKT cells also recognized glycolipids, specifically a diacylglycerol, from Borrelia burgdorferi, which causes Lyme disease. The B. burgdorferi-derived, glycolipid- induced NKT cell proliferation and cytokine production and the antigenic potency of this glycolipid was dependent on acyl chain length and saturation. These data indicate that NKT cells recognize categories of glycolipids beyond those in sphingomonas and suggest that NKT cell responses driven by T cell receptor-mediated glycolipid recognition may provide protection against diverse pathogens.	La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Rockefeller Univ, Aaron Diamond AIDS Res Ctr, HIV & Malaria Vaccine Program, New York, NY 10016 USA; Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; Scripps Res Inst, Dept Biol Mol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; NICHHD, Dev & Mol Immun Lab, NIH, Bethesda, MD 20892 USA; Gracefield Res Ctr, Carbohydrate Chem Team, Lower Hutt 6008, New Zealand; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	La Jolla Institute for Immunology; Scripps Research Institute; Scripps Research Institute; Rockefeller University; Albany Medical College; Scripps Research Institute; Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Scripps Research Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kronenberg, M (corresponding author), La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA 92037 USA.	mitch@liai.org	Tsuji, Moriya/B-1471-2008; Sellati, Timothy/ABE-8023-2021; Kronenberg, Mitchell/AAT-6078-2021; Behar, Samuel M/C-3541-2009; benhnia, mohammed rafii el idrissi/F-3019-2015	benhnia, mohammed rafii el idrissi/0000-0001-7405-9476; Hoebe, Kasper/0000-0002-3626-8098; Tsuji, Moriya/0000-0001-8587-277X; Behar, Samuel/0000-0002-3374-6699	NCI NIH HHS [CA58896] Funding Source: Medline; NIAID NIH HHS [R01 AI054546, AI054546, AI062842, AI45053, R37 AI071922, AI71922] Funding Source: Medline; NIGMS NIH HHS [GM44154, GM62116] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA058896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI062842, R01AI071922, R01AI045053, R01AI054546, R37AI071922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM044154, R01GM044154, U54GM062116] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AINGE GD, IN PRESS BIOORG MED; Ben-Menachem G, 2003, P NATL ACAD SCI USA, V100, P7913, DOI 10.1073/pnas.1232451100; Benhnia MREI, 2005, J IMMUNOL, V174, P1539, DOI 10.4049/jimmunol.174.3.1539; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Brigl M, 2006, J IMMUNOL, V176, P3625, DOI 10.4049/jimmunol.176.6.3625; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; CINCO M, 1991, FEMS MICROBIOL IMMUN, V76, P33, DOI 10.1111/j.1574-6968.1991.tb04160.x; Duthie MS, 2005, INFECT IMMUN, V73, P181, DOI 10.1128/IAI.73.1.181-192.2005; EIFFERT H, 1991, MED MICROBIOL IMMUN, V180, P229, DOI 10.1007/BF00202557; Fischer K, 2004, P NATL ACAD SCI USA, V101, P10685, DOI 10.1073/pnas.0403787101; Fujii S, 2002, NAT IMMUNOL, V3, P867, DOI 10.1038/ni827; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Goff RD, 2004, J AM CHEM SOC, V126, P13602, DOI 10.1021/ja045385q; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Kawahara K, 2002, FEMS MICROBIOL LETT, V214, P289; Kawahara K, 2000, EUR J BIOCHEM, V267, P1837, DOI 10.1046/j.1432-1327.2000.01189.x; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kinjo Y, 2005, J CLIN IMMUNOL, V25, P522, DOI 10.1007/s10875-005-8064-5; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Kumar H, 2000, J IMMUNOL, V165, P4797, DOI 10.4049/jimmunol.165.9.4797; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; MORITA M, 1995, J MED CHEM, V38, P2176, DOI 10.1021/jm00012a018; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neef A, 1999, J IND MICROBIOL BIOT, V23, P261, DOI 10.1038/sj.jim.2900768; Orloski K A, 2000, MMWR CDC Surveill Summ, V49, P1; Rauch J, 2003, J BIOL CHEM, V278, P47508, DOI 10.1074/jbc.M308089200; Schroder NWJ, 2003, J BIOL CHEM, V278, P33645, DOI 10.1074/jbc.M305799200; Sellati TJ, 1999, J IMMUNOL, V163, P2049; Sidobre S, 2002, J IMMUNOL, V169, P1340, DOI 10.4049/jimmunol.169.3.1340; Skold M, 2003, INFECT IMMUN, V71, P5447, DOI 10.1128/IAI.71.10.5447-5455.2003; SLOMIANY BL, 1987, PROG LIPID RES, V26, P29, DOI 10.1016/0163-7827(87)90007-5; Sriram V, 2005, EUR J IMMUNOL, V35, P1692, DOI 10.1002/eji.200526157; WHEELER CM, 1993, J INFECT DIS, V167, P665, DOI 10.1093/infdis/167.3.665; Wooten RM, 2001, CURR OPIN MICROBIOL, V4, P274, DOI 10.1016/S1369-5274(00)00202-2; Wu D, 2006, P NATL ACAD SCI USA, V103, P3972, DOI 10.1073/pnas.0600285103; Wu DY, 2003, J EXP MED, V198, P173, DOI 10.1084/jem.20030446; Yang XF, 1999, INFECT IMMUN, V67, P6008, DOI 10.1128/IAI.67.11.6008-6018.1999; Yu KOA, 2005, P NATL ACAD SCI USA, V102, P3383, DOI 10.1073/pnas.0407488102; Zajonc DM, 2005, NAT IMMUNOL, V6, P810, DOI 10.1038/ni1224; Zajonc DM, 2005, J EXP MED, V202, P1517, DOI 10.1084/jem.20051625; ZAJONC DM, IN PRESS J IMMUNOL; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	50	490	504	3	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2006	7	9					978	986		10.1038/ni1380	http://dx.doi.org/10.1038/ni1380			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	076FL	16921381				2022-12-18	WOS:000239942300017
J	Yamasaki, S; Ishikawa, E; Sakuma, M; Hara, H; Ogata, K; Saito, T				Yamasaki, Sho; Ishikawa, Eri; Sakuma, Machie; Hara, Hiromitsu; Ogata, Koji; Saito, Takashi			Mincle is an ITAM-coupled activating receptor that senses damaged cells	NATURE IMMUNOLOGY			English	Article							C-TYPE LECTIN; SMALL NUCLEAR RIBONUCLEOPROTEIN; INNATE IMMUNE-RESPONSES; ADAPTER PROTEIN CARD9; TOLL-LIKE RECEPTORS; APOPTOTIC CELLS; AUTOIMMUNE-DISEASE; BINDING PROTEIN; DEFICIENT MICE; MYELOID CELLS	Macrophage-inducible C-type lectin (Mincle) is expressed mainly in macrophages and is induced after exposure to various stimuli and stresses. Here we show that Mincle selectively associated with the Fc receptor common gamma-chain and activated macrophages to produce inflammatory cytokines and chemokines. Mincle-expressing cells were activated in the presence of dead cells, and we identified SAP130, a component of small nuclear ribonucloprotein, as a Mincle ligand that is released from dead cells. To investigate whether Mincle is required for normal responses to cell death in vivo, we induced thymocyte death by irradiating mice and found that transient infiltration of neutrophils into the thymus could be blocked by injection of Mincle-specific antibody. Our results suggest that Mincle is a receptor that senses nonhomeostatic cell death and thereby induces the production of inflammatory cytokines to drive the infiltration of neutrophils into damaged tissue.	[Yamasaki, Sho; Ishikawa, Eri; Sakuma, Machie; Saito, Takashi] RIKEN, Res Ctr Allergy & Immunol, Lab Cell Signaling, Tsurumi Ku, Kanagawa 2300045, Japan; [Hara, Hiromitsu] Saga Univ, Fac Med, Dept Biomol Sci, Saga 8498501, Japan; [Ogata, Koji] Hosp Sick Children, Ctr Computat Biol, Toronto, ON M5G 1X8, Canada; [Saito, Takashi] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Suita, Osaka 8650871, Japan	RIKEN; Saga University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Osaka University	Saito, T (corresponding author), RIKEN, Res Ctr Allergy & Immunol, Lab Cell Signaling, Tsurumi Ku, 1-7-22 Suehiro Cho, Kanagawa 2300045, Japan.	sho@rcai.riken.jp; saito@rcai.riken.jp	Saito, Takashi/C-9684-2009; Ogata, Koji/H-4925-2019	Saito, Takashi/0000-0001-9495-3547; Ogata, Koji/0000-0001-9002-9621; Yamasaki, Sho/0000-0002-5184-6917				Akira S, 1997, ADV IMMUNOL, V65, P1, DOI 10.1016/S0065-2776(08)60740-3; Bakker ABH, 1999, P NATL ACAD SCI USA, V96, P9792, DOI 10.1073/pnas.96.17.9792; Bjorkbacka H, 2004, PHYSIOL GENOMICS, V19, P319, DOI 10.1152/physiolgenomics.00128.2004; Brand M, 2001, EMBO J, V20, P3187, DOI 10.1093/emboj/20.12.3187; Cao W, 2006, J EXP MED, V203, P1399, DOI 10.1084/jem.20052454; Caricchio R, 2003, J IMMUNOL, V171, P5778, DOI 10.4049/jimmunol.171.11.5778; Das BK, 1999, MOL CELL BIOL, V19, P6796; Delneste Y, 2002, IMMUNITY, V17, P353, DOI 10.1016/S1074-7613(02)00388-6; DRICKAMER K, 1992, NATURE, V360, P183, DOI 10.1038/360183a0; Fadok VA, 2001, J CLIN INVEST, V108, P957, DOI 10.1172/JCI14122; Flornes LM, 2004, IMMUNOGENETICS, V56, P506, DOI 10.1007/s00251-004-0714-x; Franz S, 2006, CYTOM PART A, V69A, P230, DOI 10.1002/cyto.a.20206; Fuller GLJ, 2007, J BIOL CHEM, V282, P12397, DOI 10.1074/jbc.M609558200; Green RS, 2007, IMMUNITY, V27, P308, DOI 10.1016/j.immuni.2007.06.008; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Hazenbos WLW, 1996, IMMUNITY, V5, P181, DOI 10.1016/S1074-7613(00)80494-X; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Ioan-Facsinay A, 2002, IMMUNITY, V16, P391, DOI 10.1016/S1074-7613(02)00294-7; Iyoda T, 2005, J IMMUNOL, V175, P3475, DOI 10.4049/jimmunol.175.6.3475; Kanazawa N, 2003, J BIOL CHEM, V278, P32645, DOI 10.1074/jbc.M304226200; Kim HS, 2007, IMMUNITY, V27, P321, DOI 10.1016/j.immuni.2007.06.010; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; Li JW, 2005, CELL CYCLE, V4, P1599, DOI 10.4161/cc.4.11.2117; Lorimore SA, 2001, ONCOGENE, V20, P7085, DOI 10.1038/sj.onc.1204903; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; MATSUMOTO K, 1999, FUNCT LANG, V6, P163; MIMORI T, 1984, J BIOL CHEM, V259, P560; Nakamura N, 2006, DNA RES, V13, P169, DOI 10.1093/dnares/dsl006; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nauta AJ, 2003, EUR J IMMUNOL, V33, P2853, DOI 10.1002/eji.200323888; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Ohtsuka M, 2004, P NATL ACAD SCI USA, V101, P8126, DOI 10.1073/pnas.0401119101; Oka K, 1998, P NATL ACAD SCI USA, V95, P9535, DOI 10.1073/pnas.95.16.9535; Park SY, 1998, J CLIN INVEST, V102, P1229, DOI 10.1172/JCI3256; Ribbhammar U, 2003, HUM MOL GENET, V12, P2087, DOI 10.1093/hmg/ddg224; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Savarese E, 2006, BLOOD, V107, P3229, DOI 10.1182/blood-2005-07-2650; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Uchimura E, 2000, J LEUKOCYTE BIOL, V67, P780, DOI 10.1002/jlb.67.6.780; Vollmer J, 2005, J EXP MED, V202, P1575, DOI 10.1084/jem.20051696; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Yamasaki S, 2006, NAT IMMUNOL, V7, P67, DOI 10.1038/ni1290; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Yuita H, 2005, GLYCOBIOLOGY, V15, P1368, DOI 10.1093/glycob/cwj028; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	52	489	510	4	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2008	9	10					1179	1188		10.1038/ni.1651	http://dx.doi.org/10.1038/ni.1651			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	349XC	18776906				2022-12-18	WOS:000259315600017
J	Ostermann, G; Weber, KSC; Zernecke, A; Schroder, A; Weber, C				Ostermann, G; Weber, KSC; Zernecke, A; Schroder, A; Weber, C			JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes	NATURE IMMUNOLOGY			English	Article							JUNCTIONAL ADHESION MOLECULE; FUNCTION-ASSOCIATED ANTIGEN-1; IMMUNOGLOBULIN SUPERFAMILY; CELL-ADHESION; VASCULAR ENDOTHELIUM; MONOCLONAL-ANTIBODY; PLATELET RECEPTOR; CHEMOKINES; BINDING; ARREST	Inflammatory recruitment of leukocytes is governed by dynamic interactions between integrins and endothelial immunoglobulin superfamily (IgSF) proteins. We have identified the IgSF member junctional adhesion molecule 1 (JAM-1) as a ligand of the 2 integrin lymphocyte function-associated antigen 1 (LFA-1). Under static and physiological flow conditions, JAM-1 contributed to LFA-1-dependent transendothelial migration of T cells and neutrophils as well as LFA-1-mediated arrest of T cells. The latter was triggered by chemokines on endothelium that was stimulated with cytokines to redistribute JAM-1 from the tight junctions. Transfectants expressing JAM-1 supported LFA-1-mediated adhesion of leukocytes, which required the membrane-proximal Ig-like domain 2 of JAM-1. Thus, JAM-1 is a counter-receptor for LFA-1 that is ideally situated to guide and control transmigration during leukocyte recruitment.	Univ Munich, Inst Prevent Cardiovasc Dis, Munich, Germany; Rhein Westfal TH Aachen, Univ Hosp Aachen, Dept Mol Cardiovasc Res, D-52074 Aachen, Germany	University of Munich; RWTH Aachen University; RWTH Aachen University Hospital	Weber, C (corresponding author), Univ Munich, Inst Prevent Cardiovasc Dis, Munich, Germany.	cweber@ukaachen.de	Weber, Christian/AAW-2153-2020	Weber, Christian/0000-0003-4610-8714				Aurrand-Lions M, 2001, J BIOL CHEM, V276, P2733, DOI 10.1074/jbc.M005458200; Aurrand-Lions MA, 2000, CURR TOP MICROBIOL, V251, P91; AYALON O, 1994, J CELL BIOL, V126, P247, DOI 10.1083/jcb.126.1.247; Bazzoni G, 2000, J BIOL CHEM, V275, P30970, DOI 10.1074/jbc.M003946200; Bazzoni G, 2000, J BIOL CHEM, V275, P20520, DOI 10.1074/jbc.M905251199; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; Bleijs DA, 2000, J CELL SCI, V113, P391; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Cunningham SA, 2000, J BIOL CHEM, V275, P34750, DOI 10.1074/jbc.M002718200; Davis HL, 1995, ANN NY ACAD SCI, V772, P21, DOI 10.1111/j.1749-6632.1995.tb44728.x; DEFOUGEROLLES AR, 1992, J EXP MED, V175, P185, DOI 10.1084/jem.175.1.185; Del Maschio A, 1999, J EXP MED, V190, P1351, DOI 10.1084/jem.190.9.1351; DIAMOND MS, 1991, CELL, V65, P961, DOI 10.1016/0092-8674(91)90548-D; Ebnet K, 2000, J BIOL CHEM, V275, P27979; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; Gopalan PK, 2000, J LEUKOCYTE BIOL, V68, P47; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Klickstein LB, 1996, J BIOL CHEM, V271, P23920, DOI 10.1074/jbc.271.39.23920; KORNECKI E, 1990, J BIOL CHEM, V265, P10042; Kostrewa D, 2001, EMBO J, V20, P4391, DOI 10.1093/emboj/20.16.4391; Kukreti S, 1997, BLOOD, V89, P4104, DOI 10.1182/blood.V89.11.4104; Liang TW, 2000, AM J PHYSIOL-CELL PH, V279, pC1733, DOI 10.1152/ajpcell.2000.279.6.C1733; LUSCINSKAS FW, 1995, J EXP MED, V181, P1179, DOI 10.1084/jem.181.3.1179; Malergue F, 1998, MOL IMMUNOL, V35, P1111, DOI 10.1016/S0161-5890(98)00102-3; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; MULLER WA, 1993, J EXP MED, V178, P449, DOI 10.1084/jem.178.2.449; Naik UP, 2001, J CELL SCI, V114, P539; NAIK UP, 1995, BIOCHEM J, V310, P155, DOI 10.1042/bj3100155; Nanki T, 2000, J IMMUNOL, V165, P6590, DOI 10.4049/jimmunol.165.11.6590; NORTAMO P, 1991, J IMMUNOL, V146, P2530; Ozaki H, 2000, BIOCHEM BIOPH RES CO, V276, P873, DOI 10.1006/bbrc.2000.3574; Ozaki H, 1999, J IMMUNOL, V163, P553; Palmeri D, 2000, J BIOL CHEM, V275, P19139, DOI 10.1074/jbc.M003189200; Peled A, 1999, J CLIN INVEST, V104, P1199, DOI 10.1172/JCI7615; PIALI L, 1995, J CELL BIOL, V130, P451, DOI 10.1083/jcb.130.2.451; ROTHLEIN R, 1986, J IMMUNOL, V137, P1270; SMITH CW, 1989, J CLIN INVEST, V83, P2008, DOI 10.1172/JCI114111; Sobocka MB, 2000, BLOOD, V95, P2600; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Weber C, 2001, BLOOD, V97, P1144, DOI 10.1182/blood.V97.4.1144; Weber C, 1997, J IMMUNOL, V159, P3968; Weber C, 1996, J CELL BIOL, V134, P1063, DOI 10.1083/jcb.134.4.1063; Weber C, 1996, P NATL ACAD SCI USA, V93, P10939, DOI 10.1073/pnas.93.20.10939; Weber KSC, 1999, MOL BIOL CELL, V10, P861, DOI 10.1091/mbc.10.4.861; Weber KSC, 1997, J IMMUNOL, V158, P273; Weber KSC, 1999, EUR J IMMUNOL, V29, P700, DOI 10.1002/(SICI)1521-4141(199902)29:02<700::AID-IMMU700>3.3.CO;2-T; Williams LA, 1999, MOL IMMUNOL, V36, P1175, DOI 10.1016/S0161-5890(99)00122-4	48	489	507	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2002	3	2					151	158		10.1038/ni755	http://dx.doi.org/10.1038/ni755			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	516PJ	11812992				2022-12-18	WOS:000173562400015
J	Liu, YJ; Kanzler, H; Soumelis, V; Gilliet, M				Liu, YJ; Kanzler, H; Soumelis, V; Gilliet, M			Dendritic cell lineage, plasticity and cross-regulation	NATURE IMMUNOLOGY			English	Review							T-HELPER-CELL; CPG-CONTAINING OLIGODEOXYNUCLEOTIDES; IL-12 PRODUCTION; INTERFERON-ALPHA/BETA; IN-VITRO; IMMUNE-RESPONSE; PRODUCE IL-12; BACTERIAL-DNA; CUTTING EDGE; TYPE-2 TH2	Dendritic cells (DCs) are professional antigen-presenting cells that have an extraordinary capacity to stimulate naive T cells and initiate primary immune responses. Here we review progress in understanding the additional functions of DCs in regulating the types of T cell-mediated immune responses and innate immunity to microbes. In addition, evidence for the existence of myeloid and lymphoid DC lineages and their different functions are summarized. We propose that the diverse functions of DCs in immune regulation are dictated by the instructions they received during innate immune responses to different pathogens and from their evolutionary lineage heritage.	DNAX Res Inst Molec & Cellular Biol Inc, Palo Alto, CA 94304 USA	Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.	Liu, YJ (corresponding author), DNAX Res Inst Molec & Cellular Biol Inc, 901 Calif Ave, Palo Alto, CA 94304 USA.	yliu@dnax.org						Akiba H, 2000, J EXP MED, V191, P375, DOI 10.1084/jem.191.2.375; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; ARDAVIN C, 1993, NATURE, V362, P761, DOI 10.1038/362761a0; Arpinati M, 2000, BLOOD, V95, P2484, DOI 10.1182/blood.V95.8.2484; ASSELINPASTUREL.C, 2001, KEYST S DENDR CELL I; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Benlagha K, 2000, SEMIN IMMUNOL, V12, P537, DOI 10.1006/smim.2000.0276; Bjorck P, 1998, J IMMUNOL, V161, P5795; BJORCK P, 2001, UNPUB ISOLATION CHAR; BLANCO P, 2001, UNPUB INTERFERON ALP; Blom B, 2000, J EXP MED, V192, P1785, DOI 10.1084/jem.192.12.1785; Brasel K, 2000, BLOOD, V96, P3029, DOI 10.1182/blood.V96.9.3029.h8003029_3029_3039; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; CELLA M, 2001, NAT IMMUNOL, V5, P919; Cousens LP, 1999, J EXP MED, V189, P1315, DOI 10.1084/jem.189.8.1315; Cousens LP, 1997, P NATL ACAD SCI USA, V94, P634, DOI 10.1073/pnas.94.2.634; d'Ostiani CF, 2000, J EXP MED, V191, P1661, DOI 10.1084/jem.191.10.1661; Delespesse G, 1999, INT ARCH ALLERGY IMM, V118, P384, DOI 10.1159/000024143; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; FACCHETTI F, 1988, AM J PATHOL, V133, P15; Farrar JD, 2000, NAT IMMUNOL, V1, P65, DOI 10.1038/76932; FITZGERALDBOCARSLY P, 1993, PHARMACOL THERAPEUT, V60, P39, DOI 10.1016/0163-7258(93)90021-5; Fort MM, 2001, J IMMUNOL, V166, P2793, DOI 10.4049/jimmunol.166.4.2793; GILLIET M, 2001, UNPUB NATURE IMMUNOL; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hartmann G, 1999, P NATL ACAD SCI USA, V96, P9305, DOI 10.1073/pnas.96.16.9305; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; Hochrein H, 2000, J EXP MED, V192, P823, DOI 10.1084/jem.192.6.823; Ito T, 2001, J IMMUNOL, V166, P2961, DOI 10.4049/jimmunol.166.5.2961; Iwasaki A, 1999, J EXP MED, V190, P229, DOI 10.1084/jem.190.2.229; Jahnsen FL, 2000, J IMMUNOL, V165, P4062, DOI 10.4049/jimmunol.165.7.4062; Jakob T, 1999, INT ARCH ALLERGY IMM, V118, P457, DOI 10.1159/000024163; Jakob T, 1998, J IMMUNOL, V161, P3042; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Kadowaki N, 2001, J EXP MED, V193, P1221, DOI 10.1084/jem.193.10.1221; Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9; Kalinski P, 2000, J IMMUNOL, V165, P1877, DOI 10.4049/jimmunol.165.4.1877; Kalinski P, 1999, J IMMUNOL, V162, P3231; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; Khanna A, 2000, J IMMUNOL, V164, P1346, DOI 10.4049/jimmunol.164.3.1346; King C, 1998, IMMUNITY, V8, P601, DOI 10.1016/S1074-7613(00)80565-8; Koch F, 1996, J EXP MED, V184, P741, DOI 10.1084/jem.184.2.741; Kohrgruber N, 1999, J IMMUNOL, V163, P3250; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; LENNERT K, 1975, LANCET, V1, P1031; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; McRae BL, 1998, J IMMUNOL, V160, P4298; Mencacci A, 1998, J EXP MED, V187, P307, DOI 10.1084/jem.187.3.307; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; ODOHERTY U, 1994, IMMUNOLOGY, V82, P487; Olweus J, 1997, P NATL ACAD SCI USA, V94, P12551, DOI 10.1073/pnas.94.23.12551; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Pulendran B, 1997, J IMMUNOL, V159, P2222; Pulendran B, 2001, TRENDS IMMUNOL, V22, P41, DOI 10.1016/S1471-4906(00)01794-4; Ramanathan S, 1996, J IMMUNOL, V157, P2209; Res PCM, 1999, BLOOD, V94, P2647, DOI 10.1182/blood.V94.8.2647.420k06_2647_2657; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; Rogge L, 1998, J IMMUNOL, V161, P6567; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Seder RA, 1998, J IMMUNOL, V160, P5719; Shortman K, 2000, IMMUNOL CELL BIOL, V78, P161, DOI 10.1046/j.1440-1711.2000.00901.x; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Sorg RV, 1999, BLOOD, V93, P2302, DOI 10.1182/blood.V93.7.2302.407a25_2302_2307; Sousa CRE, 1997, J EXP MED, V186, P1819, DOI 10.1084/jem.186.11.1819; Sousa CRE, 1999, CURR OPIN IMMUNOL, V11, P392, DOI 10.1016/S0952-7915(99)80066-1; Sousa CRE, 1999, IMMUNITY, V11, P637, DOI 10.1016/S1074-7613(00)80138-7; Sparwasser T, 1998, EUR J IMMUNOL, V28, P2045, DOI 10.1002/(SICI)1521-4141(199806)28:06<2045::AID-IMMU2045>3.0.CO;2-8; Spits H, 2000, J EXP MED, V192, P1775, DOI 10.1084/jem.192.12.1775; Strobl H, 1998, J IMMUNOL, V161, P740; Stumbles PA, 1998, J EXP MED, V188, P2019, DOI 10.1084/jem.188.11.2019; Tanaka H, 2000, J EXP MED, V192, P405, DOI 10.1084/jem.192.3.405; Traver D, 2000, SCIENCE, V290, P2152, DOI 10.1126/science.290.5499.2152; Verdijk RM, 1999, J IMMUNOL, V163, P57; Vremec D, 1997, J IMMUNOL, V159, P565; Whelan M, 2000, J IMMUNOL, V164, P6453, DOI 10.4049/jimmunol.164.12.6453; YAMAGUCHI Y, 2001, KEYST S DENDR CELL I	87	488	514	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2001	2	7					585	589		10.1038/89726	http://dx.doi.org/10.1038/89726			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	449JU	11429541				2022-12-18	WOS:000169682100010
J	Puga, I; Cols, M; Barra, CM; He, B; Cassis, L; Gentile, M; Comerma, L; Chorny, A; Shan, MM; Xu, WF; Magri, G; Knowles, DM; Tam, W; Chiu, A; Bussel, JB; Serrano, S; Lorente, JA; Bellosillo, B; Lloreta, J; Juanpere, N; Alameda, F; Baro, T; de Heredia, RD; Toran, N; Catala, A; Torrebadell, M; Fortuny, C; Cusi, V; Carreras, C; Diaz, GA; Blander, JM; Farber, CM; Silvestri, G; Cunningham-Rundles, C; Calvillo, M; Dufour, C; Notarangelo, LD; Lougaris, V; Plebani, A; Casanova, JL; Ganal, SC; Diefenbach, A; Arostegui, JI; Juan, M; Yague, J; Mahlaoui, N; Donadieu, J; Chen, K; Cerutti, A				Puga, Irene; Cols, Montserrat; Barra, Carolina M.; He, Bing; Cassis, Linda; Gentile, Maurizio; Comerma, Laura; Chorny, Alejo; Shan, Meimei; Xu, Weifeng; Magri, Giuliana; Knowles, Daniel M.; Tam, Wayne; Chiu, April; Bussel, James B.; Serrano, Sergi; Antonio Lorente, Jose; Bellosillo, Beatriz; Lloreta, Josep; Juanpere, Nuria; Alameda, Francesc; Baro, Teresa; Diaz de Heredia, Ristina; Toran, Nuria; Catala, Albert; Torrebadell, Montserrat; Fortuny, Claudia; Cusi, Victoria; Carreras, Carmen; Diaz, George A.; Blander, J. Magarian; Farber, Claire-Michele; Silvestri, Guido; Cunningham-Rundles, Charlotte; Calvillo, Michaela; Dufour, Carlo; Notarangelo, Lucia Dora; Lougaris, Vassilios; Plebani, Alessandro; Casanova, Jean-Laurent; Ganal, Stephanie C.; Diefenbach, Andreas; Ignacio Arostegui, Juan; Juan, Manel; Yaguee, Jordi; Mahlaoui, Nizar; Donadieu, Jean; Chen, Kang; Cerutti, Andrea			B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen	NATURE IMMUNOLOGY			English	Article							CLASS SWITCH RECOMBINATION; INFLAMMATORY RESPONSES; SOMATIC HYPERMUTATION; COMMENSAL BACTERIA; ANTIBODY-RESPONSES; ACTIVATION; RECEPTOR; MEMORY; APRIL; DEGRADATION	Neutrophils use immunoglobulins to clear antigen, but their role in immunoglobulin production is unknown. Here we identified neutrophils around the marginal zone (MZ) of the spleen, a B cell area specialized in T cell-independent immunoglobulin responses to circulating antigen. Neutrophils colonized peri-MZ areas after postnatal mucosal colonization by microbes and enhanced their B cell-helper function after receiving reprogramming signals, including interleukin 10 (IL-10), from splenic sinusoidal endothelial cells. Splenic neutrophils induced immunoglobulin class switching, somatic hypermutation and antibody production by activating MZ B cells through a mechanism that involved the cytokines BAFF, APRIL and IL-21. Neutropenic patients had fewer and hypomutated MZ B cells and a lower abundance of preimmune immunoglobulins to T cell-independent antigens, which indicates that neutrophils generate an innate layer of antimicrobial immunoglobulin defense by interacting with MZ B cells.	[Puga, Irene; Barra, Carolina M.; Cassis, Linda; Gentile, Maurizio; Magri, Giuliana; Cerutti, Andrea] Hosp del Mar, Inst Municipal Invest Med, Barcelona, Spain; [Cols, Montserrat; He, Bing; Chorny, Alejo; Shan, Meimei; Xu, Weifeng; Blander, J. Magarian; Cunningham-Rundles, Charlotte; Chen, Kang; Cerutti, Andrea] Mt Sinai Sch Med, Inst Immunol, New York, NY USA; [Comerma, Laura; Lloreta, Josep] Univ Autonoma Barcelona, Hosp Mar, Dept Pathol, E-08193 Barcelona, Spain; [Comerma, Laura; Lloreta, Josep] Univ Pompeu Fabra, Barcelona, Spain; [Knowles, Daniel M.; Tam, Wayne] Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; [Chiu, April] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Bussel, James B.] Weill Cornell Med Coll, Dept Pediat, New York, NY USA; [Antonio Lorente, Jose] Hosp del Mar, Dept Urol, Barcelona, Spain; [Diaz de Heredia, Ristina] Hosp Univ Vall dHebron, Dept Pediat Hematol & Oncol, Barcelona, Spain; [Toran, Nuria] Hosp Univ Vall dHebron, Dept Pathol, Barcelona, Spain; [Catala, Albert; Blander, J. Magarian] Hosp St de Joan Barcelona, Dept Hematol, Barcelona, Spain; [Fortuny, Claudia] Hosp St de Joan Barcelona, Dept Pediat, Barcelona, Spain; [Cusi, Victoria] Hosp St de Joan Barcelona, Dept Pathol, Barcelona, Spain; [Carreras, Carmen] Hosp La Fe, Children Hematol Unit, E-46009 Valencia, Spain; [Diaz, George A.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Farber, Claire-Michele] Univ Libre Bruxelles, Erasme Hosp, Unit Immunodeficiency, Brussels, Belgium; [Silvestri, Guido] Emory Univ, Yerkes Reg Primate Res Ctr, Atlanta, GA 30322 USA; [Calvillo, Michaela; Dufour, Carlo] G Gaslini Childrens Inst, Hematol Unit, Genoa, Italy; [Notarangelo, Lucia Dora] Childrens Hosp, Oncohematol & Bone Marrow Transplantat Unit, Brescia, Italy; [Plebani, Alessandro] Univ Brescia, Pediat Clin, Brescia, Italy; [Plebani, Alessandro] Univ Brescia, Inst Mol Med A Nocivelli, Brescia, Italy; [Plebani, Alessandro] Childrens Hosp, Brescia, Italy; [Casanova, Jean-Laurent] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10021 USA; [Casanova, Jean-Laurent] Inst Natl Sante & Rech Med, Necker Branch, Lab Human Genet Infect Dis, U550, Paris, France; [Casanova, Jean-Laurent] Necker Enfants Malades Med Sch, Paris, France; [Ganal, Stephanie C.; Diefenbach, Andreas] Univ Freiburg, Inst Med Microbiol & Hyg, D-79106 Freiburg, Germany; [Juan, Manel; Yaguee, Jordi] Hosp Clin Barcelona, Serv Immunol, Barcelona, Spain; [Mahlaoui, Nizar] Hop Necker Enfants Malad, French Natl Reference Ctr Primary Immune Deficien, Immunol & Rheumatol Unit, Paris, France; [Donadieu, Jean] Hop Trousseau, Serv Hemato Oncol Pediat, Registre Neutropenies Congenitales, F-75571 Paris, France; [Cerutti, Andrea] Catalan Inst Res & Adv Studies, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Icahn School of Medicine at Mount Sinai; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; Cornell University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Cornell University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron; Hospital Universitari i Politecnic La Fe; Icahn School of Medicine at Mount Sinai; Universite Libre de Bruxelles; Emory University; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Brescia; University of Brescia; Rockefeller University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Freiburg; University of Barcelona; Hospital Clinic de Barcelona; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; ICREA	Cerutti, A (corresponding author), Hosp del Mar, Inst Municipal Invest Med, Barcelona, Spain.	acerutti@imim.es	Xu, Weifeng/I-7662-2019; Diaz, George/AAF-6199-2021; Magri, Giuliana/K-6552-2014; Dufour, Carlo/AAB-1000-2021; MAHLAOUI, Nizar/AAH-6103-2020; de Heredia, Cristina Diaz/G-4016-2016; Lloreta-Trull, Josep/GRR-9682-2022; Blesa, Laura Comerma/AAQ-9455-2020; Barra, Carolina/AAF-1324-2019; Cols, Montserrat/J-3387-2013; Lloreta-Trull, Josep/AAZ-1229-2020; Ganal-Vonarburg, Stephanie C./AAE-5705-2019; Casanova, Jean-Laurent/I-3418-2017; Diefenbach, Andreas/T-2589-2018; Mahlaoui, Nizar/J-7928-2017; Cassis, Linda/K-9633-2014; Juan, Manel/Q-2931-2019; Lloreta, J/I-2112-2014; Calvillo, Michaela/AAB-1705-2021	Xu, Weifeng/0000-0001-7598-1489; Magri, Giuliana/0000-0002-0163-3542; MAHLAOUI, Nizar/0000-0002-0030-8094; de Heredia, Cristina Diaz/0000-0001-8086-296X; Blesa, Laura Comerma/0000-0002-0249-4636; Barra, Carolina/0000-0002-6836-4906; Cols, Montserrat/0000-0001-6578-8378; Ganal-Vonarburg, Stephanie C./0000-0002-2548-7754; Diefenbach, Andreas/0000-0002-9176-9530; Mahlaoui, Nizar/0000-0002-0030-8094; Cassis, Linda/0000-0003-4544-9816; Lloreta, J/0000-0003-1644-9470; Calvillo, Michaela/0000-0002-5925-4318; Juan, Manel/0000-0002-3064-1648; Cerutti, Andrea/0000-0003-3026-4704; Arostegui, Juan Ignacio/0000-0003-4757-504X; Chorny, Alejo/0000-0001-5874-350X; Puga, Irene/0000-0003-2208-3196; Casanova, Jean-Laurent/0000-0002-7782-4169; Torrebadell, Montserrat/0000-0002-0027-3215; CATALA, ALBERT/0000-0003-0133-1752; Blander, Julie Magarian/0000-0001-9207-1700	Ministerio de Ciencia e Innovacion [SAF 2008-02725]; US National Institutes of Health [R01 AI074378, P01 AI61093, U01 AI95613, P01 096187]; European Commission [HEALTH-F2-2008-201549]; Juan de la Cierva Program; Instituto de Salud Carlos III; Yerkes National Primate Research Center [P51 RR00165]; Fondazione C. Golgi di Brescia, Associazione Immunodeficienze Primitive; ICREA Funding Source: Custom; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095613, U19AI096187, P01AI061093, R01AI074378, R01AI057653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK072201] Funding Source: NIH RePORTER	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); Juan de la Cierva Program; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Yerkes National Primate Research Center; Fondazione C. Golgi di Brescia, Associazione Immunodeficienze Primitive; ICREA(ICREA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Farres, J. Yelamos, A. Muntasell and M. Lopez-Botet (Institut Municipal d'Investigacio Medica-Hospital del Mar) for reagents, samples and discussions; N. Romo, S. Bascones, E. Ramirez and O. Fornas for help with cell sorting; and S. Mojal for help with the statistical analysis. Supported by Ministerio de Ciencia e Innovacion (SAF 2008-02725 to A.Ce.), the US National Institutes of Health (R01 AI074378, P01 AI61093, U01 AI95613 and P01 096187 to A.Ce.), the European Commission (EUROPADnet HEALTH-F2-2008-201549 to A.Ce.), the Juan de la Cierva Program (I. P. and G. M.), the Instituto de Salud Carlos III (C. M. B. and M. G. and A.Ch.), the Ministerio de Ciencia e Innovacion (C. M. B. and M. G.), Yerkes National Primate Research Center (P51 RR00165 to G. S.) and Fondazione C. Golgi di Brescia, Associazione Immunodeficienze Primitive (A. P.).	Avery DT, 2010, J EXP MED, V207, P155, DOI 10.1084/jem.20091706; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Berkowska MA, 2011, BLOOD, V118, P2150, DOI 10.1182/blood-2011-04-345579; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Cerutti A, 2011, TRENDS IMMUNOL, V32, P202, DOI 10.1016/j.it.2011.02.004; Cerutti A, 2011, ANNU REV IMMUNOL, V29, P273, DOI 10.1146/annurev-immunol-031210-101317; Chen K, 2009, NAT IMMUNOL, V10, P889, DOI 10.1038/ni.1748; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; De Santo C, 2010, NAT IMMUNOL, V11, P1039, DOI 10.1038/ni.1942; DiStasi MR, 2009, TRENDS IMMUNOL, V30, P539, DOI 10.1016/j.it.2009.07.012; Donadieu J, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-26; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Haas A, 2011, GUT, V60, P1506, DOI 10.1136/gut.2010.224774; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; He B, 2010, NAT IMMUNOL, V11, P836, DOI 10.1038/ni.1914; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Huard B, 2008, J CLIN INVEST, V118, P2887, DOI 10.1172/JCI33760; Klein C, 2011, ANNU REV IMMUNOL, V29, P399, DOI 10.1146/annurev-immunol-030409-101259; KRUEGER JM, 1984, J BIOL CHEM, V259, P2659; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Liu Y, 2009, TRENDS IMMUNOL, V30, P557, DOI 10.1016/j.it.2009.09.006; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Pasquier B, 2005, IMMUNITY, V22, P31, DOI 10.1016/j.immuni.2004.11.017; Scapini P, 2003, J EXP MED, V197, P297, DOI 10.1084/jem.20021343; Scheeren FA, 2008, J EXP MED, V205, P2033, DOI 10.1084/jem.20070447; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Soehnlein O, 2009, TRENDS IMMUNOL, V30, P511, DOI 10.1016/j.it.2009.07.002; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Tsuboi N, 2008, IMMUNITY, V28, P833, DOI 10.1016/j.immuni.2008.04.013; van Gisbergen KPJM, 2005, TRENDS IMMUNOL, V26, P626, DOI 10.1016/j.it.2005.09.007; Van TC, 2011, NAT IMMUNOL, V12, P151, DOI 10.1038/ni.1981; Weill JC, 2009, ANNU REV IMMUNOL, V27, P267, DOI 10.1146/annurev.immunol.021908.132607; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Xu WF, 2007, NAT IMMUNOL, V8, P294, DOI 10.1038/ni1434; Yang D, 2009, TRENDS IMMUNOL, V30, P531, DOI 10.1016/j.it.2009.07.004; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhang X, 2009, IMMUNITY, V31, P761, DOI 10.1016/j.immuni.2009.09.016; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	48	486	507	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2012	13	2					170	180		10.1038/ni.2194	http://dx.doi.org/10.1038/ni.2194			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	879FL	22197976	Green Accepted			2022-12-18	WOS:000299315000014
J	Paust, S; Gill, HS; Wang, BZ; Flynn, MP; Moseman, EA; Senman, B; Szczepanik, M; Telenti, A; Askenase, PW; Compans, RW; von Andrian, UH				Paust, Silke; Gill, Harvinder S.; Wang, Bao-Zhong; Flynn, Michael P.; Moseman, E. Ashley; Senman, Balimkiz; Szczepanik, Marian; Telenti, Amalio; Askenase, Philip W.; Compans, Richard W.; von Andrian, Ulrich H.			Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; GAMMA CHAIN; T-CELLS; LYMPHOID DEVELOPMENT; INFLUENZA INFECTION; ADAPTIVE IMMUNITY; DENDRITIC CELLS; HLA-B; EXPRESSION; MICE	Hepatic natural killer (NK) cells mediate antigen-specific contact hypersensitivity (CHS) in mice deficient in T cells and B cells. We report here that hepatic NK cells, but not splenic or naive NK cells, also developed specific memory of vaccines containing antigens from influenza, vesicular stomatitis virus (VSV) or human immunodeficiency virus type 1 (HIV-1). Adoptive transfer of virus-sensitized NK cells into naive recipient mice enhanced the survival of the mice after lethal challenge with the sensitizing virus but not after lethal challenge with a different virus. NK cell memory of haptens and viruses depended on CXCR6, a chemokine receptor on hepatic NK cells that was required for the persistence of memory NK cells but not for antigen recognition. Thus, hepatic NK cells can develop adaptive immunity to structurally diverse antigens, an activity that requires NK cell-expressed CXCR6.	[Paust, Silke; Flynn, Michael P.; Moseman, E. Ashley; Senman, Balimkiz; von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Paust, Silke; Telenti, Amalio] MGH & Harvard, MIT, Ragon Inst, Charlestown, MA USA; [Gill, Harvinder S.; Wang, Bao-Zhong; Compans, Richard W.] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Gill, Harvinder S.; Wang, Bao-Zhong; Compans, Richard W.] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Gill, Harvinder S.] Texas Tech Univ, Dept Chem Engn, Lubbock, TX 79409 USA; [Szczepanik, Marian] Jagiellonian Univ, Coll Med, Dept Human Dev Biol, Krakow, Poland; [Telenti, Amalio] Univ Lausanne, Univ Hosp, Inst Microbiol, Lausanne, Switzerland; [Szczepanik, Marian; Askenase, Philip W.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [von Andrian, Ulrich H.] Immune Dis Inst, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Emory University; Emory University; Texas Tech University System; Texas Tech University; Jagiellonian University; Collegium Medicum Jagiellonian University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Yale University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	von Andrian, UH (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	uva@hms.harvard.edu	Telenti, Amalio/AAY-1674-2021; von Andrian, Ulrich H/A-5775-2008; Gill, Harvinder Singh/D-8252-2014; Szczepanik, Marian/ABA-7001-2021; Compans, Richard W/I-4087-2013	Gill, Harvinder Singh/0000-0003-0832-5291; Compans, Richard W/0000-0003-2360-335X; Wang, Bao-Zhong/0000-0002-1561-4318; Paust, Silke/0000-0002-0526-3999	US National Institutes of Health [AI069259, AI072252, AI078897, HL56949, AR42689]; Ragon Institute; Cancer Research Institute; Ragon Institute of MIT, Harvard and MGH; NATIONAL CANCER INSTITUTE [P01CA071932] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI078897, R01AI072252, R01AI090840, R01AI069259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR042689] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ragon Institute; Cancer Research Institute; Ragon Institute of MIT, Harvard and MGH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank G. Cheng and J.D. Sullivan for technical support and A. Wagers (Harvard Medical School) for Act(EGFP) mice. Supported by the US National Institutes of Health (AI069259, AI072252, AI078897, HL56949 and AR42689), the Ragon Institute (U.H.v.A.), the Cancer Research Institute (S.P.) and the Ragon Institute of MIT, Harvard and MGH (S.P.).	Aktas E, 2009, CELL IMMUNOL, V254, P149, DOI 10.1016/j.cellimm.2008.08.007; Alter G, 2007, J EXP MED, V204, P3027, DOI 10.1084/jem.20070695; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Berahovich RD, 2006, J IMMUNOL, V177, P7833, DOI 10.4049/jimmunol.177.11.7833; Boehncke WH, 2005, EXP DERMATOL, V14, P70, DOI 10.1111/j.0906-6705.2005.290b.x; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Carbone T, 2010, J IMMUNOL, V184, P1102, DOI 10.4049/jimmunol.0902518; CROWLE AJ, 1959, SCIENCE, V130, P159, DOI 10.1126/science.130.3368.159; Day CE, 2009, J IMMUNOL METHODS, V342, P91, DOI 10.1016/j.jim.2008.12.001; Dhabhar FS, 2000, P NATL ACAD SCI USA, V97, P2846, DOI 10.1073/pnas.050569397; Di Santo JP, 1998, IMMUNOL REV, V165, P29; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; Draghi M, 2007, J IMMUNOL, V178, P2688, DOI 10.4049/jimmunol.178.5.2688; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Hangartner L, 2006, NAT REV IMMUNOL, V6, P231, DOI 10.1038/nri1783; Jamieson AM, 2004, J IMMUNOL, V172, P864, DOI 10.4049/jimmunol.172.2.864; Jonsson AH, 2009, ADV IMMUNOL, V101, P27, DOI 10.1016/S0065-2776(08)01002-X; Kang SM, 2009, VIRUS RES, V143, P140, DOI 10.1016/j.virusres.2009.04.005; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Limou S, 2010, J INFECT DIS, V202, P908, DOI 10.1086/655782; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Matangkasombut P, 2008, BLOOD, V111, P271, DOI 10.1182/blood-2007-06-096487; Matloubian M, 2000, NAT IMMUNOL, V1, P298, DOI 10.1038/79738; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Orme IM, 1999, IMMUNOL TODAY, V20, P307, DOI 10.1016/S0167-5699(98)01438-8; PARK BK, 1987, BIOCHEM PHARMACOL, V36, P591, DOI 10.1016/0006-2952(87)90707-6; Paust S, 2010, IMMUNOL REV, V235, P286, DOI 10.1111/j.0105-2896.2010.00906.x; PHANUPHAK P, 1974, J IMMUNOL, V112, P849; Quan FS, 2007, J VIROL, V81, P3514, DOI 10.1128/JVI.02052-06; RAULET DH, 1992, NATURE, V358, P21, DOI 10.1038/358021a0; Sato T, 2005, J IMMUNOL, V174, P277, DOI 10.4049/jimmunol.174.1.277; Scalzo AA, 2005, IMMUNOL CELL BIOL, V83, P144, DOI 10.1111/j.1440-1711.2005.01311.x; Scholz F, 2007, J INVEST DERMATOL, V127, P1444, DOI 10.1038/sj.jid.5700751; Shultz LD, 2000, J IMMUNOL, V164, P2496, DOI 10.4049/jimmunol.164.5.2496; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Szczepanik M, 2003, J IMMUNOL, V171, P6225, DOI 10.4049/jimmunol.171.11.6225; van der Voort R, 2010, J LEUKOCYTE BIOL, V87, P1029, DOI 10.1189/jlb.0709482; Wang BZ, 2007, J VIROL, V81, P10869, DOI 10.1128/JVI.00542-07; Wilbanks A, 2001, J IMMUNOL, V166, P5145, DOI 10.4049/jimmunol.166.8.5145	45	486	505	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2010	11	12					1127	U128		10.1038/ni.1953	http://dx.doi.org/10.1038/ni.1953			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	680UX	20972432	Green Accepted			2022-12-18	WOS:000284262200012
J	Good-Jacobson, KL; Szumilas, CG; Chen, LP; Sharpe, AH; Tomayko, MM; Shlomchik, MJ				Good-Jacobson, Kim L.; Szumilas, Courtney G.; Chen, Lieping; Sharpe, Arlene H.; Tomayko, Mary M.; Shlomchik, Mark J.			PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells	NATURE IMMUNOLOGY			English	Article							PRIMARY IMMUNE-RESPONSE; HELPER T-CELLS; MURINE MEMORY; LYMPH-NODES; CD40 LIGAND; IN-SITU; EXPRESSION; SELECTION; IL-21; GENERATION	Memory B and plasma cells (PCs) are generated in the germinal center (GC). Because follicular helper T cells (T-FH cells) have high expression of the immunoinhibitory receptor PD-1, we investigated the role of PD-1 signaling in the humoral response. We found that the PD-1 ligands PD-L1 and PD-L2 were upregulated on GC B cells. Mice deficient in PD-L2 (Pdcd1lg2(-/-)), PD-L1 and PD-L2 (Cd274(-/-)Pdcd1lg2(-/-)) or PD-1 (Pdcd1(-/-)) had fewer long-lived PCs. The mechanism involved more GC cell death and less T-FH cell cytokine production in the absence of PD-1; the effect was selective, as remaining PCs had greater affinity for antigen. PD-1 expression on T cells and PD-L2 expression on B cells controlled T-FH cell and PC numbers. Thus, PD-1 regulates selection and survival in the GC, affecting the quantity and quality of long-lived PCs.	[Good-Jacobson, Kim L.; Szumilas, Courtney G.; Shlomchik, Mark J.] Yale Univ, Dept Lab Med, New Haven, CT 06520 USA; [Good-Jacobson, Kim L.; Szumilas, Courtney G.; Shlomchik, Mark J.] Yale Univ, Dept Immunobiol, New Haven, CT USA; [Chen, Lieping] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Sharpe, Arlene H.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Tomayko, Mary M.] Yale Univ, Dept Dermatol, New Haven, CT 06520 USA	Yale University; Yale University; Johns Hopkins University; Harvard University; Harvard Medical School; Yale University	Shlomchik, MJ (corresponding author), Yale Univ, Dept Lab Med, New Haven, CT 06520 USA.	mark.shlomchik@yale.edu	Shlomchik, Mark J./AAN-6189-2020	Shlomchik, Mark J./0000-0002-2152-0959; Chen, Lieping/0000-0002-6825-3069; Good-Jacobson, Kim/0000-0003-1891-7274	National Institutes of Health [AI43603, AI40614, K08AI78533]; National Health and Medical Research Council; Arthritis Australia; NATIONAL CANCER INSTITUTE [R01CA142779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI078533, R01AI043603, R37AI038310, R01AI040614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Arthritis Australia; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank K. Rajewsky (Harvard University) for B1-8 knock-in mice; T. Honjo (Kyoto University) for Pdcd1<SUP>-/-</SUP> mice; E. Song and G. Zuccarino-Catania for technical assistance; U. Hershberg for assistance in analyzing memory B cell sequencing data; the Yale Cell Sorter Facility for cell sorting; the Yale Animal Resource Center for animal care; the Craft and Haberman laboratories for oligonucleotides; and S. Kerfoot for critical reading of the manuscript. Supported by the National Institutes of Health (AI43603 to M.J.S., AI40614 to A. H. S. and K08AI78533 to M. M. T), the National Health and Medical Research Council (K.L.G.-J.) and Arthritis Australia (K.L.G.-J.).	Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; ALLEN RC, 1993, SCIENCE, V259, P990, DOI 10.1126/science.7679801; Anderson SM, 2007, J EXP MED, V204, P2103, DOI 10.1084/jem.20062571; Anderson SM, 2009, J IMMUNOL, V183, P7314, DOI 10.4049/jimmunol.0902452; Avery DT, 2010, J EXP MED, V207, P155, DOI 10.1084/jem.20091706; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Blink EJ, 2005, J EXP MED, V201, P545, DOI 10.1084/jem.20042060; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; CHEN JZ, 1993, INT IMMUNOL, V5, P647, DOI 10.1093/intimm/5.6.647; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Good KL, 2009, J IMMUNOL, V182, P890, DOI 10.4049/jimmunol.182.2.890; Ha SJ, 2008, J EXP MED, V205, P543, DOI 10.1084/jem.20071949; HAN SH, 1995, J IMMUNOL, V155, P556; Hannum LG, 2000, J EXP MED, V192, P931, DOI 10.1084/jem.192.7.931; Hannum LG, 1996, J EXP MED, V184, P1269, DOI 10.1084/jem.184.4.1269; Hasbold J, 2004, NAT IMMUNOL, V5, P55, DOI 10.1038/ni1016; Hershberg U, 2008, INT IMMUNOL, V20, P683, DOI 10.1093/intimm/dxn026; Hodgkin PD, 1998, IMMUNOL CELL BIOL, V76, P448, DOI 10.1046/j.1440-1711.1998.00776.x; Inamine A, 2005, INT IMMUNOL, V17, P581, DOI 10.1093/intimm/dxh241; JACOB J, 1993, J EXP MED, V178, P1293, DOI 10.1084/jem.178.4.1293; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Joshi NS, 2008, J IMMUNOL, V180, P1309, DOI 10.4049/jimmunol.180.3.1309; Keir ME, 2007, J IMMUNOL, V179, P5064, DOI 10.4049/jimmunol.179.8.5064; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; King IL, 2009, J EXP MED, V206, P1001, DOI 10.1084/jem.20090313; Kinter AL, 2008, J IMMUNOL, V181, P6738, DOI 10.4049/jimmunol.181.10.6738; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Nishimura H, 1998, INT IMMUNOL, V10, P1563, DOI 10.1093/intimm/10.10.1563; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; PRAK EL, 1995, J EXP MED, V182, P541, DOI 10.1084/jem.182.2.541; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Shin T, 2003, J EXP MED, V198, P31, DOI 10.1084/jem.20030242; SHLOMCHIK MJ, 1993, INT IMMUNOL, V5, P1329, DOI 10.1093/intimm/5.10.1329; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; Takahashi Y, 1999, J EXP MED, V190, P399, DOI 10.1084/jem.190.3.399; Takahashi Y, 1998, J EXP MED, V187, P885, DOI 10.1084/jem.187.6.885; Takahashi Y, 2001, IMMUNITY, V14, P181, DOI 10.1016/S1074-7613(01)00100-5; Toellner KM, 1996, J EXP MED, V183, P2303, DOI 10.1084/jem.183.5.2303; Tomayko MM, 2008, J IMMUNOL, V181, P27, DOI 10.4049/jimmunol.181.1.27; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538; Zhong XM, 2007, EUR J IMMUNOL, V37, P2405, DOI 10.1002/eji.200737461; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	50	486	514	1	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2010	11	6					535	U107		10.1038/ni.1877	http://dx.doi.org/10.1038/ni.1877			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	598FV	20453843	Green Accepted			2022-12-18	WOS:000277821300015
J	Umetsu, DT; McIntire, JJ; Akbari, O; Macaubas, C; DeKruyff, RH				Umetsu, DT; McIntire, JJ; Akbari, O; Macaubas, C; DeKruyff, RH			Asthma: an epidemic of dysregulated immunity	NATURE IMMUNOLOGY			English	Review							T-CELL-ACTIVATION; DENDRITIC CELLS; ORAL TOLERANCE; INTERFERON-GAMMA; AIRWAY HYPERREACTIVITY; MOLECULE ICOS; EARLY-LIFE; IN-VITRO; EXPOSURE; ALLERGEN	`The remarkable increase in asthma prevalence that has occurred over the last two decades is thought to be caused by changes in the environment due to improved hygiene and fewer childhood infections. However, the specific infections that limit T helper type 2 (T(H)2)-biased inflammation and asthma are not fully known. Infectious organisms, including commensal bacteria in the gastrointestinal tract and hepatitis A virus, may normally induce the development of regulatory T (T-R) cells and protective immunity that limit airway inflammation and promote tolerance to respiratory allergens. In the absence of such infections, T(H)2 cells-which are developmentally related to T-R cells-develop instead and coordinate the development of asthmatic inflammation.	Stanford Univ, Dept Pediat, Div Immunol & Allergy, Stanford, CA 94305 USA	Stanford University	Umetsu, DT (corresponding author), Stanford Univ, Dept Pediat, Div Immunol & Allergy, Stanford, CA 94305 USA.	umetsu@stanford.edu	Jones, Jennifer/C-8691-2015	Jones, Jennifer/0000-0002-9488-7719				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Aicher A, 2000, J IMMUNOL, V164, P4689, DOI 10.4049/jimmunol.164.9.4689; Akbari O, 2001, NAT IMMUNOL, V2, P725, DOI 10.1038/90667; AKBARI O, 2002, IN PRESS NATURE MED; Akdis CA, 1998, J CLIN INVEST, V102, P98, DOI 10.1172/JCI2250; Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Bjorksten B, 1999, CLIN EXP ALLERGY, V29, P342, DOI 10.1046/j.1365-2222.1999.00560.x; CEMBRZYNSKANOWAK M, 1993, AM REV RESPIR DIS, V147, P291, DOI 10.1164/ajrccm/147.2.291; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; CHEN YH, 1995, NATURE, V376, P177, DOI 10.1038/376177a0; COFFMAN RL, 1991, IMMUNOL REV, V123, P189, DOI 10.1111/j.1600-065X.1991.tb00611.x; COFFMAN RL, 1988, IMMUNOL REV, V102, P5, DOI 10.1111/j.1600-065X.1988.tb00739.x; Cookson W, 1999, NATURE, V402, pB5, DOI 10.1038/35037002; CORRIGAN CJ, 1990, AM REV RESPIR DIS, V141, P970, DOI 10.1164/ajrccm/141.4_Pt_1.; Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X; Diez-Gonzalez F, 1998, SCIENCE, V281, P1666, DOI 10.1126/science.281.5383.1666; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Durham SR, 1999, NEW ENGL J MED, V341, P468, DOI 10.1056/NEJM199908123410702; Fahy J V, 2000, Curr Opin Pulm Med, V6, P15, DOI 10.1097/00063198-200001000-00004; Gehring U, 2001, J ALLERGY CLIN IMMUN, V108, P847, DOI 10.1067/mai.2001.119026; Genain CP, 1996, SCIENCE, V274, P2054, DOI 10.1126/science.274.5295.2054; Gern JE, 2002, NAT REV IMMUNOL, V2, P132, DOI 10.1038/nri725; Gerosa F, 1996, J EXP MED, V183, P2559, DOI 10.1084/jem.183.6.2559; Gonzalo JA, 2001, NAT IMMUNOL, V2, P597, DOI 10.1038/89739; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Haneda K, 1997, J IMMUNOL, V159, P4484; Hansen G, 1999, J CLIN INVEST, V103, P175, DOI 10.1172/JCI5155; HANSEN G, 2000, J CLIN INVEST, V11, P89; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hurst SD, 2001, J IMMUNOL, V166, P4922, DOI 10.4049/jimmunol.166.8.4922; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; IWAMOTO I, 1993, J EXP MED, V177, P573, DOI 10.1084/jem.177.2.573; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; Lafaille JJ, 1997, J EXP MED, V186, P307, DOI 10.1084/jem.186.2.307; Levings MK, 2000, J ALLERGY CLIN IMMUN, V106, pS109, DOI 10.1067/mai.2000.106635; Lorenz E, 2001, AM J PHYSIOL-LUNG C, V281, pL1106, DOI 10.1152/ajplung.2001.281.5.L1106; Lynch NR, 1998, J ALLERGY CLIN IMMUN, V101, P217, DOI 10.1016/S0091-6749(98)70386-0; Mages HW, 2000, EUR J IMMUNOL, V30, P1040, DOI 10.1002/(SICI)1521-4141(200004)30:4<1040::AID-IMMU1040>3.0.CO;2-6; Mahanty S, 1996, J INFECT DIS, V173, P769, DOI 10.1093/infdis/173.3.769; Makela MJ, 2000, P NATL ACAD SCI USA, V97, P6007, DOI 10.1073/pnas.100118997; Matricardi PM, 2000, BMJ-BRIT MED J, V320, P412, DOI 10.1136/bmj.320.7232.412; Matricardi PM, 1997, BRIT MED J, V314, P999, DOI 10.1136/bmj.314.7086.999; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; McIntire JJ, 2001, NAT IMMUNOL, V2, P1109, DOI 10.1038/ni739; McKeever TM, 2002, J ALLERGY CLIN IMMUN, V109, P43, DOI 10.1067/mai.2002.121016; McWilliam AS, 1996, J EXP MED, V184, P2429, DOI 10.1084/jem.184.6.2429; Moller C, 2002, J ALLERGY CLIN IMMUN, V109, P251, DOI 10.1067/mai.2002.121317; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Nakajima A, 1997, INT IMMUNOL, V9, P637, DOI 10.1093/intimm/9.5.637; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; OH JW, 2002, IN PRESS J ALLERGY C; Pakala SV, 1997, J EXP MED, V186, P299, DOI 10.1084/jem.186.2.299; Passalacqua G, 1999, J ALLERGY CLIN IMMUN, V104, P964, DOI 10.1016/S0091-6749(99)70076-X; Platts-Mills T, 2001, LANCET, V357, P752, DOI 10.1016/S0140-6736(00)04168-4; Prescott SL, 1997, INT ARCH ALLERGY IMM, V113, P75, DOI 10.1159/000237512; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3; Rottman JB, 2001, NAT IMMUNOL, V2, P605, DOI 10.1038/89750; Russo M, 2001, AM J RESP CELL MOL, V24, P518, DOI 10.1165/ajrcmb.24.5.4320; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; SECRIST H, 1993, J EXP MED, V178, P2123, DOI 10.1084/jem.178.6.2123; Seymour BWP, 1998, J EXP MED, V187, P721, DOI 10.1084/jem.187.5.721; Shirakawa T, 1997, SCIENCE, V275, P77, DOI 10.1126/science.275.5296.77; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Strannegard IL, 1998, ALLERGY, V53, P249, DOI 10.1111/j.1398-9995.1998.tb03884.x; Sudo N, 1997, J IMMUNOL, V159, P1739; Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Tighe H, 2000, J ALLERGY CLIN IMMUN, V106, P124, DOI 10.1067/mai.2000.107927; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Tsitoura DC, 1999, J IMMUNOL, V163, P2592; Tsitoura DC, 2000, J ALLERGY CLIN IMMUN, V106, P239; Tsitoura DC, 2002, INT IMMUNOL, V14, P659, DOI 10.1093/intimm/dxf032; Tsitoura DC, 2000, J IMMUNOL, V165, P3484, DOI 10.4049/jimmunol.165.6.3484; Umetsu DT, 1997, J ALLERGY CLIN IMMUN, V100, P1, DOI 10.1016/S0091-6749(97)70186-6; VANEERDEWEGH P, 2002, NATURE          0710, DOI DOI 10.1038/NATURE00878; von Hertzen L, 1999, J ALLERGY CLIN IMMUN, V104, P1211, DOI 10.1016/S0091-6749(99)70015-1; von Mutius E, 2000, J ALLERGY CLIN IMMUN, V105, P9, DOI 10.1016/S0091-6749(00)90171-4; VONMUTIUS E, 1994, BRIT MED J, V308, P692, DOI 10.1136/bmj.308.6930.692; WANNEMUEHLER MJ, 1982, J IMMUNOL, V129, P959; Weiner HL, 2001, NAT IMMUNOL, V2, P671, DOI 10.1038/90604; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490; Zuany-Amorim C, 2002, NAT MED, V8, P625, DOI 10.1038/nm0602-625	89	486	508	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2002	3	8					715	720		10.1038/ni0802-715	http://dx.doi.org/10.1038/ni0802-715			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	578LF	12145657				2022-12-18	WOS:000177118500009
J	Mills, EL; Kelly, B; O'Neill, LAJ				Mills, Evanna L.; Kelly, Beth; O'Neill, Luke A. J.			Mitochondria are the powerhouses of immunity	NATURE IMMUNOLOGY			English	Review							T-CELL-ACTIVATION; NLRP3 INFLAMMASOME ACTIVATION; SPARE RESPIRATORY CAPACITY; ONE-CARBON METABOLISM; FATTY-ACID OXIDATION; MACROPHAGE POLARIZATION; COMPLEX-I; SUCCINATE-DEHYDROGENASE; SIGNAL-TRANSDUCTION; AEROBIC GLYCOLYSIS	Recent evidence indicates that mitochondria lie at the heart of immunity. Mitochondrial DNA acts as a danger-associated molecular pattern (DAMP), and the mitochondrial outer membrane is a platform for signaling molecules such as MAVS in RIG-I signaling, and for the NLRP3 inflammasome. Mitochondrial biogenesis, fusion and fission have roles in aspects of immune-cell activation. Most important, Krebs cycle intermediates such as succinate, fumarate and citrate engage in processes related to immunity and inflammation, in both innate and adaptive immune cells. These discoveries are revealing mitochondrial targets that could potentially be exploited for therapeutic gain in inflammation and cancer.	[Mills, Evanna L.; O'Neill, Luke A. J.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland; [Kelly, Beth] Max Planck Inst Immunobiol & Epigenet, Dept Immunometab, Freiburg, Germany	Trinity College Dublin; Max Planck Society	O'Neill, LAJ (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland.	laoneill@tcd.ie		Kelly, Beth/0000-0002-3195-6860; O'Neill, Luke/0000-0002-4333-2748	Science Foundation Ireland; Wellcome Trust	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by grants from Science Foundation Ireland and The Wellcome Trust.	Acin-Perez R, 2014, BBA-BIOENERGETICS, V1837, P444, DOI 10.1016/j.bbabio.2013.12.009; Arts RJW, 2016, CELL METAB, V24, P807, DOI 10.1016/j.cmet.2016.10.008; Baixauli F, 2015, CELL METAB, V22, P485, DOI 10.1016/j.cmet.2015.07.020; Balmer ML, 2016, IMMUNITY, V44, P1312, DOI 10.1016/j.immuni.2016.03.016; Beltran B, 2000, P NATL ACAD SCI USA, V97, P14602, DOI 10.1073/pnas.97.26.14602; Bengsch B, 2016, IMMUNITY, V45, P358, DOI 10.1016/j.immuni.2016.07.008; Benit P, 2014, BBA-BIOENERGETICS, V1837, P1330, DOI 10.1016/j.bbabio.2014.03.013; Benn CS, 2013, TRENDS IMMUNOL, V34, P431, DOI 10.1016/j.it.2013.04.004; Bird L, 2016, NAT REV IMMUNOL, V16, DOI 10.1038/nri.2016.79; Blagih J, 2015, IMMUNITY, V42, P41, DOI 10.1016/j.immuni.2014.12.030; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Buskiewicz IA, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf1933; Fernandez-Aguera MC, 2015, CELL METAB, V22, P825, DOI 10.1016/j.cmet.2015.09.004; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Champagne DP, 2016, IMMUNITY, V44, P1299, DOI 10.1016/j.immuni.2016.02.018; Chandel NS, 2001, J BIOL CHEM, V276, P42728, DOI 10.1074/jbc.M103074200; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; Cui GL, 2015, CELL, V161, P750, DOI 10.1016/j.cell.2015.03.021; D'Souza AD, 2007, MITOCHONDRION, V7, P374, DOI 10.1016/j.mito.2007.08.001; Delgoffe GM, 2016, IMMUNITY, V45, P953, DOI 10.1016/j.immuni.2016.11.001; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Everts B, 2012, BLOOD, V120, P1422, DOI 10.1182/blood-2012-03-419747; Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Fox JT, 2008, VITAM HORM, V79, P1, DOI 10.1016/S0083-6729(08)00401-9; Frank M, 2012, BBA-MOL CELL RES, V1823, P2297, DOI 10.1016/j.bbamcr.2012.08.007; Garaude J, 2016, NAT IMMUNOL, V17, P1037, DOI 10.1038/ni.3509; Garcia-Manteiga JM, 2011, J PROTEOME RES, V10, P4165, DOI 10.1021/pr200328f; Geiger R, 2016, CELL, V167, P829, DOI 10.1016/j.cell.2016.09.031; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Gross CJ, 2016, IMMUNITY, V45, P761, DOI 10.1016/j.immuni.2016.08.010; Gubser PM, 2013, NAT IMMUNOL, V14, P1064, DOI 10.1038/ni.2687; Hatle KM, 2013, MOL CELL BIOL, V33, P2302, DOI 10.1128/MCB.00189-13; He L, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040215; Hensley CT, 2013, J CLIN INVEST, V123, P3678, DOI 10.1172/JCI69600; HILLIER S, 1981, J BACTERIOL, V145, P452, DOI 10.1128/JB.145.1.452-458.1981; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Infantino V, 2011, BIOCHEM J, V438, P433, DOI 10.1042/BJ20111275; Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001; Jang KJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7750; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Jin ZX, 2014, CELL METAB, V20, P483, DOI 10.1016/j.cmet.2014.07.011; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Kaminski MM, 2012, CELL REP, V2, P1300, DOI 10.1016/j.celrep.2012.10.009; Kawalekar OU, 2016, IMMUNITY, V44, P380, DOI 10.1016/j.immuni.2016.01.021; Kelly B, 2015, J BIOL CHEM, V290, P20348, DOI 10.1074/jbc.M115.662114; Kemmerer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130893; Krauss S, 2001, IMMUNITY, V15, P497, DOI 10.1016/S1074-7613(01)00205-9; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Lampropoulou V, 2016, CELL METAB, V24, P158, DOI 10.1016/j.cmet.2016.06.004; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Ledderose C, 2014, J BIOL CHEM, V289, P25936, DOI 10.1074/jbc.M114.575308; Liesa M, 2016, CELL, V166, P9, DOI 10.1016/j.cell.2016.06.035; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; LOOS JA, 1973, EXP CELL RES, V79, P136, DOI 10.1016/0014-4827(73)90498-9; MCFADDEN BA, 1977, J BACTERIOL, V131, P136, DOI 10.1128/JB.131.1.136-144.1977; McInerney J, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0323; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Mills E, 2014, TRENDS CELL BIOL, V24, P313, DOI 10.1016/j.tcb.2013.11.008; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Mishra P, 2014, CELL METAB, V19, P630, DOI 10.1016/j.cmet.2014.03.011; Moon JS, 2015, J CLIN INVEST, V125, P665, DOI 10.1172/JCI78253; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Namgaladze D, 2014, BBA-MOL CELL BIOL L, V1841, P1329, DOI 10.1016/j.bbalip.2014.06.007; Nanjappa SG, 2008, J CLIN INVEST, V118, P1027, DOI 10.1172/JCI32020; Naujoks J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005408; Nicholls DG, 2009, BIOCHEM SOC T, V37, P1385, DOI 10.1042/BST0371385; Nomura M, 2016, NAT IMMUNOL, V17, P216, DOI 10.1038/ni.3366; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Panda S, 2016, MOL CELL, V63, P457, DOI 10.1016/j.molcel.2016.06.021; Park S, 2013, J IMMUNOL, V191, P4358, DOI 10.4049/jimmunol.1301170; Patel CH, 2016, SCIENCE, V354, P419, DOI 10.1126/science.aak9776; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pellegrini M, 2011, CELL, V144, P601, DOI 10.1016/j.cell.2011.01.011; Peng M, 2016, SCIENCE, V354, P481, DOI 10.1126/science.aaf6284; Perez-Perez R, 2016, CELL REP, V16, P2387, DOI 10.1016/j.celrep.2016.07.081; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Phan AT, 2016, IMMUNITY, V45, P1024, DOI 10.1016/j.immuni.2016.10.017; Pollizzi KN, 2016, NAT IMMUNOL, V17, P704, DOI 10.1038/ni.3438; Qiu FM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004761; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Ron-Harel N, 2016, CELL METAB, V24, P104, DOI 10.1016/j.cmet.2016.06.007; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Scharping NE, 2016, IMMUNITY, V45, P374, DOI [10.1016/j.immuni.2016.07.009, 10.1016/j.immuni.2016.08.009]; Scialo F, 2016, CELL METAB, V23, P725, DOI 10.1016/j.cmet.2016.03.009; Selleri S, 2016, ONCOTARGET, V7, P30193, DOI 10.18632/oncotarget.8623; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Singh DK, 2005, CELL, V121, P281, DOI 10.1016/j.cell.2005.02.036; Sukumar M, 2016, CELL METAB, V23, P63, DOI 10.1016/j.cmet.2015.11.002; Tan Z, 2015, J IMMUNOL, V194, P6082, DOI 10.4049/jimmunol.1402469; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Wang DL, 2012, ANGEW CHEM INT EDIT, V51, P9302, DOI 10.1002/anie.201204589; Watanabe-Matsui M, 2011, BLOOD, V117, P5438, DOI 10.1182/blood-2010-07-296483; Wei XW, 2015, CELL RES, V25, P237, DOI 10.1038/cr.2015.9; Weinberg SE, 2015, IMMUNITY, V42, P406, DOI 10.1016/j.immuni.2015.02.002; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wu DJ, 2016, IMMUNITY, V44, P1325, DOI 10.1016/j.immuni.2016.06.006; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yadava N, 2007, J NEUROSCI, V27, P7310, DOI 10.1523/JNEUROSCI.0212-07.2007; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zhang Hao, 2016, Int J Biol Sci, V12, P718, DOI 10.7150/ijbs.14405; Zhang JZ, 2014, INT J MOL MED, V33, P817, DOI 10.3892/ijmm.2014.1650; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	119	485	499	16	298	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2017	18	5					488	498		10.1038/ni.3704	http://dx.doi.org/10.1038/ni.3704			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ES2SR	28418387				2022-12-18	WOS:000399378700006
J	Sabatos, CA; Chakravarti, S; Cha, E; Schubart, A; Sanchez-Fueyo, A; Zheng, XX; Coyle, AJ; Strom, TB; Freeman, GJ; Kuchroo, VK				Sabatos, CA; Chakravarti, S; Cha, E; Schubart, A; Sanchez-Fueyo, A; Zheng, XX; Coyle, AJ; Strom, TB; Freeman, GJ; Kuchroo, VK			Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance	NATURE IMMUNOLOGY			English	Article							HEPATITIS-A VIRUS; CHEMOKINE RECEPTOR EXPRESSION; AUTOIMMUNE-DISEASE; IN-VIVO; CUTTING EDGE; CYTOCHROME-C; RICH REGION; GENE FAMILY; CELLS; LYMPHOCYTES	T helper type 1 (T(H)1) immune responses are central in cell-mediated immunity, and a T(H)1-specific cell surface molecule called Tim-3 (T cell immunoglobulin domain, mucin domain) has been identified. Here we report the identification of a secreted form of Tim-3 that contains only the immunoglobulin (Ig) variable (V) domain of the full-length molecule. Fusion proteins (Tim-3-Ig) of both Tim-3 isoforms specifically bound CD4(+) T cells, indicating that a Tim-3 ligand is expressed on CD4(+) T cells. Administration of Tim-3-Ig to immunized mice caused hyperproliferation of T(H)1 cells and T(H)1 cytokine release. Tim-3-Ig also abrogated tolerance induction in T(H)1 cells, and Tim-3-deficient mice were refractory to the induction of high-dose tolerance. These data indicate that interaction of Tim-3 with Tim-3 ligand may serve to inhibit effector T(H)1 cells during a normal immune response and may be crucial for the induction of peripheral tolerance.	Brigham & Womens Hosp, Dept Neurol, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Immunol, Boston, MA 02215 USA; Millennium Pharmaceut, Inflammat Dept, Div Expt Med, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Kuchroo, VK (corresponding author), Brigham & Womens Hosp, Dept Neurol, Ctr Neurol Dis, 75 Francis St, Boston, MA 02115 USA.		Freeman, Gordon/AAC-5380-2019; Strom, Terry B./E-9268-2010	Freeman, Gordon/0000-0002-7210-5616; Strom, Terry B./0000-0002-7570-0736; Cha, Eugene/0000-0002-8807-2353; Schubart, Anna/0000-0003-4253-0600	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039671, R01AI044880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM020927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS030843, P01NS038037, R01NS035685, R01NS045937] Funding Source: NIH RePORTER; NIAID NIH HHS [1R01AI44880-03, 2P01AI39671-07] Funding Source: Medline; NIGMS NIH HHS [1F31GM20927-01] Funding Source: Medline; NINDS NIH HHS [1PO1NS38037-04, 1R01NS045937-01, 2R01NS35685-06, 2R37NS30843-11] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; BRISKIN MJ, 1993, NATURE, V363, P461, DOI 10.1038/363461a0; BURSTEIN HJ, 1993, J EXP MED, V177, P457, DOI 10.1084/jem.177.2.457; Greenwald RJ, 2001, IMMUNITY, V14, P145, DOI 10.1016/S1074-7613(01)00097-8; Hofstra CL, 1998, J IMMUNOL, V161, P5054; JENTOFT N, 1990, TRENDS BIOCHEM SCI, V15, P291, DOI 10.1016/0968-0004(90)90014-3; Jourdan P, 1998, J IMMUNOL, V160, P4153; Kaplan G, 1996, EMBO J, V15, P4282, DOI 10.1002/j.1460-2075.1996.tb00803.x; KOVAC Z, 1985, J IMMUNOL, V134, P3233; Kuchroo VK, 2003, NAT REV IMMUNOL, V3, P454, DOI 10.1038/nri1111; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; LACK G, 1994, J IMMUNOL, V152, P2546; LIBLAU RS, 1995, IMMUNOL TODAY, V16, P34, DOI 10.1016/0167-5699(95)80068-9; Loetscher P, 1998, NATURE, V391, P344, DOI 10.1038/34814; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; MATIS LA, 1983, J IMMUNOL, V130, P1527; McAdam AJ, 2000, J IMMUNOL, V165, P5035, DOI 10.4049/jimmunol.165.9.5035; McIntire JJ, 2001, NAT IMMUNOL, V2, P1109, DOI 10.1038/ni739; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; MOSMANN T, 1996, IMMUNOL TODAY, V7, P138; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Nicholson LB, 1997, P NATL ACAD SCI USA, V94, P9279, DOI 10.1073/pnas.94.17.9279; NICHOLSON LB, 1995, IMMUNITY, V3, P397, DOI 10.1016/1074-7613(95)90169-8; Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; SANCHEZFUEYO A, 2003, NAT IMMUNOL     1012; SHER A, 1992, ANNU REV IMMUNOL, V10, P385, DOI 10.1146/annurev.iy.10.040192.002125; Silberstein E, 2001, J VIROL, V75, P717, DOI 10.1128/JVI.75.2.717-725.2001; Syrbe U, 1999, SPRINGER SEMIN IMMUN, V21, P263, DOI 10.1007/BF00812257; Thompson P, 1998, J VIROL, V72, P3751, DOI 10.1128/JVI.72.5.3751-3761.1998; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Venkataraman C, 2000, J IMMUNOL, V165, P632, DOI 10.4049/jimmunol.165.2.632; Xing L, 2000, EMBO J, V19, P1207, DOI 10.1093/emboj/19.6.1207; ZHENG XX, 1995, J IMMUNOL, V154, P5590; Zingoni A, 1998, J IMMUNOL, V161, P547	36	485	556	2	28	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2003	4	11					1102	1110		10.1038/ni988	http://dx.doi.org/10.1038/ni988			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	737PN	14556006				2022-12-18	WOS:000186241100014
J	Bousso, P; Robey, E				Bousso, P; Robey, E			Dynamics of CD8(+) T cell priming by dendritic cells in intact lymph nodes	NATURE IMMUNOLOGY			English	Article							ANTIGEN PRESENTATION; IN-VIVO; IDENTIFICATION; ENGAGEMENT; MOTILITY; AFFINITY; SYNAPSE; MICE	The cellular dynamics underlying activation of CD8(+) T cells by dendritic cells (DCs) in the lymph node are not known. Here we have tracked the behavior of T cells and DCs by subjecting intact lymph nodes to real-time two-photon microscopy. We show that DCs scan at least 500 different T cells per hour in the absence of antigen. Antigen-bearing DCs are highly efficient in recruiting peptide-specific T cells and can engage more than ten T cells simultaneously. The duration of these interactions is of the order of hours, not minutes. The overall avidity of the interaction influences the probability that T cells will be stably captured by DCs, providing a possible basis for T cell competition. Taken together, our results identify the cellular behaviors that promote an efficient CD8(+) T cell response in the lymph node.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Bousso, P (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	bousso@pasteur.fr	BOUSSO, Philippe/M-6547-2014	BOUSSO, Philippe/0000-0002-6362-561X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042033, R01AI032985] Funding Source: NIH RePORTER; NIAID NIH HHS [AI42033, AI32985] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bousso P, 2002, SCIENCE, V296, P1876, DOI 10.1126/science.1070945; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Cumberbatch M, 2002, IMMUNOLOGY, V105, P466, DOI 10.1046/j.1365-2567.2002.01381.x; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Grufman P, 1999, EUR J IMMUNOL, V29, P2197, DOI 10.1002/(SICI)1521-4141(199907)29:07<2197::AID-IMMU2197>3.0.CO;2-B; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; Ingulli E, 2002, J IMMUNOL, V169, P2247, DOI 10.4049/jimmunol.169.5.2247; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; Kedl RM, 2000, J EXP MED, V192, P1105, DOI 10.1084/jem.192.8.1105; Kedl RM, 2002, NAT IMMUNOL, V3, P27, DOI 10.1038/ni742; McGavern DB, 2002, NAT IMMUNOL, V3, P918, DOI 10.1038/ni843; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Norbury CC, 2002, NAT IMMUNOL, V3, P265, DOI 10.1038/ni762; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Porgador A, 1998, J EXP MED, V188, P1075, DOI 10.1084/jem.188.6.1075; Rees W, 1999, P NATL ACAD SCI USA, V96, P9781, DOI 10.1073/pnas.96.17.9781; Reichert P, 2001, J IMMUNOL, V166, P4278, DOI 10.4049/jimmunol.166.7.4278; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Underhill DM, 1999, J EXP MED, V190, P1909, DOI 10.1084/jem.190.12.1909; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266	27	485	496	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2003	4	6					579	585		10.1038/ni928	http://dx.doi.org/10.1038/ni928			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	683XC	12730692				2022-12-18	WOS:000183175500018
J	Pallotta, MT; Orabona, C; Volpi, C; Vacca, C; Belladonna, ML; Bianchi, R; Servillo, G; Brunacci, C; Calvitti, M; Bicciato, S; Mazza, EMC; Boon, L; Grassi, F; Fioretti, MC; Fallarino, F; Puccetti, P; Grohmann, U				Pallotta, Maria T.; Orabona, Ciriana; Volpi, Claudia; Vacca, Carmine; Belladonna, Maria L.; Bianchi, Roberta; Servillo, Giuseppe; Brunacci, Cinzia; Calvitti, Mario; Bicciato, Silvio; Mazza, Emilia M. C.; Boon, Louis; Grassi, Fabio; Fioretti, Maria C.; Fallarino, Francesca; Puccetti, Paolo; Grohmann, Ursula			Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells	NATURE IMMUNOLOGY			English	Article							TRYPTOPHAN CATABOLISM; PROTEASOMAL DEGRADATION; CUTTING EDGE; IDO; INTERFERON; SOCS3; INHIBITION; EXPRESSION; INSIGHTS; RECEPTOR	Regulation of tryptophan metabolism by indoleamine 2,3-dioxygenase (IDO) in dendritic cells (DCs) is a highly versatile modulator of immunity. In inflammation, interferon-gamma is the main inducer of IDO for the prevention of hyperinflammatory responses, yet IDO is also responsible for self-tolerance effects in the longer term. Here we show that treatment of mouse plasmacytoid DCs (pDCs) with transforming growth factor-beta (TGF-beta) conferred regulatory effects on IDO that were mechanistically separable from its enzymic activity. We found that IDO was involved in intracellular signaling events responsible for the self-amplification and maintenance of a stably regulatory phenotype in pDCs. Thus, IDO has a tonic, nonenzymic function that contributes to TGF-beta-driven tolerance in noninflammatory contexts.	[Pallotta, Maria T.; Orabona, Ciriana; Volpi, Claudia; Vacca, Carmine; Belladonna, Maria L.; Bianchi, Roberta; Calvitti, Mario; Fioretti, Maria C.; Fallarino, Francesca; Puccetti, Paolo; Grohmann, Ursula] Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy; [Servillo, Giuseppe; Brunacci, Cinzia] Univ Perugia, Dept Clin & Expt Med, I-06100 Perugia, Italy; [Bicciato, Silvio; Mazza, Emilia M. C.] Univ Modena, Dept Biomed Sci, I-41100 Modena, Italy; [Boon, Louis] Bioceros, Utrecht, Netherlands; [Grassi, Fabio] Biomed Res Inst, Bellinzona, Switzerland	University of Perugia; University of Perugia; Universita di Modena e Reggio Emilia; Universita della Svizzera Italiana	Grohmann, U (corresponding author), Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy.	ugrohmann@tin.it	Grohmann, Ursula/T-6545-2019; Vacca, Carmine/AAE-7046-2019; Bicciato, Silvio/C-9825-2009; Fallarino, Francesca/O-3358-2013; Orabona, Ciriana/L-8725-2015; Pallotta, Maria Teresa/K-7021-2016; BICCIATO, Silvio/J-4466-2019; Boon, Laurence/HCI-3629-2022	Vacca, Carmine/0000-0002-3799-8164; Bicciato, Silvio/0000-0002-1944-7078; Fallarino, Francesca/0000-0002-8501-2136; Orabona, Ciriana/0000-0003-3113-0572; Pallotta, Maria Teresa/0000-0002-0417-1638; BICCIATO, Silvio/0000-0002-1944-7078; CALVITTI, Mario/0000-0002-0320-3714; Puccetti, Paolo/0000-0001-6674-2128; Boon, Louis/0000-0002-0937-9171; Servillo, Giuseppe/0000-0001-7960-7689; Bianchi, Roberta/0000-0001-5914-4701; VOLPI, CLAUDIA/0000-0002-3967-7954; GRASSI, FABIO/0000-0003-3348-1712; Mazza, Emilia Maria Cristina/0000-0003-2424-3640; Grohmann, Ursula/0000-0001-7952-1850; Belladonna, Maria Laura/0000-0001-6522-0870	Italian Ministry of Health [GR-2008-1138004]; Associazione per l'Aiuto ai Giovani con Diabete dell'Umbria; Associazione Italiana per la Ricerca sul Cancro	Italian Ministry of Health(Ministry of Health, Italy); Associazione per l'Aiuto ai Giovani con Diabete dell'Umbria; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	We thank G.C. Prendergast (Lankenau Institute for Medical Research) for the mIDOprom900-luc plasmid, and G. Andrielli for digital art and image editing. Supported by the Italian Ministry of Health (GR-2008-1138004 ('Innovative IDO-targeting interventions in autoimmunity') to C.O.), the Associazione per l'Aiuto ai Giovani con Diabete dell'Umbria (U.G.) and Associazione Italiana per la Ricerca sul Cancro (P.P.).	Abu-Dayyeh I, 2010, DEV COMP IMMUNOL, V34, P481, DOI 10.1016/j.dci.2009.12.012; An HZ, 2008, NAT IMMUNOL, V9, P542, DOI 10.1038/ni.1604; Ball HJ, 2009, INT J BIOCHEM CELL B, V41, P467, DOI 10.1016/j.biocel.2008.01.005; Belladonna ML, 2008, J IMMUNOL, V181, P5194, DOI 10.4049/jimmunol.181.8.5194; Belladonna ML, 2009, TRENDS MOL MED, V15, P41, DOI 10.1016/j.molmed.2008.11.006; Belladonna ML, 2006, CYTOKINE, V34, P161, DOI 10.1016/j.cyto.2006.04.011; Belladonna ML, 2002, J IMMUNOL, V168, P5448, DOI 10.4049/jimmunol.168.11.5448; Billadeau DD, 2002, J CLIN INVEST, V109, P161, DOI 10.1172/JCI14843; Bisognin A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-201; Daeron M, 2008, IMMUNOL REV, V224, P11, DOI 10.1111/j.1600-065X.2008.00666.x; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Fallarino F, 2010, NAT MED, V16, P897, DOI 10.1038/nm.2183; Fallarino F, 2009, J IMMUNOL, V183, P6303, DOI 10.4049/jimmunol.0901577; Fazekas de St Groth B, 1998, IMMUNOL TODAY, V19, P448, DOI 10.1016/S0167-5699(98)01328-0; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Forouhar F, 2007, P NATL ACAD SCI USA, V104, P473, DOI 10.1073/pnas.0610007104; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Grohmann U, 2003, J IMMUNOL, V171, P2581, DOI 10.4049/jimmunol.171.5.2581; Grohmann U, 2003, J EXP MED, V198, P153, DOI 10.1084/jem.20030633; Grohmann U, 2003, TRENDS IMMUNOL, V24, P242, DOI 10.1016/S1471-4906(03)00072-3; Grohmann U, 2007, NAT MED, V13, P579, DOI 10.1038/nm1563; Grohmann U, 2010, IMMUNOL REV, V236, P243, DOI 10.1111/j.1600-065X.2010.00915.x; Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641; Huang L, 2010, INT REV IMMUNOL, V29, P133, DOI 10.3109/08830180903349669; Irla M, 2010, J EXP MED, V207, P1891, DOI 10.1084/jem.20092627; Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n; Lande R, 2010, ANN NY ACAD SCI, V1183, P89, DOI 10.1111/j.1749-6632.2009.05152.x; Matta BM, 2010, EUR J IMMUNOL, V40, P2667, DOI 10.1002/eji.201040839; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Metz R, 2007, CANCER RES, V67, P7082, DOI 10.1158/0008-5472.CAN-07-1872; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Muller AJ, 2005, NAT MED, V11, P312, DOI 10.1038/nm1196; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Orabona C, 2006, BLOOD, V107, P2846, DOI 10.1182/blood-2005-10-4077; Orabona C, 2005, J IMMUNOL, V174, P6582, DOI 10.4049/jimmunol.174.11.6582; Orabona C, 2004, NAT IMMUNOL, V5, P1134, DOI 10.1038/ni1124; Orabona C, 2008, P NATL ACAD SCI USA, V105, P20828, DOI 10.1073/pnas.0810278105; Orr SJ, 2007, J BIOL CHEM, V282, P3418, DOI 10.1074/jbc.C600216200; Orr SJ, 2007, BLOOD, V109, P1061, DOI 10.1182/blood-2006-05-023556; Puccetti P, 2007, NAT REV IMMUNOL, V7, P817, DOI 10.1038/nri2163; Puccetti P, 2007, EUR J IMMUNOL, V37, P876, DOI 10.1002/eji.200737184; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Sweeney MC, 2005, BIOCHEMISTRY-US, V44, P14932, DOI 10.1021/bi051408h; Swiecki M, 2010, IMMUNOL REV, V234, P142, DOI 10.1111/j.0105-2896.2009.00881.x; Tas SW, 2007, BLOOD, V110, P1540, DOI 10.1182/blood-2006-11-056010; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; Williams JC, 1998, TRENDS BIOCHEM SCI, V23, P179, DOI 10.1016/S0968-0004(98)01202-X	50	483	504	2	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2011	12	9					870	U91		10.1038/ni.2077	http://dx.doi.org/10.1038/ni.2077			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	814NA	21804557				2022-12-18	WOS:000294461200011
J	Saijo, S; Fujikado, N; Furuta, T; Chung, SH; Kotaki, H; Seki, K; Sudo, K; Akira, S; Adachi, Y; Ohno, N; Kinjo, T; Nakamura, K; Kawakami, K; Iwakura, Y				Saijo, Shinobu; Fujikado, Noriyuki; Furuta, Takahisa; Chung, Soo-hyun; Kotaki, Hayato; Seki, Keisuke; Sudo, Katsuko; Akira, Shizuo; Adachi, Yoshiyuki; Ohno, Naohito; Kinjo, Takeshi; Nakamura, Kiwamu; Kawakami, Kazuyoshi; Iwakura, Yoichiro			Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans	NATURE IMMUNOLOGY			English	Article							BETA-GLUCAN RECEPTOR; TOLL-LIKE RECEPTOR-2; C-TYPE LECTIN; MANNOSE RECEPTOR; SPARASSIS-CRISPA; DEFICIENT MICE; IFN-GAMMA; IN-VITRO; RECOGNITION; INDUCTION	Dectin-1 is a C-type lectin involved in the recognition of beta-glucans found in the cell walls of fungi. We generated dectin-1-deficient mice to determine the importance of dectin-1 in the defense against pathogenic fungi. In vitro, beta-glucan-induced cytokine production from wild-type dendritic cells and macrophages was abolished in cells homozygous for dectin-1 deficiency ('dectin-1-knockout' cells). In vivo, dectin-1-knockout mice were more susceptible than wild-type mice to pneumocystis infection, even though their cytokine production was normal. However, pneumocystis-infected dectin-1-knockout macrophages did show defective production of reactive oxygen species. In contrast to those results, wild-type and dectin-1-knockout mice were equally susceptible to candida infection. Thus, dectin-1 is required for immune responses to some fungal infections, as protective immunity to pneumocystis, but not to candida, required dectin-1 for the production of antifungal reactive oxygen species.	Univ Tokyo, Inst Med Sci, Ctr Med Expt, Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Inst Med Sci, Dept Immunol & Microbiol, Minato Ku, Tokyo 1088639, Japan; Osaka Univ, Res Inst Microbial Dis, Dept Host Def, Suita, Osaka 5650871, Japan; Tokyo Univ Pharm & Life Sci, Sch Pharm, Lab Immunopharmacol Microbial Prod, Hachioji, Tokyo 1920392, Japan; Univ Ryukyus, Fac Med, Dept Med & Therapeut Control & Prevent Infect Dis, Okinawa 9030215, Japan; Tohoku Univ, Sch Hlth Sci, Dept Med Technol, Aoba Ku, Sendai, Miyagi 98088575, Japan	University of Tokyo; University of Tokyo; Osaka University; Tokyo University of Pharmacy & Life Sciences; University of the Ryukyus; Tohoku University	Saijo, S (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Med Expt, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	iwakura@ims.u-tokyo.ac.jp	Akira, Shizuo/C-3134-2009; Iwakura, Yoichiro/E-5457-2011; Saijo, Shinobu/I-1501-2017; 関, 啓介/GVR-9360-2022	Iwakura, Yoichiro/0000-0002-9934-5775; Saijo, Shinobu/0000-0002-3802-8821; Fujikado, Noriyuki/0000-0002-3183-5866; Chung, Soo-Hyun/0000-0003-2808-1327; Fujikado, Noriyuki/0000-0002-0415-5929				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Adachi Y, 2004, INFECT IMMUN, V72, P4159, DOI 10.1128/IAI.72.7.4159-4171.2004; Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2003, IMMUNITY, V19, P311, DOI 10.1016/S1074-7613(03)00233-4; DICARLO FJ, 1958, SCIENCE, V127, P756, DOI 10.1126/science.127.3301.756-a; Edwards AD, 2002, J IMMUNOL, V169, P3652, DOI 10.4049/jimmunol.169.7.3652; Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723; FITZPATRICK FW, 1964, J RETICULOENDOTH SOC, V1, P423; Furuta T, 1998, ANTIMICROB AGENTS CH, V42, P37, DOI 10.1128/AAC.42.1.37; FURUTA T, 1984, JPN J EXP MED, V54, P57; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Habu K, 1999, J IMMUNOL, V162, P2956; Hanano R, 1998, INFECT IMMUN, V66, P305, DOI 10.1128/IAI.66.1.305-314.1998; Harada T, 2002, J INTERF CYTOK RES, V22, P1227, DOI 10.1089/10799900260475759; Hida S, 2006, MICROBIOL IMMUNOL, V50, P453, DOI 10.1111/j.1348-0421.2006.tb03814.x; Ishibashia K, 2002, INT IMMUNOPHARMACOL, V2, P1109, DOI 10.1016/S1567-5769(02)00062-0; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kopp EB, 1999, CURR OPIN IMMUNOL, V11, P13, DOI 10.1016/S0952-7915(99)80003-X; Lee SJ, 2003, INFECT IMMUN, V71, P437, DOI 10.1128/IAI.71.1.437-445.2003; Mansour MK, 2002, CURR OPIN MICROBIOL, V5, P359, DOI 10.1016/S1369-5274(02)00342-9; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nakae S, 2001, IMMUNOLOGY, V104, P402, DOI 10.1046/j.1365-2567.2001.01337.x; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; ODDS FC, 1988, CANDIDA CANDIDOSIS, P252; Ohno N, 2000, BIOL PHARM BULL, V23, P866, DOI 10.1248/bpb.23.866; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Ross GD, 1999, IMMUNOPHARMACOLOGY, V42, P61, DOI 10.1016/S0162-3109(99)00013-2; Rudmann DG, 1998, J IMMUNOL, V161, P360; Saijo S, 2002, ARTHRITIS RHEUM-US, V46, P533, DOI 10.1002/art.10172; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; Smits GJ, 1999, CURR OPIN MICROBIOL, V2, P348; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; Steele C, 2003, J EXP MED, V198, P1677, DOI 10.1084/jem.20030932; Swain SD, 2003, INFECT IMMUN, V71, P6213, DOI 10.1128/IAI.71.11.6213-6221.2003; Tada H, 2002, MICROBIOL IMMUNOL, V46, P503, DOI 10.1111/j.1348-0421.2002.tb02727.x; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Villamon E, 2005, RES MICROBIOL, V156, P115, DOI 10.1016/j.resmic.2004.08.003	42	483	510	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2007	8	1					39	46		10.1038/ni1425	http://dx.doi.org/10.1038/ni1425			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	118HZ	17159982				2022-12-18	WOS:000242934400012
J	Thelen, M				Thelen, M			Dancing to the tune of chemokines	NATURE IMMUNOLOGY			English	Review							PROTEIN-KINASE-B; HUMAN INTERLEUKIN-8 RECEPTOR; BETA-GAMMA-SUBUNITS; SIGNAL-TRANSDUCTION PATHWAYS; HUMAN NEUTROPHIL LEUKOCYTES; PLECKSTRIN HOMOLOGY DOMAIN; COUPLED RECEPTORS; CHEMOATTRACTANT RECEPTORS; PHOSPHOINOSITIDE 3-KINASE; SDF-1-ALPHA TRIGGERS	Since their discovery 13 years ago, chemokines have emerged as the most important regulators of leukocyte trafficking. On target cells, chemokines bind to seven-transmembrane-domain receptors that are coupled to heterotrimeric G(i) proteins. The common response of all cells to chemokine stimulation is chemotaxis. In addition,leukocyte activation triggers diverse signal transduction cascades; which cascade is triggered depends on the chemokine and receptor engaged. The selective activation of distinct pathways suggests that the receptors couple not only to G proteins but also to additional downstream effecters. This review discusses recent advances in the elucidation of the signal transduction that occurs in proximity to receptors and that leads to the early biochemical events in leukocyte activation.	Inst Res Biomed, CH-6500 Bellinzona, Switzerland	Universita della Svizzera Italiana	Thelen, M (corresponding author), Inst Res Biomed, CH-6500 Bellinzona, Switzerland.							AbdAlla S, 1999, J BIOL CHEM, V274, P26079, DOI 10.1074/jbc.274.37.26079; AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Ali H, 1999, J BIOL CHEM, V274, P6027, DOI 10.1074/jbc.274.10.6027; Ali H, 1998, J BIOL CHEM, V273, P11012, DOI 10.1074/jbc.273.18.11012; Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139; Aragay AM, 1998, P NATL ACAD SCI USA, V95, P2985, DOI 10.1073/pnas.95.6.2985; Bacon KB, 1996, J EXP MED, V184, P873, DOI 10.1084/jem.184.3.873; BACON KB, 1995, SCIENCE, V269, P1727, DOI 10.1126/science.7569902; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Barr AJ, 2000, BIOCHEMISTRY-US, V39, P1800, DOI 10.1021/bi992021f; Bauer PH, 1998, J BIOL CHEM, V273, P9465, DOI 10.1074/jbc.273.16.9465; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bondeva T, 1998, SCIENCE, V282, P293, DOI 10.1126/science.282.5387.293; Bottomley MJ, 1998, BBA-MOL CELL BIOL L, V1436, P165, DOI 10.1016/S0005-2760(98)00141-6; BOULAY F, 1990, BIOCHEMISTRY-US, V29, P11123, DOI 10.1021/bi00502a016; Bowman EP, 1998, J BIOL CHEM, V273, P28040, DOI 10.1074/jbc.273.43.28040; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Cicala C, 1999, J IMMUNOL, V163, P420; Davis CB, 1997, J EXP MED, V186, P1793, DOI 10.1084/jem.186.10.1793; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; Didichenko SA, 1996, CURR BIOL, V6, P1271, DOI 10.1016/S0960-9822(02)70713-6; Dikic I, 1998, J BIOL CHEM, V273, P14301, DOI 10.1074/jbc.273.23.14301; Fanning AS, 1999, J CLIN INVEST, V103, P767, DOI 10.1172/JCI6509; Feniger-Barish R, 2000, BLOOD, V95, P1551, DOI 10.1182/blood.V95.5.1551.005a36_1551_1559; Frech M, 1997, J BIOL CHEM, V272, P8474, DOI 10.1074/jbc.272.13.8474; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; GIANNINI E, 1995, J IMMUNOL, V154, P4055; Grimm MC, 1998, J EXP MED, V188, P317, DOI 10.1084/jem.188.2.317; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; Hemmings BA, 1997, SCIENCE, V277, P534, DOI 10.1126/science.277.5325.534; HERBERT TE, 1996, J BIOL CHEM, V271, P16384; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; Huang RY, 1998, MOL CELL BIOL, V18, P7130, DOI 10.1128/MCB.18.12.7130; Ilangumaran S, 2000, IMMUNOL TODAY, V21, P2, DOI 10.1016/S0167-5699(99)01494-2; Jin T, 2000, SCIENCE, V287, P1034, DOI 10.1126/science.287.5455.1034; Jones SA, 1996, P NATL ACAD SCI USA, V93, P6682, DOI 10.1073/pnas.93.13.6682; JONES SA, 1995, FEBS LETT, V364, P211, DOI 10.1016/0014-5793(95)00397-R; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Kehrl JH, 1998, IMMUNITY, V8, P1, DOI 10.1016/S1074-7613(00)80453-7; Klippel A, 1997, MOL CELL BIOL, V17, P338, DOI 10.1128/MCB.17.1.338; Knall C, 1996, J BIOL CHEM, V271, P2832, DOI 10.1074/jbc.271.5.2832; Kuhmann SE, 2000, J VIROL, V74, P7005, DOI 10.1128/JVI.74.15.7005-7015.2000; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; Mandeville JTH, 1997, J CELL PHYSIOL, V171, P168, DOI 10.1002/(SICI)1097-4652(199705)171:2<168::AID-JCP7>3.0.CO;2-M; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; Meinhardt H, 1999, J CELL SCI, V112, P2867; Mellado M, 1998, J IMMUNOL, V161, P805; Murphy PM, 2000, PHARMACOL REV, V52, P145; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; Nanki T, 2000, J IMMUNOL, V164, P5010, DOI 10.4049/jimmunol.164.10.5010; Neptune ER, 1999, J BIOL CHEM, V274, P2824, DOI 10.1074/jbc.274.5.2824; Neptune ER, 1997, P NATL ACAD SCI USA, V94, P14489, DOI 10.1073/pnas.94.26.14489; Nieto M, 1997, J EXP MED, V186, P153, DOI 10.1084/jem.186.1.153; Oppermann M, 1999, J BIOL CHEM, V274, P8875, DOI 10.1074/jbc.274.13.8875; Orsini MJ, 1999, J BIOL CHEM, V274, P31076, DOI 10.1074/jbc.274.43.31076; Overton MC, 2000, CURR BIOL, V10, P341, DOI 10.1016/S0960-9822(00)00386-9; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Ptasznik A, 1996, J BIOL CHEM, V271, P25204, DOI 10.1074/jbc.271.41.25204; Reif K, 2000, J IMMUNOL, V164, P4720, DOI 10.4049/jimmunol.164.9.4720; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Richardson RM, 1998, J BIOL CHEM, V273, P10690, DOI 10.1074/jbc.273.17.10690; RICHARDSON RM, 1995, BIOCHEMISTRY-US, V34, P14193, DOI 10.1021/bi00043a025; Rodriguez-Frade JM, 1999, P NATL ACAD SCI USA, V96, P3628, DOI 10.1073/pnas.96.7.3628; Sankaran B, 1998, J BIOL CHEM, V273, P7148, DOI 10.1074/jbc.273.12.7148; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Servant G, 1999, MOL BIOL CELL, V10, P1163, DOI 10.1091/mbc.10.4.1163; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Shen WP, 2000, BLOOD, V96, P2887, DOI 10.1182/blood.V96.8.2887.h8002887_2887_2894; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; Signoret N, 1997, J CELL BIOL, V139, P651, DOI 10.1083/jcb.139.3.651; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; THELEN M, 1988, FASEB J, V2, P2702, DOI 10.1096/fasebj.2.11.2840318; Thelen M, 1995, BIOCHEM BIOPH RES CO, V217, P1255, DOI 10.1006/bbrc.1995.2903; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tilton B, 2000, J EXP MED, V192, P313, DOI 10.1084/jem.192.3.313; Tilton B, 1997, J BIOL CHEM, V272, P28096, DOI 10.1074/jbc.272.44.28096; Toker A, 2000, CELL, V103, P185, DOI 10.1016/S0092-8674(00)00110-0; Ugolini S, 1997, J IMMUNOL, V159, P3000; Vicente-Manzanares M, 1998, EUR J IMMUNOL, V28, P2197, DOI 10.1002/(SICI)1521-4141(199807)28:07<2197::AID-IMMU2197>3.0.CO;2-F; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; Vila-Coro AJ, 2000, P NATL ACAD SCI USA, V97, P3388, DOI 10.1073/pnas.050457797; Wang JF, 2000, BLOOD, V95, P2505, DOI 10.1182/blood.V95.8.2505.008k24_2505_2513; Ward SG, 1998, IMMUNITY, V9, P1, DOI 10.1016/S1074-7613(00)80583-X; WU DQ, 1993, SCIENCE, V261, P101, DOI 10.1126/science.8316840; WYMANN MP, 1987, BIOCHEM BIOPH RES CO, V147, P361, DOI 10.1016/S0006-291X(87)80130-4; Xiao Z, 1997, J CELL BIOL, V139, P365, DOI 10.1083/jcb.139.2.365; Zlotnik A, 1999, CRIT REV IMMUNOL, V19, P1	104	483	490	1	40	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2001	2	2					129	134		10.1038/84224	http://dx.doi.org/10.1038/84224			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	398WD	11175805				2022-12-18	WOS:000166778700008
J	Skon, CN; Lee, JY; Anderson, KG; Masopust, D; Hogquist, KA; Jameson, SC				Skon, Cara N.; Lee, June-Yong; Anderson, Kristin G.; Masopust, David; Hogquist, Kristin A.; Jameson, Stephen C.			Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8(+) T cells	NATURE IMMUNOLOGY			English	Article							KRUPPEL-LIKE FACTOR-2; LYMPHOCYTE EGRESS; CUTTING EDGE; RM CELLS; TISSUE; INFECTION; EFFECTOR; DIFFERENTIATION; TRAFFICKING; EXPRESSION	Cell-mediated immunity critically depends on the localization of lymphocytes at sites of infection. While some memory T cells recirculate, a distinct lineage (resident memory T cells (T-RM cells)) are embedded in nonlymphoid tissues (NLTs) and mediate potent protective immunity. However, the defining transcriptional basis for the establishment of T-RM cells is unknown. We found that CD8(+) T-RM cells lacked expression of the transcription factor KLF2 and its target gene S1pr1 (which encodes S1P(1), a receptor for sphingosine 1-phosphate). Forced expression of S1P(1) prevented the establishment of T-RM cells. Cytokines that induced a T-RM cell phenotype (including transforming growth factor-beta (TGF-beta), interleukin 33 (IL-33) and tumor-necrosis factor) elicited downregulation of KLF2 expression in a pathway dependent on phosphatidylinositol-3-OH kinase (PI(3) K) and the kinase Akt, which suggested environmental regulation. Hence, regulation of KLF2 and S1P(1) provides a switch that dictates whether CD8(+) T cells commit to recirculating or tissue-resident memory populations.	[Skon, Cara N.; Lee, June-Yong; Hogquist, Kristin A.; Jameson, Stephen C.] Univ Minnesota, Dept Lab Med & Pathol, Ctr Immunol, Minneapolis, MN 55455 USA; [Anderson, Kristin G.; Masopust, David] Univ Minnesota, Dept Microbiol, Ctr Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Jameson, SC (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Ctr Immunol, Minneapolis, MN 55455 USA.	james024@umn.edu	Anderson, Kristin/AAD-3100-2022; masopust, david/B-5027-2008; Jameson, Stephen C/D-9892-2013	Anderson, Kristin/0000-0001-9263-4438; Jameson, Stephen C/0000-0001-9137-1146; Lee, June-Yong/0000-0002-4476-725X; Hogquist, Kristin/0000-0001-9963-5687; Skon-Hegg, Cara/0000-0003-0703-3553	US National Institutes of Health [R37 AI38903, R37 AI39560, T32 AI07313, T90 DE022732]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007313, R37AI039560, R37AI038903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE022732] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank J. Cyster (University of California, San Francisco) for the vector MSCV-S1PR1-hCD4; J. Chen (Massachusetts Institute of Technology) for the retroviral vector MSCV-IRES-Thy1.1 (MiT); K. Walkowiak and J. Schenkel for input on parabiosis; L. Mackay and D. Kaplan for advice on DNFB studies; and the Jamequist laboratory for intellectual support. Supported by the US National Institutes of Health (R37 AI38903 to S. C. J.; R37 AI39560 to K. A. H.; T32 AI07313 to C.N.S.; and T90 DE022732 to K.G.A.).	Anderson KG, 2012, J IMMUNOL, V189, P2702, DOI 10.4049/jimmunol.1201682; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Ariotti S, 2012, ADV IMMUNOL, V114, P203, DOI 10.1016/B978-0-12-396548-6.00008-1; Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632; Bankovich AJ, 2010, J BIOL CHEM, V285, P22328, DOI 10.1074/jbc.M110.123299; Bevan MJ, 2011, EUR J IMMUNOL, V41, P1192, DOI 10.1002/eji.201041377; Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Finlay D, 2011, NAT REV IMMUNOL, V11, P109, DOI 10.1038/nri2888; Freeman BE, 2012, P NATL ACAD SCI USA, V109, P9971, DOI 10.1073/pnas.1203543109; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Grahler MH, 2005, J IMMUNOL, V174, P1997; Grayson JM, 2001, J IMMUNOL, V166, P795, DOI 10.4049/jimmunol.166.2.795; Hart GT, 2012, J IMMUNOL, V188, P521, DOI 10.4049/jimmunol.1101530; Hedrick SM, 2009, NAT IMMUNOL, V10, P1057, DOI 10.1038/ni.1784; Hofmann M, 2011, P NATL ACAD SCI USA, V108, P16741, DOI 10.1073/pnas.1107200108; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Ledgerwood LG, 2008, NAT IMMUNOL, V9, P42, DOI 10.1038/ni1534; Liu LZ, 2010, NAT MED, V16, P224, DOI 10.1038/nm.2078; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; MACKAY CR, 1990, J EXP MED, V171, P801, DOI 10.1084/jem.171.3.801; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Masopust D, 2012, J IMMUNOL, V188, P5811, DOI 10.4049/jimmunol.1102695; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Odumade OA, 2010, J IMMUNOL, V184, P6060, DOI 10.4049/jimmunol.1000511; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; Rutishauser RL, 2010, IMMUNOL REV, V235, P219, DOI 10.1111/j.0105-2896.2010.00901.x; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Schober SL, 1999, J IMMUNOL, V163, P3662; Sheridan BS, 2011, NAT IMMUNOL, V12, P485, DOI 10.1038/ni.2029; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Takada K, 2011, J IMMUNOL, V186, P775, DOI 10.4049/jimmunol.1000094; Valcu M, 2011, NAT METHODS, V8, P104, DOI 10.1038/nmeth0211-104; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Weinreich MA, 2009, IMMUNITY, V31, P122, DOI 10.1016/j.immuni.2009.05.011; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhu J, 2013, NATURE, V497, P494, DOI 10.1038/nature12110; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x	53	475	484	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2013	14	12					1285	+		10.1038/ni.2745	http://dx.doi.org/10.1038/ni.2745			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	254FG	24162775	Green Accepted			2022-12-18	WOS:000327149400014
J	Sigmundsdottir, H; Pan, JL; Debes, GF; Alt, C; Habtezion, A; Soler, D; Butcher, EC				Sigmundsdottir, Hekla; Pan, Junliang; Debes, Gudrun F.; Alt, Carsten; Habtezion, Aida; Soler, Dulce; Butcher, Eugene C.			DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27	NATURE IMMUNOLOGY			English	Article							LYMPHOCYTE-ASSOCIATED ANTIGEN; DENDRITIC CELLS; HUMAN-SKIN; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; IMMUNE SURVEILLANCE; IN-VITRO; 1,25-DIHYDROXYVITAMIN D-3; 25-HYDROXYVITAMIN D; HOMING RECEPTOR; EXPRESSION	During adaptive immune responses, dendritic cells activate T cells and endow them with specific homing properties. Mechanisms that 'imprint' specific tropisms, however, are not well defined. We show here that 1,25(OH) D-2(3), the active form of vitamin D3, signaled T cells to express CC chemokine receptor 10, which enabled them to migrate to the skin-specific chemokine CCL27 secreted by keratinocytes of the epidermis. In contrast, 1,25(OH)(2)D-3 suppressed the gut-homing receptors alpha 4 beta 7 and CCR9. Vitamin D3, the inactive prohormone naturally generated in the skin by exposure to the sun, was processed by dendritic cells and T cells to the active metabolite, providing a mechanism for the local regulation of T cell 'epidermotropism'. Our findings support a model in which dendritic cells process and 'interpret' locally produced metabolites to 'program' T cell homing and microenvironmental positioning.	Stanford Univ, Sch Med, Dept Pathol, Lab Immunol & Vasc Biol, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Ctr Mol Biol & Med, Palo Alto, CA 94304 USA; Millennium Pharmaceut Inc, Cambridge, MA 02139 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Butcher, EC (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Lab Immunol & Vasc Biol, Stanford, CA 94305 USA.	ebutcher@stanford.edu		Debes, Gudrun/0000-0003-4208-7362	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290, R01AI072618] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI072618, T32 AI007290, 5 T32 AI07290-21] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BERG EL, 1991, J EXP MED, V174, P1461, DOI 10.1084/jem.174.6.1461; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; Campbell JJ, 1999, NATURE, V400, P776, DOI 10.1038/23495; Cantorna MT, 2005, J RHEUMATOL, V32, P11; Cantorna MT, 2004, AM J CLIN NUTR, V80, p1717S, DOI 10.1093/ajcn/80.6.1717S; Carpenter KJ, 1999, J NUTR, V129, P923, DOI 10.1093/jn/129.5.923; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Eksteen B, 2006, J IMMUNOL, V177, P593, DOI 10.4049/jimmunol.177.1.593; Fritsche J, 2003, BLOOD, V102, P3314, DOI 10.1182/blood-2002-11-3521; Gombert M, 2005, J IMMUNOL, V174, P5082, DOI 10.4049/jimmunol.174.8.5082; Griffin MD, 2001, P NATL ACAD SCI USA, V98, P6800, DOI 10.1073/pnas.121172198; GUO YD, 1993, P NATL ACAD SCI USA, V90, P8668, DOI 10.1073/pnas.90.18.8668; GUPTA VK, 1993, VET IMMUNOL IMMUNOP, V39, P93, DOI 10.1016/0165-2427(93)90168-4; HADDAD JG, 1993, J CLIN INVEST, V91, P2552, DOI 10.1172/JCI116492; Harris SS, 2002, J AM COLL NUTR, V21, P357, DOI 10.1080/07315724.2002.10719235; HOLICK MF, 1980, SCIENCE, V210, P203, DOI 10.1126/science.6251551; Homey B, 2000, J IMMUNOL, V164, P6621, DOI 10.4049/jimmunol.164.12.6621; Homey B, 2002, NAT MED, V8, P157, DOI 10.1038/nm0202-157; Hudak S, 2002, J IMMUNOL, V169, P1189, DOI 10.4049/jimmunol.169.3.1189; ISSEKUTZ TB, 1980, CELL IMMUNOL, V54, P79, DOI 10.1016/0008-8749(80)90191-4; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Iwata M, 2003, INT IMMUNOL, V15, P1017, DOI 10.1093/intimm/dxg101; Kang KF, 1996, J IMMUNOL, V156, P1402; Kunkel EJ, 2003, J CLIN INVEST, V111, P1001, DOI 10.1172/JCI200317244; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; Kupper TS, 2004, NAT REV IMMUNOL, V4, P211, DOI 10.1038/nri1310; Lehmann B, 2000, EXP DERMATOL, V9, P97, DOI 10.1034/j.1600-0625.2000.009002097.x; Lehmann B, 2001, J INVEST DERMATOL, V117, P1179, DOI 10.1046/j.0022-202x.2001.01538.x; LEUNG DYM, 1995, J EXP MED, V181, P747, DOI 10.1084/jem.181.2.747; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; LOMRI A, 1992, P NATL ACAD SCI USA, V89, P4688, DOI 10.1073/pnas.89.10.4688; MACLAUGHLIN JA, 1982, SCIENCE, V216, P1001, DOI 10.1126/science.6281884; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Mathieu C, 2001, J BONE MINER RES, V16, P2057, DOI 10.1359/jbmr.2001.16.11.2057; Mora JR, 2005, J EXP MED, V201, P303, DOI 10.1084/jem.20041645; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Morales J, 1999, P NATL ACAD SCI USA, V96, P14470, DOI 10.1073/pnas.96.25.14470; MULLER G, 1994, J CLIN INVEST, V94, P1799, DOI 10.1172/JCI117528; NEMANIC MK, 1985, BIOCHIM BIOPHYS ACTA, V841, P267, DOI 10.1016/0304-4165(85)90068-6; OHYAMA Y, 1994, J BIOL CHEM, V269, P10545; Pan JL, 2000, J IMMUNOL, V165, P2943, DOI 10.4049/jimmunol.165.6.2943; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; PICKER LJ, 1990, AM J PATHOL, V136, P1053; Piemonti L, 2000, J IMMUNOL, V164, P4443, DOI 10.4049/jimmunol.164.9.4443; Platz EA, 2000, CANCER EPIDEM BIOMAR, V9, P1059; Prosser DE, 2004, TRENDS BIOCHEM SCI, V29, P664, DOI 10.1016/j.tibs.2004.10.005; Quelo I, 1998, J BIOL CHEM, V273, P10638, DOI 10.1074/jbc.273.17.10638; Reiss Y, 2001, J EXP MED, V194, P1541, DOI 10.1084/jem.194.10.1541; Rottman JB, 2001, LAB INVEST, V81, P335, DOI 10.1038/labinvest.3780242; Sallusto F, 2001, CURR OPIN ALLERGY CL, V1, P441, DOI 10.1097/00130832-200110000-00010; Schaerli P, 2004, J EXP MED, V199, P1265, DOI 10.1084/jem.20032177; Sigmundsdottir H, 2004, CLIN IMMUNOL, V111, P119, DOI 10.1016/j.clim.2004.01.003; Soler D, 2003, BLOOD, V101, P1677, DOI 10.1182/blood-2002-07-2348; Stagg AJ, 2002, EUR J IMMUNOL, V32, P1445, DOI 10.1002/1521-4141(200205)32:5<1445::AID-IMMU1445>3.0.CO;2-E; Stoffels K, 2006, J BONE MINER RES, V21, P37, DOI 10.1359/JBMR.050908; van Etten E, 2005, J STEROID BIOCHEM, V97, P93, DOI 10.1016/j.jsbmb.2005.06.002; Vieth R, 1999, AM J CLIN NUTR, V69, P842; WEBB AR, 1988, ANNU REV NUTR, V8, P375, DOI 10.1146/annurev.nu.08.070188.002111; YOUNG AJ, 1997, MANUAL IMMUNOLOGICAL, P2039	59	475	492	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2007	8	3					285	293		10.1038/ni1433	http://dx.doi.org/10.1038/ni1433			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	137EF	17259988				2022-12-18	WOS:000244275100014
J	Schittek, B; Hipfel, R; Sauer, B; Bauer, J; Kalbacher, H; Stevanovic, S; Schirle, M; Schroeder, K; Blin, N; Meier, F; Rassner, G; Garbe, C				Schittek, B; Hipfel, R; Sauer, B; Bauer, J; Kalbacher, H; Stevanovic, S; Schirle, M; Schroeder, K; Blin, N; Meier, F; Rassner, G; Garbe, C			Dermcidin: a novel human antibiotic peptide secreted by sweat glands	NATURE IMMUNOLOGY			English	Article							ANTIMICROBIAL PEPTIDES; HUMAN-SKIN; HUMAN BETA-DEFENSIN-1; TISSUES; IDENTIFICATION; SEPARATION; EXPRESSION; DISORDERS; BINDING; BIOLOGY	Antimicrobial peptides are an important component of the innate response in many species. Here we describe the isolation of the gene Dermcidin, which encodes an antimicrobial peptide that has a broad spectrum of activity and no homology to other known antimicrobial peptides. This protein was specifically and constitutively expressed in the sweat glands, secreted into the sweat and transported to the epidermal surface. In sweat, a proteolytically processed 47-amino acid peptide was generated that showed antimicrobial activity in response to a variety of pathogenic microorganisms. The activity of the peptide was maintained over a broad pH range and in high salt concentrations that resembled the conditions in human sweat. This indicated that sweat plays a role in the regulation of human skin flora through the presence of an antimicrobial peptide. This peptide may help limit infection by potential pathogens in the first few hours following bacterial colonization.	Univ Tubingen, Dept Dermatol, D-72074 Tubingen, Germany; Univ Tubingen, Med & Nat Sci Res Ctr, D-72074 Tubingen, Germany; Univ Tubingen, Inst Cell Biol, Dept Immunol, Tubingen, Germany; Univ Tubingen, Inst Cell Biol, Dept Mol Biol, Tubingen, Germany; Univ Tubingen, Inst Anthropol & Human Genet, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Schittek, B (corresponding author), Univ Tubingen, Dept Dermatol, D-72074 Tubingen, Germany.		Garbe, Claus/ABH-2128-2021; Bauer, Jurgen/B-4656-2008	Garbe, Claus/0000-0001-8530-780X; Bauer, Jurgen/0000-0001-8789-1536; Schittek, Birgit/0000-0003-0081-2001				AHMED AA, 1994, ACTA DERM-VENEREOL, V74, P435; Bals R, 2000, Respir Res, V1, P141, DOI 10.1186/rr25; Cunningham TJ, 1998, J NEUROSCI, V18, P7047; Cunningham TJ, 2000, EXP NEUROL, V163, P457, DOI 10.1006/exnr.2000.7390; DIDIERJEAN L, 1990, Cytokine, V2, P438, DOI 10.1016/1043-4666(90)90053-V; FRAKI JE, 1970, ACTA DERM-VENEREOL, V50, P321; FRAKI JE, 1976, ARCH DERMATOL RES, V255, P317, DOI 10.1007/BF00561502; Frohm M, 1997, J BIOL CHEM, V272, P15258, DOI 10.1074/jbc.272.24.15258; Gallo RL, 1998, J INVEST DERMATOL, V111, P739, DOI 10.1046/j.1523-1747.1998.00361.x; GALLO RL, 1994, P NATL ACAD SCI USA, V91, P11035, DOI 10.1073/pnas.91.23.11035; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Hipfel R, 2000, BRIT J CANCER, V82, P1149; Hipfel R, 1998, J BIOCHEM BIOPH METH, V37, P131, DOI 10.1016/S0165-022X(98)00023-2; JONES AP, 1995, J LEUKOCYTE BIOL, V57, P434, DOI 10.1002/jlb.57.3.434; JONES DE, 1993, FEBS LETT, V315, P187, DOI 10.1016/0014-5793(93)81160-2; MYAL Y, 1991, MOL CELL ENDOCRINOL, V80, P165, DOI 10.1016/0303-7207(91)90153-J; OKADA T, 1988, J INVEST DERMATOL, V90, P648, DOI 10.1111/1523-1747.ep12560807; SATO K, 1989, J AM ACAD DERMATOL, V20, P537, DOI 10.1016/S0190-9622(89)70063-3; SCHAUMBURGLEVER G, 1990, J INVEST DERMATOL, V94, P465, DOI 10.1111/1523-1747.ep12874590; Todorov P, 1996, NATURE, V379, P739, DOI 10.1038/379739a0; Todorov PT, 1997, J BIOL CHEM, V272, P12279, DOI 10.1074/jbc.272.19.12279; Tossi A, 2000, BIOPOLYMERS, V55, P4; Valore EV, 1998, J CLIN INVEST, V101, P1633, DOI 10.1172/JCI1861; Wollina U, 1999, ACTA DERM-VENEREOL, V79, P183	27	471	512	1	73	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2001	2	12					1133	1137		10.1038/ni732	http://dx.doi.org/10.1038/ni732			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	497UE	11694882				2022-12-18	WOS:000172473200015
J	Heneka, MT; Golenbock, DT; Latz, E				Heneka, Michael T.; Golenbock, Douglas T.; Latz, Eicke			Innate immunity in Alzheimer's disease	NATURE IMMUNOLOGY			English	Review							AMYLOID-BETA PEPTIDE; EXACERBATES TAU PATHOLOGY; NITRIC-OXIDE SYNTHASE; COGNITIVE IMPAIRMENT; MOUSE MODEL; PRECURSOR PROTEIN; MICROGLIAL PHAGOCYTOSIS; ANTIINFLAMMATORY DRUGS; MEDIATED INHIBITION; MYD88 DEFICIENCY		[Heneka, Michael T.] Univ Bonn, Dept Neurol, Bonn, Germany; [Heneka, Michael T.; Golenbock, Douglas T.; Latz, Eicke] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA USA; [Heneka, Michael T.; Latz, Eicke] German Ctr Neurodegenerat Dis, Bonn, Germany; [Latz, Eicke] Univ Bonn, Inst Innate Immunol, Bonn, Germany	University of Bonn; University of Massachusetts System; University of Massachusetts Worcester; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn	Heneka, MT (corresponding author), Univ Bonn, Dept Neurol, Bonn, Germany.	michael.heneka@ukb.uni-bonn.de	Latz, Eicke/H-3951-2014; Heneka, Michael/AAE-8011-2019; Heneka, Michael/E-8072-2015	Latz, Eicke/0000-0003-1488-5666; Heneka, Michael/0000-0003-4996-1630	Deutsche Forschungsgemeinschaft (Excellence Cluster ImmunoSensation) [KFO177]; US National Institutes of Health [1R01HL112661]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112661] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (Excellence Cluster ImmunoSensation)(German Research Foundation (DFG)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by the Deutsche Forschungsgemeinschaft (Excellence Cluster ImmunoSensation and KFO177 to E.L. and M.T.H.) and by the US National Institutes of Health (1R01HL112661 to E.L.).	ADOLFSSON R, 1979, BRIT J PSYCHIAT, V135, P216, DOI 10.1192/bjp.135.3.216; Bachstetter AD, 2012, J NEUROSCI, V32, P10201, DOI 10.1523/JNEUROSCI.1496-12.2012; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; Bouchon A, 2001, J EXP MED, V194, P1111, DOI 10.1084/jem.194.8.1111; Bradshaw EM, 2013, NAT NEUROSCI, V16, P848, DOI 10.1038/nn.3435; Breitner JCS, 1996, ANNU REV MED, V47, P401; Cagnin A, 2001, LANCET, V358, P461, DOI 10.1016/S0140-6736(01)05625-2; Cameron B, 2012, J NEUROSCI, V32, P15112, DOI 10.1523/JNEUROSCI.1729-12.2012; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Cho SH, 2011, J BIOL CHEM, V286, P32713, DOI 10.1074/jbc.M111.254268; Cribbs DH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-179; Cumiskey D, 2007, NEUROSCI LETT, V412, P206, DOI 10.1016/j.neulet.2006.11.007; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Epstein EA, 2008, CELL MICROBIOL, V10, P1413, DOI 10.1111/j.1462-5822.2008.01148.x; Frank S, 2008, GLIA, V56, P1438, DOI 10.1002/glia.20710; Ghosh S, 2013, J NEUROSCI, V33, P5053, DOI 10.1523/JNEUROSCI.4361-12.2013; Gorlovoy P, 2009, FASEB J, V23, P2502, DOI 10.1096/fj.08-123877; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Grommes C, 2008, J NEUROIMMUNE PHARM, V3, P130, DOI 10.1007/s11481-007-9090-2; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Hammer ND, 2007, P NATL ACAD SCI USA, V104, P12494, DOI 10.1073/pnas.0703310104; Heneka MT, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-22; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Heneka MT, 2010, P NATL ACAD SCI USA, V107, P6058, DOI 10.1073/pnas.0909586107; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Holmes C, 2009, NEUROLOGY, V73, P768, DOI 10.1212/WNL.0b013e3181b6bb95; Hoshino T, 2011, J NEUROSCI, V31, P5225, DOI 10.1523/JNEUROSCI.5478-10.2011; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Kamer AR, 2008, ALZHEIMERS DEMENT, V4, P242, DOI 10.1016/j.jalz.2007.08.004; Karch CM, 2014, NEURON, V83, P11, DOI 10.1016/j.neuron.2014.05.041; Kitazawa M, 2005, J NEUROSCI, V25, P8843, DOI 10.1523/JNEUROSCI.2868-05.2005; Kumar S, 2012, J BIOL CHEM, V287, P8641, DOI 10.1074/jbc.M111.279133; Kummer MP, 2012, J NEUROSCI, V32, P17824, DOI 10.1523/JNEUROSCI.1504-12.2012; Lajaunias F, 2005, EUR J IMMUNOL, V35, P243, DOI 10.1002/eji.200425273; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lee CYD, 2010, J NEURAL TRANSM, V117, P949, DOI 10.1007/s00702-010-0433-4; Lee M, 2011, J BIOL CHEM, V286, P41230, DOI 10.1074/jbc.M111.270470; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Lemstra AW, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-4; Liang YH, 2001, GENOMICS, V72, P119, DOI 10.1006/geno.2000.6472; Lim JE, 2012, BEHAV BRAIN RES, V227, P36, DOI 10.1016/j.bbr.2011.10.027; Lim JE, 2011, AM J PATHOL, V179, P1095, DOI 10.1016/j.ajpath.2011.05.045; Liu SR, 2012, J IMMUNOL, V188, P1098, DOI 10.4049/jimmunol.1101121; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lynch MA, 2015, BRAIN RES, V1621, P197, DOI 10.1016/j.brainres.2014.08.040; Maezawa I, 2011, J BIOL CHEM, V286, P3693, DOI 10.1074/jbc.M110.135244; Mandrekar-Colucci S, 2012, J NEUROSCI, V32, P10117, DOI 10.1523/JNEUROSCI.5268-11.2012; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Melchior B, 2010, ASN NEURO, V2, P157, DOI 10.1042/AN20100010; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Neniskyte U, 2011, J BIOL CHEM, V286, P39904, DOI 10.1074/jbc.M111.267583; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Pickering M, 2005, EXP PHYSIOL, V90, P663, DOI 10.1113/expphysiol.2005.030734; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Reed-Geaghan EG, 2009, J NEUROSCI, V29, P11982, DOI 10.1523/JNEUROSCI.3158-09.2009; Sastre M, 2003, J NEUROSCI, V23, P9796; Semmler A, 2013, J NEUROL NEUROSUR PS, V84, P62, DOI 10.1136/jnnp-2012-302883; Sheng JG, 2003, NEUROBIOL DIS, V14, P133, DOI 10.1016/S0969-9961(03)00069-X; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Sojkova J, 2011, CURR ALZHEIMER RES, V8, P366, DOI 10.2174/156720511795745375; Stalder M, 1999, AM J PATHOL, V154, P1673, DOI 10.1016/S0002-9440(10)65423-5; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Sy M, 2011, AM J PATHOL, V178, P2811, DOI 10.1016/j.ajpath.2011.02.012; Takata K, 2010, J BIOL CHEM, V285, P40180, DOI 10.1074/jbc.M110.142356; Tamboli IY, 2010, J BIOL CHEM, V285, P37405, DOI 10.1074/jbc.M110.149468; Terwel D, 2011, J NEUROSCI, V31, P7049, DOI 10.1523/JNEUROSCI.6546-10.2011; Tong LQ, 2012, J NEUROSCI, V32, P17714, DOI 10.1523/JNEUROSCI.1253-12.2012; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Vodovotz Y, 1996, J EXP MED, V184, P1425, DOI 10.1084/jem.184.4.1425; vom Berg J, 2012, NAT MED, V18, P1812, DOI 10.1038/nm.2965; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang QW, 2004, J NEUROSCI, V24, P6049, DOI 10.1523/JNEUROSCI.0233-04.2004; Weberpals M, 2009, J NEUROSCI, V29, P14177, DOI 10.1523/JNEUROSCI.3238-09.2009; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Wright AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059586; Yamanaka M, 2012, J NEUROSCI, V32, P17321, DOI 10.1523/JNEUROSCI.1569-12.2012; Yasuno F, 2012, PSYCHIAT RES-NEUROIM, V203, P67, DOI 10.1016/j.pscychresns.2011.08.013; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Youm YH, 2013, CELL METAB, V18, P519, DOI 10.1016/j.cmet.2013.09.010; Yuyama K, 2012, J BIOL CHEM, V287, P10977, DOI 10.1074/jbc.M111.324616; Zhu YY, 2011, J NEUROSCI, V31, P1355, DOI 10.1523/JNEUROSCI.3268-10.2011	88	469	481	3	126	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2015	16	3					229	236		10.1038/ni.3102	http://dx.doi.org/10.1038/ni.3102			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB7XN	25689443				2022-12-18	WOS:000349842100006
J	Toscano, MA; Bianco, GA; Ilarregui, JM; Croci, DO; Correale, J; Hernandez, JD; Zwirner, NW; Poirier, F; Riley, EM; Baum, LG; Rabinovich, GA				Toscano, Marta A.; Bianco, German A.; Ilarregui, Juan M.; Croci, Diego O.; Correale, Jorge; Hernandez, Joseph D.; Zwirner, Norberto W.; Poirier, Francoise; Riley, Eleanor M.; Baum, Linda G.; Rabinovich, Gabriel A.			Differential glycosylation of T(H)1, T(H)2 and T-H-17 effector cells selectively regulates susceptibility to cell death	NATURE IMMUNOLOGY			English	Article							T-HELPER TYPE-1; DENDRITIC CELLS; CHRONIC INFLAMMATION; GENE-EXPRESSION; N-GLYCANS; GALECTIN-1; TH1; DISTINCT; SIGNALS; LINEAGE	Regulated glycosylation controls T cell processes, including activation, differentiation and homing by creating or masking ligands for endogenous lectins. Here we show that stimuli promoting T helper type 1 (T(H)1), T(H)2 or interleukin 17-producing T helper (T-H-17) differentiation can differentially regulate the glycosylation pattern of T helper cells and modulate their susceptibility to galectin-1, a glycan-binding protein with anti-inflammatory activity. Although T(H)1- and T-H-17-differentiated cells expressed the repertoire of cell surface glycans critical for galectin-1-induced cell death, T(H)2 cells were protected from galectin-1 through differential sialylation of cell surface glycoproteins. Consistent with those findings, galectin-1-deficient mice developed greater T(H)1 and T-H-17 responses and enhanced susceptibility to autoimmune neuroinflammation. Our findings identify a molecular link among differential glycosylation of T helper cells, susceptibility to cell death and termination of the inflammatory response.	Inst Invest Neurol Dr Raul Carrea, Dept Neurol, RA-1428 Buenos Aires, DF, Argentina; Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; Univ Paris 06, Inst Jacques Monod, UMR 7592, CNRS, F-75251 Paris, France; Univ Paris 07, F-75251 Paris, France; Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Univ Buenos Aires, Fac Med, Div Immunogenet, Hosp Clin Jose San Martin, RA-1120 Buenos Aires, DF, Argentina	University of California System; University of California Los Angeles; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of London; London School of Hygiene & Tropical Medicine; University of Buenos Aires; Hospital de Clinicas Jose de San Martin	Rabinovich, GA (corresponding author), Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, RA-1428 Buenos Aires, DF, Argentina.	gabyrabi@ciudad.com.ar	Correale, Jorge/AAG-4245-2020; Riley, Eleanor/AAL-1382-2020; Zwirner, Norberto/AAI-8961-2020; Croci, Diego/AAJ-5709-2021; Toscano, Marta/HGU-4103-2022	Riley, Eleanor/0000-0003-3447-3570; Croci, Diego/0000-0002-8623-0645; Ilarregui, Juan Martin/0000-0002-6871-6764; Zwirner, Norberto/0000-0001-7098-359X; Toscano, Marta/0000-0003-0502-8929	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Blaser C, 1998, EUR J IMMUNOL, V28, P2311, DOI 10.1002/(SICI)1521-4141(199808)28:08<2311::AID-IMMU2311>3.0.CO;2-G; Brennan PJ, 2006, INT IMMUNOL, V18, P627, DOI 10.1093/intimm/dxh344; Cervi L, 2004, J IMMUNOL, V172, P2016, DOI 10.4049/jimmunol.172.4.2016; Chen GY, 2006, P NATL ACAD SCI USA, V103, P16894, DOI 10.1073/pnas.0607926103; Chui D, 2001, P NATL ACAD SCI USA, V98, P1142, DOI 10.1073/pnas.98.3.1142; Coffman RL, 2006, NAT IMMUNOL, V7, P539, DOI 10.1038/ni0606-539; Comelli EM, 2006, J IMMUNOL, V177, P2431, DOI 10.4049/jimmunol.177.4.2431; Daniels MA, 2002, NAT IMMUNOL, V3, P903, DOI 10.1038/ni1002-903; Daniels MA, 2001, IMMUNITY, V15, P1051, DOI 10.1016/S1074-7613(01)00252-7; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Gabius HJ, 2006, CRIT REV IMMUNOL, V26, P43, DOI 10.1615/CritRevImmunol.v26.i1.30; Galvan M, 2000, J BIOL CHEM, V275, P16730, DOI 10.1074/jbc.M001117200; Garin MI, 2007, BLOOD, V109, P2058, DOI 10.1182/blood-2006-04-016451; Glimcher LH, 2000, GENE DEV, V14, P1693; Grabie N, 2002, EUR J IMMUNOL, V32, P2766, DOI 10.1002/1521-4141(2002010)32:10<2766::AID-IMMU2766>3.0.CO;2-0; Hannier S, 2002, J IMMUNOL, V169, P1904, DOI 10.4049/jimmunol.169.4.1904; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jenner J, 2006, EXP HEMATOL, V34, P1212, DOI 10.1016/j.exphem.2006.04.016; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Lim YC, 2001, J IMMUNOL, V167, P4476, DOI 10.4049/jimmunol.167.8.4476; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mitoma J, 2007, NAT IMMUNOL, V8, P409, DOI 10.1038/ni1442; Morgan R, 2004, J IMMUNOL, V173, P7200, DOI 10.4049/jimmunol.173.12.7200; OFFNER H, 1990, J NEUROIMMUNOL, V28, P177, DOI 10.1016/0165-5728(90)90032-I; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; POIRIER F, 1993, DEVELOPMENT, V119, P1229; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; Pulendran B, 2004, IMMUNOL RES, V29, P187, DOI 10.1385/IR:29:1-3:187; Rabinovich G, 1999, J EXP MED, V190, P385, DOI 10.1084/jem.190.3.385; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; Rubinstein N, 2004, CANCER CELL, V5, P241, DOI 10.1016/S1535-6108(04)00024-8; Santucci L, 2003, GASTROENTEROLOGY, V124, P1381, DOI 10.1016/S0016-5085(03)00267-1; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Stowell SR, 2004, GLYCOBIOLOGY, V14, P157, DOI 10.1093/glycob/cwh018; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Underhill GH, 2005, BLOOD, V106, P3867, DOI 10.1182/blood-2005-03-0984; van der Leij J, 2007, MOL IMMUNOL, V44, P506, DOI 10.1016/j.molimm.2006.02.011; van Vliet SJ, 2006, NAT IMMUNOL, V7, P1200, DOI 10.1038/ni1390; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Vespa GNR, 1999, J IMMUNOL, V162, P799; Zhang XH, 1997, J EXP MED, V185, P1837, DOI 10.1084/jem.185.10.1837; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	52	467	501	4	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2007	8	8					825	834		10.1038/ni1482	http://dx.doi.org/10.1038/ni1482			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	191ZB	17589510				2022-12-18	WOS:000248169400010
J	DeYoung, BJ; Innes, RW				DeYoung, Brody J.; Innes, Roger W.			Plant NBS-LRR proteins in pathogen sensing and host defense	NATURE IMMUNOLOGY			English	Review							LEUCINE-RICH REPEAT; DISEASE RESISTANCE GENE; NUCLEOTIDE-BINDING SITE; FLAX RUST RESISTANCE; BACTERIAL SPECK DISEASE; OF-FUNCTION MUTATION; MOLECULAR-BASIS; CELL-DEATH; ARABIDOPSIS-THALIANA; CASPASE-9 ACTIVATION	Plant proteins belonging to the nucleotide-binding site-leucine-rich repeat (NBS-LRR) family are used for pathogen detection. Like the mammalian Nod-LRR protein 'sensors' that detect intracellular conserved pathogen-associated molecular patterns, plant NBS-LRR proteins detect pathogen-associated proteins, most often the effector molecules of pathogens responsible for virulence. Many virulence proteins are detected indirectly by plant NBS-LRR proteins from modifications the virulence proteins inflict on host target proteins. However, some NBS-LRR proteins directly bind pathogen proteins. Association with either a modified host protein or a pathogen protein leads to conformational changes in the amino-terminal and LRR domains of plant NBS-LRR proteins. Such conformational alterations are thought to promote the exchange of ADP for ATP by the NBS domain, which activates 'downstream' signaling, by an unknown mechanism, leading to pathogen resistance.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Innes, RW (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	rinnes@indiana.edu	Innes, Roger/A-5244-2010	Innes, Roger/0000-0001-9634-1413	NIGMS NIH HHS [R01 GM046451, GM046451] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046451, R29GM046451] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Albrecht M, 2006, BIOCHEM BIOPH RES CO, V339, P459, DOI 10.1016/j.bbrc.2005.10.074; Anderson PA, 1997, PLANT CELL, V9, P641, DOI 10.1105/tpc.9.4.641; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Ayliffe MA, 1999, PLANT J, V17, P287, DOI 10.1046/j.1365-313X.1999.00377.x; Belkhadir Y, 2004, PLANT CELL, V16, P2822, DOI 10.1105/tpc.104.024117; Bendahmane A, 2002, PLANT J, V32, P195, DOI 10.1046/j.1365-313X.2002.01413.x; BENT AF, 1994, SCIENCE, V265, P1856, DOI 10.1126/science.8091210; Bryan GT, 2000, PLANT CELL, V12, P2033, DOI 10.1105/tpc.12.11.2033; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Coaker G, 2005, SCIENCE, V308, P548, DOI 10.1126/science.1108633; Day B, 2005, PLANT CELL, V17, P1292, DOI 10.1105/tpc.104.030163; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Deslandes L, 2002, P NATL ACAD SCI USA, V99, P2404, DOI 10.1073/pnas.032485099; Dinesh-Kumar SP, 2000, P NATL ACAD SCI USA, V97, P1908, DOI 10.1073/pnas.020367497; Dodds PN, 2006, P NATL ACAD SCI USA, V103, P8888, DOI 10.1073/pnas.0602577103; Ellis JG, 1999, PLANT CELL, V11, P495, DOI 10.1105/tpc.11.3.495; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Howles P, 2005, MOL PLANT MICROBE IN, V18, P570, DOI 10.1094/MPMI-18-0570; Hu YM, 1999, EMBO J, V18, P3586, DOI 10.1093/emboj/18.13.3586; Hwang CF, 2000, PLANT CELL, V12, P1319, DOI 10.1105/tpc.12.8.1319; Hwang CF, 2003, PLANT J, V34, P585, DOI 10.1046/j.1365-313X.2003.01749.x; INNES RW, 1993, J BACTERIOL, V175, P4859, DOI 10.1128/JB.175.15.4859-4869.1993; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; Kim HS, 2005, P NATL ACAD SCI USA, V102, P6496, DOI 10.1073/pnas.0500792102; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; LAWRENCE GJ, 1995, PLANT CELL, V7, P1195, DOI 10.1105/tpc.7.8.1195; Leister D, 1998, P NATL ACAD SCI USA, V95, P370, DOI 10.1073/pnas.95.1.370; Leister RT, 2005, PLANT CELL, V17, P1268, DOI 10.1105/tpc.104.029637; Lim MTS, 2004, PLANT J, V40, P790, DOI 10.1111/j.1365-313X.2004.02251.x; Luck JE, 2000, PLANT CELL, V12, P1367, DOI 10.1105/tpc.12.8.1367; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; Mestre P, 2006, PLANT CELL, V18, P491, DOI 10.1105/tpc.105.037234; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.t01-1-00606.x; Michelmore RW, 1998, GENOME RES, V8, P1113, DOI 10.1101/gr.8.11.1113; MINDRINOS M, 1994, CELL, V78, P1089, DOI 10.1016/0092-8674(94)90282-8; Moffett P, 2002, EMBO J, V21, P4511, DOI 10.1093/emboj/cdf453; Mucyn TS, 2006, PLANT CELL, V18, P2792, DOI 10.1105/tpc.106.044016; Pan QL, 2000, J MOL EVOL, V50, P203, DOI 10.1007/s002399910023; Parker JE, 1997, PLANT CELL, V9, P879, DOI 10.1105/tpc.9.6.879; Pedley KF, 2003, ANNU REV PHYTOPATHOL, V41, P215, DOI 10.1146/annurev.phyto.41.121602.143032; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rairdan GJ, 2006, PLANT CELL, V18, P2082, DOI 10.1105/tpc.106.042747; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; SALMERON JM, 1994, PLANT CELL, V6, P511, DOI 10.1105/tpc.6.4.511; Salmeron JM, 1996, CELL, V86, P123, DOI 10.1016/S0092-8674(00)80083-5; Schreiber S, 2005, NAT REV GENET, V6, P376, DOI 10.1038/nrg1607; Scofield SR, 1996, SCIENCE, V274, P2063, DOI 10.1126/science.274.5295.2063; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; Shirano Y, 2002, PLANT CELL, V14, P3149, DOI 10.1105/tpc.005348; SIMONICH MT, 1995, MOL PLANT MICROBE IN, V8, P637, DOI 10.1094/MPMI-8-0637; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Swiderski MR, 2001, PLANT J, V26, P101, DOI 10.1046/j.1365-313x.2001.01014.x; Takken FLW, 2006, CURR OPIN PLANT BIOL, V9, P383, DOI 10.1016/j.pbi.2006.05.009; Tameling WIL, 2002, PLANT CELL, V14, P2929, DOI 10.1105/tpc.005793; Tameling WIL, 2006, PLANT PHYSIOL, V140, P1233, DOI 10.1104/pp.105.073510; Tanabe T, 2004, EMBO J, V23, P1587, DOI 10.1038/sj.emboj.7600175; Tang XY, 1996, SCIENCE, V274, P2060, DOI 10.1126/science.274.5295.2060; Tao X, 2002, BIOCHEM BIOPH RES CO, V299, P216, DOI 10.1016/S0006-291X(02)02581-0; Tao Y, 2000, PLANT CELL, V12, P2541, DOI 10.1105/tpc.12.12.2541; Tornero P, 2002, PLANT CELL, V14, P435, DOI 10.1105/tpc.010393; van Bentem SDF, 2005, PLANT J, V43, P284, DOI 10.1111/j.1365-313X.2005.02450.x; van der Biezen EA, 1998, CURR BIOL, V8, pR226, DOI 10.1016/S0960-9822(98)70145-9; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; Warren RF, 1998, PLANT CELL, V10, P1439, DOI 10.1105/tpc.10.9.1439; Weaver LM, 2006, PLANT J, V47, P829, DOI 10.1111/j.1365-313X.2006.02834.x; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yan N, 2005, NATURE, V437, P831, DOI 10.1038/nature04002; Zhang YL, 2003, PLANT CELL, V15, P2636, DOI 10.1105/tpc.015842	76	467	492	4	105	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2006	7	12					1243	1249		10.1038/ni1410	http://dx.doi.org/10.1038/ni1410			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	106TU	17110940	Green Accepted			2022-12-18	WOS:000242125200003
J	Sun, JC; Williams, MA; Bevan, MJ				Sun, JC; Williams, MA; Bevan, MJ			CD4(+) T cells are required for the maintenance, not programming, of memory CD8(+) T cells after acute infection	NATURE IMMUNOLOGY			English	Article							CUTTING EDGE; HOMEOSTATIC PROLIFERATION; SELECTIVE EXPRESSION; INTERLEUKIN (IL)-7; CD40 EXPRESSION; GENERATION; RECEPTOR; NAIVE; HELP; IL-15	Immunization in the absence of CD4(+) T cell help results in defective CD8(+) T cell memory, deficient recall responses and diminished protective immunity. Here we investigated at what stage during the immune response to pathogen CD4(+) T cells are essential in the promotion of functional CD8(+) T cell memory. Memory CD8(+) T cell numbers decreased gradually in the absence of CD4(+) T cells despite the presence of similar numbers of memory cell precursors at the peak of the effector phase. Adoptive transfer of effector or memory CD8(+) T cells into wild-type or CD4(+) T cell-deficient mice demonstrated that the presence of CD4(+) T cells was important only after, not during, the early CD8(+) T cell programming phase. In the absence of CD4(+) T cells, memory CD8(+) T cells became functionally impaired and decreased in quantity over time. We conclude that in the context of an acute infection, CD4(+) T cells are required only during the maintenance phase of long-lived memory CD8(+) T cells.	Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Bevan, MJ (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	mbevan@u.washington.edu		Williams, Matthew/0000-0002-4721-4482	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [T32 CA009537, CA09537] Funding Source: Medline; NIAID NIH HHS [AI056809, AI19335, R01 AI019335-19, R01 AI019335, F32 AI056809, F32 AI056809-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019335, F32AI056809, R37AI019335] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; Belz GT, 2002, J VIROL, V76, P12388, DOI 10.1128/JVI.76.23.12388-12393.2002; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bevan MJ, 2001, NAT IMMUNOL, V2, P381, DOI 10.1038/87676; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Burkett PR, 2003, P NATL ACAD SCI USA, V100, P4724, DOI 10.1073/pnas.0737048100; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Huster KM, 2004, P NATL ACAD SCI USA, V101, P5610, DOI 10.1073/pnas.0308054101; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Judge AD, 2002, J EXP MED, V196, P935, DOI 10.1084/jem.20020772; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Khanolkar A, 2004, J IMMUNOL, V172, P2834, DOI 10.4049/jimmunol.172.5.2834; Kieper WC, 2002, J EXP MED, V195, P1533, DOI 10.1084/jem.20020067; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Lanzavecchia A, 1998, NATURE, V393, P413, DOI 10.1038/30845; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Lee BO, 2003, J EXP MED, V198, P1759, DOI 10.1084/jem.20031440; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Marrack P, 2004, ANNU REV IMMUNOL, V22, P765, DOI 10.1146/annurev.immunol.22.012703.104554; Masopust D, 2004, CURR OPIN IMMUNOL, V16, P217, DOI 10.1016/j.coi.2004.02.005; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Prlic M, 2002, J EXP MED, V195, pF49, DOI 10.1084/jem.20020767; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Schluns KS, 2004, P NATL ACAD SCI USA, V101, P5616, DOI 10.1073/pnas.0307442101; Schluns KS, 2004, BLOOD, V103, P988, DOI 10.1182/blood-2003-08-2814; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Schluns KS, 2002, J IMMUNOL, V168, P4827, DOI 10.4049/jimmunol.168.10.4827; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; SHEN H, 1995, P NATL ACAD SCI USA, V92, P3987, DOI 10.1073/pnas.92.9.3987; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Sun JC, 2004, J IMMUNOL, V172, P3385, DOI 10.4049/jimmunol.172.6.3385; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Tanchot C, 2003, NAT IMMUNOL, V4, P431, DOI 10.1038/ni0503-431; van Stipdonk MJB, 2003, NAT IMMUNOL, V4, P361, DOI 10.1038/ni912; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Wang JCE, 2003, J IMMUNOL, V171, P6339, DOI 10.4049/jimmunol.171.12.6339	46	467	480	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2004	5	9					927	933		10.1038/ni1105	http://dx.doi.org/10.1038/ni1105			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	850LI	15300249	Green Accepted			2022-12-18	WOS:000223612500021
J	Wald, D; Qin, JZ; Zhao, ZD; Qian, YC; Naramura, M; Tian, LP; Towne, J; Sims, JE; Stark, GR; Li, XX				Wald, D; Qin, JZ; Zhao, ZD; Qian, YC; Naramura, M; Tian, LP; Towne, J; Sims, JE; Stark, GR; Li, XX			SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; CUTTING EDGE; IRAK; ACTIVATION; MEMBRANE; KINASE; MYD88; LIPOPOLYSACCHARIDE; RECOGNITION; ADAPTER	The Toll-like receptor-interleukin 1 receptor signaling (TLR-IL-1R) receptor superfamily is important in differentially recognizing pathogen products and eliciting appropriate immune responses. These receptors alter gene expression, mainly through the activation of nuclear factor-kappaB and activating protein 1. SIGIRR (single immunoglobulin IL-1R-related molecule), a member of this family that does not activate these factors, instead negatively modulates immune responses. Inflammation is enhanced in SIGIRR-deficient mice, as shown by their enhanced chemokine induction after IL-1 injection and reduced threshold for lethal endotoxin challenge. Cells from SIGIRR-deficient mice showed enhanced activation in response to either IL-1 or certain Toll ligands. Finally, biochemical analysis indicated that SIGIRR binds to the TLR-IL-1R signaling components in a ligand-dependent way. Our data show that SIGIRR functions as a biologically important modulator of TLR-IL-1R signaling.	Cleveland Clin Fdn, Dept Immunol, Cleveland, OH 44195 USA; Amgen Corp, Seattle, WA 98101 USA	Cleveland Clinic Foundation	Li, XX (corresponding author), Cleveland Clin Fdn, Dept Immunol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	lix@ccf.org	Eckhardt, Erik/G-1567-2010	Naramura, Mayumi/0000-0003-3658-0767; Sims, John/0000-0002-5667-9185	NIGMS NIH HHS [GM 600020] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akira S, 2000, CURR OPIN IMMUNOL, V12, P59, DOI 10.1016/S0952-7915(99)00051-5; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Ardizzone S, 2002, J INTERN MED, V252, P475, DOI 10.1046/j.1365-2796.2002.01067.x; Bingham CO, 2002, J RHEUMATOL, V29, P3; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; DINARELLO CA, 1984, REV INFECT DIS, V6, P51, DOI 10.1016/S1359-6101(97)00023-3; DUNNE A, 2003, SCI STKE, pRE3, DOI DOI 10.1126/STKE.2003.171.RE3; Glauser MP, 2000, CRIT CARE MED, V28, pS4, DOI 10.1097/00003246-200009001-00002; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoshino K, 1999, J IMMUNOL, V162, P3749; Imler JL, 2003, NAT IMMUNOL, V4, P105, DOI 10.1038/ni0203-105; Janssens S, 2002, CURR BIOL, V12, P467, DOI 10.1016/S0960-9822(02)00712-1; Jiang ZF, 2003, J BIOL CHEM, V278, P10952, DOI 10.1074/jbc.M212112200; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Jiang ZF, 2003, J BIOL CHEM, V278, P16713, DOI 10.1074/jbc.M300562200; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; MITCHELL T, 1995, J VIROL, V69, P2968, DOI 10.1128/JVI.69.5.2968-2976.1995; MOSLEY B, 1989, CELL, V59, P335, DOI 10.1016/0092-8674(89)90295-X; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Neumann D, 2000, J IMMUNOL, V165, P3350, DOI 10.4049/jimmunol.165.6.3350; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Penton-Rol G, 1999, J IMMUNOL, V162, P2931; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Saccani S, 1998, CYTOKINE, V10, P773, DOI 10.1006/cyto.1998.0359; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Thomassen E, 1999, CYTOKINE, V11, P389, DOI 10.1006/cyto.1998.0452; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668	36	467	499	0	33	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2003	4	9					920	927		10.1038/ni968	http://dx.doi.org/10.1038/ni968			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	715YN	12925853				2022-12-18	WOS:000185002200020
J	Vallabhapurapu, S; Matsuzawa, A; Zhang, WZ; Tseng, PH; Keats, JJ; Wang, HP; Vignali, DAA; Bergsagel, PL; Karin, M				Vallabhapurapu, Sivakumar; Matsuzawa, Atsushi; Zhang, WeiZhou; Tseng, Ping-Hui; Keats, Jonathan J.; Wang, Haopeng; Vignali, Dario A. A.; Bergsagel, P. Leif; Karin, Michael			Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappa B signaling	NATURE IMMUNOLOGY			English	Article							CELL-DEATH; MULTIPLE-MYELOMA; NF-KAPPA-B2 P100; CRITICAL ROLES; IMMUNE-SYSTEM; RECEPTOR; TNF; KINASE; ALPHA; CD40	The adaptor and signaling proteins TRAF2, TRAF3, cIAP1 and cIAP2 may inhibit alternative nuclear factor-kappa B (NF-kappa B) signaling in resting cells by targeting NF-kappa B-inducing kinase (NIK) for ubiquitin-dependent degradation, thus preventing processing of the NF-kappa B2 precursor protein p100 to release p52. However, the respective functions of TRAF2 and TRAF3 in NIK degradation and activation of alternative NF-kappa B signaling have remained elusive. We now show that CD40 or BAFF receptor activation result in TRAF3 degradation in a cIAP1-cIAP2- and TRAF2-dependent way owing to enhanced cIAP1, cIAP2 TRAF3-directed ubiquitin ligase activity. Receptor-induced activation of cIAP1 and cIAP2 correlated with their K63-linked ubiquitination by TRAF2. Degradation of TRAF3 prevented association of NIK with the cIAP1-cIAP2-TRAF2 ubiquitin ligase complex, which resulted in NIK stabilization and NF-kappa B2-p100 processing. Constitutive activation of this pathway causes perinatal lethality and lymphoid defects.	[Vallabhapurapu, Sivakumar; Matsuzawa, Atsushi; Zhang, WeiZhou; Tseng, Ping-Hui; Karin, Michael] Univ Calif San Diego, Ctr Canc, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, San Diego, CA 93093 USA; [Vallabhapurapu, Sivakumar; Matsuzawa, Atsushi; Zhang, WeiZhou; Tseng, Ping-Hui; Karin, Michael] Univ Calif San Diego, Ctr Canc, Dept Pathol, Lab Gene Regulat & Signal Transduct, San Diego, CA 93093 USA; [Keats, Jonathan J.; Bergsagel, P. Leif] Mayo Clin Arizona, Ctr Comprehens Canc, Scottsdale, AZ 85259 USA; [Wang, Haopeng; Vignali, Dario A. A.] St Jude Childrens Hosp, Dept Immunol, Memphis, TN 38105 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Mayo Clinic; Mayo Clinic Phoenix; St Jude Children's Research Hospital	Karin, M (corresponding author), Univ Calif San Diego, Ctr Canc, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, San Diego, CA 93093 USA.	karinoffice@ucsd.edu	Bergsagel, Peter Leif/A-7842-2011; Wang, Haopeng/F-3263-2012; Matsuzawa, Atsushi/GLU-1387-2022	Bergsagel, Peter Leif/0000-0003-1523-7388; Matsuzawa, Atsushi/0000-0001-8303-3905; Keats, Jonathan/0000-0003-4375-7399; Wang, Haopeng/0000-0002-4995-0838	NCI NIH HHS [P50 CA100707-070008, R01 CA118165-02, R01 CA133966-01A2, P50 CA100707, R01 CA136671, R01 CA118165, R01 CA136671-01, R01 CA133966] Funding Source: Medline; NIAID NIH HHS [R01 AI043477-12, R01 AI043477] Funding Source: Medline; NIA NIH HHS [R01 AG020686-05, R01 AG020686] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA100707, R01CA118165, R01CA133966, R01CA136671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020686] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Ben-Neriah Y, 2002, NAT IMMUNOL, V3, P20, DOI 10.1038/ni0102-20; Bishop GA, 2004, NAT REV IMMUNOL, V4, P775, DOI 10.1038/nri1462; Brown KD, 2001, J EXP MED, V193, P943, DOI 10.1084/jem.193.8.943; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Chen ZJ, 2006, CELL DEATH DIFFER, V13, P687, DOI 10.1038/sj.cdd.4401869; Chung JY, 2002, J CELL SCI, V115, P679; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Cohen J J, 1992, Semin Immunol, V4, P363; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Derudder E, 2003, J BIOL CHEM, V278, P23278, DOI 10.1074/jbc.M300106200; DINARELLO CA, 1987, NEW ENGL J MED, V317, P940, DOI 10.1056/NEJM198710083171506; Enzler T, 2006, IMMUNITY, V25, P403, DOI 10.1016/j.immuni.2006.07.010; Fong A, 2002, J BIOL CHEM, V277, P22111, DOI 10.1074/jbc.C200151200; Gallagher E, 2007, NAT IMMUNOL, V8, P57, DOI 10.1038/ni1421; Gardam S, 2008, IMMUNITY, V28, P391, DOI 10.1016/j.immuni.2008.01.009; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Grech AP, 2004, IMMUNITY, V21, P629, DOI 10.1016/j.immuni.2004.09.011; Gurova KV, 2004, CANCER RES, V64, P1951, DOI 10.1158/0008-5472.CAN-03-1541; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; He JQ, 2007, J BIOL CHEM, V282, P3688, DOI 10.1074/jbc.M610271200; He JQ, 2006, J EXP MED, V203, P2413, DOI 10.1084/jem.20061166; Hu SM, 2003, J BIOL CHEM, V278, P10055, DOI 10.1074/jbc.M207197200; Igarashi H, 2005, INT IMMUNOL, V17, P501, DOI 10.1093/intimm/dxh230; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Matsuzawa A, 2008, SCIENCE, V321, P663, DOI 10.1126/science.1157340; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shi CS, 2003, J BIOL CHEM, V278, P15429, DOI 10.1074/jbc.M211796200; Sivakumar V, 2003, J EXP MED, V197, P1613, DOI 10.1084/jem.20022234; Tada K, 2001, J BIOL CHEM, V276, P36530, DOI 10.1074/jbc.M104837200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Xie P, 2007, IMMUNITY, V27, P253, DOI 10.1016/j.immuni.2007.07.012; Xu Y, 1996, IMMUNITY, V5, P407, DOI 10.1016/S1074-7613(00)80497-5; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Yilmaz ZB, 2003, EMBO J, V22, P121, DOI 10.1093/emboj/cdg004	49	466	481	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2008	9	12					1364	1370		10.1038/ni.1678	http://dx.doi.org/10.1038/ni.1678			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	372FY	18997792	Green Accepted			2022-12-18	WOS:000260888700011
J	El Kasmi, KC; Qualls, JE; Pesce, JT; Smith, AM; Thompson, RW; Henao-Tamayo, M; Basaraba, RJ; Konig, T; Schleicher, U; Koo, MS; Kaplan, G; Fitzgerald, KA; Tuomanen, EI; Orme, IM; Kanneganti, TD; Bogdan, C; Wynn, TA; Murray, PJ				El Kasmi, Karim C.; Qualls, Joseph E.; Pesce, John T.; Smith, Amber M.; Thompson, Robert W.; Henao-Tamayo, Marcela; Basaraba, Randall J.; Koenig, Till; Schleicher, Ulrike; Koo, Mi-Sun; Kaplan, Gilla; Fitzgerald, Katherine A.; Tuomanen, Elaine I.; Orme, Ian M.; Kanneganti, Thirumala-Devi; Bogdan, Christian; Wynn, Thomas A.; Murray, Peter J.			Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens	NATURE IMMUNOLOGY			English	Article							NITRIC-OXIDE SYNTHASE; L-ARGININE METABOLISM; MYCOBACTERIUM-TUBERCULOSIS; HELICOBACTER-PYLORI; MURINE MACROPHAGES; PULMONARY TUBERCULOSIS; TOXOPLASMA-GONDII; CUTTING EDGE; INFECTION; EXPRESSION	Toll-like receptor (TLR) signaling in macrophages is required for antipathogen responses, including the biosynthesis of nitric oxide from arginine, and is essential for immunity to Mycobacterium tuberculosis, Toxoplasma gondii and other intracellular pathogens. Here we report a 'loophole' in the TLR pathway that is advantageous to these pathogens. Intracellular pathogens induced expression of the arginine hydrolytic enzyme arginase 1 (Arg1) in mouse macrophages through the TLR pathway. In contrast to diseases dominated by T helper type 2 responses in which Arg1 expression is greatly increased by interleukin 4 and 13 signaling through the transcription factor STAT6, TLR-mediated Arg1 induction was independent of the STAT6 pathway. Specific elimination of Arg1 in macrophages favored host survival during T. gondii infection and decreased lung bacterial load during tuberculosis infection.	[El Kasmi, Karim C.; Qualls, Joseph E.; Smith, Amber M.; Kanneganti, Thirumala-Devi; Murray, Peter J.] St Jude Childrens Hosp, Dept Immunol, Memphis, TN 38015 USA; [Pesce, John T.; Thompson, Robert W.; Wynn, Thomas A.] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Henao-Tamayo, Marcela; Basaraba, Randall J.; Orme, Ian M.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Koenig, Till] Univ Clin Freiburg, Inst Med Microbiol & Hyg, Dept Microbiol & Hyg, D-79104 Freiburg, Germany; [Koenig, Till] Univ Clin Erlangen, Inst Clin Microbiol Immunol & Hyg, D-91054 Erlangen, Germany; [Koo, Mi-Sun; Kaplan, Gilla] Univ Med & Dent New Jersey, Publ Hlth Res Inst Ctr, Lab Mycobacterial Immun & Pathogenesis, Newark, NJ 07103 USA; [Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Immunol & Infect Dis, Worcester, MA 01605 USA; [El Kasmi, Karim C.; Qualls, Joseph E.; Smith, Amber M.; Murray, Peter J.] St Jude Childrens Hosp, Dept Infect Dis, Memphis, TN 38015 USA	St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Colorado State University; University of Freiburg; University of Erlangen Nuremberg; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Massachusetts System; University of Massachusetts Worcester; St Jude Children's Research Hospital	Murray, PJ (corresponding author), Univ Colorado Denver, Dept Pediat, Div Gastroenterol & Hepatol, Anschutz Med Campus, Aurora, CO 80045 USA.	twynn@niaid.nih.gov; peter.murray@stjude.org	Henao-Tamayo, Marcela/D-8189-2017; Wynn, Thomas A/AAO-3523-2021; Kanneganti, Thirumala-Devi/M-9435-2018; Kanneganti, Thirumala-Devi/Y-2503-2019; Fitzgerald, Katherine/ABE-6317-2020; Murray, Peter J/K-4725-2018; Wynn, Thomas A/C-2797-2011; Tuomanen, Elaine I/N-3081-2018	Henao-Tamayo, Marcela/0000-0002-4249-9650; Wynn, Thomas A/0000-0002-7244-8731; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Murray, Peter J/0000-0001-6329-9802; Tuomanen, Elaine I/0000-0003-0349-8716; Fitzgerald, Kate/0000-0003-3175-609X; Qualls, Joseph/0000-0002-0113-2166; Bogdan, Christian/0000-0002-2300-0631	Sandler Program for Asthma Research; National Institutes of Health [AI062921, AI27913, AI66046]; CORE [P30 CA21765]; NIAID; German Research Foundation; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000829, R01AI062921, R01AI027913, R01AI066046] Funding Source: NIH RePORTER	Sandler Program for Asthma Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CORE(Luxembourg National Research Fund); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); German Research Foundation(German Research Foundation (DFG)); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank I. Forster (Technical University of Munich) for the LysMcre mice; M. Yanagisawa (University of Texas Southwestern) for the Tie2cre mice; P. Ney (St. Jude Children's Research Hospital) for the CMV-cre mice; D. Green (St. Jude Children's Research Hospital) and S. Akira (Osaka University) for the MyD88-deficient mice; S. Morris (University of Pittsburgh) for the antibodies to Arg1; C. Nathan (Weill Medical School of Cornell University) for the antibody to iNOS; S. Smale (University of California, Los Angeles) for the insulated reporter constructs; D. Bush for nitrotyrosine staining of BCG-infected livers; Xenogen for construction of luciferase-bearing pneumococci; Ozgene for microinjection of the targeted Bruce4 cells into C57BL/6 blastocysts and chimera generation; A. DeFreitas for technical assistance; B. Schulman for discussions and generation of Supplementary Figure 6b; and M. Koyanagi and M. Bix for discussion and preliminary infection experiments. Supported by the Sandler Program for Asthma Research (P.J.M.), the National Institutes of Health (AI062921 to P.J.M.; AI27913 to E. I. T.; AI66046 to G. K.; CORE grant P30 CA21765 and the NIAID intramural research program to T. A. W.), the German Research Foundation (SFB620 project A9 to C. B. and U. S.) and the American Lebanese Syrian Associated Charities.	Albina JE, 2005, SHOCK, V23, P168, DOI 10.1097/01.shk.0000148054.74268.e2; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Bussiere FI, 2005, J BIOL CHEM, V280, P2409, DOI 10.1074/jbc.C400498200; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Choi HS, 2002, AM J RESP CRIT CARE, V166, P178, DOI 10.1164/rccm.2201023; Cooper AM, 2000, INFECT IMMUN, V68, P6879, DOI 10.1128/IAI.68.12.6879-6882.2000; Davis AS, 2007, PLOS PATHOG, V3, P1887, DOI 10.1371/journal.ppat.0030186; Di Costanzo L, 2005, P NATL ACAD SCI USA, V102, P13058, DOI 10.1073/pnas.0504027102; El-Gayar S, 2003, J IMMUNOL, V171, P4561, DOI 10.4049/jimmunol.171.9.4561; Gaur U, 2007, J IMMUNOL, V179, P8446, DOI 10.4049/jimmunol.179.12.8446; Gingras S, 2004, J BIOL CHEM, V279, P54702, DOI 10.1074/jbc.M411043200; Gobert AP, 2002, J IMMUNOL, V168, P4692, DOI 10.4049/jimmunol.168.9.4692; Gobert AP, 2001, P NATL ACAD SCI USA, V98, P13844, DOI 10.1073/pnas.241443798; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gray MJ, 2005, GENE, V353, P98, DOI 10.1016/j.gene.2005.04.004; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Igietseme JU, 1998, INFECT IMMUN, V66, P1282, DOI 10.1128/IAI.66.4.1282-1286.1998; Iyer RK, 2002, MOL CELL BIOL, V22, P4491, DOI 10.1128/MCB.22.13.4491-4498.2002; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; Kerr AR, 2004, MICROB PATHOGENESIS, V36, P303, DOI 10.1016/j.micpath.2004.02.001; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; MODOLELL M, 1995, EUR J IMMUNOL, V25, P1101, DOI 10.1002/eji.1830250436; Munder M, 1999, J IMMUNOL, V163, P3771; Munder M, 1998, J IMMUNOL, V160, P5347; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Orihuela CJ, 2004, J INFECT DIS, V190, P1661, DOI 10.1086/424596; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Pauleau AL, 2004, J IMMUNOL, V172, P7565, DOI 10.4049/jimmunol.172.12.7565; Poole RK, 2005, BIOCHEM SOC T, V33, P176, DOI 10.1042/BST0330176; Reiling N, 2002, J IMMUNOL, V169, P3480, DOI 10.4049/jimmunol.169.7.3480; Rodriguez N, 2007, PHYSIOL GENOMICS, V30, P134, DOI 10.1152/physiolgenomics.00011.2007; Rutschman R, 2001, J IMMUNOL, V166, P2173, DOI 10.4049/jimmunol.166.4.2173; RYAN JL, 1980, AM J PATHOL, V99, P451; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; SchartonKersten TM, 1997, J EXP MED, V185, P1261, DOI 10.1084/jem.185.7.1261; Schluter D, 1999, J IMMUNOL, V162, P3512; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Sonoki T, 1997, J BIOL CHEM, V272, P3689, DOI 10.1074/jbc.272.6.3689; Talaue MT, 2006, J BACTERIOL, V188, P4830, DOI 10.1128/JB.01687-05; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Wanasen N, 2008, IMMUNOL RES, V41, P15, DOI 10.1007/s12026-007-8012-y; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Zea AH, 2006, J INFECT DIS, V194, P1385, DOI 10.1086/508200; Zhou L, 2007, MOL CELL BIOL, V27, P2698, DOI 10.1128/MCB.00788-06	50	465	473	2	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2008	9	12					1399	1406		10.1038/ni.1671	http://dx.doi.org/10.1038/ni.1671			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	372FY	18978793	Green Accepted			2022-12-18	WOS:000260888700015
J	Schwab, SR; Cyster, JG				Schwab, Susan R.; Cyster, Jason G.			Finding a way out: lymphocyte egress from lymphoid organs	NATURE IMMUNOLOGY			English	Review							SPHINGOSINE 1-PHOSPHATE RECEPTOR; PROTEIN-COUPLED RECEPTOR; T-CELL TRAFFICKING; MICE DEFICIENT; IN-VIVO; FTY720; SPHINGOSINE-1-PHOSPHATE; S1P(1); EXPRESSION; THYMOCYTE	The egress of lymphocytes from the thymus and secondary lymphoid organs into circulatory fluids is essential for normal immune function. The discovery that a small-molecule inhibitor of lymphocyte exit, FTY720, is a ligand for sphingosine 1-phosphate (S1P) receptors led to studies demonstrating that S1P receptor type 1 (S1P1) is needed in T cells and B cells for their egress from lymphoid organs. S1P exists in higher concentrations in blood and lymph than in lymphoid organs, and this differential is also required for lymphocyte exit. Transcriptional and post-translational mechanisms regulate S1P1 and thus the egress of lymphocytes. In this review we discuss the body of evidence supporting a model in which lymphocyte egress is promoted by encounter with S1P at exit sites. We relate this model to work examining the effects of S1P receptor agonists on endothelium.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Schwab, SR (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA.	schwab@saturn.med.nyu.edu; Jason.Cyster@ucsf.edu		Schwab, Susan/0000-0002-0834-0822				ADACHI K, 1995, BIOORG MED CHEM LETT, V5, P853, DOI 10.1016/0960-894X(95)00127-F; Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2002, CURR OPIN IMMUNOL, V14, P569, DOI 10.1016/S0952-7915(02)00374-6; Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; CHAFFIN KE, 1991, EUR J IMMUNOL, V21, P2565, DOI 10.1002/eji.1830211038; Chi HB, 2005, J IMMUNOL, V174, P2485, DOI 10.4049/jimmunol.174.5.2485; Chiba K, 1998, J IMMUNOL, V160, P5037; Chu Peter, 2003, J Biol, V2, P21, DOI 10.1186/1475-4924-2-21; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; CINAMON G, IN PRESS NAT IMMUNOL; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Czeloth N, 2005, J IMMUNOL, V175, P2960, DOI 10.4049/jimmunol.175.5.2960; Daniel C, 2007, J IMMUNOL, V178, P2458, DOI 10.4049/jimmunol.178.4.2458; Don AS, 2007, J BIOL CHEM, V282, P15833, DOI 10.1074/jbc.M609124200; Feng CG, 2002, INT IMMUNOL, V14, P535, DOI 10.1093/intimm/dxf020; Forrest M, 2004, J PHARMACOL EXP THER, V309, P758, DOI 10.1124/jpet.103.062828; Foss FW, 2007, BIOORGAN MED CHEM, V15, P663, DOI 10.1016/j.bmc.2006.10.060; Gonzalez-Cabrera PJ, 2007, J BIOL CHEM, V282, P7254, DOI 10.1074/jbc.M610581200; Gowans JL, 1996, IMMUNOL TODAY, V17, P288, DOI 10.1016/0167-5699(96)80547-0; Graeler M, 2002, FASEB J, V16, P1874, DOI 10.1096/fj.02-0548com; Grahler MH, 2005, J IMMUNOL, V174, P1997; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Halin C, 2005, BLOOD, V106, P1314, DOI 10.1182/blood-2004-09-3687; HALL JG, 1965, BRIT J EXP PATHOL, V46, P450; Han SH, 2004, BLOOD, V104, P4129, DOI 10.1182/blood-2004-06-2075; Hannun YA, 2001, BIOCHEMISTRY-US, V40, P4893, DOI 10.1021/bi002836k; HAY JB, 1974, CELL IMMUNOL, V10, P145, DOI 10.1016/0008-8749(74)90158-0; Hofmann M, 2006, INT IMMUNOPHARMACOL, V6, P1902, DOI 10.1016/j.intimp.2006.07.030; Huang MC, 2007, J IMMUNOL, V178, P6806, DOI 10.4049/jimmunol.178.11.6806; Idzko M, 2006, J CLIN INVEST, V116, P2935, DOI 10.1172/JCI28295; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Ishizaki H, 2006, J IMMUNOL, V177, P8512, DOI 10.4049/jimmunol.177.12.8512; Ito K, 2007, BIOCHEM BIOPH RES CO, V357, P212, DOI 10.1016/j.bbrc.2007.03.123; Jolly PS, 2004, J EXP MED, V199, P959, DOI 10.1084/jem.20030680; Kabashima K, 2006, J EXP MED, V203, P2683, DOI 10.1084/jem.20061289; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Kato S, 1997, MICROSC RES TECHNIQ, V38, P287, DOI 10.1002/(SICI)1097-0029(19970801)38:3<287::AID-JEMT9>3.0.CO;2-J; Kharel Y, 2005, J BIOL CHEM, V280, P36865, DOI 10.1074/jbc.M506293200; Kobayashi N, 2006, J LIPID RES, V47, P614, DOI 10.1194/jlr.M500468-JLR200; Kunisawa J, 2007, BLOOD, V109, P3749, DOI 10.1182/blood-2006-08-041582; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Maeda Y, 2007, J IMMUNOL, V178, P3437, DOI 10.4049/jimmunol.178.6.3437; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mitra P, 2006, P NATL ACAD SCI USA, V103, P16394, DOI 10.1073/pnas.0603734103; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Morris MA, 2005, EUR J IMMUNOL, V35, P3570, DOI 10.1002/eji.200526218; Muller H, 2005, EUR J IMMUNOL, V35, P533, DOI 10.1002/eji.200425556; Murata N, 2000, BIOCHEM J, V352, P809, DOI 10.1042/0264-6021:3520809; Nakayama T, 2002, J IMMUNOL, V168, P87, DOI 10.4049/jimmunol.168.1.87; Nombela-Arrieta C, 2007, J EXP MED, V204, P497, DOI 10.1084/jem.20061780; Olivera A, 2007, IMMUNITY, V26, P287, DOI 10.1016/j.immuni.2007.02.008; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Pabst O, 2006, J IMMUNOL, V176, P1474, DOI 10.4049/jimmunol.176.3.1474; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pinschewer DD, 2000, J IMMUNOL, V164, P5761, DOI 10.4049/jimmunol.164.11.5761; RISSO A, 1991, J IMMUNOL, V146, P4105; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Rosen H, 2003, P NATL ACAD SCI USA, V100, P10907, DOI 10.1073/pnas.1832725100; Rosen H, 2007, TRENDS IMMUNOL, V28, P102, DOI 10.1016/j.it.2007.01.007; Saba JD, 2004, CIRC RES, V94, P724, DOI 10.1161/01.RES.0000122383.60368.24; Sakata D, 2007, J EXP MED, V204, P2031, DOI 10.1084/jem.20062647; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Sanna MG, 2004, J BIOL CHEM, V279, P13839, DOI 10.1074/jbc.M311743200; Sawicka E, 2005, J IMMUNOL, V175, P7973, DOI 10.4049/jimmunol.175.12.7973; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; SPRENT J, 1971, CELL IMMUNOL, V2, P171, DOI 10.1016/0008-8749(71)90036-0; Ueno T, 2002, IMMUNITY, V16, P205, DOI 10.1016/S1074-7613(02)00267-4; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Vora KA, 2005, J LEUKOCYTE BIOL, V78, P471, DOI 10.1189/jlb.0904487; Walzer T, 2007, NAT IMMUNOL, V8, P1337, DOI 10.1038/ni1523; Wei Y. S., 1928, J AGR, V1; Xie JH, 2003, J IMMUNOL, V170, P3662, DOI 10.4049/jimmunol.170.7.3662; Zemann B, 2006, BLOOD, V107, P1454, DOI 10.1182/blood-2005-07-2628	85	465	482	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2007	8	12					1295	1301		10.1038/ni1545	http://dx.doi.org/10.1038/ni1545			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	235XG	18026082				2022-12-18	WOS:000251267000010
J	Dostert, C; Jouanguy, E; Irving, P; Troxler, L; Galiana-Arnoux, D; Hetru, C; Hoffmann, JA; Imler, JL				Dostert, C; Jouanguy, E; Irving, P; Troxler, L; Galiana-Arnoux, D; Hetru, C; Hoffmann, JA; Imler, JL			The Jak-STAT signaling pathway is required but not sufficient for the antiviral response of drosophila	NATURE IMMUNOLOGY			English	Article							GENOME-WIDE ANALYSIS; IMMUNE-RESPONSE; TYROSINE PHOSPHORYLATION; JAPANESE ENCEPHALITIS; INNATE IMMUNITY; PROTEIN; INFECTION; RECOGNITION; ACTIVATION; RECEPTOR	The response of drosophila to bacterial and fungal infections involves two signaling pathways, Toll and Imd, which both activate members of the transcription factor NF- kappa B family. Here we have studied the global transcriptional response of flies to infection with drosophila C virus. Viral infection induced a set of genes distinct from those regulated by the Toll or Imd pathways and triggered a signal transducer and activator of transcription ( STAT) DNA- binding activity. Genetic experiments showed that the Jak kinase Hopscotch was involved in the control of the viral load in infected flies and was required but not sufficient for the induction of some virus- regulated genes. Our results indicate that in addition to Toll and Imd, a third, evolutionary conserved innate immunity pathway functions in drosophila and counters viral infection.	Inst Biol Mol & Cellulaire, CNRS UPR9022, F-67000 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Imler, JL (corresponding author), Inst Biol Mol & Cellulaire, CNRS UPR9022, F-67000 Strasbourg, France.	jl.imler@ibmc.u-strasbg.fr	Jouanguy, Emmanuelle/H-7901-2017; Dostert, Catherine/AAJ-5473-2020; Imler, Jean-Luc/GXH-4323-2022	Jouanguy, Emmanuelle/0000-0002-7358-9157; 				Agaisse H, 2003, DEV CELL, V5, P441, DOI 10.1016/S1534-5807(03)00244-2; Barillas-Mury C, 1999, EMBO J, V18, P959, DOI 10.1093/emboj/18.4.959; Betz A, 2001, P NATL ACAD SCI USA, V98, P9563, DOI 10.1073/pnas.171302098; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Brandt SM, 2004, PLOS BIOL, V2, P2067, DOI 10.1371/journal.pbio.0020418; Brennan CA, 2004, ANNU REV IMMUNOL, V22, P457, DOI 10.1146/annurev.immunol.22.012703.104626; Brown S, 2001, CURR BIOL, V11, P1700, DOI 10.1016/S0960-9822(01)00524-3; Chen HW, 2002, GENE DEV, V16, P388, DOI 10.1101/gad.955202; Cherry S, 2005, GENE DEV, V19, P445, DOI 10.1101/gad.1267905; Cherry S, 2004, NAT IMMUNOL, V5, P81, DOI 10.1038/ni1019; Chinchar VG, 2004, VIROLOGY, V323, P268, DOI 10.1016/j.virol.2004.02.029; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Diveu C, 2003, J BIOL CHEM, V278, P49850, DOI 10.1074/jbc.M307286200; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Ekengren S, 2001, CURR BIOL, V11, P714, DOI 10.1016/S0960-9822(01)00203-2; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gobert V, 2003, SCIENCE, V302, P2126, DOI 10.1126/science.1085432; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Harrison DA, 1998, GENE DEV, V12, P3252, DOI 10.1101/gad.12.20.3252; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; Harvey NL, 2001, J BIOL CHEM, V276, P25342, DOI 10.1074/jbc.M009444200; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Hombria JCG, 2002, CURR BIOL, V12, pR569, DOI 10.1016/S0960-9822(02)01057-6; Hou SX, 2002, DEV CELL, V3, P765, DOI 10.1016/S1534-5807(02)00376-3; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Irusta PM, 2003, CURR OPIN CELL BIOL, V15, P700, DOI 10.1016/j.ceb.2003.10.007; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Johnson KN, 1998, J GEN VIROL, V79, P191, DOI 10.1099/0022-1317-79-1-191; JOUSSET FX, 1977, J GEN VIROL, V34, P269, DOI 10.1099/0022-1317-34-2-269; Jung AC, 2001, BIOTECHNIQUES, V30, P594, DOI 10.2144/01303rr04; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101; Lagueux M, 2000, P NATL ACAD SCI USA, V97, P11427, DOI 10.1073/pnas.97.21.11427; Lecellier CH, 2004, IMMUNOL REV, V198, P285, DOI 10.1111/j.0105-2896.2004.00128.x; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Lin CC, 2004, J BIOL CHEM, V279, P3308, DOI 10.1074/jbc.M309749200; LUO H, 1995, EMBO J, V14, P1412, DOI 10.1002/j.1460-2075.1995.tb07127.x; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; PERRIMON N, 1986, DEV BIOL, V118, P28, DOI 10.1016/0012-1606(86)90070-9; Pili-Floury S, 2004, J BIOL CHEM, V279, P12848, DOI 10.1074/jbc.M313324200; Roxstrom-Lindquist K, 2004, EMBO REP, V5, P207, DOI 10.1038/sj.embor.7400073; Sabatier L, 2003, EUR J BIOCHEM, V270, P3398, DOI 10.1046/j.1432-1033.2003.03725.x; SHUAL K, 1993, NATURE, V366, P580, DOI 10.1038/366580a0; SILVENNOINEN O, 1993, NATURE, V366, P583, DOI 10.1038/366583a0; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Tihova M, 2004, J VIROL, V78, P2897, DOI 10.1128/JVI.78.6.2897-2905.2004; Tzou P, 2002, CURR OPIN MICROBIOL, V5, P102, DOI 10.1016/S1369-5274(02)00294-1; WATLING D, 1993, NATURE, V366, P166, DOI 10.1038/366166a0; Yan RQ, 1996, CELL, V84, P421, DOI 10.1016/S0092-8674(00)81287-8	50	464	489	2	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2005	6	9					946	953		10.1038/ni1237	http://dx.doi.org/10.1038/ni1237			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	957KX	16086017				2022-12-18	WOS:000231369800025
J	Su, IH; Basavaraj, A; Krutchinsky, AN; Hobert, O; Ullrich, A; Chait, BT; Tarakhovsky, A				Su, IH; Basavaraj, A; Krutchinsky, AN; Hobert, O; Ullrich, A; Chait, BT; Tarakhovsky, A			Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement	NATURE IMMUNOLOGY			English	Article							POLYCOMB-GROUP GENE; METHYLTRANSFERASE ACTIVITY; DROSOPHILA ENHANCER; MOUSE; CHROMATIN; PROTEINS; ENX-1; PROLIFERATION; RECOMBINATION; ACTIVATION	Polycomb group protein Ezh2 is an essential epigenetic regulator of embryonic development in mice, but its role in the adult organism is unknown. High expression of Ezh2 in developing murine lymphocytes suggests Ezh2 involvement in lymphopoiesis. Using Cre-mediated conditional mutagenesis, we demonstrated a critical role for Ezh2 in early B cell development and rearrangement of the immunoglobulin heavy chain gene (Igh). We also revealed Ezh2 as a key regulator of histone H3 methylation in early B cell progenitors. Our data suggest Ezh2-dependent histone H3 methylation as a novel regulatory mechanism controlling Igh rearrangement during early murine B cell development.	Rockefeller Univ, Lab Lymphocyte Signaling, New York, NY 10021 USA; Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10021 USA; Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA; Max Planck Inst Biochem, Dept Mol Biol, D-82152 Martinsried, Germany	Rockefeller University; Rockefeller University; Columbia University; Max Planck Society	Tarakhovsky, A (corresponding author), Rockefeller Univ, Lab Lymphocyte Signaling, 1230 York Ave, New York, NY 10021 USA.	tarakho@mail.rockefeller.edu	Su, I-hsin/A-2207-2011	Su, I-hsin/0000-0002-5894-9580; Basavaraj, Ashwin/0000-0002-9904-6230; Hobert, Oliver/0000-0002-7634-2854	NCRR NIH HHS [RR0086] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Akasaka T, 1997, IMMUNITY, V7, P135, DOI 10.1016/S1074-7613(00)80516-6; Baird AM, 1999, CURR OPIN IMMUNOL, V11, P157, DOI 10.1016/S0952-7915(99)80027-2; Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Carrington EA, 1996, DEVELOPMENT, V122, P4073; Chowdhury D, 2001, EMBO J, V20, P6394, DOI 10.1093/emboj/20.22.6394; CONNOR AM, 1995, J IMMUNOL, V155, P5268; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; Core N, 1997, DEVELOPMENT, V124, P721; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; EHLICH A, 1993, CELL, V72, P695, DOI 10.1016/0092-8674(93)90398-A; Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039; FRANKE A, 1992, EMBO J, V11, P2941, DOI 10.1002/j.1460-2075.1992.tb05364.x; Fukuyama T, 2000, BRIT J HAEMATOL, V108, P842, DOI 10.1046/j.1365-2141.2000.01914.x; Gould A, 1997, CURR OPIN GENET DEV, V7, P488, DOI 10.1016/S0959-437X(97)80075-5; Grawunder U, 2001, CURR OPIN IMMUNOL, V13, P186, DOI 10.1016/S0952-7915(00)00203-X; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hobert O, 1996, MOL CELL BIOL, V16, P3066; Hobert O, 1996, MECH DEVELOP, V55, P171, DOI 10.1016/0925-4773(96)00499-6; Hofmeister R, 1999, CYTOKINE GROWTH F R, V10, P41, DOI 10.1016/S1359-6101(98)00025-2; Katoh-Fukui Y, 1998, NATURE, V393, P688, DOI 10.1038/31482; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Krutchinsky AN, 2000, J AM SOC MASS SPECTR, V11, P493, DOI 10.1016/S1044-0305(00)00114-8; Krutchinsky AN, 2001, ANAL CHEM, V73, P5066, DOI 10.1021/ac010682o; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Laible G, 1997, EMBO J, V16, P3219, DOI 10.1093/emboj/16.11.3219; Li SL, 1998, IMMUNITY, V8, P135, DOI 10.1016/S1074-7613(00)80466-5; LIN WC, 1995, IMMUNOL TODAY, V16, P279, DOI 10.1016/0167-5699(95)80182-0; Mahmoudi T, 2001, ONCOGENE, V20, P3055, DOI 10.1038/sj.onc.1204330; MALYNN BA, 1990, J EXP MED, V171, P843, DOI 10.1084/jem.171.3.843; Mecklenbrauker I, 2002, NATURE, V416, P860, DOI 10.1038/416860a; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Raaphorst FM, 2000, AM J PATHOL, V157, P709, DOI 10.1016/S0002-9440(10)64583-X; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Sambrook J., 1989, MOL CLONING; Schlissel M S, 1997, Semin Immunol, V9, P161, DOI 10.1006/smim.1997.0066; Sewalt RGAB, 1998, MOL CELL BIOL, V18, P3586, DOI 10.1128/MCB.18.6.3586; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taverna SD, 2002, CELL, V110, P701, DOI 10.1016/S0092-8674(02)00941-8; Tokimasa S, 2001, EXP HEMATOL, V29, P93, DOI 10.1016/S0301-472X(00)00620-2; TORRES RM, 2002, METHOD MOL BIOL, V180, P175; TSCHIERSCH B, 1994, EMBO J, V13, P3822, DOI 10.1002/j.1460-2075.1994.tb06693.x; van Lohuizen M, 1998, MOL CELL BIOL, V18, P3572, DOI 10.1128/MCB.18.6.3572; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; WU GE, 1986, EMBO J, V5, P3475, DOI 10.1002/j.1460-2075.1986.tb04672.x	50	464	478	0	19	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2003	4	2					124	131		10.1038/ni876	http://dx.doi.org/10.1038/ni876			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	640JW	12496962				2022-12-18	WOS:000180686500011
J	Godfrey, DI; Stankovic, S; Baxter, AG				Godfrey, Dale I.; Stankovic, Sanda; Baxter, Alan G.			Raising the NKT cell family	NATURE IMMUNOLOGY			English	Review							KILLER T-CELLS; NF-KAPPA-B; ALDRICH SYNDROME PROTEIN; ROR-GAMMA-T; NATURAL-KILLER; CUTTING EDGE; TRANSCRIPTION FACTOR; ALPHA-GALACTOSYLCERAMIDE; AIRWAY HYPERREACTIVITY; FUNCTIONALLY DISTINCT	Natural killer T cells (NKT cells) are CD1d-restricted, lipid antigen-reactive, immunoregulatory T lymphocytes that can promote cell-mediated immunity to tumors and infectious organisms, including bacteria and viruses, yet paradoxically they can also suppress the cell-mediated immunity associated with autoimmune disease and allograft rejection. Furthermore, in some diseases, such as atherosclerosis and allergy, NKT cell activity can be deleterious to the host. Although the precise means by which these cells carry out such contrasting functions is unclear, recent studies have highlighted the existence of many functionally distinct NKT cell subsets. Because their frequency and number vary widely between individuals, it is important to understand the mechanisms that regulate the development and maintenance of NKT cells and subsets thereof, which is the subject of this review.	[Godfrey, Dale I.; Stankovic, Sanda] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Baxter, Alan G.] James Cook Univ, Comparat Genom Ctr, Townsville, Qld, Australia	University of Melbourne; James Cook University	Godfrey, DI (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia.	godfrey@unimelb.edu.au	Baxter, Alan G/A-1412-2010	Baxter, Alan G/0000-0002-6960-9821; Godfrey, Dale/0000-0002-3009-5472				Akbari O, 2008, J IMMUNOL, V180, P5448, DOI 10.4049/jimmunol.180.8.5448; Allerstam F, 2007, SEMICOND SCI TECH, V22, P307, DOI 10.1088/0268-1242/22/4/002; Ambrosino E, 2007, J IMMUNOL, V179, P5126, DOI 10.4049/jimmunol.179.8.5126; ARASE H, 1995, J EXP MED, V182, P891, DOI 10.1084/jem.182.3.891; Astrakhan A, 2009, J IMMUNOL, V182, P7370, DOI 10.4049/jimmunol.0804256; Baev DV, 2004, BLOOD, V104, P4150, DOI 10.1182/blood-2004-04-1629; Barral DC, 2007, NAT REV IMMUNOL, V7, P929, DOI 10.1038/nri2191; BENDELAC A, 1995, J EXP MED, V182, P2091, DOI 10.1084/jem.182.6.2091; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; Berzins SP, 2004, IMMUNOL CELL BIOL, V82, P247, DOI 10.1046/j.1440-1711.2004.01238.x; Berzins SP, 2005, EUR J IMMUNOL, V35, P1399, DOI 10.1002/eji.200425958; Berzins SP, 2006, J IMMUNOL, V176, P4059, DOI 10.4049/jimmunol.176.7.4059; Berzofsky JA, 2008, J IMMUNOL, V180, P3627, DOI 10.4049/jimmunol.180.6.3627; Bezbradica JS, 2006, IMMUNITY, V25, P487, DOI 10.1016/j.immuni.2006.06.017; Bezbradica JS, 2005, P NATL ACAD SCI USA, V102, P5114, DOI 10.1073/pnas.0408449102; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Borowski C, 2005, J EXP MED, V201, P833, DOI 10.1084/jem.20050339; Chan AC, 2009, CLIN EXP IMMUNOL, V156, P238, DOI 10.1111/j.1365-2249.2009.03888.x; Chan GD, 2001, EUR J IMMUNOL, V31, P2403, DOI 10.1002/1521-4141(200108)31:8<2403::AID-IMMU2403>3.0.CO;2-O; Chang DH, 2008, BLOOD, V112, P1308, DOI 10.1182/blood-2008-04-149831; Christiano AM, 2008, CELL STEM CELL, V3, P3, DOI 10.1016/j.stem.2008.06.014; Chun T, 2003, J EXP MED, V197, P907, DOI 10.1084/jem.20021366; Chung B, 2005, J IMMUNOL, V174, P3153, DOI 10.4049/jimmunol.174.6.3153; Chung Y, 2008, J IMMUNOL, V180, P2276, DOI 10.4049/jimmunol.180.4.2276; Cohen NR, 2009, ADV IMMUNOL, V102, P1, DOI 10.1016/S0065-2776(09)01201-2; Coles MC, 2000, J IMMUNOL, V164, P2412, DOI 10.4049/jimmunol.164.5.2412; Coquet JM, 2008, P NATL ACAD SCI USA, V105, P11287, DOI 10.1073/pnas.0801631105; Coquet JM, 2007, J IMMUNOL, V178, P2827, DOI 10.4049/jimmunol.178.5.2827; Crowe NY, 2005, J EXP MED, V202, P1279, DOI 10.1084/jem.20050953; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Diao HY, 2008, P NATL ACAD SCI USA, V105, P15884, DOI 10.1073/pnas.0806089105; Doisne JM, 2009, J IMMUNOL, V183, P2142, DOI 10.4049/jimmunol.0901059; Doisne JM, 2009, J EXP MED, V206, P1365, DOI 10.1084/jem.20090127; Duarte N, 2004, J IMMUNOL, V173, P3112, DOI 10.4049/jimmunol.173.5.3112; Eberl G, 1999, J IMMUNOL, V163, P4091; Egawa T, 2005, IMMUNITY, V22, P705, DOI 10.1016/j.immuni.2005.03.011; Elewaut D, 2003, J EXP MED, V197, P1623, DOI 10.1084/jem.20030141; Emoto M, 1999, J IMMUNOL, V162, P5094; Fedeli M, 2009, J IMMUNOL, V183, P2506, DOI 10.4049/jimmunol.0901361; Felices M, 2009, P NATL ACAD SCI USA, V106, P8308, DOI 10.1073/pnas.0808459106; Franki AS, 2006, P NATL ACAD SCI USA, V103, P9160, DOI 10.1073/pnas.0508892103; Gadue P, 1999, J EXP MED, V190, P1189, DOI 10.1084/jem.190.8.1189; Gadue P, 2002, J IMMUNOL, V169, P2397, DOI 10.4049/jimmunol.169.5.2397; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Germanov E, 2008, J IMMUNOL, V181, P81, DOI 10.4049/jimmunol.181.1.81; Godfrey DI, 2007, NAT REV IMMUNOL, V7, P505, DOI 10.1038/nri2116; Godfrey DI, 2010, SEMIN IMMUNOL, V22, P61, DOI 10.1016/j.smim.2009.10.004; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Goto M, 2009, CELL IMMUNOL, V254, P81, DOI 10.1016/j.cellimm.2008.10.002; Griewank K, 2007, IMMUNITY, V27, P751, DOI 10.1016/j.immuni.2007.08.020; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; Guo WJ, 2002, WORLD J GASTROENTERO, V8, P476, DOI 10.3748/wjg.v8.i3.476; Hager E, 2007, J IMMUNOL, V179, P2228, DOI 10.4049/jimmunol.179.4.2228; Halder RC, 2007, J CLIN INVEST, V117, P2302, DOI 10.1172/JCI31602; Hammond KJL, 2001, J IMMUNOL, V167, P1164, DOI 10.4049/jimmunol.167.3.1164; Harada M, 2006, J EXP MED, V203, P2929, DOI 10.1084/jem.20062206; Iwabuchi K, 2001, BLOOD, V97, P1765, DOI 10.1182/blood.V97.6.1765; Iwai T, 2006, J IMMUNOL, V177, P8400, DOI 10.4049/jimmunol.177.12.8400; Jahng A, 2004, J EXP MED, V199, P947, DOI 10.1084/jem.20031389; Jordan MA, 2004, IMMUNOL CELL BIOL, V82, P276, DOI 10.1111/j.0818-9641.2004.01264.x; Jordan MA, 2007, J IMMUNOL, V178, P1618, DOI 10.4049/jimmunol.178.3.1618; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kim PJ, 2006, J IMMUNOL, V177, P6650, DOI 10.4049/jimmunol.177.10.6650; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kreslavsky T, 2009, P NATL ACAD SCI USA, V106, P12453, DOI 10.1073/pnas.0903895106; Kunisaki Y, 2006, J IMMUNOL, V176, P4640, DOI 10.4049/jimmunol.176.8.4640; Lacorazza HD, 2002, IMMUNITY, V17, P437, DOI 10.1016/S1074-7613(02)00422-3; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Lawson VJ, 2009, J IMMUNOL, V183, P2575, DOI 10.4049/jimmunol.0803577; Lazarevic V, 2009, NAT IMMUNOL, V10, P306, DOI 10.1038/ni.1696; Lee PT, 2002, J EXP MED, V195, P637, DOI 10.1084/jem.20011908; Lee PT, 2002, J CLIN INVEST, V110, P793, DOI 10.1172/JCI200215832; Li W, 2007, IMMUNITY, V27, P763, DOI 10.1016/j.immuni.2007.10.008; Li W, 2007, J EXP MED, V204, P2145, DOI 10.1084/jem.20070321; Locci M, 2009, J EXP MED, V206, P735, DOI 10.1084/jem.20081773; Ma CS, 2007, ANNU REV IMMUNOL, V25, P337, DOI 10.1146/annurev.immunol.25.022106.141651; Maeda M, 2007, IMMUNOBIOLOGY, V212, P537, DOI 10.1016/j.imbio.2007.03.007; Mallevaey T, 2009, IMMUNITY, V31, P60, DOI 10.1016/j.immuni.2009.05.010; Marrella V, 2007, J CLIN INVEST, V117, P1260, DOI 10.1172/JCI30928; Matsuda JL, 2005, CURR OPIN IMMUNOL, V17, P122, DOI 10.1016/j.coi.2005.01.002; Matsuda JL, 2002, NAT IMMUNOL, V3, P966, DOI 10.1038/ni837; Mcnab FW, 2007, J IMMUNOL, V179, P6630, DOI 10.4049/jimmunol.179.10.6630; McNab FW, 2005, J IMMUNOL, V175, P3762, DOI 10.4049/jimmunol.175.6.3762; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; Michel ML, 2008, P NATL ACAD SCI USA, V105, P19845, DOI 10.1073/pnas.0806472105; Monticelli LA, 2009, P NATL ACAD SCI USA, V106, P19461, DOI 10.1073/pnas.0908249106; Montoya CJ, 2007, IMMUNOLOGY, V122, P1, DOI 10.1111/j.1365-2567.2007.02647.x; Mycko MP, 2009, J IMMUNOL, V182, P4641, DOI 10.4049/jimmunol.0803394; Nichols KE, 2005, NAT MED, V11, P340, DOI 10.1038/nm1189; Ohteki T, 1999, J IMMUNOL, V162, P3753; Ohteki T, 1998, J EXP MED, V187, P967, DOI 10.1084/jem.187.6.967; Park SH, 2001, J EXP MED, V193, P893, DOI 10.1084/jem.193.8.893; Pasquier B, 2005, J EXP MED, V201, P695, DOI 10.1084/jem.20042432; Pellicci DG, 2009, IMMUNITY, V31, P47, DOI 10.1016/j.immuni.2009.04.018; Pellicci DG, 2003, EUR J IMMUNOL, V33, P1816, DOI 10.1002/eji.200323894; Pellicci DG, 2002, J EXP MED, V195, P835, DOI 10.1084/jem.20011544; Pichavant M, 2008, J EXP MED, V205, P385, DOI 10.1084/jem.20071507; Porubsky S, 2007, P NATL ACAD SCI USA, V104, P5977, DOI 10.1073/pnas.0611139104; Poulton LD, 2001, INT IMMUNOL, V13, P887, DOI 10.1093/intimm/13.7.887; Rachitskaya AV, 2008, J IMMUNOL, V180, P5167, DOI 10.4049/jimmunol.180.8.5167; Ranson T, 2003, P NATL ACAD SCI USA, V100, P2663, DOI 10.1073/pnas.0535482100; Rymarchyk SL, 2008, IMMUNOLOGY, V125, P331, DOI 10.1111/j.1365-2567.2008.02846.x; Sandberg JK, 2004, P NATL ACAD SCI USA, V101, P7058, DOI 10.1073/pnas.0305986101; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Schmidt-Supprian M, 2004, P NATL ACAD SCI USA, V101, P4566, DOI 10.1073/pnas.0400885101; Shimamura M, 1997, EUR J IMMUNOL, V27, P1576, DOI 10.1002/eji.1830270638; Sivakumar V, 2003, J EXP MED, V197, P1613, DOI 10.1084/jem.20022234; Stanic AK, 2004, J IMMUNOL, V172, P4667, DOI 10.4049/jimmunol.172.8.4667; Stanic AK, 2004, J IMMUNOL, V172, P2265, DOI 10.4049/jimmunol.172.4.2265; Takahashi T, 2002, J IMMUNOL, V168, P3140, DOI 10.4049/jimmunol.168.7.3140; Terabe M, 2005, J EXP MED, V202, P1627, DOI 10.1084/jem.20051381; Terashima A, 2008, J EXP MED, V205, P2727, DOI 10.1084/jem.20080698; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Treiner E, 2006, CURR OPIN IMMUNOL, V18, P519, DOI 10.1016/j.coi.2006.07.001; Vallabhapurapu S, 2008, EUR J IMMUNOL, V38, P3508, DOI 10.1002/eji.200737830; Van Rhijn I, 2004, P NATL ACAD SCI USA, V101, P13578, DOI 10.1073/pnas.0402838101; Walunas TL, 2000, J IMMUNOL, V164, P2857, DOI 10.4049/jimmunol.164.6.2857; Watanabe S, 2010, IMMUNOL LETT, V128, P51, DOI 10.1016/j.imlet.2009.11.002; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wei DG, 2005, J EXP MED, V202, P239, DOI 10.1084/jem.20050413; Yoshiga Y, 2008, INT J MOL MED, V22, P369, DOI 10.3892/ijmm_00000032; Yu SH, 2008, P NATL ACAD SCI USA, V105, P5207, DOI 10.1073/pnas.0711558105; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zheng XC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002703; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440; Zhou L, 2009, P NATL ACAD SCI USA, V106, P10266, DOI 10.1073/pnas.0811119106; Zullo AJ, 2007, J IMMUNOL, V178, P58, DOI 10.4049/jimmunol.178.1.58	130	463	501	1	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2010	11	3					197	206		10.1038/ni.1841	http://dx.doi.org/10.1038/ni.1841			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	556QI	20139988				2022-12-18	WOS:000274605800007
J	Kim, S; Iizuka, K; Kang, HSP; Dokun, A; French, AR; Greco, S; Yokoyama, WM				Kim, S; Iizuka, K; Kang, HSP; Dokun, A; French, AR; Greco, S; Yokoyama, WM			In vivo developmental stages in murine natural killer cell maturation	NATURE IMMUNOLOGY			English	Article							BONE-MARROW PROGENITORS; NK CELLS; CUTTING EDGE; T-CELL; RECEPTOR; DIFFERENTIATION; EXPRESSION; ACQUISITION; ACTIVATION; INTEGRIN	Natural killer (NK) cells develop in the bone marrow, but their in vivo stages of maturation, expansion and acquisition of receptors that guide target cell specificity are not well defined. We describe here such stages of development. We also show that developing NK cells actively proliferate at a phenotypically distinguishable immature stage after they have acquired expression of Ly49 and CD94-NKG2 receptors. These studies provide a developmental framework for NK cell maturation in vivo and suggest the possible involvement of the Ly49 and CD94-NKG2 receptors themselves in modulating expansion of NK cell populations with a given NK cell receptor repertoire.	Barnes Jewish Hosp, Howard Hughes Med Inst, St Louis, MO 63110 USA; Barnes Jewish Hosp, Dept Internal Med, Div Rheumatol, St Louis, MO 63110 USA; Washington Univ, Sch Med, St Louis, MO 63110 USA	Barnes-Jewish Hospital; Howard Hughes Medical Institute; Washington University (WUSTL); Barnes-Jewish Hospital; Washington University (WUSTL); Washington University (WUSTL)	Kim, S (corresponding author), Barnes Jewish Hosp, Howard Hughes Med Inst, St Louis, MO 63110 USA.							Arase H, 2001, J IMMUNOL, V167, P1141, DOI 10.4049/jimmunol.167.3.1141; Arroyo AG, 1999, IMMUNITY, V11, P555, DOI 10.1016/S1074-7613(00)80131-4; BIRON CA, 1983, J IMMUNOL, V131, P1539; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Carlyle JR, 1997, J EXP MED, V186, P173, DOI 10.1084/jem.186.2.173; Daniels KA, 2001, J EXP MED, V194, P29, DOI 10.1084/jem.194.1.29; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Dorfman JR, 1998, J EXP MED, V187, P609, DOI 10.1084/jem.187.4.609; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; HACKETT J, 1986, J IMMUNOL, V136, P3124; Idris AH, 1999, P NATL ACAD SCI USA, V96, P6330, DOI 10.1073/pnas.96.11.6330; Iizuka K, 1999, P NATL ACAD SCI USA, V96, P6336, DOI 10.1073/pnas.96.11.6336; Ikawa T, 1999, J EXP MED, V190, P1617, DOI 10.1084/jem.190.11.1617; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kim S, 2000, P NATL ACAD SCI USA, V97, P2731, DOI 10.1073/pnas.050588297; LANIER LL, 1986, J IMMUNOL, V137, P2735; Lanier LL, 2001, CURR OPIN IMMUNOL, V13, P326, DOI 10.1016/S0952-7915(00)00222-3; Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/88247; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Loza MJ, 2002, BLOOD, V99, P1273, DOI 10.1182/blood.V99.4.1273; Loza MJ, 2001, NAT IMMUNOL, V2, P917, DOI 10.1038/ni1001-917; MASON LH, 1995, J EXP MED, V182, P293, DOI 10.1084/jem.182.2.293; Puzanov IJ, 1996, J IMMUNOL, V157, P4282; Raulet DH, 1997, IMMUNOL REV, V155, P41, DOI 10.1111/j.1600-065X.1997.tb00938.x; Raulet DH, 2001, ANNU REV IMMUNOL, V19, P291, DOI 10.1146/annurev.immunol.19.1.291; Rosmaraki EE, 2001, EUR J IMMUNOL, V31, P1900, DOI 10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M; Roth C, 2000, IMMUNITY, V13, P143, DOI 10.1016/S1074-7613(00)00015-7; Salcedo M, 2000, EUR J IMMUNOL, V30, P1094, DOI 10.1002/(SICI)1521-4141(200004)30:4<1094::AID-IMMU1094>3.0.CO;2-9; Sato H, 1999, P NATL ACAD SCI USA, V96, P7439, DOI 10.1073/pnas.96.13.7439; Schmeissner PJ, 2001, J IMMUNOL, V167, P3715, DOI 10.4049/jimmunol.167.7.3715; Shimizu Y, 1999, ADV IMMUNOL, V72, P325, DOI 10.1016/S0065-2776(08)60024-3; Sivakumar PV, 1999, J IMMUNOL, V162, P6976; Smith HRC, 2000, J EXP MED, V191, P1341, DOI 10.1084/jem.191.8.1341; Suzuki H, 1997, J EXP MED, V185, P499, DOI 10.1084/jem.185.3.499; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; WELSH RM, 1991, J EXP MED, V173, P1053, DOI 10.1084/jem.173.5.1053; Williams NS, 2000, EUR J IMMUNOL, V30, P2074, DOI 10.1002/1521-4141(200007)30:7<2074::AID-IMMU2074>3.0.CO;2-#; Williams NS, 1999, J IMMUNOL, V163, P2648; Williams NS, 1998, IMMUNOL REV, V165, P47, DOI 10.1111/j.1600-065X.1998.tb01229.x; Williams NS, 1997, J EXP MED, V186, P1609, DOI 10.1084/jem.186.9.1609; Zamai L, 1998, J EXP MED, V188, P2375, DOI 10.1084/jem.188.12.2375	41	463	472	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2002	3	6					523	528		10.1038/ni796	http://dx.doi.org/10.1038/ni796			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	556XR	12006976				2022-12-18	WOS:000175874700010
J	Feske, S; Giltnane, J; Dolmetsch, R; Staudt, LM; Rao, A				Feske, S; Giltnane, J; Dolmetsch, R; Staudt, LM; Rao, A			Gene regulation mediated by calcium signals in T lymphocytes	NATURE IMMUNOLOGY			English	Article							INOSITOL TRISPHOSPHATE; INTRACELLULAR CALCIUM; TRANSCRIPTION FACTORS; STORE DEPLETION; PLASMA-MEMBRANE; CA2+; RECEPTOR; EXPRESSION; CELLS; CALCINEURIN	Modulation of many signaling pathways in antigen-stimulated T and B cells results in global changes in gene expression. Here we investigate the contribution of calcium signaling to gene expression in T cells using cell lines from two severe-combined immunodeficiency patients with several cytokine deficiencies and diminished activation of the transcription factor NFAT nuclear factor of activated T cells. These T cells show a strong defect in transmembrane calcium influx that is also apparent in their B cells and fibroblasts. DNA microarray analysis of calcium entry-deficient and control T cells shows that Ca2+ signals both activate and repress gene expression and are largely transduced through the phosphatase calcineurin. We demonstrate an elaborate network of signaling pathways downstream of the T cell receptor, explaining the complexity of changes in gene expression during T cell activation.	Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; NCI, Metab Branch, Div Clin Sci, Bethesda, MD 20892 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Rao, A (corresponding author), Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA.	arao@cbr.med.harvard.edu	Giltnane, Jennifer/D-2584-2013; Feske, stefan/ABB-3554-2021; Staudt, Louis/AAC-5324-2019	Feske, stefan/0000-0001-5431-8178; 	NATIONAL CANCER INSTITUTE [R37CA042471, R01CA042471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040127] Funding Source: NIH RePORTER; NCI NIH HHS [CA42471] Funding Source: Medline; NIAID NIH HHS [AI40127] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alizadeh A, 1999, COLD SPRING HARB SYM, V64, P71, DOI 10.1101/sqb.1999.64.71; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Aramburu J, 2000, CURR TOP CELL REGUL, V36, P237; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Boulay G, 1999, P NATL ACAD SCI USA, V96, P14955, DOI 10.1073/pnas.96.26.14955; BRAUN J, 1979, J CELL BIOL, V82, P755, DOI 10.1083/jcb.82.3.755; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Chuvpilo S, 1999, IMMUNITY, V10, P261, DOI 10.1016/S1074-7613(00)80026-6; CLAPHAM DE, 1995, NATURE, V375, P634, DOI 10.1038/375634a0; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; Derisi Joseph L., 1999, Current Opinion in Oncology, V11, P76, DOI 10.1097/00001622-199901000-00015; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; FANGER CM, 1995, J CELL BIOL, V131, P655, DOI 10.1083/jcb.131.3.655; Feske S, 2000, IMMUNOBIOLOGY, V202, P134, DOI 10.1016/S0171-2985(00)80060-1; Feske S, 2000, J IMMUNOL, V165, P297, DOI 10.4049/jimmunol.165.1.297; Feske S, 1996, EUR J IMMUNOL, V26, P2119, DOI 10.1002/eji.1830260924; Gonzalez JE, 1997, CHEM BIOL, V4, P269, DOI 10.1016/S1074-5521(97)90070-3; GONZALEZ JE, 1995, BIOPHYS J, V69, P1272, DOI 10.1016/S0006-3495(95)80029-9; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hofer AM, 1998, J CELL BIOL, V140, P325, DOI 10.1083/jcb.140.2.325; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Kiani A, 2000, IMMUNITY, V12, P359, DOI 10.1016/S1074-7613(00)80188-0; Kiselyov K, 1999, MOL CELL, V4, P423, DOI 10.1016/S1097-2765(00)80344-5; LEDEIST F, 1995, BLOOD, V85, P1053, DOI 10.1182/blood.V85.4.1053.bloodjournal8541053; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; Loh C, 1996, J BIOL CHEM, V271, P10884, DOI 10.1074/jbc.271.18.10884; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Montell C, 1997, MOL PHARMACOL, V52, P755, DOI 10.1124/mol.52.5.755; OKAMURA H, 2001, IN PRESS CURR OPIN C; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; PARTISETI M, 1994, J BIOL CHEM, V269, P32327; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Putney JW, 1999, BIOESSAYS, V21, P38; Putney JW, 1999, CELL, V99, P5, DOI 10.1016/S0092-8674(00)80056-2; Putney JW, 2000, CELL MOL LIFE SCI, V57, P1272, DOI 10.1007/PL00000765; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rogge L, 2000, NAT GENET, V25, P96, DOI 10.1038/75671; Schlesier M, 1993, Immunodeficiency, V4, P133; SERAFINI AT, 1995, IMMUNITY, V3, P239, DOI 10.1016/1074-7613(95)90093-4; Teague TK, 1999, P NATL ACAD SCI USA, V96, P12691, DOI 10.1073/pnas.96.22.12691; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; TOKUMITSU H, 1995, J BIOL CHEM, V270, P19320, DOI 10.1074/jbc.270.33.19320; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; van Leeuwen JEM, 1999, CURR OPIN IMMUNOL, V11, P242, DOI 10.1016/S0952-7915(99)80040-5; Wang DZ, 1995, ANN NY ACAD SCI, V766, P182, DOI 10.1111/j.1749-6632.1995.tb26661.x; Youn HD, 2000, J BIOL CHEM, V275, P22563, DOI 10.1074/jbc.C000304200; Youn HD, 1999, SCIENCE, V286, P790, DOI 10.1126/science.286.5440.790	50	463	490	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2001	2	4					316	324		10.1038/86318	http://dx.doi.org/10.1038/86318			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	420AZ	11276202				2022-12-18	WOS:000167982900012
J	Ringelhan, M; Pfister, D; O'Connor, T; Pikarsky, E; Heikenwalder, M				Ringelhan, Marc; Pfister, Dominik; O'Connor, Tracy; Pikarsky, Eli; Heikenwalder, Mathias			The immunology of hepatocellular carcinoma	NATURE IMMUNOLOGY			English	Review							CD8(+) T-CELLS; NF-KAPPA-B; LIVER-CANCER; DENDRITIC CELLS; NONALCOHOLIC STEATOHEPATITIS; IMMUNE-RESPONSES; NKT CELLS; PHARMACOLOGICAL INHIBITION; INFLAMMASOME ACTIVATION; LYMPHOID STRUCTURES	In contrast to most other malignancies, hepatocellular carcinoma (HCC), which accounts for approximately 90% of primary liver cancers, arises almost exclusively in the setting of chronic inflammation. Irrespective of etiology, a typical sequence of chronic necroinflammation, compensatory liver regeneration, induction of liver fibrosis and subsequent cirrhosis often precedes hepatocarcinogenesis. The liver is a central immunomodulator that ensures organ and systemic protection while maintaining immunotolerance. Deregulation of this tightly controlled liver immunological network is a hallmark of chronic liver disease and HCC. Notably, immunotherapies have raised hope for the successful treatment of advanced HCC. Here we summarize the roles of specific immune cell subsets in chronic liver disease, with a focus on non-alcoholic steatohepatitis and HCC. We review new advances in immunotherapeutic approaches for the treatment of HCC and discuss the challenges posed by the immunotolerant hepatic environment and the dual roles of adaptive and innate immune cells in HCC.	[Ringelhan, Marc] Tech Univ Munich, Univ Hosp Rechts Isar, Dept Internal Med 2, Munich, Germany; [Ringelhan, Marc] Tech Univ Munich, Inst Virol, Helmholtz Zentrum Munich, Munich, Germany; [Ringelhan, Marc] German Ctr Infect Res DZIF, Partner Site Munich, Munich, Germany; [Pfister, Dominik; Heikenwalder, Mathias] German Canc Res Ctr, Div Chron Inflammat & Canc, Heidelberg, Germany; [O'Connor, Tracy; Heikenwalder, Mathias] Tech Univ Munich, Inst Mol Immunol & Expt Oncol, Munich, Germany; [Pikarsky, Eli] Inst Med Res Israel Canada, Lautenberg Ctr Immunol & Canc Res, Jerusalem, Israel; [Pikarsky, Eli] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Pathol, Jerusalem, Israel	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; German Center for Infection Research; Helmholtz Association; German Cancer Research Center (DKFZ); Technical University of Munich; Hebrew University of Jerusalem	Heikenwalder, M (corresponding author), German Canc Res Ctr, Div Chron Inflammat & Canc, Heidelberg, Germany.; Heikenwalder, M (corresponding author), Tech Univ Munich, Inst Mol Immunol & Expt Oncol, Munich, Germany.	m.heikenwaelder@dkfz.de	Pfister, Dominik/AAK-7358-2021; Heikenwalder, Mathias/AAA-2269-2020; pikarsky, eli/GXV-7099-2022	Pfister, Dominik/0000-0002-0542-2638; Ringelhan, Marc/0000-0003-3131-5657; pikarsky, eli/0000-0003-4186-7105	Else-Kroner-Stiftung; Deutsche Forschungsgemeinschaft [5892/5-1]; European Research Council (consolidator grant HepatoMetaboPath); European Research Council [SFBTR36, SFBTR179, SFBTR209]; European Research Council (European Union's Horizon research and innovation programme) [667273]	Else-Kroner-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council (consolidator grant HepatoMetaboPath); European Research Council(European Research Council (ERC)European Commission); European Research Council (European Union's Horizon research and innovation programme)	Supported by Else-Kroner-Stiftung (M.R., as a member of the Else-Kroner-Forschungskolleg Munchen "Microbial triggers in disease development"), Deutsche Forschungsgemeinschaft (5892/5-1 to T.O.) and the European Research Council (consolidator grant HepatoMetaboPath to M.H.; SFBTR36, SFBTR179 and SFBTR209 to M.H.; and the European Union's Horizon 2020 research and innovation programme (under grant agreement 667273), for M.H.).	Ahlen G, 2009, GUT, V58, P560, DOI 10.1136/gut.2007.147264; Anson M, 2012, J CLIN INVEST, V122, P586, DOI 10.1172/JCI43937; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Boege Y, 2017, CANCER CELL, V32, P342, DOI 10.1016/j.ccell.2017.08.010; Bosman FT, 2010, WHO CLASSIFICATION T; Bricard G, 2009, J IMMUNOL, V182, P5140, DOI 10.4049/jimmunol.0711086; Bridgewater J, 2014, J HEPATOL, V60, P1268, DOI 10.1016/j.jhep.2014.01.021; Brunner SM, 2015, HEPATOLOGY, V61, P1957, DOI 10.1002/hep.27728; Chattergoon MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004082; Chen J, 2016, ONCOTARGET, V7, P41274, DOI 10.18632/oncotarget.8978; Cheng JT, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.7; Chiang EY, 2009, NAT MED, V15, P766, DOI 10.1038/nm.1984; Connolly MK, 2009, J CLIN INVEST, V119, P3213, DOI 10.1172/JCI37581; Coppola D, 2011, AM J PATHOL, V179, P37, DOI 10.1016/j.ajpath.2011.03.007; Das A, 2008, J EXP MED, V205, P2111, DOI 10.1084/jem.20072076; Diehl L, 2008, HEPATOLOGY, V47, P296, DOI 10.1002/hep.21965; Dimeloe S, 2017, IMMUNOLOGY, V150, P35, DOI 10.1111/imm.12655; Duffy AG, 2017, J HEPATOL, V66, P545, DOI 10.1016/j.jhep.2016.10.029; Eggert T, 2016, CANCER CELL, V30, P533, DOI 10.1016/j.ccell.2016.09.003; Ehling J, 2014, GUT, V63, P1960, DOI 10.1136/gutjnl-2013-306294; El-Khoueiry AB, 2017, LANCET, V389, P2492, DOI 10.1016/S0140-6736(17)31046-2; Endig J, 2016, CANCER CELL, V30, P308, DOI 10.1016/j.ccell.2016.06.009; Fan ZW, 2017, HEPATOLOGY, V65, P1904, DOI 10.1002/hep.29127; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Ferlay J., 2012, INT J CANC, V136; Finkin S, 2015, NAT IMMUNOL, V16, P1235, DOI 10.1038/ni.3290; Flecken T, 2014, HEPATOLOGY, V59, P1415, DOI 10.1002/hep.26731; Fu JL, 2013, HEPATOLOGY, V58, P139, DOI 10.1002/hep.26054; Garcia-Martinez I., J CLIN INVEST, V126; Garnelo M, 2017, GUT, V66, P342, DOI 10.1136/gutjnl-2015-310814; Ge XD, 2014, J BIOL CHEM, V289, P22672, DOI 10.1074/jbc.M114.552141; Gomes AL, 2016, CANCER CELL, V30, P161, DOI 10.1016/j.ccell.2016.05.020; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Guidotti LG, 2015, CELL, V161, P486, DOI 10.1016/j.cell.2015.03.005; Gur C, 2012, GUT, V61, P885, DOI 10.1136/gutjnl-2011-301400; Harding JJ, 2016, CANCER-AM CANCER SOC, V122, P367, DOI 10.1002/cncr.29769; Hassin D, 2011, IMMUNOLOGY, V133, P190, DOI 10.1111/j.1365-2567.2011.03426.x; Haybaeck J, 2009, CANCER CELL, V16, P295, DOI 10.1016/j.ccr.2009.08.021; He GB, 2010, CANCER CELL, V17, P286, DOI 10.1016/j.ccr.2009.12.048; Hedegaard DL, 2017, J HEPATOL, V66, P28, DOI 10.1016/j.jhep.2016.07.048; Heier EC, 2017, J HEPATOL, V66, P1241, DOI 10.1016/j.jhep.2017.01.008; Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039; Henning JR, 2013, HEPATOLOGY, V58, P589, DOI 10.1002/hep.26267; Hernandez-Gea V, 2013, GASTROENTEROLOGY, V144, P512, DOI 10.1053/j.gastro.2013.01.002; Heymann F, 2015, HEPATOLOGY, V62, P279, DOI 10.1002/hep.27793; Hiroishi K, 2010, J GASTROENTEROL, V45, P451, DOI 10.1007/s00535-009-0155-2; HUANG L, 1994, IMMUNITY, V1, P741, DOI 10.1016/S1074-7613(94)80016-2; Huang LR, 2013, NAT IMMUNOL, V14, P574, DOI 10.1038/ni.2573; Ibusuki R, 2013, LIVER INT, V33, P1549, DOI 10.1111/liv.12203; Iracheta-Vellve A, 2015, J HEPATOL, V63, P1147, DOI 10.1016/j.jhep.2015.06.013; Jenne CN, 2013, NAT IMMUNOL, V14, P996, DOI 10.1038/ni.2691; Jia YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117458; Jors S, 2015, J CLIN INVEST, V125, P2445, DOI 10.1172/JCI78585; Kahraman A, 2010, HEPATOLOGY, V51, P92, DOI 10.1002/hep.23253; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Kelly A, 2014, J HEPATOL, V60, P135, DOI 10.1016/j.jhep.2013.08.007; Kessoku T, 2016, SCI REP-UK, V6, DOI 10.1038/srep22251; Knee DA, 2016, EUR J CANCER, V67, P1, DOI 10.1016/j.ejca.2016.06.028; Knolle PA, 1998, HEPATOLOGY, V27, P93, DOI 10.1002/hep.510270116; Knolle PA, 1999, J IMMUNOL, V162, P1401; Knolle PA, 2014, GASTROENTEROLOGY, V146, P1193, DOI 10.1053/j.gastro.2013.12.036; Koh MY, 2016, HEPATOLOGY, V63, P1576, DOI 10.1002/hep.28468; Kong LX, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0412-1; Lacotte S, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1234565; Lee JH, 2015, GASTROENTEROLOGY, V148, P1383, DOI 10.1053/j.gastro.2015.02.055; Levrero M, 2016, J HEPATOL, V64, pS84, DOI 10.1016/j.jhep.2016.02.021; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Li XG, 2017, GUT, V66, P157, DOI 10.1136/gutjnl-2015-310514; Li X, 2017, ONCOTARGET, V8, P24380, DOI 10.18632/oncotarget.15456; Limmer A, 2000, NAT MED, V6, P1348, DOI 10.1038/82161; Liu J, 2014, GUT, V63, P1648, DOI 10.1136/gutjnl-2013-305785; Llovet JM, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.18, 10.1038/nrdp.2016.19]; Llovet JM, 2014, CLIN CANCER RES, V20, P2072, DOI 10.1158/1078-0432.CCR-13-0547; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Lopes AR, 2008, J CLIN INVEST, V118, P1835, DOI 10.1172/JCI33402; Lucifora J, 2014, SCIENCE, V343, P1221, DOI 10.1126/science.1243462; LUMSDEN AB, 1988, HEPATOLOGY, V8, P232, DOI 10.1002/hep.1840080207; Ma C, 2016, NATURE, V531, P253, DOI 10.1038/nature16969; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Mathurin P, 2012, J HEPATOL, V57, P399, DOI 10.1016/j.jhep.2012.04.004; Matter MS, 2016, HEPATOLOGY, V63, P1888, DOI 10.1002/hep.28487; Medina-Echeverz J, 2015, CANCER IMMUNOL IMMUN, V64, P931, DOI 10.1007/s00262-015-1736-y; Messina JL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00765; Meyer T, 2017, LANCET GASTROENTEROL, V2, P565, DOI 10.1016/S2468-1253(17)30156-5; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mizukoshi E, 2013, HEPATOLOGY, V57, P1448, DOI 10.1002/hep.26153; Nakagawa H, 2014, CANCER CELL, V26, P331, DOI 10.1016/j.ccr.2014.07.001; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Nault JC, 2017, LANCET, V389, P4, DOI 10.1016/S0140-6736(16)32480-1; Nault JC, 2016, CLIN RES HEPATOL GAS, V40, P9, DOI 10.1016/j.clinre.2015.07.006; Notas G, 2009, CLIN IMMUNOL, V130, P16, DOI 10.1016/j.clim.2008.08.008; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Ouyang FZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13453; Pallett LJ, 2015, NAT MED, V21, P591, DOI 10.1038/nm.3856; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Pedroza-Gonzalez A, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1008355; Personeni N, 2017, ONCOTARGET, V8, P14408, DOI 10.18632/oncotarget.14797; Petrasek J, 2013, J GASTROEN HEPATOL, V28, P93, DOI 10.1111/jgh.12020; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Protzer U, 2012, NAT REV IMMUNOL, V12, P201, DOI 10.1038/nri3169; Rai V, 2018, MOL CELL BIOCHEM, V437, P13, DOI 10.1007/s11010-017-3092-z; Reid DT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159524; Ringelhan M., 2017, PHIL T R SOC LOND B; Robert O, 2016, J HEPATOL, V64, P916, DOI 10.1016/j.jhep.2015.11.023; Robinson MW, 2016, CELL MOL IMMUNOL, V13, P267, DOI 10.1038/cmi.2016.3; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Sangro B, 2013, J HEPATOL, V59, P81, DOI 10.1016/j.jhep.2013.02.022; Sautes-Fridman C, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00407; Schlageter M, 2016, PATHOBIOLOGY, V83, P301, DOI 10.1159/000446245; Schneider C, 2012, GUT, V61, P1733, DOI 10.1136/gutjnl-2011-301116; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Shalapour S, 2017, NATURE, V551, P340, DOI 10.1038/nature24302; Shen Y, CELL PHYSL BIOCH, V35; Sia D, 2017, GASTROENTEROLOGY, V153, P812, DOI 10.1053/j.gastro.2017.06.007; Sia D, 2017, GASTROENTEROLOGY, V152, P745, DOI 10.1053/j.gastro.2016.11.048; Sideras K, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2016.1273309; Spear TT, 2016, CANCER IMMUNOL IMMUN, V65, P293, DOI 10.1007/s00262-016-1800-2; Subramaniam A, 2013, BBA-REV CANCER, V1835, P46, DOI 10.1016/j.bbcan.2012.10.002; Sui QJ, 2014, J IMMUNOL, V193, P2016, DOI 10.4049/jimmunol.1302389; Sun C, 2016, ONCOIMMUNOLOGY, V6; Sun K, 2017, CANCER LETT, V388, P198, DOI 10.1016/j.canlet.2016.12.004; Sun ZP, 2016, BIOSCI TRENDS, V10, P85, DOI 10.5582/bst.2015.01128; Sunami Y, 2016, HEPATOLOGY, V63, P1592, DOI 10.1002/hep.28435; Sutti S, 2015, CLIN SCI, V129, P797, DOI 10.1042/CS20150053; Svendsen P, 2017, MOL THER-METH CLIN D, V4, P50, DOI 10.1016/j.omtm.2016.11.004; Syn WK, 2012, GUT, V61, P1323, DOI 10.1136/gutjnl-2011-301857; Syn WK, 2010, HEPATOLOGY, V51, P1998, DOI 10.1002/hep.23599; Szabo G, 2015, NAT REV GASTRO HEPAT, V12, P387, DOI 10.1038/nrgastro.2015.94; Tacke F, 2017, J HEPATOL, V66, P1300, DOI 10.1016/j.jhep.2017.02.026; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tosello-Trampont AC, 2016, HEPATOLOGY, V63, P799, DOI 10.1002/hep.28389; Totoki Y, 2014, NAT GENET, V46, P1267, DOI 10.1038/ng.3126; Villanueva A, 2013, NAT REV GASTRO HEPAT, V10, P34, DOI 10.1038/nrgastro.2012.199; Wang Y, 2016, CELL PHYSIOL BIOCHEM, V38, P306, DOI 10.1159/000438631; Wiedemann GM, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1175794; Wieland D, 2017, DIGEST DIS, V35, P334, DOI 10.1159/000456584; Wieland D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15050; Wolf MJ, 2014, CANCER CELL, V26, P549, DOI 10.1016/j.ccell.2014.09.003; Wong VWS, 2016, LANCET GASTROENTEROL, V1, P56, DOI 10.1016/S2468-1253(16)30011-5; Wu J, 2010, IMMUNOLOGY, V129, P363, DOI 10.1111/j.1365-2567.2009.03179.x; Xie QK, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1181252; Xu RN, 2014, CELL MOL IMMUNOL, V11, P224, DOI 10.1038/cmi.2014.2; Xue HW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154815; Yuan DT, 2017, CANCER CELL, V31, P771, DOI 10.1016/j.ccell.2017.05.006; Zang SF, 2016, CLIN EXP PHARMACOL P, V43, P13, DOI 10.1111/1440-1681.12499; Zhang QF, 2017, CELL MOL IMMUNOL, V14, P819, DOI 10.1038/cmi.2016.28; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035; Zhou SL, 2016, GASTROENTEROLOGY, V150, P1646, DOI 10.1053/j.gastro.2016.02.040; Zucman-Rossi J, 2015, GASTROENTEROLOGY, V149, P1226, DOI 10.1053/j.gastro.2015.05.061	150	462	486	13	205	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2018	19	3					222	232		10.1038/s41590-018-0044-z	http://dx.doi.org/10.1038/s41590-018-0044-z			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FY6XZ	29379119				2022-12-18	WOS:000427007500012
J	Mauer, J; Chaurasia, B; Goldau, J; Vogt, MC; Ruud, J; Nguyen, KD; Theurich, S; Hausen, AC; Schmitz, J; Bronneke, HS; Estevez, E; Allen, TL; Mesaros, A; Partridge, L; Febbraio, MA; Chawla, A; Wunderlich, FT; Bruning, JC				Mauer, Jan; Chaurasia, Bhagirath; Goldau, Julia; Vogt, Merly C.; Ruud, Johan; Nguyen, Khoa D.; Theurich, Sebastian; Hausen, A. Christine; Schmitz, Joel; Broenneke, Hella S.; Estevez, Emma; Allen, Tamara L.; Mesaros, Andrea; Partridge, Linda; Febbraio, Mark A.; Chawla, Ajay; Wunderlich, F. Thomas; Bruening, Jens C.			Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin	NATURE IMMUNOLOGY			English	Article							HEPATIC INFLAMMATION; SKELETAL-MUSCLE; ADIPOSE-TISSUE; DEFICIENT MICE; IKK-BETA; CELLS; INTERLEUKIN-6; METABOLISM; SENSITIVITY; HOMEOSTASIS	Obesity and resistance to insulin are closely associated with the development of low-grade inflammation. Interleukin 6 (IL-6) is linked to obesity-associated inflammation; however, its role in this context remains controversial. Here we found that mice with an inactivated gene encoding the IL-6R. chain of the receptor for IL-6 in myeloid cells (116ra(Delta myel) mice) developed exaggerated deterioration of glucose homeostasis during diet-induced obesity, due to enhanced resistance to insulin. Tissues targeted by insulin showed increased inflammation and a shift in macrophage polarization. IL-6 induced expression of the receptor for IL-4 and augmented the response to IL-4 in macrophages in a cell-autonomous manner. 116ra(Delta myel) mice were resistant to IL-4-mediated alternative polarization of macrophages and exhibited enhanced susceptibility to lipopolysaccharide (LPS)-induced endotoxemia. Our results identify signaling via IL-6 as an important determinant of the alternative activation of macrophages and assign an unexpected homeostatic role to IL-6 in limiting inflammation.	[Mauer, Jan; Chaurasia, Bhagirath; Goldau, Julia; Vogt, Merly C.; Ruud, Johan; Theurich, Sebastian; Hausen, A. Christine; Schmitz, Joel; Wunderlich, F. Thomas; Bruening, Jens C.] Univ Cologne, Inst Genet, Dept Mouse Genet & Metab, Cologne, Germany; [Mauer, Jan; Vogt, Merly C.; Ruud, Johan; Theurich, Sebastian; Hausen, A. Christine; Broenneke, Hella S.; Wunderlich, F. Thomas; Bruening, Jens C.] Max Planck Inst Neurol Res, D-50931 Cologne, Germany; [Mauer, Jan; Vogt, Merly C.; Ruud, Johan; Theurich, Sebastian; Hausen, A. Christine; Broenneke, Hella S.; Wunderlich, F. Thomas; Bruening, Jens C.] Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Nguyen, Khoa D.; Chawla, Ajay] Univ Calif San Francisco, Dept Physiol & Med, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Schmitz, Joel; Bruening, Jens C.] Univ Hosp Cologne, Ctr Endocrinol Diabet & Prevent Med, Cologne, Germany; [Schmitz, Joel; Bruening, Jens C.] Ctr Mol Med Cologne, Cologne, Germany; [Estevez, Emma; Allen, Tamara L.; Febbraio, Mark A.] Baker IDI Heart & Diabet Inst, Cellular & Mol Metab Lab, Melbourne, Vic, Australia; [Mesaros, Andrea; Partridge, Linda] Max Planck Inst Biol Ageing, Cologne, Germany	University of Cologne; Max Planck Society; University of Cologne; University of California System; University of California San Francisco; University of Cologne; University of Cologne; Baker Heart and Diabetes Institute; Max Planck Society	Bruning, JC (corresponding author), Univ Cologne, Inst Genet, Dept Mouse Genet & Metab, Cologne, Germany.	bruening@nf.mpg.de	Partridge, Linda/E-7342-2015; Theurich, Sebastian/AAB-2855-2022; Ruud, Johan/W-7407-2019; Febbraio, Mark/AAE-9632-2019; Vogt, Merly/AAF-3789-2021; Theurich, Sebastian/C-9995-2018	Theurich, Sebastian/0000-0001-5706-8258; Partridge, Linda/0000-0001-9615-0094; Estevez, Emma/0000-0002-5125-2190; Mauer, Jan/0000-0002-0189-5876; Nguyen, Khoa/0000-0002-6720-2470; Febbraio, Mark/0000-0002-9296-4418	Deutsche Forschungsgemeinschaft [SFB 612, SFB 670]; Leibniz Preis [BR 1492/7-1]; US National Institutes of Health [DP1AR064158, HL076746, DK094641]; National Health and Medical Research Council of Australia [APP1041760, APP1042465, SPRF APP1021168]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [DP1AR064158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094641] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Leibniz Preis; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank G. Schmall and T. Rayle for secretarial assistance, and B. Hampel and D. Kutyniok for technical assistance. Supported by the Deutsche Forschungsgemeinschaft (SFB 612 and SFB 670 to J. C. B.), the Leibniz Preis (BR 1492/7-1 to J. C. B.), the Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases ( funded by the Deutsche Forschungsgemeinschaft within the Excellence Initiative by German Federal and State Governments), the US National Institutes of Health (DP1AR064158, HL076746 and DK094641 to A. C.) and the National Health and Medical Research Council of Australia (APP1041760, APP1042465 and SPRF APP1021168 to M. A. F.).	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Baumgartl J, 2006, CELL METAB, V3, P247, DOI 10.1016/j.cmet.2006.02.010; Belgardt BF, 2010, P NATL ACAD SCI USA, V107, P6028, DOI 10.1073/pnas.1001796107; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Chaurasia B, 2010, MOL CELL BIOL, V30, P4354, DOI 10.1128/MCB.00069-10; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Duluc D, 2007, BLOOD, V110, P4319, DOI 10.1182/blood-2007-02-072587; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; FERRE P, 1985, BIOCHEM J, V228, P103, DOI 10.1042/bj2280103; Gunschmann C, 2013, DEV CELL, V26, P176, DOI 10.1016/j.devcel.2013.05.017; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hutchins AP, 2012, BLOOD, V119, pE110, DOI 10.1182/blood-2011-09-381483; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Matthews VB, 2010, DIABETOLOGIA, V53, P2431, DOI 10.1007/s00125-010-1865-y; Mauer J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000938; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Norris AW, 2003, J CLIN INVEST, V112, P608, DOI 10.1172/JCI200317305; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Pedersen BK, 2007, J APPL PHYSIOL, V102, P814, DOI 10.1152/japplphysiol.01208.2006; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Ricardo-Gonzalez RR, 2010, P NATL ACAD SCI USA, V107, P22617, DOI 10.1073/pnas.1009152108; Ruud J, 2013, FASEB J, V27, P1973, DOI 10.1096/fj.12-225433; Sadagurski M, 2010, DIABETOLOGIA, V53, P525, DOI 10.1007/s00125-009-1580-8; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Spence S, 2013, IMMUNITY, V38, P66, DOI 10.1016/j.immuni.2012.09.013; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Vogt MC, 2013, TRENDS ENDOCRIN MET, V24, P76, DOI 10.1016/j.tem.2012.11.004; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Wermeling F, 2013, P NATL ACAD SCI USA, V110, P13487, DOI 10.1073/pnas.1312525110; Wunderlich CM, 2012, J IMMUNOL, V188, P4141, DOI 10.4049/jimmunol.1102137; Wunderlich FT, 2010, CELL METAB, V12, P237, DOI 10.1016/j.cmet.2010.06.011; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	49	462	473	3	108	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2014	15	5					423	+		10.1038/ni.2865	http://dx.doi.org/10.1038/ni.2865			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AF4FU	24681566	Green Accepted, Green Submitted			2022-12-18	WOS:000334667900007
J	Lillemeier, BF; Mortelmaier, MA; Forstner, MB; Huppa, JB; Groves, JT; Davis, MM				Lillemeier, Bjoern F.; Moertelmaier, Manuel A.; Forstner, Martin B.; Huppa, Johannes B.; Groves, Jay T.; Davis, Mark M.			TCR and Lat are expressed on separate protein islands on T cell membranes and concatenate during activation	NATURE IMMUNOLOGY			English	Article							FC-EPSILON-RI; PLASMA-MEMBRANE; SIGNALING MOLECULES; CORRELATION SPECTROSCOPY; RECEPTOR MICROCLUSTERS; MULTIVALENT STRUCTURE; ANTIGEN RECEPTOR; SPATIAL-PATTERNS; MICROSCOPY; TRACKING	The organization and dynamics of receptors and other molecules in the plasma membrane are not well understood. Here we analyzed the spatio-temporal dynamics of T cell antigen receptor (TCR) complexes and linker for activation of T cells (Lat), a key adaptor molecule in the TCR signaling pathway, in T cell membranes using high-speed photoactivated localization microscopy, dual-color fluorescence cross-correlation spectroscopy and transmission electron microscopy. In quiescent T cells, both molecules existed in separate membrane domains (protein islands), and these domains concatenated after T cell activation. These concatemers were identical to signaling microclusters, a prominent hallmark of T cell activation. This separation versus physical juxtapositioning of receptor domains and domains containing downstream signaling molecules in quiescent versus activated T cells may be a general feature of plasma membrane-associated signal transduction.	[Lillemeier, Bjoern F.; Moertelmaier, Manuel A.; Huppa, Johannes B.; Davis, Mark M.] Stanford Univ, Howard Hughes Med Inst, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Forstner, Martin B.; Groves, Jay T.] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem, Phys Biosci Div, Berkeley, CA 94720 USA; [Forstner, Martin B.; Groves, Jay T.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Davis, MM (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.	mmdavis@stanford.edu	Huppa, Johannes Bernhard/AAY-9471-2021; Forstner, Martin/A-8903-2008	Huppa, Johannes Bernhard/0000-0003-2634-8198; Forstner, Martin/0000-0003-0413-8659; Lillemeier, Bjorn/0000-0002-9425-6327; Moertelmaier, Manuel/0000-0003-4239-9809; Davis, Mark/0000-0001-6868-657X	US National Institutes of Health [AI 55277]; US National Science Foundation; Howard Hughes Medical Institute; Human Frontier Science Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI055277, R01AI022511, U19AI057229] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Wilson for advice on TEM and plasma membrane sheet preparation; J. Perrino from the Cell Sciences Imaging Facility for expertise and service; and F. Tynan for comments on the manuscript. Supported by the US National Institutes of Health (AI 55277 to M. M. D.), the US National Science Foundation (J. T. G.), the Howard Hughes Medical Institute (M. M. D. and J. T. G.) and the Human Frontier Science Program (B. F. L.).	Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bonefeld CM, 2003, J IMMUNOL, V171, P3003, DOI 10.4049/jimmunol.171.6.3003; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Chu DH, 1998, IMMUNOL REV, V165, P167, DOI 10.1111/j.1600-065X.1998.tb01238.x; Chudakov DM, 2004, NAT BIOTECHNOL, V22, P1435, DOI 10.1038/nbt1025; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; EXLEY M, 1995, MOL IMMUNOL, V32, P829, DOI 10.1016/0161-5890(95)00046-H; Fahmy TM, 2001, IMMUNITY, V14, P135, DOI 10.1016/S1074-7613(09)00099-5; Fernandez-Miguel G, 1999, P NATL ACAD SCI USA, V96, P1547, DOI 10.1073/pnas.96.4.1547; Forstner MB, 2006, J AM CHEM SOC, V128, P15221, DOI 10.1021/ja064093h; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Groves JT, 2008, ANNU REV BIOMED ENG, V10, P311, DOI 10.1146/annurev.bioeng.10.061807.160431; Hess ST, 2007, P NATL ACAD SCI USA, V104, P17370, DOI 10.1073/pnas.0708066104; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; James JR, 2007, P NATL ACAD SCI USA, V104, P17662, DOI 10.1073/pnas.0700411104; Kusumi A, 2005, SEMIN IMMUNOL, V17, P3, DOI 10.1016/j.smim.2004.09.004; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; Liu J, 1996, J BIOL CHEM, V271, P33639, DOI 10.1074/jbc.271.52.33639; MAGDE D, 1974, BIOPOLYMERS, V13, P29, DOI 10.1002/bip.1974.360130103; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; RIPLEY BD, 1979, J ROY STAT SOC B MET, V41, P368; SAKO Y, 1994, J CELL BIOL, V125, P1251, DOI 10.1083/jcb.125.6.1251; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; SANAN DA, 1991, J HISTOCHEM CYTOCHEM, V39, P1017, DOI 10.1177/39.8.1906908; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; Shroff H, 2008, NAT METHODS, V5, P417, DOI 10.1038/NMETH.1202; Sigalov AB, 2006, BIOCHEMISTRY-US, V45, P15731, DOI 10.1021/bi061108f; SIMSON R, 1995, BIOPHYS J, V69, P989, DOI 10.1016/S0006-3495(95)79972-6; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Wilson BS, 2000, J CELL BIOL, V149, P1131, DOI 10.1083/jcb.149.5.1131; Wilson BS, 2001, J CELL BIOL, V154, P645, DOI 10.1083/jcb.200104049; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Zhang J, 2006, MICRON, V37, P14, DOI 10.1016/j.micron.2005.03.014	39	462	469	2	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2010	11	1					90	U106		10.1038/ni.1832	http://dx.doi.org/10.1038/ni.1832			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	533WE	20010844	Green Accepted			2022-12-18	WOS:000272855300018
J	Perrigoue, JG; Saenz, SA; Siracusa, MC; Allenspach, EJ; Taylor, BC; Giacomin, PR; Nair, MG; Du, YR; Zaph, C; van Rooijen, N; Comeau, MR; Pearce, EJ; Laufer, TM; Artis, D				Perrigoue, Jacqueline G.; Saenz, Steven A.; Siracusa, Mark C.; Allenspach, Eric J.; Taylor, Betsy C.; Giacomin, Paul R.; Nair, Meera G.; Du, Yurong; Zaph, Colby; van Rooijen, Nico; Comeau, Michael R.; Pearce, Edward J.; Laufer, Terri M.; Artis, David			MHC class II-dependent basophil-CD4(+) T cell interactions promote T(H)2 cytokine-dependent immunity	NATURE IMMUNOLOGY			English	Article							THYMIC STROMAL LYMPHOPOIETIN; DENDRITIC CELLS; TYPE-2 IMMUNITY; CUTTING EDGE; TH2 RESPONSE; MAST-CELLS; IN-VIVO; IL-4; EOSINOPHILS; INFECTION	Dendritic cells can prime naive CD4(+) T cells; however, here we demonstrate that dendritic cell-mediated priming was insufficient for the development of T helper type 2 cell-dependent immunity. We identify basophils as a dominant cell population that coexpressed major histocompatibility complex class II and interleukin 4 message after helminth infection. Basophilia was promoted by thymic stromal lymphopoietin, and depletion of basophils impaired immunity to helminth infection. Basophils promoted antigen-specific CD4(+) T cell proliferation and interleukin 4 production in vitro, and transfer of basophils augmented the population expansion of helminth-responsive CD4(+) T cells in vivo. Collectively, our studies suggest that major histocompatibility complex class II-dependent interactions between basophils and CD4(+) T cells promote T helper type 2 cytokine responses and immunity to helminth infection.	[Perrigoue, Jacqueline G.; Saenz, Steven A.; Siracusa, Mark C.; Taylor, Betsy C.; Giacomin, Paul R.; Nair, Meera G.; Du, Yurong; Pearce, Edward J.; Artis, David] Univ Penn, Dept Pathobiol, Philadelphia, PA 19104 USA; [Allenspach, Eric J.; Laufer, Terri M.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Zaph, Colby] Univ British Columbia, Biomed Res Ctr, Dept Pathol & Lab Med, Vancouver, BC, Canada; [van Rooijen, Nico] Vrije Univ Amsterdam, Dept Mol Cell Biol, Amsterdam, Netherlands; [Comeau, Michael R.] Amgen Inc, Inflammat Res, Seattle, WA USA; [Laufer, Terri M.] Univ Penn, Philadelphia Vet Affairs Med Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of British Columbia; Vrije Universiteit Amsterdam; Amgen; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Artis, D (corresponding author), Univ Penn, Dept Pathobiol, Philadelphia, PA 19104 USA.	dartis@vet.upenn.edu	Van Rooijen, Nico/Z-1578-2019	Artis, David/0000-0002-1753-4100; Giacomin, Paul/0000-0002-6326-6792; Nair, Meera/0000-0002-1807-5161; Zaph, Colby/0000-0002-9889-9848; Allenspach, Eric/0000-0001-7346-5835	NATIONAL CANCER INSTITUTE [T32CA009140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007532, R01AI053825, R01AI032573, R56AI032573, R01AI061570, R01AI074878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM082187] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA09140-30] Funding Source: Medline; NIAID NIH HHS [AI074878, R01 AI061570-05, R01 AI061570, AI61570, R56 AI032573, AI32573, R01 AI074878-02, R01 AI032573, R01 AI053825, T32 AI007532-08, T32 AI007532, R01 AI074878, AI53825] Funding Source: Medline; NIDDK NIH HHS [DK50306, P30 DK050306] Funding Source: Medline; NIGMS NIH HHS [F31 GM082187] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allakhverdi Z, 2007, J IMMUNOL, V179, P2051, DOI 10.4049/jimmunol.179.4.2051; Allenspach EJ, 2008, IMMUNITY, V29, P795, DOI 10.1016/j.immuni.2008.08.013; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Artis D, 2004, P NATL ACAD SCI USA, V101, P13596, DOI 10.1073/pnas.0404034101; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; BROWN SJ, 1982, J IMMUNOL, V129, P790; Cliffe LJ, 2004, ADV PARASIT, V57, P255, DOI 10.1016/S0065-308X(04)57004-5; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; Denzel A, 2008, NAT IMMUNOL, V9, P733, DOI 10.1038/ni.1621; Ehrlich P., 1879, ARCH ANAT PHYSL, V3, P166; Ekkens MJ, 2003, J IMMUNOL, V170, P384, DOI 10.4049/jimmunol.170.1.384; Else KJ, 1998, INT J PARASITOL, V28, P1145, DOI 10.1016/S0020-7519(98)00087-3; Else KJ, 1996, INFECT IMMUN, V64, P2950, DOI 10.1128/IAI.64.8.2950-2954.1996; ELSE KJ, 1994, J EXP MED, V179, P347, DOI 10.1084/jem.179.1.347; Falcone FH, 2001, TRENDS PARASITOL, V17, P126, DOI 10.1016/S1471-4922(00)01846-8; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; GAUCHAT JF, 1993, NATURE, V365, P340, DOI 10.1038/365340a0; Gessner A, 2005, J IMMUNOL, V174, P1063, DOI 10.4049/jimmunol.174.2.1063; Humphreys NE, 2008, J IMMUNOL, V180, P2443, DOI 10.4049/jimmunol.180.4.2443; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Lemos MP, 2003, J IMMUNOL, V171, P5077, DOI 10.4049/jimmunol.171.10.5077; MacDonald AS, 2008, J EXP MED, V205, P13, DOI 10.1084/jem.20072665; MacDonald AS, 2002, J IMMUNOL, V168, P537, DOI 10.4049/jimmunol.168.2.537; MacKenzie JR, 2001, J IMMUNOL, V167, P3146, DOI 10.4049/jimmunol.167.6.3146; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; Min Booki, 2006, Allergol Int, V55, P99, DOI 10.2332/allergolint.55.99; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Mowen KA, 2004, IMMUNOL REV, V202, P203, DOI 10.1111/j.0105-2896.2004.00209.x; Obata K, 2007, BLOOD, V110, P913, DOI 10.1182/blood-2007-01-068718; Oh K, 2007, BLOOD, V109, P2921, DOI 10.1182/blood-2006-07-037739; Ohnmacht C, 2009, BLOOD, V113, P2816, DOI 10.1182/blood-2008-05-154773; Owyang AM, 2006, J EXP MED, V203, P843, DOI 10.1084/jem.20051496; Padigel UM, 2007, J INFECT DIS, V196, P1844, DOI 10.1086/522968; Pecaric-Petkovic T, 2009, BLOOD, V113, P1526, DOI 10.1182/blood-2008-05-157818; Perrigoue JG, 2008, CELL MICROBIOL, V10, P1757, DOI 10.1111/j.1462-5822.2008.01174.x; Reiner SL, 2007, CELL, V129, P33, DOI 10.1016/j.cell.2007.03.019; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Scheu S, 2006, NAT IMMUNOL, V7, P644, DOI 10.1038/ni1338; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Schramm G, 2007, J IMMUNOL, V178, P6023, DOI 10.4049/jimmunol.178.10.6023; Shen T, 2008, INT IMMUNOL, V20, P1201, DOI 10.1093/intimm/dxn077; Skokos D, 2003, J IMMUNOL, V170, P3037, DOI 10.4049/jimmunol.170.6.3037; Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Suzukawa M, 2008, J IMMUNOL, V181, P5981, DOI 10.4049/jimmunol.181.9.5981; Taylor BC, 2009, J EXP MED, V206, P655, DOI 10.1084/jem.20081499; Taylor JJ, 2006, J IMMUNOL, V176, P5839, DOI 10.4049/jimmunol.176.10.5839; VANROOIJEN N, 1989, J IMMUNOL METHODS, V124, P1, DOI 10.1016/0022-1759(89)90178-6; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590; Zaph C, 2006, J IMMUNOL, V177, P511, DOI 10.4049/jimmunol.177.1.511; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	59	462	476	0	39	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2009	10	7					697	U45		10.1038/ni.1740	http://dx.doi.org/10.1038/ni.1740			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	459WF	19465906	Green Accepted, Green Submitted			2022-12-18	WOS:000267142600008
J	Sporri, R; Sousa, CRE				Sporri, R; Sousa, CRE			Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4(+) T cell populations lacking helper function	NATURE IMMUNOLOGY			English	Article							DOUBLE-STRANDED-RNA; TOLL-LIKE RECEPTOR; NECROSIS-FACTOR-ALPHA; IL-12 PRODUCTION; CUTTING EDGE; DANGER SIGNAL; IMMUNE-SYSTEM; I INTERFERONS; B-CELLS; ANTIGEN	Dendritic cells (DCs) can be activated directly by triggering of receptors for pathogens or, indirectly, by exposure to inflammatory signals. It remains unclear, however, whether the two pathways result in qualitatively similar DCs or lead to equivalent adaptive immune responses. Here we report that indirect activation by inflammatory mediators generated DCs that supported CD4(+) T cell clonal expansion but failed to direct T helper cell differentiation. In contrast, exposure to pathogen components resulted in fully activated DCs that promoted T helper responses. These results indicate that inflammation cannot substitute for contact with pathogen components in DC activation and suggest that the function of pattern recognition by DCs is to couple the quality of the adaptive immune response to the nature of the pathogen.	London Res Inst, Immunobiol Lab, Canc Res UK, London WC2A 3PX, England	Cancer Research UK	Sousa, CRE (corresponding author), London Res Inst, Immunobiol Lab, Canc Res UK, London WC2A 3PX, England.	caetano@cancer.org.uk	Reis e Sousa, Caetano/ABD-7322-2021; Reis e Sousa, Caetano/O-1657-2014	Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119				Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Albert ML, 2001, NAT IMMUNOL, V2, P1010, DOI 10.1038/ni722; Aliberti J, 2003, J IMMUNOL, V170, P5349, DOI 10.4049/jimmunol.170.11.5349; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Didierlaurent A, 2004, J IMMUNOL, V172, P6922, DOI 10.4049/jimmunol.172.11.6922; Doxsee CL, 2003, J IMMUNOL, V171, P1156, DOI 10.4049/jimmunol.171.3.1156; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Gett AV, 1998, P NATL ACAD SCI USA, V95, P9488, DOI 10.1073/pnas.95.16.9488; Hamerman JA, 2004, J IMMUNOL, V172, P2001, DOI 10.4049/jimmunol.172.4.2001; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Honda K, 2003, P NATL ACAD SCI USA, V100, P10872, DOI 10.1073/pnas.1934678100; Hoshino K, 2002, INT IMMUNOL, V14, P1225, DOI 10.1093/intimm/dxf089; Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jankovic D, 2002, IMMUNITY, V16, P429, DOI 10.1016/S1074-7613(02)00278-9; Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Lebre MC, 2003, J INVEST DERMATOL, V120, P990, DOI 10.1046/j.1523-1747.2003.12245.x; Liu NS, 2003, NAT IMMUNOL, V4, P687, DOI 10.1038/ni941; Luft T, 2002, J IMMUNOL, V168, P713, DOI 10.4049/jimmunol.168.2.713; Luft T, 1998, J IMMUNOL, V161, P1947; Manickasingham S, 2000, J IMMUNOL, V165, P5027, DOI 10.4049/jimmunol.165.9.5027; Mattei F, 2001, J IMMUNOL, V167, P1179, DOI 10.4049/jimmunol.167.3.1179; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Menges M, 2002, J EXP MED, V195, P15, DOI 10.1084/jem.20011341; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; Pasare C, 2004, IMMUNITY, V21, P733, DOI 10.1016/j.immuni.2004.10.006; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Peterson DA, 1999, IMMUNITY, V11, P453, DOI 10.1016/S1074-7613(00)80120-X; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Scanga CA, 2002, J IMMUNOL, V168, P5997, DOI 10.4049/jimmunol.168.12.5997; SCHULER G, 1985, J EXP MED, V161, P526, DOI 10.1084/jem.161.3.526; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Sousa CRE, 2004, SEMIN IMMUNOL, V16, P27, DOI 10.1016/j.smim.2003.10.004; Sousa CRE, 2004, CURR OPIN IMMUNOL, V16, P21, DOI 10.1016/j.coi.2003.11.007; Sporri R, 2003, J IMMUNOL, V171, P6406, DOI 10.4049/jimmunol.171.12.6406; Stefanova I, 2003, IMMUNOL REV, V191, P97, DOI 10.1034/j.1600-065X.2003.00006.x; STEVENS TL, 1988, NATURE, V334, P255, DOI 10.1038/334255a0; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Zhong GM, 1997, P NATL ACAD SCI USA, V94, P13856, DOI 10.1073/pnas.94.25.13856	49	462	486	2	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2005	6	2					163	170		10.1038/ni1162	http://dx.doi.org/10.1038/ni1162			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	889UL	15654341				2022-12-18	WOS:000226468100019
J	Tai, XG; Cowan, M; Feigenbaum, L; Singer, A				Tai, XG; Cowan, M; Feigenbaum, L; Singer, A			CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2	NATURE IMMUNOLOGY			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; NEGATIVE SELECTION; CD4(+)CD8(+) THYMOCYTES; CYTOPLASMIC DOMAIN; SURFACE MOLECULES; CLONAL DELETION; CUTTING EDGE; ANTIGEN 4; CD4(+)CD25(+); RECEPTOR	Efficient generation of regulatory T cells (T-reg cells) in the thymus requires CD28 costimulation, but it is not known why. Here, molecular mapping of CD28 costimulation showed that T-reg cell generation requires a motif that binds the tyrosine kinase Lck, precisely the same motif that is required for CD28 costimulation of interleukin 2 production. Nevertheless, CD28 costimulation provides more than interleukin 2 to developing T-reg cells, as CD28 costimulation of T cell receptor-signaled double-positive thymocytes induced expression of Foxp3, considered to be the T-reg 'master gene', as well as GITR and CTLA-4, two proteins expressed on T-reg cells. Thus, CD28 costimulation directly signals developing thymocytes to express Foxp3 and to initiate the T-reg cell differentiation program.	NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; NCI, SAIC Frederick, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Singer, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA.	singera@nih.gov			NATIONAL CANCER INSTITUTE [ZICBC009255, ZIABC009273, Z01BC009255, Z01BC009273] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Almeida ARM, 2002, J IMMUNOL, V169, P4850, DOI 10.4049/jimmunol.169.9.4850; Andres PG, 2004, NAT IMMUNOL, V5, P435, DOI 10.1038/ni1044; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Bensinger SJ, 2001, J EXP MED, V194, P427, DOI 10.1084/jem.194.4.427; Bhandoola A, 2002, IMMUNITY, V17, P425, DOI 10.1016/S1074-7613(02)00417-X; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; Burr JS, 2001, J IMMUNOL, V166, P5331, DOI 10.4049/jimmunol.166.9.5331; Cibotti R, 1997, IMMUNITY, V6, P245, DOI 10.1016/S1074-7613(00)80327-1; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Harada Y, 2001, J IMMUNOL, V166, P3797, DOI 10.4049/jimmunol.166.6.3797; Holdorf AD, 1999, J EXP MED, V190, P375, DOI 10.1084/jem.190.3.375; Holdorf AD, 2002, NAT IMMUNOL, V3, P259, DOI 10.1038/ni761; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; JENKINS MK, 1991, J IMMUNOL, V147, P2461; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kishimoto H, 1999, J EXP MED, V190, P65, DOI 10.1084/jem.190.1.65; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Marengere LEM, 1997, J IMMUNOL, V159, P3220; MARRACK P, 1988, CELL, V53, P627, DOI 10.1016/0092-8674(88)90578-8; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; McKean DJ, 2001, J IMMUNOL, V166, P3468, DOI 10.4049/jimmunol.166.5.3468; Oehen S, 1996, J EXP MED, V183, P2617, DOI 10.1084/jem.183.6.2617; Okkenhaug K, 2001, NAT IMMUNOL, V2, P325, DOI 10.1038/86327; PAGES F, 1994, NATURE, V369, P327, DOI 10.1038/369327a0; Papiernik M, 1998, INT IMMUNOL, V10, P371, DOI 10.1093/intimm/10.4.371; PRASAD KVS, 1994, P NATL ACAD SCI USA, V91, P2834, DOI 10.1073/pnas.91.7.2834; PUNT JA, 1994, J EXP MED, V179, P709, DOI 10.1084/jem.179.2.709; Punt JA, 1997, J EXP MED, V186, P1911, DOI 10.1084/jem.186.11.1911; RAMSDELL F, 1989, SCIENCE, V246, P1038, DOI 10.1126/science.2511629; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; ROBERTS JL, 1990, J EXP MED, V171, P935, DOI 10.1084/jem.171.3.935; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shevach EM, 2001, IMMUNOL REV, V182, P58, DOI 10.1034/j.1600-065X.2001.1820104.x; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Walker LSK, 2002, NAT REV IMMUNOL, V2, P11, DOI 10.1038/nri701	49	462	485	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2005	6	2					152	162		10.1038/ni1160	http://dx.doi.org/10.1038/ni1160			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	889UL	15640801				2022-12-18	WOS:000226468100018
J	Phan, TG; Grigorova, I; Okada, T; Cyster, JG				Phan, Tri Giang; Grigorova, Irina; Okada, Takaharu; Cyster, Jason G.			Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells	NATURE IMMUNOLOGY			English	Article							FOLLICULAR DENDRITIC CELLS; MARGINAL ZONE; ANTIBODY-RESPONSES; GERMINAL-CENTERS; MICE DEFICIENT; ANTIGEN; FOLLICLES; RECEPTOR; LOCALIZATION; SINUS	The mechanism of B cell-antigen encounter in lymphoid tissues is incompletely understood. It is also unclear how immune complexes are transported to follicular dendritic cells. Here, using real-time two-photon microscopy we noted rapid delivery of immune complexes through the lymph to macrophages in the lymph node subcapsular sinus. B cells captured immune complexes by a complement receptor-dependent mechanism from macrophage processes that penetrated the follicle and transported the complexes to follicular dendritic cells. Furthermore, cognate B cells captured antigen-containing immune complexes from macrophage processes and migrated to the T zone. Our findings identify macrophages lining the subcapsular sinus as an important site of B cell encounter with immune complexes and show that intrafollicular B cell migration facilitates the transport of immune complexes as well as encounters with cognate antigen.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	jason.cyster@ucsf.edu	Grigorova, Irina/AAR-8795-2020; Okada, Takaharu/N-7931-2015; Phan, Tri Giang/G-3937-2012	Grigorova, Irina/0000-0002-4963-7403; Phan, Tri Giang/0000-0002-4909-2984	NIAID NIH HHS [AI40098, AI45073] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040098, R01AI045073, R37AI040098] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Boes M, 1998, J IMMUNOL, V160, P4776; BROWN JC, 1970, NATURE, V228, P367, DOI 10.1038/228367a0; Carroll MC, 1998, ANNU REV IMMUNOL, V16, P545, DOI 10.1146/annurev.immunol.16.1.545; Cascalho M, 1996, SCIENCE, V272, P1649, DOI 10.1126/science.272.5268.1649; Ehrenstein MR, 1998, P NATL ACAD SCI USA, V95, P10089, DOI 10.1073/pnas.95.17.10089; FARR AG, 1980, AM J ANAT, V157, P265, DOI 10.1002/aja.1001570304; Ferguson AR, 2004, INT IMMUNOL, V16, P1411, DOI 10.1093/intimm/dxh142; FOSSUM S, 1980, SCAND J IMMUNOL, V12, P433, DOI 10.1111/j.1365-3083.1980.tb00087.x; GRAY D, 1984, IMMUNOLOGY, V52, P659; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; GROENEVELD PHP, 1986, IMMUNOLOGY, V58, P285; Hadjantonakis Anna-Katerina, 2002, BMC Biotechnol, V2, P11, DOI 10.1186/1472-6750-2-11; HEINEN E, 1986, EUR J IMMUNOL, V16, P167, DOI 10.1002/eji.1830160211; Heyman B, 2000, ANNU REV IMMUNOL, V18, P709, DOI 10.1146/annurev.immunol.18.1.709; KRAAL G, 1992, INT REV CYTOL, V132, P31, DOI 10.1016/S0074-7696(08)62453-5; MartinezPomares L, 1996, J EXP MED, V184, P1927, DOI 10.1084/jem.184.5.1927; MILLER JJ, 1964, J EXP MED, V120, P1075, DOI 10.1084/jem.120.6.1075; MITCHELL J, 1965, NATURE, V208, P500, DOI 10.1038/208500b0; Molina H, 1996, P NATL ACAD SCI USA, V93, P3357, DOI 10.1073/pnas.93.8.3357; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Mueller CGF, 2001, J IMMUNOL, V167, P5052, DOI 10.4049/jimmunol.167.9.5052; NOSSAL GJV, 1965, IMMUNOLOGY, V9, P349; NOSSAL GJV, 1968, J EXP MED, V127, P277, DOI 10.1084/jem.127.2.277; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Pape KA, 2007, IMMUNITY, V26, P491, DOI 10.1016/j.immuni.2007.02.011; Phan TG, 2003, J EXP MED, V197, P845, DOI 10.1084/jem.20022144; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Qin DH, 2000, J IMMUNOL, V164, P6268, DOI 10.4049/jimmunol.164.12.6268; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; SZAKAL AK, 1983, J IMMUNOL, V131, P1714; SZAKAL AK, 1989, ANNU REV IMMUNOL, V7, P91, DOI 10.1146/annurev.immunol.7.1.91; TEW JG, 1984, AM J ANAT, V170, P407, DOI 10.1002/aja.1001700314; TEW JG, 1980, IMMUNOL REV, V53, P175; VEERMAN AJP, 1975, CELL TISSUE RES, V161, P211, DOI 10.1007/BF00220369; Whipple EC, 2004, J IMMUNOL, V173, P2297, DOI 10.4049/jimmunol.173.4.2297	38	461	464	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2007	8	9					992	1000		10.1038/ni1494	http://dx.doi.org/10.1038/ni1494			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	202QN	17660822	Bronze			2022-12-18	WOS:000248918200023
J	Steinman, L				Steinman, L			Multiple sclerosis: a two-stage disease	NATURE IMMUNOLOGY			English	News Item							PEPTIDE; SCREEN; CELL	The pathogenesis of multiple sclerosis consists of an inflammatory and neurodegnerative phase. Better understanding of these stages has aided the development of specific therapeutic targets.	Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Stanford University	Steinman, L (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.			Steinman, Lawrence/0000-0002-2437-2250				Conlon P, 1999, NEUROBIOL DIS, V6, P149, DOI 10.1006/nbdi.1999.0239; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; Haines JL, 1996, NAT GENET, V13, P469, DOI 10.1038/ng0896-469; Kappos L, 2000, NAT MED, V6, P1176, DOI 10.1038/80525; LOSEFF NA, 1996, BRAIN, V119, P701; Lucchinetti CF, 1996, BRAIN PATHOL, V6, P259, DOI 10.1111/j.1750-3639.1996.tb00854.x; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Wucherpfennig KW, 1997, J CLIN INVEST, V100, P1114, DOI 10.1172/JCI119622	10	461	500	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2001	2	9					762	764		10.1038/ni0901-762	http://dx.doi.org/10.1038/ni0901-762			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	468WM	11526378				2022-12-18	WOS:000170781200004
J	Hajjar, AM; Ernst, RK; Tsai, JH; Wilson, CB; Miller, SI				Hajjar, AM; Ernst, RK; Tsai, JH; Wilson, CB; Miller, SI			Human Toll-like receptor 4 recognizes host-specific LPS modifications	NATURE IMMUNOLOGY			English	Article							CYSTIC-FIBROSIS; CUTTING EDGE; SALMONELLA-TYPHIMURIUM; ESCHERICHIA-COLI; LIPOPOLYSACCHARIDE; TLR4; MICE; RESISTANCE; MUTATIONS; ENDOTOXIN	Lipopolysaccharide (LPS) is the principal proinflammatory component of the Gram-negative bacterial envelope and is recognized by the Toll-like receptor 4 (TLR4)-MD-2 receptor complex. Bacteria can alter the acylation state of their LPS in response to environmental changes. One opportunistic bacterium, Pseudomonas aeruginosa, synthesizes more highly acylated ( hexa-acylated) LPS structures during adaptation to the cystic fibrosis airway. Here we show that human, but not murine, TLR4-MD-2 recognizes this adaptation and transmits robust proinflammatory signals in response to hexa-acylated but not penta-acylated LPS from P. aeruginosa. Whereas responses to lipid(IVA) and taxol are dependent on murine MD-2, discrimination of P. aeruginosa LPS structures is mediated by an 82-amino-acid region of human TLR4 that is hypervariable across species. Thus, in contrast to mice, humans use TLR4 to recognize a molecular signature of bacterial-host adaptation to modulate the innate immune response.	Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Dept Pediat, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Miller, SI (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.			Hajjar, Adeline/0000-0002-4838-8070	NHLBI NIH HHS [HL65898, HL69503] Funding Source: Medline; NIAID NIH HHS [AI47938] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065898, R01HL069503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047938] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akashi S, 2001, INT IMMUNOL, V13, P1595, DOI 10.1093/intimm/13.12.1595; Akashi S, 2000, J IMMUNOL, V164, P3471, DOI 10.4049/jimmunol.164.7.3471; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Bals R, 1999, J CLIN INVEST, V103, P303, DOI 10.1172/JCI6277; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; Burns JL, 2001, J INFECT DIS, V183, P444, DOI 10.1086/318075; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; Davis PB, 1996, AM J RESP CRIT CARE, V154, P1229, DOI 10.1164/ajrccm.154.5.8912731; Ernst RK, 1999, SCIENCE, V286, P1561, DOI 10.1126/science.286.5444.1561; Grubb Barbara R., 1999, Physiological Reviews, V79, pS193; Guggino WB, 2001, NAT MED, V7, P888, DOI 10.1038/90914; Guggino WB, 1999, CELL, V96, P607, DOI 10.1016/S0092-8674(00)80570-X; Gunn JS, 2000, INFECT IMMUN, V68, P6139, DOI 10.1128/IAI.68.11.6139-6146.2000; Gunn JS, 1998, MOL MICROBIOL, V27, P1171, DOI 10.1046/j.1365-2958.1998.00757.x; Guo L, 1998, CELL, V95, P189, DOI 10.1016/S0092-8674(00)81750-X; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; Hajjar AM, 2001, J IMMUNOL, V166, P15, DOI 10.4049/jimmunol.166.1.15; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kawasaki K, 2000, J BIOL CHEM, V275, P2251, DOI 10.1074/jbc.275.4.2251; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; OBRIEN AD, 1980, J IMMUNOL, V124, P20; Pilewski Joseph M., 1999, Physiological Reviews, V79, pS215; Poltorak A, 2000, P NATL ACAD SCI USA, V97, P2163, DOI 10.1073/pnas.040565397; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; RAETZ CRH, 1996, ESCHERICHIA COLI SAL, P1035; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Somerville JE, 1996, J CLIN INVEST, V97, P359, DOI 10.1172/JCI118423; Supajatura V, 2001, J IMMUNOL, V167, P2250, DOI 10.4049/jimmunol.167.4.2250; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Visintin A, 2001, P NATL ACAD SCI USA, V98, P12156, DOI 10.1073/pnas.211445098; Walker K, 2000, P NATL ACAD SCI USA, V97, P13591, DOI 10.1073/pnas.250491997	36	459	488	3	38	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2002	3	4					354	359		10.1038/ni777	http://dx.doi.org/10.1038/ni777			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	535BD	11912497				2022-12-18	WOS:000174623600016
J	Peng, YC; Mentzer, AJ; Liu, GH; Yao, X; Yin, ZX; Dong, DN; Dejnirattisai, W; Rostron, T; Supasa, P; Liu, C; Lopez-Camacho, C; Slon-Campos, J; Zhao, YG; Stuart, DI; Paesen, GC; Grimes, JM; Antson, AA; Bayfield, OW; Hawkins, DEDP; Ker, DS; Wang, BB; Turtle, L; Subramaniam, K; Thomson, P; Zhang, P; Dold, C; Ratcliff, J; Simmonds, P; de Silva, T; Sopp, P; Wellington, D; Rajapaksa, U; Chen, YL; Salio, M; Napolitani, G; Paes, W; Borrow, P; Kessler, BM; Fry, JW; Schwabe, NF; Semple, MG; Baillie, JK; Moore, SC; Openshaw, PJM; Ansari, MA; Dunachie, S; Barnes, E; Frater, J; Kerr, G; Goulder, P; Lockett, T; Levin, R; Zhang, YH; Jing, RH; Ho, LP; Cornall, RJ; Conlon, CP; Klenerman, P; Screaton, GR; Mongkolsapaya, J; McMichael, A; Knight, JC; Ogg, G; Dong, T				Peng, Yanchun; Mentzer, Alexander J.; Liu, Guihai; Yao, Xuan; Yin, Zixi; Dong, Danning; Dejnirattisai, Wanwisa; Rostron, Timothy; Supasa, Piyada; Liu, Chang; Lopez-Camacho, Cesar; Slon-Campos, Jose; Zhao, Yuguang; Stuart, David, I; Paesen, Guido C.; Grimes, Jonathan M.; Antson, Alfred A.; Bayfield, Oliver W.; Hawkins, Dorothy E. D. P.; Ker, De-Sheng; Wang, Beibei; Turtle, Lance; Subramaniam, Krishanthi; Thomson, Paul; Zhang, Ping; Dold, Christina; Ratcliff, Jeremy; Simmonds, Peter; de Silva, Thushan; Sopp, Paul; Wellington, Dannielle; Rajapaksa, Ushani; Chen, Yi-Ling; Salio, Mariolina; Napolitani, Giorgio; Paes, Wayne; Borrow, Persephone; Kessler, Benedikt M.; Fry, Jeremy W.; Schwabe, Nikolai F.; Semple, Malcolm G.; Baillie, J. Kenneth; Moore, Shona C.; Openshaw, Peter J. M.; Ansari, M. Azim; Dunachie, Susanna; Barnes, Eleanor; Frater, John; Kerr, Georgina; Goulder, Philip; Lockett, Teresa; Levin, Robert; Zhang, Yonghong; Jing, Ronghua; Ho, Ling-Pei; Cornall, Richard J.; Conlon, Christopher P.; Klenerman, Paul; Screaton, Gavin R.; Mongkolsapaya, Juthathip; McMichael, Andrew; Knight, Julian C.; Ogg, Graham; Dong, Tao		Oxford Immunology Network Covid-19; ISARIC4C Investigators	Broad and strong memory CD4(+)and CD8(+)T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19	NATURE IMMUNOLOGY			English	Article							T-CELLS; RESPONSES; CORONAVIRUSES; REPLICATION; PROTECTION; PHENOTYPE; H5N1	The development of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines and therapeutics will depend on understanding viral immunity. We studied T cell memory in 42 patients following recovery from COVID-19 (28 with mild disease and 14 with severe disease) and 16 unexposed donors, using interferon-gamma-based assays with peptides spanning SARS-CoV-2 except ORF1. The breadth and magnitude of T cell responses were significantly higher in severe as compared with mild cases. Total and spike-specific T cell responses correlated with spike-specific antibody responses. We identified 41 peptides containing CD4(+)and/or CD8(+)epitopes, including six immunodominant regions. Six optimized CD8(+)epitopes were defined, with peptide-MHC pentamer-positive cells displaying the central and effector memory phenotype. In mild cases, higher proportions of SARS-CoV-2-specific CD8(+)T cells were observed. The identification of T cell responses associated with milder disease will support an understanding of protective immunity and highlights the potential of including non-spike proteins within future COVID-19 vaccine design. Questions have arisen as to whether patients with severe COVID-19 disease can generate a T cell response against SARS-CoV-2. Tao Dong and colleagues report that convalescent patients with COVID-19 harbor functional memory CD4(+)and CD8(+)T cells that recognize multiple epitopes that span the viral proteome. CD4(+)T cells predominated the memory response in patients with severe disease, whereas higher proportions of CD8(+)T cells were found in patients with mild disease.	[Peng, Yanchun; Yao, Xuan; Yin, Zixi; Wellington, Dannielle; Chen, Yi-Ling; Salio, Mariolina; Napolitani, Giorgio; Ho, Ling-Pei; Cornall, Richard J.; Ogg, Graham; Dong, Tao] Univ Oxford, MRC Weatherall Inst Mol Med, Radcliffe Dept Med, MRC Human Immunol Unit, Oxford, England; [Peng, Yanchun; Liu, Guihai; Yao, Xuan; Yin, Zixi; Dong, Danning; Liu, Chang; Stuart, David, I; Wang, Beibei; Wellington, Dannielle; Rajapaksa, Ushani; Kessler, Benedikt M.; Zhang, Yonghong; Ho, Ling-Pei; Conlon, Christopher P.; Mongkolsapaya, Juthathip; McMichael, Andrew; Knight, Julian C.; Ogg, Graham; Dong, Tao] Univ Oxford, Oxford Inst COI, Chinese Acad Med Sci CAMS, Oxford, England; [Mentzer, Alexander J.; Lopez-Camacho, Cesar; Stuart, David, I; Paesen, Guido C.; Grimes, Jonathan M.; Knight, Julian C.] Univ Oxford, Wellcome Ctr Human Genet, Oxford, England; [Mentzer, Alexander J.; Liu, Guihai; Yao, Xuan; Dong, Danning; Dejnirattisai, Wanwisa; Supasa, Piyada; Liu, Chang; Lopez-Camacho, Cesar; Slon-Campos, Jose; Zhao, Yuguang; Stuart, David, I; Grimes, Jonathan M.; Wang, Beibei; Zhang, Ping; Ratcliff, Jeremy; Simmonds, Peter; Rajapaksa, Ushani; Paes, Wayne; Borrow, Persephone; Kessler, Benedikt M.; Ansari, M. Azim; Dunachie, Susanna; Barnes, Eleanor; Frater, John; Kerr, Georgina; Goulder, Philip; Ho, Ling-Pei; Cornall, Richard J.; Conlon, Christopher P.; Klenerman, Paul; Screaton, Gavin R.; Mongkolsapaya, Juthathip; McMichael, Andrew; Knight, Julian C.; Dong, Tao] Univ Oxford, Nuffield Dept Med, Oxford, England; [Mentzer, Alexander J.; Dunachie, Susanna; Barnes, Eleanor; Frater, John; Goulder, Philip; Lockett, Teresa; Cornall, Richard J.; Conlon, Christopher P.; Klenerman, Paul; Screaton, Gavin R.; Knight, Julian C.; Ogg, Graham] Oxford Univ Hosp NHS Fdn Trust, Oxford, England; [Liu, Guihai; Zhang, Yonghong; Jing, Ronghua] Capital Med Univ, Beijing Youan Hosp, Beijing, Peoples R China; [Dong, Danning] Xinjiang Med Univ, Xinjiang Tumor Hosp, CAMS Key Lab Tumor Immunol & Radiat Therapy, Urumqi, Xinjiang, Peoples R China; [Rostron, Timothy; Sopp, Paul] Univ Oxford, Weatherall Inst Mol Med, Sequencing & Flow Cytometry Facil, Oxford, England; [Stuart, David, I; Grimes, Jonathan M.] Diamond Light Source, Didcot, Oxon, England; [Antson, Alfred A.; Bayfield, Oliver W.; Hawkins, Dorothy E. D. P.; Ker, De-Sheng] Univ York, Dept Chem, York Struct Biol Lab, York, N Yorkshire, England; [Turtle, Lance] Liverpool Univ Hosp NHS Fdn Trust, Trop & Infect Dis Unit, Liverpool, Merseyside, England; [Turtle, Lance; Subramaniam, Krishanthi; Thomson, Paul; Semple, Malcolm G.; Moore, Shona C.] Univ Liverpool, Inst Infect Vet & Ecol Sci, NIHR Hlth Protect Res Unit Emerging & Zoonot Infe, Liverpool, Merseyside, England; [Dold, Christina] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England; [Dold, Christina] Univ Oxford, NIHR Oxford Biomed Res Ctr, Ctr Clin Vaccinol & Trop Med, Oxford, England; [de Silva, Thushan] Univ Sheffield, Dept Infect Immun & Cardiovasc Dis, Florey Inst Host Pathogen Interact, Sheffield, S Yorkshire, England; [Fry, Jeremy W.; Schwabe, Nikolai F.] ProImmune, Oxford, England; [Semple, Malcolm G.] Alder Hey Childrens Hosp, Resp Med, Inst Pk, Liverpool, Merseyside, England; [Baillie, J. Kenneth] Univ Edinburgh, Anaesthesia Crit Care & Pain Med Div Hlth Sci, Edinburgh, Midlothian, Scotland; [Openshaw, Peter J. M.] Imperial Coll London, Fac Med, Natl Heart & Lung Inst, London, England; [Barnes, Eleanor; Ho, Ling-Pei; Klenerman, Paul; Screaton, Gavin R.; Mongkolsapaya, Juthathip; Ogg, Graham] NIHR Oxford Biomed Res Ctr, Oxford, England; [Levin, Robert] Worthing Dist Hosp, Worthing, England; [Mongkolsapaya, Juthathip] Mahidol Univ, Siriraj Hosp, Fac Med, Off Res & Dev,Dengue Hemorrhag Fever Res Unit, Bangkok, Thailand	University of Oxford; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Oxford University Hospitals NHS Foundation Trust; Capital Medical University; Xinjiang Medical University; University of Oxford; Diamond Light Source; University of York - UK; University of Liverpool; University of Oxford; University of Oxford; University of Sheffield; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; University of Edinburgh; Imperial College London; University of Oxford; Mahidol University	Dong, T (corresponding author), Univ Oxford, MRC Weatherall Inst Mol Med, Radcliffe Dept Med, MRC Human Immunol Unit, Oxford, England.; Dong, T (corresponding author), Univ Oxford, Oxford Inst COI, Chinese Acad Med Sci CAMS, Oxford, England.; Dong, T (corresponding author), Univ Oxford, Nuffield Dept Med, Oxford, England.	tao.dong@imm.ox.ac.uk	Baillie, Kenneth/AEK-6650-2022; Lopez-Camacho, Cesar/AID-3761-2022; Asiimwe, Innocent/AAD-7175-2022; Semple, Malcolm Gracie/A-8790-2008; Ho, Ling-Pei/AAL-4776-2021; Baillie, John Kenneth/F-3124-2011; Kessler, Benedikt/AAY-8614-2021; Knight, Julian Charles/W-2399-2019; Moore, Shona C/AAY-5049-2021; Dold, Christina/ABA-4237-2021; Ratcliff, Jeremy/AAE-6586-2021; Subramaniam, Krishanthi/AAW-8777-2021; Antson, Alfred/N-2551-2016	Baillie, Kenneth/0000-0001-5258-793X; Lopez-Camacho, Cesar/0000-0001-7932-2341; Asiimwe, Innocent/0000-0002-1196-1822; Semple, Malcolm Gracie/0000-0001-9700-0418; Baillie, John Kenneth/0000-0001-5258-793X; Kessler, Benedikt/0000-0002-8160-2446; Knight, Julian Charles/0000-0002-0377-5536; Moore, Shona C/0000-0001-8610-2806; Subramaniam, Krishanthi/0000-0002-1734-9351; Antson, Alfred/0000-0002-4533-3816; Ratcliff, Jeremy/0000-0001-6522-138X; Mentzer, Alexander/0000-0002-4502-2209; Dong, Tao/0000-0003-3545-3758; Slon Campos, Jose Luis/0000-0002-0012-5247; Dunachie, Susanna/0000-0001-5665-6293; Borrow, Persephone/0000-0002-3877-9780; Fry, Jeremy/0000-0003-3689-6606; Frater, John/0000-0001-7163-7277; de Silva, Thushan/0000-0002-6498-9212; dold, christina/0000-0003-2314-507X; klenerman, paul/0000-0003-4307-9161; Screaton, Gavin/0000-0002-3549-4309; Ho, Ling Pei/0000-0001-8319-301X; Wellington, Dannielle/0000-0002-9277-0306; Chen, Yi-Ling/0000-0003-3758-0638; Ansari, M. Azim/0000-0003-2790-8353; Zhang, Ping/0000-0001-7063-7769; McDonald, Sarah/0000-0003-2776-7415; Wang, Beibei/0000-0002-3746-0188; Green, Christopher/0000-0002-1984-4014; Bayfield, Oliver William/0000-0003-1421-7780; Grimes, Jonathan Mark/0000-0001-9698-0389; Barnes, Eleanor/0000-0002-0860-0831; Salio, Mariolina/0000-0002-4821-3801; Ogg, Graham/0000-0002-3097-045X	Oxford Immunology Network COVID-19 Response T Cell Consortium (Supplementary Table 4); UK Medical Research Council; Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences (CIFMS), China [2018-I2M-2-002]; National Institutes of Health, National Key R&D Program of China [2020YFE0202400]; China Scholarship Council; National Institute for Health Research (NIHR) [CO-CIN-01]; Medical Research Council [MC_PC_19059]; Wellcome Trust; Department for International Development [215091/Z/18/Z]; Bill and Melinda Gates Foundation [OPP1209135]; NIHR Oxford Biomedical Research Centre; Health Protection Research Unit in Respiratory Infections [NIHR200927/WHRG_P82523]; NIHR Senior Investigator Award [NIHR201385/WHRR P84026]; Imperial College Biomedical Research Centre [IS-BRC-1215-20013]; National Institute of Allergy and Infectious Diseases (Consortium for HIV/AIDS Vaccine Development) [UM1 AI 144371, R01 AI 118549]; NIHR Health Protection Research Unit (HPRU) in Emerging and Zoonotic Infections at the University of Liverpool [NIHR200907]; Public Health England (PHE); Schmidt Futures; Liverpool School of Tropical Medicine; University of Oxford; Wellcome Trust [205228/Z/16/Z, 110058/Z/15/Z, 206377, 095541/A/11/Z]; MRC [MR/L018942/1, MR/N00065X/1, MC_UU_00008/6, MC_PC_19059, MC_UU_00008/5, MC_PC_19025, MC_PC_20002, G116/150, MC_UU_12010/5, MC_U137881017] Funding Source: UKRI; UKRI [MR/S032304/1] Funding Source: UKRI	Oxford Immunology Network COVID-19 Response T Cell Consortium (Supplementary Table 4); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences (CIFMS), China; National Institutes of Health, National Key R&D Program of China(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Department for International Development; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Health Protection Research Unit in Respiratory Infections; NIHR Senior Investigator Award; Imperial College Biomedical Research Centre; National Institute of Allergy and Infectious Diseases (Consortium for HIV/AIDS Vaccine Development); NIHR Health Protection Research Unit (HPRU) in Emerging and Zoonotic Infections at the University of Liverpool; Public Health England (PHE); Schmidt Futures; Liverpool School of Tropical Medicine; University of Oxford; Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UKRI	We are grateful to all of the participants for donating their samples and data for these analyses, and to the research teams involved in the consenting, recruitment and sampling of these participants. We acknowledge the support of the Oxford Immunology Network COVID-19 Response T Cell Consortium (Supplementary Table 4) and ISARIC4C Investigators (Supplementary Table 5). This work is supported by the UK Medical Research Council (to T.D., G.O., Y.P., M.S., G.N. and Y.-L.C.); Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences (CIFMS), China (grant number 2018-I2M-2-002 to T.D., Y.P., X.Y., G.L., D.D., D.I.S., J.M. and G.R.S.); National Institutes of Health, National Key R&D Program of China (2020YFE0202400 to T.D., Y. Zhang and R.J.); China Scholarship Council (Z.Y., G.L. and C.L.); National Institute for Health Research (NIHR) (award CO-CIN-01 to M.G.S.); Medical Research Council (grant MC_PC_19059 to M.G.S.); Wellcome Trust and Department for International Development (215091/Z/18/Z to M.G.S.); and the Bill and Melinda Gates Foundation (OPP1209135 to M.G.S.). The study is also funded by the NIHR Oxford Biomedical Research Centre (to L.-P.H., G.O., P.K., E.B. and G.R.S.), Senior Investigator Award (to G.O.), Clinical Research Network (to G.O.), Schmidt Futures (G.R.S.), Health Protection Research Unit in Respiratory Infections (NIHR200927/WHRG_P82523 to P.J.M.O.), NIHR Senior Investigator Award (NIHR201385/WHRR P84026 to P.J.M.O.), Imperial College Biomedical Research Centre (IS-BRC-1215-20013 to P.J.M.O.) and National Institute of Allergy and Infectious Diseases (Consortium for HIV/AIDS Vaccine Development UM1 AI 144371 to P.B. and A.M. and R01 AI 118549 to P.B.). L.T., P.K. and P. Simmonds are supported by the NIHR Health Protection Research Unit (HPRU) in Emerging and Zoonotic Infections (NIHR200907) at the University of Liverpool in partnership with Public Health England (PHE), in collaboration with the Liverpool School of Tropical Medicine and University of Oxford. L.T. is based at the University of Liverpool. P.K. and P. Simmonds are based at the University of Oxford. L.T., T.d.S. and A.A.A. are supported by the Wellcome Trust (grant numbers 205228/Z/16/Z to L.T., 110058/Z/15/Z to T.d.S. and 206377 to A.A.A.). G.R.S. is supported as a Wellcome Trust Senior Investigator (grant 095541/A/11/Z). P.B. and A.M. are Jenner Institute investigators. This work uses data provided by patients and collected by the NHS as part of their care, and supports the Data Saves Lives initiative. The views expressed are those of the authors and not necessarily those of the Department of Health and Social Care, DID, NIHR, MRC, Wellcome Trust or PHE.	Ahmed SF, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12030254; Braun J, 2020, NATURE, V587, P270, DOI 10.1038/s41586-020-2598-9; Campion SL, 2014, J EXP MED, V211, P1273, DOI 10.1084/jem.20130555; de Silva TI, 2013, BLOOD, V121, P4330, DOI 10.1182/blood-2012-12-472787; Diao B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00827; Dong T, 2011, BLOOD, V118, P98, DOI 10.1182/blood-2010-06-291963; Fehr A.R., 2015, METHOD MOL BIOL, P1, DOI [10.1007/978-1-4939-2438-7_1, DOI 10.1007/978-1-4939-2438-7_1]; Feng Z., 2020, MEDRXIV, p2020.03.27.20045427, DOI 10.1101/2020.03.27.20045427; Folegatti PM, 2020, LANCET, V396, P467, DOI 10.1016/S0140-6736(20)31604-4; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hayward AC, 2015, AM J RESP CRIT CARE, V191, P1422, DOI 10.1164/rccm.201411-1988OC; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; Li CKF, 2008, J IMMUNOL, V181, P5490, DOI 10.4049/jimmunol.181.8.5490; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Lillie PJ, 2012, CLIN INFECT DIS, V55, P19, DOI 10.1093/cid/cis327; Ni L, 2020, IMMUNITY, V52, P971, DOI 10.1016/j.immuni.2020.04.023; Ogg GS, 1998, AIDS, V12, P1561, DOI 10.1097/00002030-199812000-00026; Peng YC, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00287; Pereira BI, 2020, NAT IMMUNOL, V21, P684, DOI 10.1038/s41590-020-0643-3; Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147; Pizzolla A, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam6970; Powell TJ, 2012, J INFECT DIS, V205, P20, DOI 10.1093/infdis/jir689; Sekine T., 2020, CELL, DOI [10.1101/2020.06.29.174888, DOI 10.1016/J.CELL.2020.08.017, 10.1016/j.cell.2020.08.017]; Sette A, 2020, NAT REV IMMUNOL, V20, P457, DOI 10.1038/s41577-020-0389-z; Shomuradova AS, 2020, IMMUNITY, V53, P1245, DOI 10.1016/j.immuni.2020.11.004; St John AL, 2019, NAT REV IMMUNOL, V19, P218, DOI 10.1038/s41577-019-0123-x; Su LF, 2013, IMMUNOL REV, V255, P95, DOI 10.1111/imr.12095; Turner DL, 2014, MUCOSAL IMMUNOL, V7, P501, DOI 10.1038/mi.2013.67; van Doremalen N, 2020, NATURE, V586, P578, DOI [10.1038/s41586-020-2608-y, 10.1101/2020.05.13.093195]; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Yoshizawa A, 2018, EUR J IMMUNOL, V48, P128, DOI 10.1002/eji.201747174; Yu JY, 2020, SCIENCE, V369, P806, DOI 10.1126/science.abc6284; Zhu FC, 2020, LANCET, V395, P1845, DOI 10.1016/S0140-6736(20)31208-3	36	458	467	1	13	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2020	21	11					1336	+		10.1038/s41590-020-0782-6	http://dx.doi.org/10.1038/s41590-020-0782-6		SEP 2020	16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OD0BT	32577665	Green Accepted, Green Submitted, Green Published, Bronze			2022-12-18	WOS:000566073200001
J	Licona-Limon, P; Kim, LK; Palm, NW; Flavell, RA				Licona-Limon, Paula; Kim, Lark Kyun; Palm, Noah W.; Flavell, Richard A.			T(H)2, allergy and group 2 innate lymphoid cells	NATURE IMMUNOLOGY			English	Review							THYMIC STROMAL LYMPHOPOIETIN; TRANSCRIPTION FACTOR GATA3; T-CELLS; AIRWAY HYPERRESPONSIVENESS; ADAPTIVE IMMUNITY; DENDRITIC CELLS; MAST-CELLS; LUNG; CYTOKINE; INFLAMMATION	The initiation of type 2 immune responses by the epithelial cell-derived cytokines IL-25, IL-33 and TSLP has been an area of extensive research in the past decade. Such studies have led to the identification of a new innate lymphoid subset that produces the canonical type 2 cytokines IL-5, IL-9 and IL-13 in response to IL-25 and IL-33. These group 2 or type 2 innate lymphoid cells (ILC2 cells) represent a critical source of type 2 cytokines in vivo and serve an important role in orchestrating the type 2 response to helminths and allergens. Further characterization of ILC2 cell biology will enhance the understanding of type 2 responses and may identify new treatments for asthma, allergies and parasitic infections. Interactions between ILC2 cells and the adaptive immune system, as well as examination of potential roles for ILC2 cells in the maintenance of homeostasis, promise to be particularly fruitful areas of future research.	[Licona-Limon, Paula; Kim, Lark Kyun; Palm, Noah W.; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Kim, Lark Kyun; Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	Yale University; Howard Hughes Medical Institute; Yale University	Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	richard.flavell@yale.edu		Palm, Noah/0000-0001-7262-9455	NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Ballantyne SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1324, DOI 10.1016/j.jaci.2007.07.051; Barlow JL, 2012, J ALLERGY CLIN IMMUN, V129, P191, DOI 10.1016/j.jaci.2011.09.041; Barnig C, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004812; Carroll NG, 2002, EUR RESPIR J, V19, P879, DOI 10.1183/09031936.02.00275802; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Dolgachev V, 2009, J IMMUNOL, V183, P5705, DOI 10.4049/jimmunol.0901666; Erpenbeck VJ, 2003, J ALLERGY CLIN IMMUN, V111, P1319, DOI 10.1067/mai.2003.1485; FALLON PG, 2006, J EXP MED, V203, P1105, DOI DOI 10.1084/JEM.20051615; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; Fukuoka A, 2013, INT IMMUNOL, V25, P373, DOI 10.1093/intimm/dxs160; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; GOUNNI AS, 1994, NATURE, V367, P183, DOI 10.1038/367183a0; Gregory LG, 2011, TRENDS IMMUNOL, V32, P402, DOI 10.1016/j.it.2011.06.006; Halim TYF, 2012, IMMUNITY, V37, P463, DOI 10.1016/j.immuni.2012.06.012; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hammad H, 2006, J ALLERGY CLIN IMMUN, V118, P331, DOI 10.1016/j.jaci.2006.03.041; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; He R, 2008, P NATL ACAD SCI USA, V105, P11875, DOI 10.1073/pnas.0801532105; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Hsu CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011944; Humphreys NE, 2008, J IMMUNOL, V180, P2443, DOI 10.4049/jimmunol.180.4.2443; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Jung JS, 2009, CHEST, V135, P1173, DOI 10.1378/chest.08-1595; KAWABORI S, 1995, CLIN EXP ALLERGY, V25, P173, DOI 10.1111/j.1365-2222.1995.tb01023.x; Kim BS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005374; Kim HY, 2012, J ALLERGY CLIN IMMUN, V129, P216, DOI 10.1016/j.jaci.2011.10.036; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Kitajima M, 2011, EUR J IMMUNOL, V41, P1862, DOI 10.1002/eji.201041195; Kondo Y, 2008, INT IMMUNOL, V20, P791, DOI 10.1093/intimm/dxn037; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Koyasu S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00101; Lantz CS, 1998, NATURE, V392, P90, DOI 10.1038/32190; Li L, 1999, ALLERGY, V54, P306, DOI 10.1034/j.1398-9995.1999.00086.x; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Loke P'ng, 2002, BMC Immunol, V3, P7, DOI 10.1186/1471-2172-3-7; Mishra A, 1999, J CLIN INVEST, V103, P1719, DOI 10.1172/JCI6560; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Reed CE, 2004, J ALLERGY CLIN IMMUN, V114, P997, DOI 10.1016/j.jaci.2004.07.060; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shimbara A, 2000, J ALLERGY CLIN IMMUN, V105, P108, DOI 10.1016/S0091-6749(00)90185-4; Siracusa MC, 2012, ADV IMMUNOL, V115, P141, DOI 10.1016/B978-0-12-394299-9.00005-9; Siracusa MC, 2011, NATURE, V477, P229, DOI 10.1038/nature10329; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Wolterink RGJK, 2012, EUR J IMMUNOL, V42, P1106, DOI 10.1002/eji.201142018; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Yao WG, 2013, IMMUNITY, V38, P360, DOI 10.1016/j.immuni.2013.01.007; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Zaiss DM, 2006, SCIENCE, V314, P1746, DOI 10.1126/science.1133715; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	77	458	483	7	177	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2013	14	6					536	542		10.1038/ni.2617	http://dx.doi.org/10.1038/ni.2617			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	146RG	23685824				2022-12-18	WOS:000319107600006
J	Ichinohe, T; Pang, IK; Iwasaki, A				Ichinohe, Takeshi; Pang, Iris K.; Iwasaki, Akiko			Influenza virus activates inflammasomes via its intracellular M2 ion channel	NATURE IMMUNOLOGY			English	Article							A VIRUS; STRANDED-RNA; NALP3 INFLAMMASOME; IMMUNE-RESPONSES; CYTOPLASMIC DNA; RIG-I; INNATE; CASPASE-1; INFECTION; PROTEIN	Influenza virus, a negative-stranded RNA virus that causes severe illness in humans and animals, stimulates the inflammasome through the Nod-like receptor NLRP3. However, the mechanism by which influenza virus activates the NLRP3 inflammasome is unknown. Here we show that the influenza virus M2 protein, a proton-selective ion channel important in viral pathogenesis, stimulates the NLRP3 inflammasome pathway. M2 channel activity was required for the activation of inflammasomes by influenza and was sufficient to activate inflammasomes in primed macrophages and dendritic cells. M2-induced activation of inflammasomes required its localization to the Golgi apparatus and was dependent on the pH gradient. Our results show a mechanism by which influenza virus infection activates inflammasomes and identify the sensing of disturbances in intracellular ionic concentrations as a previously unknown pathogen-recognition pathway.	[Ichinohe, Takeshi; Pang, Iris K.; Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Yale University	Iwasaki, A (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	akiko.iwasaki@yale.edu	Iwasaki, Akiko/Z-1591-2019	Iwasaki, Akiko/0000-0002-7824-9856	National Institutes of Health [AI062428, AI064705, AI083242]; Japan Society for the Promotion of Science; Burroughs Wellcome; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI062428, R21AI083242, R01AI062428, R01AI064705] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Burroughs Wellcome(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Z.J. Chen (University of Texas Southwestern Medical Center) for MAVS-deficient mice; H. Hasegawa (National Institute of Infectious Diseases, Tokyo) for influenza virus strains A/Puerto Rico/8/34, A/Yamagata/120/86, A/Beijing/262/95, A/Aichi/2/68, A/Sydney/5/97 (subtype H3N2), A/Guizhou/54/89 x A/Puerto Rico/8/34 and B/Ibaraki/2/85; M.K. Collins (University College London) for lentiviral vector pHRSIN-CSGW (expressing GFP); R. Lamb (Northwestern University) for influenza virus A/Udorn/307/72 strain and the mutant virus M2del29-31; D. DiMaio (Yale University) for plasmids pT2H-HA-E5 and pT2H-HA-Q17G; C. Roy (Yale University) for GalNAc-T2-YFP BSC-1 cells; R. Medzhitov (Yale University) for monoclonal antibody 3ZD to IL- 1; M. Caplan, J. Kagan, I. Brodsky, W. Kee, E. Ip, H. K. Lee, Y. Yanagi and S. Ikegame for advice; and R. Medzhitov and J. M. Thompson for critical reading of the manuscript. Supported by the National Institutes of Health (AI062428, AI064705 and AI083242 to A.I.), the Japan Society for the Promotion of Science (T.I.) and Burroughs Wellcome (A.I.).	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Axelsson MAB, 2004, MOL BIOL CELL, V15, P1843, DOI 10.1091/mbc.E03-07-0459; Aymeric L, 2010, CANCER RES, V70, P855, DOI 10.1158/0008-5472.CAN-09-3566; Besnier C, 2002, P NATL ACAD SCI USA, V99, P11920, DOI 10.1073/pnas.172384599; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Fischer WB, 2002, BBA-BIOMEMBRANES, V1561, P27, DOI 10.1016/S0304-4157(01)00009-0; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; HARA N, 1990, FEBS LETT, V267, P281, DOI 10.1016/0014-5793(90)80945-F; HOLSINGER LJ, 1994, J VIROL, V68, P1551, DOI 10.1128/JVI.68.3.1551-1563.1994; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Johnston JB, 2005, IMMUNITY, V23, P587, DOI 10.1016/j.immuni.2005.10.003; Jones CA, 2000, VIROLOGY, V278, P137, DOI 10.1006/viro.2000.0628; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Klein O, 1998, J VIROL, V72, P8921, DOI 10.1128/JVI.72.11.8921-8932.1998; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pinto LH, 2006, J BIOL CHEM, V281, P8997, DOI 10.1074/jbc.R500020200; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Rowe HM, 2006, MOL THER, V13, P310, DOI 10.1016/j.ymthe.2005.08.025; Sakaguchi T, 1996, J CELL BIOL, V133, P733, DOI 10.1083/jcb.133.4.733; Schapiro F, 2000, J CELL BIOL, V148, P305, DOI 10.1083/jcb.148.2.305; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Takeda M, 2002, J VIROL, V76, P1391, DOI 10.1128/JVI.76.3.1391-1399.2002; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Venkataraman P, 2005, J BIOL CHEM, V280, P21463, DOI 10.1074/jbc.M412406200; Watanabe T, 2001, J VIROL, V75, P5656, DOI 10.1128/JVI.75.12.5656-5662.2001; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007	45	458	482	1	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2010	11	5					404	U61		10.1038/ni.1861	http://dx.doi.org/10.1038/ni.1861			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	585TN	20383149	Green Accepted			2022-12-18	WOS:000276852200009
J	Zhu, JF; Min, B; Hu-Li, J; Watson, CJ; Grinberg, A; Wang, Q; Killeen, N; Urban, JF; Guo, LY; Paul, WE				Zhu, JF; Min, B; Hu-Li, J; Watson, CJ; Grinberg, A; Wang, Q; Killeen, N; Urban, JF; Guo, LY; Paul, WE			Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR GATA-3; CYTOKINE GENE-EXPRESSION; T-CELLS; IN-VIVO; TH2 DIFFERENTIATION; LINEAGE COMMITMENT; IL-4 PRODUCTION; ACTIVATED RAT; CUTTING EDGE; MICE	Expression of the transcription factor GATA-3 is strongly associated with T helper type 2 (T(H)2) differentiation, but genetic evidence for its involvement in this process has been lacking. Here, we generated a conditional GATA-3-deficient mouse line. In vitro deletion of Gata3 diminished both interleukin 4 (IL-4)-dependent and IL-4-independent T(H)2 cell differentiation; without GATA-3, T(H)1 differentiation occurred in the absence of IL-12 and interferon-gamma. Gata3 deletion limited the growth of T(H)2 cells but not T(H)1 cells. Deletion of Gata3 from established T(H)2 cells abolished IL-5 and IL-13 but not IL-4 production. In vivo deletion of Gata3 using OX40-Cre eliminated T H 2 responses and allowed the development of interferon-gamma-producing cells in mice infected with Nippostrongylus brasiliensis. Thus, GATA-3 serves as a principal switch in determining T(H)1-T(H)2 responses.	NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; USDA, Nutrient Requirements & Funct Lab, Beltsville Human Nutr Res Ctr, Beltsville, MD 20705 USA; NICHHD, Lab Mammalian Genes & Dev, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California San Francisco; United States Department of Agriculture (USDA); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Zhu, JF (corresponding author), NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	jfzhu@niaid.nih.gov	Zhu, Jinfang/B-7574-2012	Zhu, Jinfang/0000-0002-0117-4745; Urban, Joseph/0000-0002-1590-8869	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000493, Z01AI000493] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; AlShamkhani A, 1996, EUR J IMMUNOL, V26, P1695, DOI 10.1002/eji.1830260805; Cote-Sierra J, 2004, P NATL ACAD SCI USA, V101, P3880, DOI 10.1073/pnas.0400339101; Finkelman FD, 2000, J IMMUNOL, V164, P2303, DOI 10.4049/jimmunol.164.5.2303; GEORGE KM, 1994, DEVELOPMENT, V120, P2673; Guo LY, 2002, P NATL ACAD SCI USA, V99, P10623, DOI 10.1073/pnas.162360199; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; Hu-Li J, 2001, IMMUNITY, V14, P1, DOI 10.1016/S1074-7613(01)00084-X; Jankovic D, 2000, J IMMUNOL, V164, P3047, DOI 10.4049/jimmunol.164.6.3047; KATONA IM, 1983, J IMMUNOL, V130, P350; Kim JI, 1999, IMMUNITY, V10, P745, DOI 10.1016/S1074-7613(00)80073-4; Kishikawa H, 2001, J IMMUNOL, V167, P4414, DOI 10.4049/jimmunol.167.8.4414; Klein-Hessling S, 2003, J IMMUNOL, V170, P2956, DOI 10.4049/jimmunol.170.6.2956; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lavenu-Bombled C, 2002, J BIOL CHEM, V277, P18313, DOI 10.1074/jbc.M110013200; Lee DU, 2002, IMMUNITY, V16, P649, DOI 10.1016/S1074-7613(02)00314-X; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Pai SY, 2004, P NATL ACAD SCI USA, V101, P1993, DOI 10.1073/pnas.0308697100; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; PATERSON DJ, 1987, MOL IMMUNOL, V24, P1281, DOI 10.1016/0161-5890(87)90122-2; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; SIEGEL MD, 1995, J BIOL CHEM, V270, P24548, DOI 10.1074/jbc.270.41.24548; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Takemoto N, 2000, J IMMUNOL, V165, P6687, DOI 10.4049/jimmunol.165.12.6687; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Usui T, 2003, IMMUNITY, V18, P415, DOI 10.1016/S1074-7613(03)00057-8; Van Esch H, 2000, NATURE, V406, P419, DOI 10.1038/35019088; Zhang DH, 1999, IMMUNITY, V11, P473, DOI 10.1016/S1074-7613(00)80122-3; Zhang DH, 1998, J IMMUNOL, V161, P3817; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2002, IMMUNITY, V16, P733, DOI 10.1016/S1074-7613(02)00317-5; Zhu JF, 2003, IMMUNITY, V19, P739, DOI 10.1016/S1074-7613(03)00292-9; Zhu JF, 2001, J IMMUNOL, V166, P7276, DOI 10.4049/jimmunol.166.12.7276; Zou YR, 2001, NAT GENET, V29, P332, DOI 10.1038/ng750	48	457	475	2	23	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2004	5	11					1157	1165		10.1038/ni1128	http://dx.doi.org/10.1038/ni1128			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	865HG	15475959				2022-12-18	WOS:000224692700013
J	Naik, SH; Metcalf, D; Van Nieuwenhuijze, A; Wicks, I; Wu, L; O'Keeffe, M; Shortman, K				Naik, Shalin H.; Metcalf, Donald; Van Nieuwenhuijze, Annemarie; Wicks, Ian; Wu, Li; O'Keeffe, Meredith; Shortman, Ken			Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes	NATURE IMMUNOLOGY			English	Article							COLONY-STIMULATING FACTOR; INTERFERON-PRODUCING CELLS; NITRIC-OXIDE; FLT3 LIGAND; MOUSE-BLOOD; T-CELLS; CD8-ALPHA(+); SPLEEN; DIFFERENTIATION; MACROPHAGES	Immediate precursors of the many subtypes of dendritic cells (DCs) remain obscure. Here we purified a splenic precursor population that produced all splenic CD8(+) and CD8(-) conventional DCs (cDCs) but not plasmacytoid DCs or other lineages. This 'pre-cDC' population included cells 'precommitted' to form either CD8(+) or CD8(-) cDCs. The pre-cDCs, which comprised 0.05% of splenocytes, expressed a CD11c(int)CD45RA(Io)CD43(int)SIRP-alpha(int)CD4(-)CD8(-) major histocompatibility complex class II-negative surface phenotype. The pre-cDCs were not monocytes. Monocytes generated few cDCs in steady-state recipient mice. However, when transferred into mice with an inflammatory milieu dependent on granulocyte-macrophage colony-stimulating factor, monocytes produced a distinct type of splenic DC. Thus, the inflammatory status of the host influences the developmental origin and type of DC present in lymphoid tissues.	Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; Cooperat Res Ctr Vaccine Technol, Parkville, Vic 3050, Australia; Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; University of Melbourne	Naik, SH (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	naik@wehi.edu.au; shortman@wehi.edu.au	Naik, Shalin/B-1148-2008; Naik, Shalin/AFD-5605-2022; O'Keeffe, Meredith/U-9347-2017	Naik, Shalin/0000-0003-0299-3301; O'Keeffe, Meredith/0000-0002-0779-4654; Shortman, Ken/0000-0002-9107-3007; van Nieuwenhuijze, Annemarie/0000-0001-8576-7523				Berthier R, 2000, J IMMUNOL METHODS, V239, P95, DOI 10.1016/S0022-1759(00)00186-1; Bruno L, 2001, EUR J IMMUNOL, V31, P3403, DOI 10.1002/1521-4141(200111)31:11<3403::AID-IMMU3403>3.0.CO;2-T; Cook AD, 2004, J IMMUNOL, V173, P4643, DOI 10.4049/jimmunol.173.7.4643; CROWLEY M, 1989, CELL IMMUNOL, V118, P108, DOI 10.1016/0008-8749(89)90361-4; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; del Hoyo GM, 2004, NATURE, V429, P205, DOI 10.1038/nature02479; del Hoyo GM, 2002, BLOOD, V99, P999, DOI 10.1182/blood.V99.3.999; del Hoyo GM, 2002, NATURE, V415, P1043, DOI 10.1038/4151043a; Diao J, 2004, J IMMUNOL, V173, P1826, DOI 10.4049/jimmunol.173.3.1826; Eriksson U, 2003, NAT MED, V9, P1484, DOI 10.1038/nm960; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; Kabashima K, 2005, IMMUNITY, V22, P439, DOI 10.1016/j.immuni.2005.02.007; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Krutzik SR, 2005, NAT MED, V11, P653, DOI 10.1038/nm1246; Laouar Y, 2003, IMMUNITY, V19, P903, DOI 10.1016/S1074-7613(03)00332-7; Leon B, 2004, BLOOD, V103, P2668, DOI 10.1182/blood-2003-01-0286; Leung BP, 2002, J IMMUNOL, V169, P7071, DOI 10.4049/jimmunol.169.12.7071; Lu LN, 1996, J IMMUNOL, V157, P3577; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Metcalf D, 2002, STEM CELLS, V20, P552, DOI 10.1002/stem.200552; Naik S, 2003, BLOOD, V102, P601, DOI 10.1182/blood-2002-10-3186; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Naik SH, 2005, IMMUNOL CELL BIOL, V83, P563, DOI 10.1111/j.1440-1711.2005.01390.x; O'Keeffe M, 2002, J EXP MED, V196, P1307, DOI 10.1084/jem.20021031; O'Keeffe M, 2003, BLOOD, V101, P1453, DOI 10.1182/blood-2002-03-0974; O'Neill HC, 2004, STEM CELLS, V22, P475, DOI 10.1634/stemcells.22-4-475; Powell TJ, 2003, IMMUNOLOGY, V109, P197, DOI 10.1046/j.1365-2567.2003.01639.x; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Randolph GJ, 2002, J EXP MED, V196, P517, DOI 10.1084/jem.20011608; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shortman K, 2004, NAT IMMUNOL, V5, P1105, DOI 10.1038/ni1104-1105; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Spits H, 2000, J EXP MED, V192, P1775, DOI 10.1084/jem.192.12.1775; Steinman RM, 2003, APMIS, V111, P675, DOI 10.1034/j.1600-0463.2003.11107802.x; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Traver D, 2000, SCIENCE, V290, P2152, DOI 10.1126/science.290.5499.2152; Villadangos JA, 2005, SEMIN IMMUNOL, V17, P262, DOI 10.1016/j.smim.2005.05.015; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Vremec D, 1997, EUR J IMMUNOL, V27, P40, DOI 10.1002/eji.1830270107; Vremec D, 1997, J IMMUNOL, V159, P565; Walzer T, 2005, J ALLERGY CLIN IMMUN, V115, P192, DOI 10.1016/j.jaci.2004.08.046; Wang Y, 2002, BLOOD, V100, P569, DOI 10.1182/blood.V100.2.569; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; WITMERPACK MD, 1993, J CELL SCI, V104, P1021; Wu L, 2001, BLOOD, V98, P3376, DOI 10.1182/blood.V98.12.3376; Zhang MH, 2004, NAT IMMUNOL, V5, P1124, DOI 10.1038/ni1130; Zuniga EI, 2004, NAT IMMUNOL, V5, P1227, DOI 10.1038/ni1136	58	454	470	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2006	7	6					663	671		10.1038/ni1340	http://dx.doi.org/10.1038/ni1340			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	045OK	16680143				2022-12-18	WOS:000237751200022
J	Sokol, CL; Chu, NQ; Yu, S; Nish, SA; Laufer, TM; Medzhitov, R				Sokol, Caroline L.; Chu, Ngoc-Quynh; Yu, Shuang; Nish, Simone A.; Laufer, Terri M.; Medzhitov, Ruslan			Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response	NATURE IMMUNOLOGY			English	Article							HUMAN IGE SYNTHESIS; DENDRITIC CELLS; MAST-CELLS; NALP3 INFLAMMASOME; IN-VIVO; B-CELLS; ACTIVATION; EXPRESSION; IMMUNITY; INDUCTION	T helper type 2 (T(H)2)-mediated immune responses are induced after infection with multicellular parasites and can be triggered by a variety of allergens. The mechanisms of induction and the antigen-presenting cells involved in the activation of T(H)2 responses remain poorly defined, and the innate immune sensing pathways activated by parasites and allergens are largely unknown. Basophils are required for the in vivo induction of T(H)2 responses by protease allergens. Here we show that basophils also function as antigen-presenting cells. We show that although dendritic cells were dispensable for allergen-induced activation of T(H)2 responses in vitro and in vivo, antigen presentation by basophils was necessary and sufficient for this. Thus, basophils function as antigen-presenting cells for T(H)2 differentiation in response to protease allergens.	[Sokol, Caroline L.; Chu, Ngoc-Quynh; Yu, Shuang; Nish, Simone A.; Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Sokol, Caroline L.; Chu, Ngoc-Quynh; Yu, Shuang; Nish, Simone A.; Medzhitov, Ruslan] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Laufer, Terri M.] Univ Penn, Immunol Grad Grp, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; Yale University; Yale University; University of Pennsylvania	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.	ruslan.medzhitov@yale.edu			Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI046688-05, R01 AI055502, R01 AI046688, R01 AI055502-05, R01 AI46688] Funding Source: Medline; NIGMS NIH HHS [T32 GM007205, TG2T32GM07205] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046688, R01AI055502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Chambers L, 1998, BIOCHEM BIOPH RES CO, V253, P837, DOI 10.1006/bbrc.1998.9862; CHANG CH, 1995, J EXP MED, V181, P765, DOI 10.1084/jem.181.2.765; CHANG CH, 1994, J EXP MED, V180, P1367, DOI 10.1084/jem.180.4.1367; Denzel A, 2008, NAT IMMUNOL, V9, P733, DOI 10.1038/ni.1621; Domen J, 1998, BLOOD, V91, P2272, DOI 10.1182/blood.V91.7.2272.2272_2272_2282; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549; GAUCHAT JF, 1993, NATURE, V365, P340, DOI 10.1038/365340a0; Gough L, 1999, J EXP MED, V190, P1897, DOI 10.1084/jem.190.12.1897; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hida S, 2005, BLOOD, V106, P2011, DOI 10.1182/blood-2005-04-1344; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kambayashi T, 2008, BLOOD, V111, P1489, DOI 10.1182/blood-2007-07-102111; Karasuyama H, 2009, NAT REV IMMUNOL, V9, P9, DOI 10.1038/nri2458; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Lemos MP, 2004, J EXP MED, V199, P725, DOI 10.1084/jem.20030795; Lemos MP, 2003, J IMMUNOL, V171, P5077, DOI 10.4049/jimmunol.171.10.5077; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Li HF, 2007, J IMMUNOL, V178, P5271, DOI 10.4049/jimmunol.178.8.5271; MacDonald AS, 2001, J IMMUNOL, V167, P1982, DOI 10.4049/jimmunol.167.4.1982; Mack M, 2005, J IMMUNOL, V174, P735, DOI 10.4049/jimmunol.174.2.735; McGuinness DH, 2003, TRENDS PARASITOL, V19, P312, DOI 10.1016/S1471-4922(03)00123-5; McKerrow JH, 2006, ANNU REV PATHOL-MECH, V1, P497, DOI 10.1146/annurev.pathol.1.110304.100151; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; Min B, 2008, NAT IMMUNOL, V9, P1333, DOI 10.1038/ni.f.217; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; Oh K, 2007, BLOOD, V109, P2921, DOI 10.1182/blood-2006-07-037739; Piggott DA, 2005, J CLIN INVEST, V115, P459, DOI 10.1172/JCI200522462; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Reith W, 2005, NAT REV IMMUNOL, V5, P793, DOI 10.1038/nri1708; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; Sullivan BM, 2009, IMMUNITY, V30, P12, DOI 10.1016/j.immuni.2008.12.006; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Tsujimura Y, 2008, IMMUNITY, V28, P581, DOI 10.1016/j.immuni.2008.02.008; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Yanagihara Y, 1998, CLIN EXP IMMUNOL, V111, P136; Zammit DJ, 2005, IMMUNITY, V22, P561, DOI 10.1016/j.immuni.2005.03.005; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	53	453	468	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2009	10	7					713	U63		10.1038/ni.1738	http://dx.doi.org/10.1038/ni.1738			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	459WF	19465907	Green Accepted			2022-12-18	WOS:000267142600010
J	Badovinac, VP; Porter, BB; Harty, JT				Badovinac, VP; Porter, BB; Harty, JT			Programmed contraction of CD8(+) T cells after infection	NATURE IMMUNOLOGY			English	Article							RECEPTOR-BETA CHAIN; IFN-GAMMA RECEPTOR; LISTERIA-MONOCYTOGENES; PROTECTIVE IMMUNITY; RESPONSES; PERFORIN; MEMORY; IDENTIFICATION; MECHANISMS; EXPANSION	The extent of infection and rate of pathogen clearance are thought to determine both the magnitude of antigen-specific CD8(+) T cell expansion and the ensuing contraction to a stable number of memory cells. We show that CD8(+) T cell expansion after Listeria monocytogenes infection was primarily dependent on the initial infection dose or amount of antigen displayed, and was also influenced by the rate of pathogen clearance. However, the onset and kinetics of CD8(+) T cell contraction after L. monocytogenes and lymphocytic choriomeningitis virus infections were independent of the magnitude of expansion, dose and duration of infection or amount of antigen displayed. Thus, major features of antigen-specific CD8(+) T cell homeostasis, including the contraction phase of an immune response, may be programmed early after infection.	Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; Univ Iowa, Interdisciplinary Grad Program Immun, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Harty, JT (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.	john-harty@uiowa.edu	badovinac, Vladimir/O-7760-2015	Badovinac, Vladimir/0000-0003-3180-2439; Harty, John/0000-0001-7266-2802	NIAID NIH HHS [AI42767, AI46653, AI50073] Funding Source: Medline; NIGMS NIH HHS [T32 GM007337] Funding Source: Medline; PHS HHS [T32A07485] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046653, R21AI042767, R01AI050073, R01AI042767, R37AI042767] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; BACH EA, 1995, SCIENCE, V270, P1215, DOI 10.1126/science.270.5239.1215; Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; Badovinac VP, 2000, J IMMUNOL METHODS, V238, P107, DOI 10.1016/S0022-1759(00)00153-8; Badovinac VP, 2000, SCIENCE, V290, P1354, DOI 10.1126/science.290.5495.1354; Bevan MJ, 2001, NAT IMMUNOL, V2, P381, DOI 10.1038/87676; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Chen WS, 2000, METH MOL B, V156, P245; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Gallimore A, 1998, J EXP MED, V187, P1647; GAVIN MA, 1993, J IMMUNOL, V151, P3971; HARTY JT, 1995, IMMUNITY, V3, P109, DOI 10.1016/1074-7613(95)90163-9; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; HAYFLICK L, 1984, MECH AGEING DEV, V28, P177, DOI 10.1016/0047-6374(84)90018-6; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kagi D, 1996, ANNU REV IMMUNOL, V14, P207, DOI 10.1146/annurev.immunol.14.1.207; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; Marshall DR, 2001, P NATL ACAD SCI USA, V98, P6313, DOI 10.1073/pnas.101132698; Matloubian M, 1999, J VIROL, V73, P2527, DOI 10.1128/JVI.73.3.2527-2536.1999; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; PAMER EG, 1994, J IMMUNOL, V152, P686; PAMER EG, 1991, NATURE, V353, P852, DOI 10.1038/353852a0; PERNIS A, 1995, SCIENCE, V269, P245, DOI 10.1126/science.7618088; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Shen H, 1998, CELL, V92, P535, DOI 10.1016/S0092-8674(00)80946-0; SMITH GA, 1995, INFECT IMMUN, V63, P4231, DOI 10.1128/IAI.63.11.4231-4237.1995; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Tau GZ, 2001, J IMMUNOL, V167, P5574, DOI 10.4049/jimmunol.167.10.5574; Tvinnereim AR, 2002, INFECT IMMUN, V70, P153, DOI 10.1128/IAI.70.1.153-162.2002; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; vanderMost RG, 1996, J IMMUNOL, V157, P5543; White DW, 1999, J IMMUNOL, V162, P980; Wong P, 2001, J IMMUNOL, V166, P5864, DOI 10.4049/jimmunol.166.10.5864; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	36	453	467	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2002	3	7					619	626		10.1038/ni804	http://dx.doi.org/10.1038/ni804			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	566RH	12055624				2022-12-18	WOS:000176441700011
J	Sedy, JR; Gavrieli, M; Potter, KG; Hurchla, MA; Lindsley, RC; Hildner, K; Scheu, S; Pfeffer, K; Ware, CF; Murphy, TL; Murphy, KM				Sedy, JR; Gavrieli, M; Potter, KG; Hurchla, MA; Lindsley, RC; Hildner, K; Scheu, S; Pfeffer, K; Ware, CF; Murphy, TL; Murphy, KM			B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator	NATURE IMMUNOLOGY			English	Article							TNF SUPERFAMILY; FAMILY-MEMBER; MOUSE T; LIGHT; RECEPTOR; PROTEIN; EXPRESSION; MOLECULE; LIGAND; CTLA-4	B and T lymphocyte attenuator (BTLA) provides an inhibitory signal to B and T cells. Previously, indirect observations suggested that B7x was a ligand for BTLA. Here we show that BTLA does not bind B7x; instead, we identify herpesvirus entry mediator (HVEM) as the unique BTLA ligand. BTLA bound the most membrane-distal cysteine-rich domain of HVEM, distinct from regions where the ligands LIGHT and lymphotoxin-alpha bound HVEM. HVEM induced BTLA tyrosine phosphorylation and association of the tyrosine phosphatase SHP-2 and repressed antigen-driven T cell proliferation, providing an example of reverse signaling to a non-tumor necrosis factor family ligand. The conservation of the BTLA-HVEM interaction between mouse and human suggests that this system is an important pathway regulating lymphocyte activation and/or homeostasis in the immune response.	Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Ctr Immunol, St Louis, MO 63110 USA; La Jolla Inst Allergy & Immunol, Div Mol Immunol, San Diego, CA 92121 USA; Univ Dusseldorf, Inst Med Microbiol, D-4000 Dusseldorf, Germany; Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); La Jolla Institute for Immunology; Heinrich Heine University Dusseldorf; Howard Hughes Medical Institute; Washington University (WUSTL)	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA.	murphy@pathology.wustl.edu	Scheu, Stefanie/H-3670-2019; Lindsley, Coleman/AAA-3040-2021	Scheu, Stefanie/0000-0002-9707-8191; Sedy, John/0000-0002-6428-1054; Pfeffer, Klaus/0000-0002-5652-6330; Lindsley, Coleman/0000-0001-9822-806X	NCI NIH HHS [CA69381] Funding Source: Medline; NHLBI NIH HHS [P50 HL54619] Funding Source: Medline; NIAID NIH HHS [AI33068, AI48073, P01 AI31238] Funding Source: Medline; NIA NIH HHS [AG00252] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA069381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048073, P01AI031238, R37AI033068, R01AI033068] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Arthos J, 2002, J BIOL CHEM, V277, P11456, DOI 10.1074/jbc.M111191200; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Carfi A, 2001, MOL CELL, V8, P169, DOI 10.1016/S1097-2765(01)00298-2; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Gavrieli M, 2003, BIOCHEM BIOPH RES CO, V312, P1236, DOI 10.1016/j.bbrc.2003.11.070; Han P, 2004, J IMMUNOL, V172, P5931, DOI 10.4049/jimmunol.172.10.5931; Jung HW, 2003, EXP MOL MED, V35, P501, DOI 10.1038/emm.2003.65; Kirchner S, 2004, J LEUKOCYTE BIOL, V75, P324, DOI 10.1189/jlb.0703343; Kwon BS, 1997, J BIOL CHEM, V272, P14272, DOI 10.1074/jbc.272.22.14272; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; Lybarger L, 2003, J BIOL CHEM, V278, P27105, DOI 10.1074/jbc.M303716200; Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0; MCDONALD NQ, 1993, CELL, V73, P421, DOI 10.1016/0092-8674(93)90127-C; Morel Y, 2000, J IMMUNOL, V165, P4397, DOI 10.4049/jimmunol.165.8.4397; Morel Y, 2001, J IMMUNOL, V167, P2479, DOI 10.4049/jimmunol.167.5.2479; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Paust S, 2004, P NATL ACAD SCI USA, V101, P10398, DOI 10.1073/pnas.0403342101; Prasad DVR, 2003, IMMUNITY, V18, P863, DOI 10.1016/S1074-7613(03)00147-X; Sarrias MR, 2000, MOL IMMUNOL, V37, P665, DOI 10.1016/S0161-5890(00)00089-4; Scheu S, 2002, J EXP MED, V195, P1613, DOI 10.1084/jem.20020215; Shi GX, 2002, BLOOD, V100, P3279, DOI 10.1182/blood-2002-05-1404; Sica GL, 2003, IMMUNITY, V18, P849, DOI 10.1016/S1074-7613(03)00152-3; Suzuki Y, 1997, J IMMUNOL, V158, P2736; Tamada K, 2000, J IMMUNOL, V164, P4105, DOI 10.4049/jimmunol.164.8.4105; Taylor PA, 2004, J IMMUNOL, V172, P34, DOI 10.4049/jimmunol.172.1.34; Watanabe N, 2003, NAT IMMUNOL, V4, P670, DOI 10.1038/ni944; Wiley SR, 1996, J IMMUNOL, V157, P3635; Zang XX, 2003, P NATL ACAD SCI USA, V100, P10388, DOI 10.1073/pnas.1434299100	31	452	541	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2005	6	1					90	98		10.1038/ni1144	http://dx.doi.org/10.1038/ni1144			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	881SA	15568026				2022-12-18	WOS:000225888500022
J	Zarnegar, BJ; Wang, YY; Mahoney, DJ; Dempsey, PW; Cheung, HH; He, J; Shiba, T; Yang, XL; Yeh, WC; Mak, TW; Korneluk, RG; Cheng, GH				Zarnegar, Brian J.; Wang, Yaya; Mahoney, Douglas J.; Dempsey, Paul W.; Cheung, Herman H.; He, Jeannie; Shiba, Travis; Yang, Xiaolu; Yeh, Wen-chen; Mak, Tak W.; Korneluk, Robert G.; Cheng, Genhong			Noncanonical NF-kappa B activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK	NATURE IMMUNOLOGY			English	Article							LYMPHOTOXIN-BETA-RECEPTOR; TARGETED DISRUPTION; ALPHA; INHIBITOR; TNF; PROTEINS; PATHWAYS; DEGRADATION; NF-KAPPA-B2; LETHALITY	Recent studies suggest that nuclear factor kappa B-inducing kinase (NIK) is suppressed through constitutive proteasome-mediated degradation regulated by TRAF2, TRAF3 and cIAP1 or cIAP2. Here we demonstrated that the degradation of NIK occurs upon assembly of a regulatory complex through TRAF3 recruitment of NIK and TRAF2 recruitment of cIAP1 and cIAP2. In contrast to TRAF2 and TRAF3, cIAP1 and cIAP2 seem to play redundant roles in the degradation of NIK, as inhibition of both cIAPs was required for noncanonical NF-kappa B activation and increased survival and proliferation of primary B lymphocytes. Furthermore, the lethality of TRAF3 deficiency in mice could be rescued by a single NIK gene, highlighting the importance of tightly regulated NIK.	[Zarnegar, Brian J.; Wang, Yaya; Dempsey, Paul W.; He, Jeannie; Shiba, Travis; Cheng, Genhong] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; [Mahoney, Douglas J.; Cheung, Herman H.; Korneluk, Robert G.] Childrens Hosp Eastern Ontario, Apoptosis Res Ctr, Ottawa, ON K1H 8L1, Canada; [Yang, Xiaolu] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Yang, Xiaolu] Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Yeh, Wen-chen; Mak, Tak W.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; [Yeh, Wen-chen; Mak, Tak W.] Univ Toronto, Univ Hlth Network, Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2C1, Canada	University of California System; University of California Los Angeles; University of Ottawa; Children's Hospital of Eastern Ontario; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Cheng, GH (corresponding author), Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, 609 Charles E Young Dr E, Los Angeles, CA 90095 USA.	gcheng@mednet.ucla.edu	Wang, Yaya/G-7587-2012		US National Institutes of Health [R01GM078607, R01GM57559]; Canadian Institutes of Health Research; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078607, R01GM057559] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank X. Wang (University of Texas Southwestern Medical Center) for the SMAC mimetic compound, L. Zawel and Novartis Pharmaceuticals for LBW242, and Amgen for BAFF and for Map3k14<SUP>-/-</SUP> mice. Supported by the US National Institutes of Health (R01GM078607 and R01GM57559, G. C.) and the Canadian Institutes of Health Research and Howard Hughes Medical Institute (R. G. K.).	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Brown KD, 2001, J EXP MED, V193, P943, DOI 10.1084/jem.193.8.943; Brown KD, 2002, J BIOL CHEM, V277, P19433, DOI 10.1074/jbc.M111522200; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Conte D, 2006, MOL CELL BIOL, V26, P699, DOI 10.1128/MCB.26.2.699-708.2006; Conze DB, 2005, MOL CELL BIOL, V25, P3348, DOI 10.1128/MCB.25.8.3348-3356.2005; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Dadgostar H, 1998, J BIOL CHEM, V273, P24775, DOI 10.1074/jbc.273.38.24775; Dejardin E, 2006, BIOCHEM PHARMACOL, V72, P1161, DOI 10.1016/j.bcp.2006.08.007; Fischer U, 2007, BIODRUGS, V21, P273, DOI 10.2165/00063030-200721050-00001; Gaither A, 2007, CANCER RES, V67, P11493, DOI 10.1158/0008-5472.CAN-07-5173; Gardam S, 2008, IMMUNITY, V28, P391, DOI 10.1016/j.immuni.2008.01.009; Grech AP, 2004, IMMUNITY, V21, P629, DOI 10.1016/j.immuni.2004.09.011; He JQ, 2007, J BIOL CHEM, V282, P3688, DOI 10.1074/jbc.M610271200; He JQ, 2006, J EXP MED, V203, P2413, DOI 10.1084/jem.20061166; He LS, 2004, J BIOL CHEM, V279, P55855, DOI 10.1074/jbc.M407284200; Holcik M, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-5; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; KOPP EB, 1995, ADV IMMUNOL, V58, P1, DOI 10.1016/S0065-2776(08)60618-5; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Matsushima A, 2001, J EXP MED, V193, P631, DOI 10.1084/jem.193.5.631; Matsuzawa A, 2008, SCIENCE, V321, P663, DOI 10.1126/science.1157340; Moore CR, 2005, J IMMUNOL, V175, P3780, DOI 10.4049/jimmunol.175.6.3780; Ng LG, 2006, EUR J IMMUNOL, V36, P1837, DOI 10.1002/eji.200635956; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; SCHERLE PA, 1990, P NATL ACAD SCI USA, V87, P1908, DOI 10.1073/pnas.87.5.1908; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Xu Y, 1996, IMMUNITY, V5, P407, DOI 10.1016/S1074-7613(00)80497-5; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Zandi E, 1999, MOL CELL BIOL, V19, P4547; Zarnegar B, 2008, P NATL ACAD SCI USA, V105, P3503, DOI 10.1073/pnas.0707959105	43	451	465	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2008	9	12					1371	1378		10.1038/ni.1676	http://dx.doi.org/10.1038/ni.1676			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	372FY	18997794	Green Accepted			2022-12-18	WOS:000260888700012
J	Fukao, T; Tanabe, M; Terauchi, Y; Ota, T; Matsuda, S; Asano, T; Kadowaki, T; Takeuchi, T; Koyasu, S				Fukao, T; Tanabe, M; Terauchi, Y; Ota, T; Matsuda, S; Asano, T; Kadowaki, T; Takeuchi, T; Koyasu, S			PI3K-mediated negative feedback regulation of IL-12 production in DCs	NATURE IMMUNOLOGY			English	Article							ANTIGEN-PRESENTING CELLS; DENDRITIC CELLS; INTERLEUKIN-12 PRODUCTION; SIGNAL-TRANSDUCTION; P85-ALPHA SUBUNIT; IN-VIVO; ACTIVATION; MICE; IMMUNITY; INNATE	Although interleukin 12 (IL-12) production by dendritic cells (DCs) confers protection against harmful invasions by regulating both innate and adaptive immunity, its dysregulation may have detrimental effects on the host. We show here that phosphoinositide 3-kinase (PI3K) negatively regulates IL-12 synthesis by DCs. We found that numerous stimuli that induced IL-12 production concomitantly elicited PI3K activation in DCs, but both PI3K(-/-) and PI3K inhibitor-treated DCs showed increased IL-12 production. Accordingly, an enhanced T helper type 1 (THI) response was observed upon Leishmania major infection in PI3K(-/-) mice. Our findings indicate that a negative feedback mechanism exists that regulates IL-12 production during DC activation and may help prevent the excessive THI polarization that causes undesirable immune responses.	Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1608582, Japan; Keio Univ, Sch Med, Dept Trop Med & Parasitol, Shinjuku Ku, Tokyo 1608582, Japan; Univ Tokyo, Dept Metab Dis, Grad Sch Med, Bunkyo Ku, Tokyo 1138655, Japan	Keio University; Keio University; University of Tokyo	Koyasu, S (corresponding author), Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	koyasu@sc.itc.keio.ac.jp	Eckhardt, Erik/G-1567-2010; Koyasu, Shigeo/J-5583-2015; Ota, Takayuki/Q-5528-2017; Fukao, Taro/I-3246-2014; Terauchi, Yasuo/AAO-4347-2020	Koyasu, Shigeo/0000-0001-9585-3038; Ota, Takayuki/0000-0001-6249-0664; 				AFONSO LCC, 1994, SCIENCE, V263, P235, DOI 10.1126/science.7904381; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Aliberti J, 2002, NAT IMMUNOL, V3, P76, DOI 10.1038/ni745; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Athie-M V, 2000, EUR J IMMUNOL, V30, P1425, DOI 10.1002/(SICI)1521-4141(200005)30:5<1425::AID-IMMU1425>3.0.CO;2-Q; Baek KH, 2001, J IMMUNOL, V167, P2847, DOI 10.4049/jimmunol.167.5.2847; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Braun MC, 2000, J IMMUNOL, V164, P3009, DOI 10.4049/jimmunol.164.6.3009; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Falcone M, 1999, CURR OPIN IMMUNOL, V11, P670, DOI 10.1016/S0952-7915(99)00035-7; Finkelman FD, 1997, ANNU REV IMMUNOL, V15, P505, DOI 10.1146/annurev.immunol.15.1.505; Frucht DM, 2001, TRENDS IMMUNOL, V22, P556, DOI 10.1016/S1471-4906(01)02005-1; Fukao T, 2002, NAT IMMUNOL, V3, P295, DOI 10.1038/ni768; Fukao T, 2001, J IMMUNOL, V166, P4446, DOI 10.4049/jimmunol.166.7.4446; Fukao T, 2000, EUR J IMMUNOL, V30, P1453, DOI 10.1002/(SICI)1521-4141(200005)30:5<1453::AID-IMMU1453>3.0.CO;2-W; Gately MK, 1998, ANNU REV IMMUNOL, V16, P495, DOI 10.1146/annurev.immunol.16.1.495; Gratton JP, 2001, J BIOL CHEM, V276, P30359, DOI 10.1074/jbc.M009698200; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; He JP, 2000, J EXP MED, V191, P1605, DOI 10.1084/jem.191.9.1605; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; HerreraVelit P, 1997, J BIOL CHEM, V272, P16445, DOI 10.1074/jbc.272.26.16445; Hochrein H, 2000, J EXP MED, V192, P823, DOI 10.1084/jem.192.6.823; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Li W, 2001, J IMMUNOL, V166, P5619, DOI 10.4049/jimmunol.166.9.5619; Louis J, 1998, CURR OPIN IMMUNOL, V10, P459, DOI 10.1016/S0952-7915(98)80121-0; Lu HT, 1999, EMBO J, V18, P1845, DOI 10.1093/emboj/18.7.1845; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; Moulin V, 2000, J EXP MED, V192, P475, DOI 10.1084/jem.192.4.475; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Ohteki T, 2001, ARCH IMMUNOL THER EX, V49, pS47; REN CL, 1994, J EXP MED, V179, P673, DOI 10.1084/jem.179.2.673; Rennick DM, 1997, J LEUKOCYTE BIOL, V61, P389, DOI 10.1002/jlb.61.4.389; Schulz O, 2000, IMMUNITY, V13, P453, DOI 10.1016/S1074-7613(00)00045-5; Sotsios Y, 2000, IMMUNOL REV, V177, P217, DOI 10.1034/j.1600-065X.2000.17712.x; Sousa CRE, 1999, IMMUNITY, V11, P637, DOI 10.1016/S1074-7613(00)80138-7; Suzuki H, 1999, SCIENCE, V283, P390, DOI 10.1126/science.283.5400.390; Terauchi Y, 1999, NAT GENET, V21, P230, DOI 10.1038/6023; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.iy.13.040195.001343; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Wilson M, 1996, J BIOL CHEM, V271, P8537, DOI 10.1074/jbc.271.15.8537; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4	48	451	456	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2002	3	9					875	881		10.1038/ni825	http://dx.doi.org/10.1038/ni825			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	588GZ	12154357				2022-12-18	WOS:000177694900017
J	Sawa, S; Lochner-, M; Satoh-Takayama, N; Dulauroy, S; Berard, M; Kleinschek, M; Cua, D; Di Santo, JP; Eberl, G				Sawa, Shinichiro; Lochner-, Matthias; Satoh-Takayama, Naoko; Dulauroy, Sophie; Berard, Marion; Kleinschek, Melanie; Cua, Daniel; Di Santo, James P.; Eberl, Gerard			ROR gamma t(+) innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota	NATURE IMMUNOLOGY			English	Article							ROR-GAMMA-T; PROINFLAMMATORY IL-17(+); INTERLEUKIN-22 PROTECTS; IMMUNE-RESPONSES; HOST-DEFENSE; TH17 CELLS; IL-22; DIFFERENTIATION; EXPRESSION; GUT	Lymphoid cells that express the nuclear hormone receptor ROR gamma t are involved in containment of the large intestinal microbiota and defense against pathogens through the production of interleukin 17 (IL-17) and IL-22. They include adaptive IL-17-producing helper T cells (T(H)17 cells), as well as innate lymphoid cells (ILCs) such as lymphoid tissue-inducer (LTi) cells and IL-22-producing NKp46(+) cells. Here we show that in contrast to T(H)17 cells, both types of ROR gamma t(+) ILCs constitutively produced most of the intestinal IL-22 and that the symbiotic microbiota repressed this function through epithelial expression of IL-25. This function was greater in the absence of adaptive immunity and was fully restored and required after epithelial damage, which demonstrates a central role for ROR gamma t(+) ILCs in intestinal homeostasis. Our data identify a finely tuned equilibrium among intestinal symbionts, adaptive immunity and ROR gamma t(+) ILCs.	[Sawa, Shinichiro; Lochner-, Matthias; Dulauroy, Sophie; Eberl, Gerard] Inst Pasteur, Lymphoid Tissue Dev Unit, Paris, France; [Sawa, Shinichiro; Lochner-, Matthias; Dulauroy, Sophie; Eberl, Gerard] CNRS, URA 1961, Paris, France; [Lochner-, Matthias] Ctr Expt & Clin Infect Res, TWINCORE, Inst Infect Immunol, Hannover, Germany; [Satoh-Takayama, Naoko; Di Santo, James P.] Inst Pasteur, Innate Immun Unit, Paris, France; [Satoh-Takayama, Naoko; Di Santo, James P.] INSERM, U668, Paris, France; [Kleinschek, Melanie; Cua, Daniel] Merck Res Labs, DNAX Discovery Res, Palo Alto, CA USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Helmholtz Association; Helmholtz-Center for Infection Research; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.	Eberl, G (corresponding author), Inst Pasteur, Lymphoid Tissue Dev Unit, Paris, France.	gerard.eberl@pasteur.fr	Di Santo, James P/M-4298-2014; Lochner, Matthias/L-6963-2015; Eberl, Gerard/A-1160-2013	Di Santo, James P/0000-0002-7146-1862; Lochner, Matthias/0000-0002-7979-5613; Eberl, Gerard/0000-0002-1119-5638	Institut Pasteur; Mairie de Paris; Agence Nationale de la Recherche; European Commission; Schlumberger Foundation; Deutsche Forschungsgemeinschaft	Institut Pasteur(European Commission); Mairie de Paris(Region Ile-de-France); Agence Nationale de la Recherche(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Schlumberger Foundation(Schlumberger); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank the members of the Lymphoid Tissue Development Unit for discussions and critical reading of the manuscript; L. Polomack for technical assistance; J. Perez and E. Maranghi for work on germ-free mice; and B. Ryffel for p19-deficient mice. Supported by the Institut Pasteur, the Mairie de Paris, the Agence Nationale de la Recherche, the European Commission, Deutsche Forschungsgemeinschaft (M.L.) and the Schlumberger Foundation (M.L.).	Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; De Luca A, 2010, MUCOSAL IMMUNOL, V3, P361, DOI 10.1038/mi.2010.22; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Duerkop BA, 2009, IMMUNITY, V31, P368, DOI 10.1016/j.immuni.2009.08.009; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Eberl G, 2010, MUCOSAL IMMUNOL, V3, P450, DOI 10.1038/mi.2010.20; Eberl G, 2009, MUCOSAL IMMUNOL, V2, P478, DOI 10.1038/mi.2009.114; Eberl G, 2010, NATURE, V464, P1285, DOI 10.1038/4641285a; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Geier MS, 2009, DIGEST DIS SCI, V54, P1222, DOI 10.1007/s10620-008-0495-4; Hans W, 2000, EUR J GASTROEN HEPAT, V12, P267, DOI 10.1097/00042737-200012030-00002; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Kleinschek MA, 2007, J EXP MED, V204, P161, DOI 10.1084/jem.20061738; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kreymborg K, 2007, J IMMUNOL, V179, P8098, DOI 10.4049/jimmunol.179.12.8098; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Lochner M, 2011, J EXP MED, V208, P125, DOI 10.1084/jem.20100052; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Michel ML, 2008, P NATL ACAD SCI USA, V105, P19845, DOI 10.1073/pnas.0806472105; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Pan HN, 2004, CELL MOL IMMUNOL, V1, P43; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Sarra M, 2010, INFLAMM BOWEL DIS, V16, P1808, DOI 10.1002/ibd.21248; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643; Zaph C, 2008, J EXP MED, V205, P2191, DOI 10.1084/jem.20080720; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zenewicz LA, 2009, TRENDS MOL MED, V15, P199, DOI 10.1016/j.molmed.2009.03.002; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	58	448	469	1	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2011	12	4					320	U71		10.1038/ni.2002	http://dx.doi.org/10.1038/ni.2002			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	737UJ	21336274	Green Submitted			2022-12-18	WOS:000288593400010
J	Nikolich-Zugich, J				Nikolich-Zugich, Janko			The twilight of immunity: emerging concepts in aging of the immune system	NATURE IMMUNOLOGY			English	Review							T-CELL RESPONSES; AGE-RELATED DEFECTS; FIBROBLASTIC RETICULAR CELLS; LIFE-SPAN; CALORIC RESTRICTION; CUTTING EDGE; OLDER-ADULTS; IN-VIVO; CYTOMEGALOVIRUS-INFECTION; MICROBIAL TRANSLOCATION	Immunosenescence is a series of age-related changes that affect the immune system and, with time, lead to increased vulnerability to infectious diseases. This Review addresses recent developments in the understanding of age-related changes that affect key components of immunity, including the effect of aging on cells of the (mostly adaptive) immune system, on soluble molecules that guide the maintenance and function of the immune system and on lymphoid organs that coordinate both the maintenance of lymphocytes and the initiation of immune responses. I further address the effect of the metagenome and exposome as key modifiers of immune-system aging and discuss a conceptual framework in which age-related changes in immunity might also affect the basic rules by which the immune system operates.	[Nikolich-Zugich, Janko] Univ Arizona, Coll Med Tucson, Dept Immunobiol, Tucson, AZ 85721 USA; [Nikolich-Zugich, Janko] Univ Arizona, Coll Med Tucson, Arizona Ctr Aging, Tucson, AZ 85721 USA	University of Arizona; University of Arizona	Nikolich-Zugich, J (corresponding author), Univ Arizona, Coll Med Tucson, Dept Immunobiol, Tucson, AZ 85721 USA.; Nikolich-Zugich, J (corresponding author), Univ Arizona, Coll Med Tucson, Arizona Ctr Aging, Tucson, AZ 85721 USA.	nikolich@email.arizona.edu			US Public Health Service [AG020719, AG048021, AG053259]; US National Institutes of Health [HHSN272201100017C, HHSN272200900059C]; Elizabeth Bowman Endowed Professorship in Medical Science	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Elizabeth Bowman Endowed Professorship in Medical Science	I thank past and present members of the Nikolich lab and the UA Department of Immunobiology for collaborative work that led to some of the concepts crystallized in this work; E. Goldberg for suggestions; I. Jeftic, M. Jergovic, M. Smithey and H. Thompson for help with illustrations and critical perusal of the manuscript; and M. Kuhns for the suggestion that rules of immune system might change with aging and for critical perusal of the manuscript. Supported by the US Public Health Service (AG020719, AG048021 and AG053259), the US National Institutes of Health (HHSN272201100017C and HHSN272200900059C) and the Elizabeth Bowman Endowed Professorship in Medical Science.	Agius E, 2009, J EXP MED, V206, P1929, DOI 10.1084/jem.20090896; Aiello AE, 2017, GEROSCIENCE, V39, P261, DOI 10.1007/s11357-017-9983-9; Albright J.F., 2003, AGING IMMUNITY INFEC; Aprahamian T, 2008, CLIN EXP IMMUNOL, V152, P448, DOI 10.1111/j.1365-2249.2008.03658.x; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Becklund BR, 2016, SCI REP-UK, V6, DOI 10.1038/srep30842; Beura LK, 2016, NATURE, V532, P512, DOI 10.1038/nature17655; Bhadra R, 2014, J CLIN INVEST, V124, P2441, DOI 10.1172/JCI70522; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brien JD, 2009, J EXP MED, V206, P2735, DOI 10.1084/jem.20090222; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Brown FD, 2015, J IMMUNOL, V194, P1389, DOI 10.4049/jimmunol.1402520; Bruns T, 2015, J HEPATOL, V63, P38, DOI 10.1016/j.jhep.2015.02.046; Cambier J, 2005, IMMUNOL REV, V205, P5, DOI 10.1111/j.0105-2896.2005.00276.x; Cebra JJ, 1999, AM J CLIN NUTR, V69, p1046S, DOI 10.1093/ajcn/69.5.1046s; Chen JC, 1998, J GERONTOL A-BIOL, V53, pB330, DOI 10.1093/gerona/53A.5.B330; Chinn IK, 2012, SEMIN IMMUNOL, V24, P309, DOI 10.1016/j.smim.2012.04.005; Chiu BC, 2013, J IMMUNOL, V191, P5793, DOI 10.4049/jimmunol.1302509; Chougnet CA, 2015, J IMMUNOL, V195, P2624, DOI 10.4049/jimmunol.1501006; Cicin-Sain L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002849; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Cumberbatch M, 2002, IMMUNOLOGY, V105, P466, DOI 10.1046/j.1365-2567.2002.01381.x; Davies J. S., 2017, J GERONTOL A; De Martinis M, 2005, FEBS LETT, V579, P2035, DOI 10.1016/j.febslet.2005.02.055; Decman V, 2012, J IMMUNOL, V188, P1933, DOI 10.4049/jimmunol.1101098; Desai A, 2010, J LEUKOCYTE BIOL, V87, P1001, DOI 10.1189/jlb.0809542; Di Mitri D, 2011, J IMMUNOL, V187, P2093, DOI 10.4049/jimmunol.1100978; EFFROS RB, 1983, CELL IMMUNOL, V81, P298, DOI 10.1016/0008-8749(83)90237-X; FAGIOLO U, 1993, EUR J IMMUNOL, V23, P2375, DOI 10.1002/eji.1830230950; Fang M, 2010, J EXP MED, V207, P2369, DOI 10.1084/jem.20100282; Ferrucci L, 2005, BLOOD, V105, P2294, DOI 10.1182/blood-2004-07-2599; Frasca D, 2004, J IMMUNOL, V172, P2155, DOI 10.4049/jimmunol.172.4.2155; Frasca D, 2016, VACCINE, V34, P2834, DOI 10.1016/j.vaccine.2016.04.023; Furman D, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2293; Garcia GG, 1997, CELL IMMUNOL, V175, P51, DOI 10.1006/cimm.1996.1040; Garcia GG, 2007, J IMMUNOL, V179, P6403, DOI 10.4049/jimmunol.179.10.6403; Garcia GG, 2011, AGEING RES REV, V10, P26, DOI 10.1016/j.arr.2009.11.003; Goldberg EL, 2015, AGING CELL, V14, P130, DOI 10.1111/acel.12280; Goldberg EL, 2014, J IMMUNOL, V193, P757, DOI 10.4049/jimmunol.1400188; Greene M, 2015, JAIDS-J ACQ IMM DEF, V69, P161, DOI 10.1097/QAI.0000000000000556; Hao Y, 2011, BLOOD, V118, P1294, DOI 10.1182/blood-2011-01-330530; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Haynes L, 1997, MECH AGEING DEV, V93, P95, DOI 10.1016/S0047-6374(96)01826-X; Haynes L, 1999, J EXP MED, V190, P1013, DOI 10.1084/jem.190.7.1013; Haynes L, 2004, J IMMUNOL, V172, P5194, DOI 10.4049/jimmunol.172.9.5194; Hazeldine J, 2015, BIOGERONTOLOGY, V16, P187, DOI 10.1007/s10522-014-9514-3; Holtappels R, 2000, J VIROL, V74, P11495, DOI 10.1128/JVI.74.24.11495-11503.2000; Jeong JH, 2017, SCI REP-UK, V7, DOI 10.1038/srep39848; Kieper WC, 2005, J IMMUNOL, V174, P3158, DOI 10.4049/jimmunol.174.6.3158; Kline GH, 1999, J IMMUNOL, V162, P3342; Kogut I, 2012, SEMIN IMMUNOL, V24, P342, DOI 10.1016/j.smim.2012.04.004; Lal H, 2015, NEW ENGL J MED, V372, P2087, DOI 10.1056/NEJMoa1501184; Lanna A, 2017, NAT IMMUNOL, V18, P354, DOI 10.1038/ni.3665; Laudisio A, 2015, J GERONTOL A-BIOL, V70, P899, DOI 10.1093/gerona/glu211; Leng SX, 2017, GEROSCIENCE, V39, P251, DOI 10.1007/s11357-017-9985-7; Li G, 2012, AGING CELL, V11, P968, DOI 10.1111/j.1474-9726.2012.00867.x; Li GJ, 2012, NAT MED, V18, P1518, DOI 10.1038/nm.2963; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Lord JM, 2001, MECH AGEING DEV, V122, P1521, DOI 10.1016/S0047-6374(01)00285-8; Mannick JB, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009892; Manser AR, 2016, CANCER IMMUNOL IMMUN, V65, P417, DOI 10.1007/s00262-015-1750-0; Marandu TF, 2015, J VIROL, V89, P11715, DOI 10.1128/JVI.01989-15; Martinez-Jimenez CP, 2017, SCIENCE, V355, P1433, DOI 10.1126/science.aah4115; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; Mekker A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002850; Messaoudi I, 2006, P NATL ACAD SCI USA, V103, P19448, DOI 10.1073/pnas.0606661103; Metcalf TU, 2017, J IMMUNOL, V199, P1405, DOI 10.4049/jimmunol.1700148; Metcalf TU, 2015, AGING CELL, V14, P421, DOI 10.1111/acel.12320; Miller R A, 1982, Lymphokine Res, V1, P79; Montgomery RR, 2015, J LEUKOCYTE BIOL, V98, P937, DOI 10.1189/jlb.5MR0315-104R; Moskowitz DM, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag0192; Munks MW, 2006, J IMMUNOL, V176, P3760, DOI 10.4049/jimmunol.176.6.3760; Nikolich-Zugich J, 2014, J IMMUNOL, V193, P2622, DOI 10.4049/jimmunol.1401174; Notas G, 2009, CLIN IMMUNOL, V130, P16, DOI 10.1016/j.clim.2008.08.008; Pathai S, 2014, J GERONTOL A-BIOL, V69, P833, DOI 10.1093/gerona/glt168; Pulko V, 2016, NAT IMMUNOL, V17, P966, DOI 10.1038/ni.3483; Qi Q, 2014, P NATL ACAD SCI USA, V111, P13139, DOI 10.1073/pnas.1409155111; Renkema KR, 2014, J IMMUNOL, V192, P151, DOI 10.4049/jimmunol.1301453; Richner JM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005027; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Rudd BD, 2011, P NATL ACAD SCI USA, V108, P13694, DOI 10.1073/pnas.1107594108; Rudd BD, 2011, J IMMUNOL, V186, P2056, DOI 10.4049/jimmunol.1003013; Sage PT, 2015, CELL REP, V12, P163, DOI 10.1016/j.celrep.2015.06.015; Sahin H, 2012, HEPATOLOGY, V55, P1610, DOI 10.1002/hep.25545; Sharma S, 2008, CANCER IMMUNOL IMMUN, V57, P549, DOI 10.1007/s00262-007-0393-1; Shaw AC, 2010, CURR OPIN IMMUNOL, V22, P507, DOI 10.1016/j.coi.2010.05.003; Simell B, 2011, VACCINE, V29, P1929, DOI 10.1016/j.vaccine.2010.12.121; Smithey MJ, 2012, J IMMUNOL, V189, P5356, DOI 10.4049/jimmunol.1201867; Smithey MJ, 2011, EUR J IMMUNOL, V41, P1352, DOI 10.1002/eji.201041141; Solana R, 2012, SEMIN IMMUNOL, V24, P331, DOI 10.1016/j.smim.2012.04.008; Souquette A, 2017, GEROSCIENCE, V39, P293, DOI 10.1007/s11357-017-9982-x; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Stehle JR, 2012, J GERONTOL A-BIOL, V67, P1212, DOI 10.1093/gerona/gls178; Stephan RP, 1997, J IMMUNOL, V158, P1598; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098; Thome JJC, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah6506; Thompson HL, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00706; Tseng CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041454; Tsukamoto H, 2010, J IMMUNOL, V185, P4535, DOI 10.4049/jimmunol.1001668; Tsukamoto H, 2009, P NATL ACAD SCI USA, V106, P18333, DOI 10.1073/pnas.0910139106; Turner VM, 2017, IMMUNOLOGY, V151, P239, DOI 10.1111/imm.12727; Ucar D, 2017, J EXP MED, V214, P3123, DOI 10.1084/jem.20170416; Uhrlaub JL, 2017, J IMMUNOL, V199, P403, DOI 10.4049/jimmunol.1700625; Uhrlaub JL, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005891; van Duin D, 2007, J IMMUNOL, V178, P970, DOI 10.4049/jimmunol.178.2.970; Ventevogel MS, 2013, CURR OPIN IMMUNOL, V25, P516, DOI 10.1016/j.coi.2013.06.002; Wertheimer AM, 2014, J IMMUNOL, V192, P2143, DOI 10.4049/jimmunol.1301721; Wick G, 2010, TRENDS IMMUNOL, V31, P110, DOI 10.1016/j.it.2009.12.001; Woodward NC, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0858-x; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804; Zacca ER, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140672; Zhang BJ, 2016, P NATL ACAD SCI USA, V113, P9858, DOI 10.1073/pnas.1601634113; Zhao JC, 2011, J CLIN INVEST, V121, P4921, DOI 10.1172/JCI59777	114	446	456	13	129	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2018	19	1					10	19		10.1038/s41590-017-0006-x	http://dx.doi.org/10.1038/s41590-017-0006-x			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Immunology	FS4MA	29242543				2022-12-18	WOS:000419765300009
J	Oh-Hora, M; Yamashita, M; Hogan, PG; Sharma, S; Lamperti, E; Chung, W; Prakriya, M; Feske, S; Rao, A				Oh-hora, Masatsugu; Yamashita, Megumi; Hogan, Patrick G.; Sharma, Sonia; Lamperti, Ed; Chung, Woo; Prakriya, Murali; Feske, Stefan; Rao, Anjana			Dual functions for the endoplasmic reticulum calcium sensors STIM1 and STIM2 in T cell activation and tolerance	NATURE IMMUNOLOGY			English	Article							STROMAL INTERACTION MOLECULE-1; NF-KAPPA-B; CRAC CHANNELS; CA2+ STORE; AUTOIMMUNE-DISEASE; TYROSINE RESIDUES; NUCLEAR FACTOR; MUTATION; IDENTIFICATION; LYMPHOCYTES	Store-operated Ca2+ entry through calcium release-activated calcium channels is the chief mechanism for increasing intracellular Ca2+ in immune cells. Here we show that mouse T cells and fibroblasts lacking the calcium sensor STIM1 had severely impaired store-operated Ca2+ influx, whereas deficiency in the calcium sensor STIM2 had a smaller effect. However, T cells lacking either STIM1 or STIM2 had much less cytokine production and nuclear translocation of the transcription factor NFAT. T cell-specific ablation of both STIM1 and STIM2 resulted in a notable lymphoproliferative phenotype and a selective decrease in regulatory T cell numbers. We conclude that both STIM1 and STIM2 promote store-operated Ca2+ entry into T cells and fibroblasts and that STIM proteins are required for the development and function of regulatory T cells.	[Oh-hora, Masatsugu; Hogan, Patrick G.; Sharma, Sonia; Lamperti, Ed; Feske, Stefan; Rao, Anjana] Immune Dis Inst, Boston, MA 02115 USA; [Yamashita, Megumi; Chung, Woo; Prakriya, Murali] Northwestern Univ, Feinberg Sch Med, Dept Biol Chem & Mol Pharmacol, Chicago, IL 60611 USA; [Oh-hora, Masatsugu; Hogan, Patrick G.; Sharma, Sonia; Lamperti, Ed; Feske, Stefan; Rao, Anjana] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Northwestern University; Feinberg School of Medicine; Harvard University; Harvard Medical School	Feske, S (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10016 USA.	stefan.feske@med.nyu.edu; arao@cbr.med.harvard.edu	Feske, stefan/ABB-3554-2021	Feske, stefan/0000-0001-5431-8178; Prakriya, Murali/0000-0003-0781-4480; Yamashita, Megumi/0000-0003-0196-0428	NIAID NIH HHS [R01 AI048213-08, R01 AI048213, R01 AI040127-17, R01 AI040127] Funding Source: Medline; NIGMS NIH HHS [R01 GM075256, R01 GM075256-03] Funding Source: Medline; NINDS NIH HHS [R01 NS057499, R01 NS057499-02, R01 NS057499-01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048213, R01AI040127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057499] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aguado E, 2002, SCIENCE, V296, P2036, DOI 10.1126/science.1069057; Ansel KM, 2004, NAT IMMUNOL, V5, P1251, DOI 10.1038/ni1135; Baba Y, 2008, NAT IMMUNOL, V9, P81, DOI 10.1038/ni1546; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Bopp T, 2005, J EXP MED, V201, P181, DOI 10.1084/jem.20041538; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Carafoli E, 2003, NAT REV MOL CELL BIO, V4, P326, DOI 10.1038/nrm1073; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Feske S, 2003, BIOCHEM BIOPH RES CO, V311, P1117, DOI 10.1016/j.bbrc.2003.09.174; Feske S, 2000, J IMMUNOL, V165, P297, DOI 10.4049/jimmunol.165.1.297; Feske S, 1996, EUR J IMMUNOL, V26, P2119, DOI 10.1002/eji.1830260924; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Fontenot JD, 2006, NAT IMMUNOL, V7, P427, DOI 10.1038/ni0406-427b; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; HO AM, 1994, J BIOL CHEM, V269, P28181; Hogan PG, 2007, TRENDS BIOCHEM SCI, V32, P235, DOI 10.1016/j.tibs.2007.03.009; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Koonpaew S, 2006, J EXP MED, V203, P119, DOI 10.1084/jem.20050903; LEDEIST F, 1995, BLOOD, V85, P1053, DOI 10.1182/blood.V85.4.1053.bloodjournal8541053; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lin J, 2001, J BIOL CHEM, V276, P29588, DOI 10.1074/jbc.M102221200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; PARTISETI M, 1994, J BIOL CHEM, V269, P32327; Paz PE, 2001, BIOCHEM J, V356, P461, DOI 10.1042/0264-6021:3560461; Prakriya M, 2003, CELL CALCIUM, V33, P311, DOI 10.1016/S0143-4160(03)00045-9; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Prakriya M, 2006, J GEN PHYSIOL, V128, P373, DOI 10.1085/jgp.200609588; Putney JW, 2007, J CELL SCI, V120, P1959, DOI 10.1242/jcs.03462; Ranger AM, 1998, IMMUNITY, V9, P627, DOI 10.1016/S1074-7613(00)80660-3; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; SAKAGUCHI S, 1988, J EXP MED, V167, P1479, DOI 10.1084/jem.167.4.1479; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Schmidt-Supprian M, 2004, P NATL ACAD SCI USA, V101, P4566, DOI 10.1073/pnas.0400885101; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Sommers CL, 2005, J EXP MED, V201, P1125, DOI 10.1084/jem.20041869; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Vorndran C, 1995, BIOPHYS J, V69, P2112, DOI 10.1016/S0006-3495(95)80082-2; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Xu PY, 2006, BIOCHEM BIOPH RES CO, V350, P969, DOI 10.1016/j.bbrc.2006.09.134; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200; Zheng L, 2008, BIOCHEM BIOPH RES CO, V369, P240, DOI 10.1016/j.bbrc.2007.12.129	67	446	468	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2008	9	4					432	443		10.1038/ni1574	http://dx.doi.org/10.1038/ni1574			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	276ED	18327260	Green Accepted			2022-12-18	WOS:000254123200019
J	Bromley, SK; Mempel, TR; Luster, AD				Bromley, Shannon K.; Mempel, Thorsten R.; Luster, Andrew D.			Orchestrating the orchestrators: chemokines in control of T cell traffic	NATURE IMMUNOLOGY			English	Review							HIGH ENDOTHELIAL VENULES; LYMPH-NODE CORTEX; CD1D-RESTRICTED NKT CELLS; LYMPHOCYTES IN-VIVO; HUMAN TH17 CELLS; DENDRITIC CELLS; CUTTING EDGE; LEUKOCYTE MIGRATION; RECEPTOR EXPRESSION; REGULATORY-CELLS	The understanding of how chemokines orchestrate the trafficking and activity of immune cells has increased considerably. So far, over 50 chemokines and 20 chemokine receptors have been identified. Detailed analyses have demonstrated the function of chemokine receptors on T cell subsets, the temporal and spatial expression patterns of chemokines in vivo and the phenotypes of animals genetically deficient in one component or several components of the chemokine-chemokine receptor system. New microscopy modalities for studying the influence of chemokines on the migratory activity of T cells in the lymph node have also brought new insights. Here we review such advances with particular emphasis on control of the migration of T cell subsets in lymph nodes and in peripheral tissues in homeostasis and inflammation.	[Bromley, Shannon K.; Mempel, Thorsten R.; Luster, Andrew D.] Harvard Univ, Div Rheumatol Allergy & Immunol, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis,Sch Med, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Luster, AD (corresponding author), Harvard Univ, Div Rheumatol Allergy & Immunol, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis,Sch Med, Charlestown, MA 02129 USA.	aluster@mgh.harvard.edu	Luster, Andrew/ABE-6504-2020	Luster, Andrew/0000-0001-9679-7912	NIAID NIH HHS [R37 AI040618] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Agace WW, 2006, NAT REV IMMUNOL, V6, P682, DOI 10.1038/nri1869; Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Alon R, 2007, IMMUNITY, V26, P17, DOI 10.1016/j.immuni.2007.01.002; Andrew DP, 2001, J IMMUNOL, V166, P103, DOI 10.4049/jimmunol.166.1.103; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Asperti-Boursin F, 2007, J EXP MED, V204, P1167, DOI 10.1084/jem.20062079; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Baekkevold ES, 2001, J EXP MED, V193, P1105, DOI 10.1084/jem.193.9.1105; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Boehm T, 2007, NAT IMMUNOL, V8, P131, DOI 10.1038/ni1435; Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; Cahalan MD, 2003, CURR OPIN IMMUNOL, V15, P372, DOI 10.1016/S0952-7915(03)00079-7; Campbell JJ, 2007, J IMMUNOL, V178, P3358, DOI 10.4049/jimmunol.178.6.3358; Carlsen HS, 2005, BLOOD, V106, P444, DOI 10.1182/blood-2004-11-4353; CARMAN CV, 2008, CURR OPIN CELL BIOL; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Chen Q, 2006, NAT IMMUNOL, V7, P1299, DOI 10.1038/ni1406; Denning TL, 2005, J IMMUNOL, V174, P7487, DOI 10.4049/jimmunol.174.12.7487; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Ebert LM, 2006, J IMMUNOL, V176, P4331, DOI 10.4049/jimmunol.176.7.4331; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Germanov E, 2008, J IMMUNOL, V181, P81, DOI 10.4049/jimmunol.181.1.81; Glatzel A, 2002, J IMMUNOL, V168, P4920, DOI 10.4049/jimmunol.168.10.4920; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Grogan JL, 2002, CURR OPIN IMMUNOL, V14, P366, DOI 10.1016/S0952-7915(02)00340-0; Guarda G, 2007, NAT IMMUNOL, V8, P743, DOI 10.1038/ni1469; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Hess C, 2004, BLOOD, V104, P3463, DOI 10.1182/blood-2004-03-1067; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Huang JH, 2007, J IMMUNOL, V178, P7747, DOI 10.4049/jimmunol.178.12.7747; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Huehn J, 2005, TRENDS IMMUNOL, V26, P632, DOI 10.1016/j.it.2005.10.001; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Johnston B, 2003, J IMMUNOL, V171, P2960, DOI 10.4049/jimmunol.171.6.2960; Kabashima K, 2003, NAT IMMUNOL, V4, P694, DOI 10.1038/ni943; Katakai T, 2004, INT IMMUNOL, V16, P1133, DOI 10.1093/intimm/dxh113; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Kuklin NA, 2000, J CLIN INVEST, V106, P1541, DOI 10.1172/JCI10927; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lammermann T, 2008, IMMUNOL REV, V221, P26, DOI 10.1111/j.1600-065X.2008.00592.x; Lee I, 2005, J EXP MED, V201, P1037, DOI 10.1084/jem.20041709; Lee JH, 2007, J IMMUNOL, V178, P301, DOI 10.4049/jimmunol.178.1.301; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lim HW, 2004, J CLIN INVEST, V114, P1640, DOI 10.1172/JCI22325; Lim HW, 2008, J IMMUNOL, V180, P122, DOI 10.4049/jimmunol.180.1.122; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Lord GM, 2005, BLOOD, V106, P3432, DOI 10.1182/blood-2005-04-1393; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; Luther SA, 2002, J IMMUNOL, V169, P424, DOI 10.4049/jimmunol.169.1.424; Mackay CR, 2008, NAT IMMUNOL, V9, P988, DOI 10.1038/ni.f.210; MACKAY CR, 1992, EUR J IMMUNOL, V22, P2205, DOI 10.1002/eji.1830220904; Mathew A, 2001, J EXP MED, V193, P1087, DOI 10.1084/jem.193.9.1087; Mempel TR, 2006, IMMUNITY, V25, P867, DOI 10.1016/j.immuni.2006.11.002; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Menning A, 2007, EUR J IMMUNOL, V37, P1575, DOI 10.1002/eji.200737201; Meyer EH, 2007, J IMMUNOL, V179, P4661, DOI 10.4049/jimmunol.179.7.4661; Mikhak Z, 2006, J IMMUNOL, V176, P4959, DOI 10.4049/jimmunol.176.8.4959; Muller M, 2007, J IMMUNOL, V179, P2774, DOI 10.4049/jimmunol.179.5.2774; Mueller SN, 2007, SCIENCE, V317, P670, DOI 10.1126/science.1144830; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Nistala K, 2008, ARTHRITIS RHEUM-US, V58, P875, DOI 10.1002/art.23291; Okada T, 2002, J EXP MED, V196, P65, DOI 10.1084/jem.20020201; Okada T, 2007, J IMMUNOL, V178, P2973, DOI 10.4049/jimmunol.178.5.2973; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Pham THM, 2008, IMMUNITY, V28, P122, DOI 10.1016/j.immuni.2007.11.017; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; Pittet MJ, 2008, IMMUNOL REV, V221, P107, DOI 10.1111/j.1600-065X.2008.00584.x; Reiss Y, 2001, J EXP MED, V194, P1541, DOI 10.1084/jem.194.10.1541; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; ROT A, 1993, EUR J IMMUNOL, V23, P303, DOI 10.1002/eji.1830230150; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sato W, 2007, J IMMUNOL, V178, P7525, DOI 10.4049/jimmunol.178.12.7525; Schneider MA, 2007, J EXP MED, V204, P735, DOI 10.1084/jem.20061405; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Scimone ML, 2004, J EXP MED, V199, P1113, DOI 10.1084/jem.20031645; Siegmund K, 2005, BLOOD, V106, P3097, DOI 10.1182/blood-2005-05-1864; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; Singh SP, 2008, J IMMUNOL, V180, P214, DOI 10.4049/jimmunol.180.1.214; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Stachowiak AN, 2006, J IMMUNOL, V177, P2340, DOI 10.4049/jimmunol.177.4.2340; Stein JV, 2000, J EXP MED, V191, P61, DOI 10.1084/jem.191.1.61; Sundrud MS, 2003, J IMMUNOL, V171, P3542, DOI 10.4049/jimmunol.171.7.3542; Syrbe U, 1999, SPRINGER SEMIN IMMUN, V21, P263, DOI 10.1007/BF00812257; Szanya V, 2002, J IMMUNOL, V169, P2461, DOI 10.4049/jimmunol.169.5.2461; Tager AM, 2003, NAT IMMUNOL, V4, P982, DOI 10.1038/ni970; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Taylor PA, 2004, BLOOD, V104, P3804, DOI 10.1182/blood-2004-05-1850; Tedla N, 1998, J IMMUNOL, V161, P5663; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Thomas SY, 2003, J IMMUNOL, V171, P2571, DOI 10.4049/jimmunol.171.5.2571; Thomsen AR, 2003, IMMUNOL LETT, V85, P119, DOI 10.1016/S0165-2478(02)00236-5; Ueha S, 2007, J LEUKOCYTE BIOL, V82, P1230, DOI 10.1189/jlb.0906574; Vassileva G, 1999, J EXP MED, V190, P1183, DOI 10.1084/jem.190.8.1183; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wang SJ, 2006, J EXP MED, V203, P1519, DOI 10.1084/jem.20051210; Wei S, 2006, BLOOD, V108, P426, DOI 10.1182/blood-2006-01-0177; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706; Wurbel MA, 2007, J IMMUNOL, V178, P7598, DOI 10.4049/jimmunol.178.12.7598; Yoneyama H, 2004, INT IMMUNOL, V16, P915, DOI 10.1093/intimm/dxh093; Yuan Q, 2007, J EXP MED, V204, P1327, DOI 10.1084/jem.20062076; Yurchenko E, 2006, J EXP MED, V203, P2451, DOI 10.1084/jem.20060956	111	445	458	0	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2008	9	9					970	980		10.1038/ni.f.213	http://dx.doi.org/10.1038/ni.f.213			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339DZ	18711434				2022-12-18	WOS:000258559600005
J	Maynard, CL; Harrington, LE; Janowski, KM; Oliver, JR; Zindl, CL; Rudensky, AY; Weaver, CT				Maynard, Craig L.; Harrington, Laurie E.; Janowski, Karen M.; Oliver, James R.; Zindl, Carlene L.; Rudensky, Alexander Y.; Weaver, Casey T.			Regulatory T cells expressing interleukin 10 develop from Foxp3(+) and Foxp3(-) precursor cells in the absence of interleukin 10	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR FOXP3; CONTROL INTESTINAL INFLAMMATION; TGF-BETA; IN-VIVO; AIRWAY HYPERREACTIVITY; CYTOKINE PRODUCTION; IMMUNE-RESPONSES; DENDRITIC CELLS; ORAL TOLERANCE; HELPER-CELL	CD4(+) regulatory T cells (T(reg) cells) that produce interleukin 10 (IL-10) are important contributors to immune homeostasis. We generated mice with a 'dual-reporter' system of the genes encoding IL-10 and the transcription factor Foxp3 to track Treg subsets based on coordinate or differential expression of these genes. Secondary lymphoid tissues, lung and liver had enrichment of Foxp3(+) IL-10-T(reg) cells, whereas the large and small intestine had enrichment of Foxp3+ IL-10(+) and Foxp3(-)IL-10(+) T(reg) cells, respectively. Although negative for II10 expression, both Foxp3(+) and Foxp3(-)CD4(+) thymic precursor cells gave rise to peripheral IL-10(+) T(reg) cells, with only Foxp3-precursor cells giving rise to all Treg subsets. Each T(reg) subset developed in IL-10-deficient mice, but this was blocked by treatment with antibody to transforming growth factor-beta. Thus, Foxp3(+) and Foxp3 precursor cells give rise to peripheral IL-10-expressing Treg cells by a mechanism dependent on transforming growth factor-beta and independent of IL-10.	Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA; Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Weaver, CT (corresponding author), Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA.	cweaver@uab.edu		Weaver, Casey/0000-0002-2180-1793; Zindl, Carlene/0000-0003-4841-3552				Akbari O, 2002, NAT MED, V8, P1024, DOI 10.1038/nm745; Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Belkaid Y, 2001, J EXP MED, V194, P1497, DOI 10.1084/jem.194.10.1497; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brooks DG, 2005, J VIROL, V79, P10514, DOI 10.1128/JVI.79.16.10514-10527.2005; Cazac BB, 2000, IMMUNITY, V13, P443, DOI 10.1016/S1074-7613(00)00044-3; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cong YZ, 2002, J IMMUNOL, V169, P6112, DOI 10.4049/jimmunol.169.11.6112; Davidson NJ, 1996, J EXP MED, V184, P241, DOI 10.1084/jem.184.1.241; DEFRANCE T, 1992, J EXP MED, V175, P671, DOI 10.1084/jem.175.3.671; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Foussat A, 2003, J IMMUNOL, V171, P5018, DOI 10.4049/jimmunol.171.10.5018; Groux H, 1999, J IMMUNOL, V162, P1723; Groux H, 2003, TRANSPLANTATION, V75, p8S, DOI 10.1097/01.TP.0000067944.90241.BD; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; KARNANAKA M, 2006, IMMUNITY, V25, P941; Kitani A, 2003, J EXP MED, V198, P1179, DOI 10.1084/jem.20030917; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Levings MK, 2001, J IMMUNOL, V166, P5530, DOI 10.4049/jimmunol.166.9.5530; Levings MK, 2005, BLOOD, V105, P1162, DOI 10.1182/blood-2004-03-1211; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lohning M, 2003, J EXP MED, V197, P181, DOI 10.1084/jem.20020632; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; Poussier P, 2002, J EXP MED, V195, P1491, DOI 10.1084/jem.20011793; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Roers A, 2004, J EXP MED, V200, P1289, DOI 10.1084/jem.20041789; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Stock P, 2004, NAT IMMUNOL, V5, P1149, DOI 10.1038/ni1122; Tone M, 2003, P NATL ACAD SCI USA, V100, P15059, DOI 10.1073/pnas.2334901100; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; van Montfrans C, 2002, GASTROENTEROLOGY, V123, P1865, DOI 10.1053/gast.2002.37067; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vieira PL, 2004, J IMMUNOL, V172, P5986, DOI 10.4049/jimmunol.172.10.5986; VIEIRA PL, 2004, J IMMUNOL, V105, P1162; Wakkach A, 2003, IMMUNITY, V18, P605, DOI 10.1016/S1074-7613(03)00113-4; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Weiner HL, 2001, MICROBES INFECT, V3, P947, DOI 10.1016/S1286-4579(01)01456-3; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455	56	445	474	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2007	8	9					931	941		10.1038/ni1504	http://dx.doi.org/10.1038/ni1504			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	202QN	17694059				2022-12-18	WOS:000248918200016
J	Robinette, ML; Fuchs, A; Cortez, VS; Lee, JS; Wang, YM; Durum, SK; Gilfillan, S; Colonna, M				Robinette, Michelle L.; Fuchs, Anja; Cortez, Victor S.; Lee, Jacob S.; Wang, Yaming; Durum, Scott K.; Gilfillan, Susan; Colonna, Marco		Immunological Genome Consortium	Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; REGULATORY T-CELLS; ADAPTIVE IMMUNITY; GENE-EXPRESSION; FACTOR GATA3; BET; DIFFERENTIATION; ACTIVATION; RECEPTORS; IDENTITY	The recognized diversity of innate lymphoid cells (ILCs) is rapidly expanding. Three ILC classes have emerged, ILC1, ILC2 and ILC3, with ILC1 and ILC3 including several subsets. The classification of some subsets is unclear, and it remains controversial whether natural killer (NK) cells and ILC1 cells are distinct cell types. To address these issues, we analyzed gene expression in ILCs and NK cells from mouse small intestine, spleen and liver, as part of the Immunological Genome Project. The results showed unique gene-expression patterns for some ILCs and overlapping patterns for ILC1 cells and NK cells, whereas other ILC subsets remained indistinguishable. We identified a transcriptional program shared by small intestine ILCs and a core ILC signature. We revealed and discuss transcripts that suggest previously unknown functions and developmental paths for ILCs.	[Robinette, Michelle L.; Cortez, Victor S.; Wang, Yaming; Gilfillan, Susan; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Fuchs, Anja] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Lee, Jacob S.] Merck Res Labs, Palo Alto, CA USA; [Durum, Scott K.] NCI, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD 21701 USA	Washington University (WUSTL); Washington University (WUSTL); Merck & Company; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	mcolonna@wustl.edu		durum, scott/0000-0003-1307-9582; Fairfax, Keke/0000-0002-8382-2960; Colonna, Marco/0000-0001-5222-4987	US National Institutes of Health [R24A1072073, 1U01A1095542, R01DE021255, R21CA16719, T32 GM07200, T32 AI 7172-34]; NATIONAL CANCER INSTITUTE [ZIABC009287, ZIABC011150, R21CA167192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095542, R24AI072073, T32AI007172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK107053] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank our colleagues in the ImmGen consortium, especially C. Benoist and L. Lanier, for input and discussion; the core ImmGen team, K. Rothamel and A. Rhodes, for contributions and technical assistance; M. Artyomov, G. Krishnan and J. Siegel for computational assistance; D. Sojka for discussion; E. Lantelme and D. Brinja for sorting assistance; P. Wang for microscopy assistance; and eBioscience and Affymetrix for support of the ImmGen Project. Supported by the US National Institutes of Health (R24A1072073 to the ImmGen Consortium; 1U01A1095542, R01DE021255 and R21CA16719 to the Colonna laboratory; MSTP T32 GM07200 to M. L. R.; and Infectious Disease Training Grant T32 AI 7172-34 to V.S.C.).	Allan D.S., 2014, MUCOSAL IMMUNOL; Bando J.K., 2014, NAT IMMUNOL; Bezman NA, 2012, NAT IMMUNOL, V13, P1000, DOI 10.1038/ni.2395; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Carpenter S, 2014, NAT REV IMMUNOL, V14, P361, DOI 10.1038/nri3682; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Daussy C, 2014, J EXP MED, V211, P563, DOI 10.1084/jem.20131560; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Gasteiger G, 2013, J EXP MED, V210, P1179, DOI 10.1084/jem.20122571; Geiger TL, 2014, J EXP MED, V211, P1723, DOI 10.1084/jem.20140212; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Kamizono S, 2009, J EXP MED, V206, P2977, DOI 10.1084/jem.20092176; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Kumanogoh A, 2013, NAT REV IMMUNOL, V13, P802, DOI 10.1038/nri3545; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; LEVITT LJ, 1991, J CLIN INVEST, V88, P67, DOI 10.1172/JCI115306; McKenzie ANJ, 2014, IMMUNITY, V41, P366, DOI 10.1016/j.immuni.2014.09.006; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Mohebiany A.N., 2014, NEUROLOGICAL DIS ADV, V8; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Muller PA, 2014, CELL, V158, P300, DOI 10.1016/j.cell.2014.04.050; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Ramirez K, 2012, IMMUNITY, V36, P921, DOI 10.1016/j.immuni.2012.04.006; Rankin LC, 2013, NAT IMMUNOL, V14, P389, DOI 10.1038/ni.2545; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Reynders A, 2011, EMBO J, V30, P2934, DOI 10.1038/emboj.2011.201; Satoh-Takayama N, 2014, IMMUNITY, V41, P776, DOI 10.1016/j.immuni.2014.10.007; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Sciume G, 2012, J EXP MED, V209, P2331, DOI 10.1084/jem.20122097; Seillet C, 2014, J EXP MED, V211, P1733, DOI 10.1084/jem.20140145; Shen W, 2014, P NATL ACAD SCI USA, V111, pE2977, DOI 10.1073/pnas.1401820111; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Turner JE, 2013, J EXP MED, V210, P2951, DOI 10.1084/jem.20130071; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Ye SK, 1999, IMMUNITY, V11, P213, DOI 10.1016/S1074-7613(00)80096-5; Yu JH, 2013, TRENDS IMMUNOL, V34, P573, DOI 10.1016/j.it.2013.07.005; Yu XF, 2014, ELIFE, V3, DOI 10.7554/eLife.04406; Zhao H, 2005, NAT IMMUNOL, V6, P1263, DOI 10.1038/ni1267	51	444	453	3	85	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2015	16	3					306	U142		10.1038/ni.3094	http://dx.doi.org/10.1038/ni.3094			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB7XN	25621825	Green Accepted			2022-12-18	WOS:000349842100014
J	Godfrey, DI; Uldrich, AP; McCluskey, J; Rossjohn, J; Moody, DB				Godfrey, Dale I.; Uldrich, Adam P.; McCluskey, James; Rossjohn, Jamie; Moody, D. Branch			The burgeoning family of unconventional T cells	NATURE IMMUNOLOGY			English	Review							MAJOR HISTOCOMPATIBILITY COMPLEX; INVARIANT NKT CELLS; ANTIGEN RECEPTOR RECOGNITION; VITAMIN-B METABOLITES; CLASS-IB MOLECULE; GAMMA-DELTA; MAIT CELLS; IN-VIVO; CUTTING EDGE; GLYCOLIPID ANTIGENS	While most studies of T lymphocytes have focused on T cells reactive to complexes of peptide and major histocompatibility complex (MHC) proteins, many other types of T cells do not fit this paradigm. These include CD1-restricted T cells, MR1-restricted mucosal associated invariant T cells (MAIT cells), MHC class lb reactive T cells, and gamma(delta) T cells. Collectively, these T cells are considered 'unconventional', in part because they can recognize lipids, small-molecule metabolites and specially modified peptides. Unlike MHC-reactive T cells, these apparently disparate T cell types generally show simplified patterns of T cell antigen receptor (TCR) expression, rapid effector responses and 'public' antigen specificities. Here we review evidence showing that unconventional T cells are an abundant component of the human immune system and discuss the immunotherapeutic potential of these cells and their antigenic targets.	[Godfrey, Dale I.; Uldrich, Adam P.; McCluskey, James] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Godfrey, Dale I.; Uldrich, Adam P.] Univ Melbourne, Australian Res Council Ctr Excellence Adv Mol Ima, Parkville, Vic 3052, Australia; [Rossjohn, Jamie] Monash Univ, Infect & Immun Program, Biomed Discovery Inst, Clayton, Vic, Australia; [Rossjohn, Jamie] Monash Univ, Dept Biochem & Mol Biol, Biomed Discovery Inst, Clayton, Vic, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF10 3AX, S Glam, Wales; [Rossjohn, Jamie] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic, Australia; [Moody, D. Branch] Harvard Univ, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Dept Med,Med Sch, Boston, MA 02115 USA	University of Melbourne; University of Melbourne; Monash University; Monash University; Cardiff University; Monash University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Godfrey, DI (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia.	godfrey@unimelb.edu.au	Uldrich, Adam/AAX-3785-2020; Rossjohn, Jamie/F-9032-2013; McCluskey, James/A-1291-2007	Rossjohn, Jamie/0000-0002-2020-7522; McCluskey, James/0000-0002-8597-815X; Godfrey, Dale/0000-0002-3009-5472; ULDRICH, ADAM/0000-0002-6350-5976	National Health and Medical Research Council of Australia [1013667, 1063587, 1020770, AF50]; Australian Research Council [CE140100011, LE110100106, FT140100278]; Cancer Council Victoria; Bill and Melinda Gates Foundation Vaccine Accelerator; National Institute of Allergy and Infectious Diseases [AI049313, AR048632, U19111224]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048632] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Bill and Melinda Gates Foundation Vaccine Accelerator; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank M. Sugita and N. LaGruta for discussions. Supported by the National Health and Medical Research Council of Australia (1013667 and 1063587; 1020770 to DIG.; and AF50 to JR.), the Australian Research Council (CE140100011 and LE110100106; and FT140100278 to A.P.U.), Cancer Council Victoria, the Bill and Melinda Gates Foundation Vaccine Accelerator, and the National Institute of Allergy and Infectious Diseases (AI049313, AR048632 and U19111224).	Agea E, 2005, J EXP MED, V202, P295, DOI 10.1084/jem.20050773; Allison TJ, 2001, NATURE, V411, P820, DOI 10.1038/35081115; Ambrosino E, 2007, J IMMUNOL, V179, P5126, DOI 10.4049/jimmunol.179.8.5126; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Bai L, 2012, EUR J IMMUNOL, V42, P2505, DOI 10.1002/eji.201242531; Barakonyi A, 2002, J IMMUNOL, V168, P2683, DOI 10.4049/jimmunol.168.6.2683; Bedel R, 2012, NAT IMMUNOL, V13, P705, DOI 10.1038/ni.2347; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; Berzins SP, 2005, EUR J IMMUNOL, V35, P1399, DOI 10.1002/eji.200425958; Birkinshaw RW, 2015, NAT IMMUNOL, V16, P258, DOI 10.1038/ni.3098; Bourgeois EA, 2015, J EXP MED, V212, P149, DOI 10.1084/jem.20141505; Brennan PJ, 2014, P NATL ACAD SCI USA, V111, P13433, DOI 10.1073/pnas.1415357111; Brown LCW, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001610; Bruder J, 2012, J BIOL CHEM, V287, P20986, DOI 10.1074/jbc.M112.356709; Bukowski JF, 1999, IMMUNITY, V11, P57, DOI 10.1016/S1074-7613(00)80081-3; Caccamo N, 2022, EUR J IMMUNOL, DOI 10.1002/eji.201445193; CALABI F, 1989, EUR J IMMUNOL, V19, P285, DOI 10.1002/eji.1830190211; Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451; Chan AC, 2013, CLIN EXP IMMUNOL, V172, P129, DOI 10.1111/cei.12045; Chandra S, 2015, NAT IMMUNOL, V16, P799, DOI 10.1038/ni.3203; Chang DH, 2008, BLOOD, V112, P1308, DOI 10.1182/blood-2008-04-149831; Chang PP, 2012, NAT IMMUNOL, V13, P35, DOI 10.1038/ni.2166; Chiang EY, 2005, J IMMUNOL, V174, P5367, DOI 10.4049/jimmunol.174.9.5367; Chien YH, 2014, ANNU REV IMMUNOL, V32, P121, DOI 10.1146/annurev-immunol-032713-120216; Chiu NM, 1999, J EXP MED, V190, P1869, DOI 10.1084/jem.190.12.1869; Cho HS, 2011, J IMMUNOL, V186, P489, DOI 10.4049/jimmunol.1002639; Cho YN, 2014, J IMMUNOL, V193, P3891, DOI 10.4049/jimmunol.1302701; Coquet JM, 2008, P NATL ACAD SCI USA, V105, P11287, DOI 10.1073/pnas.0801631105; Corbett AJ, 2014, NATURE, V509, P361, DOI 10.1038/nature13160; Crowe NY, 2003, J IMMUNOL, V171, P4020, DOI 10.4049/jimmunol.171.8.4020; Crowley MP, 2000, SCIENCE, V287, P314, DOI 10.1126/science.287.5451.314; Crowley MP, 1997, J EXP MED, V185, P1223, DOI 10.1084/jem.185.7.1223; Croxford JL, 2006, NAT IMMUNOL, V7, P987, DOI 10.1038/ni1370; Dascher CC, 1999, J IMMUNOL, V163, P5478; de Jong A, 2014, NAT IMMUNOL, V15, P177, DOI 10.1038/ni.2790; de Jong A, 2010, NAT IMMUNOL, V11, P1102, DOI 10.1038/ni.1956; de Lalla C, 2011, EUR J IMMUNOL, V41, P602, DOI 10.1002/eji.201041211; De Santo C, 2008, J CLIN INVEST, V118, P4036, DOI 10.1172/JCI36264; DEUSCH K, 1991, EUR J IMMUNOL, V21, P1053, DOI 10.1002/eji.1830210429; Dougan SK, 2007, CURR TOP MICROBIOL, V314, P113; DUPUY P, 1990, J INVEST DERMATOL, V94, P764, DOI 10.1111/1523-1747.ep12874626; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Eberl G, 2000, EUR J IMMUNOL, V30, P985, DOI 10.1002/(SICI)1521-4141(200004)30:4<985::AID-IMMU985>3.0.CO;2-E; Ebert LM, 2006, J IMMUNOL, V176, P4331, DOI 10.4049/jimmunol.176.7.4331; Eckle SBG, 2014, J EXP MED, V211, P1585, DOI 10.1084/jem.20140484; Exley MA, 2001, J IMMUNOL, V167, P5531, DOI 10.4049/jimmunol.167.10.5531; Felio K, 2009, J EXP MED, V206, P2497, DOI 10.1084/jem.20090898; Fernandez CS, 2015, IMMUNOL CELL BIOL, V93, P177, DOI 10.1038/icb.2014.91; Fujii S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00409; Fujii SI, 2004, J EXP MED, V199, P1607, DOI 10.1084/jem.20040317; Galli G, 2003, J EXP MED, V197, P1051, DOI 10.1084/jem.20021616; Gerber DJ, 1999, J IMMUNOL, V163, P3076; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Gold MC, 2014, J EXP MED, V211, P1601, DOI 10.1084/jem.20140507; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Gomes AQ, 2010, CANCER RES, V70, P10024, DOI 10.1158/0008-5472.CAN-10-3236; Gu Siyi, 2014, Front Immunol, V5, P688, DOI 10.3389/fimmu.2014.00688; Guillonneau C, 2009, P NATL ACAD SCI USA, V106, P3330, DOI 10.1073/pnas.0813309106; Hammond KJL, 2001, J IMMUNOL, V167, P1164, DOI 10.4049/jimmunol.167.3.1164; Hintz M, 2001, FEBS LETT, V509, P317, DOI 10.1016/S0014-5793(01)03191-X; Hofstetter AR, 2012, J IMMUNOL, V188, P3071, DOI 10.4049/jimmunol.1103554; Huang SX, 2011, P NATL ACAD SCI USA, V108, P19335, DOI 10.1073/pnas.1112969108; ITOHARA S, 1990, NATURE, V343, P754, DOI 10.1038/343754a0; Jahng A, 2004, J EXP MED, V199, P947, DOI 10.1084/jem.20031389; Jenkins MK, 2012, J IMMUNOL, V188, P4135, DOI 10.4049/jimmunol.1102661; Kain L, 2015, MOL IMMUNOL, V68, P94, DOI 10.1016/j.molimm.2015.06.009; Kain L, 2014, IMMUNITY, V41, P543, DOI 10.1016/j.immuni.2014.08.017; Karunakaran MM, 2014, IMMUNOGENETICS, V66, P243, DOI 10.1007/s00251-014-0763-8; Kasmar A, 2009, CURR OPIN IMMUNOL, V21, P397, DOI 10.1016/j.coi.2009.05.022; Kasmar AG, 2013, J IMMUNOL, V191, P4499, DOI 10.4049/jimmunol.1301660; Kasmar AG, 2011, J EXP MED, V208, P1741, DOI 10.1084/jem.20110665; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; King IL, 2012, NAT IMMUNOL, V13, P44, DOI 10.1038/ni.2172; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Kong Y, 2009, BLOOD, V114, P310, DOI 10.1182/blood-2008-12-196287; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Leeansyah E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005072; Leeansyah E, 2013, BLOOD, V121, P1124, DOI 10.1182/blood-2012-07-445429; Lepore M, 2014, J EXP MED, V211, P1360, DOI 10.1084/jem.20140410; Lepore M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4866; Li HM, 1998, NATURE, V391, P502, DOI 10.1038/35172; LIEBER MR, 1991, FASEB J, V5, P2934, DOI 10.1096/fasebj.5.14.1752360; Lockridge JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021701; Luoma AM, 2013, IMMUNITY, V39, P1032, DOI 10.1016/j.immuni.2013.11.001; Ly D, 2013, J EXP MED, V210, P729, DOI 10.1084/jem.20120624; Magalhaes I, 2015, J CLIN INVEST, V125, P1752, DOI 10.1172/JCI78941; Mangan BA, 2013, J IMMUNOL, V191, P30, DOI 10.4049/jimmunol.1300121; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Meierovics A, 2013, P NATL ACAD SCI USA, V110, pE3119, DOI 10.1073/pnas.1302799110; Melero I, 2015, NAT REV CANCER, V15, P457, DOI 10.1038/nrc3973; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; O'Brien RL, 2015, CELL IMMUNOL, V296, P62, DOI 10.1016/j.cellimm.2015.01.011; O'Brien RL, 2010, SEMIN IMMUNOL, V22, P193, DOI 10.1016/j.smim.2010.03.006; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Patel O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3142; Pei B, 2012, ANN NY ACAD SCI, V1253, P68, DOI 10.1111/j.1749-6632.2011.06435.x; Pereira P, 1997, P NATL ACAD SCI USA, V94, P5761, DOI 10.1073/pnas.94.11.5761; PORCELLI S, 1989, NATURE, V341, P447, DOI 10.1038/341447a0; Rahimpour A, 2015, J EXP MED, V212, P1095, DOI 10.1084/jem.20142110; Reantragoon R, 2013, J EXP MED, V210, P2305, DOI 10.1084/jem.20130958; Rhodes DA, 2015, J IMMUNOL, V194, P2390, DOI 10.4049/jimmunol.1401064; Rhost S, 2012, SCAND J IMMUNOL, V76, P246, DOI 10.1111/j.1365-3083.2012.02750.x; Robertson FC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00543; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; Rodgers JR, 2005, NAT REV IMMUNOL, V5, P459, DOI 10.1038/nri1635; Rohrlich PS, 2005, P NATL ACAD SCI USA, V102, P12855, DOI 10.1073/pnas.0502309102; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Rossjohn J, 2012, NAT REV IMMUNOL, V12, P845, DOI 10.1038/nri3328; Russano AM, 2006, J ALLERGY CLIN IMMUN, V117, P1178, DOI 10.1016/j.jaci.2006.01.001; Sag D, 2014, J CLIN INVEST, V124, P3725, DOI 10.1172/JCI72308; Salio M, 2014, ANNU REV IMMUNOL, V32, P323, DOI 10.1146/annurev-immunol-032713-120243; Sandstrom A, 2014, IMMUNITY, V40, P490, DOI 10.1016/j.immuni.2014.03.003; Schmieg J, 2003, J EXP MED, V198, P1631, DOI 10.1084/jem.20031192; Serriari NE, 2014, CLIN EXP IMMUNOL, V176, P266, DOI 10.1111/cei.12277; Shimizu K, 2007, J EXP MED, V204, P2641, DOI 10.1084/jem.20070458; SIM GK, 1994, INT IMMUNOL, V6, P1287, DOI 10.1093/intimm/6.9.1287; Smith DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109891; Soudais C, 2015, J IMMUNOL, V194, P4641, DOI 10.4049/jimmunol.1403224; Spada FM, 2000, J EXP MED, V191, P937, DOI 10.1084/jem.191.6.937; Speak AO, 2007, P NATL ACAD SCI USA, V104, P5971, DOI 10.1073/pnas.0607285104; Sullivan LC, 2008, TISSUE ANTIGENS, V72, P415, DOI 10.1111/j.1399-0039.2008.01138.x; Sullivan LC, 2006, TRENDS IMMUNOL, V27, P413, DOI 10.1016/j.it.2006.07.006; Swanson PA, 2008, J EXP MED, V205, P1647, DOI 10.1084/jem.20080570; TAKAGAKI Y, 1989, NATURE, V339, P712, DOI 10.1038/339712a0; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; Tatituri RVV, 2013, P NATL ACAD SCI USA, V110, P1827, DOI 10.1073/pnas.1220601110; Tefit JN, 2014, VACCINE, V32, P6138, DOI 10.1016/j.vaccine.2014.08.070; Tefit JN, 2010, METHODS MOL BIOL, V626, P149, DOI 10.1007/978-1-60761-585-9_11; Terabe M, 2005, J EXP MED, V202, P1627, DOI 10.1084/jem.20051381; Teunissen MBM, 2014, J INVEST DERMATOL, V134, P2898, DOI 10.1038/jid.2014.261; Toulon A, 2009, J EXP MED, V206, P743, DOI 10.1084/jem.20081787; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Uldrich AP, 2013, NAT IMMUNOL, V14, P1137, DOI 10.1038/ni.2713; Ussher JE, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00450; Ussher JE, 2014, EUR J IMMUNOL, V44, P195, DOI 10.1002/eji.201343509; van Meijgaarden KE, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004671; Van Rhijn I, 2004, P NATL ACAD SCI USA, V101, P13578, DOI 10.1073/pnas.0402838101; Van Rhijn I, 2015, NAT REV IMMUNOL, V15, P643, DOI 10.1038/nri3889; Van Rhijn I, 2015, J IMMUNOL, V195, P1927, DOI 10.4049/jimmunol.1500943; Van Rhijn I, 2014, J IMMUNOL, V192, P4054, DOI 10.4049/jimmunol.1400158; Van Rhijn I, 2013, NAT IMMUNOL, V14, P706, DOI 10.1038/ni.2630; van Schaik B, 2014, J IMMUNOL, V193, P5338, DOI 10.4049/jimmunol.1401380; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Vavassori S, 2013, NAT IMMUNOL, V14, P908, DOI 10.1038/ni.2665; Venkataswamy MM, 2009, J IMMUNOL, V183, P1644, DOI 10.4049/jimmunol.0900858; Vincent MS, 2002, NAT IMMUNOL, V3, P1163, DOI 10.1038/ni851; Willcox CR, 2012, NAT IMMUNOL, V13, P872, DOI 10.1038/ni.2394; Wilson MT, 2003, P NATL ACAD SCI USA, V100, P10913, DOI 10.1073/pnas.1833166100; Wingender G, 2010, J IMMUNOL, V185, P2721, DOI 10.4049/jimmunol.1001018; Wu J, 2002, J IMMUNOL, V169, P1236, DOI 10.4049/jimmunol.169.3.1236; Wu Lan, 2011, Front Biosci (Schol Ed), V3, P236, DOI 10.2741/s148; Yamasaki K, 2011, CLIN IMMUNOL, V138, P255, DOI 10.1016/j.clim.2010.11.014; Zeissig S, 2012, NAT MED, V18, P1060, DOI 10.1038/nm.2811; Zeng X, 2012, IMMUNITY, V37, P524, DOI 10.1016/j.immuni.2012.06.011; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	157	443	447	10	124	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2015	16	11					1114	1123		10.1038/ni.3298	http://dx.doi.org/10.1038/ni.3298			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CT8VW	26482978				2022-12-18	WOS:000363096000005
J	Luci, C; Reynders, A; Ivanov, II; Cognet, C; Chiche, L; Chasson, L; Hardwigsen, J; Anguiano, E; Banchereau, J; Chaussabel, D; Dalod, M; Littman, DR; Vivier, E; Tomasello, E				Luci, Carmelo; Reynders, Ana; Ivanov, Ivaylo I.; Cognet, Celine; Chiche, Laurent; Chasson, Lionel; Hardwigsen, Jean; Anguiano, Esperanza; Banchereau, Jacques; Chaussabel, Damien; Dalod, Marc; Littman, Dan R.; Vivier, Eric; Tomasello, Elena			Influence of the transcription factor ROR gamma t on the development of NKp46(+) cell populations in gut and skin	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELL; NK-CELLS; HOST-DEFENSE; INTERLEUKIN-22; IMMUNITY; SUBSETS; DERMATITIS; CONTACT	NKp46(+)CD3(-) natural killer lymphocytes isolated from blood, lymphoid organs, lung, liver and uterus can produce granule-dependent cytotoxicity and interferon-gamma. Here we identify in dermis, gut lamina propria and cryptopatches distinct populations of NKp46(+)CD3(-) cells with a diminished capacity to degranulate and produce interferon-gamma. In the gut, expression of the transcription factor ROR gamma t, which is involved in the development of lymphoid tissue-inducer cells, defined a previously unknown subset of NKp46+CD3- lymphocytes. Unlike ROR gamma t(-) lamina propria and dermis natural killer cells, gut ROR gamma t(+)NKp46(+) cells produced interleukin 22. Our data show that lymphoid tissue-inducer cells and natural killer cells shared unanticipated similarities and emphasize the heterogeneity of NKp46(+)CD3(-) cells in innate immunity, lymphoid organization and local tissue repair.	[Luci, Carmelo; Reynders, Ana; Cognet, Celine; Chiche, Laurent; Chasson, Lionel; Dalod, Marc; Vivier, Eric; Tomasello, Elena] Univ Mediterranee, Ctr Immunol Marseille Luminy, Inst Natl Sante & Rech Med, U631, F-13288 Marseille, France; [Luci, Carmelo; Reynders, Ana; Cognet, Celine; Chiche, Laurent; Chasson, Lionel; Dalod, Marc; Vivier, Eric; Tomasello, Elena] CNRS, Unite Mixte Rech 6102, F-13288 Marseille, France; [Ivanov, Ivaylo I.; Littman, Dan R.] NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Ivanov, Ivaylo I.; Littman, Dan R.] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Cognet, Celine; Chiche, Laurent; Hardwigsen, Jean; Vivier, Eric] Hop Conception, Assistance Publ Hop Marseille, F-13005 Marseille, France; [Anguiano, Esperanza; Banchereau, Jacques; Chaussabel, Damien] Baylor Inst Immunol Res, U899, Inst Natl Sante & Rech Med, Dallas, TX 75204 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); New York University; Howard Hughes Medical Institute; New York University; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Baylor Scott & White Health; Institut National de la Sante et de la Recherche Medicale (Inserm)	Tomasello, E (corresponding author), Univ Mediterranee, Ctr Immunol Marseille Luminy, Inst Natl Sante & Rech Med, U631, Case 906,Campus Luminy, F-13288 Marseille, France.	vivier@ciml.univ-mrs.fr; tomasello@ciml.univ-mrs.fr	Dalod, Marc/AAK-6163-2020; Vivier, Eric/F-8939-2010; LUCI, Carmelo/ABA-6373-2021; Chaussabel, Damien/AAX-1909-2020	Dalod, Marc/0000-0002-6436-7966; Vivier, Eric/0000-0001-7022-8287; LUCI, Carmelo/0000-0001-9687-4164; Tomasello, Elena/0000-0002-6839-5219; Chaussabel, Damien/0000-0002-6131-7242	Ligue Nationale contre le Cancer ('Equipe labellise e La Ligue'); Agence Nationale de la Recherche; Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; Ministere de l'Enseignement Superieur et de la Recherche; Fondation pour la Recherche Medicale; Region Provence Alpes Cote d'Azur-Institut National de la Sante et de la Recherche Medicale; Crohn's and Colitis Foundation of America; Institut Universitaire de France	Ligue Nationale contre le Cancer ('Equipe labellise e La Ligue')(Institut National du Cancer (INCA) France); Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Region Provence Alpes Cote d'Azur-Institut National de la Sante et de la Recherche Medicale(Region Provence-Alpes-Cote d'Azur); Crohn's and Colitis Foundation of America; Institut Universitaire de France	We thank the mouse functional genomics platform of Marseille-Nice Genopole for immunohistology; P. Grenot, M. Barad and A. Zouine from the Centre d'Immunologie de Marseille-Luminy flow cytometry core facility and M. Fallet from the Centre d'Immunologie de Marseille-Luminy microscopy facility for assistance; M. Betizeau for contributions to the initial phases of this work; M. Baratin, T. Walzer and S. Ugolini for discussions; and M. Ito ( Central Institute for Experimental Animals) for Rag2<SUP>-/-</SUP>Il2rg<SUP>-/-</SUP> mice. Anti-human NKVSF1 was provided by A. Poggi ( National Cancer Institute, Genoa, Italy), and anti-IL-22 (MH22B2) was provided by J.C. Renauld ( Ludwig Institute for Cancer Research). E. V. and E. T. are joint senior authors. Supported by Ligue Nationale contre le Cancer ('Equipe labellise e La Ligue'), Agence Nationale de la Recherche, Institut National de la Sante et de la Recherche Medicale, Centre National de la Recherche Scientifique, Ministere de l'Enseignement Superieur et de la Recherche, Fondation pour la Recherche Medicale ( C. L.), Region Provence Alpes Cote d'Azur-Institut National de la Sante et de la Recherche Medicale ( A. R.), the Crohn's and Colitis Foundation of America ( I. I. I.) and the Institut Universitaire de France ( E. V.).	Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bangert C, 2003, J INVEST DERMATOL, V121, P1409, DOI 10.1111/j.1523-1747.2003.12623.x; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Buentke E, 2002, J INVEST DERMATOL, V119, P850, DOI 10.1046/j.1523-1747.2002.00132.x; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Chaix J, 2008, J IMMUNOL, V181, P1627, DOI 10.4049/jimmunol.181.3.1627; Cohavy O, 2005, J IMMUNOL, V174, P646, DOI 10.4049/jimmunol.174.2.646; CUPEDO T, 2008, NAT IMMUNOL     1123, DOI DOI 10.1038/NI1668; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Eberl G, 2005, NAT REV IMMUNOL, V5, P413, DOI 10.1038/nri1600; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Ebert LM, 2006, J IMMUNOL, V176, P4331, DOI 10.4049/jimmunol.176.7.4331; Eiras P, 2000, SCAND J IMMUNOL, V52, P1; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Gregoire C, 2007, IMMUNOL REV, V220, P169, DOI 10.1111/j.1600-065X.2007.00563.x; HARRINGTON L, 2007, FEMS IMMUNOL MED MIC, V76, P3045; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Hayakawa Y, 2006, IMMUNOL REV, V214, P47, DOI 10.1111/j.1600-065X.2006.00454.x; Iwasaki A, 2007, ANNU REV IMMUNOL, V25, P381, DOI 10.1146/annurev.immunol.25.022106.141634; Jameson J, 2007, IMMUNOL REV, V215, P114, DOI 10.1111/j.1600-065X.2006.00483.x; Jamieson AM, 2004, J IMMUNOL, V172, P864, DOI 10.4049/jimmunol.172.2.864; Kim MY, 2008, IMMUNOLOGY, V124, P166, DOI 10.1111/j.1365-2567.2007.02750.x; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Kupper TS, 2004, NAT REV IMMUNOL, V4, P211, DOI 10.1038/nri1310; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; McDermott JR, 2005, J IMMUNOL, V175, P3207, DOI 10.4049/jimmunol.175.5.3207; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Meresse B, 2006, J EXP MED, V203, P1343, DOI 10.1084/jem.20060028; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Nolte-'t Hoen ENM, 2007, BLOOD, V109, P670, DOI 10.1182/blood-2006-07-036509; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Ottaviani C, 2006, EUR J IMMUNOL, V36, P118, DOI 10.1002/eji.200535243; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Parolini S, 2007, BLOOD, V109, P3625, DOI 10.1182/blood-2006-08-038844; Pessino A, 1998, J EXP MED, V188, P953, DOI 10.1084/jem.188.5.953; SANOS SL, 2008, NAT IMMUNOL     1123, DOI DOI 10.1038/NI1684; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Spaggiari GM, 2002, BLOOD, V100, P4098, DOI 10.1182/blood-2002-04-1284; Stewart CA, 2007, EUR J IMMUNOL, V37, P1442, DOI 10.1002/eji.200737354; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Wolk K, 2006, CYTOKINE GROWTH F R, V17, P367, DOI 10.1016/j.cytogfr.2006.09.001; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	49	443	452	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2009	10	1					75	82		10.1038/ni.1681	http://dx.doi.org/10.1038/ni.1681			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	385BV	19029904				2022-12-18	WOS:000261788800014
J	Leulier, F; Parquet, C; Pili-Floury, S; Ryu, JH; Caroff, M; Lee, WJ; Mengin-Lecreulx, D; Lemaitre, B				Leulier, F; Parquet, C; Pili-Floury, S; Ryu, JH; Caroff, M; Lee, WJ; Mengin-Lecreulx, D; Lemaitre, B			The Drosophila immune system detects bacteria through specific peptidoglycan recognition	NATURE IMMUNOLOGY			English	Article							INNATE IMMUNITY; MICROBIAL ACTIVATION; HOST-DEFENSE; CELL-WALLS; PROTEIN; TOLL; SILKWORM; PROPHENOLOXIDASE; INDUCTION; INFECTION	The Drosophila immune system discriminates between different classes of infectious microbes and responds with pathogen-specific defense reactions through selective activation of the Toll and the immune deficiency (Imd) signaling pathways. The Toll pathway mediates most defenses against Gram-positive bacteria and fungi, whereas the Imd pathway is required to resist infection by Gram-negative bacteria. The bacterial components recognized by these pathways remain to be defined. Here we report that Gram-negative diaminopimelic acid-type peptidoglycan is the most potent inducer of the Imd pathway and that the Toll pathway is predominantly activated by Gram-positive lysine-type peptidoglycan. Thus, the ability of Drosophila to discriminate between Gram-positive and Gram-negative bacteria relies on the recognition of specific forms of peptidoglycan.	CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France; Univ Paris 11, CNRS, UMR 8619, IBBMC, F-91405 Orsay, France; Ewha Womans Univ, Div Mol Life Sci, Mol & Cellular Biol Lab, Seoul 120750, South Korea	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Ewha Womans University	Lemaitre, B (corresponding author), CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France.	lemaitre@cgrn.cnrs-gif.fr	Lemaitre, Bruno/T-8146-2019; Caroff, Martine/N-4293-2019	Lemaitre, Bruno/0000-0001-7970-1667; CAROFF, Martine/0000-0002-7329-5247; MENGIN-LECREULX, Dominique/0000-0003-3205-0275				Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; ASHIDA M, 1983, BIOCHEM BIOPH RES CO, V113, P562, DOI 10.1016/0006-291X(83)91762-X; Aussel L, 2000, RAPID COMMUN MASS SP, V14, P595, DOI 10.1002/(SICI)1097-0231(20000415)14:7<595::AID-RCM919>3.0.CO;2-4; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; GLAUNER B, 1988, J BIOL CHEM, V263, P10088; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Iketani M, 1999, INSECT BIOCHEM MOLEC, V29, P19, DOI 10.1016/S0965-1748(98)00099-X; Imler JL, 2000, J ENDOTOXIN RES, V6, P459, DOI 10.1177/09680519000060060801; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; KARIBIAN D, 1993, J BACTERIOL, V175, P2988, DOI 10.1128/JB.175.10.2988-2993.1993; Khush RS, 2001, TRENDS IMMUNOL, V22, P260, DOI 10.1016/S1471-4906(01)01887-7; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Leulier F, 2000, EMBO REP, V1, P353, DOI 10.1093/embo-reports/kvd073; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; MENGINLECREULX D, 1985, J BACTERIOL, V163, P208, DOI 10.1128/JB.163.1.208-212.1985; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; PARK JT, 1995, MOL MICROBIOL, V17, P421, DOI 10.1111/j.1365-2958.1995.mmi_17030421.x; PYE AE, 1974, NATURE, V251, P610, DOI 10.1038/251610a0; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; SAMAKOVLIS C, 1992, BIOCHEM BIOPH RES CO, V188, P1169, DOI 10.1016/0006-291X(92)91354-S; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; SHANDS JW, 1980, J BIOL CHEM, V255, P1221; Takehana A, 2002, P NATL ACAD SCI USA, V99, P13705, DOI 10.1073/pnas.212301199; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tzou P, 2002, CURR OPIN MICROBIOL, V5, P102, DOI 10.1016/S1369-5274(02)00294-1; Tzou P, 2002, METHOD MICROBIOL, V31, P507, DOI 10.1016/S0580-9517(02)31028-6; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; YOSHIDA H, 1986, INSECT BIOCHEM, V16, P539, DOI 10.1016/0020-1790(86)90031-4; Yoshida H, 1996, J BIOL CHEM, V271, P13854, DOI 10.1074/jbc.271.23.13854	42	442	458	3	53	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2003	4	5					478	484		10.1038/ni922	http://dx.doi.org/10.1038/ni922			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	674YN	12692550	Green Published			2022-12-18	WOS:000182665400016
J	Yang, XP; Ghoreschi, K; Steward-Tharp, SM; Rodriguez-Canales, J; Zhu, JF; Grainger, JR; Hirahara, K; Sun, HW; Wei, L; Vahedi, G; Kanno, Y; O'Shea, JJ; Laurence, A				Yang, Xiang-Ping; Ghoreschi, Kamran; Steward-Tharp, Scott M.; Rodriguez-Canales, Jaime; Zhu, Jinfang; Grainger, John R.; Hirahara, Kiyoshi; Sun, Hong-Wei; Wei, Lai; Vahedi, Golnaz; Kanno, Yuka; O'Shea, John J.; Laurence, Arian			Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5	NATURE IMMUNOLOGY			English	Article							T(H)17 CELL-DIFFERENTIATION; T-HELPER-CELLS; TGF-BETA; IN-VIVO; CYTOKINE; ACTIVATION; PLASTICITY; DISTINCT; DISEASE; TH17	Interleukin 2 (IL-2), a cytokine linked to human autoimmune disease, limits IL-17 production. Here we found that deletion of the gene encoding the transcription factor STAT3 in T cells abrogated IL-17 production and attenuated autoimmunity associated with IL-2 deficiency. Whereas STAT3 induced IL-17 and the transcription factor ROR gamma t and inhibited the transcription factor Foxp3, IL-2 inhibited IL-17 independently of Foxp3 and ROR gamma t. STAT3 and STAT5 bound to multiple common sites across the locus encoding IL-17. The induction of STAT5 binding by IL-2 was associated with less binding of STAT3 at these sites and the inhibition of associated active epigenetic marks. 'Titration' of the relative activation of STAT3 and STAT5 modulated the specification of cells to the IL-17-producing helper T cell (T(H)17 cell) subset. Thus, the balance rather than the absolute magnitude of these signals determined the propensity of cells to make a key inflammatory cytokine.	[Yang, Xiang-Ping; Ghoreschi, Kamran; Steward-Tharp, Scott M.; Hirahara, Kiyoshi; Sun, Hong-Wei; Vahedi, Golnaz; Kanno, Yuka; O'Shea, John J.; Laurence, Arian] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Rodriguez-Canales, Jaime] NCI, Laser Capture Microdissect Core Lab Pathol, NIH, Bethesda, MD 20892 USA; [Zhu, Jinfang] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Grainger, John R.] NIAID, Mucosal Immunol Sect, NIH, Bethesda, MD 20892 USA; [Wei, Lai] NEI, Clin Immunol Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Laurence, A (corresponding author), NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA.	laurencea@mail.nih.gov	cheng, yong/I-4270-2012; Laurence, Arian/H-5534-2019; Hirahara, Kiyoshi/E-2460-2017; Wei, Lai/D-1088-2014; Zhu, Jinfang/B-7574-2012; Kanno, Yuka/B-5802-2013; Laurence, Arian/A-8770-2009; Yang, Xiangping/B-4833-2011	Laurence, Arian/0000-0003-0942-8292; Hirahara, Kiyoshi/0000-0002-9128-9449; Zhu, Jinfang/0000-0002-0117-4745; Kanno, Yuka/0000-0001-5668-9319; Laurence, Arian/0000-0003-0942-8292; Steward-Tharp, Scott/0000-0002-5865-4539; Grainger, John/0000-0002-4052-5923; Yang, Xiang-Ping/0000-0001-9003-1772; Rodriguez-Canales, Jaime/0000-0002-0885-2377; Ghoreschi, Kamran/0000-0002-5526-7517	National Institute of Arthritis, Musculoskeletal and Skin Diseases; National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041159, ZIHAR041173, ZIAAR041167] Funding Source: NIH RePORTER	National Institute of Arthritis, Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank J. Simone, J. Lay and the National Institute of Arthritis, Musculoskeletal and Skin Diseases Laboratory Animal Care and Use Section staff for technical support; D. Levy (New York University) for mice with loxP-flanked Stat3 alleles; C. Dong (MD Anderson) for IL-17F-RFP reporter mice; W. Ouyang (Genentech) for monoclonal anti-IL-22; and S. Kuchen, F. C. Eberle and K. Tarbell for comments on the manuscript. Supported by the Intramural Research programs of National Institute of Arthritis, Musculoskeletal and Skin Diseases and National Institute of Allergy and Infectious Diseases.	Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Bettelli E, 2007, CURR OPIN IMMUNOL, V19, P652, DOI 10.1016/j.coi.2007.07.020; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cenit MC, 2010, GENES IMMUN, V11, P264, DOI 10.1038/gene.2010.10; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Cohen AC, 2006, J IMMUNOL, V177, P2770, DOI 10.4049/jimmunol.177.5.2770; Diveu C, 2009, J IMMUNOL, V182, P5748, DOI 10.4049/jimmunol.0801162; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Esashi E, 2008, IMMUNITY, V28, P509, DOI 10.1016/j.immuni.2008.02.013; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hoyer KK, 2009, BLOOD, V113, P389, DOI 10.1182/blood-2008-04-153346; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lee CK, 2002, IMMUNITY, V17, P63, DOI 10.1016/S1074-7613(02)00336-9; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Nakajima H, 2001, EMBO J, V20, P6836, DOI 10.1093/emboj/20.23.6836; Park JH, 2010, NAT IMMUNOL, V11, P257, DOI 10.1038/ni.1840; Rayman JB, 2002, GENE DEV, V16, P933, DOI 10.1101/gad.969202; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; SADLACK B, 1995, EUR J IMMUNOL, V25, P3053, DOI 10.1002/eji.1830251111; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sharfe N, 1997, P NATL ACAD SCI USA, V94, P3168, DOI 10.1073/pnas.94.7.3168; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Takahashi Y, 2000, GENE DEV, V14, P804; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Walker SR, 2009, MOL CANCER RES, V7, P966, DOI 10.1158/1541-7786.MCR-08-0238; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Wells J, 2000, MOL CELL BIOL, V20, P5797, DOI 10.1128/MCB.20.16.5797-5807.2000; Wong PKK, 2006, J CLIN INVEST, V116, P1571, DOI 10.1172/JCI25660; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	50	441	467	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2011	12	3					247	U84		10.1038/ni.1995	http://dx.doi.org/10.1038/ni.1995			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	721KZ	21278738	Green Accepted			2022-12-18	WOS:000287354400012
J	Ginhoux, F; Schultze, JL; Murray, PJ; Ochando, J; Biswas, SK				Ginhoux, Florent; Schultze, Joachim L.; Murray, Peter J.; Ochando, Jordi; Biswas, Subhra K.			New insights into the multidimensional concept of macrophage ontogeny, activation and function	NATURE IMMUNOLOGY			English	Article							TUMOR-ASSOCIATED MACROPHAGES; TISSUE-RESIDENT MACROPHAGES; CELL RNA-SEQ; INFLAMMATORY MONOCYTES; ALVEOLAR MACROPHAGES; FETAL MONOCYTES; GENE-EXPRESSION; ANTIINFLAMMATORY PROPERTIES; ANALYSIS REVEALS; DENDRITIC CELLS	Macrophages have protective roles in immunity to pathogens, tissue development, homeostasis and repair following damage. Maladaptive immunity and inflammation provoke changes in macrophage function that are causative of disease. Despite a historical wealth of knowledge about macrophages, recent advances have revealed unknown aspects of their development and function. Following development, macrophages are activated by diverse signals. Such tissue microenvironmental signals together with epigenetic changes influence macrophage development, activation and functional diversity, with consequences in disease and homeostasis. We discuss here how recent discoveries in these areas have led to a multidimensional concept of macrophage ontogeny, activation and function. In connection with this, we also discuss how technical advances facilitate a new roadmap for the isolation and analysis of macrophages at high resolution.	[Ginhoux, Florent; Biswas, Subhra K.] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore; [Schultze, Joachim L.] Univ Bonn, LIMES Life & Med Sci Inst, Genom & Immunoregulat, Bonn, Germany; [Schultze, Joachim L.] German Ctr Neurodegenerat Dis, Bonn, Germany; [Murray, Peter J.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Murray, Peter J.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Ochando, Jordi] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Ochando, Jordi] Inst Salud Carlos III, Ctr Nacl Microbiol, Immunol Trasplantes, Madrid, Spain	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); St Jude Children's Research Hospital; St Jude Children's Research Hospital; Icahn School of Medicine at Mount Sinai; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Ginhoux, F (corresponding author), ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore.	Florent_Ginhoux@immunol.a-star.edu.sg; j.schultze@uni-bonn.de; Peter.Murray@stjude.org; jordi.ochando@mssm.edu; subhra_biswas@immunol.a-star.edu.sg	Ochando, jordi/ABE-2358-2020; Ochando, Jordi/B-6219-2008; Schultze, Joachim L/D-7794-2011; Schultze, Joachim L./ABA-8176-2020; Murray, Peter J/K-4725-2018	Ochando, jordi/0000-0001-7037-1681; Ochando, Jordi/0000-0001-7037-1681; Schultze, Joachim L/0000-0003-2812-9853; Schultze, Joachim L./0000-0003-2812-9853; Murray, Peter J/0000-0001-6329-9802; Ginhoux, Florent/0000-0002-2857-7755	Singapore Immunology Network (A*STAR); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056067] Funding Source: NIH RePORTER	Singapore Immunology Network (A*STAR)(Agency for Science Technology & Research (A*STAR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	F.G. and S.K.B. are supported by core funding from the Singapore Immunology Network (A*STAR).	A-Gonzalez N, 2013, NAT IMMUNOL, V14, P831, DOI 10.1038/ni.2622; ADAMS DO, 1984, ANNU REV IMMUNOL, V2, P283, DOI 10.1146/annurev.iy.02.040184.001435; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Bai B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007869; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Bekkering S, 2013, CURR OPIN LIPIDOL, V24, P487, DOI 10.1097/MOL.0000000000000023; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; BILYK N, 1995, IMMUNOLOGY, V86, P231; BILYK N, 1993, J EXP MED, V177, P1773, DOI 10.1084/jem.177.6.1773; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bleriot C, 2015, IMMUNITY, V42, P145, DOI 10.1016/j.immuni.2014.12.020; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Butovsky O, 2012, J CLIN INVEST, V122, P3063, DOI 10.1172/JCI62636; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Conde P, 2015, IMMUNITY, V42, P1143, DOI 10.1016/j.immuni.2015.05.009; Dal-Secco D, 2015, J EXP MED, V212, P447, DOI 10.1084/jem.20141539; Egawa M, 2013, IMMUNITY, V38, P570, DOI 10.1016/j.immuni.2012.11.014; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Ghassabeh GH, 2006, BLOOD, V108, P575, DOI 10.1182/blood-2005-04-1485; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Gibbings SL, 2015, BLOOD, V126, P1357, DOI 10.1182/blood-2015-01-624809; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Gosselin D, 2014, IMMUNOL REV, V262, P96, DOI 10.1111/imr.12213; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Haldar M, 2014, CELL, V156, P1223, DOI 10.1016/j.cell.2014.01.069; Helm O, 2014, INT J CANCER, V135, P843, DOI 10.1002/ijc.28736; Hoeffel G., 2014, MACROPHAGES BIOL ROL, P183; Hoeffel G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00486; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; HOLT PG, 1979, IMMUNOLOGY, V37, P437; Hutchinson JA, 2011, J IMMUNOL, V187, P2072, DOI 10.4049/jimmunol.1100762; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Kayama H, 2012, P NATL ACAD SCI USA, V109, P5010, DOI 10.1073/pnas.1114931109; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Kratochvill F, 2015, CELL REP, V12, P1902, DOI 10.1016/j.celrep.2015.08.033; Kratochvill F, 2015, CANCER RES, V75, P3054, DOI 10.1158/0008-5472.CAN-15-0205; Lambert C, 2008, J IMMUNOL, V181, P8288, DOI 10.4049/jimmunol.181.12.8288; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Leuschner F, 2011, NAT BIOTECHNOL, V29, P1005, DOI 10.1038/nbt.1989; Li L, 2008, KIDNEY INT, V74, P1526, DOI 10.1038/ki.2008.500; Li T, 2010, NAT IMMUNOL, V11, P799, DOI 10.1038/ni.1918; Li ZH, 2014, P NATL ACAD SCI USA, V111, P1002, DOI 10.1073/pnas.1313768111; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2013, BLOOD, V121, pE57, DOI 10.1182/blood-2012-06-436212; Mia S, 2014, SCAND J IMMUNOL, V79, P305, DOI 10.1111/sji.12162; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Morris MC, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00680; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nahrendorf M, 2013, CIRC RES, V112, P1624, DOI 10.1161/CIRCRESAHA.113.300890; Netea MG, 2014, SEMIN IMMUNOL, V26, P512, DOI 10.1016/j.smim.2014.09.006; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Parsa R, 2012, DIABETES, V61, P2881, DOI 10.2337/db11-1635; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Rabani M, 2014, CELL, V159, P1698, DOI 10.1016/j.cell.2014.11.015; Riquelme P, 2013, MOL THER, V21, P409, DOI 10.1038/mt.2012.168; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Schebesch C, 1997, IMMUNOLOGY, V92, P478, DOI 10.1046/j.1365-2567.1997.00371.x; Schiwon M, 2014, CELL, V156, P456, DOI 10.1016/j.cell.2014.01.006; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Schroder K, 2012, P NATL ACAD SCI USA, V109, pE944, DOI 10.1073/pnas.1110156109; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Shay T, 2013, P NATL ACAD SCI USA, V110, P2946, DOI 10.1073/pnas.1222738110; Sheng JP, 2015, IMMUNITY, V43, P382, DOI 10.1016/j.immuni.2015.07.016; Smale ST, 2014, ANNU REV IMMUNOL, V32, P489, DOI 10.1146/annurev-immunol-031210-101303; Soudja SM, 2012, IMMUNITY, V37, P549, DOI 10.1016/j.immuni.2012.05.029; Speliotes EK, 1996, NEUROSCIENCE, V70, P67, DOI 10.1016/0306-4522(95)00301-X; Squarzoni P, 2014, CELL REP, V8, P1271, DOI 10.1016/j.celrep.2014.07.042; Stables MJ, 2011, BLOOD, V118, pE192, DOI 10.1182/blood-2011-04-345330; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Suzuki T, 2014, NATURE, V514, P450, DOI 10.1038/nature13807; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Thornley TB, 2014, J CLIN INVEST, V124, P3443, DOI 10.1172/JCI73527; Ueda Y, 2010, INT IMMUNOL, V22, P953, DOI 10.1093/intimm/dxq449; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	96	439	452	7	135	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2016	17	1					34	40		10.1038/ni.3324	http://dx.doi.org/10.1038/ni.3324			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CY8RK	26681460				2022-12-18	WOS:000366675800006
J	Dzierzak, E; Speck, NA				Dzierzak, Elaine; Speck, Nancy A.			Of lineage and legacy: the development of mammalian hematopoietic stem cells	NATURE IMMUNOLOGY			English	Review							BONE MORPHOGENETIC PROTEIN-4; FETAL LIVER HEMATOPOIESIS; BLOOD-ISLAND FORMATION; MURINE YOLK-SAC; MOUSE EMBRYO; DEFINITIVE HEMATOPOIESIS; GROWTH-FACTOR; AVIAN EMBRYO; ENDOTHELIAL-CELLS; CHICK-EMBRYO	The hematopoietic system is one of the first complex tissues to develop in the mammalian conceptus. Of particular interest in the field of developmental hematopoiesis is the origin of adult bone marrow hematopoietic stem cells. Tracing their origin is complicated because blood is a mobile tissue and because hematopoietic cells emerge from many embryonic sites. The origin of the adult mammalian blood system remains a topic of lively discussion and intense research. Interest is also focused on developmental signals that induce the adult hematopoietic stem cell program, as these may prove useful for generating and expanding these clinically important cell populations ex vivo. This review presents a historical overview of and the most recent data on the developmental origins of hematopoiesis.	[Dzierzak, Elaine] Erasmus Univ, Med Ctr, Dept Cell Biol, NL-3000 CA Rotterdam, Netherlands; [Dzierzak, Elaine; Speck, Nancy A.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Hanover, NH 03755 USA	Erasmus University Rotterdam; Erasmus MC; Dartmouth College	Dzierzak, E (corresponding author), Erasmus Univ, Med Ctr, Dept Cell Biol, NL-3000 CA Rotterdam, Netherlands.	e.dzierzak@erasmusmc.nl; nancy.a.speck@dartmouth.edu			NATIONAL CANCER INSTITUTE [R01CA058343, P30CA023108] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK054077, R01DK054077] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA058343, P30 CA023108] Funding Source: Medline; NHLBI NIH HHS [R01 HL091724] Funding Source: Medline; NIDDK NIH HHS [R37 DK054077, R37 DK54077, R01 DK054077, R01 DK054077-08] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alvarez-Silva M, 2003, DEVELOPMENT, V130, P5437, DOI 10.1242/dev.00755; Belaoussoff M, 1998, DEVELOPMENT, V125, P5009; Bertrand JY, 2006, DEVELOPMENT, V133, P3619, DOI 10.1242/dev.02510; Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; BREIER G, 1995, DEV DYNAM, V204, P228, DOI 10.1002/aja.1002040303; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; Byrd N, 2002, DEVELOPMENT, V129, P361; Cai ZL, 2000, IMMUNITY, V13, P423, DOI 10.1016/S1074-7613(00)00042-X; Caprioli A, 2001, DEV BIOL, V238, P64, DOI 10.1006/dbio.2001.0362; Choi K, 1998, DEVELOPMENT, V125, P725; Ciau-Uitz A, 2000, CELL, V102, P787, DOI 10.1016/S0092-8674(00)00067-2; Corbel C, 2007, DEV BIOL, V301, P478, DOI 10.1016/j.ydbio.2006.08.069; CORMIER F, 1988, DEVELOPMENT, V102, P279; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; Cumano A, 2001, IMMUNITY, V15, P477, DOI 10.1016/S1074-7613(01)00190-X; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; de Bruijn MFTR, 2002, IMMUNITY, V16, P673, DOI 10.1016/S1074-7613(02)00313-8; DIETERLENLIEVRE F, 1975, J EMBRYOL EXP MORPH, V33, P607; Downs KM, 1998, CURR TOP DEV BIOL, V39, P1, DOI 10.1016/S0070-2153(08)60451-2; DUMONT DJ, 1995, DEV DYNAM, V203, P80, DOI 10.1002/aja.1002030109; DURAND C, 2007, P NATL ACAD SCI 1217; Dyer MA, 2001, DEVELOPMENT, V128, P1717; Emambokus NR, 2003, IMMUNITY, V19, P33, DOI 10.1016/S1074-7613(03)00173-0; Esner M, 2006, DEVELOPMENT, V133, P737, DOI 10.1242/dev.02226; Faloon P, 2000, DEVELOPMENT, V127, P1931; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Ferkowicz MJ, 2005, EXP HEMATOL, V33, P1041, DOI 10.1016/j.exphem.2005.06.006; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; Gekas C, 2005, DEV CELL, V8, P365, DOI 10.1016/j.devcel.2004.12.016; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; Gothert JR, 2005, BLOOD, V105, P2724, DOI 10.1182/blood-2004-08-3037; Gottgens B, 2002, EMBO J, V21, P3039, DOI 10.1093/emboj/cdf286; HOUSSAINT E, 1981, CELL DIFFER DEV, V10, P243, DOI 10.1016/0045-6039(81)90007-5; HUANG G, 2007, NAT GENET       1111; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Jaffredo T, 2005, INT J DEV BIOL, V49, P269, DOI 10.1387/ijdb.041948tj; Jaffredo T, 2000, DEV BIOL, V224, P204, DOI 10.1006/dbio.2000.9799; JAFFREDO T, 1998, DEVELOPMENT, V125; JOHANSSON BM, 1995, MOL CELL BIOL, V15, P141, DOI 10.1128/MCB.15.1.141; JOHNSON GR, 1975, NATURE, V258, P726, DOI 10.1038/258726a0; JOTEREAU FV, 1982, J IMMUNOL, V129, P1869; Kanatsu M, 1996, DEVELOPMENT, V122, P823; Kinder SJ, 1999, DEVELOPMENT, V126, P4691; KISSA K, 2007, BLOOD           1012; Kumano K, 2003, IMMUNITY, V18, P699, DOI 10.1016/S1074-7613(03)00117-1; Kumaravelu P, 2002, DEVELOPMENT, V129, P4891; LAWSON KA, 1991, DEVELOPMENT, V113, P891; Ling KW, 2004, J EXP MED, V200, P871, DOI 10.1084/jem.20031556; LUX CT, 2007, BLOOD           1017; Marshall CJ, 2000, BLOOD, V96, P1591, DOI 10.1182/blood.V96.4.1591.h8001591_1591_1593; McGrath KE, 2005, EXP HEMATOL, V33, P1021, DOI 10.1016/j.exphem.2005.06.012; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; MEDVINSKY AL, 1993, NATURE, V364, P64, DOI 10.1038/364064a0; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Minegishi N, 1999, BLOOD, V93, P4196, DOI 10.1182/blood.V93.12.4196.412k23_4196_4207; MIURA Y, 1969, DEV BIOL, V19, P201, DOI 10.1016/0012-1606(69)90055-4; MOORE MAS, 1970, BRIT J HAEMATOL, V18, P279, DOI 10.1111/j.1365-2141.1970.tb01443.x; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; MURRAY PDF, 1932, P R SOC LOND, V11, P497; Nakagawa M, 2006, BLOOD, V108, P3329, DOI 10.1182/blood-2006-04-019570; North T, 1999, DEVELOPMENT, V126, P2563; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Nottingham WT, 2007, BLOOD, V110, P4188, DOI 10.1182/blood-2007-07-100883; Oberlin E, 2002, DEVELOPMENT, V129, P4147; Ody C, 1999, BLOOD, V93, P2898; Okada H, 1998, ONCOGENE, V17, P2287, DOI 10.1038/sj.onc.1202151; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Ottersbach K, 2005, DEV CELL, V8, P377, DOI 10.1016/j.devcel.2005.02.001; Palis J, 1999, DEVELOPMENT, V126, P5073; PARDANAUD L, 1993, ANAT EMBRYOL, V187, P107; Pardanaud L, 1999, DEVELOPMENT, V126, P617; Pardanaud L, 1996, DEVELOPMENT, V122, P1363; Pouget C, 2006, DEVELOPMENT, V133, P1013, DOI 10.1242/dev.02269; Rampon C, 2003, INT J DEV BIOL, V47, P273; Robert-Moreno A, 2005, DEVELOPMENT, V132, P1117, DOI 10.1242/dev.01660; Robin C, 2006, DEV CELL, V11, P171, DOI 10.1016/j.devcel.2006.07.002; SABIN FR, 1920, CARNEGIE CONTRIB EMB, V272, P214; Sadlon TJ, 2004, STEM CELLS, V22, P457, DOI 10.1634/stemcells.22-4-457; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Sanchez MJ, 1996, IMMUNITY, V5, P513, DOI 10.1016/S1074-7613(00)80267-8; Sanchez MJ, 2001, DEVELOPMENT, V128, P4815; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Sugiyama D, 2003, BLOOD, V101, P4733, DOI 10.1182/blood-2002-09-2799; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takeuchi M, 2002, BLOOD, V99, P1190, DOI 10.1182/blood.V99.4.1190; Taoudi S, 2005, DEVELOPMENT, V132, P4179, DOI 10.1242/dev.01974; Taoudi S, 2007, P NATL ACAD SCI USA, V104, P9399, DOI 10.1073/pnas.0700984104; Tavian M, 2001, IMMUNITY, V15, P487, DOI 10.1016/S1074-7613(01)00193-5; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Turpen JB, 1997, IMMUNITY, V7, P325, DOI 10.1016/S1074-7613(00)80354-4; TURPEN JB, 1981, DEV BIOL, V85, P99, DOI 10.1016/0012-1606(81)90239-6; Ueno H, 2006, DEV CELL, V11, P519, DOI 10.1016/j.devcel.2006.08.001; van Ewijk W, 2000, DEVELOPMENT, V127, P1583; Walmsley M, 2002, DEVELOPMENT, V129, P5683, DOI 10.1242/dev.00169; WALMSLEY M, 2007, BLOOD           1017; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; WEISSMAN I, 1978, DIFFERENTIATION NORM; WILT FH, 1965, SCIENCE, V147, P1588, DOI 10.1126/science.147.3665.1588; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yashiro K, 2007, NATURE, V450, P285, DOI 10.1038/nature06254; Yoder MC, 1997, IMMUNITY, V7, P335, DOI 10.1016/S1074-7613(00)80355-6; Yokota T, 2006, DEVELOPMENT, V133, P2041, DOI 10.1242/dev.02349; Zeigler BM, 2006, DEVELOPMENT, V133, P4183, DOI 10.1242/dev.02596	107	437	454	3	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2008	9	2					129	136		10.1038/ni1560	http://dx.doi.org/10.1038/ni1560			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	253FB	18204427	Green Accepted			2022-12-18	WOS:000252503000009
J	Waskow, C; Liu, K; Darrasse-Jeze, G; Guermonprez, P; Ginhoux, F; Merad, M; Shengelia, T; Yao, KH; Nussenzweig, M				Waskow, Claudia; Liu, Kang; Darrasse-Jeze, Guillaume; Guermonprez, Pierre; Ginhoux, Florent; Merad, Miriam; Shengelia, Tamara; Yao, Kaihui; Nussenzweig, Michel			The receptor tyrosine kinase FIt3 is required for dendritic cell development in peripheral lymphoid tissues	NATURE IMMUNOLOGY			English	Article							FLT3 LIGAND; IN-VIVO; BONE-MARROW; HEMATOPOIETIC PRECURSORS; MICE; PROGENITORS; MONOCYTES; DIFFERENTIATION; INHIBITION; ONTOGENY	Dendritic cell (DC) development begins in the bone marrow but is not completed until after immature progenitors reach their sites of residence in lymphoid organs. The hematopoietic growth factors regulating these processes are poorly understood. Here we examined the effects of signaling by the receptor tyrosine kinase Flt3 on macrophage DC progenitors in the bone marrow and on peripheral DCs. We found that the macrophage DC progenitor compartment was responsive to superphysiological amounts of Flt3 ligand but was not dependent on Flt3 for its homeostatic maintenance in vivo. In contrast, Flt3 was essential to the regulation of homeostatic DC development in the spleen, where it was needed to maintain normal numbers of DCs by controlling their division in the periphery.	[Waskow, Claudia; Liu, Kang; Darrasse-Jeze, Guillaume; Guermonprez, Pierre; Shengelia, Tamara; Yao, Kaihui; Nussenzweig, Michel] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Ginhoux, Florent; Merad, Miriam] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; [Nussenzweig, Michel] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Icahn School of Medicine at Mount Sinai; Howard Hughes Medical Institute; Rockefeller University	Waskow, C (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	claudia.waskow@crt-dresden.de	Waskow, Claudia/F-8146-2010; Nussenzweig, Michel/AAE-7292-2019; Guermonprez, Pierre/ABE-7718-2020; Darrasse-Jeze, Guillaume/AAG-5153-2020	Waskow, Claudia/0000-0003-3261-0922; Guermonprez, Pierre/0000-0001-5621-2262; Darrasse-Jeze, Guillaume/0000-0003-3069-8211	Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [P01 AI051573-060004, P01 AI051573] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI051573] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brasel K, 1996, BLOOD, V88, P2004, DOI 10.1182/blood.V88.6.2004.bloodjournal8862004; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; Dakic A, 2004, J IMMUNOL, V172, P1018, DOI 10.4049/jimmunol.172.2.1018; del Hoyo GM, 2002, NATURE, V415, P1043, DOI 10.1038/4151043a; Diao J, 2007, J IMMUNOL, V179, P2713, DOI 10.4049/jimmunol.179.5.2713; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Herzenberg LA, 2006, NAT IMMUNOL, V7, P681, DOI 10.1038/ni0706-681; Kabashima K, 2005, IMMUNITY, V22, P439, DOI 10.1016/j.immuni.2005.02.007; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Laouar Y, 2003, IMMUNITY, V19, P903, DOI 10.1016/S1074-7613(03)00332-7; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Maraskovsky E, 1996, J EXP MED, V184, P1953, DOI 10.1084/jem.184.5.1953; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; ROBB L, 1995, P NATL ACAD SCI USA, V92, P9565, DOI 10.1073/pnas.92.21.9565; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011; Sitnicka E, 2002, IMMUNITY, V17, P463, DOI 10.1016/S1074-7613(02)00419-3; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Sun CM, 2003, BLOOD, V102, P585, DOI 10.1182/blood-2002-09-2966; Traver D, 2000, SCIENCE, V290, P2152, DOI 10.1126/science.290.5499.2152; Tussiwand R, 2005, J IMMUNOL, V175, P3674, DOI 10.4049/jimmunol.175.6.3674; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Waskow C, 2004, BLOOD, V104, P1688, DOI 10.1182/blood-2004-04-1247; Whartenby KA, 2005, P NATL ACAD SCI USA, V102, P16741, DOI 10.1073/pnas.0506088102; Wu L, 2001, BLOOD, V98, P3376, DOI 10.1182/blood.V98.12.3376	33	436	443	2	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2008	9	6					676	683		10.1038/ni.1615	http://dx.doi.org/10.1038/ni.1615			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	303VB	18469816	Green Accepted			2022-12-18	WOS:000256067900018
J	Fitzgerald, DC; Zhang, GX; El-Behi, M; Fonseca-Kelly, Z; Li, H; Yu, S; Saris, CJM; Gran, B; Ciric, B; Rostami, A				Fitzgerald, Denise C.; Zhang, Guang-Xian; El-Behi, Mohamed; Fonseca-Kelly, Zoe; Li, Hongmei; Yu, Shuo; Saris, Christiaan J. M.; Gran, Bruno; Ciric, Bogoljub; Rostami, Abdolmohamad			Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells	NATURE IMMUNOLOGY			English	Article							PROINFLAMMATORY CYTOKINE PRODUCTION; IFN-GAMMA PRODUCTION; TH1 DIFFERENTIATION; TGF-BETA; IL-2 PRODUCTION; TRANSCRIPTION FACTOR; PRODUCE IL-10; CUTTING EDGE; MICE; ENCEPHALOMYELITIS	Excessive inflammation occurs during infection and autoimmunity in mice lacking the alpha- subunit of the interleukin 27 (IL-27) receptor. The molecular mechanisms underlying this increased inflammation are incompletely understood. Here we report that IL-27 upregulated IL-10 in effector T cells that produced interferon-gamma and expressed the transcription factor T- bet but did not express the transcription factor Foxp3. These IFN-gamma(+) T- bet(+) Foxp3(-) cells resembled effector T cells that have been identified as the main source of host-protective IL- 10 during inflammation. IL-27-induced production of IL- 10 was associated with less secretion of IL- 17, and exogenous IL- 27 reduced the severity of adoptively transferred experimental autoimmune encephalomyelitis by a mechanism dependent on IL-10. Our data show that IL-27-induced production of IL- 10 by effector T cells contributes to the immunomodulatory function of IL-27.	Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA; Amgen Inc, Dept Inflammat Res, Thousand Oaks, CA 91320 USA	Jefferson University; Amgen	Rostami, A (corresponding author), Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA.	a.m.rostami@jefferson.edu	Gran, Bruno/A-2288-2013; BEHI, Mohamed EL/D-5346-2014	Gran, Bruno/0000-0001-6384-2342; BEHI, Mohamed EL/0000-0003-2287-2056; , denise/0000-0002-8608-430X; Fonseca-Kelly, Zoe/0000-0002-3960-7796	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061818] Funding Source: NIH RePORTER; NIAID NIH HHS [5R01AI061818] Funding Source: Medline; NINDS NIH HHS [5R01NS0467892] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Bettelli E, 1998, J IMMUNOL, V161, P3299; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Deshpande P, 2006, J NEUROIMMUNOL, V173, P35, DOI 10.1016/j.jneuroim.2005.11.016; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Endharti AT, 2005, J IMMUNOL, V175, P7093, DOI 10.4049/jimmunol.175.11.7093; Fitzgerald DC, 2007, J IMMUNOL, V179, P3268, DOI 10.4049/jimmunol.179.5.3268; Hamano S, 2003, IMMUNITY, V19, P657, DOI 10.1016/S1074-7613(03)00298-X; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Ito A, 2003, J IMMUNOL, V170, P4802, DOI 10.4049/jimmunol.170.9.4802; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Larousserie F, 2006, J IMMUNOL, V176, P5890, DOI 10.4049/jimmunol.176.10.5890; Lucas S, 2003, P NATL ACAD SCI USA, V100, P15047, DOI 10.1073/pnas.2536517100; MAEDA H, 1995, J IMMUNOL, V155, P4926; McRae BL, 1997, EUR J IMMUNOL, V27, P2650, DOI 10.1002/eji.1830271026; Miyazaki Y, 2005, J IMMUNOL, V175, P2401, DOI 10.4049/jimmunol.175.4.2401; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; MORRIS SC, 1994, J IMMUNOL, V152, P1047; O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097; Owaki T, 2005, J IMMUNOL, V175, P2191, DOI 10.4049/jimmunol.175.4.2191; Owaki T, 2006, J IMMUNOL, V177, P7579, DOI 10.4049/jimmunol.177.11.7579; Owaki T, 2006, J IMMUNOL, V176, P2773, DOI 10.4049/jimmunol.176.5.2773; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Roers A, 2004, J EXP MED, V200, P1289, DOI 10.1084/jem.20041789; Rosas LE, 2006, AM J PATHOL, V168, P158, DOI 10.2353/ajpath.2006.050013; Samoilova EB, 1998, CELL IMMUNOL, V188, P118, DOI 10.1006/cimm.1998.1365; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Sullivan BM, 2005, J IMMUNOL, V175, P4593, DOI 10.4049/jimmunol.175.7.4593; Sullivan BM, 2003, P NATL ACAD SCI USA, V100, P15818, DOI 10.1073/pnas.2636938100; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; TAGA K, 1992, J IMMUNOL, V148, P1143; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Villarino AV, 2006, J IMMUNOL, V176, P237, DOI 10.4049/jimmunol.176.1.237; Villarino AV, 2005, J IMMUNOL, V174, P7684, DOI 10.4049/jimmunol.174.12.7684; Wirtz S, 2005, J IMMUNOL, V174, P2814, DOI 10.4049/jimmunol.174.5.2814; Wirtz S, 2006, J EXP MED, V203, P1875, DOI 10.1084/jem.20060471; Yoshimura T, 2006, J IMMUNOL, V177, P5377, DOI 10.4049/jimmunol.177.8.5377; Zheng SG, 2004, J IMMUNOL, V172, P5213, DOI 10.4049/jimmunol.172.9.5213	45	436	460	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2007	8	12					1372	U6		10.1038/ni1540	http://dx.doi.org/10.1038/ni1540			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	235XG	17994023				2022-12-18	WOS:000251267000018
J	Ribot, JC; deBarros, A; Pang, DJ; Neves, JF; Peperzak, V; Roberts, SJ; Girardi, M; Borst, J; Hayday, AC; Pennington, DJ; Silva-Santos, B				Ribot, Julie C.; deBarros, Ana; Pang, Dick John; Neves, Joana F.; Peperzak, Victor; Roberts, Scott J.; Girardi, Michael; Borst, Jannie; Hayday, Adrian C.; Pennington, Daniel J.; Silva-Santos, Bruno			CD27 is a thymic determinant of the balance between interferon-gamma-and interleukin 17-producing gamma delta T cell subsets	NATURE IMMUNOLOGY			English	Article							PLASMODIUM-FALCIPARUM MALARIA; ALPHA-BETA; PROINFLAMMATORY IL-17(+); CEREBRAL MALARIA; IMMUNE-RESPONSE; HELPER-CELLS; TGF-BETA; IN-VIVO; DIFFERENTIATION; LINEAGE	The production of cytokines such as interferon-gamma and interleukin 17 by alpha beta and gamma delta T cells influences the outcome of immune responses. Here we show that most gamma delta T lymphocytes expressed the tumor necrosis factor receptor family member CD27 and secreted interferon-gamma, whereas interleukin 17 production was restricted to CD27(-) gamma delta T cells. In contrast to the apparent plasticity of gamma delta T cells, the cytokine profiles of these distinct alpha beta T cell subsets were essentially stable, even during infection. These phenotypes were established during thymic development, when CD27 functions as a regulator of the differentiation of gamma delta T cells at least in part by inducing expression of the lymphotoxin-beta receptor and genes associated with trans-conditioning and interferon-gamma production. Thus, the cytokine profiles of peripheral gamma delta T cells are predetermined mainly by a mechanism involving CD27.	[Ribot, Julie C.; deBarros, Ana; Silva-Santos, Bruno] Univ Lisbon, Fac Med, Inst Mol Med, Mol Immunol Unit, P-1699 Lisbon, Portugal; [Ribot, Julie C.; deBarros, Ana; Silva-Santos, Bruno] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Pang, Dick John; Neves, Joana F.; Pennington, Daniel J.] Queen Mary London Univ, Barts & London Sch Med, Inst Cell & Mol Sci, London, England; [Neves, Joana F.] Univ Coimbra, Ctr Neurociencias & Biol Expt, Programa Doutoral Biol Expt & Biomed, Coimbra, Portugal; [Peperzak, Victor; Borst, Jannie] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands; [Roberts, Scott J.; Girardi, Michael] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Hayday, Adrian C.] Guys Hosp, Borough Wing, Kings Coll London, Peter Gorer Dept Immunobiol, London SE1 9RT, England	Universidade de Lisboa; Instituto Gulbenkian de Ciencia; University of London; Queen Mary University London; Universidade de Coimbra; Netherlands Cancer Institute; Yale University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Silva-Santos, B (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, Mol Immunol Unit, P-1699 Lisbon, Portugal.	bssantos@fm.ul.pt	Neves, Joana F/J-9406-2014; Ribot, Julie/D-5487-2014	Neves, Joana F/0000-0001-5842-4162; Ribot, Julie/0000-0002-7852-343X; Silva-Santos, Bruno/0000-0003-4141-9302; de Barros, Ana/0000-0002-6493-4676; HAYDAY, ADRIAN/0000-0002-9495-5793; Girardi, Michael/0000-0003-1887-9343; Borst, Jannie/0000-0002-8043-5009; Pennington, Daniel/0000-0001-7889-9923	European Molecular Biology Organization [YIP 1440]; The Research Advisory Board of St. Bartholomew's and The Royal London Charity [RAB 06/PJ/08]; Wellcome Trust; Portuguese Ministry of Science [PTDC/BIA-BCM/71663]; Medical Research Council [G0600698B] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA102703] Funding Source: NIH RePORTER	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); The Research Advisory Board of St. Bartholomew's and The Royal London Charity; Wellcome Trust(Wellcome TrustEuropean Commission); Portuguese Ministry of Science(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the European Molecular Biology Organization (YIP 1440 to B. S.-S.), The Research Advisory Board of St. Bartholomew's and The Royal London Charity (RAB 06/PJ/08 to D. J. Pa. and D. J. Pe.), the Wellcome Trust A. C. H.), and the Portuguese Ministry of Science ( J. C. R., A. d. B. and J. F. N.; and PTDC/BIA-BCM/71663 to B. S.-S.).	Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Betti M, 2006, ANN ONCOL, V17, P235; Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; Born WK, 2006, CURR OPIN IMMUNOL, V18, P31, DOI 10.1016/j.coi.2005.11.007; Borst J, 2005, CURR OPIN IMMUNOL, V17, P275, DOI 10.1016/j.coi.2005.04.004; Carr JM, 2006, P NATL ACAD SCI USA, V103, P19454, DOI 10.1073/pnas.0609706104; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Ciofani M, 2006, IMMUNITY, V25, P105, DOI 10.1016/j.immuni.2006.05.010; D'Ombrain MC, 2007, EUR J IMMUNOL, V37, P1864, DOI 10.1002/eji.200636889; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Gao YF, 2003, J EXP MED, V198, P433, DOI 10.1084/jem.20030584; Hayday AC, 2007, NAT IMMUNOL, V8, P137, DOI 10.1038/ni1436; Hendricks J, 2003, J EXP MED, V198, P1369, DOI 10.1084/jem.20030916; Hendriks J, 2000, NAT IMMUNOL, V1, P433, DOI 10.1038/80877; HO M, 1990, IMMUNOL LETT, V25, P139, DOI 10.1016/0165-2478(90)90105-Y; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Kisielow J, 2008, J IMMUNOL, V181, P1710, DOI 10.4049/jimmunol.181.3.1710; Laky K, 2006, IMMUNOL REV, V209, P274, DOI 10.1111/j.0105-2896.2006.00358.x; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; Michel ML, 2008, P NATL ACAD SCI USA, V105, P19845, DOI 10.1073/pnas.0806472105; Nolte MA, 2005, NAT IMMUNOL, V6, P412, DOI 10.1038/ni1174; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Pennington DJ, 2006, NATURE, V444, P1073, DOI 10.1038/nature06051; Pennington DJ, 2003, NAT IMMUNOL, V4, P991, DOI 10.1038/ni979; Ramsburg E, 2003, J EXP MED, V198, P1403, DOI 10.1084/jem.20030050; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; Roark CL, 2007, J IMMUNOL, V179, P5576, DOI 10.4049/jimmunol.179.8.5576; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Ruprecht CR, 2005, J EXP MED, V201, P1793, DOI 10.1084/jem.20050085; Shibata K, 2008, J IMMUNOL, V181, P5940, DOI 10.4049/jimmunol.181.9.5940; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Silva-Santos B, 2005, SCIENCE, V307, P925, DOI 10.1126/science.1103978; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Tesselaar K, 2003, J IMMUNOL, V170, P33, DOI 10.4049/jimmunol.170.1.33; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vermijlen D, 2007, J IMMUNOL, V178, P4304, DOI 10.4049/jimmunol.178.7.4304; Vossen MTM, 2008, J IMMUNOL, V180, P3739, DOI 10.4049/jimmunol.180.6.3739; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Yanez DM, 1999, INFECT IMMUN, V67, P446; Yang Y, 2008, J IMMUNOL, V181, P8700, DOI 10.4049/jimmunol.181.12.8700; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zuany-Amorim C, 1998, SCIENCE, V280, P1265, DOI 10.1126/science.280.5367.1265	50	435	442	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2009	10	4					427	436		10.1038/ni.1717	http://dx.doi.org/10.1038/ni.1717			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	422KE	19270712	Green Accepted			2022-12-18	WOS:000264425800017
J	Cobaleda, C; Schebesta, A; Delogu, A; Busslinger, M				Cobaleda, Cesar; Schebesta, Alexandra; Delogu, Alessio; Busslinger, Meinrad			Pax5: the guardian of B cell identity and function	NATURE IMMUNOLOGY			English	Review							TRANSCRIPTION FACTOR BSAP; GENE-EXPRESSION; LYMPHOID LINEAGE; IN-VIVO; ALLELIC EXCLUSION; DIFFERENTIATION; REPRESSION; LOCUS; BINDING; PROTEIN	The transcription factor Pax5 is essential for commitment of lymphoid progenitors to the B lymphocyte lineage. Pax5 fulfils a dual role by repressing B lineage 'inappropriate' genes and simultaneously activating B lineage-specific genes. This transcriptional reprogramming restricts the broad signaling capacity of uncommitted progenitors to the B cell pathway, regulates cell adhesion and migration, induces V-H-DJ(H) recombination, facilitates (pre-) B cell receptor signaling and promotes development to the mature B cell stage. Conditional Pax5 inactivation in early and late B lymphocytes revealed an essential role for Pax5 in controlling the identity and function of B cells throughout B lymphopoiesis. PAX5 has also been implicated in human B cell malignancies, as it is deregulated by chromosomal translocations in a subset of acute lymphoblastic leukemias and non-Hodgkin lymphomas.	Res Inst Mol Pathol, Vienna Bioctr, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Busslinger, M (corresponding author), Res Inst Mol Pathol, Vienna Bioctr, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	busslinger@imp.ac.at	Busslinger, Meinrad J./J-1249-2016; Delogu, Alessio/F-5033-2010; Cobaleda, Cesar/D-4668-2011	Busslinger, Meinrad J./0000-0002-9111-9351; Delogu, Alessio/0000-0002-4414-4714; Cobaleda, Cesar/0000-0003-3807-9204	MRC [G9900989] Funding Source: UKRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005085] Funding Source: NIH RePORTER; Medical Research Council [G9900989] Funding Source: Medline; NHGRI NIH HHS [R01 HG005085] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ADAMS B, 1992, GENE DEV, V6, P1589, DOI 10.1101/gad.6.9.1589; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; ANDERSON K, 2007, BLOOD; Balciunaite G, 2005, EUR J IMMUNOL, V35, P2019, DOI 10.1002/eji.200526318; BARBERIS A, 1990, GENE DEV, V4, P849, DOI 10.1101/gad.4.5.849; Barlev NA, 2003, MOL CELL BIOL, V23, P6944, DOI 10.1128/MCB.23.19.6944-6957.2003; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; BOUSQUET M, 2007, BLOOD; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Busslinger M, 1996, P NATL ACAD SCI USA, V93, P6129, DOI 10.1073/pnas.93.12.6129; Cazzaniga G, 2001, CANCER RES, V61, P4666; Cotta CV, 2003, BLOOD, V101, P4342, DOI 10.1182/blood-2002-10-3139; Czerny T, 1999, MOL CELL, V3, P297, DOI 10.1016/S1097-2765(00)80457-8; CZERNY T, 1993, GENE DEV, V7, P2048, DOI 10.1101/gad.7.10.2048; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Dorfler P, 1996, EMBO J, V15, P1971, DOI 10.1002/j.1460-2075.1996.tb00548.x; Eberhard D, 2000, EMBO J, V19, P2292, DOI 10.1093/emboj/19.10.2292; Eberhard D, 1999, CANCER RES, V59, p1716S; Emelyanov AV, 2002, J BIOL CHEM, V277, P11156, DOI 10.1074/jbc.M111763200; Fitzsimmons D, 1996, GENE DEV, V10, P2198, DOI 10.1101/gad.10.17.2198; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Fuxa M, 2007, J IMMUNOL, V178, P3031, DOI 10.4049/jimmunol.178.5.3031; Garvie CW, 2001, MOL CELL, V8, P1267, DOI 10.1016/S1097-2765(01)00410-5; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Hayashi K, 2003, IMMUNITY, V18, P825, DOI 10.1016/S1074-7613(03)00142-0; Heavey B, 2003, EMBO J, V22, P3887, DOI 10.1093/emboj/cdg380; Hesslein DGT, 2003, GENE DEV, V17, P37, DOI 10.1101/gad.1031403; Hirokawa S, 2003, EUR J IMMUNOL, V33, P1824, DOI 10.1002/eji.200323974; Hoflinger S, 2004, J IMMUNOL, V173, P3935, DOI 10.4049/jimmunol.173.6.3935; Holmes ML, 2006, GENE DEV, V20, P933, DOI 10.1101/gad.1396206; Horcher M, 2001, IMMUNITY, V14, P779, DOI 10.1016/S1074-7613(01)00153-4; Hsu CL, 2006, P NATL ACAD SCI USA, V103, P672, DOI 10.1073/pnas.0510304103; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Johnson K, 2004, NAT IMMUNOL, V5, P853, DOI 10.1038/ni1099; Johnston CM, 2006, J IMMUNOL, V176, P4221, DOI 10.4049/jimmunol.176.7.4221; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; KOZMIK Z, 1992, MOL CELL BIOL, V12, P2662, DOI 10.1128/MCB.12.6.2662; LIAO F, 1994, J IMMUNOL, V152, P2904; Lin KI, 2002, MOL CELL BIOL, V22, P4771, DOI 10.1128/MCB.22.13.4771-4780.2002; Mikkola I, 2002, SCIENCE, V297, P110, DOI 10.1126/science.1067518; Morrison AM, 1998, BLOOD, V92, P3865, DOI 10.1182/blood.V92.10.3865.422k01_3865_3878; Morshead KB, 2003, P NATL ACAD SCI USA, V100, P11577, DOI 10.1073/pnas.1932643100; MULLIGHAN CG, 2007, NATURE; Nera KP, 2006, IMMUNITY, V24, P283, DOI 10.1016/j.immuni.2006.02.003; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Nutt SL, 1999, NAT GENET, V21, P390, DOI 10.1038/7720; O'Riordan M, 1999, IMMUNITY, V11, P21, DOI 10.1016/S1074-7613(00)80078-3; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Poppe B, 2005, GENE CHROMOSOME CANC, V44, P218, DOI 10.1002/gcc.20214; Reimold AM, 1996, J EXP MED, V183, P393, DOI 10.1084/jem.183.2.393; Roessler S, 2007, MOL CELL BIOL, V27, P579, DOI 10.1128/MCB.01192-06; Roldan E, 2005, NAT IMMUNOL, V6, P31, DOI 10.1038/ni1150; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Sayegh C, 2005, GENE DEV, V19, P322, DOI 10.1101/gad.1254305; Schaniel C, 2002, BLOOD, V99, P472, DOI 10.1182/blood.V99.2.472; Schaniel C, 2002, BLOOD, V99, P2760, DOI 10.1182/blood.V99.8.2760; Schebesta M, 2002, IMMUNITY, V17, P473, DOI 10.1016/S1074-7613(02)00418-1; Seet CS, 2004, J EXP MED, V199, P1689, DOI 10.1084/jem.20032202; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Souabni A, 2002, IMMUNITY, V17, P781, DOI 10.1016/S1074-7613(02)00472-7; Souabni A, 2007, BLOOD, V109, P281, DOI 10.1182/blood-2006-03-009670; Strehl S, 2003, LEUKEMIA, V17, P1121, DOI 10.1038/sj.leu.2402923; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Tagoh H, 2006, EMBO J, V25, P1070, DOI 10.1038/sj.emboj.7600997; Tian JY, 1997, EUR J IMMUNOL, V27, P750, DOI 10.1002/eji.1830270325; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; WATERS SH, 1989, MOL CELL BIOL, V9, P5594, DOI 10.1128/MCB.9.12.5594; WEAVER D, 1987, P NATL ACAD SCI USA, V84, P1516, DOI 10.1073/pnas.84.6.1516; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Ying H, 1998, J IMMUNOL, V161, P4760; Zhang ZX, 2006, NAT IMMUNOL, V7, P616, DOI 10.1038/ni1339	77	435	454	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2007	8	5					463	470		10.1038/ni1454	http://dx.doi.org/10.1038/ni1454			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	158YM	17440452				2022-12-18	WOS:000245831600007
J	Lipsky, PE				Lipsky, PE			Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity	NATURE IMMUNOLOGY			English	News Item							T-CELLS; RECEPTOR; GENES	B cells can regulate many aspects of immune reactivity, as well as differentiate into anti body-producing cells. In SLE, a systemic autoimmune disease, recent research suggests enhanced B cell function is the defining pathogenic event.	NIAMSD, Autoimmun Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Lipsky, PE (corresponding author), NIAMSD, Autoimmun Branch, NIH, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041127] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Chan OTM, 1999, J EXP MED, V189, P1639, DOI 10.1084/jem.189.10.1639; Dorner T, 1998, J CLIN INVEST, V102, P688, DOI 10.1172/JCI3113; Dorner T, 1999, IMMUNOLOGIST, V7, P153; Flynn S, 1998, J EXP MED, V188, P297, DOI 10.1084/jem.188.2.297; Golovkina TV, 1999, SCIENCE, V286, P1965, DOI 10.1126/science.286.5446.1965; Gonzalez M, 1998, J EXP MED, V187, P997, DOI 10.1084/jem.187.7.997; Grammer A., 2001, MOL PATHOL AUTOIMMUN, V2, P282; Harris DP, 2000, NAT IMMUNOL, V1, P475, DOI 10.1038/82717; James JA, 2001, ARTHRITIS RHEUM-US, V44, P1122, DOI 10.1002/1529-0131(200105)44:5<1122::AID-ANR193>3.0.CO;2-D; Kelsoe G, 1996, IMMUNITY, V4, P107, DOI 10.1016/S1074-7613(00)80675-5; Kono D H, 2000, Int Rev Immunol, V19, P367, DOI 10.3109/08830180009055504; SHLOMCHIK MJ, 1994, J EXP MED, V180, P1295, DOI 10.1084/jem.180.4.1295; Winchester R. J., 1997, ARTHRITIS ALLIED CON, P1361; WINKLER TH, 1992, EUR J IMMUNOL, V22, P1719, DOI 10.1002/eji.1830220709	14	435	469	0	24	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2001	2	9					764	766		10.1038/ni0901-764	http://dx.doi.org/10.1038/ni0901-764			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	468WM	11526379				2022-12-18	WOS:000170781200005
J	Hotchkiss, RS; Chang, KC; Swanson, PE; Tinsley, KW; Hui, JJ; Klender, P; Xanthoudakis, S; Roy, S; Black, C; Grimm, E; Aspiotis, R; Han, Y; Nicholson, DW; Karl, IE				Hotchkiss, RS; Chang, KC; Swanson, PE; Tinsley, KW; Hui, JJ; Klender, P; Xanthoudakis, S; Roy, S; Black, C; Grimm, E; Aspiotis, R; Han, Y; Nicholson, DW; Karl, IE			Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte	NATURE IMMUNOLOGY			English	Article							CELL-DEATH; APOPTOSIS; MICE; INDUCTION	Sepsis induces lymphocyte apoptosis and prevention of lymphocyte death may improve the chances of surviving this disorder. We compared the efficacy of a selective caspase-3 inhibitor to a polycaspase inhibitor and to caspase-3(-/-) mice. Both inhibitors prevented lymphocyte apoptosis and improved survival. Caspase-3(-/-) mice shared a decreased, but not total, block of apoptosis, The polycaspase inhibitor caused a very substantial decrease in bacteremia. Caspase inhibitors did not benefit RAG-I-/- mice, which had a >tenfold increase in bacteremia compared to controls. Adoptive transfer of T cells that overexpressed the anti-apoptotic protein Bcl-2 increased survival. T cells stimulated with anti-CD3 and anti-CD28 produced increased interleukin 2 and interferon gamma by 6 h. Thus, caspase inhibitors enhance immunity by preventing lymphocyte apoptosis and lymphocytes act rapidly, within 24 h, to control infection.	Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Comparat Med, St Louis, MO 63110 USA; Merck Frosst Ctr Therapeut Res, Dept Biochem, Pointe Claire, PQ H9R 4P8, Canada; Merck Frosst Ctr Therapeut Res, Dept Mol Biol, Pointe Claire, PQ H9R 4P8, Canada; Merck Frosst Ctr Therapeut Res, Dept Med Chem, Pointe Claire, PQ H9R 4P8, Canada	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Merck & Company; Merck & Company; Merck & Company	Hotchkiss, RS (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.	hotch@morpheus.wustl.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM044118, R01GM044118, R01GM055194] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM44118, GM 55194] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABBAS AK, 2000, CELL MOL IMMUNOLOGY; Ayala A, 1996, BLOOD, V87, P4261, DOI 10.1182/blood.V87.10.4261.bloodjournal87104261; BAKER CC, 1983, SURGERY, V94, P331; BELL LM, 1985, PEDIATRICS, V76, P901; Braun JS, 1999, NAT MED, V5, P298, DOI 10.1038/6514; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; ENDRES M, 1988, J CERE BLOOD FLOW ME, V18, P238; Fukuzuka K, 1999, ANN SURG, V229, P851, DOI 10.1097/00000658-199906000-00012; Garcia-Calvo M, 1999, CELL DEATH DIFFER, V6, P362, DOI 10.1038/sj.cdd.4400497; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; GORONZY J, 1989, J IMMUNOL, V142, P1134; Grobmyer SR, 1999, MOL MED, V5, P585, DOI 10.1007/BF03402071; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hotchkiss RS, 1999, J IMMUNOL, V162, P4148; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Hotchkiss RS, 1997, CRIT CARE MED, V25, P1298, DOI 10.1097/00003246-199708000-00015; HOTCHKISS RS, 1991, AM J PHYSIOL, V30, P965; JANEWAY CA, 1999, CURRENT BIOL PUBLICA, V219; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Oberholzer A, 2000, CRIT CARE MED, V28, pN3, DOI 10.1097/00003246-200004001-00002; Remick DG, 2000, SHOCK, V13, P110, DOI 10.1097/00024382-200013020-00004; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; WANG SD, 1994, J IMMUNOL, V152, P5014; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; YAGUPSKY P, 1990, CLIN MICROBIOL REV, V3, P269, DOI 10.1128/CMR.3.3.269-279.1990; Zheng TS, 1999, CELL DEATH DIFFER, V6, P1043, DOI 10.1038/sj.cdd.4400593	32	435	463	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2000	1	6					496	501		10.1038/82741	http://dx.doi.org/10.1038/82741			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	380VR	11101871				2022-12-18	WOS:000165724600013
J	Wong, SH; Walker, JA; Jolin, HE; Drynan, LF; Hams, E; Camelo, A; Barlow, JL; Neill, DR; Panova, V; Koch, U; Radtke, F; Hardman, CS; Hwang, YY; Fallon, PG; McKenzie, ANJ				Wong, See Heng; Walker, Jennifer A.; Jolin, Helen E.; Drynan, Lesley F.; Hams, Emily; Camelo, Ana; Barlow, Jillian L.; Neill, Daniel R.; Panova, Veera; Koch, Ute; Radtke, Freddy; Hardman, Clare S.; Hwang, You Yi; Fallon, Padraic G.; McKenzie, Andrew N. J.			Transcription factor ROR alpha is critical for nuocyte development	NATURE IMMUNOLOGY			English	Article							INNATE LYMPHOID-CELLS; DELTA-LIKE 4; T-CELLS; GAMMA-T; DENDRITIC CELLS; RECEPTOR-ALPHA; STEM-CELLS; NOTCH; DIFFERENTIATION; IL-4	Nuocytes are essential in innate type 2 immunity and contribute to the exacerbation of asthma responses. Here we found that nuocytes arose in the bone marrow and differentiated from common lymphoid progenitors, which indicates they are distinct, previously unknown members of the lymphoid lineage. Nuocytes required interleukin 7 (IL-7), IL-33 and Notch signaling for development in vitro. Pro-T cell progenitors at double-negative stage 1 (DN1) and DN2 maintained nuocyte potential in vitro, although the thymus was not essential for nuocyte development. Notably, the transcription factor ROR alpha was critical for the development of nuocytes and their role in the expulsion of parasitic worms.	[Wong, See Heng; Walker, Jennifer A.; Jolin, Helen E.; Drynan, Lesley F.; Camelo, Ana; Barlow, Jillian L.; Neill, Daniel R.; Panova, Veera; Hardman, Clare S.; Hwang, You Yi; McKenzie, Andrew N. J.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Hams, Emily; Fallon, Padraic G.] Trinity Coll Dublin, Inst Mol Med, Sch Med, Dublin, Ireland; [Radtke, Freddy] Ecole Polytech Fed Lausanne, Inst Suisse Rech Expt Canc, Lausanne, Switzerland; [Fallon, Padraic G.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Med, Dublin, Ireland; [Fallon, Padraic G.] Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin, Ireland	MRC Laboratory Molecular Biology; Trinity College Dublin; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Trinity College Dublin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin	McKenzie, ANJ (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	anm@mrc-lmb.cam.ac.uk	Neill, Daniel/Q-6290-2019; Neill, Daniel/E-1403-2012; Drynan, Lesley/V-2984-2019; Radtke, Freddy/Q-3198-2017; Fallon, Padraic/Y-2711-2019	Neill, Daniel/0000-0002-7911-8153; Neill, Daniel/0000-0002-7911-8153; Radtke, Freddy/0000-0003-4315-4045; Fallon, Padraic/0000-0002-8401-7293; Barlow, Jillian Lynne/0000-0002-8680-3589; Koch, Ute/0000-0001-7914-7061; Hardman, Clare/0000-0002-1127-6446; Hams, Emily/0000-0002-9745-3246	Centocor; American Asthma Foundation; Science Foundation Ireland; National Children's Research Centre; Medical Research Council; MRC [MC_U105178805] Funding Source: UKRI; Medical Research Council [1274331, MC_U105178805] Funding Source: researchfish	Centocor; American Asthma Foundation; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Children's Research Centre; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank S. Bell for critical reading of the manuscript; A. Corcoran (Babraham Institute) for IL-7R alpha-deficient mice; M. Turner and E. Vigorito (Babraham Institute) for B6/SJL mice; J.C. Zuniga-Pflucker (University of Toronto) for OP9-DL1 cells; T. Honjo (Kyoto University) for mice with loxP-flanked alleles encoding Rbpj kappa; M. Daly for flow cytometry and J. Cruickshank and the staff of the animal facility for experimental support. Supported by Centocor (S. H. W., J. L. B. and A.N.J.M.), the American Asthma Foundation (J. A. W.), Science Foundation Ireland (P. G. F.), the National Children's Research Centre (P. G. F.), the Medical Research Council (A.N.J.M.) and the American Asthma Foundation (A.N.J.M.).	Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Barlow JL, 2012, J ALLERGY CLIN IMMUN, V129, P191, DOI 10.1016/j.jaci.2011.09.041; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Dzhagalov I, 2004, J IMMUNOL, V173, P2952, DOI 10.4049/jimmunol.173.5.2952; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Fallon PG, 2002, IMMUNITY, V17, P7, DOI 10.1016/S1074-7613(02)00332-1; Feyerabend TB, 2009, IMMUNITY, V30, P67, DOI 10.1016/j.immuni.2008.10.016; Franco CB, 2010, CELL STEM CELL, V6, P361, DOI 10.1016/j.stem.2010.02.013; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hamilton BA, 1996, NATURE, V379, P736, DOI 10.1038/379736a0; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; He YW, 1996, J EXP MED, V184, P289, DOI 10.1084/jem.184.1.289; Hozumi K, 2008, J EXP MED, V205, P2507, DOI 10.1084/jem.20080134; Jaradat M, 2006, AM J RESP CRIT CARE, V174, P1299, DOI 10.1164/rccm.200510-1672OC; Karsunky H, 2008, BLOOD, V111, P5562, DOI 10.1182/blood-2007-11-126219; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Maillard I, 2008, CELL STEM CELL, V2, P356, DOI 10.1016/j.stem.2008.02.011; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Neill DR, 2011, TRENDS PARASITOL, V27, P214, DOI 10.1016/j.pt.2011.01.001; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Okamoto M, 2009, J IMMUNOL, V183, P2995, DOI 10.4049/jimmunol.0900692; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Radtke F, 2004, NAT IMMUNOL, V5, P247, DOI 10.1038/ni1045; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Wada H, 2008, NATURE, V452, P768, DOI 10.1038/nature06839; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016	50	434	456	1	54	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2012	13	3					229	U43		10.1038/ni.2208	http://dx.doi.org/10.1038/ni.2208			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	895QF	22267218	Green Accepted			2022-12-18	WOS:000300510600009
J	Casola, S; Otipoby, KL; Alimzhanov, M; Humme, S; Uyttersprot, N; Kutok, JL; Carroll, MC; Rajewsky, K				Casola, S; Otipoby, KL; Alimzhanov, M; Humme, S; Uyttersprot, N; Kutok, JL; Carroll, MC; Rajewsky, K			B cell receptor signal strength determines B cell fate	NATURE IMMUNOLOGY			English	Article							MEMBRANE-PROTEIN 2A; BARR-VIRUS LMP2A; MARGINAL-ZONE; POSITIVE SELECTION; B-1 CELLS; SURFACE-IMMUNOGLOBULIN; ANTIGEN RECEPTOR; ACTIVATION MOTIF; ABSENCE; LYMPHOCYTES	B cell receptor (BCR)-mediated antigen recognition is thought to regulate B cell differentiation. BCR signal strength may also influence B cell fate decisions. Here, we used the Epstein-Barr virus protein LMP2A as a constitutively active BCR surrogate to study the contribution of BCR signal strength in B cell differentiation. Mice carrying a targeted replacement of Igh by LMP2A leading to high or low expression of the LMP2A protein developed B-1 or follicular and marginal zone B cells, respectively. These data indicate that BCR signal strength, rather than antigen specificity, determines mature B cell fate. Furthermore, spontaneous germinal centers developed in gut-associated lymphoid tissue of LMP2A mice, indicating that microbial antigens can promote germinal centers independently of BCR-mediated antigen recognition.	Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Univ Cologne, Inst Genet, D-50931 Cologne, Germany; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; University of Cologne; Harvard University; Brigham & Women's Hospital	Rajewsky, K (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA.	rajewsky@cbr.med.harvard.edu	Casola, Stefano/AAN-8319-2021; Casola, Stefano/O-3922-2014	Casola, Stefano/0000-0001-5580-0986; Rajewsky, Klaus/0000-0002-6633-6370	NCI NIH HHS [CA 098285-01A1, CA 92625] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA098285, P01CA092625] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Bannish G, 2001, J EXP MED, V194, P1583, DOI 10.1084/jem.194.11.1583; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; BIRKENBACH M, 1993, J VIROL, V67, P2209, DOI 10.1128/JVI.67.4.2209-2220.1993; Caldwell RG, 1998, IMMUNITY, V9, P405, DOI 10.1016/S1074-7613(00)80623-8; Cariappa A, 2002, CURR OPIN IMMUNOL, V14, P241, DOI 10.1016/S0952-7915(02)00328-X; Carroll MC, 1998, ANNU REV IMMUNOL, V16, P545, DOI 10.1146/annurev.immunol.16.1.545; CEBRA JJ, 1991, IMMUNOL RES, V10, P393, DOI 10.1007/BF02919728; Chen XJ, 1997, INT IMMUNOL, V9, P27, DOI 10.1093/intimm/9.1.27; Clarke SH, 1998, J EXP MED, V187, P1325, DOI 10.1084/jem.187.8.1325; Donis-Hernandez FR, 2001, EUR J IMMUNOL, V31, P1261, DOI 10.1002/1521-4141(200104)31:4<1261::AID-IMMU1261>3.0.CO;2-H; Dykstra ML, 2001, IMMUNITY, V14, P57, DOI 10.1016/S1074-7613(01)00089-9; Engels N, 2001, J EXP MED, V194, P255, DOI 10.1084/jem.194.3.255; Fruehling S, 1998, J VIROL, V72, P7796, DOI 10.1128/JVI.72.10.7796-7806.1998; Fruehling S, 1997, VIROLOGY, V235, P241, DOI 10.1006/viro.1997.8690; Girkontaite I, 2001, NAT IMMUNOL, V2, P855, DOI 10.1038/ni0901-855; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Hao ZY, 2001, J EXP MED, V194, P1151, DOI 10.1084/jem.194.8.1151; Hayakawa K, 2003, J EXP MED, V197, P87, DOI 10.1084/jem.20021459; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Herzenberg LA, 2000, IMMUNOL REV, V175, P9, DOI 10.1111/j.1600-065X.2000.imr017520.x; Hoshino K, 1999, J IMMUNOL, V162, P3749; Ikeda A, 2003, J VIROL, V77, P5529, DOI 10.1128/JVI.77.9.5529-5534.2003; Jenne CN, 2003, J IMMUNOL, V170, P3739, DOI 10.4049/jimmunol.170.7.3739; Kanzler H, 1996, J EXP MED, V184, P1495, DOI 10.1084/jem.184.4.1495; Koni PA, 1999, J EXP MED, V189, P855, DOI 10.1084/jem.189.5.855; Kraus M, 2001, J EXP MED, V194, P455, DOI 10.1084/jem.194.4.455; Kuppers R, 1998, ANNU REV IMMUNOL, V16, P471, DOI 10.1146/annurev.immunol.16.1.471; LALOR PA, 1990, EUR J IMMUNOL, V20, P485, DOI 10.1002/eji.1830200305; Lam KP, 1999, J EXP MED, V190, P471, DOI 10.1084/jem.190.4.471; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lanning D, 2000, IMMUNOL REV, V175, P214, DOI 10.1034/j.1600-065X.2000.017516.x; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Merchant M, 2000, J VIROL, V74, P9115, DOI 10.1128/JVI.74.19.9115-9124.2000; MILLER CL, 1995, IMMUNITY, V2, P155, DOI 10.1016/S1074-7613(95)80040-9; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Neutra MR, 2001, NAT IMMUNOL, V2, P1004, DOI 10.1038/ni1101-1004; Pelanda R, 1996, IMMUNITY, V5, P229, DOI 10.1016/S1074-7613(00)80318-0; Pelanda R, 1997, IMMUNITY, V7, P765, DOI 10.1016/S1074-7613(00)80395-7; Portis T, 2003, J VIROL, V77, P105, DOI 10.1128/JVI.77.1.105-114.2003; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rescigno M, 2001, IMMUNOBIOLOGY, V204, P572, DOI 10.1078/0171-2985-00094; REYNAUD CA, 1991, CELL, V64, P995, DOI 10.1016/0092-8674(91)90323-Q; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; SATO S, 1995, P NATL ACAD SCI USA, V92, P11558, DOI 10.1073/pnas.92.25.11558; SAUER B, 1993, METHOD ENZYMOL, V225, P890; Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0; Schneider P, 2001, J EXP MED, V194, P1691, DOI 10.1084/jem.194.11.1691; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Watanabe N, 1999, J EXP MED, V190, P461, DOI 10.1084/jem.190.4.461; Weller S, 2001, P NATL ACAD SCI USA, V98, P1166, DOI 10.1073/pnas.98.3.1166; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490	59	432	459	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2004	5	3					317	327		10.1038/ni1036	http://dx.doi.org/10.1038/ni1036			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	779ZV	14758357				2022-12-18	WOS:000189344600015
J	Fujii, S; Shimizu, K; Kronenberg, M; Steinman, RM				Fujii, S; Shimizu, K; Kronenberg, M; Steinman, RM			Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs	NATURE IMMUNOLOGY			English	Article							KILLER T-CELLS; NONOBESE DIABETIC MICE; INNATE IMMUNE-SYSTEM; DENDRITIC CELLS; IN-VIVO; TUMOR-METASTASIS; GENE-EXPRESSION; CD1D TETRAMERS; CUTTING EDGE; BONE-MARROW	Natural killer T (NKT) lymphocytes mediate a rapid reaction to the glycolipid drug galactosylceramide (alphaGalCer), which triggers release of large amounts of cytokines into the serum within 12 h, starting with interleukin 4 (IL-4). When alphaGalCer is administered to mice on dendritic cells (DCs) instead, the response is more prolonged (> 4 days) and marked by a large expansion in IFN-gamma-producing NKT cells as well as greater resistance to metastases of the B16 melanoma. Nevertheless, DCs from mice given free alphaGalCer are able to induce strong IFN-gamma-producing NKT responses when transferred to naive mice, but not when transferred to alphaGalCer-treated recipients. In the latter, the NKT cells are anergized and can respond to glycolipid only in the presence of supplemental IL-2.Therefore, when alphaGalCer is selectively targeted to DCs, mice develop a stronger, more prolonged and effector type of NKT response, but this response can be blocked by the induction of anergy after presentation of alphaGalCer on other cells.	Rockefeller Univ, Cellular Physiol & Immunol Lab, New York, NY 10021 USA; La Jolla Inst Allergy & Immunol, San Diego, CA 92121 USA	Rockefeller University; La Jolla Institute for Immunology	Steinman, RM (corresponding author), Rockefeller Univ, Cellular Physiol & Immunol Lab, 1230 York Ave, New York, NY 10021 USA.		Steinman, Ralph/F-7729-2012; Fujii, Shin-ichiro/O-6218-2015	Fujii, Shin-ichiro/0000-0003-3586-3976				Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; Burdin N, 1998, J IMMUNOL, V161, P3271; Carnaud C, 1999, J IMMUNOL, V163, P4647; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Dunne J, 2001, J IMMUNOL, V167, P3129, DOI 10.4049/jimmunol.167.6.3129; Eberl G, 1998, IMMUNITY, V9, P345, DOI 10.1016/S1074-7613(00)80617-2; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Gonzalez-Aseguinolaza G, 2000, P NATL ACAD SCI USA, V97, P8461, DOI 10.1073/pnas.97.15.8461; Grant EP, 1999, J EXP MED, V189, P195, DOI 10.1084/jem.189.1.195; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; Hayakawa Y, 2001, EUR J IMMUNOL, V31, P1720, DOI 10.1002/1521-4141(200106)31:6<1720::AID-IMMU1720>3.3.CO;2-L; Hong S, 2001, NAT MED, V7, P1052, DOI 10.1038/nm0901-1052; Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927; INABA K, 1990, J EXP MED, V172, P631, DOI 10.1084/jem.172.2.631; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Ishikawa H, 2000, INT IMMUNOL, V12, P1267, DOI 10.1093/intimm/12.9.1267; Jahng AW, 2001, J EXP MED, V194, P1789, DOI 10.1084/jem.194.12.1789; Kadowaki N, 2001, J EXP MED, V193, P1221, DOI 10.1084/jem.193.10.1221; Kakimi K, 2000, J EXP MED, V192, P921, DOI 10.1084/jem.192.7.921; Kawano T, 1998, P NATL ACAD SCI USA, V95, P5690, DOI 10.1073/pnas.95.10.5690; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kitamura H, 1999, J EXP MED, V189, P1121, DOI 10.1084/jem.189.7.1121; Macdougall IC, 2000, NEPHROL DIAL TRANSPL, V15, P20; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Matsuda JL, 2001, CURR OPIN IMMUNOL, V13, P19, DOI 10.1016/S0952-7915(00)00176-X; MORITA M, 1995, J MED CHEM, V38, P2176, DOI 10.1021/jm00012a018; Muller G, 2000, J INVEST DERMATOL, V114, P142; Nakagawa R, 2001, J IMMUNOL, V166, P6578, DOI 10.4049/jimmunol.166.11.6578; Nakui M, 2000, CLIN EXP METASTAS, V18, P147, DOI 10.1023/A:1006715221088; Nishimura T, 2000, INT IMMUNOL, V12, P987, DOI 10.1093/intimm/12.7.987; Osman Y, 2000, EUR J IMMUNOL, V30, P1919, DOI 10.1002/1521-4141(200007)30:7<1919::AID-IMMU1919>3.0.CO;2-3; Pal E, 2001, J IMMUNOL, V166, P662, DOI 10.4049/jimmunol.166.1.662; Sharif S, 2001, NAT MED, V7, P1057, DOI 10.1038/nm0901-1057; Shin T, 2001, INT J CANCER, V91, P523, DOI 10.1002/1097-0215(20010215)91:4<523::AID-IJC1087>3.0.CO;2-L; Singh AK, 2001, J EXP MED, V194, P1801, DOI 10.1084/jem.194.12.1801; Smyth MJ, 2000, J EXP MED, V191, P661, DOI 10.1084/jem.191.4.661; Smyth MJ, 2000, J IMMUNOL, V165, P2665, DOI 10.4049/jimmunol.165.5.2665; Smyth MJ, 2002, BLOOD, V99, P1259, DOI 10.1182/blood.V99.4.1259; Spada FM, 1998, J EXP MED, V188, P1529, DOI 10.1084/jem.188.8.1529; Takahashi T, 2000, J IMMUNOL, V164, P4458, DOI 10.4049/jimmunol.164.9.4458; Takeda K, 2000, INT IMMUNOL, V12, P909, DOI 10.1093/intimm/12.6.909; Tomura M, 1999, J IMMUNOL, V163, P93; Toura I, 1999, J IMMUNOL, V163, P2387; Trobonjaca Z, 2001, J IMMUNOL, V167, P1413, DOI 10.4049/jimmunol.167.3.1413; Wang B, 2001, J EXP MED, V194, P313, DOI 10.1084/jem.194.3.313; Wilson SB, 2001, CURR OPIN IMMUNOL, V13, P555, DOI 10.1016/S0952-7915(00)00258-2; Yang OO, 2000, J IMMUNOL, V165, P3756, DOI 10.4049/jimmunol.165.7.3756; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339	50	429	463	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2002	3	9					867	+		10.1038/ni827	http://dx.doi.org/10.1038/ni827			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	588GZ	12154358				2022-12-18	WOS:000177694900016
J	Arthos, J; Cicala, C; Martinelli, E; Macleod, K; Van Ryk, D; Wei, D; Xiao, Z; Veenstra, TD; Conrad, TP; Lempicki, RA; McLaughlin, S; Pascuccio, M; Gopaul, R; McNally, J; Cruz, CC; Censoplano, N; Chung, E; Reitano, KN; Kottilil, S; Goode, DJ; Fauci, AS				Arthos, James; Cicala, Claudia; Martinelli, Elena; Macleod, Katilyn; Van Ryk, Donald; Wei, Danlan; Xiao, Zhen; Veenstra, Timothy D.; Conrad, Thomas P.; Lempicki, Richard A.; McLaughlin, Sherry; Pascuccio, Massimiliano; Gopaul, Ravindra; McNally, Jonathan; Cruz, Catherine C.; Censoplano, Nina; Chung, Eva; Reitano, Kristin N.; Kottilil, Shyam; Goode, Diana J.; Fauci, Anthony S.			HIV-1 envelope protein binds to and signals through integrin alpha(4)beta(7), the gut mucosal homing receptor for peripheral T cells	NATURE IMMUNOLOGY			English	Article							MACROPHAGE-TROPIC HIV; INFECTION; SIV; DEPLETION; LFA-1; ALPHA-4-BETA-7; REPLICATION; NEUTRALIZATION; ASSOCIATION; INDUCTION	Infection with human immunodeficiency virus 1 (HIV-1) results in the dissemination of virus to gut-associated lymphoid tissue. Subsequently, HIV-1 mediates massive depletion of gut CD4(+) T cells, which contributes to HIV-1-induced immune dysfunction. The migration of lymphocytes to gut-associated lymphoid tissue is mediated by integrin alpha(4)beta(7). We demonstrate here that the HIV-1 envelope protein gp120 bound to an activated form of alpha(4)beta(7). This interaction was mediated by a tripeptide in the V2 loop of gp120, a peptide motif that mimics structures presented by the natural ligands of alpha(4)beta(7). On CD4(+) T cells, engagement of alpha(4)beta(7) by gp120 resulted in rapid activation of LFA-1, the central integrin involved in the establishment of virological synapses, which facilitate efficient cell-to-cell spreading of HIV-1.	[Arthos, James; Cicala, Claudia; Macleod, Katilyn; Van Ryk, Donald; Wei, Danlan; Pascuccio, Massimiliano; Gopaul, Ravindra; McNally, Jonathan; Cruz, Catherine C.; Censoplano, Nina; Chung, Eva; Reitano, Kristin N.; Kottilil, Shyam; Goode, Diana J.; Fauci, Anthony S.] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Martinelli, Elena] Univ Genoa, Ctr Excellence Biomed Res, Genoa, Italy; [Xiao, Zhen; Veenstra, Timothy D.; Conrad, Thomas P.] Sci Applicat Int Corp, Lab Proteom & Analyt Technol, Frederick, MD 21702 USA; [Lempicki, Richard A.] Sci Applicat Int Corp, Lab Immunopathogenesis & Bioinformat, Frederick, MD 21702 USA; [McLaughlin, Sherry] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Genoa; Science Applications International Corporation (SAIC); Science Applications International Corporation (SAIC); University of Washington; University of Washington Seattle	Arthos, J (corresponding author), NIAID, Immunoregulat Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	jarthos@niaid.nih.gov	Lempicki, Richard A/E-1844-2012; Kottilil, Shyam/ABF-7605-2021	Lempicki, Richard A/0000-0002-7059-409X; Martinelli, Elena/0000-0002-3416-9627	Intramural NIH HHS Funding Source: Medline; NIAID NIH HHS [AI047734, AI058894] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058894, Z01AI000887, Z01AI000883, R01AI047734, Z01AI000886, R37AI047734] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BARGATZE RF, 1995, IMMUNITY, V3, P99, DOI 10.1016/1074-7613(95)90162-0; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Chan JR, 2000, J IMMUNOL, V164, P746, DOI 10.4049/jimmunol.164.2.746; Cicala C, 1999, J IMMUNOL, V163, P420; DAAR ES, 1990, P NATL ACAD SCI USA, V87, P6574, DOI 10.1073/pnas.87.17.6574; Davenport RJ, 2007, DRUG DISCOV TODAY, V12, P569, DOI 10.1016/j.drudis.2007.05.001; Drbal K, 2001, IMMUNOBIOLOGY, V203, P687, DOI 10.1016/S0171-2985(01)80017-6; Fortin JF, 1998, J VIROL, V72, P2105, DOI 10.1128/JVI.72.3.2105-2112.1998; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706; Harouse JM, 1999, SCIENCE, V284, P816, DOI 10.1126/science.284.5415.816; Harouse JM, 2001, J ACQ IMMUN DEF SYND, V27, P222; Harouse JM, 2001, J VIROL, V75, P1990, DOI 10.1128/JVI.75.4.1990-1995.2001; Ho SH, 2005, J VIROL, V79, P12296, DOI 10.1128/JVI.79.19.12296-12303.2005; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Jackson DY, 2002, CURR PHARM DESIGN, V8, P1229, DOI 10.2174/1381612023394737; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; JUSZCZAK RJ, 1991, J BIOL CHEM, V266, P11176; Kottilil S, 2006, J IMMUNOL, V176, P1107, DOI 10.4049/jimmunol.176.2.1107; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mehandru S, 2007, J VIROL, V81, P599, DOI 10.1128/JVI.01739-06; Park SI, 2001, LETT PEPT SCI, V8, P171, DOI 10.1007/BF02446514; Picker LJ, 2006, CURR OPIN IMMUNOL, V18, P399, DOI 10.1016/j.coi.2006.05.001; Piguet V, 2004, J CLIN INVEST, V114, P605, DOI 10.1172/JCI200422812; SCHIFFER SG, 1995, J BIOL CHEM, V270, P14270, DOI 10.1074/jbc.270.24.14270; SCHWEIGHOFFER T, 1993, J IMMUNOL, V151, P717; Sourisseau M, 2007, J VIROL, V81, P1000, DOI 10.1128/JVI.01629-06; Tardif MR, 2005, J IMMUNOL, V175, P926, DOI 10.4049/jimmunol.175.2.926; Tardif MR, 2005, J VIROL, V79, P13714, DOI 10.1128/JVI.79.21.13714-13724.2005; Vanderslice P, 1997, J IMMUNOL, V158, P1710; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wagner N, 1996, NATURE, V382, P366, DOI 10.1038/382366a0; Weissman D, 1997, NATURE, V389, P981, DOI 10.1038/40173; Zeller Y, 2001, J CELL BIOCHEM, V83, P304, DOI 10.1002/jcb.1197; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	40	428	462	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2008	9	3					301	309		10.1038/ni1566	http://dx.doi.org/10.1038/ni1566			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	266BQ	18264102				2022-12-18	WOS:000253406700016
J	Allman, D; Sambandam, A; Kim, S; Miller, JP; Pagan, A; Well, D; Meraz, A; Bhandoola, A				Allman, D; Sambandam, A; Kim, S; Miller, JP; Pagan, A; Well, D; Meraz, A; Bhandoola, A			Thymopoiesis independent of common lymphoid progenitors	NATURE IMMUNOLOGY			English	Article							B-LINEAGE DIFFERENTIATION; MURINE BONE-MARROW; PRECURSOR CELLS; C-KIT; GENE REARRANGEMENT; STEM-CELLS; IDENTIFICATION; RECEPTOR; TCR; EXPRESSION	Early T lineage progenitors (ETPs) in the thymus are thought to develop from common lymphoid progenitors (CLPs) in the bone marrow (BM). We compared thymic ETPs to BM CLPs in mice and found that they differed in several respects. Thymic ETPs were not interleukin 7 (IL-7)-responsive and generated B lineage progeny with delayed kinetics, whereas BM CLPs were IL-7-responsive and rapidly generated B cells. ETPs sustained production of T lineage progeny for longer periods of time than BM CLPs. Analysis of Ikaros-deficient mice that exhibit ongoing thymopoiesis without B lymphopoeisis revealed near-normal frequencies of thymic ETPs, yet undetectable numbers of BM CLPs. We conclude that ETPs can develop via a CLP-independent pathway.	Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Haverford Coll, Haverford, PA 19041 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Haverford College	Bhandoola, A (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	bhandooa@mail.med.upenn.edu	Pagan, Antonio/AAB-1604-2019		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052861, R03AI053284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG020818] Funding Source: NIH RePORTER; NIAID NIH HHS [AI053284, AI52861] Funding Source: Medline; NIA NIH HHS [AG20818] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Allman D, 2002, CELL, V109, pS1, DOI 10.1016/S0092-8674(02)00689-X; BORN W, 1988, J IMMUNOL, V140, P3228; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; DONSKOY E, 1992, J IMMUNOL, V148, P1604; Foss DL, 2002, INT IMMUNOL, V14, P331, DOI 10.1093/intimm/14.3.331; Foss DL, 2001, J EXP MED, V193, P365, DOI 10.1084/jem.193.3.365; Gilbert SF, 2000, DEV BIOL; GODFREY DI, 1992, J IMMUNOL, V149, P2281; GODFREY DI, 1993, J IMMUNOL, V150, P4244; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; Izon D, 2001, J IMMUNOL, V167, P1387, DOI 10.4049/jimmunol.167.3.1387; Katsura Y, 2002, NAT REV IMMUNOL, V2, P127, DOI 10.1038/nri721; King AG, 2002, P NATL ACAD SCI USA, V99, P4508, DOI 10.1073/pnas.072087899; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; KRONENBERG M, 1986, ANNU REV IMMUNOL, V4, P529, DOI 10.1146/annurev.iy.04.040186.002525; KUROSAWA Y, 1981, NATURE, V290, P565, DOI 10.1038/290565a0; Laky K, 1998, J IMMUNOL, V161, P707; Li YS, 1996, IMMUNITY, V5, P527, DOI 10.1016/S1074-7613(00)80268-X; MATSUZAKI Y, 1993, J EXP MED, V178, P1283, DOI 10.1084/jem.178.4.1283; MCKEARN JP, 1985, P NATL ACAD SCI USA, V82, P7414, DOI 10.1073/pnas.82.21.7414; Medina KL, 2001, NAT IMMUNOL, V2, P718, DOI 10.1038/90659; Miller JP, 2002, J EXP MED, V196, P705, DOI 10.1084/jem.20020784; Nichogiannopoulou A, 1999, J EXP MED, V190, P1201, DOI 10.1084/jem.190.9.1201; RODEWALD HR, 1994, EMBO J, V13, P4229, DOI 10.1002/j.1460-2075.1994.tb06743.x; Rolink A, 1996, J EXP MED, V183, P187, DOI 10.1084/jem.183.1.187; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; Shortman K, 1996, ANNU REV IMMUNOL, V14, P29, DOI 10.1146/annurev.immunol.14.1.29; SOLOFF RS, 1995, J IMMUNOL, V154, P3888; SUDO T, 1993, P NATL ACAD SCI USA, V90, P9125, DOI 10.1073/pnas.90.19.9125; Tudor KSRS, 2000, IMMUNITY, V12, P335, DOI 10.1016/S1074-7613(00)80186-7; vonBoehmer H, 1997, ANNU REV IMMUNOL, V15, P433, DOI 10.1146/annurev.immunol.15.1.433; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Winandy S, 1999, J EXP MED, V190, P1039, DOI 10.1084/jem.190.8.1039; WU L, 1991, J EXP MED, V174, P1617, DOI 10.1084/jem.174.6.1617; WU L, 1991, NATURE, V349, P71, DOI 10.1038/349071a0	39	428	435	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2003	4	2					168	174		10.1038/ni878	http://dx.doi.org/10.1038/ni878			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	640JW	12514733				2022-12-18	WOS:000180686500017
J	Guinamard, R; Okigaki, M; Schlessinger, J; Ravetch, JV				Guinamard, R; Okigaki, M; Schlessinger, J; Ravetch, JV			Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response	NATURE IMMUNOLOGY			English	Article							CHEMOKINE RECEPTOR CXCR4; ANTIBODY-RESPONSES; LYMPHOCYTES; IMMUNITY; PROTEIN; KINASE; LYMPHOPOIESIS; MYELOPOIESIS; CHEMOTAXIS; ENGAGEMENT	The lymphoid organs contain specialized microanatomic structures composed of lymphoid, myeloid and stromal cells that are vital to the generation of an effective adaptive immune response,Although the existence of these specialized structures has been known for over a century, the developmental signals that generate them and the specific roles of these structures in the immune response have remained largely elusive, Because of their position adjacent to the marginal sinuses, marginal zone B (MZB) cells are amongst the first population of cells seen by blood born antigens and are presumed to have a critical role in host defense against bacterial pathogens. Here we demonstrate that a deficiency of the tyrosine kinase (Pyk-2) results in a cell autonomous defect of MZB cell production. In response to repetitive polysaccharide antigens (T-independent type II (TI-II)) Pyk-2-deficient mice displayed marked suppression of IgM, IgG3 and IgG2a production. Furthermore, complement receptor engagement proved necessary for the specific targeting of polysaccharide antigens to MZB cells,These results suggest how innate immune responses mediated through complement coupling are translated into an adaptive response by MZB cells, and provide a potential mechanism for the T cell independence of humoral responses to polysaccharide antigens.	Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA; NYU, Med Ctr, Dept Pharmacol, New York, NY 10016 USA	Rockefeller University; New York University	Ravetch, JV (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10021 USA.	ravetch@rockefeller.edu	Ravetch, Jeffrey/Z-1596-2019; Guinamard, Rodolphe/P-9804-2016	Ravetch, Jeffrey/0000-0003-2024-9041; Guinamard, Rodolphe/0000-0002-7400-582X				Bleul CC, 1998, J EXP MED, V187, P753, DOI 10.1084/jem.187.5.753; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Carroll MC, 1998, CURR OPIN IMMUNOL, V10, P36; Davis CB, 1997, J EXP MED, V186, P1793, DOI 10.1084/jem.186.10.1793; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Guinamard R, 1999, J EXP MED, V189, P1461, DOI 10.1084/jem.189.9.1461; Gunn MD, 1998, NATURE, V391, P799, DOI 10.1038/35876; HAYAKAWA K, 1983, J EXP MED, V157, P202, DOI 10.1084/jem.157.1.202; ILGEN CL, 1974, IMMUNOLOGY, V26, P659; Inaoki M, 1997, J EXP MED, V186, P1923, DOI 10.1084/jem.186.11.1923; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; LALOR PA, 1990, EUR J IMMUNOL, V20, P485, DOI 10.1002/eji.1830200305; LANE PJL, 1986, EUR J IMMUNOL, V16, P1569, DOI 10.1002/eji.1830161216; Lev S, 1999, MOL CELL BIOL, V19, P2278; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; LIAKKA KA, 1994, DIFFERENTIATION, V56, P183, DOI 10.1046/j.1432-0436.1994.5630183.x; Ma EA, 1997, EUR J IMMUNOL, V27, P329, DOI 10.1002/eji.1830270147; Ma Q, 1999, IMMUNITY, V10, P463, DOI 10.1016/S1074-7613(00)80046-1; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; MacLennan ICM, 1998, CURR OPIN IMMUNOL, V10, P220, DOI 10.1016/S0952-7915(98)80252-5; Makowska A, 1999, EUR J IMMUNOL, V29, P3285, DOI 10.1002/(SICI)1521-4141(199910)29:10<3285::AID-IMMU3285>3.3.CO;2-G; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Ochsenbein AF, 1999, J EXP MED, V190, P1165, DOI 10.1084/jem.190.8.1165; OKIGAKI M, UNPUB NATURE CELL BI; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Oliver AM, 1999, J IMMUNOL, V162, P7198; Opstelten D, 1998, 10TH INTERNATIONAL CONGRESS ON IMMUNOLOGY, VOLS 1 AND 2, P63; PRIOR L, 1995, IMMUNOLOGY, V84, P172; Qin XF, 1998, EMBO J, V17, P5066, DOI 10.1093/emboj/17.17.5066; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Roark JH, 1998, J IMMUNOL, V160, P3121; SCHER I, 1982, ADV IMMUNOL, V33, P1, DOI 10.1016/S0065-2776(08)60834-2; Smith KGC, 1996, EUR J IMMUNOL, V26, P444, DOI 10.1002/eji.1830260226; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	38	428	433	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2000	1	1					31	36		10.1038/76882	http://dx.doi.org/10.1038/76882			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BV	10881171				2022-12-18	WOS:000089814800010
J	Engelhardt, B; Vajkoczy, P; Weller, RO				Engelhardt, Britta; Vajkoczy, Peter; Weller, Roy O.			The movers and shapers in immune privilege of the CNS	NATURE IMMUNOLOGY			English	Review							CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CEREBRAL AMYLOID ANGIOPATHY; CERVICAL LYMPH-NODES; BLOOD-BRAIN-BARRIER; CHOROID-PLEXUS; CEREBROSPINAL-FLUID; T-CELLS; ALZHEIMERS-DISEASE; INTERSTITIAL FLUID	Discoveries leading to an improved understanding of immune surveillance of the central nervous system (CNS) have repeatedly provoked dismissal of the existence of immune privilege of the CNS. Recent rediscoveries of lymphatic vessels within the dura mater surrounding the brain, made possible by modern live-cell imaging technologies, have revived this discussion. This review emphasizes the fact that understanding immune privilege of the CNS requires intimate knowledge of its unique anatomy. Endothelial, epithelial and glial brain barriers establish compartments in the CNS that differ strikingly with regard to their accessibility to immune-cell subsets. There is a unique system of lymphatic drainage from the CNS to the peripheral lymph nodes. We summarize current knowledge on the cellular and molecular mechanisms involved in immune-cell trafficking and lymphatic drainage from the CNS, and we take into account differences in rodent and human CNS anatomy.	[Engelhardt, Britta] Univ Bern, Theodor Kocher Inst, Bern, Switzerland; [Vajkoczy, Peter] Charite, Dept Neurosurg, Berlin, Germany; [Weller, Roy O.] Southampton Univ Hosp, Neuropathol, Southampton, Hants, England	University of Bern; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Southampton	Engelhardt, B (corresponding author), Univ Bern, Theodor Kocher Inst, Bern, Switzerland.; Weller, RO (corresponding author), Southampton Univ Hosp, Neuropathol, Southampton, Hants, England.	bengel@tki.unibe.ch; row@soton.ac.uk	Engelhardt, Britta/K-7267-2014	Engelhardt, Britta/0000-0003-3059-9846	Swiss National Science Foundation [154483, 170131]; Swiss Multiple Sclerosis Society; Novartis Foundation for Medical-Biological Research; EU FP7 ITN nEUROinflammation [607962]; EU Horizon ITN BtRAIN [675619]; EU/Eureka Eurostars Siagen-MS [9059]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Multiple Sclerosis Society; Novartis Foundation for Medical-Biological Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU FP7 ITN nEUROinflammation; EU Horizon ITN BtRAIN; EU/Eureka Eurostars Siagen-MS	B.E. is supported by the Swiss National Science Foundation (grants 154483, 154483 and 170131), the Swiss Multiple Sclerosis Society, the Novartis Foundation for Medical-Biological Research, EU FP7 ITN nEUROinflammation (607962), EU Horizon 2020 ITN BtRAIN (675619) and the EU/Eureka-funded Eurostars Siagen-MS (9059).	Agrawal S, 2006, J EXP MED, V203, P1007, DOI 10.1084/jem.20051342; ALCOLADO R, 1988, NEUROPATH APPL NEURO, V14, P1, DOI 10.1111/j.1365-2990.1988.tb00862.x; ANDERSSON PB, 1992, NEUROSCIENCE, V48, P169, DOI 10.1016/0306-4522(92)90347-5; Arbel-Ornath M, 2013, ACTA NEUROPATHOL, V126, P353, DOI 10.1007/s00401-013-1145-2; Asgari M, 2016, SCI REP-UK, V6, DOI 10.1038/srep38635; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Atangana E., 2016, TRANSL STROKE RES; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; Barua NU, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-2; Baruch K, 2013, BRAIN BEHAV IMMUN, V34, P11, DOI 10.1016/j.bbi.2013.04.002; Bayerl SH, 2016, GLIA, V64, P1210, DOI 10.1002/glia.22994; Beach TG, 2000, NEUROSCI LETT, V283, P9, DOI 10.1016/S0304-3940(00)00916-2; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; BILLINGHAM RE, 1953, PROC R SOC SER B-BIO, V141, P392, DOI 10.1098/rspb.1953.0049; Blinder P, 2013, NAT NEUROSCI, V16, P889, DOI 10.1038/nn.3426; Carare RO, 2008, NEUROPATH APPL NEURO, V34, P131, DOI 10.1111/j.1365-2990.2007.00926.x; Carare RO, 2014, BRAIN BEHAV IMMUN, V36, P9, DOI 10.1016/j.bbi.2013.10.012; Carare RO, 2013, NEUROPATH APPL NEURO, V39, P593, DOI 10.1111/nan.12042; Carare RO, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-48; Carson MJ, 2006, IMMUNOL REV, V213, P48, DOI 10.1111/j.1600-065X.2006.00441.x; Clapham R, 2010, CLIN ANAT, V23, P43, DOI 10.1002/ca.20887; CSERR HF, 1992, BRAIN PATHOL, V2, P269, DOI 10.1111/j.1750-3639.1992.tb00703.x; CSERR HF, 1992, IMMUNOL TODAY, V13, P507, DOI 10.1016/0167-5699(92)90027-5; Czabanka M, 2009, J CEREBR BLOOD F MET, V29, P1383, DOI 10.1038/jcbfm.2009.69; Engelhardt B, 2001, CHOROID PLEXUS HLTH, V52; Engelhardt Britta, 2003, Methods Mol Med, V89, P83; Engelhardt B, 2016, ACTA NEUROPATHOL, V132, P317, DOI 10.1007/s00401-016-1606-5; Engelhardt B, 2012, TRENDS IMMUNOL, V33, P579, DOI 10.1016/j.it.2012.07.004; Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004; Goldmann J, 2006, J LEUKOCYTE BIOL, V80, P797, DOI 10.1189/jlb.0306176; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Hatterer E, 2006, BLOOD, V107, P806, DOI 10.1182/blood-2005-01-0154; Hawkes CA, 2011, ACTA NEUROPATHOL, V121, P431, DOI 10.1007/s00401-011-0801-7; Herzig MC, 2006, BRAIN PATHOL, V16, P40, DOI 10.1111/j.1750-3639.2006.tb00560.x; Hladky SB, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-26; Howell OW, 2015, NEUROPATH APPL NEURO, V41, P798, DOI 10.1111/nan.12199; HUTCHINGS M, 1986, J NEUROSURG, V65, P316, DOI 10.3171/jns.1986.65.3.0316; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Kaminski M, 2012, J LEUKOCYTE BIOL, V92, P31, DOI 10.1189/jlb.0511241; Kawakami N, 2005, J EXP MED, V201, P1805, DOI 10.1084/jem.20050011; Kawakami N, 2004, J EXP MED, V199, P185, DOI 10.1084/jem.20031064; Kerfoot SM, 2002, J IMMUNOL, V169, P1000, DOI 10.4049/jimmunol.169.2.1000; KIDA S, 1993, NEUROPATH APPL NEURO, V19, P480, DOI 10.1111/j.1365-2990.1993.tb00476.x; Kivisakk P, 2003, P NATL ACAD SCI USA, V100, P8389, DOI 10.1073/pnas.1433000100; Klein RS, 2017, NAT IMMUNOL, V18, P132, DOI 10.1038/ni.3656; Knopf PM, 1998, J IMMUNOL, V161, P692; Lane B, 2015, J NEUROSURG, V122, P618, DOI 10.3171/2014.10.JNS132766; Locatelli G, 2012, NAT NEUROSCI, V15, P543, DOI 10.1038/nn.3062; Lodygin D, 2013, NAT MED, V19, P784, DOI 10.1038/nm.3182; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; MASON DW, 1986, NEUROSCIENCE, V19, P685, DOI 10.1016/0306-4522(86)90292-7; McCandless EE, 2006, J IMMUNOL, V177, P8053, DOI 10.4049/jimmunol.177.11.8053; MEDAWAR PB, 1948, BRIT J EXP PATHOL, V29, P58; Mezey E, 2015, NATURE, V524, P415, DOI 10.1038/524415b; Morris AWJ, 2016, ACTA NEUROPATHOL, V131, P725, DOI 10.1007/s00401-016-1555-z; NICHOLAS DS, 1988, J NEUROSURG, V69, P276, DOI 10.3171/jns.1988.69.2.0276; NICHOLAS MK, 1987, J IMMUNOL, V139, P2275; Odoardi F, 2012, NATURE, V488, P675, DOI 10.1038/nature11337; Owens T, 2008, J NEUROPATH EXP NEUR, V67, P1113, DOI 10.1097/NEN.0b013e31818f9ca8; Pappolla M, 2014, NEUROBIOL DIS, V71, P215, DOI 10.1016/j.nbd.2014.07.012; Phillips MJ, 1997, J PATHOL, V182, P457; Pinheiro MAL, 2016, BBA-MOL BASIS DIS, V1862, P461, DOI 10.1016/j.bbadis.2015.10.018; Pollock H, 1997, J ANAT, V191, P337, DOI 10.1046/j.1469-7580.1997.19130337.x; Preston SD, 2003, NEUROPATH APPL NEURO, V29, P106, DOI 10.1046/j.1365-2990.2003.00424.x; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Raper D, 2016, TRENDS NEUROSCI, V39, P581, DOI 10.1016/j.tins.2016.07.001; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; RENNELS ML, 1985, BRAIN RES, V326, P47, DOI 10.1016/0006-8993(85)91383-6; Salzman KL, 2005, AM J NEURORADIOL, V26, P298; SAPSFORD I, 1983, NEUROPATH APPL NEURO, V9, P181, DOI 10.1111/j.1365-2990.1983.tb00106.x; Schebesch KM, 2013, ACTA NEUROCHIR, V155, P693, DOI 10.1007/s00701-013-1643-y; Schley D, 2006, J THEOR BIOL, V238, P962, DOI 10.1016/j.jtbi.2005.07.005; Sharp MK, 2016, ANN BIOMED ENG, V44, P1553, DOI 10.1007/s10439-015-1457-6; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; SHINKAI Y, 1995, ANN NEUROL, V38, P421, DOI 10.1002/ana.410380312; Shirai Y., 1921, JAP MED WORLD, V1, P14, DOI DOI 10.1038/NM.4041; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; Song J, 2015, CELL REP, V10, P1040, DOI 10.1016/j.celrep.2015.01.037; Spector R, 2015, EXP NEUROL, V273, P57, DOI 10.1016/j.expneurol.2015.07.027; Steffen BJ, 1996, AM J PATHOL, V148, P1819; SZENTISTVANYI I, 1984, AM J PHYSIOL, V246, pF835, DOI 10.1152/ajprenal.1984.246.6.F835; Tietz S, 2015, J CELL BIOL, V209, P493, DOI 10.1083/jcb.201412147; Traka M, 2016, NAT NEUROSCI, V19, P65, DOI 10.1038/nn.4193; UPTON ML, 1985, J NEUROSURG, V63, P867, DOI 10.3171/jns.1985.63.6.0867; Vajkoczy P, 2001, J CLIN INVEST, V108, P557; van Zwam M, 2009, J PATHOL, V217, P543, DOI 10.1002/path.2476; Vandenabeele F, 1996, J ANAT, V189, P417; Weller R. O., 2005, Morphologie, V89, P22, DOI 10.1016/S1286-0115(05)83235-7; Weller RO, 2008, BRAIN PATHOL, V18, P253, DOI 10.1111/j.1750-3639.2008.00133.x; Weller RO, 2015, ACTA NEUROPATHOL, V129, P763, DOI 10.1007/s00401-015-1416-1; Woitzik J, 2006, STROKE, V37, P1549, DOI 10.1161/01.STR.0000221671.94521.51; Wolburg K, 1999, CELL TISSUE RES, V296, P259, DOI 10.1007/s004410051287; Yasuda K, 2013, DRUG METAB DISPOS, V41, P923, DOI 10.1124/dmd.112.050344; ZAMVIL SS, 1990, ANNU REV IMMUNOL, V8, P579, DOI 10.1146/annurev.iy.08.040190.003051; Zekonyte J, 2015, BIOCHIM BIOPHYS ACTA, V1862, P1047; ZHANG ET, 1992, ACTA NEUROPATHOL, V83, P233, DOI 10.1007/BF00296784; ZHANG ET, 1990, J ANAT, V170, P111; Zhang XL, 2013, J IMMUNOL, V191, P4551, DOI 10.4049/jimmunol.1300931	99	427	437	3	127	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2017	18	2					123	131		10.1038/ni.3666	http://dx.doi.org/10.1038/ni.3666			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EI3AE	28092374				2022-12-18	WOS:000392360900003
J	Radtke, F; Wilson, A; Mancini, SJC; MacDonald, HR				Radtke, F; Wilson, A; Mancini, SJC; MacDonald, HR			Notch regulation of lymphocyte development and function	NATURE IMMUNOLOGY			English	Review							T-CELL FATE; HEMATOPOIETIC STEM-CELLS; ANKYRIN-REPEAT PROTEIN; B-CELL; ALPHA-BETA; CHROMOSOMAL TRANSLOCATIONS; IMMATURE THYMOCYTES; SIGNALING PROMOTES; ACTIVATED NOTCH1; LIGAND JAGGED-1	Notch proteins regulate a broad spectrum of cell fate decisions and differentiation processes during fetal and postnatal development. Mammals have four Notch receptors that bind five different ligands. The function of Notch signaling during lymphopoiesis and T cell neoplasia, based on gain-of-function and conditional loss-of-function approaches for the Notch1 receptor, indicates Notch1 is essential in T cell lineage commitment. Recent studies have addressed the involvement of other Notch receptors and ligands as well as their downstream targets, demonstrating additional functions of Notch signaling in embryonic hematopoiesis, intrathymic T cell development, B cell development and peripheral T cell function.	Univ Lausanne, Ludwig Inst Canc Res, Lausanne Branch, CH-1066 Epalinges, Switzerland	Ludwig Institute for Cancer Research; University of Lausanne	Radtke, F (corresponding author), Univ Lausanne, Ludwig Inst Canc Res, Lausanne Branch, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.	freddy.radtke@isrec.unil.ch; anne.wilson@isrec.unil.ch	Wilson, Anne/A-7131-2011; Radtke, Freddy/Q-3198-2017; Mancini, Stéphane J/R-4109-2016	Radtke, Freddy/0000-0003-4315-4045; Mancini, Stéphane J/0000-0001-9255-4606				Adler SH, 2003, J IMMUNOL, V171, P2896, DOI 10.4049/jimmunol.171.6.2896; Allman D, 2001, J EXP MED, V194, P99, DOI 10.1084/jem.194.1.99; Anastasi E, 2003, J IMMUNOL, V171, P4504, DOI 10.4049/jimmunol.171.9.4504; Anderson G, 2001, EUR J IMMUNOL, V31, P3349, DOI 10.1002/1521-4141(200111)31:11<3349::AID-IMMU3349>3.0.CO;2-S; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bellavia D, 2000, EMBO J, V19, P3337, DOI 10.1093/emboj/19.13.3337; Bellavia D, 2002, P NATL ACAD SCI USA, V99, P3788, DOI 10.1073/pnas.062050599; Beverly LJ, 2003, CANCER CELL, V3, P551, DOI 10.1016/S1535-6108(03)00137-5; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Carlesso N, 1999, BLOOD, V93, P838, DOI 10.1182/blood.V93.3.838.403k29_838_848; Choi K, 1998, DEVELOPMENT, V125, P725; Cotta CV, 2003, BLOOD, V101, P4342, DOI 10.1182/blood-2002-10-3139; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; de Bruijn MFTR, 2002, IMMUNITY, V16, P673, DOI 10.1016/S1074-7613(02)00313-8; Deftos ML, 2000, IMMUNITY, V13, P73, DOI 10.1016/S1074-7613(00)00009-1; Dorsch M, 2002, BLOOD, V100, P2046, DOI 10.1182/blood.V100.6.2046.h81802002046_2046_2055; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Feldman BJ, 2000, BLOOD, V96, P1906, DOI 10.1182/blood.V96.5.1906.h8001906_1906_1913; Felli MP, 1999, INT IMMUNOL, V11, P1017, DOI 10.1093/intimm/11.7.1017; Fowlkes BJ, 2002, J IMMUNOL, V169, P1817, DOI 10.4049/jimmunol.169.4.1817; French MB, 2002, J IMMUNOL, V168, P3173, DOI 10.4049/jimmunol.168.7.3173; Frise E, 1996, P NATL ACAD SCI USA, V93, P11925, DOI 10.1073/pnas.93.21.11925; Girard L, 1996, GENE DEV, V10, P1930, DOI 10.1101/gad.10.15.1930; Godin I, 2002, NAT REV IMMUNOL, V2, P593, DOI 10.1038/nri857; Greenwald I, 1998, GENE DEV, V12, P1751, DOI 10.1101/gad.12.12.1751; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Haltiwanger RS, 2002, BBA-GEN SUBJECTS, V1573, P328, DOI 10.1016/S0304-4165(02)00400-2; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Han W, 2000, BLOOD, V95, P1616, DOI 10.1182/blood.V95.5.1616.005k31_1616_1625; Harman BC, 2003, J IMMUNOL, V170, P1299, DOI 10.4049/jimmunol.170.3.1299; Hasserjian RP, 1996, BLOOD, V88, P970, DOI 10.1182/blood.V88.3.970.bloodjournal883970; Hoyne GF, 2000, INT IMMUNOL, V12, P177, DOI 10.1093/intimm/12.2.177; Hozumi K, 2003, J IMMUNOL, V170, P4973, DOI 10.4049/jimmunol.170.10.4973; Hsieh JJD, 1999, P NATL ACAD SCI USA, V96, P23, DOI 10.1073/pnas.96.1.23; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; Huang EY, 2003, J IMMUNOL, V171, P2296, DOI 10.4049/jimmunol.171.5.2296; Hubmann R, 2002, BLOOD, V99, P3742, DOI 10.1182/blood.V99.10.3742; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Izon DJ, 2002, IMMUNITY, V16, P231, DOI 10.1016/S1074-7613(02)00271-6; Jaleco AC, 2001, J EXP MED, V194, P991, DOI 10.1084/jem.194.7.991; Jeffries S, 2002, MOL CELL BIOL, V22, P3927, DOI 10.1128/MCB.22.11.3927-3941.2002; Jiang RL, 1998, GENE DEV, V12, P1046, DOI 10.1101/gad.12.7.1046; Jones P, 1998, BLOOD, V92, P1505, DOI 10.1182/blood.V92.5.1505.417k42_1505_1511; Jonsson JI, 2001, EUR J IMMUNOL, V31, P3240, DOI 10.1002/1521-4141(200111)31:11<3240::AID-IMMU3240>3.0.CO;2-E; Jundt F, 2002, BLOOD, V99, P3398, DOI 10.1182/blood.V99.9.3398; Kaneta M, 2000, J IMMUNOL, V164, P256, DOI 10.4049/jimmunol.164.1.256; Kang J, 2001, J EXP MED, V193, P689, DOI 10.1084/jem.193.6.689; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Karanu FN, 2001, BLOOD, V97, P1960, DOI 10.1182/blood.V97.7.1960; Karanu FN, 2000, J EXP MED, V192, P1365, DOI 10.1084/jem.192.9.1365; Karanu FN, 2003, LEUKEMIA, V17, P1366, DOI 10.1038/sj.leu.2402973; Kawamata S, 2002, ONCOGENE, V21, P3855, DOI 10.1038/sj.onc.1205487; KIDD S, 1986, MOL CELL BIOL, V6, P3094, DOI 10.1128/MCB.6.9.3094; Koch U, 2001, IMMUNITY, V15, P225, DOI 10.1016/S1074-7613(01)00189-3; Krebs LT, 2003, GENESIS, V37, P139, DOI 10.1002/gene.10241; Krebs LT, 2001, DEV BIOL, V238, P110, DOI 10.1006/dbio.2001.0408; Kumano K, 2003, IMMUNITY, V18, P699, DOI 10.1016/S1074-7613(03)00117-1; Kunisato A, 2003, BLOOD, V101, P1777, DOI 10.1182/blood-2002-07-2051; Kuroda K, 2003, IMMUNITY, V18, P301, DOI 10.1016/S1074-7613(03)00029-3; Lauring AS, 2000, MOL CELL, V6, P939, DOI 10.1016/S1097-2765(05)00084-5; MacDonald HR, 2001, CURR OPIN IMMUNOL, V13, P219, DOI 10.1016/S0952-7915(00)00207-7; Maekawa Y, 2003, IMMUNITY, V19, P549, DOI 10.1016/S1074-7613(03)00270-X; MATSUNO K, 1995, DEVELOPMENT, V121, P2633; Milner LA, 1999, BLOOD, V93, P2431, DOI 10.1182/blood.V93.8.2431.408k33_2431_2448; Morgan TH, 1917, AM NAT, V51, P513, DOI 10.1086/279629; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Newton K, 2000, EMBO J, V19, P931, DOI 10.1093/emboj/19.5.931; Ohishi K, 2002, J CLIN INVEST, V110, P1165, DOI 10.1172/JCI200216167; Ohishi K, 2003, SEMIN CELL DEV BIOL, V14, P143, DOI 10.1016/S1084-9521(02)00183-0; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Oswald F, 2002, EMBO J, V21, P5417, DOI 10.1093/emboj/cdf549; Palaga T, 2003, J IMMUNOL, V171, P3019, DOI 10.4049/jimmunol.171.6.3019; PARDANAUD L, 1989, DEVELOPMENT, V105, P473; Parks AL, 2000, DEVELOPMENT, V127, P1373; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Radtke F, 2002, IMMUNOL REV, V187, P65, DOI 10.1034/j.1600-065X.2002.18706.x; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Reizis B, 2002, GENE DEV, V16, P295, DOI 10.1101/gad.960702; REYNOLDS TC, 1987, CELL, V50, P107, DOI 10.1016/0092-8674(87)90667-2; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; Rohn JL, 1996, J VIROL, V70, P8071, DOI 10.1128/JVI.70.11.8071-8080.1996; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Singh N, 2000, EXP HEMATOL, V28, P527, DOI 10.1016/S0301-472X(00)00146-6; Souabni A, 2002, IMMUNITY, V17, P781, DOI 10.1016/S1074-7613(02)00472-7; Stier S, 2002, BLOOD, V99, P2369, DOI 10.1182/blood.V99.7.2369; Talora C, 2003, EMBO REP, V4, P1067, DOI 10.1038/sj.embor.7400013; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Tsai S, 2000, BLOOD, V96, P950, DOI 10.1182/blood.V96.3.950.015k43_950_957; Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390; Varnum-Finney B, 1998, BLOOD, V91, P4084, DOI 10.1182/blood.V91.11.4084.411k05_4084_4091; Varnum-Finney B, 2003, BLOOD, V101, P1784, DOI 10.1182/blood-2002-06-1862; Vigouroux S, 2003, J VIROL, V77, P10872, DOI 10.1128/JVI.77.20.10872-10880.2003; Walker L, 2001, STEM CELLS, V19, P543, DOI 10.1634/stemcells.19-6-543; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; Weijzen S, 2002, J IMMUNOL, V169, P4273, DOI 10.4049/jimmunol.169.8.4273; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; Wilson A, 2000, J IMMUNOL, V165, P5397, DOI 10.4049/jimmunol.165.10.5397; Wilson A, 2001, J EXP MED, V194, P1003, DOI 10.1084/jem.194.7.1003; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Wong KK, 2003, J CLIN INVEST, V112, P1741, DOI 10.1172/JCI18020; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Yamaguchi E, 2002, IMMUNOL LETT, V81, P59, DOI 10.1016/S0165-2478(01)00326-1; Yan XQ, 2001, BLOOD, V98, P3793, DOI 10.1182/blood.V98.13.3793; Yun TJ, 2003, J IMMUNOL, V170, P5834, DOI 10.4049/jimmunol.170.12.5834; Yvon ES, 2003, BLOOD, V102, P3815, DOI 10.1182/blood-2002-12-3826; Zhou SF, 2000, MOL CELL BIOL, V20, P2400, DOI 10.1128/MCB.20.7.2400-2410.2000	112	426	440	2	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2004	5	3					247	253		10.1038/ni1045	http://dx.doi.org/10.1038/ni1045			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	779ZV	14985712				2022-12-18	WOS:000189344600007
J	Zhang, F; Wei, K; Slowikowski, K; Fonseka, CY; Rao, DA; Kelly, S; Goodman, SM; Tabechian, D; Hughes, LB; Salomon-Escoto, K; Watts, GFM; Jonsson, AH; Rangel-Moreno, J; Meednu, N; Rozo, C; Apruzzese, W; Eisenhaure, TM; Lieb, DJ; Boyle, DL; Mandelin, AM; Boyce, BF; DiCarlo, E; Gravallese, EM; Gregersen, PK; Moreland, L; Firestein, GS; Hacohen, N; Nusbaum, C; Lederer, JA; Perlman, H; Pitzalis, C; Filer, A; Holers, VM; Bykerk, VP; Donlin, LT; Anolik, JH; Brenner, MB; Raychaudhuri, S; Albrecht, J; Bridges, SL; Buckley, CD; Buckner, JH; Dolan, J; Guthridge, JM; Gutierrez-Arcelus, M; Ivashkiv, LB; James, EA; James, JA; Keegan, J; Lee, YC; McGeachy, MJ; McNamara, MA; Mears, JR; Mizoguchi, F; Nguyen, JP; Noma, A; Orange, DE; Rohani-Pichavant, M; Ritchlin, C; Robinson, WH; Seshadri, A; Sutherby, D; Seifert, J; Turner, JD; Utz, PJ				Zhang, Fan; Wei, Kevin; Slowikowski, Kamil; Fonseka, Chamith Y.; Rao, Deepak A.; Kelly, Stephen; Goodman, Susan M.; Tabechian, Darren; Hughes, Laura B.; Salomon-Escoto, Karen; Watts, Gerald F. M.; Jonsson, A. Helena; Rangel-Moreno, Javier; Meednu, Nida; Rozo, Cristina; Apruzzese, William; Eisenhaure, Thomas M.; Lieb, David J.; Boyle, David L.; Mandelin, Arthur M., II; Boyce, Brendan F.; DiCarlo, Edward; Gravallese, Ellen M.; Gregersen, Peter K.; Moreland, Larry; Firestein, Gary S.; Hacohen, Nir; Nusbaum, Chad; Lederer, James A.; Perlman, Harris; Pitzalis, Costantino; Filer, Andrew; Holers, V. Michael; Bykerk, Vivian P.; Donlin, Laura T.; Anolik, Jennifer H.; Brenner, Michael B.; Raychaudhuri, Soumya; Albrecht, Jennifer; Bridges, S. Louis, Jr.; Buckley, Christopher D.; Buckner, Jane H.; Dolan, James; Guthridge, Joel M.; Gutierrez-Arcelus, Maria; Ivashkiv, Lionel B.; James, Eddie A.; James, Judith A.; Keegan, Josh; Lee, Yvonne C.; McGeachy, Mandy J.; McNamara, Michael A.; Mears, Joseph R.; Mizoguchi, Fumitaka; Nguyen, Jennifer P.; Noma, Akiko; Orange, Dana E.; Rohani-Pichavant, Mina; Ritchlin, Christopher; Robinson, William H.; Seshadri, Anupamaa; Sutherby, Danielle; Seifert, Jennifer; Turner, Jason D.; Utz, Paul J.		Accelerating Medicines Partnersh	Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry	NATURE IMMUNOLOGY			English	Article							B-CELLS; SUBSETS; PATHOPHYSIOLOGY; PATHOGENESIS; FIBROBLASTS; MACROPHAGES; EXPRESSION; SYSTEM; IMMUNE	To define the cell populations that drive joint inflammation in rheumatoid arthritis (RA), we applied single-cell RNA sequencing (scRNA-seq), mass cytometry, bulk RNA sequencing (RNA-seq) and flow cytometry to Tcells, B cells, monocytes, and fibroblasts from 51 samples of synovial tissue from patients with RA or osteoarthritis (OA). Utilizing an integrated strategy based on canonical correlation analysis of 5,265 scRNA-seq profiles, we identified 18 unique cell populations. Combining mass cytometry and transcriptomics revealed cell states expanded in RA synovia: THY1(CD90)(+)HLA-DRA(hi) sublining fibroblasts, IL1B(+) pro-inflammatory monocytes, ITGAX(+)TBX21(+) autoimmune-associated B cells and PDCD1(+) peripheral helper T (T-PH) cells and follicular helper T (T-FH) cells. We defined distinct subsets of CD8(+)Tcells characterized by GZMIK(+), GZMB(+), and GNLY(+) phenotypes. We mapped inflammatory mediators to their source cell populations; for example, we attributed 1L6 expression to THYl(+)HLA-DRA(hi) fibroblasts and IL1B production to pro-inflammatory monocytes. These populations are potentially key mediators of RA pathogenesis.	[Zhang, Fan; Slowikowski, Kamil; Fonseka, Chamith Y.; Raychaudhuri, Soumya; Gutierrez-Arcelus, Maria; Mears, Joseph R.] Brigham & Womens Hosp, Ctr Data Sci, 75 Francis St, Boston, MA 02115 USA; [Zhang, Fan; Slowikowski, Kamil; Fonseka, Chamith Y.; Raychaudhuri, Soumya; Gutierrez-Arcelus, Maria; Mears, Joseph R.] Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Zhang, Fan; Wei, Kevin; Slowikowski, Kamil; Fonseka, Chamith Y.; Rao, Deepak A.; Watts, Gerald F. M.; Jonsson, A. Helena; Apruzzese, William; Lederer, James A.; Brenner, Michael B.; Raychaudhuri, Soumya; Dolan, James; Gutierrez-Arcelus, Maria; Keegan, Josh; Mears, Joseph R.; Mizoguchi, Fumitaka; Nguyen, Jennifer P.; Seshadri, Anupamaa] Harvard Med Sch, Boston, MA 02115 USA; [Zhang, Fan; Slowikowski, Kamil; Fonseka, Chamith Y.; Raychaudhuri, Soumya; Gutierrez-Arcelus, Maria; Mears, Joseph R.] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Zhang, Fan; Slowikowski, Kamil; Fonseka, Chamith Y.; Eisenhaure, Thomas M.; Lieb, David J.; Hacohen, Nir; Nusbaum, Chad; Raychaudhuri, Soumya; Gutierrez-Arcelus, Maria; Mears, Joseph R.; Noma, Akiko; Sutherby, Danielle] Broad Inst & Harvard, Cambridge, MA 02142 USA; [Zhang, Fan; Wei, Kevin; Slowikowski, Kamil; Fonseka, Chamith Y.; Rao, Deepak A.; Watts, Gerald F. M.; Jonsson, A. Helena; Apruzzese, William; Brenner, Michael B.; Raychaudhuri, Soumya; Gutierrez-Arcelus, Maria; Mears, Joseph R.; Mizoguchi, Fumitaka] Brigham & Womens Hosp, Div Rheumatol, Immunol, Allergy, 75 Francis St, Boston, MA 02115 USA; [Kelly, Stephen] Barts Hlth NHS Trust, Dept Rheumatol, London, England; [Goodman, Susan M.; Bykerk, Vivian P.; McNamara, Michael A.; Orange, Dana E.] Hosp Special Surg, Div Rheumatol, 535 E 70th St, New York, NY 10021 USA; [Goodman, Susan M.; Bykerk, Vivian P.; Donlin, Laura T.; Ivashkiv, Lionel B.; McNamara, Michael A.] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Tabechian, Darren; Rangel-Moreno, Javier; Meednu, Nida; Anolik, Jennifer H.; Albrecht, Jennifer; Ritchlin, Christopher] Univ Rochester, Med Ctr, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Hughes, Laura B.; Bridges, S. Louis, Jr.] Univ Alabama Birmingham, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA; [Salomon-Escoto, Karen; Gravallese, Ellen M.] Univ Massachusetts, Sch Med, Dept Med, Div Rheumatol, Worcester, MA USA; [Rozo, Cristina; Donlin, Laura T.] Hosp Special Surg, Arthrit & Tissue Degenerat, 535 E 70th St, New York, NY 10021 USA; [Boyle, David L.; Firestein, Gary S.] Univ Calif San Diego, Dept Med, Div Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA; [Mandelin, Arthur M., II; Perlman, Harris; Lee, Yvonne C.] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Rheumatol, Chicago, IL 60611 USA; [DiCarlo, Edward] Hosp Special Surg, Dept Pathol & Lab Med, 535 E 70th St, New York, NY 10021 USA; [Gregersen, Peter K.] Northwell Hlth, Feinstein Inst Med Res, Manhasset, NY USA; [Moreland, Larry; McGeachy, Mandy J.] Univ Pittsburgh, Sch Med, Div Rheumatol & Clin Immunol, Pittsburgh, PA USA; [Lederer, James A.; Dolan, James; Keegan, Josh; Nguyen, Jennifer P.; Seshadri, Anupamaa] Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA; [Pitzalis, Costantino] Queen Mary Univ London, William Harvey Res Inst, Ctr Expt Med & Rheumatol, London, England; [Filer, Andrew; Buckley, Christopher D.; Turner, Jason D.] Univ Hosp Birmingham NHS Fdn Trust, NIHR Birmingham Biomed Res Ctr, Birmingham, W Midlands, England; [Filer, Andrew; Buckley, Christopher D.; Turner, Jason D.] Univ Birmingham, Birmingham, W Midlands, England; [Filer, Andrew] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England; [Holers, V. Michael; Seifert, Jennifer] Univ Colorado, Sch Med, Div Rheumatol, Aurora, CO USA; [Anolik, Jennifer H.] Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY 14642 USA; [Raychaudhuri, Soumya] Univ Manchester, Ctr Musculoskeletal Res, Arthrit Res UK Ctr Genet & Gen, Manchester, Lancs, England; [Buckner, Jane H.; James, Eddie A.] Virginia Mason, Benaroya Res Inst, Translat Res Program, Seattle, VA USA; [Guthridge, Joel M.; James, Judith A.] Oklahoma Med Res Fdn, Dept Arthrit & Clin Immunol, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Ivashkiv, Lionel B.] Weill Cornell Grad Sch Med Sci, Grad Program Immunol & Microbial Pathogenes, New York, NY USA; [Ivashkiv, Lionel B.] Hosp Special Surg, David Z Rosensweig Genom Res Ctr, 535 E 70th St, New York, NY 10021 USA; [Mizoguchi, Fumitaka] Tokyo Med & Dent Univ, Dept Rheumatol, Grad Sch Med & Dent Sci, Tokyo, Japan; [Orange, Dana E.] Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA; [Rohani-Pichavant, Mina; Robinson, William H.; Utz, Paul J.] Stanford Univ, Sch Med, Dept Med, Div Immunol & Rheumatol, Palo Alto, CA 94304 USA; [Rohani-Pichavant, Mina; Robinson, William H.; Utz, Paul J.] Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; Univ Rochester Med Ctr, Dept Pathol & Lab Med, Rochester, NY USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Barts Health NHS Trust; Cornell University; University of Rochester; University of Alabama System; University of Alabama Birmingham; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California San Diego; Northwestern University; Feinberg School of Medicine; Northwell Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Brigham & Women's Hospital; University of London; Queen Mary University London; University of Birmingham; University of Birmingham; University of Birmingham; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Rochester; University of Manchester; Benaroya Research Institute; Virginia Mason Medical Center; Oklahoma Medical Research Foundation; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Tokyo Medical & Dental University (TMDU); Rockefeller University; Stanford University; Stanford University; University of Rochester	Raychaudhuri, S (corresponding author), Brigham & Womens Hosp, Ctr Data Sci, 75 Francis St, Boston, MA 02115 USA.; Raychaudhuri, S (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.; Raychaudhuri, S (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Raychaudhuri, S (corresponding author), Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA.; Raychaudhuri, S (corresponding author), Broad Inst & Harvard, Cambridge, MA 02142 USA.; Raychaudhuri, S (corresponding author), Brigham & Womens Hosp, Immunol, Allergy, Div Rheumatol, 75 Francis St, Boston, MA 02115 USA.; Raychaudhuri, S (corresponding author), Univ Manchester, Ctr Musculoskeletal Res, Arthrit Res UK Ctr Genet & Gen, Manchester, Lancs, England.	soumya@broadinstitute.org	Zhang, Fan/ABD-7525-2021; Filer, Andrew/AAP-9179-2021; Donlin, Laura T/P-2483-2019; Slowikowski, Kamil/K-3728-2016; Lee, Yvonne Claire/AAL-4826-2021; Kelly, Stephen/GZH-1668-2022; Buckley, Christopher/AAN-6378-2021; Mizoguchi, Fumitaka/Y-3271-2018; DiCarlo, Edward/AAC-5321-2019; Mandelin, Arthur/AAY-1499-2021; James, Eddie/V-4929-2019	Zhang, Fan/0000-0002-6102-2970; Filer, Andrew/0000-0001-8164-6249; Donlin, Laura T/0000-0002-1428-090X; Slowikowski, Kamil/0000-0002-2843-6370; Lee, Yvonne Claire/0000-0002-2105-3393; Buckley, Christopher/0000-0001-6924-6402; Mizoguchi, Fumitaka/0000-0002-3956-7122; James, Eddie/0000-0002-7217-5729; Rangel-Moreno, Javier/0000-0002-9738-1182; ritchlin, christopher/0000-0002-2602-1219; Moreland, Larry/0000-0003-4483-0359; Meednu, Nida/0000-0002-2868-3339; Turner, Jason/0000-0002-5423-5302; Raychaudhuri, Soumya/0000-0002-1901-8265; Robinson, William/0000-0003-4385-704X; Seshadri, Anupamaa/0000-0001-8432-7518; Anolik, Jennifer/0000-0002-1450-1549; Pitzalis, Costantino/0000-0003-1326-5051; Jonsson, Anna Helena/0000-0002-9558-2474; Watts, Gerald/0000-0003-2276-1524	Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus Network; National Institutes of Health [UH2-AR067676, UH2-AR067677, UH2-AR067679, UH2-AR067681, UH2-AR067685, UH2-AR067688, UH2-AR067689, UH2-AR067690, UH2-AR067691, UH2-AR067694, UM2-AR067678]; Ruth L. Kirschstein National Research Service Award [NIAMS F31AR070582]; Rheumatology Research Foundation Scientist Development Award; KL2/Catalyst Medical Research Investigator Training award (an appointed KL2 award) from Harvard Catalyst, The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health) [KL2 TR002542]; NIAMS [1R01AR063759-01A1, K08 AR072791-01, K01 AR066063]; Bertha and Louis Weinstein research fund; NIAID [U19 AI111224]; NHGRI [U01 HG009379]; Doris Duke Charitable Foundation [2013097]; Arthritis National Research Foundation; Arthritis Research UK Rheumatoid Arthritis [20298]; National Institute for Health Research (NIHR)'s Birmingham Biomedical Research Centre program; National Institute for Health Research/Wellcome Trust Clinical Research Facility at University Hospitals Birmingham NHS Foundation Trust;  [R21 AR071670]; MRC [MR/N026977/1, G0800648, MR/S025308/1] Funding Source: UKRI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR002542] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL134375] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG009379, T32HG002295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046712, U19AI111224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [UH2AR067679, UH2AR067688, UH2AR067681, UH2AR067691, UH2AR067690, K01AR066063, R01AR046713, R01AR063759, R21AR071670, UH2AR067694, UM2AR067678, UH2AR067677, UH2AR067676, K08AR072791, UH2AR067689, UH2AR067685, F31AR070582] Funding Source: NIH RePORTER	Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus Network; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rheumatology Research Foundation Scientist Development Award; KL2/Catalyst Medical Research Investigator Training award (an appointed KL2 award) from Harvard Catalyst, The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Bertha and Louis Weinstein research fund; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Arthritis National Research Foundation(National Research Foundation of Korea); Arthritis Research UK Rheumatoid Arthritis; National Institute for Health Research (NIHR)'s Birmingham Biomedical Research Centre program; National Institute for Health Research/Wellcome Trust Clinical Research Facility at University Hospitals Birmingham NHS Foundation Trust; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus Network. AMP is a public-private partnership (AbbVie Inc., Arthritis Foundation, Bristol-Myers Squibb Company, Lupus Foundation of America, Lupus Research Alliance, Merck Sharp & Dohme Corp., National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Pfizer Inc., Rheumatology Research Foundation, Sanofi and Takeda Pharmaceuticals International, Inc.) created to develop new ways of identifying and validating promising biological targets for diagnostics and drug development. Funding was provided through grants from the National Institutes of Health (UH2-AR067676, UH2-AR067677, UH2-AR067679, UH2-AR067681, UH2-AR067685, UH2-AR067688, UH2-AR067689, UH2-AR067690, UH2-AR067691, UH2-AR067694, and UM2-AR067678). K.S. is supported by the Ruth L. Kirschstein National Research Service Award (NIAMS F31AR070582). K.W. is supported by a Rheumatology Research Foundation Scientist Development Award, and KL2/Catalyst Medical Research Investigator Training award (an appointed KL2 award) from Harvard Catalyst, The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health Award KL2 TR002542). D.A.R. is supported by NIAMS K08 AR072791-01. L.T.D. is supported by NIAMS K01 AR066063. J.H.A. is supported by R21 AR071670, and the Bertha and Louis Weinstein research fund. S.R. is supported by NIAMS 1R01AR063759-01A1, NIAID U19 AI111224, NHGRI U01 HG009379, and Doris Duke Charitable Foundation Grant #2013097. A.H.J. is supported by an Arthritis National Research Foundation Grant. A.F., C.D.B. and J.D.T. were supported by the Arthritis Research UK Rheumatoid Arthritis (#20298), and by the National Institute for Health Research (NIHR)'s Birmingham Biomedical Research Centre program, supported by the National Institute for Health Research/Wellcome Trust Clinical Research Facility at University Hospitals Birmingham NHS Foundation Trust.	Al-Mayouf SM, 2011, NAT GENET, V43, P1186, DOI 10.1038/ng.975; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bjornson ZB, 2013, CURR OPIN IMMUNOL, V25, P484, DOI 10.1016/j.coi.2013.07.004; De Maesschalck R, 2000, CHEMOMETR INTELL LAB, V50, P1, DOI 10.1016/S0169-7439(99)00047-7; Dennis G, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4555; Donlin LT, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1631-y; Ellebedy AH, 2016, NAT IMMUNOL, V17, P1226, DOI 10.1038/ni.3533; Filer A, 2013, CURR OPIN PHARMACOL, V13, P413, DOI 10.1016/j.coph.2013.02.006; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Fonseka CY, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aaq0305; Frara N, 2016, J CELL PHYSIOL, V231, P72, DOI 10.1002/jcp.25020; Gibofsky A, 2014, AM J MANAG CARE, V20, pS128; Gizinski AM, 2014, CURR OPIN RHEUMATOL, V26, P204, DOI 10.1097/BOR.0000000000000036; Gonzalez I, 2008, J STAT SOFTW, V23, P1; Hashimshony T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0938-8; Hicks SC, 2018, BIOSTATISTICS, V19, P562, DOI 10.1093/biostatistics/kxx053; Jenks SA, 2018, IMMUNITY, V49, P725, DOI 10.1016/j.immuni.2018.08.015; Kinne RW, 2000, ARTHRITIS RES, V2, P189, DOI 10.1186/ar86; Krenn V, 2002, PATHOL RES PRACT, V198, P317, DOI 10.1078/0344-0338-5710261; Lee EB, 2014, NEW ENGL J MED, V370, P2377, DOI 10.1056/NEJMoa1310476; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lindberg J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1903; McInnes IB, 2005, NAT CLIN PRACT RHEUM, V1, P31, DOI 10.1038/ncprheum0020; McInnes IB, 1996, NAT MED, V2, P175, DOI 10.1038/nm0296-175; Mizoguchi F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02892-y; Mulherin D, 1996, ARTHRITIS RHEUM, V39, P115, DOI 10.1002/art.1780390116; MullerLadner U, 1996, AM J PATHOL, V149, P1607; Namekawa T, 1998, ARTHRITIS RHEUM, V41, P2108; Orange DE, 2018, ARTHRITIS RHEUMATOL, V70, P690, DOI 10.1002/art.40428; Orr C, 2017, NAT REV RHEUMATOL, V13, P463, DOI 10.1038/nrrheum.2017.115; Pap T, 2000, ARTHRITIS RES, V2, P361, DOI 10.1186/ar113; Papalexi E, 2018, NAT REV IMMUNOL, V18, P35, DOI 10.1038/nri.2017.76; Parkhomenko E, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1406; Peterson VM, 2017, NAT BIOTECHNOL, V35, P936, DOI 10.1038/nbt.3973; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pillai S, 2011, BLOOD, V118, P1187, DOI 10.1182/blood-2011-06-355131; Pitzalis C, 2013, CURR OPIN RHEUMATOL, V25, P334, DOI 10.1097/BOR.0b013e32835fd8eb; Rao DA, 2017, NATURE, V542, P110, DOI 10.1038/nature20810; Reparon-Schuijt CC, 2001, ARTHRITIS RHEUM, V44, P41, DOI 10.1002/1529-0131(200101)44:1<41::AID-ANR6>3.0.CO;2-0; Reynolds AP., 2006, J MATH MODEL ALGORIT, V5, P475, DOI [DOI 10.1007/S10852-005-9022-1, 10.1007/s10852-005-9022-1]; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Rubtsov AV, 2015, J IMMUNOL, V195, P71, DOI 10.4049/jimmunol.1500055; Schelker M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02289-3; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Smolen JS, 2010, NAT REV RHEUMATOL, V6, P247, DOI 10.1038/nrrheum.2010.58; Snelling SJB, 2016, OSTEOARTHR CARTILAGE, V24, P883, DOI 10.1016/j.joca.2015.11.021; Stephenson W, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02659-x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Todd DJ, 2009, J EXP MED, V206, P2151, DOI 10.1084/jem.20090738; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Wang S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03750-7; Weissmann G, 2006, BULL HOSP JT DIS, V64, P12; Westra HJ, 2018, NAT GENET, V50, P1366, DOI 10.1038/s41588-018-0216-7; Witten DM, 2009, BIOSTATISTICS, V10, P515, DOI 10.1093/biostatistics/kxp008; WOLFE F, 1994, ARTHRITIS RHEUM-US, V37, P481, DOI 10.1002/art.1780370408; Zizzo G, 2012, J IMMUNOL, V189, P3508, DOI 10.4049/jimmunol.1200662	59	425	433	27	261	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2019	20	7					928	+		10.1038/s41590-019-0378-1	http://dx.doi.org/10.1038/s41590-019-0378-1			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7VW	31061532	Green Accepted, Green Published, Green Submitted			2022-12-18	WOS:000471891900022
J	Aschenbrenner, K; D'Cruz, LM; Vollmann, EH; Hinterberger, M; Emmerich, J; Swee, LK; Rolink, A; Klein, L				Aschenbrenner, Katharina; D'Cruz, Louise M.; Vollmann, Elisabeth H.; Hinterberger, Maria; Emmerich, Jan; Swee, Lee Kim; Rolink, Antonius; Klein, Ludger			Selection of Foxp3(+) regulatory T cells specific for self antigen expressed and presented by Aire(+) medullary thymic epithelial cells	NATURE IMMUNOLOGY			English	Article							PROMISCUOUS GENE-EXPRESSION; CLASS-II MOLECULES; NEGATIVE SELECTION; CENTRAL TOLERANCE; INTERCELLULAR TRANSFER; POSITIVE SELECTION; DENDRITIC CELLS; CLONAL DELETION; IN-VIVO; COMPLEX	The parameters specifying whether autoreactive CD4(+) thymocytes are deleted ( recessive tolerance) or differentiate into regulatory T cells ( dominant tolerance) remain unresolved. Dendritic cells directly delete thymocytes, partly through cross-presentation of peripheral antigens ` promiscuously' expressed in medullary thymic epithelial cells ( mTECs) positive for the autoimmune regulator Aire. It is unclear if and how mTECs themselves act as antigen-presenting cells during tolerance induction. Here we found that an absence of major histocompatibility class II molecules on mTECs resulted in fewer polyclonal regulatory T cells. Furthermore, targeting of a model antigen to Aire(+) mTECs led to the generation of specific regulatory T cells independently of antigen transfer to dendritic cells. Thus, 'routing' of mTEC-derived self antigens may determine whether specific thymocytes are deleted or enter the regulatory T cell lineage.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Univ Basel, Dept Clin & Biol Sci, Ctr Biomed, CH-4051 Basel, Switzerland; Harvard Univ, CBR Inst Biomed Res, Dept Pathol, Brigham & Womens Hosp,Med Sch, Boston, MA 02115 USA	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Basel; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Brigham & Women's Hospital; Harvard Medical School	Klein, L (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	klein@imp.univie.ac.at	Klein, Ludger/G-8785-2011	Emmerich, Jan/0000-0002-7216-2231; Klein, Ludger/0000-0003-2054-071X				Akiyama T, 2005, SCIENCE, V308, P248, DOI 10.1126/science.1105677; Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Bensinger SJ, 2001, J EXP MED, V194, P427, DOI 10.1084/jem.194.4.427; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Bot A, 1996, J IMMUNOL, V157, P3436; Brocker T, 1997, J EXP MED, V185, P541, DOI 10.1084/jem.185.3.541; Cabarrocas J, 2006, P NATL ACAD SCI USA, V103, P8453, DOI 10.1073/pnas.0603086103; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; HUMBLET C, 1994, INT IMMUNOL, V6, P1949, DOI 10.1093/intimm/6.12.1949; Itoh M, 1999, J IMMUNOL, V162, P5317; JENKINSON EJ, 1994, CURR OPIN IMMUNOL, V6, P293, DOI 10.1016/0952-7915(94)90104-X; Jiang Qi, 2006, BMC Immunol, V7, P6, DOI 10.1186/1471-2172-7-6; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kawahata K, 2002, J IMMUNOL, V168, P4399, DOI 10.4049/jimmunol.168.9.4399; King CG, 2006, NAT MED, V12, P1088, DOI 10.1038/nm1449; KIRBERG J, 1994, J EXP MED, V180, P25, DOI 10.1084/jem.180.1.25; Kishimoto H, 1999, J EXP MED, V190, P65, DOI 10.1084/jem.190.1.65; Klein L, 2003, P NATL ACAD SCI USA, V100, P8886, DOI 10.1073/pnas.1533365100; Klein L, 2001, EUR J IMMUNOL, V31, P2476, DOI 10.1002/1521-4141(200108)31:8<2476::AID-IMMU2476>3.0.CO;2-T; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; LeDouarin N, 1996, IMMUNOL REV, V149, P35; Lerman MA, 2004, J IMMUNOL, V173, P236, DOI 10.4049/jimmunol.173.1.236; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Liu YJ, 2006, TRENDS IMMUNOL, V27, P215, DOI 10.1016/j.it.2006.03.004; Lohr J, 2004, J IMMUNOL, V173, P5028, DOI 10.4049/jimmunol.173.8.5028; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Mathis D, 2004, IMMUNITY, V20, P509, DOI 10.1016/S1074-7613(04)00111-6; Modigliani Y, 1996, EUR J IMMUNOL, V26, P1807, DOI 10.1002/eji.1830260822; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; Papiernik M, 1998, INT IMMUNOL, V10, P371, DOI 10.1093/intimm/10.4.371; Ribot J, 2006, J IMMUNOL, V177, P1101, DOI 10.4049/jimmunol.177.2.1101; Rodewald HR, 2001, NATURE, V414, P763, DOI 10.1038/414763a; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Su MA, 2004, CURR OPIN IMMUNOL, V16, P746, DOI 10.1016/j.coi.2004.09.009; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Thorstenson KM, 2001, J IMMUNOL, V167, P188, DOI 10.4049/jimmunol.167.1.188; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; vanMeerwijk JPM, 1997, J EXP MED, V185, P377, DOI 10.1084/jem.185.3.377; Viret C, 1999, IMMUNOL TODAY, V20, P8, DOI 10.1016/S0167-5699(98)01372-3; Walker LSK, 2003, J EXP MED, V198, P249, DOI 10.1084/jem.20030315; Watanabe N, 2005, NATURE, V436, P1181, DOI 10.1038/nature03886	52	425	436	0	18	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2007	8	4					351	358		10.1038/ni1444	http://dx.doi.org/10.1038/ni1444			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	148LK	17322887				2022-12-18	WOS:000245075900010
J	Gazit, R; Gruda, R; Elboim, M; Arnon, TI; Katz, G; Achdout, H; Hanna, J; Qimron, U; Landau, G; Greenbaum, E; Zakay-Rones, Z; Porgador, A; Mandelboim, O				Gazit, R; Gruda, R; Elboim, M; Arnon, TI; Katz, G; Achdout, H; Hanna, J; Qimron, U; Landau, G; Greenbaum, E; Zakay-Rones, Z; Porgador, A; Mandelboim, O			Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1	NATURE IMMUNOLOGY			English	Article							MHC CLASS-I; CYTOTOXICITY RECEPTORS; NK CELLS; MOLECULAR-CLONING; MEDIATED LYSIS; HUMAN NKP46; RECOGNITION; NKP30; MICE; HEMAGGLUTININS	The elimination of viruses and tumors by natural killer cells is mediated by specific natural killer cell receptors. To study the in vivo function of a principal activating natural killer cell receptor, NCR1 (NKp46 in humans), we replaced the gene encoding this receptor (Ncr1) with a green fluorescent protein reporter cassette. There was enhanced spread of certain tumors in 129/Sv but not C57BL/6 Ncr1(gfp/gfp) mice, and influenza virus infection was lethal in both 129/Sv and C57BL/6 Ncr1(gfp/gfp) mice. We noted accumulation of natural killer cells at the site of influenza infection by tracking the green fluorescent protein. Our results demonstrate a critical function for Ncr1 in the in vivo eradication of influenza virus.	Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Canc Res Ctr, IL-84105 Beer Sheva, Israel; Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Virol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Ben Gurion University; Ben Gurion University; Hebrew University of Jerusalem; Hadassah University Medical Center	Mandelboim, O (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel.	oferman@md2.huji.ac.il	Gazit, Roi/J-3352-2017; Hanna, Jacob/K-1339-2012; Gazit, Ehud/AHE-9332-2022	Hanna, Jacob/0000-0003-2042-9974; Porgador, Angel/0000-0003-1540-4449; Arnon, Tal/0000-0003-4629-5820; Mandelboim, Ofer/0000-0002-9354-1855; Gazit, Roi/0000-0002-0548-2147; Qimron, Udi/0000-0003-2169-5270				Arase H, 2001, J IMMUNOL, V167, P1141, DOI 10.4049/jimmunol.167.3.1141; Arnon TI, 2004, BLOOD, V103, P664, DOI 10.1182/blood-2003-05-1716; Arnon TI, 2001, EUR J IMMUNOL, V31, P2680, DOI 10.1002/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A; Biassoni R, 1999, EUR J IMMUNOL, V29, P1014, DOI 10.1002/(SICI)1521-4141(199903)29:03<1014::AID-IMMU1014>3.0.CO;2-O; Biassoni R, 2003, J CELL MOL MED, V7, P376, DOI 10.1111/j.1582-4934.2003.tb00240.x; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; Bloushtain N, 2004, J IMMUNOL, V173, P2392, DOI 10.4049/jimmunol.173.4.2392; Colucci F, 2002, NAT IMMUNOL, V3, P288, DOI 10.1038/ni764; Costello RT, 2002, BLOOD, V99, P3661, DOI 10.1182/blood.V99.10.3661; De Maria A, 2003, EUR J IMMUNOL, V33, P2410, DOI 10.1002/eji.200324141; De Maria A, 2001, EUR J IMMUNOL, V31, P3546, DOI 10.1002/1521-4141(200112)31:12<3546::AID-IMMU3546>3.0.CO;2-W; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Falco M, 1999, IMMUNOL LETT, V68, P411, DOI 10.1016/S0165-2478(99)00052-8; Karre K, 2002, SCAND J IMMUNOL, V55, P221, DOI 10.1046/j.1365-3083.2002.01053.x; Long EO, 2002, SEMIN CANCER BIOL, V12, P57, DOI 10.1006/scbi.2001.0398; Mandelboim O, 2001, INT J BIOCHEM CELL B, V33, P1147, DOI 10.1016/S1357-2725(01)00078-4; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Markel G, 2004, BLOOD, V103, P1770, DOI 10.1182/blood-2003-06-2114; McVicar DW, 2002, J IMMUNOL, V169, P1721, DOI 10.4049/jimmunol.169.4.1721; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Moretta L, 2004, EMBO J, V23, P255, DOI 10.1038/sj.emboj.7600019; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Oberg L, 2004, EUR J IMMUNOL, V34, P1646, DOI 10.1002/eji.200424913; Orange JS, 2002, MICROBES INFECT, V4, P1545, DOI 10.1016/S1286-4579(02)00038-2; Pessino A, 1998, J EXP MED, V188, P953, DOI 10.1084/jem.188.5.953; Qimron U, 2004, VACCINE, V22, P1390, DOI 10.1016/j.vaccine.2003.11.043; Rolink A, 1996, J EXP MED, V183, P187, DOI 10.1084/jem.183.1.187; Schleypen JS, 2003, INT J CANCER, V106, P905, DOI 10.1002/ijc.11321; Sivori S, 2003, EUR J IMMUNOL, V33, P3439, DOI 10.1002/eji.200324533; Sivori S, 1999, EUR J IMMUNOL, V29, P1656, DOI 10.1002/(SICI)1521-4141(199905)29:05<1656::AID-IMMU1656>3.0.CO;2-1; Sivori S, 2000, HUM IMMUNOL, V61, P1055, DOI 10.1016/S0198-8859(00)00201-9; Sivori S, 2000, J NEUROIMMUNOL, V107, P220, DOI 10.1016/S0165-5728(00)00221-6; Spaggiari GM, 2001, EUR J IMMUNOL, V31, P1656, DOI 10.1002/1521-4141(200106)31:6<1656::AID-IMMU1656>3.0.CO;2-V; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; STEINSTREILEIN J, 1986, J IMMUNOL, V136, P1435; Storset AK, 2003, EUR J IMMUNOL, V33, P980, DOI 10.1002/eji.200323710; Vankayalapati R, 2002, J IMMUNOL, V168, P3451, DOI 10.4049/jimmunol.168.7.3451; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; Warfield KL, 2004, J EXP MED, V200, P169, DOI 10.1084/jem.20032141; Weiss L, 2004, BONE MARROW TRANSPL, V33, P1137, DOI 10.1038/sj.bmt.1704475; Yokoyama WM, 2004, ANNU REV IMMUNOL, V22, P405, DOI 10.1146/annurev.immunol.22.012703.104711	42	424	447	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2006	7	5					517	523		10.1038/ni1322	http://dx.doi.org/10.1038/ni1322			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	035NT	16565719				2022-12-18	WOS:000237008800017
J	Das, J; Chen, CH; Yang, LY; Cohn, L; Ray, P; Ray, A				Das, J; Chen, CH; Yang, LY; Cohn, L; Ray, P; Ray, A			A critical role for NF-kappa B in Gata3 expression and T(H)2 differentiation in allergic airway inflammation	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR GATA-3; CYTOKINE GENE-EXPRESSION; CUTTING EDGE; TH2 CELLS; IMMUNE-RESPONSES; T-CELLS; ACTIVATION; INHIBITION; INDUCTION; PROMOTER	The transcription factor GATA-3 is expressed in T helper 2 (T(H)2) but not T(H)1 cells and plays a critical role in T(H)2 differentiation and allergic airway inflammation in vivo. Mice that lack the p50 subunit of nuclear factor kappaB (NF-kappaB) are unable to mount airway eosinophilic inflammation. We show here that this is not due to defects in TH2 cell recruitment but due to the inability of the p50(-/-) mice to produce interleukin 4 (IL-4), IL-5 and IL-13: cytokines that play distinct roles in asthma pathogenesis. CD4(+) T cells from p50(-/-) mice failed to induce Gata3 expression under T(H)2-differentiating conditions but showed unimpaired T-bet expression and interferon gamma (IFN-gamma) production under T(H)1-differentiating conditions. Inhibition of NF-kappaB activity prevented GATA-3 expression and T(H)2 cytokine production in developing, but not committed,T(H)2 cells. Our studies provide a molecular basis for the need for both T cell receptor and cytokine signaling for GATA-3 expression and, in turn,T(H)2 differentiation.	Yale Univ, Sch Med, Dept Med, Pulm & Crit Care Sect, New Haven, CT 06520 USA	Yale University	Ray, A (corresponding author), Yale Univ, Sch Med, Dept Med, Pulm & Crit Care Sect, 333 Cedar St,LCI 105, New Haven, CT 06520 USA.							Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Cohn L, 1998, J IMMUNOL, V161, P3813; Cohn L, 1997, J EXP MED, V186, P1737, DOI 10.1084/jem.186.10.1737; DELPHIN S, 1995, J EXP MED, V181, P181, DOI 10.1084/jem.181.1.181; GEORGE KM, 1994, DEVELOPMENT, V120, P2673; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; JAMIESON C, 1991, J IMMUNOL, V147, P416; KANG SM, 1992, SCIENCE, V256, P1451; Kuo CT, 1999, ANNU REV IMMUNOL, V17, P149, DOI 10.1146/annurev.immunol.17.1.149; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Liu RY, 1999, J BIOL CHEM, V274, P13877, DOI 10.1074/jbc.274.20.13877; Matsumoto S, 1997, BIOCHEM BIOPH RES CO, V234, P454, DOI 10.1006/bbrc.1997.6665; MCKENZIE ANJ, 1993, J IMMUNOL, V150, P5436; Mikita T, 1996, MOL CELL BIOL, V16, P5811; MURPHY TL, 1995, MOL CELL BIOL, V15, P5258; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Ranganath S, 1998, J IMMUNOL, V161, P3822; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Ray A, 1999, J CLIN INVEST, V104, P985, DOI 10.1172/JCI8204; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Sha WC, 1998, J EXP MED, V187, P143, DOI 10.1084/jem.187.2.143; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Shen CH, 1998, MOL CELL BIOL, V18, P3395, DOI 10.1128/MCB.18.6.3395; Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412; SIEGEL MD, 1995, J BIOL CHEM, V270, P24548, DOI 10.1074/jbc.270.41.24548; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; WALKER C, 1992, AM REV RESPIR DIS, V146, P109, DOI 10.1164/ajrccm/146.1.109; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Yang LY, 1998, J EXP MED, V188, P1739, DOI 10.1084/jem.188.9.1739; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1; Zhang DH, 1999, IMMUNITY, V11, P473, DOI 10.1016/S1074-7613(00)80122-3; Zhang DH, 1998, J IMMUNOL, V161, P3817; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	39	423	442	3	26	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2001	2	1					45	50		10.1038/83158	http://dx.doi.org/10.1038/83158			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	389WK	11135577				2022-12-18	WOS:000166261500013
J	Purbhoo, MA; Irvine, DJ; Huppa, JB; Davis, MM				Purbhoo, MA; Irvine, DJ; Huppa, JB; Davis, MM			T cell killing does not require the formation of a stable mature immunological synapse	NATURE IMMUNOLOGY			English	Article							SUPRAMOLECULAR ACTIVATION CLUSTERS; ANTIGEN SENSITIVITY; PEPTIDE COMPLEXES; PROTEIN-SYNTHESIS; MINIMAL NUMBER; MHC; RECEPTOR; RECOGNITION; COSTIMULATION; QUANTITATION	A notable feature of T lymphocyte recognition on other cell surfaces is the formation of a stable mature immunological synapse. Here we use a single-molecule labeling method to directly measure the number of ligands a cytotoxic T cell engages and track the consequences of that interaction by three-dimensional video microscopy. Like helper T cells, cytotoxic T cells were able to detect even a single foreign antigen but required about ten complexes of peptide-major histocompatibility complex (pMHC) to achieve full calcium increase and to form a mature synapse. Thus, cytotoxic T cells and helper T cells are more uniform in their antigen sensitivities than previously thought. Furthermore, only three pMHC complexes were required for killing, showing that stable synapse formation and complete signaling are not required for cytotoxicity.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Davis, MM (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	mdavis@cmgm.stanford.edu	Fang, Zhijun/L-9620-2013	Huppa, Johannes/0000-0003-2634-8198; Davis, Mark/0000-0001-6868-657X				Alam SM, 1999, IMMUNITY, V10, P227, DOI 10.1016/S1074-7613(00)80023-0; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; BROWER RC, 1994, MOL IMMUNOL, V31, P1285, DOI 10.1016/0161-5890(94)90079-5; CHRISTINCK ER, 1991, NATURE, V352, P67, DOI 10.1038/352067a0; Davis MM, 2003, ANNU REV BIOCHEM, V72, P717, DOI 10.1146/annurev.biochem.72.121801.161625; Degano M, 2000, IMMUNITY, V12, P251, DOI 10.1016/S1074-7613(00)80178-8; Delon J, 2000, CURR BIOL, V10, pR923, DOI 10.1016/S0960-9822(00)00870-8; DEMOTZ S, 1990, SCIENCE, V249, P1028, DOI 10.1126/science.2118680; DUSTIN ML, 1988, J EXP MED, V167, P1323, DOI 10.1084/jem.167.4.1323; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; HARDING CV, 1990, NATURE, V346, P574, DOI 10.1038/346574a0; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Kimachi K, 1997, EUR J IMMUNOL, V27, P3310, DOI 10.1002/eji.1830271230; Kojima H, 2000, INT IMMUNOL, V12, P365, DOI 10.1093/intimm/12.3.365; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; LUC, 2001, P NATL ACAD SCI USA, V98, P2387; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; POTTER TA, 1989, NATURE, V337, P73, DOI 10.1038/337073a0; Potter TA, 2001, P NATL ACAD SCI USA, V98, P12624, DOI 10.1073/pnas.221458898; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Purbhoo MA, 2001, J BIOL CHEM, V276, P32786, DOI 10.1074/jbc.M102498200; Reay PA, 2000, J IMMUNOL, V164, P5626, DOI 10.4049/jimmunol.164.11.5626; Shimaoka M, 2001, P NATL ACAD SCI USA, V98, P6009, DOI 10.1073/pnas.101130498; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Valitutti S, 1996, J EXP MED, V183, P1917, DOI 10.1084/jem.183.4.1917; van der Merwe PA, 2002, NAT IMMUNOL, V3, P1122, DOI 10.1038/ni1202-1122; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741; Wulfing C, 1998, P NATL ACAD SCI USA, V95, P6302, DOI 10.1073/pnas.95.11.6302; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Yewdell JW, 2001, TRENDS CELL BIOL, V11, P294, DOI 10.1016/S0962-8924(01)02030-X	36	422	433	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2004	5	5					524	530		10.1038/ni1058	http://dx.doi.org/10.1038/ni1058			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	816HN	15048111				2022-12-18	WOS:000221101100017
J	Heissmeyer, V; Macian, F; Im, SH; Varma, R; Feske, S; Venuprasad, K; Gu, H; Liu, YC; Dustin, ML; Rao, A				Heissmeyer, V; Macian, F; Im, SH; Varma, R; Feske, S; Venuprasad, K; Gu, H; Liu, YC; Dustin, ML; Rao, A			Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins	NATURE IMMUNOLOGY			English	Article							IMMUNOLOGICAL SYNAPSE; CBL-B; GENE-TRANSCRIPTION; DOWN-REGULATION; KINASE-C; IN-VIVO; ACTIVATION; RECEPTOR; ANTIGEN; RAP1	Sustained calcium signaling induces a state of anergy or antigen unresponsiveness in T cells, mediated through calcineurin and the transcription factor NFAT. We show here that Ca2+-induced anergy is a multistep program that is implemented at least partly through proteolytic degradation of specific signaling proteins. Calcineurin increased mRNA and protein of the E3 ubiquitin ligases Itch, Cbl-b and GRAIL and induced expression of Tsg101, the ubiquitin-binding component of the ESCRT-1 endosomal sorting complex. Subsequent stimulation or homotypic cell adhesion promoted membrane translocation of Itch and the related protein Nedd4, resulting in degradation of two key signaling proteins, PKC-theta and PLC-gamma1. T cells from Itch- and Cbl-b-deficient mice were resistant to anergy induction. Anergic T cells showed impaired calcium mobilization after TCR triggering and were unable to maintain a mature immunological synapse, instead showing late disorganization of the outer ring containing lymphocyte function-associated antigen 1. Our results define a complex molecular program that links gene transcription induced by calcium and calcineurin to a paradoxical impairment of signal transduction in anergic T cells.	Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; NYU, Sch Med, Program Mol Pathogenesis, New York, NY 10016 USA; NYU, Sch Med, Dept Pathol, Skirball Inst Mol Med, New York, NY 10016 USA; La Jolla Inst Allergy & Immunol, Div Cell Biol, San Diego, CA 92121 USA; Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; New York University; New York University; La Jolla Institute for Immunology; Columbia University	Rao, A (corresponding author), Harvard Univ, Sch Med, Ctr Blood Res, 200 Longwood Ave, Boston, MA 02115 USA.	arao@cbr.med.harvard.edu	Im, Sin-Hyeog/AAM-9586-2021; Im, Sin-Hyeog/E-6811-2013; Dustin, Michael/AAM-4611-2020; Varma, Rajat/I-1209-2012; Feske, stefan/ABB-3554-2021	Im, Sin-Hyeog/0000-0002-3173-1856; Im, Sin-Hyeog/0000-0002-3173-1856; Varma, Rajat/0000-0001-5131-0402; Feske, stefan/0000-0001-5431-8178; Heissmeyer, Vigo/0000-0002-2263-8545; LIU, YUN-CAI/0000-0002-0996-7109; Macian, Fernando/0000-0003-2666-035X; Dustin, Michael/0000-0003-4983-6389	NIAID NIH HHS [R01 AI 50280, AI 43542, R21 AI 48542, R01 AI 40127, R01 AI 48213] Funding Source: Medline; NICHD NIH HHS [R03 HD 39685] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD039685] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI048542, R01AI050280, R01AI040127, R01AI043542, R01AI048213, R37AI043542] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anandasabapathy N, 2003, IMMUNITY, V18, P535, DOI 10.1016/S1074-7613(03)00084-0; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Boussiotis VA, 1997, SCIENCE, V278, P124, DOI 10.1126/science.278.5335.124; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Courbard JR, 2002, J BIOL CHEM, V277, P45267, DOI 10.1074/jbc.M206460200; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; GAJEWSKI TF, 1994, P NATL ACAD SCI USA, V91, P38, DOI 10.1073/pnas.91.1.38; Glynne R, 2000, NATURE, V403, P672, DOI 10.1038/35001102; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Irvin BJ, 2000, MOL CELL BIOL, V20, P9149, DOI 10.1128/MCB.20.24.9149-9161.2000; Ishida D, 2003, P NATL ACAD SCI USA, V100, P10919, DOI 10.1073/pnas.1834525100; Kaji T, 2003, J BIOL CHEM, V278, P27836, DOI 10.1074/jbc.M212820200; Katagiri K, 2002, MOL CELL BIOL, V22, P1001, DOI 10.1128/MCB.22.4.1001-1015.2002; Katagiri K, 2000, MOL CELL BIOL, V20, P1956, DOI 10.1128/MCB.20.6.1956-1969.2000; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Khoshnan A, 2000, J IMMUNOL, V165, P6933, DOI 10.4049/jimmunol.165.12.6933; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; Korthauer U, 2000, J IMMUNOL, V164, P308, DOI 10.4049/jimmunol.164.1.308; Kowanetz K, 2003, J BIOL CHEM, V278, P39735, DOI 10.1074/jbc.M304541200; Lechner O, 2001, CURR BIOL, V11, P587, DOI 10.1016/S0960-9822(01)00160-9; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; Plant PJ, 2000, J CELL BIOL, V149, P1473, DOI 10.1083/jcb.149.7.1473; Rao N, 2002, J LEUKOCYTE BIOL, V71, P753; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; Seto ES, 2002, GENE DEV, V16, P1314, DOI 10.1101/gad.989602; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Suga K, 2001, FEBS LETT, V489, P249, DOI 10.1016/S0014-5793(00)02222-5; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Valitutti S, 1997, J EXP MED, V185, P1859, DOI 10.1084/jem.185.10.1859; Wells AD, 2003, J IMMUNOL, V170, P4127, DOI 10.4049/jimmunol.170.8.4127; Yokoi N, 2002, NAT GENET, V31, P391, DOI 10.1038/ng927	51	422	443	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2004	5	3					255	265		10.1038/ni1047	http://dx.doi.org/10.1038/ni1047			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	779ZV	14973438				2022-12-18	WOS:000189344600008
J	Liu, PS; Wang, HP; Li, XY; Chao, T; Christen, TTS; Christen, S; Di Conza, G; Cheng, WC; Chou, CH; Vavakova, M; Muret, C; Debackere, K; Mazzone, M; Huang, HD; Fendt, SM; Ivanisevic, J; Ho, PC				Liu, Pu-Ste; Wang, Haiping; Li, Xiaoyun; Chao, Tung; Teav, Tony; Christen, Stefan; Di Conza, Giusy; Cheng, Wan-Chen; Chou, Chih-Hung; Vavakova, Magdalena; Muret, Charlotte; Debackere, Koen; Mazzone, Massimiliano; Huang, Hsien-Da; Fendt, Sarah-Maria; Ivanisevic, Julijana; Ho, Ping-Chih			alpha-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; ALTERNATIVE ACTIVATION; ENDOTOXIN TOLERANCE; HUMAN MONOCYTES; STEM-CELLS; POLARIZATION; IMMUNOMETABOLISM; INFLAMMATION; CONTRIBUTES; EXPRESSION	Glutamine metabolism provides synergistic support for macrophage activation and elicitation of desirable immune responses; however, the underlying mechanisms regulated by glutamine metabolism to orchestrate macrophage activation remain unclear. Here we show that the production of alpha-ketoglutarate (alpha KG) via glutaminolysis is important for alternative (M2) activation of macrophages, including engagement of fatty acid oxidation (FAO) and Jmjd3-dependent epigenetic reprogramming of M2 genes. This M2-promoting mechanism is further modulated by a high alpha KG/succinate ratio, whereas a low ratio strengthens the proinflammatory phenotype in classically activated (M1) macrophages. As such, aKG contributes to endotoxin tolerance after M1 activation. This study reveals new mechanistic regulations by which glutamine metabolism tailors the immune responses of macrophages through metabolic and epigenetic reprogramming.	[Liu, Pu-Ste; Wang, Haiping; Li, Xiaoyun; Chao, Tung; Di Conza, Giusy; Cheng, Wan-Chen; Vavakova, Magdalena; Muret, Charlotte; Ho, Ping-Chih] Univ Lausanne, Fac Biol & Med, Dept Fundamental Oncol, Epalinges, Switzerland; [Liu, Pu-Ste; Wang, Haiping; Li, Xiaoyun; Chao, Tung; Di Conza, Giusy; Cheng, Wan-Chen; Vavakova, Magdalena; Muret, Charlotte; Ho, Ping-Chih] Ludwig Lausanne Branch, Epalinges, Switzerland; [Teav, Tony; Ivanisevic, Julijana] Univ Lausanne, Fac Biol & Med, Metabol Unit, Lausanne, Switzerland; [Christen, Stefan; Fendt, Sarah-Maria] VIB, Ctr Canc Biol, Lab Cellular Metab & Metab Regulat, Leuven, Belgium; [Christen, Stefan; Fendt, Sarah-Maria] Katholieke Univ Leuven, Dept Oncol, Lab Cellular Metab & Metab Regulat, Leuven, Belgium; [Christen, Stefan; Fendt, Sarah-Maria] Leuven Canc Inst LKI, Leuven, Belgium; [Chou, Chih-Hung; Huang, Hsien-Da] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Chou, Chih-Hung; Huang, Hsien-Da] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Debackere, Koen; Mazzone, Massimiliano] VIB, Vesalius Res Ctr, Lab Tumor Inflammat & Angiogenesis, Leuven, Belgium; [Debackere, Koen; Mazzone, Massimiliano] Katholieke Univ Leuven, Dept Oncol, Lab Tumor Inflammat & Angiogenesis, Leuven, Belgium	University of Lausanne; University of Lausanne; Flanders Institute for Biotechnology (VIB); KU Leuven; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Flanders Institute for Biotechnology (VIB); KU Leuven	Ho, PC (corresponding author), Univ Lausanne, Fac Biol & Med, Dept Fundamental Oncol, Epalinges, Switzerland.; Ho, PC (corresponding author), Ludwig Lausanne Branch, Epalinges, Switzerland.	ping-chih.ho@unil.ch	Huang, Hsien-Da/AAA-7376-2019; Ivanisevic, Julijana/AAT-3901-2021; Chou, Chih-Hung/K-9077-2015; Di Conza, Giusy/AAU-9661-2020; Di Conza, Giusy/GPP-1438-2022; Liu, Po-Tsun/C-4774-2019	Ivanisevic, Julijana/0000-0001-8267-2705; Chou, Chih-Hung/0000-0001-5714-1718; Liu, Po-Tsun/0000-0001-8560-3668; Debackere, Koen/0000-0002-7701-326X; Ho, Ping-Chih/0000-0003-3078-3774; Di Conza, Giusy/0000-0003-1353-5867; Fendt, Sarah-Maria/0000-0001-6018-9296; Chao, Tung/0000-0003-3641-4996; Mazzone, Massimiliano/0000-0001-8824-4015	Swiss National Science Foundation [31003A_163204]; Swiss Institute for Experimental Cancer Research [26075483]; Harry J. Lloyd Charitable Foundation; Swiss Cancer Foundation [KFS-3949-08-2016]; Melanoma Research Alliance Young Investigator Award; Flanders Research Foundation (FWO) research grant; Eugene Yourassowsky Schenking; University of Lausanne; Ministry of Science and Technology of Taiwan [MOST105-2627-M-009-007, MOST103-2628-B-009-001-MY3]; University of Lausanne FBM PhD fellowship; National scholarship program of the Slovak Republic	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Institute for Experimental Cancer Research; Harry J. Lloyd Charitable Foundation; Swiss Cancer Foundation; Melanoma Research Alliance Young Investigator Award; Flanders Research Foundation (FWO) research grant; Eugene Yourassowsky Schenking; University of Lausanne; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); University of Lausanne FBM PhD fellowship; National scholarship program of the Slovak Republic	We thank F. Cottard and C.-P. Lin for technical help and P. Romero and C. Hess for discussion. Supported by Swiss National Science Foundation project grant (31003A_163204), the Swiss Institute for Experimental Cancer Research (26075483), the Harry J. Lloyd Charitable Foundation, the Swiss Cancer Foundation (KFS-3949-08-2016) and a Melanoma Research Alliance Young Investigator Award to P.-C.H. S.-M. F. is supported by a Flanders Research Foundation (FWO) research grant and by Eugene Yourassowsky Schenking. J.I. is supported by the University of Lausanne. H.-D.H. is supported by the Ministry of Science and Technology of Taiwan (MOST105-2627-M-009-007 and MOST103-2628-B-009-001-MY3). T.C. is supported by a University of Lausanne FBM PhD fellowship. M.V. is supported by the National scholarship program of the Slovak Republic.	Altman BJ, 2016, NAT REV CANCER, V16, P619, DOI 10.1038/nrc.2016.71; Arts RJW, 2016, CELL METAB, V24, P807, DOI 10.1016/j.cmet.2016.10.008; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981; Chen J, 2010, P NATL ACAD SCI USA, V107, P19438, DOI 10.1073/pnas.1007816107; Cheng SC, 2016, NAT IMMUNOL, V17, P406, DOI 10.1038/ni.3398; Christen S, 2016, CELL REP, V17, P837, DOI 10.1016/j.celrep.2016.09.042; Clever D, 2016, CELL, V166, P1117, DOI 10.1016/j.cell.2016.07.032; Covarrubias AJ, 2016, ELIFE, V5, DOI 10.7554/eLife.11612; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; del Fresno C, 2005, J IMMUNOL, V174, P3032, DOI 10.4049/jimmunol.174.5.3032; Fendt SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3236; Fraisl P, 2009, NAT REV DRUG DISCOV, V8, P139, DOI 10.1038/nrd2761; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Ho PC, 2012, NAT IMMUNOL, V13, P379, DOI 10.1038/ni.2238; Huang SCC, 2016, IMMUNITY, V45, P817, DOI 10.1016/j.immuni.2016.09.016; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Ivashkiv LB, 2013, TRENDS IMMUNOL, V34, P216, DOI 10.1016/j.it.2012.11.001; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Liu LL, 2016, P NATL ACAD SCI USA, V113, P1564, DOI 10.1073/pnas.1518000113; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Pan DN, 2015, DEV CELL, V35, DOI 10.1016/j.devcel.2015.11.002; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Sawhney S, 2001, ARCH DIS CHILD, V85, P421, DOI 10.1136/adc.85.5.421; Shalova IN, 2015, IMMUNITY, V42, P484, DOI 10.1016/j.immuni.2015.02.001; Su XD, 2015, NAT IMMUNOL, V16, P838, DOI 10.1038/ni.3205; Takeda Y, 2011, NATURE, V479, P122, DOI 10.1038/nature10507; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; TeSlaa T, 2016, CELL METAB, V24, P485, DOI 10.1016/j.cmet.2016.07.002; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Ye D, 2013, CANCER CELL, V23, P274, DOI 10.1016/j.ccr.2013.03.005; Zhang Q, 2015, NATURE, V525, P389, DOI 10.1038/nature15252	45	421	437	31	131	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2017	18	9					985	+		10.1038/ni.3796	http://dx.doi.org/10.1038/ni.3796			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FE3TD	28714978	Green Accepted			2022-12-18	WOS:000408137700008
J	Trowsdale, J; Betz, AG				Trowsdale, J; Betz, AG			Mother's little helpers: mechanisms of maternal-fetal tolerance	NATURE IMMUNOLOGY			English	Review							REGULATORY T-CELLS; NATURAL-KILLER-CELLS; HLA-G; AUTOIMMUNE-DISEASES; HUMAN TROPHOBLASTS; DENDRITIC CELLS; SELF-TOLERANCE; PREGNANCY; ANTIGEN; RECEPTORS	The evolutionary adaptation in mammals that allows implantation of their embryos in the mother's womb creates an immunological problem. Although it ensures optimal nourishment and protection of the fetus throughout its early development, intimate contact with the mother's uterine tissue makes the fetus a potential target for her immune system. As half the fetal genes are derived from the father, the developing embryo and placenta must be considered a 'semi-allograft'. Such a mismatched organ transplant would be readily rejected without powerful immune suppression. During pregnancy, however, the semi-allogeneic fetus is protected from assault by the maternal immune system over an extended period of time. The mother's immune system seems to recognize the fetus as 'temporary self'. How this feat is managed is key to understanding immunological tolerance and intervention in treating disease.	MRC, Lab Mol Biol Prot & Nucl Acid Chem, Cambridge CB2 2QH, England; Univ Cambridge, Dept Pathol, Div Immunol, Cambridge CB2 1QP, England	University of Cambridge	Betz, AG (corresponding author), MRC, Lab Mol Biol Prot & Nucl Acid Chem, Cambridge CB2 2QH, England.	betz@mrc-lmb.cam.ac.uk	Betz, Alexander/GQQ-2221-2022		MRC [G9800943, G0401569, MC_U105184296] Funding Source: UKRI; Medical Research Council [G0401569, G9800943, MC_U105184296] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Abrahams VM, 2005, PLACENTA, V26, P540, DOI 10.1016/j.placenta.2004.08.010; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Aoki K, 2001, NAT IMMUNOL, V2, P333, DOI 10.1038/86336; Arck PC, 1997, AM J REPROD IMMUNOL, V37, P492; Ashkar AA, 2003, J IMMUNOL, V171, P2937, DOI 10.4049/jimmunol.171.6.2937; Baban B, 2004, J REPROD IMMUNOL, V61, P67, DOI 10.1016/j.jri.2003.11.003; BARTRAMS J, 1971, BIBL HAEMATOL, V37, P98; Beagley KW, 2003, FEMS IMMUNOL MED MIC, V38, P13, DOI 10.1016/S0928-8244(03)00202-5; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; Blois S, 2004, AM J REPROD IMMUNOL, V51, P40, DOI 10.1046/j.8755-8920.2003.00120.x; BRAMBELL FWR, 1951, ANTIBODIES EMBRYOS; Chang CC, 2002, NAT IMMUNOL, V3, P237, DOI 10.1038/ni760; CHAOUAT G, 1979, J IMMUNOL, V122, P1383; CHAOUAT G, 1977, ANN INST PASTEUR IMM, VC128, P21; Collins KL, 1999, IMMUNOL REV, V168, P65, DOI 10.1111/j.1600-065X.1999.tb01283.x; Colonna M, 1999, J LEUKOCYTE BIOL, V66, P375, DOI 10.1002/jlb.66.3.375; CONDREA P, 1961, Arch Roum Pathol Exp Microbiol, V20, P549; EICHMANN K, 1988, SCAND J IMMUNOL, V28, P273, DOI 10.1111/j.1365-3083.1988.tb01448.x; Fallon PG, 2002, IMMUNITY, V17, P7, DOI 10.1016/S1074-7613(02)00332-1; Ferguson TA, 1997, IMMUNOL REV, V156, P167, DOI 10.1111/j.1600-065X.1997.tb00967.x; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fruh K, 1999, IMMUNOL REV, V168, P157, DOI 10.1111/j.1600-065X.1999.tb01290.x; GODFREY VL, 1991, P NATL ACAD SCI USA, V88, P5528, DOI 10.1073/pnas.88.13.5528; GOODFELLOW PN, 1976, TRANSPLANTATION, V22, P595, DOI 10.1097/00007890-197612000-00009; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; HAQUE A, 1982, NATURE, V299, P361, DOI 10.1038/299361a0; HEARD DH, 1949, J HYG-CAMBRIDGE, V47, P119, DOI 10.1017/S0022172400014376; Heikkinen J, 2004, CLIN EXP IMMUNOL, V136, P373, DOI 10.1111/j.1365-2249.2004.02441.x; Hiby SE, 2004, J EXP MED, V200, P957, DOI 10.1084/jem.20041214; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hunt JS, 1997, J IMMUNOL, V158, P4122; Huppertz B, 2004, J SOC GYNECOL INVEST, V11, P353, DOI 10.1016/j.jsgi.2004.06.002; Ishitani A, 1999, IMMUNOGENETICS, V49, P808, DOI 10.1007/s002510050555; Jin LP, 2004, J IMMUNOL, V173, P3612, DOI 10.4049/jimmunol.173.6.3612; KAMIMURA S, 1991, ACTA MED OKAYAMA, V45, P135; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; KOVATS S, 1990, SCIENCE, V248, P220, DOI 10.1126/science.2326636; LIN H, 1993, J IMMUNOL, V151, P4562; MATTSSON R, 1991, CLIN EXP IMMUNOL, V85, P41, DOI 10.1111/j.1365-2249.1991.tb05679.x; Mattsson R, 1998, AM J REPROD IMMUNOL, V40, P383, DOI 10.1111/j.1600-0897.1998.tb00422.x; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; MEDAWAR PB, 1978, NATURE, V271, P164, DOI 10.1038/271164a0; MEDAWAR PB, 1953, SYM SOC EXP BIOL, V7, P320; MEDAWAR PB, 1956, J ENDOCRINOL, V14, P240, DOI 10.1677/joe.0.0140240; Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886; MOLLER G, 1988, SCAND J IMMUNOL, V27, P247, DOI 10.1111/j.1365-3083.1988.tb02344.x; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Navarro F, 1999, EUR J IMMUNOL, V29, P277, DOI 10.1002/(SICI)1521-4141(199901)29:01<277::AID-IMMU277>3.0.CO;2-4; Nelson JL, 2003, AUTOIMMUNITY, V36, P5, DOI 10.1080/0891693031000067304; Ostensen M, 2002, TRANSPL IMMUNOL, V9, P155, DOI 10.1016/S0966-3274(02)00017-5; OWEN RD, 1945, SCIENCE, V102, P400, DOI 10.1126/science.102.2651.400; Parham P, 2004, J EXP MED, V200, P951, DOI 10.1084/jem.20041783; Pearson H, 2002, NATURE, V420, P265, DOI 10.1038/420265a; PEYMAN JA, 1992, TRANSPLANT P, V24, P470; Piccinni MP, 1998, NAT MED, V4, P1020, DOI 10.1038/2006; Rajagopalan S, 1999, J EXP MED, V189, P1093, DOI 10.1084/jem.189.7.1093; RAJAGOPALAN S, 2006, IN PRESS PLOS BIOL; ROONEY IA, 1993, IMMUNOL RES, V12, P276, DOI 10.1007/BF02918258; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; SAKAGUCHI S, 1985, J EXP MED, V161, P72, DOI 10.1084/jem.161.1.72; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sasaki Y, 2004, MOL HUM REPROD, V10, P347, DOI 10.1093/molehr/gah044; Shao L, 2005, J IMMUNOL, V174, P7539, DOI 10.4049/jimmunol.174.12.7539; Shiroishi M, 2003, P NATL ACAD SCI USA, V100, P8856, DOI 10.1073/pnas.1431057100; Somerset DA, 2004, IMMUNOLOGY, V112, P38, DOI 10.1111/j.1365-2567.2004.01869.x; Stallmach T, 2004, VIRCHOWS ARCH, V445, P9, DOI 10.1007/s00428-004-1032-2; Streilein JW, 1996, TRANSPLANT P, V28, P2066; TAFURI A, 1995, SCIENCE, V270, P630, DOI 10.1126/science.270.5236.630; van den Elsen PJ, 2004, CURR OPIN IMMUNOL, V16, P67, DOI 10.1016/j.coi.2003.11.015; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Xu CG, 2000, SCIENCE, V287, P498, DOI 10.1126/science.287.5452.498; Zenclussen AC, 2005, J REPROD IMMUNOL, V65, P101, DOI 10.1016/j.jri.2005.01.003	74	421	443	4	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2006	7	3					241	246		10.1038/ni1317	http://dx.doi.org/10.1038/ni1317			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	012SR	16482172				2022-12-18	WOS:000235360400008
J	Mansell, A; Smith, R; Doyle, SL; Gray, P; Fenner, JE; Crack, PJ; Nicholson, SE; Hilton, DJ; O'Neill, LAJ; Hertzog, PJ				Mansell, A; Smith, R; Doyle, SL; Gray, P; Fenner, JE; Crack, PJ; Nicholson, SE; Hilton, DJ; O'Neill, LAJ; Hertzog, PJ			Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; BRUTONS TYROSINE KINASE; INDUCED STAT INHIBITOR; SOCS PROTEINS; ACTIVATION; LIPOPOLYSACCHARIDE; TLR4; BOX; PHOSPHORYLATION; TRANSDUCTION	Toll-like receptor (TLR) signals that initiate innate immune responses to pathogens must be tightly regulated to prevent excessive inflammatory damage to the host. The adaptor protein Mal is specifically involved in signaling via TLR2 and TLR4. We demonstrate here that after TLR2 and TLR4 stimulation Mal becomes phosphorylated by Bruton's tyrosine kinase (Btk) and then interacts with SOCS-1, which results in Mal polyubiquitination and subsequent degradation. Removal of SOCS-1 regulation potentiates Mal-dependent p65 phosphorylation and transactivation of NF-kappa B, leading to amplified inflammatory responses. These data identify a target of SOCS-1 that regulates TLR signaling via a mechanism distinct from an autocrine cytokine response. The transient activation of Mal and subsequent SOCS-1-mediated degradation is a rapid and selective means of limiting primary innate immune response.	Monash Univ, Monash Inst Med Res, Ctr Funct Genom & Human Dis, Melbourne, Vic, Australia; Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland; Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia	Monash University; Trinity College Dublin; Walter & Eliza Hall Institute	Hertzog, PJ (corresponding author), Monash Univ, Monash Inst Med Res, Ctr Funct Genom & Human Dis, Melbourne, Vic, Australia.	paul.hertzog@med.monash.edu.au	Hertzog, Paul J/G-6734-2013; Mansell, Ashley/B-9553-2008; Hilton, Douglas J/C-7250-2013; Doyle, Sarah/C-1453-2014; Hertzog, Paul J/I-7053-2013; Crack, Peter/ABE-2065-2020; Crack, Peter J/A-1980-2011	Hertzog, Paul J/0000-0002-1373-8472; Mansell, Ashley/0000-0002-6540-1281; Hilton, Douglas J/0000-0002-7698-2392; Hertzog, Paul J/0000-0002-1373-8472; Crack, Peter/0000-0002-5030-0330; O'Neill, Luke/0000-0002-4333-2748; , Sandra/0000-0002-1314-2134; Doyle, Sarah/0000-0002-6294-9380				Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Baetz A, 2004, J BIOL CHEM, V279, P54708, DOI 10.1074/jbc.M410992200; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Doyle SL, 2005, J BIOL CHEM, V280, P23496, DOI 10.1074/jbc.C500053200; Dunne A, 2005, FEBS LETT, V579, P3330, DOI 10.1016/j.febslet.2005.04.024; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Fenner JE, 2006, NAT IMMUNOL, V7, P33, DOI 10.1038/ni1287; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Gingras S, 2004, J BIOL CHEM, V279, P54702, DOI 10.1074/jbc.M411043200; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Inagaki-Ohara K, 2003, CURR OPIN PHARMACOL, V3, P435, DOI 10.1016/S1471-4892(03)00070-5; Janssens S, 2003, FEBS LETT, V548, P103, DOI 10.1016/S0014-5793(03)00747-6; Kamizono S, 2001, J BIOL CHEM, V276, P12530, DOI 10.1074/jbc.M010074200; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Mansell A, 2004, J BIOL CHEM, V279, P37227, DOI 10.1074/jbc.C400289200; Naiki Y, 2005, J BIOL CHEM, V280, P5491, DOI 10.1074/jbc.C400503200; Naka T, 1999, TRENDS BIOCHEM SCI, V24, P394, DOI 10.1016/S0968-0004(99)01454-1; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Nicholson SE, 1999, EMBO J, V18, P375, DOI 10.1093/emboj/18.2.375; O'Neill LAJ, 2003, TRENDS IMMUNOL, V24, P287, DOI 10.1016/S1471-4906(03)00115-7; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Sanaa N, 2004, J BIOL CHEM, V279, P25189, DOI 10.1074/jbc.M312431200; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Sweet MJ, 2001, J IMMUNOL, V166, P6633, DOI 10.4049/jimmunol.166.11.6633; TAKEDA K, 2003, ANN REV IMMUNOL, V21; Vermeulen L, 2002, BIOCHEM PHARMACOL, V64, P963, DOI 10.1016/S0006-2952(02)01161-9; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540; Yoshimura A, 2004, J LEUKOCYTE BIOL, V75, P422, DOI 10.1189/jlb.0403194; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071	42	421	456	2	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2006	7	2					148	155		10.1038/ni1299	http://dx.doi.org/10.1038/ni1299			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	005DB	16415872				2022-12-18	WOS:000234801700015
J	Neutra, MR; Mantis, NJ; Kraehenbuhl, JP				Neutra, MR; Mantis, NJ; Kraehenbuhl, JP			Collaboration of epithelial cells with organized mucosal lymphoid tissues	NATURE IMMUNOLOGY			English	Review							FOLLICLE-ASSOCIATED EPITHELIUM; MOUSE PEYERS-PATCHES; INTESTINAL M-CELLS; HUMAN-IMMUNODEFICIENCY-VIRUS; DENDRITIC CELLS; YERSINIA-PSEUDOTUBERCULOSIS; IMMUNE-RESPONSES; DISTINCT ROLES; DEFICIENT MICE; LECTIN-BINDING	Immune surveillance of mucosal surfaces requires the delivery of intact macromolecules and microorganisms across epithelial barriers to organized mucosal lymphoid tissues. Transport, processing and presentation of foreign antigens, as well as local induction and clonal expansion of antigen-specific effector lymphocytes, involves a close collaboration between organized lymphoid tissues and the specialized follicle-associated epithelium. M cells in the follicle-associated epithelium transport foreign macromolecules and microorganisms to antigen-presenting cells within and under the epithelial barrier. Determination of the earliest cellular interactions that occur in and under the follicle-associated epithelium could greatly facilitate the design of effective mucosal vaccines in the future.	Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Lausanne, Inst Biochem, CH-1066 Epalinges, Switzerland; Univ Lausanne, Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Lausanne; Swiss Institute Experimental Cancer Research; University of Lausanne	Neutra, MR (corresponding author), Childrens Hosp, Enders 1220,300 Longwood Ave, Boston, MA 02115 USA.	marion.neutra@tch.harvard.edu		Mantis, Nicholas/0000-0002-5083-8640				ALLAN CH, 1991, GASTROENTEROLOGY, V100, P1172; ANDINO R, 1994, SCIENCE, V265, P1448, DOI 10.1126/science.8073288; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BARGATZE RF, 1995, IMMUNITY, V3, P99, DOI 10.1016/1074-7613(95)90162-0; BHALLA DK, 1983, CELL IMMUNOL, V81, P105, DOI 10.1016/0008-8749(83)90216-2; BIENENSTOCK J, 1999, MUCOSAL IMMUNOLOGY, P283; Borghesi C, 1999, LAB INVEST, V79, P1393; Brandtzaeg P, 1999, IMMUNOL TODAY, V20, P141, DOI 10.1016/S0167-5699(98)01413-3; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; BYE WA, 1984, GASTROENTEROLOGY, V86, P789; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; CHEN JZ, 1993, INT IMMUNOL, V5, P647, DOI 10.1093/intimm/5.6.647; Clark MA, 1998, INFECT IMMUN, V66, P1237, DOI 10.1128/IAI.66.3.1237-1243.1998; COOK DG, 1994, VIROLOGY, V201, P206, DOI 10.1006/viro.1994.1287; Cook DN, 2000, IMMUNITY, V12, P495, DOI 10.1016/S1074-7613(00)80201-0; Corthesy B, 1996, J BIOL CHEM, V271, P33670, DOI 10.1074/jbc.271.52.33670; Czerkinsky C, 1999, IMMUNOL REV, V170, P197, DOI 10.1111/j.1600-065X.1999.tb01339.x; Debard N, 2001, GASTROENTEROLOGY, V120, P1173, DOI 10.1053/gast.2001.22476; ERMAK TH, 1994, AM J TROP MED HYG, V50, P14; ERMAK TH, 1990, IMMUNOLOGY, V71, P530; FARSTAD IN, 1994, IMMUNOLOGY, V83, P457; FINZI G, 1993, HISTOCHEMISTRY, V99, P201, DOI 10.1007/BF00269138; Forstner Janet F., 1995, P71; Frey A, 1996, J EXP MED, V184, P1045, DOI 10.1084/jem.184.3.1045; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Gebert A, 1996, INT REV CYTOL, V167, P91, DOI 10.1016/S0074-7696(08)61346-7; GEBERT A, 1993, GASTROENTEROLOGY, V105, P1350, DOI 10.1016/0016-5085(93)90139-4; Gebert A, 1999, AM J PATHOL, V154, P1573, DOI 10.1016/S0002-9440(10)65410-7; GEBERT A, 1992, CELL TISSUE RES, V269, P331, DOI 10.1007/BF00319625; GIANNASCA PJ, 1994, AM J PHYSIOL-GASTR L, V267, pG1108, DOI 10.1152/ajpgi.1994.267.6.G1108; Giannasca PJ, 1999, INFECT IMMUN, V67, P946, DOI 10.1128/IAI.67.2.946-953.1999; Golovkina TV, 1999, SCIENCE, V286, P1965, DOI 10.1126/science.286.5446.1965; Hantman M.J., 1999, MUCOSAL IMMUNOLOGY, P779; Hein WR, 1999, CURR TOP MICROBIOL, V236, P1; Hopkins SA, 2000, CELL MICROBIOL, V2, P59; Huang GTJ, 1996, J CLIN INVEST, V98, P572, DOI 10.1172/JCI118825; Iwasaki A, 1999, AM J PHYSIOL-GASTR L, V276, pG1074, DOI 10.1152/ajpgi.1999.276.5.G1074; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Iwasaki A, 2001, J IMMUNOL, V166, P4884, DOI 10.4049/jimmunol.166.8.4884; Izadpanah A, 2001, AM J PHYSIOL-GASTR L, V280, pG710, DOI 10.1152/ajpgi.2001.280.4.G710; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Kagnoff MF, 1997, J CLIN INVEST, V100, P6, DOI 10.1172/JCI119522; Kellermann SA, 2001, J IMMUNOL, V167, P682, DOI 10.4049/jimmunol.167.2.682; Kelsall B, 1999, MUCOSAL IMMUNOLOGY, P293; Kelsall BL, 1996, J EXP MED, V183, P237, DOI 10.1084/jem.183.1.237; Kerneis S, 1997, SCIENCE, V277, P949, DOI 10.1126/science.277.5328.949; KITAMURA D, 1992, NATURE, V356, P154, DOI 10.1038/356154a0; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; Kraehenbuhl JP, 2000, ANNU REV CELL DEV BI, V16, P301, DOI 10.1146/annurev.cellbio.16.1.301; Kuprash DV, 1999, J IMMUNOL, V163, P6575; Lamm ME, 1997, ANNU REV MICROBIOL, V51, P311, DOI 10.1146/annurev.micro.51.1.311; Lelouard H, 1999, INFECT IMMUN, V67, P357, DOI 10.1128/IAI.67.1.357-367.1999; Lelouard H, 2001, J CELL SCI, V114, P2077; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJS, 2001, NAT IMMUNOL, V2, P625, DOI 10.1038/89775; Madara J L, 1990, Monogr Pathol, P306; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; Mantis NJ, 2000, AM J PHYSIOL-GASTR L, V278, pG915, DOI 10.1152/ajpgi.2000.278.6.G915; Maric I, 1996, J IMMUNOL, V156, P1408; Marra A, 1997, INFECT IMMUN, V65, P3412, DOI 10.1128/IAI.65.8.3412-3421.1997; Masurier C, 1998, J VIROL, V72, P7822, DOI 10.1128/JVI.72.10.7822-7829.1998; MAURY J, 1995, EUR J BIOCHEM, V228, P323; MCCLUGAGE SG, 1986, GASTROENTEROLOGY, V91, P1128, DOI 10.1016/S0016-5085(86)80007-5; McGhee J. R., 1999, MUCOSAL IMMUNOLOGY, P485; MOWAT AM, 1999, MUCOSAL IMMUNOLOGY, P587; MOXEY PC, 1979, ANAT RECORD, V195, P462, DOI 10.1002/ar.1091950307; Neutra Marian R., 1995, P163; Neutra MR, 1996, CELL, V86, P345, DOI 10.1016/S0092-8674(00)80106-3; Neutra MR, 1999, SEMIN IMMUNOL, V11, P171, DOI 10.1006/smim.1999.0173; NEUTRA MR, 1987, CELL TISSUE RES, V247, P537, DOI 10.1007/BF00215747; Neutra MR, 1996, ANNU REV IMMUNOL, V14, P275, DOI 10.1146/annurev.immunol.14.1.275; OLEARY AD, 1986, HISTOPATHOLOGY, V10, P267, DOI 10.1111/j.1365-2559.1986.tb02481.x; Ouellette AJ, 1996, FASEB J, V10, P1280, DOI 10.1096/fasebj.10.11.8836041; OWEN RL, 1983, AM J ANAT, V168, P199, DOI 10.1002/aja.1001680207; Owen RL, 1999, SEMIN IMMUNOL, V11, P157, DOI 10.1006/smim.1999.0171; PAPPO J, 1988, GASTROENTEROLOGY, V95, P1173, DOI 10.1016/0016-5085(88)90347-2; Phalipon A, 1999, CURR TOP MICROBIOL, V236, P163; Pron B, 2001, CELL MICROBIOL, V3, P331, DOI 10.1046/j.1462-5822.2001.00120.x; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; ROY MJ, 1987, CELL TISSUE RES, V248, P645, DOI 10.1007/BF00216495; Ruedl C, 1996, EUR J IMMUNOL, V26, P1801, DOI 10.1002/eji.1830260821; Sakamoto N, 2001, EUR J IMMUNOL, V31, P1310, DOI 10.1002/1521-4141(200105)31:5<1310::AID-IMMU1310>3.0.CO;2-N; SAVIDGE TC, 1995, ADV EXP MED BIOL, V371, P239; Schon MP, 1999, J IMMUNOL, V162, P6641; Schulte R, 2000, CELL MICROBIOL, V2, P173, DOI 10.1046/j.1462-5822.2000.00047.x; Sharma R, 1996, HISTOCHEM CELL BIOL, V105, P459, DOI 10.1007/BF01457659; Shibuya A, 2000, NAT IMMUNOL, V1, P441, DOI 10.1038/80886; SICINSKI P, 1990, GASTROENTEROLOGY, V98, P56, DOI 10.1016/0016-5085(90)91290-M; Siebers A, 1996, TRENDS MICROBIOL, V4, P22, DOI 10.1016/0966-842X(96)81501-0; Sierro F, 2000, GASTROENTEROLOGY, V119, P734, DOI 10.1053/gast.2000.16481; SIERRO F, 2001, IN PRESS P NATL ACAD; SILVEY K, 1999, IMMUNOL LETT, V69; Tanaka Y, 1999, EUR J IMMUNOL, V29, P633, DOI 10.1002/(SICI)1521-4141(199902)29:02<633::AID-IMMU633>3.0.CO;2-I; UEKI T, 1995, ACTA MED OKAYAMA, V49, P145; WELTZIN R, 1989, J CELL BIOL, V108, P1673, DOI 10.1083/jcb.108.5.1673; Wurbel MA, 2000, EUR J IMMUNOL, V30, P262, DOI 10.1002/1521-4141(200001)30:1<262::AID-IMMU262>3.0.CO;2-0; Yamanaka T, 2001, EUR J IMMUNOL, V31, P107, DOI 10.1002/1521-4141(200101)31:1<107::AID-IMMU107>3.0.CO;2-4; ZHOU F, 1995, VACCINE, V13, P637, DOI 10.1016/0264-410X(94)00029-M	100	421	441	2	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2001	2	11					1004	1009		10.1038/ni1101-1004	http://dx.doi.org/10.1038/ni1101-1004			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	490JY	11685223				2022-12-18	WOS:000172049800012
J	Avni, O; Lee, D; Macian, F; Szabo, SJ; Glimcher, LH; Rao, A				Avni, O; Lee, D; Macian, F; Szabo, SJ; Glimcher, LH; Rao, A			T-H cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR; IN-VIVO; COORDINATE REGULATOR; LINEAGE COMMITMENT; IMMUNE-SYSTEM; CUTTING EDGE; TH1 CELLS; IL-4; EXPRESSION; STAT6	Naive T cells differentiate into effector cells upon stimulation with antigen, a process that is accompanied by changes in the chromatin structure of effector cytokine genes. Using histone acetylation to evaluate these changes, we showed that T cell receptor (TCR) stimulation results in early activation of the genes encoding both interleukin 4 and interferon-gamma. We found that continued culture in the presence of polarizing cytokines established a selective pattern of histone acetylation on both cytokine genes; this correlated with restricted access of the transcription factor NFAT1 to these gene regulatory regions as well as mutually exclusive gene expression by the differentiated T cells. Our data point to a biphasic process in which cytokine- driven signaling pathways maintain and reinforce chromatin structural changes initiated by the TCR. This process ensures that cytokine genes remain accessible to the relevant transcription factors and promotes functional cooperation of the inducible transcription factor NFAT with lineage-specific transcription factors such as GATA-3 and T-bet.	Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Rao, A (corresponding author), Harvard Univ, Sch Med, Ctr Blood Res, 200 Longwood Ave, Boston, MA 02115 USA.			Macian, Fernando/0000-0003-2666-035X				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Avni O, 2000, CURR OPIN IMMUNOL, V12, P654, DOI 10.1016/S0952-7915(00)00158-8; Avots A, 1999, IMMUNITY, V10, P515, DOI 10.1016/S1074-7613(00)80051-5; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; CROFT M, 1995, J IMMUNOL, V154, P4269; Finkelman FD, 2000, J IMMUNOL, V164, P2303, DOI 10.4049/jimmunol.164.5.2303; Garcia-Rodriguez C, 1998, J EXP MED, V187, P2031, DOI 10.1084/jem.187.12.2031; Gingras S, 1999, NUCLEIC ACIDS RES, V27, P2722, DOI 10.1093/nar/27.13.2722; Glimcher LH, 2000, GENE DEV, V14, P1693; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; HENKEL G, 1994, P NATL ACAD SCI USA, V91, P7737, DOI 10.1073/pnas.91.16.7737; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Jankovic D, 2000, J IMMUNOL, V164, P3047, DOI 10.4049/jimmunol.164.6.3047; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KAMOGAWA Y, 1993, CELL, V75, P985, DOI 10.1016/0092-8674(93)90542-X; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; Kurata H, 1999, IMMUNITY, V11, P677, DOI 10.1016/S1074-7613(00)80142-9; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lederer JA, 1996, J EXP MED, V184, P397, DOI 10.1084/jem.184.2.397; Lee DU, 2002, IMMUNITY, V16, P649, DOI 10.1016/S1074-7613(02)00314-X; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Luo C, 1996, MOL CELL BIOL, V16, P3955; Macian F, 2000, EMBO J, V19, P4783, DOI 10.1093/emboj/19.17.4783; Mohrs M, 2001, NAT IMMUNOL, V2, P842, DOI 10.1038/ni0901-842; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Noben-Trauth N, 2000, J IMMUNOL, V165, P3620, DOI 10.4049/jimmunol.165.7.3620; O'Garra A, 2000, TRENDS CELL BIOL, V10, P542, DOI 10.1016/S0962-8924(00)01856-0; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Parekh BS, 1999, MOL CELL, V3, P125, DOI 10.1016/S1097-2765(00)80181-1; Ranganath S, 1998, J IMMUNOL, V161, P3822; Reiner SL, 2001, CURR OPIN IMMUNOL, V13, P351, DOI 10.1016/S0952-7915(00)00226-0; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; SOLYMAR DC, 2002, IN PRESS IMMUNITY; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Takemoto N, 2000, J IMMUNOL, V165, P6687, DOI 10.4049/jimmunol.165.12.6687; Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981; TEPPER RI, 1989, CELL, V57, P503, DOI 10.1016/0092-8674(89)90925-2; Wang DZ, 1995, ANN NY ACAD SCI, V766, P182, DOI 10.1111/j.1749-6632.1995.tb26661.x; Wurster AL, 2000, ONCOGENE, V19, P2577, DOI 10.1038/sj.onc.1203485; Zhang DH, 1999, IMMUNITY, V11, P473, DOI 10.1016/S1074-7613(00)80122-3; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	55	420	432	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2002	3	7					643	651		10.1038/ni808	http://dx.doi.org/10.1038/ni808			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	566RH	12055628				2022-12-18	WOS:000176441700014
J	Chinen, T; Kannan, AK; Levine, AG; Fan, XY; Klein, U; Zheng, Y; Gasteiger, G; Feng, YQ; Fontenot, JD; Rudensky, AY				Chinen, Takatoshi; Kannan, Arun K.; Levine, Andrew G.; Fan, Xiying; Klein, Ulf; Zheng, Ye; Gasteiger, Georg; Feng, Yongqiang; Fontenot, Jason D.; Rudensky, Alexander Y.			An essential role for the IL-2 receptor in T-reg cell function	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR FOXP3; IN-VIVO; SUPPRESSOR FUNCTION; CUTTING EDGE; INTERLEUKIN-2; EXPRESSION; INDUCTION; LINEAGE; STAT5; GENE	Regulatory T cells (T-reg cells), which have abundant expression of the interleukin 2 receptor (IL-2R), are reliant on IL-2 produced by activated T cells. This feature indicates a key role for a simple network based on the consumption of IL-2 by T-reg cells in their suppressor function. However, congenital deficiency in IL-2R results in reduced expression of the T-reg cell lineage-specification factor Foxp3, which has confounded experimental efforts to understand the role of IL-2R expression and signaling in the suppressor function of T-reg cells. Using genetic gain-and loss-of-function approaches, we found that capture of IL-2 was dispensable for the control of CD4(+) T cells but was important for limiting the activation of CD8(+) T cells, and that IL-2R-dependent activation of the transcription factor STAT5 had an essential role in the suppressor function of T-reg cells separable from signaling via the T cell antigen receptor.	[Chinen, Takatoshi; Levine, Andrew G.; Fan, Xiying; Gasteiger, Georg; Feng, Yongqiang; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; [Chinen, Takatoshi; Levine, Andrew G.; Fan, Xiying; Gasteiger, Georg; Feng, Yongqiang; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA; [Kannan, Arun K.; Fontenot, Jason D.] Biogen, Immunol Discovery, Cambridge, MA USA; [Klein, Ulf] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Klein, Ulf] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Klein, Ulf] Columbia Univ, Dept Microbiol & Immunol, New York, NY USA; [Zheng, Ye] Salk Inst Biol Studies, Nomis Fdn, Labs Immunobiol & Microbial Pathogenesis, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Gasteiger, Georg] Johannes Gutenberg Univ Mainz, Med Ctr, Inst Med Microbiol & Hyg, Mainz, Germany; [Kannan, Arun K.] AbbVie, Biotechnol, N Chicago, IL 60064 USA; [Fontenot, Jason D.] Juno Therapeut, Exploratory Biol, Seattle, WA 98109 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Biogen; Columbia University; Columbia University; Columbia University; Salk Institute; Johannes Gutenberg University of Mainz; AbbVie	Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA.; Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA.; Fontenot, JD (corresponding author), Biogen, Immunol Discovery, Cambridge, MA USA.; Fontenot, JD (corresponding author), Juno Therapeut, Exploratory Biol, Seattle, WA 98109 USA.	jason.fontenot@junotherapeutics.com; rudenska@mskcc.org	Feng, Yongqiang/N-2731-2018; Feng, Yongqiang/AAR-7719-2021	Feng, Yongqiang/0000-0002-2320-5063; Feng, Yongqiang/0000-0002-2320-5063; Gasteiger, Georg/0000-0001-6986-127X; Fan, Xiying/0000-0003-3090-381X	Japan Society for the Promotion of Science; Lucille Castori Center for Microbes, Inflammation Cancer; US National Institutes of Health Medical Scientist Training Program [T32GM07739]; US National Institutes of Health [P30 CA008748, R37 AI034206]; DFG Emmy Noether programme; Ludwig Center at Memorial Sloan Kettering Cancer Center; Hilton-Ludwig Cancer Prevention Initiative - Conrad N. Hilton Foundation; Ludwig Cancer Research; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA014195, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F30AI122721, R01AI107027, R37AI034206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Lucille Castori Center for Microbes, Inflammation Cancer; US National Institutes of Health Medical Scientist Training Program; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG Emmy Noether programme(German Research Foundation (DFG)); Ludwig Center at Memorial Sloan Kettering Cancer Center; Hilton-Ludwig Cancer Prevention Initiative - Conrad N. Hilton Foundation; Ludwig Cancer Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Kitamura (The University of Tokyo) for the mSTAT5b-CA vector (pMX-STAT5B(1*6)); K. Rajewsky (Max Delbruck Center) for the Rosa26 construct; and L. Henninghausen (US National Institutes of Health) for Stat5a-StatSb<SUP>fl</SUP> mice. Supported by the Japan Society for the Promotion of Science, Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation (T.C.), Lucille Castori Center for Microbes, Inflammation & Cancer (T.C.), the US National Institutes of Health Medical Scientist Training Program (T32GM07739 to the Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD-PhD Program, for A.G.L. and X.F.), the US National Institutes of Health (P30 CA008748 to Memorial Sloan Kettering Cancer Center Core Facilities; and R37 AI034206 to A.Y.R.), DFG Emmy Noether programme (G.G.), the Ludwig Center at Memorial Sloan Kettering Cancer Center (A.Y.R.), Hilton-Ludwig Cancer Prevention Initiative funded by the Conrad N. Hilton Foundation and Ludwig Cancer Research (A.Y.R.), and the Howard Hughes Medical Institute (A.Y.R.).	Almeida ARM, 2002, J IMMUNOL, V169, P4850, DOI 10.4049/jimmunol.169.9.4850; Andersen KG, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00113; Arvey A, 2014, NAT IMMUNOL, V15, P580, DOI 10.1038/ni.2868; Barron L, 2010, J IMMUNOL, V185, P6426, DOI 10.4049/jimmunol.0903940; Barthlott T, 2005, INT IMMUNOL, V17, P279, DOI 10.1093/intimm/dxh207; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Busse D, 2010, P NATL ACAD SCI USA, V107, P3058, DOI 10.1073/pnas.0812851107; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen Y, 2011, IMMUNITY, V34, P409, DOI 10.1016/j.immuni.2011.02.011; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Feng YQ, 2014, CELL, V158, P749, DOI 10.1016/j.cell.2014.07.031; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Furtado GC, 2002, J EXP MED, V196, P851, DOI 10.1084/jem.20020190; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hori S, 2014, IMMUNOL REV, V259, P159, DOI 10.1111/imr.12175; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; Malin S, 2010, NAT IMMUNOL, V11, P171, DOI 10.1038/ni.1827; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Rudra D, 2009, NAT IMMUNOL, V10, P1170, DOI 10.1038/ni.1795; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shanmugasundaram R, 2011, J IMMUNOL, V186, P1997, DOI 10.4049/jimmunol.1002040; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; Sojka DK, 2004, J IMMUNOL, V172, P6136, DOI 10.4049/jimmunol.172.10.6136; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Thornton AM, 2004, J IMMUNOL, V172, P6519, DOI 10.4049/jimmunol.172.11.6519; Tran DQ, 2009, J IMMUNOL, V182, P2929, DOI 10.4049/jimmunol.0803827; Vahl JC, 2014, IMMUNITY, V41, P722, DOI 10.1016/j.immuni.2014.10.012; Vang KB, 2008, J IMMUNOL, V181, P3285, DOI 10.4049/jimmunol.181.5.3285; WALDMANN TA, 1989, ANNU REV BIOCHEM, V58, P875, DOI 10.1146/annurev.bi.58.070189.004303; Yamaguchi T, 2013, P NATL ACAD SCI USA, V110, pE2116, DOI 10.1073/pnas.1307185110; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789	43	419	432	4	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2016	17	11					1322	1333		10.1038/ni.3540	http://dx.doi.org/10.1038/ni.3540			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DZ9KE	27595233	Green Accepted			2022-12-18	WOS:000386193200012
J	Kim, HY; DeKruyff, RH; Umetsu, DT				Kim, Hye Young; DeKruyff, Rosemarie H.; Umetsu, Dale T.			The many paths to asthma: phenotype shaped by innate and adaptive immunity	NATURE IMMUNOLOGY			English	Review							THYMIC STROMAL LYMPHOPOIETIN; ALLERGIC AIRWAY INFLAMMATION; KILLER T-CELLS; DENDRITIC CELLS; MAST-CELLS; IN-VIVO; NKT CELLS; T-HELPER-1 CELLS; INHALED ANTIGEN; TH2 RESPONSES	Asthma is a very complex and heterogeneous disease that is characterized by airway inflammation and airway hyper-reactivity (AHR). The pathogenesis of asthma is associated with environmental factors, many cell types, and several molecular and cellular pathways. These include allergic, non-allergic and intrinsic pathways, which involve many cell types and cytokines. Animal models of asthma have helped to clarify some of the underlying mechanisms of asthma, demonstrating the importance of T helper type 2 (T(H)2)-driven allergic responses, as well as of the non-allergic and intrinsic pathways, and contributing to understanding of the heterogeneity of asthma. Further study of these many pathways to asthma will greatly increase understanding of the distinct asthma phenotypes, and such studies may lead to new therapies for this important public health problem.	[Kim, Hye Young; DeKruyff, Rosemarie H.; Umetsu, Dale T.] Harvard Univ, Childrens Hosp, Sch Med, Div Immunol & Allergy, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Umetsu, DT (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Div Immunol & Allergy, Boston, MA 02115 USA.	dale.umetsu@childrens.harvard.edu	Kim, Hye Young/AAF-7609-2020	Kim, Hye Young/0000-0001-5978-512X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI054456, R01AI026322] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL062348, R01 HL062348-09] Funding Source: Medline; NIAID NIH HHS [R01 AI026322-19, R01 AI026322, P01 AI054456-05, P01 AI054456] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Akuthota P, 2008, CLIN EXP ALLERGY, V38, P1254, DOI 10.1111/j.1365-2222.2008.03037.x; Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211; Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Ballantyne SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1324, DOI 10.1016/j.jaci.2007.07.051; Barczyk A, 2003, RESP MED, V97, P726, DOI 10.1053/rmed.2003.1507; Barrett NA, 2009, IMMUNITY, V31, P425, DOI 10.1016/j.immuni.2009.08.014; Bedoret D, 2009, J CLIN INVEST, V119, P3723, DOI 10.1172/JCI39717; Betti M, 2006, ANN ONCOL, V17, P235; Bourgeois E, 2009, EUR J IMMUNOL, V39, P1046, DOI 10.1002/eji.200838575; Carlsen Kai-Hakon, 2002, Paediatr Respir Rev, V3, P154, DOI 10.1016/S1526-0550(02)00009-4; Cherry WB, 2008, J ALLERGY CLIN IMMUN, V121, P1484, DOI 10.1016/j.jaci.2008.04.005; Cohn L, 1999, J EXP MED, V190, P1309, DOI 10.1084/jem.190.9.1309; Cohn L, 1997, J EXP MED, V186, P1737, DOI 10.1084/jem.186.10.1737; Corry DB, 1996, J EXP MED, V183, P109, DOI 10.1084/jem.183.1.109; Coyle AJ, 1999, J EXP MED, V190, P895, DOI 10.1084/jem.190.7.895; Dolgachev V, 2009, J IMMUNOL, V183, P5705, DOI 10.4049/jimmunol.0901666; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; FRANDJI P, 1993, J IMMUNOL, V151, P6318; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hadeiba H, 2000, J IMMUNOL, V164, P4933, DOI 10.4049/jimmunol.164.9.4933; Haitchi HM, 2009, J ALLERGY CLIN IMMUN, V124, P590, DOI 10.1016/j.jaci.2009.06.026; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hayashi N, 2007, P NATL ACAD SCI USA, V104, P14765, DOI 10.1073/pnas.0706378104; Holgate ST, 2008, NAT REV IMMUNOL, V8, P218, DOI 10.1038/nri2262; HOLT PG, 1993, J EXP MED, V177, P397, DOI 10.1084/jem.177.2.397; Hoshino K, 1999, J EXP MED, V190, P1541, DOI 10.1084/jem.190.10.1541; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Johnston RA, 2007, AM J RESP CRIT CARE, V176, P650, DOI 10.1164/rccm.200702-323OC; Kearley J, 2009, AM J RESP CRIT CARE, V179, P772, DOI 10.1164/rccm.200805-666OC; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Kim S, 2010, J IMMUNOL, V184, P1143, DOI 10.4049/jimmunol.0902447; Kondo Y, 2008, INT IMMUNOL, V20, P791, DOI 10.1093/intimm/dxn037; Kurowska-Stolarska M, 2009, J IMMUNOL, V183, P6469, DOI 10.4049/jimmunol.0901575; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Lambrecht BN, 2000, J CLIN INVEST, V106, P551, DOI 10.1172/JCI8107; Lambrecht BN, 1998, J IMMUNOL, V160, P4090; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; Letuve S, 2006, J ALLERGY CLIN IMMUN, V117, P590, DOI 10.1016/j.jaci.2005.10.025; Li L, 2010, J CLIN INVEST, V120, P331, DOI 10.1172/JCI38702; Li N, 2003, CLIN IMMUNOL, V109, P250, DOI 10.1016/j.clim.2003.08.006; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Liu XJ, 2009, BIOCHEM BIOPH RES CO, V386, P181, DOI 10.1016/j.bbrc.2009.06.008; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; LUCEY DR, 1989, P NATL ACAD SCI USA, V86, P1348, DOI 10.1073/pnas.86.4.1348; MacKenzie JR, 2001, J IMMUNOL, V167, P3146, DOI 10.4049/jimmunol.167.6.3146; Maecker HT, 2001, J IMMUNOL, V166, P959, DOI 10.4049/jimmunol.166.2.959; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Matangkasombut P, 2009, MUCOSAL IMMUNOL, V2, P383, DOI 10.1038/mi.2009.96; Matangkasombut P, 2009, J ALLERGY CLIN IMMUN, V123, P1181, DOI 10.1016/j.jaci.2009.02.013; McIntire JJ, 2001, NAT IMMUNOL, V2, P1109, DOI 10.1038/ni739; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Nagata Y, 2007, INT ARCH ALLERGY IMM, V144, P305, DOI 10.1159/000106319; Nair MG, 2009, J EXP MED, V206, P937, DOI 10.1084/jem.20082048; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; NEILL DR, 2010, NATURE; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Pichavant M, 2008, J EXP MED, V205, P385, DOI 10.1084/jem.20071507; Prussin C, 2006, J ALLERGY CLIN IMMUN, V117, pS450, DOI 10.1016/j.jaci.2005.11.016; Reynolds C, 2009, J ALLERGY CLIN IMMUN, V124, P860, DOI 10.1016/j.jaci.2009.07.022; Robays LJ, 2009, MUCOSAL IMMUNOL, V2, P206, DOI 10.1038/mi.2009.7; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Seshasayee D, 2007, J CLIN INVEST, V117, P3868, DOI 10.1172/JCI33559; Silver MR, 2010, INFLAMM RES, V59, P207, DOI 10.1007/s00011-009-0088-5; Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Song CW, 2008, J IMMUNOL, V181, P6117, DOI 10.4049/jimmunol.181.9.6117; Stock P, 2009, J IMMUNOL, V182, P5116, DOI 10.4049/jimmunol.0804213; Subrata LS, 2009, J IMMUNOL, V183, P2793, DOI 10.4049/jimmunol.0900695; Sugimoto T, 2004, J EXP MED, V199, P535, DOI 10.1084/jem.20031368; Tamachi T, 2006, J ALLERGY CLIN IMMUN, V118, P606, DOI 10.1016/j.jaci.2006.04.051; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Taube C, 2004, J IMMUNOL, V172, P6398, DOI 10.4049/jimmunol.172.10.6398; Terashima A, 2008, J EXP MED, V205, P2727, DOI 10.1084/jem.20080698; Umetsu DT, 2002, NAT IMMUNOL, V3, P715, DOI 10.1038/ni0802-715; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; von Mutius E, 2009, J ALLERGY CLIN IMMUN, V123, P3, DOI 10.1016/j.jaci.2008.10.046; Walter DM, 2001, J IMMUNOL, V166, P6392, DOI 10.4049/jimmunol.166.10.6392; WANG W, 2010, CURR DRUG TARGE 0423, DOI DOI 10.2174/1389210204120454501; Wang XS, 2007, ALLERGY, V62, P620, DOI 10.1111/j.1398-9995.2007.01364.x; Wenzel S, 2006, AM J RESP CRIT CARE, V174, P1173, DOI 10.1164/rccm.2609002; Williams CMM, 2000, J EXP MED, V192, P455, DOI 10.1084/jem.192.3.455; Wilson DH, 2006, MED J AUSTRALIA, V184, P226, DOI 10.5694/j.1326-5377.2006.tb00207.x; Wilson RH, 2009, AM J RESP CRIT CARE, V180, P720, DOI 10.1164/rccm.200904-0573OC; Yang M, 2010, CLIN EXP ALLERGY, V40, P163, DOI 10.1111/j.1365-2222.2009.03393.x; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	100	419	448	0	89	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2010	11	7					577	584		10.1038/ni.1892	http://dx.doi.org/10.1038/ni.1892			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612TO	20562844	Green Accepted			2022-12-18	WOS:000278926400013
J	Dogan, I; Bertocci, B; Vilmont, V; Delbos, F; Megret, J; Storck, S; Reynaud, CA; Weill, JC				Dogan, Ismail; Bertocci, Barbara; Vilmont, Valerie; Delbos, Frederic; Megret, Jerome; Storck, Sebastien; Reynaud, Claude-Agnes; Weill, Jean-Claude			Multiple layers of B cell memory with different effector functions	NATURE IMMUNOLOGY			English	Article							CLASS SWITCH RECOMBINATION; CXC CHEMOKINE RECEPTOR-5; CYTIDINE DEAMINASE AID; PERSISTING ANTIGEN; SOMATIC MUTATION; GERMINAL-CENTERS; PLASMA-CELLS; T-CELLS; IMMUNOGLOBULIN; EXPRESSION	Memory B cells are at the center of longstanding controversies regarding the presence of antigen for their survival and their re-engagement in germinal centers after secondary challenge. Using a new mouse model of memory B cell labeling dependent on the cytidine deaminase AID, we show that after immunization with a particulate antigen, B cell memory appeared in several subsets, comprising clusters of immunoglobulin M-positive (IgM(+)) and IgG1(+) B cells in germinal center-like structures that persisted up to 8 months after immunization, as well as IgM(+) and IgG1(+) B cells with a memory phenotype outside of B cell follicles. After challenge, the IgG subset differentiated into plasmocytes, whereas the IgM subset reinitiated a germinal center reaction. This model, in which B cell memory appears in several layers with different functions, reconciles previous conflicting propositions.	[Dogan, Ismail; Bertocci, Barbara; Vilmont, Valerie; Delbos, Frederic; Megret, Jerome; Storck, Sebastien; Reynaud, Claude-Agnes; Weill, Jean-Claude] Univ Paris 05, INSERM, Dev Syst Immunitaire U783, Fac Med, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Weill, JC (corresponding author), Univ Paris 05, INSERM, Dev Syst Immunitaire U783, Fac Med, Site Necker Enfants Malad, Paris, France.	claude-agnes.reynaud@inserm.fr; jean-claude.weill@inserm.fr	Bertocci, Barbara/L-9115-2018		Agence National de la Recherche; Fondation Princesse Grace; Ligue Contre le Cancer	Agence National de la Recherche(French National Research Agency (ANR)); Fondation Princesse Grace; Ligue Contre le Cancer(Ligue nationale contre le cancer)	We thank D. Metzger (Institute of Genetics and Molecular and Cellular Biology) for vector containing Cre-ERT2; P. Charnay (Institut National de la Sante et de la Recherche Medicale U368) for Rosa26-loxP-EYFP mice on a mixed C57BL/6 x DBA/2 background; A. De Smet for assistance with embryonic stem cell culture; D. Lecoeuche for technical help; the Service d'Experimentation Animale et de Transgenese (Villejuif) for the production of the AID-CreERT2 mouse line; the Necker Laboratoire d'Experimentation Animale et de Transgenese for maintaining mouse lines (V. Caulet, Y. Lepage, Y. Moreau and A. David); M. Garfa-Traore and N. Goudin for training in confocal microscopy; and C. Berek and A. Cumano for critical reading of the manuscript. Supported by the Agence National de la Recherche (Microbiologie et Immunologie `Immune Memory'), the Fondation Princesse Grace and the Ligue Contre le Cancer (equipe labellisee).	Anderson SM, 2007, J EXP MED, V204, P2103, DOI 10.1084/jem.20062571; Bachmann MF, 1996, J EXP MED, V183, P2259, DOI 10.1084/jem.183.5.2259; BEREK C, 1992, IMMUNOL REV, V126, P5, DOI 10.1111/j.1600-065X.1992.tb00628.x; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; BEREK C, 1987, IMMUNOL REV, V96, P23, DOI 10.1111/j.1600-065X.1987.tb00507.x; Blink EJ, 2005, J EXP MED, V201, P545, DOI 10.1084/jem.20042060; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Delbos F, 2005, J EXP MED, V201, P1191, DOI 10.1084/jem.20050292; Dorner T, 2007, IMMUNITY, V27, P384, DOI 10.1016/j.immuni.2007.09.002; Fazilleau N, 2007, NAT IMMUNOL, V8, P753, DOI 10.1038/ni1472; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Gatto D, 2007, J IMMUNOL, V178, P67, DOI 10.4049/jimmunol.178.1.67; GRAY D, 1988, NATURE, V336, P70, DOI 10.1038/336070a0; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Kaisho T, 1997, SCIENCE, V276, P412, DOI 10.1126/science.276.5311.412; MACLENNAN ICM, 1990, CURR TOP MICROBIOL, V159, P37; Mamani-Matsuda M, 2008, BLOOD, V111, P4653, DOI 10.1182/blood-2007-11-123844; MANDEL TE, 1981, IMMUNOLOGY, V43, P353; Martin SW, 2002, NAT IMMUNOL, V3, P182, DOI 10.1038/ni752; Maruyama M, 2000, NATURE, V407, P636, DOI 10.1038/35036600; McBride KM, 2008, J EXP MED, V205, P2585, DOI 10.1084/jem.20081319; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; MCHEYZERWILLIAMS MG, 1991, NATURE, V350, P502, DOI 10.1038/350502a0; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Oliver AM, 1997, J IMMUNOL, V158, P1108; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; REICHERT RA, 1983, J EXP MED, V157, P813, DOI 10.1084/jem.157.3.813; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Richard K, 2008, J IMMUNOL, V181, P1746, DOI 10.4049/jimmunol.181.3.1746; Ridderstad A, 1998, J IMMUNOL, V160, P4688; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; SCHITTEK B, 1990, NATURE, V346, P749, DOI 10.1038/346749a0; Shinall SM, 2000, J IMMUNOL, V164, P5729, DOI 10.4049/jimmunol.164.11.5729; SIEKEVITZ M, 1987, CELL, V48, P757, DOI 10.1016/0092-8674(87)90073-0; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Takahashi Y, 2001, IMMUNITY, V14, P181, DOI 10.1016/S1074-7613(01)00100-5; Takizawa M, 2008, J EXP MED, V205, P1949, DOI 10.1084/jem.20081007; Wakabayashi C, 2002, SCIENCE, V298, P2392, DOI 10.1126/science.1076963; Weill JC, 2009, ANNU REV IMMUNOL, V27, P267, DOI 10.1146/annurev.immunol.021908.132607; White H, 2000, J EXP MED, V191, P2209, DOI 10.1084/jem.191.12.2209; Williams GT, 2000, IMMUNITY, V13, P409, DOI 10.1016/S1074-7613(00)00040-6; Wolniak KL, 2006, J IMMUNOL, V177, P2072, DOI 10.4049/jimmunol.177.4.2072	43	418	425	0	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2009	10	12					1292	U9		10.1038/ni.1814	http://dx.doi.org/10.1038/ni.1814			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	520TX	19855380				2022-12-18	WOS:000271872800013
J	Dunn, GP; Bruce, AT; Sheehan, KCF; Shankaran, V; Uppaluri, R; Bui, JD; Diamond, MS; Koebel, CM; Arthur, C; White, JM; Schreiber, RD				Dunn, GP; Bruce, AT; Sheehan, KCF; Shankaran, V; Uppaluri, R; Bui, JD; Diamond, MS; Koebel, CM; Arthur, C; White, JM; Schreiber, RD			A critical function for type I interferons in cancer immunoediting	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; IFN-GAMMA RECEPTOR; CD4(+) T-CELLS; DENDRITIC CELLS; ADAPTIVE IMMUNITY; TUMOR-DEVELOPMENT; PLASMID DNA; VIVO; MICE; EXPRESSION	Cancer immunoediting' is a process wherein the immune system protects hosts against tumor development and facilitates outgrowth of tumors with reduced immunogenicity. Although interferon-gamma (IFN-gamma) is known to be involved in this process, the involvement of type 1 interferons (IFN-alpha/beta) has not been elucidated. We now show that, like IFN-gamma, endogenously produced IFN-alpha/beta was required for the prevention of the growth of primary carcinogen-induced and transplantable tumors. Although tumor cells are important IFN-gamma targets, they are not functionally relevant sites of the actions of the type 1 interferons. Instead, host hematopoietic cells are critical IFN-alpha/beta targets during development of protective antitumor responses. Therefore, type 1 interferons are important components of the cancer immunoediting process and function in a way that does not completely overlap the functions of IFN-gamma.	Washington Univ, Sch Med, Ctr Immunol, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Schreiber, RD (corresponding author), Washington Univ, Sch Med, Ctr Immunol, Dept Pathol & Immunol, St Louis, MO 63110 USA.	schreiber@immunology.wustl.edu	Schreiber, Robert/Q-7550-2019; uppaluri, ravi/AAU-2132-2020; Schreiber, Robert D/A-1276-2013; Diamond, Michael/AAH-1733-2019	Schreiber, Robert D/0000-0001-6311-0432; Diamond, Michael/0000-0002-8791-3165; Schreiber, Robert/0000-0003-1590-2341; White, James Michael/0000-0001-5110-6567	NCI NIH HHS [CA107527, CA43059] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA043059, R37CA043059, R01CA107527] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AFFABRIS E, 1987, HAEMATOLOGICA, V72, P76; Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; BELARDELLI F, 1982, INT J CANCER, V30, P813, DOI 10.1002/ijc.2910300621; Belardelli F, 2002, CYTOKINE GROWTH F R, V13, P119, DOI 10.1016/S1359-6101(01)00022-3; Colonna M, 2002, CURR OPIN IMMUNOL, V14, P373, DOI 10.1016/S0952-7915(02)00349-7; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; DIGHE AS, 1993, J BIOL CHEM, V268, P10645; DIGHE AS, 1994, IMMUNITY, V1, P447, DOI 10.1016/1074-7613(94)90087-6; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Enzler T, 2003, J EXP MED, V197, P1213, DOI 10.1084/jem.20021258; Fallarino F, 1999, J IMMUNOL, V163, P4109; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; GRESSER I, 1983, J EXP MED, V158, P2095, DOI 10.1084/jem.158.6.2095; GRESSER I, 1974, J NATL CANCER I, V52, P553, DOI 10.1093/jnci/52.2.553; GRESSER I, 1988, J EXP MED, V168, P1271, DOI 10.1084/jem.168.4.1271; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Lesinski GB, 2003, J CLIN INVEST, V112, P170, DOI 10.1172/JCI200316603; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521; Montoya M, 2002, BLOOD, V99, P3263, DOI 10.1182/blood.V99.9.3263; Mumberg D, 1999, P NATL ACAD SCI USA, V96, P8633, DOI 10.1073/pnas.96.15.8633; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Qin ZH, 2002, J EXP MED, V195, P1479, DOI 10.1084/jem.20011887; Qin ZH, 2000, IMMUNITY, V12, P677, DOI 10.1016/S1074-7613(00)80218-6; Sato K, 2001, EUR J IMMUNOL, V31, P3138, DOI 10.1002/1521-4141(200111)31:11<3138::AID-IMMU3138>3.0.CO;2-B; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; SHEEHAN KCF, 1995, J EXP MED, V181, P607, DOI 10.1084/jem.181.2.607; SOSS JM, 2003, CYTOKINE HDB, V1, P549; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Tough DF, 2004, LEUKEMIA LYMPHOMA, V45, P257, DOI 10.1080/1042819031000149368; Wu J, 2003, ADV CANCER RES, V90, P127, DOI 10.1016/S0065-230X(03)90004-2; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6	42	418	445	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2005	6	7					722	729		10.1038/ni1213	http://dx.doi.org/10.1038/ni1213			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	938BS	15951814				2022-12-18	WOS:000229975500016
J	Arandjelovic, S; Ravichandran, KS				Arandjelovic, Sanja; Ravichandran, Kodi S.			Phagocytosis of apoptotic cells in homeostasis	NATURE IMMUNOLOGY			English	Review							RECEPTOR TYROSINE KINASE; GLYCATION END-PRODUCTS; BRAIN ANGIOGENESIS INHIBITOR-1; ALPHA-V INTEGRINS; PHOSPHATIDYLSERINE RECEPTORS; EXPOSES PHOSPHATIDYLSERINE; EARLY ATHEROSCLEROSIS; SCAVENGER RECEPTOR; GAS6 DEFICIENCY; FIND-ME	Human bodies collectively turn over about 200 billion to 300 billion cells every day. Such turnover is an integral part of embryonic and postnatal development, as well as routine tissue homeostasis. This process involves the induction of programmed cell death in specific cells within the tissues and the specific recognition and removal of dying cells by a clearance 'crew' composed of professional, non-professional and specialized phagocytes. In the past few years, considerable progress has been made in identifying many features of apoptotic cell clearance. Some of these new observations challenge the way dying cells themselves are viewed, as well as how healthy cells interact with and respond to dying cells. Here we focus on the homeostatic removal of apoptotic cells in tissues.	[Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA; Univ Virginia, Ctr Cell Clearance, Charlottesville, VA USA	University of Virginia; University of Virginia	Ravichandran, KS (corresponding author), Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA.	ravi@virginia.edu		Ravichandran, Kodi/0000-0001-9049-1410	US National Institutes of Health [NIGMS GM064709, HD074981, GM107848, HL120840, MH096484]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD074981] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD057242] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL120840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107848, R01GM064709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096484] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the members of the Ravichandran laboratory, as well as colleagues in the field, for comments and discussions. Supported by the US National Institutes of Health (NIGMS GM064709, HD074981, GM107848, HL120840 and MH096484).	A-Gonzalez N, 2009, IMMUNITY, V31, P245, DOI 10.1016/j.immuni.2009.06.018; Acharya M, 2010, J CLIN INVEST, V120, P4445, DOI 10.1172/JCI43796; Adachi H, 2002, J BIOL CHEM, V277, P34264, DOI 10.1074/jbc.M204277200; Ait-Oufella H, 2007, CIRCULATION, V115, P2168, DOI 10.1161/CIRCULATIONAHA.106.662080; Akitake-Kawano R, 2013, CARCINOGENESIS, V34, P1567, DOI 10.1093/carcin/bgt069; Albacker LA, 2010, J IMMUNOL, V185, P6839, DOI 10.4049/jimmunol.1001360; Angelillo-Scherrer A, 2001, NAT MED, V7, P215, DOI 10.1038/84667; Aziz M, 2012, J IMMUNOL, V189, P393, DOI 10.4049/jimmunol.1200262; Balasubramanian K, 2003, ANNU REV PHYSIOL, V65, P701, DOI 10.1146/annurev.physiol.65.092101.142459; Barclay AN, 2014, ANNU REV IMMUNOL, V32, P25, DOI 10.1146/annurev-immunol-032713-120142; Bhatia VK, 2007, AM J PATHOL, V170, P416, DOI 10.2353/ajpath.2007.060406; Bilimoria PM, 2015, BRAIN RES, V1617, P7, DOI 10.1016/j.brainres.2014.11.032; Binder MD, 2008, J NEUROSCI, V28, P5195, DOI 10.1523/JNEUROSCI.1180-08.2008; Binder MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017727; Bossi F, 2014, P NATL ACAD SCI USA, V111, P4209, DOI 10.1073/pnas.1311968111; Bosurgi L, 2013, P NATL ACAD SCI USA, V110, P13091, DOI 10.1073/pnas.1302507110; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Brindley MA, 2011, VIROLOGY, V415, P83, DOI 10.1016/j.virol.2011.04.002; Brown S, 2002, NATURE, V418, P200, DOI 10.1038/nature00811; Burnier L, 2010, BLOOD, V115, P3390, DOI 10.1182/blood-2009-02-206920; Burstyn-Cohen T, 2012, NEURON, V76, P1123, DOI 10.1016/j.neuron.2012.10.015; Cal L., 2012, PLOS ONE, V7; Callahan MK, 2003, J IMMUNOL, V170, P4840, DOI 10.4049/jimmunol.170.9.4840; Camenisch TD, 1999, J IMMUNOL, V162, P3498; Cantoni C, 2015, ACTA NEUROPATHOL, V129, P429, DOI 10.1007/s00401-015-1388-1; Chen YH, 2015, CELL, V160, P619, DOI 10.1016/j.cell.2015.01.032; Chera S, 2009, DEV CELL, V17, P279, DOI 10.1016/j.devcel.2009.07.014; Chu YX, 2010, P NATL ACAD SCI USA, V107, P7975, DOI 10.1073/pnas.0913449107; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; DaMatta RA, 2007, FEMS MICROBIOL LETT, V266, P29, DOI 10.1111/j.1574-6968.2006.00495.x; Darland-Ransom M, 2008, SCIENCE, V320, P528, DOI 10.1126/science.1155847; Das S, 2011, P NATL ACAD SCI USA, V108, P2136, DOI 10.1073/pnas.1014775108; Dini L, 2002, MICROSC RES TECHNIQ, V57, P530, DOI 10.1002/jemt.10107; Duman JG, 2013, J NEUROSCI, V33, P6964, DOI 10.1523/JNEUROSCI.3978-12.2013; Duncan JL, 2003, INVEST OPHTH VIS SCI, V44, P826, DOI 10.1167/iovs.02-0438; Elliott JI, 2005, NAT CELL BIOL, V7, P808, DOI 10.1038/ncb1279; Elliott MR, 2010, NATURE, V467, P333, DOI 10.1038/nature09356; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; Englert JM, 2011, INT J CLIN EXP PATHO, V4, P241; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fan Y, 2008, TRENDS CELL BIOL, V18, P467, DOI 10.1016/j.tcb.2008.08.001; Flannagan RS, 2014, MOL BIOL CELL, V25, P1511, DOI 10.1091/mbc.E13-04-0212; Fond AM, 2015, J CLIN INVEST, V125, P2748, DOI 10.1172/JCI80300; Frasch SC, 2004, J BIOL CHEM, V279, P17625, DOI 10.1074/jbc.M313414200; Freeman GJ, 2010, IMMUNOL REV, V235, P172, DOI 10.1111/j.0105-2896.2010.00903.x; Fricker M, 2012, J NEUROSCI, V32, P2657, DOI 10.1523/JNEUROSCI.4837-11.2012; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Garcia M, 2003, HISTOL HISTOPATHOL, V18, P1205, DOI 10.14670/HH-18.1205; Gatza E, 2008, BLOOD, V112, P1515, DOI 10.1182/blood-2007-11-125542; Gaultier A, 2009, J CELL SCI, V122, P1155, DOI 10.1242/jcs.040717; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Greenberg ME, 2006, J EXP MED, V203, P2613, DOI 10.1084/jem.20060370; Gude DR, 2008, FASEB J, V22, P2629, DOI 10.1096/fj.08-107169; Hamann J, 2015, PHARMACOL REV, V67, P338, DOI 10.1124/pr.114.009647; Hamoud N, 2014, P NATL ACAD SCI USA, V111, P3745, DOI 10.1073/pnas.1313886111; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; He M, 2007, AM J PHYSIOL-LUNG C, V293, pL1427, DOI 10.1152/ajplung.00075.2007; He M, 2011, EMBO REP, V12, P358, DOI 10.1038/embor.2011.28; Henson PM, 2005, NAT IMMUNOL, V6, P1179, DOI 10.1038/ni1205-1179; Hirose Y, 2012, P NATL ACAD SCI USA, V109, P4263, DOI 10.1073/pnas.1117560109; Hochreiter-Hufford AE, 2013, NATURE, V497, P263, DOI 10.1038/nature12135; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Hunt CL, 2011, J VIROL, V85, P334, DOI 10.1128/JVI.01278-09; Janko C, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00070; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Ji HF, 2014, HEPATOLOGY, V60, P2052, DOI 10.1002/hep.27334; Juncadella IJ, 2013, NATURE, V493, P547, DOI 10.1038/nature11714; Karikoski M, 2014, CLIN CANCER RES, V20, P6452, DOI 10.1158/1078-0432.CCR-14-1236; Kaur B, 2005, ONCOGENE, V24, P3632, DOI 10.1038/sj.onc.1208317; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Kennedy DJ, 2009, ARTERIOSCL THROM VAS, V29, P1481, DOI 10.1161/ATVBAHA.109.191940; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Kiss RS, 2006, CURR BIOL, V16, P2252, DOI 10.1016/j.cub.2006.09.043; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; Kusunoki R, 2015, J GASTROENTEROL, V50, P862, DOI 10.1007/s00535-014-1036-x; Lacy-Hulbert A, 2007, P NATL ACAD SCI USA, V104, P15823, DOI 10.1073/pnas.0707421104; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Lavin Y, 2013, CANCER IMMUNOL RES, V1, P201, DOI 10.1158/2326-6066.CIR-13-0117; Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076; Lew ED, 2014, ELIFE, V3, DOI 10.7554/eLife.03385; Li F, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000634; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Llacuna L, 2010, HEPATOLOGY, V52, P1371, DOI 10.1002/hep.23833; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Lu ZJ, 2011, NAT CELL BIOL, V13, P1076, DOI 10.1038/ncb2299; Lysiak JJ, 2000, BIOL REPROD, V63, P1465, DOI 10.1095/biolreprod63.5.1465; Marcel YL, 2008, CURR OPIN LIPIDOL, V19, P455, DOI 10.1097/MOL.0b013e32830f4a1d; Martin S, 2000, INT ARCH ALLERGY IMM, V123, P249, DOI 10.1159/000024451; Mazaheri F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5046; McCarty JH, 2005, DEVELOPMENT, V132, P165, DOI 10.1242/dev.01551; McCarty JH, 2008, AM J PATHOL, V172, P1740, DOI 10.2353/ajpath.2008.070700; Means TK, 2009, J EXP MED, V206, P637, DOI 10.1084/jem.20082109; Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Miksa M, 2007, MOL MED, V13, P553, DOI 10.2119/2007-00019.Miksa; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Miyanishi M, 2012, INT IMMUNOL, V24, P551, DOI 10.1093/intimm/dxs064; Monks J, 2005, CELL DEATH DIFFER, V12, P107, DOI 10.1038/sj.cdd.4401517; Morizono K, 2014, J VIROL, V88, P4275, DOI 10.1128/JVI.03287-13; Mukundan L, 2009, NAT MED, V15, P1266, DOI 10.1038/nm.2048; N'Diaye EN, 2009, J CELL BIOL, V184, P215, DOI 10.1083/jcb.200808080; Nagata S, 2007, IMMUNOL REV, V220, P237, DOI 10.1111/j.1600-065X.2007.00571.x; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Nandrot EF, 2008, OPHTHALMIC RES, V40, P120, DOI 10.1159/000119861; Neher JJ, 2013, P NATL ACAD SCI USA, V110, pE4098, DOI 10.1073/pnas.1308679110; Neher JJ, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00027; Oram JF, 2005, PHYSIOL REV, V85, P1343, DOI 10.1152/physrev.00005.2005; Overton CD, 2007, CIRC RES, V100, P670, DOI 10.1161/01.RES.0000260204.40510.aa; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Park D, 2011, NATURE, V477, P220, DOI 10.1038/nature10340; Park D, 2009, CURR BIOL, V19, P346, DOI 10.1016/j.cub.2009.01.042; Parks BW, 2013, J LIPID RES, V54, P1114, DOI 10.1194/jlr.M035352; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Peng YF, 2011, J CLIN INVEST, V121, P2221, DOI 10.1172/JCI43254; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Peter C, 2010, APOPTOSIS, V15, P1007, DOI 10.1007/s10495-010-0472-1; Poliani PL, 2015, J CLIN INVEST, V125, P2161, DOI 10.1172/JCI77983; Poon IKH, 2010, CELL DEATH DIFFER, V17, P381, DOI 10.1038/cdd.2009.195; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011; Ramirez-Ortiz ZG, 2013, NAT IMMUNOL, V14, P917, DOI 10.1038/ni.2670; Ravichandran KS, 2010, J EXP MED, V207, P1807, DOI 10.1084/jem.20101157; Remijsen Q, 2011, CELL DEATH DIFFER, V18, P581, DOI 10.1038/cdd.2011.1; Rodriguez-Manzanet R, 2010, P NATL ACAD SCI USA, V107, P8706, DOI 10.1073/pnas.0910359107; Rongvaux A, 2014, CELL, V159, P1563, DOI 10.1016/j.cell.2014.11.037; Roszer T, 2011, J IMMUNOL, V186, P621, DOI 10.4049/jimmunol.1002230; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Schauer C, 2014, NAT MED, V20, P511, DOI 10.1038/nm.3547; Schledzewski K, 2011, J CLIN INVEST, V121, P703, DOI 10.1172/JCI44740; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Seabra SH, 2004, BIOCHEM BIOPH RES CO, V324, P744, DOI 10.1016/j.bbrc.2004.09.114; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; Silva EAC, 2013, IMMUNITY, V39, P160, DOI 10.1016/j.immuni.2013.06.010; Simhadri VR, 2012, BLOOD, V119, P2799, DOI 10.1182/blood-2011-08-372425; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Subramanian M, 2014, J CLIN INVEST, V124, P1296, DOI 10.1172/JCI72051; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Tasdemir-Yilmaz OE, 2014, GENE DEV, V28, P20, DOI 10.1101/gad.229518.113; Tian LJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4146; Toda S, 2014, BLOOD, V123, P3963, DOI 10.1182/blood-2014-01-547976; Todt JC, 2004, J LEUKOCYTE BIOL, V75, P705, DOI 10.1189/jlb.0903439; Truman LA, 2008, BLOOD, V112, P5026, DOI 10.1182/blood-2008-06-162404; Tseng AS, 2007, DEV BIOL, V301, P62, DOI 10.1016/j.ydbio.2006.10.048; Uderhardt S, 2012, IMMUNITY, V36, P834, DOI 10.1016/j.immuni.2012.03.010; van den Eijnde SM, 2001, J CELL SCI, V114, P3631; VANFURTH R, 1972, B WORLD HEALTH ORGAN, V46, P845; Vlaskalin T, 2004, DEV GENES EVOL, V214, P423, DOI 10.1007/s00427-004-0417-1; Wanderley JLM, 2006, J IMMUNOL, V176, P1834, DOI 10.4049/jimmunol.176.3.1834; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Weinger JG, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-49; Wong K, 2010, P NATL ACAD SCI USA, V107, P8712, DOI 10.1073/pnas.0910929107; Wood W, 2000, DEVELOPMENT, V127, P5245; Wu Y, 2005, J CELL SCI, V118, P539, DOI 10.1242/jcs.01632; Yanagita M, 2002, J CLIN INVEST, V110, P239, DOI 10.1172/JCI200214861; Yancey PG, 2011, CIRCULATION, V124, P454, DOI 10.1161/CIRCULATIONAHA.111.032268; Yancey PG, 2010, ARTERIOSCL THROM VAS, V30, P787, DOI 10.1161/ATVBAHA.109.202051; Yoshida H, 2005, NATURE, V437, P754, DOI 10.1038/nature03964; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146; Zagorska A, 2014, NAT IMMUNOL, V15, P920, DOI 10.1038/ni.2986; Zhang YZ, 2015, LAB INVEST, V95, P480, DOI 10.1038/labinvest.2015.32; Zhu D, 2015, J CLIN INVEST, V125, P1497, DOI 10.1172/JCI74603	169	417	427	10	114	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2015	16	9					907	917		10.1038/ni.3253	http://dx.doi.org/10.1038/ni.3253			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP4UA	26287597	Green Accepted			2022-12-18	WOS:000359876900008
J	Veiga-Fernandes, H; Walter, U; Bourgeois, C; McLean, A; Rocha, B				Veiga-Fernandes, H; Walter, U; Bourgeois, C; McLean, A; Rocha, B			Response of naive and memory CD8(+) T cells to antigen stimulation in vivo	NATURE IMMUNOLOGY			English	Article							IN-VIVO; VIRAL-INFECTION; LYMPHOCYTES; ACTIVATION; MICE; EXPRESSION; DIFFERENTIATION; PROLIFERATION; TOLERANCE; PHENOTYPE	We studied the influence of memory T cell properties on the efficiency of secondary immune responses by comparing the in vivo immune response of the same numbers of T cell receptor (TCR) transgenic (Tg) naive and memory T cells. Compared to naive Tg cells, memory cells divided after a shorter lag time; had an increased division rate; a lower loss rate; and showed move rapid and efficient differentiation to effector functions. We found that initial naive T cell priming resulted in cells expressing mutually exclusive effector functions, whereas memory T cells were multifunctional after reactivation, with each individual cell expressing two to three different effector functions simultaneously. These special properties of memory T cells ensure the immediate control of reinfection.	Inst Necker, INSERM, U345, Paris, France; Inst Necker, INSERM, U373, Paris, France; Inst Anim Hlth, Compton, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Veiga-Fernandes, H (corresponding author), Inst Necker, INSERM, U345, Paris, France.	veiga-fernandes@necker.fr	Bourgeois, Christine/ABA-1432-2021; Bourgeois, Christine/L-5944-2018	Bourgeois, Christine/0000-0003-1146-6087; Bourgeois, Christine/0000-0003-1146-6087; Veiga-Fernandes, Henrique/0000-0001-6216-1836				Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Bachmann MF, 1999, J EXP MED, V189, P1521, DOI 10.1084/jem.189.10.1521; Bachmann MF, 1999, EUR J IMMUNOL, V29, P291, DOI 10.1002/(SICI)1521-4141(199901)29:01<291::AID-IMMU291>3.0.CO;2-K; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Borghans JAM, 1999, P NATL ACAD SCI USA, V96, P10782, DOI 10.1073/pnas.96.19.10782; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; BRUNO L, 1995, IMMUNITY, V2, P37, DOI 10.1016/1074-7613(95)90077-2; BUDD RC, 1987, J IMMUNOL, V138, P3120; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Cho BK, 1999, P NATL ACAD SCI USA, V96, P2976, DOI 10.1073/pnas.96.6.2976; Curtsinger JM, 1998, J IMMUNOL, V160, P3236; De Boer RJ, 1998, J IMMUNOL, V160, P5832; Doherty PC, 1996, IMMUNOL REV, V150, P23, DOI 10.1111/j.1600-065X.1996.tb00694.x; Fitzpatrick DR, 1999, J IMMUNOL, V162, P5053; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Garcia S, 1999, IMMUNITY, V11, P163, DOI 10.1016/S1074-7613(00)80091-6; Gett AV, 1998, P NATL ACAD SCI USA, V95, P9488, DOI 10.1073/pnas.95.16.9488; Gudmundsdottir H, 1999, J IMMUNOL, V162, P5212; Itoh Y, 1997, J EXP MED, V186, P757, DOI 10.1084/jem.186.5.757; Karulin AY, 2000, J IMMUNOL, V164, P1862, DOI 10.4049/jimmunol.164.4.1862; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; LESLIE PH, 1948, BIOMETRIKA, V35, P213, DOI 10.1093/biomet/35.3-4.213; Lewin B, 1998, CELL, V93, P301, DOI 10.1016/S0092-8674(00)81154-X; Loffert D, 1996, IMMUNITY, V4, P133, DOI 10.1016/S1074-7613(00)80678-0; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Mackay C R, 1992, Semin Immunol, V4, P51; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; McHeyzer-Williams LJ, 1999, J EXP MED, V189, P1823, DOI 10.1084/jem.189.11.1823; McLean AR, 1997, P NATL ACAD SCI USA, V94, P5792, DOI 10.1073/pnas.94.11.5792; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Naramura M, 1998, IMMUNITY, V9, P209, DOI 10.1016/S1074-7613(00)80603-2; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; OWEN JA, 1982, CELL IMMUNOL, V67, P49, DOI 10.1016/0008-8749(82)90198-8; PANNETIER C, 1993, NUCLEIC ACIDS RES, V21, P577, DOI 10.1093/nar/21.3.577; Richter A, 1999, J EXP MED, V190, P1439, DOI 10.1084/jem.190.10.1439; ROCHA B, 1995, J EXP MED, V181, P993, DOI 10.1084/jem.181.3.993; SAD S, 1994, J IMMUNOL, V153, P3514; Saparov A, 1999, IMMUNITY, V11, P271, DOI 10.1016/S1074-7613(00)80102-8; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Selin LK, 1997, J IMMUNOL, V158, P5366; Selin LK, 1999, IMMUNITY, V11, P733, DOI 10.1016/S1074-7613(00)80147-8; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SIMINOVITCH L, 1963, J CELL COMPAR PHYSL, V62, P327, DOI 10.1002/jcp.1030620313; Sprent J, 1997, IMMUNOL REV, V156, P79, DOI 10.1111/j.1600-065X.1997.tb00960.x; Swain SL, 1996, IMMUNOL REV, V150, P143, DOI 10.1111/j.1600-065X.1996.tb00700.x; TAFURI A, 1994, LEUKEMIA, V8, P749; Tanchot C, 1998, IMMUNITY, V8, P581, DOI 10.1016/S1074-7613(00)80563-4; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Tanchot C, 1998, IMMUNOL TODAY, V19, P575, DOI 10.1016/S0167-5699(98)01344-9; TASWELL C, 1984, J IMMUNOL METHODS, V72, P29, DOI 10.1016/0022-1759(84)90430-7; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; TRIPP RA, 1995, J IMMUNOL, V155, P3719; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; Waldrop SL, 1998, J IMMUNOL, V161, P5284; Weaver CT, 1998, IMMUNOL RES, V17, P279, DOI 10.1007/BF02786452; Zimmermann C, 1999, EUR J IMMUNOL, V29, P284, DOI 10.1002/(SICI)1521-4141(199901)29:01<284::AID-IMMU284>3.0.CO;2-C	59	417	423	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2000	1	1					47	53		10.1038/76907	http://dx.doi.org/10.1038/76907			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BV	10881174				2022-12-18	WOS:000089814800013
J	Cretney, E; Xin, AN; Shi, W; Minnich, M; Masson, F; Miasari, M; Belz, GT; Smyth, GK; Busslinger, M; Nutt, SL; Kallies, A				Cretney, Erika; Xin, Annie; Shi, Wei; Minnich, Martina; Masson, Frederick; Miasari, Maria; Belz, Gabrielle T.; Smyth, Gordon K.; Busslinger, Meinrad; Nutt, Stephen L.; Kallies, Axel			The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells	NATURE IMMUNOLOGY			English	Article							TERMINAL DIFFERENTIATION; REPRESSOR BLIMP-1; MATURE B; EXPRESSION; HOMEOSTASIS; LYMPHOCYTES; FOXP3; INTERLEUKIN-10; BIOTINYLATION; RESPONSES	Regulatory T cells (T-reg cells) are required for peripheral tolerance. Evidence indicates that T-reg cells can adopt specialized differentiation programs in the periphery that are controlled by transcription factors usually associated with helper T cell differentiation. Here we demonstrate that expression of the transcription factor Blimp-1 defined a population of T-reg cells that localized mainly to mucosal sites and produced IL-10. Blimp-1 was required for IL-10 production by these cells and for their tissue homeostasis. We provide evidence that the transcription factor IRF4, but not the transcription factor T-bet, was essential for Blimp-1 expression and for the differentiation of all effector T-reg cells. Thus, our study defines a differentiation pathway that leads to the acquisition of T-reg cell effector functions and requires both IRF4 and Blimp-1.	[Cretney, Erika; Xin, Annie; Shi, Wei; Masson, Frederick; Miasari, Maria; Belz, Gabrielle T.; Smyth, Gordon K.; Nutt, Stephen L.; Kallies, Axel] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Cretney, Erika; Xin, Annie; Masson, Frederick; Miasari, Maria; Belz, Gabrielle T.; Nutt, Stephen L.; Kallies, Axel] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Shi, Wei] Univ Melbourne, Dept Comp Sci & Software Engn, Parkville, Vic 3052, Australia; [Minnich, Martina; Busslinger, Meinrad] Vienna Bioctr, Res Inst Mol Pathol, Vienna, Austria; [Smyth, Gordon K.] Univ Melbourne, Dept Math & Stat, Parkville, Vic 3052, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Melbourne	Kallies, A (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	nutt@wehi.edu.au; kallies@wehi.edu.au	Nutt, Stephen L/C-9256-2013; Smyth, Gordon/B-5276-2008; Busslinger, Meinrad J./J-1249-2016; Belz, Gabrielle T/C-9350-2013	Nutt, Stephen L/0000-0002-0020-6637; Smyth, Gordon/0000-0001-9221-2892; Busslinger, Meinrad J./0000-0002-9111-9351; Belz, Gabrielle T/0000-0002-9660-9587; Masson, Frederic/0000-0001-9909-2985; Kallies, Axel/0000-0002-6312-6968	National Health and Medical Research Council of Australia; Swiss National Science Foundation; Viertel Foundation; Howard Hughes Medical Institute; Pfizer Australia; Leukemia & Lymphoma Society; Boehringer Ingelheim (Busslinger group); European Union; L'Oreal Australia For Women in Science Fellowship	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Viertel Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Pfizer Australia(PfizerPfizer Australia); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Boehringer Ingelheim (Busslinger group)(Boehringer Ingelheim); European Union(European Commission); L'Oreal Australia For Women in Science Fellowship(L'Oreal Group)	We thank T. Mak, L. Wu, J. Altin and P. Bouillet for mice; S. Sterle, N. Bernard, R. Thong and K. Elder for technical support; Y. Zhan, I. Campbell and K. Shortman for antibodies; L. Corcoran and D. Tarlinton for discussion and reagents; and Y. Zheng and A. Rudensky for the full microarray data set already published in part<SUP>17</SUP>. Supported by the National Health and Medical Research Council of Australia (E.C., G.T.B., S.L.N. and A.K.), L'Oreal Australia For Women in Science Fellowship (E.C.), the Swiss National Science Foundation (F.M.), the Viertel Foundation, the Howard Hughes Medical Institute (G.T.B.), the Pfizer Australia Research Fellowship program (S.L.N.), the Leukemia & Lymphoma Society (A.K.), Boehringer Ingelheim (Busslinger group) and the European Union Sixth Framework Programme FP6 (EuTRACC project, Busslinger group).	Ahyi ANN, 2009, J IMMUNOL, V183, P1598, DOI 10.4049/jimmunol.0803302; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Cimmino L, 2008, J IMMUNOL, V181, P2338, DOI 10.4049/jimmunol.181.4.2338; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Decker T, 2009, IMMUNITY, V30, P508, DOI 10.1016/j.immuni.2009.01.012; Driegen S, 2005, TRANSGENIC RES, V14, P477, DOI 10.1007/s11248-005-7220-2; EBERT A, IMMUNITY IN PRESS; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Friedline RH, 2009, J EXP MED, V206, P421, DOI 10.1084/jem.20081811; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gong DP, 2007, J IMMUNOL, V178, P242, DOI 10.4049/jimmunol.178.1.242; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kallies A, 2006, NAT IMMUNOL, V7, P466, DOI 10.1038/ni1321; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Kallies A, 2007, IMMUNITY, V26, P555, DOI 10.1016/j.immuni.2007.04.007; Kallies A, 2007, CURR OPIN IMMUNOL, V19, P156, DOI 10.1016/j.coi.2007.01.003; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kitamura K, 2010, J IMMUNOL, V185, P3295, DOI 10.4049/jimmunol.1001156; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Kleinewietfeld M, 2005, BLOOD, V105, P2877, DOI 10.1182/blood-2004-07-2505; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Lee CG, 2009, MOL IMMUNOL, V46, P613, DOI 10.1016/j.molimm.2008.07.037; Lu LF, 2009, GENE DEV, V23, P1270, DOI 10.1101/gad.1791009; Magnusdottir E, 2007, P NATL ACAD SCI USA, V104, P14988, DOI 10.1073/pnas.0707323104; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Nutt SL, 2007, NAT REV IMMUNOL, V7, P923, DOI 10.1038/nri2204; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Santner-Nanan B, 2006, SIGNAL TRANSDUCT, V6, P268, DOI 10.1002/sita.200500062; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; SHI W, NUCL ACIDS IN PRESS; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Strauss L, 2008, J IMMUNOL, V180, P2967, DOI 10.4049/jimmunol.180.5.2967; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wu D, 2010, BIOINFORMATICS, V26, P2176, DOI 10.1093/bioinformatics/btq401; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; Zhang N, 2009, IMMUNITY, V30, P458, DOI 10.1016/j.immuni.2008.12.022; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	64	416	432	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2011	12	4					304	U53		10.1038/ni.2006	http://dx.doi.org/10.1038/ni.2006			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	737UJ	21378976				2022-12-18	WOS:000288593400008
J	Qian, YC; Liu, CN; Hartupee, J; Altuntas, CZ; Gulen, MF; Jane-Wit, D; Xiao, JH; Lu, Y; Giltiay, N; Liu, JB; Kordula, T; Zhang, QW; Vallance, B; Swaidani, S; Aronica, M; Tuohy, VK; Hamilton, T; Li, XX				Qian, Youcun; Liu, Caini; Hartupee, Justin; Altuntas, Cengiz Zubeyir; Gulen, Muhammet Fatih; Jane-wit, Daniel; Xiao, Jianhua; Lu, Yi; Giltiay, Natalia; Liu, Jinbo; Kordula, Tomasz; Zhang, Qi-Wei; Vallance, Bruce; Swaidani, Shadi; Aronica, Mark; Tuohy, Vincent K.; Hamilton, Thomas; Li, Xiaoxia			The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease	NATURE IMMUNOLOGY			English	Article							T-CELLS; EPITHELIAL-CELLS; MULTIPLE-SCLEROSIS; RECEPTOR COMPLEX; FAMILY-MEMBERS; DEFICIENT MICE; CUTTING EDGE; EXPRESSION; PATHWAYS; ENCEPHALOMYELITIS	T helper cells that produce interleukin 17 (IL-17) are associated with inflammation and the control of certain bacteria. We report here the essential involvement of the adaptor protein Act1 in IL-17 receptor (IL-17R) signaling and IL-17-dependent immune responses. After stimulation with IL-17, recruitment of Act1 to IL-17R required the IL-17R conserved cytoplasmic 'SEFIR' domain, followed by recruitment of the kinase TAK1 and E3 ubiquitin ligase TRAF6, which mediate 'downstream' activation of transcription factor NF-kappa B. IL-17-induced expression of inflammation-related genes was abolished in Act1-deficient primary astroglial and gut epithelial cells. This reduction was associated with much less inflammatory disease in vivo in both autoimmune encephalomyelitis and dextran sodium sulfate-induced colitis. Our data show that Act1 is essential in IL-17-dependent signaling in autoimmune and inflammatory disease.	Cleveland Clin, Dept Immunol, Cleveland, OH 44195 USA; Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; Virginia Commonwealth Univ, Dept Biochem, Sch Med, Richmond, VA 23298 USA; Univ British Columbia, Div Gastroenterol, Vancouver, BC V6T 1Z4, Canada; BC Childrens Hosp, Vancouver, BC V6T 1Z4, Canada; Cleveland Clin Fdn, Dept Pathobiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Case Western Reserve University; Virginia Commonwealth University; University of British Columbia; BC Childrens Hospital; University of British Columbia; Cleveland Clinic Foundation	Li, XX (corresponding author), Cleveland Clin, Dept Immunol, Cleveland, OH 44195 USA.	lix@ccf.org	Hamilton, Thomas A/A-7756-2009; Giltiay, Natalia/AAH-2130-2019; Giltiay, Natalia V./H-8655-2019; Xiao, Jian/GYU-4351-2022	Giltiay, Natalia/0000-0001-7284-514X; Vallance, Bruce/0000-0003-1345-6747; Hamilton, Thomas/0000-0002-9817-242X; Swaidani, Shadi/0000-0003-1506-4472; Gulen, Muhammet/0000-0002-7139-6781	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065470] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 065470] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Awane M, 1999, J IMMUNOL, V162, P5337; Becher B, 2006, J MOL MED, V84, P532, DOI 10.1007/s00109-006-0065-1; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen Y, 2006, J CLIN INVEST, V116, P1317, DOI 10.1172/JCI25308; Chen Y, 2003, J BIOL CHEM, V278, P17036, DOI 10.1074/jbc.M210429200; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Han YL, 2000, GLIA, V30, P1; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hjelmstrom P, 1998, J IMMUNOL, V161, P4480; Inoue D, 2006, BIOCHEM BIOPH RES CO, V347, P852, DOI 10.1016/j.bbrc.2006.06.137; Iwakura Y, 2006, J CLIN INVEST, V116, P1218, DOI 10.1172/JCI28508; Koenders MI, 2005, ARTHRITIS RHEUM-US, V52, P3239, DOI 10.1002/art.21342; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Kordula T, 1998, J BIOL CHEM, V273, P4112, DOI 10.1074/jbc.273.7.4112; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Leonardi A, 2000, P NATL ACAD SCI USA, V97, P10494, DOI 10.1073/pnas.190245697; Li QT, 2000, GENE DEV, V14, P1729; Li XX, 2000, P NATL ACAD SCI USA, V97, P10489, DOI 10.1073/pnas.160265197; Liang L, 2002, J EXP MED, V196, P97, DOI 10.1084/jem.20020298; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Novatchkova M, 2003, TRENDS BIOCHEM SCI, V28, P226, DOI 10.1016/S0968-0004(03)00067-7; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Qian YC, 2004, IMMUNITY, V21, P575, DOI 10.1016/j.immuni.2004.09.001; Qian YC, 2002, P NATL ACAD SCI USA, V99, P9386, DOI 10.1073/pnas.142294499; Ruddy MJ, 2004, J BIOL CHEM, V279, P2559, DOI 10.1074/jbc.M308809200; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Schwandner R, 2000, J EXP MED, V191, P1233, DOI 10.1084/jem.191.7.1233; Schwartz S, 2005, BIOCHEM BIOPH RES CO, V337, P505, DOI 10.1016/j.bbrc.2005.09.075; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Trajkovic V, 2001, J NEUROIMMUNOL, V119, P183, DOI 10.1016/S0165-5728(01)00391-5; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weaver A, 2005, FASEB J, V19, P1668, DOI 10.1096/fj.04-2030fje; Wen F, 2003, GENESIS, V35, P100, DOI 10.1002/gene.10169; Yao ZB, 1997, CYTOKINE, V9, P794, DOI 10.1006/cyto.1997.0240; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Zhang Z, 2006, INFLAMM BOWEL DIS, V12, P382, DOI 10.1097/01.MIB.0000218764.06959.91; Zhao ZD, 2003, J IMMUNOL, V170, P5674, DOI 10.4049/jimmunol.170.11.5674	43	416	449	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2007	8	3					247	256		10.1038/ni1439	http://dx.doi.org/10.1038/ni1439			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	137EF	17277779				2022-12-18	WOS:000244275100010
J	Chen, YG; Satpathy, AT; Chang, HY				Chen, Y. Grace; Satpathy, Ansuman T.; Chang, Howard Y.			Gene regulation in the immune system by long noncoding RNAs	NATURE IMMUNOLOGY			English	Review							EDITING ENZYME ADAR1; THEILERS-VIRUS; CIRCULAR RNAS; TRANSCRIPTION FACTOR; CANDIDATE GENE; X-CHROMOSOME; EXPRESSION; REVEALS; CANCER; METHYLATION	Long noncoding RNAs (lncRNAs) are emerging as critical regulators of gene expression in the immune system. Studies have shown that lncRNAs are expressed in a highly lineage-specific manner and control the differentiation and function of innate and adaptive cell types. In this Review, we focus on mechanisms used by lncRNAs to regulate genes encoding products involved in the immune response, including direct interactions with chromatin, RNA and proteins. In addition, we address new areas of lncRNA biology, such as the functions of enhancer RNAs, circular RNAs and chemical modifications to RNA in cellular processes. We emphasize critical gaps in knowledge and future prospects for the roles of lncRNAs in the immune system and autoimmune disease.	[Chen, Y. Grace; Satpathy, Ansuman T.; Chang, Howard Y.] Stanford Univ, Sch Med, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA; [Chen, Y. Grace; Satpathy, Ansuman T.; Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Satpathy, Ansuman T.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Chang, HY (corresponding author), Stanford Univ, Sch Med, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA.; Chang, HY (corresponding author), Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA.	howchang@stanford.edu		Satpathy, Ansuman/0000-0002-5167-537X	US National Institutes of Health [P50HG007735]; Parker Institute for Cancer Immunotherapy; Scleroderma Research Foundation; Cancer Research Institute (Irvington Fellowship)	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker Institute for Cancer Immunotherapy; Scleroderma Research Foundation; Cancer Research Institute (Irvington Fellowship)	We thank members of the Chang laboratory for discussions, and J. Tumey for figure artwork. Supported by the US National Institutes of Health (P50HG007735), the Parker Institute for Cancer Immunotherapy, the Scleroderma Research Foundation (H.Y.C.) and the Cancer Research Institute (Irvington Fellowship to A.T.S.).	Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Atianand MK, 2016, CELL, V165, P1672, DOI 10.1016/j.cell.2016.05.075; Bass BL, 1997, RNA, V3, P947; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Bihl F, 1999, GENETICS, V152, P385; Blanco S, 2014, CURR OPIN CELL BIOL, V31, P1, DOI 10.1016/j.ceb.2014.06.006; Bokar JA, 1997, RNA, V3, P1233; BOKAR JA, 1994, J BIOL CHEM, V269, P17697; Bonafe L, 2005, PLOS GENET, V1, P444, DOI 10.1371/journal.pgen.0010047; Brahic M, 2005, ANNU REV MICROBIOL, V59, P279, DOI 10.1146/annurev.micro.59.030804.121242; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; BUREAU JF, 1993, NAT GENET, V5, P87, DOI 10.1038/ng0993-87; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cao GC, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160003; Carlile TM, 2014, NATURE, V515, P143, DOI 10.1038/nature13802; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Castellanos-Rubio A, 2016, SCIENCE, V352, P91, DOI 10.1126/science.aad0467; Chen YG, 2017, MOL CELL, V67, P228, DOI 10.1016/j.molcel.2017.05.022; Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025; Clark MB, 2012, GENOME RES, V22, P885, DOI 10.1101/gr.131037.111; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Collier SP, 2014, J IMMUNOL, V193, P3959, DOI 10.4049/jimmunol.1401099; Collier SP, 2012, J IMMUNOL, V189, P2084, DOI 10.4049/jimmunol.1200774; Cruz JA, 2009, CELL, V136, P604, DOI 10.1016/j.cell.2009.02.003; Desterro JMP, 2003, J CELL SCI, V116, P1805, DOI 10.1242/jcs.00371; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dijkstra Johannes M, 2014, F1000Res, V3, P160, DOI 10.12688/f1000research.4711.1; Dimitrova N, 2014, MOL CELL, V54, P777, DOI 10.1016/j.molcel.2014.04.025; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Dou YC, 2016, SCI REP-UK, V6, DOI 10.1038/srep37982; Dunin-Horkawicz S, 2006, NUCLEIC ACIDS RES, V34, pD145, DOI 10.1093/nar/gkj084; Eckmann CR, 2001, MOL BIOL CELL, V12, P1911, DOI 10.1091/mbc.12.7.1911; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Flynn RA, 2014, CELL STEM CELL, V14, P752, DOI 10.1016/j.stem.2014.05.014; Fumagalli D, 2015, CELL REP, V13, P277, DOI 10.1016/j.celrep.2015.09.032; Funabiki M, 2014, IMMUNITY, V40, P199, DOI 10.1016/j.immuni.2013.12.014; Gallo A, 2012, BIOL REV, V87, P95, DOI 10.1111/j.1469-185X.2011.00186.x; Geuens T, 2016, HUM GENET, V135, P851, DOI 10.1007/s00439-016-1683-5; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Goldstein B, 2017, GENOME RES, V27, P462, DOI 10.1101/gr.211169.116; Gomez JA, 2013, CELL, V152, P743, DOI 10.1016/j.cell.2013.01.015; Gong J, 2017, NUCLEIC ACIDS RES, V45, pD79, DOI 10.1093/nar/gkw835; Guo JU, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0409-z; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Han L, 2015, CANCER CELL, V28, DOI 10.1016/j.ccell.2015.08.013; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Hu GQ, 2013, NAT IMMUNOL, V14, P1190, DOI 10.1038/ni.2712; Huang W, 2015, NATURE, V528, P517, DOI 10.1038/nature16193; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hung T, 2015, SCIENCE, V350, P455, DOI 10.1126/science.aac7442; Ivanov A, 2015, CELL REP, V10, P170, DOI 10.1016/j.celrep.2014.12.019; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Klungland A, 2014, CURR OPIN GENET DEV, V26, P47, DOI 10.1016/j.gde.2014.05.006; Kotzin JJ, 2016, NATURE, V537, P239, DOI 10.1038/nature19346; Krawczyk M, 2014, ELIFE, V3, DOI 10.7554/eLife.01776; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Latos PA, 2012, SCIENCE, V338, P1469, DOI 10.1126/science.1228110; Lee JT, 2013, CELL, V152, P1308, DOI 10.1016/j.cell.2013.02.016; Lee N, 2015, CELL, V160, P607, DOI 10.1016/j.cell.2015.01.015; Legnini I, 2017, MOL CELL, V66, P22, DOI 10.1016/j.molcel.2017.02.017; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Levillayer F, 2007, GENETICS, V176, P1835, DOI 10.1534/genetics.107.073536; Li LJ, 2013, CELL REP, V5, P3, DOI 10.1016/j.celrep.2013.09.003; Li Y, 2016, CELL CHEM BIOL, V23, P1325, DOI 10.1016/j.chembiol.2016.09.011; Li ZY, 2015, NAT STRUCT MOL BIOL, V22, P256, DOI 10.1038/nsmb.2959; Li ZH, 2014, P NATL ACAD SCI USA, V111, P1002, DOI 10.1073/pnas.1313768111; Liang DM, 2014, GENE DEV, V28, P2233, DOI 10.1101/gad.251926.114; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; LIMBACH PA, 1994, NUCLEIC ACIDS RES, V22, P2183, DOI 10.1093/nar/22.12.2183; Liu BD, 2015, CANCER CELL, V27, P370, DOI 10.1016/j.ccell.2015.02.004; Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234; Liu ZH, 2011, NAT IMMUNOL, V12, P1063, DOI 10.1038/ni.2113; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Luo M, 2015, CELL STEM CELL, V16, P426, DOI 10.1016/j.stem.2015.02.002; Makitie O, 1998, EUR J PEDIATR, V157, P816, DOI 10.1007/s004310050943; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Marcu-Malina V, 2016, ONCOTARGET, V7, P54370, DOI 10.18632/oncotarget.11029; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Mattick JS, 2015, NAT STRUCT MOL BIOL, V22, P5, DOI 10.1038/nsmb.2942; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Monnier P, 2013, P NATL ACAD SCI USA, V110, P20693, DOI 10.1073/pnas.1310201110; Motorin Y, 2011, WIRES RNA, V2, P611, DOI 10.1002/wrna.79; NARAYAN P, 1988, SCIENCE, V242, P1159, DOI 10.1126/science.3187541; Natoli G, 2012, ANNU REV GENET, V46, P1, DOI 10.1146/annurev-genet-110711-155459; Ng WL, 2016, RNA BIOL, V13, P861, DOI 10.1080/15476286.2016.1207036; Nie YZ, 2004, J BIOL CHEM, V279, P13249, DOI 10.1074/jbc.M312753200; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Patil DP, 2016, NATURE, V537, P369, DOI 10.1038/nature19342; Paz-Yaacov N, 2015, CELL REP, V13, P267, DOI 10.1016/j.celrep.2015.08.080; Peschansky VJ, 2014, EPIGENETICS-US, V9, P3, DOI 10.4161/epi.27473; Petruk S, 2006, CELL, V127, P1209, DOI 10.1016/j.cell.2006.10.039; Picardi E, 2015, SCI REP-UK, V5, DOI 10.1038/srep14941; Picardi Ernesto, 2014, Front Bioeng Biotechnol, V2, P64, DOI 10.3389/fbioe.2014.00064; Poulsen H, 2001, MOL CELL BIOL, V21, P7862, DOI 10.1128/MCB.21.22.7862-7871.2001; Ramaswami G, 2014, NUCLEIC ACIDS RES, V42, pD109, DOI 10.1093/nar/gkt996; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/NMETH.1982, 10.1038/nmeth.1982]; Ranzani V, 2015, NAT IMMUNOL, V16, P318, DOI 10.1038/ni.3093; Rapicavoli NA, 2013, ELIFE, V2, DOI 10.7554/eLife.00762; Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Roost C, 2015, J AM CHEM SOC, V137, P2107, DOI 10.1021/ja513080v; Salameh A, 2015, P NATL ACAD SCI USA, V112, P8403, DOI 10.1073/pnas.1507882112; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; Schmitz KM, 2010, GENE DEV, V24, P2264, DOI 10.1101/gad.590910; Schwartz S, 2014, CELL, V159, P148, DOI 10.1016/j.cell.2014.08.028; Sharma S, 2011, P NATL ACAD SCI USA, V108, P11381, DOI 10.1073/pnas.1019711108; Sigova AA, 2015, SCIENCE, V350, P978, DOI 10.1126/science.aad3346; Silberberg G, 2012, HUM MOL GENET, V21, P311, DOI 10.1093/hmg/ddr461; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Spitale RC, 2015, NATURE, V519, P486, DOI 10.1038/nature14263; Spurlock CF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7932; Squires JE, 2012, NUCLEIC ACIDS RES, V40, P5023, DOI 10.1093/nar/gks144; Sun S, 2013, CELL, V153, P1537, DOI 10.1016/j.cell.2013.05.028; Tsai MC, 2011, CANCER RES, V71, P3, DOI 10.1158/0008-5472.CAN-10-2483; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Venkatraman A, 2013, NATURE, V500, P345, DOI 10.1038/nature12303; Vigneau S, 2003, J VIROL, V77, P5632, DOI 10.1128/JVI.77.10.5632-5638.2003; Vigneau S, 2001, GENOMICS, V78, P206, DOI 10.1006/geno.2001.6656; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090859; Wang P, 2014, SCIENCE, V344, P310, DOI 10.1126/science.1251456; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2015, P NATL ACAD SCI USA, V112, pE3883, DOI 10.1073/pnas.1501662112; Wang Y, 2013, DEV CELL, V25, P69, DOI 10.1016/j.devcel.2013.03.002; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Washietl S, 2014, GENOME RES, V24, P616, DOI 10.1101/gr.165035.113; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Wilusz Jeremy E, 2015, Mob Genet Elements, V5, P1; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035; Yang Y, 2017, CELL RES, V27, P626, DOI 10.1038/cr.2017.31; Zhao BXS, 2017, NATURE, V542, P475, DOI 10.1038/nature21355; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	153	415	431	6	111	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2017	18	9					962	972		10.1038/ni.3771	http://dx.doi.org/10.1038/ni.3771			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FE3TD	28829444				2022-12-18	WOS:000408137700006
J	Li, S; Rouphael, N; Duraisingham, S; Romero-Steiner, S; Presnell, S; Davis, C; Schmidt, DS; Johnson, SE; Milton, A; Rajam, G; Kasturi, S; Carlone, GM; Quinn, C; Chaussabel, D; Palucka, AK; Mulligan, MJ; Ahmed, R; Stephens, DS; Nakaya, HI; Pulendran, B				Li, Shuzhao; Rouphael, Nadine; Duraisingham, Sai; Romero-Steiner, Sandra; Presnell, Scott; Davis, Carl; Schmidt, Daniel S.; Johnson, Scott E.; Milton, Andrea; Rajam, Gowrisankar; Kasturi, Sudhir; Carlone, George M.; Quinn, Charlie; Chaussabel, Damien; Palucka, A. Karolina; Mulligan, Mark J.; Ahmed, Rafi; Stephens, David S.; Nakaya, Helder I.; Pulendran, Bali			Molecular signatures of antibody responses derived from a systems biology study of five human vaccines	NATURE IMMUNOLOGY			English	Article							REGULATORY NETWORKS; IMMUNE-SYSTEM; EXPRESSION; INFLUENZA; VACCINATION; ACTIVATION; PROTECTION	Many vaccines induce protective immunity via antibodies. Systems biology approaches have been used to determine signatures that can be used to predict vaccine-induced immunity in humans, but whether there is a 'universal signature' that can be used to predict antibody responses to any vaccine is unknown. Here we did systems analyses of immune responses to the polysaccharide and conjugate vaccines against meningococcus in healthy adults, in the broader context of published studies of vaccines against yellow fever virus and influenza virus. To achieve this, we did a large-scale network integration of publicly available human blood transcriptomes and systems-scale databases in specific biological contexts and deduced a set of transcription modules in blood. Those modules revealed distinct transcriptional signatures of antibody responses to different classes of vaccines, which provided key insights into primary viral, protein recall and anti-polysaccharide responses. Our results elucidate the early transcriptional programs that orchestrate vaccine immunity in humans and demonstrate the power of integrative network modeling.	[Li, Shuzhao; Rouphael, Nadine; Duraisingham, Sai; Davis, Carl; Kasturi, Sudhir; Mulligan, Mark J.; Ahmed, Rafi; Stephens, David S.; Nakaya, Helder I.; Pulendran, Bali] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Li, Shuzhao; Duraisingham, Sai; Kasturi, Sudhir; Nakaya, Helder I.; Pulendran, Bali] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Rouphael, Nadine; Mulligan, Mark J.] Emory Univ, Div Infect Dis, Emory Vaccine Ctr, Hope Clin, Decatur, GA USA; [Romero-Steiner, Sandra; Schmidt, Daniel S.; Johnson, Scott E.; Milton, Andrea; Rajam, Gowrisankar; Carlone, George M.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Div Bacterial Dis, Meningitis & Vaccine Preventable Dis Branch, Atlanta, GA USA; [Presnell, Scott; Quinn, Charlie; Chaussabel, Damien] Benaroya Res Inst, Seattle, WA USA; [Presnell, Scott; Quinn, Charlie; Chaussabel, Damien; Palucka, A. Karolina] Baylor Res Inst, Baylor Inst Immunol Res, Dallas, TX USA; [Davis, Carl; Mulligan, Mark J.; Stephens, David S.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA; [Ahmed, Rafi] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Nakaya, Helder I.; Pulendran, Bali] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Centers for Disease Control & Prevention - USA; Benaroya Research Institute; Baylor Scott & White Health; Baylor University Medical Center; Emory University; Emory University; Emory University	Pulendran, B (corresponding author), Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	bpulend@emory.edu	Pulendran, Bali/AAW-9550-2021; Mulligan, Mark/V-9275-2019; Nakaya, Helder/AAF-1738-2020; Chaussabel, Damien/AAX-1909-2020; Nakaya, Helder I/A-1397-2010	Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder I/0000-0001-5297-9108; Romero-Steiner, Sandra/0000-0003-4128-7768; Rouphael, Nadine/0000-0002-2512-7919; Chaussabel, Damien/0000-0002-6131-7242; Li, Shuzhao/0000-0002-7386-2539; Pulendran, Bali/0000-0001-6517-4333; Presnell, Scott/0000-0001-9203-6403	US National Institutes of Health [U19AI090023, U54AI057157, R37AI48638, R37DK057665, U19AI057266, AI100663-02]; Georgia Research Alliance GRA and Emory University Research Committee; Clinical and Translational Science Award Program (National Center for Research Resources of the US National Institutes of Health); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165, UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090023, R37AI048638, U19AI057266, U19AI096187, U54AI057157, UM1AI100663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057665, R37DK057665] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Research Alliance GRA and Emory University Research Committee; Clinical and Translational Science Award Program (National Center for Research Resources of the US National Institutes of Health); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank B. Weaver and the Hope Clinic staff for assistance with the clinical study. Supported by the US National Institutes of Health (U19AI090023, U54AI057157, R37AI48638, R37DK057665, U19AI057266 and AI100663-02 to the B.P. laboratory), the Georgia Research Alliance GRA and Emory University Research Committee and the Clinical and Translational Science Award Program (National Center for Research Resources of the US National Institutes of Health; to N.R.). The findings and conclusions in this report are those of the author(s) and do not necessarily represent the views of the Centers for Disease Control and Prevention.	Avci FY, 2011, NAT MED, V17, P1602, DOI 10.1038/nm.2535; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Borrow R, 2005, VACCINE, V23, P2222, DOI 10.1016/j.vaccine.2005.01.051; Bucasas KL, 2011, J INFECT DIS, V203, P921, DOI 10.1093/infdis/jiq156; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chaussabel D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-84; Chaveroux C, 2009, MOL CELL BIOL, V29, P6515, DOI 10.1128/MCB.00489-09; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Findlow H, 2006, CLIN VACCINE IMMUNOL, V13, P507, DOI 10.1128/CVI.13.4.507-510.2006; Fraser IDC, 2009, NAT IMMUNOL, V10, P327, DOI 10.1038/ni.1711; Fredlund E, 2008, P NATL ACAD SCI USA, V105, P14094, DOI 10.1073/pnas.0804455105; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Furman D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.15; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Geeraedts F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000138; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307; Haining WN, 2012, CURR OPIN IMMUNOL, V24, P332, DOI 10.1016/j.coi.2012.03.010; Jokhdar H, 2004, CLIN DIAGN LAB IMMUN, V11, P83, DOI 10.1128/CDLI.11.1.83-88.2004; KAYHTY H, 1980, J INFECT DIS, V142, P861, DOI 10.1093/infdis/142.6.861; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Klein SL, 2013, VACCINE, V31, P2599, DOI 10.1016/j.vaccine.2013.02.070; Koyama S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000759; Lau E, 2012, J CELL SCI, V125, P2815, DOI 10.1242/jcs.095000; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Lefebvre C, 2012, WIRES SYST BIOL MED, V4, P311, DOI 10.1002/wsbm.1159; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Li SZ, 2013, SEMIN IMMUNOL, V25, P209, DOI 10.1016/j.smim.2013.05.003; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Nakaya HI, 2012, WIRES SYST BIOL MED, V4, P193, DOI 10.1002/wsbm.163; Nakaya HI, 2012, CURR OPIN HIV AIDS, V7, P24, DOI 10.1097/COH.0b013e32834dc37b; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Nibbe RK, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000639; Oberg AL, 2011, CURR OPIN IMMUNOL, V23, P436, DOI 10.1016/j.coi.2011.04.005; Obermoser G, 2013, IMMUNITY, V38, P831, DOI 10.1016/j.immuni.2012.12.008; Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006; Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Ravindran R., SCIENCE IN PRESS; Rouphael NG, 2012, METHODS MOL BIOL, V799, P1, DOI 10.1007/978-1-61779-346-2_1; Sales G, 2011, BIOINFORMATICS, V27, P1876, DOI 10.1093/bioinformatics/btr274; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trautmann L, 2011, NAT IMMUNOL, V12, P729, DOI 10.1038/ni.2078; Vahey MT, 2010, J INFECT DIS, V201, P580, DOI 10.1086/650310; Vitour D, 2009, J BIOL CHEM, V284, P21797, DOI 10.1074/jbc.M109.018275; Zak DE, 2012, P NATL ACAD SCI USA, V109, pE3503, DOI 10.1073/pnas.1208972109; Zhang WQ, 2010, MOL BIOL CELL, V21, P2500, DOI 10.1091/mbc.E09-08-0715; Zughaier SM, 2011, J LEUKOCYTE BIOL, V89, P469, DOI 10.1189/jlb.0610369	51	415	419	4	89	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2014	15	2					195	204		10.1038/ni.2789	http://dx.doi.org/10.1038/ni.2789			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	295XV	24336226	Green Accepted			2022-12-18	WOS:000330150600014
J	Brint, EK; Xu, DM; Liu, HY; Dunne, A; McKenzie, ANJ; O'Neill, LAJ; Liew, FY				Brint, EK; Xu, DM; Liu, HY; Dunne, A; McKenzie, ANJ; O'Neill, LAJ; Liew, FY			ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; ADAPTER MOLECULE; NEGATIVE REGULATOR; T1/ST2; MYD88; CELLS; ACTIVATION; EXPRESSION; TIRAP; IRAK	The Toll-interleukin 1 receptor (TIR) superfamily, defined by the presence of an intracellular TIR domain, initiates innate immunity through activation of the transcription factor NF-kappaB, leading to the production of proinflammatory cytokines. ST2 is a member of the TIR family that does not activate NF-kappaB and has been suggested as an important effector molecule of T helper type 2 (T(H)2) responses. We show here that the membrane-bound form of ST2 negatively regulated type I interleukin 1 receptor (IL-1RI) and Toll-like receptor 4 (TLR4) but not TLR3 signaling by sequestrating the adaptors MyD88 and Mal. In contrast to wild-type mice, ST2-deficient mice failed to develop endotoxin tolerance. Thus, these results provide a molecular explanation for the function of ST2 in T(H)2 responses, as inhibition of TLRs promotes a T(H)2 response, and also identify ST2 as a key regulator of endotoxin tolerance.	Univ Glasgow, Div Immunol Infect & Inflammat, Glasgow G11 6NT, Lanark, Scotland; Univ Dublin Trinity Coll, Dept Biochem, Dublin 2, Ireland; MRC, Mol Biol Lab, Cambridge CB2 2QH, England	University of Glasgow; Trinity College Dublin; MRC Laboratory Molecular Biology	O'Neill, LAJ (corresponding author), Univ Glasgow, Div Immunol Infect & Inflammat, Glasgow G11 6NT, Lanark, Scotland.	laoneill@tcd.ie; fyl1h@clinmed.gla.ac.uk	Xu, Damo/A-8212-2011	dunne, aisling/0000-0002-2342-9518; O'Neill, Luke/0000-0002-4333-2748; Brint, Elizabeth/0000-0001-9214-149X				Brint EK, 2002, J BIOL CHEM, V277, P49205, DOI 10.1074/jbc.M209685200; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Coyle AJ, 1999, J EXP MED, V190, P895, DOI 10.1084/jem.190.7.895; DINARELLO CA, 1994, EUR CYTOKINE NETW, V5, P517; DUNNE A, 2003, SCI STKE, V171, pRE3, DOI DOI 10.1126/STKE.2003.171.RE3; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; GREISMAN SE, 1969, J CLIN INVEST, V48, P613, DOI 10.1172/JCI106020; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Janssens S, 2003, FEBS LETT, V548, P103, DOI 10.1016/S0014-5793(03)00747-6; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; KLEMENZ R, 1989, P NATL ACAD SCI USA, V86, P5708, DOI 10.1073/pnas.86.15.5708; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; McGuirk P, 2002, J EXP MED, V195, P221, DOI 10.1084/jem.20011288; Moritz DR, 1998, J IMMUNOL, V161, P4866; Muraille E, 2003, J IMMUNOL, V170, P4237, DOI 10.4049/jimmunol.170.8.4237; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; O'Neill LAJ, 2000, IMMUNOL TODAY, V21, P206, DOI 10.1016/S0167-5699(00)01611-X; O'Neill LAJ, 2002, CURR TOP MICROBIOL, V270, P47; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Saccani S, 1998, CYTOKINE, V10, P773, DOI 10.1006/cyto.1998.0359; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Sweet MJ, 2001, J IMMUNOL, V166, P6633, DOI 10.4049/jimmunol.166.11.6633; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; TOMINAGA S, 1989, FEBS LETT, V258, P301, DOI 10.1016/0014-5793(89)81679-5; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; WERENSKIOLD AK, 1989, MOL CELL BIOL, V9, P5207, DOI 10.1128/MCB.9.11.5207; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Xu D, 1998, J EXP MED, V187, P787, DOI 10.1084/jem.187.5.787; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; 1994, LAB ANIM, V28, P13	39	415	465	0	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2004	5	4					373	379		10.1038/ni1050	http://dx.doi.org/10.1038/ni1050			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	807QL	15004556				2022-12-18	WOS:000220515900009
J	Chang, HC; Sehra, S; Goswami, R; Yao, WG; Yu, Q; Stritesky, GL; Jabeen, R; McKinley, C; Ahyi, AN; Han, L; Nguyen, ET; Robertson, MJ; Perumal, NB; Tepper, RS; Nutt, SL; Kaplan, MH				Chang, Hua-Chen; Sehra, Sarita; Goswami, Ritobrata; Yao, Weiguo; Yu, Qing; Stritesky, Gretta L.; Jabeen, Rukhsana; McKinley, Carl; Ahyi, Ayele-Nati; Han, Ling; Nguyen, Evelyn T.; Robertson, Michael J.; Perumal, Narayanan B.; Tepper, Robert S.; Nutt, Stephen L.; Kaplan, Mark H.			The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation	NATURE IMMUNOLOGY			English	Article							AIRWAY INFLAMMATION; TGF-BETA; IL-9; EXPRESSION; DIFFERENTIATION; LINEAGE; INTERLEUKIN-9; PROMOTES; TH17; HYPERREACTIVITY	CD4(+) helper T cells acquire effector phenotypes that promote specialized inflammatory responses. We show that the ETS-family transcription factor PU.1 was required for the development of an interleukin 9 (IL-9)-secreting subset of helper T cells. Decreasing PU.1 expression either by conditional deletion in mouse T cells or the use of small interfering RNA in human T cells impaired IL-9 production, whereas ectopic PU.1 expression promoted IL-9 production. Mice with PU.1-deficient T cells developed normal T helper type 2 (T(H)2) responses in vivo but showed attenuated allergic pulmonary inflammation that corresponded to lower expression of Il9 and chemokines in peripheral T cells and in lungs than that of wild-type mice. Together our data suggest a critical role for PU.1 in generating the IL-9-producing (T(H)9) phenotype and in the development of allergic inflammation.	[Chang, Hua-Chen; Sehra, Sarita; Goswami, Ritobrata; Yao, Weiguo; Yu, Qing; Stritesky, Gretta L.; Jabeen, Rukhsana; McKinley, Carl; Ahyi, Ayele-Nati; Han, Ling; Nguyen, Evelyn T.; Tepper, Robert S.; Kaplan, Mark H.] Indiana Univ, Sch Med, Dept Pediat, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Goswami, Ritobrata; Stritesky, Gretta L.; Ahyi, Ayele-Nati; Kaplan, Mark H.] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Robertson, Michael J.] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Perumal, Narayanan B.] Indiana Univ Purdue Univ, Sch Informat, Indianapolis, IN 46202 USA; [Nutt, Stephen L.] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Walter & Eliza Hall Institute	Kaplan, MH (corresponding author), Indiana Univ, Sch Med, Dept Pediat, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA.	mkaplan2@iupui.edu	Goswami, Ritobrata/W-9057-2019; Nutt, Stephen L/C-9256-2013; Perumal, Narayanan/A-8318-2009	Goswami, Ritobrata/0000-0002-4388-7962; Nutt, Stephen L/0000-0002-0020-6637; Kaplan, Mark/0000-0002-2923-8245	National Institutes of Health [R01 AI57459, U19 AI070448, R01 CA118118, R01 HL080071, T32 AI060519]; NATIONAL CANCER INSTITUTE [R01CA118118] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060519, R01AI057459, U19AI070448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the National Institutes of Health (R01 AI57459 and U19 AI070448 to M. H. K., R01 CA118118 to M.J.R.; R01 HL080071 to R. S. T.; and T32 AI060519 to G. L. S.).	Ahyi ANN, 2009, J IMMUNOL, V183, P1598, DOI 10.4049/jimmunol.0803302; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Chang HC, 2005, IMMUNITY, V22, P693, DOI 10.1016/j.immuni.2005.03.016; Chang HC, 2009, J IMMUNOL, V183, P4887, DOI 10.4049/jimmunol.0900363; Cheng G, 2002, AM J RESP CRIT CARE, V166, P409, DOI 10.1164/rccm.2105079; Dakic A, 2005, J EXP MED, V201, P1487, DOI 10.1084/jem.20050075; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Elyaman W, 2009, P NATL ACAD SCI USA, V106, P12885, DOI 10.1073/pnas.0812530106; Erpenbeck VJ, 2003, J ALLERGY CLIN IMMUN, V111, P1319, DOI 10.1067/mai.2003.1485; Faulkner H, 1998, INFECT IMMUN, V66, P3832, DOI 10.1128/IAI.66.8.3832-3840.1998; Forbes EE, 2008, J EXP MED, V205, P897, DOI 10.1084/jem.20071046; Gonzalo JA, 1999, J IMMUNOL, V163, P403; Hauber HP, 2004, INT ARCH ALLERGY IMM, V134, P79, DOI 10.1159/000078384; Kawasaki S, 2001, J IMMUNOL, V166, P2055, DOI 10.4049/jimmunol.166.3.2055; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; McMillan S, 2002, J EXP MED, V195, P51, DOI 10.1084/jem.20011732; Mikhak Z, 2009, J ALLERGY CLIN IMMUN, V123, P67, DOI 10.1016/j.jaci.2008.09.049; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nowak EC, 2009, J EXP MED, V206, P1653, DOI 10.1084/jem.20090246; SCHMITT E, 1994, J IMMUNOL, V153, P3989; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Shimbara A, 2000, J ALLERGY CLIN IMMUN, V105, P108, DOI 10.1016/S0091-6749(00)90185-4; Steenwinckel V, 2007, J IMMUNOL, V178, P3244, DOI 10.4049/jimmunol.178.5.3244; Steenwinckel V, 2009, J IMMUNOL, V182, P4737, DOI 10.4049/jimmunol.0801941; Stritesky GL, 2008, J IMMUNOL, V181, P5948, DOI 10.4049/jimmunol.181.9.5948; Temann UA, 2002, J CLIN INVEST, V109, P29, DOI 10.1172/JCI13696; Temann UA, 1998, J EXP MED, V188, P1307, DOI 10.1084/jem.188.7.1307; Temann UA, 2007, INT IMMUNOL, V19, P1, DOI 10.1093/intimm/dxl117; Tepper RS, 2008, J ALLERGY CLIN IMMUN, V122, P760, DOI 10.1016/j.jaci.2008.07.022; Thieu VT, 2008, IMMUNITY, V29, P679, DOI 10.1016/j.immuni.2008.08.017; Townsend MJ, 2000, IMMUNITY, V13, P573, DOI 10.1016/S1074-7613(00)00056-X; van Rijt LS, 2004, J IMMUNOL METHODS, V288, P111, DOI 10.1016/j.jim.2004.03.004; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; White B, 2009, CLIN THER, V31, P728, DOI 10.1016/j.clinthera.2009.04.019; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	44	414	461	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2010	11	6					527	U98		10.1038/ni.1867	http://dx.doi.org/10.1038/ni.1867			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	598FV	20431622	Green Accepted			2022-12-18	WOS:000277821300014
J	Liu, YZ; Zhang, P; Li, J; Kulkarni, AB; Perruche, S; Chen, WJ				Liu, Yongzhong; Zhang, Pin; Li, Jun; Kulkarni, Ashok B.; Perruche, Sylvain; Chen, WanJun			A critical function for TGF-beta signaling in the development of natural CD4(+)CD25(+)Foxp3(+) regulatory T cells	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR FOXP3; NEONATAL-PERIOD; SELF-TOLERANCE; CUTTING EDGE; REG CELLS; IN-VITRO; INTERLEUKIN-2; MECHANISMS; MICE; AUTOIMMUNITY	The molecular mechanisms directing the development of 'natural' CD4(+)CD25(+)Foxp3(+) regulatory T cells (T-reg cells) in the thymus are not thoroughly understood. We show here that conditional deletion of transforming growth factor-beta receptor I (T beta RI) in T cells blocked the appearance of CD4(+)CD25(+)Foxp3(+) thymocytes at postnatal days 3-5. Paradoxically, however, beginning 1 week after birth, the same T beta RI-mutant mice showed accelerated expansion of thymic CD4(+)CD25(+)Foxp3(+) populations. This rapid recovery of Foxp3(+) thymocytes was attributable mainly to overproduction of and heightened responsiveness to interleukin 2, as genetic ablation of interleukin 2 in T beta RI-mutant mice resulted in a complete absence of CD4(+)CD25(+)Foxp3(+) cells from the thymus and periphery. Thus, transforming growth factor-beta signaling is critical to the thymic development of natural CD4(+)CD25(+)Foxp3(+) T-reg cells.	[Liu, Yongzhong; Zhang, Pin; Li, Jun; Perruche, Sylvain; Chen, WanJun] Natl Inst Dent & Craniofacial Res, Mucosal Immunol Unit, Oral Infect & Immun Branch, NIH, Bethesda, MD 20892 USA; [Kulkarni, Ashok B.] Natl Inst Dent & Craniofacial Res, Craniofacial Dev Biol & Regenerat Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Chen, WJ (corresponding author), Natl Inst Dent & Craniofacial Res, Mucosal Immunol Unit, Oral Infect & Immun Branch, NIH, Bethesda, MD 20892 USA.	wchen@mail.nih.gov	perruche, sylvain/N-4813-2017; perruche, sylvain/T-2109-2019; Li, Jun/N-6267-2015	perruche, sylvain/0000-0002-2334-3116; Liu, Yongzhong/0000-0002-1477-116X	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000101, ZIADE000723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000723, Z01DE000101] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Bayer AL, 2005, J EXP MED, V201, P769, DOI 10.1084/jem.20041179; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Bonasio R, 2006, NAT IMMUNOL, V7, P1092, DOI 10.1038/ni1385; Carrier Y, 2007, J IMMUNOL, V178, P172, DOI 10.4049/jimmunol.178.1.172; Chen WJ, 2001, J EXP MED, V194, P439, DOI 10.1084/jem.194.4.439; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fu S, 2004, AM J TRANSPLANT, V4, P1614, DOI 10.1111/j.1600-6143.2004.00566.x; Hennet T, 1995, P NATL ACAD SCI USA, V92, P12070, DOI 10.1073/pnas.92.26.12070; Hill JA, 2007, NAT IMMUNOL, V8, P124, DOI 10.1038/ni0207-124; Hori S, 2003, ADV IMMUNOL, V81, P331, DOI 10.1016/S0065-2776(03)81008-8; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Larsson J, 2003, BLOOD, V102, P3129, DOI 10.1182/blood-2003-04-1300; LETTERIO JJ, 1994, SCIENCE, V264, P1936, DOI 10.1126/science.8009224; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Liu YZ, 2006, TRANSPLANTATION, V82, P953, DOI 10.1097/01.tp.0000232330.46688.37; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Pennington DJ, 2006, NATURE, V444, P1073, DOI 10.1038/nature06051; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Sakaguchi S, 2007, SCIENCE, V317, P627, DOI 10.1126/science.1142331; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Schwartz RH, 2005, NAT IMMUNOL, V6, P327, DOI 10.1038/ni1184; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; SURH CD, 1993, J EXP MED, V177, P379, DOI 10.1084/jem.177.2.379; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Waldmann H, 2006, IMMUNOL REV, V212, P301, DOI 10.1111/j.0105-2896.2006.00406.x; Walker LSK, 2003, J EXP MED, V198, P249, DOI 10.1084/jem.20030315; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Zheng SG, 2004, J IMMUNOL, V172, P5213, DOI 10.4049/jimmunol.172.9.5213	51	414	436	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2008	9	6					632	640		10.1038/ni.1607	http://dx.doi.org/10.1038/ni.1607			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	303VB	18438410				2022-12-18	WOS:000256067900013
J	Turville, SG; Cameron, PU; Handley, A; Lin, G; Pohlmann, S; Doms, RW; Cunningham, AL				Turville, SG; Cameron, PU; Handley, A; Lin, G; Pohlmann, S; Doms, RW; Cunningham, AL			Diversity of receptors binding HIV on dendritic cell subsets	NATURE IMMUNOLOGY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; C-TYPE LECTIN; DC-SIGN; LANGERHANS CELLS; T-CELLS; HUMAN SKIN; INTRAVAGINAL INOCULATION; PRODUCTIVE INFECTION; BIRBECK GRANULES; MANNOSE RECEPTOR	The ability of HIV-1 to use dendritic cells (DCs) for transport and to transfer virus to activated T cells in the lymph node may be crucial in early HIV-1 pathogenesis. We have characterized primary DCs for the receptors involved in viral envelope attachment and observed that C-type lectin receptor (CLR) binding was predominant in skin DCs, whereas binding to emigrating and tonsil DCs was CD4-dependent. No one CLR was solely responsible for envelope binding on all skin DC subsets. DC-SIGN (DC-specific ICAM-3-grabbing nonintegrin) was only expressed by CD14(+)CD1a(lo) dermal DCs. The mannose receptor was expressed by CD1a(hi) and CD14(+C)D1a(lo) dermal DCs, and langerin was expressed by Langerhans cells. The diversity of CLRs able to bind HIV-1 in skin DCs may reflect their ability to bind a range of microbial glycoproteins.	Westmead Hosp, Westmead Millennium Inst, Ctr Virus Res, Sydney, NSW 2145, Australia; Univ Sydney, Sydney, NSW 2145, Australia; Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA	University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of Melbourne; University of Pennsylvania; University of Pennsylvania	Cunningham, AL (corresponding author), Westmead Hosp, Westmead Millennium Inst, Ctr Virus Res, Sydney, NSW 2145, Australia.		Gw, Safwan/ABG-4675-2020; Pöhlmann, Stefan/H-2395-2011	Gw, Safwan/0000-0001-6764-1038; Pöhlmann, Stefan/0000-0001-6086-9136; Cameron, Paul Urquhart/0000-0002-1906-6945; Turville, Stuart/0000-0003-1918-5343; Cunningham, Anthony/0000-0002-6744-5667	PHS HHS [R0140880] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; Blauvelt A, 1997, J CLIN INVEST, V100, P2043, DOI 10.1172/JCI119737; Cameron P, 1996, J LEUKOCYTE BIOL, V59, P158, DOI 10.1002/jlb.59.2.158; CAMERON PU, 1992, SCIENCE, V257, P383, DOI 10.1126/science.1352913; Chakrabarti S, 1997, BIOTECHNIQUES, V23, P1094, DOI 10.2144/97236st07; CURTIS BM, 1992, P NATL ACAD SCI USA, V89, P8356, DOI 10.1073/pnas.89.17.8356; DEZUTTER-DAMBUYANT C, 1991, Journal of Dermatology (Tokyo), V18, P377; DezutterDambuyant C, 1995, ADV EXP MED BIOL, V378, P447; Endres MJ, 1996, CELL, V87, P745, DOI 10.1016/S0092-8674(00)81393-8; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Granelli-Piperno A, 1999, CURR BIOL, V9, P21, DOI 10.1016/S0960-9822(99)80043-8; Grassi F, 1998, J LEUKOCYTE BIOL, V64, P484, DOI 10.1002/jlb.64.4.484; Hart DNJ, 1997, BLOOD, V90, P3245, DOI 10.1182/blood.V90.9.3245; Hladik F, 1999, J VIROL, V73, P5833, DOI 10.1128/JVI.73.7.5833-5842.1999; Hoffman TL, 1999, P NATL ACAD SCI USA, V96, P6359, DOI 10.1073/pnas.96.11.6359; Hu JJ, 2000, J VIROL, V74, P6087, DOI 10.1128/JVI.74.13.6087-6095.2000; Kato M, 2000, INT IMMUNOL, V12, P1511, DOI 10.1093/intimm/12.11.1511; Kawamura T, 2000, J EXP MED, V192, P1491, DOI 10.1084/jem.192.10.1491; Lee B, 2001, J VIROL, V75, P12028, DOI 10.1128/JVI.75.24.12028-12038.2001; LENZ A, 1993, J CLIN INVEST, V92, P2587, DOI 10.1172/JCI116873; Lewin SR, 1999, J VIROL, V73, P6099, DOI 10.1128/JVI.73.7.6099-6103.1999; MACDONALD KPA, 2002, IN PRESS BLOOD; MACDONALD KPA, 2002, LEUCOCYTE TYPING, V7; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; Masurier C, 1998, J VIROL, V72, P7822, DOI 10.1128/JVI.72.10.7822-7829.1998; McLellan AD, 1998, J INVEST DERMATOL, V111, P841, DOI 10.1046/j.1523-1747.1998.00375.x; Mukhtar M, 2002, VIROLOGY, V297, P78, DOI 10.1006/viro.2002.1376; NESTLE FO, 1993, J IMMUNOL, V151, P6535; PINCHUK LM, 1994, IMMUNITY, V1, P317, DOI 10.1016/1074-7613(94)90083-3; Pohlmann S, 2001, J VIROL, V75, P4664, DOI 10.1128/JVI.75.10.4664-4672.2001; Pohlmann S, 2001, P NATL ACAD SCI USA, V98, P2670, DOI 10.1073/pnas.051631398; POPE M, 1995, J EXP MED, V182, P2045, DOI 10.1084/jem.182.6.2045; POPE M, 1994, CELL, V78, P389, DOI 10.1016/0092-8674(94)90418-9; Reece JC, 1998, J EXP MED, V187, P1623, DOI 10.1084/jem.187.10.1623; ROMANI N, 1989, J EXP MED, V169, P1169, DOI 10.1084/jem.169.3.1169; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Soilleux EJ, 2002, J LEUKOCYTE BIOL, V71, P445; Soilleux EJ, 2001, BLOOD, V98, P1987, DOI 10.1182/blood.V98.6.1987; Soilleux EJ, 2000, J IMMUNOL, V165, P2937, DOI 10.4049/jimmunol.165.6.2937; Spira AI, 1996, J EXP MED, V183, P215, DOI 10.1084/jem.183.1.215; Stahl-Hennig C, 1999, SCIENCE, V285, P1261, DOI 10.1126/science.285.5431.1261; Stent G, 2002, CYTOMETRY, V48, P167, DOI 10.1002/cyto.10118; TAYLOR ME, 1993, J BIOL CHEM, V268, P399; Turville SG, 2001, J CLIN VIROL, V22, P229, DOI 10.1016/S1386-6532(01)00194-9; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353	49	414	429	0	26	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2002	3	10					975	983		10.1038/ni841	http://dx.doi.org/10.1038/ni841			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	597VU	12352970	Bronze			2022-12-18	WOS:000178242100019
J	Hettinger, J; Richards, DM; Hansson, J; Barra, MM; Joschko, AC; Krijgsveld, J; Feuerer, M				Hettinger, Jan; Richards, David M.; Hansson, Jenny; Barra, Melanie M.; Joschko, Ann-Cathrin; Krijgsveld, Jeroen; Feuerer, Markus			Origin of monocytes and macrophages in a committed progenitor	NATURE IMMUNOLOGY			English	Article							DENDRITIC CELL-DEVELOPMENT; BONE-MARROW; INFLAMMATORY MONOCYTES; GENE-EXPRESSION; MYELOID CELLS; IDENTIFICATION; NETWORKS; CX(3)CR1; REVEALS; SUBSETS	Monocytes, macrophages and dendritic cells (DCs) are developmentally related regulators of the immune system that share the monocyte-macrophage DC progenitor (MDP) as a common precursor. Unlike differentiation into DCs, the distal pathways for differentiation into monocytes and monocyte-derived macrophages are not fully elucidated. We have now demonstrated the existence of a clonogenic, monocyte- and macrophage-restricted progenitor cell derived from the MDP. This progenitor was a Ly6C(+) proliferating cell present in the bone marrow and spleen that generated the major monocyte subsets and macrophages, but not DCs or neutrophils. By in-depth quantitative proteomics, we characterized changes in the proteome during monocyte differentiation, which provided insight into the molecular principles of developing monocytes, such as their functional maturation. Thus, we found that monocytes and macrophages were renewed independently of DCs from a committed progenitor.	[Hettinger, Jan; Richards, David M.; Barra, Melanie M.; Joschko, Ann-Cathrin; Feuerer, Markus] German Canc Res Ctr, Tumor Immunol Program, Heidelberg, Germany; [Hansson, Jenny; Krijgsveld, Jeroen] European Mol Biol Lab, Genome Biol Unit, D-69012 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); European Molecular Biology Laboratory (EMBL)	Feuerer, M (corresponding author), German Canc Res Ctr, Tumor Immunol Program, Heidelberg, Germany.	m.feuerer@dkfz-heidelberg.de	Hansson, Jenny/J-5062-2014	Hansson, Jenny/0000-0001-9174-8089; Krijgsveld, Jeroen/0000-0001-7549-9326; Richards, David/0000-0003-4907-752X	Helmholtz Association of German Research Centers; Netherlands Organization for Scientific Research	Helmholtz Association of German Research Centers(Helmholtz Association); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	We thank A. Rudensky (Memorial Sloan-Kettering Cancer Center, New York) for B6N.129(Cg)-Foxp3<SUP>tm3Ayr</SUP> mice; M. Platten (German Cancer Research Center) for Cx3cr1-eGFP reporter mice; F. Rosenbauer and S. Ghani for help with the in vitro differentiation assay; the Central Animal Laboratory, Flow Cytometry and Light Microscopy core facilities of the German Cancer Research Center, as well as the European Molecular Biology Laboratory Proteomics Core Facility, for training and support; H.R. Rodewald, T. Feyerabend and B. Kyewski for support and discussions; P. Pyl for statistical advice; K. Lobbes, A. Schmalzle and C. Maul for technical support; and the Immunological Genome Project Consortium for assembled data<SUP>35,44</SUP>. Supported by the Helmholtz Association of German Research Centers (J.He. and M.M.B.; and HZ-NG-505 to M.F.) and the Netherlands Organization for Scientific Research (to J.K.).	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Ancuta P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-403; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Auffray C, 2009, J EXP MED, V206, P595, DOI 10.1084/jem.20081385; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; GOUD TJLM, 1975, J EXP MED, V142, P1180, DOI 10.1084/jem.142.5.1180; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Ingersoll MA, 2010, BLOOD, V115, pE10, DOI 10.1182/blood-2009-07-235028; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Leuschner F, 2011, NAT BIOTECHNOL, V29, P1005, DOI 10.1038/nbt.1989; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Martin AP, 2008, DIABETES, V57, P3025, DOI 10.2337/db08-0625; Merad M, 2009, BLOOD, V113, P3418, DOI 10.1182/blood-2008-12-180646; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Nikolsky Y, 2005, TOXICOL LETT, V158, P20, DOI 10.1016/j.toxlet.2005.02.004; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Garcia MR, 2010, J CLIN INVEST, V120, P2486, DOI 10.1172/JCI41628; Saha P, 2011, IMMUNOL CELL BIOL, V89, P2, DOI 10.1038/icb.2010.130; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; SHEN FW, 1985, P NATL ACAD SCI USA, V82, P7360, DOI 10.1073/pnas.82.21.7360; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; VANFURTH R, 1970, J EXP MED, V132, P794, DOI 10.1084/jem.132.4.794; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	50	412	417	3	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2013	14	8					821	+		10.1038/ni.2638	http://dx.doi.org/10.1038/ni.2638			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185ZN	23812096				2022-12-18	WOS:000322010600011
J	Goronzy, JJ; Weyand, CM				Goronzy, Joerg J.; Weyand, Cornelia M.			Understanding immunosenescence to improve responses to vaccines	NATURE IMMUNOLOGY			English	Review							T-CELL RESPONSES; HEMATOPOIETIC STEM-CELLS; AGE-RELATED-CHANGES; INFLUENZA VACCINE; IMMUNE SENESCENCE; SIGNALING PATHWAYS; GERMINAL-CENTERS; ELDERLY-PEOPLE; OLD-AGE; DIFFERENTIATION	In the older adult, the benefits of vaccination to prevent infectious disease are limited, mainly because of the adaptive immune system's inability to generate protective immunity. The age-dependent decrease in immunological competence, often referred to as 'immunosenescence', results from the progressive deterioration of innate and adaptive immune responses. Most insights into mechanisms of immunological aging have been derived from studies of mouse models. In this Review, we explore how well such models are applicable to understanding the aging process throughout the 80-100 years of human life and discuss recent advances in identifying and characterizing the mechanisms that underlie age-associated defective adaptive immunity in humans.	[Goronzy, Joerg J.; Weyand, Cornelia M.] Stanford Univ, Dept Med, Sch Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA; [Goronzy, Joerg J.; Weyand, Cornelia M.] Palo Alto Vet Adm Hlth Care Syst, Dept Med, Palo Alto, CA USA	Stanford University	Goronzy, JJ (corresponding author), Stanford Univ, Dept Med, Sch Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA.	jgoronzy@stanford.edu	Weyand, Cornelia/AAH-3343-2021	Goronzy, Jorg/0000-0001-7670-1856	US National Institutes of Health [U19-AI057266, U19-AI090019, U01-AI089859, R01-AR042527, R01-AI44142, R01-EY011916, P01-HL058000]; NATIONAL EYE INSTITUTE [R01EY011916] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058000, R01HL117913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044142, R01AI108891, U01AI089859, U19AI057266, U19AI090019, R01AI108906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042527] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by the US National Institutes of Health (U19-AI057266, U19-AI090019, U01-AI089859 to J.J.G. and R01-AR042527, R01-AI44142, R01-EY011916 and P01-HL058000 to C.M.W.).	Adachi K, 2011, P NATL ACAD SCI USA, V108, P1549, DOI 10.1073/pnas.1017340108; Ademokun A, 2010, BIOGERONTOLOGY, V11, P125, DOI 10.1007/s10522-009-9256-9; Akbar AN, 2011, NAT REV IMMUNOL, V11, P289, DOI 10.1038/nri2959; Akha AAS, 2005, CURR OPIN IMMUNOL, V17, P486, DOI 10.1016/j.coi.2005.07.004; Ambrose CS, 2008, INFLUENZA OTHER RESP, V2, P193, DOI 10.1111/j.1750-2659.2008.00056.x; Andrews NP, 2010, GERONTOLOGY, V56, P390, DOI 10.1159/000268620; Aspinall R, 2010, J COMP PATHOL, V141, pS111, DOI 10.1016/j.jcpa.2009.10.022; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Berent-Maoz B, 2012, SEMIN IMMUNOL, V24, P303, DOI 10.1016/j.smim.2012.04.006; Blackman MA, 2011, CURR OPIN IMMUNOL, V23, P537, DOI 10.1016/j.coi.2011.05.005; Boraschi D., SCI TRANSL IN PRESS; Boraschi D, 2010, VACCINE, V28, P3627, DOI 10.1016/j.vaccine.2010.03.035; Brown LE, 2010, VACCINE, V28, P8043, DOI 10.1016/j.vaccine.2010.09.024; Cancro MP, 2009, TRENDS IMMUNOL, V30, P313, DOI 10.1016/j.it.2009.04.005; Castermans E, 2011, HAEMATOL-HEMATOL J, V96, P298, DOI 10.3324/haematol.2010.029702; Cavanagh MM, 2012, CURR OPIN IMMUNOL, V24, P488, DOI 10.1016/j.coi.2012.04.003; Cavanagh MM, 2011, AGING DIS, V2, P398; Chen WH, 2009, TRENDS IMMUNOL, V30, P351, DOI 10.1016/j.it.2009.05.002; Chinn IK, 2012, SEMIN IMMUNOL, V24, P309, DOI 10.1016/j.smim.2012.04.005; Cicin-Sain L, 2007, P NATL ACAD SCI USA, V104, P19960, DOI 10.1073/pnas.0705905104; Cicin-Sain L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002849; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Colmegna I, 2008, ARTHRITIS RHEUM, V58, P990, DOI 10.1002/art.23287; Couch RB, 2007, VACCINE, V25, P7656, DOI 10.1016/j.vaccine.2007.08.042; Czesnikiewicz-Guzik M, 2008, CLIN IMMUNOL, V127, P107, DOI 10.1016/j.clim.2007.12.002; Davis MM, 2012, SCI TRANSL MED, V4; Decman V, 2012, J IMMUNOL, V188, P1933, DOI 10.4049/jimmunol.1101098; den Braber I, 2012, IMMUNITY, V36, P288, DOI 10.1016/j.immuni.2012.02.006; DENIS F, 1984, J INFECT DIS, V149, P1019, DOI 10.1093/infdis/149.6.1019; Di Mitri D, 2011, J IMMUNOL, V187, P2093, DOI 10.4049/jimmunol.1100978; Dixit VD, 2012, SEMIN IMMUNOL, V24, P321, DOI 10.1016/j.smim.2012.04.002; Dormitzer PR, 2011, IMMUNOL REV, V239, P167, DOI 10.1111/j.1600-065X.2010.00974.x; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Dowling MR, 2009, TRENDS IMMUNOL, V30, P295, DOI 10.1016/j.it.2009.04.006; Dunn-Walters DK, 2010, CURR OPIN IMMUNOL, V22, P514, DOI 10.1016/j.coi.2010.04.009; Dutilh BE, 2003, J THEOR BIOL, V224, P351, DOI 10.1016/S0022-5193(03)00172-3; Effros RB, 2007, EXP GERONTOL, V42, P416, DOI 10.1016/j.exger.2006.11.005; Fragoso R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002855; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Frasca D, 2008, J IMMUNOL, V180, P5283, DOI 10.4049/jimmunol.180.8.5283; Frasca D, 2011, AGING DIS, V2, P361; Fujii H, 2009, P NATL ACAD SCI USA, V106, P4360, DOI 10.1073/pnas.0811332106; Gagliardi A. M., 2012, COCHRANE DB SYST REV, V10; Gibson KL, 2009, AGING CELL, V8, P18, DOI 10.1111/j.1474-9726.2008.00443.x; Gomez I, 2004, EXP GERONTOL, V39, P597, DOI 10.1016/j.exger.2003.11.018; Goronzy JJ, 2005, CURR OPIN IMMUNOL, V17, P468, DOI 10.1016/j.coi.2005.07.020; Goronzy JJ, 2003, ARTHRITIS RES THER, V5, P225, DOI 10.1186/ar974; Goronzy JJ, 2001, J VIROL, V75, P12182, DOI 10.1128/JVI.75.24.12182-12187.2001; Goronzy JJ, 2012, SEMIN IMMUNOL, V24, P365, DOI 10.1016/j.smim.2012.04.003; Goronzy JJ, 2012, CELL MOL LIFE SCI, V69, P1615, DOI 10.1007/s00018-012-0970-0; Goronzy JJ, 2010, RHEUM DIS CLIN N AM, V36, P297, DOI 10.1016/j.rdc.2010.03.001; Guerrettaz LM, 2008, P NATL ACAD SCI USA, V105, P11898, DOI 10.1073/pnas.0805498105; Hakim FT, 2005, J CLIN INVEST, V115, P930, DOI 10.1172/JCI22492; Haynes L, 1999, J EXP MED, V190, P1013, DOI 10.1084/jem.190.7.1013; Haynes L, 2005, IMMUNOL REV, V205, P220, DOI 10.1111/j.0105-2896.2005.00255.x; Haynes L, 2011, AGING DIS, V2, P374; Hazenberg MD, 2003, NAT IMMUNOL, V4, P97, DOI 10.1038/ni0203-97; High KP, 2012, SEMIN IMMUNOL, V24, P373, DOI 10.1016/j.smim.2012.04.007; Jackson ML, 2008, LANCET, V372, P398, DOI 10.1016/S0140-6736(08)61160-5; Jefferson T, 2005, LANCET, V366, P1165, DOI 10.1016/S0140-6736(05)67339-4; Jiang N, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004794; Johnson PLF, 2012, P NATL ACAD SCI USA, V109, P21432, DOI 10.1073/pnas.1209283110; Kanapuru B, 2009, AM J MED, V122, P605, DOI 10.1016/j.amjmed.2009.01.030; Khurana S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002920; Khurana S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002336; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Kogut I, 2012, SEMIN IMMUNOL, V24, P342, DOI 10.1016/j.smim.2012.04.004; Kohler S, 2005, EUR J IMMUNOL, V35, P1987, DOI 10.1002/eji.200526181; Lang A, 2011, J IMMUNOL, V187, P3759, DOI 10.4049/jimmunol.1100666; Lee WW, 2008, REJUV RES, V11, P1001, DOI 10.1089/rej.2008.0747; Levin MJ, 2012, CURR OPIN IMMUNOL, V24, P494, DOI 10.1016/j.coi.2012.06.002; Li GJ, 2012, NAT MED, V18, P1518, DOI 10.1038/nm.2963; Li GM, 2012, P NATL ACAD SCI USA, V109, P9047, DOI 10.1073/pnas.1118979109; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Liu Y, 2011, BLOOD, V117, P3257, DOI 10.1182/blood-2010-09-304402; Liu Y, 2009, CURR OPIN IMMUNOL, V21, P431, DOI 10.1016/j.coi.2009.05.011; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Mandal PK, 2012, CELL, V148, P847, DOI 10.1016/j.cell.2012.02.011; Maue AC, 2009, TRENDS IMMUNOL, V30, P301, DOI 10.1016/j.it.2009.04.007; McElhaney JE, 2009, CURR OPIN IMMUNOL, V21, P418, DOI 10.1016/j.coi.2009.05.023; Mekker A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002850; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; MILLER C, 1995, J IMMUNOL, V155, P3377; Naylor K, 2005, J IMMUNOL, V174, P7446, DOI 10.4049/jimmunol.174.11.7446; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Nikolich-Zugich J, 2008, NAT REV IMMUNOL, V8, P512, DOI 10.1038/nri2318; Nikolich-Zugich J, 2012, SEMIN IMMUNOL, V24, P356, DOI 10.1016/j.smim.2012.04.009; Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108; Pawelec G, 2012, CURR OPIN IMMUNOL, V24, P507, DOI 10.1016/j.coi.2012.04.002; Rudd BD, 2011, P NATL ACAD SCI USA, V108, P13694, DOI 10.1073/pnas.1107594108; Sasaki S, 2011, J CLIN INVEST, V121, P3109, DOI 10.1172/JCI57834; Sauce D, 2011, CURR OPIN IMMUNOL, V23, P543, DOI 10.1016/j.coi.2011.05.001; Sauce D, 2009, J CLIN INVEST, V119, P3070, DOI 10.1172/JCI39269; Saurwein-Teissl M, 2002, J IMMUNOL, V168, P5893, DOI 10.4049/jimmunol.168.11.5893; Shao L, 2010, EMBO MOL MED, V2, P415, DOI 10.1002/emmm.201000096; Shao L, 2009, J EXP MED, V206, P1435, DOI 10.1084/jem.20082251; Shaw AC, 2010, CURR OPIN IMMUNOL, V22, P507, DOI 10.1016/j.coi.2010.05.003; Smithey MJ, 2012, J IMMUNOL, V189, P5356, DOI 10.4049/jimmunol.1201867; Solana R, 2012, SEMIN IMMUNOL, V24, P331, DOI 10.1016/j.smim.2012.04.008; STEINMANN GG, 1985, SCAND J IMMUNOL, V22, P563, DOI 10.1111/j.1365-3083.1985.tb01916.x; Su LF, 2013, IMMUNITY, V38, P373, DOI 10.1016/j.immuni.2012.10.021; Thomas-Crusells Judith, 2012, Vaccine, V30, P6007, DOI 10.1016/j.vaccine.2012.07.025; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Vukmanovic-Stejic M, 2011, CURR OPIN IMMUNOL, V23, P525, DOI 10.1016/j.coi.2011.05.008; Wang GC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003647; Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040; Weng NP, 2009, TRENDS IMMUNOL, V30, P306, DOI 10.1016/j.it.2009.03.013; Weng NP, 2006, IMMUNITY, V24, P495, DOI 10.1016/j.immuni.2006.05.001; Weston WM, 2012, VACCINE, V30, P1721, DOI 10.1016/j.vaccine.2011.12.055; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wils EJ, 2011, HAEMATOL-HEMATOL J, V96, P1846, DOI 10.3324/haematol.2011.047696; Wong K, 2012, ARCH INTERN MED, V172, P484, DOI 10.1001/archinternmed.2011.2038; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Yang XH, 1996, J EXP MED, V183, P959, DOI 10.1084/jem.183.3.959; Yu MC, 2012, P NATL ACAD SCI USA, V109, pE879, DOI 10.1073/pnas.1109797109	116	411	424	8	119	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2013	14	5					428	436		10.1038/ni.2588	http://dx.doi.org/10.1038/ni.2588			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	127XL	23598398	Green Accepted			2022-12-18	WOS:000317732100007
J	Hanna, RN; Carlin, LM; Hubbeling, HG; Nackiewicz, D; Green, AM; Punt, JA; Geissmann, F; Hedrick, CC				Hanna, Richard N.; Carlin, Leo M.; Hubbeling, Harper G.; Nackiewicz, Dominika; Green, Angela M.; Punt, Jennifer A.; Geissmann, Frederic; Hedrick, Catherine C.			The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C(-) monocytes	NATURE IMMUNOLOGY			English	Article							ORPHAN STEROID-RECEPTOR; NUCLEAR RECEPTORS; DENDRITIC CELLS; NGFI-B; CLONAL DELETION; GROWTH-FACTORS; LYMPH-NODES; T-CELLS; SUBSETS; MACROPHAGES	The transcription factors that regulate differentiation into the monocyte subset in bone marrow have not yet been identified. Here we found that the orphan nuclear receptor NR4A1 controlled the differentiation of Ly6C(-) monocytes. Ly6C(-) monocytes, which function in a surveillance role in circulation, were absent from Nr4a1(-/-) mice. Normal numbers of myeloid progenitor cells were present in Nr4a1(-/-) mice, which indicated that the defect occurred during later stages of monocyte development. The defect was cell intrinsic, as wild-type mice that received bone marrow from Nr4a1(-/-) mice developed fewer patrolling monocytes than did recipients of wild-type bone marrow. The Ly6C(-) monocytes remaining in the bone marrow of Nr4a1(-/-) mice were arrested in S phase of the cell cycle and underwent apoptosis. Thus, NR4A1 functions as a master regulator of the differentiation and survival of 'patrolling' Ly6C(-) monocytes.	[Hanna, Richard N.; Green, Angela M.; Hedrick, Catherine C.] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA USA; [Carlin, Leo M.; Geissmann, Frederic] Kings Coll London, Ctr Mol & Cellular Biol Inflammat, London WC2R 2LS, England; [Hubbeling, Harper G.; Punt, Jennifer A.] Haverford Coll, Dept Biol, Haverford, PA 19041 USA; [Nackiewicz, Dominika] Univ Lodz, Dept Genet Microorganisms, PL-90131 Lodz, Poland	La Jolla Institute for Immunology; University of London; King's College London; Haverford College; University of Lodz	Hedrick, CC (corresponding author), La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA USA.	hedrick@liai.org	Carlin, Leo Marc/E-3434-2012; Hedrick, Catherine/D-1106-2012	Carlin, Leo Marc/0000-0001-7172-5234; Nackiewicz, Dominika/0000-0001-5836-8789; geissmann, frederic/0000-0001-5029-2468	US National Institutes of Health [R01 HL071141, R01 HL079621]; MRC [G0900867] Funding Source: UKRI; Medical Research Council [G0900867] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071141, R01HL079621] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank K.A. Hogquist (University of Minnesota) for NR4A1-GFP reporter mice; M. Mack (Klinikum der Universitat Regensburg) for antibody to CCR2 (MC-21); K. Ley and I. Shaked for discussions; and A. Blatchley, D. Yoakum and D. Huynh for assistance with management of the mouse colony. Supported by the US National Institutes of Health (R01 HL071141 and R01 HL079621 to C.C.H.).	Arkenbout EK, 2002, CIRCULATION, V106, P1530, DOI 10.1161/01.CIR.0000028811.03056.BF; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Auffray C, 2009, J EXP MED, V206, P595, DOI 10.1084/jem.20081385; Baker KD, 2003, CELL, V113, P731, DOI 10.1016/S0092-8674(03)00420-3; Bonta PI, 2006, ARTERIOSCL THROM VAS, V26, P2288, DOI 10.1161/01.ATV.0000238346.84458.5d; Bonta PI, 2010, CARDIOVASC RES, V87, P561, DOI 10.1093/cvr/cvq064; Cho HJ, 2003, J IMMUNOL, V170, P10, DOI 10.4049/jimmunol.170.1.10; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; FAHRNER TJ, 1990, MOL CELL BIOL, V10, P6454, DOI 10.1128/MCB.10.12.6454; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; HAZEL TG, 1988, P NATL ACAD SCI USA, V85, P8444, DOI 10.1073/pnas.85.22.8444; Infante A, 2008, CELL CYCLE, V7, P3915, DOI 10.4161/cc.7.24.7379; Landsman L, 2007, J IMMUNOL, V178, P2000, DOI 10.4049/jimmunol.178.4.2000; Landsman L, 2009, BLOOD, V113, P963, DOI 10.1182/blood-2008-07-170787; Lee JM, 2002, P NATL ACAD SCI USA, V99, P11878, DOI 10.1073/pnas.182552499; LEE SL, 1995, SCIENCE, V269, P532, DOI 10.1126/science.7624775; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Li QX, 2006, HISTOL HISTOPATHOL, V21, P533, DOI 10.14670/HH-21.533; LIM RW, 1987, ONCOGENE, V1, P263; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Mack M, 2001, J IMMUNOL, V166, P4697, DOI 10.4049/jimmunol.166.7.4697; Martinez-Gonzalez J, 2005, CARDIOVASC RES, V65, P609, DOI 10.1016/j.cardiores.2004.10.002; Moll UM, 2006, ONCOGENE, V25, P4725, DOI 10.1038/sj.onc.1209601; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Mullican SE, 2007, NAT MED, V13, P730, DOI 10.1038/nm1579; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Narni-Mancinelli E, 2007, J EXP MED, V204, P2075, DOI 10.1084/jem.20070204; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Pei LM, 2005, J BIOL CHEM, V280, P29256, DOI 10.1074/jbc.M502606200; Rajpal A, 2003, EMBO J, V22, P6526, DOI 10.1093/emboj/cdg620; Ramirez-Herrick AM, 2011, BLOOD, V117, P2681, DOI 10.1182/blood-2010-02-267906; Randolph GJ, 2008, CURR OPIN LIPIDOL, V19, P462, DOI 10.1097/MOL.0b013e32830d5f09; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Sirin O, 2010, NAT CELL BIOL, V12, P1213, DOI 10.1038/ncb2125; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Thompson J, 2008, J EXP MED, V205, P1029, DOI 10.1084/jem.20080101; Trikha P, 2011, J BIOL CHEM, V286, P4783, DOI 10.1074/jbc.M110.182733; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Wallen-Mackenzie A, 2003, GENE DEV, V17, P3036, DOI 10.1101/gad.276003; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; You B, 2009, CIRC RES, V104, P742, DOI 10.1161/CIRCRESAHA.108.192286; Yrlid U, 2006, J IMMUNOL, V176, P4155, DOI 10.4049/jimmunol.176.7.4155; Zhou T, 1996, J EXP MED, V183, P1879, DOI 10.1084/jem.183.4.1879	51	411	423	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2011	12	8					778	U148		10.1038/ni.2063	http://dx.doi.org/10.1038/ni.2063			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	794BT	21725321	Green Accepted			2022-12-18	WOS:000292870700016
J	Abbas, AK; Benoist, C; Bluestone, JA; Campbell, DJ; Ghosh, S; Hori, S; Jiang, SP; Kuchroo, VK; Mathis, D; Roncarolo, MG; Rudensky, A; Sakaguchi, S; Shevach, EM; Vignali, DAA; Ziegler, SF				Abbas, Abul K.; Benoist, Christophe; Bluestone, Jeffrey A.; Campbell, Daniel J.; Ghosh, Sankar; Hori, Shohei; Jiang, Shuiping; Kuchroo, Vijay K.; Mathis, Diane; Roncarolo, Maria Grazia; Rudensky, Alexander; Sakaguchi, Shimon; Shevach, Ethan M.; Vignali, Dario A. A.; Ziegler, Steve F.			Regulatory T cells: recommendations to simplify the nomenclature	NATURE IMMUNOLOGY			English	Letter									[Abbas, Abul K.] Univ Calif San Francisco, Sch Med, Dept Pathol, San Francisco, CA 94143 USA; [Benoist, Christophe; Mathis, Diane] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA USA; [Bluestone, Jeffrey A.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Campbell, Daniel J.; Ziegler, Steve F.] Benaroya Res Inst, Immunol Program, Seattle, WA USA; [Ghosh, Sankar] Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA; [Hori, Shohei] RIKEN Res Ctr Allergy & Immunol, Res Unit Immune Homeostasis, Yokohama, Kanagawa, Japan; [Jiang, Shuiping] Immunis Clin, Beijing, Peoples R China; [Kuchroo, Vijay K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Roncarolo, Maria Grazia] Ist Sci San Raffaele, San Raffaele Telethon Inst Gene Therapy, Div Regenerat Med Stem Cells & Gene Therapy, I-20132 Milan, Italy; [Rudensky, Alexander] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; [Sakaguchi, Shimon] Osaka Univ, World Premier Initiat Immunol Frontier Res Ctr, Expt Immunol Lab, Osaka, Japan; [Shevach, Ethan M.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Vignali, Dario A. A.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	University of California System; University of California San Francisco; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; Benaroya Research Institute; Columbia University; RIKEN; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Osaka University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); St Jude Children's Research Hospital	Abbas, AK (corresponding author), Univ Calif San Francisco, Sch Med, Dept Pathol, San Francisco, CA 94143 USA.	dario.vignali@stjude.org	Hori, Shohei/O-6163-2019; Sakaguchi, Shimon/C-9535-2009	Hori, Shohei/0000-0001-8770-4593; RONCAROLO, Maria Grazia/0000-0002-2193-9186	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000959, R01AI046643] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI046643] Funding Source: Medline; Telethon [TGT11E01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Telethon(Fondazione Telethon)			0	410	434	1	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2013	14	4					307	308		10.1038/ni.2554	http://dx.doi.org/10.1038/ni.2554			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	113EG	23507634	Green Published			2022-12-18	WOS:000316648700001
J	Galiana-Arnoux, D; Dostert, C; Schneemann, A; Hoffmann, JA; Imler, JL				Galiana-Arnoux, Delphine; Dostert, Catherine; Schneemann, Anette; Hoffmann, Jules A.; Imler, Jean-Luc			Essential function in vivo for Dicer-2 in host defense against RNA viruses in drosophila	NATURE IMMUNOLOGY			English	Article							INNATE IMMUNE RECOGNITION; CAENORHABDITIS-ELEGANS; ANTIVIRAL RESPONSE; VIRAL-INFECTION; DISTINCT ROLES; ANIMAL VIRUS; INTERFERENCE; GENE; INHIBITION; SIRNA	The fruit fly Drosophila melanogaster is a model system for studying innate immunity, including antiviral host defense. Infection with drosophila C virus triggers a transcriptional response that is dependent in part on the Jak kinase Hopscotch. Here we show that successful infection and killing of drosophila with the insect nodavirus flock house virus was strictly dependent on expression of the viral protein B2, a potent inhibitor of processing of double-stranded RNA mediated by the essential RNA interference factor Dicer. Conversely, flies with a loss-of-function mutation in the gene encoding Dicer-2 (Dcr-2) showed enhanced susceptibility to infection by flock house virus, drosophila C virus and Sindbis virus, members of three different families of RNA viruses. These data demonstrate the importance of RNA interference for controlling virus replication in vivo and establish Dcr-2 as a host susceptibility locus for virus infections.	CNRS, UPR9022, Inst Biol Mol & Cellulaire, F-67000 Strasbourg, France; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Scripps Research Institute	Imler, JL (corresponding author), CNRS, UPR9022, Inst Biol Mol & Cellulaire, F-67000 Strasbourg, France.	jl.imler@ibmc.u-strasbg.fr	Imler, Jean-Luc/GXH-4323-2022; Dostert, Catherine/AAJ-5473-2020		NIGMS NIH HHS [GM053491] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053491] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agaisse Herve, 2004, Immunol Rev, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x; Albarino CG, 2001, VIROLOGY, V289, P269, DOI 10.1006/viro.2001.1125; BALL LA, 1995, J VIROL, V69, P720, DOI 10.1128/JVI.69.2.720-727.1995; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brennan CA, 2004, ANNU REV IMMUNOL, V22, P457, DOI 10.1146/annurev.immunol.22.012703.104626; Chao JA, 2005, NAT STRUCT MOL BIOL, V12, P952, DOI 10.1038/nsmb1005; Cherry S, 2005, GENE DEV, V19, P445, DOI 10.1101/gad.1267905; Cherry S, 2004, NAT IMMUNOL, V5, P81, DOI 10.1038/ni1019; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103; Galiana-Arnoux D, 2006, TISSUE ANTIGENS, V67, P267, DOI 10.1111/j.1399-0039.2006.00583.x; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Ge Q, 2004, P NATL ACAD SCI USA, V101, P8676, DOI 10.1073/pnas.0402486101; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101; Krishna NK, 2003, VIROLOGY, V305, P10, DOI 10.1006/viro.2002.1740; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li BJ, 2005, NAT MED, V11, P944, DOI 10.1038/nm1280; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Li WX, 2004, P NATL ACAD SCI USA, V101, P1350, DOI 10.1073/pnas.0308308100; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Miller LK, 1999, TRENDS CELL BIOL, V9, P323, DOI 10.1016/S0962-8924(99)01609-8; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; Palliser D, 2006, NATURE, V439, P89, DOI 10.1038/nature04263; Ratcliff F, 1997, SCIENCE, V276, P1558, DOI 10.1126/science.276.5318.1558; Roignant JY, 2003, RNA, V9, P299, DOI 10.1261/rna.2154103; Roxstrom-Lindquist K, 2004, EMBO REP, V5, P207, DOI 10.1038/sj.embor.7400073; Sabatier L, 2003, EUR J BIOCHEM, V270, P3398, DOI 10.1046/j.1432-1033.2003.03725.x; Schneemann A, 1998, ADV VIRUS RES, V50, P381, DOI 10.1016/S0065-3527(08)60812-X; Schott DH, 2005, P NATL ACAD SCI USA, V102, P18420, DOI 10.1073/pnas.0507123102; Tompkins SM, 2004, P NATL ACAD SCI USA, V101, P8682, DOI 10.1073/pnas.0402630101; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; Wilkins C, 2005, NATURE, V436, P1044, DOI 10.1038/nature03957; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zhang WD, 2005, NAT MED, V11, P56, DOI 10.1038/nm1174	48	410	430	1	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2006	7	6					590	597		10.1038/ni1335	http://dx.doi.org/10.1038/ni1335			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	045OK	16554838				2022-12-18	WOS:000237751200014
J	Kovalovsky, D; Uche, OU; Eladad, S; Hobbs, RM; Yi, W; Alonzo, E; Chua, K; Eidson, M; Kim, HJ; Im, JS; Pandolfi, PP; Sant'Angelo, DB				Kovalovsky, Damian; Uche, Olisambu U.; Eladad, Sonia; Hobbs, Robin M.; Yi, Woelsung; Alonzo, Eric; Chua, Kevin; Eidson, Maggie; Kim, Hye-Jung; Im, Jin S.; Pandolfi, Pier Paolo; Sant'Angelo, Derek B.			The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions	NATURE IMMUNOLOGY			English	Article							V-ALPHA-14I NKT CELLS; TEC KINASES ITK; LINEAGE COMMITMENT; GROWTH SUPPRESSION; CUTTING EDGE; ACTIVE ITK; EXPRESSION; PROTEIN; MICE; DIFFERENTIATION	Invariant natural killer T cells (iNKT cells) have an innate immunity-like rapidity of response and the ability to modulate the effector functions of other cells. We show here that iNKT cells specifically expressed the BTB-zinc finger transcriptional regulator PLZF. In the absence of PLZF, iNKT cells developed, but they lacked many features of innate T cells. PLZF-deficient iNKT cells accumulated in lymph nodes rather than in the liver, did not express NK markers and did not have the characteristic activated phenotype. PLZF-deficient iNKT cells failed to secrete large amounts of interleukin 4 and interferon-c after activation; however, some cells produced either interleukin 4 or interferon-c but not both. PLZF, therefore, is an iNKT cell-specific transcription factor that is necessary for full functionality.	[Kovalovsky, Damian; Eladad, Sonia; Yi, Woelsung; Chua, Kevin; Kim, Hye-Jung; Sant'Angelo, Derek B.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Immunol, New York, NY 10065 USA; [Uche, Olisambu U.; Sant'Angelo, Derek B.] Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10065 USA; [Hobbs, Robin M.; Pandolfi, Pier Paolo] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, Sloan Kettering Inst, New York, NY 10065 USA; [Alonzo, Eric; Sant'Angelo, Derek B.] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, New York, NY 10065 USA; [Eidson, Maggie] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10065 USA; [Im, Jin S.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Yeshiva University; Albert Einstein College of Medicine	Sant'Angelo, DB (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Immunol, New York, NY 10065 USA.	santangd@mskcc.org	Hobbs, Robin/I-2577-2014	Hobbs, Robin/0000-0002-3853-2614	NCI NIH HHS [P30-CA 08748, T32 CA009149] Funding Source: Medline; NIAID NIH HHS [R01 AI059739, R01 AI059739-02, AI059739, R01 AI059739-03, R01 AI059739-01A2] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009149, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059739] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Au-Yeung BB, 2007, J IMMUNOL, V179, P111, DOI 10.4049/jimmunol.179.1.111; Barna M, 2002, DEV CELL, V3, P499, DOI 10.1016/S1534-5807(02)00289-7; Barna M, 2000, NAT GENET, V25, P166, DOI 10.1038/76014; Bendelac A, 2002, J EXP MED, V195, pF19, DOI 10.1084/jem.20020073; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; Berg LJ, 2007, NAT REV IMMUNOL, V7, P479, DOI 10.1038/nri2091; Bezbradica JS, 2006, IMMUNITY, V25, P487, DOI 10.1016/j.immuni.2006.06.017; Borowski C, 2005, J EXP MED, V201, P833, DOI 10.1084/jem.20050339; Broussard C, 2006, IMMUNITY, V25, P93, DOI 10.1016/j.immuni.2006.05.011; Chung B, 2005, J IMMUNOL, V174, P3153, DOI 10.4049/jimmunol.174.6.3153; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Dao T, 2004, EUR J IMMUNOL, V34, P3542, DOI 10.1002/eji.200425546; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Eberl G, 1999, J IMMUNOL, V163, P4091; Egawa T, 2005, IMMUNITY, V22, P705, DOI 10.1016/j.immuni.2005.03.011; Exley MA, 2008, EUR J IMMUNOL, V38, P1756, DOI 10.1002/eji.200737389; Falk I, 1996, J IMMUNOL, V156, P1362; Felices M, 2008, J IMMUNOL, V180, P3007, DOI 10.4049/jimmunol.180.5.3007; Filipponi D, 2007, MOL CELL BIOL, V27, P6770, DOI 10.1128/MCB.00479-07; Gadue P, 1999, J EXP MED, V190, P1189, DOI 10.1084/jem.190.8.1189; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Griewank K, 2007, IMMUNITY, V27, P751, DOI 10.1016/j.immuni.2007.08.020; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; Hammond KJL, 1999, EUR J IMMUNOL, V29, P3768, DOI 10.1002/(SICI)1521-4141(199911)29:11<3768::AID-IMMU3768>3.3.CO;2-7; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Horai R, 2007, IMMUNITY, V27, P775, DOI 10.1016/j.immuni.2007.09.012; Hu JF, 2008, J IMMUNOL, V180, P6544, DOI 10.4049/jimmunol.180.10.6544; Hu J, 2007, EUR J IMMUNOL, V37, P2892, DOI 10.1002/eji.200737311; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kelly KF, 2006, TRENDS CELL BIOL, V16, P578, DOI 10.1016/j.tcb.2006.09.003; Koken MHM, 1997, P NATL ACAD SCI USA, V94, P10255, DOI 10.1073/pnas.94.19.10255; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Kronenberg M, 2005, NATURE, V435, P598, DOI 10.1038/nature03725; Kronenberg M, 2007, CURR OPIN IMMUNOL, V19, P186, DOI 10.1016/j.coi.2007.02.009; Lamb TJ, 2008, IMMUNITY, V28, P288, DOI 10.1016/j.immuni.2008.02.003; Liu Y, 2006, J IMMUNOL METHODS, V312, P34, DOI 10.1016/j.jim.2006.02.009; Maeda T, 2007, SCIENCE, V316, P860, DOI 10.1126/science.1140881; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Matsuda JL, 2005, CURR OPIN IMMUNOL, V17, P122, DOI 10.1016/j.coi.2005.01.002; McConnell MJ, 2007, CURR TOP MICROBIOL, V313, P31; McConnell MJ, 2003, MOL CELL BIOL, V23, P9375, DOI 10.1128/MCB.23.24.9375-9388.2003; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Nichols KE, 2005, NAT MED, V11, P340, DOI 10.1038/nm1189; Parrado A, 2004, P NATL ACAD SCI USA, V101, P1898, DOI 10.1073/pnas.0308358100; Pasquier B, 2005, J EXP MED, V201, P695, DOI 10.1084/jem.20042432; Pellicci DG, 2005, J IMMUNOL, V175, P4416, DOI 10.4049/jimmunol.175.7.4416; Pellicci DG, 2002, J EXP MED, V195, P835, DOI 10.1084/jem.20011544; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Quaranta MT, 2006, ONCOGENE, V25, P399, DOI 10.1038/sj.onc.1209060; Rothenberg EV, 2002, DEV BIOL, V246, P29, DOI 10.1006/dbio.2002.0667; Shiraishi K, 2007, ONCOGENE, V26, P339, DOI 10.1038/sj.onc.1209800; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Veillette A, 2006, NAT REV IMMUNOL, V6, P56, DOI 10.1038/nri1761; Yu KOA, 2007, J IMMUNOL METHODS, V323, P11, DOI 10.1016/j.jim.2007.03.006; Zelent A, 2001, ONCOGENE, V20, P7186, DOI 10.1038/sj.onc.1204766	62	408	411	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2008	9	9					1055	1064		10.1038/ni.1641	http://dx.doi.org/10.1038/ni.1641			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339DZ	18660811	Green Accepted			2022-12-18	WOS:000258559600018
J	Lucas, CL; Kuehn, HS; Zhao, F; Niemel, JE; Deenick, EK; Palendira, U; Avery, DT; Moens, L; Cannons, JL; Lanai, MB; Stoddard, J; Ouyane, W; Frucht, DM; Rao, VK; Atkinson, TP; Agharahimi, A; Hussey, AA; Folioll, LR; Olivier, KN; Fleisher, TA; Pittaluga, S; Holland, SM; Cohen, JI; Oliveira, JB; Tangye, SG; Schwartzberg, PL; Lenardol, MJ; Uzel, G				Lucas, Carrie L.; Kuehn, Hye Sun; Zhao, Fang; Niemel, Julie E.; Deenick, Elissa K.; Palendira, Umaimainthan; Avery, Danielle T.; Moens, Leen; Cannons, Jennifer L.; Lanai, Matthew Bianca; Stoddard, Jennifer; Ouyane, Weiming; Frucht, David M.; Rao, V. Koneti; Atkinson, T. Prescott; Agharahimi, Anahita; Hussey, Ashleigh A.; Folioll, Les R.; Olivier, Kenneth N.; Fleisher, Thomas A.; Pittaluga, Stefania; Holland, Steven M.; Cohen, Jeffrey I.; Oliveira, Joao B.; Tangye, Stuart G.; Schwartzberg, Pamela L.; Lenardol, Michael J.; Uzel, Gulbu			Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110 delta result in T cell senescence and human immunodeficiency	NATURE IMMUNOLOGY			English	Article							IMPAIRED B-CELL; PHOSPHOINOSITIDE 3-KINASE; P85-ALPHA SUBUNIT; CLASS IPI3K; P110 DELTA; MTOR; MEMORY; DIFFERENTIATION; KINASE; METABOLISM	The p110 delta subunit of phosphatidylinositol-3-OH kinase (PI(3)K) is selectively expressed in leukocytes and is critical for lymphocyte biology. Here we report fourteen patients from seven families who were heterozygous for three different germline, gain-of-function mutations in PIK3CD (which encodes p110 delta). These patients presented with sinopulmonary infections, lymphadenopathy, nodular lymphoid hyperplasia and viremia due to cytomegalovirus (CMV) and/or Epstein-Barr virus (EBV). Strikingly, they had a substantial deficiency in naive T cells but an over-representation of senescent effector T cells. In vitro, T cells from patients exhibited increased phosphorylation of the kinase Akt and hyperactivation of the metabolic checkpoint kinase mTOR, enhanced glucose uptake and terminal effector differentiation. Notably, treatment with rapamycin to inhibit mTOR activity in vivo partially restored the abundance of naive T cells, largely 'rescued' the in vitro T cell defects and improved the clinical course.	[Lucas, Carrie L.; Lanai, Matthew Bianca; Lenardol, Michael J.] NIAID, Immunol Lab, NIH, Mol Dev Immune Syst Sect, Bethesda, MD 20892 USA; [Kuehn, Hye Sun; Niemel, Julie E.; Stoddard, Jennifer; Fleisher, Thomas A.] NIH, Ctr Clin, Dept Lab Med, Bethesda, MD USA; [Zhao, Fang; Cannons, Jennifer L.; Schwartzberg, Pamela L.] NHGRI, NIH, Genet Dis Res Branch, Cell Signaling Sect, Bethesda, MD 20892 USA; [Zhao, Fang] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Deenick, Elissa K.; Palendira, Umaimainthan; Avery, Danielle T.; Moens, Leen] Garvan Inst Med Res, Immunol & Immunodeficiency Grp, Program Immunol, Sydney, NSW, Australia; [Deenick, Elissa K.; Palendira, Umaimainthan] Univ New S Wales, Fac Med, St Vincents Clin Sch, Sydney, NSW, Australia; [Ouyane, Weiming; Frucht, David M.] United States Food & Drug Adm, Ctr Drug Evaluat & Res, Off Biotechnol Prod, Div Monoclonal Antibodies,Lab Cell Biol, Bethesda, MD USA; [Atkinson, T. Prescott] Univ Alabama Birmingham, Dept Pediat, Div Allergy & Immunol, Birmingham, AL USA; [Olivier, Kenneth N.; Holland, Steven M.] Frederick Natl Lab Clin Res, Sci Applicatidns Int Corp Frederick, Clin Monitoring Res Program, Clin Res Directorate,Lab Clin Infect Dis, Frederick, MD USA; [Agharahimi, Anahita] NIH, Ctr Clin, Bethesda, MD USA; [Folioll, Les R.] Natl Canc Inst, NIH, Pathol Lab, Bethesda, MD USA; [Pittaluga, Stefania] Natl Inst Allergy & Infect Dis, Natl Inst Hlth, Lab Infect Dis, Bethesda, MD USA; [Cohen, Jeffrey I.] Inst Med Integral Prof Fernando Figue, Recife Pernambuco, Brazil	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Chicago; Garvan Institute of Medical Research; University of New South Wales Sydney; US Food & Drug Administration (FDA); University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Instituto de Medicina Integral Professor Fernando Figueira (IMIP)	Uzel, G (corresponding author), NIAID, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	guzel@niaid.nih.gov	Palendira, Umaimainthan/AAA-6447-2022; Tangye, Stuart G/H-4023-2014; de Oliveira, João/GWV-0126-2022; Rao, V. Koneti/AAR-2171-2020; Oliveira, Joao Bosco/AAC-9947-2021; Deenick, Elissa/AAY-8998-2020	Tangye, Stuart G/0000-0002-5360-5180; Rao, V. Koneti/0000-0002-7881-6902; Oliveira, Joao Bosco/0000-0001-9388-8173; Deenick, Elissa/0000-0002-9271-0004; Niemela, Julie/0000-0003-4197-3792; Biancalana, Matthew/0000-0002-1078-1838; Zhao, Fang/0000-0002-5059-0833; Lucas, Carrie/0000-0002-5754-0820	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Clinical Center of the US National Institutes of Health; National Human Genome Research Institute of the US National Institutes of Health; Frederick National Laboratory for Cancer Research of the US National Institutes of Health [HHSN261200800001E]; National Health and Medical Research Council of Australia; Cancer Council NSW; Cancer Institute NSW; Research Foundation-Flanders, Belgium; National Institute of General Medical Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006201] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000646, ZIAAI000769, ZIAAI000913, ZIAAI000647, ZIAAI000717, ZIAAI000732] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Clinical Center of the US National Institutes of Health; National Human Genome Research Institute of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Frederick National Laboratory for Cancer Research of the US National Institutes of Health; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council NSW(Cancer Council New South Wales); Cancer Institute NSW; Research Foundation-Flanders, Belgium(FWO); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the referring physicians, as well as the patients and families. Supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Clinical Center of the US National Institutes of Health (C.L.L., H.S.K., J.E.N., M.B., J.S., WO., V.K.R., A.A., A.A.H., K.N.O., T.A.F., S.P., S.M.H., J.I.C., M.J.L., G.U.), the National Human Genome Research Institute of the US National Institutes of Health (F.Z., J.L.C., P.L.S.), the Frederick National Laboratory for Cancer Research of the US National Institutes of Health (HHSN261200800001E), the National Health and Medical Research Council of Australia (E.K.D., UP., S.G.T.), Cancer Council NSW (S.G.T.), the Cancer Institute NSW (U.P.), the Research Foundation-Flanders, Belgium (L.M.) and the National Institute of General Medical Sciences (C.L.L. and R.Z.). The content of this publication does not necessarily reflect the views or policies of the US Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US Government.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Amzel LM, 2008, NAT REV CANCER, V8, P665, DOI 10.1038/nrc2443; Angulo I, 2013, SCIENCE, V342, P866, DOI 10.1126/science.1243292; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Astle MV, 2012, ONCOGENE, V31, P1949, DOI 10.1038/onc.2011.394; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Berndt A, 2010, NAT CHEM BIOL, V6, P117, DOI [10.1038/nchembio.293, 10.1038/NCHEMBIO.293]; Billottet C, 2006, ONCOGENE, V25, P6648, DOI 10.1038/sj.onc.1209670; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Chantry D, 1997, J BIOL CHEM, V272, P19236, DOI 10.1074/jbc.272.31.19236; Conley ME, 2012, J EXP MED, V209, P463, DOI 10.1084/jem.20112533; Damgaard RB, 2013, EMBO MOL MED, V5, P1278, DOI 10.1002/emmm.201303090; Denley A, 2008, ONCOGENE, V27, P2561, DOI 10.1038/sj.onc.1210918; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Gourley TS, 2004, SEMIN IMMUNOL, V16, P323, DOI 10.1016/j.smim.2004.08.013; Gubser PM, 2013, NAT IMMUNOL, V14, P1064, DOI 10.1038/ni.2687; Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Jarrett AF, 1996, ANN ONCOL, V7, P5; Jou ST, 2006, INT J IMMUNOGENET, V33, P361, DOI 10.1111/j.1744-313X.2006.00627.x; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kim EH, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00020; Kim EH, 2012, J IMMUNOL, V188, P4305, DOI 10.4049/jimmunol.1103568; Lannutti BJ, 2011, BLOOD, V117, P591, DOI 10.1182/blood-2010-03-275305; Li FY, 2011, NATURE, V475, P471, DOI 10.1038/nature10246; Mandelker D, 2009, P NATL ACAD SCI USA, V106, P16996, DOI 10.1073/pnas.0908444106; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Okkenhaug K, 2002, SCIENCE, V297, P1031; Omori SA, 2006, IMMUNITY, V25, P545, DOI 10.1016/j.immuni.2006.08.015; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Suzuki H, 1999, SCIENCE, V283, P390, DOI 10.1126/science.283.5400.390; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wu HY, 2009, P NATL ACAD SCI USA, V106, P20258, DOI 10.1073/pnas.0902369106; Xu XJ, 2012, SEMIN IMMUNOL, V24, P429, DOI 10.1016/j.smim.2012.12.005; Yang K, 2012, SEMIN IMMUNOL, V24, P421, DOI 10.1016/j.smim.2012.12.004; Yentrapalli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070024; Zhao L, 2008, ONCOGENE, V27, P5486, DOI 10.1038/onc.2008.244; Zhao L, 2008, P NATL ACAD SCI USA, V105, P2652, DOI 10.1073/pnas.0712169105; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014	48	407	427	1	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2014	15	1					88	97		10.1038/ni.2771	http://dx.doi.org/10.1038/ni.2771			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	277DZ	24165795	Green Accepted			2022-12-18	WOS:000328800500016
J	Klesney-Tait, J; Turnbull, IR; Colonna, M				Klesney-Tait, Julia; Turnbull, Isaiah R.; Colonna, Marco			The TREM receptor family and signal integration	NATURE IMMUNOLOGY			English	Review							NASU-HAKOLA-DISEASE; MIGRATION-INHIBITORY FACTOR; MYELOID CELLS-1 TREM-1; CUTTING EDGE; PRESENILE-DEMENTIA; CRYSTAL-STRUCTURE; SCLEROSING LEUKOENCEPHALOPATHY; OSTEOCLAST DIFFERENTIATION; DAP12-ASSOCIATED RECEPTOR; AMPLIFIES INFLAMMATION	TREM proteins are a family of cell surface receptors that participate in diverse cell processes, including inflammation, bone homeostasis, neurological development and coagulation. TREM-1, the first to be identified, acts to amplify inflammation. Other TREM proteins regulate the differentiation and function of macrophages, microglia, dendritic cells, osteoclasts and platelets. Here we discuss the state of the field, putative ligands of TREM proteins and the challenges that remain in understanding TREM biology.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	mcolonna@pathology.wustl.edu		Colonna, Marco/0000-0001-5222-4987; Klesney-Tait, julia/0000-0002-0261-8395				Agarwal PK, 2003, NEW ENGL J MED, V348, P1600; Aguilar H, 2004, J IMMUNOL, V173, P6703, DOI 10.4049/jimmunol.173.11.6703; Allcock RJN, 2003, EUR J IMMUNOL, V33, P567, DOI 10.1002/immu.200310033; Aoki N, 2004, INFECT IMMUN, V72, P2477, DOI 10.1128/IAI.72.5.2477-2483.2004; Barrow AD, 2004, J IMMUNOL, V172, P5838, DOI 10.4049/jimmunol.172.10.5838; Barrow AD, 2006, EUR J IMMUNOL, V36, P1646, DOI 10.1002/eji.200636195; Begum NA, 2004, INFECT IMMUN, V72, P937, DOI 10.1128/IAI.72.2.937-948.2004; Blasius AL, 2006, TRENDS IMMUNOL, V27, P255, DOI 10.1016/j.it.2006.04.005; Bleharski JR, 2003, J IMMUNOL, V170, P3812, DOI 10.4049/jimmunol.170.7.3812; Bouchon A, 2001, J EXP MED, V194, P1111, DOI 10.1084/jem.194.8.1111; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; Cella M, 2003, J EXP MED, V198, P645, DOI 10.1084/jem.20022220; Chung DH, 2002, EUR J IMMUNOL, V32, P59, DOI 10.1002/1521-4141(200201)32:1<59::AID-IMMU59>3.0.CO;2-U; Chung DH, 2003, J IMMUNOL, V171, P6541, DOI 10.4049/jimmunol.171.12.6541; Clark GJ, 2000, TISSUE ANTIGENS, V55, P101, DOI 10.1034/j.1399-0039.2000.550201.x; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Daws MR, 2001, EUR J IMMUNOL, V31, P783, DOI 10.1002/1521-4141(200103)31:3<783::AID-IMMU783>3.0.CO;2-U; Daws MR, 2003, J IMMUNOL, V171, P594, DOI 10.4049/jimmunol.171.2.594; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Faccio R, 2003, J CELL BIOCHEM, V90, P871, DOI 10.1002/jcb.10694; Gattis JL, 2006, J BIOL CHEM, V281, P13396, DOI 10.1074/jbc.M600489200; Gibot S, 2004, J EXP MED, V200, P1419, DOI 10.1084/jem.20040708; Gibot S, 2004, NEW ENGL J MED, V350, P451, DOI 10.1056/NEJMoa031544; Gibot S, 2004, ANN INTERN MED, V141, P9, DOI 10.7326/0003-4819-141-1-200407060-00009; Gingras MC, 2002, MOL IMMUNOL, V38, P817, DOI 10.1016/S0161-5890(02)00004-4; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Green BJ, 1998, INT IMMUNOL, V10, P891, DOI 10.1093/intimm/10.7.891; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; HAMERMAN JA, 2006, SCI STKE, pRE1, DOI DOI 10.1126/STKE.3202006RE1; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Humphrey MB, 2006, J BONE MINER RES, V21, P237, DOI 10.1359/JBMR.051016; Humphrey MB, 2004, J BONE MINER RES, V19, P224, DOI 10.1359/JBMR.0301234; JACKSON DG, 1992, EUR J IMMUNOL, V22, P1157, DOI 10.1002/eji.1830220508; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Karpanen T, 2006, FASEB J, V20, P1462, DOI 10.1096/fj.05-5646com; Kelker MS, 2004, J MOL BIOL, V342, P1237, DOI 10.1016/j.jmb.2004.07.089; Kelker MS, 2004, J MOL BIOL, V344, P1175, DOI 10.1016/j.jmb.2004.10.009; King RG, 2006, J IMMUNOL, V176, P6012, DOI 10.4049/jimmunol.176.10.6012; KITAJIMA I, 1989, J NEUROL SCI, V91, P35, DOI 10.1016/0022-510X(89)90074-9; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Kondo T, 2002, NEUROLOGY, V59, P1105, DOI 10.1212/WNL.59.7.1105; Koussoulas V, 2006, EUR J GASTROEN HEPAT, V18, P375, DOI 10.1097/00042737-200604000-00010; Lanier LL, 2003, CURR OPIN IMMUNOL, V15, P308, DOI 10.1016/S0952-7915(03)00039-6; Mahdy AM, 2006, CLIN VACCINE IMMUNOL, V13, P492, DOI 10.1128/CVI.13.4.492-495.2006; MCVICAR DW, 2001, SCI STKE, pRE1, DOI DOI 10.1126/STKE.2001.75.RE1; Mohamadzadeh M, 2006, J VIROL, V80, P7235, DOI 10.1128/JVI.00543-06; Murakami Y, 2006, ARTHRITIS RHEUM-US, V54, P455, DOI 10.1002/art.21633; Nataf S, 2005, AM J PATHOL, V166, P275, DOI 10.1016/S0002-9440(10)62251-1; Nathan C, 2001, NAT MED, V7, P530, DOI 10.1038/87846; NETEA MG, IN PRESS J LEUKOCYTE; Nochi H, 2003, AM J PATHOL, V162, P1191, DOI 10.1016/S0002-9440(10)63915-6; Paloneva J, 2003, J EXP MED, V198, P669, DOI 10.1084/jem.20030027; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Radaev S, 2003, STRUCTURE, V11, P1527, DOI 10.1016/j.str.2003.11.001; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Ru LB, 2006, ARTHRITIS RHEUM-US, V54, P383, DOI 10.1002/art.21634; Schenk M, 2005, J IMMUNOL, V174, P517, DOI 10.4049/jimmunol.174.1.517; Schmid CD, 2002, J NEUROCHEM, V83, P1309, DOI 10.1046/j.1471-4159.2002.01243.x; Sessa G, 2004, EUR J NEUROSCI, V20, P2617, DOI 10.1111/j.1460-9568.2004.03729.x; Stet RJM, 2005, IMMUNOGENETICS, V57, P77, DOI 10.1007/s00251-005-0771-9; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Takegahara N, 2006, NAT CELL BIOL, V8, P615, DOI 10.1038/ncb1416; Tamagnone L, 2006, NAT CELL BIOL, V8, P545, DOI 10.1038/ncb0606-545; Tanaka J, 2000, NEUROPATHOLOGY, V20, pS25; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Turnbull IR, 2005, J EXP MED, V202, P363, DOI 10.1084/jem.20050986; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; Tzivras M, 2006, WORLD J GASTROENTERO, V12, P3416, DOI 10.3748/wjg.v12.i21.3416; Verloes A, 1997, J MED GENET, V34, P753, DOI 10.1136/jmg.34.9.753; Viertlboeck BC, 2006, IMMUNOGENETICS, V58, P180, DOI 10.1007/s00251-006-0091-8; Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Washington AV, 2004, BLOOD, V104, P1042, DOI 10.1182/blood-2004-01-0315; Washington AV, 2002, BLOOD, V100, P3822, DOI 10.1182/blood-2002-02-0523; Yang H, 2001, SHOCK, V15, P247, DOI 10.1097/00024382-200115040-00001	81	406	436	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2006	7	12					1266	1273		10.1038/ni1411	http://dx.doi.org/10.1038/ni1411			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	106TU	17110943				2022-12-18	WOS:000242125200006
J	Saric, T; Chang, SC; Hattori, A; York, IA; Markant, S; Rock, KL; Tsujimoto, M; Goldberg, AL				Saric, T; Chang, SC; Hattori, A; York, IA; Markant, S; Rock, KL; Tsujimoto, M; Goldberg, AL			An IFN-gamma-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides	NATURE IMMUNOLOGY			English	Article							DISTINCT PROTEOLYTIC PROCESSES; HISTOCOMPATIBILITY CLASS-I; T-LYMPHOCYTE EPITOPES; MAJOR HISTOCOMPATIBILITY; ENDOPLASMIC-RETICULUM; LEUCINE AMINOPEPTIDASE; ANTIGEN PRESENTATION; INTERFERON-GAMMA; BINDING PEPTIDES; CELL-PROTEINS	Precursors to major histocompatibility complex (MHC) class I-presented peptides with extra NH2-terminal residues can be efficiently trimmed to mature epitopes in the endoplasmic reticulum (ER). Here, we purified from liver microsomes a lumenal, soluble aminopeptidase that removes NH2-terminal residues from many antigenic precursors. It was identified as a metallopeptidase named "adipocyte-derived leucine" or "puromycin-insensitive leucine-specific" aminopeptidase. However, because we localized it to the ER, we propose it be renamed ER-aminopeptidase 1 (ERAP1). ERAP1 is inhibited by agents that block precursor trimming in ER vesicles and although it trimmed NH2-extended precursors, it spared presented peptides of 8 amino acid and less. Like other proteins involved in antigen presentation, ERAP1 is induced by interferon-gamma. When overexpressed in vivo, we found that ERAP1 stimulates the processing and presentation of an antigenic precursor in the ER.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; RIKEN, Lab Cellular Biochem, Wako, Saitama 3510198, Japan; Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA	Harvard University; Harvard Medical School; RIKEN; University of Massachusetts System; University of Massachusetts Worcester	Goldberg, AL (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.		Hsiao, Wei-Hung/B-9931-2013; Saric, Tomo/B-3415-2015; York, Ian/X-9351-2019	Saric, Tomo/0000-0001-8344-1095; York, Ian/0000-0002-3478-3344; CHANG, SHIH-CHUNG/0000-0002-5015-8178				Beninga J, 1998, J BIOL CHEM, V273, P18734, DOI 10.1074/jbc.273.30.18734; Botbol V, 1985, Prog Clin Biol Res, V180, P573; Brouwenstijn N, 2001, IMMUNITY, V15, P95, DOI 10.1016/S1074-7613(01)00174-1; Cascio P, 2002, EMBO J, V21, P2636, DOI 10.1093/emboj/21.11.2636; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Cerundolo V, 1997, EUR J IMMUNOL, V27, P336, DOI 10.1002/eji.1830270148; Craiu A, 1997, P NATL ACAD SCI USA, V94, P10850, DOI 10.1073/pnas.94.20.10850; Craiu A, 1997, J BIOL CHEM, V272, P13437, DOI 10.1074/jbc.272.20.13437; ELLIOTT T, 1995, J EXP MED, V181, P1481, DOI 10.1084/jem.181.4.1481; FALK K, 1990, NATURE, V348, P248, DOI 10.1038/348248a0; Fruci D, 2001, IMMUNITY, V15, P467, DOI 10.1016/S1074-7613(01)00203-5; GACZYNSKA M, 1994, P NATL ACAD SCI USA, V91, P9213, DOI 10.1073/pnas.91.20.9213; Gaczynska M, 1996, J BIOL CHEM, V271, P17275, DOI 10.1074/jbc.271.29.17275; GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0; Goldberg AL, 2002, MOL IMMUNOL, V39, P147, DOI 10.1016/S0161-5890(02)00098-6; HARDING CV, 1995, J IMMUNOL, V155, P1767; HARRIS CA, 1992, J BIOL CHEM, V267, P6865; Hattori A, 1999, J BIOCHEM-TOKYO, V125, P931, DOI 10.1093/oxfordjournals.jbchem.a022371; Hattori A, 2001, J BIOCHEM-TOKYO, V130, P235, DOI 10.1093/oxfordjournals.jbchem.a002977; Hattori A, 2000, J BIOCHEM-TOKYO, V128, P755, DOI 10.1093/oxfordjournals.jbchem.a022812; KELLER SR, 1995, J BIOL CHEM, V270, P23612, DOI 10.1074/jbc.270.40.23612; Kisselev AF, 1999, J BIOL CHEM, V274, P3363, DOI 10.1074/jbc.274.6.3363; Knuehl C, 2001, J IMMUNOL, V167, P1515, DOI 10.4049/jimmunol.167.3.1515; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Komlosh A, 2001, J BIOL CHEM, V276, P30050, DOI 10.1074/jbc.M103177200; Lauvau G, 1999, J EXP MED, V190, P1227, DOI 10.1084/jem.190.9.1227; Lobigs M, 2000, EUR J IMMUNOL, V30, P1496, DOI 10.1002/(SICI)1521-4141(200005)30:5<1496::AID-IMMU1496>3.0.CO;2-6; Lucchiari-Hartz M, 2000, J EXP MED, V191, P239, DOI 10.1084/jem.191.2.239; LYKO F, 1995, J BIOL CHEM, V270, P19873, DOI 10.1074/jbc.270.34.19873; Menoret A, 2001, J BIOL CHEM, V276, P33313, DOI 10.1074/jbc.M103383200; Miyashita H, 2002, BLOOD, V99, P3241, DOI 10.1182/blood.V99.9.3241; Mo XY, 1999, J IMMUNOL, V163, P5851; NEISIG A, 1995, J IMMUNOL, V154, P1273; Paz P, 1999, IMMUNITY, V11, P241, DOI 10.1016/S1074-7613(00)80099-0; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Reed RC, 2002, J BIOL CHEM, V277, P25082, DOI 10.1074/jbc.M203195200; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; ROELSE J, 1994, J EXP MED, V180, P1591, DOI 10.1084/jem.180.5.1591; Rogi T, 1996, J BIOL CHEM, V271, P56, DOI 10.1074/jbc.271.1.56; Saric T, 2001, J BIOL CHEM, V276, P36474, DOI 10.1074/jbc.M105517200; Schomburg L, 2000, EUR J BIOCHEM, V267, P3198, DOI 10.1046/j.1432-1327.2000.01348.x; Serwold T, 2001, NAT IMMUNOL, V2, P644, DOI 10.1038/89800; SNYDER HL, 1994, J EXP MED, V180, P2389, DOI 10.1084/jem.180.6.2389; Snyder HL, 1998, EUR J IMMUNOL, V28, P1339; Stoltze L, 2000, NAT IMMUNOL, V1, P413, DOI 10.1038/80852; WALTER P, 1983, METHOD ENZYMOL, V96, P84; Wang L, 1999, FEBS LETT, V457, P316, DOI 10.1016/S0014-5793(99)01075-3; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Yamamoto N, 2002, HUM MUTAT, V19, P251, DOI 10.1002/humu.10047; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860	51	406	431	1	22	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2002	3	12					1169	1176		10.1038/ni859	http://dx.doi.org/10.1038/ni859			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	619GP	12436109				2022-12-18	WOS:000179467800015
J	Whitsett, JA; Alenghat, T				Whitsett, Jeffrey A.; Alenghat, Theresa			Respiratory epithelial cells orchestrate pulmonary innate immunity	NATURE IMMUNOLOGY			English	Review							SURFACTANT PROTEIN-C; ENDOPLASMIC-RETICULUM STRESS; TOLL-LIKE RECEPTORS; PRIMARY CILIARY DYSKINESIA; SYNCYTIAL VIRUS-INFECTION; AIRWAY MUCOUS METAPLASIA; HOUSE-DUST MITE; ALVEOLAR PROTEINOSIS; ALLERGIC INFLAMMATION; LUNG INJURY	The epithelial surfaces of the lungs are in direct contact with the environment and are subjected to dynamic physical forces as airway tubes and alveoli are stretched and compressed during ventilation. Mucociliary clearance in conducting airways, reduction of surface tension in the alveoli, and maintenance of near sterility have been accommodated by the evolution of a multi-tiered innate host-defense system. The biophysical nature of pulmonary host defenses are integrated with the ability of respiratory epithelial cells to respond to and 'instruct' the professional immune system to protect the lungs from infection and injury.	[Whitsett, Jeffrey A.] Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Div Neonatol, Div Perinatal Biol, Cincinnati, OH 45229 USA; [Whitsett, Jeffrey A.] Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Div Pulm Biol, Cincinnati, OH 45229 USA; [Whitsett, Jeffrey A.; Alenghat, Theresa] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Alenghat, Theresa] Cincinnati Childrens Hosp Med Ctr, Div Immunol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Whitsett, JA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Div Neonatol, Div Perinatal Biol, Cincinnati, OH 45229 USA.	jeff.whitsett@cchmc.org			US National Institutes of Health [HL110964, HL122642, HL110967, DK093784]; Burroughs Wellcome Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL110964, U01HL122642, U01HL110967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092306, K08DK093784] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank B. Trapnell, J. Kitzmiller, T. Thatava and S. Wert for images and artwork, and A. Maher for manuscript preparation. Supported by the US National Institutes of Health (HL110964, HL122642 and HL110967 to J.A.W., and DK093784) and the Burroughs Wellcome Fund (T.A.).	Akei H, 2006, AM J PHYSIOL-LUNG C, V291, pL572, DOI 10.1152/ajplung.00060.2006; Alevy YG, 2012, J CLIN INVEST, V122, P4555, DOI 10.1172/JCI64896; Ariki S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/532071; Armstrong L, 2004, AM J RESP CELL MOL, V31, P241, DOI 10.1165/rcmb.2004-0078OC; Augusto LA, 2002, J BIOL CHEM, V277, P23484, DOI 10.1074/jbc.M111925200; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Berclaz PY, 2007, AM J RESP CELL MOL, V36, P114, DOI 10.1165/rcmb.2006-0174OC; Bertolusso R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093396; Bhattacharya J, 2013, ANNU REV PHYSIOL, V75, P593, DOI 10.1146/annurev-physiol-030212-183756; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Button B, 2012, SCIENCE, V337, P937, DOI 10.1126/science.1223012; Chen G, 2014, AM J RESP CRIT CARE, V189, P301, DOI 10.1164/rccm.201306-1181OC; Chen G, 2009, J CLIN INVEST, V119, P2914, DOI 10.1172/JCI39731; Chen R, 2004, BIOCHEM BIOPH RES CO, V324, P1087, DOI 10.1016/j.bbrc.2004.09.157; Choksi SP, 2014, DEVELOPMENT, V141, P1427, DOI 10.1242/dev.074666; Cleaver JO, 2014, MUCOSAL IMMUNOL, V7, P78, DOI 10.1038/mi.2013.26; Cloonan SM, 2014, AUTOPHAGY, V10, P532, DOI 10.4161/auto.27641; Dahlin K, 2004, AM J RESP CELL MOL, V31, P309, DOI 10.1165/rcmb.2003-0423OC; Dickson RP, 2013, EXPERT REV RESP MED, V7, P245, DOI [10.1586/ERS.13.24, 10.1586/ers.13.24]; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Ehre C, 2012, P NATL ACAD SCI USA, V109, P16528, DOI 10.1073/pnas.1206552109; Ellson CD, 2014, AM J RESP CELL MOL, V51, P163, DOI 10.1165/rcmb.2013-0366TR; Erle DJ, 2014, J CELL BIOL, V205, P621, DOI 10.1083/jcb.201401050; Fingerlin TE, 2013, NAT GENET, V45, P613, DOI 10.1038/ng.2609; Frank JA, 2012, ANN NY ACAD SCI, V1257, P175, DOI 10.1111/j.1749-6632.2012.06533.x; Fujisawa T, 2011, AM J RESP CELL MOL, V45, P246, DOI 10.1165/rcmb.2009-0313OC; Georas SN, 2014, J ALLERGY CLIN IMMUN, V134, P509, DOI 10.1016/j.jaci.2014.05.049; Gieseler F., CELL COMMUN SIGNAL, V11; Glasser SW, 2013, AM J RESP CELL MOL, V49, P845, DOI 10.1165/rcmb.2012-0374OC; Glasser SW, 2009, AM J PHYSIOL-LUNG C, V297, pL64, DOI 10.1152/ajplung.90640.2008; Glasser SW, 2003, J BIOL CHEM, V278, P14291, DOI 10.1074/jbc.M210909200; Grainge CL, 2013, CHEST, V144, P1906, DOI 10.1378/chest.12-1944; Groskreutz DJ, 2006, J IMMUNOL, V176, P1733, DOI 10.4049/jimmunol.176.3.1733; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Guseh JS, 2009, DEVELOPMENT, V136, P1751, DOI 10.1242/dev.029249; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hansel TT, 2013, LANCET, V381, P861, DOI 10.1016/S0140-6736(12)62202-8; Hartshorn Kevan L, 2010, Front Biosci (Schol Ed), V2, P527; Hasnain SZ, 2011, J EXP MED, V208, P893, DOI 10.1084/jem.20102057; Heaton NS, 2014, J EXP MED, V211, P1707, DOI 10.1084/jem.20140488; Henderson AG, 2014, J CLIN INVEST, V124, P3047, DOI 10.1172/JCI73469; Hertz CJ, 2003, J IMMUNOL, V171, P6820, DOI 10.4049/jimmunol.171.12.6820; Hill DA, 2012, NAT MED, V18, P538, DOI 10.1038/nm.2657; Hoegger MJ, 2014, P NATL ACAD SCI USA, V111, P2355, DOI 10.1073/pnas.1323633111; Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; Huang F, 2012, P NATL ACAD SCI USA, V109, P16354, DOI 10.1073/pnas.1214596109; Ibrahim ZA, 2013, MOL IMMUNOL, V56, P739, DOI 10.1016/j.molimm.2013.07.008; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Juncadella IJ, 2013, NATURE, V493, P547, DOI 10.1038/nature11714; Kang JH, 2015, IMMUNOLOGY, V144, P79, DOI 10.1111/imm.12352; Knowles MR, 2013, AM J RESP CRIT CARE, V188, P913, DOI 10.1164/rccm.201301-0059CI; Koeppen M, 2013, MUCOSAL IMMUNOL, V6, P762, DOI 10.1038/mi.2012.114; Korfei M, 2008, AM J RESP CRIT CARE, V178, P838, DOI 10.1164/rccm.200802-313OC; Korfhagen TR, 2012, P NATL ACAD SCI USA, V109, P16630, DOI 10.1073/pnas.1208092109; Kotton DN, 2014, NAT MED, V20, P822, DOI 10.1038/nm.3642; Kouzaki H, 2013, AM J RESP CELL MOL, V49, P741, DOI 10.1165/rcmb.2012-0304OC; Kouzaki H, 2009, J IMMUNOL, V183, P1427, DOI 10.4049/jimmunol.0900904; Koval M, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24518; Koval M, 2013, ANNU REV PHYSIOL, V75, P551, DOI 10.1146/annurev-physiol-030212-183809; Kreda SM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009589; LaFemina MJ, 2014, AM J RESP CELL MOL, V51, P550, DOI 10.1165/rcmb.2013-0456OC; Lambrecht BN, 2014, J ALLERGY CLIN IMMUN, V134, P499, DOI 10.1016/j.jaci.2014.06.036; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Li DQ, 2011, J ALLERGY CLIN IMMUN, V128, P1318, DOI 10.1016/j.jaci.2011.06.041; Luan XJ, 2014, P NATL ACAD SCI USA, V111, P12930, DOI 10.1073/pnas.1406414111; Maeda Y, 2011, AM J RESP CRIT CARE, V184, P421, DOI 10.1164/rccm.201101-0106OC; Maguire JA, 2011, AM J RESP CELL MOL, V44, P404, DOI 10.1165/rcmb.2009-0382OC; Martin FJ, 2008, J IMMUNOL, V180, P4986, DOI 10.4049/jimmunol.180.7.4986; Martinez-Moczygemba M, 2008, J EXP MED, V205, P2711, DOI 10.1084/jem.20080759; Martino MB, 2013, MUCOSAL IMMUNOL, V6, P639, DOI 10.1038/mi.2012.105; Matsui H, 2006, P NATL ACAD SCI USA, V103, P18131, DOI 10.1073/pnas.0606428103; McCormack FX, 2002, J CLIN INVEST, V109, P707, DOI 10.1172/JCI200215293; McKenzie Casey W, 2013, Cilia, V2, P18, DOI 10.1186/2046-2530-2-18; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Monick MM, 2003, J BIOL CHEM, V278, P53035, DOI 10.1074/jbc.M308093200; Monticelli LA, 2012, CURR OPIN IMMUNOL, V24, P284, DOI 10.1016/j.coi.2012.03.012; Morimoto M, 2012, DEVELOPMENT, V139, P4365, DOI 10.1242/dev.083840; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Nakahira K, 2013, AM J PHYSIOL-LUNG C, V305, pL93, DOI 10.1152/ajplung.00072.2013; Nhu QM, 2010, MUCOSAL IMMUNOL, V3, P29, DOI 10.1038/mi.2009.120; Numata M, 2013, J LIPID RES, V54, P2133, DOI 10.1194/jlr.M037077; Numata M, 2010, P NATL ACAD SCI USA, V107, P320, DOI 10.1073/pnas.0909361107; Osorio F, 2013, SEMIN IMMUNOPATHOL, V35, P293, DOI 10.1007/s00281-013-0368-6; Pace E, 2008, IMMUNOLOGY, V124, P401, DOI 10.1111/j.1365-2567.2007.02788.x; Pace E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033601; Parker D, 2011, TRENDS IMMUNOL, V32, P582, DOI 10.1016/j.it.2011.09.003; Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT; Popatia R, 2014, PEDIAT ALLER IMM PUL, V27, P51, DOI 10.1089/ped.2013.0314; Pouwels SD, 2014, MUCOSAL IMMUNOL, V7, P215, DOI 10.1038/mi.2013.77; Regueiro V, 2009, INFECT IMMUN, V77, P714, DOI 10.1128/IAI.00852-08; Rock JR, 2011, CELL STEM CELL, V8, P639, DOI 10.1016/j.stem.2011.04.003; Roy MG, 2014, NATURE, V505, P412, DOI 10.1038/nature12807; Ryan MA, 2006, J IMMUNOL, V176, P416, DOI 10.4049/jimmunol.176.1.416; Saab JB, 2014, FEBS LETT, V588, P1288, DOI 10.1016/j.febslet.2014.02.059; Scudieri P, 2012, J PHYSIOL-LONDON, V590, P6141, DOI 10.1113/jphysiol.2012.240838; Shornick LP, 2008, J IMMUNOL, V180, P3319, DOI 10.4049/jimmunol.180.5.3319; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Steele MP, 2013, ANNU REV MED, V64, P265, DOI 10.1146/annurev-med-042711-142004; Suzuki T, 2011, EUR RESPIR J, V37, P201, DOI 10.1183/09031936.00090610; Suzuki T, 2014, NATURE, V514, P450, DOI 10.1038/nature13807; Suzuki T, 2010, AM J RESP CRIT CARE, V182, P1292, DOI 10.1164/rccm.201002-0271OC; Suzuki T, 2008, J EXP MED, V205, P2703, DOI 10.1084/jem.20080990; Sze MA, 2012, AM J RESP CRIT CARE, V185, P1073, DOI 10.1164/rccm.201111-2075OC; Tan AM, 2010, J IMMUNOL, V184, P3535, DOI 10.4049/jimmunol.0900340; Tanjore H, 2012, AM J PHYSIOL-LUNG C, V302, pL721, DOI 10.1152/ajplung.00410.2011; Tecle T, 2010, INNATE IMMUN-LONDON, V16, P151, DOI 10.1177/1753425910365734; Thai P, 2008, ANNU REV PHYSIOL, V70, P405, DOI 10.1146/annurev.physiol.70.113006.100441; Trapnell BC, 2003, NEW ENGL J MED, V349, P2527, DOI 10.1056/NEJMra023226; Trapnell BC, 2009, CURR OPIN IMMUNOL, V21, P514, DOI 10.1016/j.coi.2009.09.004; Uehara A, 2007, MOL IMMUNOL, V44, P3100, DOI 10.1016/j.molimm.2007.02.007; Van Maele L, 2014, MUCOSAL IMMUNOL, V7, P489, DOI 10.1038/mi.2013.66; Voynow JA, 2009, CHEST, V135, P505, DOI 10.1378/chest.08-0412; Wang Q, 2009, J IMMUNOL, V183, P6989, DOI 10.4049/jimmunol.0901386; Wang XR, 2003, FASEB J, V17, P1727, DOI 10.1096/fj.02-0616fje; Westphalen K, 2014, NATURE, V506, P503, DOI 10.1038/nature12902; Whitsett JA, 2010, ANNU REV MED, V61, P105, DOI 10.1146/annurev.med.60.041807.123500; Willart MAM, 2012, J EXP MED, V209, P1505, DOI 10.1084/jem.20112691; Williams OW, 2006, AM J RESP CELL MOL, V34, P527, DOI 10.1165/rcmb.2005-0436SF; Yang L, 2010, J IMMUNOL, V184, P975, DOI 10.4049/jimmunol.0900650; Zhu L, 2009, AM J RESP CELL MOL, V40, P610, DOI 10.1165/rcmb.2008-0223OC	122	405	420	16	134	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2015	16	1					27	35		10.1038/ni.3045	http://dx.doi.org/10.1038/ni.3045			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AW8ET	25521682	Bronze, Green Accepted			2022-12-18	WOS:000346494200006
J	Hsieh, CS; Zheng, Y; Liang, YQ; Fontenot, JD; Rudensky, AY				Hsieh, CS; Zheng, Y; Liang, YQ; Fontenot, JD; Rudensky, AY			An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires	NATURE IMMUNOLOGY			English	Article							IN-VIVO; TOLERANCE; INDUCTION; FOXP3; AUTOIMMUNITY; EXPRESSION; SELECTION; PROTECT; THYMUS	The relationship between the T cell receptor (TCR) repertoires used by self-reactive transcription factor Foxp3-positive (Foxp3(+)) CD4(+) regulatory T cells (T-reg cells) and nonregulatory T cells with autoimmune potential is unclear. Here we found that the TCR repertoire of thymic T-reg cells in TCR beta-transgenic mice was diverse and was more similar to that of peripheral T-reg cells than that of nonregulatory T cells, suggesting that thymic T-reg cells make a substantial contribution to the peripheral T-reg cell population. Activated T cells in Foxp3-deficient mice, which lack T-reg cells, 'preferentially' used TCRs found in the TCR repertoire of T-reg cells in Foxp3-sufficient TCR beta-transgenic mice, suggesting that these self-reactive TCRs contribute to the pathology of Foxp3-deficient mice. Our analyses suggest that T-reg cells and potentially pathogenic autoimmune T cells use overlapping pools of self-reactive TCRs.	Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Div Rheumatol, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hsieh, CS (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	chsieh@im.wustl.edu; aruden@u.washington.edu	Zheng, Ye/G-4866-2015	Zheng, Ye/0000-0001-5012-4309				Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bhandoola A, 2002, IMMUNITY, V17, P425, DOI 10.1016/S1074-7613(02)00417-X; Casrouge A, 2000, J IMMUNOL, V164, P5782, DOI 10.4049/jimmunol.164.11.5782; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen ZB, 2005, P NATL ACAD SCI USA, V102, P14735, DOI 10.1073/pnas.0507014102; Colwell R.K., 2013, ESTIMATES STAT ESTIM; Correia-Neves M, 2001, IMMUNITY, V14, P21, DOI 10.1016/S1074-7613(01)00086-3; Fisson S, 2003, J EXP MED, V198, P737, DOI 10.1084/jem.20030686; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Itoh M, 1999, J IMMUNOL, V162, P5317; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Klein L, 2003, P NATL ACAD SCI USA, V100, P8886, DOI 10.1073/pnas.1533365100; Mach N, 2000, CANCER RES, V60, P3239; Magurran A.E, 1988, ECOLOGICAL DIVERSITY; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Olivares-Villagomez D, 1998, J EXP MED, V188, P1883, DOI 10.1084/jem.188.10.1883; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; SAKAGUCHI S, 1990, J EXP MED, V172, P537, DOI 10.1084/jem.172.2.537; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Seddon B, 1999, J EXP MED, V189, P877, DOI 10.1084/jem.189.5.877; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; TAGUCHI O, 1994, IMMUNOLOGY, V82, P365; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; Walker LSK, 2003, J EXP MED, V198, P249, DOI 10.1084/jem.20030315; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Wong P, 2000, J IMMUNOL, V164, P6252, DOI 10.4049/jimmunol.164.12.6252; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287	38	404	417	0	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2006	7	4					401	410		10.1038/ni1318	http://dx.doi.org/10.1038/ni1318			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	024BX	16532000				2022-12-18	WOS:000236171000014
J	Brenchley, JM; Price, DA; Douek, DC				Brenchley, JM; Price, DA; Douek, DC			HIV disease: fallout from a mucosal catastrophe?	NATURE IMMUNOLOGY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL DEPLETION; ACTIVE ANTIRETROVIRAL THERAPY; VERSUS-HOST-DISEASE; GASTROINTESTINAL-TRACT; TYPE-1 INFECTION; IMMUNE-RESPONSES; CD4 LYMPHOCYTES; LYMPHOID-TISSUE; SIV INFECTION	The pathogenesis of human immunodeficiency virus has long been thought to center on a gradual depletion of CD4(+) T cells, with an average of 100 cells lost per microliter of blood per year. However, studies of macaques infected with simian immunodeficiency virus and humans infected with human immunodeficiency virus have shown that the infection rapidly kills most CD4(+) T cells at mucosal surfaces. Although most CD4(+) T cells reside at these sites, the magnitude of this assault on the immune system is not reflected in the peripheral blood. Here we consider models of human immunodeficiency virus disease pathogenesis given those findings and propose a hypothesis to account for particular aspects of the disease during the chronic phase of infection that can be directly attributed to early depletion of mucosal CD4(+) T cells.	NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Brenchley, JM (corresponding author), NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA.	ddouek@nih.gov	Brenchley, Jason/AAC-5085-2019; Price, David A/C-7876-2013	Price, David A/0000-0001-9416-2737; Brenchley, Jason/0000-0001-8357-2984	MRC [G108/441] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI005034, ZIAAI005034] Funding Source: NIH RePORTER; Medical Research Council [G108/441] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Acheson DWK, 2004, BEST PRACT RES CL GA, V18, P387, DOI 10.1016/j.bpg.2003.11.002; Brenchley JM, 2004, J VIROL, V78, P1160, DOI 10.1128/JVI.78.3.1160-1168.2004; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Clayton F, 1997, CLIN EXP IMMUNOL, V107, P288, DOI 10.1111/j.1365-2249.1997.236-ce1111.x; Cooke KR, 1998, J CLIN INVEST, V102, P1882, DOI 10.1172/JCI4285; Cooke KR, 2002, J ENDOTOXIN RES, V8, P441, DOI 10.1179/096805102125001046; Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109; Dion ML, 2004, IMMUNITY, V21, P757, DOI 10.1016/j.immuni.2004.10.013; Douek DC, 2003, ANNU REV IMMUNOL, V21, P265, DOI 10.1146/annurev.immunol.21.120601.141053; Douek DC, 2001, J IMMUNOL, V167, P6663, DOI 10.4049/jimmunol.167.11.6663; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; EMBRETSON J, 1993, NATURE, V362, P359, DOI 10.1038/362359a0; George MD, 2005, J VIROL, V79, P2709, DOI 10.1128/JVI.79.5.2709-2719.2005; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Grossman Z, 2002, NAT MED, V8, P319, DOI 10.1038/nm0402-319; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Kieper WC, 2005, J IMMUNOL, V174, P3158, DOI 10.4049/jimmunol.174.6.3158; Kotler DP, 2005, AIDS, V19, P107, DOI 10.1097/00002030-200501280-00002; Lederman MM, 2004, SCIENCE, V306, P485, DOI 10.1126/science.1099288; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Lifson JD, 2000, J VIROL, V74, P2584, DOI 10.1128/JVI.74.6.2584-2593.2000; LIM SG, 1993, CLIN EXP IMMUNOL, V92, P448, DOI 10.1111/j.1365-2249.1993.tb03419.x; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; Picker LJ, 2004, J EXP MED, V200, P1299, DOI 10.1084/jem.20041049; Sankaran S, 2005, P NATL ACAD SCI USA, V102, P9860, DOI 10.1073/pnas.0503463102; Schacker TW, 2002, J CLIN INVEST, V110, P1133, DOI [10.1172/JCI200216413, 10.1172/JCI0216413]; Schneider T, 1996, Semin Gastrointest Dis, V7, P19; Sewell AK, 2000, STEM CELLS, V18, P230, DOI 10.1634/stemcells.18-4-230; Smed-Sorensen A, 2005, J VIROL, V79, P8861, DOI 10.1128/JVI.79.14.8861-8869.2005; Tesselaar K, 2003, NAT IMMUNOL, V4, P49, DOI 10.1038/ni869; VANBEKKUM DW, 1967, JNCI-J NATL CANCER I, V38, P223; Veazey RS, 2005, NATURE, V438, P99, DOI 10.1038/nature04055; Veazey RS, 2003, J INFECT DIS, V187, P769, DOI 10.1086/368386; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427	38	404	433	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2006	7	3					235	239		10.1038/ni1316	http://dx.doi.org/10.1038/ni1316			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	012SR	16482171				2022-12-18	WOS:000235360400007
J	Schenkel, JM; Fraser, KA; Vezys, V; Masopust, D				Schenkel, Jason M.; Fraser, Kathryn A.; Vezys, Vaiva; Masopust, David			Sensing and alarm function of resident memory CD8(+) T cells	NATURE IMMUNOLOGY			English	Article							RM CELLS; TISSUE; EFFECTOR; INFECTION; IMMUNITY; INNATE; SURVEILLANCE; PROTECTION; CHEMOKINES; MIGRATION	CD8(+) T cells eliminate intracellular infections through two contact-dependent effector functions: cytolysis and secretion of antiviral cytokines. Here we identify the following additional function for memory CD8(+) T cells that persist at front-line sites of microbial exposure: to serve as local sensors of previously encountered antigens that precipitate innate-like alarm signals and draw circulating memory CD8(+) T cells into the tissue. When memory CD8(+) T cells residing in the female mouse reproductive tract encountered cognate antigen, they expressed interferon-gamma (IFN-gamma), potentiated robust local expression of inflammatory chemokines and induced rapid recruitment of circulating memory CD8(+) T cells. Anamnestic responses in front-line tissues are thus an integrated collaboration between front-line and circulating populations of memory CD8(+) T cells, and vaccines should establish both populations to maximize rapid responses.	[Schenkel, Jason M.; Fraser, Kathryn A.; Vezys, Vaiva; Masopust, David] Univ Minnesota, Sch Med, Dept Microbiol, Ctr Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Masopust, D (corresponding author), Univ Minnesota, Sch Med, Dept Microbiol, Ctr Immunol, Minneapolis, MN 55455 USA.	masopust@umn.edu	Vezys, Vaiva/N-3144-2013; masopust, david/B-5027-2008; Schenkel, Jason/AAV-8184-2020	Schenkel, Jason/0000-0003-4641-6872; Vezys, Vaiva/0000-0002-2520-809X	US National Institutes of Health [R01AI084913-01, T32AI007313]; US National Institutes of Health (by the Office of The Director) [DP2OD006467]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084913, T32AI007313] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006467] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health (by the Office of The Director); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Mescher (University of Minnesota) for IFN-gamma-deficient OT-I mice, and S. Jameson for discussions. Supported by the US National Institutes of Health (R01AI084913-01 to D. M., DP2OD006467 (by the Office of The Director) to D. M., and T32AI007313 to J.M.S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Ariotti S, 2012, P NATL ACAD SCI USA, V109, P19739, DOI 10.1073/pnas.1208927109; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Bevan MJ, 2011, EUR J IMMUNOL, V41, P1192, DOI 10.1002/eji.201041377; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Cauley LS, 2013, MUCOSAL IMMUNOL, V6, P14, DOI 10.1038/mi.2012.96; Collins MK, 2009, J CLIN INVEST, V119, P2062, DOI 10.1172/JCI38714; Cuburu N, 2012, J CLIN INVEST, V122, P4606, DOI 10.1172/JCI63287; Eberlein J, 2010, J CLIN INVEST, V120, P907, DOI 10.1172/JCI40645; Gebhardt T, 2013, TRENDS IMMUNOL, V34, P27, DOI 10.1016/j.it.2012.08.008; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Hofmann M, 2011, P NATL ACAD SCI USA, V108, P16741, DOI 10.1073/pnas.1107200108; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Luster AD, 2002, CURR OPIN IMMUNOL, V14, P129, DOI 10.1016/S0952-7915(01)00308-9; Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Masopust D, 2012, J IMMUNOL, V188, P5811, DOI 10.4049/jimmunol.1102695; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Strutt TM, 2010, NAT MED, V16, P558, DOI 10.1038/nm.2142; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wakim LM, 2008, J IMMUNOL, V181, P5837, DOI 10.4049/jimmunol.181.9.5837; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889	31	403	410	2	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2013	14	5					509	+		10.1038/ni.2568	http://dx.doi.org/10.1038/ni.2568			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	127XL	23542740	Green Accepted			2022-12-18	WOS:000317732100016
J	Schmidt, M; Raghavan, B; Muller, V; Vogl, T; Fejer, G; Tchaptchet, S; Keck, S; Kalis, C; Nielsen, PJ; Galanos, C; Roth, J; Skerra, A; Martin, SF; Freudenberg, MA; Goebeler, M				Schmidt, Marc; Raghavan, Badrinarayanan; Mueller, Verena; Vogl, Thomas; Fejer, Gyoergy; Tchaptchet, Sandrine; Keck, Simone; Kalis, Christoph; Nielsen, Peter J.; Galanos, Chris; Roth, Johannes; Skerra, Arne; Martin, Stefan F.; Freudenberg, Marina A.; Goebeler, Matthias			Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; PROINFLAMMATORY GENE-EXPRESSION; ADAPTIVE IMMUNE-RESPONSES; HUMAN ENDOTHELIAL-CELLS; INNATE IMMUNITY; ACTIVATION; HYPERSENSITIVITY; COMPLEX; MICE; RECOGNITION	Allergies to nickel (Ni2+) are the most frequent cause of contact hypersensitivity (CHS) in industrialized countries. The efficient development of CHS requires both a T lymphocyte-specific signal and a proinflammatory signal. Here we show that Ni2+ triggered an inflammatory response by directly activating human Toll-like receptor 4 (TLR4). Ni2+-induced TLR4 activation was species-specific, as mouse TLR4 could not generate this response. Studies with mutant TLR4 proteins revealed that the non-conserved histidines 456 and 458 of human TLR4 are required for activation by Ni2+ but not by the natural ligand lipopolysaccharide. Accordingly, transgenic expression of human TLR4 in TLR4-deficient mice allowed efficient sensitization to Ni2+ and elicitation of CHS. Our data implicate site-specific human TLR4 inhibition as a potential strategy for therapeutic intervention in CHS that would not affect vital immune responses.	[Schmidt, Marc; Raghavan, Badrinarayanan; Mueller, Verena; Goebeler, Matthias] Univ Heidelberg, Univ Hosp Mannheim, Dept Dermatol, D-6800 Mannheim, Germany; [Schmidt, Marc; Raghavan, Badrinarayanan; Mueller, Verena; Goebeler, Matthias] Univ Giessen, Dept Dermatol, Giessen, Germany; [Vogl, Thomas; Roth, Johannes] Univ Munster, Inst Immunol, Munster, Germany; [Fejer, Gyoergy; Tchaptchet, Sandrine; Keck, Simone; Kalis, Christoph; Nielsen, Peter J.; Galanos, Chris; Freudenberg, Marina A.] Max Planck Inst Immunobiol, D-7800 Freiburg, Germany; [Skerra, Arne] Tech Univ Munich, Munich Ctr Integrated Prot Sci, D-8050 Freising Weihenstephan, Germany; [Skerra, Arne] Tech Univ Munich, Chair Biol Chem, D-8050 Freising Weihenstephan, Germany; [Martin, Stefan F.] Univ Med Ctr Freiburg, Dept Dermatol, Allergy Res Grp, Freiburg, Germany	Ruprecht Karls University Heidelberg; Justus Liebig University Giessen; University of Munster; Max Planck Society; Technical University of Munich; Technical University of Munich; University of Freiburg	Goebeler, M (corresponding author), Univ Heidelberg, Univ Hosp Mannheim, Dept Dermatol, D-6800 Mannheim, Germany.	matthias.goebeler@derma.med.uni-giessen.de	Fejer, Gyorgy/D-5080-2011; Schmidt, Marc/E-8821-2010; Raghavan, Badrinarayanan/AAG-6839-2020; Skerra, Arne/A-2269-2013; Goebeler, Matthias/F-7118-2013; raghavan, badrinarayanan/I-1259-2012; Goebeler, Matthias/P-3612-2019; Fejer, Gyorgy/F-8515-2019	Schmidt, Marc/0000-0002-8643-1615; Raghavan, Dr. Badrinarayanan/0000-0001-5773-0731; Skerra, Arne/0000-0002-5717-498X; Freudenberg, Marina Alexandra/0000-0001-5894-1805; Fejer, Gyorgy/0000-0001-6761-0506	Landesstiftung Baden-Wurttemberg [P-LS-AL2/07]; Deutsche Forschungsgemeinschaft [GO 811/1-3, SPP 1110, Fr 448/4]; European Commission [LSHB-CT-2005-018681]	Landesstiftung Baden-Wurttemberg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank M. Muroi (National Institute of Health Sciences, Tokyo) for hMD2 and mMD2 expression constructs; A. M. Hajjar (Department of Immunology, University of Washington Medical School) for expression constructs for chimeric TLR4; A. Poltorak and B. Beutler (Scripps Research Institute, La Jolla, CA) for the BAC clone containing TLR4; B. Kanzler (Max-Planck-Institute for Immunobiology, Freiburg, Germany) for help in generating transgenic mice; and N. Schmidt, A. Huss, R. Alt, S. Sole, J. Ippisch and A. Meier for technical assistance. Supported by the Landesstiftung Baden-Wurttemberg (P-LS-AL2/07 to M.G. and M.S.), the Deutsche Forschungsgemeinschaft (GO 811/1-3 to M.G. and SPP 1110, project Fr 448/4 to M.A.F.) and the European Commission (LSHB-CT-2005-018681 to S.F.M.).	Ade N, 2007, TOXICOL SCI, V99, P488, DOI 10.1093/toxsci/kfm178; Artik S, 1999, J IMMUNOL, V163, P1143; Brinen LS, 1996, BIOCHEMISTRY-US, V35, P5999, DOI 10.1021/bi9530200; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Czymai T, 2010, J BIOL CHEM, V285, P10163, DOI 10.1074/jbc.M109.056663; DeLano W. L, 2002, PYMOL MOL GENETICS G; Denk A, 2001, J BIOL CHEM, V276, P28451, DOI 10.1074/jbc.M102698200; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Fejer G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000208; Freudenberg MA, 2009, GIORN ITAL DERMAT V, V144, P173; FREUDENBERG MA, 1986, INFECT IMMUN, V51, P891, DOI 10.1128/IAI.51.3.891-895.1986; GOEBELER M, 1995, J IMMUNOL, V155, P2459; Goebeler M, 2001, AM J PATHOL, V158, P431, DOI 10.1016/S0002-9440(10)63986-7; Grabbe S, 1998, IMMUNOL TODAY, V19, P37, DOI 10.1016/S0167-5699(97)01186-9; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Harding MM, 2004, ACTA CRYSTALLOGR D, V60, P849, DOI 10.1107/S0907444904004081; Kalis C, 2003, EUR J IMMUNOL, V33, P798, DOI 10.1002/eji.200323431; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Liden C, 2008, CONTACT DERMATITIS, V59, P31, DOI 10.1111/j.1600-0536.2008.01363.x; Martin SF, 2008, J EXP MED, V205, P2151, DOI 10.1084/jem.20070509; Martin SF, 2008, CURR OPIN ALLERGY CL, V8, P289, DOI 10.1097/ACI.0b013e3283088cf9; Mattila L, 2001, CONTACT DERMATITIS, V44, P218, DOI 10.1034/j.1600-0536.2001.044004218.x; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Muller V, 2007, J IMMUNOL, V179, P8435, DOI 10.4049/jimmunol.179.12.8435; Muroi M, 2002, INFECT IMMUN, V70, P3546, DOI 10.1128/IAI.70.7.3546-3550.2002; Nestle FO, 2002, NATURE, V419, P132, DOI 10.1038/419132a; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Poltorak A, 1998, BLOOD CELL MOL DIS, V24, P340, DOI 10.1006/bcmd.1998.0201; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; ROTH J, 1993, BLOOD, V82, P1875; Sato N, 2007, CLIN EXP ALLERGY, V37, P743, DOI 10.1111/j.1365-2222.2007.02705.x; SPIEWAK R, 2008, EXPERT REV CLIN IMMU, V3, P851; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Viemann D, 2007, J IMMUNOL, V178, P3198, DOI 10.4049/jimmunol.178.5.3198; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1	36	403	423	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2010	11	9					814	U64		10.1038/ni.1919	http://dx.doi.org/10.1038/ni.1919			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	641HN	20711192				2022-12-18	WOS:000281115500009
J	Kaufmann, DE; Kavanagh, DG; Pereyra, F; Zaunders, JJ; Mackey, EW; Miura, T; Palmer, S; Brockman, M; Rathod, A; Piechocka-Trocha, A; Baker, B; Zhu, B; Le Gall, S; Waring, MT; Ahern, R; Moss, K; Kelleher, AD; Coffin, JM; Freeman, GJ; Rosenberg, ES; Walker, BD				Kaufmann, Daniel E.; Kavanagh, Daniel G.; Pereyra, Florencia; Zaunders, John J.; Mackey, Elizabeth W.; Miura, Toshiyuki; Palmer, Sarah; Brockman, Mark; Rathod, Almas; Piechocka-Trocha, Alicja; Baker, Brett; Zhu, Baogong; Le Gall, Sylvie; Waring, Michael T.; Ahern, Ryan; Moss, Kristin; Kelleher, Anthony D.; Coffin, John M.; Freeman, Gordon J.; Rosenberg, Eric S.; Walker, Bruce D.			Upregulation of CTLA-4 by HIV-specific CD4(+) T cells correlates with disease progression and defines a reversible immune dysfunction	NATURE IMMUNOLOGY			English	Article							INFECTED INDIVIDUALS; METASTATIC MELANOMA; ANTIGEN-4 BLOCKADE; TGF-BETA; IN-VITRO; EXPRESSION; RESPONSES; SUPPRESSION; PD-1; ACTIVATION	In progressive viral infection, antiviral T cell function is impaired by poorly understood mechanisms. Here we report that the inhibitory immunoregulatory receptor CTLA-4 was selectively upregulated in human immunodeficiency virus (HIV)-specific CD4(+) T cells but not CD8(+) T cells in all categories of HIV-infected subjects evaluated, with the exception of rare people able to control viremia in the absence of antiretroviral therapy. CTLA-4 expression correlated positively with disease progression and negatively with the capacity of CD4(+) T cells to produce interleukin 2 in response to viral antigen. Most HIV-specific CD4(+) T cells coexpressed CTLA-4 and another inhibitory immunoregulatory receptor, PD-1. In vitro blockade of CTLA-4 augmented HIV-specific CD4(+) T cell function. These data, indicating a reversible immunoregulatory pathway selectively associated with CD4(+) T cell dysfunction, provide a potential target for immunotherapy in HIV-infected patients.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Partners AIDS Res Ctr, Boston, MA 02115 USA; Harvard Univ, Sch Med, Div AIDS, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; St Vincents Hosp, Ctr Immunol, Darlinghurst, NSW 2010, Australia; Howard Hughes Med Inst, Chevy Chase, MD 20185 USA; NCI, HIV Drug Resistance Program, NIH, Frederick, MD 21702 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol,Dept Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; St Vincents Hospital Sydney; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Kaufmann, DE (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Partners AIDS Res Ctr, Boston, MA 02115 USA.	dkaufmann@partners.org	Zaunders, John/J-6553-2012; Freeman, Gordon/AAC-5380-2019; Brockman, Mark/D-1669-2016	Zaunders, John/0000-0002-5912-5989; Freeman, Gordon/0000-0002-7210-5616; Brockman, Mark/0000-0001-6432-1426; Le Gall, Sylvie/0000-0003-0385-926X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, F32AI058457] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL092565] Funding Source: Medline; NIAID NIH HHS [F32 AI058457, P30 AI060354] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Addo MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000321; Anderson KM, 2006, J IMMUNOL, V176, P5306, DOI 10.4049/jimmunol.176.9.5306; Bachmann MF, 1998, J IMMUNOL, V160, P95; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; Boritz E, 2004, J VIROL, V78, P12638, DOI 10.1128/JVI.78.22.12638-12646.2004; Brown JA, 2003, J IMMUNOL, V170, P1257, DOI 10.4049/jimmunol.170.3.1257; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Day CL, 2003, J EXP MED, V198, P1773, DOI 10.1084/jem.20031947; Dorfman DM, 2006, AM J SURG PATHOL, V30, P802, DOI 10.1097/01.pas.0000209855.28282.ce; Egen JG, 2002, NAT IMMUNOL, V3, P611, DOI 10.1038/ni0702-611; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gomes NA, 2000, J IMMUNOL, V164, P2001, DOI 10.4049/jimmunol.164.4.2001; Graefe SEB, 2004, PARASITE IMMUNOL, V26, P19, DOI 10.1111/j.0141-9838.2004.00679.x; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Harari A, 2004, BLOOD, V103, P966, DOI 10.1182/blood-2003-04-1203; Hodi FS, 2003, P NATL ACAD SCI USA, V100, P4712, DOI 10.1073/pnas.0830997100; Homann D, 2006, J VIROL, V80, P270, DOI 10.1128/JVI.80.1.270-280.2006; Hryniewicz A, 2006, BLOOD, V108, P3834, DOI 10.1182/blood-2006-04-010637; Iyasere C, 2003, J VIROL, V77, P10900, DOI 10.1128/JVI.77.20.10900-10909.2003; Jacobs T, 2002, J IMMUNOL, V169, P2323, DOI 10.4049/jimmunol.169.5.2323; Kaufmann DE, 2004, J VIROL, V78, P4463, DOI 10.1128/JVI.78.9.4463-4477.2004; Kinter AL, 2004, J EXP MED, V200, P331, DOI 10.1084/jem.20032069; Kinter A, 2007, P NATL ACAD SCI USA, V104, P3390, DOI 10.1073/pnas.0611423104; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Leng QB, 2002, AIDS, V16, P519, DOI 10.1097/00002030-200203080-00002; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Nilsson J, 2006, BLOOD, V108, P3808, DOI 10.1182/blood-2006-05-021576; Palmer BE, 2004, J IMMUNOL, V172, P3337, DOI 10.4049/jimmunol.172.5.3337; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Phan GQ, 2003, P NATL ACAD SCI USA, V100, P8372, DOI 10.1073/pnas.1533209100; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; Teft WA, 2006, ANNU REV IMMUNOL, V24, P65, DOI 10.1146/annurev.immunol.24.021605.090535; Thio CL, 2004, J VIROL, V78, P11258, DOI 10.1128/JVI.78.20.11258-11262.2004; Tilton JC, 2007, J VIROL, V81, P2713, DOI 10.1128/JVI.01830-06; TRAUTMANN L, 2006, NAT MED; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Zaunders JJ, 2006, J VIROL, V80, P10162, DOI 10.1128/JVI.00249-06; Zubairi S, 2004, EUR J IMMUNOL, V34, P1433, DOI 10.1002/eji.200324021	46	402	426	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2007	8	11					1246	1254		10.1038/ni1515	http://dx.doi.org/10.1038/ni1515			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	222ZR	17906628				2022-12-18	WOS:000250338900017
J	Woodfin, A; Voisin, MB; Beyrau, M; Colom, B; Caille, D; Diapouli, FM; Nash, GB; Chavakis, T; Albelda, SM; Rainger, GE; Meda, P; Imhof, BA; Nourshargh, S				Woodfin, Abigail; Voisin, Mathieu-Benoit; Beyrau, Martina; Colom, Bartomeu; Caille, Dorothee; Diapouli, Frantzeska-Maria; Nash, Gerard B.; Chavakis, Triantafyllos; Albelda, Steven M.; Rainger, G. Ed; Meda, Paolo; Imhof, Beat A.; Nourshargh, Sussan			The junctional adhesion molecule JAM-C regulates polarized transendothelial migration of neutrophils in vivo	NATURE IMMUNOLOGY			English	Article							GREEN FLUORESCENT PROTEIN; TRANSCELLULAR MIGRATION; LEUKOCYTE TRANSMIGRATION; INFLAMMATION; EXTRAVASATION; PERMEABILITY; ENDOTHELIUM; RECRUITMENT; INSERTION; CONTACTS	The migration of neutrophils into inflamed tissues is a fundamental component of innate immunity. A decisive step in this process is the polarized migration of blood neutrophils through endothelial cells (ECs) lining the venular lumen (transendothelial migration (TEM)) in a luminal-to-abluminal direction. By real-time confocal imaging, we found that neutrophils had disrupted polarized TEM ('hesitant' and 'reverse') in vivo. We noted these events in inflammation after ischemia-reperfusion injury, characterized by lower expression of junctional adhesion molecule C (JAM-C) at EC junctions, and they were enhanced by blockade or genetic deletion of JAM-C in ECs. Our results identify JAM-C as a key regulator of polarized neutrophil TEM in vivo and suggest that reverse TEM of neutrophils can contribute to the dissemination of systemic inflammation.	[Woodfin, Abigail; Voisin, Mathieu-Benoit; Beyrau, Martina; Colom, Bartomeu; Nourshargh, Sussan] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Caille, Dorothee; Meda, Paolo; Imhof, Beat A.] Ctr Med Univ Geneva, Geneva, Switzerland; [Diapouli, Frantzeska-Maria; Nash, Gerard B.; Rainger, G. Ed] Univ Birmingham, Cardiovasc Res Ctr, Sch Clin & Expt Med, Coll Med & Dent, Birmingham, W Midlands, England; [Chavakis, Triantafyllos] Tech Univ Dresden, D-8027 Dresden, Germany; [Albelda, Steven M.] Univ Penn, Philadelphia, PA 19104 USA	University of London; Queen Mary University London; University of Geneva; University of Birmingham; Technische Universitat Dresden; University of Pennsylvania	Nourshargh, S (corresponding author), Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, Charterhouse Sq, London, England.	s.nourshargh@qmul.ac.uk	Sawant, Kirti V/H-3778-2013; Colom, Bartomeu/A-6905-2013; Nash, Gerard B/E-4182-2010; Colom, Bartomeu/AAA-7539-2019; Chavakis, Triantafyllos/ABE-8845-2020	Nash, Gerard B/0000-0002-5935-2831; Nourshargh, Sussan/0000-0001-5677-1806; , Mathieu-Benoit/0000-0003-3001-0894; Colom, Bartomeu/0000-0001-6256-6462	Wellcome Trust [081172/Z/06/Z]; UK National Institute for Health Research; Swiss National Science Foundation [310000-122423, 310000-109402, CR32I3_129987, 310030- 120184]; Juvenile Diabetes Research Foundation [40-2011-11]; European Union [BETAIMAGE 222980, IMIDIA, C2008-T7, FP7-PEOPLE-2009-IEF-252091]; US National Institutes of Health; National Cancer Institute; Deutsche Forschungsgemeinschaft	Wellcome Trust(Wellcome Trust); UK National Institute for Health Research(National Institute for Health Research (NIHR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); European Union(European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank E. Dejana (FIRC Institute of Molecular Oncology) for mAb BV11 to JAM-A; S.J. Weiss for critical reading of the manuscript; R. Yadav for advice on surgical procedures; and H.M. McGetterick for contributions to analysis of rTEM neutrophils generated in vitro. Supported by the Wellcome Trust (081172/Z/06/Z to S.N.), the UK National Institute for Health Research (for the translational research portfolio of Barts and the London Cardiovascular Biomedical Research Unit, to which the work of S.N. contributes), the Swiss National Science Foundation (310000-122423, 310000-109402 and CR32I3_129987 to P. M. and 310030- 120184 for B.A.I.), the Juvenile Diabetes Research Foundation (40-2011-11 to P.M.), the European Union (BETAIMAGE 222980; IMIDIA and C2008-T7 to P.M.; and a Marie Curie Fellowship (FP7-PEOPLE-2009-IEF-252091) to M. B.), the Intramural Research Program of the US National Institutes of Health (T.C.), the National Cancer Institute (T.C.) and Deutsche Forschungsgemeinschaft (T.C.).	Aurrand-Lions M, 2005, J IMMUNOL, V174, P6406, DOI 10.4049/jimmunol.174.10.6406; Bradfield PF, 2007, BLOOD, V110, P2545, DOI 10.1182/blood-2007-03-078733; Bradfield PF, 2007, ARTERIOSCL THROM VAS, V27, P2104, DOI 10.1161/ATVBAHA.107.147694; Buckley CD, 2006, J LEUKOCYTE BIOL, V79, P303, DOI 10.1189/jlb.0905496; Burns AR, 1997, J IMMUNOL, V159, P2893; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Chavakis T, 2004, J BIOL CHEM, V279, P55602, DOI 10.1074/jbc.M404676200; ChristofidouSolomidou M, 1997, J IMMUNOL, V158, P4872; Cinamon G, 2004, J IMMUNOL, V173, P7282, DOI 10.4049/jimmunol.173.12.7282; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Faust N, 2000, BLOOD, V96, P719; Feng D, 1998, J EXP MED, V187, P903, DOI 10.1084/jem.187.6.903; Hoshi O, 1999, ARCH HISTOL CYTOL, V62, P253, DOI 10.1679/aohc.62.253; HURLEY JV, 1963, AUST J EXP BIOL MED, V41, P171, DOI 10.1038/icb.1963.17; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Lamagna C, 2005, MOL BIOL CELL, V16, P4992, DOI 10.1091/mbc.E05-04-0310; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Mamdouh Z, 2009, J EXP MED, V206, P2795, DOI 10.1084/jem.20082745; MARCHESI V. T., 1960, QUART JOUR EXPTL PHYSIOL, V45, P343; Marmon S, 2009, EXP DERMATOL, V18, P88, DOI 10.1111/j.1600-0625.2008.00796.x; Marmon S, 2009, AM J PATHOL, V174, P684, DOI 10.2353/ajpath.2009.080091; Mathias JR, 2006, J LEUKOCYTE BIOL, V80, P1281, DOI 10.1189/jlb.0506346; Millan J, 2006, NAT CELL BIOL, V8, P113, DOI 10.1038/ncb1356; Mulero V, 2011, J LEUKOCYTE BIOL, V89, P645, DOI 10.1189/jlb.0111013; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; Muller WA, 2009, CIRC RES, V105, P223, DOI 10.1161/CIRCRESAHA.109.200717; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; Nourshargh S, 2006, J LEUKOCYTE BIOL, V80, P714, DOI 10.1189/jlb.1105645; Orlova VV, 2006, J EXP MED, V203, P2703, DOI 10.1084/jem.20051730; Randolph GJ, 1996, J EXP MED, V183, P451, DOI 10.1084/jem.183.2.451; Santoso S, 2002, J EXP MED, V196, P679, DOI 10.1084/jem.20020267; Scheiermann C, 2009, ARTERIOSCL THROM VAS, V29, P1509, DOI 10.1161/ATVBAHA.109.187559; Sumagin R, 2010, J IMMUNOL, V184, P5242, DOI 10.4049/jimmunol.0903319; Thompson RD, 2001, BLOOD, V97, P1854, DOI 10.1182/blood.V97.6.1854; Tsukamoto T, 2010, INJURY, V41, P21, DOI 10.1016/j.injury.2009.07.010; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942; Yoo SK, 2011, J LEUKOCYTE BIOL, V89, P661, DOI 10.1189/jlb.1010567	38	401	412	4	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2011	12	8					761	U145		10.1038/ni.2062	http://dx.doi.org/10.1038/ni.2062			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	794BT	21706006	Green Accepted, Green Published			2022-12-18	WOS:000292870700014
J	Yoshimoto, T; Yasuda, K; Tanaka, H; Nakahira, M; Imai, Y; Fujimori, Y; Nakanishi, K				Yoshimoto, Tomohiro; Yasuda, Koubun; Tanaka, Hidehisa; Nakahira, Masakiyo; Imai, Yasutomo; Fujimori, Yoshihiro; Nakanishi, Kenji			Basophils contribute to T(H)2-IgE responses in vivo via IL-4 production and presentation of peptide-MHC class II complexes to CD4(+) T cells	NATURE IMMUNOLOGY			English	Article							FC-EPSILON-RI; MAST-CELLS; TH2 CELLS; IGE; EXPRESSION; INTERLEUKIN-4; CHALLENGE; RECEPTORS; INDUCTION; MECHANISM	Basophils express major histocompatibility complex class II, CD80 and CD86 and produce interleukin 4 (IL-4) in various conditions. Here we show that when incubated with IL-3 and antigen or complexes of antigen and immunoglobulin E (IgE), basophils internalized, processed and presented antigen as complexes of peptide and major histocompatibility complex class II and produced IL-4. Intravenous administration of ovalbumin-pulsed basophils into naive mice 'preferentially' induced the development of naive ovalbumin-specific CD4(+) T cells into T helper type 2 (T(H)2) cells. Mice immunized in this way, when challenged by intravenous administration of ovalbumin, promptly produced ovalbumin-specific IgG1 and IgE. Finally, intravenous administration of IgE complexes rapidly induced T(H)2 cells only in the presence of endogenous basophils, which suggests that basophils are potent antigen-presenting cells that 'preferentially' augment T(H)2-IgE responses by capturing IgE complex.	[Yoshimoto, Tomohiro; Yasuda, Koubun; Tanaka, Hidehisa; Nakahira, Masakiyo; Imai, Yasutomo; Nakanishi, Kenji] Hyogo Coll Med, Dept Immunol & Med Zool, Nishinomiya, Hyogo, Japan; [Yoshimoto, Tomohiro; Yasuda, Koubun; Tanaka, Hidehisa; Nakahira, Masakiyo; Imai, Yasutomo; Nakanishi, Kenji] Japan Sci & Technol Corp, Collaborat Dev Innovat Seeds, Saitama, Japan; [Fujimori, Yoshihiro] Hyogo Coll Med, Lab Cell Transplantat, Inst Adv Med Sci, Nishinomiya, Hyogo, Japan	Hyogo College of Medicine; Japan Science & Technology Agency (JST); Hyogo College of Medicine	Nakanishi, K (corresponding author), Hyogo Coll Med, Dept Immunol & Med Zool, Nishinomiya, Hyogo, Japan.	nakaken@hyo-med.ac.jp	Yoshimoto, Tomohiro/E-2224-2014; Yasuda, Koubun/GQA-7622-2022	Yasuda, Koubun/0000-0002-3533-1702; Imai, Yasutomo/0000-0003-3169-5717	Japanese Ministry of Education, Culture, Sports, Science and Technology [18073016]; Japan Society for the Promotion of Science [20390145, 19390121]; Japanese Ministry of Health, Labor and Welfare	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan)	We thank W. E. Paul and H. Yamane for suggestions after critical reading of this manuscript and Y. Taki, H. Seki and S. Futatsugi-Yumikura for technical assistance. Supported by The Japanese Ministry of Education, Culture, Sports, Science and Technology (Grant-in-Aid for Scientific Research on Priority Areas 18073016 and Hitech Research Center Grant), the Japan Society for the Promotion of Science (Grants-in-Aid for Scientific Research 20390145 and 19390121) and the Japanese Ministry of Health, Labor and Welfare (Grants for Research on Emerging and Re-emerging Infectious Diseases).	Adcock IM, 2008, LANCET, V372, P1073, DOI 10.1016/S0140-6736(08)61449-X; Arinobu Y, 2005, P NATL ACAD SCI USA, V102, P18105, DOI 10.1073/pnas.0509148102; BENSASSON SZ, 1990, P NATL ACAD SCI USA, V87, P1421, DOI 10.1073/pnas.87.4.1421; BRADLEY LM, 1994, J EXP MED, V180, P2401, DOI 10.1084/jem.180.6.2401; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Denzel A, 2008, NAT IMMUNOL, V9, P733, DOI 10.1038/ni.1621; EISEN HN, 1954, J IMMUNOL, V73, P296; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Galli SJ, 2000, CURR OPIN HEMATOL, V7, P32, DOI 10.1097/00062752-200001000-00007; GAUCHAT JF, 1993, NATURE, V365, P340, DOI 10.1038/365340a0; Gauvreau GM, 2000, AM J RESP CRIT CARE, V161, P1473, DOI 10.1164/ajrccm.161.5.9908090; Hu-Li J, 2001, IMMUNITY, V14, P1, DOI 10.1016/S1074-7613(01)00084-X; Irani AMA, 1998, J ALLERGY CLIN IMMUN, V101, P354, DOI 10.1016/S0091-6749(98)70248-9; Karasuyama H, 2009, NAT REV IMMUNOL, V9, P9, DOI 10.1038/nri2458; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Kondo Y, 2008, INT IMMUNOL, V20, P791, DOI 10.1093/intimm/dxn037; Kosaka H, 2008, NAT MED, V14, P437, DOI 10.1038/nm1733; Koshino T, 1996, J ASTHMA, V33, P89, DOI 10.3109/02770909609054536; Lantz CS, 1997, J IMMUNOL, V158, P2517; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; Macfarlane AJ, 2000, J ALLERGY CLIN IMMUN, V105, P99, DOI 10.1016/S0091-6749(00)90184-2; Mack M, 2005, J IMMUNOL, V174, P735, DOI 10.4049/jimmunol.174.2.735; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; Min B, 2008, NAT IMMUNOL, V9, P1333, DOI 10.1038/ni.f.217; Min BK, 2008, CURR OPIN HEMATOL, V15, P59, DOI 10.1097/MOH.0b013e3282f13ce8; Min Booki, 2006, Allergol Int, V55, P99, DOI 10.2332/allergolint.55.99; Mukai K, 2005, IMMUNITY, V23, P191, DOI 10.1016/j.immuni.2005.06.011; Nakae S, 2007, BLOOD, V110, P2565, DOI 10.1182/blood-2006-11-058800; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; Nakanishi K, 2001, CYTOKINE GROWTH F R, V12, P53, DOI 10.1016/S1359-6101(00)00015-0; Oh K, 2007, BLOOD, V109, P2921, DOI 10.1182/blood-2006-07-037739; Ohnmacht C, 2009, BLOOD, V113, P2816, DOI 10.1182/blood-2008-05-154773; Ohteki T, 2001, NAT IMMUNOL, V2, P1138, DOI 10.1038/ni729; Okubo Kimihiro, 2008, Allergol Int, V57, P205, DOI 10.2332/allergolint.R-08-164; Reimer JM, 2006, ALLERGY, V61, P1063, DOI 10.1111/j.1398-9995.2006.01149.x; Saini SS, 2000, J ALLERGY CLIN IMMUN, V106, P514, DOI 10.1067/mai.2000.108431; Sasaki Y, 2005, J EXP MED, V202, P607, DOI 10.1084/jem.20042202; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Sullivan BM, 2009, IMMUNITY, V30, P12, DOI 10.1016/j.immuni.2008.12.006; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Tsujimura Y, 2008, IMMUNITY, V28, P581, DOI 10.1016/j.immuni.2008.02.008; Verbruggen K, 2009, INT ARCH ALLERGY IMM, V148, P87, DOI 10.1159/000155739; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3; Yamaguchi M, 1997, J EXP MED, V185, P663, DOI 10.1084/jem.185.4.663; Yoshimoto T, 1999, P NATL ACAD SCI USA, V96, P13962, DOI 10.1073/pnas.96.24.13962; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285; Yoshimoto T, 2007, J IMMUNOL, V179, P4415, DOI 10.4049/jimmunol.179.7.4415	49	401	410	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2009	10	7					706	U54		10.1038/ni.1737	http://dx.doi.org/10.1038/ni.1737			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	459WF	19465908				2022-12-18	WOS:000267142600009
J	Wilson, NS; Dixit, V; Ashkenazi, A				Wilson, Nicholas S.; Dixit, Vishva; Ashkenazi, Avi			Death receptor signal transducers: nodes of coordination in immune signaling networks	NATURE IMMUNOLOGY			English	Review							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; APOPTOSIS-INDUCING LIGAND; T-CELL-ACTIVATION; FLICE-INHIBITORY PROTEIN; NATURAL-KILLER-CELLS; FAS-MEDIATED APOPTOSIS; HELICASE ANTIVIRAL PATHWAY; TOLL-LIKE-RECEPTORS; CASPASE-8 ACTIVATION	Death receptors (DRs) are members of the tumor necrosis factor receptor superfamily that possess a cytoplasmic death domain (DD). DRs regulate important operational and homeostatic aspects of the immune system. They transmit signals through apical protein complexes, which are nucleated by the DD adaptors FADD and TRADD, to control cellular outcomes that range from apoptosis to gene activation. FADD and TRADD also nucleate several distal signaling complexes, which mediate cross-talk between distinct DR signaling pathways. Moreover, together with other DR signal transducers, FADD and TRADD participate in functional complexes assembled by certain non-DR immune cell receptors, such as pattern-recognition receptors. Thus, DR signal transducers may provide important nodes of coordination in immune signaling networks.	[Wilson, Nicholas S.; Dixit, Vishva; Ashkenazi, Avi] Genentech Inc, San Francisco, CA 94080 USA	Roche Holding; Genentech	Dixit, V (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	dixit@gene.com; aa@gene.com	dixit, vishva m/A-4496-2012; Ashkenazi, Avi/ABG-2712-2020	dixit, vishva m/0000-0001-6983-0326; Ashkenazi, Avi/0000-0002-6890-4589				Alappat EC, 2003, J BIOL CHEM, V278, P41585, DOI 10.1074/jbc.C300385200; ARASE H, 1995, J EXP MED, V181, P1235, DOI 10.1084/jem.181.3.1235; Arechiga AF, 2007, J IMMUNOL, V179, P5291, DOI 10.4049/jimmunol.179.8.5291; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Ashkenazi A, 2008, CYTOKINE GROWTH F R, V19, P325, DOI 10.1016/j.cytogfr.2008.04.001; Baseta JG, 2000, J IMMUNOL, V165, P5621, DOI 10.4049/jimmunol.165.10.5621; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bidere N, 2006, ANNU REV IMMUNOL, V24, P321, DOI 10.1146/annurev.immunol.24.021605.090513; Boatright KM, 2004, BIOCHEM J, V382, P651, DOI 10.1042/BJ20040809; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; Budd RC, 2006, NAT REV IMMUNOL, V6, P196, DOI 10.1038/nri1787; Carey GB, 2000, IMMUNOL REV, V176, P105; Ch'en IL, 2008, P NATL ACAD SCI USA, V105, P17463, DOI 10.1073/pnas.0808043105; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chau H, 2005, J EXP MED, V202, P405, DOI 10.1084/jem.20050118; Chen M, 2007, BLOOD, V109, P4360, DOI 10.1182/blood-2006-11-056424; Chen NJ, 2008, P NATL ACAD SCI USA, V105, P12429, DOI 10.1073/pnas.0806585105; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Conte D, 2006, MOL CELL BIOL, V26, P699, DOI 10.1128/MCB.26.2.699-708.2006; Cretney E, 2003, J EXP MED, V198, P491, DOI 10.1084/jem.20030634; Cusson-Hermance N, 2005, J BIOL CHEM, V280, P36560, DOI 10.1074/jbc.M506831200; Di Santo JP, 2006, ANNU REV IMMUNOL, V24, P257, DOI 10.1146/annurev.immunol.24.021605.090700; Diehl GE, 2004, IMMUNITY, V21, P877, DOI 10.1016/j.immuni.2004.11.008; Dohrman A, 2005, J IMMUNOL, V174, P5270, DOI 10.4049/jimmunol.174.9.5270; Ermolaeva MA, 2008, NAT IMMUNOL, V9, P1037, DOI 10.1038/ni.1638; Fanger NA, 1999, J EXP MED, V190, P1155, DOI 10.1084/jem.190.8.1155; Feig C, 2007, EMBO J, V26, P221, DOI 10.1038/sj.emboj.7601460; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Finnberg N, 2008, J CLIN INVEST, V118, P111, DOI 10.1172/JCI29900; Fluur C, 2007, J IMMUNOL, V178, P5340, DOI 10.4049/jimmunol.178.8.5340; Golks A, 2006, J EXP MED, V203, P1295, DOI 10.1084/jem.20051556; Goodnow CC, 2007, CELL, V130, P25, DOI 10.1016/j.cell.2007.06.033; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Green DR, 2008, IMMUNITY, V28, P141, DOI 10.1016/j.immuni.2008.01.004; Green DR, 2003, NAT IMMUNOL, V4, P207, DOI 10.1038/ni0303-207; Griffith TS, 1999, J EXP MED, V189, P1343, DOI 10.1084/jem.189.8.1343; Hamilton SE, 2006, NAT IMMUNOL, V7, P475, DOI 10.1038/ni1326; Han LH, 2008, APOPTOSIS, V13, P1198, DOI 10.1007/s10495-008-0252-3; Hayakawa Y, 2004, J IMMUNOL, V172, P123, DOI 10.4049/jimmunol.172.1.123; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hua ZC, 2003, IMMUNITY, V18, P513, DOI 10.1016/S1074-7613(03)00083-9; Huntington ND, 2007, NAT REV IMMUNOL, V7, P703, DOI 10.1038/nri2154; Imtiyaz HZ, 2006, J IMMUNOL, V176, P6852, DOI 10.4049/jimmunol.176.11.6852; Ishikawa E, 2005, J VIROL, V79, P7658, DOI 10.1128/JVI.79.12.7658-7663.2005; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Jin ZY, 2006, MOL CELL BIOL, V26, P8136, DOI 10.1128/MCB.00257-06; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kataoka T, 2004, MOL CELL BIOL, V24, P2627, DOI 10.1128/MCB.24.7.2627-2636.2004; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Kawadler H, 2008, MOL CELL, V31, P415, DOI 10.1016/j.molcel.2008.06.008; Kim S, 2000, P NATL ACAD SCI USA, V97, P2731, DOI 10.1073/pnas.050588297; Koenig A, 2008, CELL DEATH DIFFER, V15, P1701, DOI 10.1038/cdd.2008.100; Kokkonen TS, 2004, J HISTOCHEM CYTOCHEM, V52, P693, DOI 10.1177/002215540405200513; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; Lamhamedi-Cherradi SE, 2003, NAT IMMUNOL, V4, P255, DOI 10.1038/ni894; Lanier LL, 2008, NAT REV IMMUNOL, V8, P259, DOI 10.1038/nri2276; Lavrik IN, 2008, J BIOL CHEM, V283, P26401, DOI 10.1074/jbc.M800823200; Lens SMA, 2002, MOL CELL BIOL, V22, P5419, DOI 10.1128/MCB.22.15.5419-5433.2002; Liao W, 2008, CURR BIOL, V18, P641, DOI 10.1016/j.cub.2008.04.017; Liu YC, 2007, SEMIN IMMUNOL, V19, P197, DOI 10.1016/j.smim.2007.02.003; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Ma YY, 2004, NAT IMMUNOL, V5, P380, DOI 10.1038/ni1054; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; Micheau O, 2002, J BIOL CHEM, V277, P45162, DOI 10.1074/jbc.M206882200; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Mirandola P, 2004, BLOOD, V104, P2418, DOI 10.1182/blood-2004-04-1294; Misra RS, 2007, J BIOL CHEM, V282, P19365, DOI 10.1074/jbc.M610610200; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Moriyama H, 2007, IMMUNOL LETT, V109, P36, DOI 10.1016/j.imlet.2006.12.009; Muppidi JR, 2004, NAT IMMUNOL, V5, P182, DOI 10.1038/ni1024; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Newton K, 1998, EMBO J, V17, P706, DOI 10.1093/emboj/17.3.706; Norian LA, 2000, J IMMUNOL, V164, P4471, DOI 10.4049/jimmunol.164.9.4471; O'Donnell MA, 2007, CURR BIOL, V17, P418, DOI 10.1016/j.cub.2007.01.027; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Oh S, 2008, P NATL ACAD SCI USA, V105, P5201, DOI 10.1073/pnas.0801003105; Pan GH, 1998, FEBS LETT, V431, P351, DOI 10.1016/S0014-5793(98)00791-1; Panka DJ, 2001, J BIOL CHEM, V276, P6893, DOI 10.1074/jbc.C000569200; Park Y, 2002, J IMMUNOL, V168, P5, DOI 10.4049/jimmunol.168.1.5; Perlman H, 1999, J EXP MED, V190, P1679, DOI 10.1084/jem.190.11.1679; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Pietras EM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.130pe36; Pinkoski MJ, 2000, AM J PHYSIOL-GASTR L, V278, pG354, DOI 10.1152/ajpgi.2000.278.3.G354; Pobezinskaya YL, 2008, NAT IMMUNOL, V9, P1047, DOI 10.1038/ni.1639; Ren X, 2007, CELL DEATH DIFFER, V14, P2076, DOI 10.1038/sj.cdd.4402220; Rethi B, 2008, BLOOD, V112, P1195, DOI 10.1182/blood-2007-12-126698; Sacks JA, 2008, J IMMUNOL, V180, P4570, DOI 10.4049/jimmunol.180.7.4570; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Sakamaki K, 1998, EUR J BIOCHEM, V253, P399, DOI 10.1046/j.1432-1327.1998.2530399.x; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Sato K, 2001, EUR J IMMUNOL, V31, P3138, DOI 10.1002/1521-4141(200111)31:11<3138::AID-IMMU3138>3.0.CO;2-B; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Seki N, 2003, CANCER RES, V63, P207; Shambharkar PB, 2007, EMBO J, V26, P1794, DOI 10.1038/sj.emboj.7601622; Sharp DA, 2005, J BIOL CHEM, V280, P19401, DOI 10.1074/jbc.M413962200; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Smyth MJ, 2001, J EXP MED, V193, P661, DOI 10.1084/jem.193.6.661; Sneller MC, 2003, CURR OPIN RHEUMATOL, V15, P417, DOI 10.1097/00002281-200307000-00008; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Sun HH, 2008, CELL, V133, P415, DOI 10.1016/j.cell.2008.03.026; Sun M, 2007, J IMMUNOL, V179, P4307, DOI 10.4049/jimmunol.179.7.4307; Sun SC, 2008, TRENDS IMMUNOL, V29, P469, DOI 10.1016/j.it.2008.07.003; Suzuki I, 2000, J IMMUNOL, V165, P5537, DOI 10.4049/jimmunol.165.10.5537; Symons A, 2006, TRENDS IMMUNOL, V27, P40, DOI 10.1016/j.it.2005.11.007; Takahashi K, 2006, J IMMUNOL, V176, P4520, DOI 10.4049/jimmunol.176.8.4520; Takeda K, 2005, BLOOD, V105, P2082, DOI 10.1182/blood-2004-08-3262; Takeda K, 2001, NAT MED, V7, P94, DOI 10.1038/83416; Ueffing N, 2008, CELL DEATH DIFFER, V15, P773, DOI 10.1038/sj.cdd.4402314; Ueffing N, 2008, BLOOD, V112, P690, DOI 10.1182/blood-2008-02-141382; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2008, CELL CYCLE, V7, P1511, DOI 10.4161/cc.7.11.5959; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Washburn B, 2003, J IMMUNOL, V170, P1814, DOI 10.4049/jimmunol.170.4.1814; Weckmann M, 2007, NAT MED, V13, P1308, DOI 10.1038/nm1660; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wu CJ, 2008, P NATL ACAD SCI USA, V105, P3023, DOI 10.1073/pnas.0712313105; Wu GS, 1999, CANCER RES, V59, P2770; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yoshida R, 2008, J BIOL CHEM, V283, P36211, DOI 10.1074/jbc.M806576200; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; Zhang N, 2008, J IMMUNOL, V181, P5368, DOI 10.4049/jimmunol.181.8.5368; Zhang N, 2008, J IMMUNOL, V180, P5506, DOI 10.4049/jimmunol.180.8.5506; Zhang YH, 2005, J IMMUNOL, V175, P3033, DOI 10.4049/jimmunol.175.5.3033; Zheng LX, 2006, MOL CELL BIOL, V26, P3505, DOI 10.1128/MCB.26.9.3505-3513.2006; Zornig M, 1998, CURR BIOL, V8, P467, DOI 10.1016/S0960-9822(98)70182-4	141	401	421	1	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2009	10	4					348	355		10.1038/ni.1714	http://dx.doi.org/10.1038/ni.1714			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	422KE	19295631				2022-12-18	WOS:000264425800005
J	Geijtenbeek, TBH; Krooshoop, DJEB; Bleijs, DA; van Vliet, SJ; van Duijnhoven, GCF; Grabovsky, V; Alon, R; Figdor, CG; van Kooyk, Y				Geijtenbeek, TBH; Krooshoop, DJEB; Bleijs, DA; van Vliet, SJ; van Duijnhoven, GCF; Grabovsky, V; Alon, R; Figdor, CG; van Kooyk, Y			DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking	NATURE IMMUNOLOGY			English	Article							PHYSIOLOGICAL FLOW; T-CELLS; ADHESION; SELECTIN; EXPRESSION; INTEGRINS; VCAM-1	Dendritic cells (DCs) are recruited from blood into tissues to patrol for foreign antigens, After antigen uptake and processing, DCs migrate to the secondary lymphoid organs to initiate immune responses. We now show that DC-SIGN, a CC-specific C-type lectin, supports tethering and rolling of DC-SIGN-positive cells on the vascular ligand ICAM-2 under shear flow, a prerequisite for emigration from blood. The DC-SIGN-ICAM-2 interaction regulates chemokine-induced transmigration of DCs across both resting and activated endothelium. Thus, DC-SIGN is central to the unusual trafficking capacity of DCs, further supported by the expression of DC-SIGN on precursors in blood and on immature and mature DCs in both peripheral and lymphoid tissues.	Univ Nijmegen, Med Ctr St Radboud, Dept Tumor Immunol, NL-6525 EX Nijmegen, Netherlands; Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Radboud University Nijmegen; Weizmann Institute of Science	van Kooyk, Y (corresponding author), Univ Nijmegen, Med Ctr St Radboud, Dept Tumor Immunol, Philips van Leydenlaan 25, NL-6525 EX Nijmegen, Netherlands.		ALON, RONEN/GRX-6987-2022; Geijtenbeek, Teunis/C-2229-2009; Figdor, Carl G/A-4232-2010	Figdor, Carl G/0000-0002-2366-9212; Alon, Ronen/0000-0001-9161-6369; van Vliet, Sandra/0000-0003-1811-2687				Alon R, 1997, J CELL BIOL, V138, P1169, DOI 10.1083/jcb.138.5.1169; ALON R, 1995, J CELL BIOL, V128, P1243, DOI 10.1083/jcb.128.6.1243; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; Chen C, 1999, J IMMUNOL, V162, P1084; D'Amico G, 1998, BLOOD, V92, P207, DOI 10.1182/blood.V92.1.207.413a02_207_214; DEFOUGEROLLES AR, 1993, J EXP MED, V177, P1187, DOI 10.1084/jem.177.4.1187; Delgado E, 1998, IMMUNOBIOLOGY, V198, P490, DOI 10.1016/S0171-2985(98)80073-9; DRICKAMER K, 1995, CURR OPIN STRUC BIOL, V5, P612, DOI 10.1016/0959-440X(95)80052-2; Geijtenbeek TBH, 1999, BLOOD, V94, P754, DOI 10.1182/blood.V94.2.754.414k11_754_764; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Heisig N., 1968, ADV MICROCIRCULAT, V1, P89; INABA K, 1993, J EXP MED, V178, P479, DOI 10.1084/jem.178.2.479; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; Mullin NP, 1997, J BIOL CHEM, V272, P5668, DOI 10.1074/jbc.272.9.5668; NORTAMO P, 1991, EUR J IMMUNOL, V21, P2629, DOI 10.1002/eji.1830211049; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sallusto F, 1999, J EXP MED, V189, P611, DOI 10.1084/jem.189.4.611; Smith MJ, 1999, BIOPHYS J, V77, P3371, DOI 10.1016/S0006-3495(99)77169-9; SPRINGER TA, 1994, CELL, V78, P301; Svensson M, 1997, J IMMUNOL, V158, P4229; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181	25	401	423	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2000	1	4					353	357		10.1038/79815	http://dx.doi.org/10.1038/79815			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364AK	11017109				2022-12-18	WOS:000089869700020
J	Ziegler, SF; Artis, D				Ziegler, Steven F.; Artis, David			Sensing the outside world: TSLP regulates barrier immunity	NATURE IMMUNOLOGY			English	Review							THYMIC STROMAL LYMPHOPOIETIN; RESPIRATORY SYNCYTIAL VIRUS; DENDRITIC CELLS INDUCE; HUMAN EPITHELIAL-CELLS; IGM(+) B-CELLS; T-CELLS; ATOPIC-DERMATITIS; TH2 RESPONSES; IN-VITRO; EXPRESSION	Thymic stromal lymphopoietin (TSLP) is an interleukin 7 (IL-7)-like cytokine originally characterized by its ability to promote the activation of B cells and dendritic cells (DCs). Subsequent studies have shown that TSLP promotes T helper type 2 (T(H)2) cell responses associated with immunity to some helminth parasites and the pathogenesis of many inflammatory diseases, including atopic dermatitis and asthma. This review will focus on recent findings indicating that in addition to influencing B cell and DC function, TSLP can promote T(H)2 cytokine-associated inflammation by directly promoting the effector functions of CD4(+) T(H)2 cells, basophils and other granulocyte populations while simultaneously limiting the expression of DC-derived proinflammatory cytokines and promoting regulatory T cell responses in peripheral tissues.	[Ziegler, Steven F.] Benaroya Res Inst, Program Immunol, Seattle, WA USA; [Artis, David] Univ Penn, Dept Pathobiol, Philadelphia, PA 19104 USA	Benaroya Research Institute; University of Pennsylvania	Ziegler, SF (corresponding author), Benaroya Res Inst, Program Immunol, Seattle, WA USA.	sziegler@benaroyaresearch.org; dartis@vet.upenn.edu		Artis, David/0000-0002-1753-4100	National Institutes of Health [AI068731, AI044259, AR055695, AR56113, AI061570, AI074878, AI083480]; Burroughs Wellcome Fund; Crohn's and Colitis Foundation of America; University of Pennsylvania; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061570, R21AI083480, R01AI074878, R01AI068731, R01AI044259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055695, R01AR056113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Crohn's and Colitis Foundation of America; University of Pennsylvania; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank D. Campbell, M. Siracusa and G. Sonnenberg for reviewing the manuscript. Supported by the National Institutes of Health (AI068731, AI044259, AR055695 and AR56113 to S. F. Z., and AI061570, AI074878 and AI083480 to D. A.), the Burroughs Wellcome Fund (D. A.), the Crohn's and Colitis Foundation of America (D. A.) and the University of Pennsylvania (D. A.).	Al-Shami A, 2005, J EXP MED, V202, P829, DOI 10.1084/jem.20050199; Al-Shami A, 2004, J EXP MED, V200, P159, DOI 10.1084/jem.20031975; Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211; Allakhverdi Z, 2009, J ALLERGY CLIN IMMUN, V123, P958, DOI 10.1016/j.jaci.2009.01.059; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Demehri S, 2008, PLOS BIOL, V6, P992, DOI 10.1371/journal.pbio.0060123; Demehri S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000067; Fogg MI, 2003, J ALLERGY CLIN IMMUN, V112, P796, DOI 10.1016/S0091-6749(03)01715-9; FRIEND SL, 1994, EXP HEMATOL, V22, P321; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Hahn EL, 2005, IMMUNOL ALLERGY CLIN, V25, P231, DOI 10.1016/j.iac.2005.02.004; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; Harada M, 2009, AM J RESP CELL MOL, V40, P368, DOI 10.1165/rcmb.2008-0041OC; He JQ, 2009, J ALLERGY CLIN IMMUN, V124, P222, DOI 10.1016/j.jaci.2009.04.018; Headley MB, 2009, J IMMUNOL, V182, P1641, DOI 10.4049/jimmunol.182.3.1641; Holt PG, 2002, J EXP MED, V196, P1271, DOI 10.1084/jem.20021572; Hunninghake GM, 2008, AM J RESP CRIT CARE, V177, P830, DOI 10.1164/rccm.200711-1697OC; Iliev ID, 2009, GUT, V58, P1481, DOI 10.1136/gut.2008.175166; Iliev ID, 2007, J EXP MED, V204, P2253, DOI 10.1084/jem.20062535; Isaksen DE, 1999, J IMMUNOL, V163, P5971; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Iwasaki A, 1999, J EXP MED, V190, P229, DOI 10.1084/jem.190.2.229; Iwasaki A, 2007, ANNU REV IMMUNOL, V25, P381, DOI 10.1146/annurev.immunol.25.022106.141634; JUDGE MR, 1994, BRIT J DERMATOL, V131, P615, DOI 10.1111/j.1365-2133.1994.tb04971.x; Kato A, 2007, J IMMUNOL, V179, P1080, DOI 10.4049/jimmunol.179.2.1080; Ker J, 2009, ANN ALLERG ASTHMA IM, V103, P282, DOI 10.1016/S1081-1206(10)60526-1; Kido M, 2010, INFECT IMMUN, V78, P108, DOI 10.1128/IAI.00762-09; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Lambrecht BN, 2000, J CLIN INVEST, V106, P551, DOI 10.1172/JCI8107; Lee HC, 2007, P NATL ACAD SCI USA, V104, P914, DOI 10.1073/pnas.0607305104; Leonard WJ, 2002, NAT IMMUNOL, V3, P605, DOI 10.1038/ni0702-605; Levin SD, 1999, J IMMUNOL, V162, P677; Li M, 2005, P NATL ACAD SCI USA, V102, P14795, DOI 10.1073/pnas.0507385102; Martinez FD, 2003, PEDIATR INFECT DIS J, V22, pS76, DOI 10.1097/00006454-200302001-00011; Massacand JC, 2009, P NATL ACAD SCI USA, V106, P13968, DOI 10.1073/pnas.0906367106; Miyata M, 2008, EUR J IMMUNOL, V38, P1487, DOI 10.1002/eji.200737809; Mou Z, 2008, ACTA OTO-LARYNGOL, V8, P1; Nagata Y, 2007, INT ARCH ALLERGY IMM, V144, P305, DOI 10.1159/000106319; Omori M, 2007, J IMMUNOL, V178, P1396, DOI 10.4049/jimmunol.178.3.1396; Pandey A, 2000, NAT IMMUNOL, V1, P59, DOI 10.1038/76923; Park LS, 2000, J EXP MED, V192, P659, DOI 10.1084/jem.192.5.659; Pearce EJ, 2006, CHEM IMMUNOL ALLERGY, V90, P82, DOI 10.1159/000088882; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Quentmeier H, 2001, LEUKEMIA, V15, P1286, DOI 10.1038/sj.leu.2402175; Ramalingam TR, 2009, J IMMUNOL, V182, P6452, DOI 10.4049/jimmunol.0900181; Ray RJ, 1996, EUR J IMMUNOL, V26, P10, DOI 10.1002/eji.1830260103; Reche PA, 2001, J IMMUNOL, V167, P336, DOI 10.4049/jimmunol.167.1.336; Rimoldi M, 2005, BLOOD, V106, P2818, DOI 10.1182/blood-2004-11-4321; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Sims JE, 2000, J EXP MED, V192, P671, DOI 10.1084/jem.192.5.671; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Taylor BC, 2009, J EXP MED, V206, P655, DOI 10.1084/jem.20081499; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Wang YH, 2006, IMMUNITY, V24, P827, DOI 10.1016/j.immuni.2006.03.019; Watanabe N, 2004, NAT IMMUNOL, V5, P426, DOI 10.1038/ni1048; WONG CK, 2009, AM J RESP CELL  1020, DOI DOI 10.1165/RCMB.2009-01680C; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Ying S, 2008, J IMMUNOL, V181, P2790, DOI 10.4049/jimmunol.181.4.2790; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Yoon JS, 2007, PEDIATR PULM, V42, P277, DOI 10.1002/ppul.20574; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590; Zeuthen LH, 2008, IMMUNOLOGY, V123, P197, DOI 10.1111/j.1365-2567.2007.02687.x; Zhang Z, 2009, P NATL ACAD SCI USA, V106, P1536, DOI 10.1073/pnas.0812668106; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	70	400	415	1	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2010	11	4					289	293		10.1038/ni.1852	http://dx.doi.org/10.1038/ni.1852			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	572RC	20300138	Green Accepted			2022-12-18	WOS:000275849500007
J	Steinman, L				Steinman, L			Elaborate interactions between the immune and nervous systems	NATURE IMMUNOLOGY			English	Review							T-CELL; AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; MAST-CELLS; PROINFLAMMATORY CYTOKINE; DIFFERENTIAL EXPRESSION; INDUCED ENHANCEMENT; VAGUS NERVE; TNF-ALPHA; RECEPTOR	The immune system and the nervous system maintain extensive communication, including 'hardwiring' of sympathetic and parasympathetic nerves to lymphoid organs. Neurotransmitters such as acetylcholine, norepinephrine, vasoactive intestinal peptide, substance P and histamine modulate immune activity. Neuroendocrine hormones such as corticotropin-releasing factor, leptin and alpha-melanocyte stimulating hormone regulate cytokine balance. The immune system modulates brain activity, including body temperature, sleep and feeding behavior. Molecules such as the major histocompatibility complex not only direct T cells to immunogenic molecules held in its cleft but also modulate development of neuronal connections. Neurobiologists and immunologists are exploring common ideas like the synapse to understand properties such as memory that are shared in these two systems.	Beckman Ctr Mol Med, Interdept Program Immunol, Dept Neurol Sci & Neurol & Pediat, Stanford, CA 94305 USA		Steinman, L (corresponding author), Beckman Ctr Mol Med, Interdept Program Immunol, Dept Neurol Sci & Neurol & Pediat, Stanford, CA 94305 USA.	steinman@stanford.edu		Steinman, Lawrence/0000-0002-2437-2250				ADER R, 1975, PSYCHOSOM MED, V37, P333, DOI 10.1097/00006842-197507000-00007; ADER R, 1982, SCIENCE, V215, P1534, DOI 10.1126/science.7063864; Arnett HA, 2001, NAT NEUROSCI, V4, P1116, DOI 10.1038/nn738; BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; Baumann H, 1996, P NATL ACAD SCI USA, V93, P8374, DOI 10.1073/pnas.93.16.8374; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; Benoist C, 2002, NATURE, V420, P875, DOI 10.1038/nature01324; Blatteis CM, 2000, J PHYSIOL-LONDON, V526, P470; Boneberg EM, 2003, J IMMUNOL, V171, P664, DOI 10.4049/jimmunol.171.2.664; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; BRAIN SD, 1988, NATURE, V335, P73, DOI 10.1038/335073a0; Cartmell T, 2003, J PHYSIOL-LONDON, V549, P653, DOI 10.1113/jphysiol.2002.037291; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Counce Dianne, 2001, Curr Treat Options Neurol, V3, P555, DOI 10.1007/s11940-001-0018-5; Darnell RB, 2003, NEW ENGL J MED, V349, P1543, DOI 10.1056/NEJMra023009; Demas GE, 2002, NEUROENDOCRINOLOGY, V76, P178, DOI 10.1159/000064527; Dhabhar FS, 2000, P NATL ACAD SCI USA, V97, P2846, DOI 10.1073/pnas.050569397; DRACHMAN DB, 1978, NEW ENGL J MED, V298, P1116, DOI 10.1056/NEJM197805182982004; Dustin ML, 2002, SCIENCE, V298, P785, DOI 10.1126/science.1076386; Engblom D, 2002, J MOL MED, V80, P5, DOI 10.1007/s00109-001-0289-z; ENGEL AG, 1976, J NEUROPATH EXP NEUR, V35, P569, DOI 10.1097/00005072-197609000-00008; Fekete C, 2003, BRAIN RES, V969, P70, DOI 10.1016/S0006-8993(03)02279-0; Feldmann M, 2003, NAT MED, V9, P1245, DOI 10.1038/nm939; FELTEN SY, 1988, PROG ALLERGY, V43, P14; Fetissov SO, 2002, P NATL ACAD SCI USA, V99, P17155, DOI 10.1073/pnas.222658699; Frenkel J, 2002, ARTHRITIS RHEUM, V46, P2794, DOI 10.1002/art.10550; Goehler LE, 1999, J NEUROSCI, V19, P2799; Grabbe S, 1996, J IMMUNOL, V156, P473; Grimm MC, 2003, J IMMUNOL, V171, P4990, DOI 10.4049/jimmunol.171.10.4990; HOOD L, 1985, CELL, V40, P225, DOI 10.1016/0092-8674(85)90133-3; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Imamura K, 2003, ACTA NEUROPATHOL, V106, P518, DOI 10.1007/s00401-003-0766-2; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Ishii T, 2003, CURR BIOL, V13, P394, DOI 10.1016/S0960-9822(03)00092-7; JOLY E, 1991, SCIENCE, V253, P1283, DOI 10.1126/science.1891717; Jutel M, 2001, NATURE, V413, P420, DOI 10.1038/35096564; Karpuj MV, 2002, NAT MED, V8, P143, DOI 10.1038/nm0202-143; Kerschensteiner M, 2003, ANN NEUROL, V53, P292, DOI 10.1002/ana.10446; Kuchroo VK, 2003, NAT REV IMMUNOL, V3, P454, DOI 10.1038/nri1111; Kumanogoh A, 2002, NATURE, V419, P629, DOI 10.1038/nature01037; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; LENNON VA, 1971, LANCET, V1, P630; Li SX, 2003, BRAIN RES, V992, P76, DOI 10.1016/j.brainres.2003.08.033; LIVNAT S, 1985, J NEUROIMMUNOL, V10, P5, DOI 10.1016/0165-5728(85)90031-1; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Loconto J, 2003, CELL, V112, P607, DOI 10.1016/S0092-8674(03)00153-3; Malamud V, 2003, J NEUROIMMUNOL, V138, P115, DOI 10.1016/S0165-5728(03)00090-0; Martinez C, 2002, P NATL ACAD SCI USA, V99, P1053, DOI 10.1073/pnas.012367999; Matarese G, 2001, J IMMUNOL, V166, P5909, DOI 10.4049/jimmunol.166.10.5909; McGeer EG, 2003, PROG NEURO-PSYCHOPH, V27, P741, DOI 10.1016/S0278-5846(03)00124-6; Miller LE, 2002, J RHEUMATOL, V29, P427; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; NEUMANN H, 1995, SCIENCE, V269, P549, DOI 10.1126/science.7624779; NORCROSS MA, 1984, ANN INST PASTEUR IMM, VD135, P113, DOI 10.1016/S0769-2625(84)81105-8; PATRICK J, 1973, SCIENCE, V180, P871, DOI 10.1126/science.180.4088.871; Pedotti R, 2001, NAT IMMUNOL, V2, P216, DOI 10.1038/85266; Pedotti R, 2003, P NATL ACAD SCI USA, V100, P1867, DOI 10.1073/pnas.252777399; Pedotti R, 2003, TRENDS IMMUNOL, V24, P479, DOI 10.1016/S1471-4906(03)00233-3; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Poliak S, 1997, J IMMUNOL, V158, P5751; Prinz M, 2003, NATURE, V425, P957, DOI 10.1038/nature02072; Prinz M, 2002, P NATL ACAD SCI USA, V99, P919, DOI 10.1073/pnas.022626399; Rayner DV, 2001, J MOL MED, V79, P8, DOI 10.1007/s001090100198; ROGERS SW, 1994, SCIENCE, V265, P648, DOI 10.1126/science.8036512; Rosin L, 1998, NEUROLOGY, V50, P94, DOI 10.1212/WNL.50.1.94; SAKAI K, 1990, ANN NEUROL, V28, P692, DOI 10.1002/ana.410280515; Sanders VM, 1997, J IMMUNOL, V158, P4200; Sanna V, 2003, J CLIN INVEST, V111, P241, DOI 10.1172/JCI200316721; SOLIMENA M, 1990, NEW ENGL J MED, V322, P1555, DOI 10.1056/NEJM199005313222202; Steinhoff M, 2000, NAT MED, V6, P151, DOI 10.1038/72247; STEINMAN L, 1992, NEUROLOGY, V42, P276, DOI 10.1212/WNL.42.2.276; Steinman L, 2003, NATURE, V422, P671, DOI 10.1038/422671a; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Steinman L, 2002, ANNU REV NEUROSCI, V25, P491, DOI 10.1146/annurev.neuro.25.112701.142913; STEINMAN L, 1990, FASEB J, V4, P2726, DOI 10.1096/fasebj.4.10.2197152; STEINMAN L, 1993, P NATL ACAD SCI USA, V90, P7912, DOI 10.1073/pnas.90.17.7912; Steinman L, 2003, J CLIN INVEST, V111, P183, DOI 10.1172/JCI200317622; Streilein JW, 2000, ANN NY ACAD SCI, V917, P297; Syken J, 2003, P NATL ACAD SCI USA, V100, P13048, DOI 10.1073/pnas.1735415100; Tanzola MB, 2003, J IMMUNOL, V171, P4385, DOI 10.4049/jimmunol.171.8.4385; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; TRACEY KJ, 1988, J EXP MED, V167, P1211, DOI 10.1084/jem.167.3.1211; Ueda Risa, 2003, Kagakushi Kenkyu, V42, P76; Villoslada P, 2000, J EXP MED, V191, P1799, DOI 10.1084/jem.191.10.1799; Voice JK, 2003, J IMMUNOL, V170, P308, DOI 10.4049/jimmunol.170.1.308; Webster EL, 2002, J RHEUMATOL, V29, P1252; Wekerle H, 2002, NATURE, V420, P39, DOI 10.1038/420039a; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; Woolley DE, 2000, ARTHRITIS RES, V2, P65, DOI 10.1186/ar70; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158; Zamvil SS, 2003, NEURON, V38, P685, DOI 10.1016/S0896-6273(03)00326-X	94	400	424	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2004	5	6					575	581		10.1038/ni1078	http://dx.doi.org/10.1038/ni1078			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	824DH	15164017				2022-12-18	WOS:000221664000015
J	Huang, YF; Guo, LY; Qiu, J; Chen, X; Hu-Li, J; Siebenlist, U; Williamson, PR; Urban, JF; Paul, WE				Huang, Yuefeng; Guo, Liying; Qiu, Jin; Chen, Xi; Hu-Li, Jane; Siebenlist, Ulrich; Williamson, Peter R.; Urban, Joseph F.; Paul, William E.			IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential 'inflammatory' type 2 innate lymphoid cells	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR GATA3; T(H)2; POPULATION; ELICITS; IL-25; FATE	Innate lymphoid cells (ILCs) are lymphocyte-like cells that lack T cell or B cell antigen receptors and mediate protective and repair functions through cytokine secretion. Among these, type 2 ILCs (ILC2 cells) are able to produce type 2 cytokines. We report the existence of an inflammatory ILC2 (iILC2) population responsive to interleukin 25 (IL-25) that complemented IL-33-responsive natural ILC2 (nILC2) cells. iILC2 cells developed into nILC2-like cells in vitro and in vivo and contributed to the expulsion of Nippostrongylus brasiliensis. They also acquired IL-17-producing ability and provided partial protection against Candida albicans. We propose that iILC2 cells are transient progenitors of ILCs mobilized by inflammation and infection that develop into nILC2-like cells or ILC3-like cells and contribute to immunity to both helminths and fungi.	[Huang, Yuefeng; Guo, Liying; Chen, Xi; Hu-Li, Jane; Paul, William E.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Qiu, Jin; Williamson, Peter R.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Siebenlist, Ulrich] NIAID, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Urban, Joseph F.] ARS, Diet Genom & Immunol Lab, Beltsville Human Nutr Res Ctr, USDA, Beltsville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); United States Department of Agriculture (USDA)	Paul, WE (corresponding author), NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	wpaul@niaid.nih.gov		Urban, Joseph/0000-0002-1590-8869	NIAID Division of Intramural Research (US National Institutes of Health); ARS [ARS-0426497] Funding Source: Federal RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001095, ZIAAI000493, ZIAAI001124, ZIAAI001123] Funding Source: NIH RePORTER	NIAID Division of Intramural Research (US National Institutes of Health); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Zhu for critical reading of the manuscript; J. Edwards for assistance in the preparation of sorter-purified cells; L. Feigenbaum of the SAIC Laboratory Animal Sciences Program for injection of the recombinant bacterial artificial chromosome into oocytes, transfer into pseudopregnant females and screening of pups; C. Dong (MD Anderson Cancer Center) for IL-17F-RFP reporter mice; A. McKenzie (MRC Laboratory of Molecular Biology, Cambridge) for Il1rl1<SUP>-/-</SUP> mice; and members of Laboratory of Immunology at NIAID for discussions. Supported by the NIAID Division of Intramural Research (US National Institutes of Health).	Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Gladiator A, 2013, J IMMUNOL, V190, P521, DOI 10.4049/jimmunol.1202924; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Hwang YY, 2013, ADV EXP MED BIOL, V785, P9, DOI 10.1007/978-1-4614-6217-0_2; Licona-Limon P, 2013, NAT IMMUNOL, V14, P536, DOI 10.1038/ni.2617; Magri G, 2014, NAT IMMUNOL, V15, P354, DOI 10.1038/ni.2830; Mchedlidze T, 2013, IMMUNITY, V39, P357, DOI 10.1016/j.immuni.2013.07.018; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Motomura Y, 2014, IMMUNITY, V40, P758, DOI 10.1016/j.immuni.2014.04.013; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Saenz SA, 2013, J EXP MED, V210, P1823, DOI 10.1084/jem.20122332; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Spooner CJ, 2013, NAT IMMUNOL, V14, P1229, DOI 10.1038/ni.2743; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Yang Q, 2013, IMMUNITY, V38, P694, DOI 10.1016/j.immuni.2012.12.003	29	399	406	2	64	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2015	16	2					161	+		10.1038/ni.3078	http://dx.doi.org/10.1038/ni.3078			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AZ3QZ	25531830	Green Accepted			2022-12-18	WOS:000348143100008
J	Mishra, BB; Rathinam, VAK; Martens, GW; Martinot, AJ; Kornfeld, H; Fitzgerald, KA; Sassetti, CM				Mishra, Bibhuti B.; Rathinam, Vijay A. K.; Martens, Gregory W.; Martinot, Amanda J.; Kornfeld, Hardy; Fitzgerald, Katherine A.; Sassetti, Christopher M.			Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1 beta	NATURE IMMUNOLOGY			English	Article							HOST-DEFENSE; CELL-DEATH; INFECTION; CASPASE-1; INTERLEUKIN-1; NEUTROPHILS; INNATE; NITROSYLATION; ACTIVATION; SYNTHASE	Interleukin 1 (IL-1) is an important mediator of innate immunity but can also promote inflammatory tissue damage. During chronic infections such as tuberculosis, the beneficial antimicrobial role of IL-1 must be balanced with the need to prevent immunopathology. By exogenously controlling the replication of Mycobacterium tuberculosis in vivo, we obviated the requirement for antimicrobial immunity and discovered that both IL-1 production and infection-induced immunopathology were suppressed by lymphocyte-derived interferon-gamma (IFN-gamma). This effect was mediated by nitric oxide (NO), which we found specifically inhibited assembly of the NLRP3 inflammasome via thiol nitrosylation. Our data indicate that the NO produced as a result of adaptive immunity is indispensable in modulating the destructive innate inflammatory responses elicited during persistent infections.	[Mishra, Bibhuti B.; Sassetti, Christopher M.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01605 USA; [Rathinam, Vijay A. K.; Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA USA; [Martens, Gregory W.; Kornfeld, Hardy] Univ Massachusetts, Sch Med, Dept Med, Div Pulm Allergy & Crit Care, Worcester, MA USA; [Martinot, Amanda J.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Sassetti, Christopher M.] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard T.H. Chan School of Public Health; Howard Hughes Medical Institute	Sassetti, CM (corresponding author), Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01605 USA.	christopher.sassetti@umassmed.edu	Rathinam, Vijay/ABE-7544-2020; Kornfeld, Hardy/AAS-2903-2021; Fitzgerald, Katherine/ABE-6317-2020	Rathinam, Vijay/0000-0002-8009-3977; Fitzgerald, Kate/0000-0003-3175-609X	US National Institutes of Health [AI064282, HL004884, A1083713, U54 A1057159]; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064884, R01HL081149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007638, R01AI064282, U54AI057159, R01AI083713] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Swain (University of Massachusetts Medical School) for IfngrI<SUP>-/-</SUP> mice; A. Campos-Neto (Forsyth Institute) for M. tuberculosis strain 18b; B. McCormick (University of Massachusetts Medical School) for Salmonella enterica serovar Typhimurium; E. Alnemri (Thomas Jefferson University) for rabbit polyclonal antibody to mouse AIM2; G. Nunez (University of Michigan) for rat monoclonal antibody to ASC; B. McCormick, K. Rock, R. Mishra, A.K. Pandey and J. Lee for scientific insight; and H. Ducharme for animal husbandry. Supported by the US National Institutes of Health (AI064282 to C.M.S.; HL004884 to H.K.; A1083713 to K.A.F.; and U54 A1057159 to V.A.K.R.) and the Howard Hughes Medical Institute (C.M.S.).	Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Capuano SV, 2003, INFECT IMMUN, V71, P5831, DOI 10.1128/IAI.71.10.5831-5844.2003; Carlsson F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000895; Chackerian AA, 2001, INFECT IMMUN, V69, P2666, DOI 10.1128/IAI.69.4.2666-2674.2001; CHAN J, 1995, INFECT IMMUN, V63, P736, DOI 10.1128/IAI.63.2.736-740.1995; Coulombe F, 2009, J EXP MED, V206, P1709, DOI 10.1084/jem.20081779; Dimmeler S, 1997, J EXP MED, V185, P601, DOI 10.1084/jem.185.4.601; DINARELLO CA, 1992, IMMUNOL REV, V127, P119, DOI 10.1111/j.1600-065X.1992.tb01411.x; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Eruslanov EB, 2005, INFECT IMMUN, V73, P1744, DOI 10.1128/IAI.73.3.1744-1753.2005; Eum SY, 2010, CHEST, V137, P122, DOI 10.1378/chest.09-0903; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Forrester MT, 2007, J BIOL CHEM, V282, P13977, DOI 10.1074/jbc.M609684200; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Hobbs AJ, 1996, METHOD ENZYMOL, V269, P134; HONORE N, 1995, ANTIMICROB AGENTS CH, V39, P769, DOI 10.1128/AAC.39.3.769; Hopkins N, 2006, J PATHOL, V209, P198, DOI 10.1002/path.1963; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Kang DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016161; Kashino SS, 2006, CLIN VACCINE IMMUNOL, V13, P1014, DOI 10.1128/CVI.00120-06; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Koo IC, 2008, CELL MICROBIOL, V10, P1866, DOI 10.1111/j.1462-5822.2008.01177.x; Lamkanfi M, 2009, IMMUNOL REV, V227, P95, DOI 10.1111/j.1600-065X.2008.00730.x; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Mayer-Barber KD, 2011, IMMUNITY, V35, P1023, DOI 10.1016/j.immuni.2011.12.002; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Meissner F, 2008, NAT IMMUNOL, V9, P866, DOI 10.1038/ni.1633; Minguela A, 2007, J IMMUNOL, V178, P134, DOI 10.4049/jimmunol.178.1.134; Mishra BB, 2010, CELL MICROBIOL, V12, P1046, DOI 10.1111/j.1462-5822.2010.01450.x; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Pandey AK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000500; Pelegrin P, 2007, J BIOL CHEM, V282, P2386, DOI 10.1074/jbc.M610351200; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Schon T, 2003, EUR RESPIR J, V21, P483, DOI 10.1183/09031936.03.00090702; Seiler P, 2003, EUR J IMMUNOL, V33, P2676, DOI 10.1002/eji.200323956; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; TeKippe EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012320; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007	47	399	420	3	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2013	14	1					52	60		10.1038/ni.2474	http://dx.doi.org/10.1038/ni.2474			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	055RG	23160153	Green Accepted			2022-12-18	WOS:000312433800010
J	Zamboni, DS; Kobayashi, KS; Kohlsdorf, T; Ogura, Y; Long, EM; Vance, RE; Kuida, K; Mariathasan, S; Dixit, VM; Flavell, RA; Dietrich, WF; Roy, CR				Zamboni, DS; Kobayashi, KS; Kohlsdorf, T; Ogura, Y; Long, EM; Vance, RE; Kuida, K; Mariathasan, S; Dixit, VM; Flavell, RA; Dietrich, WF; Roy, CR			The Birc1e cytosolic pattern-recognition receptor contributes to the detection and control of Legionella pneumophila infection	NATURE IMMUNOLOGY			English	Article							APOPTOSIS INHIBITORY PROTEIN; INTRACELLULAR GROWTH; MACROPHAGE APOPTOSIS; VIRULENCE SYSTEM; GENE; MICE; LGN1; SUSCEPTIBILITY; ACTIVATION; RESISTANCE	Baculovirus inhibitor of apoptosis repeat-containing 1 (Birc1) proteins have homology to several germline-encoded receptors of the innate immune system. However, their function in immune surveillance is not clear. Here we describe a Birc1e-dependent signaling pathway that restricted replication of the intracellular pathogen Legionella pneumophila in mouse macrophages. Translocation of bacterial products into host-cell cytosol was essential for Birc1e-mediated control of bacterial replication. Caspase-1 was required for Birc1e-dependent antibacterial responses ex vivo in macrophages and in a mouse model of Legionnaires' disease. The interleukin 1 beta converting enzyme-protease-activating factor was necessary for L. pneumophila growth restriction, but interleukin 1 beta was not required. These results establish Birc1e as a nucleotide-binding oligomerization-leucine-rich repeat protein involved in the detection and control of intracellular L. pneumophila.	Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Dana Farber Canc Inst, Boston, MA 02115 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Ecol & Evolutionary Biol, New Haven, CT 06510 USA; Harvard Univ, Sch Med, Dept Genet, Howard Hughes Med Inst, Boston, MA 02115 USA; Vertex Pharmaceut, Cambridge, MA 02139 USA; Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA	Yale University; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Yale University; Yale University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Vertex Pharmaceuticals; Roche Holding; Genentech	Roy, CR (corresponding author), Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA.	craig.roy@yale.edu	Kohlsdorf, Tiana/C-3463-2012; Zamboni, Dario S/D-3024-2012; dixit, vishva m/A-4496-2012	Kohlsdorf, Tiana/0000-0002-3873-2042; Zamboni, Dario S/0000-0002-7856-7512; dixit, vishva m/0000-0001-6983-0326; Kobayashi, Koichi/0000-0003-2930-0114; Starke, Michelle/0000-0003-3239-4801; Roy, Craig/0000-0003-4490-440X	NIAID NIH HHS [AI049987, AI062017, AI48770, AI41699] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049987, R01AI041699, R29AI041699, R01AI048770, F32AI062017] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BECKERS MC, 1995, MAMM GENOME, V6, P540, DOI 10.1007/BF00356173; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Chen YJ, 1996, EMBO J, V15, P3853, DOI 10.1002/j.1460-2075.1996.tb00759.x; Coers J, 2000, MOL MICROBIOL, V38, P719, DOI 10.1046/j.1365-2958.2000.02176.x; Damiano JS, 2004, J IMMUNOL, V173, P6338, DOI 10.4049/jimmunol.173.10.6338; Derre I, 2004, INFECT IMMUN, V72, P6221, DOI 10.1128/IAI.72.11.6221-6229.2004; DIETRICH WF, 1995, GENOMICS, V26, P443, DOI 10.1016/0888-7543(95)80161-E; Diez E, 2000, J IMMUNOL, V164, P1470, DOI 10.4049/jimmunol.164.3.1470; Diez E, 2003, NAT GENET, V33, P55, DOI 10.1038/ng1065; Edelstein PH, 2003, ANTIMICROB AGENTS CH, V47, P533, DOI 10.1128/AAC.47.2.533-540.2003; Hersh D, 1999, P NATL ACAD SCI USA, V96, P2396, DOI 10.1073/pnas.96.5.2396; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Kagan JC, 2004, J EXP MED, V199, P1201, DOI 10.1084/jem.20031706; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Maier JKX, 2002, J NEUROSCI, V22, P2035, DOI 10.1523/JNEUROSCI.22-06-02035.2002; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Miller LK, 1999, TRENDS CELL BIOL, V9, P323, DOI 10.1016/S0962-8924(99)01609-8; Molmeret M, 2004, CELL MICROBIOL, V6, P33, DOI 10.1046/j.1462-5822.2003.00335.x; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Roy CR, 2002, J CELL BIOL, V158, P415, DOI 10.1083/jcb.200205011; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; Sanna MG, 2002, MOL CELL BIOL, V22, P1754, DOI 10.1128/MCB.22.6.1754-1766.2002; Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Smolewski P, 2001, CYTOMETRY, V44, P73, DOI 10.1002/1097-0320(20010501)44:1<73::AID-CYTO1084>3.0.CO;2-S; Ting JPY, 2005, ANNU REV IMMUNOL, V23, P387, DOI 10.1146/annurev.immunol.23.021704.115616; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Viala M, 2004, CR BIOL, V327, P551, DOI 10.1016/j.crvi.2004.02.010; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Wright EK, 2003, CURR BIOL, V13, P27, DOI 10.1016/S0960-9822(02)01359-3; YAMAMOTO Y, 1988, INFECT IMMUN, V56, P370, DOI 10.1128/IAI.56.2.370-375.1988; Zamboni DS, 2003, INFECT IMMUN, V71, P1225, DOI 10.1128/IAI.71.3.1225-1233.2003; Zuckman DM, 1999, MOL MICROBIOL, V32, P990, DOI 10.1046/j.1365-2958.1999.01410.x	34	399	413	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2006	7	3					318	325		10.1038/ni1305	http://dx.doi.org/10.1038/ni1305			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	012SR	16444259				2022-12-18	WOS:000235360400017
J	Probst, HC; McCoy, K; Okazaki, T; Honjo, T; van den Broek, M				Probst, HC; McCoy, K; Okazaki, T; Honjo, T; van den Broek, M			Resting dendritic cells induce peripheral CD8(+) T cell tolerance through PD-1 and CTLA-4	NATURE IMMUNOLOGY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; PROMISCUOUS GENE-EXPRESSION; IN-VIVO; ANTIGEN PRESENTATION; STEADY-STATE; CROSS-PRESENTATION; SELF-TOLERANCE; CUTTING EDGE; ACTIVATION; MICE	T cells recognizing self proteins exist without causing autoimmunity in healthy individuals. These autoreactive T cells are kept in check by peripheral tolerance. Using a model for peripheral CD8(+) T cell tolerance resulting from antigen presentation by resting dendritic cells in vivo, we show here that CD8(+) T cell tolerance operates through T cell-intrinsic mechanisms such as deletion or functional inactivation. Peripheral CD8(+) T cell tolerance depended on signaling via the costimulatory molecule PD-1, as an absence of PD-1 converted tolerance induction into priming. Blocking of the costimulatory molecule CTLA-4 resulted in impaired tolerance and enhanced the effect of the absence of PD-1, suggesting that PD-1 and CTLA-4 act synergistically. Thus PD-1 and CTLA-4 are crucial molecules for peripheral CD8(+) T cell tolerance induced by resting dendritic cells.	Univ Zurich Hosp, Inst Expt Immunol, CH-8091 Zurich, Switzerland; Kyoto Univ, Fac Med, Dept Med Chem, Sakyo Ku, Kyoto 606, Japan	University of Zurich; University Zurich Hospital; Kyoto University	van den Broek, M (corresponding author), Univ Zurich Hosp, Inst Expt Immunol, CH-8091 Zurich, Switzerland.	maries@pathol.unizh.ch	McCoy, Kathy/ABD-5814-2021; van den Broek, Maries/L-6532-2019; Honjo, Tasuku/N-4470-2016; van den Broek, Maries/G-4128-2016	van den Broek, Maries/0000-0002-9489-3692; Okazaki, Taku/0000-0003-4790-1925; PROBST, Hans Christian/0000-0002-7926-0651				Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Albert ML, 2004, NAT REV IMMUNOL, V4, P223, DOI 10.1038/nri11308; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; Bjorses P, 1998, HUM MOL GENET, V7, P1547, DOI 10.1093/hmg/7.10.1547; Blank C, 2003, J IMMUNOL, V171, P4574, DOI 10.4049/jimmunol.171.9.4574; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bouneaud C, 2000, IMMUNITY, V13, P829, DOI 10.1016/S1074-7613(00)00080-7; Brunner MC, 1999, J IMMUNOL, V162, P5813; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Dhodapkar MV, 2002, BLOOD, V100, P174, DOI 10.1182/blood.V100.1.174; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Groux H, 1999, J IMMUNOL, V162, P1723; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hernandez J, 2001, J EXP MED, V194, P707, DOI 10.1084/jem.194.6.707; Hou WS, 2004, NAT IMMUNOL, V5, P583, DOI 10.1038/ni1071; Hugues S, 2002, IMMUNITY, V16, P169, DOI 10.1016/S1074-7613(02)00273-X; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Kyewski B, 2002, TRENDS IMMUNOL, V23, P364, DOI 10.1016/S1471-4906(02)02248-2; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; LEHMANNGRUBE F, 1971, VIROL MONOGR, V10, P1; Lin YL, 2003, EUR J IMMUNOL, V33, P2736, DOI 10.1002/eji.200324087; LINDSTEN T, 1993, J IMMUNOL, V151, P3489; LO D, 1992, EUR J IMMUNOL, V22, P1013, DOI 10.1002/eji.1830220421; Mahnke K, 2003, BLOOD, V101, P4862, DOI 10.1182/blood-2002-10-3229; McCoy KD, 1999, J EXP MED, V189, P1157, DOI 10.1084/jem.189.7.1157; Misra N, 2004, J IMMUNOL, V172, P4676, DOI 10.4049/jimmunol.172.8.4676; Mondino A, 1996, P NATL ACAD SCI USA, V93, P2245, DOI 10.1073/pnas.93.6.2245; Morgan DJ, 1999, J IMMUNOL, V163, P723; Moser M, 2003, IMMUNITY, V19, P5, DOI 10.1016/S1074-7613(03)00182-1; Nishimura H, 2000, J EXP MED, V191, P891, DOI 10.1084/jem.191.5.891; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Okazaki T, 2002, CURR OPIN IMMUNOL, V14, P779, DOI 10.1016/S0952-7915(02)00398-9; Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8; Probst HC, 2003, J IMMUNOL, V171, P5415, DOI 10.4049/jimmunol.171.10.5415; Probst HC, 2002, J IMMUNOL, V168, P5387, DOI 10.4049/jimmunol.168.11.5387; Probst HC, 2003, IMMUNITY, V18, P713, DOI 10.1016/S1074-7613(03)00120-1; ROBINSON SP, 1991, DRUG METAB DISPOS, V19, P36; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Scheinecker C, 2002, J EXP MED, V196, P1079, DOI 10.1084/jem.20020991; Steinman RM, 2003, ANN NY ACAD SCI, V987, P15, DOI 10.1111/j.1749-6632.2003.tb06029.x; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Walker LSK, 2002, NAT REV IMMUNOL, V2, P11, DOI 10.1038/nri701; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Walunas TL, 1998, J IMMUNOL, V160, P3855; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985	56	395	424	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2005	6	3					280	286		10.1038/ni1165	http://dx.doi.org/10.1038/ni1165			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899AN	15685176	Green Accepted			2022-12-18	WOS:000227117400020
J	Poeck, H; Bscheider, M; Gross, O; Finger, K; Roth, S; Rebsamen, M; Hannesschlager, N; Schlee, M; Rothenfusser, S; Barchet, W; Kato, H; Akira, S; Inoue, S; Endres, S; Peschel, C; Hartmann, G; Hornung, V; Ruland, J				Poeck, Hendrik; Bscheider, Michael; Gross, Olaf; Finger, Katrin; Roth, Susanne; Rebsamen, Manuele; Hannesschlaeger, Nicole; Schlee, Martin; Rothenfusser, Simon; Barchet, Winfried; Kato, Hiroki; Akira, Shizuo; Inoue, Satoshi; Endres, Stefan; Peschel, Christian; Hartmann, Gunther; Hornung, Veit; Ruland, Juergen			Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; DOUBLE-STRANDED-RNA; INNATE IMMUNE-RESPONSES; ADAPTER PROTEIN CARD9; TOLL-LIKE RECEPTOR; NLRP3 INFLAMMASOME; CYTOPLASMIC DNA; CUTTING EDGE; ANTIVIRAL RESPONSES; 5'-TRIPHOSPHATE RNA	Interleukin 1 beta (IL-1 beta) is a potent proinflammatory factor during viral infection. Its production is tightly controlled by transcription of Il1b dependent on the transcription factor NF-kappa B and subsequent processing of pro-IL-1 beta by an inflammasome. However, the sensors and mechanisms that facilitate RNA virus-induced production of IL-1 beta are not well defined. Here we report a dual role for the RNA helicase RIG-I in RNA virus-induced proinflammatory responses. Whereas RIG-I-mediated activation of NF-kappa B required the signaling adaptor MAVS and a complex of the adaptors CARD9 and Bcl-10, RIG-I also bound to the adaptor ASC to trigger caspase-1-dependent inflammasome activation by a mechanism independent of MAVS, CARD9 and the Nod-like receptor protein NLRP3. Our results identify the CARD9-Bcl-10 module as an essential component of the RIG-I-dependent proinflammatory response and establish RIG-I as a sensor able to activate the inflammasome in response to certain RNA viruses.	[Poeck, Hendrik; Gross, Olaf; Finger, Katrin; Roth, Susanne; Hannesschlaeger, Nicole; Peschel, Christian; Ruland, Juergen] Tech Univ Munich, Klinikum Rechts Isar, Med Klin 3, D-8000 Munich, Germany; [Poeck, Hendrik; Schlee, Martin; Barchet, Winfried; Hartmann, Gunther; Hornung, Veit] Univ Klinikum Bonn, Inst Clin Chem & Pharmacol, Bonn, Germany; [Poeck, Hendrik; Bscheider, Michael; Rothenfusser, Simon; Endres, Stefan] Univ Munich, Ctr Integrated Prot Sci Munich, Munich, Germany; [Poeck, Hendrik; Bscheider, Michael; Rothenfusser, Simon; Endres, Stefan] Univ Munich, Div Clin Pharmacol, Dept Internal Med, Munich, Germany; [Roth, Susanne; Ruland, Juergen] Res Ctr Environm Hlth, Helmholtz Zentrum Munchen Germany, Lab Signaling Immune Syst, Neuherberg, Germany; [Rebsamen, Manuele] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Kato, Hiroki; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 565, Japan; [Inoue, Satoshi] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Tokyo, Japan; [Inoue, Satoshi] Saitama Med Sch, Res Ctr Genom Med, Saitama, Japan	Technical University of Munich; University of Bonn; University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Lausanne; Osaka University; University of Tokyo; Saitama Medical University	Ruland, J (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Med Klin 3, D-8000 Munich, Germany.	jruland@lrz.tum.de	Rebsamen, Manuele/A-7980-2011; Ruland, Jürgen/Q-6680-2018; Hartmann, Gunther/P-7492-2017; Schlee, Martin/AAL-1238-2021; Hornung, Veit/C-3565-2012; Akira, Shizuo/C-3134-2009; Gross, Olaf/E-4570-2010	Rebsamen, Manuele/0000-0001-6172-4211; Ruland, Jürgen/0000-0002-8381-3597; Hartmann, Gunther/0000-0003-1021-2018; Hornung, Veit/0000-0002-4150-194X; Gross, Olaf/0000-0001-8660-3619; Schlee, Martin/0000-0003-3671-7639; Barchet, Winfried/0000-0002-6745-6606	Bundesministerium fur Bildung und Forschung Biofuture; Deutsche Forschungsgemeinschaft [SFB704, SFB670, SFB832, KFO177]; Sonderforschungsbereiche; Graduiertenkolleg [1202, RO 2525/3-1]; Center for Integrated Protein Science Munich; European Research Council; Deutsche Krebshilfe	Bundesministerium fur Bildung und Forschung Biofuture(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sonderforschungsbereiche; Graduiertenkolleg(German Research Foundation (DFG)); Center for Integrated Protein Science Munich; European Research Council(European Research Council (ERC)European Commission); Deutsche Krebshilfe(Deutsche Krebshilfe)	We thank J. Tschopp (University of Lausanne) for critical reading of the manuscript, discussions and NLRP3-deficient, ASC-deficient and MAVS-deficient mice and plasmids; and A. Krug (Technical University of Munich) for EMCV. This work includes parts of a thesis by M. B. at the University of Munich. Supported by Bundesministerium fur Bildung und Forschung Biofuture (G. H.), Deutsche Forschungsgemeinschaft (SFB704, SFB670, SFB832 and KFO177 to G. H.; Sonderforschungsbereiche to S. E., V. H. and J. R.; Graduiertenkolleg 1202 to M. B.; and RO 2525/3-1 to S. R.), the Center for Integrated Protein Science Munich (S. E.), the European Research Council (V. H.) and Deutsche Krebshilfe (J. R.).	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Colonna M, 2007, NAT IMMUNOL, V8, P554, DOI 10.1038/ni0607-554; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Goodridge HS, 2009, J IMMUNOL, V182, P1146, DOI 10.4049/jimmunol.182.2.1146; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Hara H, 2009, TRENDS IMMUNOL, V30, P234, DOI 10.1016/j.it.2009.03.002; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; Nakhaei P, 2009, SEMIN IMMUNOL, V21, P215, DOI 10.1016/j.smim.2009.05.001; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Poeck H, 2008, NAT MED, V14, P1256, DOI 10.1038/nm.1887; Rawlings DJ, 2006, NAT REV IMMUNOL, V6, P799, DOI 10.1038/nri1944; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Schroder K, 2009, CURR BIOL, V19, pR262, DOI 10.1016/j.cub.2009.02.011; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Steinberg C, 2009, EUR J IMMUNOL, V39, P1007, DOI 10.1002/eji.200838814; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Takahashi K, 2006, J IMMUNOL, V176, P4520, DOI 10.4049/jimmunol.176.8.4520; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Wang L, 2001, J BIOL CHEM, V276, P21405, DOI 10.1074/jbc.M102488200; Werninghaus K, 2009, J EXP MED, V206, P89, DOI 10.1084/jem.20081445; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007	50	394	413	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2010	11	1					63	1824		10.1038/ni.1824	http://dx.doi.org/10.1038/ni.1824			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	533WE	19915568				2022-12-18	WOS:000272855300014
J	Opferman, JT; Korsmeyer, SJ				Opferman, JT; Korsmeyer, SJ			Apoptosis in the development and maintenance of the immune system	NATURE IMMUNOLOGY			English	Review							RESCUES T-LYMPHOPOIESIS; RECEPTOR-DEFICIENT MICE; BCL-2 FAMILY-MEMBERS; B-CELL-DEVELOPMENT; CYTOCHROME-C; MITOCHONDRIAL APOPTOSIS; NEGATIVE SELECTION; CHROMOSOMAL BREAKPOINT; LYMPHOID DEVELOPMENT; GLUT4 TRANSLOCATION	Programmed cell death is essential for the development and maintenance of cellular homeostasis of the immune system. The Bcl-2 family of proteins comprises both pro-apoptotic and. anti-apoptotic members. A subset of pro-apoptotic members, called 'BH3-only' proteins, share sequence homology only in the minimal death domain, designated the Bcl-2 homology 3 (BH3) domain. BH3-only proteins operate as upstream sentinels, selectively sensing both intrinsic and extrinsic death stimuli. They communicate this information to the pro. apoptotic 'multidomain' members Bax or Bak-a process that is antagonized by anti-apoptotic members of the Bcl-2 family. The functional balance of pro-apoptotic versus anti-apoptotic influences, which operates at organelles, determines whether a lymphocyte will live or die. BH3-only molecules, often working in concert, compete for downstream multidomain pro-and anti-apoptotic BCL-2 members to control serial stages of lymphocyte development and homeostasis.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Korsmeyer, SJ (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Howard Hughes Med Inst, 44 Binney St, Boston, MA 02115 USA.	stanley_korsmeyer@dfci.harvard.edu	Opferman, Joseph T/M-5331-2018	Opferman, Joseph T/0000-0002-1147-5621				Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Akbar AN, 1996, EUR J IMMUNOL, V26, P294, DOI 10.1002/eji.1830260204; ASHTONRICKARDT PG, 1994, IMMUNOL TODAY, V15, P362, DOI 10.1016/0167-5699(94)90174-0; Baird AM, 2000, J IMMUNOL, V165, P3680, DOI 10.4049/jimmunol.165.7.3680; Baird AM, 1999, CURR OPIN IMMUNOL, V11, P157, DOI 10.1016/S0952-7915(99)80027-2; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Bouillet P, 2001, DEV CELL, V1, P645, DOI 10.1016/S1534-5807(01)00083-1; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Boussiotis VA, 1997, J IMMUNOL, V159, P3156; Chao DT, 1997, INT IMMUNOL, V9, P1375, DOI 10.1093/intimm/9.9.1375; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; Datta SR, 2002, DEV CELL, V3, P631, DOI 10.1016/S1534-5807(02)00326-X; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; Fisher M., 1995, HDBK OPER R, V8, P1; GRIBBEN JG, 1995, P NATL ACAD SCI USA, V92, P811, DOI 10.1073/pnas.92.3.811; Grillot DAM, 1996, J EXP MED, V183, P381, DOI 10.1084/jem.183.2.381; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Hara H, 2002, J IMMUNOL, V168, P2288, DOI 10.4049/jimmunol.168.5.2288; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; Jiang AM, 2001, J IMMUNOL, V166, P6025, DOI 10.4049/jimmunol.166.10.6025; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; JUNE CH, 1987, MOL CELL BIOL, V7, P4472, DOI 10.1128/MCB.7.12.4472; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Kondo M, 1997, IMMUNITY, V7, P155, DOI 10.1016/S1074-7613(00)80518-X; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Lens SMA, 2002, MOL CELL BIOL, V22, P5419, DOI 10.1128/MCB.22.15.5419-5433.2002; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; LINETTE GP, 1995, BLOOD, V86, P1255, DOI 10.1182/blood.V86.4.1255.bloodjournal8641255; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; Maraskovsky E, 1998, INT IMMUNOL, V10, P1367, DOI 10.1093/intimm/10.9.1367; Marsden VS, 2002, NATURE, V419, P634, DOI 10.1038/nature01101; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; MIYAZAKI T, 1995, CELL, V81, P223, DOI 10.1016/0092-8674(95)90332-1; Motoyama N, 1999, J EXP MED, V189, P1691, DOI 10.1084/jem.189.11.1691; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Newton K, 1998, EMBO J, V17, P706, DOI 10.1093/emboj/17.3.706; NOSAKA T, 1995, SCIENCE, V270, P800, DOI 10.1126/science.270.5237.800; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; OWEN JJT, 1992, ANN NY ACAD SCI, V663, P305, DOI 10.1111/j.1749-6632.1992.tb38673.x; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Ranger AM, 2001, NAT GENET, V28, P113, DOI 10.1038/88815; Rathmell JC, 2002, NAT IMMUNOL, V3, P932, DOI 10.1038/ni834; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; Shimamura A, 2000, CURR BIOL, V10, P127, DOI 10.1016/S0960-9822(00)00310-9; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; STRASSER A, 1994, NATURE, V368, P457, DOI 10.1038/368457a0; STRASSER A, 1994, P NATL ACAD SCI USA, V91, P1376, DOI 10.1073/pnas.91.4.1376; Strasser A, 1995, EMBO J, V14, P6136, DOI 10.1002/j.1460-2075.1995.tb00304.x; Summers SA, 1998, MOL CELL BIOL, V18, P5457, DOI 10.1128/MCB.18.9.5457; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; THOMIS DC, 1995, SCIENCE, V270, P794, DOI 10.1126/science.270.5237.794; Thompson CB, 1999, COLD SPRING HARB SYM, V64, P383, DOI 10.1101/sqb.1999.64.383; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; Uren AG, 1996, P NATL ACAD SCI USA, V93, P4974, DOI 10.1073/pnas.93.10.4974; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; VEIS DJ, 1993, J IMMUNOL, V151, P2546; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; vonFreedenJeffry U, 1997, IMMUNITY, V7, P147, DOI 10.1016/S1074-7613(00)80517-8; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; Zhang ZP, 1998, CHINESE PHYS LETT, V15, P591, DOI 10.1088/0256-307X/15/8/017; Zinkel SS, 2003, GENE DEV, V17, P229, DOI 10.1101/gad.1045603	101	394	409	1	28	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2003	4	5					410	415		10.1038/ni0503-410	http://dx.doi.org/10.1038/ni0503-410			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	674YN	12719730				2022-12-18	WOS:000182665400004
J	Lang, HLE; Jacobsen, H; Ikemizu, S; Andersson, C; Harlos, K; Madsen, L; Hjorth, P; Sondergaard, L; Svejgaard, A; Wucherpfennig, K; Stuart, DI; Bell, JI; Jones, EY; Fugger, L				Lang, HLE; Jacobsen, H; Ikemizu, S; Andersson, C; Harlos, K; Madsen, L; Hjorth, P; Sondergaard, L; Svejgaard, A; Wucherpfennig, K; Stuart, DI; Bell, JI; Jones, EY; Fugger, L			A functional and structural basis for TCR cross-reactivity in multiple sclerosis	NATURE IMMUNOLOGY			English	Article							T-CELL-RECEPTOR; ELECTRON-DENSITY MAPS; MOLECULAR MIMICRY; CRYSTAL-STRUCTURE; IMMUNODOMINANT PEPTIDE; AUTOIMMUNE-DISEASE; PROTEIN; MYELIN; HLA-DR2; COMPLEX	The multiple sclerosis (MS)-associated HLA major histocompatibility complex (MHC) class II alleles DRB1*1501, DRB5*0101 and DQB1*0602 are in strong linkage disequilibrium, making it difficult to determine which is the principal MS risk gene. Here we show that together the DRB1 and DRB5 loci may influence susceptibility to MS. We demonstrate that a T cell receptor (TCR) from an MS patient recognized both a DRB1*1501-restricted myelin basic protein (MBP) and DRB5*0101-restricted Epstein-Barr virus (EBV) peptide. Crystal structure determination of the DRB5*0101-EBV peptide complex revealed a marked degree of structural equivalence to the DRB1*1501-MBP peptide complex at the surface presented for TCR recognition. This provides structural evidence for molecular mimicry involving HLA molecules. The structural details suggest an explanation for the preponderance of MHC class II associations in HLA-associated diseases.	Univ Oxford, Div Struct Biol, Oxford OX3 7BN, England; John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; Aarhus Univ Hosp, Skejby Sygehus, Dept Clin Immunol, DK-8200 Aarhus N, Denmark; Rigshosp, Dept Clin Immunol, DK-2200 Copenhagen N, Denmark; Aarhus Univ, Inst Mol & Struct Biol, DK-8000 Aarhus C, Denmark; Univ Copenhagen, Inst Mol Biol, DK-1353 Copenhagen K, Denmark; Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA	University of Oxford; University of Oxford; Aarhus University; Rigshospitalet; Aarhus University; University of Copenhagen; Harvard University; Dana-Farber Cancer Institute	Jones, EY (corresponding author), Univ Oxford, Div Struct Biol, Henry Wellcome Bldg Genom Med,Roosevelt Dr, Oxford OX3 7BN, England.	yvonne@strubi.ox.ac.uk; fugger@inet.uni2.dk	Jones, Yvonne/J-2293-2016; Jones, Yvonne/N-8111-2019	Jones, Yvonne/0000-0002-3834-1893; Jones, Yvonne/0000-0002-3834-1893; Lang, Heather/0000-0002-9710-0627; Stuart, David/0000-0002-3426-4210				Bachmaier K, 1999, SCIENCE, V283, P1335, DOI 10.1126/science.283.5406.1335; Basu D, 2000, J IMMUNOL, V164, P5788, DOI 10.4049/jimmunol.164.11.5788; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Buljevac D, 2002, BRAIN, V125, P952, DOI 10.1093/brain/awf098; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; FOGDELL A, 1995, TISSUE ANTIGENS, V46, P333, DOI 10.1111/j.1399-0039.1995.tb02503.x; Gauthier L, 1998, P NATL ACAD SCI USA, V95, P11828, DOI 10.1073/pnas.95.20.11828; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KOUSKOFF V, 1995, J IMMUNOL METHODS, V180, P273, DOI 10.1016/0022-1759(95)00002-R; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krogsgaard M, 2000, J EXP MED, V191, P1395, DOI 10.1084/jem.191.8.1395; Li YL, 2000, J MOL BIOL, V304, P177, DOI 10.1006/jmbi.2000.4198; Madsen LS, 1999, NAT GENET, V23, P343, DOI 10.1038/15525; MARTIN R, 1990, J IMMUNOL, V145, P540; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; OLDSTONE MBA, 1987, CELL, V50, P819, DOI 10.1016/0092-8674(87)90507-1; OTA K, 1990, NATURE, V346, P183, DOI 10.1038/346183a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panoutsakopoulou V, 2001, IMMUNITY, V15, P137, DOI 10.1016/S1074-7613(01)00172-8; PETTE M, 1990, P NATL ACAD SCI USA, V87, P7968, DOI 10.1073/pnas.87.20.7968; Reid SW, 1996, J EXP MED, V184, P2279, DOI 10.1084/jem.184.6.2279; SADOVNICK AD, 1993, ANN NEUROL, V33, P281, DOI 10.1002/ana.410330309; SIBLEY WA, 1985, LANCET, V1, P1313; Smith KJ, 1998, J EXP MED, V188, P1511, DOI 10.1084/jem.188.8.1511; Speir JA, 1998, IMMUNITY, V8, P553, DOI 10.1016/S1074-7613(00)80560-9; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; ZAMVIL SS, 1990, ANNU REV IMMUNOL, V8, P579, DOI 10.1146/annurev.iy.08.040190.003051; Zhao R, 1999, J EXP MED, V189, P359, DOI 10.1084/jem.189.2.359	36	394	417	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2002	3	10					940	943		10.1038/ni835	http://dx.doi.org/10.1038/ni835			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	597VU	12244309				2022-12-18	WOS:000178242100014
J	Lee, YJ; Holzapfel, KL; Zhu, JF; Jameson, SC; Hogquist, KA				Lee, You Jeong; Holzapfel, Keli L.; Zhu, Jinfang; Jameson, Stephen C.; Hogquist, Kristin A.			Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells	NATURE IMMUNOLOGY			English	Article							CD8(+) T-CELLS; NKT CELLS; CYTOKINE PRODUCTION; ZINC-FINGER; INNATE; RESPONSES; ASTHMA; MICE; BET; EXPRESSION	Invariant natural killer T cells (iNKT cells) can produce copious amounts of interleukin 4 (IL-4) early during infection. However, indirect evidence suggests they may produce this immunomodulatory cytokine in the steady state. Through intracellular staining for transcription factors, we have defined three subsets of iNKT cells (NKT1, NKT2 and NKT17) that produced distinct cytokines; these represented diverse lineages and not developmental stages, as previously thought. These subsets exhibited substantial interstrain variation in numbers. In several mouse strains, including BALB/c, NKT2 cells were abundant and were stimulated by self ligands to produce IL-4. In those strains, steady-state IL-4 conditioned CD8(+) T cells to become 'memory-like', increased serum concentrations of immunoglobulin E (IgE) and caused dendritic cells to produce chemokines. Thus, iNKT cell-derived IL-4 altered immunological properties under normal steady-state conditions.	[Lee, You Jeong; Holzapfel, Keli L.; Jameson, Stephen C.; Hogquist, Kristin A.] Univ Minnesota, Dept Lab Med & Pathol, Dept Lab Med, Minneapolis, MN 55455 USA; [Zhu, Jinfang] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA	University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Hogquist, KA (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Dept Lab Med, Minneapolis, MN 55455 USA.	hogqu001@umn.edu	Jameson, Stephen C/D-9892-2013; Zhu, Jinfang/B-7574-2012; Lee, You Jeong/T-6086-2019	Jameson, Stephen C/0000-0001-9137-1146; Zhu, Jinfang/0000-0002-0117-4745; Hogquist, Kristin/0000-0001-9963-5687	US National Institute of Health, Division of Intramural Research, National Institute of Allergy and Infectious Diseases [R37-AI39560, RO1-AI075168, T32 HD060536]; US National Cancer Research Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075168, R37AI039560, ZIAAI001169] Funding Source: NIH RePORTER	US National Institute of Health, Division of Intramural Research, National Institute of Allergy and Infectious Diseases; US National Cancer Research Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Ding and S. Perry for technical support; M. Mohrs (Trudeau Institute) for KN2 mice on the B6 and BALB/c background; D. B. Sant'Angelo (Rutgers University) for Alexa Fluor 488-conjugated antibody to PLZF; M. Mohrs and M. Kronenberg for discussions; and S. Hamilton for critical review of the manuscript. Supported by the US National Institutes of Health (R37-AI39560 to K. A. H.; RO1-AI075168 to S. C. J.; T32 HD060536 to K. L. H.; and the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, for J.Z.) and the Cancer Research Institute (Y.J.L.).	Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Alonzo ES, 2010, J IMMUNOL, V184, P1268, DOI 10.4049/jimmunol.0903218; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; Berg LJ, 2007, NAT REV IMMUNOL, V7, P479, DOI 10.1038/nri2091; Berzins SP, 2006, J IMMUNOL, V176, P4059, DOI 10.4049/jimmunol.176.7.4059; Brennan PJ, 2011, NAT IMMUNOL, V12, P1202, DOI 10.1038/ni.2143; Chang PP, 2012, NAT IMMUNOL, V13, P35, DOI 10.1038/ni.2166; COFFMAN RL, 1986, J IMMUNOL, V136, P4538; Constantinides MG, 2013, CURR OPIN IMMUNOL, V25, P161, DOI 10.1016/j.coi.2013.01.003; Dickgreber N, 2012, J LEUKOCYTE BIOL, V92, P999, DOI 10.1189/jlb.0512242; Facciotti F, 2012, NAT IMMUNOL, V13, P474, DOI 10.1038/ni.2245; Finotto S, 2002, SCIENCE, V295, P336, DOI 10.1126/science.1065544; Hansen DS, 2003, IMMUNITY, V18, P391, DOI 10.1016/S1074-7613(03)00052-9; Johnson TR, 2002, J VIROL, V76, P4294, DOI 10.1128/JVI.76.9.4294-4303.2002; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Kim HY, 2009, J IMMUNOL, V182, P3252, DOI 10.4049/jimmunol.0803339; Kim PJ, 2006, J IMMUNOL, V177, P6650, DOI 10.4049/jimmunol.177.10.6650; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Lai DZ, 2011, J EXP MED, V208, P1093, DOI 10.1084/jem.20101527; Lee YJ, 2011, TRENDS IMMUNOL, V32, P50, DOI 10.1016/j.it.2010.12.004; Mcnab FW, 2007, J IMMUNOL, V179, P6630, DOI 10.4049/jimmunol.179.10.6630; Min HS, 2011, J IMMUNOL, V186, P5749, DOI 10.4049/jimmunol.1002825; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Morrot A, 2005, J EXP MED, V202, P551, DOI 10.1084/jem.20042463; Pochanke V, 2006, EUR J IMMUNOL, V36, P2434, DOI 10.1002/eji.200635949; Proietto AI, 2008, P NATL ACAD SCI USA, V105, P19869, DOI 10.1073/pnas.0810268105; Rafei M, 2011, J IMMUNOL, V187, P3133, DOI 10.4049/jimmunol.1101097; Saenz SA, 2010, TRENDS IMMUNOL, V31, P407, DOI 10.1016/j.it.2010.09.001; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Semmling V, 2010, NAT IMMUNOL, V11, P313, DOI 10.1038/ni.1848; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Terashima A, 2008, J EXP MED, V205, P2727, DOI 10.1084/jem.20080698; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Tupin E, 2007, NAT REV MICROBIOL, V5, P405, DOI 10.1038/nrmicro1657; Verykokakis M, 2010, IMMUNITY, V33, P203, DOI 10.1016/j.immuni.2010.07.013; Watarai H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001255; Wei G, 2011, IMMUNITY, V35, P299, DOI 10.1016/j.immuni.2011.08.007; Weinreich MA, 2010, NAT IMMUNOL, V11, P709, DOI 10.1038/ni.1898; Weinreich MA, 2009, IMMUNITY, V31, P122, DOI 10.1016/j.immuni.2009.05.011; Yuan J, 2012, SCIENCE, V335, P1195, DOI 10.1126/science.1216557; Zhang DH, 1999, IMMUNITY, V11, P473, DOI 10.1016/S1074-7613(00)80122-3; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440; Zhu JF, 2012, IMMUNITY, V37, P660, DOI 10.1016/j.immuni.2012.09.007; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	46	392	395	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2013	14	11					1146	U126		10.1038/ni.2731	http://dx.doi.org/10.1038/ni.2731			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	239KV	24097110	Green Accepted			2022-12-18	WOS:000326023400011
J	Parravicini, V; Gadina, M; Kovarova, M; Odom, S; Gonzalez-Espinosa, C; Furumoto, Y; Saitoh, S; Samelson, LE; O'Shea, JJ; Rivera, J				Parravicini, V; Gadina, M; Kovarova, M; Odom, S; Gonzalez-Espinosa, C; Furumoto, Y; Saitoh, S; Samelson, LE; O'Shea, JJ; Rivera, J			Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation	NATURE IMMUNOLOGY			English	Article							FC-EPSILON-RI; PROTEIN-TYROSINE KINASE; LYN-DEFICIENT MICE; HIGH-AFFINITY; T-CELL; AUTOIMMUNE-DISEASE; PLASMA-MEMBRANE; GAMMA-CHAIN; SH2 DOMAIN; ACTIVATION	FcepsilonRI activation of mast cells is thought to involve Lyn and Syk kinases proximal to the receptor and the signaling complex organized by the linker for activation of T cells (LAT). We report here that FcepsilonRI also uses a Fyn kinase-dependent pathway that does not require Lyn kinase or the adapter LAT for its initiation, but is necessary for mast cell degranulation. Lyn-deficiency enhanced Fyn-dependent signals and degranulation, but inhibited the calcium response. Fyn-deficiency impaired degranulation, whereas Lyn-mediated signaling and calcium was normal. Thus, FcepsilonRI-dependent mast cell degranulation involves cross-talk between Fyn and Lyn kinases.	NCI, Cellular & Mol Biol Lab, NIH, Bethesda, MD 20892 USA; NIAMSD, Mol Inflammat Sect, NIH, Bethesda, MD 20892 USA; NIAMSD, Lymphocyte Cell Biol Sect, NIH, Bethesda, MD 20892 USA; Acad Sci Czech Republ, Inst Mol Genet, Prague, Czech Republic	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Rivera, J (corresponding author), IPN, CINVESTAV, Pharmacobiol Dept, Tenorios 235, Mexico City 14330, DF, Mexico.		Gadina, Massimo/R-4195-2019; Gonzalez-Espinosa, Claudia/C-4417-2019	Gonzalez-Espinosa, Claudia/0000-0001-7332-3829; Kovarova, Martina/0000-0001-7152-1709	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041106, Z01AR041101, ZIAAR041101, ZIAAR041106] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Arudchandran R, 2000, J EXP MED, V191, P47, DOI 10.1084/jem.191.1.47; BENHAMOU M, 1993, J BIOL CHEM, V268, P23318; CAMBIER JC, 1995, IMMUNOL TODAY, V16, P110, DOI 10.1016/0167-5699(95)80105-7; Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; Costello PS, 1996, ONCOGENE, V13, P2595; EISEMAN E, 1992, NATURE, V355, P78; ElHillal O, 1997, P NATL ACAD SCI USA, V94, P1919, DOI 10.1073/pnas.94.5.1919; FIELD KA, 1995, P NATL ACAD SCI USA, V92, P9201, DOI 10.1073/pnas.92.20.9201; Gadina M, 2000, J BIOL CHEM, V275, P26959; Geng LP, 2001, P NATL ACAD SCI USA, V98, P11527, DOI 10.1073/pnas.191378198; Griffiths EK, 2001, SCIENCE, V293, P2260, DOI 10.1126/science.1063397; Gross BS, 1999, J BIOL CHEM, V274, P5963, DOI 10.1074/jbc.274.9.5963; Gu HH, 2001, NATURE, V412, P186, DOI 10.1038/35084076; Gu HH, 1998, MOL CELL, V2, P729, DOI 10.1016/S1097-2765(00)80288-9; Hamawy MM, 1997, J BIOL CHEM, V272, P30498, DOI 10.1074/jbc.272.48.30498; Harder KW, 2001, IMMUNITY, V15, P603, DOI 10.1016/S1074-7613(01)00208-4; Hasegawa M, 2001, J IMMUNOL, V167, P2469, DOI 10.4049/jimmunol.167.5.2469; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Huber M, 1998, P NATL ACAD SCI USA, V95, P11330, DOI 10.1073/pnas.95.19.11330; Kawakami Y, 2000, J IMMUNOL, V165, P1210, DOI 10.4049/jimmunol.165.3.1210; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Kovarova M, 2001, MOL CELL BIOL, V21, P8318, DOI 10.1128/MCB.21.24.8318-8328.2001; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; LIU FT, 1980, J IMMUNOL, V124, P2728; LO TN, 1987, J BIOL CHEM, V262, P4141; Manetz TS, 2001, MOL CELL BIOL, V21, P3763, DOI 10.1128/MCB.21.11.3763-3774.2001; MINOGUCHI K, 1994, J BIOL CHEM, V269, P16902; Nishida K, 1999, BLOOD, V93, P1809, DOI 10.1182/blood.V93.6.1809.406k35_1809_1816; Nishizumi H, 1997, J IMMUNOL, V158, P2350; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; OZAWA K, 1993, J BIOL CHEM, V268, P1749; Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486; Pivniouk VI, 1999, J CLIN INVEST, V103, P1737; PRIBLUDA VS, 1994, P NATL ACAD SCI USA, V91, P11246, DOI 10.1073/pnas.91.23.11246; Ptasznik A, 1996, J BIOL CHEM, V271, P25204, DOI 10.1074/jbc.271.41.25204; Rivera J, 2001, INT ARCH ALLERGY IMM, V124, P137, DOI 10.1159/000053692; RIVERA J, 1988, MOL IMMUNOL, V25, P647, DOI 10.1016/0161-5890(88)90100-9; RODGERS W, 1994, MOL CELL BIOL, V14, P5384, DOI 10.1128/MCB.14.8.5384; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Su YW, 1999, EUR J IMMUNOL, V29, P3702, DOI 10.1002/(SICI)1521-4141(199911)29:11<3702::AID-IMMU3702>3.0.CO;2-R; Takahashi T, 1997, J IMMUNOL, V159, P2532; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; Tang H, 1999, J BIOL CHEM, V274, P12401, DOI 10.1074/jbc.274.18.12401; Wilson BS, 2001, J CELL BIOL, V154, P645, DOI 10.1083/jcb.200104049; Wolf I, 2002, MOL CELL BIOL, V22, P231, DOI 10.1128/MCB.22.1.231-244.2002; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zhao CM, 1999, J BIOL CHEM, V274, P19649, DOI 10.1074/jbc.274.28.19649	49	392	404	1	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2002	3	8					741	748		10.1038/ni817	http://dx.doi.org/10.1038/ni817			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	578LF	12089510				2022-12-18	WOS:000177118500013
J	Suh, WK; Gajewska, BU; Okada, H; Gronski, MA; Bertram, EM; Dawicki, W; Duncan, GS; Bukczynski, J; Plyte, S; Elia, A; Wakeham, A; Itie, A; Chung, S; Da Costa, J; Arya, S; Horan, T; Campbell, P; Gaida, K; Ohashi, PS; Watts, TH; Yoshinaga, SK; Bray, MR; Jordana, M; Mak, TW				Suh, WK; Gajewska, BU; Okada, H; Gronski, MA; Bertram, EM; Dawicki, W; Duncan, GS; Bukczynski, J; Plyte, S; Elia, A; Wakeham, A; Itie, A; Chung, S; Da Costa, J; Arya, S; Horan, T; Campbell, P; Gaida, K; Ohashi, PS; Watts, TH; Yoshinaga, SK; Bray, MR; Jordana, M; Mak, TW			The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses	NATURE IMMUNOLOGY			English	Article							CELL-ACTIVATION; ALLERGIC SENSITIZATION; ICOS; MOLECULE; RECEPTOR; COSTIMULATION; MICE; STIMULATION; INHIBITION; ENGAGEMENT	We investigated the in vivo function of the B7 family member B7-H3 (also known as B7RP-2) by gene targeting. B7-H3 inhibited T cell proliferation mediated by antibody to T cell receptor or allogeneic antigen-presenting cells. B7-H3-deficient mice developed more severe airway inflammation than did wild-type mice in conditions in which T helper cells differentiated toward type 1 (T(H)1) rather than type 2 (T H 2). B7-H3 expression was consistently enhanced by interferon-gamma but suppressed by interleukin 4 in dendritic cells. B7-H3-deficient mice developed experimental autoimmune encephalomyelitis several days earlier than their wild-type littermates, and accumulated higher concentrations of autoantibodies to DNA. Thus, B7-H3 is a negative regulator that preferentially affects T(H)1 responses.	Univ Toronto, Ontario Canc Inst, Adv Med Discovery Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada; McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; Amgen Inc, Thousand Oaks, CA 91320 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; McMaster University; University of Toronto; Amgen	Mak, TW (corresponding author), Univ Toronto, Ontario Canc Inst, Adv Med Discovery Inst, 620 Univ Ave, Toronto, ON M5G 2C1, Canada.	tmak@uhnres.utoronto.ca	Duncan, Gordon/AIE-7011-2022	Gronski, Matthew/0000-0003-4779-5720; Suh, Woong-Kyung/0000-0002-6420-3283; Ohashi, Pamela S./0000-0003-2915-9317; Bray, Mark/0000-0003-4609-6127				Bertram EM, 2002, J IMMUNOL, V168, P3777, DOI 10.4049/jimmunol.168.8.3777; Brodie D, 2000, CURR BIOL, V10, P333, DOI 10.1016/S0960-9822(00)00383-3; Brunner MC, 1999, J IMMUNOL, V162, P5813; Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; Carter LL, 2002, EUR J IMMUNOL, V32, P634, DOI 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9; Chapoval AI, 2001, NAT IMMUNOL, V2, P269, DOI 10.1038/85339; Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X; Coyle AJ, 2001, NAT IMMUNOL, V2, P203, DOI 10.1038/85251; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Dong HD, 1999, NAT MED, V5, P1365; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; FUNGLEUNG WP, 1991, J EXP MED, V174, P1425, DOI 10.1084/jem.174.6.1425; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kundig TM, 1996, IMMUNITY, V5, P41, DOI 10.1016/S1074-7613(00)80308-8; Lanzavecchia A, 1999, CELL, V96, P1, DOI 10.1016/S0092-8674(00)80952-6; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Liang L, 2002, CURR OPIN IMMUNOL, V14, P384, DOI 10.1016/S0952-7915(02)00342-4; Ling V, 2000, J IMMUNOL, V164, P1653, DOI 10.4049/jimmunol.164.4.1653; Mandelbrot DA, 1999, J EXP MED, V189, P435, DOI 10.1084/jem.189.2.435; Mazanet MM, 2002, J IMMUNOL, V169, P3581, DOI 10.4049/jimmunol.169.7.3581; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Prasad DVR, 2003, IMMUNITY, V18, P863, DOI 10.1016/S1074-7613(03)00147-X; Raptis L, 1997, CELL GROWTH DIFFER, V8, P891; Segal BM, 1998, J EXP MED, V187, P537, DOI 10.1084/jem.187.4.537; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Sica GL, 2003, IMMUNITY, V18, P849, DOI 10.1016/S1074-7613(03)00152-3; Stampfli MR, 1998, J CLIN INVEST, V102, P1704, DOI 10.1172/JCI4160; Stampfli MR, 1999, AM J RESP CELL MOL, V21, P317; Suen WE, 1997, J EXP MED, V186, P1233, DOI 10.1084/jem.186.8.1233; Sun MY, 2002, J IMMUNOL, V168, P6294, DOI 10.4049/jimmunol.168.12.6294; Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839; Wang SD, 2000, BLOOD, V96, P2808; Watanabe N, 2003, NAT IMMUNOL, V4, P670, DOI 10.1038/ni944; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Watts TH, 1999, CURR OPIN IMMUNOL, V11, P286, DOI 10.1016/S0952-7915(99)80046-6; Wiley RE, 2001, J IMMUNOL, V166, P2750, DOI 10.4049/jimmunol.166.4.2750; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582	47	390	455	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2003	4	9					899	906		10.1038/ni967	http://dx.doi.org/10.1038/ni967			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	715YN	12925852				2022-12-18	WOS:000185002200017
J	McIntire, JJ; Umetsu, SE; Akbari, O; Potter, M; Kuchroo, VK; Barsh, GS; Freeman, GJ; Umetsu, DT; DeKruyff, RH				McIntire, JJ; Umetsu, SE; Akbari, O; Potter, M; Kuchroo, VK; Barsh, GS; Freeman, GJ; Umetsu, DT; DeKruyff, RH			Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family	NATURE IMMUNOLOGY			English	Article							HEAT-KILLED LISTERIA; T-CELLS; CHROMOSOME 5Q31-Q33; CELLULAR RECEPTOR; ASTHMA; ATOPY; RESPONSES; LINKAGE; ANTIGEN; MICE	To simplify the analysis of asthma susceptibility genes located at human chromosome 5q23-35, we examined congenic mice that differed at the homologous chromosomal segment. We identified a Mendelian trait encoded by T cell and Airway Phenotype Regulator (Tapr). Tapr is genetically distinct from known cytokine genes and controls the development of airway hyperreactivity and T cell production of interleukin 4 (IL-4) and IL-13. Positional cloning identified a gene family that encodes T cell membrane proteins (TIMs); major sequence variants of this gene family (Tim) completely cosegregated with Tapr. The human homolog of TIM-I is the hepatitis A virus (HAV) receptor, which may explain the inverse relationship between HAV infection and the development of atopy.	Stanford Univ, Dept Pediat, Div Immunol & Allergy, Stanford, CA 94305 USA; Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; NCI, Bethesda, MD 20892 USA; Brigham & Womens Hosp, Ctr Neurol Dis, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Harvard Univ, Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	DeKruyff, RH (corresponding author), Stanford Univ, Dept Pediat, Div Immunol & Allergy, Stanford, CA 94305 USA.	rdk@stanford.edu	Jones, Jennifer/C-8691-2015; Freeman, Gordon/AAC-5380-2019	Jones, Jennifer/0000-0002-9488-7719; Freeman, Gordon/0000-0002-7210-5616	NCI NIH HHS [CA84500, CA09302] Funding Source: Medline; NIAID NIH HHS [AI-24571] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA084500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI024571, R01AI024571] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Brady KP, 1997, GENOME RES, V7, P1085, DOI 10.1101/gr.7.11.1085; Cohn L, 1997, J EXP MED, V186, P1737, DOI 10.1084/jem.186.10.1737; COOKSON WOCM, 1988, LANCET, V1, P86; COOKSON WOCM, 1989, LANCET, V1, P1292; DEKRUYFF RH, 1992, J IMMUNOL, V149, P3468; Feigelstock D, 1998, J VIROL, V72, P6621, DOI 10.1128/JVI.72.8.6621-6628.1998; Feigelstock D, 1998, J VIROL, V72, P6218, DOI 10.1128/JVI.72.7.6218-6222.1998; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; Frazer KA, 1997, GENOME RES, V7, P495, DOI 10.1101/gr.7.5.495; Guler ML, 1999, J IMMUNOL, V162, P1339; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; Hansen G, 1999, J CLIN INVEST, V103, P175, DOI 10.1172/JCI5155; Hansen G, 2000, J IMMUNOL, V164, P223, DOI 10.4049/jimmunol.164.1.223; HARGREAVE FE, 1981, J ALLERGY CLIN IMMUN, V68, P347, DOI 10.1016/0091-6749(81)90132-9; Hershey GKK, 1997, NEW ENGL J MED, V337, P1720, DOI 10.1056/NEJM199712113372403; Hjern A, 2000, CLIN EXP ALLERGY, V30, P521; Howard TD, 2000, J ALLERGY CLIN IMMUN, V105, pS477, DOI 10.1016/S0091-6749(00)90046-0; HSIEH CS, 1992, P NATL ACAD SCI USA, V89, P6065, DOI 10.1073/pnas.89.13.6065; Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; *JACKS LAB, 2001, JACKS LAB MOUS GEN I; JUNIPER EF, 1978, THORAX, V33, P705, DOI 10.1136/thx.33.6.705; KAMOGAWA Y, 1993, CELL, V75, P985, DOI 10.1016/0092-8674(93)90542-X; Lahn M, 1999, NAT MED, V5, P1150, DOI 10.1038/13476; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Macaulay AE, 1997, J IMMUNOL, V158, P4171; Macaulay AE, 1998, J IMMUNOL, V160, P1694; Marsh DG, 1997, NAT GENET, V15, P389; MARSH DG, 1994, SCIENCE, V264, P1152, DOI 10.1126/science.8178175; Matricardi PM, 2000, BMJ-BRIT MED J, V320, P412, DOI 10.1136/bmj.320.7232.412; Matricardi PM, 1999, LANCET, V354, P430, DOI 10.1016/S0140-6736(05)75853-0; Matricardi PM, 1997, BRIT MED J, V314, P999, DOI 10.1136/bmj.314.7086.999; McNally NJ, 1998, SOC SCI MED, V46, P729, DOI 10.1016/S0277-9536(97)00174-3; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; MONNEY L, 2001, SCAND J IMMUNOL, V54, P35; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Noguchi E, 1997, AM J RESP CRIT CARE, V156, P1390, DOI 10.1164/ajrccm.156.5.9702084; Ober C, 2000, AM J HUM GENET, V66, P517, DOI 10.1086/302781; Palmer LJ, 2000, GENOME RES, V10, P1280, DOI 10.1101/gr.143400; POSTMA DS, 1995, NEW ENGL J MED, V333, P894, DOI 10.1056/NEJM199510053331402; POTTER M, 1983, INFECT IMMUN, V40, P1234, DOI 10.1128/IAI.40.3.1234-1235.1983; POTTER M, 1994, CANCER RES, V54, P969; RUSCETTI S, 1985, J EXP MED, V162, P1579, DOI 10.1084/jem.162.5.1579; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Schneider-Schaulies J, 2000, J GEN VIROL, V81, P1413, DOI 10.1099/0022-1317-81-6-1413; Shirakawa T, 1997, SCIENCE, V275, P77, DOI 10.1126/science.275.5296.77; Silver L.M., 1995, MOUSE GENETICS CONCE; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Teuscher C, 1999, J IMMUNOL, V163, P2262; Trowsdale J, 2001, IMMUNITY, V15, P363, DOI 10.1016/S1074-7613(01)00197-2; Turkey J. W., 1977, EXPLORATORY DATA ANA; Van Etten WJ, 1999, NAT GENET, V22, P384, DOI 10.1038/11962; Walley AJ, 2001, GENOMICS, V72, P15, DOI 10.1006/geno.2000.6435; Weiss KB, 2001, J ALLERGY CLIN IMMUN, V107, P3, DOI 10.1067/mai.2001.112262; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Woolcock AJ, 1997, CIBA F SYMP, V206, P122; Wu CB, 2001, NAT IMMUNOL, V2, P410, DOI 10.1038/87713; Yeung VP, 1998, J IMMUNOL, V161, P4146; Yokouchi Y, 2000, GENOMICS, V66, P152, DOI 10.1006/geno.2000.6201; Zhu YW, 2000, P NATL ACAD SCI USA, V97, P1137, DOI 10.1073/pnas.97.3.1137	63	389	463	3	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2001	2	12					1109	1116		10.1038/ni739	http://dx.doi.org/10.1038/ni739			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	497UE	11725301				2022-12-18	WOS:000172473200012
J	Granucci, F; Vizzardelli, C; Pavelka, N; Feau, S; Persico, M; Virzi, E; Rescigno, M; Moro, G; Ricciardi-Castagnoli, P				Granucci, F; Vizzardelli, C; Pavelka, N; Feau, S; Persico, M; Virzi, E; Rescigno, M; Moro, G; Ricciardi-Castagnoli, P			Inducible IL-2 production by dendritic cells revealed by global gene expression analysis	NATURE IMMUNOLOGY			English	Article							CLASS-I MOLECULES; T-CELLS; VAV FAMILY; MOUSE; ACTIVATION; MATURATION; ANTIGENS; RESPONSES; TRANSPORT; KINETICS	Dendritic cells (DCs) are strong activators of primary T cell responses. Their priming ability is acquired upon encounter with maturation stimuli. To identify the genes that are differentially expressed upon maturation induced by exposure to Gram-negative bacteria, a kinetic study of DC gene expression was done with microarrays representing 11,000 genes and ESTs (expressed sequence tags). Approximately 3000 differentially expressed transcripts were identified. We found that functional interleukin 2 (IL-2) mRNA, which gave rise to IL-2 production, was transiently up. regulated at early time-points after bacterial encounter. In contrast, macrophages did not produce IL-2 upon bacterial stimulation. Thus, IL-2 is an additional key cytokine that confers unique T cell stimulatory capacity to DCs.	Univ Milano Bicocca, Dept Biosci & Biotechnol, Milan, Italy	University of Milano-Bicocca	Ricciardi-Castagnoli, P (corresponding author), Univ Milano Bicocca, Dept Biosci & Biotechnol, Piazza Sci 2, Milan, Italy.	paolo.castagnoli@unimib.it	Rescigno, Maria/J-9704-2012; Castagnoli, Paola/E-8288-2010; GRANUCCI, Francesca/K-6150-2019; Pavelka, Norman/G-4577-2018; Persico, Maria/Q-8961-2018	Rescigno, Maria/0000-0002-6464-509X; Pavelka, Norman/0000-0003-4542-9970; Vizzardelli, Caterina/0000-0001-9262-6710; Persico, Maria/0000-0002-5816-9760; granucci, francesca/0000-0002-7046-4914				Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Borisy GG, 2000, CURR OPIN CELL BIOL, V12, P104, DOI 10.1016/S0955-0674(99)00063-0; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Klein L, 2000, NAT MED, V6, P56, DOI 10.1038/71540; KRAMER S, 1994, EUR J IMMUNOL, V24, P2317, DOI 10.1002/eji.1830241009; Kronin V, 1998, INT IMMUNOL, V10, P237, DOI 10.1093/intimm/10.2.237; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Lutz MB, 1997, J IMMUNOL, V159, P3707; Movilla N, 1999, MOL CELL BIOL, V19, P7870; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Rescigno M, 1998, J EXP MED, V188, P2175, DOI 10.1084/jem.188.11.2175; Rescigno M, 1998, P NATL ACAD SCI USA, V95, P5229, DOI 10.1073/pnas.95.9.5229; Rescigno M, 2000, J EXP MED, V192, P1661, DOI 10.1084/jem.192.11.1661; Rodriguez A, 1999, NAT CELL BIOL, V1, P362, DOI 10.1038/14058; Sallusto F, 1999, EUR J IMMUNOL, V29, P1617, DOI 10.1002/(SICI)1521-4141(199905)29:05<1617::AID-IMMU1617>3.0.CO;2-3; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schuurhuis DH, 2000, J EXP MED, V192, P145, DOI 10.1084/jem.192.1.145; Singh-Jasuja H, 2000, J EXP MED, V191, P1965, DOI 10.1084/jem.191.11.1965; Staudt LM, 2000, ANNU REV IMMUNOL, V18, P829, DOI 10.1146/annurev.immunol.18.1.829; STEINMAN RM, 1980, J INVEST DERMATOL, V75, P14, DOI 10.1111/1523-1747.ep12521052; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Teague TK, 1999, P NATL ACAD SCI USA, V96, P12691, DOI 10.1073/pnas.96.22.12691; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Zeller JC, 1999, J IMMUNOL, V163, P3684	32	389	421	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2001	2	9					882	888		10.1038/ni0901-882	http://dx.doi.org/10.1038/ni0901-882			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	468WM	11526406				2022-12-18	WOS:000170781200030
J	Katagiri, K; Maeda, A; Shimonaka, M; Kinashi, T				Katagiri, K; Maeda, A; Shimonaka, M; Kinashi, T			RAPL, a Rap1-binding molecule that mediates Rap1-induced adhesion through spatial regulation of LFA-1	NATURE IMMUNOLOGY			English	Article							T-CELL ACTIVATION; FUNCTION-ASSOCIATED ANTIGEN-1; NERVE GROWTH-FACTOR; INTEGRIN ACTIVATION; HUMAN NEUTROPHILS; MIGRATION; PROTEIN; GTPASE; MORPHOGENESIS; ADHESIVENESS	The small GTPase Rap1 is a potent activator of leukocyte integrin. However, the regulatory mechanism involved is unknown. Here, we identify the Rap1 effector, RAPL, as an essential regulator in this activation. RAPL was enriched in mouse lymphoid tissues and associated with Rap1 after stimulation by the T cell receptor and with chemokine CXCL12. Human RAPL stimulated lymphocyte polarization and the patch-like redistribution of lymphocyte-function-associated antigen 1 (LFA-1) to the leading edge, resulting in enhanced adhesion to intercellular adhesion molecule 1 (ICAM-1). Triggered by activated Rap1, RAPL associated with LFA-1 and rapidly relocated to the leading edge and accumulated at immunological synapses. Thus, RAPL regulates lymphocyte adhesion through the spatial distribution of LFA-1.	Kyoto Univ, Grad Sch Med, Dept Mol Immunol & Allergy, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Dept Dermatol, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Kyoto University	Kinashi, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Mol Immunol & Allergy, Sakyo Ku, Kyoto 6068501, Japan.	tkinashi@mfour.med.kyoto-u.ac.jp	Maeda, Akito/AAX-6252-2020	Maeda, Akito/0000-0001-8776-9135				Asha H, 1999, EMBO J, V18, P605, DOI 10.1093/emboj/18.3.605; BERGER G, 1994, BRIT J HAEMATOL, V88, P372, DOI 10.1111/j.1365-2141.1994.tb05033.x; Bertoni A, 2002, J BIOL CHEM, V277, P25715, DOI 10.1074/jbc.M202791200; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Boussiotis VA, 1997, SCIENCE, V278, P124, DOI 10.1126/science.278.5335.124; CHANT J, 1995, CELL, V81, P1, DOI 10.1016/0092-8674(95)90363-1; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; D'Silva NJ, 1998, AM J PHYSIOL-CELL PH, V274, pC1667, DOI 10.1152/ajpcell.1998.274.6.C1667; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Freiberg BA, 2002, NAT IMMUNOL, V3, P911, DOI 10.1038/ni836; Gomez-Mouton C, 2001, P NATL ACAD SCI USA, V98, P9642, DOI 10.1073/pnas.171160298; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Griffiths EK, 2001, SCIENCE, V293, P2260, DOI 10.1126/science.1063397; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Katagiri K, 2002, MOL CELL BIOL, V22, P1001, DOI 10.1128/MCB.22.4.1001-1015.2002; Katagiri K, 2000, MOL CELL BIOL, V20, P1956, DOI 10.1128/MCB.20.6.1956-1969.2000; KISHIRO Y, 1995, CELL STRUCT FUNCT, V20, P151, DOI 10.1247/csf.20.151; Kucik DF, 1996, J CLIN INVEST, V97, P2139, DOI 10.1172/JCI118651; Lu CF, 1997, J IMMUNOL, V159, P268; MARIDONNEAUPARINI I, 1992, J BIOL CHEM, V267, P6396; McLeod SJ, 2002, J IMMUNOL, V169, P1365, DOI 10.4049/jimmunol.169.3.1365; MILLER J, 1995, J EXP MED, V182, P1231, DOI 10.1084/jem.182.5.1231; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486; PIZON V, 1994, J CELL SCI, V107, P1661; QUINN MT, 1992, BLOOD, V79, P1563; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; REILLY PL, 1995, J IMMUNOL, V155, P529; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; Stewart MP, 1998, J CELL BIOL, V140, P699, DOI 10.1083/jcb.140.3.699; Suga K, 2001, FEBS LETT, V489, P249, DOI 10.1016/S0014-5793(00)02222-5; Tohyama Y, 2003, MOL BIOL CELL, V14, P2570, DOI 10.1091/mbc.E02-09-0615; Tommasi S, 2002, ONCOGENE, V21, P2713, DOI 10.1038/sj.onc.1205365; van Kooyk Y, 2000, CURR OPIN CELL BIOL, V12, P542, DOI 10.1016/S0955-0674(00)00129-0; Wu CB, 2001, J NEUROSCI, V21, P5406, DOI 10.1523/JNEUROSCI.21-15-05406.2001; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451	42	388	406	2	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2003	4	8					741	748		10.1038/ni950	http://dx.doi.org/10.1038/ni950			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	706FA	12845325				2022-12-18	WOS:000184441500010
J	Winkler, ES; Bailey, AL; Kafai, NM; Nair, S; McCune, BT; Yu, JS; Fox, JM; Chen, RTE; Earnest, JT; Keeler, SP; Ritter, JH; Kang, LI; Dort, S; Robichaud, A; Head, R; Holtzman, MJ; Diamond, MS				Winkler, Emma S.; Bailey, Adam L.; Kafai, Natasha M.; Nair, Sharmila; McCune, Broc T.; Yu, Jinsheng; Fox, Julie M.; Chen, Rita E.; Earnest, James T.; Keeler, Shamus P.; Ritter, Jon H.; Kang, Liang-, I; Dort, Sarah; Robichaud, Annette; Head, Richard; Holtzman, Michael J.; Diamond, Michael S.			SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function	NATURE IMMUNOLOGY			English	Article							INTERFERON; SARS; CORONAVIRUS; MATURATION; COVID-19; VIRUS; ALPHA; BETA	Diamond and colleagues generate a K18-hACE2 model of SARS-CoV-2 infection that shares many features of severe COVID-19 infection and can be used to define the basis of lung disease and test immune and antiviral-based countermeasures. Although animal models have been evaluated for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, none have fully recapitulated the lung disease phenotypes seen in humans who have been hospitalized. Here, we evaluate transgenic mice expressing the human angiotensin I-converting enzyme 2 (ACE2) receptor driven by the cytokeratin-18 (K18) gene promoter (K18-hACE2) as a model of SARS-CoV-2 infection. Intranasal inoculation of SARS-CoV-2 in K18-hACE2 mice results in high levels of viral infection in lungs, with spread to other organs. A decline in pulmonary function occurs 4 days after peak viral titer and correlates with infiltration of monocytes, neutrophils and activated T cells. SARS-CoV-2-infected lung tissues show a massively upregulated innate immune response with signatures of nuclear factor-kappa B-dependent, type I and II interferon signaling, and leukocyte activation pathways. Thus, the K18-hACE2 model of SARS-CoV-2 infection shares many features of severe COVID-19 infection and can be used to define the basis of lung disease and test immune and antiviral-based countermeasures.	[Winkler, Emma S.; Kafai, Natasha M.; Nair, Sharmila; McCune, Broc T.; Fox, Julie M.; Chen, Rita E.; Earnest, James T.; Keeler, Shamus P.; Holtzman, Michael J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Winkler, Emma S.; Bailey, Adam L.; Kafai, Natasha M.; Chen, Rita E.; Ritter, Jon H.; Kang, Liang-, I; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Yu, Jinsheng; Head, Richard] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Keeler, Shamus P.; Holtzman, Michael J.] Washington Univ, Sch Med, Div Pulm & Crit Care Med, St Louis, MO USA; [Dort, Sarah; Robichaud, Annette] SCIREQ Sci Resp Equipment, Montreal, PQ, Canada; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63130 USA.	diamond@wusm.wustl.edu	Fox, Julie/GLQ-8895-2022; Keeler, Shamus/ABC-1774-2020	Keeler, Shamus/0000-0002-1301-0852; Kang, Liang-I/0000-0001-7025-3095; Fox, Julie/0000-0003-0567-738X	NIH [75N93019C00062, R01 AI127828, R01 AI130591, R35 HL145242]; Defense Advanced Research Projects Agency [HR001117S0019];  [T32 AI007163];  [F32 AI138392];  [T32 EB021955]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); ; ; 	This study was supported by NIH contracts and grants (75N93019C00062, R01 AI127828, R01 AI130591 and R35 HL145242) and the Defense Advanced Research Projects Agency (HR001117S0019). E.S.W. is supported by T32 AI007163. B.T.M. is supported by F32 AI138392. L.-I.K. is supported by T32 EB021955. We thank S. Whelan, S. Cook and J. Philips for facilitating the studies with SARS-CoV-2 at biosafety level 3; C. Lutz and The Jackson Laboratory for providing mice; A. Kim for purifying the CR3022 anti-S monoclonal antibody; H. Janova and M. Cain for experimental advice; and R. Schmidt for reviewing brain histology slides. We also thank D. Brunet at SCIREQ for facilitating use of the flexiVent mouse ventilator.	Bao LN, 2020, NATURE, V583, P830, DOI 10.1038/s41586-020-2312-y; BARNETT EM, 1993, NEUROSCIENCE, V57, P1007, DOI 10.1016/0306-4522(93)90045-H; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Bost P, 2020, CELL, V181, P1475, DOI 10.1016/j.cell.2020.05.006; Channappanavar R, 2016, CELL HOST MICROBE, V19, P181, DOI 10.1016/j.chom.2016.01.007; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Chen X, 2020, CHINA PERSPECT-SER, P1; Chua RL, 2020, NAT BIOTECHNOL, V38, P970, DOI 10.1038/s41587-020-0602-4; Cleary SJ, 2020, BRIT J PHARMACOL, V177, P4851, DOI 10.1111/bph.15143; Cook LE, 2020, J VIROL, V94, DOI 10.1128/JVI.00841-19; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fu LW, 2020, J INFECTION, V80, P656, DOI 10.1016/j.jinf.2020.03.041; Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Hassan AO, 2020, CELL, V182, P744, DOI 10.1016/j.cell.2020.06.011; Israelow B, 2020, J EXP MED, V217, DOI [10.1084/jem.20201241, 10.1101/2020.05.27.118893]; Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07; Jiang RD, 2020, CELL, V182, P50, DOI 10.1016/j.cell.2020.05.027; Lai CC, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106024; Lazear HM, 2019, IMMUNITY, V50, P907, DOI 10.1016/j.immuni.2019.03.025; Letko M, 2020, NAT MICROBIOL, V5, P562, DOI [10.1038/s41564-020-0688-y, 10.1101/2020.01.22.915660]; Li YW, 2020, PHARMACOL RES, V157, DOI 10.1016/j.phrs.2020.104833; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu J, 2020, EBIOMEDICINE, V55, DOI 10.1016/j.ebiom.2020.102763; Liu R, 2020, CLIN CHIM ACTA, V508, P110, DOI 10.1016/j.cca.2020.05.019; Liu RJ, 2015, NUCLEIC ACIDS RES, V43, pE97, DOI 10.1093/nar/gkv412; McCray PB, 2007, J VIROL, V81, P813, DOI 10.1128/JVI.02012-06; McGovern TK, 2013, JOVE-J VIS EXP, DOI 10.3791/50172; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Mostafavi S, 2016, CELL, V164, P564, DOI 10.1016/j.cell.2015.12.032; Mukherjee S, 2016, VIROLOGY, V497, P33, DOI 10.1016/j.virol.2016.06.022; Netland J, 2008, J VIROL, V82, P7264, DOI 10.1128/JVI.00737-08; Ng CT, 2016, CELL, V164, P349, DOI 10.1016/j.cell.2015.12.027; Ng CT, 2015, CELL HOST MICROBE, V17, P653, DOI 10.1016/j.chom.2015.04.005; Pan F, 2020, RADIOLOGY, V295, P715, DOI 10.1148/radiol.2020200370; Park A, 2020, CELL HOST MICROBE, V27, P870, DOI 10.1016/j.chom.2020.05.008; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robichaud A, 2015, EXP LUNG RES, V41, P84, DOI 10.3109/01902148.2014.971921; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rockx Barry, 2020, Science, V368, P1012, DOI 10.1126/science.abb7314; Spinato G, 2020, JAMA-J AM MED ASSOC, V323, P2089, DOI 10.1001/jama.2020.6771; Sun SH, 2020, CELL HOST MICROBE, V28, P124, DOI 10.1016/j.chom.2020.05.020; Tan L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0148-4; Torres A, 2020, ANN AM THORAC SOC, V17, P1164, DOI 10.1513/AnnalsATS.202005-462RL; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wang YB, 2020, CLIN INFECT DIS, V71, P2132, DOI 10.1093/cid/ciaa629; Wilk AJ, 2020, NAT MED, V26, P1070, DOI [10.1038/s41591-020-0944-y, 10.1101/2020.04.17.20069930]; Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Yang XL, 2014, CIRC RES, V114, P511, DOI 10.1161/CIRCRESAHA.114.300558; Yang Y, 2020, J ALLERGY CLIN IMMUN, V146, P119, DOI 10.1016/j.jaci.2020.04.027; Zhou Z, 2020, CELL HOST MICROBE, V27, P883, DOI 10.1016/j.chom.2020.04.017; Ziegler CGK, 2020, CELL, V181, P1016, DOI 10.1016/j.cell.2020.04.035	55	387	391	14	25	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2020	21	11					1327	+		10.1038/s41590-020-0778-2	http://dx.doi.org/10.1038/s41590-020-0778-2		AUG 2020	21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OD0BT	32839612	Bronze, Green Accepted			2022-12-18	WOS:000562393000001
J	Robinson, MJ; Sancho, D; Slack, EC; LeibundGut-Landmann, S; Sousa, CRE				Robinson, Matthew J.; Sancho, David; Slack, Emma C.; LeibundGut-Landmann, Salome; Sousa, Caetano Reis e			Myeloid C-type lectins in innate immunity	NATURE IMMUNOLOGY			English	Review							PATTERN-RECOGNITION RECEPTOR; MACROPHAGE MANNOSE RECEPTOR; ANTIGEN-PRESENTING CELLS; MARGINAL ZONE MACROPHAGES; GRAM-NEGATIVE BACTERIA; DENDRITIC CELLS; DC-SIGN; PATHOGEN RECOGNITION; IN-VIVO; CARBOHYDRATE-RECOGNITION	C-type lectins expressed on myeloid cells comprise a family of proteins that share a common structural motif, and some act as receptors in pathogen recognition. But just as the presence of leucine-rich repeats alone is not sufficient to define a Toll-like receptor, the characterization of C-type lectin receptors in innate immunity requires the identification of accompanying signaling motifs. Here we focus on the known signaling pathways of myeloid C-type lectins and on their possible functions as autonomous activating or inhibitory receptors involved in innate responses to pathogens or self.	London Res Inst, Canc Res UK, Immunobiol Lab, London WC2A 3PX, England	Cancer Research UK	Sousa, CRE (corresponding author), London Res Inst, Canc Res UK, Immunobiol Lab, London WC2A 3PX, England.	caetano@cancer.org.uk	Slack, Emma/AAD-5837-2019; Reis e Sousa, Caetano/O-1657-2014; Reis e Sousa, Caetano/ABD-7322-2021; Slack, Emma/B-1612-2016; Sancho, David/D-3433-2009	Slack, Emma/0000-0002-2473-1145; Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119; Slack, Emma/0000-0002-2473-1145; Sancho, David/0000-0003-2890-3984; LeibundGut-Landmann, Salome/0000-0002-5724-4837	Swiss National Science Foundation [106884] Funding Source: Medline	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)		Aarnoudse CA, 2006, CURR OPIN IMMUNOL, V18, P105, DOI 10.1016/j.coi.2005.11.001; Adachi Y, 2004, INFECT IMMUN, V72, P4159, DOI 10.1128/IAI.72.7.4159-4171.2004; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Allavena P, 2004, CRIT REV IMMUNOL, V24, P179, DOI 10.1615/CritRevImmunol.v24.i3.20; Aragane Y, 2003, J IMMUNOL, V171, P3801, DOI 10.4049/jimmunol.171.7.3801; Arce I, 2004, EUR J IMMUNOL, V34, P210, DOI 10.1002/eji.200324230; Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199; Bakker ABH, 1999, P NATL ACAD SCI USA, V96, P9792, DOI 10.1073/pnas.96.17.9792; Barrow AD, 2006, EUR J IMMUNOL, V36, P1646, DOI 10.1002/eji.200636195; Bergman MP, 2004, J EXP MED, V200, P979, DOI 10.1084/jem.20041061; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Caparros E, 2006, BLOOD, V107, P3950, DOI 10.1182/blood-2005-03-1252; Carrasco YR, 2006, CURR OPIN IMMUNOL, V18, P286, DOI 10.1016/j.coi.2006.03.013; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chen CH, 2006, BLOOD, V107, P1459, DOI 10.1182/blood-2005-08-3264; Chieppa M, 2003, J IMMUNOL, V171, P4552, DOI 10.4049/jimmunol.171.9.4552; Colonna M, 2000, EUR J IMMUNOL, V30, P697; Crocker PR, 2005, CURR OPIN PHARMACOL, V5, P431, DOI 10.1016/j.coph.2005.03.003; Delneste Y, 2002, IMMUNITY, V17, P353, DOI 10.1016/S1074-7613(02)00388-6; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Dzionek A, 2001, J EXP MED, V194, P1823, DOI 10.1084/jem.194.12.1823; Edwards AD, 2002, J IMMUNOL, V169, P3652, DOI 10.4049/jimmunol.169.7.3652; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; HAMERMAN JA, 2006, SCI STKE, pRE1, DOI DOI 10.1126/STKE.3202006RE1; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Howard MJ, 2002, J BIOL CHEM, V277, P32320, DOI 10.1074/jbc.M203631200; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kanazawa N, 2003, J BIOL CHEM, V278, P32645, DOI 10.1074/jbc.M304226200; Kanazawa N, 2002, J INVEST DERMATOL, V118, P261, DOI 10.1046/j.0022-202x.2001.01633.x; Kang PB, 2005, J EXP MED, V202, P987, DOI 10.1084/jem.20051239; Kang YS, 2003, INT IMMUNOL, V15, P177, DOI 10.1093/intimm/dxg019; Kang YS, 2004, P NATL ACAD SCI USA, V101, P215, DOI 10.1073/pnas.0307124101; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kim YS, 2000, J BIOL CHEM, V275, P32721, DOI 10.1074/jbc.M003934200; Koppel EA, 2005, EUR J IMMUNOL, V35, P2962, DOI 10.1002/eji.200526216; Koppel EA, 2005, CELL MICROBIOL, V7, P157, DOI 10.1111/J.1462-5822.2004.00480.x; Kumamoto Y, 2004, J BIOL CHEM, V279, P49274, DOI 10.1074/jbc.M409300200; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lee SJ, 2003, INFECT IMMUN, V71, P437, DOI 10.1128/IAI.71.1.437-445.2003; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; Marshall ASJ, 2004, J BIOL CHEM, V279, P14792, DOI 10.1074/jbc.M313127200; Mc Dermott R, 2002, MOL BIOL CELL, V13, P317, DOI 10.1091/mbc.01-06-0300; McGreal EP, 2006, GLYCOBIOLOGY, V16, P422, DOI 10.1093/glycob/cwj077; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Mi YL, 2002, J CLIN INVEST, V109, P269, DOI 10.1172/JCI13997; Nagaoka K, 2005, INT IMMUNOL, V17, P827, DOI 10.1093/intimm/dxh264; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; O'Rourke D, 2006, GENOME RES, V16, P1005, DOI 10.1101/gr.50823006; Ochiai M, 2000, J BIOL CHEM, V275, P4995, DOI 10.1074/jbc.275.7.4995; Oka K, 1998, P NATL ACAD SCI USA, V95, P9535, DOI 10.1073/pnas.95.16.9535; Palma AS, 2006, J BIOL CHEM, V281, P5771, DOI 10.1074/jbc.M511461200; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Richard M, 2006, MOL IMMUNOL, V43, P1716, DOI 10.1016/j.molimm.2005.10.006; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Ryan EJ, 2002, J IMMUNOL, V169, P5638, DOI 10.4049/jimmunol.169.10.5638; Sato K, 2005, INT IMMUNOL, V17, P559, DOI 10.1093/intimm/dxh235; STAHL P, 1980, CELL, V19, P207, DOI 10.1016/0092-8674(80)90402-X; Stambach NS, 2003, GLYCOBIOLOGY, V13, P401, DOI 10.1093/glycob/cwg045; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Swain SD, 2003, INFECT IMMUN, V71, P6213, DOI 10.1128/IAI.71.11.6213-6221.2003; Tacken PJ, 2006, IMMUNOBIOLOGY, V211, P599, DOI 10.1016/j.imbio.2006.05.021; Tada Y, 2006, J INVEST DERMATOL, V126, P1549, DOI 10.1038/sj.jid.5700283; Takada A, 2004, J VIROL, V78, P2943, DOI 10.1128/JVI.78.6.2943-2947.2004; Takahashi K, 2006, CURR OPIN IMMUNOL, V18, P16, DOI 10.1016/j.coi.2005.11.014; Tsuiji M, 2002, J BIOL CHEM, V277, P28892, DOI 10.1074/jbc.M203774200; Turville S, 2003, J LEUKOCYTE BIOL, V74, P710, DOI 10.1189/jlb.0503208; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; van Gisbergen KPJM, 2005, FEBS LETT, V579, P6159, DOI 10.1016/j.febslet.2005.09.089; van Gisbergen KPJM, 2005, CANCER RES, V65, P5935, DOI 10.1158/0008-5472.CAN-04-4140; van Gisbergen KPJM, 2005, J EXP MED, V201, P1281, DOI 10.1084/jem.20041276; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; van Vliet SJ, 2006, NAT IMMUNOL, V7, P1200, DOI 10.1038/ni1390; van Vliet SJ, 2005, INT IMMUNOL, V17, P661, DOI 10.1093/intimm/dxh246; Yoshida T, 2003, J BIOCHEM, V133, P271, DOI 10.1093/jb/mvg037; Yuita H, 2005, GLYCOBIOLOGY, V15, P1368, DOI 10.1093/glycob/cwj028; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	92	386	405	3	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2006	7	12					1258	1265		10.1038/ni1417	http://dx.doi.org/10.1038/ni1417			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	106TU	17110942				2022-12-18	WOS:000242125200005
J	Hacker, C; Kirsch, RD; Ju, XS; Hieronymus, T; Gust, TC; Kuhl, C; Jorgas, T; Kurz, SM; Rose-John, S; Yokota, Y; Zenke, M				Hacker, C; Kirsch, RD; Ju, XS; Hieronymus, T; Gust, TC; Kuhl, C; Jorgas, T; Kurz, SM; Rose-John, S; Yokota, Y; Zenke, M			Transcriptional profiling identifies Id2 function in dendritic cell development	NATURE IMMUNOLOGY			English	Article							HELIX INHIBITOR ID2; MOUSE BONE-MARROW; GENE-EXPRESSION; NATURAL-KILLER; LANGERHANS CELLS; T-CELLS; DIFFERENTIATION; PROGENITOR; PROTEINS; SPLEEN	Dendritic cells (DCs) are potent antigen-presenting cells with a pivotal role in antigen-specific immune responses. Here, we found that the helix-loop-helix transcription factor Id2 is up-regulated during DC development in vitro and crucial for the development of distinct DC subsets in vivo. Id2(-/-) mice lack Langerhans cells (LCs), the cutaneous contingent of DCs, and the splenic CD8alpha(+) DC subset is markedly reduced. Mice deficient for transforming growth factor (TGF)-beta also lack LCs, and we demonstrate here that, in DCs, TGF-beta induces Id2 expression. We also show that Id2 represses B cell genes in DCs. These findings reveal a TGF-beta-Id2 signaling pathway in DCs and suggest a mechanism by which Id2 affects the lineage choice of B cell and DC progenitors.	Max Delbruck Ctr Mol Med, MDC, D-13092 Berlin, Germany; Univ Kiel, Dept Biochem, D-24098 Kiel, Germany; Fukui Med Univ, Dept Biochem, Fukui, Japan	Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Kiel; University of Fukui	Zenke, M (corresponding author), Max Delbruck Ctr Mol Med, MDC, Robert Rossle Str 10, D-13092 Berlin, Germany.		Hieronymus, Thomas/AAU-1995-2020; Rose-John, Stefan/A-7998-2010	Hieronymus, Thomas/0000-0002-7879-6518; Rose-John, Stefan/0000-0002-7519-3279; Hacker, Christine/0000-0002-6545-0104				Ardavin C, 2001, TRENDS IMMUNOL, V22, P691, DOI 10.1016/S1471-4906(01)02059-2; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Becker-Herman S, 2002, J IMMUNOL, V168, P5507, DOI 10.4049/jimmunol.168.11.5507; BOEHMELT G, 1995, CELL, V80, P341, DOI 10.1016/0092-8674(95)90417-4; Borkowski TA, 1996, J EXP MED, V184, P2417, DOI 10.1084/jem.184.6.2417; Boudjelal M, 1997, GENE DEV, V11, P2052, DOI 10.1101/gad.11.16.2052; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; del Hoyo GM, 2002, NATURE, V415, P1043, DOI 10.1038/4151043a; Diebold SS, 1999, HUM GENE THER, V10, P775, DOI 10.1089/10430349950018535; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Fukuyama S, 2002, IMMUNITY, V17, P31, DOI 10.1016/S1074-7613(02)00339-4; GALY A, 1995, IMMUNITY, V3, P459, DOI 10.1016/1074-7613(95)90175-2; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Hinz M, 2002, J EXP MED, V196, P605, DOI 10.1084/jem.20020062; Hochrein H, 2001, J IMMUNOL, V166, P5448, DOI 10.4049/jimmunol.166.9.5448; Ikawa T, 2001, P NATL ACAD SCI USA, V98, P5164, DOI 10.1073/pnas.091537598; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; JU XJ, 2003, METHODS MOL MED CYTO, P399; Kee BL, 2001, NAT IMMUNOL, V2, P242, DOI 10.1038/85303; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kurz SM, 2002, EUR J IMMUNOL, V32, P1832, DOI 10.1002/1521-4141(200207)32:7<1832::AID-IMMU1832>3.0.CO;2-2; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Liu YJ, 2001, NAT IMMUNOL, V2, P585, DOI 10.1038/89726; Madruga J, 1999, J CELL SCI, V112, P1685; Manickasingham S, 2000, J IMMUNOL, V165, P5027, DOI 10.4049/jimmunol.165.9.5027; Manz MG, 2001, BLOOD, V97, P3333, DOI 10.1182/blood.V97.11.3333; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Mori S, 2000, EMBO J, V19, P5772, DOI 10.1093/emboj/19.21.5772; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Norton JD, 1998, TRENDS CELL BIOL, V8, P58, DOI 10.1016/S0962-8924(97)01183-5; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Spits H, 2000, J EXP MED, V192, P1775, DOI 10.1084/jem.192.12.1775; Strobl H, 1999, MICROBES INFECT, V1, P1283, DOI 10.1016/S1286-4579(99)00256-7; Sugai M, 2003, NAT IMMUNOL, V4, P25, DOI 10.1038/ni874; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Traver D, 2000, SCIENCE, V290, P2152, DOI 10.1126/science.290.5499.2152; Valladeau J, 2002, J IMMUNOL, V168, P782, DOI 10.4049/jimmunol.168.2.782; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Wong J, 2001, DNA CELL BIOL, V20, P465, DOI 10.1089/104454901316976091; Wu L, 1998, IMMUNITY, V9, P839, DOI 10.1016/S1074-7613(00)80649-4; Wu L, 2001, BLOOD, V98, P3376, DOI 10.1182/blood.V98.12.3376; Yokota Y, 2001, ONCOGENE, V20, P8290, DOI 10.1038/sj.onc.1205090; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yoshida H, 2002, IMMUNITY, V17, P823, DOI 10.1016/S1074-7613(02)00479-X	52	386	391	0	15	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2003	4	4					380	386		10.1038/ni903	http://dx.doi.org/10.1038/ni903			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	663CG	12598895				2022-12-18	WOS:000181987700019
J	Yan, N; Regalado-Magdos, AD; Stiggelbout, B; Lee-Kirsch, MA; Lieberman, J				Yan, Nan; Regalado-Magdos, Ashton D.; Stiggelbout, Bart; Lee-Kirsch, Min Ae; Lieberman, Judy			The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1	NATURE IMMUNOLOGY			English	Article							ASSEMBLY PROTEIN SET; I INTERFERON; ADAPTER PROTEIN; HIV-1 INFECTION; KAPPA-B; DNA; ALPHA; IDENTIFICATION; MUTATIONS; RECEPTORS	Viral infection triggers innate immune sensors to produce type I interferon. However, infection of T cells and macrophages with human immunodeficiency virus (HIV) does not trip those alarms. How HIV avoids activating nucleic acid sensors is unknown. Here we found that the cytosolic exonuclease TREX1 suppressed interferon triggered by HIV. In Trex1(-/-) mouse cells and human CD4(+) T cells and macrophages in which TREX1 was inhibited by RNA-mediated interference, cytosolic HIV DNA accumulated and HIV infection induced type I interferon that inhibited HIV replication and spreading. TREX1 bound to cytosolic HIV DNA and digested excess HIV DNA that would otherwise activate interferon expression via a pathway dependent on the kinase TBK1, the adaptor STING and the transcription factor IRF3. HIV-stimulated interferon production in cells deficient in TREX1 did not involve known nucleic acid sensors.	[Yan, Nan; Regalado-Magdos, Ashton D.; Stiggelbout, Bart; Lieberman, Judy] Childrens Hosp, Immune Dis Inst, Boston, MA 02115 USA; [Yan, Nan; Regalado-Magdos, Ashton D.; Stiggelbout, Bart; Lieberman, Judy] Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Yan, Nan; Regalado-Magdos, Ashton D.; Stiggelbout, Bart; Lieberman, Judy] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Lee-Kirsch, Min Ae] Tech Univ Dresden, Childrens Hosp, Dresden, Germany	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Technische Universitat Dresden	Lieberman, J (corresponding author), Childrens Hosp, Immune Dis Inst, 300 Longwood Ave, Boston, MA 02115 USA.	lieberman@idi.harvard.edu	Lieberman, Judy/A-2717-2015; Lee-Kirsch, Min Ae/C-5769-2018		US National Institutes of Health [AI45587, T32 HL066987]; Harvard Center for AIDS Research; Harvard Summer Honors Undergraduate Research Program; Deutsche Forschungsgemeinschaft [Le 1074/3-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, R56AI045587, R01AI045587] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Center for AIDS Research; Harvard Summer Honors Undergraduate Research Program; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Stetson (University of Washington) for wild-type, Trex1<SUP>-/-</SUP> and Trex1<SUP>-/-</SUP>Irf3<SUP>-/-</SUP> primary MEFs, under agreement with D. Barnes and T. Lindahl (Cancer Research UK); J. Jung (University of Southern California) for RIG-I-deficient (Ddx58<SUP>-/-</SUP>) MEFs; S. Harvey and F. Perrino (Wake Forest University) for wild-type and Trex1<SUP>-/-</SUP> transformed MEFs; A. Engelman (Dana-Farber Cancer Institute) for the HIV-luciferase plasmid (pNL4-3/Env<SUP>-</SUP>); D. Gabuzda (Dana-Farber Cancer Institute) for the HIV-GFP plasmid (pNL4-3/Env<SUP>-</SUP>); T. Fujita (Kyoto University) for antiserum to mouse IRF3; S. Nagata (Kyoto University) for the hemagglutinin-tagged MAVS plasmid; K. Fitzgerald (University of Massachusetts) for siRNA and inhibitors of RNA polymerase III; J. Hiscott (McGill University) for IFNB-luciferase plasmid; L. Gehrke (Harvard Medical School) for CMV-renilla luciferase plasmid; and members of the Lieberman lab for discussions. Supported by the US National Institutes of Health (AI45587 to J.L., and T32 HL066987 to N.Y.), the Harvard Center for AIDS Research (N.Y.), Harvard Summer Honors Undergraduate Research Program (A.D.R.-M.) and Deutsche Forschungsgemeinschaft (Le 1074/3-1 to M.A.L.-K.).	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Agy MB, 1995, VIROLOGY, V214, P379, DOI 10.1006/viro.1995.0047; BACAREGEN L, 1994, J VIROL, V68, P7559, DOI 10.1128/JVI.68.11.7559-7565.1994; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; BOWERMAN B, 1989, GENE DEV, V3, P469, DOI 10.1101/gad.3.4.469; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; COCCIA EM, 1994, J BIOL CHEM, V269, P23087; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; El Gazzar M, 2009, MOL CELL BIOL, V29, P1959, DOI 10.1128/MCB.01862-08; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; Fan ZS, 2002, MOL CELL BIOL, V22, P2810, DOI 10.1128/MCB.22.8.2810-2820.2002; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; GOLDFELD AE, 1991, J ACQ IMMUN DEF SYND, V4, P41; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; He JL, 1997, NATURE, V385, P645, DOI 10.1038/385645a0; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lee-Kirsch MA, 2007, J MOL MED-JMM, V85, P531, DOI 10.1007/s00109-007-0199-9; Lehming N, 1998, P NATL ACAD SCI USA, V95, P7322, DOI 10.1073/pnas.95.13.7322; Lehtinen DA, 2008, J BIOL CHEM, V283, P31649, DOI 10.1074/jbc.M806155200; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Pagans S, 2005, PLOS BIOL, V3, P210, DOI 10.1371/journal.pbio.0030041; Paz S, 2009, MOL CELL BIOL, V29, P3401, DOI 10.1128/MCB.00880-08; Schroder K, 2009, CURR BIOL, V19, pR262, DOI 10.1016/j.cub.2009.02.011; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; SHIRAZI Y, 1992, J VIROL, V66, P1321, DOI 10.1128/JVI.66.3.1321-1328.1992; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Shun MC, 2007, J VIROL, V81, P166, DOI 10.1128/JVI.01953-06; Siva AC, 2002, J VIROL, V76, P11904, DOI 10.1128/JVI.76.23.11904-11910.2002; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Uzri D, 2009, J VIROL, V83, P4174, DOI 10.1128/JVI.02449-08; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yan N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000327; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Zandman-Goddard Gisele, 2002, Autoimmunity Reviews, V1, P329, DOI 10.1016/S1568-9972(02)00086-1; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	50	385	396	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2010	11	11					1005	U53		10.1038/ni.1941	http://dx.doi.org/10.1038/ni.1941			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	666PI	20871604	Green Accepted			2022-12-18	WOS:000283127800010
J	Doedens, AL; Phan, AT; Stradner, MH; Fujimoto, JK; Nguyen, JV; Yang, E; Johnson, RS; Goldrath, AW				Doedens, Andrew L.; Phan, Anthony T.; Stradner, Martin H.; Fujimoto, Jessica K.; Nguyen, Jessica V.; Yang, Edward; Johnson, Randall S.; Goldrath, Ananda W.			Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen	NATURE IMMUNOLOGY			English	Article							CHRONIC VIRAL-INFECTION; CHUVASH POLYCYTHEMIA; SELECTIVE EXPRESSION; TUMOR-SUPPRESSOR; EXHAUSTION; DISEASE; GENE; INFLAMMATION; CANCER; MEMORY	Cytolytic activity by CD8(+) cytotoxic T lymphocytes (CTLs) is a powerful strategy for the elimination of intracellular pathogens and tumor cells. The destructive capacity of CTLs is progressively dampened during chronic infection, yet the environmental cues and molecular pathways that influence immunological 'exhaustion' remain unclear. Here we found that CTL immunity was regulated by the central transcriptional response to hypoxia, which is controlled in part by hypoxia-inducible factors (HIFs) and the von Hippel-Lindau tumor suppressor VHL. Loss of VHL, the main negative regulator of HIFs, led to lethal CTL-mediated immunopathology during chronic infection, and VHL-deficient CTLs displayed enhanced control of persistent viral infection and neoplastic growth. We found that HIFs and oxygen influenced the expression of pivotal transcription, effector and costimulatory-inhibitory molecules of CTLs, which was relevant to strategies that promote the clearance of viruses and tumors.	[Doedens, Andrew L.; Phan, Anthony T.; Stradner, Martin H.; Fujimoto, Jessica K.; Nguyen, Jessica V.; Yang, Edward; Goldrath, Ananda W.] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA; [Stradner, Martin H.] Med Univ Graz, Div Rheumatol & Immunol, Graz, Austria; [Johnson, Randall S.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	University of California System; University of California San Diego; Medical University of Graz; University of Cambridge	Goldrath, AW (corresponding author), Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA.	agoldrath@ucsd.edu	Johnson, Randall/AAM-1189-2021; Stradner, Martin H/D-6473-2011	Johnson, Randall/0000-0002-4084-6639; Stradner, Martin H/0000-0002-7884-6626; Doedens, Andrew/0000-0003-2461-3496; Phan, Anthony/0000-0003-2935-6070	US National Institutes of Health; Pew Scholars Program; Leukemia Lymphoma Society; US National Institutes of Health and University of California, San Diego; Cancer Biology Fund; University of California, San Diego; US National Institutes of Health Cell; Austrian Science Fund; Austrian Science Fund (FWF) [J 3189] Funding Source: researchfish; Wellcome Trust [092738/Z/10/Z] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI096852, R01AI072117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007240] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholars Program; Leukemia Lymphoma Society(Leukemia and Lymphoma Society); US National Institutes of Health and University of California, San Diego; Cancer Biology Fund; University of California, San Diego(University of California System); US National Institutes of Health Cell(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Zuniga Laboratory at the University of California, San Diego, for technical advice, discussions and reagents; V. Jhaveri for technical assistance; A. Best for assistance with bioinformatics; the Immunological Genome Project for microarray reagents, processing and assistance; members of the Hedrick Laboratory (University of California, San Diego) for human IL-2; and E. Zuniga, S. Hedrick, G. Barton and J. Harker for discussions and review of the manuscript. Supported by the US National Institutes of Health (A. W. G. and R.S.J.), the Pew Scholars Program and the Leukemia Lymphoma Society (A. W. G.), the US National Institutes of Health and University of California, San Diego, Cancer Biology Fund (A. L. D.), the University of California, San Diego, and US National Institutes of Health Cell (A. T. P.) and the Austrian Science Fund (M.H.S.).	Ang SO, 2002, NAT GENET, V32, P614, DOI 10.1038/ng1019; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Biju MP, 2004, MOL CELL BIOL, V24, P9038, DOI 10.1128/MCB.24.20.9038-9047.2004; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Doedens AL, 2010, CANCER RES, V70, P7465, DOI 10.1158/0008-5472.CAN-10-1439; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Frauwirth KA, 2004, J IMMUNOL, V172, P4661, DOI 10.4049/jimmunol.172.8.4661; Frebel H, 2012, J EXP MED, V209, P2485, DOI 10.1084/jem.20121015; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Matsuzaki J, 2010, P NATL ACAD SCI USA, V107, P7875, DOI 10.1073/pnas.1003345107; McNamee EN, 2013, IMMUNOL RES, V55, P58, DOI 10.1007/s12026-012-8349-8; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Miasnikova GY, 2011, HAEMATOL-HEMATOL J, V96, P1371, DOI 10.3324/haematol.2011.045609; Nakamoto N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000313; Nakamura H, 2005, J IMMUNOL, V174, P7592, DOI 10.4049/jimmunol.174.12.7592; Niu XM, 2009, AM J HEMATOL, V84, P74, DOI 10.1002/ajh.21327; OLDSTONE MBA, 1989, CELL, V56, P517, DOI 10.1016/0092-8674(89)90573-4; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Semenza GL, 2000, GENE DEV, V14, P1983; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Snell LM, 2011, IMMUNOL REV, V244, P197, DOI 10.1111/j.1600-065X.2011.01063.x; Takeda N, 2010, GENE DEV, V24, P491, DOI 10.1101/gad.1881410; Tomasic NL, 2013, HAEMATOLOGICA, V98, P560, DOI 10.3324/haematol.2012.070508; VAUPEL P, 1977, MICROVASC RES, V13, P399, DOI 10.1016/0026-2862(77)90106-6; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Welsh RM, 2009, IMMUNITY, V31, P178, DOI 10.1016/j.immuni.2009.08.005; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Zhang DJ, 2005, J IMMUNOL, V174, P6725, DOI 10.4049/jimmunol.174.11.6725	50	384	396	3	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2013	14	11					1173	U99		10.1038/ni.2714	http://dx.doi.org/10.1038/ni.2714			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	239KV	24076634	Green Accepted			2022-12-18	WOS:000326023400014
J	Zhang, FP; Meng, GX; Strober, W				Zhang, Fuping; Meng, Guangxun; Strober, Warren			Interactions among the transcription factors Runx1, ROR gamma t and Foxp3 regulate the differentiation of interleukin 17-producing T cells	NATURE IMMUNOLOGY			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; GENE-EXPRESSION; IFN-GAMMA; BINDING-SITE; RECEPTOR; IL-21; SUSCEPTIBILITY; INDUCTION; ARTHRITIS	The molecular mechanisms underlying the differentiation of interleukin 17-producing T helper cells (T-H-17 cells) are still poorly understood. Here we show that optimal transcription of the gene encoding interleukin 17 (Il17) required a 2-kilobase promoter and at least one conserved noncoding (enhancer) sequence, CNS-5. Both cis-regulatory elements contained regions that bound the transcription factors ROR gamma t and Runx1. Runx1 influenced T-H-17 differentiation by inducing ROR gamma t expression and by binding to and acting together with ROR gamma t during Il17 transcription. However, Runx1 also interacts with the transcription factor Foxp3, and this interaction was necessary for the negative effect of Foxp3 on T-H-17 differentiation. Thus, our data support a model in which the differential association of Runx1 with Foxp3 and with ROR gamma t regulates T-H-17 differentiation.	[Zhang, Fuping; Meng, Guangxun; Strober, Warren] NIAID, Mucosal Immun Sect, Host Def Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Strober, W (corresponding author), NIAID, Mucosal Immun Sect, Host Def Lab, NIH, Bethesda, MD 20892 USA.	wstrober@niaid.nih.gov		孟, 广勋/0000-0002-4253-9675	Intramural NIH HHS [Z01 AI000432-23, Z01 AI000354-25] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000354, Z01AI000432] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Ansel KM, 2004, NAT IMMUNOL, V5, P1251, DOI 10.1038/ni1135; Betti M, 2006, ANN ONCOL, V17, P235; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; He YW, 1998, IMMUNITY, V9, P797, DOI 10.1016/S1074-7613(00)80645-7; Helms C, 2003, NAT GENET, V35, P349, DOI 10.1038/ng1268; Hu H, 2007, TRENDS IMMUNOL, V28, P329, DOI 10.1016/j.it.2007.06.006; Ito Y, 2004, ONCOGENE, V23, P4198, DOI 10.1038/sj.onc.1207755; Ito Y, 2003, CURR OPIN GENET DEV, V13, P43, DOI 10.1016/S0959-437X(03)00007-8; Ito Y, 2008, ADV CANCER RES, V99, P33, DOI 10.1016/S0065-230X(07)99002-8; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Lee DU, 2004, J BIOL CHEM, V279, P4802, DOI 10.1074/jbc.M307904200; Levanon D, 2004, ONCOGENE, V23, P4211, DOI 10.1038/sj.onc.1207670; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Oestreich KJ, 2006, IMMUNITY, V24, P381, DOI 10.1016/j.immuni.2006.02.009; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; Solymar DC, 2002, IMMUNITY, V17, P41, DOI 10.1016/S1074-7613(02)00334-5; Taniuchi I, 2004, ONCOGENE, V23, P4341, DOI 10.1038/sj.onc.1207671; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wong CK, 2001, CLIN EXP IMMUNOL, V125, P177, DOI 10.1046/j.1365-2249.2001.01602.x; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Xi HK, 2006, IMMUNITY, V24, P813, DOI 10.1016/j.immuni.2006.03.023; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhang FP, 2006, J EXP MED, V203, P1493, DOI 10.1084/jem.20060066; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	37	383	402	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2008	9	11					1297	1306		10.1038/ni.1663	http://dx.doi.org/10.1038/ni.1663			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363EA	18849990	Green Accepted			2022-12-18	WOS:000260248600017
J	York, IA; Chang, SC; Saric, T; Keys, JA; Favreau, JM; Goldberg, AL; Rock, KL				York, IA; Chang, SC; Saric, T; Keys, JA; Favreau, JM; Goldberg, AL; Rock, KL			The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues	NATURE IMMUNOLOGY			English	Article							DISTINCT PROTEOLYTIC PROCESSES; HISTOCOMPATIBILITY CLASS-I; ENDOPLASMIC-RETICULUM; LEUCINE AMINOPEPTIDASE; MONOCLONAL-ANTIBODY; PRECURSOR PEPTIDES; GAMMA-INTERFERON; BINDING PEPTIDES; C-TERMINI; PROTEASOME	Endoplasmic reticulum (ER) aminopeptidase 1 (ERAP1) appears to be specialized to produce peptides presented on class I major histocompatibility complex molecules. We found that purified ERAP1 trimmed peptides that were ten residues or longer, but spared eight-residue peptides. In vivo, ERAP1 enhanced production of an eight-residue ovalbumin epitope from precursors extended on the NH2 terminus that were generated either in the ER or cytosol. Purified ERAP1 also trimmed nearly half the nine-residue peptides tested. By destroying such nine-residue peptides in normal human cells, ERAP1 reduced the overall supply of antigenic peptides. However, after interferon-gamma treatment, which causes proteasomes to produce more NH2-extended antigenic precursors, ERAP1 increased the supply of peptides for MHC class I antigen presentation.	Univ Massachusetts, Med Ctr, Dept Pathol, Worcester, MA 01655 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School	York, IA (corresponding author), Univ Massachusetts, Med Ctr, Dept Pathol, Worcester, MA 01655 USA.		Hsiao, Wei-Hung/B-9931-2013; York, Ian/X-9351-2019; Saric, Tomo/B-3415-2015	York, Ian/0000-0002-3478-3344; Saric, Tomo/0000-0001-8344-1095; CHANG, SHIH-CHUNG/0000-0002-5015-8178				AHN JY, 1995, FEBS LETT, V366, P37, DOI 10.1016/0014-5793(95)00492-R; Beninga J, 1998, J BIOL CHEM, V273, P18734, DOI 10.1074/jbc.273.30.18734; Brouwenstijn N, 2001, IMMUNITY, V15, P95, DOI 10.1016/S1074-7613(01)00174-1; Cascio P, 2002, EMBO J, V21, P2636, DOI 10.1093/emboj/21.11.2636; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Craiu A, 1997, P NATL ACAD SCI USA, V94, P10850, DOI 10.1073/pnas.94.20.10850; DRISCOLL J, 1993, NATURE, V365, P262, DOI 10.1038/365262a0; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; ELLIOTT T, 1995, J EXP MED, V181, P1481, DOI 10.1084/jem.181.4.1481; Fruci D, 2001, IMMUNITY, V15, P467, DOI 10.1016/S1074-7613(01)00203-5; GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0; GOLDBERG AL, 2002, MOL IMMUNOL, V1169, P1; Hattori A, 1999, J BIOCHEM-TOKYO, V125, P931, DOI 10.1093/oxfordjournals.jbchem.a022371; Hattori A, 2000, J BIOCHEM-TOKYO, V128, P755, DOI 10.1093/oxfordjournals.jbchem.a022812; Kisselev AF, 1999, J BIOL CHEM, V274, P3363, DOI 10.1074/jbc.274.6.3363; Knuehl C, 2001, J IMMUNOL, V167, P1515, DOI 10.4049/jimmunol.167.3.1515; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Komlosh A, 2001, J BIOL CHEM, V276, P30050, DOI 10.1074/jbc.M103177200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lauvau G, 1999, J EXP MED, V190, P1227, DOI 10.1084/jem.190.9.1227; Lobigs M, 2000, EUR J IMMUNOL, V30, P1496, DOI 10.1002/(SICI)1521-4141(200005)30:5<1496::AID-IMMU1496>3.0.CO;2-6; Lucchiari-Hartz M, 2000, J EXP MED, V191, P239, DOI 10.1084/jem.191.2.239; Mo XY, 1999, J IMMUNOL, V163, P5851; MOMBURG F, 1994, CURR OPIN IMMUNOL, V6, P32, DOI 10.1016/0952-7915(94)90030-2; ONEIL BH, 1993, J IMMUNOL, V151, P1410; PARHAM P, 1979, J IMMUNOL, V123, P342; PARHAM P, 1978, NATURE, V276, P397, DOI 10.1038/276397a0; Paz P, 1999, IMMUNITY, V11, P241, DOI 10.1016/S1074-7613(00)80099-0; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; RESTIFO NP, 1995, J IMMUNOL, V154, P4414; Rock KL, 2002, ADV IMMUNOL, V80, P1, DOI 10.1016/S0065-2776(02)80012-8; ROELSE J, 1994, J EXP MED, V180, P1591, DOI 10.1084/jem.180.5.1591; Saric T, 2001, J BIOL CHEM, V276, P36474, DOI 10.1074/jbc.M105517200; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Schomburg L, 2000, EUR J BIOCHEM, V267, P3198, DOI 10.1046/j.1432-1327.2000.01348.x; Serwold T, 2001, NAT IMMUNOL, V2, P644, DOI 10.1038/89800; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Shastri N, 2002, ANNU REV IMMUNOL, V20, P463, DOI 10.1146/annurev.immunol.20.100301.064819; SNYDER HL, 1994, J EXP MED, V180, P2389, DOI 10.1084/jem.180.6.2389; Snyder HL, 1998, EUR J IMMUNOL, V28, P1339; STAM NJ, 1986, J IMMUNOL, V137, P2299; Stoltze L, 2000, NAT IMMUNOL, V1, P413, DOI 10.1038/80852; Stoltze L, 1998, EUR J IMMUNOL, V28, P4029, DOI 10.1002/(SICI)1521-4141(199812)28:12<4029::AID-IMMU4029>3.0.CO;2-N; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; York IA, 1999, IMMUNOL REV, V172, P49, DOI 10.1111/j.1600-065X.1999.tb01355.x	46	383	390	1	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2002	3	12					1177	1184		10.1038/ni860	http://dx.doi.org/10.1038/ni860			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	619GP	12436110	Green Submitted			2022-12-18	WOS:000179467800016
J	Hayday, A; Theodoridis, E; Ramsburg, E; Shires, J				Hayday, A; Theodoridis, E; Ramsburg, E; Shires, J			Intraepithelial lymphocytes: exploring the Third Way in immunology	NATURE IMMUNOLOGY			English	Review							T-CELL-RECEPTOR; MURINE INTESTINAL EPITHELIUM; DENDRITIC EPIDERMAL-CELLS; DELTA-ANTIGEN RECEPTORS; GONDII ORAL INFECTION; TOXIC EFFECTOR-CELLS; COMPLEX CLASS-I; GAMMA-DELTA; TOXOPLASMA-GONDII; LAMINA PROPRIA	Locally resident intraepithelial lymphocytes (IELs) are primarily T cells with potent cytolytic and immunoregulatory capacities, which they use to sustain epithelial integrity. Here, we consider that most IEL compartments comprise a variable mixture of two cell types:T cells primed to conventional antigen in the systemic compartment and T cells with ill-defined reactivities and origins, whose properties seem to place them midway between the adaptive and innate immune responses. We review the capacity of IELs to limit the dissemination of infectious pathogens and malignant cells and to control the infiltration of epithelial surfaces by systemic cells. An improved characterization of IELs would seem essential if we are to understand how immune responses and immunopathologies develop at body surfaces.	Univ London, GKT Sch Med, Peter Gorer Dept Immunobiol, Guys Hosp, London SE1 9RT, England; Yale Univ, Dept Mol Cell & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Immunobiol Sect, New Haven, CT 06520 USA	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Yale University; Yale University	Hayday, A (corresponding author), Univ London, GKT Sch Med, Peter Gorer Dept Immunobiol, Guys Hosp, 3rd Floor New Guys House, London SE1 9RT, England.	adrian.hayday@kcl.ac.uk		HAYDAY, ADRIAN/0000-0002-9495-5793				Agace WW, 2000, CURR OPIN CELL BIOL, V12, P563, DOI 10.1016/S0955-0674(00)00132-0; Agace WW, 2000, EUR J IMMUNOL, V30, P819, DOI 10.1002/1521-4141(200003)30:3<819::AID-IMMU819>3.0.CO;2-Y; ALLISON JP, 1991, ANNU REV IMMUNOL, V9, P679, DOI 10.1146/annurev.iy.09.040191.003335; Anumanthan A, 1998, J IMMUNOL, V161, P2780; Arstila T, 2000, J EXP MED, V191, P823, DOI 10.1084/jem.191.5.823; ASARNOW DM, 1988, CELL, V55, P837, DOI 10.1016/0092-8674(88)90139-0; BANDEIRA A, 1990, J EXP MED, V172, P239, DOI 10.1084/jem.172.1.239; BARRETT TA, 1992, J IMMUNOL, V149, P1124; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Beagley KW, 1998, CRIT REV IMMUNOL, V18, P237, DOI 10.1615/CritRevImmunol.v18.i3.40; Boismenu R, 1997, CURR OPIN IMMUNOL, V9, P57, DOI 10.1016/S0952-7915(97)80159-8; BOISMENU R, 1994, SCIENCE, V266, P1253, DOI 10.1126/science.7973709; Boismenu R, 1996, J IMMUNOL, V157, P985; BUCY RP, 1988, J IMMUNOL, V141, P2200; Buzoni-Gatel D, 1999, J IMMUNOL, V162, P5846; Camerini V, 1998, J IMMUNOL, V160, P2608; CAMERINI V, 1993, J IMMUNOL, V151, P1765; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; CHARDES T, 1994, J IMMUNOL, V153, P4596; Corazza N, 2000, J IMMUNOL, V164, P398, DOI 10.4049/jimmunol.164.1.398; CORREA I, 1992, P NATL ACAD SCI USA, V89, P653, DOI 10.1073/pnas.89.2.653; Coussens LM, 2001, J EXP MED, V193, pF23, DOI 10.1084/jem.193.6.F23; Crowley MP, 2000, SCIENCE, V287, P314, DOI 10.1126/science.287.5451.314; DARLINGTON D, 1966, J ANAT, V100, P813; Das G, 2000, J EXP MED, V192, P1521, DOI 10.1084/jem.192.10.1521; Das G, 1999, J EXP MED, V190, P881, DOI 10.1084/jem.190.6.881; DAVIES MDJ, 1980, CLIN EXP IMMUNOL, V42, P273; DEUSCH K, 1991, EUR J IMMUNOL, V21, P1053, DOI 10.1002/eji.1830210429; DHARAKUL T, 1990, J VIROL, V64, P4375, DOI 10.1128/JVI.64.9.4375-4382.1990; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; DUNON D, 1993, J EXP MED, V177, P257, DOI 10.1084/jem.177.2.257; Eisenbraun MD, 2000, DEV COMP IMMUNOL, V24, P783, DOI 10.1016/S0145-305X(00)00029-X; ERNST PB, 1985, IMMUNOL TODAY, V6, P50, DOI 10.1016/0167-5699(85)90047-7; ERNST PB, 1986, J IMMUNOL, V136, P2121; Fahrer AM, 2001, P NATL ACAD SCI USA, V98, P10261, DOI 10.1073/pnas.171320798; FERGUSON A, 1977, GUT, V18, P921, DOI 10.1136/gut.18.11.921; FERGUSON A, 1971, GUT, V12, P988, DOI 10.1136/gut.12.12.988; FERGUSON A, 1972, CLIN EXP IMMUNOL, V12, P477; FICHTELIUS KE, 1967, EXP CELL RES, V46, P231, DOI 10.1016/0014-4827(67)90427-2; FINDLY RC, 1993, EUR J IMMUNOL, V23, P2557, DOI 10.1002/eji.1830231027; Fragoso G, 1998, INFECT IMMUN, V66, P760, DOI 10.1128/IAI.66.2.760-764.1998; FUJIHASHI K, 1990, J IMMUNOL, V145, P2010; Fujiura Y, 1996, J IMMUNOL, V156, P2710; Giddens A., 1998, 3 WAY RENEWAL SOCIAL; GIRARDI M, 2001, SCIENCE; GOODMAN T, 1988, NATURE, V333, P855, DOI 10.1038/333855a0; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Guehler SR, 1998, J IMMUNOL, V160, P5341; Guy-Grand D, 1998, EUR J IMMUNOL, V28, P730, DOI 10.1002/(SICI)1521-4141(199802)28:02<730::AID-IMMU730>3.0.CO;2-U; GUYGRAND D, 1994, J EXP MED, V180, P673, DOI 10.1084/jem.180.2.673; GUYGRAND D, 1978, J EXP MED, V148, P1661, DOI 10.1084/jem.148.6.1661; GUYGRAND D, 1974, EUR J IMMUNOL, V4, P435, DOI 10.1002/eji.1830040610; HAVRAN WL, 1991, SCIENCE, V252, P1430, DOI 10.1126/science.1828619; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; HAYDAY AC, 1994, P 6 INT S COEL DIS, P46; Holtmeier V, 2001, J INVEST DERMATOL, V116, P275, DOI 10.1046/j.1523-1747.2001.01250.x; ITOHARA S, 1989, P NATL ACAD SCI USA, V86, P5094, DOI 10.1073/pnas.86.13.5094; JANEWAY CA, 1988, IMMUNOL TODAY, V9, P73, DOI 10.1016/0167-5699(88)91267-4; JARRY A, 1990, EUR J IMMUNOL, V20, P1097, DOI 10.1002/eji.1830200523; Kanamori Y, 1996, J EXP MED, V184, P1449, DOI 10.1084/jem.184.4.1449; Ke Y, 1997, J IMMUNOL, V158, P3610; KILSHAW PJ, 1991, EUR J IMMUNOL, V21, P2591, DOI 10.1002/eji.1830211041; KLEIN JR, 1986, J EXP MED, V164, P309, DOI 10.1084/jem.164.1.309; KLEIN JR, 1984, J EXP MED, V160, P1931, DOI 10.1084/jem.160.6.1931; KLEIN JR, 1993, MUCOSAL IMMUNOLOGY I, P33; KOMANO H, 1995, P NATL ACAD SCI USA, V92, P6147, DOI 10.1073/pnas.92.13.6147; Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761; Laky K, 2000, J EXP MED, V191, P1569, DOI 10.1084/jem.191.9.1569; Lefrancois L, 1999, J EXP MED, V189, P1631, DOI 10.1084/jem.189.10.1631; Lefrancois L, 1997, J IMMUNOL, V159, P538; LEFRANCOIS L, 1991, J IMMUNOL, V147, P1746; Lepage AC, 1998, J IMMUNOL, V161, P4902; Lin TS, 1999, J CLIN INVEST, V104, P1297, DOI 10.1172/JCI7437; Lundqvist C, 1996, J IMMUNOL, V157, P1926; MACDONALD TT, 1978, GASTROENTEROLOGY, V74, P496; MARSH MN, 1975, GUT, V16, P665, DOI 10.1136/gut.16.9.665; Masopust D, 2001, J IMMUNOL, V166, P2348, DOI 10.4049/jimmunol.166.4.2348; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Matsuda S, 2001, JPN J CANCER RES, V92, P880, DOI 10.1111/j.1349-7006.2001.tb01176.x; MAYRHOFER G, 1980, BLOOD, V55, P532; MEADER RD, 1967, AM J ANAT, V121, P763, DOI 10.1002/aja.1001210318; MEUWISSEN SGM, 1976, GUT, V17, P770, DOI 10.1136/gut.17.10.770; MOSELY R, 1994, INT IMMUNOL, V2, P231; MOSLEY RL, 1994, DEV COMP IMMUNOL, V18, P155, DOI 10.1016/0145-305X(94)90243-7; MOWAT AM, 1982, GASTROENTEROLOGY, V83, P417; Muller S, 2000, J IMMUNOL, V164, P1986, DOI 10.4049/jimmunol.164.4.1986; NANNO M, 1994, J IMMUNOL, V153, P2014; OHTEKI T, 1993, EUR J IMMUNOL, V23, P1251, DOI 10.1002/eji.1830230609; Page ST, 1997, EUR J IMMUNOL, V27, P554, DOI 10.1002/eji.1830270229; Park SH, 1999, J EXP MED, V190, P885, DOI 10.1084/jem.190.6.885; POUSSIER P, 1992, J EXP MED, V176, P187, DOI 10.1084/jem.176.1.187; POUSSIER P, 1994, REV IMMUNOL, V145, P521; PUDDINGTON L, 1994, IMMUNITY, V1, P733, DOI 10.1016/S1074-7613(94)80015-4; REGNAULT A, 1994, J EXP MED, V180, P1345, DOI 10.1084/jem.180.4.1345; RIEF K, 2000, J IMMUNOL, V164, P4720; Robey D, 1996, INFORM SYST RES, V7, P93, DOI 10.1287/isre.7.1.93; ROCHA B, 1994, J EXP MED, V180, P681, DOI 10.1084/jem.180.2.681; ROCHA B, 1991, J EXP MED, V173, P483, DOI 10.1084/jem.173.2.483; ROCHA B, 1992, P NATL ACAD SCI USA, V89, P5336, DOI 10.1073/pnas.89.12.5336; ROPKE C, 1976, ANAT REC, V185, P101, DOI 10.1002/ar.1091850110; RUDZIK O, 1974, LAB INVEST, V30, P260; Shibahara T, 2001, GASTROENTEROLOGY, V120, P60, DOI 10.1053/gast.2001.20904; Shiohara T, 1996, J EXP MED, V183, P1483, DOI 10.1084/jem.183.4.1483; Shires J, 2001, IMMUNITY, V15, P419, DOI 10.1016/S1074-7613(01)00192-3; SLAVIN RE, 1973, CLIN IMMUNOL IMMUNOP, V1, P472, DOI 10.1016/0090-1229(73)90005-6; Smith AL, 2000, IMMUNOLOGY, V101, P325, DOI 10.1046/j.1365-2567.2000.00122.x; Spada FM, 2000, J EXP MED, V191, P937, DOI 10.1084/jem.191.6.937; STINGL G, 1987, P NATL ACAD SCI USA, V84, P4586, DOI 10.1073/pnas.84.13.4586; Sydora BC, 1996, J IMMUNOL, V156, P4209; SYDORA BC, 1993, J IMMUNOL, V150, P2179; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; TAGLIABUE A, 1982, J EXP MED, V155, P1785, DOI 10.1084/jem.155.6.1785; TAGUCHI T, 1991, J IMMUNOL, V147, P3736; Takahashi C, 1999, J IMMUNOL, V162, P5037; TICE DG, 1990, TRANSPLANT P, V22, P2458; TRIEBEL F, 1989, IMMUNOL TODAY, V10, P186, DOI 10.1016/0167-5699(89)90321-6; Tsujimura K, 2001, J IMMUNOL, V167, P759, DOI 10.4049/jimmunol.167.2.759; Umesaki Y, 1999, INFECT IMMUN, V67, P3504, DOI 10.1128/IAI.67.7.3504-3511.1999; Vezys V, 2000, IMMUNITY, V12, P505, DOI 10.1016/S1074-7613(00)80202-2; Vinay DS, 1998, SEMIN IMMUNOL, V10, P481, DOI 10.1006/smim.1998.0157; VINEY JL, 1990, EUR J IMMUNOL, V20, P1623, DOI 10.1002/eji.1830200734; WEBER E, 1847, PHYSL WISSENSCHAFTLI, P400; YAMAMOTO K, 1994, EUR J IMMUNOL, V24, P1301, DOI 10.1002/eji.1830240609; Yoshikai Y, 1999, IMMUNOL RES, V20, P219, DOI 10.1007/BF02790405; Young JD, 1999, NAT MED, V5, P1424	125	383	391	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2001	2	11					997	1003		10.1038/ni1101-997	http://dx.doi.org/10.1038/ni1101-997			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	490JY	11685222				2022-12-18	WOS:000172049800011
J	Bystry, RS; Aluvihare, V; Welch, KA; Kallikourdis, M; Betz, AG				Bystry, RS; Aluvihare, V; Welch, KA; Kallikourdis, M; Betz, AG			B cells and professional APCs recruit regulatory T cells via CCL4	NATURE IMMUNOLOGY			English	Article							SELF-TOLERANCE; AUTOIMMUNE-DISEASE; LYMPHOCYTES; CHEMOKINES	Using gene expression profiling, we show here that activation of B cells and professional antigen-presenting cells (APCs) induces the expression of common chemokines. Among these, CCL4 was the most potent chemoattractant of a CD4(+)CD25(+), T cell population, which is a characteristic phenotype of regulatory T cells. Depletion of either regulatory T cells or CCL4 resulted in a deregulated humoral response, which culminated in the production of autoantibodies. This suggested that the recruitment of regulatory T cells to B cells and APCs by CCL4 plays a central role in the normal initiation of T cell and humoral responses, and failure to do this leads to autoimmune activation.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; MRC, Wellcome Trust Immunol Unit, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology; University of Cambridge	Betz, AG (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	betz@mrc-lmb.cam.ac.uk	Betz, Alexander/GQQ-2221-2022; Kallikourdis, Marinos/AAA-5593-2019	Kallikourdis, Marinos/0000-0001-9318-3368	Medical Research Council [MC_U105184296] Funding Source: Medline; MRC [MC_U105184296] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Cederbom L, 2000, EUR J IMMUNOL, V30, P1538, DOI 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X; CYSTER JG, 1994, NATURE, V371, P389, DOI 10.1038/371389a0; Glynne R, 2000, NATURE, V403, P672, DOI 10.1038/35001102; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Itoh M, 1999, J IMMUNOL, V162, P5317; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kelsoe G, 1995, ADV IMMUNOL, V60, P267, DOI 10.1016/S0065-2776(08)60587-8; Luther SA, 2001, NAT IMMUNOL, V2, P102, DOI 10.1038/84205; MALANCHERE E, 1995, EUR J IMMUNOL, V25, P1358, DOI 10.1002/eji.1830250534; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; MORDES JP, 1987, DIABETOLOGIA, V30, P22, DOI 10.1007/BF01788902; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Roncarolo MG, 2000, CURR OPIN IMMUNOL, V12, P676, DOI 10.1016/S0952-7915(00)00162-X; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi Shimon, 1994, P203; Seddon B, 1999, J EXP MED, V189, P877, DOI 10.1084/jem.189.5.877; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Shevach EM, 2000, CURR BIOL, V10, pR572, DOI 10.1016/S0960-9822(00)00617-5; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; [No title captured]	32	382	411	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2001	2	12					1126	1132		10.1038/ni735	http://dx.doi.org/10.1038/ni735			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	497UE	11702067				2022-12-18	WOS:000172473200014
J	Feuerer, M; Hill, JA; Mathis, D; Benoist, C				Feuerer, Markus; Hill, Jonathan A.; Mathis, Diane; Benoist, Christophe			Foxp3(+) regulatory T cells: differentiation, specification, subphenotypes	NATURE IMMUNOLOGY			English	Review							DE-NOVO DIFFERENTIATION; TGF-BETA; NEGATIVE SELECTION; THYMIC DEVELOPMENT; SELF-TOLERANCE; CUTTING EDGE; TARGET GENES; TREG CELLS; NAIVE-LIKE; REG-CELLS	Regulatory T cells (T-reg cells) characterized by expression of the transcription factor Foxp3 play a key role in immune homeostasis. Rather than a monomorphic population strictly determined by Foxp3 as a 'master regulator', the emerging view is one of T-reg cells as a population with many levels of complexity. Several regulatory factors partake in the control of their transcriptional 'signature', with Foxp3 being a key regulator but insufficient and unnecessary to specify all aspects of the lineage. Distinct subphenotypes of Foxp3(+) T-reg cells are found in different anatomical locations. Some subphenotypes specifically control different facets of effector T cell function and, perhaps surprisingly, share transcriptional control elements with the very cells they regulate. This review will focus on these novel aspects of T-reg cell diversity.	[Feuerer, Markus; Hill, Jonathan A.; Mathis, Diane; Benoist, Christophe] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Mathis, D (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	cbdm@hms.harvard.edu; cbdm@hms.harvard.edu			US National Institutes of Health [R01-AI051530]; Juvenile Diabetes Research Foundation [4-2007-1057]; German Research Foundation [FE 801/1-1]; Charles A. King Fund; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051530] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); German Research Foundation(German Research Foundation (DFG)); Charles A. King Fund; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Powell, R. Flavell, D. Campbell, J. Lafaille, R. Maizels, V. Kuchroo and A. Rudensky for discussions and communication of unpublished data. Supported by the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health (R01-AI051530), the Juvenile Diabetes Research Foundation (4-2007-1057), the German Research Foundation (Emmy-Noether Fellowship FE 801/1-1 to M. F.), the Charles A. King Fund (M. F.) and the Canadian Institutes of Health Research (J. H.).	Allan SE, 2008, EUR J IMMUNOL, V38, P3282, DOI 10.1002/eji.200838373; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Bacchetta R, 2006, J CLIN INVEST, V116, P1713, DOI 10.1172/JCI25112; Barnes MJ, 2009, PLOS BIOL, V7, P513, DOI 10.1371/journal.pbio.1000051; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Beriou G, 2009, BLOOD, V113, P4240, DOI 10.1182/blood-2008-10-183251; Betti M, 2006, ANN ONCOL, V17, P235; Beyersdorf N, 2007, EUR J IMMUNOL, V37, P3445, DOI 10.1002/eji.200737126; Bienvenu B, 2005, J IMMUNOL, V175, P246, DOI 10.4049/jimmunol.175.1.246; Bisikirska B, 2005, J CLIN INVEST, V115, P2904, DOI 10.1172/JCI23961; Bonasio R, 2006, NAT IMMUNOL, V7, P1092, DOI 10.1038/ni1385; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Brusko T, 2007, DIABETES, V56, P604, DOI 10.2337/db06-1248; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; de Lafaille MAC, 2004, J IMMUNOL, V173, P7259, DOI 10.4049/jimmunol.173.12.7259; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; DELGOFFE GM, IMMUNITY IN PRESS; DiPaolo RJ, 2009, EUR J IMMUNOL, V39, P234, DOI 10.1002/eji.200838772; Dudda JC, 2008, J EXP MED, V205, P1559, DOI 10.1084/jem.20072594; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Feuerer M, 2007, P NATL ACAD SCI USA, V104, P18181, DOI 10.1073/pnas.0708899104; Fisson S, 2003, J EXP MED, V198, P737, DOI 10.1084/jem.20030686; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Glimcher LH, 2007, NAT IMMUNOL, V8, P448, DOI 10.1038/ni0507-448; Gupta S, 2008, MOL IMMUNOL, V46, P213, DOI 10.1016/j.molimm.2008.08.275; Haribhai D, 2009, J IMMUNOL, V182, P3461, DOI 10.4049/jimmunol.0802535; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; HILL J, 2007, IMMUNITY, V25, P693; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hori S, 2008, EUR J IMMUNOL, V38, P928, DOI 10.1002/eji.200838147; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; HUESMANN M, 1991, CELL, V66, P533, DOI 10.1016/0092-8674(81)90016-7; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kawahata K, 2002, J IMMUNOL, V168, P4399, DOI 10.4049/jimmunol.168.9.4399; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Knoechel B, 2005, J EXP MED, V202, P1375, DOI 10.1084/jem.20050855; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Lathrop SK, 2008, J EXP MED, V205, P3105, DOI 10.1084/jem.20081359; Lehmann J, 2002, P NATL ACAD SCI USA, V99, P13031, DOI 10.1073/pnas.192162899; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Liston A, 2008, P NATL ACAD SCI USA, V105, P11903, DOI 10.1073/pnas.0801506105; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Medoff BD, 2009, EUR J IMMUNOL, V39, P78, DOI 10.1002/eji.200838734; MERKENSCHLAGER M, 1994, P NATL ACAD SCI USA, V91, P11694, DOI 10.1073/pnas.91.24.11694; Molinero LL, 2009, J IMMUNOL, V182, P6736, DOI 10.4049/jimmunol.0900498; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Pacholczyk R, 2007, IMMUNITY, V27, P493, DOI 10.1016/j.immuni.2007.07.019; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; Peng SL, 2002, P NATL ACAD SCI USA, V99, P5545, DOI 10.1073/pnas.082114899; Pesu M, 2008, NATURE, V455, P246, DOI 10.1038/nature07210; Qu YY, 2007, TRANSPL IMMUNOL, V17, P153, DOI 10.1016/j.trim.2007.01.002; Romagnoli P, 2005, EUR J IMMUNOL, V35, P3525, DOI 10.1002/eji.200535225; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Saoudi A, 1996, IMMUNOL REV, V149, P195, DOI 10.1111/j.1600-065X.1996.tb00905.x; Sather BD, 2007, J EXP MED, V204, P1335, DOI 10.1084/jem.20070081; Sato S, 2006, INT IMMUNOL, V18, P1405, DOI 10.1093/intimm/dxl082; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Schmidt-Supprian M, 2004, P NATL ACAD SCI USA, V101, P4566, DOI 10.1073/pnas.0400885101; Schmidt-Supprian M, 2003, IMMUNITY, V19, P377, DOI 10.1016/S1074-7613(03)00237-1; Schneider MA, 2007, J EXP MED, V204, P735, DOI 10.1084/jem.20061405; Siegmund K, 2005, BLOOD, V106, P3097, DOI 10.1182/blood-2005-05-1864; Siewert C, 2008, J IMMUNOL, V180, P146, DOI 10.4049/jimmunol.180.1.146; Singh B, 2001, IMMUNOL REV, V182, P190, DOI 10.1034/j.1600-065X.2001.1820115.x; Stephens GL, 2007, J IMMUNOL, V178, P6901, DOI 10.4049/jimmunol.178.11.6901; Strauss L, 2007, J IMMUNOL, V178, P320, DOI 10.4049/jimmunol.178.1.320; Suffia I, 2005, J IMMUNOL, V174, P5444, DOI 10.4049/jimmunol.174.9.5444; Sugimoto N, 2006, INT IMMUNOL, V18, P1197, DOI 10.1093/intimm/dxl060; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Taylor MD, 2009, EUR J IMMUNOL, V39, P192, DOI 10.1002/eji.200838727; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Verginis P, 2008, P NATL ACAD SCI USA, V105, P3479, DOI 10.1073/pnas.0800149105; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Walker LSK, 2003, J EXP MED, V198, P249, DOI 10.1084/jem.20030315; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; Wong J, 2007, J EXP MED, V204, P2039, DOI 10.1084/jem.20070822; Wong J, 2007, J IMMUNOL, V178, P7032, DOI 10.4049/jimmunol.178.11.7032; Yamaguchi T, 2006, SEMIN CANCER BIOL, V16, P115, DOI 10.1016/j.semcancer.2005.11.005; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yu AX, 2009, IMMUNITY, V30, P204, DOI 10.1016/j.immuni.2008.11.014; Zheng XX, 2003, IMMUNITY, V19, P503, DOI 10.1016/S1074-7613(03)00259-0; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	112	381	403	2	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2009	10	7					689	695		10.1038/ni.1760	http://dx.doi.org/10.1038/ni.1760			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	459WF	19536194				2022-12-18	WOS:000267142600007
J	Bromley, SK; Thomas, SY; Luster, AD				Bromley, SK; Thomas, SY; Luster, AD			Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics	NATURE IMMUNOLOGY			English	Article							LYMPHOID-ORGAN CHEMOKINE; HIGH ENDOTHELIAL VENULES; MICE LACKING EXPRESSION; MATURE DENDRITIC CELLS; TRANSGENIC MICE; LEUKOTRIENE B-4; CUTTING EDGE; MEMORY; EFFECTOR; LUNG	T cell circulation between peripheral tissues and the lymphoid compartment is critical for immunosurveillance and host defense. However, the factors that determine whether T cells remain in peripheral tissue or return to the circulation are undefined. Here we demonstrate that the chemokine receptor CCR7 is a critical signal that determines T cell exit from peripheral tissue. Both CCR7 (-) and CCR7(+) effector T cells entered mouse asthmatic lung and while CCR7 (-) T cells accumulated, CCR7(+) T cells continued to migrate into afferent lymph. Delivery of both CCR7(+) and CCR7(-) T cells directly into the airways showed that only CCR7(+) T cells exited the lung and entered draining lymph nodes. Our study establishes a molecular basis for T cell exit from peripheral tissues.	Harvard Univ, Div Rheumatol Allergy & Immunol, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis,Sch Med, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Luster, AD (corresponding author), Harvard Univ, Div Rheumatol Allergy & Immunol, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis,Sch Med, Charlestown, MA 02129 USA.	luster.andrew@mgh.harvard.edu	Luster, Andrew/ABE-6504-2020	Luster, Andrew/0000-0001-9679-7912; Thomas, Seddon/0000-0003-0075-0744	NIAID NIH HHS [F32-AI054107, R01-AI40618] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040618, F32AI054107] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Burman A, 2005, J IMMUNOL, V174, P1693, DOI 10.4049/jimmunol.174.3.1693; Campbell DJ, 2003, IMMUNOL REV, V195, P58, DOI 10.1034/j.1600-065X.2003.00067.x; Christopherson KW, 2003, BLOOD, V101, P801, DOI 10.1182/blood-2002-05-1586; Debes GF, 2004, J VIROL, V78, P7528, DOI 10.1128/JVI.78.14.7528-7535.2004; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Goodarzi K, 2003, NAT IMMUNOL, V4, P965, DOI 10.1038/ni972; Gowans J L, 1980, Ciba Found Symp, V71, P113, DOI 10.1002/9780470720547.ch7; Grakoui A, 1999, J IMMUNOL, V162, P1923; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Gunn MD, 1998, P NATL ACAD SCI USA, V95, P258, DOI 10.1073/pnas.95.1.258; Hogan RJ, 2001, J IMMUNOL, V166, P1813, DOI 10.4049/jimmunol.166.3.1813; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Kallinich T, 2005, CLIN EXP ALLERGY, V35, P26, DOI 10.1111/j.1365-2222.2004.02132.x; Lehmann C, 2001, ANAT REC, V264, P229, DOI 10.1002/ar.1163; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; MACKAY CR, 1990, J EXP MED, V171, P801, DOI 10.1084/jem.171.3.801; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Mathew A, 2002, J IMMUNOL, V169, P651, DOI 10.4049/jimmunol.169.2.651; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mori S, 2001, J EXP MED, V193, P207, DOI 10.1084/jem.193.2.207; Nakano H, 2001, J IMMUNOL, V166, P361, DOI 10.4049/jimmunol.166.1.361; Ostler T, 2001, EUR J IMMUNOL, V31, P2574, DOI 10.1002/1521-4141(200109)31:9<2574::AID-IMMU2574>3.0.CO;2-V; Roman E, 2002, J EXP MED, V196, P957, DOI 10.1084/jem.20021052; Saeki H, 1999, J IMMUNOL, V162, P2472; Sallusto F, 1999, EUR J IMMUNOL, V29, P2037, DOI 10.1002/(SICI)1521-4141(199906)29:06<2037::AID-IMMU2037>3.0.CO;2-V; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Stein JV, 2000, J EXP MED, V191, P61, DOI 10.1084/jem.191.1.61; Tager AM, 2003, NAT IMMUNOL, V4, P982, DOI 10.1038/ni970; Unsoeld H, 2005, J VIROL, V79, P4510, DOI 10.1128/JVI.79.7.4510-4513.2005; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	37	381	391	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2005	6	9					895	901		10.1038/ni1240	http://dx.doi.org/10.1038/ni1240			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	957KX	16116469				2022-12-18	WOS:000231369800019
J	Gett, AV; Sallusto, F; Lanzavecchia, A; Geginat, J				Gett, AV; Sallusto, F; Lanzavecchia, A; Geginat, J			T cell fitness determined by signal strength	NATURE IMMUNOLOGY			English	Article							IN-VIVO; CROSS-PRESENTATION; EFFECTOR FUNCTION; DENDRITIC CELLS; SELF-ANTIGENS; MEMORY CELLS; NAIVE; DIFFERENTIATION; RECEPTOR; EXPRESSION	Two potential outcomes confront proliferating antigen-stimulated naive T cells: differentiation to effector and memory cells, or deletion. How stimulation affects cell fate is unclear. Autonomous CD8(+) T cell differentiation has been proposed, but this does not explain the abortive proliferation of T cells induced by immature dendritic cells. Here we show that human and mouse CD4(+) and CD8(+) T cells receiving short or weak stimulation of the T cell receptor proliferate in response to interleukin 2 (IL-2) but are not 'fit' because they die by neglect, fail to proliferate in response to IL-7 and IL-15 and disappear in vivo. Conversely, prolonged or strong stimulation promotes 'fitness' by enhancing survival and cytokine responsiveness. Our results are consistent with the concept that signal strength drives progressive T cell differentiation and the acquisition of fitness.	Inst Res Biomed, CH-6500 Bellinzona, Switzerland	Universita della Svizzera Italiana	Lanzavecchia, A (corresponding author), Inst Res Biomed, Via Vela 6, CH-6500 Bellinzona, Switzerland.	lanzavecchia@irb.unisi.ch; jens.geginat@irb.unisi.ch	Geginat, Jens/AAA-5818-2019	Geginat, Jens/0000-0003-4813-0384				Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; BROOME HE, 1995, J IMMUNOL, V155, P2311; CANTRELL DA, 1983, J EXP MED, V158, P1895, DOI 10.1084/jem.158.6.1895; Ferreira C, 2000, J IMMUNOL, V165, P3689, DOI 10.4049/jimmunol.165.7.3689; FRASER JD, 1991, SCIENCE, V251, P313, DOI 10.1126/science.1846244; Geginat J, 2001, J EXP MED, V194, P1711, DOI 10.1084/jem.194.12.1711; Gett AV, 1998, P NATL ACAD SCI USA, V95, P9488, DOI 10.1073/pnas.95.16.9488; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512; Hernandez J, 2002, J EXP MED, V196, P323, DOI 10.1084/jem.20011612; Hernandez J, 2001, J EXP MED, V194, P707, DOI 10.1084/jem.194.6.707; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Iezzi G, 1999, EUR J IMMUNOL, V29, P4092, DOI 10.1002/(SICI)1521-4141(199912)29:12<4092::AID-IMMU4092>3.3.CO;2-1; Iezzi G, 2001, J EXP MED, V193, P987, DOI 10.1084/jem.193.8.987; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Langenkamp A, 2002, EUR J IMMUNOL, V32, P2046, DOI 10.1002/1521-4141(200207)32:7<2046::AID-IMMU2046>3.0.CO;2-M; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Lauvau G, 2001, SCIENCE, V294, P1735, DOI 10.1126/science.1064571; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Newton K, 2000, Adv Immunol, V76, P179; Plas DR, 2002, NAT IMMUNOL, V3, P515, DOI 10.1038/ni0602-515; Potsch C, 1999, EUR J IMMUNOL, V29, P3562, DOI 10.1002/(SICI)1521-4141(199911)29:11<3562::AID-IMMU3562>3.0.CO;2-R; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Schwartz RH, 1997, CURR OPIN IMMUNOL, V9, P351, DOI 10.1016/S0952-7915(97)80081-7; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Sugamura K, 1996, ANNU REV IMMUNOL, V14, P179, DOI 10.1146/annurev.immunol.14.1.179; Tanchot C, 1998, IMMUNITY, V8, P581, DOI 10.1016/S1074-7613(00)80563-4; Tuosto L, 1998, EUR J IMMUNOL, V28, P2131, DOI 10.1002/(SICI)1521-4141(199807)28:07<2131::AID-IMMU2131>3.0.CO;2-Q; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; WEBER S, 1992, NATURE, V356, P793, DOI 10.1038/356793a0; Wells AD, 2000, J IMMUNOL, V165, P2432, DOI 10.4049/jimmunol.165.5.2432; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Wulfing C, 1997, J EXP MED, V185, P1815, DOI 10.1084/jem.185.10.1815; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6	50	381	394	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2003	4	4					355	360		10.1038/ni908	http://dx.doi.org/10.1038/ni908			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	663CG	12640450				2022-12-18	WOS:000181987700015
J	Tanigakik, K; Han, H; Yamamoto, N; Tashiro, K; Ikegawa, M; Kuroda, K; Suzuki, A; Nakano, T; Honjo, T				Tanigakik, K; Han, H; Yamamoto, N; Tashiro, K; Ikegawa, M; Kuroda, K; Suzuki, A; Nakano, T; Honjo, T			Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR; GENE-EXPRESSION; KAPPA-B; ACTIVATION; MICE; DIFFERENTIATION; RECOMBINATION; CONSERVATION; MATURATION; SELECTION	RBP-J is a key mediator of Notch signaling that regulates cell fate determination in various lineages. To investigate the function of Notch-RBP-J in mature B cell differentiation, we generated mice that selectively lacked B cell RBP-J expression using conditional mutagenesis. Absence of RBP-J led to the loss of marginal zone B (MZB) cells with a concomitant increase in follicular B cells; in contrast, B I cells in the peritoneal cavity were unaffected. Lack of RBP-J caused no defects in B cells maintenance, survival, plasma cell differentiation or activation. It is therefore likely that Notch-RBP-J signaling regulates the lineage commitment of mature B cells into follicular versus MZB cells. In addition, in mice with RBP-J-deficient B cells, had no obvious changes in immunoglobulin production in response to Ficoll, lipopolysaccharide or chicken gammaglobulin. In contrast, these mice exhibited increased mortality rates after blood-borne bacterial infection, which indicates that MZB cells play pivotal roles in the clearance of these bacteria.	Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Ctr Mol Biol & Genet, Sakyo Ku, Kyoto 6068501, Japan; Akita Univ, Sch Med, Dept Biochem, Akita 0108543, Japan; Osaka Univ, Microbial Dis Res Inst, Dept Mol Cell Biol, Suita, Osaka 5650871, Japan	Kyoto University; Kyoto University; Akita University; Osaka University	Honjo, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.	honjo@mour.med.kyoto-u.ac.jp	Ikegawa, Masaya/AAG-5327-2020; Suzuki, Akira/GYD-6697-2022; Honjo, Tasuku/N-4470-2016	Suzuki, Akira/0000-0002-5950-8808; Yamamoto, Norio/0000-0001-8924-0710				ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Bang AG, 1995, DEV BIOL, V172, P479, DOI 10.1006/dbio.1995.8033; Betz UAK, 1996, CURR BIOL, V6, P1307, DOI 10.1016/S0960-9822(02)70717-3; Cariappa A, 2000, J EXP MED, V192, P1175, DOI 10.1084/jem.192.8.1175; Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2; delaPompa J, 1997, DEVELOPMENT, V124, P1139; DEVOS T, 1991, J IMMUNOL METHODS, V141, P285, DOI 10.1016/0022-1759(91)90155-9; DUNNWALTERS DK, 1995, J EXP MED, V182, P559, DOI 10.1084/jem.182.2.559; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Girkontaite I, 2001, NAT IMMUNOL, V2, P855, DOI 10.1038/ni0901-855; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; HUA H, 2002, IN PRESS INT IMMUNOL; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; Karanu FN, 2000, J EXP MED, V192, P1365, DOI 10.1084/jem.192.9.1365; Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238; Kurooka H, 1998, NUCLEIC ACIDS RES, V26, P5448, DOI 10.1093/nar/26.23.5448; Li LH, 1998, IMMUNITY, V8, P43, DOI 10.1016/S1074-7613(00)80457-4; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Makowska A, 1999, EUR J IMMUNOL, V29, P3285, DOI 10.1002/(SICI)1521-4141(199910)29:10<3285::AID-IMMU3285>3.3.CO;2-G; Martin F, 2000, IMMUNITY, V12, P39, DOI 10.1016/S1074-7613(00)80157-0; Martin F, 2001, CURR OPIN IMMUNOL, V13, P195, DOI 10.1016/S0952-7915(00)00204-1; Morelli AE, 2000, J VIROL, V74, P9617, DOI 10.1128/JVI.74.20.9617-9628.2000; Morimura T, 2001, J IMMUNOL, V166, P3277, DOI 10.4049/jimmunol.166.5.3277; Morimura T, 2000, J BIOL CHEM, V275, P36523, DOI 10.1074/jbc.M006415200; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; NAKANE A, 1995, INFECT IMMUN, V63, P1165, DOI 10.1128/IAI.63.4.1165-1172.1995; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; OKA C, 1995, DEVELOPMENT, V121, P3291; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radkov SA, 1997, J VIROL, V71, P8552, DOI 10.1128/JVI.71.11.8552-8562.1997; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Roark JH, 1998, J IMMUNOL, V160, P3121; SAKAI T, 1995, J BIOCHEM-TOKYO, V118, P621, DOI 10.1093/oxfordjournals.jbchem.a124955; Sato S, 1997, J IMMUNOL, V158, P4662; Schroeder T, 2000, EMBO J, V19, P2558, DOI 10.1093/emboj/19.11.2558; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Strobl LJ, 2000, J VIROL, V74, P1727, DOI 10.1128/JVI.74.4.1727-1735.2000; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965; Wang JH, 1998, IMMUNITY, V9, P543, DOI 10.1016/S1074-7613(00)80637-8; Weih DS, 2001, J IMMUNOL, V167, P1909, DOI 10.4049/jimmunol.167.4.1909; WON WJ, 2000, FASEB J, V14, P1191; ZIMBERSTROBL U, 1994, EMBO J, V13, P4973, DOI 10.1002/j.1460-2075.1994.tb06824.x	51	381	386	0	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2002	3	5					443	450		10.1038/ni793	http://dx.doi.org/10.1038/ni793			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	548VU	11967543				2022-12-18	WOS:000175411200012
J	Kerdiles, YM; Beisner, DR; Tinoco, R; Dejean, AS; Castrillon, DH; DePinho, RA; Hedrick, SM				Kerdiles, Yann M.; Beisner, Daniel R.; Tinoco, Roberto; Dejean, Anne S.; Castrillon, Diego H.; DePinho, Ronald A.; Hedrick, Stephen M.			Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTORS; PHOSPHATIDYLINOSITOL 3-KINASE; TRANSGENIC MICE; FAMILY-MEMBER; FORKHEAD; HOMEOSTASIS; EXPRESSION; IL-7; LYMPHOCYTE; ACTIVATION	Foxo transcription factors have a conserved role in the adaptation of cells and organisms to nutrient and growth factor availability. Here we show that Foxo1 has a crucial, nonredundant role in T cells. In naive T cells, Foxo1 controlled the expression of the adhesion molecule L-selectin, the chemokine receptor CCR7 and the transcription factor Klf2, and its deletion was sufficient to alter lymphocyte trafficking. Furthermore, Foxo1 deficiency resulted in a severe defect in interleukin 7 receptor alpha-chain (IL-7R alpha) expression associated with its ability to bind an Il7r enhancer. Finally, growth factor withdrawal induced a Foxo1-dependent increase in Sell, Klf2 and Il7r expression. These data suggest that Foxo1 regulates the homeostasis and life span of naive T cells by sensing growth factor availability and regulating homing and survival signals.	[Kerdiles, Yann M.; Beisner, Daniel R.; Tinoco, Roberto; Dejean, Anne S.; Hedrick, Stephen M.] Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Kerdiles, Yann M.; Beisner, Daniel R.; Tinoco, Roberto; Dejean, Anne S.; Hedrick, Stephen M.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Castrillon, Diego H.; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst,Dept Adult Oncol, Ctr Appl Canc Sci,Belfer Inst Innovat Canc Sci, Boston, MA 02115 USA; [Castrillon, Diego H.; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med, Boston, MA 02115 USA; [Castrillon, Diego H.; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Genet, Boston, MA 02115 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Hedrick, SM (corresponding author), Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA.	shedrick@ucsd.edu	kerdiles, yann/U-2190-2018; Dejean, Anne S/K-6739-2014; Hedrick, Stephen M/E-9171-2010	kerdiles, yann/0000-0002-8605-1073; Dejean, Anne S./0000-0002-8846-1113; Hedrick, Stephen/0000-0002-6345-8751; DePinho, Ronald/0000-0002-5625-577X; Tinoco, Roberto/0000-0001-5420-9692	University of California; San Diego Division of Biological Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR024196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073885] Funding Source: NIH RePORTER	University of California(University of California System); San Diego Division of Biological Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank W. D'Souza and M. McGargill for discussions and assistance with adoptive transfer experiments; T. Ludwig (Columbia University) for ERCre mice; C. Murre (University of California at San Diego) for PTEN<SUP>f/f</SUP>-ERCre mice; H. Cheroutre (La Jolla Institute for Allergy and Immunology) for Il7r<SUP>-/-</SUP> mice; S. Kaech for identifying the evolutionarily conserved regions of Il7r; and A. Goldrath and P. Marrack for critical reading of the manuscript. Supported by funds made available by the University of California, San Diego Division of Biological Sciences.	Almeida ARM, 2005, SEMIN IMMUNOL, V17, P239, DOI 10.1016/j.smim.2005.02.002; Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632; Barata JT, 2004, J EXP MED, V200, P659, DOI 10.1084/jem.20040789; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Berzins SP, 1998, J EXP MED, V187, P1839, DOI 10.1084/jem.187.11.1839; Birkenkamp KU, 2003, J IMMUNOL, V171, P1623, DOI 10.4049/jimmunol.171.4.1623; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Chao CC, 1997, J IMMUNOL, V159, P1686; Charvet C, 2006, J IMMUNOL, V177, P5024, DOI 10.4049/jimmunol.177.8.5024; Cinalli RM, 2005, EUR J IMMUNOL, V35, P786, DOI 10.1002/eji.200425729; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; CYSTER JG, 1995, J EXP MED, V182, P581, DOI 10.1084/jem.182.2.581; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Fabre S, 2005, J IMMUNOL, V174, P4161, DOI 10.4049/jimmunol.174.7.4161; Fabre S, 2008, J IMMUNOL, V181, P2980, DOI 10.4049/jimmunol.181.5.2980; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Freitas AA, 1999, CURR OPIN IMMUNOL, V11, P152, DOI 10.1016/S0952-7915(99)80026-0; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Guo KY, 2007, ENDOCRINOLOGY, V148, P3987, DOI 10.1210/en.2007-0261; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Herzog S, 2008, NAT IMMUNOL, V9, P623, DOI 10.1038/ni.1616; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Jameson SC, 2005, SEMIN IMMUNOL, V17, P231, DOI 10.1016/j.smim.2005.02.003; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Lantz O, 2000, NAT IMMUNOL, V1, P54, DOI 10.1038/76917; Lee HC, 2005, J IMMUNOL, V174, P7800, DOI 10.4049/jimmunol.174.12.7800; Lee SK, 2005, IMMUNOL REV, V208, P169, DOI 10.1111/j.0105-2896.2005.00339.x; Leenders H, 2000, EUR J IMMUNOL, V30, P2980, DOI 10.1002/1521-4141(200010)30:10<2980::AID-IMMU2980>3.0.CO;2-9; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Maeurer M J, 1998, Int Rev Immunol, V16, P309, DOI 10.3109/08830189809042999; Marrack P, 2004, ANNU REV IMMUNOL, V22, P765, DOI 10.1146/annurev.immunol.22.012703.104554; Martinez-Gac L, 2004, MOL CELL BIOL, V24, P2181, DOI 10.1128/MCB.24.5.2181-2189.2004; MERTSCHING E, 1995, INT IMMUNOL, V7, P401, DOI 10.1093/intimm/7.3.401; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pallard C, 1999, IMMUNITY, V10, P525, DOI 10.1016/S1074-7613(00)80052-7; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Park JH, 2007, NAT IMMUNOL, V8, P1049, DOI 10.1038/ni1512; Peng SL, 2008, ONCOGENE, V27, P2337, DOI 10.1038/onc.2008.26; Riou C, 2007, J EXP MED, V204, P79, DOI 10.1084/jem.20061681; SAMARIDIS J, 1991, EUR J IMMUNOL, V21, P453, DOI 10.1002/eji.1830210230; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Sebzda E, 2008, NAT IMMUNOL, V9, P292, DOI 10.1038/ni1565; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; Vivien L, 2001, INT IMMUNOL, V13, P763, DOI 10.1093/intimm/13.6.763; WALLIS VJ, 1979, IMMUNOLOGY, V38, P163; Wojciechowski S, 2007, J EXP MED, V204, P1665, DOI 10.1084/jem.20070618; Xue HH, 2004, NAT IMMUNOL, V5, P1036, DOI 10.1038/ni1117; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353	62	379	387	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2009	10	2					176	184		10.1038/ni.1689	http://dx.doi.org/10.1038/ni.1689			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	404UM	19136962	Green Accepted			2022-12-18	WOS:000263178500011
J	Friedl, P; Weigelin, B				Friedl, Peter; Weigelin, Bettina			Interstitial leukocyte migration and immune function	NATURE IMMUNOLOGY			English	Review							SECONDARY LYMPHOID ORGANS; ANTIGEN-PRESENTING CELLS; SPLENIC MARGINAL ZONE; CHRONIC HEPATITIS-C; T-CELL; DENDRITIC CELLS; IN-VIVO; RHEUMATOID-ARTHRITIS; BASEMENT-MEMBRANE; LEUKOTRIENE B-4	The trafficking of leukocytes into and within lymphoid and peripheral tissues is central to immune cell development, immunosurveillance and effector function. Interstitial leukocyte trafficking is the result of amoeboid polarization and migration, guided by soluble or tissue-bound chemoattractant signals for positioning and local arrest. In contrast to other migration modes, amoeboid movement is particularly suited for scanning cellular networks and tissues. Here, we review mechanisms of leukocyte migration and sensing involved in diapedesis, tissue-based interstitial migration and egress, immune cell positioning in inflammation, and emerging therapeutic interference strategies.	[Friedl, Peter] Radboud Univ Nijmegen, Dept Cell Biol, Nijmegen Ctr Mol Life Sci, Med Ctr, NL-6500 HB Nijmegen, Netherlands; Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany; Univ Wurzburg, Dept Dermatol, D-97080 Wurzburg, Germany	Radboud University Nijmegen; University of Wurzburg; University of Wurzburg	Friedl, P (corresponding author), Radboud Univ Nijmegen, Dept Cell Biol, Nijmegen Ctr Mol Life Sci, Med Ctr, Geert Grooteplein 28, NL-6500 HB Nijmegen, Netherlands.	p.friedl@ncmls.ru.nl	Weigelin, Bettina/H-8604-2015; Friedl, Peter/A-8961-2010	Friedl, Peter/0000-0002-0119-4041; Weigelin, Bettina/0000-0003-4460-3113	Deutsche Forschungsgemeinschaft [FR1155/6-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by Deutsche Forschungsgemeinschaft grant FR1155/6-3 (P. F.).	Adair-Kirk TL, 2003, J IMMUNOL, V171, P398, DOI 10.4049/jimmunol.171.1.398; Agrawal S, 2006, J EXP MED, V203, P1007, DOI 10.1084/jem.20051342; Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P443, DOI 10.1161/hq0302.105593; Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; APPLEGATE KG, 1990, CANCER RES, V50, P7153; Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Barber DF, 2005, NAT MED, V11, P933, DOI 10.1038/nm1291; Beemiller P, 2006, PLOS BIOL, V4, P987, DOI 10.1371/journal.pbio.0040162; Ben-Chetrit E, 2006, RHEUMATOLOGY, V45, P274, DOI 10.1093/rheumatology/kei140; Bendix PM, 2008, BIOPHYS J, V94, P3126, DOI 10.1529/biophysj.107.117960; Berg LP, 2002, J IMMUNOL, V168, P3227, DOI 10.4049/jimmunol.168.7.3227; Bhakta NR, 2005, NAT IMMUNOL, V6, P143, DOI 10.1038/ni1161; Boissonnas A, 2007, J EXP MED, V204, P345, DOI 10.1084/jem.20061890; Breart B, 2008, J CLIN INVEST, V118, P1390, DOI 10.1172/JCI34388; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Brown CE, 2007, J IMMUNOL, V179, P3332, DOI 10.4049/jimmunol.179.5.3332; Cahalan MD, 2008, ANNU REV IMMUNOL, V26, P585, DOI 10.1146/annurev.immunol.24.021605.090620; Campello S, 2006, J EXP MED, V203, P2879, DOI 10.1084/jem.20061877; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Charest PG, 2006, CURR OPIN GENET DEV, V16, P339, DOI 10.1016/j.gde.2006.06.016; Chiba K, 2005, PHARMACOL THERAPEUT, V108, P308, DOI 10.1016/j.pharmthera.2005.05.002; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Chung A, 2007, BIOMATERIALS, V28, P285, DOI 10.1016/j.biomaterials.2006.08.038; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Dangerfield J, 2002, J EXP MED, V196, P1201, DOI 10.1084/jem.20020324; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; DENICHILO MO, 1993, P NATL ACAD SCI USA, V90, P2517, DOI 10.1073/pnas.90.6.2517; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; Eddy RJ, 2002, MOL BIOL CELL, V13, P4470, DOI 10.1091/mbc.E02-04-0241; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; El-Shabrawi Y, 2004, J NEUROIMMUNOL, V155, P13, DOI 10.1016/j.jneuroim.2004.05.010; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; FernandezSegura E, 1996, CELL IMMUNOL, V171, P120, DOI 10.1006/cimm.1996.0181; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Friedl P, 2004, INT J DEV BIOL, V48, P441, DOI 10.1387/ijdb.041821pf; FRIEDL P, 1995, CANCER RES, V55, P4557; Friedl P, 2005, NAT REV IMMUNOL, V5, P532, DOI 10.1038/nri1647; Friedl P, 2003, BIOCHEM SOC SYMP, V70, P277, DOI 10.1042/bss0700277; Friedl P, 2002, IMMUNOL REV, V186, P83, DOI 10.1034/j.1600-065X.2002.18608.x; Friedl P, 1998, EUR J IMMUNOL, V28, P2331, DOI 10.1002/(SICI)1521-4141(199808)28:08<2331::AID-IMMU2331>3.0.CO;2-C; Friedl P, 2000, Dev Immunol, V7, P249, DOI 10.1155/2000/56473; Friedman RS, 2006, NAT IMMUNOL, V7, P1101, DOI 10.1038/ni1384; Gal I, 2005, ARTHRITIS RHEUM-US, V52, P3269, DOI 10.1002/art.21532; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; Gunzer M, 2004, BLOOD, V104, P2801, DOI 10.1182/blood-2004-03-1193; Gunzer M, 1997, ADV EXP MED BIOL, V417, P97; HAUZENBERGER D, 1994, J IMMUNOL, V153, P960; Heit B, 2008, NAT IMMUNOL, V9, P743, DOI 10.1038/ni.1623; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Hokeness KL, 2007, J VIROL, V81, P1241, DOI 10.1128/JVI.01937-06; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Ibarra N, 2005, BIOCHEM SOC T, V33, P1243, DOI 10.1042/BST0331243; JAASKELAINEN J, 1992, J IMMUNOL, V149, P260; Kawakami N, 2005, J EXP MED, V201, P1805, DOI 10.1084/jem.20050011; Kratz A, 1996, J EXP MED, V183, P1461, DOI 10.1084/jem.183.4.1461; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lalor PF, 1999, J CLIN PATHOL-MOL PA, V52, P214, DOI 10.1136/mp.52.4.214; LASKIN DL, 1986, J LEUKOCYTE BIOL, V39, P255, DOI 10.1002/jlb.39.3.255; Le Floc'h A, 2007, J EXP MED, V204, P559, DOI 10.1084/jem.20061524; Ledgerwood LG, 2008, NAT IMMUNOL, V9, P42, DOI 10.1038/ni1534; LEPPERT D, 1995, J IMMUNOL, V154, P4379; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Mackay CR, 2008, NAT IMMUNOL, V9, P988, DOI 10.1038/ni.f.210; Mandeville JTH, 1997, J LEUKOCYTE BIOL, V61, P188, DOI 10.1002/jlb.61.2.188; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Marttila-Ichihara F, 2008, BLOOD, V112, P64, DOI 10.1182/blood-2007-10-118984; Mathis S, 2007, AUTOIMMUN REV, V7, P12, DOI 10.1016/j.autrev.2007.03.005; McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Mempel TR, 2004, CURR OPIN IMMUNOL, V16, P406, DOI 10.1016/j.coi.2004.05.018; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Mrass P, 2006, J EXP MED, V203, P2749, DOI 10.1084/jem.20060710; Murphy G, 2008, TRENDS IMMUNOL, V29, P75, DOI 10.1016/j.it.2007.10.009; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Nemoto E, 2002, J LEUKOCYTE BIOL, V72, P538; Nobile C, 2008, BLOOD, V111, P3579, DOI 10.1182/blood-2007-08-107755; Nombela-Arrieta C, 2004, IMMUNITY, V21, P429, DOI 10.1016/j.immuni.2004.07.012; O'Hayre M, 2008, BIOCHEM J, V409, P635, DOI 10.1042/BJ20071493; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pals ST, 2007, BLOOD, V110, P3102, DOI 10.1182/blood-2007-05-075176; Pasvolsky R, 2008, J IMMUNOL, V180, P2815, DOI 10.4049/jimmunol.180.5.2815; Pham THM, 2008, IMMUNITY, V28, P122, DOI 10.1016/j.immuni.2007.11.017; PYTOWSKI B, 1990, J CELL BIOL, V110, P661, DOI 10.1083/jcb.110.3.661; Rommel C, 2007, NAT REV IMMUNOL, V7, P191, DOI 10.1038/nri2036; Roussel E, 1997, J LEUKOCYTE BIOL, V62, P356, DOI 10.1002/jlb.62.3.356; Salmi M, 2004, BLOOD, V104, P3849, DOI 10.1182/blood-2004-01-0222; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Schon MP, 2008, ONCOGENE, V27, P190, DOI 10.1038/sj.onc.1210913; Schon MP, 2002, J INVEST DERMATOL, V119, P190, DOI 10.1046/j.1523-1747.2002.17973.x; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; SENIOR RM, 1992, J CLIN INVEST, V90, P2251, DOI 10.1172/JCI116111; Servant G, 1999, MOL BIOL CELL, V10, P1163, DOI 10.1091/mbc.10.4.1163; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Silzle T, 2003, EUR J IMMUNOL, V33, P1311, DOI 10.1002/eji.200323057; Sims TN, 2007, CELL, V129, P773, DOI 10.1016/j.cell.2007.03.037; Stambolic V, 2006, TRENDS CELL BIOL, V16, P461, DOI 10.1016/j.tcb.2006.07.001; Stanley P, 2008, EMBO J, V27, P62, DOI 10.1038/sj.emboj.7601959; Steadman R, 1997, INT J BIOCHEM CELL B, V29, P993, DOI 10.1016/S1357-2725(97)00038-1; Stoitzner P, 2002, J INVEST DERMATOL, V118, P117, DOI 10.1046/j.0022-202x.2001.01631.x; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Thomsen AR, 2003, IMMUNOL LETT, V85, P119, DOI 10.1016/S0165-2478(02)00236-5; THURESONKLEIN A, 1986, TISSUE CELL, V18, P1, DOI 10.1016/0040-8166(86)90002-9; Valiante NM, 2000, IMMUNOL REV, V174, P77, DOI 10.1034/j.1600-0528.2002.017417.x; Van Lint P, 2007, J LEUKOCYTE BIOL, V82, P1375, DOI 10.1189/jlb.0607338; VANVLIET E, 1986, J HISTOCHEM CYTOCHEM, V34, P883, DOI 10.1177/34.7.3519751; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wang SJ, 2006, J EXP MED, V203, P1519, DOI 10.1084/jem.20051210; Warren A, 2006, HEPATOLOGY, V44, P1182, DOI 10.1002/hep.21378; Wei SH, 2007, J IMMUNOL, V179, P1586, DOI 10.4049/jimmunol.179.3.1586; Wei XB, 1999, P NATL ACAD SCI USA, V96, P8471, DOI 10.1073/pnas.96.15.8471; Wenzel J, 2005, J CUTAN PATHOL, V32, P257, DOI 10.1111/j.0303-6987.2005.00297.x; Winter H, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-56; Wolf K, 2003, BLOOD, V102, P3262, DOI 10.1182/blood-2002-12-3791; WOLF K, 2008, CLIN EXP METAST 0704; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; Xu XD, 2008, LIVER INT, V28, P319, DOI 10.1111/j.1478-3231.2008.01671.x; Young RE, 2007, BRIT J PHARMACOL, V151, P628, DOI 10.1038/sj.bjp.0707267; Zeremski M, 2007, J VIRAL HEPATITIS, V14, P675, DOI 10.1111/j.1365-2893.2006.00838.x; Zhang B, 2008, J IMMUNOL, V180, P2641, DOI 10.4049/jimmunol.180.4.2641; Zhang TQ, 2005, J IMMUNOL, V174, P5856, DOI 10.4049/jimmunol.174.9.5856	141	378	382	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2008	9	9					960	969		10.1038/ni.f.212	http://dx.doi.org/10.1038/ni.f.212			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339DZ	18711433				2022-12-18	WOS:000258559600004
J	von Essen, MR; Kongsbak, M; Schjerling, P; Olgaard, K; Odum, N; Geisler, C				von Essen, Marina Rode; Kongsbak, Martin; Schjerling, Peter; Olgaard, Klaus; Odum, Niels; Geisler, Carsten			Vitamin D controls T cell antigen receptor signaling and activation of human T cells	NATURE IMMUNOLOGY			English	Article							PROTEIN-KINASE; MEDIATED ACTIVATION; IMMUNE-SYSTEM; IN-VITRO; DIFFERENTIAL ACTIVATION; PHOSPHOLIPASE C-GAMMA-1; DOWN-REGULATION; TCR; PHOSPHORYLATION; REQUIREMENTS	Phospholipase C (PLC) isozymes are key signaling proteins downstream of many extracellular stimuli. Here we show that naive human T cells had very low expression of PLC-gamma 1 and that this correlated with low T cell antigen receptor (TCR) responsiveness in naive T cells. However, TCR triggering led to an upregulation of similar to 75-fold in PLC-gamma 1 expression, which correlated with greater TCR responsiveness. Induction of PLC-gamma 1 was dependent on vitamin D and expression of the vitamin D receptor (VDR). Naive T cells did not express VDR, but VDR expression was induced by TCR signaling via the alternative mitogen-activated protein kinase p38 pathway. Thus, initial TCR signaling via p38 leads to successive induction of VDR and PLC-gamma 1, which are required for subsequent classical TCR signaling and T cell activation.	[von Essen, Marina Rode; Kongsbak, Martin; Odum, Niels; Geisler, Carsten] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Schjerling, Peter] Univ Copenhagen, Ctr Healthy Aging, Fac Hlth Sci, Copenhagen, Denmark; [Odum, Niels] Univ Copenhagen, Dept Biol, Fac Sci, Copenhagen, Denmark; [Schjerling, Peter] Univ Copenhagen, Bispebjerg Hosp, Inst Sports Med, Copenhagen, Denmark; [Olgaard, Klaus] Univ Copenhagen, Rigshosp, Dept Nephrol, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; Rigshospitalet; University of Copenhagen	Geisler, C (corresponding author), Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark.	cge@sund.ku.dk	Schjerling, Peter/F-6194-2011; von Essen, marina/AAG-9686-2021; Geisler, Carsten/A-7056-2012	Schjerling, Peter/0000-0001-7138-3211; Geisler, Carsten/0000-0002-8472-0771; Kongsbak-Wismann, Martin/0000-0002-3496-9333; Olgaard, Klaus/0000-0002-4063-1283; von Essen, Marina/0000-0001-9367-5020				Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; AKBAR AN, 1988, J IMMUNOL, V140, P2171; Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Bonefeld CM, 2008, J IMMUNOL, V181, P7786, DOI 10.4049/jimmunol.181.11.7786; BYRNE JA, 1988, J IMMUNOL, V141, P3249; CHAKRABARTI R, 1994, J IMMUNOL, V152, P2660; COSTA EM, 1987, ENDOCRINOLOGY, V120, P1173, DOI 10.1210/endo-120-3-1173; CROFT M, 1994, J IMMUNOL, V152, P2675; Curtsinger JM, 1998, J IMMUNOL, V160, P3236; Dienz O, 2003, J IMMUNOL, V170, P365, DOI 10.4049/jimmunol.170.1.365; Dong S, 2006, J EXP MED, V203, P2509, DOI 10.1084/jem.20060650; Ericsson PO, 1996, J IMMUNOL, V156, P2045; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; GEISLER C, 1988, SCAND J IMMUNOL, V27, P685, DOI 10.1111/j.1365-3083.1988.tb02402.x; Harden TK, 2006, ANNU REV PHARMACOL, V46, P355, DOI 10.1146/annurev.pharmtox.46.120604.141223; Irvin BJ, 2000, MOL CELL BIOL, V20, P9149, DOI 10.1128/MCB.20.24.9149-9161.2000; Kadi F, 2004, J PHYSIOL-LONDON, V558, P1005, DOI 10.1113/jphysiol.2004.065904; Lauritsen JPH, 1998, J IMMUNOL, V161, P260; Lin J, 1999, J BIOL CHEM, V274, P28861, DOI 10.1074/jbc.274.41.28861; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; LUQMAN M, 1992, J IMMUNOL, V149, P2300; Maiti A, 2008, J BIOL CHEM, V283, P175, DOI 10.1074/jbc.M707269200; Margulies DH, 2001, NAT IMMUNOL, V2, P669, DOI 10.1038/90601; Mathieu C, 2001, J BONE MINER RES, V16, P2057, DOI 10.1359/jbmr.2001.16.11.2057; Mittelstadt PR, 2009, J BIOL CHEM, V284, P15469, DOI 10.1074/jbc.M901004200; Mizwicki MT, 2007, J STEROID BIOCHEM, V103, P243, DOI 10.1016/j.jsbmb.2006.12.004; Mizwicki MT, 2009, J BIOL CHEM, V284, P36292, DOI 10.1074/jbc.M109.042069; Neufeld TP, 1998, CURR OPIN CELL BIOL, V10, P784, DOI 10.1016/S0955-0674(98)80122-1; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Pihlgren M, 1996, J EXP MED, V184, P2141, DOI 10.1084/jem.184.6.2141; PROVVEDINI DM, 1983, SCIENCE, V221, P1181, DOI 10.1126/science.6310748; Qi XM, 2002, J BIOL CHEM, V277, P25884, DOI 10.1074/jbc.M203039200; ROBINSON AT, 1993, EUR J IMMUNOL, V23, P61, DOI 10.1002/eji.1830230111; SAGERSTROM CG, 1993, P NATL ACAD SCI USA, V90, P8987, DOI 10.1073/pnas.90.19.8987; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Salvador JM, 2005, NAT IMMUNOL, V6, P390, DOI 10.1038/ni1177; SANDERS ME, 1989, EUR J IMMUNOL, V19, P803, DOI 10.1002/eji.1830190504; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Slifka MK, 2001, NAT IMMUNOL, V2, P711, DOI 10.1038/90650; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; SREEKUMAR P, 1995, J CLIN INVEST, V96, P602, DOI 10.1172/JCI118075; TING AT, 1992, J EXP MED, V176, P1751, DOI 10.1084/jem.176.6.1751; Veldman CM, 2000, ARCH BIOCHEM BIOPHYS, V374, P334, DOI 10.1006/abbi.1999.1605; Whitmire JK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000041; Xie ZJ, 1997, J BIOL CHEM, V272, P6573, DOI 10.1074/jbc.272.10.6573; Yu SH, 2008, P NATL ACAD SCI USA, V105, P5207, DOI 10.1073/pnas.0711558105; Yu SH, 2008, P NATL ACAD SCI USA, V105, P20834, DOI 10.1073/pnas.0808700106; Zhang WG, 1999, INT IMMUNOL, V11, P943, DOI 10.1093/intimm/11.6.943; Zugel U, 2009, EXP DERMATOL, V18, P619, DOI 10.1111/j.1600-0625.2009.00845.x; Zugel U, 2002, J INVEST DERMATOL, V119, P1434, DOI 10.1046/j.1523-1747.2002.19623.x	50	377	384	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2010	11	4					344	U56		10.1038/ni.1851	http://dx.doi.org/10.1038/ni.1851			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	572RC	20208539				2022-12-18	WOS:000275849500014
J	Cinamon, G; Zachariah, MA; Lam, OM; Foss, FW; Cyster, JG				Cinamon, Guy; Zachariah, Marcus A.; Lam, Olivia M.; Foss, Frank W., Jr.; Cyster, Jason G.			Follicular shuttling of marginal zone B cells facilitates antigen transport	NATURE IMMUNOLOGY			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTOR; TUMOR-NECROSIS-FACTOR; SPLENIC WHITE PULP; IMMUNE-COMPLEXES; LYMPHOID FOLLICLES; DENDRITIC CELLS; SPHINGOSINE-1-PHOSPHATE; MICE; LOCALIZATION; CHEMOKINES	The splenic marginal zone is a site of blood flow, and the specialized B cell population that inhabits this compartment has been linked to the capture and follicular delivery of blood-borne antigens. However, the mechanism of this antigen transport has remained unknown. Here we show that marginal zone B cells were not confined to the marginal zone but continuously shuttled between the marginal zone and follicular areas, such that many of the cells visited a follicle every few hours. Migration to the follicle required the chemokine receptor CXCR5, whereas return to the marginal zone was promoted by the sphingosine 1-phosphate receptors S1P(1) and S1P(3). Treatment with an SIP, antagonist caused displacement of marginal zone B cells from the marginal zone. Marginal zone-follicle shuttling of marginal zone B cells provides an efficient mechanism for systemic antigen capture and delivery to follicular dendritic cells.	[Cinamon, Guy; Zachariah, Marcus A.; Lam, Olivia M.; Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Cinamon, Guy; Zachariah, Marcus A.; Lam, Olivia M.; Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Foss, Frank W., Jr.] Univ Virginia, Dept Chem, Charlottesville, VA 22094 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Virginia	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	jason.cyster@ucsf.edu	Foss, Frank W/Z-2824-2019; Foss, Frank/A-3318-2009	Foss, Frank W/0000-0003-1940-6580; Foss, Frank/0000-0003-1940-6580	Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R37 AI040098-11, N01AI40098, R37 AI040098-09, R37 AI040098, R37 AI040098-10, R37 AI040098-12, R37 AI040098-08] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI040098, R01AI040098] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Ansel KM, 2002, IMMUNITY, V16, P67, DOI 10.1016/S1074-7613(01)00257-6; BROWN JC, 1973, IMMUNOLOGY, V24, P955; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Ferguson AR, 2004, INT IMMUNOL, V16, P1411, DOI 10.1093/intimm/dxh142; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Foss FW, 2007, BIOORGAN MED CHEM, V15, P663, DOI 10.1016/j.bmc.2006.10.060; Girkontaite I, 2004, J EXP MED, V200, P1491, DOI 10.1084/jem.20041483; Gonzalez-Cabrera PJ, 2007, J BIOL CHEM, V282, P7254, DOI 10.1074/jbc.M610581200; GRAY D, 1984, IMMUNOLOGY, V52, P659; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; GROENEVELD PHP, 1986, IMMUNOLOGY, V58, P285; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Gunn MD, 1998, NATURE, V391, P799, DOI 10.1038/35876; Kono M, 2004, J BIOL CHEM, V279, P29367, DOI 10.1074/jbc.M403937200; KRAAL G, 1992, INT REV CYTOL, V132, P31, DOI 10.1016/S0074-7696(08)62453-5; Liu CH, 1999, MOL BIOL CELL, V10, P1179, DOI 10.1091/mbc.10.4.1179; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Lo CG, 2003, J EXP MED, V197, P353, DOI 10.1084/jem.20021569; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; MACLENNAN ICM, 1982, IMMUNOL TODAY, V3, P305, DOI 10.1016/0167-5699(82)90032-9; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Martin F, 2000, IMMUNITY, V12, P39, DOI 10.1016/S1074-7613(00)80157-0; MITCHELL J, 1971, IMMUNOLOGY, V21, P207; Molina H, 1996, P NATL ACAD SCI USA, V93, P3357, DOI 10.1073/pnas.93.8.3357; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Nolte MA, 2003, J EXP MED, V198, P505, DOI 10.1084/jem.20021801; Nolte MA, 2000, EUR J IMMUNOL, V30, P626; NOSSAL GJV, 1966, INT ARCH ALLER A IMM, V29, P368, DOI 10.1159/000229718; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pasparakis M, 2000, CELL IMMUNOL, V201, P33, DOI 10.1006/cimm.2000.1636; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Rosen H, 2007, TRENDS IMMUNOL, V28, P102, DOI 10.1016/j.it.2007.01.007; Sanchez T, 2003, J BIOL CHEM, V278, P47281, DOI 10.1074/jbc.M306896200; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Taylor PR, 2002, EUR J IMMUNOL, V32, P1888; VEERMAN AJP, 1975, CELL TISSUE RES, V161, P211, DOI 10.1007/BF00220369; Voigt I, 2000, EUR J IMMUNOL, V30, P560, DOI 10.1002/1521-4141(200002)30:2<560::AID-IMMU560>3.0.CO;2-T; Vora KA, 2005, J LEUKOCYTE BIOL, V78, P471, DOI 10.1189/jlb.0904487; Whipple EC, 2004, J IMMUNOL, V173, P2297, DOI 10.4049/jimmunol.173.4.2297; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499	48	377	386	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2008	9	1					54	62		10.1038/ni1542	http://dx.doi.org/10.1038/ni1542			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	243TS	18037889	Green Accepted			2022-12-18	WOS:000251820800011
J	Carty, M; Goodbody, R; Schroder, M; Stack, J; Moynagh, PN; Bowie, AG				Carty, Michael; Goodbody, Rory; Schroeder, Martina; Stack, Julianne; Moynagh, Paul N.; Bowie, Andrew G.			The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; DOMAIN-CONTAINING ADAPTER; DOUBLE-STRANDED-RNA; HEPATITIS-C VIRUS; CAENORHABDITIS-ELEGANS; IMMUNE-RESPONSES; RIG-I; PATHWAY; ACTIVATION; MYD88	Toll-like receptors discriminate between different pathogen-associated molecules and activate signaling cascades that lead to immune responses. The specificity of Toll-like receptor signaling occurs by means of adaptor proteins containing Toll-interleukin 1 receptor (TIR) domains. Activating functions have been assigned to four TIR adaptors: MyD88, Mal, TRIF and TRAM. Here we characterize a fifth TIR adaptor, SARM, as a negative regulator of TRIF-dependent Toll-like receptor signaling. Expression of SARM blocked gene induction `downstream' of TRIF but not of MyD88. SARM associated with TRIF, and `knockdown' of endogenous SARM expression by interfering RNA led to enhanced TRIF-dependent cytokine and chemokine induction. Thus, the fifth mammalian TIR adaptor SARM is a negative regulator of Toll-like receptor signaling.	Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland; Natl Univ Ireland Univ Coll Dublin, Conway Inst, Sch Biomol & Biomed Sci, Dublin 4, Ireland	Trinity College Dublin; University College Dublin	Bowie, AG (corresponding author), Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland.	agbowie@tcd.ie	Schroder, Martina/E-5493-2010; Carty, Michael/AAG-1249-2022; Carty, Michael/AFK-2889-2022	Bowie, Andrew/0000-0001-5316-4373; Carty, Michael/0000-0003-1588-7479; Schroeder, Martina/0000-0003-1899-6048; Moynagh, Paul/0000-0002-4139-3061				Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Chuang CF, 2005, GENE DEV, V19, P270, DOI 10.1101/gad.1276505; Clemens MJ, 1997, INT J BIOCHEM CELL B, V29, P945, DOI 10.1016/S1357-2725(96)00169-0; Couillault C, 2004, NAT IMMUNOL, V5, P488, DOI 10.1038/ni1060; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Kariko K, 2004, CELLS TISSUES ORGANS, V177, P132, DOI 10.1159/000079987; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kim CA, 2003, TRENDS BIOCHEM SCI, V28, P625, DOI 10.1016/j.tibs.2003.11.001; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Liberati NT, 2004, P NATL ACAD SCI USA, V101, P6593, DOI 10.1073/pnas.0308625101; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; McGettrick AF, 2004, MOL IMMUNOL, V41, P577, DOI 10.1016/j.molimm.2004.04.006; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Mink M, 2001, GENOMICS, V74, P234, DOI 10.1006/geno.2001.6548; Moynagh PN, 2005, TRENDS IMMUNOL, V26, P469, DOI 10.1016/j.it.2005.06.009; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; O'Neill LAJ, 2003, TRENDS IMMUNOL, V24, P287, DOI 10.1016/S1471-4906(03)00115-7; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; Weighardt H, 2004, EUR J IMMUNOL, V34, P558, DOI 10.1002/eji.200324714; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	35	377	406	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2006	7	10					1074	1081		10.1038/ni1382	http://dx.doi.org/10.1038/ni1382			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HE	16964262	Green Accepted, Green Submitted, Bronze, Green Published			2022-12-18	WOS:000241437100013
J	Li, JH; Liu, KC; Liu, Y; Xu, Y; Zhang, F; Yang, HJ; Liu, JX; Pan, TT; Chen, JL; Wu, M; Zhou, XH; Yuan, ZH				Li, Jianhua; Liu, Kuancheng; Liu, Yang; Xu, Yan; Zhang, Fei; Yang, Huijuan; Liu, Jiangxia; Pan, Tingting; Chen, Jieliang; Wu, Min; Zhou, Xiaohui; Yuan, Zhenghong			Exosomes mediate the cell-to-cell transmission of IFN-alpha-induced antiviral activity	NATURE IMMUNOLOGY			English	Article							HEPATITIS-B-VIRUS; INTERFERON-INDUCED TRANSFER; DENDRITIC CELLS; INTERCELLULAR COMMUNICATION; VIRAL RESISTANCE; INNATE IMMUNITY; INFECTED-CELLS; CHIMERIC MICE; TUMOR-GROWTH; C VIRUS	The cell-to-cell transmission of viral resistance is a potential mechanism for amplifying the interferon-induced antiviral response. In this study, we report that interferon-alpha (IFN-alpha) induced the transfer of resistance to hepatitis B virus (HBV) from nonpermissive liver nonparenchymal cells (LNPCs) to permissive hepatocytes via exosomes. Exosomes from IFN-alpha-treated LNPCs were rich in molecules with antiviral activity. Moreover, exosomes from LNPCs were internalized by hepatocytes, which mediated the intercellular transfer of antiviral molecules. Finally, we found that exosomes also contributed to the antiviral response of IFN-alpha to mouse hepatitis virus A59 and adenovirus in mice. Thus, we propose an antiviral mechanism of IFN-alpha activity that involves the induction and intercellular transfer of antiviral molecules via exosomes.	[Li, Jianhua; Liu, Kuancheng; Liu, Yang; Xu, Yan; Zhang, Fei; Yang, Huijuan; Liu, Jiangxia; Pan, Tingting; Chen, Jieliang; Yuan, Zhenghong] Fudan Univ, Sch Basic Med Sci, Shanghai Med Coll, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Wu, Min; Yuan, Zhenghong] Fudan Univ, Res Unit, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China; [Zhou, Xiaohui] Fudan Univ, Ctr Lab Anim, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Yuan, ZH (corresponding author), Fudan Univ, Sch Basic Med Sci, Shanghai Med Coll, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China.	zhyuan@shaphc.org	Zhang, Fei/AAY-2674-2020	Li, Jianhua/0000-0001-7329-5688	National Key Basic Research Program of China [2012CB519000]; National Megaprojects of China for Infectious Diseases [2012ZX10002007-001]; German Research Foundation [SFB/Transregio TRR60]; National Natural Science Foundation of China [31200129]; China Postdoctoral Science Foundation [201104232]	National Key Basic Research Program of China(National Basic Research Program of China); National Megaprojects of China for Infectious Diseases; German Research Foundation(German Research Foundation (DFG)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	We thank C. Dong, N. Weng, J. Guo, J. Hu, S. Zhou and Q. Cai for suggestions and critical reading of the manuscript. Supported by the National Key Basic Research Program of China (2012CB519000 to Z. Y.), the National Megaprojects of China for Infectious Diseases (2012ZX10002007-001 to Z. Y.), the German Research Foundation (SFB/Transregio TRR60 to Z. Y.), the National Natural Science Foundation of China (31200129 to J. Li) and the China Postdoctoral Science Foundation (201104232 to J. Li).	AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Bianco F, 2009, EMBO J, V28, P1043, DOI 10.1038/emboj.2009.45; BLALOCK JE, 1977, NATURE, V269, P422, DOI 10.1038/269422a0; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Chang JH, 2012, ANTIVIR RES, V96, P405, DOI 10.1016/j.antiviral.2012.10.001; Chen JL, 2013, HEPATOLOGY, V57, P470, DOI 10.1002/hep.26064; Chevaliez Stephane, 2009, V189, P203, DOI 10.1007/978-3-540-79086-0_8; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Dreux M, 2012, CELL HOST MICROBE, V12, P558, DOI 10.1016/j.chom.2012.08.010; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Fadel BM, 1999, J BIOL CHEM, V274, P20376, DOI 10.1074/jbc.274.29.20376; Gao B, 2008, HEPATOLOGY, V47, P729, DOI 10.1002/hep.22034; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Hiraga N, 2009, J HEPATOL, V51, P1046, DOI 10.1016/j.jhep.2009.09.002; Ishibashi H, 2009, SEMIN IMMUNOPATHOL, V31, P399, DOI 10.1007/s00281-009-0155-6; Ke BB, 2010, MOL THER, V18, P1019, DOI 10.1038/mt.2009.285; Keller S, 2009, CANCER LETT, V278, P73, DOI 10.1016/j.canlet.2008.12.028; Khatua AK, 2009, J VIROL, V83, P512, DOI 10.1128/JVI.01658-08; Kock J, 2008, J GEN VIROL, V89, P1184, DOI 10.1099/vir.0.83507-0; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kwon H, 2011, NAT REV GASTRO HEPAT, V8, P275, DOI 10.1038/nrgastro.2011.33; Li JH, 2010, J VIROL, V84, P6387, DOI 10.1128/JVI.00236-10; Liu W, 2011, PROTEOMICS, V11, P3556, DOI 10.1002/pmic.201100157; Lutgehetmann M, 2011, GASTROENTEROLOGY, V140, P2074, DOI 10.1053/j.gastro.2011.02.057; Mao RC, 2011, J VIROL, V85, P1048, DOI 10.1128/JVI.01998-10; Meckes DG, 2011, J VIROL, V85, P12844, DOI 10.1128/JVI.05853-11; Meckes DG, 2010, P NATL ACAD SCI USA, V107, P20370, DOI 10.1073/pnas.1014194107; Mittelbrunn M, 2012, NAT REV MOL CELL BIO, V13, P328, DOI 10.1038/nrm3335; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; MOZES LW, 1982, VIROLOGY, V116, P359, DOI 10.1016/0042-6822(82)90428-7; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Park IH, 2011, MOL CELLS, V32, P167, DOI 10.1007/s10059-011-1059-6; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; PINKERT CA, 1987, GENE DEV, V1, P268, DOI 10.1101/gad.1.3.268; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Takahashi K, 2010, P NATL ACAD SCI USA, V107, P7431, DOI 10.1073/pnas.1002301107; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Weiss SR, 2005, MICROBIOL MOL BIOL R, V69, P635, DOI 10.1128/MMBR.69.4.635-664.2005; Wu M, 2007, J GEN VIROL, V88, P3260, DOI 10.1099/vir.0.82959-0; Xi WJ, 2011, MOL IMMUNOL, V48, P1203, DOI 10.1016/j.molimm.2011.03.002; Yang PL, 2002, P NATL ACAD SCI USA, V99, P13825, DOI 10.1073/pnas.202398599; ZHANG DE, 1994, MOL CELL BIOL, V14, P373, DOI 10.1128/MCB.14.1.373; Zhang JD, 1999, J CELL BIOL, V145, P99, DOI 10.1083/jcb.145.1.99	52	374	403	3	107	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2013	14	8					793	+		10.1038/ni.2647	http://dx.doi.org/10.1038/ni.2647			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185ZN	23832071				2022-12-18	WOS:000322010600008
J	Djuretic, IM; Levanon, D; Negreanu, V; Groner, Y; Rao, A; Ansel, KM				Djuretic, Ivana M.; Levanon, Ditsa; Negreanu, Varda; Groner, Yoram; Rao, Anjana; Ansel, K. Mark			Transcription factors T-bet and Runx3 cooperate to activate lfng and silence ll4 in T helper type 1 cells	NATURE IMMUNOLOGY			English	Article							TH2 CYTOKINE LOCUS; IL-4 GENE; ENHANCER ACTIVITY; CUTTING EDGE; EXPRESSION; CHROMATIN; DIFFERENTIATION; CD4; REPRESSION; T-HELPER-1	Cell differentiation involves activation and silencing of lineage-specific genes. Here we show that the transcription factor Runx3 is induced in T helper type 1 (T(H)1) cells in a T-bet-dependent manner, and that both transcription factors T-bet and Runx3 are required for maximal production of interferon-gamma (IFN-gamma) and silencing of the gene encoding interleukin 4 (Il4) in T(H)1 cells. T-bet does not repress Il4 in Runx3- deficient T(H)2 cells, but coexpression of Runx3 and T-bet induces potent repression in those cells. Both T-bet and Runx3 bind to the Ifng promoter and the Il4 silencer, and deletion of the silencer decreases the sensitivity of Il4 to repression by either factor. Our data indicate that cytokine gene expression in TH1 cells may be controlled by a feed-forward regulatory circuit in which T-bet induces Runx3 and then 'partners' with Runx3 to direct lineage-specific gene activation and silencing.	Harvard Univ, Sch Med, Boston, MA 02115 USA; CBR, Biomed Res Inst, Boston, MA 02115 USA; Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Weizmann Institute of Science	Ansel, KM (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	arao@cbr.med.harvard.edu; ansel@cbr.med.harvard.edu			NHLBI NIH HHS [HL67664] Funding Source: Medline; NIAID NIH HHS [AI144432] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL067664, P01HL067664] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Ansel KM, 2004, NAT IMMUNOL, V5, P1251, DOI 10.1038/ni1135; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Baguet A, 2004, P NATL ACAD SCI USA, V101, P11410, DOI 10.1073/pnas.0403334101; Ben Aziz-Aloya R, 1998, CELL DEATH DIFFER, V5, P765, DOI 10.1038/sj.cdd.4400415; Berenson LS, 2004, IMMUNOL REV, V202, P157, DOI 10.1111/j.0105-2896.2004.00208.x; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Brenner O, 2004, P NATL ACAD SCI USA, V101, P16016, DOI 10.1073/pnas.0407180101; Cho JY, 2003, INT IMMUNOL, V15, P1149, DOI 10.1093/intimm/dxg113; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; DAVIDSON EH, 2001, GENOMIC REGULATORY D; de Bruijn MFTR, 2004, ONCOGENE, V23, P4238, DOI 10.1038/sj.onc.1207763; Durst KL, 2004, ONCOGENE, V23, P4220, DOI 10.1038/sj.onc.1207122; Fainaru O, 2005, P NATL ACAD SCI USA, V102, P10598, DOI 10.1073/pnas.0504787102; Fainaru O, 2004, EMBO J, V23, P969, DOI 10.1038/sj.emboj.7600085; Fields PE, 2004, IMMUNITY, V21, P865, DOI 10.1016/j.immuni.2004.10.015; Finotto S, 2002, SCIENCE, V295, P336, DOI 10.1126/science.1065544; Grogan JL, 2003, J IMMUNOL, V171, P6672, DOI 10.4049/jimmunol.171.12.6672; Grueter B, 2005, J IMMUNOL, V175, P1694, DOI 10.4049/jimmunol.175.3.1694; Hutchins AS, 2005, J IMMUNOL, V175, P5606, DOI 10.4049/jimmunol.175.9.5606; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Komine O, 2003, J EXP MED, V198, P51, DOI 10.1084/jem.20021200; Le XF, 1999, J BIOL CHEM, V274, P21651, DOI 10.1074/jbc.274.31.21651; Lee DU, 2004, P NATL ACAD SCI USA, V101, P16010, DOI 10.1073/pnas.0407031101; Lee DU, 2004, J BIOL CHEM, V279, P4802, DOI 10.1074/jbc.M307904200; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; Lee J, 2004, ONCOGENE, V23, P4346, DOI 10.1038/sj.onc.1207669; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Levanon D, 2004, ONCOGENE, V23, P4211, DOI 10.1038/sj.onc.1207670; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; Medina KL, 2004, DEV CELL, V7, P607, DOI 10.1016/j.devcel.2004.08.006; Mohrs M, 2001, NAT IMMUNOL, V2, P842, DOI 10.1038/ni0901-842; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Nardone J, 2004, NAT IMMUNOL, V5, P768, DOI 10.1038/ni0804-768; Ranganath S, 1998, J IMMUNOL, V161, P3822; Reiner SL, 2005, HUM MOL GENET, V14, pR41, DOI 10.1093/hmg/ddi115; Sato T, 2005, IMMUNITY, V22, P317, DOI 10.1016/j.immuni.2005.01.012; Shnyreva M, 2004, P NATL ACAD SCI USA, V101, P12622, DOI 10.1073/pnas.0400849101; Solymar DC, 2002, IMMUNITY, V17, P41, DOI 10.1016/S1074-7613(02)00334-5; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Stetson DB, 2004, ADV IMMUNOL, V83, P163; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981; Tanaka S, 2006, IMMUNITY, V24, P689, DOI 10.1016/j.immuni.2006.04.009; Taniuchi I, 2004, ONCOGENE, V23, P4341, DOI 10.1038/sj.onc.1207671; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; Westendorf JJ, 1999, J CELL BIOCHEM, P51; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Yarmus M, 2006, P NATL ACAD SCI USA, V103, P7384, DOI 10.1073/pnas.0602470103; Zheng WP, 2004, J IMMUNOL, V172, P114, DOI 10.4049/jimmunol.172.1.114; Zhong JA, 2006, NEURON, V49, P325, DOI 10.1016/j.neuron.2006.01.013	57	374	384	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2007	8	2					145	153		10.1038/ni1424	http://dx.doi.org/10.1038/ni1424			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	127PA	17195845				2022-12-18	WOS:000243597600011
J	Afonina, IS; Zhong, ZY; Karin, M; Beyaert, R				Afonina, Inna S.; Zhong, Zhenyu; Karin, Michael; Beyaert, Rudi			Limiting inflammation-the negative regulation of NF-kappa B and the NLRP3 inflammasome	NATURE IMMUNOLOGY			English	Review							ONSET AUTOINFLAMMATORY DISEASE; INNATE IMMUNE-RESPONSES; SPATA2 LINKS CYLD; CELL-DEATH; IRAK-M; DEUBIQUITINATING ENZYME; SYSTEMIC INFLAMMATION; MESSENGER-RNAS; I INTERFERON; TNF-ALPHA	A properly mounted immune response is indispensable for recognizing and eliminating danger arising from foreign invaders and tissue trauma. However, the 'inflammatory fire' kindled by the host response must be tightly controlled to prevent it from spreading and causing irreparable damage. Accordingly, acute inflammation is self-limiting and is normally attenuated after elimination of noxious stimuli, restoration of homeostasis and initiation of tissue repair. However, unresolved inflammation may lead to the development of chronic autoimmune and degenerative diseases and cancer. Here, we discuss the key molecular mechanisms that contribute to the self-limiting nature of inflammatory signaling, with emphasis on the negative regulation of the NF-kappa B pathway and the NLRP3 inflammasome. Understanding these negative regulatory mechanisms should facilitate the development of much-needed therapeutic strategies for treatment of inflammatory and autoimmune pathologies.	[Afonina, Inna S.; Beyaert, Rudi] VIB, Unit Mol Signal Transduct Inflammat, Ctr Inflammat Res, Ghent, Belgium; [Afonina, Inna S.; Beyaert, Rudi] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium; [Zhong, Zhenyu; Karin, Michael] Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, Sch Med, La Jolla, CA 92093 USA; [Zhong, Zhenyu; Karin, Michael] Univ Calif San Diego, Dept Pathol, Sch Med, La Jolla, CA 92093 USA	Flanders Institute for Biotechnology (VIB); Ghent University; University of California System; University of California San Diego; University of California System; University of California San Diego	Beyaert, R (corresponding author), VIB, Unit Mol Signal Transduct Inflammat, Ctr Inflammat Res, Ghent, Belgium.; Beyaert, R (corresponding author), Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium.	rudi.beyaert@irc.vib-ugent.be	Beyaert, Rudi/B-2589-2009; Afonina, Inna/AAM-8978-2020	Afonina, Inna/0000-0001-8894-5305; Beyaert, Rudi/0000-0002-5704-582X; Zhong, Zhenyu/0000-0002-9441-7645	VIB; Fund for Scientific Research Flanders (FWO); Foundation Against Cancer; Ghent University (Concerted Research Actions, GOA); FWO postdoctoral fellowship; FWO research grant; Cancer Research Irvington Postdoctoral Fellowship; Prevent Cancer Foundation Board of Directors Award; American Association for the Study of Liver Diseases (AASLD) Pinnacle Research Award; NIH [AI043477, CA163798]; Leukemia and Lymphoma Society SCOR [20132569]; Alliance for Lupus Research [257214]	VIB; Fund for Scientific Research Flanders (FWO)(FWO); Foundation Against Cancer; Ghent University (Concerted Research Actions, GOA); FWO postdoctoral fellowship(FWO); FWO research grant(FWO); Cancer Research Irvington Postdoctoral Fellowship; Prevent Cancer Foundation Board of Directors Award; American Association for the Study of Liver Diseases (AASLD) Pinnacle Research Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society SCOR(Leukemia and Lymphoma Society); Alliance for Lupus Research	Work in the laboratory of R.B. is supported by grants from the VIB, the Fund for Scientific Research Flanders (FWO), the Foundation Against Cancer and Ghent University (Concerted Research Actions, GOA). I.S.A. is supported by an FWO postdoctoral fellowship and an FWO research grant. Z.Z. was supported by a Cancer Research Irvington Postdoctoral Fellowship, a Prevent Cancer Foundation Board of Directors Award and an American Association for the Study of Liver Diseases (AASLD) Pinnacle Research Award. Research was supported by grants from the NIH (AI043477 and CA163798) to M.K., the Leukemia and Lymphoma Society SCOR (20132569) to M.K. and the Alliance for Lupus Research (257214) to M.K., who is supported as an American Cancer Research Professor and as the Ben and Wanda Hildyard Chair for Mitochondrial and Metabolic Diseases.	Abdul-Sater AA, 2017, NAT IMMUNOL, V18, P26, DOI 10.1038/ni.3618; Afonina IS, 2016, EMBO REP, V17, P914, DOI 10.15252/embr.201642109; Afonina IS, 2015, FEBS J, V282, P3286, DOI 10.1111/febs.13325; Alves BN, 2014, J IMMUNOL, V192, P3121, DOI 10.4049/jimmunol.1302351; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Bauernfeind F, 2012, J IMMUNOL, V189, P4175, DOI 10.4049/jimmunol.1201516; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Brechmann M, 2012, IMMUNITY, V37, P697, DOI 10.1016/j.immuni.2012.07.014; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Brydges SD, 2013, J CLIN INVEST, V123, P4695, DOI 10.1172/JCI71543; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Catrysse L, 2014, TRENDS IMMUNOL, V35, P22, DOI 10.1016/j.it.2013.10.005; Coornaert B, 2008, NAT IMMUNOL, V9, P263, DOI 10.1038/ni1561; Damgaard RB, 2016, CELL, V166, P1215, DOI 10.1016/j.cell.2016.07.019; De A, 2014, EMBO REP, V15, P775, DOI 10.15252/embr.201338305; Demeyer A, 2016, TRENDS MOL MED, V22, P135, DOI 10.1016/j.molmed.2015.12.004; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; DIXIT VM, 1990, J BIOL CHEM, V265, P2973; Elliott EI, 2015, IMMUNOL REV, V265, P35, DOI 10.1111/imr.12286; Elliott PR, 2016, MOL CELL, V63, P990, DOI 10.1016/j.molcel.2016.08.001; Elliott PR, 2014, MOL CELL, V54, P335, DOI 10.1016/j.molcel.2014.03.018; Fiil BK, 2013, MOL CELL, V50, P818, DOI 10.1016/j.molcel.2013.06.004; Gantier MP, 2012, NUCLEIC ACIDS RES, V40, P8048, DOI 10.1093/nar/gks521; Garg AV, 2015, IMMUNITY, V43, P475, DOI 10.1016/j.immuni.2015.07.021; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Guarda G, 2009, NATURE, V460, P269, DOI 10.1038/nature08100; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Hardy MP, 2004, J BIOL CHEM, V279, P27699, DOI 10.1074/jbc.M403068200; Headland SE, 2015, SEMIN IMMUNOL, V27, P149, DOI 10.1016/j.smim.2015.03.014; Hu HB, 2016, CELL RES, V26, P457, DOI 10.1038/cr.2016.40; Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001; Jeltsch KM, 2014, NAT IMMUNOL, V15, P1079, DOI 10.1038/ni.3008; Jin J, 2016, NAT IMMUNOL, V17, P259, DOI 10.1038/ni.3347; Karin M, 2016, NATURE, V529, P307, DOI 10.1038/nature17039; Kathania M, 2016, NAT IMMUNOL, V17, P997, DOI 10.1038/ni.3488; Keusekotten K, 2013, CELL, V153, P1312, DOI 10.1016/j.cell.2013.05.014; Klei LR, 2016, CELL REP, V17, P221, DOI 10.1016/j.celrep.2016.08.080; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Koop A, 2011, EUR J IMMUNOL, V41, P224, DOI 10.1002/eji.201040814; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Kupka S, 2016, CELL REP, V16, P2271, DOI 10.1016/j.celrep.2016.07.086; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lin A, 2003, SEMIN CANCER BIOL, V13, P107, DOI 10.1016/S1044-579X(02)00128-1; Liu T, 2014, CELL REP, V8, P974, DOI 10.1016/j.celrep.2014.07.012; Lork M, 2017, CELL DEATH DIFFER, V24, P1172, DOI 10.1038/cdd.2017.46; Lu TT, 2013, IMMUNITY, V38, P896, DOI 10.1016/j.immuni.2013.03.008; Ma A, 2012, NAT REV IMMUNOL, V12, P774, DOI 10.1038/nri3313; Maelfait J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005410; Malcomson B, 2016, P NATL ACAD SCI USA, V113, pE3725, DOI 10.1073/pnas.1520289113; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Matmati M, 2011, NAT GENET, V43, P908, DOI 10.1038/ng.874; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mehta A, 2016, NAT REV IMMUNOL, V16, P279, DOI 10.1038/nri.2016.40; Miao RD, 2013, IMMUNOL CELL BIOL, V91, P368, DOI 10.1038/icb.2013.11; Mino T, 2015, CELL, V161, P1058, DOI 10.1016/j.cell.2015.04.029; Mishra BB, 2013, NAT IMMUNOL, V14, P52, DOI 10.1038/ni.2474; Miyata M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7062; Molle C, 2013, J EXP MED, V210, P1675, DOI 10.1084/jem.20120707; Moscat J, 2016, CELL, V167, P606, DOI 10.1016/j.cell.2016.09.030; Murphy SF, 2014, AM J PHYSIOL-GASTR L, V307, pG871, DOI 10.1152/ajpgi.00020.2014; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Netea MG, 2015, ANNU REV IMMUNOL, V33, P49, DOI 10.1146/annurev-immunol-032414-112306; Newton K, 2016, CELL DEATH DIFFER, V23, P1565, DOI 10.1038/cdd.2016.46; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; O'Shea JJ, 2015, ANNU REV MED, V66, P311, DOI 10.1146/annurev-med-051113-024537; Onizawa M, 2015, NAT IMMUNOL, V16, P618, DOI 10.1038/ni.3172; Peng BL, 2010, P NATL ACAD SCI USA, V107, P15193, DOI 10.1073/pnas.1005533107; Pratama A, 2013, IMMUNITY, V38, P669, DOI 10.1016/j.immuni.2013.01.011; Reboldi A, 2014, SCIENCE, V345, P679, DOI 10.1126/science.1254790; Rivkin E, 2013, NATURE, V498, P318, DOI 10.1038/nature12296; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Schlicher L, 2016, EMBO REP, V17, P1485, DOI 10.15252/embr.201642592; Schuijs MJ, 2015, SCIENCE, V349, P1106, DOI 10.1126/science.aac6623; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Shembade N, 2011, NAT IMMUNOL, V12, P834, DOI 10.1038/ni.2066; Shen XF, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00008; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Song LB, 2013, CELL RES, V23, P274, DOI 10.1038/cr.2012.174; Staal J, 2011, EMBO J, V30, P1742, DOI 10.1038/emboj.2011.85; Sugimoto MA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00160; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tang DL, 2012, IMMUNOL REV, V249, P158, DOI 10.1111/j.1600-065X.2012.01146.x; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Teh CE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13353; Traves PG, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.90; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Uehata T, 2013, CELL, V153, P1036, DOI 10.1016/j.cell.2013.04.034; Umemura A, 2016, CANCER CELL, V29, P935, DOI 10.1016/j.ccell.2016.04.006; Vande Walle L, 2014, NATURE, V512, P69, DOI 10.1038/nature13322; Vereecke L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6103; Verhelst K, 2012, EMBO J, V31, P3845, DOI 10.1038/emboj.2012.240; Wagner SA, 2016, EMBO J, V35, P1868, DOI 10.15252/embj.201694300; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wertz IE, 2015, NATURE, V528, P370, DOI 10.1038/nature16165; Yan YQ, 2015, CELL, V160, P62, DOI 10.1016/j.cell.2014.11.047; Zhang Q, 2017, CELL, V168, P37, DOI 10.1016/j.cell.2016.12.012; Zhao JL, 2011, P NATL ACAD SCI USA, V108, P9184, DOI 10.1073/pnas.1105398108; Zhong Z, 2016, CLIN EXP RHEUMATOL, V34, pS12; Zhong ZY, 2016, CELL, V166, P288, DOI 10.1016/j.cell.2016.05.051; Zhong ZY, 2016, CELL, V164, P896, DOI 10.1016/j.cell.2015.12.057; Zhong ZY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2608; Zhou H, 2013, EMBO J, V32, P583, DOI 10.1038/emboj.2013.2; Zhou Q, 2016, P NATL ACAD SCI USA, V113, P10127, DOI 10.1073/pnas.1612594113; Zhou Q, 2016, NAT GENET, V48, P67, DOI 10.1038/ng.3459; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou XK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4619; Zilberman-Rudenko J, 2016, P NATL ACAD SCI USA, V113, P1612, DOI 10.1073/pnas.1518163113	115	373	394	9	111	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2017	18	8					861	869		10.1038/ni.3772	http://dx.doi.org/10.1038/ni.3772			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FB0FT	28722711				2022-12-18	WOS:000405821100006
J	Grimbaldeston, MA; Nakae, S; Kalesnikoff, J; Tsai, M; Galli, SJ				Grimbaldeston, Michele A.; Nakae, Susumu; Kalesnikoff, Janet; Tsai, Mindy; Galli, Stephen J.			Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B	NATURE IMMUNOLOGY			English	Article							DELAYED-TYPE HYPERSENSITIVITY; TUMOR-NECROSIS-FACTOR; CD8(+) T-CELLS; IMMUNE-RESPONSES; DEFICIENT W/WV; IFN-GAMMA; MICE; URUSHIOL; SENSITIVITY; MECHANISMS	Allergic contact dermatitis, such as in response to poison, ivy or poison oak, and chronic low-dose ultraviolet B irradiation can damage the skin. Mast cells produce proinflammatory mediators that are thought to exacerbate these prevalent acquired immune or innate responses. Here we found that, unexpectedly, mast cells substantially limited the pathology associated with these responses, including infiltrates of leukocytes, epidermal hyperplasia and epidermal necrosis. Production of interleukin 10 by mast cells contributed to the anti-inflammatory or immunosuppressive effects of mast cells in these conditions. Our findings identify a previously unrecognized function for mast cells and mast cell-derived interleukin 10 in limiting leukocyte infiltration, inflammation and tissue damage associated with immunological or innate responses that can injure the skin.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University; Stanford University	Galli, SJ (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	sgalli@stanford.edu		Tsai, Mindy/0000-0002-8421-4721				Alard P, 1999, J INVEST DERMATOL, V113, P983, DOI 10.1046/j.1523-1747.1999.00772.x; ASKENASE PW, 1983, J IMMUNOL, V131, P2687; Atochina O, 2001, J IMMUNOL, V167, P4293, DOI 10.4049/jimmunol.167.8.4293; BARKER JNWN, 1991, LANCET, V337, P211, DOI 10.1016/0140-6736(91)92168-2; Belsito DV, 2003, FITZPATRICKS DERMATO, V6th, P1164; Biedermann T, 2000, J EXP MED, V192, P1441, DOI 10.1084/jem.192.10.1441; BOUR H, 1995, EUR J IMMUNOL, V25, P3006, DOI 10.1002/eji.1830251103; Bryce PJ, 2004, IMMUNITY, V20, P381, DOI 10.1016/S1074-7613(04)00080-9; Buxbaum LU, 2005, INFECT IMMUN, V73, P2101, DOI 10.1128/IAI.73.4.2101-2108.2005; CHERVENI.PA, 1969, J CELL PHYSIOL, V73, P25, DOI 10.1002/jcp.1040730104; Chong RKY, 2003, REC RES DEV BIOMECH, V1, P65; Depinay N, 2006, J IMMUNOL, V176, P4141, DOI 10.4049/jimmunol.176.7.4141; DOMBROWICZ D, 1993, CELL, V75, P969, DOI 10.1016/0092-8674(93)90540-7; DUNN IS, 1987, J INVEST DERMATOL, V89, P296, DOI 10.1111/1523-1747.ep12471534; Fecho K, 1998, J LEUKOCYTE BIOL, V64, P373, DOI 10.1002/jlb.64.3.373; Firer MA, 2003, LEUKEMIA LYMPHOMA, V44, P681, DOI 10.1080/1042819031000063381; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; GALLI SJ, 1987, AM J PATHOL, V127, P191; GALLI SJ, 1994, ADV IMMUNOL, V55, P1; GALLI SJ, 1984, SCIENCE, V226, P710, DOI 10.1126/science.6494907; Gonzalez S, 1999, PHOTOCHEM PHOTOBIOL, V70, P248, DOI 10.1562/0031-8655(1999)070<0248:CPISOM>2.3.CO;2; Grimbaldeston MA, 2006, PHOTOCH PHOTOBIO SCI, V5, P177, DOI 10.1039/b504344a; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Groux H, 1998, J IMMUNOL, V160, P3188; Hart PH, 1998, J EXP MED, V187, P2045, DOI 10.1084/jem.187.12.2045; KALISH RS, 1990, J IMMUNOL, V145, P3706; KALISH RS, 1994, J CLIN INVEST, V93, P2039, DOI 10.1172/JCI117198; Kalish RS, 1997, J INVEST DERMATOL, V108, P253, DOI 10.1111/1523-1747.ep12286447; Kim TH, 2003, PHOTOCHEM PHOTOBIOL, V78, P37, DOI 10.1562/0031-8655(2003)078<0037:AOUHMV>2.0.CO;2; KITAMURA Y, 1978, BLOOD, V52, P447; Kligman LH, 1996, CLIN DERMATOL, V14, P183, DOI 10.1016/0738-081X(95)00154-8; LIU FT, 1980, J IMMUNOL, V124, P2728; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; MEKORI YA, 1985, J IMMUNOL, V135, P879; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Moodycliffe AM, 1996, J IMMUNOL, V157, P2891; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; NOONAN FP, 1992, IMMUNOL TODAY, V13, P250, DOI 10.1016/0167-5699(92)90005-R; Pedotti R, 2003, TRENDS IMMUNOL, V24, P479, DOI 10.1016/S1471-4906(03)00233-3; Rabe JH, 2006, J AM ACAD DERMATOL, V55, P1, DOI 10.1016/j.jaad.2005.05.010; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Rennick DM, 1997, J LEUKOCYTE BIOL, V61, P389, DOI 10.1002/jlb.61.4.389; Robbie-Ryan M, 2003, J IMMUNOL, V170, P1630, DOI 10.4049/jimmunol.170.4.1630; Schwarz A, 2002, EXP DERMATOL, V11, P9, DOI 10.1034/j.1600-0625.11.s.1.3.x; Shreedhar V, 1998, J IMMUNOL, V160, P3783; Taylor A, 2006, IMMUNOLOGY, V117, P433, DOI 10.1111/j.1365-2567.2006.02321.x; Ullrich SE, 2005, MUTAT RES-FUND MOL M, V571, P185, DOI 10.1016/j.mrfmmm.2004.06.059; Wakabayashi T, 2005, IMMUNOL CELL BIOL, V83, P18, DOI 10.1111/j.1440-1711.2005.01310.x; Walker SL, 2006, INT J DERMATOL, V45, P810, DOI 10.1111/j.1365-4632.2006.02825.x; Wang BH, 2000, J IMMUNOL, V165, P6783, DOI 10.4049/jimmunol.165.12.6783; Watanabe H, 2002, J INTERF CYTOK RES, V22, P407, DOI 10.1089/10799900252952181; Wolters PJ, 2005, CLIN EXP ALLERGY, V35, P82, DOI 10.1111/j.1365-2222.2005.02136.x; Xu H, 1996, J EXP MED, V183, P1001, DOI 10.1084/jem.183.3.1001	53	371	380	0	13	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2007	8	10					1095	1104		10.1038/ni1503	http://dx.doi.org/10.1038/ni1503			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	213UA	17767162				2022-12-18	WOS:000249691400024
J	Park, B; Brinkmann, MM; Spooner, E; Lee, CC; Kim, YM; Ploegh, HL				Park, Boyoun; Brinkmann, Melanie M.; Spooner, Eric; Lee, Clarissa C.; Kim, You-Me; Ploegh, Hidde L.			Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9	NATURE IMMUNOLOGY			English	Article							ANTIGEN PRESENTATION; PATTERN-RECOGNITION; CATHEPSIN-L; TLR9; MOLECULE; PATHWAY; FAMILY; MICE; LPS; DNA	Toll-like receptors (TLRs) activate the innate immune system in response to pathogens. Here we show that TLR9 proteolytic cleavage is a prerequisite for TLR9 signaling. Inhibition of lysosomal proteolysis rendered TLR9 inactive. The carboxy-terminal fragment of TLR9 thus generated included a portion of the TLR9 ectodomain, as well as the transmembrane and cytoplasmic domains. This cleavage fragment bound to the TLR9 ligand CpG DNA and, when expressed in Tlr9(-/-) dendritic cells, restored CpG DNA-induced cytokine production. Although cathepsin L generated the requisite TLR9 cleavage products in a cell-free in vitro system, several proteases influenced TLR9 cleavage in intact cells. Lysosomal proteolysis thus contributes to innate immunity by facilitating specific cleavage of TLR9.	[Park, Boyoun; Brinkmann, Melanie M.; Spooner, Eric; Lee, Clarissa C.; Ploegh, Hidde L.] MIT, Whitehead Inst Biomed Res, Boston, MA 02115 USA; [Kim, You-Me] Novartis Inst Biomed Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Novartis	Ploegh, HL (corresponding author), MIT, Whitehead Inst Biomed Res, Boston, MA 02115 USA.	ploegh@wi.mit.edu	Kim, You-Me/I-5553-2013	Kim, You-Me/0000-0001-8780-704X	National Institutes of Health; Novartis; Charles A. King Trust; Bank of America; Whitehead Institute for Biomedical Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057182, R01AI034893, R01AI033456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062502] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis(Novartis); Charles A. King Trust; Bank of America; Whitehead Institute for Biomedical Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G.-P. Shi(Brigham and Women's Hospital and Harvard Medical School) for the selective inhibitors of cathepsins S, L and K and for mice deficient in cathepsins K, S and L; S. Akira (Osaka University), A. Marshak-Rothstein (Boston University) and K. Kiefer (Boston University) for Tlr9<SUP>-/-</SUP> mice; S. K. Dougan and C. Schlieker for critical reading of the manuscript; and T. DiCesare for graphic design. Supported by the National Institutes of Health (H. L. P.), Novartis (H. L. P.), the Charles A. King Trust, Bank of America (M. M. B.) and the Whitehead Institute for Biomedical Research, Landon T. Clay (B. R.).	Asagiri M, 2008, SCIENCE, V319, P624, DOI 10.1126/science.1150110; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Bogyo M, 2000, CHEM BIOL, V7, P27, DOI 10.1016/S1074-5521(00)00061-2; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Felbor U, 2002, P NATL ACAD SCI USA, V99, P7883, DOI 10.1073/pnas.112632299; Greenbaum DC, 2002, CHEM BIOL, V9, P1085, DOI 10.1016/S1074-5521(02)00238-7; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Huppa JB, 1997, J EXP MED, V186, P393, DOI 10.1084/jem.186.3.393; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; KOMINAMI E, 1991, FEBS LETT, V287, P189, DOI 10.1016/0014-5793(91)80048-8; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; Lennon-Dumenil AM, 2002, CURR OPIN IMMUNOL, V14, P15, DOI 10.1016/S0952-7915(01)00293-X; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Maehr R, 2005, J IMMUNOL, V174, P7066, DOI 10.4049/jimmunol.174.11.7066; Matsumoto F, 2008, BIOCHEM BIOPH RES CO, V367, P693, DOI 10.1016/j.bbrc.2007.12.130; Nishiya T, 2005, J BIOL CHEM, V280, P37107, DOI 10.1074/jbc.M504951200; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Villadangos JA, 2000, IMMUNITY, V12, P233, DOI 10.1016/S1074-7613(00)80176-4; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yang M, 2007, NAT CELL BIOL, V9, P970, DOI 10.1038/ncb1623	39	370	380	2	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2008	9	12					1407	1414		10.1038/ni.1669	http://dx.doi.org/10.1038/ni.1669			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	372FY	18931679	Green Accepted			2022-12-18	WOS:000260888700016
J	Wilhelm, C; Hirota, K; Stieglitz, B; Van Snick, J; Tolaini, M; Lahl, K; Sparwasser, T; Helmby, H; Stockinger, B				Wilhelm, Christoph; Hirota, Keiji; Stieglitz, Benjamin; Van Snick, Jacques; Tolaini, Mauro; Lahl, Katharina; Sparwasser, Tim; Helmby, Helena; Stockinger, Brigitta			An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation	NATURE IMMUNOLOGY			English	Article							AIRWAY INFLAMMATION; T-CELLS; MAST-CELLS; EXPRESSION; CYTOKINE; INTERLEUKIN-9; PROMOTES; ANTIBODY; IMMUNITY; ASTHMA	Interleukin 9 (IL-9) is a cytokine linked to lung inflammation, but its cellular origin and function remain unclear. Here we describe a reporter mouse strain designed to map the fate of cells that have activated IL-9. We found that during papain-induced lung inflammation, IL-9 production was largely restricted to innate lymphoid cells (ILCs). IL-9 production by ILCs depended on IL-2 from adaptive immune cells and was rapidly lost in favor of other cytokines, such as IL-13 and IL-5. Blockade of IL-9 production via neutralizing antibodies resulted in much lower expression of IL-13 and IL-5, which suggested that ILCs provide the missing link between the well-established functions of IL-9 in the regulation of type 2 helper T cell cytokines and responses.	[Wilhelm, Christoph; Hirota, Keiji; Tolaini, Mauro; Stockinger, Brigitta] MRC, Natl Inst Med Res, Div Mol Immunol, Mill Hill, England; [Stieglitz, Benjamin] MRC, Natl Inst Med Res, Div Mol Struct, Mill Hill, England; [Van Snick, Jacques] Ludwig Inst Canc Res, Brussels, Belgium; [Lahl, Katharina] Stanford Univ, Dept Pathol, Lab Immunol & Vasc Biol, Sch Med, Stanford, CA 94305 USA; [Lahl, Katharina; Sparwasser, Tim] Twincore, Inst Infekt Immunol, Hannover, Germany; [Helmby, Helena] London Sch Hyg & Trop Med, London WC1, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research; Ludwig Institute for Cancer Research; Stanford University; Helmholtz Association; Helmholtz-Center for Infection Research; University of London; London School of Hygiene & Tropical Medicine	Stockinger, B (corresponding author), MRC, Natl Inst Med Res, Div Mol Immunol, Mill Hill, England.	bstocki@nimr.mrc.ac.uk	Sparwasser, Tim/AAF-7085-2019; Sparwasser, Tim D/AAA-4306-2022; Helmby, Helena/ABE-1649-2020; Lahl, Katharina/AAA-1909-2021; Stieglitz, Benjamin/AAY-4140-2020; Wilhelm, Christoph/ABE-7176-2020	Sparwasser, Tim/0000-0001-5645-902X; Helmby, Helena/0000-0003-0761-7348; Lahl, Katharina/0000-0003-4919-331X; Stieglitz, Benjamin/0000-0003-3634-6997; Wilhelm, Christoph/0000-0002-9839-0291; Stockinger, Brigitta/0000-0001-8781-336X; Hirota, Keiji/0000-0002-4737-0661	Medical Research Council UK [U117512792];  [Sonderforschungsbereich (SFB 587)]; MRC [MC_U117512792] Funding Source: UKRI; Medical Research Council [MC_U117512792] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. Wilson and A. Potocnik for advice and discussion and the Division of Biological Services for breeding and maintenance of our mouse strains. Supported by the Medical Research Council UK (U117512792) and Sonderforschungsbereich (SFB 587 to T.S. and K.L.).	Angkasekwinai P, 2010, NAT IMMUNOL, V11, P250, DOI 10.1038/ni.1846; Belyaev NN, 2010, NAT IMMUNOL, V11, P477, DOI 10.1038/ni.1869; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Cheng G, 2002, AM J RESP CRIT CARE, V166, P409, DOI 10.1164/rccm.2105079; Cho JY, 2004, J CLIN INVEST, V113, P551, DOI 10.1172/JCI200419133; Erpenbeck VJ, 2003, J ALLERGY CLIN IMMUN, V111, P1319, DOI 10.1067/mai.2003.1485; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Faulkner H, 1997, EUR J IMMUNOL, V27, P2536, DOI 10.1002/eji.1830271011; Faulkner H, 1998, INFECT IMMUN, V66, P3832, DOI 10.1128/IAI.66.8.3832-3840.1998; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Gounni AS, 2000, J ALLERGY CLIN IMMUN, V106, P460, DOI 10.1067/mai.2000.109172; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; HOUSSIAU FA, 1995, J IMMUNOL, V154, P2624; HOUSSIAU FA, 1992, J IMMUNOL, V148, P3147; Hultner L, 2000, J IMMUNOL, V164, P5556, DOI 10.4049/jimmunol.164.11.5556; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Kearley J, 2011, AM J RESP CRIT CARE, V183, P865, DOI 10.1164/rccm.200909-1462OC; Kung TT, 2001, AM J RESP CELL MOL, V25, P600, DOI 10.1165/ajrcmb.25.5.4533; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; NOVEY HS, 1979, J ALLERGY CLIN IMMUN, V63, P98, DOI 10.1016/0091-6749(79)90198-2; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Richard M, 2000, P NATL ACAD SCI USA, V97, P767, DOI 10.1073/pnas.97.2.767; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Shimbara A, 2000, J ALLERGY CLIN IMMUN, V105, P108, DOI 10.1016/S0091-6749(00)90185-4; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Stassen M, 2000, J IMMUNOL, V164, P5549, DOI 10.4049/jimmunol.164.11.5549; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Steenwinckel V, 2009, J IMMUNOL, V182, P4737, DOI 10.4049/jimmunol.0801941; Tan CY, 2010, J IMMUNOL, V185, P6795, DOI 10.4049/jimmunol.1001676; Temann UA, 2002, J CLIN INVEST, V109, P29, DOI 10.1172/JCI13696; Temann UA, 1998, J EXP MED, V188, P1307, DOI 10.1084/jem.188.7.1307; Temann UA, 2007, INT IMMUNOL, V19, P1, DOI 10.1093/intimm/dxl117; Townsend MJ, 2000, IMMUNITY, V13, P573, DOI 10.1016/S1074-7613(00)00056-X; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Wang YH, 2010, J EXP MED, V207, P2479, DOI 10.1084/jem.20101376; White B, 2009, CLIN THER, V31, P728, DOI 10.1016/j.clinthera.2009.04.019; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142	41	368	383	1	35	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2011	12	11					1071	U73		10.1038/ni.2133	http://dx.doi.org/10.1038/ni.2133			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	841GG	21983833	Green Accepted			2022-12-18	WOS:000296500100012
J	Lin, YC; Jhunjhunwala, S; Benner, C; Heinz, S; Welinder, E; Mansson, R; Sigvardsson, M; Hagman, J; Espinoza, CA; Dutkowski, J; Ideker, T; Glass, CK; Murre, C				Lin, Yin C.; Jhunjhunwala, Suchit; Benner, Christopher; Heinz, Sven; Welinder, Eva; Mansson, Robert; Sigvardsson, Mikael; Hagman, James; Espinoza, Celso A.; Dutkowski, Janusz; Ideker, Trey; Glass, Christopher K.; Murre, Cornelis			A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate	NATURE IMMUNOLOGY			English	Article							LOOP-HELIX PROTEIN; CHROMATIN SIGNATURES; COMMITMENT; EXPRESSION; PTEN; PROLIFERATION; SPECIFICATION; CYTOSCAPE; ENHANCERS; DISTINCT	It is now established that the transcription factors E2A, EBF1 and Foxo1 have critical roles in B cell development. Here we show that E2A and EBF1 bound regulatory elements present in the Foxo1 locus. E2A and EBF1, as well as E2A and Foxo1, in turn, were wired together by a vast spectrum of cis-regulatory sequences. These associations were dynamic during developmental progression. Occupancy by the E2A isoform E47 directly resulted in greater abundance, as well as a pattern of monomethylation of histone H3 at lysine 4 (H3K4) across putative enhancer regions. Finally, we divided the pro-B cell epigenome into clusters of loci with occupancy by E2A, EBF and Foxo1. From this analysis we constructed a global network consisting of transcriptional regulators, signaling and survival factors that we propose orchestrates B cell fate.	[Benner, Christopher; Heinz, Sven; Dutkowski, Janusz; Ideker, Trey; Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Lin, Yin C.; Jhunjhunwala, Suchit; Welinder, Eva; Mansson, Robert; Murre, Cornelis] Univ Calif San Diego, Dept Mol Biol, La Jolla, CA 92093 USA; [Welinder, Eva] Lund Univ, Ctr Stem Cell Biol & Cell Therapy, Lund, Sweden; [Sigvardsson, Mikael] Linkoping Univ, Dept Biomed & Surg, Linkoping, Sweden; [Hagman, James] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO USA; [Espinoza, Celso A.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Dutkowski, Janusz; Ideker, Trey] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Dutkowski, Janusz; Ideker, Trey] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Lund University; Linkoping University; National Jewish Health; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Glass, CK (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	cglass@ucsd.edu; murre@biomail.ucsd.edu	Mansson, Robert/D-4372-2014; Hagman, James/R-7013-2019; Glass, Christopher/AAI-3933-2021; Califano, Andrea/F-7239-2012; Jhunjhunwala, Suchit/GNH-2256-2022	Mansson, Robert/0000-0003-0738-0328; Hagman, James/0000-0002-5436-8455; Glass, Christopher/0000-0003-4344-3592; Jhunjhunwala, Suchit/0000-0003-3484-0588; Benner, Christopher/0000-0002-4618-0719; Lin, Yin/0000-0003-4925-5453; Heinz, Sven/0000-0002-4665-1007; Ideker, Trey/0000-0002-1708-8454; Sigvardsson, Mikael/0000-0001-8527-7276	National Institutes of Health [1F32CA130276, P01DK074868, F32HL083752, CA52599, AI05466, CA054198-20]; National Science Foundation [IIS-0803937, BIOGEM DK063491]; NATIONAL CANCER INSTITUTE [R01CA052599, R01CA054198, F32CA130276, R37CA054198, R01CA078384] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL083752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082850, R01AI054661, R01AI081878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK074868, P30DK063491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank G. Hardiman, C. Ludka, L. Edsall and Z. Ye for help with Solexa DNA sequencing; R. DePinho (Harvard Medical School) for Foxo1-deficient mice; J. Sprague and R. Sasik for microarray analysis; and members of the Murre laboratory for comments on the manuscript. Supported by the National Institutes of Health (1F32CA130276 to Y.C.L., P01DK074868 to C. B., F32HL083752 to S. H., CA52599 to C. K. G., AI05466 to J. H. and CA054198-20 to C. M.) and the National Science Foundation (IIS-0803937 to T. I. and BIOGEM DK063491 to the University of California, San Diego Core Facility).	Agata Y, 2007, IMMUNITY, V27, P871, DOI 10.1016/j.immuni.2007.11.015; Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; Anzelon AN, 2003, NAT IMMUNOL, V4, P287, DOI 10.1038/ni892; Bain G, 1997, IMMUNITY, V6, P145, DOI 10.1016/S1074-7613(00)80421-5; Bain G, 1997, MOL CELL BIOL, V17, P4782, DOI 10.1128/MCB.17.8.4782; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beck K, 2009, J EXP MED, V206, P2271, DOI 10.1084/jem.20090756; Cosgrove MS, 2007, EXPERT REV PROTEOMIC, V4, P465, DOI 10.1586/14789450.4.4.465; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Decker T, 2009, IMMUNITY, V30, P508, DOI 10.1016/j.immuni.2009.01.012; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Dias S, 2008, IMMUNITY, V29, P217, DOI 10.1016/j.immuni.2008.05.015; Engel I, 2004, EMBO J, V23, P202, DOI 10.1038/sj.emboj.7600017; Engel I, 2002, P NATL ACAD SCI USA, V99, P11322, DOI 10.1073/pnas.162373999; Hagenbeek TJ, 2004, J EXP MED, V200, P883, DOI 10.1084/jem.20040495; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Ikawa T, 2004, IMMUNITY, V20, P349, DOI 10.1016/S1074-7613(04)00049-4; Ikawa T, 2006, J EXP MED, V203, P1329, DOI 10.1084/jem.20060268; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Kee BL, 1998, J EXP MED, V188, P699, DOI 10.1084/jem.188.4.699; Liu PT, 2003, NAT IMMUNOL, V4, P525, DOI 10.1038/ni925; Llorian M, 2007, J IMMUNOL, V178, P1981, DOI 10.4049/jimmunol.178.4.1981; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Medina KL, 2004, DEV CELL, V7, P607, DOI 10.1016/j.devcel.2004.08.006; Murre C, 2009, GENE DEV, V23, P2366, DOI 10.1101/gad.1861709; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; O'Riordan M, 1999, IMMUNITY, V11, P21, DOI 10.1016/S1074-7613(00)80078-3; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Pongubala JMR, 2008, NAT IMMUNOL, V9, P203, DOI 10.1038/ni1555; Quong MW, 2004, J EXP MED, V199, P1101, DOI 10.1084/jem.20031180; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Roessler S, 2007, MOL CELL BIOL, V27, P579, DOI 10.1128/MCB.01192-06; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sayegh CE, 2003, NAT IMMUNOL, V4, P586, DOI 10.1038/ni923; Semerad CL, 2009, P NATL ACAD SCI USA, V106, P1930, DOI 10.1073/pnas.0808866106; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Suzuki A, 2003, J EXP MED, V197, P657, DOI 10.1084/jem.20021101; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Yang Q, 2008, J IMMUNOL, V181, P5885, DOI 10.4049/jimmunol.181.9.5885	43	367	371	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2010	11	7					635	U109		10.1038/ni.1891	http://dx.doi.org/10.1038/ni.1891			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612TO	20543837	Green Accepted			2022-12-18	WOS:000278926400020
J	Hao, SL; Baltimore, D				Hao, Shengli; Baltimore, David			The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules	NATURE IMMUNOLOGY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; AU-RICH ELEMENTS; EXPRESSION PROGRAMS; ALPHA; IDENTIFICATION; DISTINCT; PROTEIN; CELLS; LIPOPOLYSACCHARIDE	The inflammatory response plays out over time in a reproducible and organized way after an initiating stimulus. Here we show that genes activated in cultured mouse fibroblasts in response to the cytokine tumor necrosis factor could be categorized into roughly three groups, each with different induction kinetics. Although differences in transcription were important in determining the grouping of these genes, differences in mRNA stability also exerted a strong influence on the temporal order of gene expression, in some cases overriding that of transcriptional control elements. Transcripts of mRNA expressed early had abundant AU-rich elements in their 3' untranslated regions, whereas those expressed later had fewer. Thus, mRNA stability and transcriptional control, two intrinsic characteristics of genes, control the kinetics of gene expression induced by proinflammatory cytokines.	[Hao, Shengli; Baltimore, David] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Baltimore, D (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	baltimo@caltech.edu			National Institutes of Health [2R01GM039458]; Millard and Muriel Jacobs Genetics and Genomics Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039458] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Millard and Muriel Jacobs Genetics and Genomics Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Boldin, R. O'Connell, X. Luo and K. Taganov for comments on the manuscript, and A. Balazs (California Institute of Technology) for the plasmid pHAGE2-CMV-eGFP-W. Supported by the National Institutes of Health (2R01GM039458 to D. B.) and the Millard and Muriel Jacobs Genetics and Genomics Laboratory at California Institute of Technology (microarray analysis).	Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; BECKER S, 1987, J IMMUNOL, V139, P3703; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; BEUTLER B, 1986, SCIENCE, V232, P977, DOI 10.1126/science.3754653; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chen YL, 2006, BIOCHEM BIOPH RES CO, V346, P160, DOI 10.1016/j.bbrc.2006.05.093; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; FRANKLIN RM, 1962, COLD SPRING HARB SYM, V27, P175, DOI 10.1101/SQB.1962.027.001.019; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; HAN J, 1990, J EXP MED, V171, P465, DOI 10.1084/jem.171.2.465; Hartigan J.A., 1975, CLUSTERING ALGORITHM; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kong WY, 2007, J CELL PHYSIOL, V210, P153, DOI 10.1002/jcp.20830; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; LEE WMF, 1988, MOL CELL BIOL, V8, P5521, DOI 10.1128/MCB.8.12.5521; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Li X, 2002, J BIOL CHEM, V277, P45129, DOI 10.1074/jbc.M205165200; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; McQuibban GA, 2002, BLOOD, V100, P1160, DOI 10.1182/blood.V100.4.1160.h81602001160_1160_1167; MILLER AD, 1984, CELL, V36, P51; Morse D., 1976, MED HIST, V20, P461; NEISH AS, 1992, J EXP MED, V176, P1583, DOI 10.1084/jem.176.6.1583; ROLLINS BJ, 1991, CANCER CELL-MON REV, V3, P517; Sarojini H, 2008, J CELL BIOCHEM, V104, P1793, DOI 10.1002/jcb.21748; Sauer I, 2006, BLOOD, V107, P4790, DOI 10.1182/blood-2005-07-3058; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Schwamborn J, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-46; Shim J, 2002, MOL CELLS, V14, P323; Stramer BM, 2007, J INVEST DERMATOL, V127, P1009, DOI 10.1038/sj.jid.5700811; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Tian B, 2005, J BIOL CHEM, V280, P17435, DOI 10.1074/jbc.M500437200; Tullai JW, 2007, J BIOL CHEM, V282, P23981, DOI 10.1074/jbc.M702044200; VANDAMME J, 1992, J EXP MED, V176, P59, DOI 10.1084/jem.176.1.59; Viemann D, 2006, J LEUKOCYTE BIOL, V80, P174, DOI 10.1189/jlb.0905530; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; WILSON T, 1988, NATURE, V336, P396, DOI 10.1038/336396a0; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Zhao BT, 2003, AM J PHYSIOL-CELL PH, V284, pC1577, DOI 10.1152/ajpcell.00243.2002; ZUBIAGA AM, 1995, MOL CELL BIOL, V15, P2219	50	367	375	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2009	10	3					281	288		10.1038/ni.1699	http://dx.doi.org/10.1038/ni.1699			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	408SY	19198593	Green Accepted			2022-12-18	WOS:000263456500012
J	Seddon, B; Tomlinson, P; Zamoyska, R				Seddon, B; Tomlinson, P; Zamoyska, R			Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells	NATURE IMMUNOLOGY			English	Article							GAMMA-CHAIN; DEFICIENT MICE; IN-VIVO; SURVIVAL; NAIVE; PROLIFERATION; TCR; IL-7; PHENOTYPE; MHC	Immunological memory depends on the long-term maintenance of memory T cells. Although the factors that maintain CD8 T cell memory are well understood, those responsible for CD4 memory are not well defined. We have shown here that interleukin 7 (IL-7) was an important survival factor for CD4 memory T cells that together with T cell receptor (TCR) signals regulated homeostasis of the CD4 memory population in lymphopenic conditions and in the intact immune system. Thus, IL-7 contributes to the maintenance of all naive and memory T cell subsets, and therefore controls the overall size of the T cell pool.	Natl Inst Med Res, Div Mol Immunol, London NW7 1AA, England	MRC National Institute for Medical Research	Zamoyska, R (corresponding author), Natl Inst Med Res, Div Mol Immunol, Mill Hill, London NW7 1AA, England.			Seddon, Benedict/0000-0003-4352-3373; Zamoyska, Rose/0000-0001-9816-2638				Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; Brocker T, 1997, J EXP MED, V186, P1223, DOI 10.1084/jem.186.8.1223; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Dorfman JR, 2000, NAT IMMUNOL, V1, P329, DOI 10.1038/79783; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Gozalo-Sanmillan S, 2001, J IMMUNOL, V166, P727, DOI 10.4049/jimmunol.166.2.727; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Kassiotis G, 2002, NAT IMMUNOL, V3, P244, DOI 10.1038/ni766; Kieper WC, 1999, P NATL ACAD SCI USA, V96, P13306, DOI 10.1073/pnas.96.23.13306; Kieper WC, 2002, J EXP MED, V195, P1533, DOI 10.1084/jem.20020067; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Lantz O, 2000, NAT IMMUNOL, V1, P54, DOI 10.1038/76917; Legname G, 2000, IMMUNITY, V12, P537, DOI 10.1016/S1074-7613(00)80205-8; Maraskovsky E, 1996, J IMMUNOL, V157, P5315; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Nakajima H, 1997, J EXP MED, V185, P189, DOI 10.1084/jem.185.2.189; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898; Rooke R, 1997, IMMUNITY, V7, P123, DOI 10.1016/S1074-7613(00)80515-4; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Seddon B, 2000, SCIENCE, V290, P127, DOI 10.1126/science.290.5489.127; Seddon B, 2002, J IMMUNOL, V169, P3752, DOI 10.4049/jimmunol.169.7.3752; Seddon B, 2002, J IMMUNOL, V169, P2997, DOI 10.4049/jimmunol.169.6.2997; SPRENT J, 1994, CELL, V76, P315, DOI 10.1016/0092-8674(94)90338-7; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; SWAIN SL, 1991, IMMUNOL REV, V123, P115, DOI 10.1111/j.1600-065X.1991.tb00608.x; Swanson BJ, 2002, IMMUNITY, V17, P605, DOI 10.1016/S1074-7613(02)00456-9; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; THOMIS DC, 1995, SCIENCE, V270, P794, DOI 10.1126/science.270.5237.794; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Viret C, 1999, IMMUNITY, V10, P559, DOI 10.1016/S1074-7613(00)80055-2; Vivien L, 2001, INT IMMUNOL, V13, P763, DOI 10.1093/intimm/13.6.763; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Witherden D, 2000, J EXP MED, V191, P355, DOI 10.1084/jem.191.2.355; Zhang ZP, 1998, CHINESE PHYS LETT, V15, P591, DOI 10.1088/0256-307X/15/8/017	41	367	381	1	8	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2003	4	7					680	686		10.1038/ni946	http://dx.doi.org/10.1038/ni946			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	697PN	12808452				2022-12-18	WOS:000183952500016
J	Koyasu, S				Koyasu, S			The role of PI3K in immune cells	NATURE IMMUNOLOGY			English	Review							INCREASED INSULIN SENSITIVITY; KAPPA-B ACTIVATION; FC-EPSILON-RI; PHOSPHOINOSITIDE 3-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; EMBRYONIC LETHALITY; PROTEIN-KINASE; ACTIN CYTOSKELETON; NEGATIVE REGULATOR	Members of the phosphoinositide-3 kinase (PI3K) family control several cellular responses including cell growth, survival, cytoskeletal remodeling and the trafficking of intracellular organelles in many different types of cell. In particular PI3K has important functions in the immune system. It has been difficult to evaluate the roles of distinct PI3Ks in cellular immune responses because no PI3K inhibitors are specific for individual family members and because most stimuli activate several PI3K enzymes. The development of gene-targeted mice now enables us to examine the physiological functions of individual PI3K enzymes in the immune system in vivo.	Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 1608582, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Kawaguchi 3320012, Japan	Keio University; Japan Science & Technology Agency (JST)	Koyasu, S (corresponding author), Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 1608582, Japan.	koyasu@sc.itc.keio.ac.jp	Koyasu, Shigeo/J-5583-2015	Koyasu, Shigeo/0000-0001-9585-3038				Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Andjelic S, 2000, J IMMUNOL, V165, P3860, DOI 10.4049/jimmunol.165.7.3860; Anzelon AN, 2003, NAT IMMUNOL, V4, P287, DOI 10.1038/ni892; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Ardeshna KM, 2000, BLOOD, V96, P1039, DOI 10.1182/blood.V96.3.1039.015k04_1039_1046; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; Bi L, 2002, MAMM GENOME, V13, P169, DOI 10.1007/s00335-001-2123-x; Bone H, 2001, INT IMMUNOL, V13, P807, DOI 10.1093/intimm/13.6.807; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Celli J, 2001, EMBO J, V20, P1245, DOI 10.1093/emboj/20.6.1245; Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000; Clayton E, 2002, J EXP MED, V196, P753, DOI 10.1084/jem.20020805; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Didichenko SA, 2001, J BIOL CHEM, V276, P48135, DOI 10.1074/jbc.M104610200; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Ellson CD, 2001, NAT CELL BIOL, V3, P679, DOI 10.1038/35083076; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; Fang DY, 2001, NAT IMMUNOL, V2, P870, DOI 10.1038/ni0901-870; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Frucht DM, 2001, TRENDS IMMUNOL, V22, P556, DOI 10.1016/S1471-4906(01)02005-1; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Fukao T, 2002, NAT IMMUNOL, V3, P295, DOI 10.1038/ni768; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Gibbins JM, 1998, J BIOL CHEM, V273, P34437, DOI 10.1074/jbc.273.51.34437; Gu HH, 2001, NATURE, V412, P186, DOI 10.1038/35084076; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; Harada Y, 2001, J IMMUNOL, V166, P3797, DOI 10.4049/jimmunol.166.6.3797; Harriague J, 2002, NAT IMMUNOL, V3, P1090, DOI 10.1038/ni847; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Huber M, 1998, P NATL ACAD SCI USA, V95, P11330, DOI 10.1073/pnas.95.19.11330; Ireton K, 1999, J BIOL CHEM, V274, P17025, DOI 10.1074/jbc.274.24.17025; Ishii KJ, 2002, J EXP MED, V196, P269, DOI 10.1084/jem.20020773; Jiang K, 2000, NAT IMMUNOL, V1, P419, DOI 10.1038/80859; Jones RG, 2002, J EXP MED, V196, P335, DOI 10.1084/jem.20020307; Jou ST, 2002, MOL CELL BIOL, V22, P8580, DOI 10.1128/MCB.22.24.8580-8591.2002; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Kissel H, 2000, EMBO J, V19, P1312, DOI 10.1093/emboj/19.6.1312; Kurosaki T, 2001, Int Rev Immunol, V20, P697, DOI 10.3109/08830180109045586; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; Laffargue M, 2002, IMMUNITY, V16, P441, DOI 10.1016/S1074-7613(02)00282-0; Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Liu QR, 1998, J EXP MED, V188, P1333, DOI 10.1084/jem.188.7.1333; Liu QR, 1999, GENE DEV, V13, P786, DOI 10.1101/gad.13.7.786; Lu-Kuo JM, 2000, J BIOL CHEM, V275, P6022, DOI 10.1074/jbc.275.8.6022; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Mansell A, 2001, J BIOL CHEM, V276, P43597, DOI 10.1074/jbc.M105202200; Marshall AJ, 2000, IMMUNOL REV, V176, P30; Nishida K, 2002, BLOOD, V99, P1866, DOI 10.1182/blood.V99.5.1866; Norris FA, 1998, P NATL ACAD SCI USA, V95, P14057, DOI 10.1073/pnas.95.24.14057; Okada T, 2000, IMMUNITY, V13, P817, DOI 10.1016/S1074-7613(00)00079-0; Okkenhaug K, 2001, Sci STKE, V2001, ppe1; Okkenhaug K, 2002, SCIENCE, V297, P1031; Okkenhaug K, 2001, NAT IMMUNOL, V2, P325, DOI 10.1038/86327; Ono M, 1997, CELL, V90, P293, DOI 10.1016/S0092-8674(00)80337-2; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Pappu R, 1999, SCIENCE, V286, P1949, DOI 10.1126/science.286.5446.1949; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Satterthwaite AB, 1998, SEMIN IMMUNOL, V10, P309, DOI 10.1006/smim.1998.0123; Siddhanta U, 1998, J CELL BIOL, V143, P1647, DOI 10.1083/jcb.143.6.1647; Suzuki A, 2003, J EXP MED, V197, P657, DOI 10.1084/jem.20021101; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Suzuki H, 2003, NAT IMMUNOL, V4, P280, DOI 10.1038/ni890; Suzuki H, 1999, SCIENCE, V283, P390, DOI 10.1126/science.283.5400.390; Tedford K, 2001, NAT IMMUNOL, V2, P548, DOI 10.1038/88756; Terauchi Y, 1999, NAT GENET, V21, P230, DOI 10.1038/6023; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.iy.13.040195.001343; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; Ueki K, 2002, P NATL ACAD SCI USA, V99, P419, DOI 10.1073/pnas.012581799; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Wang Y, 2002, IMMUNITY, V17, P501, DOI 10.1016/S1074-7613(02)00426-0; Ward SG, 2001, CURR OPIN IMMUNOL, V13, P332, DOI 10.1016/S0952-7915(00)00223-5; Wymann MP, 1998, BBA-MOL CELL BIOL L, V1436, P127, DOI 10.1016/S0005-2760(98)00139-8	87	367	384	1	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2003	4	4					313	319		10.1038/ni0403-313	http://dx.doi.org/10.1038/ni0403-313			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	663CG	12660731				2022-12-18	WOS:000181987700009
J	Schenkel, AR; Mamdouh, Z; Chen, X; Liebman, RM; Muller, WA				Schenkel, AR; Mamdouh, Z; Chen, X; Liebman, RM; Muller, WA			CD99 plays a major role in the migration of monocytes through endothelial junctions	NATURE IMMUNOLOGY			English	Article							CELL-ADHESION MOLECULE-1; MIC2 GENE-PRODUCT; TRANSENDOTHELIAL MIGRATION; IN-VIVO; NEUTROPHIL RECRUITMENT; REPERFUSION INJURY; CYTOPLASMIC DOMAIN; FLOW CONDITIONS; PECAM-1; CLONING	CD99 is a heavily O-glycosylated 32-kD type I transmembrane protein that is expressed on most hematopoietic cells. We show here that CD99 is expressed on endothelial cells and is concentrated at the borders between confluent cells. We found that a monoclonal antibody to CD99, hec2, selectively inhibited diapedesis of monocytes across endothelial cells by >90%. Diapedesis involved the homophilic interaction of CD99 on monocytes with CD99 on endothelial junctions. CD99 functioned distally to the point at which platelet-endothelial cell adhesion molecule 1 (PECAM-1, also known as CD31), another adhesion molecule involved in transmigration, played its critical role. Confocal microscopy showed that anti-PECAM-1 arrested leukocytes on the apical surface of endothelium, whereas blocking CD99 arrested monocytes at a point where they were partially through the junction. Therefore, diapedesis, the forward migration of leukocytes through endothelial junctions, is regulated sequentially by two distinct molecules, PECAM-1 and CD99.	Cornell Univ, Weill Med Coll, Dept Pathol, New York, NY 10021 USA	Cornell University	Muller, WA (corresponding author), Cornell Univ, Weill Med Coll, Dept Pathol, 1300 York Ave, New York, NY 10021 USA.	wamuller@med.cornell.edu	Schenkel, Alan/G-1880-2017	Schenkel, Alan/0000-0002-1603-5713	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064744, F32HL010311, R01HL046849] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL46849, F32 HL10311, R01 HL64744] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ali J, 1997, MICROCIRCULATION-LON, V4, P267, DOI 10.3109/10739689709146790; Allport JR, 2000, J CELL BIOL, V148, P203, DOI 10.1083/jcb.148.1.203; AUBRIT F, 1989, EUR J IMMUNOL, V19, P1431, DOI 10.1002/eji.1830190813; BANTING GS, 1989, MOL IMMUNOL, V26, P181, DOI 10.1016/0161-5890(89)90100-4; Berman ME, 1996, J IMMUNOL, V156, P1515; BERNARD A, 1997, LEUCOCYTE TYPING, V6, P75; Bernard G, 2000, EUR J IMMUNOL, V30, P3061, DOI 10.1002/1521-4141(200010)30:10<3061::AID-IMMU3061>3.0.CO;2-M; Bernard G, 1997, J IMMUNOL, V158, P2543; BERNARD G, 1995, J IMMUNOL, V154, P26; Bernard G, 2001, FASEB J, V15, pA332; BOGEN S, 1994, J EXP MED, V179, P1059, DOI 10.1084/jem.179.3.1059; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Choi FY, 1998, J IMMUNOL, V161, P749; ChristofidouSolomidou M, 1997, J IMMUNOL, V158, P4872; Cinamon G, 2001, NAT IMMUNOL, V2, P515, DOI 10.1038/88710; DELISSER HM, 1993, J BIOL CHEM, V268, P16037; Duncan GS, 1999, J IMMUNOL, V162, P3022; ELLIS NA, 1994, NAT GENET, V6, P394, DOI 10.1038/ng0494-394; ELLIS NA, 1994, NAT GENET, V8, P285, DOI 10.1038/ng1194-285; GELIN C, 1989, EMBO J, V8, P3253, DOI 10.1002/j.1460-2075.1989.tb08485.x; Gumina RJ, 1996, CIRCULATION, V94, P3327, DOI 10.1161/01.CIR.94.12.3327; Hahn JH, 1997, J IMMUNOL, V159, P2250; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; JAFFE SH, 1990, P NATL ACAD SCI USA, V87, P3589, DOI 10.1073/pnas.87.9.3589; Kitayama J, 2000, CELL IMMUNOL, V203, P39, DOI 10.1006/cimm.2000.1671; Liao F, 1999, J IMMUNOL, V163, P5640; LIAO F, 1995, J EXP MED, V182, P1337, DOI 10.1084/jem.182.5.1337; Liao F, 1997, J EXP MED, V185, P1349, DOI 10.1084/jem.185.7.1349; Mishell B.B., 1980, SELECTED METHODS CEL; MULLER WA, 1992, J EXP MED, V176, P819, DOI 10.1084/jem.176.3.819; MULLER WA, 1992, J EXP MED, V175, P1401, DOI 10.1084/jem.175.5.1401; MULLER WA, 1993, J EXP MED, V178, P449, DOI 10.1084/jem.178.2.449; MULLER WA, 1989, J EXP MED, V170, P399, DOI 10.1084/jem.170.2.399; Muller WA, 1999, INFLAMMATION BASIC P, P585; Mullin M.M., 1975, Marine Sci Commun, V1, P1; Murohara T, 1996, J IMMUNOL, V156, P3550; NAGAFUCHI A, 1988, EMBO J, V7, P3679, DOI 10.1002/j.1460-2075.1988.tb03249.x; NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; RANDOLPH GJ, 1995, J IMMUNOL, V155, P3610; SMITH CW, 1991, J CLIN INVEST, V87, P609, DOI 10.1172/JCI115037; Sobocka MB, 2000, BLOOD, V95, P2600; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Sun J, 1996, J BIOL CHEM, V271, P18561, DOI 10.1074/jbc.271.31.18561; VAPORCIYAN AA, 1993, SCIENCE, V262, P1580, DOI 10.1126/science.8248808; Waclavicek M, 1998, J IMMUNOL, V161, P4671; Wingett D, 1999, CELL IMMUNOL, V193, P17, DOI 10.1006/cimm.1999.1470; XIE Y, 1993, P NATL ACAD SCI USA, V90, P5569, DOI 10.1073/pnas.90.12.5569; ZIMMERMAN GA, 1990, J CELL BIOL, V110, P529, DOI 10.1083/jcb.110.2.529	50	367	382	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2002	3	2					143	150		10.1038/ni749	http://dx.doi.org/10.1038/ni749			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	516PJ	11812991				2022-12-18	WOS:000173562400014
J	Dokun, AO; Kim, S; Smith, HRC; Kang, HSP; Chu, DT; Yokoyama, WM				Dokun, AO; Kim, S; Smith, HRC; Kang, HSP; Chu, DT; Yokoyama, WM			Specific and nonspecific NK cell activation during virus infection	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; MURINE CYTOMEGALOVIRUS-INFECTION; T-CELL; GENE-COMPLEX; ANTIVIRAL DEFENSE; IN-VIVO; MICE; RECEPTORS; INTERFERON; INVIVO	The natural killer (NK) cell activation receptor Ly49H is required for resistance to murine cytomegalovirus (MCMV). We show here that NK cell proliferation and production of interferon-gamma (IFN-gamma) was not dependent on Ly49H expression during early MCMV infection. During a later phase of infection, however, Ly49H(+) NK cells selectively proliferated and this expansion was blocked by anti-Ly49H administration. With vaccinia virus infection, neither the early nor late phase of NK cell proliferation was selective for Ly49H(+) NK cells. These findings indicated that Ly49H(+) NK cells were specifically activated by MCMV and that MCMV infection was characterized by nonspecific and specific phases of NK cell activation in vivo.	Washington Univ, Sch Med, Howard Hughes Med Inst, Div Rheumatol,Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Howard Hughes Med Inst, Div Rheumatol,Dept Pathol & Immunol, St Louis, MO 63110 USA; CUNY Mt Sinai Sch Med, Program Mech Dis & Therapy, New York, NY 10029 USA; Washington Univ, Sch Med, Grad Program Immunol, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Washington University (WUSTL)	Yokoyama, WM (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Div Rheumatol,Dept Med, St Louis, MO 63110 USA.	yokoyama@imgate.wustl.edu						Bakker ABH, 2000, IMMUNITY, V13, P345, DOI 10.1016/S1074-7613(00)00034-0; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; BIRON CA, 1984, J LEUKOCYTE BIOL, V35, P31, DOI 10.1002/jlb.35.1.31; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; BUKOWSKI JF, 1983, J IMMUNOL, V131, P1531; Daniels KA, 2001, J EXP MED, V194, P29, DOI 10.1084/jem.194.1.29; Depatie C, 1999, INT IMMUNOL, V11, P1541, DOI 10.1093/intimm/11.9.1541; HE M, 1991, CYTOMEGALOVIRUS BIOL; HEISE MT, 1995, J VIROL, V69, P904, DOI 10.1128/JVI.69.2.904-909.1995; Idris AH, 1999, P NATL ACAD SCI USA, V96, P6330, DOI 10.1073/pnas.96.11.6330; Janeway C.A., 1999, IMMUNOBIOLOGY IMMUNE; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Lanier LL, 2000, IMMUNOL TODAY, V21, P611, DOI 10.1016/S0167-5699(00)01745-X; Lanier LL, 2000, J EXP MED, V191, P1259, DOI 10.1084/jem.191.8.1259; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/88247; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Olcese L, 1997, J IMMUNOL, V158, P5083; Orange JS, 1996, J IMMUNOL, V156, P1138; ORANGE JS, 1995, J EXP MED, V182, P1045, DOI 10.1084/jem.182.4.1045; Salazar-Mather TP, 1998, J EXP MED, V187, P1, DOI 10.1084/jem.187.1.1; SCALZO AA, 1992, J IMMUNOL, V149, P581; SCALZO AA, 1990, J EXP MED, V171, P1469, DOI 10.1084/jem.171.5.1469; Smith HRC, 2000, J EXP MED, V191, P1341, DOI 10.1084/jem.191.8.1341; Smith KM, 1998, J IMMUNOL, V161, P7; Sprent J, 2001, CURR OPIN IMMUNOL, V13, P248, DOI 10.1016/S0952-7915(00)00211-9; Takahashi M, 1996, J IMMUNOL, V156, P2436; Tay CH, 1999, J IMMUNOL, V162, P718; Tay CH, 1997, J VIROL, V71, P267, DOI 10.1128/JVI.71.1.267-275.1997; Tomasello E, 2000, IMMUNITY, V13, P355, DOI 10.1016/S1074-7613(00)00035-2; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Wang LL, 2000, J IMMUNOL, V164, P5215, DOI 10.4049/jimmunol.164.10.5215; WELSH RM, 1991, J EXP MED, V173, P1053, DOI 10.1084/jem.173.5.1053; WELSH RM, 1990, NAT IMMUN CELL GROW, V9, P112; WELSH RM, 1994, NAT IMMUN, V13, P239; WELSH RM, 1978, J EXP MED, V148, P163, DOI 10.1084/jem.148.1.163; Yokoyama W. M., 1999, FUNDAMENTAL IMMUNOLO, P575; Yokoyama WM, 1998, CURR OPIN IMMUNOL, V10, P298, DOI 10.1016/S0952-7915(98)80168-4; Yokoyama WM, 1997, BIOCHEM SOC T, V25, P691, DOI 10.1042/bst0250691; YOKOYAMA WM, 1996, WEIRS HDB EXPT IMMUN	43	367	381	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2001	2	10					951	956		10.1038/ni714	http://dx.doi.org/10.1038/ni714			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	478TM	11550009				2022-12-18	WOS:000171361500015
J	Marino, E; Richards, JL; McLeod, KH; Stanley, D; Yap, YA; Knight, J; McKenzie, C; Kranich, J; Oliveira, AC; Rossello, FJ; Krishnamurthy, B; Nefzger, CM; Macia, L; Thorburn, A; Baxter, AG; Morahan, G; Wong, LH; Polo, JM; Moore, RJ; Lockett, TJ; Clarke, JM; Topping, DL; Harrison, LC; Mackay, CR				Marino, Eliana; Richards, James L.; McLeod, Keiran H.; Stanley, Dragana; Yap, Yu Anne; Knight, Jacinta; McKenzie, Craig; Kranich, Jan; Oliveira, Ana Carolina; Rossello, Fernando J.; Krishnamurthy, Balasubramanian; Nefzger, Christian M.; Macia, Laurence; Thorburn, Alison; Baxter, Alan G.; Morahan, Grant; Wong, Lee H.; Polo, Jose M.; Moore, Robert J.; Lockett, Trevor J.; Clarke, Julie M.; Topping, David L.; Harrison, Leonard C.; Mackay, Charles R.			Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes	NATURE IMMUNOLOGY			English	Article							CHAIN FATTY-ACIDS; B-CELLS; INTESTINAL MICROBIOTA; DIETARY FIBER; NON-SELF; MICE; STARCH; PROGRESSION; HOMEOSTASIS; EXPRESSION	Gut dysbiosis might underlie the pathogenesis of type 1 diabetes. In mice of the non-obese diabetic (NOD) strain, we found that key features of disease correlated inversely with blood and fecal concentrations of the microbial metabolites acetate and butyrate. We therefore fed NOD mice specialized diets designed to release large amounts of acetate or butyrate after bacterial fermentation in the colon. Each diet provided a high degree of protection from diabetes, even when administered after breakdown of immunotolerance. Feeding mice a combined acetate-and butyrate-yielding diet provided complete protection, which suggested that acetate and butyrate might operate through distinct mechanisms. Acetate markedly decreased the frequency of autoreactive T cells in lymphoid tissues, through effects on B cells and their ability to expand populations of autoreactive T cells. A diet containing butyrate boosted the number and function of regulatory T cells, whereas acetate-and butyrate-yielding diets enhanced gut integrity and decreased serum concentration of diabetogenic cytokines such as IL-21. Medicinal foods or metabolites might represent an effective and natural approach for countering the numerous immunological defects that contribute to T cell-dependent autoimmune diseases.	[Marino, Eliana; Richards, James L.; McLeod, Keiran H.; Yap, Yu Anne; Knight, Jacinta; McKenzie, Craig; Macia, Laurence; Thorburn, Alison; Mackay, Charles R.] Monash Univ, Dept Biochem, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia; [Stanley, Dragana] Cent Queensland Univ, Sch Med & Appl Sci, Rockhampton, Qld, Australia; [Kranich, Jan] Ludwig Maximilians Univ Munchen, Inst Immunol, Munich, Germany; [Oliveira, Ana Carolina] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil; [Rossello, Fernando J.; Nefzger, Christian M.; Polo, Jose M.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Rossello, Fernando J.; Nefzger, Christian M.; Polo, Jose M.] Monash Biomed Discovery Inst, Dev & Stem Cells Program, Clayton, Vic, Australia; [Rossello, Fernando J.; Nefzger, Christian M.; Polo, Jose M.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic, Australia; [Krishnamurthy, Balasubramanian] St Vincents Inst, Islet Biol Lab, Fitzroy, Vic, Australia; [Macia, Laurence] Univ Sydney, Charles Perkins Ctr, Nutr Immunometab Node Lab, Sydney, NSW, Australia; [Macia, Laurence] Univ Sydney, Sch Med Sci, Sydney, NSW, Australia; [Baxter, Alan G.] James Cook Univ, Mol Sci, Comparat Genom Ctr, Townsville, Qld, Australia; [Morahan, Grant] Harry Perkins Inst Med Res, Nedlands, WA, Australia; [Moore, Robert J.] Monash Univ, Dept Microbiol, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia; [Moore, Robert J.] RMIT Univ, Sch Sci, Bundoora West Campus, Bundoora, Vic, Australia; [Lockett, Trevor J.] CSIRO Hlth & Biosecur, N Ryde, NSW, Australia; [Clarke, Julie M.; Topping, David L.] CSIRO Hlth & Biosecur, Adelaide, SA, Australia; [Harrison, Leonard C.] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia	Monash University; Central Queensland University; University of Munich; Universidade Federal do Rio de Janeiro; Monash University; Monash University; Australian Regenerative Medicine Institute; Monash University; St. Vincent's Institute of Medical Research; University of Sydney; University of Sydney; James Cook University; Harry Perkins Institute of Medical Research; Monash University; Royal Melbourne Institute of Technology (RMIT); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Walter & Eliza Hall Institute	Marino, E; Mackay, CR (corresponding author), Monash Univ, Dept Biochem, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia.	eliana.marino@monash.edu; charles.mackay@monash.edu	Rossello, Fernando/B-1208-2015; Macia, laurence/D-5983-2016; Morahan, Grant/T-7501-2019; Lockett, Trevor J/H-8970-2013; Mackay, Charles R/A-9673-2008; Mariño, Eliana/GPK-6544-2022; Moore, Robert J/D-8352-2011; Mariño, Eliana/C-5135-2011; Stanley, Dragana/AAC-2596-2020; Oliveira, Ana Carolina/GRF-1435-2022; Baxter, Alan G/A-1412-2010; Wong, Lee H/H-9757-2012; Clarke, Julie M/H-6762-2013; Oliveira, Ana Carolina/O-6791-2014	Rossello, Fernando/0000-0003-3885-8777; Macia, laurence/0000-0003-0835-851X; Lockett, Trevor J/0000-0002-8063-071X; Mackay, Charles R/0000-0002-6338-7340; Moore, Robert J/0000-0002-0776-5861; Mariño, Eliana/0000-0001-5371-8778; Stanley, Dragana/0000-0001-7019-4726; Baxter, Alan G/0000-0002-6960-9821; Wong, Lee H/0000-0002-4005-7330; Clarke, Julie M/0000-0003-4676-0366; Oliveira, Ana Carolina/0000-0002-0036-3720; Yap, Yu-Anne/0000-0002-2194-345X; Polo, Jose M/0000-0002-2531-778X; Kranich, Jan/0000-0002-9928-4132; Nefzger, Christian/0000-0003-4631-5633	Juvenile Diabetes Research Foundation [3-2013-94]; Diabetes Australia Research Trust [Y14M1-MARE]; Australian National Health and Medical Research Council [1016953, 606947]	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Diabetes Australia Research Trust; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	We thank S. Akira (Osaka University) for Myd88-/- mice; D.R. Powell, S. Archer, Deltagen, B. Scherer, H. Thomas, G. Jhala, L. Mason, H.Y. Goh, M. Udugama, F. Lim, Y.A. Leong, C. Ang Kim Lian, C. McKenzie and Monash Animal Services for assistance; the NIH Tetramer Facility for the IGRP and BDC2.5 tetramers; and the Monash Histology Platform of Monash University. Supported by the Juvenile Diabetes Research Foundation (3-2013-94), the Diabetes Australia Research Trust (Y14M1-MARE), and the Australian National Health and Medical Research Council (program grant 1016953 and Australia Fellowship 606947).	Amrani A, 2000, NATURE, V406, P739, DOI 10.1038/35021081; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; Brummel R, 2006, EUR J IMMUNOL, V36, P1951, DOI 10.1002/eji.200535734; BUHLMANN JE, 1995, IMMUNITY, V2, P645; Chen XF, 2012, P NATL ACAD SCI USA, V109, pE2865, DOI 10.1073/pnas.1121131109; Clarke JM, 2008, CARCINOGENESIS, V29, P2190, DOI 10.1093/carcin/bgn192; de Goffau MC, 2013, DIABETES, V62, P1238, DOI 10.2337/db12-0526; Endesfelder D, 2014, DIABETES, V63, P2006, DOI 10.2337/db13-1676; Feehily C, 2013, J APPL MICROBIOL, V114, P11, DOI 10.1111/j.1365-2672.2012.05434.x; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Kostic AD, 2015, CELL HOST MICROBE, V17, P260, DOI 10.1016/j.chom.2015.01.001; Le Leu RK, 2015, BRIT J NUTR, V114, P220, DOI 10.1017/S0007114515001750; Livanos AE, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.140, 10.1038/nmicrobiol.2016.140]; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; Macia L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7734; Marino E, 2012, DIABETES, V61, P2893, DOI 10.2337/db12-0006; Marino E, 2009, DIABETES, V58, P1568, DOI 10.2337/db08-1504; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Perry RJ, 2016, NATURE, V534, P213, DOI 10.1038/nature18309; Reddy P, 2008, J CLIN INVEST, V118, P2562, DOI 10.1172/JCI34712; Saemann MD, 2002, J LEUKOCYTE BIOL, V71, P238; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Shi GJ, 2014, J MOL ENDOCRINOL, V53, P367, DOI 10.1530/JME-14-0065; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Spolski R, 2008, P NATL ACAD SCI USA, V105, P14028, DOI 10.1073/pnas.0804358105; Sutherland APR, 2009, DIABETES, V58, P1144, DOI 10.2337/db08-0882; Tan J, 2016, CELL REP, V15, P2809, DOI 10.1016/j.celrep.2016.05.047; Thorburn AN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8320; Thorburn AN, 2014, IMMUNITY, V40, P833, DOI 10.1016/j.immuni.2014.05.014; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Turley SJ, 2005, P NATL ACAD SCI USA, V102, P17729, DOI 10.1073/pnas.0509006102; Vaarala O, 2008, DIABETES, V57, P2555, DOI 10.2337/db08-0331; van den Elsen PJ, 2004, CURR OPIN IMMUNOL, V16, P67, DOI 10.1016/j.coi.2003.11.015; Vatanen T, 2016, CELL, V165, P842, DOI 10.1016/j.cell.2016.04.007; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; White CA, 2014, J IMMUNOL, V193, P5933, DOI 10.4049/jimmunol.1401702; Zhang YX, 2013, BLOOD, V122, P2823, DOI 10.1182/blood-2013-02-481788	44	366	386	7	182	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2017	18	5					552	562		10.1038/ni.3713	http://dx.doi.org/10.1038/ni.3713			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ES2SR	28346408				2022-12-18	WOS:000399378700012
J	Wang, LC; Fuster, M; Sriramarao, P; Esko, JD				Wang, LC; Fuster, M; Sriramarao, P; Esko, JD			Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses	NATURE IMMUNOLOGY			English	Article							P-SELECTIN; LEUKOCYTE RECRUITMENT; N-SULFOTRANSFERASE; TRANSGENIC MICE; MAST-CELLS; ADHESION; BINDING; LIGANDS; GLYCOSAMINOGLYCANS; EXTRAVASATION	Here we have studied the involvement of endothelial heparan sulfate in inflammation by inactivating the enzyme N- acetyl glucosamine N- deacetylase - N- sulfotransferase- 1 in endothelial cells and leukocytes, which is required for the addition of sulfate to the heparin sulfate chains. Mutant mice developed normally but showed impaired neutrophil infiltration in various inflammation models. These effects were due to changes in heparan sulfate specifically in endothelial cells. Decreased neutrophil infiltration was partially due to altered rolling velocity correlated with weaker binding of L- selectin to endothelial cells. Chemokine transcytosis across endothelial cells and presentation on the cell surface were also reduced, resulting in decreased neutrophil firm adhesion and migration. Thus, endothelial heparan sulfate has three functions in inflammation: by acting as a ligand for L- selectin during neutrophil rolling; in chemokine transcytosis; and by binding and presenting chemokines at the lumenal surface of the endothelium.	Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, Div Pulm & Crit Care Med, San Diego, CA 92103 USA; La Jolla Inst Mol Med, Div Vasc Biol, San Diego, CA 92121 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Esko, JD (corresponding author), Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	jesko@ucsd.edu	Sawant, Kirti V/H-3778-2013	Rao, Srirama/0000-0001-9082-1029	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI050498, R29AI035796, R01AI035796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM033063, R01GM033063] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL57345, HL23594, P01 HL057345] Funding Source: Medline; NIAID NIH HHS [AI50498, R01 AI035796, AI35796] Funding Source: Medline; NIGMS NIH HHS [GM33063] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aikawa J, 2001, J BIOL CHEM, V276, P5876, DOI 10.1074/jbc.M009606200; Allport JR, 2002, J LEUKOCYTE BIOL, V71, P821; Bai XM, 1996, J BIOL CHEM, V271, P17711, DOI 10.1074/jbc.271.30.17711; BAME KJ, 1989, J BIOL CHEM, V264, P8059; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Fan GP, 2000, FEBS LETT, V467, P7, DOI 10.1016/S0014-5793(00)01111-X; Forlow SB, 2001, AM J PHYSIOL-HEART C, V280, pH634, DOI 10.1152/ajpheart.2001.280.2.H634; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Giuffre L, 1997, J CELL BIOL, V136, P945, DOI 10.1083/jcb.136.4.945; Grobe K, 2002, BBA-GEN SUBJECTS, V1573, P209, DOI 10.1016/S0304-4165(02)00386-0; GROBE K, 2005, DEVELOPMENT     0714, DOI DOI 10.1242/DEV.01935; Hayward R, 1997, J PHARMACOL EXP THER, V283, P1032; HEFFERNAN M, 1991, NUCLEIC ACIDS RES, V19, P85, DOI 10.1093/nar/19.1.85; Holmborn K, 2004, J BIOL CHEM, V279, P42355, DOI 10.1074/jbc.C400373200; Humphries DE, 1998, BIOCHEM J, V332, P303, DOI 10.1042/bj3320303; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; ISHIHARA M, 1992, ANAL BIOCHEM, V206, P400, DOI 10.1016/0003-2697(92)90385-K; Jung U, 1999, J IMMUNOL, V162, P6755; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; Kawashima H, 2003, J BIOL CHEM, V278, P13069, DOI 10.1074/jbc.M212244200; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Koenig A, 1998, J CLIN INVEST, V101, P877, DOI 10.1172/JCI1509; Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X; Lau EK, 2004, ADV PROTEIN CHEM, V68, P351; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Leppanen A, 2003, J BIOL CHEM, V278, P26391, DOI 10.1074/jbc.M303551200; Ley K, 2003, MICROCIRCULATION, V10, P289, DOI 10.1038/sj.mn.7800194; Lortat-Jacob H, 2002, P NATL ACAD SCI USA, V99, P1229, DOI 10.1073/pnas.032497699; Lowe JB, 2003, CURR OPIN CELL BIOL, V15, P531, DOI 10.1016/j.ceb.2003.08.002; Marelli-Berg FM, 2000, J IMMUNOL METHODS, V244, P205, DOI 10.1016/S0022-1759(00)00258-1; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; McEver RP, 1997, J CLIN INVEST, V100, P485, DOI 10.1172/JCI119556; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Middleton J, 2002, BLOOD, V100, P3853, DOI 10.1182/blood.V100.12.3853; NELSON RM, 1993, BLOOD, V82, P3253; NORGARDSUMNICHT K, 1995, J BIOL CHEM, V270, P12012, DOI 10.1074/jbc.270.20.12012; NORGARDSUMNICHT KE, 1993, SCIENCE, V261, P480, DOI 10.1126/science.7687382; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861; Ringvall M, 2000, J BIOL CHEM, V275, P25926, DOI 10.1074/jbc.C000359200; Robinson SD, 1999, P NATL ACAD SCI USA, V96, P11452, DOI 10.1073/pnas.96.20.11452; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; ROT A, 1993, EUR J IMMUNOL, V23, P303, DOI 10.1002/eji.1830230150; SCHNITZER JE, 1994, J BIOL CHEM, V269, P6072; Sperandio M, 2003, J EXP MED, V197, P1355, DOI 10.1084/jem.20021854; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; TEDDER TF, 1995, J EXP MED, V181, P2259, DOI 10.1084/jem.181.6.2259; Toyoda H, 1997, J CHROMATOGR B, V704, P19, DOI 10.1016/S0378-4347(97)00478-7; Tyrrell DJ, 1999, ADV PHARMACOL, V46, P151, DOI 10.1016/S1054-3589(08)60471-8; Varki A, 1997, J CLIN INVEST, V99, P158, DOI 10.1172/JCI119142; Wang LC, 2002, J CLIN INVEST, V110, P127, DOI 10.1172/JCI200214996; WIEDERMANN CJ, 1993, CURR BIOL, V3, P735, DOI 10.1016/0960-9822(93)90020-O; Xia LJ, 2002, J CLIN INVEST, V109, P939; Xie X, 2000, J BIOL CHEM, V275, P34818, DOI 10.1074/jbc.M001257200; Yoshie O, 2001, ADV IMMUNOL, V78, P57, DOI 10.1016/S0065-2776(01)78002-9	55	366	375	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2005	6	9					902	910		10.1038/ni1233	http://dx.doi.org/10.1038/ni1233			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	957KX	16056228				2022-12-18	WOS:000231369800020
J	Bruniquel, D; Schwartz, RH				Bruniquel, D; Schwartz, RH			Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process	NATURE IMMUNOLOGY			English	Article							5-METHYLCYTOSINE DNA GLYCOSYLASE; GAMMA PROMOTER DEMETHYLATION; CELL-DIFFERENTIATION; IFN-GAMMA; IN-VIVO; METHYLATION; EXPRESSION; BINDING; ACTIVATION; PROTEIN	A role for DNA demethylation in transcriptional regulation of genes expressed in differentiated somatic cells remains controversial. Here, we define a small region in the promoter-enhancer of the interleukin-2 (II2) gene that demethylates in T lymphocytes following activation, and remains demethylated thereafter. This epigenetic change was necessary and sufficient to enhance transcription in reporter plasmids. The demethylation process started as early as 20 minutes after stimulation and was not prevented by a G1 to S phase cell cycle inhibitor that blocks DNA replication. These results imply that this demethylation process proceeds by an active enzymatic mechanism.	NIAID, Cellular & Mol Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Schwartz, RH (corresponding author), NIAID, Cellular & Mol Immunol Lab, NIH, Bethesda, MD 20892 USA.	rs34r@nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000485, Z01AI000485] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Attema JL, 2002, J IMMUNOL, V169, P2466, DOI 10.4049/jimmunol.169.5.2466; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bruniquel D, 1998, IMMUNOGENETICS, V48, P116, DOI 10.1007/s002510050411; Cervoni N, 2001, J BIOL CHEM, V276, P40778, DOI 10.1074/jbc.M103921200; Crane-Robinson C, 1999, METHOD ENZYMOL, V304, P533; Detich N, 2002, J BIOL CHEM, V277, P35791, DOI 10.1074/jbc.C200408200; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; FIERING S, 1990, GENE DEV, V4, P1823, DOI 10.1101/gad.4.10.1823; Fitzpatrick DR, 1999, J IMMUNOL, V162, P5053; Fitzpatrick DR, 1998, J EXP MED, V188, P103, DOI 10.1084/jem.188.1.103; Fremont M, 1997, NUCLEIC ACIDS RES, V25, P2375, DOI 10.1093/nar/25.12.2375; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; GARRITY PA, 1994, MOL CELL BIOL, V14, P2159, DOI 10.1128/MCB.14.3.2159; GROSS JA, 1990, J IMMUNOL, V144, P3201; Gudmundsdottir H, 1999, J IMMUNOL, V162, P5212; Huang H, 1998, J IMMUNOL METHODS, V215, P173, DOI 10.1016/S0022-1759(98)00088-X; Jones PL, 1999, SEMIN CANCER BIOL, V9, P339, DOI 10.1006/scbi.1999.0134; Jost JP, 2001, NUCLEIC ACIDS RES, V29, P4452, DOI 10.1093/nar/29.21.4452; Kress C, 2001, FEBS LETT, V494, P135, DOI 10.1016/S0014-5793(01)02328-6; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; Lin IG, 2000, MOL CELL BIOL, V20, P2343, DOI 10.1128/MCB.20.7.2343-2349.2000; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Matsuo K, 1998, EMBO J, V17, P1446, DOI 10.1093/emboj/17.5.1446; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Miller C, 1999, J EXP MED, V190, P53, DOI 10.1084/jem.190.1.53; Mostoslavsky R, 1998, GENE DEV, V12, P1801, DOI 10.1101/gad.12.12.1801; Powell JD, 2001, EUR J IMMUNOL, V31, P3737, DOI 10.1002/1521-4141(200112)31:12<3737::AID-IMMU3737>3.0.CO;2-G; Ramchandani S, 1999, P NATL ACAD SCI USA, V96, P6107, DOI 10.1073/pnas.96.11.6107; Rao SH, 2001, J IMMUNOL, V167, P4494, DOI 10.4049/jimmunol.167.8.4494; Richter A, 1999, J EXP MED, V190, P1439, DOI 10.1084/jem.190.10.1439; SALUZ HP, 1986, P NATL ACAD SCI USA, V83, P7167, DOI 10.1073/pnas.83.19.7167; Schwarz S, 2000, EUR J CELL BIOL, V79, P488, DOI 10.1078/0171-9335-00070; SIEBENLIST U, 1986, MOL CELL BIOL, V6, P3042, DOI 10.1128/MCB.6.9.3042; STOREK J, 1992, J IMMUNOL METHODS, V151, P261, DOI 10.1016/0022-1759(92)90126-E; Stunkel W, 2001, J BIOL CHEM, V276, P20743, DOI 10.1074/jbc.M010967200; SULLIVAN CH, 1987, P NATL ACAD SCI USA, V84, P329, DOI 10.1073/pnas.84.2.329; Thomassin H, 2001, EMBO J, V20, P1974, DOI 10.1093/emboj/20.8.1974; Ward SB, 1998, NUCLEIC ACIDS RES, V26, P2923, DOI 10.1093/nar/26.12.2923; Weiss A, 1996, CELL, V86, P709, DOI 10.1016/S0092-8674(00)80146-4; Wolffe AP, 1999, P NATL ACAD SCI USA, V96, P5894, DOI 10.1073/pnas.96.11.5894; Zhu B, 2000, NUCLEIC ACIDS RES, V28, P4157, DOI 10.1093/nar/28.21.4157; Zhu B, 2000, P NATL ACAD SCI USA, V97, P5135, DOI 10.1073/pnas.100107597; Zhu B, 2001, P NATL ACAD SCI USA, V98, P5031, DOI 10.1073/pnas.091097298	47	366	386	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2003	4	3					235	240		10.1038/ni887	http://dx.doi.org/10.1038/ni887			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	649HH	12548284				2022-12-18	WOS:000181201000011
J	Gringhuis, SI; Kaptein, TM; Wevers, BA; Theelen, B; van der Vlist, M; Boekhout, T; Geijtenbeek, TBH				Gringhuis, Sonja I.; Kaptein, Tanja M.; Wevers, Brigitte A.; Theelen, Bart; van der Vlist, Michiel; Boekhout, Teun; Geijtenbeek, Teunis B. H.			Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1 beta via a noncanonical caspase-8 inflammasome	NATURE IMMUNOLOGY			English	Article							T-CELL-ACTIVATION; NLRP3 INFLAMMASOME; FUNGAL-INFECTIONS; HOST-DEFENSE; PARACASPASE MALT1; CANDIDA-ALBICANS; DENDRITIC CELLS; INNATE IMMUNITY; INTERLEUKIN-17; STIMULATION	Production of the proinflammatory cytokine interleukin 1 beta (IL-1 beta) by dendritic cells is crucial in host defense. Here we identify a previously unknown role for dectin-1 in the activation of a noncanonical caspase-8 inflammasome in response to fungi and mycobacteria. Dectin-1 induced both the production and maturation of IL-1 beta through signaling routes mediated by the kinase Syk. Whereas the CARD9-Bcl-10-MALT1 scaffold directed IL1B transcription, the recruitment of MALT1-caspase-8 and ASC into this scaffold was crucial for processing of pro-IL-1 beta by caspase-8. In contrast to activation of the canonical caspase-1 inflammasome, which requires additional activation of cytosolic receptors, activation of the noncanonical caspase-8 inflammasome was independent of pathogen internalization. Thus, dectin-1 acted as an extracellular sensor for pathogens that induced both IL-1 beta production and maturation through a noncanonical caspase-8-dependent inflammasome for protective immunity.	[Gringhuis, Sonja I.; Kaptein, Tanja M.; Wevers, Brigitte A.; van der Vlist, Michiel; Geijtenbeek, Teunis B. H.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [Gringhuis, Sonja I.; Kaptein, Tanja M.; Wevers, Brigitte A.; van der Vlist, Michiel; Geijtenbeek, Teunis B. H.] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [Theelen, Bart; Boekhout, Teun] Cent Bur Schimmelcultures, Utrecht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Gringhuis, SI (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	s.i.gringhuis@amc.uva.nl; t.b.geijtenbeek@amc.uva.nl	van der Vlist, Michiel/AAC-4939-2019; Theelen, Bart/GPP-7033-2022; Boekhout, Teunis/ABF-2538-2020	Boekhout, Teunis/0000-0002-0476-3609; Gringhuis, Sonja/0000-0003-0383-4978; van der Vlist, Michiel/0000-0003-0931-8982	Netherlands Organisation for Scientific Research (Netherlands Genomic Initiative) [40-41009-98-8057, Vici 918.10.619]; AIDS Foundation [2007036]	Netherlands Organisation for Scientific Research (Netherlands Genomic Initiative); AIDS Foundation	We thank J. Belisle (Colorado State University) for M. tuberculosis (as part of HHSN266200400091C ("Tuberculosis Vaccine Testing and Research Materials") from the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health); B. Appelmelk (VU Medical Center, Amsterdam) for M. bovis BCG; and J. Spencer (Colorado State University) for M. leprae. Supported by the Netherlands Organisation for Scientific Research (Netherlands Genomic Initiative 40-41009-98-8057 to S.I.G.; Vici 918.10.619 to T.B.H.G.) and the AIDS Foundation (2007036 to M.v.d.V.).	Bellocchio S, 2004, J IMMUNOL, V172, P3059, DOI 10.4049/jimmunol.172.5.3059; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Fantuzzi G, 1997, J IMMUNOL, V158, P1818; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; GEAHLEN RL, 1989, BIOCHEM BIOPH RES CO, V165, P241, DOI 10.1016/0006-291X(89)91060-7; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; GODDETTE DW, 1986, J BIOL CHEM, V261, P5974; Gringhuis SI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001259; Gringhuis SI, 2009, NAT IMMUNOL, V10, P203, DOI 10.1038/ni.1692; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Kawadler H, 2008, MOL CELL, V31, P415, DOI 10.1016/j.molcel.2008.06.008; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Louten J, 2009, J ALLERGY CLIN IMMUN, V123, P1004, DOI 10.1016/j.jaci.2009.04.003; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Maelfait J, 2008, BIOCHEM PHARMACOL, V76, P1365, DOI 10.1016/j.bcp.2008.07.034; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Masumoto J, 2003, BIOCHEM BIOPH RES CO, V303, P69, DOI 10.1016/S0006-291X(03)00309-7; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mencacci A, 2000, INFECT IMMUN, V68, P5126, DOI 10.1128/IAI.68.9.5126-5131.2000; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Oberst A, 2011, NAT REV MOL CELL BIO, V12, P757, DOI 10.1038/nrm3214; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Rawlings DJ, 2006, NAT REV IMMUNOL, V6, P799, DOI 10.1038/nri1944; Rebeaud F, 2008, NAT IMMUNOL, V9, P272, DOI 10.1038/ni1568; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Romani L, 2008, MED MYCOL, V46, P515, DOI 10.1080/13693780801971450; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Rothfuchs AG, 2007, J IMMUNOL, V179, P3463, DOI 10.4049/jimmunol.179.6.3463; Said-Sadier N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010008; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Segal BH, 2009, NEW ENGL J MED, V360, P1870, DOI 10.1056/NEJMra0808853; Thome M, 2008, NAT REV IMMUNOL, V8, P495, DOI 10.1038/nri2338; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; van Beelen AJ, 2007, IMMUNITY, V27, P660, DOI 10.1016/j.immuni.2007.08.013; van de Veerdonk FLV, 2010, J LEUKOCYTE BIOL, V88, P227, DOI 10.1189/jlb.0809550; Vonk AG, 2006, J INFECT DIS, V193, P1419, DOI 10.1086/503363; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; Zenaro E, 2009, J LEUKOCYTE BIOL, V86, P1393, DOI 10.1189/jlb.0409242	48	365	371	3	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2012	13	3					246	U63		10.1038/ni.2222	http://dx.doi.org/10.1038/ni.2222			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	895QF	22267217				2022-12-18	WOS:000300510600011
J	Debes, GF; Arnold, CN; Young, AJ; Krautwald, S; Lipp, M; Hay, JB; Butcher, EC				Debes, GF; Arnold, CN; Young, AJ; Krautwald, S; Lipp, M; Hay, JB; Butcher, EC			Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues	NATURE IMMUNOLOGY			English	Article							HIGH ENDOTHELIAL VENULES; DENDRITIC CELL-MIGRATION; IN-VIVO; ORGAN CHEMOKINE; EFFERENT LYMPH; CUTTING EDGE; MEMORY; BLOOD; RECIRCULATION; EXPRESSION	Lymphocytes travel throughout the body to carry out immune surveillance and participate in inflammatory reactions. Their path takes them from blood through tissues into lymph and back to blood. Molecules that control lymphocyte recruitment into extralymphoid tissues are well characterized, but exit is assumed to be random. Here, we showed that lymphocyte emigration from the skin was regulated and was sensitive to pertussis toxin. CD4(+) lymphocytes emigrated more efficiently than CD8(+) or B lymphocytes. T lymphocytes in the afferent lymph expressed functional chemokine receptor CCR7, and CCR7 was required for T lymphocyte exit from the skin. The regulated expression of CCR7 by tissue T lymphocytes may control their exit, acting with recruitment mechanisms to regulate lymphocyte transit and accumulation during immune surveillance and inflammation.	Stanford Univ, Dept Pathol, Stanford Univ Sch Med, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Ctr Mol Biol & Med, Palo Alto, CA 94304 USA; S Dakota State Univ, Ctr Infect Dis Res & Vaccinol, Brookings, SD 57007 USA; Univ Schleswig Holstein, Dept Hypertens & Nephrol, D-24105 Kiel, Germany; Max Delbruck Ctr Mol Med, Dept Tumor Genet & Immunogenet, D-13125 Berlin, Germany; Univ Toronto, Fac Med, Dept Immunol, Toronto, ON M5S 1A8, Canada	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; South Dakota State University; University of Kiel; Schleswig Holstein University Hospital; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Toronto	Debes, GF (corresponding author), Stanford Univ, Dept Pathol, Stanford Univ Sch Med, Stanford, CA 94305 USA.	debes@stanford.edu	Lipp, Martin/G-2235-2010; Krautwald, Stefan/J-9984-2016	Krautwald, Stefan/0000-0001-7768-2132; Debes, Gudrun/0000-0003-4208-7362; Lipp, Martin/0000-0002-0087-2672	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037734] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI047822] Funding Source: Medline; NIDDK NIH HHS [P30 DK056339, P30 DK56339] Funding Source: Medline; NIGMS NIH HHS [R37 GM037734] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABERNETHY NJ, 1990, INT IMMUNOL, V2, P231, DOI 10.1093/intimm/2.3.231; ABERNETHY NJ, 1991, IMMUNOLOGY, V72, P239; Arnold CN, 2004, J IMMUNOL, V173, P866, DOI 10.4049/jimmunol.173.2.866; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Campbell DJ, 2003, SEMIN IMMUNOL, V15, P277, DOI 10.1016/j.smim.2003.08.005; Campbell JJ, 2001, J IMMUNOL, V166, P877, DOI 10.4049/jimmunol.166.2.877; Debes GF, 2004, J VIROL, V78, P7528, DOI 10.1128/JVI.78.14.7528-7535.2004; Debes GF, 2002, J IMMUNOL, V168, P5441, DOI 10.4049/jimmunol.168.11.5441; Eberhard Yanina, 2004, BMC Immunology, V5, P1, DOI 10.1186/1471-2172-5-7; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; GOWANS JL, 1964, PROC R SOC SER B-BIO, V159, P257, DOI 10.1098/rspb.1964.0001; GOWANS JL, 1959, J PHYSIOL-LONDON, V146, P54, DOI 10.1113/jphysiol.1959.sp006177; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Gunn MD, 1998, P NATL ACAD SCI USA, V95, P258, DOI 10.1073/pnas.95.1.258; HALL JG, 1965, J EXP MED, V121, P901, DOI 10.1084/jem.121.6.901; HAWLEY RG, 1994, GENE THER, V1, P136; ISSEKUTZ TB, 1982, IMMUNOLOGY, V46, P59; Kim CH, 2001, J CLIN INVEST, V108, P1331, DOI 10.1172/JCI200113543; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; MACKAY CR, 1990, J EXP MED, V171, P801, DOI 10.1084/jem.171.3.801; MACKAY CR, 1988, J EXP MED, V167, P1755, DOI 10.1084/jem.167.6.1755; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Nakano H, 2001, J IMMUNOL, V166, P361, DOI 10.4049/jimmunol.166.1.361; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Olszewski Waldemar L, 2003, Lymphat Res Biol, V1, P11, DOI 10.1089/15396850360495655; Olszewski WL, 1995, CLIN DERMATOL, V13, P473, DOI 10.1016/0738-081X(95)00087-V; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Reinhardt RL, 2003, J EXP MED, V197, P751, DOI 10.1084/jem.20021690; Saeki H, 1999, J IMMUNOL, V162, P2472; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Salmi M, 2004, BLOOD, V104, P3849, DOI 10.1182/blood-2004-01-0222; Seabrook T, 1999, SEMIN IMMUNOL, V11, P115, DOI 10.1006/smim.1999.0167; Stein JV, 2000, J EXP MED, V191, P61, DOI 10.1084/jem.191.1.61; Unsoeld H, 2002, J IMMUNOL, V169, P638, DOI 10.4049/jimmunol.169.2.638; Vollmerhaus B, 1984, LEHRBUCH ANATOMIE HA, V3, P276; Warnock RA, 2000, J EXP MED, V191, P77, DOI 10.1084/jem.191.1.77; Young AJ, 1999, SEMIN IMMUNOL, V11, P73, DOI 10.1006/smim.1999.0163; YOUNG AJ, 1997, MANUAL IMMUNOLOGICAL, P2039	41	365	369	0	16	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2005	6	9					889	894		10.1038/ni1238	http://dx.doi.org/10.1038/ni1238			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	957KX	16116468	Green Accepted			2022-12-18	WOS:000231369800018
J	Doreau, A; Belot, A; Bastid, J; Riche, B; Trescol-Biemont, MC; Ranchin, B; Fabien, N; Cochat, P; Pouteil-Noble, C; Trolliet, P; Durieu, I; Tebib, J; Kassai, B; Ansieau, S; Puisieux, A; Eliaou, JF; Bonnefoy-Berard, N				Doreau, Agnes; Belot, Alexandre; Bastid, Jeremy; Riche, Benjamin; Trescol-Biemont, Marie-Claude; Ranchin, Bruno; Fabien, Nicole; Cochat, Pierre; Pouteil-Noble, Claire; Trolliet, Pierre; Durieu, Isabelle; Tebib, Jacques; Kassai, Berhouz; Ansieau, Stephane; Puisieux, Alain; Eliaou, Jean-Francois; Bonnefoy-Berard, Nathalie			Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus	NATURE IMMUNOLOGY			English	Article							NF-KAPPA-B; T-HELPER-CELLS; LYMPHOCYTE STIMULATOR; TOLERANCE CHECKPOINTS; RECEPTOR STIMULATION; INDUCED APOPTOSIS; GENE-EXPRESSION; UP-REGULATION; CUTTING EDGE; SURVIVAL	Studies have suggested involvement of interleukin 17 (IL-17) in autoimmune diseases, although its effect on B cell biology has not been clearly established. Here we demonstrate that IL-17 alone or in combination with B cell-activating factor controlled the survival and proliferation of human B cells and their differentiation into immunoglobulin-secreting cells. This effect was mediated mainly through the nuclear factor-kappa B-regulated transcription factor Twist-1. In support of the relevance of our observations and the potential involvement of IL-17 in B cell biology, we found that the serum of patients with systemic lupus erythematosus had higher concentrations of IL-17 than did the serum of healthy people and that IL-17 abundance correlated with the disease severity of systemic lupus erythematosus.	[Doreau, Agnes; Belot, Alexandre; Bastid, Jeremy; Riche, Benjamin; Trescol-Biemont, Marie-Claude; Ranchin, Bruno; Fabien, Nicole; Cochat, Pierre; Pouteil-Noble, Claire; Trolliet, Pierre; Durieu, Isabelle; Tebib, Jacques; Kassai, Berhouz; Ansieau, Stephane; Puisieux, Alain; Bonnefoy-Berard, Nathalie] Univ Lyon, Lyon, France; [Doreau, Agnes; Trescol-Biemont, Marie-Claude; Fabien, Nicole; Bonnefoy-Berard, Nathalie] INSERM, U851, F-69008 Lyon, France; [Doreau, Agnes; Trescol-Biemont, Marie-Claude; Bonnefoy-Berard, Nathalie] Univ Lyon 1, Inst Federatif Rech 128, F-69365 Lyon, France; [Belot, Alexandre; Ranchin, Bruno; Cochat, Pierre] Hop Femme Mere Enfant, Serv Nephrol & Rhumatol Pediat, Ctr Reference Malad Renales Rares, Bron, France; [Belot, Alexandre] CNRS, UMR5239, Oullins, France; [Bastid, Jeremy; Ansieau, Stephane; Puisieux, Alain] INSERM, U590, F-69008 Lyon, France; [Bastid, Jeremy; Ansieau, Stephane; Puisieux, Alain] Federat Natl Ctr Lutte Canc, Ctr Leon Berard, Lyon, France; [Riche, Benjamin] Ctr Hosp Lyon Sud, Hosp Civils Lyon, Serv Biostat, Lyon, France; [Fabien, Nicole] Ctr Hosp Lyon Sud, Hosp Civils Lyon, Serv Immunol, Lyon, France; [Cochat, Pierre] INSERM, U820, F-69008 Lyon, France; [Pouteil-Noble, Claire; Trolliet, Pierre] Ctr Hosp Lyon Sud, Hosp Civils Lyon, Serv Nephrol, Lyon, France; [Durieu, Isabelle] Ctr Hosp Lyon Sud, Hosp Civils Lyon, Serv Med Interne, Lyon, France; [Tebib, Jacques] Ctr Hosp Lyon Sud, Hosp Civils Lyon, Serv Rhumatol, Lyon, France; [Kassai, Berhouz] Ctr Hosp Univ Lyon, Epidemiol Pharmacol Invest Clin Informat Med Mere, Serv Pharmacol Clin, Hop L Pradel,INSERM,CIC201,UMR 5558, Lyon, France; [Eliaou, Jean-Francois] Univ Montpellier I, Serv Immunol, CHU Montpellier, Fac Med, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; CHU Lyon; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; CHU Lyon; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Universite de Montpellier; CHU de Montpellier	Bonnefoy-Berard, N (corresponding author), Univ Lyon, Lyon, France.	nathalie.bonnefoy-berard@inserm.fr	Ansieau, Stephane/I-6195-2016; Bonnefoy, Nathalie/J-2536-2012	Bonnefoy, Nathalie/0000-0003-4814-6722; ANSIEAU, Stephane/0000-0003-0989-2108; PUISIEUX, Alain/0000-0002-9938-3798; Kassai, Behrouz/0000-0002-1712-120X				Andre JM, 2007, LUPUS, V16, P95, DOI 10.1177/0961203306075382; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; Brien G, 2007, ONCOGENE, V26, P5828, DOI 10.1038/sj.onc.1210363; Bubier JA, 2009, P NATL ACAD SCI USA, V106, P1518, DOI 10.1073/pnas.0807309106; Bush TJV, 2008, EUR J IMMUNOL, V38, P400, DOI 10.1002/eji.200737602; Cheema GS, 2001, ARTHRITIS RHEUM-US, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Crispin JC, 2008, J IMMUNOL, V181, P8761, DOI 10.4049/jimmunol.181.12.8761; de Brouwer APM, 2006, MOL DIAGN THER, V10, P197; Ettinger R, 2008, ANN RHEUM DIS, V67, P83, DOI 10.1136/ard.2008.098400; Garrett-Sinha LA, 2008, CURR OPIN RHEUMATOL, V20, P519, DOI 10.1097/BOR.0b013e328304b6b5; Groom J, 2008, IMMUNOL CELL BIOL, V86, P40, DOI 10.1038/sj.icb.7100142; Grumont RJ, 1999, GENE DEV, V13, P400, DOI 10.1101/gad.13.4.400; Hsu BL, 2002, J IMMUNOL, V168, P5993, DOI 10.4049/jimmunol.168.12.5993; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Hutcheson J, 2008, IMMUNITY, V28, P206, DOI 10.1016/j.immuni.2007.12.015; ISHIGAMI T, 1992, J IMMUNOL, V148, P360; Jacob N, 2009, J IMMUNOL, V182, P2532, DOI 10.4049/jimmunol.0802948; John SA, 2008, J BIOL CHEM, V283, P951, DOI 10.1074/jbc.M705262200; Kang HK, 2007, J IMMUNOL, V178, P7849, DOI 10.4049/jimmunol.178.12.7849; Khiem D, 2008, P NATL ACAD SCI USA, V105, P17067, DOI 10.1073/pnas.0804868105; Lam QLK, 2008, P NATL ACAD SCI USA, V105, P14993, DOI 10.1073/pnas.0806044105; Lee HH, 1999, P NATL ACAD SCI USA, V96, P9136, DOI 10.1073/pnas.96.16.9136; Li XX, 2008, CYTOKINE, V41, P105, DOI 10.1016/j.cyto.2007.09.015; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Mackay F, 2002, NAT REV IMMUNOL, V2, P465, DOI 10.1038/nri844; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Meffre E, 2008, CURR OPIN IMMUNOL, V20, P632, DOI 10.1016/j.coi.2008.09.001; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; Niesner U, 2008, J EXP MED, V205, P1889, DOI 10.1084/jem.20072468; Pan HF, 2008, NAT CLIN PRACT RHEUM, V4, P352, DOI 10.1038/ncprheum0815; Pene J, 2008, J IMMUNOL, V180, P7423, DOI 10.4049/jimmunol.180.11.7423; Pham CG, 2007, MOL CELL BIOL, V27, P3920, DOI 10.1128/MCB.01219-06; Rieux-Laucat F, 2003, CELL DEATH DIFFER, V10, P124, DOI 10.1038/sj.cdd.4401190; Ruprecht CR, 2006, EUR J IMMUNOL, V36, P810, DOI 10.1002/eji.200535744; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Sims GP, 2005, BLOOD, V105, P4390, DOI 10.1182/blood-2004-11-4284; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; Stadanlick JE, 2008, NAT IMMUNOL, V9, P1379, DOI 10.1038/ni.1666; Stohl W, 2003, ARTHRITIS RHEUM-US, V48, P3475, DOI 10.1002/art.11354; Wilker PR, 2008, NAT IMMUNOL, V9, P603, DOI 10.1038/ni.1609; Wong CK, 2008, CLIN IMMUNOL, V127, P385, DOI 10.1016/j.clim.2008.01.019; Wong CK, 2000, LUPUS, V9, P589, DOI 10.1191/096120300678828703; Yurasov S, 2005, ANN NY ACAD SCI, V1062, P165, DOI 10.1196/annals.1358.019; Zhang J, 2001, J IMMUNOL, V166, P6, DOI 10.4049/jimmunol.166.1.6; Zong WX, 1999, GENE DEV, V13, P382, DOI 10.1101/gad.13.4.382	48	364	404	2	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2009	10	7					778	U142		10.1038/ni.1741	http://dx.doi.org/10.1038/ni.1741			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	459WF	19483719				2022-12-18	WOS:000267142600018
J	D'Cruz, LM; Klein, L				D'Cruz, LM; Klein, L			Development and function of agonist-induced CD25(+)Foxp3(+) regulatory T cells in the absence of interleukin 2 signaling	NATURE IMMUNOLOGY			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; IN-VIVO; PERIPHERAL EXPANSION; LETHAL AUTOIMMUNITY; SUPPRESSOR FUNCTION; THYMIC SELECTION; IL-2; MICE; RECEPTOR; ACTIVATION	Interleukin 2 signaling is believed to be critically involved in several aspects of CD25(+) CD4(+) regulatory T cell biology, such as intrathymic development, peripheral survival and suppressive function. Here we have analyzed the effects of interleukin 2 or CD25 deficiency on agonist-driven thymic development and the peripheral homeostasis of an antigen-specific population of regulatory T cells positive for forkhead family transcription factor Foxp3 and have correlated our observations with polyclonal suppressor populations. We found that the differentiation, acquisition of functional capacity and formation of a sizeable pool of suppressor T cells in the thymus was independent of interleukin 2 signaling, but that interleukin 2 was essential for the survival of mature Foxp3(+) regulatory T cells.	Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Klein, L (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	klein@nt.imp.univie.ac.at	Klein, Ludger/G-8785-2011	Klein, Ludger/0000-0003-2054-071X				Almeida ARM, 2002, J IMMUNOL, V169, P4850, DOI 10.4049/jimmunol.169.9.4850; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Bayer AL, 2005, J EXP MED, V201, P769, DOI 10.1084/jem.20041179; Bensinger SJ, 2004, J IMMUNOL, V172, P5287, DOI 10.4049/jimmunol.172.9.5287; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; de Lafaille MAC, 2004, J IMMUNOL, V173, P7259, DOI 10.4049/jimmunol.173.12.7259; Di Santo JP, 1998, CURR OPIN IMMUNOL, V10, P196, DOI 10.1016/S0952-7915(98)80249-5; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Furtado GC, 2002, J EXP MED, V196, P851, DOI 10.1084/jem.20020190; Furtado GD, 2001, IMMUNOL REV, V182, P122; Hori S, 2002, EUR J IMMUNOL, V32, P3729, DOI 10.1002/1521-4141(200212)32:12<3729::AID-IMMU3729>3.0.CO;2-2; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hori S, 2004, MICROBES INFECT, V6, P745, DOI 10.1016/j.micinf.2004.02.020; Itoh M, 1999, J IMMUNOL, V162, P5317; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; KIRBERG J, 1994, J EXP MED, V180, P25, DOI 10.1084/jem.180.1.25; Klein L, 2003, P NATL ACAD SCI USA, V100, P8886, DOI 10.1073/pnas.1533365100; KRAMER S, 1995, J EXP MED, V182, P1769, DOI 10.1084/jem.182.6.1769; Liang S, 2005, J EXP MED, V201, P127, DOI 10.1084/jem.20041201; Malek TR, 2003, J LEUKOCYTE BIOL, V74, P961, DOI 10.1189/jlb.0603272; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Malek TR, 2000, J IMMUNOL, V164, P2905, DOI 10.4049/jimmunol.164.6.2905; Papiernik M, 1998, INT IMMUNOL, V10, P371, DOI 10.1093/intimm/10.4.371; Roncarolo MG, 2001, IMMUNOL REV, V182, P68, DOI 10.1034/j.1600-065X.2001.1820105.x; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Suzuki H, 1999, J EXP MED, V190, P1561, DOI 10.1084/jem.190.11.1561; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Thornton AM, 2004, J IMMUNOL, V172, P6519, DOI 10.4049/jimmunol.172.11.6519; Thornton AM, 2004, EUR J IMMUNOL, V34, P366, DOI 10.1002/eji.200324455; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; Walker LSK, 2003, J EXP MED, V198, P249, DOI 10.1084/jem.20030315; Weiner HL, 2001, IMMUNOL REV, V182, P207, DOI 10.1034/j.1600-065X.2001.1820117.x; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9	39	364	390	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2005	6	11					1152	1159		10.1038/ni1264	http://dx.doi.org/10.1038/ni1264			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	977WD	16227983				2022-12-18	WOS:000232833300016
J	Crotty, S; Johnston, RJ; Schoenberger, SP				Crotty, Shane; Johnston, Robert J.; Schoenberger, Stephen P.			Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation	NATURE IMMUNOLOGY			English	Review							FOLLICULAR-HELPER-CELLS; CHRONIC VIRAL-INFECTION; TRANSCRIPTIONAL REPRESSOR BLIMP-1; II TRANSACTIVATOR EXPRESSION; GERMINAL CENTER DEVELOPMENT; SECRETING PLASMA-CELLS; FINGER ENCODING GENE; IN-VIVO; SOMATIC HYPERMUTATION; IMMUNE-RESPONSES	Bcl-6 and Blimp-1 have recently been identified as key transcriptional regulators of effector and memory differentiation in CD4(+) T cells and CD8(+) T cells. Bcl-6 and Blimp-1 were previously known to be critical regulators of effector and memory differentiation of B lymphocytes. The new findings unexpectedly point to the Bcl-6 and Blimp-1 regulatory axis as a ubiquitous mechanism for controlling effector and memory lymphocyte differentiation and function. Bcl-6 and Blimp-1 are antagonistic transcription factors and can function as a self-reinforcing genetic switch for cell-fate decisions. However, their influences in different lymphocytes are complex. Here we review and examine the commonalities and differences in the functions of these transcription factors in CD4(+) follicular helper T(FH) lymphocytes, effector CD8(+) T lymphocytes and B lymphocytes.	[Crotty, Shane; Johnston, Robert J.] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA; [Crotty, Shane; Johnston, Robert J.] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Schoenberger, Stephen P.] La Jolla Inst Allergy & Immunol, Cellular Immunol Lab, La Jolla, CA USA	La Jolla Institute for Immunology; University of California System; University of California San Diego; La Jolla Institute for Immunology	Crotty, S (corresponding author), La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA.	shane@liai.org	Crotty, Shane/AAC-6703-2019; Crotty, Shane/AAE-8446-2019	Crotty, Shane/0000-0002-6484-6262; 	Pew Scholar Award; National Institutes of Health [072543, 063107]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063107, R01AI072543] Funding Source: NIH RePORTER	Pew Scholar Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by a Pew Scholar Award and the National Institutes of Health (072543 and 063107 to S. C.).	Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Allman D, 1996, BLOOD, V87, P5257, DOI 10.1182/blood.V87.12.5257.bloodjournal87125257; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; BARON BW, 1993, P NATL ACAD SCI USA, V90, P5262, DOI 10.1073/pnas.90.11.5262; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Blink EJ, 2005, J EXP MED, V201, P545, DOI 10.1084/jem.20042060; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Brooks DG, 2008, P NATL ACAD SCI USA, V105, P20428, DOI 10.1073/pnas.0811139106; Cattoretti G, 2005, CANCER CELL, V7, P445, DOI 10.1016/j.ccr.2005.03.037; Chevallier N, 2004, BLOOD, V103, P1454, DOI 10.1182/blood-2003-06-2081; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Ci WM, 2009, BLOOD, V113, P5536, DOI 10.1182/blood-2008-12-193037; Cimmino L, 2008, J IMMUNOL, V181, P2338, DOI 10.4049/jimmunol.181.4.2338; Dent AL, 1998, P NATL ACAD SCI USA, V95, P13823, DOI 10.1073/pnas.95.23.13823; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Dhordain P, 1998, NUCLEIC ACIDS RES, V26, P4645, DOI 10.1093/nar/26.20.4645; Dhordain P, 2000, ONCOGENE, V19, P6240, DOI 10.1038/sj.onc.1203976; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; EJMAES M, 2006, J EXP MED, V203, P2461; Fairfax KA, 2008, SEMIN IMMUNOL, V20, P49, DOI 10.1016/j.smim.2007.12.002; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Fujita N, 2004, CELL, V119, P75, DOI 10.1016/j.cell.2004.09.014; FUKUDA T, 1995, ONCOGENE, V11, P1657; Ghetu AF, 2008, MOL CELL, V29, P384, DOI 10.1016/j.molcel.2007.12.026; Ghosh N, 2001, J BIOL CHEM, V276, P15264, DOI 10.1074/jbc.M100862200; Gong DP, 2007, J IMMUNOL, V178, P242, DOI 10.4049/jimmunol.178.1.242; Ha SJ, 2008, IMMUNOL REV, V223, P317, DOI 10.1111/j.1600-065X.2008.00638.x; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hirata Y, 2009, BRIT J CANCER, V100, P1320, DOI 10.1038/sj.bjc.6605010; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Huynh KD, 2000, GENE DEV, V14, P1810; Ichii H, 2004, J IMMUNOL, V173, P883, DOI 10.4049/jimmunol.173.2.883; Ichii H, 2002, NAT IMMUNOL, V3, P558, DOI 10.1038/ni802; Ichii H, 2007, INT IMMUNOL, V19, P427, DOI 10.1093/intimm/dxm007; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Jardin F, 2007, PATHOL BIOL, V55, P73, DOI 10.1016/j.patbio.2006.04.001; Jaye DL, 2007, J PATHOL, V213, P106, DOI 10.1002/path.2199; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kallies A, 2006, NAT IMMUNOL, V7, P466, DOI 10.1038/ni1321; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Kallies A, 2007, IMMUNITY, V26, P555, DOI 10.1016/j.immuni.2007.04.007; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Kamimura D, 2008, J IMMUNOL, V181, P5433, DOI 10.4049/jimmunol.181.8.5433; KERCKAERT JP, 1993, NAT GENET, V5, P66, DOI 10.1038/ng0993-66; Kim CH, 2004, BLOOD, V104, P1952, DOI 10.1182/blood-2004-03-1206; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; King IL, 2009, J EXP MED, V206, P1001, DOI 10.1084/jem.20090313; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Kopf M, 1995, IMMUNOL REV, V148, P45, DOI 10.1111/j.1600-065X.1995.tb00093.x; Kuo TC, 2007, J EXP MED, V204, P819, DOI 10.1084/jem.20062104; Lin KI, 2002, MOL CELL BIOL, V22, P4771, DOI 10.1128/MCB.22.13.4771-4780.2002; Lin KI, 2000, MOL CELL BIOL, V20, P8684, DOI 10.1128/MCB.20.23.8684-8695.2000; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; Martins GA, 2008, J EXP MED, V205, P1959, DOI 10.1084/jem.20080526; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; McHeyzer-Williams LJ, 2009, CURR OPIN IMMUNOL, V21, P266, DOI 10.1016/j.coi.2009.05.010; Mendez LM, 2008, MOL CELL BIOL, V28, P2175, DOI 10.1128/MCB.01400-07; Mueller SN, 2009, P NATL ACAD SCI USA, V106, P8623, DOI 10.1073/pnas.0809818106; Niu HF, 1998, GENE DEV, V12, P1953, DOI 10.1101/gad.12.13.1953; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Okabe S, 1998, MOL CELL BIOL, V18, P4235, DOI 10.1128/MCB.18.7.4235; Parekh S, 2007, BLOOD, V110, P2067, DOI 10.1182/blood-2007-01-069575; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Piskurich JF, 2000, NAT IMMUNOL, V1, P526, DOI 10.1038/82788; Quong MW, 2002, ANNU REV IMMUNOL, V20, P301, DOI 10.1146/annurev.immunol.20.092501.162048; Rasheed AU, 2006, EUR J IMMUNOL, V36, P1892, DOI 10.1002/eji.200636136; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Scheeren FA, 2005, NAT IMMUNOL, V6, P303, DOI 10.1038/ni1172; SCHOENBERGER SP, 2008, FUNDAMENTAL IMMUNOLO, P862; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Shin H, 2007, CURR OPIN IMMUNOL, V19, P408, DOI 10.1016/j.coi.2007.06.004; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Shvarts A, 2002, GENE DEV, V16, P681, DOI 10.1101/gad.929302; Smith KM, 2000, J IMMUNOL, V165, P3136, DOI 10.4049/jimmunol.165.6.3136; Smith KM, 2004, J IMMUNOL, V173, P1640, DOI 10.4049/jimmunol.173.3.1640; Tangye S., 2009, EUR J IMMUNOL, V39, P9; Tomayko MM, 2008, J IMMUNOL, V181, P27, DOI 10.4049/jimmunol.181.1.27; Toyama H, 2002, IMMUNITY, V17, P329, DOI 10.1016/S1074-7613(02)00387-4; TSIAGBE VK, 1998, BIOL GERMINAL CTR LY, P1; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Vasanwala FH, 2002, J IMMUNOL, V169, P1922, DOI 10.4049/jimmunol.169.4.1922; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; Yoshida K, 2006, EUR J IMMUNOL, V36, P3146, DOI 10.1002/eji.200636165; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zaretsky AG, 2009, J EXP MED, V206, P991, DOI 10.1084/jem.20090303; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	100	363	393	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2010	11	2					114	120		10.1038/ni.1837	http://dx.doi.org/10.1038/ni.1837			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	545KF	20084069	Green Accepted			2022-12-18	WOS:000273730200007
J	Lightfield, KL; Persson, J; Brubaker, SW; Witte, CE; von Moltke, J; Dunipace, EA; Henry, T; Sun, YH; Cado, D; Dietrich, WF; Monack, DM; Tsolis, RM; Vance, RE				Lightfield, Karla L.; Persson, Jenny; Brubaker, Sky W.; Witte, Chelsea E.; von Moltke, Jakob; Dunipace, Eric A.; Henry, Thomas; Sun, Yao-Hui; Cado, Dragana; Dietrich, William F.; Monack, Denise M.; Tsolis, Renee M.; Vance, Russell E.			Critical function for Naip5 in inflammasome activation by a conserved carboxy-terminal domain of flagellin	NATURE IMMUNOLOGY			English	Article							LEGIONELLA-PNEUMOPHILA GROWTH; APOPTOSIS-INHIBITORY PROTEIN; NALP3 INFLAMMASOME; TNF-ALPHA; CASPASE-1 ACTIVATION; MURAMYL DIPEPTIDE; MICE DEFICIENT; RECOGNITION; INTERLEUKIN-1-BETA; MACROPHAGES	Inflammasomes are cytosolic multiprotein complexes that sense microbial infection and trigger cytokine production and cell death. However, the molecular components of inflammasomes and what they sense remain poorly defined. Here we demonstrate that 35 amino acids of the carboxyl terminus of flagellin triggered inflammasome activation in the absence of bacterial contaminants or secretion systems. To further elucidate the host flagellin-sensing pathway, we generated mice deficient in the intracellular sensor Naip5. These mice failed to activate the inflammasome in response to the 35 amino acids of flagellin or in response to Legionella pneumophila infection. Our data clarify the molecular basis for the cytosolic response to flagellin.	[Persson, Jenny; Brubaker, Sky W.; von Moltke, Jakob; Dunipace, Eric A.; Cado, Dragana; Vance, Russell E.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA; [Lightfield, Karla L.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Witte, Chelsea E.] Univ Calif Berkeley, Dept Plant & Microbial Sci, Berkeley, CA 94720 USA; [Henry, Thomas; Monack, Denise M.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Sun, Yao-Hui; Tsolis, Renee M.] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Dietrich, William F.] Novartis Inst Biomed Res, Cambridge, MA 02139 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Stanford University; University of California System; University of California Davis; Novartis	Vance, RE (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, 229 Stanley Hall, Berkeley, CA 94720 USA.	rvance@berkeley.edu	Henry, Thomas/G-3160-2013; Persson, Jenny J/H-1796-2012; Dunipace, Eric/AAP-7898-2021	Henry, Thomas/0000-0002-0687-8565; Persson, Jenny J/0000-0002-1075-4346; Dunipace, Eric/0000-0001-8909-213X; Tsolis, Renee/0000-0001-9131-6657; Monack, Denise/0000-0003-3804-2209	Cancer Research Institute; National Institutes of Health [AI075039, AI070739]; Stiftelsen Olle Engkvist Byggmastare through the Swedish Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI070739, R01AI075039] Funding Source: NIH RePORTER	Cancer Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stiftelsen Olle Engkvist Byggmastare through the Swedish Research Council(Swedish Research Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Goodart and M. Michelman for help in generating Naip5-deficient mice; V. Dixit and S. Mariathasan (Genentech) for Ipaf- deficient mice; K. Fitzgerald and D. Golenbock (University of Massachusetts) for immortalized B6 macrophages; C. Roy and C. Case ( Yale University) for caspase- 3- deficient femurs; A. Van der Velden (Stony Brook University) and M. Starnbach (Harvard Medical School) for caspase-1-deficient mice and S. typhimurium LT2 and isogenic mutants; T. Machen (University of California, Berkeley) for P. aeruginosa strain PAK; G. Barton (University of California, Berkeley) for Pam3CSK4; and D. Raulet, G. Barton, and the Barton and Vance laboratories for discussions. Supported by the Cancer Research Institute (R. E. V.), the National Institutes of Health (AI075039 and AI070739 to R. E. V.) and the Stiftelsen Olle Engkvist Byggmastare through the Swedish Research Council (J. P.).	AM AO, 2005, CELL MICROBIOL, V7, P765; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; BLASI E, 1985, NATURE, V318, P667, DOI 10.1038/318667a0; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Coers J, 2007, CELL MICROBIOL, V9, P2344, DOI 10.1111/j.1462-5822.2007.00963.x; Damiano JS, 2004, BIOCHEM J, V381, P213, DOI 10.1042/BJ20031506; Davoodi J, 2004, J BIOL CHEM, V279, P40622, DOI 10.1074/jbc.M405963200; DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9; Diez E, 2003, NAT GENET, V33, P55, DOI 10.1038/ng1065; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Fortier A, 2007, CELL MICROBIOL, V9, P910, DOI 10.1111/j.1462-5822.2006.00839.x; Franchi L, 2007, EUR J IMMUNOL, V37, P3030, DOI 10.1002/eji.200737532; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lamkanfi M, 2007, J IMMUNOL, V178, P8022, DOI 10.4049/jimmunol.178.12.8022; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Liston P, 2003, ONCOGENE, V22, P8568, DOI 10.1038/sj.onc.1207101; Maier JKX, 2002, J NEUROSCI, V22, P2035, DOI 10.1523/JNEUROSCI.22-06-02035.2002; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Marina-Garcia N, 2008, J IMMUNOL, V180, P4050, DOI 10.4049/jimmunol.180.6.4050; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Merriam JJ, 1997, INFECT IMMUN, V65, P2497, DOI 10.1128/IAI.65.6.2497-2501.1997; Miao EA, 2008, P NATL ACAD SCI USA, V105, P2562, DOI 10.1073/pnas.0712183105; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Sun YH, 2007, J BIOL CHEM, V282, P33897, DOI 10.1074/jbc.C700181200; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Sutterwala FS, 2007, J LEUKOCYTE BIOL, V82, P259, DOI 10.1189/jlb.1206755; Suzuki T, 2007, PLOS PATHOG, V3, P1082, DOI 10.1371/journal.ppat.0030111; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Watarai M, 2001, J EXP MED, V194, P1081, DOI 10.1084/jem.194.8.1081; Wright EK, 2003, CURR BIOL, V13, P27, DOI 10.1016/S0960-9822(02)01359-3; Wu H, 2007, CELL, V131, P655, DOI 10.1016/j.cell.2007.10.042; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305	53	362	379	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2008	9	10					1171	1178		10.1038/ni.1646	http://dx.doi.org/10.1038/ni.1646			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	349XC	18724372	Green Accepted			2022-12-18	WOS:000259315600016
J	Lin, W; Haribhai, D; Relland, LM; Truong, N; Carlson, MR; Williams, CB; Chatila, TA				Lin, Wen; Haribhai, Dipica; Relland, Lance M.; Truong, Nga; Carlson, Marc R.; Williams, Calvin B.; Chatila, Talal A.			Regulatory T cell development in the absence of functional Foxp3	NATURE IMMUNOLOGY			English	Article							CUTTING EDGE; REG CELLS; EXPRESSION; TRANSCRIPTION; HOMEOSTASIS; ACTIVATION; SELECTION; MUTANT; DYSREGULATION; ENTEROPATHY	Although the development of regulatory T cells ( T-reg cells) in the thymus is defined by expression of the lineage marker Foxp3, the precise function of Foxp3 in T-reg cell lineage commitment is unknown. Here we examined T-reg cell development and function in mice with a Foxp3 allele that directs expression of a nonfunctional fusion protein of Foxp3 and enhanced green fluorescent protein ( Foxp3(Delta EGFP)). Thymocyte development in Foxp3(Delta EGFP) male mice and Foxp3(Delta EGFP/+) female mice recapitulated that of wild-type mice. Although mature EGFP(+) CD4(+) T cells from Foxp3(Delta EGFP) mice lacked suppressor function, they maintained the characteristic T-reg cell 'genetic signature' and failed to develop from EGFP(-) CD4(+) T cells when transferred into lymphopenic hosts, indicative of their common ontogeny with T-reg cells. Our results indicate that T-reg cell effector function but not lineage commitment requires the expression of functional Foxp3 protein.	Univ Calif Los Angeles, Div Immunol Allergy & Rheumatol, Dept Pediat, David Geffen Sch Med, Los Angeles, CA 90095 USA; Med Coll Wisconsin, Div Rheumatol, Dept Pediat, Milwaukee, WI 53226 USA; Univ Calif Los Angeles, Dept Human Genet, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Medical College of Wisconsin; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Williams, CB (corresponding author), Univ Calif Los Angeles, Div Immunol Allergy & Rheumatol, Dept Pediat, David Geffen Sch Med, Los Angeles, CA 90095 USA.	cwilliam@mcw.edu; tchatila@mednet.ucla.edu		Williams, Calvin/0000-0002-5492-8475; Chatila, Talal/0000-0001-7439-2762	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047154] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI047154, 2R01 AI065617, R01 AI47154] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Almeida ARM, 2006, J IMMUNOL, V177, P192, DOI 10.4049/jimmunol.177.1.192; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; BENDELAC A, 1992, J EXP MED, V175, P731, DOI 10.1084/jem.175.3.731; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bensinger SJ, 2001, J EXP MED, V194, P427, DOI 10.1084/jem.194.4.427; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Cabarrocas J, 2006, P NATL ACAD SCI USA, V103, P8453, DOI 10.1073/pnas.0603086103; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Chen ZB, 2005, J EXP MED, V202, P1387, DOI 10.1084/jem.20051409; de Latour RP, 2006, BLOOD, V108, P2300, DOI 10.1182/blood-2006-04-017947; Feng CG, 2002, INT IMMUNOL, V14, P535, DOI 10.1093/intimm/dxf020; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glimcher LH, 2004, NAT REV IMMUNOL, V4, P900, DOI 10.1038/nri1490; GODFREY VL, 1991, AM J PATHOL, V138, P1379; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Grossman WJ, 2004, IMMUNITY, V21, P589, DOI 10.1016/j.immuni.2004.09.002; HARIBHAI D, IN PRESS J IMMUNOL; He YW, 2002, J LEUKOCYTE BIOL, V72, P440; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kawahata K, 2002, J IMMUNOL, V168, P4399, DOI 10.4049/jimmunol.168.9.4399; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim CH, 2001, J CLIN INVEST, V107, P595, DOI 10.1172/JCI11902; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lin W, 2005, J ALLERGY CLIN IMMUN, V116, P1106, DOI 10.1016/j.jaci.2005.08.046; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Lopes JE, 2006, J IMMUNOL, V177, P3133, DOI 10.4049/jimmunol.177.5.3133; LYON MF, 1990, P NATL ACAD SCI USA, V87, P2433, DOI 10.1073/pnas.87.7.2433; McHugh RS, 2002, J IMMUNOL, V168, P5979, DOI 10.4049/jimmunol.168.12.5979; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Stroud JC, 2006, STRUCTURE, V14, P159, DOI 10.1016/j.str.2005.10.005; Sugimoto N, 2006, INT IMMUNOL, V18, P1197, DOI 10.1093/intimm/dxl060; Sun H, 2001, NAT IMMUNOL, V2, P1040, DOI 10.1038/ni721; Taguchi O, 1996, EUR J IMMUNOL, V26, P1608, DOI 10.1002/eji.1830260730; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zhao DM, 2006, BLOOD, V107, P3925, DOI 10.1182/blood-2005-11-4502	50	361	369	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2007	8	4					359	368		10.1038/ni1445	http://dx.doi.org/10.1038/ni1445			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	148LK	17273171				2022-12-18	WOS:000245075900011
J	Ciofani, M; Zuniga-Pflucker, JC				Ciofani, M; Zuniga-Pflucker, JC			Notch promotes survival of pre-T cells at the beta-selection checkpoint by regulating cellular metabolism	NATURE IMMUNOLOGY			English	Article							FACTOR-INDEPENDENT SURVIVAL; PROTEIN-KINASE B/AKT; GLUCOSE-METABOLISM; THYMOCYTE DIFFERENTIATION; LYMPHOCYTE DEVELOPMENT; LINEAGE THYMOCYTES; SIGNALING PATHWAY; IN-VITRO; TCR; GROWTH	Notch signals are necessary for the functional outcomes of T cell receptor beta- selection, including differentiation, proliferation and rescue from apoptosis. The mechanism underlying this requirement for T cell development is unknown. Here we show that Notch receptor and Delta- like 1 ligand interactions promoted the survival of CD4(-) CD8(-) pre - T cells through the maintenance of cell size, glucose uptake and metabolism. Furthermore, the trophic effects of Notch signaling were mediated by the pathway of phosphatidylinositol- 3- OH kinase and the kinase Akt, such that expression of active Akt overcame the requirement for Notch in beta- selection. Collectively, our results demonstrate involvement of Notch receptor - ligand interactions in the regulation of cellular metabolism, thus enabling the autonomous signaling capacity of the pre - T cell receptor complex.	Univ Toronto, Dept Immunol, Sunnybrook & Womens Res Inst, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Zuniga-Pflucker, JC (corresponding author), Univ Toronto, Dept Immunol, Sunnybrook & Womens Res Inst, 2075 Bayview Ave, Toronto, ON, Canada.	jczp@swri.ca	Zuniga-Pflucker, Juan C/H-1295-2012	Ciofani, Maria/0000-0001-6472-5260; Zuniga-Pflucker, Juan Carlos/0000-0003-2538-3178				Allman D, 2001, J EXP MED, V194, P99, DOI 10.1084/jem.194.1.99; ASHCROFT SJ, 1972, BIOCHEM J, V126, P525, DOI 10.1042/bj1260525; Bellavia D, 2000, EMBO J, V19, P3337, DOI 10.1093/emboj/19.13.3337; Bellavia D, 2002, P NATL ACAD SCI USA, V99, P3788, DOI 10.1073/pnas.062050599; Belloc F, 2000, CYTOMETRY, V40, P151, DOI 10.1002/(SICI)1097-0320(20000601)40:2<151::AID-CYTO9>3.0.CO;2-9; Ciofani M, 2004, J IMMUNOL, V172, P5230, DOI 10.4049/jimmunol.172.9.5230; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; Di JA, 1996, J EXP MED, V183, P1923, DOI 10.1084/jem.183.4.1923; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Eagar TN, 2004, IMMUNITY, V20, P407, DOI 10.1016/S1074-7613(04)00081-0; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Engel I, 2004, EMBO J, V23, P202, DOI 10.1038/sj.emboj.7600017; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; GODFREY DI, 1993, J IMMUNOL, V150, P4244; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hagenbeek TJ, 2004, J EXP MED, V200, P883, DOI 10.1084/jem.20040495; Jehn BM, 1999, J IMMUNOL, V162, P635; Kim K, 1998, J IMMUNOL, V160, P5735; Livak F, 1999, J IMMUNOL, V162, P2575; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Malstrom S, 2001, P NATL ACAD SCI USA, V98, P14967, DOI 10.1073/pnas.231467698; Michie AM, 2002, SEMIN IMMUNOL, V14, P311, DOI 10.1016/S1044-5323(02)00064-7; Newton K, 2000, EMBO J, V19, P931, DOI 10.1093/emboj/19.5.931; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Nie L, 2003, EMBO J, V22, P5780, DOI 10.1093/emboj/cdg567; Pallard C, 1999, IMMUNITY, V10, P525, DOI 10.1016/S1074-7613(00)80052-7; PENIT C, 1995, J IMMUNOL, V154, P5103; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; Radtke F, 2004, NAT IMMUNOL, V5, P247, DOI 10.1038/ni1045; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Sade H, 2004, J BIOL CHEM, V279, P2937, DOI 10.1074/jbc.M309924200; Schmitt TM, 2004, J EXP MED, V200, P469, DOI 10.1084/jem.20040394; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Schmitt TM, 2005, CRIT REV IMMUNOL, V25, P141, DOI 10.1615/CritRevImmunol.v25.i2.40; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Sicinska E, 2003, CANCER CELL, V4, P451, DOI 10.1016/S1535-6108(03)00301-5; Talora C, 2003, EMBO REP, V4, P1067, DOI 10.1038/sj.embor.7400013; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; vonFreedenJeffry U, 1997, IMMUNITY, V7, P147, DOI 10.1016/S1074-7613(00)80517-8; WHETTON AD, 1984, EMBO J, V3, P409, DOI 10.1002/j.1460-2075.1984.tb01821.x; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Yu Q, 2003, J EXP MED, V197, P475, DOI 10.1084/jem.20021765; Zuniga-Pflucker JC, 2004, NAT REV IMMUNOL, V4, P67, DOI 10.1038/nri1257; Zweidler-McKay PA, 2004, SEMIN CANCER BIOL, V14, P329, DOI 10.1016/j.semcancer.2004.04.012	48	361	372	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2005	6	9					881	888		10.1038/ni1234	http://dx.doi.org/10.1038/ni1234			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	957KX	16056227				2022-12-18	WOS:000231369800017
J	Okabe, Y; Medzhitov, R				Okabe, Yasutaka; Medzhitov, Ruslan			Tissue biology perspective on macrophages	NATURE IMMUNOLOGY			English	Review							ALVEOLAR MACROPHAGES; GENE-EXPRESSION; NEURAL CREST; SPI-C; INFLAMMATION; DIFFERENTIATION; INDUCTION; DIVERSITY; CELLS; HETEROGENEITY	Macrophages are essential components of mammalian tissues. Although historically known mainly for their function in host defense and the clearance of apoptotic cells, macrophages are now increasingly recognized as serving many roles in tissue development, homeostasis and repair. In addition, tissue-resident macrophages have many tissue-specific functional characteristics, which are a reflection of distinct gene-expression programs. Here we discuss the emerging views of macrophage biology from evolutionary, developmental and homeostatic perspectives.	[Okabe, Yasutaka; Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06510 USA.	ruslan.medzhitov@yale.edu		Okabe, Yasutaka/0000-0002-1913-7280	Blavatnik Family Foundation; Else Kroner-Fresenius-Stiftung; US National Institutes of Health [AI046688, AI089771, CA157461]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA157461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046688, R37AI046688, R01AI089771] Funding Source: NIH RePORTER	Blavatnik Family Foundation; Else Kroner-Fresenius-Stiftung; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Medzhitov laboratory for discussions, and L. Kopp for reading the manuscript. Supported by The Blavatnik Family Foundation, Else Kroner-Fresenius-Stiftung, the US National Institutes of Health (AI046688, AI089771 and CA157461) and the Howard Hughes Medical Institute (all for research in the Medzhitov laboratory).	A-Gonzalez N, 2013, NAT IMMUNOL, V14, P831, DOI 10.1038/ni.2622; Arendt D, 2008, NAT REV GENET, V9, P868, DOI 10.1038/nrg2416; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Cannon WB, 1929, PHYSIOL REV, V9, P399, DOI 10.1152/physrev.1929.9.3.399; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Chovatiya R, 2014, MOL CELL, V54, P281, DOI 10.1016/j.molcel.2014.03.030; Compan V, 2012, IMMUNITY, V37, P487, DOI 10.1016/j.immuni.2012.06.013; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Desai BN, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00580; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Franco C, 2009, CIRC RES, V105, P1141, DOI 10.1161/CIRCRESAHA.109.207357; Ganeshan K, 2014, ANNU REV IMMUNOL, V32, P609, DOI 10.1146/annurev-immunol-032713-120236; Gautier EL, 2014, J EXP MED, V211, P1525, DOI 10.1084/jem.20140570; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Gerhart J, 2007, P NATL ACAD SCI USA, V104, P8582, DOI 10.1073/pnas.0701035104; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Glass CK, 2015, ARTERIOSCL THROM VAS, V35, P755, DOI 10.1161/ATVBAHA.114.304051; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; GORDON S, 1986, CIBA F SYMP, V118, P54, DOI 10.1002/9780470720998.ch5; Gordon S, 2014, IMMUNOL REV, V262, P36, DOI 10.1111/imr.12223; Gorgani NN, 2008, IMMUNOL CELL BIOL, V86, P246, DOI 10.1038/sj.icb.7100131; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Haldar M, 2014, CELL, V156, P1223, DOI 10.1016/j.cell.2014.01.069; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hickman C.P., 2009, INTEGRATED PRINCIPLE; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Ip WKE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7931; Jang JY, 2013, BLOOD, V122, P2151, DOI 10.1182/blood-2013-01-478941; Kashio M, 2012, P NATL ACAD SCI USA, V109, P6745, DOI 10.1073/pnas.1114193109; Knecht AK, 2002, NAT REV GENET, V3, P453, DOI 10.1038/nrg819; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Kotas ME, 2015, CELL, V160, P816, DOI 10.1016/j.cell.2015.02.010; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Lattin J, 2007, J LEUKOCYTE BIOL, V82, P16, DOI 10.1189/jlb.0107051; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Leitinger B, 2011, ANNU REV CELL DEV BI, V27, P265, DOI 10.1146/annurev-cellbio-092910-154013; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Link TM, 2010, NAT IMMUNOL, V11, P232, DOI 10.1038/ni.1842; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; McCutcheon JC, 1998, J LEUKOCYTE BIOL, V64, P600, DOI 10.1002/jlb.64.5.600; McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Mossadegh-Keller N, 2013, NATURE, V497, P239, DOI 10.1038/nature12026; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Rahman M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4944; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Rosas M, 2014, SCIENCE, V344, P645, DOI 10.1126/science.1251414; Santiago-Garcia J, 2003, J BIOL CHEM, V278, P6942, DOI 10.1074/jbc.M208358200; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Sieweke MH, 2013, SCIENCE, V342, P946, DOI 10.1126/science.1242974; Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272; Sturge J, 2007, J LEUKOCYTE BIOL, V82, P585, DOI 10.1189/jlb.0107053; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Suzuki T, 2014, NATURE, V514, P450, DOI 10.1038/nature13807; Tacke R, 2015, SCI REP-UK, V5, DOI 10.1038/srep10055; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tauber AI, 2003, NAT REV MOL CELL BIO, V4, P897, DOI 10.1038/nrm1244; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Varol C, 2015, ANNU REV IMMUNOL, V33, P643, DOI 10.1146/annurev-immunol-032414-112220; Weigert A, 2009, IMMUNOBIOLOGY, V214, P748, DOI 10.1016/j.imbio.2009.06.003; WOO HJ, 1990, J BIOL CHEM, V265, P7097; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354	82	360	368	8	95	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2016	17	1					9	17		10.1038/ni.3320	http://dx.doi.org/10.1038/ni.3320			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CY8RK	26681457				2022-12-18	WOS:000366675800003
J	Vasanthakumar, A; Moro, K; Xin, AN; Liao, Y; Gloury, R; Kawamoto, S; Fagarasan, S; Mielke, LA; Afshar-Sterle, S; Masters, SL; Nakae, S; Saito, H; Wentworth, JM; Li, P; Liao, W; Leonard, WJ; Smyth, GK; Shi, W; Nutt, SL; Koyasu, S; Kallies, A				Vasanthakumar, Ajithkumar; Moro, Kazuyo; Xin, Annie; Liao, Yang; Gloury, Renee; Kawamoto, Shimpei; Fagarasan, Sidonia; Mielke, Lisa A.; Afshar-Sterle, Shoukat; Masters, Seth L.; Nakae, Susumu; Saito, Hirohisa; Wentworth, John M.; Li, Peng; Liao, Wei; Leonard, Warren J.; Smyth, Gordon K.; Shi, Wei; Nutt, Stephen L.; Koyasu, Shigeo; Kallies, Axel			The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells	NATURE IMMUNOLOGY			English	Article							LYMPHOID-CELLS; REG CELLS; DIFFERENTIATION; INFLAMMATION; INTERLEUKIN-33; EXPRESSION; CYTOKINES; BLIMP-1; OBESITY; FAMILY	Foxp3(+) regulatory T (T-reg) cells in visceral adipose tissue (VAT-T-reg cells) are functionally specialized tissue-resident cells that prevent obesity-associated inflammation and preserve insulin sensitivity and glucose tolerance. Their development depends on the transcription factor PPAR-gamma; however, the environmental cues required for their differentiation are unknown. Here we show that interleukin 33 (IL-33) signaling through the IL-33 receptor ST2 and myeloid differentiation factor MyD88 is essential for development and maintenance of VAT-T-reg cells and sustains their transcriptional signature. Furthermore, the transcriptional regulators BATF and IRF4 were necessary for VAT-T-reg differentiation through direct regulation of ST2 and PPAR-gamma expression. IL-33 administration induced vigorous population expansion of VAT-T-reg cells, which tightly correlated with improvements in metabolic parameters in obese mice. Human omental adipose tissue Treg cells also showed high ST2 expression, suggesting an evolutionarily conserved requirement for IL-33 in VAT-T-reg cell homeostasis.	[Vasanthakumar, Ajithkumar; Xin, Annie; Liao, Yang; Gloury, Renee; Mielke, Lisa A.; Afshar-Sterle, Shoukat; Masters, Seth L.; Wentworth, John M.; Smyth, Gordon K.; Shi, Wei; Nutt, Stephen L.; Kallies, Axel] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Vasanthakumar, Ajithkumar; Xin, Annie; Liao, Yang; Gloury, Renee; Mielke, Lisa A.; Afshar-Sterle, Shoukat; Masters, Seth L.; Wentworth, John M.; Nutt, Stephen L.; Kallies, Axel] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Moro, Kazuyo; Koyasu, Shigeo] RIKEN, Ctr Integrat Med Sci, Lab Immune Cell Syst, Yokohama, Kanagawa, Japan; [Moro, Kazuyo; Nakae, Susumu] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Tokyo, Japan; [Moro, Kazuyo] Yokohama City Univ, Grad Sch Med Life Sci, Dept Med Life Sci, Div Immunobiol, Yokohama, Kanagawa 232, Japan; [Kawamoto, Shimpei; Fagarasan, Sidonia] RIKEN, Res Ctr Integrat Med Sci, Lab Mucosal Immun, Yokohama, Kanagawa, Japan; [Nakae, Susumu] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Lab Syst Biol, Tokyo, Japan; [Saito, Hirohisa] Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Tokyo, Japan; [Li, Peng; Liao, Wei; Leonard, Warren J.] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Li, Peng; Liao, Wei; Leonard, Warren J.] NHLBI, Ctr Immunol, NIH, Bethesda, MD 20892 USA; [Shi, Wei] Univ Melbourne, Dept Comp & Informat Syst, Parkville, Vic 3052, Australia; [Smyth, Gordon K.] Univ Melbourne, Dept Math & Stat, Parkville, Vic 3052, Australia; [Koyasu, Shigeo] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; RIKEN; Japan Science & Technology Agency (JST); Yokohama City University; RIKEN; University of Tokyo; National Center for Child Health & Development - Japan; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Melbourne; University of Melbourne; Keio University	Kallies, A (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	kallies@wehi.edu.au	Masters, Seth L/N-2886-2013; Fagarasan, Sidonia/A-5258-2016; Smyth, Gordon/B-5276-2008; Moro, Kazuyo/A-5987-2016; Nutt, Stephen L/C-9256-2013; Leonard, Warren/AAA-1397-2022; Koyasu, Shigeo/J-5583-2015	Masters, Seth L/0000-0003-4763-576X; Fagarasan, Sidonia/0000-0003-2086-6402; Smyth, Gordon/0000-0001-9221-2892; Nutt, Stephen L/0000-0002-0020-6637; Koyasu, Shigeo/0000-0001-9585-3038; Mielke, Lisa/0000-0002-9522-9320; Wentworth, John/0000-0002-5197-3529; Kallies, Axel/0000-0002-6312-6968; Saito, Hirohisa/0000-0002-6630-8337; VASANTHAKUMAR, AJITHKUMAR/0000-0002-1620-7781; , Yang/0000-0002-9746-2839; Moro, Kazuyo/0000-0002-7377-1303	National Health and Medical Research Council of Australia; Sylvia and Charles Viertel Foundation; Australian Research Council; Diabetes Australia Research Trust; PRESTO from the Japan Science and Technology Agency; Japan Society for the Promotion of Science [22229004]; Division of Intramural Research, National Heart, Blood, and Lung Institute, US National Institutes of Health;  [26293110]; Grants-in-Aid for Scientific Research [22229004] Funding Source: KAKEN	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Foundation; Australian Research Council(Australian Research Council); Diabetes Australia Research Trust; PRESTO from the Japan Science and Technology Agency; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Division of Intramural Research, National Heart, Blood, and Lung Institute, US National Institutes of Health; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank P. O'Brien for assistance with tissue collection, S. Wada for animal care, M. Febbraio and A. Lew for critical advice, E. Cretney for mice and E. Bandala-Sanchez, V. Bryant and J. Brady for reagents. We are grateful to K. Nakanishi (Hyogo College of Medicine), T. Mak (The Campbell Family Institute for Breast Cancer Research), and U. Klein (Columbia University) for mice. Supported by the National Health and Medical Research Council of Australia (A.K., S.L.N. and G.K.S.), the Sylvia and Charles Viertel Foundation (A.K.), the Australian Research Council (A.K. and S.L.N.), the Diabetes Australia Research Trust (J. M. W.), PRESTO from the Japan Science and Technology Agency (K.M.), and a Grant-in Aid for Scientific Research (B) (26293110 to K.M.) and a Grant-in-Aid for Scientific Research (S) (22229004 to S. Koyasu) from the Japan Society for the Promotion of Science. W.L., P.L. and W.J.L. are supported by the Division of Intramural Research, National Heart, Blood, and Lung Institute, US National Institutes of Health. This study was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC Independent Research Institute Infrastructure Support scheme.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Bonilla WV, 2012, SCIENCE, V335, P984, DOI 10.1126/science.1215418; Boraschi D, 2013, SEMIN IMMUNOL, V25, P394, DOI 10.1016/j.smim.2013.10.023; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Brint EK, 2002, J BIOL CHEM, V277, P49205, DOI 10.1074/jbc.M209685200; Burzyn D, 2013, NAT IMMUNOL, V14, P1007, DOI 10.1038/ni.2683; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Chaudhry A, 2013, J CLIN INVEST, V123, P939, DOI 10.1172/JCI57175; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Cretney E, 2013, TRENDS IMMUNOL, V34, P74, DOI 10.1016/j.it.2012.11.002; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Feuerer M, 2010, P NATL ACAD SCI USA, V107, P5919, DOI 10.1073/pnas.1002006107; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; Gratz IK, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00333; Grusdat M, 2014, CELL DEATH DIFFER, V21, P1050, DOI 10.1038/cdd.2014.19; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Hall AO, 2012, IMMUNITY, V37, P511, DOI 10.1016/j.immuni.2012.06.014; Han JM, 2013, J IMMUNOL, V191, P527, DOI 10.4049/jimmunol.1301035; Hoshino K, 1999, J EXP MED, V190, P1541, DOI 10.1084/jem.190.10.1541; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kakkar R, 2008, NAT REV DRUG DISCOV, V7, P827, DOI 10.1038/nrd2660; Kallies A, 2006, NAT IMMUNOL, V7, P466, DOI 10.1038/ni1321; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Kawamoto S, 2012, SCIENCE, V336, P485, DOI 10.1126/science.1217718; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Kluge Reinhart, 2012, Methods Mol Biol, V933, P59, DOI 10.1007/978-1-62703-068-7_5; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Lee HY, 2014, EXP LUNG RES, V40, P66, DOI 10.3109/01902148.2013.870261; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Licona-Limon P, 2013, NAT IMMUNOL, V14, P536, DOI 10.1038/ni.2617; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Liston A, 2014, NAT REV IMMUNOL, V14, P154, DOI 10.1038/nri3605; Makrinioti H, 2014, LANCET RESP MED, V2, P226, DOI 10.1016/S2213-2600(13)70261-3; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; Martin MU, 2013, SEMIN IMMUNOL, V25, P449, DOI 10.1016/j.smim.2013.10.006; Miller AM, 2010, CIRC RES, V107, P650, DOI 10.1161/CIRCRESAHA.110.218867; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Murphy TL, 2013, NAT REV IMMUNOL, V13, P499, DOI 10.1038/nri3470; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Pierson W, 2013, NAT IMMUNOL, V14, P959, DOI 10.1038/ni.2649; Sakaguchi S, 2013, NAT REV IMMUNOL, V13, P461, DOI 10.1038/nri3464; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; Turnquist HR, 2011, J IMMUNOL, V187, P4598, DOI 10.4049/jimmunol.1100519; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Wang YQ, 2011, IMMUNITY, V35, P337, DOI 10.1016/j.immuni.2011.08.012; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Wood IS, 2009, BIOCHEM BIOPH RES CO, V384, P105, DOI 10.1016/j.bbrc.2009.04.081; Zeyda M, 2013, INT J OBESITY, V37, P658, DOI 10.1038/ijo.2012.118; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	65	360	367	4	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2015	16	3					276	U239		10.1038/ni.3085	http://dx.doi.org/10.1038/ni.3085			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB7XN	25599561				2022-12-18	WOS:000349842100011
J	Vosshenrich, CAJ; Garcia-Ojeda, ME; Samson-Villeger, SI; Pasqualetto, V; Enault, L; Goff, ORL; Corcuff, E; Guy-Grand, D; Rocha, B; Cumano, A; Rogge, L; Ezine, S; Di Santo, JP				Vosshenrich, Christian A. J.; Garcia-Ojeda, Marcos E.; Samson-Villeger, Sandrine I.; Pasqualetto, Valerie; Enault, Laurence; Goff, Odile Richard-Le; Corcuff, Erwan; Guy-Grand, Delphine; Rocha, Benedita; Cumano, Ana; Rogge, Lars; Ezine, Sophie; Di Santo, James P.			A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127	NATURE IMMUNOLOGY			English	Article							PERIPHERAL NK CELLS; T-CELL; DENDRITIC CELLS; IN-VIVO; EFFECTOR CELLS; LYMPH-NODES; IFN-GAMMA; MATURATION; MICE; SUBSET	Natural killer ( NK) cell development is thought to occur in the bone marrow. Here we identify the transcription factor GATA-3 and CD127 ( IL-7R alpha) as molecular markers of a pathway of mouse NK cell development that originates in the thymus. Thymus-derived CD127(+) NK cells repopulated peripheral lymphoid organs, and their homeostasis was strictly dependent on GATA-3 and interleukin 7. The CD127(+) NK cells had a distinct phenotype ( CD11b(Io)CD16(-)CD69(hi)Ly49(Io)) and unusual functional attributes, including reduced cytotoxicity but considerable cytokine production. Those characteristics are reminiscent of human CD56(hi)CD16(-) NK cells, which we found expressed CD127 and had more GATA-3 expression than human CD56(+)CD16(+) NK cells. We propose that bone marrow and thymic NK cell pathways generate distinct mouse NK cells with properties similar to those of the two human CD56 NK cell subsets.	Inst Pasteur, INSERM, Unite Cytokines & Dev Lymphoide, U668, F-75724 Paris, France; INSERM, Fac Necker Enfants Malades, U591, F-75015 Paris, France; Inst Pasteur, F-75724 Paris, France; INSERM, Unite Dev Lymphocytes, U668, F-75724 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Di Santo, JP (corresponding author), Inst Pasteur, INSERM, Unite Cytokines & Dev Lymphoide, U668, F-75724 Paris, France.	disanto@pasteur.fr	Rogge, Lars/GYJ-6142-2022; Ricoux, Valerie/X-1921-2019; Di Santo, James P/M-4298-2014; GOFF, odile RICHARD-LE/ABH-9553-2020; Vosshenrich, Christian AJ/M-6523-2014	Ricoux, Valerie/0000-0002-9812-8701; Di Santo, James P/0000-0002-7146-1862; Vosshenrich, Christian AJ/0000-0002-4407-8649; samson, sandrine/0000-0001-8365-5093; Rogge, Lars/0000-0003-1262-9204; richard-le goff, odile/0000-0002-6263-2375; Cumano, Ana/0000-0002-4578-959X				Chan CW, 2006, NAT MED, V12, P207, DOI 10.1038/nm1352; Cooper MA, 2002, BLOOD, V100, P3633, DOI 10.1182/blood-2001-12-0293; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; Degli-Esposti MA, 2005, NAT REV IMMUNOL, V5, P112, DOI 10.1038/nri1549; Di Santo JP, 2006, ANNU REV IMMUNOL, V24, P257, DOI 10.1146/annurev.immunol.24.021605.090700; Dong C, 2000, Sci STKE, V2000, ppe1, DOI 10.1126/stke.2000.49.pe1; Ferlazzo G, 2004, J IMMUNOL, V172, P1333, DOI 10.4049/jimmunol.172.3.1333; Freud AG, 2005, IMMUNITY, V22, P295, DOI 10.1016/j.immuni.2005.01.013; GARNIWAGNER BA, 1990, J IMMUNOL, V144, P796; Haddad R, 2006, IMMUNITY, V24, P217, DOI 10.1016/j.immuni.2006.01.008; HALLER O, 1977, J IMMUNOL, V118, P1503; HANSSON M, 1979, NATURE, V278, P174, DOI 10.1038/278174a0; He YW, 1996, J EXP MED, V184, P289, DOI 10.1084/jem.184.1.289; Hendriks RW, 1999, EUR J IMMUNOL, V29, P1912, DOI 10.1002/(SICI)1521-4141(199906)29:06<1912::AID-IMMU1912>3.3.CO;2-4; HERBERMAN RB, 1975, INT J CANCER, V16, P230, DOI 10.1002/ijc.2910160205; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; LEIDEN JM, 1993, ANNU REV IMMUNOL, V11, P539, DOI 10.1146/annurev.iy.11.040193.002543; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Michie AM, 2000, J IMMUNOL, V164, P1730, DOI 10.4049/jimmunol.164.4.1730; Moore TA, 1996, J IMMUNOL, V157, P2366; Mowen KA, 2004, IMMUNOL REV, V202, P203, DOI 10.1111/j.0105-2896.2004.00209.x; Mrozek E, 1996, BLOOD, V87, P2632, DOI 10.1182/blood.V87.7.2632.bloodjournal8772632; PENIX L, 1993, J EXP MED, V178, P1483, DOI 10.1084/jem.178.5.1483; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Puzanov IJ, 1996, J IMMUNOL, V157, P4282; RANSON T, 2003, BLOOD; Raulet DH, 2001, ANNU REV IMMUNOL, V19, P291, DOI 10.1146/annurev.immunol.19.1.291; Rosmaraki EE, 2001, EUR J IMMUNOL, V31, P1900, DOI 10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; Samson SI, 2003, IMMUNITY, V19, P701, DOI 10.1016/S1074-7613(03)00294-2; SANCHEZ MJ, 1994, J EXP MED, V180, P859; Schott E, 2003, J EXP MED, V198, P1213, DOI 10.1084/jem.20030918; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; Spits H, 1998, IMMUNOL REV, V165, P75, DOI 10.1111/j.1600-065X.1998.tb01231.x; Taieb J, 2006, NAT MED, V12, P214, DOI 10.1038/nm1356; Takeda K, 2005, BLOOD, V105, P2082, DOI 10.1182/blood-2004-08-3262; Taki S, 2005, J IMMUNOL, V174, P6005, DOI 10.4049/jimmunol.174.10.6005; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Vosshenrich CAJ, 2005, J IMMUNOL, V174, P1213, DOI 10.4049/jimmunol.174.3.1213; Vosshenrich CAJ, 2005, CURR OPIN IMMUNOL, V17, P151, DOI 10.1016/j.coi.2005.01.005	42	360	374	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2006	7	11					1217	1224		10.1038/ni1395	http://dx.doi.org/10.1038/ni1395			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HF	17013389				2022-12-18	WOS:000241437200017
J	Hoebe, K; Janssen, EM; Kim, SO; Alexopoulou, L; Flavell, RA; Han, JH; Beutler, B				Hoebe, K; Janssen, EM; Kim, SO; Alexopoulou, L; Flavell, RA; Han, JH; Beutler, B			Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways	NATURE IMMUNOLOGY			English	Article							TOLL-LIKE RECEPTORS; T-CELL-ACTIVATION; CD40 LIGAND; IMMUNOLOGICAL PROPERTIES; DENDRITIC CELLS; IRF-2 GENES; IN-VIVO; ENDOTOXIN; MICE; LPS	Both lipopolysaccharide (LPS) and double-stranded RNA (dsRNA) are adjuvants for the adaptive immune response, inducing upregulation of costimulatory molecules (UCM) on antigen-presenting cells. Trif, an adapter protein that transduces signals from Toll-like receptor 4 (TLR4) and TLR3, permits the induction of many cytokines, including interferon-beta, which signals through the type I interferon receptor. We show here that LPS-induced UCM was strictly dependent on the TLR4 --> Trif axis, whereas dsRNA-induced UCM was only partly dependent on the TLR3 --> Trif axis. But both LPS- and dsRNA-induced UCM were entirely dependent on type I interferon receptor signaling. These findings show that UCM involves an autocrine or paracrine loop, and indicate that an alternative TLR3-independent, Trif-independent pathway contributes to dsRNA-induced UCM.	Scripps Res Inst, La Jolla, CA 92037 USA; La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92121 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA	Scripps Research Institute; La Jolla Institute for Immunology; Yale University	Beutler, B (corresponding author), Scripps Res Inst, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		KIM, Sung Ouk/A-1309-2008; Han, J/G-4671-2010; Alexopoulou, Lena/A-5041-2017; Kim, Sung Ouk/AAO-1795-2020	Alexopoulou, Lena/0000-0003-4619-697X; Kim, Sung Ouk/0000-0002-0282-6661; Hoebe, Kasper/0000-0002-3626-8098				Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Borriello F, 1997, IMMUNITY, V6, P303, DOI 10.1016/S1074-7613(00)80333-7; CAYABYAB M, 1994, J IMMUNOL, V152, P1523; CONDIE RM, 1955, P SOC EXP BIOL MED, V90, P355, DOI 10.3181/00379727-90-22032; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Freund J, 1937, P SOC EXP BIOL MED, V37, P509; Grewal IS, 1996, IMMUNOL REV, V153, P85, DOI 10.1111/j.1600-065X.1996.tb00921.x; Grewal IS, 1996, SCIENCE, V273, P1864, DOI 10.1126/science.273.5283.1864; HARADA H, 1990, CELL, V63, P303, DOI 10.1016/0092-8674(90)90163-9; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; HARADA H, 1994, MOL CELL BIOL, V14, P1500, DOI 10.1128/MCB.14.2.1500; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; HU YH, 1993, J INTERFERON RES, V13, P323, DOI 10.1089/jir.1993.13.323; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Kaisho T, 2001, TRENDS IMMUNOL, V22, P78, DOI 10.1016/S1471-4906(00)01811-1; Kaisho T, 2002, INT IMMUNOL, V14, P695, DOI 10.1093/intimm/dxf039; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kim SO, 2001, AM J PHYSIOL-LUNG C, V281, pL1095, DOI 10.1152/ajplung.2001.281.5.L1095; Lewis PA, 1924, J EXP MED, V40, P503, DOI 10.1084/jem.40.4.503; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; PINE R, 1994, EMBO J, V13, P158, DOI 10.1002/j.1460-2075.1994.tb06245.x; Poltorak A, 1998, BLOOD CELL MOL DIS, V24, P340, DOI 10.1006/bcmd.1998.0201; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; SCHMIDTKE JR, 1971, J IMMUNOL, V106, P1191; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Schoenberger SP, 1998, CANCER RES, V58, P3094; SKIDMORE BJ, 1975, J IMMUNOL, V114, P770; SKIDMORE BJ, 1976, J EXP MED, V143, P143, DOI 10.1084/jem.143.1.143; SOMOZA C, 1995, RES IMMUNOL, V146, P171, DOI 10.1016/0923-2494(96)80253-7; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	35	360	376	1	15	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2003	4	12					1223	1229		10.1038/ni1010	http://dx.doi.org/10.1038/ni1010			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	746VZ	14625548				2022-12-18	WOS:000186769500016
J	Joly, E; Hudrisier, D				Joly, E; Hudrisier, D			What is trogocytosis and what is its purpose?	NATURE IMMUNOLOGY			English	Letter							PEPTIDE-MHC COMPLEXES; IMMUNOLOGICAL SYNAPSE; T-CELLS		CHU Purpan, INSERM, U563, Inst Claude Preval, Toulouse, France	CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Joly, E (corresponding author), CHU Purpan, INSERM, U563, Inst Claude Preval, Toulouse, France.		Joly, Etienne/A-5644-2009	Joly, Etienne/0000-0002-7264-2681; Hudrisier, Denis/0000-0002-3631-9561				Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Hudrisier D, 2001, J IMMUNOL, V166, P3645, DOI 10.4049/jimmunol.166.6.3645; Hudrisier D, 2002, ELSO GAZ, V9, P1; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; Kedl RM, 2002, NAT IMMUNOL, V3, P27, DOI 10.1038/ni742; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Tabiasco J, 2003, J IMMUNOL, V170, P5993, DOI 10.4049/jimmunol.170.12.5993	7	360	373	2	35	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2003	4	9					815	815		10.1038/ni0903-815	http://dx.doi.org/10.1038/ni0903-815			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	715YN	12942076	Bronze			2022-12-18	WOS:000185002200002
J	Zeng, XM; Winter, DB; Kasmer, C; Kraemer, KH; Lehmann, AR; Gearhart, PJ				Zeng, XM; Winter, DB; Kasmer, C; Kraemer, KH; Lehmann, AR; Gearhart, PJ			DNA polymerase eta is an A-T mutator in somatic hypermutation of immunoglobulin variable genes	NATURE IMMUNOLOGY			English	Article							XERODERMA-PIGMENTOSUM VARIANT; DOUBLE-STRAND BREAKS; THYMINE-THYMINE DIMER; TRANSLESION SYNTHESIS; MICE DEFICIENT; REPAIR; FIDELITY; BYPASS; KAPPA; CELLS	To determine whether DNA polymerase eta plays a role in the hypermutation of immunoglobulin variable genes, we examined the frequency and pattern of substitutions in variable V(H)6 genes from the peripheral blood lymphocytes of three patients with xeroderma pigmentosum variant disease, whose polymerase eta had genetic defects. The frequency of mutation was normal but the types of base changes were different: there was a decrease in mutations at A and T and a concomitant rise in mutations at G and C. We propose that more than one polymerase contributes to hypermutation and that if one is absent, others compensate. The data indicate that polymerase eta is involved in generating errors that occur predominantly at A and T and that another polymerase(s) may generating errors that occur predominantly at A preferentially generate errors opposite G and C.	NIA, Mol Genet Lab, NIH, Baltimore, MD 21224 USA; Walter Reed Army Inst Res, Dept Cellular Injury, Silver Spring, MD 20910 USA; NCI, Basic Res Lab, NIH, Bethesda, MD 20892 USA; Univ Sussex, MRC, Cell Mutat Unit, Brighton, E Sussex, England	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Sussex	Gearhart, PJ (corresponding author), NIA, Mol Genet Lab, NIH, Baltimore, MD 21224 USA.	gearhartp@grc.nia.nih.gov	Gearhart, Patricia/Y-7227-2019	Kraemer, Kenneth/0000-0002-2689-3316	NATIONAL CANCER INSTITUTE [Z01BC004517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000732] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 BC004517-31] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Aoufouchi S, 2000, NUCLEIC ACIDS RES, V28, P3684, DOI 10.1093/nar/28.18.3684; BERTHJONES J, 1990, BRIT J DERMATOL, V122, P559, DOI 10.1111/j.1365-2133.1990.tb14734.x; BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6; Brezinschek HP, 1998, J IMMUNOL, V160, P4762; Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5; Corbett SJ, 1997, J MOL BIOL, V270, P587, DOI 10.1006/jmbi.1997.1141; Denepoux S, 1997, IMMUNITY, V6, P35, DOI 10.1016/S1074-7613(00)80240-X; Dominguez O, 2000, EMBO J, V19, P1731, DOI 10.1093/emboj/19.7.1731; Foster SJ, 1999, EUR J IMMUNOL, V29, P3122, DOI 10.1002/(SICI)1521-4141(199910)29:10<3122::AID-IMMU3122>3.3.CO;2-F; FRANK EG, 2001, IN PRESS EMBO J, V20; Garcia-Diaz M, 2000, J MOL BIOL, V301, P851, DOI 10.1006/jmbi.2000.4005; GEARHART PJ, 1983, P NATL ACAD SCI-BIOL, V80, P3439, DOI 10.1073/pnas.80.11.3439; Goodman MF, 2000, NAT REV MOL CELL BIO, V1, P101, DOI 10.1038/35040051; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447; Kannouche P, 2001, GENE DEV, V15, P158, DOI 10.1101/gad.187501; Kim N, 1999, J EXP MED, V190, P21, DOI 10.1084/jem.190.1.21; Kraemer K H, 1985, Clin Dermatol, V3, P33, DOI 10.1016/0738-081X(85)90096-3; LEBECQUE SG, 1990, J EXP MED, V172, P1717, DOI 10.1084/jem.172.6.1717; LEHMANN AR, 1975, P NATL ACAD SCI USA, V72, P219, DOI 10.1073/pnas.72.1.219; Masutani C, 2000, EMBO J, V19, P3100, DOI 10.1093/emboj/19.12.3100; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Matsuda T, 2000, NATURE, V404, P1011, DOI 10.1038/35010014; Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646; Ohashi E, 2000, J BIOL CHEM, V275, P39678, DOI 10.1074/jbc.M005309200; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Phung QH, 1998, J EXP MED, V187, P1745, DOI 10.1084/jem.187.11.1745; Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; Rosner K, 2001, J CLIN IMMUNOL, V21, P102, DOI 10.1023/A:1011003821798; ROSNER K, 2001, IN PRESS IMMUNOLOGY, V103; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; SANZ I, 1989, EMBO J, V8, P3741, DOI 10.1002/j.1460-2075.1989.tb08550.x; Sharief FS, 1999, GENOMICS, V59, P90, DOI 10.1006/geno.1999.5843; Smith DS, 1996, J IMMUNOL, V156, P2642; Spencer J, 1999, J IMMUNOL, V162, P6596; Tissier A, 2000, GENE DEV, V14, P1642; Tissier A, 2000, EMBO J, V19, P5259, DOI 10.1093/emboj/19.19.5259; WANG YC, 1993, MOL CELL BIOL, V13, P4276, DOI 10.1128/MCB.13.7.4276; Wiesendanger M, 2000, J EXP MED, V191, P579, DOI 10.1084/jem.191.3.579; Winter DB, 2000, MOL IMMUNOL, V37, P125, DOI 10.1016/S0161-5890(00)00040-7; Winter DB, 1998, P NATL ACAD SCI USA, V95, P6953, DOI 10.1073/pnas.95.12.6953; Wittschieben J, 2000, CURR BIOL, V10, P1217, DOI 10.1016/S0960-9822(00)00725-9; Wood RJ, 2001, PHILOS T ROY SOC B, V356, P3, DOI 10.1098/rstb.2000.0741; Yamada A, 2000, NUCLEIC ACIDS RES, V28, P2473, DOI 10.1093/nar/28.13.2473	49	360	365	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2001	2	6					537	541		10.1038/88740	http://dx.doi.org/10.1038/88740			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	438WV	11376341				2022-12-18	WOS:000169078000017
J	Lang, R; Pauleau, AL; Parganas, E; Takahashi, Y; Mages, J; Ihle, JN; Rutschman, R; Murray, PJ				Lang, R; Pauleau, AL; Parganas, E; Takahashi, Y; Mages, J; Ihle, JN; Rutschman, R; Murray, PJ			SOCS3 regulates the plasticity of gp130 signaling	NATURE IMMUNOLOGY			English	Article							MICE LACKING SUPPRESSOR; CYTOKINE SIGNALING-3; GENE-EXPRESSION; MESSENGER-RNA; ACTIVATION; TRANSDUCTION; RECEPTOR; MACROPHAGES; RESPONSES; PATHWAY	Suppressor of cytokine signaling (SOCS) proteins are feedback inhibitors of the Janus kinase (JAK) and signal transducer and activator of transcription (STAT) signaling pathway. SOCS3 is upregulated by several signals in macrophages and has been implicated as a regulator of various signaling pathways. Here we show that phosphorylation of STAT3 is prolonged in mouse Socs3-deficient macrophages after stimulation with interleukin-6 (IL-6) but not IL-10, indicating that SOCS3 specifically affects signaling mediated by IL-6 and gp130. IL-6 induces a wider transcriptional response in Socs3-deficient macrophages than in wild-type cells; this response is dominated by interferon (IFN)-regulated genes owing to an excess of STAT1 phosphorylation. Thus, SOCS3 functions to control the quality of the response to IL-6 and prevents the activation of an IFN-induced program of gene expression.	St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; Tech Univ Munich, Inst Med Mikrobiol Immunol & Hyg, Munich, Germany; St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA	St Jude Children's Research Hospital; Technical University of Munich; St Jude Children's Research Hospital	Murray, PJ (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	peter.murray@stjude.org	Lang, Roland/C-3287-2011; Murray, Peter J/K-4725-2018	Murray, Peter J/0000-0001-6329-9802; Lang, Roland/0000-0003-0502-3677	NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI053478] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA 21765] Funding Source: Medline; NIAID NIH HHS [AI53478-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alexander WS, 1999, J LEUKOCYTE BIOL, V66, P588, DOI 10.1002/jlb.66.4.588; Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Auernhammer CJ, 1999, P NATL ACAD SCI USA, V96, P6964, DOI 10.1073/pnas.96.12.6964; Berlato C, 2002, J IMMUNOL, V168, P6404, DOI 10.4049/jimmunol.168.12.6404; Bode JG, 1999, FEBS LETT, V463, P365, DOI 10.1016/S0014-5793(99)01662-2; Cacalano NA, 2001, NAT CELL BIOL, V3, P460, DOI 10.1038/35074525; Cassatella MA, 1999, BLOOD, V94, P2880, DOI 10.1182/blood.V94.8.2880.420k31_2880_2889; Costa-Pereira AP, 2002, P NATL ACAD SCI USA, V99, P8043, DOI 10.1073/pnas.122236099; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Dalpke AH, 2001, J IMMUNOL, V166, P7082, DOI 10.4049/jimmunol.166.12.7082; De Souza D, 2002, BIOCHEMISTRY-US, V41, P9229, DOI 10.1021/bi0259507; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Donnelly RP, 1999, J INTERF CYTOK RES, V19, P563, DOI 10.1089/107999099313695; Friederichs K, 2001, EUR J BIOCHEM, V268, P6401, DOI 10.1046/j.0014-2956.2001.02586.x; Greenhalgh CJ, 2002, J BIOL CHEM, V277, P40181, DOI 10.1074/jbc.C200450200; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Hortner M, 2002, J IMMUNOL, V169, P1219, DOI 10.4049/jimmunol.169.3.1219; Hortner M, 2002, EUR J BIOCHEM, V269, P2516, DOI 10.1046/j.1432-1033.2002.02916.x; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; Lang R, 2002, J IMMUNOL, V169, P2253, DOI 10.4049/jimmunol.169.5.2253; Marine JC, 1999, CELL, V98, P617, DOI 10.1016/S0092-8674(00)80049-5; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Metcalf D, 2000, NATURE, V405, P1069, DOI 10.1038/35016611; Nicholson SE, 2000, P NATL ACAD SCI USA, V97, P6493, DOI 10.1073/pnas.100135197; Ohtani T, 2000, IMMUNITY, V12, P95, DOI 10.1016/S1074-7613(00)80162-4; Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7; Roberts AW, 2001, P NATL ACAD SCI USA, V98, P9324, DOI 10.1073/pnas.161271798; Schmitz J, 2000, J BIOL CHEM, V275, P12848, DOI 10.1074/jbc.275.17.12848; Shouda T, 2001, J CLIN INVEST, V108, P1781, DOI 10.1172/JCI13568; Stoiber D, 1999, J IMMUNOL, V163, P2640; Stoiber D, 2001, J IMMUNOL, V166, P466, DOI 10.4049/jimmunol.166.1.466; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Takahashi Y, 2003, EMBO J, V22, P372, DOI 10.1093/emboj/cdg057; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763	35	358	369	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2003	4	6					546	550		10.1038/ni932	http://dx.doi.org/10.1038/ni932			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	683XC	12754506				2022-12-18	WOS:000183175500013
J	Mathewson, ND; Jenq, R; Mathew, AV; Koenigsknecht, M; Hanash, A; Toubai, T; Oravecz-Wilson, K; Wu, SR; Sun, YP; Rossi, C; Fujiwara, H; Byun, J; Shono, Y; Lindemans, C; Calafiore, M; Schmidt, TC; Honda, K; Young, VB; Pennathur, S; van den Brink, M; Reddy, P				Mathewson, Nathan D.; Jenq, Robert; Mathew, Anna V.; Koenigsknecht, Mark; Hanash, Alan; Toubai, Tomomi; Oravecz-Wilson, Katherine; Wu, Shin-Rong; Sun, Yaping; Rossi, Corinne; Fujiwara, Hideaki; Byun, Jaeman; Shono, Yusuke; Lindemans, Caroline; Calafiore, Marco; Schmidt, Thomas C.; Honda, Kenya; Young, Vincent B.; Pennathur, Subramaniam; van den Brink, Marcel; Reddy, Pavan			Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease	NATURE IMMUNOLOGY			English	Article							CHAIN FATTY-ACIDS; HISTONE DEACETYLASE INHIBITION; BONE-MARROW-TRANSPLANTATION; REGULATORY T-CELLS; STEM-CELL; GASTROINTESTINAL-TRACT; SODIUM-BUTYRATE; PERMEABILITY; COLON; HYPERTENSION	The effect of alterations in intestinal microbiota on microbial metabolites and on disease processes such as graft-versus-host disease (GVHD) is not known. Here we carried out an unbiased analysis to identify previously unidentified alterations in gastrointestinal microbiota-derived short-chain fatty acids (SCFAs) after allogeneic bone marrow transplant (allo-BMT). Alterations in the amount of only one SCFA, butyrate, were observed only in the intestinal tissue. The reduced butyrate in CD326(+) intestinal epithelial cells (IECs) after allo-BMT resulted in decreased histone acetylation, which was restored after local administration of exogenous butyrate. Butyrate restoration improved IEC junctional integrity, decreased apoptosis and mitigated GVHD. Furthermore, alteration of the indigenous microbiota with 17 rationally selected strains of high butyrate-producing Clostridia also decreased GVHD. These data demonstrate a heretofore unrecognized role of microbial metabolites and suggest that local and specific alteration of microbial metabolites has direct salutary effects on GVHD target tissues and can mitigate disease severity.	[Mathewson, Nathan D.; Toubai, Tomomi; Oravecz-Wilson, Katherine; Wu, Shin-Rong; Sun, Yaping; Rossi, Corinne; Fujiwara, Hideaki; Reddy, Pavan] Univ Michigan, Dept Internal Med, Ctr Comprehens Canc, Div Hematol Oncol, Ann Arbor, MI 48109 USA; [Mathewson, Nathan D.; Wu, Shin-Rong] Univ Michigan, Sch Med, Grad Program Immunol, Ann Arbor, MI USA; [Jenq, Robert; Hanash, Alan; Shono, Yusuke; Lindemans, Caroline; Calafiore, Marco; van den Brink, Marcel] Mem Sloan Kettering Canc Ctr, Adult Bone Marrow Transplantat Serv, 1275 York Ave, New York, NY 10021 USA; [Mathew, Anna V.; Byun, Jaeman; Pennathur, Subramaniam] Univ Michigan Hlth Syst, Div Nephrol, Dept Internal Med, Ann Arbor, MI USA; [Koenigsknecht, Mark; Schmidt, Thomas C.; Young, Vincent B.] Univ Michigan Hlth Syst, Div Infect Dis, Dept Internal Med, Ann Arbor, MI USA; [Honda, Kenya] RIKEN Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Memorial Sloan Kettering Cancer Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; RIKEN	Reddy, P (corresponding author), Univ Michigan, Dept Internal Med, Ctr Comprehens Canc, Div Hematol Oncol, Ann Arbor, MI 48109 USA.	reddypr@med.umich.edu	van den Brink, Marcel R. M./HGB-9434-2022; Young, Vincent Bensan/M-9916-2019; Fujiwara, Hideaki/ABI-6034-2020; Mathew, Anna V/V-2511-2018; Young, Vincent B/B-3179-2009	Young, Vincent Bensan/0000-0003-3687-2364; Young, Vincent B/0000-0003-3687-2364; Mathewson, Nathan/0000-0002-8895-2609; Reddy, Pavan/0000-0001-7264-8429; Schmidt, Thomas/0000-0002-8209-6055; Mathew, Anna/0000-0002-7043-4221	US National Institutes of Health (NIH) (National Heart, Lung and Blood Institute) [HL-090775, HL-128046]; US National Institutes of Health (NIH) (National Cancer Institute) [CA-173878]; Molecular Phenotyping Core, Michigan Nutrition and Obesity Center [DK089503]; Michigan Regional Metabolomics Resource Core [DK097153]; University of Michigan Cancer Center (NIH) [CA46592]; University of Michigan Gut Peptide Research Center (NIH) [DK34933]; NATIONAL CANCER INSTITUTE [P01CA023766, P30CA046592, R01CA173878] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL115355, R01HL125571, R01HL128046, R01HL090775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503, P30DK034933, U24DK097153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) (National Heart, Lung and Blood Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US National Institutes of Health (NIH) (National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Molecular Phenotyping Core, Michigan Nutrition and Obesity Center; Michigan Regional Metabolomics Resource Core; University of Michigan Cancer Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Gut Peptide Research Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the US National Institutes of Health (NIH) (National Heart, Lung and Blood Institute, grants HL-090775 and HL-128046 (to P.R.); National Cancer Institute, grant CA-173878 (to P.R.)). Metabolomic studies were performed through the Molecular Phenotyping Core, Michigan Nutrition and Obesity Center (grant DK089503 (to S.P.)) and Michigan Regional Metabolomics Resource Core (grant DK097153 (to S.P.)). We acknowledge use of the Microscopy & Image-analysis Laboratory (MIL) of the University of Michigan's Biomedical Research Core Facilities for preparation of samples and images. Support for the MIL core is provided by the University of Michigan Cancer Center (NIH grant CA46592) and the University of Michigan Gut Peptide Research Center (NIH grant DK34933).	Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; Charney AN, 1998, AM J PHYSIOL-GASTR L, V274, pG518, DOI 10.1152/ajpgi.1998.274.3.G518; Choi S, 2010, PANMINERVA MED, V52, P111; Choi SW, 2014, LANCET ONCOL, V15, P87, DOI 10.1016/S1470-2045(13)70512-6; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cook SI, 1998, ALIMENT PHARM THER, V12, P499, DOI 10.1046/j.1365-2036.1998.00337.x; Cresci GA, 2010, J GASTROINTEST SURG, V14, P449, DOI 10.1007/s11605-009-1045-x; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Ell B, 2013, TRENDS CELL BIOL, V23, P603, DOI 10.1016/j.tcb.2013.06.001; Eriguchi Y, 2012, BLOOD, V120, P223, DOI 10.1182/blood-2011-12-401166; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; FLEMING LL, 1986, AM J GASTROENTEROL, V81, P507; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Ganapathy V, 2013, CURR OPIN PHARMACOL, V13, P869, DOI 10.1016/j.coph.2013.08.006; Gao SM, 2013, EXP HEMATOL, V41, P261, DOI 10.1016/j.exphem.2012.10.012; Hanash AM, 2012, IMMUNITY, V37, P339, DOI 10.1016/j.immuni.2012.05.028; Hill GR, 2000, BLOOD, V95, P2754, DOI 10.1182/blood.V95.9.2754.009k25_2754_2759; Iyengar S, 2014, BIOL BLOOD MARROW TR, V20, P1104, DOI 10.1016/j.bbmt.2014.04.029; Jenq RR, 2012, J EXP MED, V209, P902, DOI 10.1084/jem.20112408; Jenq RR, 2010, NAT REV CANCER, V10, P213, DOI 10.1038/nrc2804; Koenigsknecht MJ, 2015, INFECT IMMUN, V83, P934, DOI 10.1128/IAI.02768-14; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lahl K, 2011, METHODS MOL BIOL, V707, P157, DOI 10.1007/978-1-61737-979-6_10; Lefrancois L., 2001, ISOLATION MOUSE SMAL; Mathew AV, 2015, J CARD FAIL, V21, P963, DOI 10.1016/j.cardfail.2015.10.003; Mathewson N, 2015, CURR STEM CELL REP, V1, P39, DOI 10.1007/s40778-014-0002-0; Mell B, 2015, PHYSIOL GENOMICS, V47, P187, DOI 10.1152/physiolgenomics.00136.2014; Narushima S, 2014, GUT MICROBES, V5, P333, DOI 10.4161/gmic.28572; Noth R, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-109; Reddy P, 2005, NAT MED, V11, P1244, DOI 10.1038/nm1309; Reddy P, 2004, P NATL ACAD SCI USA, V101, P3921, DOI 10.1073/pnas.0400380101; Reddy P, 2008, J CLIN INVEST, V118, P2562, DOI 10.1172/JCI34712; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SEALY L, 1978, CELL, V14, P115, DOI 10.1016/0092-8674(78)90306-9; Soler AP, 1999, CARCINOGENESIS, V20, P1425, DOI 10.1093/carcin/20.8.1425; Sun YP, 2009, J IMMUNOL, V182, P5899, DOI 10.4049/jimmunol.0804388; Suzuki T, 2013, CELL MOL LIFE SCI, V70, P631, DOI 10.1007/s00018-012-1070-x; Takashima S, 2011, J EXP MED, V208, P285, DOI 10.1084/jem.20101559; Taur Y, 2014, BLOOD, V124, P1174, DOI 10.1182/blood-2014-02-554725; Topham CH, 2013, CURR OPIN CELL BIOL, V25, P780, DOI 10.1016/j.ceb.2013.07.003; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015	47	356	369	5	99	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2016	17	5					505	+		10.1038/ni.3400	http://dx.doi.org/10.1038/ni.3400			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ6LA	26998764	Green Accepted			2022-12-18	WOS:000374323100009
J	Van, TC; Frohlich, A; Steinhauser, G; Scheel, T; Roch, T; Fillatreau, S; Lee, JJ; Lohning, M; Berek, C				Van Trung Chu; Froehlich, Anja; Steinhauser, Gudrun; Scheel, Tobias; Roch, Toralf; Fillatreau, Simon; Lee, James J.; Loehning, Max; Berek, Claudia			Eosinophils are required for the maintenance of plasma cells in the bone marrow	NATURE IMMUNOLOGY			English	Article							MEMORY B-CELLS; IMMUNE-RESPONSE; STROMAL CELLS; IN-VIVO; SURVIVAL; CXCR4; APRIL; EXPRESSION; MATURATION; CHEMOKINE	Plasma cells are of crucial importance for long-term immune protection. It is thought that long-lived plasma cells survive in specialized niches in the bone marrow. Here we demonstrate that bone marrow eosinophils localized together with plasma cells and were the key providers of plasma cell survival factors. In vitro, eosinophils supported the survival of plasma cells by secreting the proliferation-inducing ligand APRIL and interleukin-6 (IL-6). In eosinophil-deficient mice, plasma cell numbers were much lower in the bone marrow both at steady state and after immunization. Reconstitution experiments showed that eosinophils were crucial for the retention of plasma cells in the bone marrow. Moreover, depletion of eosinophils induced apoptosis in long-lived bone marrow plasma cells. Our findings demonstrate that the long-term maintenance of plasma cells in the bone marrow requires eosinophils.	[Van Trung Chu; Froehlich, Anja; Steinhauser, Gudrun; Scheel, Tobias; Roch, Toralf; Fillatreau, Simon; Loehning, Max; Berek, Claudia] Inst Leibniz Gemeinschaft, Deutsch Rheuma Forschungszentrum, Berlin, Germany; [Froehlich, Anja; Loehning, Max] Charite, Dept Rheumatol & Clin Immunol, D-13353 Berlin, Germany; [Lee, James J.] Mayo Clin Arizona, Div Pulm Med, Dept Biochem & Mol Biol, Scottsdale, AZ USA	Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Mayo Clinic; Mayo Clinic Phoenix	Berek, C (corresponding author), Inst Leibniz Gemeinschaft, Deutsch Rheuma Forschungszentrum, Berlin, Germany.	berek@drfz.de	Löhning, Max/AAL-2967-2021; Roch, Toralf/AAQ-7480-2021; Roch, Toralf/K-9531-2013	Löhning, Max/0000-0001-6382-7281; Chu, Van Trung/0000-0003-1327-8696; Fillatreau, Simon/0000-0002-7730-9917; Roch, Toralf/0000-0003-2948-8700	Deutsche Forschungsgemeinschaft [BE 1171/2-1, SFB 618, SFB 650]; Bundesministerium fur Bildung und Forschung [0315267D]; Volkswagen Foundation; Berlin Senate of Research and Education	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Volkswagen Foundation(Volkswagen); Berlin Senate of Research and Education	We thank N.A. Lee (Mayo Clinic, Scottsdale, Arizona, USA) for MBP-specific antibody; the members of the Deutsches Rheuma-Forschungszentrum, in particular T. Kaiser, for technical support; and R. S. Jack, A. Hegazy and A. Radbruch for critical reading of the manuscript. Supported by Deutsche Forschungsgemeinschaft (BE 1171/2-1 to C. B.; SFB 618 and SFB 650 to M. L.), Bundesministerium fur Bildung und Forschung (0315267D to M. L.), the Volkswagen Foundation (Lichtenberg Professorship to M. L.) and the Berlin Senate of Research and Education (to Deutsches Rheuma-Forschungszentrum).	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Belnoue E, 2008, BLOOD, V111, P2755, DOI 10.1182/blood-2007-09-110858; BENNER R, 1981, CLIN EXP IMMUNOL, V46, P1; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; BEREK C, 1987, IMMUNOL REV, V96, P23, DOI 10.1111/j.1600-065X.1987.tb00507.x; Blink EJ, 2005, J EXP MED, V201, P545, DOI 10.1084/jem.20042060; Cassese G, 2003, J IMMUNOL, V171, P1684, DOI 10.4049/jimmunol.171.4.1684; Cerutti A, 2008, MUCOSAL IMMUNOL, V1, P8, DOI 10.1038/mi.2007.8; Chu VT, 2007, J IMMUNOL, V179, P5947, DOI 10.4049/jimmunol.179.9.5947; DILOSA RM, 1991, J IMMUNOL, V146, P4071; Fairfax KA, 2008, SEMIN IMMUNOL, V20, P49, DOI 10.1016/j.smim.2007.12.002; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Hauser AE, 2002, J IMMUNOL, V169, P1277, DOI 10.4049/jimmunol.169.3.1277; HE B, 2007, J IMMUNOL, V28, P812; Hogan SP, 2007, INT ARCH ALLERGY IMM, V143, P3, DOI 10.1159/000101398; Huard B, 2008, J CLIN INVEST, V118, P2887, DOI 10.1172/JCI33760; Jordan MB, 2004, SCIENCE, V304, P1808, DOI 10.1126/science.1089926; JUHLIN L, 1977, LANCET, V1, P1233; Lamb RJ, 2007, J IMMUNOL, V178, P7833, DOI 10.4049/jimmunol.178.12.7833; Lee JJ, 1997, J EXP MED, V185, P2143, DOI 10.1084/jem.185.12.2143; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; Lohning M, 2008, J EXP MED, V205, P53, DOI 10.1084/jem.20071855; Ma Q, 1999, IMMUNITY, V10, P463, DOI 10.1016/S1074-7613(00)80046-1; Mamani-Matsuda M, 2008, BLOOD, V111, P4653, DOI 10.1182/blood-2007-11-123844; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; MCGARRY MP, 1991, J LEUKOCYTE BIOL, V50, P471, DOI 10.1002/jlb.50.5.471; Mckee AS, 2009, J IMMUNOL, V183, P4403, DOI 10.4049/jimmunol.0900164; Mhawech-Fauceglia P, 2006, J LEUKOCYTE BIOL, V80, P697, DOI 10.1189/jlb.1105655; Mohr E, 2009, J IMMUNOL, V182, P2113, DOI 10.4049/jimmunol.0802771; Nagase H, 2000, J IMMUNOL, V164, P5935, DOI 10.4049/jimmunol.164.11.5935; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Spencer LA, 2010, IMMUNOL CELL BIOL, V88, P250, DOI 10.1038/icb.2009.115; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Wols HAM, 2002, J IMMUNOL, V169, P4213, DOI 10.4049/jimmunol.169.8.4213; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Zimmermann N, 2008, ALLERGY, V63, P1156, DOI 10.1111/j.1398-9995.2008.01709.x	40	356	370	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2011	12	2					151	U64		10.1038/ni.1981	http://dx.doi.org/10.1038/ni.1981			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	708QF	21217761				2022-12-18	WOS:000286378400009
J	Maj, T; Wang, W; Crespo, J; Zhang, HJ; Wang, WM; Wei, S; Zhao, LL; Vatan, L; Shao, I; Szeliga, W; Lyssiotis, C; Liu, JR; Kryczek, I; Zou, WP				Maj, Tomasz; Wang, Wei; Crespo, Joel; Zhang, Hongjuan; Wang, Weimin; Wei, Shuang; Zhao, Lili; Vatan, Linda; Shao, Irene; Szeliga, Wojciech; Lyssiotis, Costas; Liu, J. Rebecca; Kryczek, Ilona; Zou, Weiping			Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor	NATURE IMMUNOLOGY			English	Article							TRANSCRIPTION FACTOR; METABOLIC CHECKPOINT; ANTITUMOR IMMUNITY; EFFECTOR FUNCTION; CANCER; ACTIVATION; FOXP3; MICROENVIRONMENT; DIFFERENTIATION; GENERATION	Live regulatory T cells (T-reg cells) suppress antitumor immunity, but how T-reg cells behave in the metabolically abnormal tumor microenvironment remains unknown. Here we show that tumor T-reg cells undergo apoptosis, and such apoptotic T-reg cells abolish spontaneous and PD-L1-blockade-mediated antitumor T cell immunity. Biochemical and functional analyses show that adenosine, but not typical suppressive factors such as PD-L1, CTLA-4, TGF-beta, IL-35, and IL-10, contributes to apoptotic T-reg-cell-mediated immunosuppression. Mechanistically, apoptotic T-reg cells release and convert a large amount of ATP to adenosine via CD39 and CD73, and mediate immunosuppression via the adenosine and A(2A) pathways. Apoptosis in T-reg cells is attributed to their weak NRF2-associated antioxidant system and high vulnerability to free oxygen species in the tumor microenvironment. Thus, the data support a model wherein tumor T-reg cells sustain and amplify their suppressor capacity through inadvertent death via oxidative stress. This work highlights the oxidative pathway as a metabolic checkpoint that controls T-reg cell behavior and affects the efficacy of therapeutics targeting cancer checkpoints.	[Maj, Tomasz; Wang, Wei; Crespo, Joel; Zhang, Hongjuan; Wang, Weimin; Wei, Shuang; Vatan, Linda; Shao, Irene; Szeliga, Wojciech; Kryczek, Ilona; Zou, Weiping] Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI 48109 USA; [Wang, Wei] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Immunol, Beijing, Peoples R China; [Wang, Wei] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Minist Publ Hlth,Key Lab Med Immunol, Beijing, Peoples R China; [Crespo, Joel; Zou, Weiping] Univ Michigan, Rackham Grad Sch, Ann Arbor, MI 48109 USA; [Wang, Weimin; Liu, J. Rebecca] Univ Michigan, Sch Med, Dept Obstet & Gynecol, Ann Arbor, MI USA; [Zhao, Lili] Univ Michigan, Sch Med, Dept Biostat, Ann Arbor, MI USA; [Lyssiotis, Costas] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [Lyssiotis, Costas; Zou, Weiping] Univ Michigan, Comprehens Canc Ctr, Ann Arbor, MI 48109 USA; [Zou, Weiping] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; Peking University; Peking University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Zou, WP (corresponding author), Univ Michigan, Rackham Grad Sch, Ann Arbor, MI 48109 USA.; Zou, WP (corresponding author), Univ Michigan, Comprehens Canc Ctr, Ann Arbor, MI 48109 USA.; Zou, WP (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA.	wzou@med.umich.edu	Lyssiotis, Costas A/AAI-1923-2019; Maj, Tomasz/ABH-9964-2020	Lyssiotis, Costas A/0000-0001-9309-6141; Crespo, Javier/0000-0001-8248-0172; Maj, Tomasz/0000-0002-8431-1361; Crespo, Joel/0000-0002-4776-7909	US National Institutes of Health [CA217540, CA123088, CA099985, CA156685, CA171306, CA190176, CA193136, CA211016, 5P30CA46592]; Ovarian Cancer Research Fund; Marsha Rivkin Center for Ovarian Cancer Research; NATIONAL CANCER INSTITUTE [R01CA193136, R01CA190176, R01CA156685, R01CA099985, R01CA211016, R01CA123088, P30CA046592, R01CA171306] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ovarian Cancer Research Fund; Marsha Rivkin Center for Ovarian Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported (in part) by the US National Institutes of Health (grants CA217540, CA123088, CA099985, CA156685, CA171306, CA190176, CA193136, CA211016, and 5P30CA46592 to W.Z.), the Ovarian Cancer Research Fund, and the Marsha Rivkin Center for Ovarian Cancer Research (W.Z.; I.K.). We are grateful to L. Carter and X. Hu for critical discussions about the A2A pathway. We thank D. Postiff, M. Vinco, R. Craig, and J. Barikdar at the Tissue and Molecular Pathology Core for their assistance. We thank C. Ruan and S. Bridges at the Metabolomics Core for their support. Cd274<SUP>-/-</SUP> mice and Pdcd1<SUP>-/-</SUP> mice were provided by L. Chen (Yale University, New Haven, Connecticut, USA) and T. Honjo (Kyoto University, Kyoto, Japan), respectively.	Arvey A, 2014, NAT IMMUNOL, V15, P580, DOI 10.1038/ni.2868; Attia P, 2005, J IMMUNOTHER, V28, P582, DOI 10.1097/01.cji.0000175468.19742.10; Barnett B, 2005, AM J REPROD IMMUNOL, V54, P369, DOI 10.1111/j.1600-0897.2005.00330.x; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Clever D, 2016, CELL, V166, P1117, DOI 10.1016/j.cell.2016.07.032; Cubillos-Ruiz JR, 2015, CELL, V161, P1527, DOI 10.1016/j.cell.2015.05.025; Cui TX, 2013, IMMUNITY, V39, P611, DOI 10.1016/j.immuni.2013.08.025; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Dannull J, 2005, J CLIN INVEST, V115, P3623, DOI 10.1172/JCI25947; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Eil R, 2016, NATURE, V537, P539, DOI 10.1038/nature19364; Erdmann AA, 2005, BLOOD, V105, P4707, DOI 10.1182/blood-2004-04-1407; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gubser PM, 2013, NAT IMMUNOL, V14, P1064, DOI 10.1038/ni.2687; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huang S, 1997, BLOOD, V90, P1600, DOI 10.1182/blood.V90.4.1600.1600_1600_1610; Ko K, 2005, J EXP MED, V202, P885, DOI 10.1084/jem.20050940; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Kurose K, 2015, CLIN CANCER RES, V21, P4327, DOI 10.1158/1078-0432.CCR-15-0357; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Maruyama T, 2011, NAT IMMUNOL, V12, P86, DOI 10.1038/ni.1965; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Peng DJ, 2015, NATURE, V527, P249, DOI 10.1038/nature15520; Saito T, 2016, NAT MED, V22, P679, DOI 10.1038/nm.4086; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Singer M, 2016, CELL, V166, P1500, DOI 10.1016/j.cell.2016.08.052; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tai X, 2013, IMMUNITY, V38, P1116, DOI 10.1016/j.immuni.2013.02.022; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wan SS, 2014, GASTROENTEROLOGY, V147, P1393, DOI 10.1053/j.gastro.2014.08.039; Wang WM, 2016, CELL, V165, P1092, DOI 10.1016/j.cell.2016.04.009; Yang J, 2010, P NATL ACAD SCI USA, V107, P4716, DOI 10.1073/pnas.0911587107; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297; Zhao ED, 2016, NAT IMMUNOL, V17, P95, DOI 10.1038/ni.3313; Zou WP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7118; Zou WP, 2001, NAT MED, V7, P1339, DOI 10.1038/nm1201-1339; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	50	355	379	10	201	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2017	18	12					1332	+		10.1038/ni.3868	http://dx.doi.org/10.1038/ni.3868			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FM8GS	29083399	Green Accepted			2022-12-18	WOS:000415324900011
J	Shibutani, ST; Saitoh, T; Nowag, H; Munz, C; Yoshimori, T				Shibutani, Shusaku T.; Saitoh, Tatsuya; Nowag, Heike; Muenz, Christian; Yoshimori, Tamotsu			Autophagy and autophagy-related proteins in the immune system	NATURE IMMUNOLOGY			English	Review							MHC CLASS-II; GENOME-WIDE ASSOCIATION; T-CELL SURVIVAL; CHAIN 3 PROTEIN; CROSS-PRESENTATION; GENE ATG16L1; UNCONVENTIONAL SECRETION; INFLAMMASOME ACTIVATION; EPITHELIAL-CELLS; INNATE IMMUNITY	Autophagy is an intracellular bulk degradation system that is highly conserved in eukaryotes. The discovery of autophagy-related ('ATG') proteins in the 1990s greatly advanced the mechanistic understanding of autophagy and clarified the fact that autophagy serves important roles in various biological processes. In addition, studies have revealed other roles for the autophagic machinery beyond autophagy. In this Review, we introduce advances in the knowledge of the roles of autophagy and its components in immunity, including innate immunity, inflammatory responses and adaptive immunity.	[Shibutani, Shusaku T.; Yoshimori, Tamotsu] Osaka Univ, Grad Sch Frontier Biosci, Lab Intracellular Membrane Dynam, Osaka, Japan; [Shibutani, Shusaku T.; Yoshimori, Tamotsu] Osaka Univ, Grad Sch Med, Dept Genet, Osaka, Japan; [Saitoh, Tatsuya] Univ Tokushima, Inst Enzyme Res, Div Mol Genet, Tokushima, Tokushima, Japan; [Nowag, Heike; Muenz, Christian] Univ Zurich, Inst Expt Immunol, Viral Immunobiol, CH-8091 Zurich, Switzerland	Osaka University; Osaka University; Tokushima University; University of Zurich	Yoshimori, T (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Lab Intracellular Membrane Dynam, Osaka, Japan.	tamyoshi@fbs.osaka-u.ac.jp	Münz, Christian/W-4881-2017	Munz, Christian/0000-0001-6419-1940	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Agency for Medical Research and Development CREST; Cancer Research Switzerland [KFS-3234-08-2013]; Worldwide Cancer Research [14-1033]; University of Zurich; Baugarten Foundation; Sobek Foundation; Fondation Acteria; Swiss Vaccine Research Institute; Swiss National Science Foundation [310030_143979, CRSII3_136241]; Grants-in-Aid for Scientific Research [25111001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development CREST(Japan Agency for Medical Research and Development (AMED)); Cancer Research Switzerland; Worldwide Cancer Research; University of Zurich; Baugarten Foundation; Sobek Foundation; Fondation Acteria; Swiss Vaccine Research Institute; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (S.T.S., T.S. and Y.T.), the Japan Agency for Medical Research and Development CREST (S.T.S., T.S. and Y.T.), Cancer Research Switzerland (KFS-3234-08-2013 for H.N. and C.M.), Worldwide Cancer Research (14-1033 for H.N. and C.M.), the clinical research programs KFSP<SUP>MS</SUP> and KFSP<SUP>HHLD</SUP> of the University of Zurich (H.N. and C.M.), the Baugarten Foundation (H.N. and C.M.), the Sobek Foundation (H.N. and C.M.), Fondation Acteria (H.N. and C.M.), the Swiss Vaccine Research Institute (H.N. and C.M.) and the Swiss National Science Foundation (310030_143979 and CRSII3_136241 for H.N. and C.M.).	Abderrazak A, 2015, CIRCULATION, V131, P1061, DOI 10.1161/CIRCULATIONAHA.114.013730; Aichinger M, 2013, J EXP MED, V210, P287, DOI 10.1084/jem.20122149; Arsov I, 2011, J IMMUNOL, V186, P2201, DOI 10.4049/jimmunol.1002223; Benjamin JL, 2013, CELL HOST MICROBE, V13, P723, DOI 10.1016/j.chom.2013.05.004; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Blanchet FP, 2010, IMMUNITY, V32, P654, DOI 10.1016/j.immuni.2010.04.011; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Castillo EF, 2012, P NATL ACAD SCI USA, V109, pE3168, DOI 10.1073/pnas.1210500109; Chaturvedi A, 2008, IMMUNITY, V28, P799, DOI 10.1016/j.immuni.2008.03.019; Chen M, 2014, NAT MED, V20, P507, DOI 10.1038/nm.3521; CLARK SL, 1957, J BIOPHYS BIOCHEM CY, V3, P349, DOI 10.1083/jcb.3.3.349; Collins AC, 2015, CELL HOST MICROBE, V17, P820, DOI 10.1016/j.chom.2015.05.005; Conway KL, 2013, GASTROENTEROLOGY, V145, P1347, DOI 10.1053/j.gastro.2013.08.035; Conway KL, 2013, AUTOPHAGY, V9, P528, DOI 10.4161/auto.23484; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; CUERVO AM, 1995, EUR J BIOCHEM, V227, P792, DOI 10.1111/j.1432-1033.1995.tb20203.x; De Luca A, 2012, J CLIN INVEST, V122, P1816, DOI 10.1172/JCI60862; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; DeSelm CJ, 2011, DEV CELL, V21, P966, DOI 10.1016/j.devcel.2011.08.016; Dey B, 2015, NAT MED, V21, P401, DOI 10.1038/nm.3813; Dooley HC, 2014, MOL CELL, V55, P238, DOI 10.1016/j.molcel.2014.05.021; Dreux M, 2010, CELL CYCLE, V9, P1295, DOI 10.4161/cc.9.7.11109; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Dupont N, 2009, CELL HOST MICROBE, V6, P137, DOI 10.1016/j.chom.2009.07.005; Duran JM, 2010, J CELL BIOL, V188, P527, DOI 10.1083/jcb.200911154; English L, 2009, NAT IMMUNOL, V10, P480, DOI 10.1038/ni.1720; Espert L, 2006, J CLIN INVEST, V116, P2161, DOI 10.1172/JCI26185; Farfariello V, 2012, J LEUKOCYTE BIOL, V92, P421, DOI 10.1189/jlb.0312123; Fiegl D, 2013, J IMMUNOL, V190, P2791, DOI 10.4049/jimmunol.1202741; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Florey O, 2011, NAT CELL BIOL, V13, P1335, DOI 10.1038/ncb2363; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Fujita N, 2013, J CELL BIOL, V203, P115, DOI 10.1083/jcb.201304188; Fujita N, 2011, CURR OPIN CELL BIOL, V23, P492, DOI 10.1016/j.ceb.2011.03.003; Fujita N, 2009, J BIOL CHEM, V284, P32602, DOI 10.1074/jbc.M109.037671; Guo WJ, 2014, AUTOPHAGY, V10, P972, DOI 10.4161/auto.28374; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Harris J, 2007, IMMUNITY, V27, P505, DOI 10.1016/j.immuni.2007.07.022; Harris J, 2011, J BIOL CHEM, V286, P9587, DOI 10.1074/jbc.M110.202911; Henault J, 2012, IMMUNITY, V37, P986, DOI 10.1016/j.immuni.2012.09.014; Henson SM, 2014, J CLIN INVEST, V124, P4004, DOI 10.1172/JCI75051; Huang J, 2014, NAT REV MICROBIOL, V12, P101, DOI 10.1038/nrmicro3160; Huett A, 2012, CELL HOST MICROBE, V12, P778, DOI 10.1016/j.chom.2012.10.019; Hung YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3111; Hwang S, 2012, CELL HOST MICROBE, V11, P397, DOI 10.1016/j.chom.2012.03.002; Ireland JM, 2011, J EXP MED, V208, P2625, DOI 10.1084/jem.20110640; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; Jia KL, 2009, P NATL ACAD SCI USA, V106, P14564, DOI 10.1073/pnas.0813319106; Jia W, 2011, J IMMUNOL, V186, P1564, DOI 10.4049/jimmunol.1001822; Jin Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093143; Johnstone C, 2012, IMMUNOL CELL BIOL, V90, P978, DOI 10.1038/icb.2012.43; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Jounai N, 2011, J IMMUNOL, V186, P1646, DOI 10.4049/jimmunol.1001654; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kageyama S, 2011, MOL BIOL CELL, V22, P2290, DOI 10.1091/mbc.E10-11-0893; Kasai M, 2009, J IMMUNOL, V183, P7278, DOI 10.4049/jimmunol.0804087; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Keller CW, 2011, J BIOL CHEM, V286, P3970, DOI 10.1074/jbc.M110.159392; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Kobayashi S, 2010, AUTOPHAGY, V6, P36, DOI 10.4161/auto.6.1.10324; Konno H, 2013, CELL, V155, P688, DOI 10.1016/j.cell.2013.09.049; Kovacs JR, 2012, CELL DEATH DIFFER, V19, P144, DOI 10.1038/cdd.2011.78; Kristensen AR, 2008, MOL CELL PROTEOMICS, V7, P2419, DOI 10.1074/mcp.M800184-MCP200; Kyei GB, 2009, J CELL BIOL, V186, P255, DOI 10.1083/jcb.200903070; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Lassen KG, 2014, P NATL ACAD SCI USA, V111, P7741, DOI 10.1073/pnas.1407001111; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Lei Y, 2012, IMMUNITY, V36, P933, DOI 10.1016/j.immuni.2012.03.025; Leung CS, 2010, P NATL ACAD SCI USA, V107, P2165, DOI 10.1073/pnas.0909448107; Li B, 2010, CANCER IMMUNOL IMMUN, V59, P313, DOI 10.1007/s00262-009-0752-1; Li YH, 2008, CANCER RES, V68, P6889, DOI 10.1158/0008-5472.CAN-08-0161; Liang QM, 2014, CELL HOST MICROBE, V15, P228, DOI 10.1016/j.chom.2014.01.009; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Lupfer C, 2013, NAT IMMUNOL, V14, P480, DOI 10.1038/ni.2563; Ma J, 2014, J IMMUNOL, V192, P1356, DOI 10.4049/jimmunol.1302835; Ma J, 2012, J BIOL CHEM, V287, P34149, DOI 10.1074/jbc.M112.382812; Maejima I, 2013, EMBO J, V32, P2336, DOI 10.1038/emboj.2013.171; Manjithaya R, 2010, J CELL BIOL, V188, P537, DOI 10.1083/jcb.200911149; Manzanillo PS, 2013, NATURE, V501, P512, DOI 10.1038/nature12566; Marchiando AM, 2013, CELL HOST MICROBE, V14, P216, DOI 10.1016/j.chom.2013.07.013; Marshall RS, 2015, MOL CELL, V58, P1053, DOI 10.1016/j.molcel.2015.04.023; Martinez J, 2015, NAT CELL BIOL, V17, P893, DOI 10.1038/ncb3192; Martinez J, 2011, P NATL ACAD SCI USA, V108, P17396, DOI 10.1073/pnas.1113421108; Martins I, 2014, CELL DEATH DIFFER, V21, P79, DOI 10.1038/cdd.2013.75; Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141; Meunier E, 2014, NATURE, V509, P366, DOI 10.1038/nature13157; Miao YX, 2015, CELL, V161, P1306, DOI 10.1016/j.cell.2015.05.009; Milan E, 2015, AUTOPHAGY, V11, P1161, DOI 10.1080/15548627.2015.1052928; Miller BC, 2008, AUTOPHAGY, V4, P309, DOI 10.4161/auto.5474; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145; Mostowy S, 2011, J BIOL CHEM, V286, P26987, DOI 10.1074/jbc.M111.223610; Murthy A, 2014, NATURE, V506, P456, DOI 10.1038/nature13044; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208; Netea MG, 2015, ANNU REV IMMUNOL, V33, P49, DOI 10.1146/annurev-immunol-032414-112306; Ng ACY, 2011, P NATL ACAD SCI USA, V108, P4631, DOI 10.1073/pnas.1000093107; NOVIKOFF AB, 1959, J BIOPHYS BIOCHEM CY, V6, P136, DOI 10.1083/jcb.6.1.136; Nowag H, 2014, EBIOMEDICINE, V1, P116, DOI 10.1016/j.ebiom.2014.11.007; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Ohsumi Y, 2014, CELL RES, V24, P9, DOI 10.1038/cr.2013.169; Orvedahl A, 2011, NATURE, V480, P113, DOI 10.1038/nature10546; Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Parekh VV, 2013, J IMMUNOL, V190, P5086, DOI 10.4049/jimmunol.1202071; Pengo N, 2013, NAT IMMUNOL, V14, P298, DOI 10.1038/ni.2524; Pilli M, 2012, IMMUNITY, V37, P223, DOI 10.1016/j.immuni.2012.04.015; Plantinga TS, 2011, GUT, V60, P1229, DOI 10.1136/gut.2010.228908; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Pua HH, 2009, J IMMUNOL, V182, P4046, DOI 10.4049/jimmunol.0801143; Puleston DJ, 2014, ELIFE, V3, DOI 10.7554/eLife.03706; Py BF, 2007, AUTOPHAGY, V3, P117, DOI 10.4161/auto.3618; Razani B, 2012, CELL METAB, V15, P534, DOI 10.1016/j.cmet.2012.02.011; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Robinson SM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004045; Romao S, 2013, J CELL BIOL, V203, P757, DOI 10.1083/jcb.201308173; Romao S, 2013, SEMIN CANCER BIOL, V23, P391, DOI 10.1016/j.semcancer.2013.03.001; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Shaw SY, 2013, ACS CHEM BIOL, V8, P2724, DOI 10.1021/cb400352d; Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009; Shen SS, 2012, MOL CELL, V48, P667, DOI 10.1016/j.molcel.2012.09.013; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Starr T, 2012, CELL HOST MICROBE, V11, P33, DOI 10.1016/j.chom.2011.12.002; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; Taylor MP, 2009, J VIROL, V83, P6599, DOI 10.1128/JVI.01819-08; Tey SK, 2012, BLOOD, V120, P994, DOI 10.1182/blood-2012-01-402404; Thorburn J, 2009, CELL DEATH DIFFER, V16, P175, DOI 10.1038/cdd.2008.143; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Uhl M, 2009, CELL DEATH DIFFER, V16, P991, DOI 10.1038/cdd.2009.8; Wang CH, 2012, P NATL ACAD SCI USA, V109, P11008, DOI 10.1073/pnas.1203952109; Watson RO, 2012, CELL, V150, P803, DOI 10.1016/j.cell.2012.06.040; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Wenger T, 2012, AUTOPHAGY, V8, P350, DOI [10.4161/auto.8.3.18806, 10.4161/auto.18806]; Willinger T, 2012, P NATL ACAD SCI USA, V109, P8670, DOI 10.1073/pnas.1205305109; Xu XJ, 2014, NAT IMMUNOL, V15, P1152, DOI 10.1038/ni.3025; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yanai H, 2013, P NATL ACAD SCI USA, V110, P20699, DOI 10.1073/pnas.1320808110; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634; Ye W, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-100; Yoneyama M, 2015, CURR OPIN IMMUNOL, V32, P48, DOI 10.1016/j.coi.2014.12.012; Yordy B, 2013, INT IMMUNOL, V25, P1, DOI 10.1093/intimm/dxs101; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	169	355	380	7	155	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2015	16	10					1014	1024		10.1038/ni.3273	http://dx.doi.org/10.1038/ni.3273			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CR9OO	26382870				2022-12-18	WOS:000361686500006
